data_2mqs_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mqs _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo . . . . . 0 N--CA 1.478 0.559 0 N-CA-C 110.241 -0.715 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -110.82 163.36 13.86 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 18.8 tt -68.59 -23.13 27.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.372 0.606 . . . . 0.0 110.698 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 45.2 m -88.51 5.52 42.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.972 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.07 -37.42 81.24 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.058 0.456 . . . . 0.0 110.696 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 85.8 174.95 50.02 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.766 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 5.4 t30 58.86 76.48 0.35 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.207 0.527 . . . . 0.0 111.304 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -95.08 174.34 7.12 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.66 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -90.25 -39.03 13.02 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 4.5 t -170.1 152.19 4.19 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.507 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 82.0 t -136.19 120.76 26.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -144.49 -179.96 6.88 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.993 0.425 . . . . 0.0 111.547 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 48.7 ttp -126.59 128.64 47.14 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 80.1 mt -122.27 112.1 17.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.938 0.399 . . . . 0.0 110.705 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 62.58 28.41 16.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.421 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 101.6 -20.22 47.28 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.333 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -94.87 136.8 34.75 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.701 0.251 . . . . 0.0 110.567 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 47.0 ttm -87.86 134.39 33.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.884 0.373 . . . . 0.0 111.377 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -122.86 121.79 37.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.657 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 46.8 t -106.63 111.64 36.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -96.47 130.02 43.71 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.772 0.32 . . . . 0.0 111.73 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -144.11 112.91 6.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.672 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 62.2 -105.21 0.17 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.315 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -116.56 9.43 14.2 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.814 0.34 . . . . 0.0 111.567 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 8.2 m-90 -129.72 161.22 31.16 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.364 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -137.94 140.75 40.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.946 0.403 . . . . 0.0 111.064 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -102.7 144.38 31.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.472 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 25.1 ttt-85 -115.76 106.07 13.44 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 1.3 m -101.43 132.44 47.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.18 0.514 . . . . 0.0 111.531 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.63 111.48 9.44 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.936 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 14.1 m120 61.18 50.17 5.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.843 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 66.73 9.23 6.54 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.452 -0.795 . . . . 0.0 113.096 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -121.45 137.87 54.53 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 122.391 -0.193 . . . . 0.0 111.058 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 38.4 t -79.58 123.82 36.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 83.5 mtp -66.34 148.84 51.28 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -66.98 153.05 44.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.56 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 84.83 10.11 79.62 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.672 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -123.74 158.83 58.34 Favored Pre-proline 0 C--N 1.326 -0.422 0 O-C-N 122.86 -0.2 . . . . 0.0 110.629 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.51 149.67 90.78 Favored 'Cis proline' 0 C--N 1.349 0.569 0 C-N-CA 123.656 -1.393 . . . . 0.0 112.955 0.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 59.8 ttm -121.83 139.82 30.85 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.445 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -55.59 138.35 80.52 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.596 2.197 . . . . 0.0 111.406 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 89.4 mt -56.46 -40.58 68.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.597 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -70.46 -2.47 42.68 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 121.251 -0.499 . . . . 0.0 114.149 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.25 -39.8 14.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.125 0.488 . . . . 0.0 109.877 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -97.62 -56.33 2.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.266 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 51.9 m95 -93.73 73.91 4.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.691 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 33.7 ttp-105 -62.37 107.9 1.0 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.012 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 123.92 -18.65 7.49 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.558 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 29.8 tp -88.67 128.25 53.31 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.681 0.277 . . . . 0.0 110.552 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.91 -175.07 2.53 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.751 2.301 . . . . 0.0 112.277 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -87.89 160.3 18.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.328 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.1 m 55.31 87.22 0.05 Allowed 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 23.0 pt -105.8 163.91 4.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.174 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -85.99 -56.7 3.34 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.677 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.23 171.22 20.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.073 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -153.39 144.39 22.88 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -164.55 164.49 21.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.635 0.255 . . . . 0.0 111.039 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -89.77 130.77 35.98 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -83.58 -174.92 5.56 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.699 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -68.22 -23.47 64.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.988 0.423 . . . . 0.0 111.473 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.68 -24.32 25.28 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.553 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 121.25 -26.53 6.67 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.318 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 32.8 mttp -63.85 154.86 32.34 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.094 0.473 . . . . 0.0 111.731 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -96.31 123.57 39.99 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.656 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 7.9 t -102.19 114.62 42.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.312 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -100.34 144.61 29.14 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -124.18 149.12 46.69 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.869 0.366 . . . . 0.0 111.87 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -157.42 97.27 1.61 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 73.73 -108.45 2.51 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.211 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -114.91 7.74 15.73 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.931 0.396 . . . . 0.0 111.142 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -111.22 149.47 30.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.649 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -131.69 146.68 52.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.385 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 17.4 m-90 -119.44 137.56 53.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.17 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 88.4 t -116.49 112.38 39.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -111.0 123.72 50.73 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.847 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -92.88 93.14 8.24 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 71.76 -79.43 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 O-C-N 123.695 0.622 . . . . 0.0 110.954 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -141.07 13.93 2.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.911 0.386 . . . . 0.0 110.648 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 5.5 m -123.48 131.8 53.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.267 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 58.4 tp -78.35 135.96 37.59 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.111 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -74.69 148.8 85.52 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.73 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -72.58 143.32 37.9 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.928 2.418 . . . . 0.0 111.751 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 89.8 32.45 10.04 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.991 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -138.57 161.05 60.9 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.13 154.7 99.76 Favored 'Cis proline' 0 C--N 1.346 0.409 0 C-N-CA 123.715 -1.369 . . . . 0.0 112.998 0.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 53.3 mttt -125.93 170.29 11.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.233 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -73.0 155.64 39.63 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.971 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 41.5 mt -59.22 -34.23 53.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.196 0.522 . . . . 0.0 110.658 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -66.74 -17.59 64.94 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.013 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -78.02 -25.47 47.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.055 0.455 . . . . 0.0 110.111 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 49.9 tp -74.7 -45.33 45.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.567 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -164.76 147.7 13.06 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.505 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -81.34 140.94 34.47 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.918 0.389 . . . . 0.0 111.0 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 101.36 -3.28 54.26 Favored Glycine 0 CA--C 1.517 0.184 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.737 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 83.7 mt -85.48 149.04 50.94 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.472 0.177 . . . . 0.0 110.732 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.31 145.16 98.67 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.008 2.472 . . . . 0.0 111.863 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.79 11.14 22.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.059 0.457 . . . . 0.0 111.255 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -94.17 -56.34 2.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.672 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -176.47 173.96 1.98 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.465 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 46.6 mm -123.17 135.04 64.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.866 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -89.14 -59.12 2.31 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -153.72 153.72 32.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.896 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -132.47 116.69 17.08 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 37.1 tp -107.64 125.61 51.55 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.377 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -96.67 113.3 24.85 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 11.9 t-105 -82.17 99.3 9.17 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 66.5 mtt -53.37 -52.96 61.59 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -47.22 -44.58 23.78 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.758 2.305 . . . . 0.0 115.319 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -101.25 -21.58 14.86 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 78.4 37.03 28.76 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.693 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' LYS . . . . . 0.475 ' HZ3' ' ND2' ' A' ' 439' ' ' ASN . 23.4 mmtt -121.24 144.85 48.39 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 15.0 m -97.95 132.17 43.75 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.045 0.45 . . . . 0.0 111.249 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -107.41 109.9 21.73 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -91.38 122.38 33.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.407 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -100.36 131.82 46.08 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.737 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -144.0 108.95 4.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.893 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 66.05 -108.38 2.36 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -121.85 19.93 10.92 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.274 0.559 . . . . 0.0 110.668 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 42.3 mmtt -127.53 152.87 47.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.761 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -132.76 139.86 47.76 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.825 0.345 . . . . 0.0 111.389 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -107.6 149.98 27.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.202 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -108.04 98.82 8.33 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -81.31 124.63 29.51 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.782 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' ASN . . . . . 0.475 ' ND2' ' HZ3' ' A' ' 426' ' ' LYS . 41.7 t-20 -93.73 104.85 16.93 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.09 -48.19 80.91 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.48 -50.66 72.34 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 88.4 mt -84.62 -12.95 52.98 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 23.6 mtp180 57.05 50.84 11.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.467 0.651 . . . . 0.0 111.704 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -159.65 169.63 23.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.684 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 86.5 t -89.19 133.13 32.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -64.34 161.63 16.46 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.368 0.417 . . . . 0.0 111.017 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 2.6 m -69.48 161.88 28.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.863 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 70.87 33.21 2.23 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.353 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -137.75 161.53 59.64 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.067 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -79.7 155.55 88.74 Favored 'Cis proline' 0 C--N 1.346 0.404 0 C-N-CA 123.477 -1.468 . . . . 0.0 112.522 0.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -105.66 176.96 4.99 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.625 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -75.2 140.73 43.47 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.0 tt -68.16 -14.62 18.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.94 0.4 . . . . 0.0 110.593 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -69.74 -1.62 9.67 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.302 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 38.1 t -60.87 -37.71 77.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 15.1 m95 -91.16 93.64 9.22 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -56.44 121.13 8.9 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 105.63 -15.03 45.94 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.722 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 25.6 mm -80.67 130.46 64.27 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 121.084 0.469 . . . . 0.0 111.245 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.04 158.24 30.59 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.733 2.289 . . . . 0.0 111.284 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -82.93 141.11 32.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.217 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.6 m 57.8 75.57 0.54 Allowed Pre-proline 0 N--CA 1.464 0.239 0 O-C-N 123.868 0.73 . . . . 0.0 112.855 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -90.5 179.86 1.77 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.689 2.259 . . . . 0.0 111.235 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.76 26.71 3.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.312 0.577 . . . . 0.0 110.42 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 175.01 137.96 2.63 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.38 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 20.9 p -161.04 99.77 1.22 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -128.99 143.9 51.02 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.839 0.352 . . . . 0.0 111.294 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 34.7 ttm -86.33 143.21 27.98 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.853 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -72.81 163.77 54.85 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.511 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.44 -7.59 20.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.053 0.454 . . . . 0.0 111.648 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -90.9 -13.24 33.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.403 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 66.87 0.04 1.81 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 55.4 t -98.2 -36.38 5.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.845 0.355 . . . . 0.0 111.264 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -112.16 144.73 41.05 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 60.8 m -122.32 137.53 54.82 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -112.95 122.62 48.17 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.148 0.499 . . . . 0.0 112.29 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -101.97 150.57 23.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.645 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -130.07 133.37 46.65 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 44.1 tttt -170.51 140.91 1.85 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.86 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 60.14 32.62 76.73 Favored Glycine 0 C--N 1.328 0.104 0 C-N-CA 121.245 -0.502 . . . . 0.0 112.609 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 1.7 t30 64.53 17.67 10.97 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.344 0.592 . . . . 0.0 111.785 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -122.81 158.48 30.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.485 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -123.98 149.53 45.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.915 0.388 . . . . 0.0 111.93 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 20.1 m-90 -118.21 138.56 52.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.452 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -99.89 93.62 5.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.089 0.471 . . . . 0.0 109.746 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 486' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -86.45 131.2 34.25 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.738 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 -97.17 114.67 26.39 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -65.15 -28.69 69.59 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -178.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -84.29 -14.61 49.27 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -109.35 -26.3 10.1 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 68.86 30.8 4.56 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.857 0.837 . . . . 0.0 110.373 -178.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -150.06 154.43 38.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.048 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 55.9 t -79.17 133.54 29.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -59.91 147.19 80.14 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.459 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -62.96 157.15 50.22 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 123.246 2.631 . . . . 0.0 112.972 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 83.91 27.19 38.65 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.874 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -129.75 165.87 30.1 Favored Pre-proline 0 C--N 1.327 -0.393 0 O-C-N 122.877 -0.19 . . . . 0.0 111.13 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -82.41 175.25 40.4 Favored 'Cis proline' 0 C--N 1.346 0.433 0 C-N-CA 123.74 -1.358 . . . . 0.0 112.871 0.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -129.7 153.98 47.62 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.406 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 41.4 t -69.36 123.92 22.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.905 0.383 . . . . 0.0 110.484 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -67.75 -18.49 64.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.885 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 13.7 mt -66.8 -46.32 75.6 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.921 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -80.94 -41.27 23.17 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.2 -45.2 34.32 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -177.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 35.0 m0 -100.12 -58.55 1.89 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 10.8 mmt -60.64 -41.28 94.62 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 98.5 25.62 9.91 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.611 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 3.5 m -110.62 103.4 54.27 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -81.32 178.59 6.59 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.509 2.139 . . . . 0.0 111.693 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 3.9 m 67.12 13.88 9.59 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.73 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.396 -1.225 . . . . 0.0 111.087 179.699 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.809 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo . . . . . 0 N--CA 1.462 -0.37 0 C-N-CA 123.277 2.651 . . . . 0.0 111.397 179.599 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.654 0 N-CA-C 112.71 -0.156 . . . . 0.0 112.71 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo . . . . . 0 CA--C 1.529 0.269 0 C-N-CA 122.986 2.458 . . . . 0.0 111.689 -179.934 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 120.144 -0.253 . . . . 0.0 112.77 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo . . . . . 0 CA--C 1.529 0.27 0 C-N-CA 122.86 2.373 . . . . 0.0 111.22 178.845 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.787 0 N-CA-C 112.019 -0.433 . . . . 0.0 112.019 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.76 142.99 95.72 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.855 2.37 . . . . 0.0 111.867 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -67.89 142.86 55.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.935 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.55 150.49 41.67 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.736 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 17.4 mt -68.28 147.8 12.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.74 151.57 46.48 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.837 0.351 . . . . 0.0 110.447 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.35 162.46 43.88 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.299 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -68.94 148.72 49.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.771 0.319 . . . . 0.0 110.426 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.18 145.0 54.74 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.216 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.2 143.43 47.45 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.948 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 t -69.49 159.24 5.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 4.6 t -55.79 143.27 9.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.901 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.53 171.48 54.86 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.498 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 97.2 mt . . . . . 0 C--N 1.325 -0.458 0 CA-C-O 120.599 0.238 . . . . 0.0 110.686 -179.853 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.59 0 CA-C-O 120.473 -0.07 . . . . 0.0 113.22 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 CA--C 1.529 0.265 0 C-N-CA 122.921 2.414 . . . . 0.0 111.859 -179.94 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.624 0 N-CA-C 112.431 -0.268 . . . . 0.0 112.431 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo . . . . . 0 C--O 1.236 0.388 0 C-N-CA 122.886 2.39 . . . . 0.0 111.512 179.219 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.648 0 CA-C-O 120.197 -0.224 . . . . 0.0 112.641 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 CA--C 1.531 0.365 0 C-N-CA 123.056 2.504 . . . . 0.0 112.213 179.592 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.512 0 CA-C-O 120.456 -0.08 . . . . 0.0 113.237 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 C--O 1.235 0.345 0 C-N-CA 122.88 2.387 . . . . 0.0 111.193 179.373 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.461 0 CA-C-O 120.109 -0.273 . . . . 0.0 112.637 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo . . . . . 0 C--O 1.235 0.36 0 C-N-CA 123.369 2.712 . . . . 0.0 112.702 -179.82 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.46 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo . . . . . 0 CA--C 1.536 0.588 0 C-N-CA 122.861 2.374 . . . . 0.0 112.449 -179.837 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.51 0 N-CA-C 112.425 -0.27 . . . . 0.0 112.425 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo . . . . . 0 C--N 1.342 0.223 0 C-N-CA 122.776 2.317 . . . . 0.0 111.197 179.44 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.429 0 N-CA-C 113.465 0.146 . . . . 0.0 113.465 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.03 157.34 62.2 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.814 2.343 . . . . 0.0 112.576 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -60.02 137.69 58.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.529 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -67.53 164.11 45.64 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.88 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 40.5 mt -67.22 144.46 14.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.42 148.04 50.15 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -63.17 147.22 50.56 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.119 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -75.17 149.97 38.84 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 122.753 -0.263 . . . . 0.0 110.366 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 9.5 ttm-85 -59.09 141.06 55.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.935 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.95 170.47 33.15 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.973 -0.558 . . . . 0.0 113.428 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 23.5 t -71.85 139.88 19.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.563 -0.319 . . . . 0.0 110.514 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 21.4 t -60.22 141.8 16.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.507 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.51 163.9 34.97 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.446 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 67.3 mt . . . . . 0 C--N 1.323 -0.545 0 O-C-N 122.895 -0.179 . . . . 0.0 110.722 -179.637 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 CA-C-O 120.288 -0.173 . . . . 0.0 112.849 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 C--O 1.236 0.405 0 C-N-CA 122.661 2.241 . . . . 0.0 112.369 -179.499 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.554 0 N-CA-C 112.705 -0.158 . . . . 0.0 112.705 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo . . . . . 0 C--O 1.237 0.438 0 C-N-CA 122.758 2.305 . . . . 0.0 112.046 -179.995 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.38 0 CA-C-O 120.571 -0.016 . . . . 0.0 113.134 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo . . . . . 0 C--O 1.235 0.371 0 C-N-CA 123.098 2.532 . . . . 0.0 111.855 -179.657 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.538 0 CA-C-O 120.273 -0.182 . . . . 0.0 112.955 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo . . . . . 0 CA--C 1.53 0.296 0 C-N-CA 122.971 2.448 . . . . 0.0 112.132 179.868 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 N-CA-C 112.205 -0.358 . . . . 0.0 112.205 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 C--N 1.348 0.516 0 C-N-CA 122.893 2.395 . . . . 0.0 111.412 179.841 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 114.381 0.512 . . . . 0.0 114.381 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo . . . . . 0 CA--C 1.53 0.316 0 C-N-CA 123.174 2.582 . . . . 0.0 110.99 178.771 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.268 0 N-CA-C 113.492 0.157 . . . . 0.0 113.492 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo . . . . . 0 CA--C 1.534 0.48 0 C-N-CA 123.516 2.811 . . . . 0.0 112.208 179.637 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.591 0 N-CA-C 112.425 -0.27 . . . . 0.0 112.425 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.78 157.35 47.97 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.549 2.166 . . . . 0.0 112.273 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -78.1 144.33 36.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.595 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -68.08 166.32 44.49 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.824 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 45.4 pt -68.29 164.73 2.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 120.835 0.35 . . . . 0.0 110.984 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -81.06 147.58 30.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.108 0.48 . . . . 0.0 111.381 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -71.89 153.02 49.59 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.411 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 48.8 mm-40 -71.55 150.6 44.61 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -64.63 160.18 20.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.185 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -62.14 156.85 36.93 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.206 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.15 152.28 9.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.5 137.25 25.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -56.68 166.63 4.51 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.918 -0.583 . . . . 0.0 114.237 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 8.6 mp . . . . . 0 C--N 1.325 -0.498 0 CA-C-N 115.719 -0.241 . . . . 0.0 110.736 -179.84 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.646 0 N-CA-C 113.299 0.08 . . . . 0.0 113.299 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo . . . . . 0 C--O 1.233 0.268 0 C-N-CA 122.838 2.359 . . . . 0.0 111.109 179.311 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 113.158 0.023 . . . . 0.0 113.158 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo . . . . . 0 C--O 1.235 0.36 0 C-N-CA 122.682 2.255 . . . . 0.0 111.716 179.833 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.766 0 N-CA-C 112.86 -0.096 . . . . 0.0 112.86 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo . . . . . 0 N--CA 1.46 -0.495 0 C-N-CA 122.642 2.228 . . . . 0.0 111.079 179.382 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.478 0.6 0 N-CA-C 110.378 -0.662 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -106.48 160.03 15.72 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.975 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 19.8 tt -75.9 -23.59 16.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.003 0.43 . . . . 0.0 111.474 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 21.4 m -80.52 0.18 34.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.283 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -67.6 -34.48 77.1 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.948 0.404 . . . . 0.0 111.178 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 82.55 -171.66 51.53 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.213 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 5.0 t30 52.41 74.04 0.3 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.18 0.514 . . . . 0.0 111.139 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -95.67 162.76 13.48 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.427 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -77.0 -35.25 57.28 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.244 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 6.7 t -178.33 155.68 0.91 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.528 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 48.4 t -133.96 127.14 51.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -144.27 172.08 13.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.997 0.427 . . . . 0.0 111.67 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 38.6 ttp -126.28 113.74 17.36 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 50.9 mt -106.88 116.53 32.08 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.567 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 57.9 27.45 14.65 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 98.18 -5.75 61.3 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.923 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -101.52 122.43 43.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.902 0.382 . . . . 0.0 111.131 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 56.7 ttm -81.45 120.81 25.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.194 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -119.24 126.76 52.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.756 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 25.5 t -107.73 119.78 57.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.434 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -95.35 121.13 36.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.012 0.434 . . . . 0.0 112.145 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -130.18 99.56 5.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.686 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 62.4 -102.9 0.12 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.02 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -116.77 13.69 15.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.1 0.476 . . . . 0.0 111.026 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 20.1 m-90 -128.88 142.9 50.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.544 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -122.35 135.49 54.72 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.937 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -100.15 151.95 20.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.572 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 14.8 ttt-85 -120.78 100.47 7.12 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 5.2 m -112.52 131.45 64.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.204 0.526 . . . . 0.0 112.09 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 6.3 ttm-85 -139.33 112.63 8.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.337 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 1.5 m120 72.97 49.78 0.15 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 61.67 24.46 14.56 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.487 178.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -143.45 145.75 32.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.053 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 22.2 t -83.41 135.75 24.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 87.9 mtp -83.2 156.07 23.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.995 0.426 . . . . 0.0 111.418 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -69.92 150.12 47.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.407 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 95.04 -8.51 70.13 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.268 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -119.21 164.01 23.65 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.58 159.82 91.55 Favored 'Cis proline' 0 C--N 1.348 0.501 0 C-N-CA 123.856 -1.31 . . . . 0.0 112.813 0.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 42.5 ttm -134.68 141.78 40.02 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.232 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -60.93 140.09 88.41 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.416 2.077 . . . . 0.0 111.165 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 78.7 mt -56.95 -44.15 81.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.605 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -69.86 3.04 10.38 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 114.283 0.473 . . . . 0.0 114.283 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.09 -46.5 7.41 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -93.79 -53.55 3.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.132 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -84.77 73.19 10.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.831 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 30.4 ttp-105 -64.46 93.88 0.11 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.187 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 129.72 -7.28 6.17 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.035 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 33.8 tp -99.41 126.37 37.85 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-O 120.57 0.224 . . . . 0.0 110.533 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.62 175.09 11.56 Favored 'Trans proline' 0 CA--C 1.528 0.216 0 C-N-CA 122.624 2.216 . . . . 0.0 111.961 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -85.8 154.91 21.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.494 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 35.0 m 55.5 82.41 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 22.7 pt -95.17 -171.22 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.29 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -108.99 -47.7 3.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.724 0.297 . . . . 0.0 111.193 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -156.44 166.34 33.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.848 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -153.4 145.51 23.77 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -161.42 159.94 28.8 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.129 0.49 . . . . 0.0 112.221 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -89.63 121.18 31.57 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -78.1 177.97 7.91 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -68.3 -38.2 81.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.863 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -31.63 71.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.632 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 129.66 -32.82 3.11 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.51 -0.852 . . . . 0.0 113.043 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -65.66 157.56 29.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.073 0.463 . . . . 0.0 111.696 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -98.67 135.04 40.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.993 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 4.7 t -113.24 121.65 65.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.842 0.353 . . . . 0.0 110.668 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -108.51 138.26 45.11 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.436 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -120.29 143.5 48.3 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.826 0.346 . . . . 0.0 111.584 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -158.34 105.75 1.91 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.517 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 76.33 -114.84 4.26 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.556 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . 0.44 ' CG ' ' HZ1' ' A' ' 386' ' ' LYS . 8.2 p-10 -114.19 4.0 15.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.932 0.396 . . . . 0.0 110.7 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . 0.44 ' HZ1' ' CG ' ' A' ' 385' ' ' ASP . 44.7 mmtm -112.6 155.92 23.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.847 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -136.3 146.78 47.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.944 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 20.5 m-90 -121.88 132.51 54.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.061 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 95.0 t -111.88 119.49 60.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -111.21 130.96 55.48 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.342 0.591 . . . . 0.0 112.211 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -95.31 87.82 4.94 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 67.35 -79.54 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.604 0.565 . . . . 0.0 110.539 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -137.7 19.32 2.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.234 0.54 . . . . 0.0 109.991 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 8.1 m -121.12 157.79 29.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.782 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 64.9 tp -104.43 135.95 44.92 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.629 0.252 . . . . 0.0 110.829 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -70.57 125.89 92.11 Favored Pre-proline 0 C--O 1.232 0.184 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.047 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.92 136.35 69.2 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.873 2.382 . . . . 0.0 111.842 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 101.04 -8.37 57.52 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.716 -0.755 . . . . 0.0 111.798 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -93.89 161.02 31.26 Favored Pre-proline 0 C--N 1.321 -0.659 0 O-C-N 122.85 -0.206 . . . . 0.0 110.815 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.04 166.55 82.96 Favored 'Cis proline' 0 C--N 1.346 0.434 0 C-N-CA 123.819 -1.325 . . . . 0.0 112.943 0.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -137.66 163.04 32.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.388 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -71.01 150.6 45.47 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 79.2 mt -54.61 -33.5 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 120.887 0.375 . . . . 0.0 111.33 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -64.22 -15.13 59.38 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.193 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -81.93 -20.22 39.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.911 0.386 . . . . 0.0 111.102 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 38.3 tp -74.94 -48.85 22.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.084 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -162.82 155.74 27.19 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.687 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -81.58 130.92 35.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.791 0.329 . . . . 0.0 110.939 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 102.29 1.76 50.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.308 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 51.3 mt -79.46 156.34 75.9 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 120.49 0.186 . . . . 0.0 111.026 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -61.51 118.14 5.0 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.614 2.209 . . . . 0.0 111.525 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.04 -3.5 59.09 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.99 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -92.3 -56.67 2.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.448 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 9.5 ptmt -176.38 171.8 2.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.863 0.363 . . . . 0.0 110.723 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 39.6 mm -117.16 133.09 65.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.694 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -90.79 -48.85 6.78 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -156.43 154.28 30.2 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.138 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -135.19 113.55 11.46 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 42.3 tp -107.94 132.69 53.22 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.269 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -98.12 116.67 30.82 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.966 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 -89.5 97.05 10.97 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 62.7 mtt -55.31 -50.81 84.56 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -45.78 -53.33 5.78 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 123.151 2.567 . . . . 0.0 114.662 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 42.4 p30 -95.62 -10.67 28.84 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 66.89 51.99 36.36 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.921 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -138.42 160.94 38.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.671 0.272 . . . . 0.0 111.03 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 26.5 m -105.7 133.26 50.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.067 0.461 . . . . 0.0 111.525 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -110.31 110.77 21.69 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -93.97 138.97 31.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.509 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -114.1 136.73 52.61 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.331 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -148.27 105.18 3.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.809 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 68.1 -109.89 3.14 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -115.12 11.4 16.35 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.23 0.538 . . . . 0.0 110.009 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt -117.01 150.48 38.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.156 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -131.41 140.26 49.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.589 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -110.5 144.38 39.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.497 -178.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -106.14 96.65 6.63 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -80.85 128.49 33.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.125 -177.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -96.74 97.87 9.69 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -44.95 -60.61 1.98 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -56.23 -36.35 68.4 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 67.1 mt -88.73 -20.56 24.65 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 67.0 mtp180 61.96 48.55 5.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.557 0.694 . . . . 0.0 110.847 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -162.03 164.53 28.17 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.749 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.0 t -88.62 138.74 18.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -61.97 166.4 4.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.201 0.524 . . . . 0.0 112.147 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.46 152.0 46.04 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 68.81 22.74 7.15 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.668 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -118.21 158.26 46.89 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.114 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -77.75 151.71 91.89 Favored 'Cis proline' 0 C--N 1.344 0.332 0 C-N-CA 123.643 -1.399 . . . . 0.0 113.521 0.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -102.38 177.09 4.97 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.847 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -75.24 140.93 43.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.573 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.2 tt -69.79 -11.5 14.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.909 0.385 . . . . 0.0 110.974 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -63.84 -6.31 5.68 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 70.7 t -67.54 -33.6 63.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 10.0 m95 -95.46 84.84 4.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.253 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -57.4 115.71 2.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.187 0.518 . . . . 0.0 112.358 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 115.17 -26.47 9.2 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.097 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 31.7 mm -73.47 130.48 83.96 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.714 0.292 . . . . 0.0 111.067 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.0 156.15 23.32 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.825 2.35 . . . . 0.0 111.869 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -77.57 141.09 39.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.412 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 5.2 m 58.0 74.59 0.62 Allowed Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -81.84 -173.87 1.94 Allowed 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.866 2.378 . . . . 0.0 112.017 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.87 20.37 3.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.239 0.542 . . . . 0.0 110.528 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 161.36 142.48 3.4 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.592 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 7.8 p -156.75 106.77 2.3 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -127.48 138.34 52.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.923 0.392 . . . . 0.0 111.613 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 46.2 ttm -90.31 142.06 28.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.291 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -71.18 162.26 54.16 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.917 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.7 -12.46 46.86 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 16.9 p30 -85.27 -13.2 50.52 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.623 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 66.98 10.84 7.99 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.14 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 40.1 t -104.43 -42.9 7.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.601 0.239 . . . . 0.0 111.44 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -112.05 144.84 40.74 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 97.8 m -126.99 134.31 50.38 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.316 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -101.82 124.89 48.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.954 0.407 . . . . 0.0 111.716 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -110.22 131.41 55.08 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -115.26 137.76 51.68 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.665 0.269 . . . . 0.0 111.669 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -163.01 104.1 1.0 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.961 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 65.94 66.03 2.6 Favored Glycine 0 CA--C 1.518 0.268 0 N-CA-C 114.828 0.691 . . . . 0.0 114.828 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 61.84 -1.2 0.37 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -119.56 148.02 43.8 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 122.291 -0.256 . . . . 0.0 110.526 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -127.95 147.55 50.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.174 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 17.4 m-90 -113.04 143.84 43.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.879 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -104.35 97.08 7.07 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 486' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -90.68 134.54 34.33 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.477 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -98.63 119.27 37.06 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -68.52 -32.93 73.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.199 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -74.84 -43.14 56.16 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.701 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -85.24 -22.56 28.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.131 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 3.7 tp 65.56 42.67 3.6 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.525 0.679 . . . . 0.0 109.889 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 16.1 tttp -156.96 153.89 28.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.61 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 69.9 t -85.15 140.18 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -61.48 131.46 92.54 Favored Pre-proline 0 C--O 1.234 0.278 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.264 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -62.11 141.84 90.04 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.669 2.246 . . . . 0.0 111.682 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 109.56 -10.24 32.83 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -94.73 170.46 8.02 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.61 -0.295 . . . . 0.0 110.333 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.88 169.5 72.11 Favored 'Cis proline' 0 C--N 1.349 0.604 0 C-N-CA 123.978 -1.259 . . . . 0.0 113.253 0.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -120.85 157.65 29.34 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.774 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 47.6 t -69.84 112.91 6.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.973 0.416 . . . . 0.0 110.263 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -66.55 -23.73 66.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.074 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 79.1 mt -65.94 -39.25 90.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.114 0.483 . . . . 0.0 110.711 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -89.06 -39.69 13.47 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.587 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.0 -36.67 61.97 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 42.9 m0 -106.37 -57.44 2.05 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 7.1 mmt -65.84 -35.42 80.63 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 91.67 38.03 5.95 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.218 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 23.0 m -115.74 86.95 16.75 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.3 160.69 48.06 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.475 2.117 . . . . 0.0 111.737 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 5.7 m 66.4 69.71 0.42 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.166 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.23 0 CA-C-O 118.306 -1.274 . . . . 0.0 111.258 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.766 0 N-CA-C 112.429 -0.268 . . . . 0.0 112.429 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo . . . . . 0 C--N 1.345 0.394 0 C-N-CA 122.745 2.297 . . . . 0.0 112.471 -179.346 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.736 0 N-CA-C 112.181 -0.368 . . . . 0.0 112.181 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo . . . . . 0 N--CA 1.459 -0.521 0 C-N-CA 122.488 2.126 . . . . 0.0 110.404 178.97 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.563 0 CA-C-O 120.365 -0.131 . . . . 0.0 112.887 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo . . . . . 0 CA--C 1.527 0.154 0 C-N-CA 122.943 2.428 . . . . 0.0 111.766 179.915 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.744 0 N-CA-C 112.062 -0.415 . . . . 0.0 112.062 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.35 149.77 69.89 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 123.006 2.471 . . . . 0.0 112.061 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -65.17 145.56 56.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.494 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.41 155.96 46.21 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.249 -0.5 . . . . 0.0 112.318 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 6.9 mt -67.44 147.28 12.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.572 0.225 . . . . 0.0 110.778 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.41 147.29 53.09 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.797 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.77 162.08 52.79 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.0 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -72.94 150.47 42.51 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -75.16 152.41 38.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.191 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.84 154.23 53.01 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.648 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 3.2 t -71.99 152.32 8.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 2.9 t -51.33 145.24 2.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 O-C-N 123.499 0.499 . . . . 0.0 110.948 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.39 160.12 53.99 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.739 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 94.0 mt . . . . . 0 C--N 1.321 -0.654 0 CA-C-O 120.479 0.181 . . . . 0.0 110.604 179.978 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.612 0 N-CA-C 112.451 -0.26 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo . . . . . 0 CA--C 1.529 0.258 0 C-N-CA 122.752 2.301 . . . . 0.0 111.764 179.742 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 113.399 0.12 . . . . 0.0 113.399 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 CA--C 1.532 0.409 0 C-N-CA 123.244 2.629 . . . . 0.0 112.035 179.969 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 112.878 -0.089 . . . . 0.0 112.878 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo . . . . . 0 CA--C 1.528 0.224 0 C-N-CA 123.176 2.584 . . . . 0.0 111.853 179.702 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.514 0 N-CA-C 112.333 -0.307 . . . . 0.0 112.333 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo . . . . . 0 N--CA 1.464 -0.228 0 C-N-CA 122.685 2.256 . . . . 0.0 111.479 179.562 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.402 0 CA-C-O 120.224 -0.209 . . . . 0.0 112.64 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo . . . . . 0 C--O 1.234 0.282 0 C-N-CA 123.057 2.505 . . . . 0.0 111.142 -179.893 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 113.689 0.236 . . . . 0.0 113.689 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 CA--C 1.533 0.44 0 C-N-CA 123.528 2.819 . . . . 0.0 112.413 -179.487 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.394 0 N-CA-C 112.421 -0.272 . . . . 0.0 112.421 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo . . . . . 0 CA--C 1.531 0.34 0 C-N-CA 122.981 2.454 . . . . 0.0 111.756 -179.885 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.243 0 N-CA-C 113.553 0.181 . . . . 0.0 113.553 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.19 156.82 64.36 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.66 2.24 . . . . 0.0 112.085 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -59.33 135.86 57.78 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.06 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -62.01 162.16 27.63 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.563 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 16.3 mt -69.3 134.73 29.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.621 0.248 . . . . 0.0 110.68 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.26 146.52 47.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.679 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -64.94 157.04 46.62 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 121.205 -0.521 . . . . 0.0 113.002 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -84.3 152.4 24.16 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 4.6 ttm180 -66.5 148.52 51.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.328 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.07 171.91 41.65 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.027 -0.606 . . . . 0.0 113.053 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 15.9 t -72.85 142.49 15.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 97.3 t -62.9 138.39 22.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.954 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.46 158.52 39.32 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 116.081 -0.508 . . . . 0.0 112.538 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 59.1 mt . . . . . 0 C--N 1.323 -0.551 0 CA-C-N 115.852 -0.174 . . . . 0.0 110.642 -179.777 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.615 0 N-CA-C 112.673 -0.171 . . . . 0.0 112.673 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 N--CA 1.464 -0.209 0 C-N-CA 122.475 2.117 . . . . 0.0 111.116 179.833 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.523 0 N-CA-C 112.774 -0.13 . . . . 0.0 112.774 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo . . . . . 0 C--O 1.236 0.381 0 C-N-CA 122.82 2.347 . . . . 0.0 111.552 179.839 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.434 0 N-CA-C 113.451 0.14 . . . . 0.0 113.451 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo . . . . . 0 C--O 1.235 0.328 0 C-N-CA 122.985 2.457 . . . . 0.0 111.731 -179.948 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.608 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo . . . . . 0 C--N 1.345 0.375 0 C-N-CA 123.107 2.538 . . . . 0.0 111.968 -179.882 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.387 0 CA-C-O 120.197 -0.224 . . . . 0.0 112.712 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo . . . . . 0 C--N 1.347 0.492 0 C-N-CA 123.153 2.569 . . . . 0.0 111.115 179.276 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 CA-C-O 120.138 -0.257 . . . . 0.0 113.606 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo . . . . . 0 C--N 1.348 0.522 0 C-N-CA 123.735 2.956 . . . . 0.0 113.04 -179.151 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.429 0 CA-C-O 120.429 -0.095 . . . . 0.0 113.033 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo . . . . . 0 N--CA 1.457 -0.64 0 C-N-CA 123.466 2.777 . . . . 0.0 111.995 179.948 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.574 0 N-CA-C 112.428 -0.269 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.06 158.48 57.25 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.502 2.134 . . . . 0.0 111.773 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -78.29 144.08 36.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.653 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -67.43 159.53 50.14 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.87 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 15.2 pt -70.76 168.85 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.655 0.264 . . . . 0.0 111.026 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -87.37 143.15 27.38 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.863 0.363 . . . . 0.0 110.595 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -65.99 162.25 42.93 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 116.02 -0.536 . . . . 0.0 113.216 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -71.08 158.94 35.62 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.783 0.325 . . . . 0.0 110.899 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -68.5 152.57 45.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.0 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -59.96 151.09 38.6 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.301 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 12.4 t -61.33 144.44 13.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 46.7 t -63.18 139.42 21.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -56.66 158.23 10.03 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.962 -0.563 . . . . 0.0 113.621 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 C--N 1.323 -0.587 0 CA-C-N 115.656 -0.272 . . . . 0.0 110.668 -179.589 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.475 0 CA-C-O 120.495 -0.058 . . . . 0.0 112.96 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo . . . . . 0 CA--C 1.528 0.177 0 C-N-CA 123.092 2.528 . . . . 0.0 111.223 179.428 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.538 0 N-CA-C 112.638 -0.185 . . . . 0.0 112.638 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo . . . . . 0 N--CA 1.46 -0.481 0 C-N-CA 122.93 2.42 . . . . 0.0 111.643 179.503 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 113.816 0.286 . . . . 0.0 113.816 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo . . . . . 0 C--N 1.342 0.219 0 C-N-CA 123.206 2.604 . . . . 0.0 111.995 179.919 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo . . . . . 0 N--CA 1.479 0.63 0 N-CA-C 110.238 -0.716 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -114.1 164.62 13.6 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 19.5 tt -71.37 -23.44 22.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.948 0.404 . . . . 0.0 111.036 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 31.2 m -87.68 6.07 36.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.727 0.299 . . . . 0.0 111.574 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.15 -50.5 70.16 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.132 0.491 . . . . 0.0 110.438 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 97.13 175.59 34.7 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 8.0 m120 51.03 73.43 0.29 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.172 0.511 . . . . 0.0 112.172 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -88.62 173.3 8.7 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.03 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.37 -51.75 27.55 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 14.5 t -170.51 147.67 2.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.435 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 76.8 t -112.71 126.62 70.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -131.67 166.7 20.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.01 0.433 . . . . 0.0 111.151 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 42.2 ttp -136.36 108.18 7.08 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 45.3 mt -106.25 127.2 53.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.574 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.06 14.85 5.71 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.55 0.531 . . . . 0.0 112.13 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 102.99 -9.29 54.92 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.23 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -93.94 129.67 40.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.631 0.253 . . . . 0.0 110.738 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 45.6 ttm -82.59 123.07 28.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.228 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -114.86 123.22 48.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.355 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 9.2 t -103.49 109.75 27.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.954 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -92.16 125.41 36.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.457 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 22.0 tptp -136.5 95.5 3.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.656 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 62.7 -100.5 0.09 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 7.7 ptm85 -104.22 -5.25 22.09 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -177.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 7.6 m0 -124.69 159.89 29.8 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.974 0.416 . . . . 0.0 111.425 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -135.93 138.2 42.13 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.372 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -108.39 152.78 24.21 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.954 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -127.07 113.4 16.38 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -101.78 113.09 37.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.175 0.512 . . . . 0.0 111.206 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.23 120.18 40.87 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 5.5 m120 61.83 32.94 17.94 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.437 0.46 . . . . 0.0 110.577 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 70.89 16.22 6.62 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.192 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -121.51 137.64 54.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.251 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 22.9 t -73.47 120.74 22.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.044 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 79.0 mtp -70.45 167.93 17.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.987 0.422 . . . . 0.0 111.542 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -85.81 163.71 17.98 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.371 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 91.54 -1.55 76.01 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.772 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -113.78 160.99 29.93 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.55 128.49 15.18 Favored 'Cis proline' 0 C--N 1.347 0.493 0 C-N-CA 123.505 -1.456 . . . . 0.0 112.519 0.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 54.2 ttm -102.87 133.52 20.35 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.711 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.76 136.09 68.1 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.398 2.065 . . . . 0.0 111.158 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 77.4 mt -53.0 -45.47 52.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.835 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -68.18 -13.55 64.85 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 121.145 -0.55 . . . . 0.0 114.04 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.51 -29.45 61.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.954 0.377 . . . . 0.0 110.202 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -112.38 -53.91 2.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.556 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -86.91 73.72 9.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.962 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -64.69 103.64 0.72 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.008 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 127.55 -13.3 6.55 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 20.0 tp -97.9 129.23 31.63 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -81.62 -178.72 4.39 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.782 2.321 . . . . 0.0 112.067 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -82.93 149.19 27.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.502 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 39.3 m 58.5 90.11 0.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.752 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 30.3 pt -95.62 168.59 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.965 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.81 -45.54 7.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.902 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.38 168.08 28.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.741 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -157.37 141.14 15.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -160.02 161.01 33.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.065 0.46 . . . . 0.0 111.859 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -94.99 125.68 39.81 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -82.87 179.71 7.69 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -178.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -64.46 -29.24 70.29 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.79 -17.21 36.41 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 116.53 -18.57 13.28 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.799 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -72.48 156.05 39.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.195 0.497 . . . . 0.0 111.077 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -100.03 125.65 46.12 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.187 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 15.4 t -108.25 116.3 51.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.041 0.448 . . . . 0.0 110.726 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -104.5 138.21 41.21 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.45 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -118.25 145.81 44.74 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.804 0.335 . . . . 0.0 111.233 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -155.0 99.55 2.12 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.957 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 71.56 -106.28 1.87 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.8 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -114.17 5.9 16.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.732 0.301 . . . . 0.0 111.432 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -116.95 154.52 30.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.91 0.386 . . . . 0.0 111.438 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -136.99 144.9 43.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.849 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 22.3 m-90 -118.8 135.13 54.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.964 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 53.3 t -113.37 114.55 47.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -107.06 121.6 44.81 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.411 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -91.5 100.13 12.94 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 69.0 -68.99 0.17 Allowed 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.722 0.639 . . . . 0.0 110.707 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -156.11 16.51 0.35 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.658 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.11 127.25 49.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.92 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 60.5 tp -75.14 131.51 40.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.218 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -66.87 133.21 93.94 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.956 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -62.24 123.62 12.82 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.997 2.465 . . . . 0.0 112.361 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 113.82 -1.84 24.47 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.413 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -100.17 161.64 23.52 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -76.35 160.53 95.27 Favored 'Cis proline' 0 C--N 1.345 0.365 0 C-N-CA 123.797 -1.335 . . . . 0.0 113.269 0.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 28.6 mttm -125.41 165.44 18.4 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.262 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -71.53 158.33 36.43 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 47.5 mt -57.78 -36.54 55.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.045 0.45 . . . . 0.0 111.374 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -66.52 -15.56 63.48 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.265 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -78.66 -25.02 44.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.887 0.375 . . . . 0.0 110.896 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 39.6 tp -74.83 -45.38 43.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.122 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -164.21 154.81 25.86 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.764 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 52.1 ttt85 -79.66 135.89 36.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.7 0.286 . . . . 0.0 110.51 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.08 -4.59 62.83 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.84 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 46.8 mt -72.66 151.32 91.33 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.858 0.329 . . . . 0.0 111.121 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.02 129.07 33.33 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.869 2.38 . . . . 0.0 112.123 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.59 -8.6 52.28 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -91.51 -54.37 3.93 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -176.95 -179.66 0.95 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.337 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 37.6 mm -124.24 137.18 58.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -88.52 -57.94 2.73 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -152.8 161.54 42.42 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.794 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -137.61 128.36 27.01 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 40.6 tp -118.92 122.17 41.65 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.824 0.345 . . . . 0.0 111.237 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -88.14 111.58 21.75 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.188 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 13.1 t-105 -80.24 96.25 6.54 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 67.9 mtt -51.35 -51.84 65.02 Favored Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -40.47 -54.52 2.25 Favored 'Trans proline' 0 C--N 1.358 1.067 0 C-N-CA 123.388 2.725 . . . . 0.0 115.139 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -104.24 -16.84 15.07 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 79.58 53.77 4.22 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.666 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -133.4 136.95 45.59 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.718 0.294 . . . . 0.0 110.436 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 17.6 m -91.65 127.42 37.1 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -99.56 114.69 27.85 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.631 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -96.17 123.31 39.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.658 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -99.12 135.92 39.83 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.186 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -148.84 101.74 3.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.651 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 73.54 -116.71 5.53 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.737 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -110.08 14.38 22.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.99 0.424 . . . . 0.0 110.651 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -127.44 151.94 48.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.983 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -130.09 143.43 50.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.657 178.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -111.05 151.21 28.29 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.211 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -111.6 99.57 8.28 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -79.76 116.82 20.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.84 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -83.47 102.13 11.87 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.211 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -56.93 -26.39 59.37 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -87.05 -14.37 41.7 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 93.0 mt -120.14 -11.65 9.2 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 25.6 mtp180 58.69 45.01 16.47 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.323 0.583 . . . . 0.0 111.177 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -162.24 157.0 22.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.989 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 96.3 t -76.71 133.53 30.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -60.57 164.38 4.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.032 0.444 . . . . 0.0 111.731 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 74.4 m -70.64 159.16 34.92 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.768 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 72.62 20.25 3.86 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.126 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -120.41 159.08 49.37 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.5 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.04 165.52 85.71 Favored 'Cis proline' 0 C--N 1.344 0.34 0 C-N-CA 123.608 -1.413 . . . . 0.0 112.95 0.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 57.6 mttm -117.64 160.65 20.94 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.664 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -67.37 135.43 53.21 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.272 0.357 . . . . 0.0 110.453 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.4 tt -64.0 -12.91 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.075 0.464 . . . . 0.0 111.323 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -62.5 -15.21 48.98 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 75.7 t -58.75 -36.94 63.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -86.06 88.53 7.6 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.11 109.04 0.38 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 107.89 -13.11 38.16 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.027 -0.606 . . . . 0.0 113.312 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 40.0 mm -83.33 126.24 72.27 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.81 0.305 . . . . 0.0 111.298 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.85 156.16 30.87 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.036 2.49 . . . . 0.0 111.983 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -73.04 149.55 43.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.177 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 3.5 m 51.64 69.46 2.49 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 114.484 1.291 . . . . 0.0 114.484 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -91.47 172.62 2.78 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.55 2.167 . . . . 0.0 109.956 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -142.91 74.56 1.45 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.542 0.686 . . . . 0.0 111.219 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 135.79 97.63 0.53 Allowed Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.345 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 2.9 p -130.13 108.34 9.99 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -130.06 144.03 51.12 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.945 0.402 . . . . 0.0 111.475 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 43.1 ttm -97.11 133.87 41.2 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.521 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -65.31 164.69 36.79 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.379 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 2.4 m -65.5 -8.03 17.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.941 0.4 . . . . 0.0 111.825 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -87.89 -13.04 43.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.517 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 64.02 11.11 5.87 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.624 -0.717 . . . . 0.0 112.509 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 98.1 t -110.79 -41.5 4.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.845 0.355 . . . . 0.0 111.403 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -105.68 123.17 47.5 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 85.6 m -111.81 141.09 45.88 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -113.52 135.0 54.37 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -118.66 127.27 53.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.415 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -109.27 133.85 52.52 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 56.6 tttt -165.66 127.69 2.01 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.223 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 61.98 38.19 95.65 Favored Glycine 0 N--CA 1.454 -0.118 0 CA-C-N 116.035 -0.53 . . . . 0.0 113.449 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 53.7 t30 74.15 -4.79 2.21 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -106.85 155.29 19.9 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -127.26 139.35 52.97 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.137 0.494 . . . . 0.0 111.563 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 17.9 m-90 -108.84 133.28 53.09 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.742 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -99.03 100.81 12.02 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.958 0.408 . . . . 0.0 110.034 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 486' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -89.65 132.63 35.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.155 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -96.66 112.42 24.18 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -59.38 -47.8 84.08 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 41.3 tp60 -85.13 37.51 0.67 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.326 0.584 . . . . 0.0 111.41 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -153.33 -27.85 0.14 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.912 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 14.7 tp 61.76 40.17 13.26 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.867 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -159.66 148.0 17.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.628 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 69.5 t -75.78 142.93 13.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -63.97 142.67 98.18 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.379 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -65.5 146.0 83.87 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.725 2.283 . . . . 0.0 111.753 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 96.12 1.75 61.05 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.21 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -108.87 167.39 9.23 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.46 176.75 42.48 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 124.037 -1.235 . . . . 0.0 113.42 0.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -133.12 166.0 23.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.939 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 4.8 t -75.49 122.14 23.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.852 0.358 . . . . 0.0 110.849 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -73.92 -21.17 60.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.86 0.362 . . . . 0.0 110.866 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 10.3 mt -70.96 -48.72 51.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.881 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -78.18 -40.18 38.53 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.999 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.79 -56.33 4.69 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -177.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -85.17 -58.51 2.65 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -177.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 11.6 mmt -63.86 -32.51 74.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 87.82 38.01 7.67 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.938 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 59.9 m -121.29 90.8 47.84 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.01 166.2 30.31 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.804 2.336 . . . . 0.0 111.721 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 11.9 m 65.91 101.36 0.04 OUTLIER 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.459 0.647 . . . . 0.0 111.793 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.865 0 CA-C-O 118.361 -1.244 . . . . 0.0 111.473 179.914 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.889 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 CA--C 1.528 0.186 0 C-N-CA 122.421 2.081 . . . . 0.0 111.369 179.642 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.559 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo . . . . . 0 CA--C 1.529 0.261 0 C-N-CA 122.683 2.255 . . . . 0.0 111.253 179.912 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.429 0 CA-C-O 120.34 -0.144 . . . . 0.0 112.969 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo . . . . . 0 CA--C 1.531 0.372 0 C-N-CA 122.995 2.463 . . . . 0.0 111.978 179.766 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.757 0 N-CA-C 112.538 -0.225 . . . . 0.0 112.538 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.91 144.55 96.68 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.119 2.546 . . . . 0.0 112.106 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -64.12 140.39 58.86 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.669 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.74 144.02 47.62 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.517 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 32.5 mt -63.67 144.69 14.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.592 0.234 . . . . 0.0 110.548 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.03 157.93 20.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.043 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.13 165.76 52.99 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.471 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -72.29 149.02 44.86 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.66 142.08 57.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.436 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.63 148.37 47.34 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.293 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 3.1 t -68.3 154.27 8.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.753 0.311 . . . . 0.0 110.502 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 14.7 t -58.33 141.4 15.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.689 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.46 168.37 53.92 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.567 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 C--N 1.324 -0.524 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 -179.815 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.572 0 CA-C-O 120.436 -0.091 . . . . 0.0 112.903 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo . . . . . 0 CA--C 1.53 0.299 0 C-N-CA 122.831 2.354 . . . . 0.0 111.798 179.836 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo . . . . . 0 C--O 1.237 0.459 0 C-N-CA 122.584 2.189 . . . . 0.0 111.924 179.93 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.816 0 CA-C-O 120.356 -0.136 . . . . 0.0 112.789 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo . . . . . 0 N--CA 1.465 -0.176 0 C-N-CA 122.915 2.41 . . . . 0.0 111.1 179.281 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.395 0 CA-C-O 120.428 -0.096 . . . . 0.0 113.138 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo . . . . . 0 N--CA 1.455 -0.781 0 C-N-CA 123.419 2.746 . . . . 0.0 111.749 179.901 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.428 0 CA-C-O 120.077 -0.291 . . . . 0.0 112.665 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo . . . . . 0 C--N 1.344 0.301 0 C-N-CA 122.929 2.42 . . . . 0.0 111.679 179.614 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.425 0 N-CA-C 113.191 0.036 . . . . 0.0 113.191 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo . . . . . 0 CA--C 1.53 0.297 0 C-N-CA 123.48 2.787 . . . . 0.0 111.739 179.712 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.583 0 N-CA-C 112.095 -0.402 . . . . 0.0 112.095 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo . . . . . 0 N--CA 1.463 -0.27 0 C-N-CA 122.926 2.417 . . . . 0.0 110.83 179.479 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.292 0 N-CA-C 113.537 0.175 . . . . 0.0 113.537 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.97 169.98 13.84 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 122.85 2.366 . . . . 0.0 112.553 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -64.75 137.78 58.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.548 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -62.23 161.35 29.95 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 116.02 -0.536 . . . . 0.0 113.095 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 2.3 mt -62.73 144.0 14.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.695 -0.252 . . . . 0.0 110.393 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.97 152.8 44.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.539 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -70.43 145.81 41.29 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.477 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -72.82 147.02 45.87 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 35.1 ttm-85 -62.45 145.81 53.14 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.758 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.18 177.39 32.34 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.806 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 61.9 t -72.84 137.48 23.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.466 -0.367 . . . . 0.0 110.365 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 93.7 t -63.94 139.25 21.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.983 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.22 157.41 28.01 Favored Glycine 0 N--CA 1.45 -0.424 0 O-C-N 123.51 0.506 . . . . 0.0 112.886 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 31.8 mt . . . . . 0 C--N 1.325 -0.481 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 -179.706 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 113.237 0.055 . . . . 0.0 113.237 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo . . . . . 0 C--O 1.234 0.294 0 C-N-CA 122.684 2.256 . . . . 0.0 111.47 179.69 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.446 0 N-CA-C 112.961 -0.055 . . . . 0.0 112.961 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 C--O 1.237 0.454 0 C-N-CA 122.595 2.196 . . . . 0.0 111.514 179.807 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.391 0 N-CA-C 113.489 0.156 . . . . 0.0 113.489 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo . . . . . 0 C--N 1.34 0.114 0 C-N-CA 123.038 2.492 . . . . 0.0 111.287 179.711 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 N-CA-C 112.112 -0.395 . . . . 0.0 112.112 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo . . . . . 0 C--O 1.233 0.259 0 C-N-CA 123.084 2.523 . . . . 0.0 112.143 -179.849 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 CA-C-O 120.043 -0.309 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo . . . . . 0 C--N 1.345 0.382 0 C-N-CA 122.985 2.457 . . . . 0.0 111.724 179.578 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.462 0 CA-C-O 120.402 -0.11 . . . . 0.0 113.032 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo . . . . . 0 N--CA 1.461 -0.398 0 C-N-CA 123.903 3.068 . . . . 0.0 112.148 -179.805 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.342 0 N-CA-C 113.567 0.187 . . . . 0.0 113.567 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo . . . . . 0 N--CA 1.457 -0.647 0 C-N-CA 123.656 2.904 . . . . 0.0 112.46 179.742 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.514 0 N-CA-C 112.011 -0.436 . . . . 0.0 112.011 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.21 157.76 58.5 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.766 2.31 . . . . 0.0 111.901 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -82.56 142.33 31.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.988 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -64.74 162.66 37.92 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 116.08 -0.509 . . . . 0.0 113.295 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 42.2 pt -71.68 159.35 5.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.926 0.393 . . . . 0.0 111.403 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -71.27 139.1 49.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.081 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -64.37 165.6 31.45 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 116.01 -0.541 . . . . 0.0 113.864 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -78.58 153.42 31.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.794 0.33 . . . . 0.0 110.486 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 33.8 mtp180 -69.79 156.23 39.34 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.543 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -64.36 154.52 47.79 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.735 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 24.5 t -65.31 144.53 14.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.98 135.98 25.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.887 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -54.15 161.22 4.16 Favored Glycine 0 N--CA 1.453 -0.216 0 O-C-N 123.799 0.687 . . . . 0.0 114.364 -178.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 10.8 mp . . . . . 0 C--N 1.322 -0.592 0 CA-C-N 115.659 -0.271 . . . . 0.0 110.587 179.988 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.597 0 CA-C-O 120.522 -0.043 . . . . 0.0 113.102 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo . . . . . 0 C--O 1.235 0.343 0 C-N-CA 122.925 2.417 . . . . 0.0 111.692 179.859 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.436 0 N-CA-C 113.25 0.06 . . . . 0.0 113.25 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo . . . . . 0 C--O 1.236 0.405 0 C-N-CA 122.835 2.356 . . . . 0.0 111.645 179.774 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.598 0 CA-C-O 120.719 0.066 . . . . 0.0 113.096 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 CA--C 1.532 0.385 0 C-N-CA 123.077 2.518 . . . . 0.0 111.926 179.682 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo . . . . . 0 N--CA 1.477 0.558 0 N-CA-C 109.922 -0.838 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -113.25 149.15 34.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.308 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 16.1 tt -72.89 -18.63 18.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 20.6 m -91.76 0.25 57.5 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 121.152 -0.219 . . . . 0.0 111.263 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -67.86 -48.04 67.23 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.102 0.477 . . . . 0.0 110.288 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 102.74 172.08 26.66 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.439 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 64.3 t30 55.56 85.73 0.06 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.468 0.651 . . . . 0.0 112.465 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -105.26 168.0 9.36 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.702 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.57 -46.87 83.92 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 6.6 t -175.43 160.75 2.62 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.472 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 49.0 t -127.56 127.51 68.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -135.23 167.93 20.1 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.007 0.432 . . . . 0.0 111.845 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 53.1 ttm -129.75 115.11 16.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.786 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 56.8 mt -111.28 117.05 32.1 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.182 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.13 20.26 8.21 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.957 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 105.69 -18.24 41.13 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.609 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -82.75 131.24 35.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.633 0.254 . . . . 0.0 110.676 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 50.2 ttm -88.23 117.74 27.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.794 0.33 . . . . 0.0 110.975 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -109.12 122.8 48.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.264 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 37.5 t -108.46 114.74 47.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -100.46 130.37 46.54 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 13.0 tptt -138.19 101.81 4.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.298 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 61.49 -95.3 0.05 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.0 ptm85 -121.06 7.08 10.29 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 5.6 m-90 -129.03 152.43 48.64 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -137.69 153.95 49.73 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.121 0.486 . . . . 0.0 111.76 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 24.5 m-90 -121.8 160.91 23.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.363 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 18.1 ttm-85 -124.38 112.18 16.64 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 91.6 t -90.71 122.66 42.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.889 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -132.71 100.92 5.09 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.553 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 66.5 54.79 0.86 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.817 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 29.2 t30 62.09 12.92 5.34 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -133.41 146.7 51.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.665 0.269 . . . . 0.0 110.61 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 39.0 t -96.71 127.88 48.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 86.2 mtp -68.28 159.84 30.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.531 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -76.65 167.74 21.3 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.679 0.276 . . . . 0.0 110.9 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 94.98 -21.77 42.02 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -101.5 158.94 30.83 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.16 139.21 57.13 Favored 'Cis proline' 0 C--N 1.346 0.424 0 C-N-CA 123.484 -1.465 . . . . 0.0 112.561 0.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 55.3 ttm -114.33 138.8 23.2 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.43 130.33 39.97 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.382 2.054 . . . . 0.0 111.175 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 76.8 mt -55.02 -45.51 76.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.987 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -71.35 -12.78 73.21 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.95 -0.643 . . . . 0.0 113.707 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -82.32 -34.32 28.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.034 0.445 . . . . 0.0 110.454 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -94.1 -55.21 3.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.357 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -90.28 74.39 7.02 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -58.29 95.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.925 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 135.37 -17.3 4.04 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 29.6 tp -94.37 125.16 53.14 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -77.21 -174.02 2.02 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.017 2.478 . . . . 0.0 111.84 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -87.8 153.96 20.93 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.08 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 72.1 m 59.23 94.92 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 27.1 pt -106.87 -166.24 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.403 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.09 -47.06 1.22 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.04 162.82 37.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.648 0.261 . . . . 0.0 111.178 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -158.35 138.48 12.37 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -160.25 162.71 33.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.903 0.382 . . . . 0.0 111.532 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -98.65 122.03 41.35 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -78.76 -179.66 6.66 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -178.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -67.61 -34.52 77.15 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.908 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -37.29 85.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.68 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 129.27 -16.19 5.74 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.421 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -80.46 166.16 21.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.881 0.372 . . . . 0.0 111.575 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -106.71 127.64 53.54 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.752 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 13.4 t -109.19 122.16 63.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.007 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -106.56 138.11 43.34 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.212 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -117.83 141.69 48.14 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -154.14 107.6 2.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.6 177.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 70.27 -112.2 4.21 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.566 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -115.29 4.38 14.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.914 0.388 . . . . 0.0 110.606 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -112.07 150.79 30.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 48.5 p-80 -131.97 147.94 52.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.176 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 22.5 m-90 -121.7 125.62 47.05 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.82 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 85.5 t -109.42 119.96 59.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.897 0.38 . . . . 0.0 110.32 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -104.87 123.66 48.1 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.932 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -92.71 95.05 9.33 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 67.52 -73.2 0.08 Allowed 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.727 0.642 . . . . 0.0 111.021 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -146.18 11.83 1.2 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.986 0.422 . . . . 0.0 110.41 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 1.7 m -125.51 127.09 45.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.253 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 55.9 tp -71.77 132.04 43.92 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.035 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -62.96 147.01 94.94 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.651 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -74.08 144.59 34.08 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.544 2.163 . . . . 0.0 113.038 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 90.37 18.15 50.3 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.459 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -109.13 162.16 21.12 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-O 120.292 0.091 . . . . 0.0 110.774 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.07 157.81 96.84 Favored 'Cis proline' 0 C--N 1.346 0.442 0 C-N-CA 123.529 -1.446 . . . . 0.0 112.562 0.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -116.48 157.82 24.58 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -73.21 151.19 41.56 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 61.2 mt -56.64 -32.75 38.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.325 0.583 . . . . 0.0 110.603 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -65.97 -20.71 66.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.485 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -84.18 -10.52 57.68 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 50.7 tp -85.32 -55.16 4.16 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.9 0.381 . . . . 0.0 110.12 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -149.08 150.9 23.1 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.798 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -77.68 126.46 30.9 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.57 0.224 . . . . 0.0 110.495 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 99.27 14.01 37.11 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.599 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 38.7 mt -92.83 147.31 33.78 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 122.794 -0.239 . . . . 0.0 111.093 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.09 124.66 16.8 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.848 2.365 . . . . 0.0 111.26 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.44 -3.93 57.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.055 0.455 . . . . 0.0 111.273 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -87.53 -55.73 3.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.315 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 6.4 ptmt -177.57 176.37 1.28 Allowed 'General case' 0 C--N 1.332 -0.196 0 O-C-N 123.306 0.378 . . . . 0.0 110.791 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 38.3 mm -127.47 133.23 68.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -87.76 -47.68 8.44 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -154.6 165.25 37.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.945 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -147.21 113.8 6.01 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.207 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 55.4 tp -106.98 124.95 50.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.932 0.396 . . . . 0.0 111.795 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -90.32 116.12 28.04 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.802 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 11.9 t-105 -86.26 94.4 9.31 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 61.5 mtt -51.19 -48.82 84.5 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -50.02 -24.12 10.31 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.817 2.345 . . . . 0.0 115.269 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 26.0 p30 -125.51 -37.73 2.32 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 108.63 2.48 32.64 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.709 -0.757 . . . . 0.0 113.457 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -91.62 154.18 19.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 117.036 0.418 . . . . 0.0 111.271 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 7.0 m -108.4 128.17 54.53 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.517 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -98.84 108.96 21.77 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -90.48 136.74 32.87 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.21 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -112.57 132.74 54.98 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.85 0.357 . . . . 0.0 111.059 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -145.32 110.64 5.28 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.831 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 64.65 -102.66 0.65 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.694 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -127.61 20.78 6.6 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.158 0.504 . . . . 0.0 110.046 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 63.3 mmtt -124.0 142.16 51.41 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.552 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -119.02 137.9 53.21 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.748 0.309 . . . . 0.0 110.383 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -110.27 144.4 39.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.908 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 36.1 ttp180 -107.29 95.74 5.92 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -84.95 129.42 34.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.117 0.484 . . . . 0.0 112.169 -178.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -99.57 111.99 24.26 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.011 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -61.08 -39.74 91.06 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -67.71 -38.5 83.7 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 94.8 mt -94.1 -10.42 33.38 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 6.8 mtt-85 56.48 41.12 29.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.195 0.521 . . . . 0.0 111.027 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -157.46 166.72 32.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.219 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 88.9 t -89.3 140.05 16.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.9 153.5 8.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.437 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 10.9 m -69.11 158.27 35.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.04 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 70.19 24.49 4.88 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.326 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -122.75 163.19 34.46 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.018 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.38 172.1 64.35 Favored 'Cis proline' 0 C--N 1.346 0.437 0 C-N-CA 123.653 -1.395 . . . . 0.0 112.673 0.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -124.75 172.45 9.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.028 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -63.76 136.07 57.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.175 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.0 tt -71.8 -11.97 15.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.261 0.553 . . . . 0.0 110.565 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -71.18 -0.01 8.81 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 64.1 t -67.2 -32.75 59.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 8.2 m95 -86.75 85.49 7.28 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.08 108.78 0.35 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 118.34 -25.23 8.3 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.054 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 32.1 mm -77.08 130.18 76.15 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 120.86 0.362 . . . . 0.0 111.175 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -81.96 166.3 16.93 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.887 2.391 . . . . 0.0 111.711 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 35.3 mp0 -80.52 136.89 36.37 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.04 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.4 m 61.13 65.4 1.94 Allowed Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -96.43 118.34 0.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.184 2.589 . . . . 0.0 110.269 178.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 3.1 ttm105 -89.59 68.55 7.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.087 0.47 . . . . 0.0 112.17 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 158.55 124.92 0.79 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 25.3 p -158.81 120.7 3.49 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.493 -0.188 . . . . 0.0 110.493 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -150.13 147.35 27.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.715 0.293 . . . . 0.0 111.315 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 43.6 ttm -98.57 140.76 32.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.069 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -70.0 169.52 45.69 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.179 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 1.5 m -73.36 -0.17 13.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.001 0.429 . . . . 0.0 111.339 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.65 -17.64 24.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.156 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 67.88 8.05 6.18 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.878 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 43.6 t -109.73 -37.66 3.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.887 0.375 . . . . 0.0 111.458 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -107.0 129.06 54.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.19 0.519 . . . . 0.0 111.911 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 95.1 m -113.92 135.32 54.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.488 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -107.24 137.58 45.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.175 0.512 . . . . 0.0 112.195 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -121.16 145.34 47.92 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.682 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -127.34 131.95 50.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.861 0.363 . . . . 0.0 111.607 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -158.54 107.68 1.98 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.472 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 60.77 60.92 7.63 Favored Glycine 0 CA--C 1.518 0.238 0 N-CA-C 114.373 0.509 . . . . 0.0 114.373 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 69.44 -15.06 0.3 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -99.39 144.58 28.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.828 0.346 . . . . 0.0 111.435 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -120.35 142.64 48.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.161 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 11.8 m-90 -110.85 146.95 35.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.506 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -114.04 99.97 8.05 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 486' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -91.26 132.26 36.25 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.307 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -95.5 112.12 23.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -64.86 -19.12 65.72 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -93.85 -14.43 26.12 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -112.5 -16.64 12.83 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.6 tp 61.91 34.85 16.67 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.653 0.74 . . . . 0.0 109.899 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 36.4 tttp -151.98 156.12 39.38 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.515 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 71.6 t -81.81 139.6 17.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.697 0.284 . . . . 0.0 110.623 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -62.49 147.39 92.28 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.566 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.64 152.1 81.38 Favored 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 122.6 2.2 . . . . 0.0 111.957 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 85.65 27.86 31.12 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -134.06 163.58 50.12 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.609 -0.295 . . . . 0.0 110.428 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -76.25 174.87 50.71 Favored 'Cis proline' 0 C--N 1.346 0.408 0 C-N-CA 123.979 -1.259 . . . . 0.0 112.849 0.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -133.99 164.21 27.81 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.596 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.81 110.54 6.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.519 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -66.03 -24.08 66.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.152 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 76.0 mt -62.47 -39.41 93.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.857 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -85.46 -42.67 14.26 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.744 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -43.04 57.35 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 47.9 m0 -98.27 -60.41 1.56 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 10.9 mmt -62.85 -25.81 68.46 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 81.42 30.17 37.79 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.14 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 30.4 m -116.35 95.29 44.98 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 120.758 0.313 . . . . 0.0 110.567 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.32 -167.53 0.52 Allowed 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.967 2.444 . . . . 0.0 111.363 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 57.01 59.82 3.28 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.089 0.471 . . . . 0.0 110.941 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.503 -1.165 . . . . 0.0 112.185 -179.326 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.598 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo . . . . . 0 N--CA 1.461 -0.437 0 C-N-CA 122.778 2.319 . . . . 0.0 111.964 179.953 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.55 0 N-CA-C 112.983 -0.047 . . . . 0.0 112.983 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo . . . . . 0 CA--C 1.532 0.386 0 C-N-CA 123.042 2.495 . . . . 0.0 112.253 179.88 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.802 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 CA--C 1.53 0.319 0 C-N-CA 122.732 2.288 . . . . 0.0 111.456 179.435 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.93 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.11 150.48 15.76 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.65 2.233 . . . . 0.0 112.223 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -71.73 151.83 43.26 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.87 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.1 151.5 38.35 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.25 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 8.4 mt -66.73 150.01 11.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.23 151.36 31.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.369 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.41 163.73 53.05 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.937 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -70.63 141.21 51.73 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -67.47 144.5 55.67 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.314 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -57.16 151.6 26.65 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.925 -0.58 . . . . 0.0 113.154 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 12.1 t -69.85 147.15 11.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 19.9 t -53.31 145.01 3.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 O-C-N 123.326 0.391 . . . . 0.0 111.033 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.79 177.7 30.35 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.991 -0.549 . . . . 0.0 113.511 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 C--N 1.325 -0.487 0 C-N-CA 122.234 0.213 . . . . 0.0 110.629 -179.526 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.677 0 N-CA-C 112.011 -0.436 . . . . 0.0 112.011 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo . . . . . 0 C--N 1.343 0.254 0 C-N-CA 122.501 2.134 . . . . 0.0 111.106 179.202 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.389 0 N-CA-C 113.704 0.242 . . . . 0.0 113.704 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo . . . . . 0 N--CA 1.462 -0.377 0 C-N-CA 123.035 2.49 . . . . 0.0 111.419 179.557 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.434 0 CA-C-O 120.446 -0.085 . . . . 0.0 113.205 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo . . . . . 0 CA--C 1.531 0.346 0 C-N-CA 123.423 2.748 . . . . 0.0 112.255 179.983 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.515 0 CA-C-O 120.231 -0.205 . . . . 0.0 112.632 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo . . . . . 0 C--N 1.343 0.245 0 C-N-CA 122.957 2.438 . . . . 0.0 111.735 179.875 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.345 0 CA-C-O 120.029 -0.317 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 C--N 1.35 0.63 0 C-N-CA 123.051 2.5 . . . . 0.0 111.83 179.661 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.343 0 CA-C-O 120.227 -0.207 . . . . 0.0 112.703 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo . . . . . 0 CA--C 1.533 0.459 0 C-N-CA 123.126 2.551 . . . . 0.0 112.542 -179.684 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.458 0 N-CA-C 112.215 -0.354 . . . . 0.0 112.215 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo . . . . . 0 C--O 1.223 -0.233 0 C-N-CA 122.638 2.226 . . . . 0.0 110.533 179.271 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.398 0 CA-C-O 120.699 0.055 . . . . 0.0 113.064 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.21 160.38 38.77 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.692 2.262 . . . . 0.0 112.753 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -57.91 135.14 56.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.997 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -68.42 154.15 53.12 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.876 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 50.2 mt -68.41 133.75 31.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.686 0.279 . . . . 0.0 110.421 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.79 153.43 24.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.331 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -65.87 151.29 51.93 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.402 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -71.18 159.12 35.23 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 11.3 ttm-85 -67.55 144.71 55.48 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.87 165.6 41.44 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.962 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 5.2 t -70.05 142.43 15.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 39.2 t -61.31 142.7 15.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.275 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.51 164.98 40.99 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.518 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 86.2 mt . . . . . 0 C--N 1.322 -0.628 0 CA-C-O 120.586 0.231 . . . . 0.0 111.13 -179.658 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.658 0 N-CA-C 112.884 -0.086 . . . . 0.0 112.884 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 C--O 1.236 0.399 0 C-N-CA 122.722 2.281 . . . . 0.0 111.501 179.822 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.57 0 N-CA-C 113.305 0.082 . . . . 0.0 113.305 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo . . . . . 0 C--O 1.235 0.352 0 C-N-CA 122.677 2.252 . . . . 0.0 111.423 179.436 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.528 0 CA-C-O 120.767 0.093 . . . . 0.0 112.929 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo . . . . . 0 C--O 1.232 0.184 0 C-N-CA 122.921 2.414 . . . . 0.0 111.411 179.859 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 CA-C-O 120.309 -0.162 . . . . 0.0 112.976 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo . . . . . 0 C--N 1.343 0.277 0 C-N-CA 123.002 2.468 . . . . 0.0 111.541 179.633 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.29 0 CA-C-O 120.031 -0.316 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo . . . . . 0 C--N 1.348 0.523 0 C-N-CA 123.364 2.709 . . . . 0.0 112.304 179.962 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.511 0 N-CA-C 114.938 0.735 . . . . 0.0 114.938 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo . . . . . 0 CA--C 1.539 0.74 0 C-N-CA 123.934 3.09 . . . . 0.0 111.752 179.114 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 CA-C-O 120.171 -0.239 . . . . 0.0 112.72 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo . . . . . 0 CA--C 1.534 0.5 0 C-N-CA 123.177 2.584 . . . . 0.0 112.706 -179.94 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.564 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.96 146.66 83.3 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.764 2.309 . . . . 0.0 111.969 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -77.13 147.04 36.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.199 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -65.43 158.28 46.4 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.923 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 41.3 pt -73.98 162.83 4.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.897 0.38 . . . . 0.0 111.324 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -70.83 137.39 49.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.347 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -63.43 164.54 29.56 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.904 -0.589 . . . . 0.0 113.146 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -75.44 151.34 38.1 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 26.4 mtp180 -67.72 153.75 43.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.829 0.347 . . . . 0.0 110.933 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -62.98 151.96 47.05 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.49 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 8.9 t -65.47 146.92 12.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 91.4 t -61.65 138.32 22.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -56.32 160.78 7.38 Favored Glycine 0 N--CA 1.451 -0.332 0 O-C-N 123.55 0.531 . . . . 0.0 113.502 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 7.3 mp . . . . . 0 C--N 1.324 -0.534 0 CA-C-N 115.636 -0.282 . . . . 0.0 110.409 -179.822 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.722 0 N-CA-C 112.166 -0.374 . . . . 0.0 112.166 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo . . . . . 0 C--O 1.238 0.476 0 C-N-CA 122.594 2.196 . . . . 0.0 111.568 179.81 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.711 0 N-CA-C 113.033 -0.027 . . . . 0.0 113.033 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo . . . . . 0 C--O 1.235 0.35 0 C-N-CA 122.874 2.383 . . . . 0.0 111.617 179.76 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.718 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo . . . . . 0 C--O 1.233 0.273 0 C-N-CA 122.832 2.355 . . . . 0.0 111.586 179.794 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.478 0.57 0 N-CA-C 110.533 -0.603 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -118.4 166.83 12.18 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 19.1 tt -79.68 -30.81 13.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.899 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 57.4 m -71.18 -7.48 46.99 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -76.75 -14.06 59.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.365 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 76.44 -148.73 36.02 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 5.9 m120 51.51 68.45 0.8 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.042 0.449 . . . . 0.0 111.737 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -97.16 143.48 27.92 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.381 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -72.53 -43.08 64.02 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 1.3 t -170.18 150.43 3.68 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.553 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 48.3 t -128.25 124.11 61.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -147.57 166.73 26.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.277 0.561 . . . . 0.0 111.955 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 33.2 ttp -121.16 119.07 31.31 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 61.7 mt -112.56 119.76 39.28 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.464 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 54.98 28.18 10.31 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 104.4 -24.97 27.37 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.593 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -94.22 130.49 40.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.954 0.377 . . . . 0.0 111.163 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 39.5 ttm -90.93 131.07 36.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.114 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -123.87 128.93 50.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.652 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 43.7 t -103.84 108.56 24.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -89.35 129.85 35.82 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.77 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -149.62 111.76 4.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.99 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 63.62 -110.54 0.3 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.784 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -113.18 9.96 18.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.03 0.443 . . . . 0.0 111.207 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -129.63 160.19 34.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.664 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -140.64 139.81 34.92 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.106 177.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 -102.41 151.14 22.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.656 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 16.2 ttt-85 -111.24 95.24 5.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.678 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 2.3 m -93.37 110.7 23.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.355 0.598 . . . . 0.0 111.143 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.63 92.01 3.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.161 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 9.3 m120 60.42 58.45 2.53 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.623 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 7.0 t30 63.85 17.33 10.45 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.288 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -124.44 130.1 51.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.561 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 39.4 t -87.72 121.13 37.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 90.7 mtp -77.55 148.72 35.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.978 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.46 164.02 22.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.789 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 85.12 4.04 87.0 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -123.73 157.7 61.92 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.584 -0.308 . . . . 0.0 110.748 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.17 140.69 48.92 Favored 'Cis proline' 0 C--N 1.347 0.492 0 C-N-CA 123.646 -1.398 . . . . 0.0 113.012 0.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 52.7 ttm -105.01 137.42 19.21 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.094 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.83 133.31 47.11 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.446 2.098 . . . . 0.0 111.587 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 78.4 mt -59.15 -41.16 82.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -67.91 -16.63 68.58 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 121.104 -0.569 . . . . 0.0 113.88 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -81.25 -54.4 5.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.095 0.447 . . . . 0.0 110.796 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -77.38 -58.89 3.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.178 0.513 . . . . 0.0 110.261 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -88.48 63.17 6.92 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -57.04 103.43 0.11 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.91 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 126.85 -19.65 6.12 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.62 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 27.1 tp -88.72 129.76 47.58 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.69 0.281 . . . . 0.0 110.458 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.29 169.71 21.91 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.726 2.284 . . . . 0.0 112.029 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -77.96 150.13 34.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.186 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 60.2 m 59.9 94.94 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 21.1 pt -107.96 173.83 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.53 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -97.85 -47.93 5.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.254 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.65 165.51 36.33 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.856 0.36 . . . . 0.0 111.489 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -153.23 141.69 20.73 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -156.12 162.69 40.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.169 0.509 . . . . 0.0 112.276 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -90.89 124.3 35.08 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -85.92 174.53 9.2 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.411 ' HZ3' ' CD ' ' A' ' 441' ' ' GLU . 18.9 tttt -65.64 -36.26 83.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.142 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -31.92 73.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.393 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 124.93 -28.03 5.26 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.678 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 31.0 mttt -77.12 174.97 10.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.162 0.506 . . . . 0.0 112.217 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -106.47 134.71 49.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.4 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 13.2 t -112.34 120.31 62.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.901 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -105.29 137.91 42.32 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.956 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -119.07 138.1 53.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.92 0.391 . . . . 0.0 111.576 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -150.47 101.6 2.97 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 74.15 -113.99 4.34 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.274 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -111.51 4.04 18.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.667 0.27 . . . . 0.0 111.17 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -113.68 148.94 35.45 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.248 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -130.32 147.43 52.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.222 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 23.3 m-90 -122.66 133.02 54.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.123 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 96.5 t -109.71 116.76 53.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -110.9 122.77 48.69 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.812 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -91.12 91.45 8.26 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 67.02 -77.51 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 O-C-N 123.874 0.734 . . . . 0.0 110.716 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -141.25 14.66 2.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.248 0.547 . . . . 0.0 109.912 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.57 118.9 28.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.91 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 47.5 tp -69.91 133.42 47.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.409 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -71.75 123.42 89.39 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -59.17 137.72 80.78 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.944 2.429 . . . . 0.0 112.257 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 108.94 6.5 30.08 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.352 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -113.43 167.12 9.84 Favored Pre-proline 0 C--N 1.323 -0.578 0 O-C-N 122.982 -0.128 . . . . 0.0 111.077 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.68 161.73 91.27 Favored 'Cis proline' 0 C--N 1.348 0.541 0 C-N-CA 123.708 -1.372 . . . . 0.0 113.165 0.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -128.39 162.62 26.69 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.072 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -70.29 157.83 37.0 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 47.8 mt -57.16 -33.49 43.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.894 0.378 . . . . 0.0 110.971 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -67.88 -16.66 64.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.844 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -78.77 -15.52 58.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.898 0.38 . . . . 0.0 110.821 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 51.7 tp -83.44 -48.78 9.97 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -159.7 166.16 34.82 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.761 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -95.46 131.1 41.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.998 0.428 . . . . 0.0 110.999 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 106.83 5.87 35.39 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.586 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 95.8 mt -92.39 148.97 37.52 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.1 135.41 69.75 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.185 2.59 . . . . 0.0 111.919 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.47 1.36 51.49 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.669 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -95.27 -56.41 2.73 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.733 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 11.9 ptmt -174.85 173.59 2.72 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.752 0.311 . . . . 0.0 110.584 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 46.6 mm -121.84 132.93 69.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -87.68 -54.08 4.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.248 0.547 . . . . 0.0 109.8 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -149.83 150.95 32.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.368 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -132.54 120.92 22.5 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 61.8 tp -115.73 127.13 54.9 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.024 0.44 . . . . 0.0 111.686 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -94.85 114.31 26.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.719 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 4.5 t-105 -84.98 94.82 8.89 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 66.5 mtt -53.84 -50.15 85.41 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -46.1 -43.37 20.59 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 122.77 2.313 . . . . 0.0 114.867 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -107.04 -23.06 12.45 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 87.05 26.8 30.26 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.036 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 38.6 mmtt -108.22 155.22 20.71 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 9.2 m -112.1 125.88 54.58 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.853 0.359 . . . . 0.0 110.828 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -103.47 119.54 39.1 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.001 0.429 . . . . 0.0 110.634 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -102.15 131.95 48.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.239 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -110.96 132.42 54.22 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.949 0.404 . . . . 0.0 111.444 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -145.29 108.39 4.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 70.54 -105.23 1.54 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.525 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -124.91 11.67 8.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.073 0.463 . . . . 0.0 110.498 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -121.38 143.02 49.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.523 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -123.36 141.13 52.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.03 0.443 . . . . 0.0 111.43 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -110.75 152.38 26.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.573 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 26.7 ttp180 -113.43 96.89 6.13 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -89.52 134.01 34.32 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.387 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -108.57 119.58 39.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.371 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.44 -45.49 73.09 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' GLU . . . . . 0.411 ' CD ' ' HZ3' ' A' ' 375' ' ' LYS . 2.4 mp0 -66.55 -49.79 65.29 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 49.9 mt -71.76 -22.02 61.66 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 60.47 33.49 20.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.369 0.604 . . . . 0.0 111.31 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -156.67 173.2 17.3 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.251 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 98.1 t -89.12 137.87 20.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.114 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.25 156.48 21.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.415 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 16.4 m -69.94 159.61 33.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.397 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 80.15 6.06 1.73 Allowed 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.817 0.698 . . . . 0.0 111.067 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -117.13 162.73 26.36 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.089 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.2 156.19 99.78 Favored 'Cis proline' 0 C--N 1.347 0.493 0 C-N-CA 123.698 -1.376 . . . . 0.0 112.431 0.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -114.68 161.63 17.87 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.172 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -65.71 135.95 55.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.456 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.7 tt -64.63 -13.14 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.107 0.48 . . . . 0.0 111.153 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -62.88 -13.08 29.7 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.877 -0.602 . . . . 0.0 112.533 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 76.0 t -60.85 -37.82 77.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -86.72 91.42 8.61 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.171 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -61.46 112.25 2.12 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 115.29 -21.25 13.24 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.811 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 39.3 mm -81.08 125.77 78.82 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-O 120.815 0.34 . . . . 0.0 110.495 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.47 157.38 32.65 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.799 2.333 . . . . 0.0 111.686 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -78.46 145.06 35.23 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.36 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.9 m 57.68 70.44 1.3 Allowed Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -90.36 179.88 1.82 Allowed 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.68 2.253 . . . . 0.0 110.614 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.42 68.46 1.03 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.396 0.617 . . . . 0.0 110.801 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 137.34 111.7 1.07 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 3.2 p -137.96 115.3 11.09 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.791 0.329 . . . . 0.0 110.177 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -136.58 145.46 44.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 46.4 ttm -101.33 142.53 32.61 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -68.99 163.21 50.86 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.514 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.99 9.29 0.57 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.08 -10.02 16.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.941 0.401 . . . . 0.0 110.8 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 69.42 5.07 4.95 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 43.9 t -111.85 -36.58 2.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 O-C-N 122.18 -0.325 . . . . 0.0 111.68 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -100.79 117.52 35.04 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 52.0 m -109.53 144.26 38.06 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.398 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -121.07 134.48 55.27 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -120.4 134.37 55.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.739 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -113.3 137.6 51.25 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.772 0.32 . . . . 0.0 111.807 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -161.98 109.77 1.4 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.424 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 65.12 58.94 8.58 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 114.614 0.606 . . . . 0.0 114.614 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 41.3 t30 62.89 4.19 1.41 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -121.99 151.07 41.19 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -130.0 152.8 49.07 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.936 0.398 . . . . 0.0 111.428 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 15.1 m-90 -116.78 148.61 41.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.082 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 24.1 tttp -106.86 100.59 10.09 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 486' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -93.12 125.36 37.68 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.297 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -94.9 115.14 27.1 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -66.92 -29.93 69.94 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -64.85 -53.7 42.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.991 0.424 . . . . 0.0 111.405 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -83.1 -14.22 54.14 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.983 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.2 tp 63.6 42.26 6.59 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.448 0.642 . . . . 0.0 109.814 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 47.0 tttt -156.66 156.52 33.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.289 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 53.5 t -79.96 139.81 17.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.149 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -69.82 146.12 95.19 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.025 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.45 153.6 73.56 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.651 2.234 . . . . 0.0 111.552 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 97.51 15.73 36.69 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -123.88 169.01 11.21 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.511 -0.344 . . . . 0.0 110.254 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.7 178.68 33.86 Favored 'Cis proline' 0 C--N 1.346 0.41 0 C-N-CA 123.851 -1.312 . . . . 0.0 112.965 0.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -136.01 150.58 49.27 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.401 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 37.3 t -69.47 128.17 35.57 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.67 -18.39 62.84 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.398 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 28.1 mt -61.68 -62.13 2.02 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.66 -11.53 59.88 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.17 -40.66 10.35 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 21.3 m0 -125.06 -39.3 2.25 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 10.8 mmt -71.82 -20.0 61.9 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 78.95 25.68 59.57 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.45 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 9.9 m -113.97 93.22 28.79 Favored Pre-proline 0 C--N 1.326 -0.434 0 O-C-N 122.845 -0.209 . . . . 0.0 110.658 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -83.58 171.29 11.05 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.866 2.377 . . . . 0.0 112.124 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 8.4 m 53.64 72.15 0.46 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.088 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.476 -1.18 . . . . 0.0 111.551 -179.949 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.735 0 N-CA-C 111.776 -0.529 . . . . 0.0 111.776 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo . . . . . 0 N--CA 1.46 -0.458 0 C-N-CA 122.614 2.21 . . . . 0.0 112.002 179.549 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.621 0 N-CA-C 112.906 -0.078 . . . . 0.0 112.906 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo . . . . . 0 CA--C 1.531 0.373 0 C-N-CA 122.555 2.17 . . . . 0.0 111.445 179.77 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.455 0 CA-C-O 120.411 -0.105 . . . . 0.0 113.207 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo . . . . . 0 CA--C 1.531 0.368 0 C-N-CA 122.999 2.466 . . . . 0.0 111.865 179.375 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.768 0 CA-C-O 120.468 -0.073 . . . . 0.0 113.087 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.87 141.66 30.58 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 123.216 2.611 . . . . 0.0 112.304 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -68.59 147.65 51.62 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.09 147.58 34.2 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.361 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 6.6 mt -61.87 150.11 8.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.4 151.37 46.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.278 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.51 169.17 53.55 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.936 -0.65 . . . . 0.0 113.112 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -78.57 147.15 33.84 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -70.82 146.51 49.66 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.87 155.47 41.92 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.706 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 t -71.88 154.44 7.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.4 t -55.65 142.76 9.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 O-C-N 123.319 0.387 . . . . 0.0 110.874 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.64 163.54 51.67 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.788 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 97.1 mt . . . . . 0 C--N 1.326 -0.435 0 CA-C-O 120.445 0.164 . . . . 0.0 110.693 -179.816 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.473 0 CA-C-O 120.281 -0.177 . . . . 0.0 112.788 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo . . . . . 0 CA--C 1.53 0.314 0 C-N-CA 122.868 2.378 . . . . 0.0 111.662 179.757 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.665 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo . . . . . 0 CA--C 1.529 0.268 0 C-N-CA 122.539 2.159 . . . . 0.0 111.73 179.858 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.445 0 N-CA-C 113.203 0.041 . . . . 0.0 113.203 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo . . . . . 0 CA--C 1.529 0.259 0 C-N-CA 123.336 2.691 . . . . 0.0 111.676 179.965 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 CA-C-O 120.331 -0.149 . . . . 0.0 113.116 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo . . . . . 0 C--N 1.345 0.367 0 C-N-CA 122.764 2.309 . . . . 0.0 111.748 179.671 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.399 0 CA-C-O 120.082 -0.288 . . . . 0.0 112.67 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo . . . . . 0 CA--C 1.53 0.305 0 C-N-CA 123.139 2.559 . . . . 0.0 112.444 -179.893 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.399 0 N-CA-C 112.132 -0.387 . . . . 0.0 112.132 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 CA--C 1.532 0.419 0 C-N-CA 122.78 2.32 . . . . 0.0 112.657 -179.576 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.584 0 N-CA-C 112.81 -0.116 . . . . 0.0 112.81 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo . . . . . 0 N--CA 1.464 -0.22 0 C-N-CA 122.865 2.377 . . . . 0.0 111.336 179.835 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.338 0 N-CA-C 114.043 0.377 . . . . 0.0 114.043 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.95 148.9 36.54 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 123.516 2.81 . . . . 0.0 113.286 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -59.34 140.52 56.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.842 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.47 161.88 38.11 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 116.01 -0.541 . . . . 0.0 113.354 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 42.0 mt -83.24 135.28 25.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.7 146.7 51.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.79 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -69.44 159.56 53.05 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.108 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -81.8 160.5 23.53 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.701 0.286 . . . . 0.0 110.742 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 42.8 ttm-85 -67.14 149.6 50.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.839 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.4 171.2 37.23 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.671 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 15.9 t -72.68 140.92 17.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 24.1 t -57.56 135.96 21.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.209 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.86 162.33 42.37 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.566 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 82.3 mt . . . . . 0 C--N 1.322 -0.59 0 CA-C-O 120.607 0.242 . . . . 0.0 110.524 -179.894 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.698 0 CA-C-O 120.532 -0.038 . . . . 0.0 113.054 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo . . . . . 0 C--O 1.235 0.35 0 C-N-CA 122.68 2.254 . . . . 0.0 111.19 179.842 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.556 0 N-CA-C 112.778 -0.129 . . . . 0.0 112.778 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 N--CA 1.459 -0.505 0 C-N-CA 122.555 2.17 . . . . 0.0 111.724 179.868 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.465 0 N-CA-C 113.461 0.144 . . . . 0.0 113.461 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo . . . . . 0 C--O 1.233 0.254 0 C-N-CA 123.141 2.561 . . . . 0.0 111.849 -179.74 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.538 0 CA-C-O 120.33 -0.15 . . . . 0.0 112.825 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 CA--C 1.531 0.375 0 C-N-CA 122.49 2.127 . . . . 0.0 111.614 179.211 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.451 0 N-CA-C 112.339 -0.304 . . . . 0.0 112.339 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo . . . . . 0 C--N 1.348 0.546 0 C-N-CA 122.608 2.205 . . . . 0.0 111.384 179.681 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 114.387 0.515 . . . . 0.0 114.387 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo . . . . . 0 CA--C 1.531 0.372 0 C-N-CA 123.745 2.964 . . . . 0.0 112.168 -179.984 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.382 0 N-CA-C 113.516 0.166 . . . . 0.0 113.516 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo . . . . . 0 CA--C 1.535 0.542 0 C-N-CA 123.149 2.566 . . . . 0.0 112.727 -179.917 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.556 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -69.11 148.45 69.32 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.957 2.438 . . . . 0.0 112.061 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -67.72 148.97 50.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.716 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -71.29 163.53 54.07 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.251 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 24.9 pt -69.55 165.38 2.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-O 120.65 0.262 . . . . 0.0 111.026 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -87.49 139.23 30.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.924 0.393 . . . . 0.0 110.842 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -61.49 161.76 26.05 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.67 -0.695 . . . . 0.0 113.525 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -73.27 160.36 32.0 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -66.63 155.64 37.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.17 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -61.98 158.21 34.08 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.878 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 25.8 t -61.74 141.88 17.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 24.6 t -62.48 138.51 22.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.206 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -58.12 154.11 24.98 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.613 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 7.2 mp . . . . . 0 C--N 1.323 -0.583 0 CA-C-O 120.742 0.306 . . . . 0.0 111.044 -179.517 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.58 0 N-CA-C 112.685 -0.166 . . . . 0.0 112.685 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo . . . . . 0 N--CA 1.463 -0.277 0 C-N-CA 122.697 2.265 . . . . 0.0 111.222 179.473 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.57 0 N-CA-C 113.734 0.253 . . . . 0.0 113.734 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo . . . . . 0 CA--C 1.532 0.407 0 C-N-CA 122.968 2.445 . . . . 0.0 111.474 179.6 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.495 0 CA-C-O 120.523 -0.043 . . . . 0.0 113.02 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo . . . . . 0 N--CA 1.464 -0.231 0 C-N-CA 122.952 2.435 . . . . 0.0 111.774 -179.919 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo . . . . . 0 N--CA 1.479 0.674 0 N-CA-C 110.066 -0.782 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -109.34 145.39 36.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.425 0.155 . . . . 0.0 110.613 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 19.3 tt -81.05 -19.1 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 121.114 0.483 . . . . 0.0 111.349 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 7.9 m -95.68 12.59 29.28 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.094 0.473 . . . . 0.0 110.244 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -68.82 -33.77 74.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.445 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 82.48 179.85 52.91 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.624 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 5.5 t30 52.17 77.75 0.14 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.172 0.511 . . . . 0.0 111.448 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -98.75 157.53 16.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.235 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -68.48 -39.38 81.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.261 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 13.4 t -176.43 153.53 1.19 Allowed 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.79 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 60.6 t -135.84 123.53 35.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -144.3 178.1 8.15 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.963 0.411 . . . . 0.0 111.62 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 51.9 ttp -130.92 121.57 25.41 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 63.9 mt -114.9 122.09 45.23 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.012 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 64.1 mtp180 55.26 25.76 7.75 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 101.57 -8.67 56.77 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.509 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -105.79 127.92 53.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.993 0.396 . . . . 0.0 110.829 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 45.3 ttm -84.9 134.06 34.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.818 0.342 . . . . 0.0 111.633 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -126.49 128.39 46.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.64 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 35.6 t -108.31 119.37 57.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.43 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -99.85 131.76 45.62 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -141.51 106.01 4.86 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.723 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 63.03 -105.18 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.55 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -115.07 10.68 16.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.868 0.366 . . . . 0.0 111.32 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 10.1 m-90 -123.93 163.02 22.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.12 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -143.83 144.44 31.78 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.978 0.418 . . . . 0.0 110.923 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -108.41 146.52 32.94 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.818 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 23.9 ttt-85 -115.83 96.08 5.43 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 3.3 m -88.21 129.6 39.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.995 0.426 . . . . 0.0 111.184 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -142.87 122.44 13.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.853 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 14.3 m120 57.65 41.0 26.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.115 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 67.77 23.71 8.48 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.187 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -134.25 154.05 51.51 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 46.0 t -90.79 121.92 41.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 1.7 ttt -65.32 144.39 57.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.748 0.308 . . . . 0.0 111.133 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -66.87 147.1 53.68 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.546 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 100.94 -0.71 55.09 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.134 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -122.07 160.11 48.81 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.86 136.61 39.87 Favored 'Cis proline' 0 C--N 1.347 0.497 0 C-N-CA 123.736 -1.36 . . . . 0.0 113.025 0.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 47.2 ttm -116.59 141.95 28.84 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.448 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.62 135.27 68.5 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.262 1.975 . . . . 0.0 111.352 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 95.3 mt -54.21 -43.74 61.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.354 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -69.87 -6.44 56.01 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 121.028 -0.606 . . . . 0.0 114.606 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -86.24 -37.11 18.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.501 0.65 . . . . 0.0 110.208 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -95.11 -53.65 3.72 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -92.26 71.73 5.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 -59.99 101.71 0.13 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.135 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 131.06 -19.42 4.91 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.452 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 22.2 tp -91.14 131.95 35.5 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.681 0.276 . . . . 0.0 110.626 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -82.67 -173.76 1.83 Allowed 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.789 2.326 . . . . 0.0 112.269 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -90.01 154.75 19.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.212 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.7 m 56.37 93.47 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 21.5 pt -110.53 179.82 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.447 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -96.45 -55.81 2.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.949 0.404 . . . . 0.0 110.949 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.9 167.91 28.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.161 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -142.86 139.21 30.76 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -152.86 166.26 32.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.06 0.457 . . . . 0.0 111.913 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -100.77 141.13 34.08 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.19 -0.914 . . . . 0.0 108.64 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -100.77 -171.65 2.05 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.494 ' HZ3' ' CD ' ' A' ' 441' ' ' GLU . 39.3 tttt -72.46 -25.74 61.55 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -177.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.21 -17.38 32.76 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 113.49 -17.27 21.26 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.805 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 46.1 mttp -74.66 158.21 34.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.097 0.475 . . . . 0.0 111.521 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -98.46 134.76 40.99 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.444 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 21.9 t -116.58 121.08 66.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.023 0.439 . . . . 0.0 110.496 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -105.57 139.03 40.79 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -119.39 144.44 46.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.773 0.321 . . . . 0.0 111.702 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -155.51 98.89 1.99 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.954 178.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 71.52 -114.75 5.29 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.815 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -105.07 6.43 33.27 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -118.28 151.4 37.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.795 0.331 . . . . 0.0 111.793 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 37.0 p-80 -136.0 145.35 46.0 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.238 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 17.8 m-90 -118.27 133.09 56.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.654 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 60.0 t -111.78 113.4 44.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -107.66 127.52 53.74 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -92.7 88.92 6.45 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 69.02 -71.3 0.12 Allowed 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.721 0.638 . . . . 0.0 111.002 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -142.41 3.18 1.5 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.174 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.84 126.48 54.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.729 0.3 . . . . 0.0 111.582 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 47.8 tp -74.09 135.21 42.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.654 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -75.63 134.78 72.23 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.859 0.362 . . . . 0.0 111.068 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -58.74 142.53 98.79 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.199 2.599 . . . . 0.0 112.28 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 104.23 -25.1 27.17 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.309 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -89.64 161.24 39.71 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 110.561 -0.163 . . . . 0.0 110.561 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.03 152.84 98.68 Favored 'Cis proline' 0 C--N 1.345 0.355 0 C-N-CA 123.77 -1.346 . . . . 0.0 113.394 0.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -126.39 169.78 12.62 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.491 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -71.75 158.09 36.74 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.656 0.265 . . . . 0.0 111.236 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 22.4 mt -59.22 -35.54 58.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.18 0.514 . . . . 0.0 110.03 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 44.1 pttt -67.05 -15.04 63.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.803 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -82.27 -28.66 31.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.851 0.357 . . . . 0.0 110.549 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 41.1 tp -72.14 -53.34 13.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.29 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -153.9 159.68 28.89 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.618 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -89.69 127.37 35.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.719 0.295 . . . . 0.0 110.533 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 106.31 -0.92 37.52 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.226 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 95.1 mt -79.0 156.51 76.91 Favored Pre-proline 0 C--N 1.32 -0.691 0 O-C-N 122.878 -0.189 . . . . 0.0 110.663 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -53.34 138.62 64.83 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.677 2.252 . . . . 0.0 112.013 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.01 -15.97 28.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.723 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -86.41 -61.01 1.84 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 10.0 pttp -175.33 179.15 1.55 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 33.4 mm -117.98 147.93 21.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -100.15 -49.54 4.25 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -157.65 156.15 31.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.258 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -136.78 120.03 16.76 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 21.9 tp -108.94 124.53 50.83 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.058 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -97.57 114.13 25.98 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 10.9 t-105 -83.6 94.81 8.16 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 10.1 mmt -49.8 -52.84 48.07 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -47.55 -42.41 29.1 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 123.036 2.491 . . . . 0.0 115.177 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 36.0 p30 -104.64 -19.36 13.99 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 78.56 34.89 34.14 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.209 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 37.4 mmtt -117.0 147.48 42.27 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.6 m -107.53 126.64 52.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.771 0.32 . . . . 0.0 110.491 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -104.04 110.61 22.84 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.862 0.363 . . . . 0.0 110.74 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -92.46 120.78 33.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.781 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -97.01 132.26 43.0 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.751 0.31 . . . . 0.0 111.183 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -144.41 104.9 4.13 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.066 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 67.15 -111.66 4.27 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.591 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -109.3 10.64 25.59 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -130.94 152.44 50.26 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.805 0.336 . . . . 0.0 111.681 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -125.87 142.65 51.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.504 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -109.43 136.11 49.37 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.671 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -97.31 99.48 10.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.161 0.505 . . . . 0.0 109.651 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -89.94 134.81 34.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.748 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -110.56 106.6 15.93 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.354 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.7 -47.23 59.08 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -178.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' GLU . . . . . 0.494 ' CD ' ' HZ3' ' A' ' 375' ' ' LYS . 2.5 mp0 -59.3 -35.85 74.54 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 67.1 mt -98.63 -15.81 19.3 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 60.96 40.09 15.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.635 0.731 . . . . 0.0 110.992 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -150.97 168.24 25.15 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.458 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 87.6 t -92.01 141.58 14.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.553 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -62.13 163.39 8.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.161 0.505 . . . . 0.0 111.514 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 20.0 m -76.71 157.6 31.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.59 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 72.69 23.43 2.97 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.532 0.682 . . . . 0.0 111.01 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -122.37 164.13 28.03 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.119 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.61 161.29 92.21 Favored 'Cis proline' 0 C--N 1.345 0.378 0 C-N-CA 123.678 -1.384 . . . . 0.0 112.697 0.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -111.77 161.32 16.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.726 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 -66.08 140.06 58.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.821 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.4 tt -64.27 -13.07 13.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.427 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 36.9 mttm -61.46 -11.99 12.91 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 79.8 t -61.53 -34.79 63.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -89.05 95.53 10.36 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -56.6 107.72 0.42 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 105.05 -1.73 40.97 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.698 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 20.1 mm -88.92 129.01 49.97 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.978 0.389 . . . . 0.0 111.335 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.26 149.07 19.27 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 123.063 2.509 . . . . 0.0 112.904 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -71.4 146.27 48.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.379 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 4.2 m 55.08 71.39 1.3 Allowed Pre-proline 0 N--CA 1.467 0.412 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -85.84 178.49 4.24 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.711 2.274 . . . . 0.0 111.745 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.6 8.44 6.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.042 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -177.23 147.57 8.35 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.824 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 19.4 p -164.19 98.17 0.82 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -128.61 140.35 51.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.925 0.393 . . . . 0.0 111.31 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 39.2 ttm -84.78 138.82 32.37 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.965 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -72.33 160.04 53.91 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.467 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -15.45 57.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.969 0.414 . . . . 0.0 111.385 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -79.14 -18.53 53.01 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.222 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 69.21 1.77 3.38 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.22 -38.21 7.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.836 0.35 . . . . 0.0 111.458 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -120.84 143.69 48.76 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 55.3 m -115.88 139.97 49.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.32 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -106.18 123.6 48.28 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -107.18 144.99 33.13 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 94.1 t80 -129.02 134.7 48.24 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 59.7 tttt -170.81 134.35 1.01 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.991 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 60.11 43.37 98.38 Favored Glycine 0 N--CA 1.454 -0.125 0 CA-C-N 115.979 -0.555 . . . . 0.0 114.039 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 39.9 t30 67.07 3.58 3.21 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -118.22 157.13 27.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.733 0.301 . . . . 0.0 110.741 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -127.07 149.62 49.84 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.499 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 19.2 m-90 -117.82 138.67 51.93 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.529 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -101.42 93.95 5.66 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 486' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -85.21 130.12 34.67 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.394 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -86.65 121.53 29.29 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -65.94 -52.25 51.42 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.25 -40.39 86.26 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -178.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -78.26 -26.16 47.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.548 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 6.1 tp 63.24 38.78 10.18 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.572 0.701 . . . . 0.0 110.222 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -153.53 148.72 26.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.438 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 77.8 t -75.83 131.27 35.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -59.45 137.35 89.15 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.836 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.28 143.1 99.86 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.912 2.408 . . . . 0.0 112.261 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 103.76 5.39 44.86 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.278 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -114.03 166.27 11.81 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.554 -0.323 . . . . 0.0 110.349 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.75 178.67 32.41 Favored 'Cis proline' 0 C--N 1.349 0.557 0 C-N-CA 123.752 -1.353 . . . . 0.0 113.075 0.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -135.23 160.12 39.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.277 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 42.4 t -69.66 125.92 28.16 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.812 0.339 . . . . 0.0 110.977 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -71.64 -22.9 61.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.284 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 26.4 mt -69.55 -47.34 64.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.53 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -75.9 -35.08 59.95 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -88.69 -46.86 8.68 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 36.1 m0 -92.72 -56.73 2.9 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -177.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 11.4 mmt -64.08 -45.43 88.74 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 105.85 29.63 4.87 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.398 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 15.1 m -106.45 105.38 54.23 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -81.11 160.92 20.6 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 123.289 2.66 . . . . 0.0 112.087 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 18.6 m 61.15 68.14 0.75 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.574 0.702 . . . . 0.0 111.653 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.388 -1.229 . . . . 0.0 111.474 -179.7 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.608 0 N-CA-C 111.893 -0.483 . . . . 0.0 111.893 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo . . . . . 0 CA--C 1.53 0.306 0 C-N-CA 122.621 2.214 . . . . 0.0 111.985 179.966 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.571 0 N-CA-C 113.46 0.144 . . . . 0.0 113.46 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 CA--C 1.531 0.331 0 C-N-CA 123.002 2.468 . . . . 0.0 111.797 179.89 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.608 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo . . . . . 0 CA--C 1.531 0.368 0 C-N-CA 122.553 2.168 . . . . 0.0 111.26 179.26 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.81 0 N-CA-C 112.198 -0.361 . . . . 0.0 112.198 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.51 147.59 71.07 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.837 2.358 . . . . 0.0 111.575 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -68.71 150.41 47.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.971 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.48 154.7 29.95 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.129 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 mt -65.24 152.57 8.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.42 145.91 47.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.371 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.48 159.57 53.64 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 121.144 -0.551 . . . . 0.0 112.633 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -72.34 146.23 47.24 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -69.89 146.67 51.08 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.2 150.97 43.18 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.76 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 4.6 t -67.11 146.34 13.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.0 t -53.76 144.94 4.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.33 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.86 167.16 54.12 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.87 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 C--N 1.322 -0.587 0 C-N-CA 121.987 0.115 . . . . 0.0 110.746 -179.755 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.649 0 N-CA-C 112.252 -0.339 . . . . 0.0 112.252 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 C--O 1.232 0.195 0 C-N-CA 122.597 2.198 . . . . 0.0 111.275 179.637 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 113.551 0.181 . . . . 0.0 113.551 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 C--O 1.235 0.351 0 C-N-CA 122.835 2.357 . . . . 0.0 111.486 179.442 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 113.458 0.143 . . . . 0.0 113.458 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo . . . . . 0 CA--C 1.531 0.358 0 C-N-CA 123.158 2.572 . . . . 0.0 111.731 179.674 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.508 0 CA-C-O 120.357 -0.135 . . . . 0.0 112.765 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 N--CA 1.462 -0.362 0 C-N-CA 122.695 2.263 . . . . 0.0 111.924 179.813 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.348 0 CA-C-O 120.086 -0.286 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo . . . . . 0 CA--C 1.53 0.283 0 C-N-CA 122.963 2.442 . . . . 0.0 111.875 179.735 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.413 0 N-CA-C 112.851 -0.1 . . . . 0.0 112.851 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo . . . . . 0 CA--C 1.531 0.373 0 C-N-CA 123.592 2.862 . . . . 0.0 112.11 -179.694 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.41 0 N-CA-C 112.299 -0.32 . . . . 0.0 112.299 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo . . . . . 0 CA--C 1.528 0.209 0 C-N-CA 122.664 2.242 . . . . 0.0 111.353 179.84 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.423 0 N-CA-C 113.915 0.326 . . . . 0.0 113.915 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -65.14 163.97 26.97 Favored 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 122.841 2.361 . . . . 0.0 112.417 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -62.16 144.45 55.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.318 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -75.51 163.65 53.83 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.98 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 21.7 mt -65.14 136.61 26.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.17 148.14 50.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.254 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.36 154.43 37.87 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.117 -0.564 . . . . 0.0 112.873 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -83.51 163.25 20.58 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 43.5 ttm-85 -68.13 148.99 50.16 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.687 0.279 . . . . 0.0 110.357 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.93 175.35 38.6 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.06 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 25.3 t -73.49 140.24 18.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 90.4 t -63.27 136.07 26.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.105 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.18 157.62 46.54 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.269 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 74.4 mt . . . . . 0 C--N 1.324 -0.526 0 CA-C-O 120.658 0.266 . . . . 0.0 111.103 -179.657 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 C--O 1.236 0.4 0 C-N-CA 122.55 2.166 . . . . 0.0 111.737 179.904 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.61 0 N-CA-C 112.818 -0.113 . . . . 0.0 112.818 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 C--O 1.237 0.462 0 C-N-CA 122.494 2.129 . . . . 0.0 111.321 179.554 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.604 0 N-CA-C 112.494 -0.243 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo . . . . . 0 N--CA 1.463 -0.293 0 C-N-CA 122.822 2.348 . . . . 0.0 111.353 179.837 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.426 0 CA-C-O 120.186 -0.23 . . . . 0.0 112.699 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo . . . . . 0 N--CA 1.462 -0.37 0 C-N-CA 122.667 2.245 . . . . 0.0 111.891 -179.706 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 201' ' ' PRO . . . . . 0.405 ' C ' ' H ' ' D' ' 203' ' ' GLY . 78.1 Cg_exo . . . . . 0 C--N 1.346 0.408 0 C-N-CA 123.014 2.476 . . . . 0.0 111.651 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 203' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' D' ' 201' ' ' PRO . . . . . . . . 0 CA--C 1.521 0.435 0 N-CA-C 114.236 0.455 . . . . 0.0 114.236 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo . . . . . 0 CA--C 1.536 0.605 0 C-N-CA 123.473 2.782 . . . . 0.0 111.965 179.213 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 CA-C-O 120.342 -0.144 . . . . 0.0 112.824 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 N--CA 1.458 -0.599 0 C-N-CA 123.475 2.783 . . . . 0.0 112.636 179.972 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 112.842 -0.103 . . . . 0.0 112.842 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -71.85 141.85 37.96 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 123.02 2.48 . . . . 0.0 111.949 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -65.84 146.42 54.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.943 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -70.05 162.97 52.66 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.897 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 39.4 pt -69.84 166.85 2.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.606 0.241 . . . . 0.0 110.971 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -83.15 144.44 29.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.884 0.373 . . . . 0.0 110.882 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -65.95 168.14 33.4 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.8 -0.636 . . . . 0.0 114.054 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 -75.95 155.77 34.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.698 0.285 . . . . 0.0 110.955 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -66.14 153.06 43.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.5 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -59.83 150.25 39.54 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.086 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 13.8 t -61.2 143.12 15.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.61 142.16 16.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.888 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -59.88 154.79 31.41 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.358 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 C--N 1.32 -0.68 0 O-C-N 122.843 -0.21 . . . . 0.0 110.795 -179.8 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.407 0 N-CA-C 113.575 0.19 . . . . 0.0 113.575 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 CA--C 1.531 0.327 0 C-N-CA 123.213 2.608 . . . . 0.0 112.09 179.611 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.709 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 C--O 1.238 0.478 0 C-N-CA 122.702 2.268 . . . . 0.0 111.809 179.903 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.697 0 N-CA-C 113.699 0.24 . . . . 0.0 113.699 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo . . . . . 0 N--CA 1.464 -0.243 0 C-N-CA 123.214 2.61 . . . . 0.0 111.263 179.567 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo . . . . . 0 N--CA 1.479 0.62 0 N-CA-C 110.477 -0.624 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -105.76 158.25 16.87 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 15.0 tt -75.39 -19.13 15.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.41 0.624 . . . . 0.0 110.046 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 69.5 m -85.7 -1.31 57.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.717 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -74.15 -23.59 59.28 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.366 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 74.46 -172.32 52.41 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.607 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 2.1 t30 54.6 81.7 0.1 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.113 0.565 . . . . 0.0 111.942 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -104.65 164.43 11.77 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.709 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -73.32 -41.26 63.73 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 9.4 t -172.78 152.5 2.49 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.535 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 97.6 t -133.0 118.28 32.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -141.58 172.94 12.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.063 0.459 . . . . 0.0 111.473 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 31.9 ttp -121.77 123.39 41.71 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.624 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 59.3 mt -116.6 118.43 32.59 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.933 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 43.7 mtp180 56.49 28.04 13.15 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 98.76 -11.86 62.69 Favored Glycine 0 CA--C 1.517 0.193 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.225 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -98.52 128.23 44.77 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.823 0.344 . . . . 0.0 110.875 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 48.7 ttm -87.39 119.9 28.13 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.504 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -112.04 128.4 56.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.055 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 26.1 t -106.8 119.91 57.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.434 -0.803 . . . . 0.0 108.913 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -107.87 130.11 55.03 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -153.44 108.24 3.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.75 177.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 69.89 -129.67 0.08 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.034 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 12.8 ptm85 -94.94 2.63 55.4 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -123.61 154.85 38.72 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.784 0.326 . . . . 0.0 111.053 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -134.16 149.76 51.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.568 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 26.2 m-90 -119.65 167.56 11.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.634 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.13 114.27 6.21 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 10.5 m -102.78 143.99 14.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.165 0.507 . . . . 0.0 112.238 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 29.1 ttm-85 -150.79 126.91 10.52 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.924 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 22.7 m120 68.55 30.89 5.0 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.203 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 39.6 t30 66.06 24.23 11.0 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.224 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -136.45 146.27 46.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.339 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 32.8 t -79.0 124.69 37.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 60.4 mtp -71.15 160.55 32.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.774 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -72.32 153.61 41.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.118 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 98.64 -4.41 59.68 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.517 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -118.6 152.6 51.42 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -73.94 149.12 93.54 Favored 'Cis proline' 0 C--O 1.234 0.315 0 C-N-CA 123.356 -1.518 . . . . 0.0 112.884 0.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 55.1 ttm -129.57 139.68 36.39 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.42 -0.809 . . . . 0.0 108.949 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.88 131.26 44.96 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.211 1.941 . . . . 0.0 111.213 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 65.6 mt -52.02 -46.21 41.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.047 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -65.05 -16.07 61.48 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 121.267 -0.492 . . . . 0.0 114.128 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -34.2 61.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.141 0.471 . . . . 0.0 110.574 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -101.25 -51.5 3.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.165 0.507 . . . . 0.0 110.062 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -87.8 85.68 7.07 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.371 0.605 . . . . 0.0 109.571 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -65.63 83.41 0.06 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.859 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 133.54 -3.6 4.7 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.164 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 22.9 tp -98.83 131.72 25.11 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 120.616 0.246 . . . . 0.0 110.858 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.55 -174.83 2.43 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.715 2.277 . . . . 0.0 111.598 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -91.35 151.34 20.9 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.938 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 18.1 m 57.45 93.52 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.483 0.919 . . . . 0.0 113.483 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 24.1 pt -107.19 172.39 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.409 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -96.64 -40.57 8.94 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -162.7 171.88 16.16 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.773 0.32 . . . . 0.0 111.347 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -162.06 144.44 11.39 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -157.35 164.16 37.87 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -95.5 122.05 37.82 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -75.57 -175.7 2.96 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -67.46 -33.18 74.59 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.988 0.423 . . . . 0.0 111.375 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.75 -50.62 19.79 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.825 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 147.63 -29.76 1.43 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.214 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -59.13 150.49 25.07 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.91 0.386 . . . . 0.0 111.088 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -95.73 136.09 36.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.612 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 3.8 t -113.86 113.96 45.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.094 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -100.52 144.78 29.11 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -126.63 141.51 51.83 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.848 0.356 . . . . 0.0 111.632 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -152.99 105.48 2.93 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 177.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 72.49 -117.07 6.04 Favored Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -109.85 10.51 24.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.848 0.356 . . . . 0.0 110.946 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -118.75 151.08 38.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.878 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 27.8 p-80 -131.38 153.28 49.82 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.028 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 26.7 m-90 -127.97 131.87 49.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.238 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 78.8 t -111.02 122.78 66.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -113.57 122.41 47.15 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -85.03 82.42 8.45 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 177.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 71.92 -68.93 0.2 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.489 -177.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -143.8 7.52 1.45 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.93 0.395 . . . . 0.0 110.915 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 2.0 m -113.76 125.01 53.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.02 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 52.3 tp -76.52 128.22 34.34 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.533 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -64.42 136.54 96.8 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.985 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.95 143.22 99.3 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.168 2.579 . . . . 0.0 112.447 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 96.51 -15.01 63.52 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.543 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -83.72 156.56 64.76 Favored Pre-proline 0 C--N 1.323 -0.577 0 O-C-N 122.672 -0.311 . . . . 0.0 110.782 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.51 156.38 97.04 Favored 'Cis proline' 0 C--N 1.349 0.593 0 C-N-CA 123.963 -1.266 . . . . 0.0 113.522 0.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -128.19 159.6 34.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.0 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -69.75 153.09 43.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.245 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 64.9 mt -56.52 -33.51 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -65.14 -12.53 51.97 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -80.91 -26.58 36.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.876 0.37 . . . . 0.0 110.772 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 32.2 tp -75.0 -47.14 30.67 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -169.37 147.82 11.44 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.759 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 33.0 ttt180 -84.68 132.96 34.41 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.745 0.307 . . . . 0.0 110.315 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 114.14 -14.77 21.1 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.551 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.17 152.9 84.29 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.571 -0.314 . . . . 0.0 110.563 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.46 130.19 38.75 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.922 2.414 . . . . 0.0 111.545 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.11 3.82 55.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.985 0.421 . . . . 0.0 111.482 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -95.52 -57.53 2.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.579 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 5.1 ptmt -172.38 171.64 4.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.919 0.39 . . . . 0.0 110.858 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 49.2 mm -120.92 127.52 75.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -86.49 -48.01 8.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.935 0.398 . . . . 0.0 110.55 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -153.87 154.38 33.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.295 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -135.1 107.27 7.18 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 40.5 tp -99.14 117.21 33.11 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.281 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -89.0 115.44 26.57 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.035 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -84.26 90.44 7.53 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 62.9 mtt -47.97 -48.73 61.95 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -48.87 -35.47 31.35 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 122.862 2.375 . . . . 0.0 114.787 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 38.3 p30 -113.29 -35.47 5.31 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 104.62 10.44 33.17 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.617 -0.802 . . . . 0.0 113.367 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -97.88 155.41 17.08 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.418 -0.46 . . . . 0.0 110.605 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 7.4 m -113.16 130.36 56.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.994 0.426 . . . . 0.0 111.568 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -100.85 108.17 19.89 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.742 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -91.47 124.57 35.74 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.226 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -99.57 132.24 45.03 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.094 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -144.4 108.08 4.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.171 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 70.14 -110.22 3.21 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.774 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 28.1 p30 -117.71 17.69 14.3 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.837 0.351 . . . . 0.0 111.158 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 52.5 mttt -133.86 158.22 43.97 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.725 0.298 . . . . 0.0 110.959 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -128.99 144.5 51.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.211 0.529 . . . . 0.0 110.984 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -110.53 133.74 53.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.596 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 19.2 ttp180 -94.86 92.14 6.78 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -84.34 129.04 34.91 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.131 0.491 . . . . 0.0 111.642 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -99.39 108.89 21.49 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -58.57 -43.04 89.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.947 0.403 . . . . 0.0 110.621 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -84.24 48.65 1.52 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.797 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -169.6 -35.03 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.706 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 37.6 mtp-105 69.58 36.94 2.04 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.429 0.633 . . . . 0.0 111.199 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -155.72 167.37 30.61 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.925 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 59.7 t -87.74 141.06 14.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.966 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -62.09 155.44 24.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.998 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.85 157.73 27.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.849 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 76.04 5.93 3.75 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.259 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -112.63 163.36 18.05 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.762 -0.199 . . . . 0.0 111.329 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.87 155.65 98.87 Favored 'Cis proline' 0 C--N 1.349 0.57 0 C-N-CA 123.624 -1.407 . . . . 0.0 112.967 0.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -116.84 162.3 17.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.305 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -65.53 139.94 58.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.718 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.1 tt -67.48 -9.6 10.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.094 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -63.47 -7.35 6.6 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 95.7 t -65.94 -37.17 79.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -88.43 93.68 9.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.94 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . 0.426 ' CD ' ' HZ2' ' A' ' 492' ' ' LYS . 0.2 OUTLIER -62.28 116.32 4.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.149 0.5 . . . . 0.0 112.072 -178.78 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 107.3 -15.57 39.02 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.716 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 33.6 mm -83.59 125.9 72.52 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 120.857 0.36 . . . . 0.0 111.304 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.44 152.93 30.55 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.758 2.306 . . . . 0.0 111.719 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -73.42 147.36 44.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.473 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 2.0 m 54.89 75.85 0.57 Allowed Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -83.5 -176.59 2.81 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.156 2.571 . . . . 0.0 112.173 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -134.81 18.96 3.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.207 0.527 . . . . 0.0 110.405 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 166.15 142.9 3.56 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 11.4 p -157.54 108.23 2.25 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -134.23 146.14 49.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.881 0.372 . . . . 0.0 111.507 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 48.0 ttm -99.03 141.06 32.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.167 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -67.69 166.74 42.5 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.179 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 2.7 m -68.74 -8.26 41.3 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.34 -14.27 27.1 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.969 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 65.39 12.17 7.9 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.241 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.7 -45.05 12.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.941 0.4 . . . . 0.0 110.682 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -114.07 141.56 47.31 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.208 0.528 . . . . 0.0 112.0 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 91.9 m -119.42 138.8 52.86 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.685 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -112.51 131.06 55.78 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.292 0.568 . . . . 0.0 112.506 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -114.65 142.78 46.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.215 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -123.75 136.84 54.67 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 111.526 0.195 . . . . 0.0 111.526 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -167.43 126.11 1.31 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.001 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 57.92 46.83 92.0 Favored Glycine 0 CA--C 1.519 0.341 0 CA-C-N 116.003 -0.544 . . . . 0.0 114.356 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 68.65 -2.25 1.72 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.775 0.658 . . . . 0.0 112.775 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -106.39 151.42 24.91 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -126.89 138.84 53.37 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.031 0.443 . . . . 0.0 111.332 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 15.1 m-90 -108.33 145.65 34.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.23 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 53.5 tttt -111.86 100.45 8.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.075 0.464 . . . . 0.0 109.927 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 486' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -89.1 130.61 35.52 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.945 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -96.82 112.38 24.16 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -64.72 -23.43 67.25 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 31.3 tp60 -78.57 -24.5 45.52 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -114.1 -6.26 13.08 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 15.3 tp 58.02 34.22 24.01 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.525 0.679 . . . . 0.0 110.375 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 492' ' ' LYS . . . . . 0.426 ' HZ2' ' CD ' ' A' ' 457' ' ' GLU . 39.3 tttp -152.46 152.71 32.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.703 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 66.7 t -76.1 133.36 31.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.696 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -61.38 148.22 86.1 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.386 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.23 149.56 85.27 Favored 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 122.743 2.295 . . . . 0.0 112.457 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 96.25 13.25 49.44 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.751 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -121.08 164.5 23.36 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.874 -0.163 . . . . 0.0 110.783 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.65 164.23 79.32 Favored 'Cis proline' 0 C--N 1.344 0.337 0 C-N-CA 123.806 -1.331 . . . . 0.0 113.647 0.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -118.68 160.77 21.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.651 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 30.1 t -71.97 115.47 11.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.946 0.403 . . . . 0.0 110.978 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -69.99 -23.67 63.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.61 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 83.5 mt -67.02 -32.0 72.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.074 0.464 . . . . 0.0 110.862 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -96.68 -35.08 11.14 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -89.65 -17.64 28.01 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 13.0 m0 -121.37 -52.63 2.04 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 11.2 mmt -67.95 -29.33 68.36 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 88.84 30.72 14.06 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.032 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 31.7 m -101.93 114.23 65.61 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.0 124.34 11.7 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.968 2.445 . . . . 0.0 112.652 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 3.9 m 68.28 153.68 0.1 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.482 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.188 -1.34 . . . . 0.0 111.19 179.957 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.771 0 N-CA-C 112.048 -0.421 . . . . 0.0 112.048 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 CA--C 1.53 0.321 0 C-N-CA 122.722 2.281 . . . . 0.0 112.01 179.916 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.61 0 N-CA-C 112.175 -0.37 . . . . 0.0 112.175 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo . . . . . 0 C--O 1.232 0.21 0 C-N-CA 122.764 2.309 . . . . 0.0 111.415 179.773 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.683 0 N-CA-C 112.318 -0.313 . . . . 0.0 112.318 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo . . . . . 0 N--CA 1.463 -0.303 0 C-N-CA 122.617 2.211 . . . . 0.0 111.361 179.085 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.673 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.64 143.6 68.88 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.88 2.387 . . . . 0.0 111.514 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -64.89 150.82 47.08 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.99 154.72 31.96 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.345 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 6.5 mt -59.58 150.38 5.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.891 0.377 . . . . 0.0 110.924 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.59 145.27 56.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.127 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.32 153.85 45.54 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.903 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -69.27 148.59 49.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.756 0.312 . . . . 0.0 110.612 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -66.34 138.64 57.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.715 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.51 145.13 49.77 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.637 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 t -63.8 149.22 10.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.496 0.148 . . . . 0.0 110.766 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 11.0 t -52.13 146.05 2.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.262 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.54 165.08 52.45 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 121.187 -0.53 . . . . 0.0 113.4 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 81.2 mt . . . . . 0 C--N 1.322 -0.598 0 CA-C-N 115.639 -0.28 . . . . 0.0 110.342 179.946 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.586 0 N-CA-C 112.226 -0.349 . . . . 0.0 112.226 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo . . . . . 0 C--O 1.234 0.314 0 C-N-CA 122.756 2.304 . . . . 0.0 111.698 179.662 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.51 0 N-CA-C 112.748 -0.141 . . . . 0.0 112.748 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo . . . . . 0 CA--C 1.532 0.423 0 C-N-CA 123.043 2.495 . . . . 0.0 112.031 -179.997 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 113.52 0.168 . . . . 0.0 113.52 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo . . . . . 0 C--N 1.345 0.392 0 C-N-CA 123.308 2.672 . . . . 0.0 112.455 -179.803 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.459 0 N-CA-C 113.8 0.28 . . . . 0.0 113.8 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo . . . . . 0 C--N 1.346 0.406 0 C-N-CA 122.952 2.435 . . . . 0.0 111.397 179.257 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.35 0 CA-C-O 120.019 -0.323 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo . . . . . 0 C--O 1.235 0.359 0 C-N-CA 122.823 2.349 . . . . 0.0 111.63 179.54 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo . . . . . 0 N--CA 1.463 -0.319 0 C-N-CA 123.074 2.516 . . . . 0.0 111.97 179.862 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.513 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo . . . . . 0 N--CA 1.466 -0.142 0 C-N-CA 122.676 2.251 . . . . 0.0 110.743 179.621 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.479 0 CA-C-O 120.454 -0.081 . . . . 0.0 113.282 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.26 160.07 32.48 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 123.216 2.611 . . . . 0.0 112.525 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -62.03 134.23 56.35 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.794 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -65.39 162.02 41.26 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.441 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 53.5 mt -72.94 138.72 20.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.8 153.09 37.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.306 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -66.56 159.39 48.29 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.351 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -88.94 150.53 22.8 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.617 0.246 . . . . 0.0 110.594 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 19.5 ttm-85 -60.97 142.11 56.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.323 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.24 167.12 49.79 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.41 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 86.0 t -66.73 142.28 16.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.675 0.274 . . . . 0.0 111.014 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 94.4 t -61.6 143.39 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.122 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.89 163.61 36.94 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.726 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 87.3 mt . . . . . 0 C--N 1.324 -0.519 0 CA-C-O 120.49 0.186 . . . . 0.0 110.755 -179.959 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.512 0 N-CA-C 113.462 0.145 . . . . 0.0 113.462 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 C--O 1.234 0.312 0 C-N-CA 122.709 2.273 . . . . 0.0 111.629 -179.918 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.565 0 N-CA-C 112.318 -0.313 . . . . 0.0 112.318 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo . . . . . 0 N--CA 1.459 -0.516 0 C-N-CA 122.666 2.244 . . . . 0.0 111.223 179.479 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.62 0 CA-C-O 120.694 0.052 . . . . 0.0 112.997 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo . . . . . 0 C--O 1.235 0.348 0 C-N-CA 122.921 2.414 . . . . 0.0 111.691 -179.94 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.555 0 CA-C-O 120.211 -0.216 . . . . 0.0 112.958 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo . . . . . 0 C--N 1.345 0.369 0 C-N-CA 122.823 2.349 . . . . 0.0 111.463 179.509 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.287 0 CA-C-O 120.056 -0.302 . . . . 0.0 112.437 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 C--N 1.345 0.366 0 C-N-CA 122.789 2.326 . . . . 0.0 111.034 179.667 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.418 0 N-CA-C 114.72 0.648 . . . . 0.0 114.72 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo . . . . . 0 CA--C 1.531 0.339 0 C-N-CA 123.528 2.819 . . . . 0.0 110.411 178.307 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.287 0 N-CA-C 113.454 0.141 . . . . 0.0 113.454 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo . . . . . 0 CA--C 1.533 0.454 0 C-N-CA 123.33 2.686 . . . . 0.0 112.803 -179.87 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.456 0 N-CA-C 112.319 -0.312 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.89 152.89 32.58 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 123.044 2.496 . . . . 0.0 111.786 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -73.91 149.32 41.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.774 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -68.02 159.45 51.2 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.486 -0.645 . . . . 0.0 111.486 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 42.1 pt -64.4 163.48 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-O 120.891 0.376 . . . . 0.0 111.484 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -74.56 145.16 43.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.333 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -67.42 158.02 51.34 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.518 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 -76.19 151.33 36.93 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -64.58 153.04 40.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.337 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -61.86 157.03 35.5 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.269 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 12.3 t -70.91 147.52 11.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.59 136.85 25.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.99 162.82 26.36 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.292 -0.48 . . . . 0.0 113.127 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 64.5 mt . . . . . 0 C--N 1.325 -0.485 0 CA-C-N 115.846 -0.177 . . . . 0.0 110.795 -179.982 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.658 0 N-CA-C 112.276 -0.33 . . . . 0.0 112.276 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo . . . . . 0 C--O 1.236 0.406 0 C-N-CA 122.602 2.202 . . . . 0.0 111.903 179.921 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.449 0 N-CA-C 114.087 0.395 . . . . 0.0 114.087 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 CA--C 1.531 0.35 0 C-N-CA 123.418 2.745 . . . . 0.0 111.485 179.587 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.506 0 N-CA-C 113.268 0.067 . . . . 0.0 113.268 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo . . . . . 0 N--CA 1.463 -0.319 0 C-N-CA 123.002 2.468 . . . . 0.0 111.394 179.519 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo . . . . . 0 N--CA 1.477 0.54 0 N-CA-C 109.8 -0.885 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -110.42 -173.98 2.38 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 15.4 tt -117.46 -6.24 11.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.247 0.546 . . . . 0.0 110.54 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 99.6 m -100.11 -0.61 38.64 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -94.02 -9.17 37.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.81 0.338 . . . . 0.0 110.598 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 84.22 -149.05 24.7 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.808 -0.711 . . . . 0.0 111.843 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 2.8 t30 55.13 68.57 0.84 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.116 0.484 . . . . 0.0 111.756 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -100.99 152.17 20.89 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.547 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -80.31 -47.09 15.05 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 4.4 t -167.33 149.67 6.0 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.021 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 47.8 t -128.49 122.29 57.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -140.44 -177.98 5.29 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.065 0.459 . . . . 0.0 111.778 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 12.8 ttp -132.02 131.17 42.26 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 51.2 mt -127.58 116.86 20.99 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 123.295 0.372 . . . . 0.0 110.397 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . 0.43 ' H ' ' CD ' ' A' ' 373' ' ' GLU . 0.9 OUTLIER 64.83 20.84 12.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.822 179.203 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 102.85 -18.59 49.54 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.347 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -89.47 135.03 33.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.669 0.271 . . . . 0.0 110.475 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 48.4 ttm -87.03 126.61 34.86 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.907 0.384 . . . . 0.0 110.632 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -116.87 122.32 44.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.32 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.72 112.46 37.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -95.3 130.4 42.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.792 0.33 . . . . 0.0 111.578 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -147.98 108.82 4.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.244 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 63.34 -113.2 0.4 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.632 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -110.23 10.35 23.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.053 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -126.19 157.47 38.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.908 0.385 . . . . 0.0 110.591 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -141.31 141.57 33.89 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.563 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -107.21 150.46 26.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.92 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 14.5 ttt85 -125.5 106.32 9.7 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 3.7 m -92.79 129.01 43.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.409 0.623 . . . . 0.0 111.485 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.43 111.89 13.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.082 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 27.9 t30 55.69 52.06 11.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.031 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 68.14 7.07 5.62 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -122.38 158.06 30.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.724 0.297 . . . . 0.0 110.881 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 38.5 t -94.26 130.32 43.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 120.681 0.276 . . . . 0.0 110.475 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 4.0 mtp -72.04 156.72 38.9 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.204 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -79.08 150.55 31.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.81 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 99.69 -6.03 58.67 Favored Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -112.64 157.69 39.61 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.55 131.7 15.38 Favored 'Cis proline' 0 C--N 1.347 0.466 0 C-N-CA 123.713 -1.369 . . . . 0.0 112.693 0.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 52.6 ttm -104.38 136.08 19.23 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.24 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.18 131.84 38.6 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.256 1.971 . . . . 0.0 111.058 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 66.5 mt -54.96 -44.1 71.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.179 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -67.99 -14.22 65.43 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 121.19 -0.529 . . . . 0.0 113.718 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -79.55 -45.79 18.57 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 117.182 0.491 . . . . 0.0 110.622 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -88.38 -53.11 4.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.591 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -88.12 74.67 8.79 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.242 0.544 . . . . 0.0 109.536 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -60.66 94.83 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.865 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 130.91 -17.31 5.2 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.264 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 19.4 tp -85.31 132.59 44.64 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.647 0.261 . . . . 0.0 111.138 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.59 178.81 6.92 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.817 2.345 . . . . 0.0 111.651 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -86.56 151.57 23.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.421 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 44.6 m 55.98 83.99 0.09 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 19.9 pt -95.56 172.86 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.924 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.42 -42.05 6.42 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.708 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.23 159.2 44.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.85 0.357 . . . . 0.0 111.513 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -149.93 140.1 22.14 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -163.88 166.79 21.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.768 0.318 . . . . 0.0 111.42 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' A' ' 330' ' ' ARG . 33.5 mt-10 -97.56 138.38 35.07 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -89.41 -173.03 3.84 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.959 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -70.42 -19.51 62.99 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.67 -23.05 17.76 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.377 -0.529 . . . . 0.0 112.422 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 124.9 -18.99 7.01 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.603 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -70.45 152.0 44.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.842 0.353 . . . . 0.0 110.605 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -96.23 133.54 40.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.269 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 14.5 t -114.56 121.31 66.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 120.796 0.332 . . . . 0.0 110.276 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -107.65 138.62 43.55 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -121.3 137.7 54.57 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -155.25 103.54 2.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.408 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 76.61 -122.38 6.33 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.606 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -106.52 4.87 28.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.884 0.373 . . . . 0.0 111.098 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -114.62 150.01 35.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.217 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 32.5 p-80 -131.78 148.79 52.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.019 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 27.1 m-90 -123.6 132.81 53.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.066 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 21.8 t -112.86 124.6 69.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -117.48 128.68 55.23 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -94.73 89.21 5.63 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 68.98 -80.41 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.409 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -136.05 11.47 3.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.089 0.471 . . . . 0.0 110.902 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 19.3 m -120.82 129.29 53.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.876 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 33.8 tp -76.07 142.04 41.87 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.961 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -69.14 148.49 97.65 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.392 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.41 133.64 19.47 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.9 2.4 . . . . 0.0 112.584 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 87.29 52.81 2.95 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.4 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -143.62 162.66 40.59 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -80.4 165.32 77.96 Favored 'Cis proline' 0 C--N 1.347 0.489 0 C-N-CA 123.633 -1.403 . . . . 0.0 112.934 0.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -132.48 168.11 18.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.987 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -68.82 156.36 38.53 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 123.236 0.335 . . . . 0.0 110.499 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 52.8 mt -55.84 -36.53 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.111 0.482 . . . . 0.0 110.879 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -65.43 -14.48 61.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.127 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -80.62 -22.06 40.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.318 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 40.6 tp -82.69 -48.21 11.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.99 0.424 . . . . 0.0 110.234 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -151.18 140.54 7.93 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.919 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.67 126.32 30.77 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.0 0.429 . . . . 0.0 110.714 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 110.77 -1.83 28.89 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.052 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 88.6 mt -83.72 150.18 58.75 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.496 0.189 . . . . 0.0 110.562 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.0 140.86 92.35 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.697 2.265 . . . . 0.0 111.871 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.14 -5.94 39.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.812 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -79.27 -57.69 3.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.494 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -179.39 176.68 0.81 Allowed 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.823 0.344 . . . . 0.0 110.421 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 44.7 mm -124.55 134.64 66.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -89.4 -54.31 4.15 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.283 0.563 . . . . 0.0 110.206 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -150.84 155.93 40.2 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.978 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -139.14 121.51 16.03 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 35.2 tp -113.97 123.8 50.6 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.421 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -90.97 113.38 25.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.67 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -80.42 99.04 7.78 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 67.0 mtt -54.62 -49.41 91.4 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -47.54 -61.41 0.6 Allowed 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 122.557 2.171 . . . . 0.0 114.501 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 52.0 p30 -85.8 -24.9 26.61 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 83.56 47.43 5.67 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.514 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -131.49 152.58 50.6 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.8 m -106.24 126.55 52.36 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.141 0.496 . . . . 0.0 111.754 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -100.65 113.15 25.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.019 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -94.93 121.79 36.9 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.394 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -99.88 130.38 46.06 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.783 0.325 . . . . 0.0 110.929 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -141.75 98.7 3.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.829 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 67.79 -116.81 8.1 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.561 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -101.64 8.45 41.7 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -128.72 149.38 50.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.815 0.341 . . . . 0.0 111.195 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -126.43 144.41 50.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.468 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -109.5 143.41 39.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.879 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -103.84 93.77 5.06 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -82.79 129.57 35.0 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.533 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -103.65 108.3 19.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.102 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -54.98 -47.59 74.38 Favored 'General case' 0 C--O 1.231 0.115 0 O-C-N 123.486 0.491 . . . . 0.0 112.159 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -62.55 -32.71 73.71 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 68.2 mt -94.99 -10.94 29.46 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 58.07 29.32 17.64 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 123.32 0.387 . . . . 0.0 111.523 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -154.38 174.12 15.28 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.331 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.8 t -90.31 144.11 9.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.863 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -67.8 164.16 20.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.894 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.38 163.96 26.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.047 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 71.83 8.93 6.15 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.167 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -113.71 163.63 18.1 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.693 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -72.32 157.06 98.15 Favored 'Cis proline' 0 C--N 1.348 0.514 0 C-N-CA 123.631 -1.404 . . . . 0.0 112.301 -0.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -115.32 170.19 8.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.907 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -60.75 128.22 35.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.316 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 11.6 tt -66.74 -14.58 18.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.113 0.482 . . . . 0.0 111.347 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -69.89 3.7 2.47 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 39.1 t -66.6 -32.55 58.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 16.7 m95 -88.27 84.06 6.89 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.32 110.21 0.38 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.718 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 119.42 -23.67 8.4 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.173 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 43.7 mm -86.07 127.87 60.12 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.845 0.355 . . . . 0.0 111.383 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -85.49 162.49 11.01 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.809 2.339 . . . . 0.0 111.421 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -71.11 153.94 42.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.533 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 10.5 m 58.1 72.68 0.84 Allowed Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 115.591 -0.732 . . . . 0.0 112.942 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -82.52 176.51 7.83 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.093 2.529 . . . . 0.0 111.859 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 8.7 tpp85 -142.51 23.24 1.97 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.318 0.58 . . . . 0.0 110.472 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 172.97 142.03 3.68 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 12.3 p -165.43 101.42 0.72 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.728 0.299 . . . . 0.0 110.686 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -132.96 138.42 46.89 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.079 0.466 . . . . 0.0 111.656 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 40.0 ttm -93.65 135.9 34.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.526 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -68.2 163.62 48.2 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.391 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.93 -9.13 26.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.169 0.509 . . . . 0.0 111.605 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -84.99 -15.24 44.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.144 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 64.47 11.57 6.67 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 57.8 t -110.48 -40.69 4.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.921 0.391 . . . . 0.0 110.908 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -105.26 126.51 52.17 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 93.7 m -114.2 130.71 56.62 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -105.55 124.35 49.4 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.228 0.537 . . . . 0.0 112.389 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -105.55 152.35 23.17 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.971 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -131.82 137.59 48.17 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.514 0.197 . . . . 0.0 111.306 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -168.61 120.04 0.78 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.65 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 64.17 48.0 79.36 Favored Glycine 0 N--CA 1.453 -0.226 0 N-CA-C 114.561 0.584 . . . . 0.0 114.561 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 66.5 t30 67.94 0.93 2.53 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -115.9 152.37 33.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.173 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -126.12 152.23 46.19 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.892 0.377 . . . . 0.0 111.523 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 18.5 m-90 -117.98 140.43 49.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.757 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -100.38 94.59 6.25 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 486' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -88.59 123.57 33.2 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.054 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -91.99 114.16 26.63 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -62.21 -33.02 73.76 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -76.06 -26.66 56.75 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -101.3 -16.91 16.78 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 10.7 tp 58.56 38.53 25.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.726 0.774 . . . . 0.0 110.25 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -156.41 152.6 27.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.595 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 75.4 t -77.95 136.65 23.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.802 0.334 . . . . 0.0 110.585 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -62.93 146.35 95.47 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.284 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.98 155.68 66.77 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.571 2.18 . . . . 0.0 112.129 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 89.57 14.43 59.87 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.273 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -121.18 167.07 14.06 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -75.64 168.32 77.69 Favored 'Cis proline' 0 C--N 1.349 0.589 0 C-N-CA 123.905 -1.29 . . . . 0.0 113.016 0.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -123.39 169.67 11.11 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.945 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 39.9 t -79.24 117.57 20.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.777 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.02 -27.04 64.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.917 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 14.2 mt -65.0 -48.33 74.34 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.195 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -79.68 -42.98 23.58 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -76.45 -54.31 6.91 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -177.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -79.36 -61.03 2.13 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 7.2 mmt -66.57 -37.68 85.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.976 0.417 . . . . 0.0 111.479 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 94.63 22.68 23.29 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.705 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 18.8 m -83.48 124.18 75.9 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-O 120.614 0.245 . . . . 0.0 110.465 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.86 156.04 61.19 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.812 2.342 . . . . 0.0 112.842 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 4.0 m 70.77 -70.23 0.16 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.466 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.327 0 CA-C-O 118.365 -1.241 . . . . 0.0 111.23 -179.487 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.731 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo . . . . . 0 C--O 1.236 0.406 0 C-N-CA 122.673 2.249 . . . . 0.0 112.256 -179.877 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.601 0 N-CA-C 112.947 -0.061 . . . . 0.0 112.947 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 N--CA 1.462 -0.337 0 C-N-CA 122.782 2.321 . . . . 0.0 111.237 179.575 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.491 0 CA-C-O 120.143 -0.254 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo . . . . . 0 CA--C 1.53 0.315 0 C-N-CA 122.979 2.452 . . . . 0.0 111.675 179.287 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.785 0 N-CA-C 112.094 -0.403 . . . . 0.0 112.094 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.78 141.47 65.74 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.848 2.366 . . . . 0.0 111.545 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -68.47 144.7 54.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.213 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.24 154.16 37.9 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.806 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.59 148.94 11.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.34 151.23 46.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.362 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.84 157.03 53.54 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.332 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -72.51 148.44 45.04 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -66.08 148.34 51.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 0.0 110.825 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.44 159.88 49.84 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.996 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.6 t -70.78 153.72 8.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.626 0.251 . . . . 0.0 110.481 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 11.9 t -58.95 145.47 10.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.454 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.87 161.51 52.89 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.127 -0.559 . . . . 0.0 113.062 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 C--N 1.326 -0.455 0 N-CA-C 110.573 -0.158 . . . . 0.0 110.573 179.859 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.652 0 N-CA-C 112.233 -0.347 . . . . 0.0 112.233 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 C--O 1.238 0.484 0 C-N-CA 122.653 2.236 . . . . 0.0 111.709 179.952 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.62 0 N-CA-C 112.444 -0.262 . . . . 0.0 112.444 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 C--O 1.237 0.441 0 C-N-CA 122.515 2.143 . . . . 0.0 111.482 179.65 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.467 0 N-CA-C 113.982 0.353 . . . . 0.0 113.982 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo . . . . . 0 CA--C 1.533 0.432 0 C-N-CA 123.053 2.502 . . . . 0.0 111.507 179.472 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.554 0 N-CA-C 112.94 -0.064 . . . . 0.0 112.94 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 N--CA 1.463 -0.285 0 C-N-CA 123.162 2.575 . . . . 0.0 111.804 179.93 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.659 -0.176 . . . . 0.0 112.659 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo . . . . . 0 C--O 1.236 0.386 0 C-N-CA 122.932 2.421 . . . . 0.0 111.931 179.712 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 113.281 0.072 . . . . 0.0 113.281 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo . . . . . 0 CA--C 1.533 0.434 0 C-N-CA 123.156 2.57 . . . . 0.0 112.367 -179.866 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.444 0 N-CA-C 112.22 -0.352 . . . . 0.0 112.22 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 N--CA 1.464 -0.223 0 C-N-CA 122.647 2.232 . . . . 0.0 111.052 179.543 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 113.567 0.187 . . . . 0.0 113.567 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -61.5 154.1 61.76 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 123.042 2.495 . . . . 0.0 113.109 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -62.79 137.52 58.29 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.617 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.24 154.74 44.23 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.34 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 41.4 mt -70.4 137.56 23.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 122.762 -0.258 . . . . 0.0 110.363 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.1 147.48 47.3 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.526 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -65.19 155.95 48.53 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.843 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -82.72 158.67 22.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.651 0.262 . . . . 0.0 110.573 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -64.69 145.18 56.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.399 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.59 172.78 34.87 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.669 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 30.3 t -67.78 141.78 17.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.642 0.258 . . . . 0.0 110.81 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 60.5 t -62.69 139.08 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.967 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.18 158.06 39.05 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 121.203 -0.523 . . . . 0.0 112.68 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 97.1 mt . . . . . 0 C--N 1.323 -0.557 0 CA-C-O 120.553 0.216 . . . . 0.0 110.546 -179.914 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 113.252 0.061 . . . . 0.0 113.252 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo . . . . . 0 C--O 1.236 0.415 0 C-N-CA 122.8 2.333 . . . . 0.0 111.832 179.949 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.676 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 N--CA 1.462 -0.336 0 C-N-CA 122.523 2.149 . . . . 0.0 110.742 179.34 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.425 0 N-CA-C 114.34 0.496 . . . . 0.0 114.34 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo . . . . . 0 C--O 1.233 0.233 0 C-N-CA 123.611 2.874 . . . . 0.0 111.926 179.995 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.286 0 N-CA-C 112.113 -0.395 . . . . 0.0 112.113 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo . . . . . 0 C--O 1.235 0.332 0 C-N-CA 123.104 2.536 . . . . 0.0 112.061 -179.682 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.49 0 CA-C-O 120.01 -0.328 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo . . . . . 0 C--N 1.346 0.419 0 C-N-CA 123.302 2.668 . . . . 0.0 112.069 178.902 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 114.102 0.401 . . . . 0.0 114.102 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo . . . . . 0 CA--C 1.534 0.497 0 C-N-CA 123.907 3.072 . . . . 0.0 112.172 179.512 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 113.404 0.122 . . . . 0.0 113.404 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo . . . . . 0 N--CA 1.458 -0.617 0 C-N-CA 123.905 3.07 . . . . 0.0 112.281 179.939 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.575 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.04 156.42 62.66 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 122.762 2.308 . . . . 0.0 112.341 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -76.61 147.15 37.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.441 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -69.2 165.31 49.4 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.35 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 10.8 pt -69.34 168.19 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 120.775 0.322 . . . . 0.0 111.141 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -83.18 146.46 28.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.951 0.405 . . . . 0.0 111.043 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -66.12 160.66 45.48 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.908 -0.587 . . . . 0.0 113.453 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -75.75 160.48 29.98 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -71.52 152.68 42.79 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -62.42 154.67 41.44 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.01 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 10.7 t -62.28 142.43 16.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 30.8 t -61.45 137.91 22.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.258 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -59.37 154.56 29.81 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.673 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 5.6 mp . . . . . 0 C--N 1.321 -0.672 0 CA-C-O 120.479 0.181 . . . . 0.0 110.813 -179.594 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.84 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo . . . . . 0 C--O 1.236 0.391 0 C-N-CA 122.796 2.33 . . . . 0.0 111.811 179.661 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 112.705 -0.158 . . . . 0.0 112.705 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo . . . . . 0 C--O 1.236 0.408 0 C-N-CA 122.64 2.226 . . . . 0.0 111.34 179.688 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.404 0 N-CA-C 113.973 0.349 . . . . 0.0 113.973 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 CA--C 1.533 0.43 0 C-N-CA 122.937 2.424 . . . . 0.0 112.145 179.752 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo . . . . . 0 N--CA 1.48 0.727 0 N-CA-C 109.68 -0.931 . . . . 0.0 109.68 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -133.44 159.46 40.29 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 13.8 tt -78.71 -17.62 13.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.263 0.554 . . . . 0.0 110.923 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 6.8 m -95.8 14.98 21.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.669 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -60.42 -40.55 91.42 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.039 0.447 . . . . 0.0 111.072 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 98.85 146.92 21.28 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.084 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 23.9 t30 54.81 91.87 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -91.74 165.59 13.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.289 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -71.45 -41.56 69.28 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 1.2 t -167.6 149.77 5.76 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.354 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 90.6 t -134.33 123.98 44.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -147.88 176.53 10.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.812 0.339 . . . . 0.0 110.903 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 38.3 ttp -128.96 119.98 25.28 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 41.6 mt -119.98 125.89 49.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.301 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? 64.1 20.56 12.24 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.521 0.513 . . . . 0.0 111.183 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 91.31 1.44 72.05 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.875 -0.678 . . . . 0.0 111.857 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -105.97 124.78 50.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.75 0.31 . . . . 0.0 110.597 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 36.4 ttm -78.67 114.87 17.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.855 0.359 . . . . 0.0 111.109 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -106.37 126.57 52.41 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.14 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 39.2 t -109.48 118.88 57.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.441 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -104.29 130.54 52.1 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.809 0.338 . . . . 0.0 111.548 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 17.7 ttpp -150.94 116.19 5.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.055 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 65.28 -119.96 0.39 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.14 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.3 ptm85 -109.56 13.61 23.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.962 0.411 . . . . 0.0 111.847 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 17.2 m-90 -129.62 152.7 48.85 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.588 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -129.77 147.49 51.55 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.973 0.416 . . . . 0.0 110.866 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 26.5 m-90 -119.2 169.26 10.11 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.263 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.45 109.48 4.48 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 1.1 m -99.94 122.88 52.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.105 -178.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 21.1 ttm-85 -117.94 102.12 8.81 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 66.6 t30 66.72 51.87 1.02 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.5 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 9.1 m120 69.2 1.7 3.34 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.242 -0.89 . . . . 0.0 113.317 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -118.71 127.73 53.84 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.963 0.411 . . . . 0.0 112.019 -179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 20.0 t -74.24 123.68 30.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.218 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 72.3 mtp -68.29 167.4 14.5 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -74.73 153.64 38.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.712 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 95.23 7.47 59.43 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.887 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -122.71 153.93 63.36 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.3 143.32 74.52 Favored 'Cis proline' 0 C--N 1.345 0.349 0 C-N-CA 123.545 -1.44 . . . . 0.0 112.598 0.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 58.0 ttm -116.68 131.83 23.7 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.554 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.7 138.39 82.87 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.588 2.192 . . . . 0.0 111.41 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 78.4 mt -56.57 -46.6 82.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.34 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -73.07 3.04 31.61 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 121.175 -0.536 . . . . 0.0 113.85 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.38 -37.2 17.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.326 0.563 . . . . 0.0 110.42 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -106.67 -44.86 4.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.446 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 62.2 m95 -89.8 74.22 7.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.315 0.578 . . . . 0.0 110.122 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -62.23 103.63 0.41 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.173 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 120.98 -14.24 9.64 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.103 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 24.0 tp -93.38 133.85 27.75 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.744 0.306 . . . . 0.0 110.562 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -82.85 177.62 6.66 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.642 2.228 . . . . 0.0 111.585 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -86.86 160.61 18.68 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.781 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 54.8 m 53.57 79.87 0.12 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 23.0 pt -94.86 -178.63 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.496 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -105.63 -47.0 4.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.724 0.297 . . . . 0.0 111.658 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.85 163.45 39.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.746 0.308 . . . . 0.0 111.591 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -152.11 142.32 22.36 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -165.07 168.69 17.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.638 0.256 . . . . 0.0 111.546 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -95.09 126.51 40.47 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -84.7 171.96 11.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.66 0.267 . . . . 0.0 111.005 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.499 ' HZ1' ' CD ' ' A' ' 441' ' ' GLU . 84.1 tttt -66.8 -32.33 73.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.999 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -33.16 71.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.407 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 124.57 -20.92 6.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.476 -0.869 . . . . 0.0 113.928 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 19.8 mttp -90.32 175.27 7.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 117.196 0.498 . . . . 0.0 112.27 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -99.2 140.29 33.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.318 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 5.9 t -120.23 122.03 67.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.199 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -108.45 144.55 35.91 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -127.5 141.16 51.73 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -151.76 103.56 2.95 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 76.12 -115.27 4.42 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.268 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -113.95 10.59 17.63 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.791 0.329 . . . . 0.0 111.125 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -116.27 151.46 35.78 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.691 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 -132.88 150.46 52.16 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.604 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 18.6 m-90 -123.36 137.3 54.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.938 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 69.7 t -117.45 117.37 54.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.049 0.452 . . . . 0.0 109.883 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -113.48 124.68 52.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.731 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -91.48 84.62 5.57 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 70.19 -70.25 0.15 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.995 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -143.39 16.06 1.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.921 0.391 . . . . 0.0 110.787 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 1.1 m -126.25 121.07 31.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.787 0.327 . . . . 0.0 111.359 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 52.7 tp -75.34 127.84 34.06 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -61.65 127.35 88.6 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.655 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.44 141.04 90.07 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.059 2.506 . . . . 0.0 112.368 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 92.53 16.26 49.99 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.252 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -112.66 163.21 18.46 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 110.712 -0.107 . . . . 0.0 110.712 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.47 169.43 74.48 Favored 'Cis proline' 0 C--N 1.347 0.491 0 C-N-CA 123.682 -1.382 . . . . 0.0 112.678 0.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -131.6 166.6 21.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.492 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -71.47 154.79 41.25 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 68.9 mt -60.98 -38.2 78.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.205 0.526 . . . . 0.0 109.799 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -66.7 -17.2 64.73 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.676 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -81.14 -23.79 38.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.921 0.391 . . . . 0.0 110.659 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 49.0 tp -77.0 -43.87 33.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.08 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -155.91 146.23 13.73 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.852 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -77.24 126.31 30.73 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.625 0.25 . . . . 0.0 110.537 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.31 -0.93 46.76 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.383 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 40.6 mt -77.27 149.65 79.36 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 120.399 0.142 . . . . 0.0 111.025 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.96 112.53 1.24 Allowed 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.987 2.458 . . . . 0.0 112.201 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.4 37.59 0.74 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.058 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -134.58 -56.7 0.84 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.271 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 10.8 ptmt -173.32 166.41 4.8 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 122.335 0.254 . . . . 0.0 110.506 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 38.9 mm -121.85 130.37 74.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -86.47 -45.39 11.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.367 0.604 . . . . 0.0 109.678 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -158.15 157.57 32.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.745 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -141.64 123.61 15.38 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 28.2 tp -120.62 134.67 55.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.297 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -106.46 117.11 33.17 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.359 -0.382 . . . . 0.0 109.982 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 4.5 t-105 -86.09 98.91 11.13 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 66.8 mtt -57.31 -52.49 73.87 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -53.23 -27.88 39.9 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.839 2.359 . . . . 0.0 115.301 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -112.93 -24.49 9.5 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 83.49 38.15 11.2 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.213 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -122.95 146.68 47.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.756 0.313 . . . . 0.0 110.737 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 7.1 m -107.05 129.35 54.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.513 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -108.36 117.47 34.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.911 0.386 . . . . 0.0 111.02 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -101.79 122.47 44.03 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.745 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -98.94 129.03 45.24 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.973 0.416 . . . . 0.0 111.535 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -139.2 103.71 4.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.409 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 67.21 -110.76 3.65 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.124 -0.791 . . . . 0.0 111.124 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -115.89 16.25 16.22 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.098 0.475 . . . . 0.0 110.236 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -119.17 145.96 45.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.115 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -125.48 131.44 52.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.966 0.412 . . . . 0.0 110.679 178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -102.71 148.1 26.01 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.947 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -114.19 98.0 6.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.313 0.578 . . . . 0.0 109.457 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -81.73 134.32 35.44 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.649 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -104.72 103.49 13.13 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.882 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -48.94 -45.33 41.62 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' GLU . . . . . 0.499 ' CD ' ' HZ1' ' A' ' 375' ' ' LYS . 15.9 mp0 -53.85 -66.26 0.42 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 74.2 mt -75.72 -14.83 60.34 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 60.37 48.41 7.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.695 0.76 . . . . 0.0 110.782 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -156.43 161.7 40.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.105 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 74.4 t -81.81 141.85 14.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -60.12 160.85 7.58 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.373 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.3 m -68.32 151.81 46.36 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.671 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 69.06 30.81 4.31 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.064 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -125.43 159.12 61.76 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.645 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -80.43 166.8 75.22 Favored 'Cis proline' 0 C--N 1.342 0.23 0 C-N-CA 123.504 -1.457 . . . . 0.0 112.592 0.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -116.42 171.32 7.91 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.338 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -71.68 146.68 48.08 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.643 0.259 . . . . 0.0 110.651 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.1 tt -70.44 -8.41 10.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.83 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -60.68 -12.08 9.31 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.76 -31.96 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 24.4 m95 -89.36 95.34 10.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.026 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.49 105.75 1.26 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 110.9 -4.31 28.91 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.044 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 30.6 mm -91.93 128.03 47.36 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-O 121.096 0.474 . . . . 0.0 111.391 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.08 158.19 26.84 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.853 2.369 . . . . 0.0 111.699 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 30.0 mp0 -80.1 148.62 30.93 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.425 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.9 m 55.45 69.4 1.97 Allowed Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.1 -175.9 2.6 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.339 2.026 . . . . 0.0 111.773 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 7.2 tpp85 -144.65 32.63 1.16 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.338 0.589 . . . . 0.0 110.328 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 167.51 140.7 2.97 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 5.7 p -161.94 101.22 1.13 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.948 0.404 . . . . 0.0 109.959 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -130.19 135.56 48.3 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.047 0.451 . . . . 0.0 111.344 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 47.3 ttm -86.96 142.3 28.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.954 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -71.8 164.59 54.13 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.911 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.54 -12.66 54.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.09 0.471 . . . . 0.0 111.587 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -83.17 -17.07 44.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.637 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 68.05 5.74 4.78 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 122.9 0.48 . . . . 0.0 111.911 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 35.1 t -104.5 -32.71 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.877 0.37 . . . . 0.0 111.13 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -117.8 138.05 52.33 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 90.6 m -120.82 133.08 55.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.409 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -104.8 129.58 53.06 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.197 0.522 . . . . 0.0 112.117 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -110.99 146.72 36.17 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.316 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -126.74 137.83 53.29 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -162.16 107.03 1.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.964 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 480' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 482' ' ' LYS . . . 60.0 57.66 18.17 Favored Glycine 0 C--N 1.331 0.258 0 CA-C-N 115.998 -0.547 . . . . 0.0 113.401 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 18.3 t30 73.24 -33.72 0.27 Allowed 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 482' ' ' LYS . . . . . 0.413 ' H ' ' C ' ' A' ' 480' ' ' GLY . 24.1 mtmt -78.66 136.54 37.49 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.048 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -121.5 149.03 43.68 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.079 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 23.0 m-90 -117.82 149.39 40.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.46 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -115.25 99.92 7.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.202 0.525 . . . . 0.0 109.787 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 486' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -88.54 127.57 35.54 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.26 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -88.1 111.93 22.11 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -66.17 -23.94 66.56 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 36.4 tp60 -86.04 -25.95 25.63 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.902 0.382 . . . . 0.0 111.614 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -104.72 -14.47 15.55 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.0 tp 61.77 39.85 13.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.478 0.656 . . . . 0.0 110.189 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 51.3 tttt -154.23 148.97 26.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.589 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 69.9 t -79.26 138.43 20.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.666 0.27 . . . . 0.0 110.401 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -62.21 153.03 76.83 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.161 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -75.56 150.94 36.5 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.749 2.3 . . . . 0.0 113.024 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 98.14 5.06 57.39 Favored Glycine 0 C--N 1.331 0.282 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.327 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -106.55 167.24 9.84 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 110.666 -0.124 . . . . 0.0 110.666 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.26 167.71 75.72 Favored 'Cis proline' 0 C--N 1.345 0.38 0 C-N-CA 123.72 -1.367 . . . . 0.0 112.756 0.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -125.73 154.82 41.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.988 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 2.7 m -72.36 111.95 8.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.494 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -62.23 -27.06 68.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.521 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 36.3 mt -56.07 -44.23 78.72 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.58 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -89.28 -37.79 14.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.354 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.01 -39.51 83.18 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 15.4 m0 -122.02 -45.69 2.24 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 10.5 mmt -64.87 -29.01 69.94 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 86.98 28.21 26.5 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.898 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 32.4 m -103.01 106.63 51.72 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.72 171.93 14.94 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 123.074 2.516 . . . . 0.0 111.59 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 5.3 m 60.55 52.1 4.76 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.375 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.369 -1.239 . . . . 0.0 111.562 179.783 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.611 0 N-CA-C 111.864 -0.494 . . . . 0.0 111.864 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo . . . . . 0 C--O 1.232 0.181 0 C-N-CA 122.769 2.313 . . . . 0.0 111.793 179.937 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.675 0 N-CA-C 112.333 -0.307 . . . . 0.0 112.333 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 C--O 1.233 0.244 0 C-N-CA 122.799 2.333 . . . . 0.0 111.782 179.664 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.572 0 N-CA-C 112.367 -0.293 . . . . 0.0 112.367 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo . . . . . 0 CA--C 1.532 0.404 0 C-N-CA 122.784 2.322 . . . . 0.0 111.484 179.372 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.791 0 N-CA-C 112.395 -0.282 . . . . 0.0 112.395 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.54 144.32 31.91 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.183 2.589 . . . . 0.0 111.785 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -73.6 148.79 42.57 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.72 153.52 40.66 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.459 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 13.1 mt -70.88 150.06 9.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.29 149.2 46.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.378 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.67 170.26 32.36 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.219 -0.515 . . . . 0.0 113.293 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -72.62 141.78 48.35 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.58 141.18 58.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.645 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.02 150.3 40.12 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.763 -0.653 . . . . 0.0 113.139 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 5.3 t -71.65 146.29 11.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 45.6 t -55.43 144.95 6.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.09 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.1 162.86 51.31 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.159 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 86.1 mt . . . . . 0 C--N 1.323 -0.56 0 CA-C-N 115.619 -0.291 . . . . 0.0 110.429 -179.869 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.503 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo . . . . . 0 C--O 1.234 0.297 0 C-N-CA 122.722 2.281 . . . . 0.0 111.835 179.843 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.593 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 C--O 1.235 0.359 0 C-N-CA 122.695 2.263 . . . . 0.0 112.06 179.905 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.414 0 CA-C-O 120.528 -0.04 . . . . 0.0 113.164 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo . . . . . 0 C--O 1.234 0.321 0 C-N-CA 123.217 2.611 . . . . 0.0 111.493 179.717 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.448 0 N-CA-C 114.217 0.447 . . . . 0.0 114.217 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo . . . . . 0 N--CA 1.461 -0.391 0 C-N-CA 123.413 2.742 . . . . 0.0 111.303 -179.821 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 CA-C-O 119.999 -0.334 . . . . 0.0 112.666 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo . . . . . 0 C--N 1.345 0.389 0 C-N-CA 123.047 2.498 . . . . 0.0 112.357 179.928 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 112.127 -0.389 . . . . 0.0 112.127 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo . . . . . 0 CA--C 1.531 0.343 0 C-N-CA 123.488 2.792 . . . . 0.0 112.313 -179.78 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.597 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 CA--C 1.528 0.203 0 C-N-CA 122.553 2.168 . . . . 0.0 110.65 179.201 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.53 0 N-CA-C 114.779 0.672 . . . . 0.0 114.779 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.93 167.6 25.51 Favored 'Trans proline' 0 C--O 1.238 0.475 0 C-N-CA 122.958 2.438 . . . . 0.0 112.345 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -60.76 142.25 56.12 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.124 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -73.74 160.88 53.8 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.892 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 33.0 mt -68.45 141.15 17.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.733 0.301 . . . . 0.0 110.713 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.19 153.73 41.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.681 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -63.29 161.18 34.63 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.574 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -84.11 153.83 23.51 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -65.55 141.44 58.45 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.81 168.33 32.47 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.179 -0.534 . . . . 0.0 113.035 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 24.1 t -71.0 140.12 18.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 24.2 t -65.77 131.79 31.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.095 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.84 158.73 36.7 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.883 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 13.4 mt . . . . . 0 C--N 1.326 -0.418 0 CA-C-O 120.473 0.178 . . . . 0.0 110.885 -179.748 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.626 0 N-CA-C 112.548 -0.221 . . . . 0.0 112.548 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo . . . . . 0 C--O 1.236 0.392 0 C-N-CA 122.532 2.155 . . . . 0.0 111.459 179.528 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.456 0 N-CA-C 112.627 -0.189 . . . . 0.0 112.627 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo . . . . . 0 C--O 1.234 0.304 0 C-N-CA 122.551 2.168 . . . . 0.0 111.452 -179.865 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.388 0 CA-C-O 120.69 0.05 . . . . 0.0 113.139 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo . . . . . 0 C--N 1.343 0.256 0 C-N-CA 122.77 2.313 . . . . 0.0 111.306 179.776 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 112.354 -0.298 . . . . 0.0 112.354 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo . . . . . 0 CA--C 1.53 0.321 0 C-N-CA 122.563 2.175 . . . . 0.0 111.361 179.683 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo . . . . . 0 C--N 1.345 0.365 0 C-N-CA 123.092 2.528 . . . . 0.0 111.774 179.577 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.405 0 N-CA-C 114.713 0.645 . . . . 0.0 114.713 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo . . . . . 0 CA--C 1.53 0.29 0 C-N-CA 123.593 2.862 . . . . 0.0 111.599 179.614 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.441 0 N-CA-C 113.219 0.048 . . . . 0.0 113.219 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 CA--C 1.533 0.453 0 C-N-CA 123.51 2.806 . . . . 0.0 112.453 -179.837 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.506 0 N-CA-C 112.345 -0.302 . . . . 0.0 112.345 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -72.71 155.22 54.27 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.875 2.383 . . . . 0.0 112.005 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -75.46 146.52 40.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.504 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -66.79 163.56 43.96 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.757 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 44.2 pt -69.94 168.47 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 120.858 0.361 . . . . 0.0 111.236 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -74.82 153.6 38.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.478 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -79.68 155.43 39.27 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.907 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -72.3 146.62 47.04 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.573 0.225 . . . . 0.0 110.41 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -65.1 155.47 34.72 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.739 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -65.75 153.99 51.11 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.793 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 14.6 t -69.07 149.39 11.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 48.4 t -68.66 141.31 17.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -62.06 161.35 29.22 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.854 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 C--N 1.327 -0.371 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.88 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.51 0 CA-C-O 120.316 -0.158 . . . . 0.0 112.89 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo . . . . . 0 C--O 1.234 0.322 0 C-N-CA 122.626 2.217 . . . . 0.0 111.061 179.418 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.383 0 N-CA-C 113.747 0.259 . . . . 0.0 113.747 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo . . . . . 0 C--O 1.234 0.294 0 C-N-CA 123.14 2.56 . . . . 0.0 111.271 179.412 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.669 0 N-CA-C 112.988 -0.045 . . . . 0.0 112.988 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo . . . . . 0 N--CA 1.459 -0.544 0 C-N-CA 122.869 2.379 . . . . 0.0 111.689 179.55 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo . . . . . 0 N--CA 1.479 0.655 0 N-CA-C 110.045 -0.79 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -105.82 151.98 23.81 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 21.1 tt -66.58 -31.74 54.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.822 0.344 . . . . 0.0 110.808 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 57.7 m -75.72 -0.53 21.17 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.056 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -69.51 -27.24 65.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.87 0.367 . . . . 0.0 110.686 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 84.62 -176.6 51.16 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.951 -0.643 . . . . 0.0 113.121 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 6.4 t30 57.22 77.37 0.27 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.44 0.696 . . . . 0.0 112.671 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -96.9 148.32 23.07 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.661 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -70.55 -42.4 71.21 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 1.9 t -167.95 155.16 8.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.687 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 72.9 t -133.62 127.89 53.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -144.18 164.75 29.81 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.683 0.278 . . . . 0.0 110.9 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 36.4 ttp -122.14 105.55 10.36 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 28.8 mt -103.5 128.01 50.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.183 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.54 17.59 7.51 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.706 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 95.59 -4.54 66.51 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.184 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -97.49 126.9 43.04 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.613 0.244 . . . . 0.0 110.415 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 39.1 tpp -77.56 117.3 18.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.062 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -113.33 119.95 39.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.047 0.451 . . . . 0.0 110.974 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 21.1 t -103.24 117.44 48.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -103.99 129.82 51.61 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -147.13 122.12 10.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.268 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 60.12 -105.82 0.24 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.274 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 10.0 ptm85 -125.58 18.63 8.08 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.019 0.437 . . . . 0.0 111.401 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 20.3 m-90 -130.3 152.92 49.19 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.888 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -132.77 141.95 48.77 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.208 0.527 . . . . 0.0 111.62 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 24.9 m-90 -111.17 159.54 17.77 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.902 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.37 106.25 6.6 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 6.7 m -101.08 142.58 15.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.343 0.592 . . . . 0.0 111.667 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -133.11 100.57 4.91 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.478 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 59.04 67.06 0.96 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.698 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 54.54 43.77 29.77 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -162.54 140.5 8.46 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 26.3 t -91.28 135.04 27.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 24.9 ttt -75.79 151.45 37.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.222 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.94 159.88 32.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.025 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 90.7 2.82 71.94 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -123.5 162.94 37.46 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.723 -0.239 . . . . 0.0 110.369 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.5 150.94 92.89 Favored 'Cis proline' 0 C--N 1.346 0.412 0 C-N-CA 123.764 -1.348 . . . . 0.0 112.675 -0.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 56.2 ttm -123.29 135.99 26.59 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.66 139.9 88.17 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.45 2.1 . . . . 0.0 110.982 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 77.8 mt -57.14 -45.18 84.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.549 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -70.39 -8.0 61.67 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 121.188 -0.53 . . . . 0.0 114.15 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.61 -24.07 25.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.363 0.581 . . . . 0.0 110.646 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -113.28 -54.4 2.62 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.228 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 68.0 m95 -85.34 79.08 9.62 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.979 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -60.37 101.47 0.13 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.241 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 122.42 -13.07 8.89 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.431 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 14.8 tp -90.0 131.41 39.24 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.783 0.325 . . . . 0.0 111.067 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -84.13 -167.18 0.42 Allowed 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.937 2.424 . . . . 0.0 112.478 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -93.27 149.15 21.44 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.825 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 8.3 m 58.34 93.92 0.03 OUTLIER 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 22.0 pt -105.54 172.09 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.57 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -98.95 -52.4 3.57 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.673 0.273 . . . . 0.0 111.583 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.3 165.85 31.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.614 0.245 . . . . 0.0 111.238 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -152.59 141.44 21.08 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -156.85 153.26 27.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.885 0.374 . . . . 0.0 111.818 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -96.2 115.38 27.34 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -82.01 172.26 13.46 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -58.29 -30.49 66.68 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.902 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -69.03 -5.94 24.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.567 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 76.94 33.73 44.87 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.06 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -126.82 150.43 49.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.675 0.274 . . . . 0.0 110.865 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -94.62 117.37 30.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.082 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 10.9 t -102.88 120.73 53.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.427 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -109.71 133.59 52.96 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -112.83 141.51 46.56 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.095 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -149.23 98.78 2.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.758 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 71.64 -111.09 3.48 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.417 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -111.39 4.99 19.4 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.972 0.415 . . . . 0.0 111.193 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -114.76 152.2 32.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.68 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 36.9 p-80 -135.54 149.57 49.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.582 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 21.8 m-90 -124.87 137.1 54.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.708 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 87.7 t -119.75 117.3 53.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.008 0.432 . . . . 0.0 110.624 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -103.33 119.82 39.61 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.593 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -94.78 102.92 14.81 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 68.25 -72.04 0.1 Allowed 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.684 0.615 . . . . 0.0 111.615 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -153.78 21.8 0.52 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.922 0.391 . . . . 0.0 110.551 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 57.9 m -137.83 132.93 33.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.981 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 30.3 tp -75.41 130.3 38.75 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -56.07 144.11 60.48 Favored Pre-proline 0 C--O 1.234 0.289 0 CA-C-O 120.746 0.307 . . . . 0.0 111.003 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.19 125.79 10.58 Favored 'Trans proline' 0 CA--C 1.528 0.216 0 C-N-CA 122.81 2.34 . . . . 0.0 111.868 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 114.16 14.32 9.24 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.994 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -109.6 163.28 17.44 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.529 0.165 . . . . 0.0 110.611 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.92 157.88 97.09 Favored 'Cis proline' 0 C--N 1.346 0.398 0 C-N-CA 123.522 -1.449 . . . . 0.0 112.861 0.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -121.13 164.35 17.0 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.071 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -76.01 149.64 37.53 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 59.7 mt -55.14 -34.1 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 121.285 0.564 . . . . 0.0 110.775 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -68.34 -12.43 61.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.616 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -86.53 -19.2 29.83 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.065 0.459 . . . . 0.0 110.359 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 40.2 tp -80.39 -39.48 28.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.961 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -160.51 153.79 24.73 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.146 -1.026 . . . . 0.0 113.204 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.52 124.88 31.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.336 -0.432 . . . . 0.0 110.1 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.8 14.63 39.48 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 121.067 -0.587 . . . . 0.0 111.928 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 23.3 mt -89.67 147.29 37.38 Favored Pre-proline 0 C--N 1.322 -0.604 0 O-C-N 122.716 -0.285 . . . . 0.0 111.6 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -52.92 114.24 1.63 Allowed 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.146 2.564 . . . . 0.0 111.637 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.38 33.69 0.89 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.419 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -130.74 -52.67 1.07 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.868 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -176.31 172.94 2.2 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.374 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 38.0 mm -124.87 130.82 73.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -89.87 -52.52 4.94 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.234 0.54 . . . . 0.0 109.577 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -140.74 154.08 46.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.052 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -139.84 102.83 4.51 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 45.1 tp -108.04 128.57 54.79 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.829 0.347 . . . . 0.0 111.629 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -99.41 117.09 33.05 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 8.5 t-105 -87.27 97.75 10.96 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 60.8 mtt -56.59 -50.76 85.98 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -49.44 -33.29 29.36 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.717 2.278 . . . . 0.0 114.97 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 41.5 p30 -111.62 -24.64 9.98 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 85.57 34.51 13.62 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.757 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 55.3 mttt -125.98 154.49 42.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.957 0.378 . . . . 0.0 110.777 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 15.4 m -105.97 135.03 48.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.018 0.437 . . . . 0.0 111.343 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -108.8 112.94 25.48 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.833 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -99.37 126.52 45.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.161 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -103.58 135.98 44.16 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.941 0.4 . . . . 0.0 111.212 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -146.0 107.01 4.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.863 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 70.11 -104.16 1.29 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.734 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -120.91 7.74 10.43 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.895 0.379 . . . . 0.0 110.683 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 48.9 mttm -120.72 153.2 37.28 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.676 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -130.98 141.18 50.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.933 179.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -109.95 147.55 33.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.807 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -109.5 99.36 8.58 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -93.63 134.99 35.36 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.207 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -101.35 122.97 44.68 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.53 -31.19 72.3 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -80.81 -37.08 30.75 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 16.0 mt -89.1 -16.86 30.48 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 4.7 mtp-105 57.52 37.94 27.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.392 0.615 . . . . 0.0 111.299 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -153.31 167.53 29.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.329 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 88.5 t -90.1 144.22 9.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.913 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -64.55 153.17 39.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.261 0.553 . . . . 0.0 111.915 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.3 m -64.07 156.05 29.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.7 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 77.69 -5.59 2.1 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.636 0.585 . . . . 0.0 111.891 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -98.41 161.05 26.57 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.361 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.42 160.43 95.32 Favored 'Cis proline' 0 C--O 1.234 0.304 0 C-N-CA 123.617 -1.409 . . . . 0.0 113.474 0.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -112.46 169.75 8.66 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.563 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -73.03 140.69 47.44 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.9 tt -66.69 -13.39 16.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.091 0.472 . . . . 0.0 110.912 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -63.53 -11.08 21.34 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 82.1 t -65.32 -31.26 53.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 29.0 m95 -87.69 87.34 7.35 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -58.42 109.36 0.76 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.888 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 110.04 -14.86 31.21 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.737 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 46.6 mm -88.76 125.93 61.26 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 120.722 0.296 . . . . 0.0 110.537 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.28 160.66 20.17 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.536 2.157 . . . . 0.0 111.704 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -71.67 149.52 45.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.096 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 2.2 m 54.96 62.14 8.22 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -96.04 100.93 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.966 2.444 . . . . 0.0 110.495 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -77.17 78.24 3.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.225 0.536 . . . . 0.0 111.501 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 149.55 120.22 1.02 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 26.2 p -154.88 127.48 7.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.726 0.298 . . . . 0.0 110.791 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -155.22 146.21 22.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.772 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 47.6 ttm -98.07 142.64 29.52 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.933 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -69.5 162.36 52.11 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.065 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.86 0.37 5.89 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.41 -15.34 21.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.922 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 69.11 6.63 5.76 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 123.753 0.658 . . . . 0.0 111.869 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 58.3 t -104.51 -39.4 5.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.931 0.396 . . . . 0.0 111.166 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -110.91 135.49 51.36 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 66.4 m -118.02 137.49 52.85 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.749 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -113.51 139.88 48.6 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.11 0.481 . . . . 0.0 112.133 -178.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -121.14 148.04 44.75 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.927 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -127.87 131.5 49.44 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.773 0.32 . . . . 0.0 111.371 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -157.62 117.06 3.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.513 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 61.6 47.7 88.95 Favored Glycine 0 CA--C 1.518 0.241 0 CA-C-N 115.878 -0.601 . . . . 0.0 113.667 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 52.0 t30 70.81 -2.94 2.11 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -105.56 142.74 34.78 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -118.65 146.27 44.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.93 0.395 . . . . 0.0 111.587 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 19.2 m-90 -117.7 148.27 42.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.465 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 54.0 tttt -115.67 105.0 12.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.211 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 486' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -97.1 129.58 44.49 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.679 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -91.45 114.31 26.81 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -63.71 -29.22 70.47 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -84.68 -11.63 55.5 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -118.76 -14.2 9.53 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 92.2 mt 59.4 36.04 23.17 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.314 0.578 . . . . 0.0 110.45 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 9.9 tttp -149.74 154.75 39.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.893 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 38.8 t -85.1 142.49 13.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -64.13 132.89 95.44 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.621 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.32 151.59 72.97 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.968 2.445 . . . . 0.0 112.363 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 92.6 16.03 50.66 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.208 -0.52 . . . . 0.0 111.977 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -115.42 166.03 12.96 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.832 -0.184 . . . . 0.0 110.814 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -84.66 176.9 29.77 Favored 'Cis proline' 0 C--N 1.347 0.499 0 C-N-CA 123.827 -1.322 . . . . 0.0 112.94 0.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -133.2 156.54 47.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.057 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 23.0 t -72.07 123.63 23.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.864 0.364 . . . . 0.0 110.843 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -65.21 -27.12 68.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.53 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 14.0 mt -62.28 -46.54 88.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.662 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -79.39 -40.22 30.63 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.493 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.98 -40.95 37.6 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -177.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -110.93 -49.13 3.05 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 9.4 mmt -64.97 -28.19 69.35 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -177.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 84.74 32.91 20.4 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.162 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 42.8 m -106.67 104.94 53.3 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.77 146.66 48.79 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.767 2.311 . . . . 0.0 111.713 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 8.0 m 54.34 76.82 0.22 Allowed 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.654 0.596 . . . . 0.0 111.031 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.135 0 CA-C-O 118.794 -1.004 . . . . 0.0 112.314 -179.143 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.871 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo . . . . . 0 C--N 1.344 0.34 0 C-N-CA 122.673 2.249 . . . . 0.0 112.316 179.87 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.606 0 CA-C-O 120.47 -0.072 . . . . 0.0 112.986 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo . . . . . 0 CA--C 1.528 0.217 0 C-N-CA 122.849 2.366 . . . . 0.0 111.126 179.425 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.66 0 N-CA-C 112.335 -0.306 . . . . 0.0 112.335 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo . . . . . 0 CA--C 1.528 0.181 0 C-N-CA 122.905 2.403 . . . . 0.0 111.322 179.685 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.769 0 N-CA-C 113.415 0.126 . . . . 0.0 113.415 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -74.37 138.12 24.22 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.027 2.485 . . . . 0.0 112.001 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -67.18 152.14 46.29 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.16 148.58 32.71 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.519 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 18.2 mt -64.02 148.03 11.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.58 141.75 57.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.851 0.358 . . . . 0.0 110.14 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.38 158.99 48.24 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.196 -0.526 . . . . 0.0 113.223 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -67.75 148.5 51.18 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -72.94 146.78 45.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.799 0.333 . . . . 0.0 110.4 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.74 157.01 39.02 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.819 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 3.8 t -73.91 152.87 7.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 12.8 t -55.41 142.92 9.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.915 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.98 162.23 48.88 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.859 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 C--N 1.324 -0.531 0 CA-C-O 120.537 0.208 . . . . 0.0 111.165 -179.747 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 112.797 -0.121 . . . . 0.0 112.797 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo . . . . . 0 C--O 1.235 0.35 0 C-N-CA 122.711 2.274 . . . . 0.0 111.917 179.936 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.62 0 N-CA-C 112.24 -0.344 . . . . 0.0 112.24 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo . . . . . 0 C--O 1.235 0.352 0 C-N-CA 122.747 2.298 . . . . 0.0 112.003 -179.606 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 113.716 0.246 . . . . 0.0 113.716 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo . . . . . 0 C--O 1.234 0.276 0 C-N-CA 123.289 2.659 . . . . 0.0 111.59 179.363 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.458 0 CA-C-O 120.417 -0.101 . . . . 0.0 112.872 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 CA--C 1.531 0.355 0 C-N-CA 122.779 2.319 . . . . 0.0 112.109 179.867 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.47 0 CA-C-O 120.323 -0.154 . . . . 0.0 113.189 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo . . . . . 0 C--N 1.343 0.287 0 C-N-CA 123.302 2.668 . . . . 0.0 111.735 179.867 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.655 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo . . . . . 0 N--CA 1.463 -0.303 0 C-N-CA 122.984 2.456 . . . . 0.0 112.04 -179.903 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.423 0 N-CA-C 112.419 -0.273 . . . . 0.0 112.419 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 C--O 1.223 -0.254 0 C-N-CA 122.745 2.296 . . . . 0.0 110.762 179.507 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.384 0 N-CA-C 113.484 0.154 . . . . 0.0 113.484 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.57 159.93 42.34 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 123.118 2.545 . . . . 0.0 112.324 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -58.23 136.68 57.35 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.035 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -66.86 160.05 48.43 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.726 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 62.3 mt -72.8 131.21 35.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.55 151.67 28.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.137 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -69.58 155.53 53.36 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.492 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -76.75 157.43 31.67 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -65.22 150.25 48.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.285 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.47 167.34 44.3 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.935 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 21.5 t -67.02 139.38 21.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.572 0.225 . . . . 0.0 110.474 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 28.6 t -64.46 138.18 23.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.372 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.27 159.44 40.97 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.99 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 81.2 mt . . . . . 0 C--N 1.322 -0.598 0 N-CA-C 110.519 -0.178 . . . . 0.0 110.519 179.921 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.415 0 N-CA-C 112.889 -0.085 . . . . 0.0 112.889 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 C--O 1.236 0.391 0 C-N-CA 122.466 2.11 . . . . 0.0 111.906 179.94 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.502 0 N-CA-C 112.783 -0.127 . . . . 0.0 112.783 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo . . . . . 0 C--O 1.237 0.465 0 C-N-CA 122.671 2.247 . . . . 0.0 111.58 179.584 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.475 0 N-CA-C 112.718 -0.153 . . . . 0.0 112.718 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo . . . . . 0 C--O 1.234 0.318 0 C-N-CA 122.628 2.219 . . . . 0.0 112.099 179.907 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 CA-C-O 120.105 -0.275 . . . . 0.0 112.418 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 CA--C 1.534 0.518 0 C-N-CA 123.195 2.597 . . . . 0.0 112.368 179.802 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.286 0 N-CA-C 112.405 -0.278 . . . . 0.0 112.405 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo . . . . . 0 C--N 1.345 0.35 0 C-N-CA 122.869 2.379 . . . . 0.0 111.502 179.828 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.505 0 N-CA-C 113.83 0.292 . . . . 0.0 113.83 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo . . . . . 0 CA--C 1.532 0.388 0 C-N-CA 123.823 3.015 . . . . 0.0 112.67 -179.936 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.373 0 N-CA-C 113.73 0.252 . . . . 0.0 113.73 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 N--CA 1.455 -0.782 0 C-N-CA 123.889 3.059 . . . . 0.0 112.682 179.8 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.385 0 CA-C-O 120.321 -0.155 . . . . 0.0 112.723 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -71.96 155.99 56.81 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.731 2.288 . . . . 0.0 112.014 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -73.22 147.92 44.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.301 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -68.17 158.75 51.89 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.186 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 20.5 mt -60.05 142.67 15.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.786 0.327 . . . . 0.0 110.948 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -65.26 139.94 58.67 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.582 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -60.37 156.04 31.12 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.11 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -78.56 159.25 28.24 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -67.75 154.33 41.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.783 0.325 . . . . 0.0 110.784 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -64.47 160.12 40.72 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.913 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 15.9 t -70.02 144.15 14.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 39.3 t -61.55 142.7 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.95 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.84 160.7 37.5 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.757 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 82.1 mt . . . . . 0 C--N 1.322 -0.628 0 CA-C-N 115.823 -0.189 . . . . 0.0 110.741 179.938 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.668 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 C--O 1.235 0.337 0 C-N-CA 122.841 2.361 . . . . 0.0 111.595 179.576 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.461 0 N-CA-C 113.971 0.349 . . . . 0.0 113.971 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo . . . . . 0 N--CA 1.461 -0.388 0 C-N-CA 123.339 2.692 . . . . 0.0 111.339 179.348 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.652 0 N-CA-C 112.896 -0.082 . . . . 0.0 112.896 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo . . . . . 0 N--CA 1.462 -0.341 0 C-N-CA 122.614 2.209 . . . . 0.0 110.679 179.645 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo . . . . . 0 N--CA 1.474 0.361 0 N-CA-C 110.733 -0.526 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -128.81 154.85 46.03 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 11.2 tt -73.65 -19.54 17.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.999 0.428 . . . . 0.0 112.08 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 62.1 m -90.94 1.72 56.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.724 0.297 . . . . 0.0 111.51 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.3 -44.68 74.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.191 0.519 . . . . 0.0 110.451 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 93.28 -177.65 38.06 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.096 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 52.59 69.82 0.64 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.299 0.571 . . . . 0.0 111.634 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -87.24 156.36 19.69 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.682 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -65.35 -41.19 94.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.019 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 5.7 t -173.4 149.88 1.77 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.156 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 60.7 t -134.24 118.12 26.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -140.17 -172.18 3.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.843 0.354 . . . . 0.0 111.412 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 44.6 ttp -136.96 126.71 25.53 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.824 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 42.5 mt -120.92 119.93 34.01 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.313 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.17 17.82 9.54 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.14 0.576 . . . . 0.0 111.918 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 102.73 -9.2 55.28 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.154 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -99.5 127.69 45.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.637 0.256 . . . . 0.0 110.66 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 44.5 ttm -77.28 137.23 38.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.95 0.405 . . . . 0.0 111.424 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -125.42 117.05 22.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.618 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 33.3 t -107.7 114.61 46.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -99.15 129.33 45.39 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -139.27 102.47 4.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.774 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 63.33 -99.14 0.07 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.493 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -116.27 -0.56 12.58 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 18.3 m0 -119.27 154.86 32.8 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.323 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -129.05 133.98 47.93 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.104 0.478 . . . . 0.0 110.83 178.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 5.6 m-90 -102.28 153.48 19.95 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.686 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -129.49 105.77 8.31 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.17 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -102.36 123.99 56.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.738 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -118.57 107.16 13.4 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.01 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 63.45 45.25 4.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.26 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 45.1 t30 66.34 32.54 7.64 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.075 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -139.64 142.8 37.0 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 24.7 t -81.79 130.65 35.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 74.7 mtp -74.97 166.32 23.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.034 0.445 . . . . 0.0 112.073 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -83.75 154.93 23.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.762 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 80.76 26.16 54.45 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.329 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -135.22 162.57 56.7 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 122.97 -0.135 . . . . 0.0 110.644 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -75.23 146.23 85.76 Favored 'Cis proline' 0 C--N 1.346 0.408 0 C-N-CA 123.754 -1.353 . . . . 0.0 112.948 0.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 56.3 ttm -114.57 140.96 25.92 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.188 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.32 140.94 90.99 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.275 1.983 . . . . 0.0 111.02 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 91.8 mt -55.7 -43.95 75.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.225 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -72.02 -6.71 64.85 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 121.052 -0.594 . . . . 0.0 113.434 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.39 -21.53 30.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.239 0.52 . . . . 0.0 110.087 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -111.6 -55.42 2.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.789 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 65.1 m95 -91.27 83.62 5.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.366 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -63.32 105.35 0.73 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.264 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 116.55 -6.65 18.39 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.552 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 18.3 tp -91.68 131.4 35.92 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.703 0.287 . . . . 0.0 110.596 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -81.3 170.9 14.34 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.778 2.319 . . . . 0.0 111.371 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -80.59 153.49 28.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.704 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 15.7 m 56.68 84.07 0.09 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 16.8 pt -98.97 -174.07 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -134.29 -24.14 1.63 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 4.8 m -141.83 145.92 35.25 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.555 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -153.58 131.46 11.67 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -163.53 165.28 23.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.888 0.375 . . . . 0.0 111.496 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -94.23 141.63 28.34 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -97.2 -169.4 1.85 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.385 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.467 ' HZ3' ' CD ' ' A' ' 441' ' ' GLU . 34.9 tttt -69.39 -34.43 74.51 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.645 0.979 . . . . 0.0 113.645 -177.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 44.7 p30 -83.02 -10.37 58.79 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 107.83 -6.2 35.12 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.669 -0.776 . . . . 0.0 113.241 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 17.4 mttp -76.54 164.24 26.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.906 0.353 . . . . 0.0 110.879 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -107.82 123.32 48.4 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -178.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 12.2 t -105.98 119.82 55.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.036 0.446 . . . . 0.0 110.446 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -106.18 143.38 34.38 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.508 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -124.1 138.26 54.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.069 0.461 . . . . 0.0 111.897 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -150.69 98.24 2.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.78 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 77.58 -111.94 3.38 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.618 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -113.09 6.9 17.81 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.685 0.278 . . . . 0.0 111.345 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -114.61 148.97 37.33 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.514 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -128.86 146.0 51.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.218 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 -120.21 131.75 55.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.09 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 99.2 t -115.52 110.44 31.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.059 0.456 . . . . 0.0 109.972 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -102.68 128.18 49.49 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.613 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -99.35 103.15 14.94 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 71.89 -53.36 0.69 Allowed 'General case' 0 N--CA 1.469 0.519 0 O-C-N 123.663 0.602 . . . . 0.0 111.298 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -166.27 -29.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.844 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.37 138.8 32.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.814 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 27.9 tp -78.29 139.84 38.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.803 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -67.21 140.75 95.72 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.443 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -67.77 147.4 75.22 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.715 2.276 . . . . 0.0 111.238 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 89.18 15.04 59.55 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.718 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -117.99 162.58 28.77 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -76.74 164.44 87.43 Favored 'Cis proline' 0 C--N 1.345 0.375 0 C-N-CA 123.634 -1.402 . . . . 0.0 113.306 0.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -130.68 163.41 27.29 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.167 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -73.22 159.87 32.8 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 33.0 mt -59.61 -31.78 47.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.344 0.592 . . . . 0.0 110.222 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -69.38 -12.03 61.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.183 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -85.58 -21.95 28.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.971 0.415 . . . . 0.0 111.253 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 47.8 tp -76.51 -53.95 7.38 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.126 0.488 . . . . 0.0 110.25 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -151.54 157.64 27.32 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.127 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 38.2 ttt180 -86.68 130.18 34.58 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.798 0.333 . . . . 0.0 110.676 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 106.34 -5.93 38.78 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.797 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 66.7 mt -76.98 151.44 81.94 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 120.633 0.254 . . . . 0.0 111.235 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.27 131.44 44.96 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.907 2.404 . . . . 0.0 111.633 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.74 -7.45 33.83 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.848 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -87.12 -56.59 3.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.197 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 8.4 ptmt -175.42 173.74 2.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.955 0.407 . . . . 0.0 111.224 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 34.6 mm -125.4 130.67 72.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.341 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -89.11 -41.95 11.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.165 0.507 . . . . 0.0 110.532 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -163.64 164.4 24.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.903 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -148.73 127.25 12.36 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 24.9 tp -118.47 119.83 35.74 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.06 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -87.81 113.91 23.93 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 4.2 t-105 -81.81 96.36 7.58 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 58.2 mtt -52.09 -51.21 73.62 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -49.29 -57.25 2.47 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.681 2.254 . . . . 0.0 114.383 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 37.1 p30 -84.29 -24.72 29.75 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 82.92 37.44 13.03 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 121.009 -0.615 . . . . 0.0 113.438 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -128.08 150.39 49.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 117.031 0.416 . . . . 0.0 110.913 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 2.0 m -101.04 127.01 47.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.035 0.445 . . . . 0.0 111.753 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -101.85 111.62 23.94 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.556 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -94.45 137.42 33.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.124 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -113.08 129.89 56.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.003 0.43 . . . . 0.0 111.321 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -141.26 105.01 4.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.23 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 67.47 -108.88 2.62 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.073 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -114.39 13.09 17.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.835 0.35 . . . . 0.0 110.763 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -123.62 151.46 42.98 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.276 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 435' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -126.95 138.92 53.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.435 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -110.58 143.78 40.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.716 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -109.35 99.5 8.74 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -92.25 132.55 36.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.521 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -106.8 113.38 26.83 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.621 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -50.89 -52.43 41.93 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' GLU . . . . . 0.467 ' CD ' ' HZ3' ' A' ' 375' ' ' LYS . 11.6 mp0 -64.89 -14.35 59.43 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -178.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 47.9 mt -113.86 -7.77 13.18 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 47.3 40.67 10.92 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.599 0.714 . . . . 0.0 112.472 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -154.73 171.32 19.75 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.505 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.5 t -96.81 142.8 13.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.278 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.55 153.0 10.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.64 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 11.1 m -70.48 155.26 40.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.365 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 71.41 26.97 3.18 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.483 0.658 . . . . 0.0 110.918 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -123.72 164.47 28.64 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.094 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -79.85 155.68 88.2 Favored 'Cis proline' 0 C--N 1.344 0.34 0 C-N-CA 123.637 -1.401 . . . . 0.0 112.631 0.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -106.78 171.84 7.14 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.853 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -68.85 136.93 53.44 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.556 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 12.9 tt -67.72 -15.73 20.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.079 0.466 . . . . 0.0 111.381 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -67.07 -2.3 5.33 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 71.6 t -62.62 -34.96 68.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -88.34 90.05 8.24 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -53.02 114.62 1.51 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.606 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 113.25 -15.96 22.57 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.347 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 45.8 mm -89.68 117.61 68.29 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.694 0.283 . . . . 0.0 111.083 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -79.2 153.24 24.49 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 123.088 2.525 . . . . 0.0 111.374 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -67.54 149.6 49.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.601 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.3 m 60.58 78.08 0.34 Allowed Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -88.05 -174.98 1.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.966 2.444 . . . . 0.0 111.481 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.79 9.6 3.34 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.108 0.48 . . . . 0.0 110.856 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 169.94 141.83 3.38 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 6.3 p -152.73 106.15 3.04 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -128.26 142.15 51.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.057 0.456 . . . . 0.0 111.605 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 47.9 ttm -95.44 134.63 38.05 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.556 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -67.08 163.22 45.39 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.018 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 1.4 m -66.46 -7.33 18.82 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.911 0.386 . . . . 0.0 111.346 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -84.94 -15.09 45.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.069 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 65.77 6.76 4.11 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 46.6 t -109.62 -40.09 4.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.738 0.304 . . . . 0.0 111.362 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -105.02 123.0 47.04 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 90.9 m -111.16 138.06 48.08 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -113.4 128.3 56.41 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -110.22 125.92 53.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.298 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -106.25 136.33 46.16 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -158.19 102.89 1.8 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.814 0.34 . . . . 0.0 111.89 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 57.63 72.33 0.61 Allowed Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 114.823 0.689 . . . . 0.0 114.823 178.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 69.62 -24.87 0.15 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -104.32 156.05 18.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.885 0.374 . . . . 0.0 111.63 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -133.29 147.04 51.89 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.107 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 10.5 m-90 -109.93 148.27 31.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.782 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -107.23 97.13 6.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.823 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 486' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -91.61 124.81 36.04 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.973 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -92.52 117.36 29.86 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -68.15 -32.15 72.22 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -76.4 -26.44 55.56 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -102.92 -15.98 16.0 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.423 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 4.1 tp 60.09 39.28 19.85 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.565 0.698 . . . . 0.0 110.641 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 31.2 tttp -159.31 149.19 18.85 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.255 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 54.9 t -73.03 134.76 29.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.114 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -70.55 146.97 94.51 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.286 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.4 160.25 40.13 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.938 2.425 . . . . 0.0 112.781 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 87.21 17.25 59.4 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -128.4 166.82 21.72 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.431 -0.385 . . . . 0.0 110.39 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.5 167.94 78.51 Favored 'Cis proline' 0 C--N 1.346 0.425 0 C-N-CA 123.857 -1.309 . . . . 0.0 113.102 0.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -121.99 164.94 16.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.155 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 22.5 t -77.56 109.35 11.44 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.94 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -68.46 -25.37 64.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.988 0.423 . . . . 0.0 110.429 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 74.1 mt -65.57 -26.74 67.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.747 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 30.2 ttm105 -99.74 -40.82 7.56 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.091 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.96 -23.57 36.03 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -177.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -114.1 -48.09 2.91 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 11.5 mmt -77.53 -26.52 51.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.026 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 83.15 26.42 44.37 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.208 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 60.4 m -98.21 110.42 56.12 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-O 120.719 0.295 . . . . 0.0 110.698 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.07 175.71 10.61 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.895 2.396 . . . . 0.0 112.07 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 6.9 m 66.55 15.63 10.17 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 CA-C-O 118.163 -1.354 . . . . 0.0 110.929 179.833 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.8 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo . . . . . 0 C--O 1.234 0.302 0 C-N-CA 122.503 2.135 . . . . 0.0 111.903 179.989 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.618 0 N-CA-C 112.439 -0.264 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo . . . . . 0 CA--C 1.53 0.297 0 C-N-CA 122.967 2.444 . . . . 0.0 110.331 179.673 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.47 0 N-CA-C 112.35 -0.3 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 CA--C 1.53 0.323 0 C-N-CA 122.961 2.441 . . . . 0.0 111.183 178.803 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.793 0 N-CA-C 111.712 -0.555 . . . . 0.0 111.712 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -58.07 135.4 68.3 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.804 2.336 . . . . 0.0 111.735 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -61.28 147.0 46.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.611 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.23 153.48 42.51 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.261 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 2.4 mt -67.0 150.63 11.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 122.669 0.388 . . . . 0.0 110.577 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.21 145.39 49.68 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.29 156.04 50.91 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.766 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -66.25 141.72 57.93 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 15.1 ttt180 -65.61 148.5 51.64 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.656 0.265 . . . . 0.0 110.967 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.78 150.56 45.34 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 116.001 -0.545 . . . . 0.0 113.447 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 8.2 t -65.9 147.53 12.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.684 -0.258 . . . . 0.0 110.513 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 6.6 t -53.42 145.1 3.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.401 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.25 165.41 46.38 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.243 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 69.2 mt . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 115.793 -0.204 . . . . 0.0 110.969 -179.789 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.628 0 N-CA-C 112.411 -0.276 . . . . 0.0 112.411 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 C--O 1.234 0.313 0 C-N-CA 122.54 2.16 . . . . 0.0 111.668 179.713 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.584 0 CA-C-O 120.356 -0.135 . . . . 0.0 112.824 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 CA--C 1.533 0.428 0 C-N-CA 122.944 2.429 . . . . 0.0 111.823 179.609 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 113.302 0.081 . . . . 0.0 113.302 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo . . . . . 0 C--O 1.236 0.381 0 C-N-CA 123.134 2.556 . . . . 0.0 112.076 179.666 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.744 0 N-CA-C 112.787 -0.125 . . . . 0.0 112.787 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo . . . . . 0 CA--C 1.529 0.251 0 C-N-CA 122.766 2.311 . . . . 0.0 110.909 179.272 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.507 0 N-CA-C 112.278 -0.329 . . . . 0.0 112.278 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo . . . . . 0 N--CA 1.465 -0.189 0 C-N-CA 123.211 2.608 . . . . 0.0 111.738 179.9 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.449 0 N-CA-C 112.559 -0.216 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo . . . . . 0 C--O 1.235 0.33 0 C-N-CA 123.114 2.543 . . . . 0.0 112.361 -179.973 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.565 -0.214 . . . . 0.0 112.565 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo . . . . . 0 CA--C 1.528 0.185 0 C-N-CA 122.674 2.249 . . . . 0.0 111.549 179.934 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.382 0 N-CA-C 113.687 0.235 . . . . 0.0 113.687 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.44 150.04 88.78 Favored 'Trans proline' 0 C--O 1.237 0.425 0 C-N-CA 122.883 2.388 . . . . 0.0 112.524 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -55.84 134.72 52.02 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.951 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.23 160.77 26.74 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.799 -0.637 . . . . 0.0 113.277 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 53.4 mt -74.03 138.43 21.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 120.755 0.312 . . . . 0.0 110.231 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.19 146.39 55.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.899 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -63.79 156.08 44.04 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.448 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -75.04 159.06 32.19 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.64 0.257 . . . . 0.0 110.577 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 14.6 ttm-85 -68.72 146.65 52.76 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.67 168.21 36.2 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.024 -0.608 . . . . 0.0 113.158 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 4.3 t -75.51 144.98 11.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 92.6 t -61.57 139.11 21.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.516 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.28 167.3 40.15 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.701 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 82.5 mt . . . . . 0 C--N 1.322 -0.589 0 CA-C-O 120.478 0.18 . . . . 0.0 111.033 -179.717 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.612 0 N-CA-C 112.75 -0.14 . . . . 0.0 112.75 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo . . . . . 0 C--O 1.234 0.309 0 C-N-CA 122.685 2.257 . . . . 0.0 111.592 179.697 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.466 0 N-CA-C 112.913 -0.075 . . . . 0.0 112.913 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo . . . . . 0 C--O 1.236 0.412 0 C-N-CA 122.673 2.249 . . . . 0.0 111.427 -179.894 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 112.972 -0.051 . . . . 0.0 112.972 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo . . . . . 0 C--O 1.237 0.454 0 C-N-CA 122.739 2.293 . . . . 0.0 111.868 179.963 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 CA-C-O 120.13 -0.261 . . . . 0.0 113.072 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo . . . . . 0 C--N 1.343 0.282 0 C-N-CA 122.65 2.234 . . . . 0.0 111.78 179.563 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 112.173 -0.371 . . . . 0.0 112.173 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo . . . . . 0 C--N 1.347 0.461 0 C-N-CA 122.935 2.423 . . . . 0.0 111.743 179.954 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.497 0 CA-C-O 120.221 -0.211 . . . . 0.0 113.344 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo . . . . . 0 CA--C 1.532 0.407 0 C-N-CA 123.551 2.834 . . . . 0.0 112.824 -179.423 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.376 0 N-CA-C 113.394 0.118 . . . . 0.0 113.394 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo . . . . . 0 N--CA 1.456 -0.694 0 C-N-CA 123.743 2.962 . . . . 0.0 112.137 -179.834 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 CA-C-O 120.354 -0.136 . . . . 0.0 112.887 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.6 160.0 48.19 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.785 2.323 . . . . 0.0 112.456 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -77.22 143.87 38.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.416 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -65.57 158.76 46.2 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.683 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 38.3 pt -67.01 151.42 10.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.893 0.377 . . . . 0.0 111.033 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -66.81 149.37 50.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.917 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -67.49 172.04 32.25 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 116.05 -0.523 . . . . 0.0 113.285 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 51.3 mm-40 -87.95 154.32 20.6 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -62.88 151.98 37.64 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.763 0.316 . . . . 0.0 111.191 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -64.23 156.81 44.53 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.324 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 6.4 t -67.43 147.2 12.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 50.5 t -63.71 143.01 16.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.98 162.05 23.27 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.225 -0.512 . . . . 0.0 112.687 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 5.9 mp . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.872 -0.164 . . . . 0.0 110.914 -179.578 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.669 0 CA-C-O 120.298 -0.168 . . . . 0.0 113.055 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo . . . . . 0 C--O 1.232 0.18 0 C-N-CA 123.208 2.605 . . . . 0.0 111.843 179.698 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.614 0 N-CA-C 113.369 0.108 . . . . 0.0 113.369 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo . . . . . 0 N--CA 1.461 -0.4 0 C-N-CA 122.897 2.398 . . . . 0.0 111.362 179.603 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.662 0 N-CA-C 112.799 -0.12 . . . . 0.0 112.799 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo . . . . . 0 N--CA 1.458 -0.609 0 C-N-CA 122.577 2.185 . . . . 0.0 111.195 179.323 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo . . . . . 0 N--CA 1.477 0.508 0 N-CA-C 109.776 -0.894 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -119.84 155.51 32.47 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 10.5 tt -69.84 -17.93 21.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.007 0.432 . . . . 0.0 111.517 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 61.3 m -88.94 3.7 50.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.243 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -72.66 -38.71 67.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.016 0.436 . . . . 0.0 110.747 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 80.5 -164.85 47.61 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.309 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 51.51 56.18 8.29 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.211 0.529 . . . . 0.0 110.877 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -79.31 160.46 26.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.412 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -73.17 -36.25 66.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.897 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 8.9 t -177.62 149.22 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.207 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 91.4 t -129.4 124.19 59.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -148.6 -176.32 5.27 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.942 0.401 . . . . 0.0 111.299 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 24.3 ttp -128.89 133.88 48.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.801 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 79.7 mt -125.91 111.24 14.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.376 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 58.24 33.06 22.79 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 102.82 -32.86 7.09 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.334 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -81.92 135.81 35.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.807 0.304 . . . . 0.0 111.24 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 44.9 ttm -90.54 124.53 35.09 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -114.49 129.85 56.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.091 0.472 . . . . 0.0 111.809 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 13.7 t -114.56 128.45 71.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -109.63 139.46 44.63 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 12.8 tptp -144.23 100.07 3.49 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.63 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 60.27 -104.46 0.19 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.13 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -110.47 8.77 23.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.588 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 15.3 m-90 -122.43 157.8 31.11 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -139.01 148.24 43.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.013 0.435 . . . . 0.0 111.351 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 4.2 m-90 -120.29 160.52 22.84 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.008 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.32 108.81 6.53 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 2.3 m -97.02 139.31 19.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.407 0.622 . . . . 0.0 111.96 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 7.6 mmt180 -138.87 111.96 7.96 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.943 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 62.87 46.5 4.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.585 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 48.5 t30 63.81 27.56 14.61 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.758 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -136.28 142.81 43.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.359 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 21.9 t -90.13 124.11 42.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 49.6 mtp -70.41 157.22 38.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.704 0.288 . . . . 0.0 111.035 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.32 158.76 34.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.024 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 95.16 -2.78 66.1 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.456 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -118.17 156.25 50.72 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.07 137.6 47.74 Favored 'Cis proline' 0 C--N 1.345 0.389 0 C-N-CA 123.504 -1.457 . . . . 0.0 112.536 0.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 59.6 ttm -114.69 135.56 22.36 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.422 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -58.86 138.0 83.16 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.369 2.046 . . . . 0.0 111.08 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 74.3 mt -52.27 -40.36 30.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.257 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -66.55 -12.66 59.4 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 121.087 -0.577 . . . . 0.0 114.255 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -79.94 -17.37 53.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.037 0.419 . . . . 0.0 111.541 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -126.82 -55.36 1.39 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.006 0.432 . . . . 0.0 110.453 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -86.99 76.82 9.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.319 0.581 . . . . 0.0 110.136 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -65.72 94.74 0.21 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.491 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 129.47 -12.68 5.97 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.162 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 21.3 tp -88.81 127.5 55.83 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.805 0.336 . . . . 0.0 111.117 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -78.81 167.89 21.68 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.096 2.531 . . . . 0.0 111.793 179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -73.18 152.86 40.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.223 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 5.7 m 57.65 86.88 0.07 Allowed 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 22.9 pt -95.44 179.97 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.329 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.36 -45.3 4.12 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 121.146 -0.222 . . . . 0.0 111.525 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.73 172.32 18.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.969 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -162.67 138.04 6.97 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -150.47 162.29 40.87 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -96.78 117.69 31.6 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -87.62 175.95 7.67 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -66.69 -16.97 64.6 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.616 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.22 -26.78 30.47 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.7 0.286 . . . . 0.0 111.675 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 114.87 -9.03 21.43 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.689 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -94.98 164.88 12.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.908 0.385 . . . . 0.0 111.427 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -99.0 127.38 44.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.591 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 15.7 t -107.57 113.6 44.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.126 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -99.27 145.1 27.64 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.803 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -124.79 143.55 50.74 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.419 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 44.3 tttp -155.21 99.28 2.07 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 75.08 -105.6 1.93 Allowed Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.539 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -119.42 7.74 11.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.937 0.399 . . . . 0.0 110.87 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -114.44 152.74 31.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.959 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -132.47 150.49 52.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.645 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 24.6 m-90 -127.53 138.96 53.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.105 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 75.3 t -117.38 115.67 49.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -106.49 126.04 51.76 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -91.88 84.68 5.4 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 177.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 69.85 -64.15 0.36 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.316 -178.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -145.51 -3.93 0.7 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 11.6 m -111.43 135.39 52.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.711 0.291 . . . . 0.0 111.284 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 62.3 tp -81.07 138.96 35.95 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.129 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -65.39 146.71 98.93 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.63 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -65.48 148.11 87.47 Favored 'Trans proline' 0 C--O 1.238 0.496 0 C-N-CA 123.036 2.491 . . . . 0.0 112.663 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 73.19 45.08 32.65 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.626 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -128.25 159.04 69.27 Favored Pre-proline 0 C--N 1.321 -0.649 0 O-C-N 122.859 -0.201 . . . . 0.0 110.811 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.6 156.61 95.78 Favored 'Cis proline' 0 C--O 1.236 0.397 0 C-N-CA 123.568 -1.43 . . . . 0.0 113.577 0.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -112.58 156.48 22.59 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -72.11 156.96 38.62 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 78.2 mt -57.33 -39.28 67.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.943 0.401 . . . . 0.0 111.087 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -69.58 -7.53 39.44 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -87.32 -15.04 39.15 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 48.8 tp -86.36 -36.83 18.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.888 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -169.65 156.09 26.7 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.731 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -90.65 136.14 33.25 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.722 0.296 . . . . 0.0 110.75 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 102.18 4.83 50.39 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.426 -0.669 . . . . 0.0 111.426 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 88.9 mt -89.79 148.51 40.04 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 120.47 0.176 . . . . 0.0 111.014 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -58.0 119.24 6.37 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.696 2.264 . . . . 0.0 111.075 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.96 7.37 31.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.58 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -99.2 -54.99 2.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.82 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 15.6 ptmt -175.53 169.69 3.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.561 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 46.2 mm -121.82 126.23 74.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -82.38 -43.7 17.04 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.895 0.378 . . . . 0.0 110.698 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -157.65 154.8 28.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.301 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -134.83 119.32 17.99 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 42.0 tp -115.17 117.97 32.03 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.872 0.368 . . . . 0.0 111.778 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -91.24 118.25 30.31 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.208 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 15.6 t-105 -87.67 99.02 11.76 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 63.3 mtt -52.44 -52.57 62.12 Favored Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -48.23 -40.34 35.01 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.898 2.399 . . . . 0.0 114.913 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 39.6 p30 -103.09 -28.79 11.75 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 88.24 29.49 19.65 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.612 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -122.29 141.61 51.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.833 0.349 . . . . 0.0 110.589 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 60.1 m -103.17 130.03 50.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.419 0.628 . . . . 0.0 111.646 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -98.64 122.79 42.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.839 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -98.54 121.73 40.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.653 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -98.6 132.31 44.11 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.473 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -145.07 107.14 4.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.205 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 69.71 -117.41 7.58 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -113.22 16.28 19.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.258 0.551 . . . . 0.0 110.712 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -125.89 150.51 47.86 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.366 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 435' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -129.85 142.7 50.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.063 0.459 . . . . 0.0 111.457 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -109.09 147.57 32.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.428 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -107.14 94.74 5.26 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -81.49 119.59 23.93 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.414 0.626 . . . . 0.0 112.068 -178.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -86.33 94.93 9.48 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -54.8 -30.74 57.83 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -82.89 -10.74 58.68 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 50.3 mt -119.28 -12.41 9.42 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 52.9 mtm180 61.24 44.39 9.88 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.443 0.639 . . . . 0.0 111.858 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -163.24 154.95 17.52 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.769 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 93.9 t -80.99 137.56 21.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.048 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -62.79 163.47 9.34 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.306 0.574 . . . . 0.0 111.883 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.99 161.93 30.19 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.283 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 72.03 20.85 4.22 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.188 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -125.0 158.97 61.15 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.999 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.0 161.16 91.5 Favored 'Cis proline' 0 C--N 1.345 0.386 0 C-N-CA 123.766 -1.347 . . . . 0.0 112.574 1.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -114.24 172.51 6.96 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.78 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -72.42 140.99 48.67 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.2 tt -67.51 -12.04 14.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.078 0.466 . . . . 0.0 110.772 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -65.84 -10.16 35.46 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 81.2 t -61.34 -34.51 61.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 177.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -88.1 84.39 6.93 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.48 115.67 2.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.763 -178.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 103.24 -11.59 55.05 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.833 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 27.5 mm -89.36 126.09 59.62 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 120.808 0.337 . . . . 0.0 111.188 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.91 152.26 21.86 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.827 2.351 . . . . 0.0 111.41 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.64 157.6 33.52 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.84 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.5 m 56.86 69.43 1.72 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.577 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -87.91 -179.29 2.47 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.04 2.493 . . . . 0.0 111.637 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 7.7 tpp85 -144.46 36.11 1.2 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.519 0.676 . . . . 0.0 110.08 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 161.81 132.8 1.38 Allowed Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.342 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 6.0 p -155.56 106.32 2.51 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -133.35 142.67 48.53 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.028 0.442 . . . . 0.0 111.782 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 42.2 ttm -92.61 140.31 29.67 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.542 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -69.32 166.95 47.59 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.274 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 1.5 m -68.03 -7.41 28.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.15 0.5 . . . . 0.0 111.681 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -86.27 -20.87 27.79 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.756 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 70.34 13.65 7.54 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.748 0.655 . . . . 0.0 112.27 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 19.4 t -114.82 -34.3 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 120.781 0.324 . . . . 0.0 111.343 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -113.76 133.79 55.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.209 0.528 . . . . 0.0 111.986 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 84.9 m -119.03 140.07 50.65 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.936 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -110.32 134.38 52.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.882 0.372 . . . . 0.0 111.782 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -116.08 141.66 47.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.47 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -120.69 134.92 55.25 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.994 0.184 . . . . 0.0 111.27 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -168.52 126.68 1.1 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.443 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 63.63 42.6 98.71 Favored Glycine 0 N--CA 1.454 -0.154 0 CA-C-N 116.086 -0.506 . . . . 0.0 113.751 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 54.6 t30 68.29 3.19 3.59 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 25.6 mtmt -116.24 157.89 24.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.048 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -130.57 146.7 52.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.023 0.44 . . . . 0.0 111.695 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 16.8 m-90 -114.62 151.25 33.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.615 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -110.76 98.65 7.75 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 486' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -90.96 131.65 36.44 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.768 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -96.02 120.42 36.27 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -66.91 -29.49 69.38 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 52.0 tp60 -83.16 -39.35 21.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.827 0.346 . . . . 0.0 111.726 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -83.53 -19.87 34.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.484 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 18.3 tp 61.22 34.02 18.93 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.481 0.658 . . . . 0.0 110.036 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 25.8 tttp -156.03 150.2 25.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.567 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 56.8 t -70.19 137.79 23.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.42 138.71 86.5 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.821 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -60.08 145.01 99.42 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 123.156 2.571 . . . . 0.0 112.644 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 109.61 -6.69 31.63 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -109.75 169.1 6.77 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -76.85 171.53 67.64 Favored 'Cis proline' 0 C--N 1.35 0.647 0 C-N-CA 124.022 -1.241 . . . . 0.0 113.083 0.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -131.83 164.28 26.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.97 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 48.1 t -72.72 122.27 21.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.512 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -67.98 -29.76 68.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.068 0.461 . . . . 0.0 110.605 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 63.6 mt -68.01 -41.58 82.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.354 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -77.75 -37.33 49.35 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -93.58 -27.49 16.59 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -176.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 36.6 m0 -109.56 -50.7 2.96 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 11.3 mmt -73.02 -26.57 61.36 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -178.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 88.77 25.91 28.49 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.813 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 21.7 m -106.03 105.74 54.58 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 120.627 0.251 . . . . 0.0 110.743 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -84.61 176.15 6.5 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.867 2.378 . . . . 0.0 111.82 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 40.2 m 62.14 46.83 6.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.468 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.421 -1.211 . . . . 0.0 110.589 179.561 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.897 0 N-CA-C 112.295 -0.322 . . . . 0.0 112.295 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 CA--C 1.53 0.288 0 C-N-CA 122.821 2.347 . . . . 0.0 111.777 179.845 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.717 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo . . . . . 0 CA--C 1.531 0.357 0 C-N-CA 122.88 2.387 . . . . 0.0 111.021 179.454 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 N-CA-C 112.326 -0.31 . . . . 0.0 112.326 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo . . . . . 0 CA--C 1.531 0.355 0 C-N-CA 122.973 2.449 . . . . 0.0 111.866 179.434 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.712 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -63.19 137.28 60.39 Favored 'Trans proline' 0 C--O 1.238 0.498 0 C-N-CA 122.87 2.38 . . . . 0.0 111.839 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -65.47 143.35 57.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.133 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.63 153.2 24.99 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.987 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 mt -72.62 150.85 8.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.73 142.45 58.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.226 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.03 168.49 33.1 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.886 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -74.36 145.09 44.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.678 0.275 . . . . 0.0 110.782 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.55 136.18 54.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.973 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.8 144.34 34.79 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.985 -0.552 . . . . 0.0 113.687 -179.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 4.1 t -64.39 147.11 12.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 9.7 t -54.57 147.13 3.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.05 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.55 177.82 46.16 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.639 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 86.7 mt . . . . . 0 C--N 1.323 -0.571 0 CA-C-O 120.418 0.151 . . . . 0.0 110.648 -179.665 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.503 0 CA-C-O 120.405 -0.108 . . . . 0.0 112.993 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo . . . . . 0 C--O 1.234 0.313 0 C-N-CA 122.772 2.314 . . . . 0.0 112.154 179.846 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.567 0 N-CA-C 113.212 0.045 . . . . 0.0 113.212 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo . . . . . 0 CA--C 1.534 0.501 0 C-N-CA 123.187 2.591 . . . . 0.0 111.627 179.689 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.637 0 N-CA-C 112.76 -0.136 . . . . 0.0 112.76 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo . . . . . 0 C--O 1.236 0.399 0 C-N-CA 123.153 2.569 . . . . 0.0 111.643 179.392 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.943 0 N-CA-C 112.783 -0.127 . . . . 0.0 112.783 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo . . . . . 0 N--CA 1.46 -0.488 0 C-N-CA 122.487 2.124 . . . . 0.0 111.098 179.403 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.433 0 N-CA-C 112.29 -0.324 . . . . 0.0 112.29 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo . . . . . 0 CA--C 1.528 0.217 0 C-N-CA 122.898 2.399 . . . . 0.0 111.9 -179.887 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 111.834 -0.507 . . . . 0.0 111.834 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo . . . . . 0 C--O 1.236 0.379 0 C-N-CA 122.895 2.396 . . . . 0.0 112.528 -179.576 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.383 0 N-CA-C 112.297 -0.321 . . . . 0.0 112.297 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 CA--C 1.528 0.18 0 C-N-CA 123.213 2.608 . . . . 0.0 110.886 179.513 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.417 0 N-CA-C 112.811 -0.115 . . . . 0.0 112.811 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.85 157.45 61.31 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.749 2.299 . . . . 0.0 112.552 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -60.78 139.0 58.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.815 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -67.61 168.33 39.54 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.029 -0.605 . . . . 0.0 113.256 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 28.4 mt -68.6 138.18 22.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.86 147.58 51.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.966 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.54 149.27 48.72 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 116.058 -0.519 . . . . 0.0 113.196 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -78.27 143.61 36.89 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 122.283 0.233 . . . . 0.0 110.617 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 52.9 ttm-85 -62.19 145.25 54.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.632 0.253 . . . . 0.0 110.742 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.45 168.9 37.92 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.691 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -77.26 149.15 6.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.521 0.2 . . . . 0.0 110.475 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 63.4 t -64.61 137.55 24.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.982 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.36 161.78 50.24 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 121.11 -0.566 . . . . 0.0 112.42 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 88.9 mt . . . . . 0 C--N 1.325 -0.464 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.92 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.442 0 N-CA-C 113.595 0.198 . . . . 0.0 113.595 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 C--O 1.235 0.356 0 C-N-CA 122.916 2.411 . . . . 0.0 111.647 179.587 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 113.365 0.106 . . . . 0.0 113.365 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo . . . . . 0 C--O 1.236 0.414 0 C-N-CA 122.632 2.222 . . . . 0.0 111.484 179.634 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 112.653 -0.179 . . . . 0.0 112.653 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo . . . . . 0 C--N 1.342 0.233 0 C-N-CA 122.795 2.33 . . . . 0.0 111.59 179.754 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.521 0 CA-C-O 119.927 -0.374 . . . . 0.0 112.551 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo . . . . . 0 CA--C 1.53 0.302 0 C-N-CA 123.005 2.47 . . . . 0.0 111.88 -179.991 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.387 0 N-CA-C 112.17 -0.372 . . . . 0.0 112.17 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo . . . . . 0 C--N 1.344 0.32 0 C-N-CA 122.783 2.322 . . . . 0.0 111.488 179.77 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.329 0 N-CA-C 114.346 0.498 . . . . 0.0 114.346 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo . . . . . 0 C--N 1.347 0.459 0 C-N-CA 123.896 3.064 . . . . 0.0 113.265 -179.394 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.421 0 CA-C-O 120.456 -0.08 . . . . 0.0 112.988 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo . . . . . 0 N--CA 1.459 -0.506 0 C-N-CA 123.187 2.591 . . . . 0.0 112.326 179.898 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.697 0 N-CA-C 112.086 -0.406 . . . . 0.0 112.086 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -68.12 158.35 57.85 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.643 2.229 . . . . 0.0 112.237 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -79.49 147.31 32.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.886 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.97 161.49 36.78 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.167 -0.54 . . . . 0.0 112.286 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 40.5 pt -66.79 166.92 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.63 0.252 . . . . 0.0 111.168 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -80.64 138.99 36.45 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.912 0.387 . . . . 0.0 110.685 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -63.15 156.08 41.98 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.017 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -71.0 150.18 45.9 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -62.29 152.25 34.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.45 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -58.97 154.2 28.87 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.667 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 15.8 t -66.74 143.15 15.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 21.9 t -63.01 143.26 15.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.047 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.22 162.66 31.98 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.777 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 7.3 mp . . . . . 0 C--N 1.323 -0.547 0 CA-C-O 120.489 0.185 . . . . 0.0 110.778 -179.8 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.805 0 N-CA-C 112.339 -0.304 . . . . 0.0 112.339 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo . . . . . 0 C--O 1.233 0.229 0 C-N-CA 122.837 2.358 . . . . 0.0 111.506 179.746 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.528 0 CA-C-O 120.466 -0.075 . . . . 0.0 112.999 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo . . . . . 0 N--CA 1.462 -0.33 0 C-N-CA 123.03 2.487 . . . . 0.0 111.443 179.907 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.581 0 N-CA-C 112.561 -0.215 . . . . 0.0 112.561 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo . . . . . 0 N--CA 1.462 -0.34 0 C-N-CA 122.654 2.236 . . . . 0.0 110.816 179.02 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 N--CA 1.479 0.65 0 N-CA-C 110.06 -0.785 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -115.27 161.2 18.8 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 17.6 tt -70.42 -23.42 24.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.08 0.467 . . . . 0.0 110.875 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 59.0 m -80.9 -1.1 42.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.227 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -71.33 -20.98 62.11 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.13 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 76.22 -177.31 50.83 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.822 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 24.4 m120 48.79 83.52 0.04 OUTLIER 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -100.62 168.67 9.55 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.222 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -77.35 -40.73 43.02 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 7.0 t -171.46 154.72 3.92 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.928 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 67.7 t -130.5 125.71 59.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -136.89 170.47 16.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.006 0.431 . . . . 0.0 110.898 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 41.4 ttp -130.08 87.06 2.47 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.568 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 45.5 mt -85.7 123.8 31.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.48 -178.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 31.5 mmt-85 63.71 19.37 11.69 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.203 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 93.2 -3.61 73.04 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.631 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -95.45 128.44 42.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.853 0.359 . . . . 0.0 110.356 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 38.5 ttm -77.03 110.92 12.07 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.251 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -110.29 122.83 48.61 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.988 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 27.2 t -109.73 122.34 64.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.47 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -106.21 132.04 52.75 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.731 0.3 . . . . 0.0 111.46 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -148.37 112.38 5.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.42 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 64.76 -113.01 0.31 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.922 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 15.4 ptt-85 -114.63 11.78 17.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.857 0.361 . . . . 0.0 111.107 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 15.0 m-90 -122.99 155.07 37.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.933 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -135.85 148.69 48.76 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.686 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 29.2 m-90 -124.47 162.5 23.82 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.462 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.13 114.99 9.07 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 2.5 m -103.3 136.86 34.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.262 0.553 . . . . 0.0 112.083 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -135.84 123.26 22.0 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 5.6 m120 66.14 35.21 6.27 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 123.564 0.54 . . . . 0.0 110.614 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 17.5 t30 63.14 33.12 14.71 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.048 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -143.03 143.52 31.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.563 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 14.0 t -83.65 131.39 33.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 91.1 mtp -84.44 172.57 11.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.904 0.383 . . . . 0.0 111.513 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -77.47 158.38 30.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.23 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 98.02 -5.47 61.48 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.045 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -117.64 152.72 50.08 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.58 140.01 63.1 Favored 'Cis proline' 0 C--N 1.343 0.286 0 C-N-CA 123.215 -1.577 . . . . 0.0 112.834 0.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 57.1 ttm -119.85 135.94 24.56 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.94 134.77 64.59 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.327 2.018 . . . . 0.0 110.931 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 94.0 mt -51.91 -42.32 33.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.814 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -67.83 -8.11 51.61 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 116.029 -0.532 . . . . 0.0 114.271 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.72 -32.87 27.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.259 0.529 . . . . 0.0 110.447 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -104.47 -56.32 2.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.966 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -86.13 74.95 9.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.712 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -63.45 100.92 0.28 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.896 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 129.31 -16.7 5.68 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.299 -0.721 . . . . 0.0 111.299 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 22.6 tp -92.38 134.05 28.82 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -82.87 -167.08 0.43 Allowed 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 123.033 2.488 . . . . 0.0 112.258 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -96.94 157.81 15.72 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.051 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 27.7 m 54.73 80.31 0.13 Allowed 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 17.9 pt -93.57 170.26 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.013 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.93 -39.25 7.02 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -178.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.13 160.45 42.89 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.657 0.265 . . . . 0.0 111.288 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -153.08 138.2 17.35 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -166.09 174.66 9.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.683 0.278 . . . . 0.0 111.076 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -104.92 131.51 52.33 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -88.61 -177.99 5.7 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.404 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.438 ' HZ3' ' CD ' ' A' ' 441' ' ' GLU . 7.6 tttp -65.64 -34.23 77.75 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -21.82 64.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.98 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 109.77 -10.99 32.45 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.962 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 19.8 mttp -86.06 160.28 19.34 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 117.266 0.533 . . . . 0.0 111.409 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -88.35 130.57 35.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.181 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 8.9 t -113.86 119.7 61.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.004 0.431 . . . . 0.0 110.194 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -107.37 140.16 40.73 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.67 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -121.49 139.91 52.87 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.983 0.421 . . . . 0.0 111.603 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -154.2 114.05 3.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.744 178.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 66.76 -107.24 1.92 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.692 -0.765 . . . . 0.0 111.481 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -122.62 8.82 9.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.21 0.529 . . . . 0.0 110.165 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -114.84 152.37 32.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.795 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 -134.27 150.93 51.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.394 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 16.7 m-90 -122.64 142.58 50.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.186 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 85.6 t -124.38 119.13 55.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -118.62 126.79 52.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.977 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -93.79 95.08 8.9 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 177.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 69.96 -78.32 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.812 0.695 . . . . 0.0 110.273 -178.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -140.87 16.87 2.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.965 0.412 . . . . 0.0 111.05 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 9.1 m -123.24 126.9 47.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.956 0.407 . . . . 0.0 111.723 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 46.6 tp -76.54 140.19 41.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.428 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -71.6 136.63 83.31 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.307 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.0 131.99 32.83 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.81 2.34 . . . . 0.0 112.096 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 108.07 -11.44 37.42 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.841 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -93.5 161.01 31.85 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 110.543 -0.169 . . . . 0.0 110.543 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.96 160.33 85.77 Favored 'Cis proline' 0 C--N 1.348 0.537 0 C-N-CA 123.909 -1.288 . . . . 0.0 113.205 0.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -135.45 161.93 34.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.819 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 -70.37 153.91 42.48 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 77.6 mt -57.61 -37.81 60.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.099 0.476 . . . . 0.0 111.095 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -68.1 -10.08 51.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.99 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -79.65 -20.6 46.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.809 0.337 . . . . 0.0 110.767 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 36.9 tp -80.15 -61.81 1.87 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.264 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -143.21 154.91 25.74 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.063 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -79.61 132.06 36.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.667 -0.266 . . . . 0.0 110.336 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 102.29 -4.3 51.5 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.317 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 50.2 mt -77.33 146.0 73.46 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 120.63 0.252 . . . . 0.0 110.976 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -57.07 131.91 48.22 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.734 2.289 . . . . 0.0 112.075 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.69 -0.5 37.24 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.293 0.568 . . . . 0.0 110.42 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -90.13 -53.13 4.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.941 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -179.15 170.9 1.39 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.826 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 42.6 mm -124.61 133.01 70.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -90.63 -47.15 7.85 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.117 0.485 . . . . 0.0 110.234 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -155.26 159.68 40.23 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.339 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -142.45 113.68 7.7 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 35.1 tp -109.61 123.2 49.04 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.407 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -88.36 114.64 25.18 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.062 0.458 . . . . 0.0 110.086 178.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 15.3 t-105 -83.63 94.23 8.06 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.509 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 62.6 mtt -50.74 -50.72 71.69 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -43.01 -48.97 7.32 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 123.011 2.474 . . . . 0.0 114.867 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -105.07 -13.8 15.62 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 75.23 33.7 53.23 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.162 -0.542 . . . . 0.0 113.204 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -116.38 149.22 39.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.796 0.298 . . . . 0.0 110.456 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 6.4 m -98.23 128.0 44.47 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.203 0.525 . . . . 0.0 112.218 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -102.78 109.08 20.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.948 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -91.89 129.68 37.81 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.461 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -106.18 129.62 54.2 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.004 0.431 . . . . 0.0 110.988 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -139.21 102.98 4.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.336 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 63.44 -109.5 2.78 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.318 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -110.82 11.96 22.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.031 0.443 . . . . 0.0 110.62 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -122.91 152.38 40.86 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.966 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 435' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -133.82 139.2 46.11 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.383 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -111.62 145.2 39.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.829 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 20.9 ttp180 -106.01 100.62 10.16 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -85.06 120.41 26.54 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.235 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -95.61 106.79 18.93 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.537 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -58.16 -39.06 77.85 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.597 0.56 . . . . 0.0 111.48 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 441' ' ' GLU . . . . . 0.438 ' CD ' ' HZ3' ' A' ' 375' ' ' LYS . 1.9 mp0 -61.16 -20.56 62.85 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 13.8 mt -127.72 3.5 6.09 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 43.03 47.37 5.03 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.493 0.663 . . . . 0.0 112.315 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -154.51 172.65 17.45 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.132 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.6 t -88.24 138.94 18.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.149 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.32 160.81 15.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.525 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.7 m -67.13 151.96 46.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.446 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 78.45 -6.68 1.9 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.51 0.724 . . . . 0.0 111.786 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -98.23 154.68 37.55 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.702 -0.227 . . . . 0.0 111.418 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.4 162.71 91.94 Favored 'Cis proline' 0 C--N 1.345 0.364 0 C-N-CA 123.439 -1.484 . . . . 0.0 112.998 0.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -121.94 178.17 5.0 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -78.07 137.01 38.01 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.721 0.296 . . . . 0.0 110.298 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.5 tt -63.97 -17.48 20.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -63.48 -9.16 11.53 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 53.7 t -63.07 -33.9 63.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -91.5 94.76 9.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.362 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -56.08 105.2 0.17 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 114.25 -7.8 22.95 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.515 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 24.7 mm -84.58 127.44 65.56 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 121.006 0.431 . . . . 0.0 111.065 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -77.99 138.93 16.87 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.893 2.395 . . . . 0.0 113.042 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -66.66 140.81 57.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.293 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 2.7 m 57.74 71.44 1.07 Allowed Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -87.28 -171.28 0.7 Allowed 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.423 2.082 . . . . 0.0 111.632 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -143.63 20.55 1.84 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.212 0.529 . . . . 0.0 110.891 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 177.92 142.0 4.44 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 13.0 p -162.65 110.65 1.31 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.6 0.238 . . . . 0.0 110.731 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -138.98 144.44 38.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.866 0.365 . . . . 0.0 111.251 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 48.7 ttm -95.47 143.05 27.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.022 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . 0.481 ' C ' ' H ' ' A' ' 471' ' ' ASP . . . -72.67 163.91 54.76 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.962 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.94 30.25 0.09 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.167 0.508 . . . . 0.0 111.901 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . 0.481 ' H ' ' C ' ' A' ' 469' ' ' GLY . 1.0 OUTLIER -126.73 -14.28 5.71 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.294 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 67.24 9.44 6.96 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.3 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 40.2 t -106.71 -45.25 7.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.859 0.361 . . . . 0.0 111.133 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -108.09 132.13 53.89 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 97.0 m -116.79 138.95 51.13 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.689 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -114.15 126.52 55.17 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -110.08 141.78 42.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.145 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -123.04 135.0 54.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.705 0.288 . . . . 0.0 111.566 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 61.8 tttt -166.87 128.25 1.66 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.078 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 59.56 43.18 97.82 Favored Glycine 0 CA--C 1.516 0.148 0 N-CA-C 114.667 0.627 . . . . 0.0 114.667 178.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 58.4 t30 68.92 3.94 4.25 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 178.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -116.84 152.19 34.95 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -128.12 145.17 51.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.114 0.483 . . . . 0.0 111.813 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 16.8 m-90 -112.77 138.09 50.11 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.499 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -101.88 96.12 6.84 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 486' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -87.77 133.26 33.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.566 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -100.32 117.13 33.89 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -66.55 -34.44 77.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.768 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -68.76 -32.93 73.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.68 -178.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -98.5 -20.54 17.02 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 1.3 tp 66.11 39.26 4.4 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.795 0.807 . . . . 0.0 109.814 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 31.5 tttp -160.17 153.36 21.88 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.386 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 52.8 t -78.04 133.5 30.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 178.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -59.42 137.46 89.04 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.41 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -61.85 152.01 77.39 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.979 2.453 . . . . 0.0 112.284 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 94.37 9.48 59.07 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.684 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -117.43 170.17 6.49 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -78.29 -178.72 24.76 Favored 'Cis proline' 0 C--N 1.348 0.53 0 C-N-CA 124.104 -1.207 . . . . 0.0 112.865 0.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -135.29 155.25 50.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.176 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.29 116.33 10.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.565 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -63.47 -23.6 67.47 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 13.4 mt -61.15 -49.65 76.35 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -83.05 -29.08 29.12 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.05 -35.73 21.69 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 44.3 m0 -116.29 -45.07 2.85 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -177.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 9.7 mmt -75.5 -17.77 60.01 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -177.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 76.41 21.95 74.15 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.742 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 16.9 m -104.38 111.07 65.11 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 120.754 0.311 . . . . 0.0 110.898 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -86.27 -167.47 0.38 Allowed 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.873 2.382 . . . . 0.0 111.525 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 16.2 m 60.34 37.63 20.08 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.046 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.386 -1.23 . . . . 0.0 111.832 -179.506 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.669 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo . . . . . 0 CA--C 1.53 0.305 0 C-N-CA 122.543 2.162 . . . . 0.0 111.433 179.683 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 113.661 0.224 . . . . 0.0 113.661 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo . . . . . 0 CA--C 1.532 0.382 0 C-N-CA 122.874 2.383 . . . . 0.0 110.966 179.586 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.612 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo . . . . . 0 CA--C 1.532 0.412 0 C-N-CA 122.678 2.252 . . . . 0.0 111.463 179.263 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.912 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.11 138.33 51.56 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.769 2.312 . . . . 0.0 111.561 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -66.67 150.27 49.3 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.084 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.18 143.07 46.24 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.355 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 mp -64.86 137.93 24.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.01 143.41 22.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.129 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.64 164.77 41.8 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.106 -0.568 . . . . 0.0 113.17 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -75.11 150.34 38.83 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -70.22 146.49 50.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.525 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.95 155.24 48.84 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.492 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.2 t -66.3 149.76 11.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.554 0.216 . . . . 0.0 110.667 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 6.0 t -53.92 145.71 3.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.24 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.99 161.25 52.08 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 116.035 -0.529 . . . . 0.0 113.153 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 87.4 mt . . . . . 0 C--N 1.323 -0.583 0 CA-C-N 115.703 -0.248 . . . . 0.0 110.756 -179.71 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.544 0 N-CA-C 112.847 -0.101 . . . . 0.0 112.847 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo . . . . . 0 C--O 1.235 0.33 0 C-N-CA 122.609 2.206 . . . . 0.0 111.412 179.565 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.575 0 N-CA-C 113.153 0.021 . . . . 0.0 113.153 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo . . . . . 0 C--O 1.235 0.355 0 C-N-CA 122.798 2.332 . . . . 0.0 111.864 179.867 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.58 0 N-CA-C 113.168 0.027 . . . . 0.0 113.168 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo . . . . . 0 C--O 1.234 0.302 0 C-N-CA 123.29 2.66 . . . . 0.0 111.766 179.516 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 113.596 0.198 . . . . 0.0 113.596 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo . . . . . 0 C--N 1.344 0.335 0 C-N-CA 122.759 2.306 . . . . 0.0 111.033 179.304 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.506 0 CA-C-O 119.952 -0.36 . . . . 0.0 112.586 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo . . . . . 0 C--N 1.345 0.364 0 C-N-CA 122.952 2.435 . . . . 0.0 112.084 179.716 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.552 0 N-CA-C 112.446 -0.261 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo . . . . . 0 N--CA 1.462 -0.375 0 C-N-CA 122.957 2.438 . . . . 0.0 111.95 179.773 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.511 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.465 -0.172 0 C-N-CA 122.961 2.44 . . . . 0.0 110.742 179.528 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.498 0 N-CA-C 112.615 -0.194 . . . . 0.0 112.615 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.27 163.98 37.01 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.886 2.391 . . . . 0.0 112.116 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -65.6 137.63 57.49 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.15 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.48 166.63 30.02 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.841 -0.618 . . . . 0.0 113.562 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 79.9 mt -63.8 137.72 24.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.752 0.31 . . . . 0.0 110.847 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.11 145.15 54.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.538 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -59.16 148.37 40.4 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.627 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -75.2 156.8 35.44 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.673 0.273 . . . . 0.0 110.464 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 38.0 ttm-85 -69.67 147.34 50.74 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.302 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.9 170.0 52.13 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.485 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 21.6 t -69.23 138.95 21.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.606 0.241 . . . . 0.0 110.651 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 58.0 t -62.42 137.33 24.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.661 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.31 158.62 30.77 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.26 -0.495 . . . . 0.0 112.851 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 95.7 mt . . . . . 0 C--N 1.324 -0.508 0 CA-C-O 120.391 0.138 . . . . 0.0 110.922 -179.92 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.643 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo . . . . . 0 CA--C 1.529 0.233 0 C-N-CA 122.691 2.261 . . . . 0.0 111.581 179.534 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.523 0 CA-C-O 120.407 -0.107 . . . . 0.0 112.902 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo . . . . . 0 C--O 1.236 0.376 0 C-N-CA 122.579 2.186 . . . . 0.0 111.562 179.551 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.669 0 N-CA-C 112.885 -0.086 . . . . 0.0 112.885 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo . . . . . 0 C--O 1.236 0.376 0 C-N-CA 122.913 2.409 . . . . 0.0 111.696 179.815 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.542 0 CA-C-O 120.257 -0.19 . . . . 0.0 112.925 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 CA--C 1.531 0.325 0 C-N-CA 122.881 2.387 . . . . 0.0 111.889 179.763 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.335 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo . . . . . 0 CA--C 1.531 0.359 0 C-N-CA 122.946 2.431 . . . . 0.0 111.807 179.964 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.406 0 CA-C-O 120.341 -0.144 . . . . 0.0 112.993 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo . . . . . 0 CA--C 1.531 0.343 0 C-N-CA 123.454 2.769 . . . . 0.0 112.722 -179.805 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.391 0 N-CA-C 112.965 -0.054 . . . . 0.0 112.965 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo . . . . . 0 N--CA 1.456 -0.696 0 C-N-CA 123.424 2.75 . . . . 0.0 112.519 -179.768 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.67 0 N-CA-C 112.05 -0.42 . . . . 0.0 112.05 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.26 141.1 73.97 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.471 2.114 . . . . 0.0 112.23 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -65.87 150.93 47.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.929 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -67.46 160.33 49.47 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.357 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 45.6 pt -69.21 174.11 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 120.819 0.343 . . . . 0.0 111.439 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -77.67 147.86 35.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.499 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -74.48 158.02 51.28 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.773 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -77.52 151.6 34.48 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.623 0.249 . . . . 0.0 110.488 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -66.58 156.23 35.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.989 0.424 . . . . 0.0 110.571 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -66.23 151.37 52.09 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.185 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 11.5 t -65.82 148.77 11.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 61.6 t -63.03 139.1 21.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-O 120.725 0.297 . . . . 0.0 110.425 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.33 157.22 28.86 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.516 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 115.751 -0.224 . . . . 0.0 110.889 -179.893 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.613 0 CA-C-O 120.47 -0.072 . . . . 0.0 113.175 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo . . . . . 0 C--O 1.236 0.382 0 C-N-CA 123.031 2.487 . . . . 0.0 111.466 179.869 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.502 0 N-CA-C 112.773 -0.131 . . . . 0.0 112.773 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 CA--C 1.53 0.314 0 C-N-CA 122.701 2.267 . . . . 0.0 111.954 -179.929 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.468 0 N-CA-C 113.444 0.137 . . . . 0.0 113.444 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo . . . . . 0 N--CA 1.458 -0.594 0 C-N-CA 123.298 2.665 . . . . 0.0 112.511 -179.982 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo . . . . . 0 N--CA 1.479 0.665 0 N-CA-C 110.26 -0.708 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -110.79 166.3 11.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.423 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 8.5 tp -72.78 -31.04 34.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.051 0.453 . . . . 0.0 110.64 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 59.0 m -82.77 10.24 8.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.94 0.4 . . . . 0.0 111.457 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.72 -32.02 70.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.437 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 79.96 -176.81 54.57 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.481 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 3.5 t30 53.9 78.79 0.15 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.046 0.45 . . . . 0.0 111.218 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -96.04 154.79 17.05 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.902 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.25 -40.53 62.31 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.221 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 1.8 t -170.86 146.54 2.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.448 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 60.6 t -131.97 126.25 56.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -149.33 176.81 10.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.053 0.454 . . . . 0.0 111.231 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 41.3 ttp -127.16 122.37 33.93 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 54.3 mt -114.64 119.75 37.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.902 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 55.82 26.04 9.14 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 101.96 -10.63 57.17 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.684 -0.77 . . . . 0.0 113.356 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -100.25 130.01 46.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.929 0.395 . . . . 0.0 111.306 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 45.2 ttm -84.05 124.43 31.08 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -119.56 120.5 36.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.132 0.492 . . . . 0.0 111.572 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 23.1 t -105.31 115.22 46.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -99.74 131.67 45.58 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -144.18 109.25 5.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.174 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 61.31 -102.39 0.12 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.894 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.7 ptm85 -119.48 12.97 12.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.878 0.37 . . . . 0.0 111.361 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 13.3 m-90 -125.71 153.73 43.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.71 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -136.35 141.76 43.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.863 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 21.0 m-90 -115.59 147.09 41.15 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.882 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -116.48 92.81 3.99 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 10.2 m -91.42 128.39 43.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.619 -179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 42.5 ttm-85 -131.82 118.85 20.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.428 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 63.03 41.42 8.29 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.869 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 34.9 t30 68.29 15.37 9.3 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.353 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -126.58 129.26 48.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.72 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.57 121.98 29.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.661 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 26.0 ttp -66.94 151.57 47.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.788 0.327 . . . . 0.0 110.501 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -69.51 161.08 30.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.195 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 90.21 7.07 68.13 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.06 -0.591 . . . . 0.0 111.908 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -128.78 162.22 52.88 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.37 144.04 76.77 Favored 'Cis proline' 0 C--N 1.346 0.396 0 C-N-CA 123.815 -1.327 . . . . 0.0 112.943 0.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.23 144.36 31.04 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.36 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -68.2 129.65 19.74 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.541 2.16 . . . . 0.0 111.358 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 85.3 mt -56.53 -41.6 73.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.479 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -65.7 -17.57 64.99 Favored Glycine 0 CA--C 1.518 0.25 0 N-CA-C 114.603 0.601 . . . . 0.0 114.603 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -84.65 -45.11 12.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.237 0.519 . . . . 0.0 111.063 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -82.72 -53.92 5.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.189 0.519 . . . . 0.0 110.555 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -92.61 70.24 4.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.553 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -59.41 101.88 0.12 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.208 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 128.95 -20.79 5.35 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 18.8 tp -85.7 134.61 39.39 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -82.43 -175.17 2.36 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.813 2.342 . . . . 0.0 112.145 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -91.06 153.0 20.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.502 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.0 m 57.12 83.06 0.11 Allowed 'General case' 0 C--O 1.233 0.232 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 13.7 pt -94.9 176.19 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.898 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -111.55 -38.2 4.99 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 1.6 m -149.97 156.23 41.36 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.798 0.332 . . . . 0.0 111.54 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -149.15 135.82 19.54 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -158.48 165.08 35.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.117 0.484 . . . . 0.0 112.191 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 62.5 tt0 -99.14 133.92 42.73 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -95.44 -170.69 2.21 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -77.17 -23.56 51.55 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -177.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.63 -11.05 57.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 104.23 -14.37 51.51 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.854 -0.689 . . . . 0.0 113.949 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 25.2 mttp -82.05 163.66 21.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.305 0.553 . . . . 0.0 111.867 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -99.96 135.56 41.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.351 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 12.2 t -116.43 122.02 68.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.254 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -108.2 139.8 42.35 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.56 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -122.01 140.15 52.83 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.71 0.291 . . . . 0.0 111.163 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -154.69 114.13 3.72 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.741 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 67.24 -110.25 3.37 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.833 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -119.32 12.96 12.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.941 0.401 . . . . 0.0 111.185 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -122.14 152.96 39.35 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.894 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -133.9 148.31 51.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.22 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 21.5 m-90 -122.4 140.41 52.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.149 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 69.5 t -120.34 120.2 62.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -115.8 127.77 55.33 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -90.79 86.26 6.28 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 176.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 69.52 -71.47 0.12 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.402 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -142.56 4.56 1.55 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.546 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 13.3 m -106.45 129.05 54.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.713 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 65.1 tp -84.16 133.75 34.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -66.1 135.34 95.08 Favored Pre-proline 0 C--O 1.238 0.489 0 CA-C-O 120.823 0.344 . . . . 0.0 111.039 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.81 128.82 21.78 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 123.152 2.568 . . . . 0.0 112.192 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 108.02 -5.27 34.17 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.836 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -94.0 159.56 34.12 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 111.526 0.195 . . . . 0.0 111.526 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.44 162.5 92.4 Favored 'Cis proline' 0 C--N 1.344 0.314 0 C-N-CA 123.477 -1.468 . . . . 0.0 112.939 0.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -125.59 161.39 27.32 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -69.9 155.89 39.89 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 67.5 mt -56.33 -40.98 69.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.368 . . . . 0.0 111.481 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.55 -12.18 59.77 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -78.93 -18.39 53.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.87 0.367 . . . . 0.0 110.946 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 38.5 tp -79.5 -31.97 42.36 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.268 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -176.82 165.77 36.12 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.261 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -90.33 132.87 35.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.572 0.225 . . . . 0.0 110.804 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.16 12.85 47.73 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.193 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 61.3 mt -92.25 146.31 32.38 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.638 0.256 . . . . 0.0 111.372 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.65 115.65 2.55 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.036 2.49 . . . . 0.0 111.232 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 1.1 m -84.49 1.88 43.56 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.505 -179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -97.24 -59.78 1.72 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.305 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -174.48 173.03 3.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.872 0.368 . . . . 0.0 110.933 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 43.9 mm -122.41 136.23 59.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.599 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -94.54 -43.31 8.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.202 0.525 . . . . 0.0 110.154 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -156.8 163.24 39.45 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.844 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -149.32 127.0 11.69 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 36.4 tp -121.88 128.86 52.07 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.028 0.442 . . . . 0.0 111.16 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -92.39 119.39 31.89 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 18.3 t-105 -85.21 91.65 8.2 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.341 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 13.9 mmt -47.28 -49.9 50.54 Favored Pre-proline 0 N--CA 1.47 0.533 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -45.93 -41.98 20.41 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.02 2.48 . . . . 0.0 115.476 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -115.34 -28.53 6.85 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 98.85 16.59 30.47 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.498 -0.858 . . . . 0.0 113.151 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -92.5 147.3 23.01 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 3.0 m -104.9 122.73 46.41 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.92 0.391 . . . . 0.0 110.867 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -99.35 111.79 24.09 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.946 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -95.69 137.37 34.84 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.876 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -112.69 127.58 56.16 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.976 0.417 . . . . 0.0 111.504 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -134.51 98.29 4.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.776 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 67.0 -107.37 1.98 Allowed Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.872 -0.603 . . . . 0.0 112.285 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -112.59 15.65 19.99 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.96 0.409 . . . . 0.0 111.278 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -128.77 141.39 51.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.823 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 435' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -120.86 142.69 49.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.031 0.443 . . . . 0.0 110.659 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -112.84 148.48 34.81 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.506 -178.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 19.7 ttp180 -112.5 91.43 3.65 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -85.14 134.99 34.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.143 0.497 . . . . 0.0 111.144 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -107.35 118.61 37.17 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.791 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.52 -57.05 13.52 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.37 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -80.12 54.52 1.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.908 0.385 . . . . 0.0 110.951 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 29.4 tp -168.35 -33.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.098 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 64.45 31.96 12.18 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.551 0.691 . . . . 0.0 111.055 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -152.36 163.83 38.69 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.454 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 86.8 t -89.37 143.0 12.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.025 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.63 156.83 18.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.462 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.5 m -69.01 151.13 46.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.343 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 85.03 -6.53 0.92 Allowed 'General case' 0 N--CA 1.471 0.575 0 O-C-N 124.269 0.981 . . . . 0.0 112.01 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -100.12 157.94 32.93 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.796 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.07 155.22 98.34 Favored 'Cis proline' 0 C--N 1.345 0.39 0 C-N-CA 123.585 -1.423 . . . . 0.0 112.797 0.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -118.88 165.71 13.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.682 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -61.06 128.07 34.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.446 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 10.7 tt -65.03 -17.23 21.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.799 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -67.73 -2.79 7.62 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 50.4 t -65.24 -33.38 63.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -83.23 90.85 7.16 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.68 108.82 0.3 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -178.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 108.32 -17.34 34.33 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.935 -0.65 . . . . 0.0 113.818 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 29.8 mm -79.32 122.93 84.64 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.98 0.419 . . . . 0.0 111.694 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.33 155.22 36.83 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.865 2.377 . . . . 0.0 111.778 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.77 144.97 43.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.679 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 2.9 m 57.03 75.28 0.58 Allowed Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.913 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.27 -176.8 3.39 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 123.011 2.474 . . . . 0.0 111.868 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.87 27.44 3.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.248 0.547 . . . . 0.0 110.327 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 153.22 144.62 3.95 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.432 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 4.1 p -156.25 123.41 5.34 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -144.43 149.61 36.32 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.721 0.296 . . . . 0.0 111.128 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 49.5 ttm -103.68 141.66 35.68 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -69.0 168.76 43.96 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.677 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 4.9 m -72.23 -10.89 60.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.084 0.469 . . . . 0.0 110.919 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -83.36 -17.15 43.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.007 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 68.22 7.92 6.22 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 48.8 t -105.8 -35.39 3.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.766 0.317 . . . . 0.0 111.443 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -110.55 131.02 55.41 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 94.1 m -114.7 141.87 47.25 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.593 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -118.97 134.49 55.15 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -117.84 134.8 54.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.232 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -109.45 133.7 52.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.562 0.22 . . . . 0.0 111.154 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -170.07 133.88 1.2 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.594 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 64.27 35.21 91.69 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 121.311 -0.471 . . . . 0.0 113.603 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 58.1 t30 67.21 10.92 8.08 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.589 0.709 . . . . 0.0 111.442 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -125.97 161.54 27.28 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.525 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -129.83 151.65 50.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.845 0.355 . . . . 0.0 111.571 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 12.4 m-90 -112.51 145.84 39.54 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.149 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 18.2 tttt -107.25 98.2 7.87 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 486' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -90.35 125.16 35.44 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.264 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -90.21 115.08 27.16 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -63.7 -33.21 75.13 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -71.17 -40.88 71.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.928 0.394 . . . . 0.0 111.725 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 490' ' ' LYS . . . . . 0.443 ' HZ1' ' CD ' ' A' ' 494' ' ' GLU . 46.1 mtpt -91.02 -14.28 31.68 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -178.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.4 tp 59.68 37.32 22.35 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.434 0.635 . . . . 0.0 110.618 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -154.37 151.78 29.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.888 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 58.5 t -74.52 132.77 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 494' ' ' GLU . . . . . 0.443 ' CD ' ' HZ1' ' A' ' 490' ' ' LYS . 5.0 mm-40 -67.53 143.56 97.13 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.549 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -61.18 149.92 86.98 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.257 2.638 . . . . 0.0 112.919 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 97.76 17.34 30.86 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -126.59 167.56 16.96 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -76.91 169.75 73.57 Favored 'Cis proline' 0 C--N 1.344 0.331 0 C-N-CA 124.001 -1.25 . . . . 0.0 112.962 0.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -124.97 150.35 46.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.537 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 37.4 t -64.4 119.76 10.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.257 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -64.83 -32.75 74.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.892 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 20.5 mt -62.81 -47.45 83.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.146 0.498 . . . . 0.0 111.16 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -75.48 -31.9 60.38 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.51 -33.47 17.76 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -177.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 15.9 m0 -127.64 -27.75 2.82 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -177.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 14.6 mmt -85.64 -6.46 59.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -177.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 71.2 42.87 57.11 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.937 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 59.9 m -120.55 93.57 48.46 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-O 120.707 0.289 . . . . 0.0 110.939 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -73.23 134.26 20.76 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.009 2.472 . . . . 0.0 111.814 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 5.1 m 55.53 68.9 0.79 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.341 0.591 . . . . 0.0 111.725 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.536 -1.146 . . . . 0.0 112.401 -179.626 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.598 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo . . . . . 0 N--CA 1.464 -0.233 0 C-N-CA 122.468 2.112 . . . . 0.0 111.304 179.565 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.46 0 N-CA-C 113.275 0.07 . . . . 0.0 113.275 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo . . . . . 0 CA--C 1.532 0.377 0 C-N-CA 122.939 2.426 . . . . 0.0 111.635 179.838 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.427 0 CA-C-O 120.308 -0.162 . . . . 0.0 112.722 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo . . . . . 0 CA--C 1.539 0.728 0 C-N-CA 123.133 2.556 . . . . 0.0 112.755 179.527 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.618 0 N-CA-C 112.598 -0.201 . . . . 0.0 112.598 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -64.76 140.91 69.7 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.987 2.458 . . . . 0.0 112.022 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -69.64 149.48 48.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.414 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.9 153.42 47.6 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.231 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 8.9 mt -67.64 149.3 11.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.66 152.89 37.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.882 0.372 . . . . 0.0 111.282 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.76 166.03 54.81 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.343 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -80.54 148.74 30.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.733 0.301 . . . . 0.0 110.353 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -76.4 141.56 41.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.356 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.28 150.85 46.43 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.787 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.9 t -69.68 155.46 7.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 3.1 t -52.89 146.6 2.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.454 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.81 168.64 54.81 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.747 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 C--N 1.32 -0.676 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 -179.823 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.534 0 CA-C-O 120.493 -0.06 . . . . 0.0 113.238 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo . . . . . 0 CA--C 1.53 0.276 0 C-N-CA 122.652 2.235 . . . . 0.0 111.576 179.252 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.509 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo . . . . . 0 C--O 1.236 0.379 0 C-N-CA 122.828 2.352 . . . . 0.0 111.802 -179.972 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.457 0 N-CA-C 113.377 0.111 . . . . 0.0 113.377 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo . . . . . 0 CA--C 1.53 0.308 0 C-N-CA 123.356 2.704 . . . . 0.0 111.734 179.659 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 112.665 -0.174 . . . . 0.0 112.665 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo . . . . . 0 N--CA 1.463 -0.268 0 C-N-CA 122.909 2.406 . . . . 0.0 111.794 179.987 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 112.733 -0.147 . . . . 0.0 112.733 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 CA--C 1.534 0.521 0 C-N-CA 122.909 2.406 . . . . 0.0 112.769 -179.414 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 CA-C-O 120.393 -0.115 . . . . 0.0 112.824 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo . . . . . 0 CA--C 1.532 0.411 0 C-N-CA 122.803 2.335 . . . . 0.0 112.296 -179.634 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.635 0 N-CA-C 111.787 -0.525 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo . . . . . 0 CA--C 1.531 0.328 0 C-N-CA 123.115 2.543 . . . . 0.0 110.437 179.303 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 120.742 0.079 . . . . 0.0 113.171 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.03 150.06 89.16 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.872 2.381 . . . . 0.0 112.021 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -61.61 140.91 58.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.261 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -66.81 152.27 52.57 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.016 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 23.3 mt -65.57 137.11 25.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.7 149.98 38.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.889 0.376 . . . . 0.0 111.123 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -65.44 162.34 40.94 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.972 -0.632 . . . . 0.0 111.909 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -85.21 153.58 22.54 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.906 -0.317 . . . . 0.0 110.604 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 35.7 ttm-85 -61.74 144.77 54.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.329 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.08 169.56 27.2 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.545 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.33 142.12 14.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.821 0.343 . . . . 0.0 110.324 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 24.8 t -62.48 143.48 15.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.427 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.02 161.05 54.23 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.406 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--N 1.322 -0.598 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 179.804 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.598 0 CA-C-O 120.372 -0.127 . . . . 0.0 112.956 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 C--O 1.236 0.379 0 C-N-CA 122.565 2.177 . . . . 0.0 111.409 179.66 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.635 0 N-CA-C 112.903 -0.079 . . . . 0.0 112.903 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 C--O 1.236 0.398 0 C-N-CA 122.672 2.248 . . . . 0.0 111.332 179.624 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 113.557 0.183 . . . . 0.0 113.557 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo . . . . . 0 CA--C 1.529 0.273 0 C-N-CA 123.141 2.561 . . . . 0.0 111.687 179.691 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.42 0 CA-C-O 119.896 -0.391 . . . . 0.0 112.294 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo . . . . . 0 C--O 1.235 0.337 0 C-N-CA 123.287 2.658 . . . . 0.0 112.14 179.91 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 N-CA-C 112.553 -0.219 . . . . 0.0 112.553 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo . . . . . 0 C--N 1.346 0.416 0 C-N-CA 123.15 2.567 . . . . 0.0 112.074 179.381 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.257 0 N-CA-C 113.978 0.351 . . . . 0.0 113.978 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo . . . . . 0 CA--C 1.532 0.376 0 C-N-CA 123.53 2.82 . . . . 0.0 111.952 179.835 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.413 0 N-CA-C 112.61 -0.196 . . . . 0.0 112.61 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo . . . . . 0 N--CA 1.461 -0.429 0 C-N-CA 123.078 2.519 . . . . 0.0 112.137 179.95 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.545 0 N-CA-C 111.988 -0.445 . . . . 0.0 111.988 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.42 141.14 73.06 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.589 2.193 . . . . 0.0 111.797 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -63.88 145.05 56.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.004 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -66.76 159.84 48.39 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.758 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 47.4 pt -74.35 164.75 3.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.774 0.321 . . . . 0.0 111.02 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -82.25 137.46 34.86 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.918 0.39 . . . . 0.0 110.725 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -65.3 164.87 36.47 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.853 -0.612 . . . . 0.0 113.039 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -68.81 156.46 38.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.675 0.274 . . . . 0.0 110.323 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -70.75 162.03 29.82 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -60.41 154.02 34.94 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.526 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 21.0 t -70.78 149.4 10.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 42.9 t -64.41 140.45 19.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.56 167.69 13.85 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.299 -0.477 . . . . 0.0 113.318 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 C--N 1.324 -0.542 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 -179.921 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 112.139 -0.384 . . . . 0.0 112.139 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo . . . . . 0 C--O 1.232 0.197 0 C-N-CA 122.877 2.385 . . . . 0.0 111.577 179.923 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.524 0 N-CA-C 113.323 0.089 . . . . 0.0 113.323 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo . . . . . 0 CA--C 1.531 0.346 0 C-N-CA 123.054 2.502 . . . . 0.0 111.475 179.743 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.551 0 N-CA-C 113.286 0.075 . . . . 0.0 113.286 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 CA--C 1.529 0.24 0 C-N-CA 123.182 2.588 . . . . 0.0 111.928 -179.996 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo . . . . . 0 N--CA 1.478 0.588 0 N-CA-C 109.714 -0.918 . . . . 0.0 109.714 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -102.69 148.61 25.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.663 0.268 . . . . 0.0 110.775 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 8.1 tp -73.57 -26.71 22.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.383 0.611 . . . . 0.0 110.681 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 37.3 m -88.74 26.33 1.54 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.81 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -76.77 -41.83 43.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.306 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 83.37 170.68 46.6 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.205 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 50.3 t30 50.65 68.97 0.69 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.198 0.523 . . . . 0.0 111.125 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -87.17 175.49 8.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.47 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -74.62 -46.96 34.95 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 14.5 t -171.34 153.95 3.75 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.518 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 57.0 t -131.39 124.42 54.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -141.59 169.04 18.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.009 0.433 . . . . 0.0 111.832 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 39.3 ttp -120.84 121.0 37.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.358 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 58.9 mt -112.18 115.7 29.26 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.666 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 44.9 mtp180 57.16 22.31 7.4 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 109.85 -14.77 31.73 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.85 -0.69 . . . . 0.0 113.656 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -99.84 129.46 45.94 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.938 0.369 . . . . 0.0 111.324 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 47.1 ttm -89.1 126.18 35.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.923 0.392 . . . . 0.0 111.082 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -119.68 132.86 55.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.114 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 23.9 t -107.02 117.33 52.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.502 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -100.68 126.62 47.21 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -139.71 102.78 4.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.157 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 63.92 -102.25 0.1 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.66 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.5 ptm85 -117.49 8.09 12.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.917 0.389 . . . . 0.0 111.962 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 3.0 m-90 -127.01 146.03 50.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.048 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -128.66 146.1 50.97 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.966 0.412 . . . . 0.0 110.985 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 20.4 m-90 -108.66 150.87 26.93 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.425 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 24.1 ttt-85 -113.8 100.89 8.79 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 3.1 m -93.49 129.43 43.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.137 0.494 . . . . 0.0 111.386 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.15 109.87 6.68 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.536 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 63.66 47.01 3.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.774 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 7.2 m120 64.68 27.96 13.13 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.185 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -142.06 150.17 40.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.952 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 47.4 t -91.76 129.19 42.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 89.5 mtp -77.23 165.44 24.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.026 0.441 . . . . 0.0 111.78 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -77.72 154.51 32.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.696 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 94.76 -5.8 69.75 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 111.701 -0.56 . . . . 0.0 111.701 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -118.85 159.0 46.25 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 110.448 -0.205 . . . . 0.0 110.448 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.67 137.88 34.4 Favored 'Cis proline' 0 C--N 1.348 0.542 0 C-N-CA 123.966 -1.264 . . . . 0.0 112.564 0.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 10.6 ttt -112.72 141.34 25.21 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.429 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.19 127.3 24.39 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.574 2.183 . . . . 0.0 111.204 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 66.8 mt -56.11 -42.42 72.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.942 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -70.3 -16.38 73.31 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.794 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -82.51 -28.28 31.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.046 0.451 . . . . 0.0 110.791 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -98.66 -53.0 3.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.239 0.543 . . . . 0.0 109.725 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -93.32 71.15 4.43 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -56.93 99.44 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.672 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 128.27 -17.09 5.95 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.969 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 30.9 tp -91.84 125.52 56.91 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-O 120.561 0.22 . . . . 0.0 110.764 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.38 170.19 19.85 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 123.06 2.507 . . . . 0.0 111.774 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -77.26 159.41 29.64 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.654 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 16.6 m 57.92 82.95 0.12 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.41 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 27.9 pt -100.38 173.23 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.911 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -95.79 -55.84 2.87 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.49 164.13 39.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.575 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -147.75 149.02 31.61 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -164.64 166.35 20.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.867 0.365 . . . . 0.0 111.768 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -97.3 125.53 41.94 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -84.44 -172.05 3.96 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -63.5 -40.72 97.81 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.01 -30.09 58.37 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 127.17 -14.7 6.54 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.731 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 38.2 mttp -70.45 149.13 47.55 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.746 0.307 . . . . 0.0 110.798 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -95.65 126.71 41.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.058 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 17.1 t -106.31 115.49 48.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.981 0.419 . . . . 0.0 110.558 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -102.72 128.95 49.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.531 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -107.77 143.32 36.49 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.398 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -152.01 92.93 1.77 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 75.71 -113.09 3.8 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -108.11 -0.73 20.94 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.032 0.444 . . . . 0.0 110.772 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -109.3 147.3 32.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.977 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 37.3 p-80 -132.64 147.87 52.35 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.357 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 20.9 m-90 -121.28 131.17 54.05 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.169 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 55.9 t -107.0 114.64 46.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -106.41 125.48 51.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.645 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -97.43 89.25 4.64 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 67.82 -85.98 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.308 -178.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -130.65 21.13 5.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.21 0.529 . . . . 0.0 110.886 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 10.2 m -133.83 135.29 43.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.02 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 57.3 tp -80.97 136.92 36.09 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.442 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.25 143.16 97.35 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.388 179.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.01 140.83 28.94 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 122.602 2.201 . . . . 0.0 112.581 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 91.24 26.26 21.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.542 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -118.88 163.54 25.59 Favored Pre-proline 0 C--N 1.324 -0.534 0 O-C-N 122.679 -0.307 . . . . 0.0 111.081 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.44 162.87 89.8 Favored 'Cis proline' 0 C--N 1.345 0.38 0 C-N-CA 123.529 -1.446 . . . . 0.0 113.067 0.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -121.0 161.46 21.59 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -74.84 153.54 38.66 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 71.2 mt -57.75 -38.62 66.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.27 0.557 . . . . 0.0 109.845 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.9 -10.74 58.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.469 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -84.45 -30.8 24.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.861 0.363 . . . . 0.0 110.435 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 47.6 tp -63.81 -51.88 62.74 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.859 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -152.69 162.45 29.99 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.296 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -86.85 129.05 35.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.592 0.234 . . . . 0.0 110.404 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.57 6.79 43.55 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.32 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 65.6 mt -86.95 156.05 55.24 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 122.961 -0.141 . . . . 0.0 110.624 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -65.13 144.47 81.78 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.626 2.217 . . . . 0.0 112.371 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.24 25.17 9.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.031 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -119.42 -76.03 0.58 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.606 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 7.8 ptmt -160.61 -176.75 5.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.82 0.343 . . . . 0.0 110.445 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 34.4 mm -125.59 135.61 63.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -94.48 -52.19 4.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.325 0.583 . . . . 0.0 110.062 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -147.13 145.63 29.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.946 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -129.01 117.18 20.5 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 57.8 tp -114.09 147.96 37.89 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.051 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -120.65 119.42 32.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.617 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 7.0 t-105 -86.85 94.8 9.66 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 64.1 mtt -51.42 -51.71 66.56 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -47.18 -33.82 16.54 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 123.029 2.486 . . . . 0.0 115.278 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 33.0 p30 -115.06 -24.54 8.52 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 87.47 23.02 41.39 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.403 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -108.21 149.9 27.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 117.131 0.465 . . . . 0.0 111.169 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.45 146.16 25.49 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.436 -178.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -124.9 110.16 13.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.498 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -98.98 123.14 43.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.797 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -98.79 130.28 45.23 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.608 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -140.05 106.81 5.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.163 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 66.72 -102.62 0.78 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.742 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -123.67 14.44 9.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.068 0.461 . . . . 0.0 110.154 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 52.0 mmtt -122.46 156.29 34.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.067 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 435' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -135.3 139.36 44.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.928 0.394 . . . . 0.0 110.573 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -108.07 143.72 36.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.699 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -106.79 103.4 12.83 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -92.42 135.23 34.22 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.482 -178.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -107.86 107.74 18.61 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -49.39 -51.3 35.93 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -54.76 -48.71 72.28 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 52.5 mt -86.45 -18.05 32.69 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 61.36 39.45 15.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.631 0.729 . . . . 0.0 110.57 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -148.79 155.07 40.45 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.497 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 97.8 t -80.31 140.13 17.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.845 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -62.49 156.95 21.48 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.4 m -66.71 152.43 45.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.82 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 72.34 29.4 2.19 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.272 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -126.39 160.9 55.5 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.192 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.81 160.77 95.51 Favored 'Cis proline' 0 C--N 1.347 0.479 0 C-N-CA 123.728 -1.363 . . . . 0.0 112.337 -0.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -109.71 176.76 4.95 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.106 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -76.8 139.82 40.49 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.518 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.4 tt -66.83 -11.99 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.109 0.48 . . . . 0.0 110.709 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 48.5 mmtt -68.69 -7.0 29.48 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.151 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 76.7 t -66.21 -30.95 51.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 6.7 m95 -97.72 85.59 3.6 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.545 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -54.43 114.78 1.79 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.62 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 108.0 -21.16 29.98 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.065 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 19.1 mm -71.04 127.15 91.94 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 120.868 0.366 . . . . 0.0 111.077 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.25 139.51 32.32 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.925 2.417 . . . . 0.0 112.603 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -68.34 138.78 55.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.002 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.3 m 59.33 70.31 1.14 Allowed Pre-proline 0 C--O 1.234 0.288 0 O-C-N 123.58 0.55 . . . . 0.0 112.177 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -85.95 -179.53 3.31 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.013 2.476 . . . . 0.0 111.164 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.39 29.21 1.61 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.439 0.638 . . . . 0.0 110.738 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 174.05 135.15 1.97 Allowed Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 5.3 p -158.49 114.38 2.69 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.706 0.289 . . . . 0.0 110.236 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -145.14 140.7 28.17 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.696 0.284 . . . . 0.0 111.215 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 46.5 ttm -89.93 141.14 28.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.244 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -70.38 166.16 51.1 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.769 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.36 -14.62 57.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.895 0.378 . . . . 0.0 111.906 -179.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -81.43 -18.39 45.53 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.391 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 68.09 11.96 8.58 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.015 0.526 . . . . 0.0 112.254 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 49.1 t -110.46 -36.12 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.891 0.377 . . . . 0.0 111.057 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -111.53 133.68 53.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.275 0.559 . . . . 0.0 111.996 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 88.3 m -116.54 133.03 56.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.381 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -101.42 135.93 42.11 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.967 0.413 . . . . 0.0 111.807 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -122.2 138.49 54.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.422 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -121.74 134.36 54.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.803 0.335 . . . . 0.0 111.524 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 48.0 tttt -166.06 131.94 2.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.222 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 56.12 44.74 88.54 Favored Glycine 0 C--N 1.33 0.227 0 CA-C-N 115.944 -0.571 . . . . 0.0 114.307 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 23.0 t30 65.47 8.49 5.07 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -118.28 158.35 25.35 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -131.7 147.6 52.52 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.989 0.424 . . . . 0.0 111.934 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 11.3 m-90 -116.36 157.21 25.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.133 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -120.45 99.38 6.53 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 486' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -86.28 127.41 34.77 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.941 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -93.18 112.81 24.86 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -63.68 -26.99 68.91 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -76.6 -30.85 57.13 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -99.2 -21.02 16.31 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.8 tp 66.17 33.4 7.4 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -177.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -152.45 159.92 43.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.044 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 77.8 t -79.29 139.55 18.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.643 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -65.98 138.44 96.3 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.322 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.19 138.36 80.96 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 123.225 2.617 . . . . 0.0 112.59 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 111.21 -1.61 28.25 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -108.87 164.49 14.6 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.825 -0.187 . . . . 0.0 111.226 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -75.98 174.75 51.27 Favored 'Cis proline' 0 C--N 1.351 0.666 0 C-N-CA 124.058 -1.226 . . . . 0.0 113.045 0.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -134.41 166.61 22.44 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.991 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 44.3 t -71.54 118.07 13.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.597 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.7 -24.26 62.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.83 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 16.8 mt -70.96 -38.81 72.82 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.974 0.416 . . . . 0.0 110.652 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 8.7 ttm180 -84.37 -55.31 4.23 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -73.14 -18.02 61.32 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 9.5 m0 -111.95 -69.79 0.85 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 9.6 mmt -59.33 -44.54 92.61 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.976 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 109.85 14.03 14.77 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.51 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 35.1 m -81.87 113.6 44.16 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -83.29 153.57 14.12 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.576 2.184 . . . . 0.0 111.903 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 16.4 m 64.34 92.33 0.07 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.722 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.155 0 CA-C-O 118.166 -1.352 . . . . 0.0 110.796 -179.917 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.758 0 N-CA-C 111.531 -0.627 . . . . 0.0 111.531 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 CA--C 1.529 0.246 0 C-N-CA 122.613 2.209 . . . . 0.0 111.477 179.796 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.563 0 N-CA-C 112.466 -0.253 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo . . . . . 0 CA--C 1.529 0.254 0 C-N-CA 123.0 2.467 . . . . 0.0 112.025 -179.953 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.778 0 N-CA-C 111.698 -0.561 . . . . 0.0 111.698 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo . . . . . 0 CA--C 1.535 0.55 0 C-N-CA 122.803 2.335 . . . . 0.0 111.429 179.135 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.974 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -62.59 139.18 74.39 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.859 2.373 . . . . 0.0 111.869 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -64.97 150.04 48.7 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.27 157.3 24.07 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.198 -0.525 . . . . 0.0 113.198 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 mt -71.21 153.93 8.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.47 150.47 47.17 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.384 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.72 160.03 53.88 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.15 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -71.49 145.29 49.29 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -68.76 140.65 55.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.794 0.331 . . . . 0.0 110.608 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.22 154.98 36.4 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.834 -0.621 . . . . 0.0 113.16 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 8.0 t -65.72 147.94 12.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.665 0.269 . . . . 0.0 110.6 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 3.9 t -54.32 148.69 2.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.335 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.36 154.46 53.19 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.31 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 71.7 mt . . . . . 0 C--N 1.32 -0.695 0 CA-C-O 120.482 0.182 . . . . 0.0 110.78 -179.834 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.643 0 N-CA-C 112.663 -0.175 . . . . 0.0 112.663 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 N--CA 1.461 -0.407 0 C-N-CA 122.638 2.225 . . . . 0.0 111.645 179.746 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.571 0 N-CA-C 112.868 -0.093 . . . . 0.0 112.868 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo . . . . . 0 C--O 1.237 0.453 0 C-N-CA 122.492 2.128 . . . . 0.0 111.432 179.639 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.565 0 CA-C-O 120.476 -0.069 . . . . 0.0 113.174 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo . . . . . 0 C--O 1.236 0.385 0 C-N-CA 122.969 2.446 . . . . 0.0 111.567 179.098 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.508 0 N-CA-C 112.253 -0.339 . . . . 0.0 112.253 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo . . . . . 0 CA--C 1.528 0.207 0 C-N-CA 122.917 2.412 . . . . 0.0 111.786 -179.783 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.565 0 CA-C-O 119.985 -0.342 . . . . 0.0 112.865 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo . . . . . 0 C--N 1.345 0.361 0 C-N-CA 123.498 2.798 . . . . 0.0 112.604 179.974 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.392 0 N-CA-C 112.552 -0.219 . . . . 0.0 112.552 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo . . . . . 0 CA--C 1.537 0.652 0 C-N-CA 123.216 2.611 . . . . 0.0 113.066 -179.421 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.633 0 N-CA-C 112.083 -0.407 . . . . 0.0 112.083 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo . . . . . 0 N--CA 1.461 -0.427 0 C-N-CA 122.648 2.232 . . . . 0.0 111.324 179.45 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.425 0 CA-C-O 120.704 0.058 . . . . 0.0 113.125 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.58 162.91 34.82 Favored 'Trans proline' 0 C--O 1.238 0.519 0 C-N-CA 122.577 2.185 . . . . 0.0 112.514 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -64.5 151.38 44.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.737 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -69.76 166.3 49.47 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.438 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 2.7 mt -67.11 144.34 14.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.01 140.73 58.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.408 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -59.38 147.68 42.07 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.277 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -69.73 153.59 43.16 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 122.47 0.308 . . . . 0.0 110.336 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 53.9 ttm-85 -71.77 150.51 44.34 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.83 164.05 46.63 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.26 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 8.8 t -68.97 144.32 14.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 32.3 t -62.23 134.56 27.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.988 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.26 160.78 45.79 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.995 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 75.2 mt . . . . . 0 C--N 1.324 -0.536 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.682 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.617 0 N-CA-C 112.695 -0.162 . . . . 0.0 112.695 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo . . . . . 0 C--O 1.235 0.363 0 C-N-CA 122.68 2.253 . . . . 0.0 111.854 179.961 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 112.954 -0.059 . . . . 0.0 112.954 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo . . . . . 0 C--O 1.234 0.298 0 C-N-CA 122.506 2.137 . . . . 0.0 111.105 179.326 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.457 0 N-CA-C 113.289 0.075 . . . . 0.0 113.289 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.46 -0.489 0 C-N-CA 122.912 2.408 . . . . 0.0 111.275 179.903 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 CA-C-O 120.223 -0.209 . . . . 0.0 112.917 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo . . . . . 0 CA--C 1.532 0.39 0 C-N-CA 122.922 2.415 . . . . 0.0 112.06 179.804 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.504 0 CA-C-O 119.939 -0.367 . . . . 0.0 112.239 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo . . . . . 0 C--N 1.347 0.481 0 C-N-CA 123.148 2.566 . . . . 0.0 111.354 179.267 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.448 0 N-CA-C 114.667 0.627 . . . . 0.0 114.667 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo . . . . . 0 C--N 1.344 0.338 0 C-N-CA 123.673 2.915 . . . . 0.0 111.084 178.916 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 CA-C-O 120.385 -0.119 . . . . 0.0 112.879 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo . . . . . 0 N--CA 1.46 -0.482 0 C-N-CA 123.891 3.061 . . . . 0.0 112.182 179.843 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.571 0 N-CA-C 112.061 -0.416 . . . . 0.0 112.061 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.73 147.15 68.79 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.627 2.218 . . . . 0.0 112.088 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -65.24 151.41 46.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.629 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -71.79 169.44 50.47 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.358 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 32.3 pt -71.54 162.41 4.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 120.91 0.386 . . . . 0.0 111.052 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -79.76 142.21 35.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.084 0.469 . . . . 0.0 110.709 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -62.65 160.94 32.41 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.369 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -81.08 155.94 26.05 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -66.1 151.44 46.9 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.806 0.336 . . . . 0.0 110.815 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -62.4 157.4 37.07 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.862 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 16.3 t -65.25 138.83 22.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 33.1 t -60.74 142.3 16.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.941 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.12 157.95 26.65 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.238 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.782 -0.209 . . . . 0.0 110.585 -179.952 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 CA-C-O 120.423 -0.098 . . . . 0.0 113.066 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo . . . . . 0 C--O 1.236 0.382 0 C-N-CA 122.856 2.371 . . . . 0.0 111.352 179.437 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.534 0 CA-C-O 120.55 -0.028 . . . . 0.0 113.142 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo . . . . . 0 N--CA 1.461 -0.427 0 C-N-CA 122.906 2.404 . . . . 0.0 111.606 179.845 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.431 0 CA-C-O 120.378 -0.123 . . . . 0.0 113.08 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo . . . . . 0 C--N 1.341 0.175 0 C-N-CA 122.945 2.43 . . . . 0.0 111.777 179.844 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo . . . . . 0 N--CA 1.478 0.559 0 N-CA-C 110.241 -0.715 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -110.82 163.36 13.86 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 18.8 tt -68.59 -23.13 27.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.372 0.606 . . . . 0.0 110.698 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 45.2 m -88.51 5.52 42.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.972 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.07 -37.42 81.24 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.058 0.456 . . . . 0.0 110.696 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 85.8 174.95 50.02 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.766 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 5.4 t30 58.86 76.48 0.35 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.207 0.527 . . . . 0.0 111.304 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -95.08 174.34 7.12 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.66 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -90.25 -39.03 13.02 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 4.5 t -170.1 152.19 4.19 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.507 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 82.0 t -136.19 120.76 26.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -144.49 -179.96 6.88 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.993 0.425 . . . . 0.0 111.547 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 48.7 ttp -126.59 128.64 47.14 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 80.1 mt -122.27 112.1 17.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.938 0.399 . . . . 0.0 110.705 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 62.58 28.41 16.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.421 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 101.6 -20.22 47.28 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.333 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -94.87 136.8 34.75 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.701 0.251 . . . . 0.0 110.567 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 47.0 ttm -87.86 134.39 33.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.884 0.373 . . . . 0.0 111.377 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -122.86 121.79 37.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.657 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 46.8 t -106.63 111.64 36.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -96.47 130.02 43.71 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.772 0.32 . . . . 0.0 111.73 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -144.11 112.91 6.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.672 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 62.2 -105.21 0.17 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.315 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -116.56 9.43 14.2 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.814 0.34 . . . . 0.0 111.567 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 8.2 m-90 -129.72 161.22 31.16 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.364 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -137.94 140.75 40.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.946 0.403 . . . . 0.0 111.064 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -102.7 144.38 31.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.472 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 25.1 ttt-85 -115.76 106.07 13.44 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 1.3 m -101.43 132.44 47.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.18 0.514 . . . . 0.0 111.531 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.63 111.48 9.44 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.936 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 14.1 m120 61.18 50.17 5.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.843 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 66.73 9.23 6.54 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.452 -0.795 . . . . 0.0 113.096 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -121.45 137.87 54.53 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 122.391 -0.193 . . . . 0.0 111.058 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 38.4 t -79.58 123.82 36.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 83.5 mtp -66.34 148.84 51.28 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -66.98 153.05 44.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.56 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 84.83 10.11 79.62 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.672 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -123.74 158.83 58.34 Favored Pre-proline 0 C--N 1.326 -0.422 0 O-C-N 122.86 -0.2 . . . . 0.0 110.629 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.51 149.67 90.78 Favored 'Cis proline' 0 C--N 1.349 0.569 0 C-N-CA 123.656 -1.393 . . . . 0.0 112.955 0.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 59.8 ttm -121.83 139.82 30.85 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.445 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -55.59 138.35 80.52 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.596 2.197 . . . . 0.0 111.406 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 89.4 mt -56.46 -40.58 68.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.597 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -70.46 -2.47 42.68 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 121.251 -0.499 . . . . 0.0 114.149 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.25 -39.8 14.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.125 0.488 . . . . 0.0 109.877 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -97.62 -56.33 2.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.266 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 51.9 m95 -93.73 73.91 4.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.691 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 33.7 ttp-105 -62.37 107.9 1.0 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.012 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 123.92 -18.65 7.49 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.558 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 29.8 tp -88.67 128.25 53.31 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.681 0.277 . . . . 0.0 110.552 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.91 -175.07 2.53 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.751 2.301 . . . . 0.0 112.277 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -87.89 160.3 18.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.328 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.1 m 55.31 87.22 0.05 Allowed 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 23.0 pt -105.8 163.91 4.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.174 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -85.99 -56.7 3.34 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.677 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.23 171.22 20.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.073 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -153.39 144.39 22.88 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -164.55 164.49 21.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.635 0.255 . . . . 0.0 111.039 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -89.77 130.77 35.98 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -83.58 -174.92 5.56 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.699 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -68.22 -23.47 64.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.988 0.423 . . . . 0.0 111.473 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.68 -24.32 25.28 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.553 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 121.25 -26.53 6.67 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.318 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 32.8 mttp -63.85 154.86 32.34 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.094 0.473 . . . . 0.0 111.731 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -96.31 123.57 39.99 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.656 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 7.9 t -102.19 114.62 42.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.312 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -100.34 144.61 29.14 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -124.18 149.12 46.69 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.869 0.366 . . . . 0.0 111.87 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -157.42 97.27 1.61 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 73.73 -108.45 2.51 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.211 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -114.91 7.74 15.73 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.931 0.396 . . . . 0.0 111.142 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -111.22 149.47 30.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.649 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -131.69 146.68 52.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.385 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 17.4 m-90 -119.44 137.56 53.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.17 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 88.4 t -116.49 112.38 39.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -111.0 123.72 50.73 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.847 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -92.88 93.14 8.24 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 71.76 -79.43 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 O-C-N 123.695 0.622 . . . . 0.0 110.954 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -141.07 13.93 2.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.911 0.386 . . . . 0.0 110.648 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 5.5 m -123.48 131.8 53.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.267 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 58.4 tp -78.35 135.96 37.59 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.111 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -74.69 148.8 85.52 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.73 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -72.58 143.32 37.9 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.928 2.418 . . . . 0.0 111.751 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 89.8 32.45 10.04 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.991 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -138.57 161.05 60.9 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.13 154.7 99.76 Favored 'Cis proline' 0 C--N 1.346 0.409 0 C-N-CA 123.715 -1.369 . . . . 0.0 112.998 0.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 53.3 mttt -125.93 170.29 11.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.233 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -73.0 155.64 39.63 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.971 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 41.5 mt -59.22 -34.23 53.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.196 0.522 . . . . 0.0 110.658 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -66.74 -17.59 64.94 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.013 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -78.02 -25.47 47.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.055 0.455 . . . . 0.0 110.111 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 49.9 tp -74.7 -45.33 45.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.567 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -164.76 147.7 13.06 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.505 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -81.34 140.94 34.47 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.918 0.389 . . . . 0.0 111.0 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 101.36 -3.28 54.26 Favored Glycine 0 CA--C 1.517 0.184 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.737 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 83.7 mt -85.48 149.04 50.94 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.472 0.177 . . . . 0.0 110.732 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.31 145.16 98.67 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.008 2.472 . . . . 0.0 111.863 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.79 11.14 22.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.059 0.457 . . . . 0.0 111.255 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -94.17 -56.34 2.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.672 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -176.47 173.96 1.98 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.465 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 46.6 mm -123.17 135.04 64.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.866 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -89.14 -59.12 2.31 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -153.72 153.72 32.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.896 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -132.47 116.69 17.08 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 37.1 tp -107.64 125.61 51.55 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.377 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -96.67 113.3 24.85 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 11.9 t-105 -82.17 99.3 9.17 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 66.5 mtt -53.37 -52.96 61.59 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -47.22 -44.58 23.78 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.758 2.305 . . . . 0.0 115.319 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -101.25 -21.58 14.86 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 78.4 37.03 28.76 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.693 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' LYS . . . . . 0.475 ' HZ3' ' ND2' ' A' ' 439' ' ' ASN . 23.4 mmtt -121.24 144.85 48.39 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 15.0 m -97.95 132.17 43.75 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.045 0.45 . . . . 0.0 111.249 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -107.41 109.9 21.73 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -91.38 122.38 33.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.407 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -100.36 131.82 46.08 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.737 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -144.0 108.95 4.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.893 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 66.05 -108.38 2.36 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -121.85 19.93 10.92 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.274 0.559 . . . . 0.0 110.668 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 42.3 mmtt -127.53 152.87 47.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.761 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -132.76 139.86 47.76 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.825 0.345 . . . . 0.0 111.389 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -107.6 149.98 27.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.202 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -108.04 98.82 8.33 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -81.31 124.63 29.51 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.782 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . 0.475 ' ND2' ' HZ3' ' A' ' 426' ' ' LYS . 41.7 t-20 -93.73 104.85 16.93 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.09 -48.19 80.91 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.48 -50.66 72.34 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 88.4 mt -84.62 -12.95 52.98 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 23.6 mtp180 57.05 50.84 11.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.467 0.651 . . . . 0.0 111.704 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -159.65 169.63 23.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.684 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 86.5 t -89.19 133.13 32.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -64.34 161.63 16.46 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.368 0.417 . . . . 0.0 111.017 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 2.6 m -69.48 161.88 28.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.863 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 70.87 33.21 2.23 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.353 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -137.75 161.53 59.64 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.067 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -79.7 155.55 88.74 Favored 'Cis proline' 0 C--N 1.346 0.404 0 C-N-CA 123.477 -1.468 . . . . 0.0 112.522 0.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -105.66 176.96 4.99 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.625 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -75.2 140.73 43.47 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.0 tt -68.16 -14.62 18.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.94 0.4 . . . . 0.0 110.593 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -69.74 -1.62 9.67 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.302 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 38.1 t -60.87 -37.71 77.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 15.1 m95 -91.16 93.64 9.22 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -56.44 121.13 8.9 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 105.63 -15.03 45.94 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.722 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 25.6 mm -80.67 130.46 64.27 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 121.084 0.469 . . . . 0.0 111.245 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.04 158.24 30.59 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.733 2.289 . . . . 0.0 111.284 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -82.93 141.11 32.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.217 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.6 m 57.8 75.57 0.54 Allowed Pre-proline 0 N--CA 1.464 0.239 0 O-C-N 123.868 0.73 . . . . 0.0 112.855 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -90.5 179.86 1.77 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.689 2.259 . . . . 0.0 111.235 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.76 26.71 3.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.312 0.577 . . . . 0.0 110.42 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 175.01 137.96 2.63 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.38 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 20.9 p -161.04 99.77 1.22 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -128.99 143.9 51.02 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.839 0.352 . . . . 0.0 111.294 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 34.7 ttm -86.33 143.21 27.98 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.853 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -72.81 163.77 54.85 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.511 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.44 -7.59 20.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.053 0.454 . . . . 0.0 111.648 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -90.9 -13.24 33.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.403 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 66.87 0.04 1.81 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 55.4 t -98.2 -36.38 5.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.845 0.355 . . . . 0.0 111.264 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -112.16 144.73 41.05 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 60.8 m -122.32 137.53 54.82 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -112.95 122.62 48.17 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.148 0.499 . . . . 0.0 112.29 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -101.97 150.57 23.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.645 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -130.07 133.37 46.65 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 44.1 tttt -170.51 140.91 1.85 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.86 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 60.14 32.62 76.73 Favored Glycine 0 C--N 1.328 0.104 0 C-N-CA 121.245 -0.502 . . . . 0.0 112.609 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 1.7 t30 64.53 17.67 10.97 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.344 0.592 . . . . 0.0 111.785 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -122.81 158.48 30.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.485 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -123.98 149.53 45.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.915 0.388 . . . . 0.0 111.93 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 20.1 m-90 -118.21 138.56 52.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.452 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -99.89 93.62 5.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.089 0.471 . . . . 0.0 109.746 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 486' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -86.45 131.2 34.25 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.738 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 -97.17 114.67 26.39 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -65.15 -28.69 69.59 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -178.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -84.29 -14.61 49.27 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -109.35 -26.3 10.1 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 68.86 30.8 4.56 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.857 0.837 . . . . 0.0 110.373 -178.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -150.06 154.43 38.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.048 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 55.9 t -79.17 133.54 29.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -59.91 147.19 80.14 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.459 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -62.96 157.15 50.22 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 123.246 2.631 . . . . 0.0 112.972 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 83.91 27.19 38.65 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.874 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -129.75 165.87 30.1 Favored Pre-proline 0 C--N 1.327 -0.393 0 O-C-N 122.877 -0.19 . . . . 0.0 111.13 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -82.41 175.25 40.4 Favored 'Cis proline' 0 C--N 1.346 0.433 0 C-N-CA 123.74 -1.358 . . . . 0.0 112.871 0.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -129.7 153.98 47.62 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.406 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 41.4 t -69.36 123.92 22.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.905 0.383 . . . . 0.0 110.484 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -67.75 -18.49 64.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.885 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 13.7 mt -66.8 -46.32 75.6 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.921 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -80.94 -41.27 23.17 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.2 -45.2 34.32 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -177.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 35.0 m0 -100.12 -58.55 1.89 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 10.8 mmt -60.64 -41.28 94.62 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 98.5 25.62 9.91 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.611 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 3.5 m -110.62 103.4 54.27 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -81.32 178.59 6.59 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.509 2.139 . . . . 0.0 111.693 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 3.9 m 67.12 13.88 9.59 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.73 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.396 -1.225 . . . . 0.0 111.087 179.699 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.809 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -84.16 153.31 12.58 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 123.277 2.651 . . . . 0.0 111.397 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.76 169.31 38.38 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.71 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -72.34 163.93 37.17 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 122.986 2.458 . . . . 0.0 111.689 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.62 179.6 40.35 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.77 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.52 165.2 6.25 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 122.86 2.373 . . . . 0.0 111.22 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 151.39 170.63 18.48 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.019 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.76 142.99 95.72 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.855 2.37 . . . . 0.0 111.867 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -67.89 142.86 55.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.935 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.55 150.49 41.67 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.736 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 17.4 mt -68.28 147.8 12.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.74 151.57 46.48 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.837 0.351 . . . . 0.0 110.447 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.35 162.46 43.88 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.299 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -68.94 148.72 49.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.771 0.319 . . . . 0.0 110.426 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.18 145.0 54.74 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.216 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.2 143.43 47.45 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.948 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 t -69.49 159.24 5.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 4.6 t -55.79 143.27 9.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.901 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.53 171.48 54.86 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.498 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 97.2 mt -81.0 142.91 32.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.599 0.238 . . . . 0.0 110.686 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.32 163.78 48.4 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.874 -0.603 . . . . 0.0 113.22 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.46 154.81 31.78 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 122.921 2.414 . . . . 0.0 111.859 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.11 162.98 41.03 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.431 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.94 165.82 31.74 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.886 2.39 . . . . 0.0 111.512 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.44 168.17 53.62 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.641 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.98 155.98 52.1 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 123.056 2.504 . . . . 0.0 112.213 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.13 133.16 45.88 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.943 -0.571 . . . . 0.0 113.237 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.66 116.12 4.09 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.88 2.387 . . . . 0.0 111.193 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.461 0 CA-C-O 120.109 -0.273 . . . . 0.0 112.637 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -59.55 135.95 67.93 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 123.369 2.712 . . . . 0.0 112.702 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 102' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -75.44 161.26 52.71 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.465 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -83.18 160.49 15.38 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.861 2.374 . . . . 0.0 112.449 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 105' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -83.62 -170.91 47.06 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.425 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -74.72 154.45 43.95 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.776 2.317 . . . . 0.0 111.197 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 108' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -57.87 167.04 5.82 Favored Glycine 0 CA--C 1.521 0.429 0 CA-C-N 115.832 -0.622 . . . . 0.0 113.465 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.03 157.34 62.2 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.814 2.343 . . . . 0.0 112.576 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -60.02 137.69 58.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.529 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -67.53 164.11 45.64 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.88 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 40.5 mt -67.22 144.46 14.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.42 148.04 50.15 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -63.17 147.22 50.56 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.119 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -75.17 149.97 38.84 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 122.753 -0.263 . . . . 0.0 110.366 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 9.5 ttm-85 -59.09 141.06 55.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.935 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.95 170.47 33.15 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.973 -0.558 . . . . 0.0 113.428 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 23.5 t -71.85 139.88 19.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.563 -0.319 . . . . 0.0 110.514 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 21.4 t -60.22 141.8 16.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.507 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.51 163.9 34.97 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.446 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 67.3 mt -77.21 141.53 40.02 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.895 -0.179 . . . . 0.0 110.722 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 123' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -64.6 161.24 39.62 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.849 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.49 154.73 35.84 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 122.661 2.241 . . . . 0.0 112.369 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 126' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -72.51 169.34 52.03 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.705 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -75.66 152.13 37.41 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.758 2.305 . . . . 0.0 112.046 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -62.52 167.46 19.26 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 116.057 -0.52 . . . . 0.0 113.134 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -75.36 154.55 40.9 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 123.098 2.532 . . . . 0.0 111.855 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 132' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.03 136.52 18.32 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.955 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.87 114.8 2.44 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.971 2.448 . . . . 0.0 112.132 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 135' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 N-CA-C 112.205 -0.358 . . . . 0.0 112.205 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.92 138.52 86.42 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.893 2.395 . . . . 0.0 111.412 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 202' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 72.41 155.57 2.7 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 114.381 0.512 . . . . 0.0 114.381 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -71.25 162.89 40.98 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.174 2.582 . . . . 0.0 110.99 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 205' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . 97.83 173.64 33.35 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.492 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -90.8 156.65 4.12 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 123.516 2.811 . . . . 0.0 112.208 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 208' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -75.78 169.95 54.7 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.425 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.78 157.35 47.97 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.549 2.166 . . . . 0.0 112.273 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -78.1 144.33 36.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.595 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -68.08 166.32 44.49 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.824 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 45.4 pt -68.29 164.73 2.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 120.835 0.35 . . . . 0.0 110.984 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -81.06 147.58 30.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.108 0.48 . . . . 0.0 111.381 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -71.89 153.02 49.59 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.411 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 48.8 mm-40 -71.55 150.6 44.61 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -64.63 160.18 20.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.185 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -62.14 156.85 36.93 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.206 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.15 152.28 9.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.5 137.25 25.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -56.68 166.63 4.51 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.918 -0.583 . . . . 0.0 114.237 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 8.6 mp -72.25 153.32 41.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.719 -0.241 . . . . 0.0 110.736 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 223' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -60.81 153.51 37.44 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 116.113 -0.494 . . . . 0.0 113.299 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -70.17 147.99 61.44 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.838 2.359 . . . . 0.0 111.109 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 226' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -63.18 166.37 24.96 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.062 -0.59 . . . . 0.0 113.158 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -79.2 160.79 26.33 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.682 2.255 . . . . 0.0 111.716 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -64.99 167.45 30.78 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.86 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -82.74 156.84 15.93 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.642 2.228 . . . . 0.0 111.079 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 232' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.478 0.6 0 N-CA-C 110.378 -0.662 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -106.48 160.03 15.72 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.975 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 19.8 tt -75.9 -23.59 16.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.003 0.43 . . . . 0.0 111.474 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 21.4 m -80.52 0.18 34.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.283 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -67.6 -34.48 77.1 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.948 0.404 . . . . 0.0 111.178 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 82.55 -171.66 51.53 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.213 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 5.0 t30 52.41 74.04 0.3 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.18 0.514 . . . . 0.0 111.139 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -95.67 162.76 13.48 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.427 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -77.0 -35.25 57.28 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.244 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 6.7 t -178.33 155.68 0.91 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.528 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 48.4 t -133.96 127.14 51.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -144.27 172.08 13.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.997 0.427 . . . . 0.0 111.67 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 38.6 ttp -126.28 113.74 17.36 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 50.9 mt -106.88 116.53 32.08 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.567 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 57.9 27.45 14.65 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 98.18 -5.75 61.3 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.923 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -101.52 122.43 43.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.902 0.382 . . . . 0.0 111.131 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 56.7 ttm -81.45 120.81 25.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.194 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -119.24 126.76 52.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.756 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 25.5 t -107.73 119.78 57.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.434 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -95.35 121.13 36.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.012 0.434 . . . . 0.0 112.145 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -130.18 99.56 5.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.686 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 62.4 -102.9 0.12 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.02 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -116.77 13.69 15.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.1 0.476 . . . . 0.0 111.026 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 20.1 m-90 -128.88 142.9 50.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.544 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -122.35 135.49 54.72 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.937 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -100.15 151.95 20.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.572 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 14.8 ttt-85 -120.78 100.47 7.12 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 5.2 m -112.52 131.45 64.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.204 0.526 . . . . 0.0 112.09 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 6.3 ttm-85 -139.33 112.63 8.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.337 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 1.5 m120 72.97 49.78 0.15 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 61.67 24.46 14.56 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.487 178.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -143.45 145.75 32.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.053 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 22.2 t -83.41 135.75 24.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 87.9 mtp -83.2 156.07 23.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.995 0.426 . . . . 0.0 111.418 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -69.92 150.12 47.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.407 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 95.04 -8.51 70.13 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.268 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -119.21 164.01 23.65 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.58 159.82 91.55 Favored 'Cis proline' 0 C--N 1.348 0.501 0 C-N-CA 123.856 -1.31 . . . . 0.0 112.813 0.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 42.5 ttm -134.68 141.78 40.02 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.232 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -60.93 140.09 88.41 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.416 2.077 . . . . 0.0 111.165 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 78.7 mt -56.95 -44.15 81.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.605 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -69.86 3.04 10.38 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 114.283 0.473 . . . . 0.0 114.283 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.09 -46.5 7.41 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -93.79 -53.55 3.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.132 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -84.77 73.19 10.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.831 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 30.4 ttp-105 -64.46 93.88 0.11 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.187 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 129.72 -7.28 6.17 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.035 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 33.8 tp -99.41 126.37 37.85 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-O 120.57 0.224 . . . . 0.0 110.533 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.62 175.09 11.56 Favored 'Trans proline' 0 CA--C 1.528 0.216 0 C-N-CA 122.624 2.216 . . . . 0.0 111.961 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -85.8 154.91 21.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.494 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 35.0 m 55.5 82.41 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 22.7 pt -95.17 -171.22 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.29 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -108.99 -47.7 3.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.724 0.297 . . . . 0.0 111.193 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -156.44 166.34 33.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.848 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -153.4 145.51 23.77 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -161.42 159.94 28.8 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.129 0.49 . . . . 0.0 112.221 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -89.63 121.18 31.57 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -78.1 177.97 7.91 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -68.3 -38.2 81.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.863 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -31.63 71.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.632 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 129.66 -32.82 3.11 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.51 -0.852 . . . . 0.0 113.043 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -65.66 157.56 29.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.073 0.463 . . . . 0.0 111.696 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -98.67 135.04 40.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.993 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 4.7 t -113.24 121.65 65.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.842 0.353 . . . . 0.0 110.668 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -108.51 138.26 45.11 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.436 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -120.29 143.5 48.3 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.826 0.346 . . . . 0.0 111.584 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -158.34 105.75 1.91 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.517 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 76.33 -114.84 4.26 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.556 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . 0.44 ' CG ' ' HZ1' ' A' ' 386' ' ' LYS . 8.2 p-10 -114.19 4.0 15.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.932 0.396 . . . . 0.0 110.7 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . 0.44 ' HZ1' ' CG ' ' A' ' 385' ' ' ASP . 44.7 mmtm -112.6 155.92 23.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.847 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -136.3 146.78 47.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.944 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 20.5 m-90 -121.88 132.51 54.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.061 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 95.0 t -111.88 119.49 60.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -111.21 130.96 55.48 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.342 0.591 . . . . 0.0 112.211 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -95.31 87.82 4.94 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 67.35 -79.54 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.604 0.565 . . . . 0.0 110.539 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -137.7 19.32 2.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.234 0.54 . . . . 0.0 109.991 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 8.1 m -121.12 157.79 29.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.782 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 64.9 tp -104.43 135.95 44.92 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.629 0.252 . . . . 0.0 110.829 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -70.57 125.89 92.11 Favored Pre-proline 0 C--O 1.232 0.184 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.047 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.92 136.35 69.2 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.873 2.382 . . . . 0.0 111.842 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 101.04 -8.37 57.52 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.716 -0.755 . . . . 0.0 111.798 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -93.89 161.02 31.26 Favored Pre-proline 0 C--N 1.321 -0.659 0 O-C-N 122.85 -0.206 . . . . 0.0 110.815 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.04 166.55 82.96 Favored 'Cis proline' 0 C--N 1.346 0.434 0 C-N-CA 123.819 -1.325 . . . . 0.0 112.943 0.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -137.66 163.04 32.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.388 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -71.01 150.6 45.47 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 79.2 mt -54.61 -33.5 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 120.887 0.375 . . . . 0.0 111.33 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -64.22 -15.13 59.38 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.193 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -81.93 -20.22 39.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.911 0.386 . . . . 0.0 111.102 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 38.3 tp -74.94 -48.85 22.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.084 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -162.82 155.74 27.19 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.687 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -81.58 130.92 35.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.791 0.329 . . . . 0.0 110.939 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 102.29 1.76 50.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.308 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 51.3 mt -79.46 156.34 75.9 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 120.49 0.186 . . . . 0.0 111.026 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -61.51 118.14 5.0 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.614 2.209 . . . . 0.0 111.525 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.04 -3.5 59.09 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.99 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -92.3 -56.67 2.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.448 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 9.5 ptmt -176.38 171.8 2.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.863 0.363 . . . . 0.0 110.723 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 39.6 mm -117.16 133.09 65.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.694 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -90.79 -48.85 6.78 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -156.43 154.28 30.2 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.138 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -135.19 113.55 11.46 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 42.3 tp -107.94 132.69 53.22 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.269 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -98.12 116.67 30.82 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.966 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 -89.5 97.05 10.97 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 62.7 mtt -55.31 -50.81 84.56 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -45.78 -53.33 5.78 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 123.151 2.567 . . . . 0.0 114.662 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 42.4 p30 -95.62 -10.67 28.84 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 66.89 51.99 36.36 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.921 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -138.42 160.94 38.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.671 0.272 . . . . 0.0 111.03 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 26.5 m -105.7 133.26 50.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.067 0.461 . . . . 0.0 111.525 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -110.31 110.77 21.69 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -93.97 138.97 31.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.509 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -114.1 136.73 52.61 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.331 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -148.27 105.18 3.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.809 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 68.1 -109.89 3.14 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -115.12 11.4 16.35 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.23 0.538 . . . . 0.0 110.009 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt -117.01 150.48 38.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.156 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -131.41 140.26 49.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.589 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -110.5 144.38 39.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.497 -178.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -106.14 96.65 6.63 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -80.85 128.49 33.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.125 -177.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -96.74 97.87 9.69 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -44.95 -60.61 1.98 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -56.23 -36.35 68.4 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 67.1 mt -88.73 -20.56 24.65 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 67.0 mtp180 61.96 48.55 5.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.557 0.694 . . . . 0.0 110.847 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -162.03 164.53 28.17 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.749 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.0 t -88.62 138.74 18.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -61.97 166.4 4.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.201 0.524 . . . . 0.0 112.147 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.46 152.0 46.04 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 68.81 22.74 7.15 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.668 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -118.21 158.26 46.89 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.114 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -77.75 151.71 91.89 Favored 'Cis proline' 0 C--N 1.344 0.332 0 C-N-CA 123.643 -1.399 . . . . 0.0 113.521 0.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -102.38 177.09 4.97 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.847 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -75.24 140.93 43.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.573 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.2 tt -69.79 -11.5 14.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.909 0.385 . . . . 0.0 110.974 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -63.84 -6.31 5.68 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 70.7 t -67.54 -33.6 63.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 10.0 m95 -95.46 84.84 4.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.253 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -57.4 115.71 2.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.187 0.518 . . . . 0.0 112.358 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 115.17 -26.47 9.2 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.097 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 31.7 mm -73.47 130.48 83.96 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.714 0.292 . . . . 0.0 111.067 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.0 156.15 23.32 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.825 2.35 . . . . 0.0 111.869 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -77.57 141.09 39.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.412 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 5.2 m 58.0 74.59 0.62 Allowed Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -81.84 -173.87 1.94 Allowed 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.866 2.378 . . . . 0.0 112.017 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.87 20.37 3.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.239 0.542 . . . . 0.0 110.528 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 161.36 142.48 3.4 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.592 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 7.8 p -156.75 106.77 2.3 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -127.48 138.34 52.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.923 0.392 . . . . 0.0 111.613 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 46.2 ttm -90.31 142.06 28.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.291 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -71.18 162.26 54.16 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.917 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.7 -12.46 46.86 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 16.9 p30 -85.27 -13.2 50.52 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.623 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 66.98 10.84 7.99 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.14 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 40.1 t -104.43 -42.9 7.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.601 0.239 . . . . 0.0 111.44 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -112.05 144.84 40.74 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 97.8 m -126.99 134.31 50.38 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.316 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -101.82 124.89 48.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.954 0.407 . . . . 0.0 111.716 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -110.22 131.41 55.08 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -115.26 137.76 51.68 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.665 0.269 . . . . 0.0 111.669 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -163.01 104.1 1.0 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.961 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 65.94 66.03 2.6 Favored Glycine 0 CA--C 1.518 0.268 0 N-CA-C 114.828 0.691 . . . . 0.0 114.828 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 61.84 -1.2 0.37 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -119.56 148.02 43.8 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 122.291 -0.256 . . . . 0.0 110.526 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -127.95 147.55 50.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.174 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 17.4 m-90 -113.04 143.84 43.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.879 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -104.35 97.08 7.07 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 486' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -90.68 134.54 34.33 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.477 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -98.63 119.27 37.06 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -68.52 -32.93 73.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.199 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -74.84 -43.14 56.16 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.701 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -85.24 -22.56 28.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.131 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 3.7 tp 65.56 42.67 3.6 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.525 0.679 . . . . 0.0 109.889 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 16.1 tttp -156.96 153.89 28.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.61 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 69.9 t -85.15 140.18 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -61.48 131.46 92.54 Favored Pre-proline 0 C--O 1.234 0.278 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.264 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -62.11 141.84 90.04 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.669 2.246 . . . . 0.0 111.682 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 109.56 -10.24 32.83 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -94.73 170.46 8.02 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.61 -0.295 . . . . 0.0 110.333 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.88 169.5 72.11 Favored 'Cis proline' 0 C--N 1.349 0.604 0 C-N-CA 123.978 -1.259 . . . . 0.0 113.253 0.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -120.85 157.65 29.34 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.774 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 47.6 t -69.84 112.91 6.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.973 0.416 . . . . 0.0 110.263 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -66.55 -23.73 66.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.074 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 79.1 mt -65.94 -39.25 90.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.114 0.483 . . . . 0.0 110.711 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -89.06 -39.69 13.47 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.587 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.0 -36.67 61.97 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 42.9 m0 -106.37 -57.44 2.05 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 7.1 mmt -65.84 -35.42 80.63 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 91.67 38.03 5.95 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.218 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 23.0 m -115.74 86.95 16.75 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.3 160.69 48.06 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.475 2.117 . . . . 0.0 111.737 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 5.7 m 66.4 69.71 0.42 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.166 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.23 0 CA-C-O 118.306 -1.274 . . . . 0.0 111.258 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.766 0 N-CA-C 112.429 -0.268 . . . . 0.0 112.429 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.7 143.63 37.98 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.745 2.297 . . . . 0.0 112.471 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -85.76 161.15 34.74 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.181 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -80.77 161.57 21.45 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.488 2.126 . . . . 0.0 110.404 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.27 -136.02 1.23 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.887 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -61.55 154.16 61.6 Favored 'Trans proline' 0 CA--C 1.527 0.154 0 C-N-CA 122.943 2.428 . . . . 0.0 111.766 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.03 160.23 17.84 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.062 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.35 149.77 69.89 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 123.006 2.471 . . . . 0.0 112.061 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -65.17 145.56 56.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.494 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.41 155.96 46.21 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.249 -0.5 . . . . 0.0 112.318 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 6.9 mt -67.44 147.28 12.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.572 0.225 . . . . 0.0 110.778 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.41 147.29 53.09 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.797 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.77 162.08 52.79 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.0 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -72.94 150.47 42.51 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -75.16 152.41 38.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.191 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.84 154.23 53.01 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.648 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 3.2 t -71.99 152.32 8.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 2.9 t -51.33 145.24 2.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 O-C-N 123.499 0.499 . . . . 0.0 110.948 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.39 160.12 53.99 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.739 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 94.0 mt -71.82 148.13 46.52 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.479 0.181 . . . . 0.0 110.604 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.73 154.66 48.76 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.451 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.22 153.23 77.93 Favored 'Trans proline' 0 CA--C 1.529 0.258 0 C-N-CA 122.752 2.301 . . . . 0.0 111.764 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.93 155.38 53.2 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.723 -0.672 . . . . 0.0 113.399 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.3 166.95 26.72 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 123.244 2.629 . . . . 0.0 112.035 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.34 173.11 51.48 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.878 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -64.07 157.52 52.86 Favored 'Trans proline' 0 CA--C 1.528 0.224 0 C-N-CA 123.176 2.584 . . . . 0.0 111.853 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.4 155.1 53.39 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.333 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -75.21 156.49 42.09 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.685 2.256 . . . . 0.0 111.479 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.402 0 CA-C-O 120.224 -0.209 . . . . 0.0 112.64 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -72.25 133.18 20.63 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 123.057 2.505 . . . . 0.0 111.142 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 102' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.63 160.85 28.28 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.832 -0.622 . . . . 0.0 113.689 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.47 164.79 28.21 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 123.528 2.819 . . . . 0.0 112.413 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 105' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -84.22 -176.05 50.99 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.421 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -82.14 158.09 17.71 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 122.981 2.454 . . . . 0.0 111.756 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 108' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -58.22 167.47 6.04 Favored Glycine 0 N--CA 1.452 -0.243 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.553 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.19 156.82 64.36 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.66 2.24 . . . . 0.0 112.085 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -59.33 135.86 57.78 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.06 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -62.01 162.16 27.63 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.563 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 16.3 mt -69.3 134.73 29.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.621 0.248 . . . . 0.0 110.68 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.26 146.52 47.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.679 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -64.94 157.04 46.62 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 121.205 -0.521 . . . . 0.0 113.002 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -84.3 152.4 24.16 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 4.6 ttm180 -66.5 148.52 51.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.328 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.07 171.91 41.65 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.027 -0.606 . . . . 0.0 113.053 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 15.9 t -72.85 142.49 15.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 97.3 t -62.9 138.39 22.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.954 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.46 158.52 39.32 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 116.081 -0.508 . . . . 0.0 112.538 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 59.1 mt -73.62 142.02 46.53 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.852 -0.174 . . . . 0.0 110.642 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 123' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -64.74 158.41 44.13 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.673 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.59 146.39 84.39 Favored 'Trans proline' 0 N--CA 1.464 -0.209 0 C-N-CA 122.475 2.117 . . . . 0.0 111.116 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 126' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -66.06 156.05 50.25 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.774 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.08 166.27 26.86 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.82 2.347 . . . . 0.0 111.552 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -70.58 -177.87 24.15 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.451 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -70.95 151.65 62.47 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.985 2.457 . . . . 0.0 111.731 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 132' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.92 119.87 5.17 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.805 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.45 110.84 2.15 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.107 2.538 . . . . 0.0 111.968 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 135' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.387 0 CA-C-O 120.197 -0.224 . . . . 0.0 112.712 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -65.85 155.45 69.26 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.153 2.569 . . . . 0.0 111.115 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 202' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 117.51 -156.6 15.55 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.071 -1.061 . . . . 0.0 113.606 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -69.57 159.95 51.62 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.735 2.956 . . . . 0.0 113.04 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 205' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . 95.26 162.93 34.45 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.033 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -86.85 148.6 8.32 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.466 2.777 . . . . 0.0 111.995 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 208' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.95 169.9 55.05 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.428 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.06 158.48 57.25 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.502 2.134 . . . . 0.0 111.773 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -78.29 144.08 36.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.653 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -67.43 159.53 50.14 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.87 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 15.2 pt -70.76 168.85 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.655 0.264 . . . . 0.0 111.026 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -87.37 143.15 27.38 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.863 0.363 . . . . 0.0 110.595 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -65.99 162.25 42.93 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 116.02 -0.536 . . . . 0.0 113.216 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -71.08 158.94 35.62 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.783 0.325 . . . . 0.0 110.899 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -68.5 152.57 45.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.0 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -59.96 151.09 38.6 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.301 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 12.4 t -61.33 144.44 13.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 46.7 t -63.18 139.42 21.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -56.66 158.23 10.03 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.962 -0.563 . . . . 0.0 113.621 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 7.1 mp -71.09 150.8 45.14 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.656 -0.272 . . . . 0.0 110.668 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 223' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -57.57 145.6 39.02 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.96 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.05 152.79 80.4 Favored 'Trans proline' 0 CA--C 1.528 0.177 0 C-N-CA 123.092 2.528 . . . . 0.0 111.223 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 226' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -74.56 171.08 53.46 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.638 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -87.36 163.59 8.27 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.93 2.42 . . . . 0.0 111.643 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -67.68 174.68 27.94 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.219 -0.515 . . . . 0.0 113.816 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -60.41 140.29 90.9 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 123.206 2.604 . . . . 0.0 111.995 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 232' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo . . . . . 0 N--CA 1.479 0.63 0 N-CA-C 110.238 -0.716 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -114.1 164.62 13.6 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 19.5 tt -71.37 -23.44 22.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.948 0.404 . . . . 0.0 111.036 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 31.2 m -87.68 6.07 36.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.727 0.299 . . . . 0.0 111.574 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.15 -50.5 70.16 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.132 0.491 . . . . 0.0 110.438 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 97.13 175.59 34.7 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 8.0 m120 51.03 73.43 0.29 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.172 0.511 . . . . 0.0 112.172 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -88.62 173.3 8.7 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.03 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.37 -51.75 27.55 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 14.5 t -170.51 147.67 2.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.435 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 76.8 t -112.71 126.62 70.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -131.67 166.7 20.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.01 0.433 . . . . 0.0 111.151 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 42.2 ttp -136.36 108.18 7.08 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 45.3 mt -106.25 127.2 53.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.574 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.06 14.85 5.71 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.55 0.531 . . . . 0.0 112.13 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 102.99 -9.29 54.92 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.23 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -93.94 129.67 40.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.631 0.253 . . . . 0.0 110.738 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 45.6 ttm -82.59 123.07 28.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.228 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -114.86 123.22 48.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.355 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 9.2 t -103.49 109.75 27.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.954 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -92.16 125.41 36.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.457 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 22.0 tptp -136.5 95.5 3.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.656 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 62.7 -100.5 0.09 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 7.7 ptm85 -104.22 -5.25 22.09 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -177.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 7.6 m0 -124.69 159.89 29.8 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.974 0.416 . . . . 0.0 111.425 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -135.93 138.2 42.13 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.372 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -108.39 152.78 24.21 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.954 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -127.07 113.4 16.38 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -101.78 113.09 37.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.175 0.512 . . . . 0.0 111.206 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.23 120.18 40.87 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 5.5 m120 61.83 32.94 17.94 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.437 0.46 . . . . 0.0 110.577 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 70.89 16.22 6.62 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.192 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -121.51 137.64 54.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.251 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 22.9 t -73.47 120.74 22.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.044 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 79.0 mtp -70.45 167.93 17.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.987 0.422 . . . . 0.0 111.542 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -85.81 163.71 17.98 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.371 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 91.54 -1.55 76.01 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.772 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -113.78 160.99 29.93 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.55 128.49 15.18 Favored 'Cis proline' 0 C--N 1.347 0.493 0 C-N-CA 123.505 -1.456 . . . . 0.0 112.519 0.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 54.2 ttm -102.87 133.52 20.35 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.711 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.76 136.09 68.1 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.398 2.065 . . . . 0.0 111.158 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 77.4 mt -53.0 -45.47 52.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.835 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -68.18 -13.55 64.85 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 121.145 -0.55 . . . . 0.0 114.04 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.51 -29.45 61.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.954 0.377 . . . . 0.0 110.202 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -112.38 -53.91 2.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.556 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -86.91 73.72 9.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.962 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -64.69 103.64 0.72 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.008 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 127.55 -13.3 6.55 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 20.0 tp -97.9 129.23 31.63 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -81.62 -178.72 4.39 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.782 2.321 . . . . 0.0 112.067 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -82.93 149.19 27.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.502 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 39.3 m 58.5 90.11 0.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.752 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 30.3 pt -95.62 168.59 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.965 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.81 -45.54 7.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.902 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.38 168.08 28.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.741 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -157.37 141.14 15.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -160.02 161.01 33.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.065 0.46 . . . . 0.0 111.859 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -94.99 125.68 39.81 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -82.87 179.71 7.69 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -178.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -64.46 -29.24 70.29 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.79 -17.21 36.41 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 116.53 -18.57 13.28 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.799 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -72.48 156.05 39.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.195 0.497 . . . . 0.0 111.077 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -100.03 125.65 46.12 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.187 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 15.4 t -108.25 116.3 51.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.041 0.448 . . . . 0.0 110.726 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -104.5 138.21 41.21 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.45 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -118.25 145.81 44.74 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.804 0.335 . . . . 0.0 111.233 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -155.0 99.55 2.12 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.957 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 71.56 -106.28 1.87 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.8 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -114.17 5.9 16.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.732 0.301 . . . . 0.0 111.432 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -116.95 154.52 30.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.91 0.386 . . . . 0.0 111.438 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -136.99 144.9 43.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.849 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 22.3 m-90 -118.8 135.13 54.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.964 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 53.3 t -113.37 114.55 47.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -107.06 121.6 44.81 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.411 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -91.5 100.13 12.94 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 69.0 -68.99 0.17 Allowed 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.722 0.639 . . . . 0.0 110.707 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -156.11 16.51 0.35 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.658 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.11 127.25 49.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.92 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 60.5 tp -75.14 131.51 40.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.218 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -66.87 133.21 93.94 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.956 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -62.24 123.62 12.82 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.997 2.465 . . . . 0.0 112.361 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 113.82 -1.84 24.47 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.413 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -100.17 161.64 23.52 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -76.35 160.53 95.27 Favored 'Cis proline' 0 C--N 1.345 0.365 0 C-N-CA 123.797 -1.335 . . . . 0.0 113.269 0.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 28.6 mttm -125.41 165.44 18.4 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.262 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -71.53 158.33 36.43 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 47.5 mt -57.78 -36.54 55.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.045 0.45 . . . . 0.0 111.374 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -66.52 -15.56 63.48 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.265 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -78.66 -25.02 44.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.887 0.375 . . . . 0.0 110.896 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 39.6 tp -74.83 -45.38 43.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.122 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -164.21 154.81 25.86 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.764 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 52.1 ttt85 -79.66 135.89 36.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.7 0.286 . . . . 0.0 110.51 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.08 -4.59 62.83 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.84 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 46.8 mt -72.66 151.32 91.33 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.858 0.329 . . . . 0.0 111.121 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.02 129.07 33.33 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.869 2.38 . . . . 0.0 112.123 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.59 -8.6 52.28 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -91.51 -54.37 3.93 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -176.95 -179.66 0.95 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.337 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 37.6 mm -124.24 137.18 58.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -88.52 -57.94 2.73 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -152.8 161.54 42.42 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.794 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -137.61 128.36 27.01 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 40.6 tp -118.92 122.17 41.65 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.824 0.345 . . . . 0.0 111.237 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -88.14 111.58 21.75 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.188 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 13.1 t-105 -80.24 96.25 6.54 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 67.9 mtt -51.35 -51.84 65.02 Favored Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -40.47 -54.52 2.25 Favored 'Trans proline' 0 C--N 1.358 1.067 0 C-N-CA 123.388 2.725 . . . . 0.0 115.139 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -104.24 -16.84 15.07 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 79.58 53.77 4.22 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.666 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -133.4 136.95 45.59 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.718 0.294 . . . . 0.0 110.436 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 17.6 m -91.65 127.42 37.1 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -99.56 114.69 27.85 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.631 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -96.17 123.31 39.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.658 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -99.12 135.92 39.83 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.186 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -148.84 101.74 3.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.651 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 73.54 -116.71 5.53 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.737 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -110.08 14.38 22.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.99 0.424 . . . . 0.0 110.651 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -127.44 151.94 48.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.983 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -130.09 143.43 50.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.657 178.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -111.05 151.21 28.29 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.211 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -111.6 99.57 8.28 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -79.76 116.82 20.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.84 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -83.47 102.13 11.87 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.211 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -56.93 -26.39 59.37 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -87.05 -14.37 41.7 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 93.0 mt -120.14 -11.65 9.2 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 25.6 mtp180 58.69 45.01 16.47 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.323 0.583 . . . . 0.0 111.177 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -162.24 157.0 22.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.989 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 96.3 t -76.71 133.53 30.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -60.57 164.38 4.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.032 0.444 . . . . 0.0 111.731 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 74.4 m -70.64 159.16 34.92 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.768 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 72.62 20.25 3.86 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.126 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -120.41 159.08 49.37 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.5 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.04 165.52 85.71 Favored 'Cis proline' 0 C--N 1.344 0.34 0 C-N-CA 123.608 -1.413 . . . . 0.0 112.95 0.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 57.6 mttm -117.64 160.65 20.94 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.664 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -67.37 135.43 53.21 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.272 0.357 . . . . 0.0 110.453 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.4 tt -64.0 -12.91 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.075 0.464 . . . . 0.0 111.323 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -62.5 -15.21 48.98 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 75.7 t -58.75 -36.94 63.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -86.06 88.53 7.6 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.11 109.04 0.38 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 107.89 -13.11 38.16 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.027 -0.606 . . . . 0.0 113.312 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 40.0 mm -83.33 126.24 72.27 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.81 0.305 . . . . 0.0 111.298 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.85 156.16 30.87 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.036 2.49 . . . . 0.0 111.983 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -73.04 149.55 43.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.177 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 3.5 m 51.64 69.46 2.49 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 114.484 1.291 . . . . 0.0 114.484 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -91.47 172.62 2.78 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.55 2.167 . . . . 0.0 109.956 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -142.91 74.56 1.45 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.542 0.686 . . . . 0.0 111.219 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 135.79 97.63 0.53 Allowed Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.345 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 2.9 p -130.13 108.34 9.99 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -130.06 144.03 51.12 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.945 0.402 . . . . 0.0 111.475 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 43.1 ttm -97.11 133.87 41.2 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.521 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -65.31 164.69 36.79 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.379 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 2.4 m -65.5 -8.03 17.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.941 0.4 . . . . 0.0 111.825 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -87.89 -13.04 43.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.517 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 64.02 11.11 5.87 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.624 -0.717 . . . . 0.0 112.509 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 98.1 t -110.79 -41.5 4.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.845 0.355 . . . . 0.0 111.403 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -105.68 123.17 47.5 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 85.6 m -111.81 141.09 45.88 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -113.52 135.0 54.37 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -118.66 127.27 53.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.415 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -109.27 133.85 52.52 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 56.6 tttt -165.66 127.69 2.01 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.223 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 61.98 38.19 95.65 Favored Glycine 0 N--CA 1.454 -0.118 0 CA-C-N 116.035 -0.53 . . . . 0.0 113.449 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 53.7 t30 74.15 -4.79 2.21 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -106.85 155.29 19.9 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -127.26 139.35 52.97 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.137 0.494 . . . . 0.0 111.563 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 17.9 m-90 -108.84 133.28 53.09 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.742 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -99.03 100.81 12.02 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.958 0.408 . . . . 0.0 110.034 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 486' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -89.65 132.63 35.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.155 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -96.66 112.42 24.18 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -59.38 -47.8 84.08 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 41.3 tp60 -85.13 37.51 0.67 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.326 0.584 . . . . 0.0 111.41 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -153.33 -27.85 0.14 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.912 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 14.7 tp 61.76 40.17 13.26 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.867 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -159.66 148.0 17.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.628 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 69.5 t -75.78 142.93 13.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -63.97 142.67 98.18 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.379 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -65.5 146.0 83.87 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.725 2.283 . . . . 0.0 111.753 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 96.12 1.75 61.05 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.21 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -108.87 167.39 9.23 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.46 176.75 42.48 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 124.037 -1.235 . . . . 0.0 113.42 0.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -133.12 166.0 23.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.939 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 4.8 t -75.49 122.14 23.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.852 0.358 . . . . 0.0 110.849 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -73.92 -21.17 60.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.86 0.362 . . . . 0.0 110.866 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 10.3 mt -70.96 -48.72 51.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.881 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -78.18 -40.18 38.53 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.999 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.79 -56.33 4.69 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -177.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -85.17 -58.51 2.65 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -177.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 11.6 mmt -63.86 -32.51 74.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 87.82 38.01 7.67 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.938 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 59.9 m -121.29 90.8 47.84 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.01 166.2 30.31 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.804 2.336 . . . . 0.0 111.721 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 11.9 m 65.91 101.36 0.04 OUTLIER 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.459 0.647 . . . . 0.0 111.793 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.865 0 CA-C-O 118.361 -1.244 . . . . 0.0 111.473 179.914 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.889 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.77 142.68 18.04 Favored 'Trans proline' 0 CA--C 1.528 0.186 0 C-N-CA 122.421 2.081 . . . . 0.0 111.369 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.72 155.48 50.09 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.489 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.21 160.49 29.58 Favored 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.683 2.255 . . . . 0.0 111.253 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.06 -147.87 14.39 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.969 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.01 163.01 20.65 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.995 2.463 . . . . 0.0 111.978 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 161.61 170.15 25.91 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.538 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.91 144.55 96.68 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.119 2.546 . . . . 0.0 112.106 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -64.12 140.39 58.86 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.669 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.74 144.02 47.62 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.517 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 32.5 mt -63.67 144.69 14.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.592 0.234 . . . . 0.0 110.548 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.03 157.93 20.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.043 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.13 165.76 52.99 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.471 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -72.29 149.02 44.86 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.66 142.08 57.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.436 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.63 148.37 47.34 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.293 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 3.1 t -68.3 154.27 8.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.753 0.311 . . . . 0.0 110.502 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 14.7 t -58.33 141.4 15.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.689 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.46 168.37 53.92 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.567 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 79.8 mt -81.38 145.95 30.56 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.29 159.01 53.79 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.903 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.9 162.35 42.19 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.831 2.354 . . . . 0.0 111.798 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.95 154.17 46.32 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.991 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.22 152.67 79.14 Favored 'Trans proline' 0 C--O 1.237 0.459 0 C-N-CA 122.584 2.189 . . . . 0.0 111.924 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.19 169.19 54.72 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.789 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -66.85 153.62 77.3 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.915 2.41 . . . . 0.0 111.1 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.39 156.45 34.61 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.99 -0.55 . . . . 0.0 113.138 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -91.61 105.99 0.25 Allowed 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.419 2.746 . . . . 0.0 111.749 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.428 0 CA-C-O 120.077 -0.291 . . . . 0.0 112.665 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -69.17 139.22 41.72 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.929 2.42 . . . . 0.0 111.679 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 102' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.52 161.29 54.34 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.191 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -79.43 162.89 24.87 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 123.48 2.787 . . . . 0.0 111.739 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 105' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -77.89 178.72 52.02 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.095 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -77.21 145.01 23.91 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.926 2.417 . . . . 0.0 110.83 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 108' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -62.7 172.75 9.84 Favored Glycine 0 CA--C 1.519 0.292 0 CA-C-N 115.636 -0.711 . . . . 0.0 113.537 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.97 169.98 13.84 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 122.85 2.366 . . . . 0.0 112.553 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -64.75 137.78 58.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.548 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -62.23 161.35 29.95 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 116.02 -0.536 . . . . 0.0 113.095 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 2.3 mt -62.73 144.0 14.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.695 -0.252 . . . . 0.0 110.393 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.97 152.8 44.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.539 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -70.43 145.81 41.29 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.477 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -72.82 147.02 45.87 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 35.1 ttm-85 -62.45 145.81 53.14 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.758 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.18 177.39 32.34 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.806 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 61.9 t -72.84 137.48 23.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.466 -0.367 . . . . 0.0 110.365 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 93.7 t -63.94 139.25 21.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.983 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.22 157.41 28.01 Favored Glycine 0 N--CA 1.45 -0.424 0 O-C-N 123.51 0.506 . . . . 0.0 112.886 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 31.8 mt -73.2 151.19 41.56 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 123' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -67.13 162.43 46.47 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.237 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.39 150.5 64.44 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.684 2.256 . . . . 0.0 111.47 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 126' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -69.67 160.44 52.99 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.961 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.08 158.92 37.82 Favored 'Trans proline' 0 C--O 1.237 0.454 0 C-N-CA 122.595 2.196 . . . . 0.0 111.514 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -65.19 175.25 14.64 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.489 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.96 147.4 84.71 Favored 'Trans proline' 0 C--N 1.34 0.114 0 C-N-CA 123.038 2.492 . . . . 0.0 111.287 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 132' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.65 132.86 22.78 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.112 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.42 111.61 3.33 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 123.084 2.523 . . . . 0.0 112.143 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 135' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 CA-C-O 120.043 -0.309 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -62.51 146.87 95.5 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.985 2.457 . . . . 0.0 111.724 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 202' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 83.42 -161.19 38.78 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.032 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -88.48 161.54 6.66 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 123.903 3.068 . . . . 0.0 112.148 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 205' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . 77.14 -177.07 52.84 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.993 -0.623 . . . . 0.0 113.567 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -98.27 160.86 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.656 2.904 . . . . 0.0 112.46 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 208' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.44 171.55 54.79 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.011 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.21 157.76 58.5 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.766 2.31 . . . . 0.0 111.901 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -82.56 142.33 31.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.988 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -64.74 162.66 37.92 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 116.08 -0.509 . . . . 0.0 113.295 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 42.2 pt -71.68 159.35 5.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.926 0.393 . . . . 0.0 111.403 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -71.27 139.1 49.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.081 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -64.37 165.6 31.45 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 116.01 -0.541 . . . . 0.0 113.864 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -78.58 153.42 31.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.794 0.33 . . . . 0.0 110.486 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 33.8 mtp180 -69.79 156.23 39.34 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.543 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -64.36 154.52 47.79 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.735 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 24.5 t -65.31 144.53 14.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.98 135.98 25.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.887 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -54.15 161.22 4.16 Favored Glycine 0 N--CA 1.453 -0.216 0 O-C-N 123.799 0.687 . . . . 0.0 114.364 -178.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 10.8 mp -76.65 146.76 37.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.659 -0.271 . . . . 0.0 110.587 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 223' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -60.83 154.13 36.42 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.102 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -66.43 146.16 79.4 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.925 2.417 . . . . 0.0 111.692 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 226' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.93 162.25 31.48 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.974 -0.631 . . . . 0.0 113.25 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -79.61 163.2 24.22 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 122.835 2.356 . . . . 0.0 111.645 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -69.11 174.2 34.18 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.954 -0.566 . . . . 0.0 113.096 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.69 154.8 34.97 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.077 2.518 . . . . 0.0 111.926 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 232' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo . . . . . 0 N--CA 1.477 0.558 0 N-CA-C 109.922 -0.838 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -113.25 149.15 34.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.308 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 16.1 tt -72.89 -18.63 18.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 20.6 m -91.76 0.25 57.5 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 121.152 -0.219 . . . . 0.0 111.263 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -67.86 -48.04 67.23 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.102 0.477 . . . . 0.0 110.288 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 102.74 172.08 26.66 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.439 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 64.3 t30 55.56 85.73 0.06 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.468 0.651 . . . . 0.0 112.465 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -105.26 168.0 9.36 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.702 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.57 -46.87 83.92 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 6.6 t -175.43 160.75 2.62 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.472 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 49.0 t -127.56 127.51 68.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -135.23 167.93 20.1 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.007 0.432 . . . . 0.0 111.845 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 53.1 ttm -129.75 115.11 16.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.786 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 56.8 mt -111.28 117.05 32.1 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.182 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.13 20.26 8.21 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.957 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 105.69 -18.24 41.13 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.609 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -82.75 131.24 35.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.633 0.254 . . . . 0.0 110.676 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 50.2 ttm -88.23 117.74 27.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.794 0.33 . . . . 0.0 110.975 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -109.12 122.8 48.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.264 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 37.5 t -108.46 114.74 47.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -100.46 130.37 46.54 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 13.0 tptt -138.19 101.81 4.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.298 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 61.49 -95.3 0.05 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.0 ptm85 -121.06 7.08 10.29 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 5.6 m-90 -129.03 152.43 48.64 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -137.69 153.95 49.73 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.121 0.486 . . . . 0.0 111.76 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 24.5 m-90 -121.8 160.91 23.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.363 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 18.1 ttm-85 -124.38 112.18 16.64 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 91.6 t -90.71 122.66 42.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.889 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -132.71 100.92 5.09 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.553 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 66.5 54.79 0.86 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.817 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 29.2 t30 62.09 12.92 5.34 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -133.41 146.7 51.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.665 0.269 . . . . 0.0 110.61 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 39.0 t -96.71 127.88 48.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 86.2 mtp -68.28 159.84 30.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.531 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -76.65 167.74 21.3 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.679 0.276 . . . . 0.0 110.9 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 94.98 -21.77 42.02 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -101.5 158.94 30.83 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.16 139.21 57.13 Favored 'Cis proline' 0 C--N 1.346 0.424 0 C-N-CA 123.484 -1.465 . . . . 0.0 112.561 0.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 55.3 ttm -114.33 138.8 23.2 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.43 130.33 39.97 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.382 2.054 . . . . 0.0 111.175 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 76.8 mt -55.02 -45.51 76.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.987 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -71.35 -12.78 73.21 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.95 -0.643 . . . . 0.0 113.707 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -82.32 -34.32 28.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.034 0.445 . . . . 0.0 110.454 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -94.1 -55.21 3.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.357 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -90.28 74.39 7.02 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -58.29 95.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.925 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 135.37 -17.3 4.04 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 29.6 tp -94.37 125.16 53.14 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -77.21 -174.02 2.02 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.017 2.478 . . . . 0.0 111.84 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -87.8 153.96 20.93 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.08 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 72.1 m 59.23 94.92 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 27.1 pt -106.87 -166.24 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.403 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.09 -47.06 1.22 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.04 162.82 37.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.648 0.261 . . . . 0.0 111.178 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -158.35 138.48 12.37 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -160.25 162.71 33.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.903 0.382 . . . . 0.0 111.532 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -98.65 122.03 41.35 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -78.76 -179.66 6.66 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -178.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -67.61 -34.52 77.15 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.908 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -37.29 85.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.68 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 129.27 -16.19 5.74 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.421 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -80.46 166.16 21.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.881 0.372 . . . . 0.0 111.575 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -106.71 127.64 53.54 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.752 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 13.4 t -109.19 122.16 63.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.007 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -106.56 138.11 43.34 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.212 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -117.83 141.69 48.14 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -154.14 107.6 2.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.6 177.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 70.27 -112.2 4.21 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.566 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -115.29 4.38 14.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.914 0.388 . . . . 0.0 110.606 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -112.07 150.79 30.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 48.5 p-80 -131.97 147.94 52.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.176 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 22.5 m-90 -121.7 125.62 47.05 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.82 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 85.5 t -109.42 119.96 59.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.897 0.38 . . . . 0.0 110.32 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -104.87 123.66 48.1 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.932 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -92.71 95.05 9.33 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 67.52 -73.2 0.08 Allowed 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.727 0.642 . . . . 0.0 111.021 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -146.18 11.83 1.2 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.986 0.422 . . . . 0.0 110.41 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 1.7 m -125.51 127.09 45.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.253 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 55.9 tp -71.77 132.04 43.92 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.035 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -62.96 147.01 94.94 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.651 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -74.08 144.59 34.08 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.544 2.163 . . . . 0.0 113.038 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 90.37 18.15 50.3 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.459 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -109.13 162.16 21.12 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-O 120.292 0.091 . . . . 0.0 110.774 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.07 157.81 96.84 Favored 'Cis proline' 0 C--N 1.346 0.442 0 C-N-CA 123.529 -1.446 . . . . 0.0 112.562 0.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -116.48 157.82 24.58 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -73.21 151.19 41.56 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 61.2 mt -56.64 -32.75 38.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.325 0.583 . . . . 0.0 110.603 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -65.97 -20.71 66.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.485 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -84.18 -10.52 57.68 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 50.7 tp -85.32 -55.16 4.16 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.9 0.381 . . . . 0.0 110.12 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -149.08 150.9 23.1 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.798 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -77.68 126.46 30.9 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.57 0.224 . . . . 0.0 110.495 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 99.27 14.01 37.11 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.599 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 38.7 mt -92.83 147.31 33.78 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 122.794 -0.239 . . . . 0.0 111.093 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.09 124.66 16.8 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.848 2.365 . . . . 0.0 111.26 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.44 -3.93 57.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.055 0.455 . . . . 0.0 111.273 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -87.53 -55.73 3.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.315 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 6.4 ptmt -177.57 176.37 1.28 Allowed 'General case' 0 C--N 1.332 -0.196 0 O-C-N 123.306 0.378 . . . . 0.0 110.791 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 38.3 mm -127.47 133.23 68.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -87.76 -47.68 8.44 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -154.6 165.25 37.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.945 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -147.21 113.8 6.01 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.207 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 55.4 tp -106.98 124.95 50.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.932 0.396 . . . . 0.0 111.795 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -90.32 116.12 28.04 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.802 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 11.9 t-105 -86.26 94.4 9.31 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 61.5 mtt -51.19 -48.82 84.5 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -50.02 -24.12 10.31 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.817 2.345 . . . . 0.0 115.269 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 26.0 p30 -125.51 -37.73 2.32 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 108.63 2.48 32.64 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.709 -0.757 . . . . 0.0 113.457 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -91.62 154.18 19.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 117.036 0.418 . . . . 0.0 111.271 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 7.0 m -108.4 128.17 54.53 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.517 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -98.84 108.96 21.77 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -90.48 136.74 32.87 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.21 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -112.57 132.74 54.98 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.85 0.357 . . . . 0.0 111.059 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -145.32 110.64 5.28 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.831 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 64.65 -102.66 0.65 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.694 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -127.61 20.78 6.6 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.158 0.504 . . . . 0.0 110.046 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 63.3 mmtt -124.0 142.16 51.41 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.552 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -119.02 137.9 53.21 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.748 0.309 . . . . 0.0 110.383 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -110.27 144.4 39.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.908 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 36.1 ttp180 -107.29 95.74 5.92 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -84.95 129.42 34.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.117 0.484 . . . . 0.0 112.169 -178.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -99.57 111.99 24.26 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.011 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -61.08 -39.74 91.06 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -67.71 -38.5 83.7 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 94.8 mt -94.1 -10.42 33.38 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 6.8 mtt-85 56.48 41.12 29.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.195 0.521 . . . . 0.0 111.027 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -157.46 166.72 32.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.219 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 88.9 t -89.3 140.05 16.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.9 153.5 8.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.437 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 10.9 m -69.11 158.27 35.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.04 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 70.19 24.49 4.88 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.326 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -122.75 163.19 34.46 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.018 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.38 172.1 64.35 Favored 'Cis proline' 0 C--N 1.346 0.437 0 C-N-CA 123.653 -1.395 . . . . 0.0 112.673 0.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -124.75 172.45 9.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.028 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -63.76 136.07 57.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.175 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.0 tt -71.8 -11.97 15.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.261 0.553 . . . . 0.0 110.565 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -71.18 -0.01 8.81 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 64.1 t -67.2 -32.75 59.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 8.2 m95 -86.75 85.49 7.28 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.08 108.78 0.35 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 118.34 -25.23 8.3 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.054 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 32.1 mm -77.08 130.18 76.15 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 120.86 0.362 . . . . 0.0 111.175 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -81.96 166.3 16.93 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.887 2.391 . . . . 0.0 111.711 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 35.3 mp0 -80.52 136.89 36.37 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.04 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.4 m 61.13 65.4 1.94 Allowed Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -96.43 118.34 0.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.184 2.589 . . . . 0.0 110.269 178.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 3.1 ttm105 -89.59 68.55 7.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.087 0.47 . . . . 0.0 112.17 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 158.55 124.92 0.79 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 25.3 p -158.81 120.7 3.49 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.493 -0.188 . . . . 0.0 110.493 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -150.13 147.35 27.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.715 0.293 . . . . 0.0 111.315 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 43.6 ttm -98.57 140.76 32.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.069 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -70.0 169.52 45.69 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.179 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 1.5 m -73.36 -0.17 13.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.001 0.429 . . . . 0.0 111.339 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.65 -17.64 24.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.156 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 67.88 8.05 6.18 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.878 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 43.6 t -109.73 -37.66 3.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.887 0.375 . . . . 0.0 111.458 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -107.0 129.06 54.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.19 0.519 . . . . 0.0 111.911 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 95.1 m -113.92 135.32 54.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.488 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -107.24 137.58 45.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.175 0.512 . . . . 0.0 112.195 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -121.16 145.34 47.92 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.682 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -127.34 131.95 50.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.861 0.363 . . . . 0.0 111.607 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -158.54 107.68 1.98 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.472 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 60.77 60.92 7.63 Favored Glycine 0 CA--C 1.518 0.238 0 N-CA-C 114.373 0.509 . . . . 0.0 114.373 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 69.44 -15.06 0.3 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -99.39 144.58 28.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.828 0.346 . . . . 0.0 111.435 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -120.35 142.64 48.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.161 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 11.8 m-90 -110.85 146.95 35.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.506 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -114.04 99.97 8.05 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 486' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -91.26 132.26 36.25 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.307 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -95.5 112.12 23.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -64.86 -19.12 65.72 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -93.85 -14.43 26.12 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -112.5 -16.64 12.83 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.6 tp 61.91 34.85 16.67 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.653 0.74 . . . . 0.0 109.899 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 36.4 tttp -151.98 156.12 39.38 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.515 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 71.6 t -81.81 139.6 17.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.697 0.284 . . . . 0.0 110.623 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -62.49 147.39 92.28 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.566 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.64 152.1 81.38 Favored 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 122.6 2.2 . . . . 0.0 111.957 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 85.65 27.86 31.12 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -134.06 163.58 50.12 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.609 -0.295 . . . . 0.0 110.428 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -76.25 174.87 50.71 Favored 'Cis proline' 0 C--N 1.346 0.408 0 C-N-CA 123.979 -1.259 . . . . 0.0 112.849 0.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -133.99 164.21 27.81 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.596 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.81 110.54 6.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.519 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -66.03 -24.08 66.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.152 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 76.0 mt -62.47 -39.41 93.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.857 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -85.46 -42.67 14.26 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.744 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -43.04 57.35 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 47.9 m0 -98.27 -60.41 1.56 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 10.9 mmt -62.85 -25.81 68.46 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 81.42 30.17 37.79 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.14 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 30.4 m -116.35 95.29 44.98 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 120.758 0.313 . . . . 0.0 110.567 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.32 -167.53 0.52 Allowed 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.967 2.444 . . . . 0.0 111.363 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 57.01 59.82 3.28 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.089 0.471 . . . . 0.0 110.941 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.503 -1.165 . . . . 0.0 112.185 -179.326 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.598 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -84.1 146.38 11.37 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.778 2.319 . . . . 0.0 111.964 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.71 170.65 45.96 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.983 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.7 163.42 38.29 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 123.042 2.495 . . . . 0.0 112.253 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.5 170.59 48.18 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.805 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.47 161.08 21.59 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.732 2.288 . . . . 0.0 111.456 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 135.29 -168.64 23.7 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.785 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.11 150.48 15.76 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.65 2.233 . . . . 0.0 112.223 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -71.73 151.83 43.26 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.87 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.1 151.5 38.35 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.25 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 8.4 mt -66.73 150.01 11.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.23 151.36 31.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.369 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.41 163.73 53.05 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.937 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -70.63 141.21 51.73 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -67.47 144.5 55.67 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.314 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -57.16 151.6 26.65 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.925 -0.58 . . . . 0.0 113.154 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 12.1 t -69.85 147.15 11.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 19.9 t -53.31 145.01 3.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 O-C-N 123.326 0.391 . . . . 0.0 111.033 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.79 177.7 30.35 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.991 -0.549 . . . . 0.0 113.511 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 96.6 mt -90.77 160.65 15.68 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 122.234 0.213 . . . . 0.0 110.629 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -73.01 150.79 44.74 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.011 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -57.43 137.72 82.84 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.501 2.134 . . . . 0.0 111.106 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.55 160.22 47.33 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.687 -0.688 . . . . 0.0 113.704 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -82.84 163.88 15.91 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 123.035 2.49 . . . . 0.0 111.419 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.73 -179.1 44.73 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.205 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -70.9 165.16 33.17 Favored 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 123.423 2.748 . . . . 0.0 112.255 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.93 134.67 37.41 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.632 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -65.33 114.51 2.89 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.957 2.438 . . . . 0.0 111.735 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.345 0 CA-C-O 120.029 -0.317 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.14 114.62 1.95 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.051 2.5 . . . . 0.0 111.83 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 102' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.41 164.92 54.51 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.703 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -85.71 164.28 10.58 Favored 'Trans proline' 0 CA--C 1.533 0.459 0 C-N-CA 123.126 2.551 . . . . 0.0 112.542 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 105' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -82.68 -163.2 33.08 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.215 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -78.44 153.2 27.1 Favored 'Trans proline' 0 C--O 1.223 -0.233 0 C-N-CA 122.638 2.226 . . . . 0.0 110.533 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 108' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -58.63 165.17 8.2 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.89 -0.595 . . . . 0.0 113.064 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.21 160.38 38.77 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.692 2.262 . . . . 0.0 112.753 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -57.91 135.14 56.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.997 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -68.42 154.15 53.12 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.876 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 50.2 mt -68.41 133.75 31.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.686 0.279 . . . . 0.0 110.421 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.79 153.43 24.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.331 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -65.87 151.29 51.93 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.402 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -71.18 159.12 35.23 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 11.3 ttm-85 -67.55 144.71 55.48 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.87 165.6 41.44 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.962 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 5.2 t -70.05 142.43 15.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 39.2 t -61.31 142.7 15.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.275 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.51 164.98 40.99 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.518 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 86.2 mt -79.84 141.73 35.92 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.586 0.231 . . . . 0.0 111.13 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 123' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -66.56 160.24 47.35 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.884 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.32 156.36 62.04 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.722 2.281 . . . . 0.0 111.501 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 126' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.74 162.71 37.85 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.878 -0.601 . . . . 0.0 113.305 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.37 162.12 36.66 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.677 2.252 . . . . 0.0 111.423 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -70.92 -176.08 21.7 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.929 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -69.95 150.66 67.33 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.921 2.414 . . . . 0.0 111.411 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 132' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.88 120.47 8.04 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.976 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.19 111.96 2.63 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.002 2.468 . . . . 0.0 111.541 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 135' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.29 0 CA-C-O 120.031 -0.316 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -52.79 138.21 60.04 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.364 2.709 . . . . 0.0 112.304 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 202' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 69.16 165.5 4.23 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 114.938 0.735 . . . . 0.0 114.938 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -75.58 172.28 16.62 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.934 3.09 . . . . 0.0 111.752 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 205' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . 105.0 169.5 24.18 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.72 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -88.42 150.29 6.49 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 123.177 2.584 . . . . 0.0 112.706 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 208' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -82.37 167.4 46.95 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.45 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.96 146.66 83.3 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.764 2.309 . . . . 0.0 111.969 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -77.13 147.04 36.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.199 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -65.43 158.28 46.4 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.923 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 41.3 pt -73.98 162.83 4.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.897 0.38 . . . . 0.0 111.324 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -70.83 137.39 49.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.347 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -63.43 164.54 29.56 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.904 -0.589 . . . . 0.0 113.146 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -75.44 151.34 38.1 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 26.4 mtp180 -67.72 153.75 43.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.829 0.347 . . . . 0.0 110.933 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -62.98 151.96 47.05 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.49 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 8.9 t -65.47 146.92 12.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 91.4 t -61.65 138.32 22.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -56.32 160.78 7.38 Favored Glycine 0 N--CA 1.451 -0.332 0 O-C-N 123.55 0.531 . . . . 0.0 113.502 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 7.3 mp -66.94 150.48 49.16 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.636 -0.282 . . . . 0.0 110.409 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 223' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -64.03 146.91 50.65 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.993 -0.623 . . . . 0.0 112.166 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.14 150.49 72.05 Favored 'Trans proline' 0 C--O 1.238 0.476 0 C-N-CA 122.594 2.196 . . . . 0.0 111.568 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 226' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -73.48 170.71 52.26 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.033 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -78.95 163.46 25.79 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.874 2.383 . . . . 0.0 111.617 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -70.1 169.08 46.77 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.487 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.85 139.54 68.94 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.832 2.355 . . . . 0.0 111.586 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 232' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.478 0.57 0 N-CA-C 110.533 -0.603 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -118.4 166.83 12.18 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 19.1 tt -79.68 -30.81 13.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.899 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 57.4 m -71.18 -7.48 46.99 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -76.75 -14.06 59.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.365 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 76.44 -148.73 36.02 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 5.9 m120 51.51 68.45 0.8 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.042 0.449 . . . . 0.0 111.737 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -97.16 143.48 27.92 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.381 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -72.53 -43.08 64.02 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 1.3 t -170.18 150.43 3.68 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.553 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 48.3 t -128.25 124.11 61.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -147.57 166.73 26.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.277 0.561 . . . . 0.0 111.955 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 33.2 ttp -121.16 119.07 31.31 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 61.7 mt -112.56 119.76 39.28 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.464 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 54.98 28.18 10.31 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 104.4 -24.97 27.37 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.593 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -94.22 130.49 40.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.954 0.377 . . . . 0.0 111.163 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 39.5 ttm -90.93 131.07 36.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.114 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -123.87 128.93 50.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.652 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 43.7 t -103.84 108.56 24.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -89.35 129.85 35.82 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.77 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -149.62 111.76 4.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.99 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 63.62 -110.54 0.3 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.784 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -113.18 9.96 18.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.03 0.443 . . . . 0.0 111.207 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -129.63 160.19 34.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.664 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -140.64 139.81 34.92 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.106 177.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 -102.41 151.14 22.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.656 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 16.2 ttt-85 -111.24 95.24 5.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.678 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 2.3 m -93.37 110.7 23.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.355 0.598 . . . . 0.0 111.143 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.63 92.01 3.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.161 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 9.3 m120 60.42 58.45 2.53 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.623 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 7.0 t30 63.85 17.33 10.45 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.288 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -124.44 130.1 51.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.561 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 39.4 t -87.72 121.13 37.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 90.7 mtp -77.55 148.72 35.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.978 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.46 164.02 22.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.789 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 85.12 4.04 87.0 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -123.73 157.7 61.92 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.584 -0.308 . . . . 0.0 110.748 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.17 140.69 48.92 Favored 'Cis proline' 0 C--N 1.347 0.492 0 C-N-CA 123.646 -1.398 . . . . 0.0 113.012 0.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 52.7 ttm -105.01 137.42 19.21 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.094 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.83 133.31 47.11 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.446 2.098 . . . . 0.0 111.587 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 78.4 mt -59.15 -41.16 82.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -67.91 -16.63 68.58 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 121.104 -0.569 . . . . 0.0 113.88 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -81.25 -54.4 5.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.095 0.447 . . . . 0.0 110.796 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -77.38 -58.89 3.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.178 0.513 . . . . 0.0 110.261 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -88.48 63.17 6.92 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -57.04 103.43 0.11 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.91 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 126.85 -19.65 6.12 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.62 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 27.1 tp -88.72 129.76 47.58 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.69 0.281 . . . . 0.0 110.458 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.29 169.71 21.91 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.726 2.284 . . . . 0.0 112.029 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -77.96 150.13 34.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.186 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 60.2 m 59.9 94.94 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 21.1 pt -107.96 173.83 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.53 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -97.85 -47.93 5.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.254 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.65 165.51 36.33 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.856 0.36 . . . . 0.0 111.489 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -153.23 141.69 20.73 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -156.12 162.69 40.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.169 0.509 . . . . 0.0 112.276 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -90.89 124.3 35.08 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -85.92 174.53 9.2 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.411 ' HZ3' ' CD ' ' A' ' 441' ' ' GLU . 18.9 tttt -65.64 -36.26 83.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.142 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -31.92 73.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.393 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 124.93 -28.03 5.26 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.678 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 31.0 mttt -77.12 174.97 10.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.162 0.506 . . . . 0.0 112.217 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -106.47 134.71 49.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.4 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 13.2 t -112.34 120.31 62.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.901 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -105.29 137.91 42.32 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.956 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -119.07 138.1 53.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.92 0.391 . . . . 0.0 111.576 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -150.47 101.6 2.97 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 74.15 -113.99 4.34 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.274 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -111.51 4.04 18.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.667 0.27 . . . . 0.0 111.17 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -113.68 148.94 35.45 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.248 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -130.32 147.43 52.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.222 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 23.3 m-90 -122.66 133.02 54.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.123 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 96.5 t -109.71 116.76 53.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -110.9 122.77 48.69 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.812 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -91.12 91.45 8.26 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 67.02 -77.51 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 O-C-N 123.874 0.734 . . . . 0.0 110.716 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -141.25 14.66 2.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.248 0.547 . . . . 0.0 109.912 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.57 118.9 28.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.91 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 47.5 tp -69.91 133.42 47.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.409 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -71.75 123.42 89.39 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -59.17 137.72 80.78 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.944 2.429 . . . . 0.0 112.257 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 108.94 6.5 30.08 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.352 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -113.43 167.12 9.84 Favored Pre-proline 0 C--N 1.323 -0.578 0 O-C-N 122.982 -0.128 . . . . 0.0 111.077 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.68 161.73 91.27 Favored 'Cis proline' 0 C--N 1.348 0.541 0 C-N-CA 123.708 -1.372 . . . . 0.0 113.165 0.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -128.39 162.62 26.69 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.072 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -70.29 157.83 37.0 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 47.8 mt -57.16 -33.49 43.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.894 0.378 . . . . 0.0 110.971 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -67.88 -16.66 64.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.844 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -78.77 -15.52 58.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.898 0.38 . . . . 0.0 110.821 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 51.7 tp -83.44 -48.78 9.97 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -159.7 166.16 34.82 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.761 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -95.46 131.1 41.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.998 0.428 . . . . 0.0 110.999 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 106.83 5.87 35.39 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.586 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 95.8 mt -92.39 148.97 37.52 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.1 135.41 69.75 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.185 2.59 . . . . 0.0 111.919 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.47 1.36 51.49 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.669 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -95.27 -56.41 2.73 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.733 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 11.9 ptmt -174.85 173.59 2.72 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.752 0.311 . . . . 0.0 110.584 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 46.6 mm -121.84 132.93 69.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -87.68 -54.08 4.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.248 0.547 . . . . 0.0 109.8 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -149.83 150.95 32.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.368 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -132.54 120.92 22.5 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 61.8 tp -115.73 127.13 54.9 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.024 0.44 . . . . 0.0 111.686 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -94.85 114.31 26.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.719 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 4.5 t-105 -84.98 94.82 8.89 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 66.5 mtt -53.84 -50.15 85.41 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -46.1 -43.37 20.59 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 122.77 2.313 . . . . 0.0 114.867 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -107.04 -23.06 12.45 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 87.05 26.8 30.26 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.036 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 38.6 mmtt -108.22 155.22 20.71 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 9.2 m -112.1 125.88 54.58 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.853 0.359 . . . . 0.0 110.828 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -103.47 119.54 39.1 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.001 0.429 . . . . 0.0 110.634 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -102.15 131.95 48.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.239 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -110.96 132.42 54.22 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.949 0.404 . . . . 0.0 111.444 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -145.29 108.39 4.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 70.54 -105.23 1.54 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.525 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -124.91 11.67 8.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.073 0.463 . . . . 0.0 110.498 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -121.38 143.02 49.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.523 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -123.36 141.13 52.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.03 0.443 . . . . 0.0 111.43 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -110.75 152.38 26.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.573 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 26.7 ttp180 -113.43 96.89 6.13 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -89.52 134.01 34.32 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.387 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -108.57 119.58 39.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.371 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.44 -45.49 73.09 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' GLU . . . . . 0.411 ' CD ' ' HZ3' ' A' ' 375' ' ' LYS . 2.4 mp0 -66.55 -49.79 65.29 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 49.9 mt -71.76 -22.02 61.66 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 60.47 33.49 20.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.369 0.604 . . . . 0.0 111.31 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -156.67 173.2 17.3 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.251 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 98.1 t -89.12 137.87 20.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.114 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.25 156.48 21.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.415 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 16.4 m -69.94 159.61 33.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.397 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 80.15 6.06 1.73 Allowed 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.817 0.698 . . . . 0.0 111.067 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -117.13 162.73 26.36 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.089 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.2 156.19 99.78 Favored 'Cis proline' 0 C--N 1.347 0.493 0 C-N-CA 123.698 -1.376 . . . . 0.0 112.431 0.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -114.68 161.63 17.87 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.172 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -65.71 135.95 55.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.456 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.7 tt -64.63 -13.14 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.107 0.48 . . . . 0.0 111.153 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -62.88 -13.08 29.7 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.877 -0.602 . . . . 0.0 112.533 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 76.0 t -60.85 -37.82 77.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -86.72 91.42 8.61 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.171 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -61.46 112.25 2.12 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 115.29 -21.25 13.24 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.811 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 39.3 mm -81.08 125.77 78.82 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-O 120.815 0.34 . . . . 0.0 110.495 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.47 157.38 32.65 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.799 2.333 . . . . 0.0 111.686 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -78.46 145.06 35.23 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.36 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.9 m 57.68 70.44 1.3 Allowed Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -90.36 179.88 1.82 Allowed 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.68 2.253 . . . . 0.0 110.614 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.42 68.46 1.03 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.396 0.617 . . . . 0.0 110.801 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 137.34 111.7 1.07 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 3.2 p -137.96 115.3 11.09 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.791 0.329 . . . . 0.0 110.177 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -136.58 145.46 44.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 46.4 ttm -101.33 142.53 32.61 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -68.99 163.21 50.86 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.514 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.99 9.29 0.57 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.08 -10.02 16.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.941 0.401 . . . . 0.0 110.8 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 69.42 5.07 4.95 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 43.9 t -111.85 -36.58 2.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 O-C-N 122.18 -0.325 . . . . 0.0 111.68 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -100.79 117.52 35.04 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 52.0 m -109.53 144.26 38.06 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.398 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -121.07 134.48 55.27 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -120.4 134.37 55.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.739 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -113.3 137.6 51.25 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.772 0.32 . . . . 0.0 111.807 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -161.98 109.77 1.4 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.424 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 65.12 58.94 8.58 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 114.614 0.606 . . . . 0.0 114.614 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 41.3 t30 62.89 4.19 1.41 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -121.99 151.07 41.19 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -130.0 152.8 49.07 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.936 0.398 . . . . 0.0 111.428 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 15.1 m-90 -116.78 148.61 41.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.082 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 24.1 tttp -106.86 100.59 10.09 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 486' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -93.12 125.36 37.68 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.297 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -94.9 115.14 27.1 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -66.92 -29.93 69.94 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -64.85 -53.7 42.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.991 0.424 . . . . 0.0 111.405 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -83.1 -14.22 54.14 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.983 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.2 tp 63.6 42.26 6.59 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.448 0.642 . . . . 0.0 109.814 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 47.0 tttt -156.66 156.52 33.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.289 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 53.5 t -79.96 139.81 17.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.149 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -69.82 146.12 95.19 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.025 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.45 153.6 73.56 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.651 2.234 . . . . 0.0 111.552 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 97.51 15.73 36.69 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -123.88 169.01 11.21 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.511 -0.344 . . . . 0.0 110.254 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.7 178.68 33.86 Favored 'Cis proline' 0 C--N 1.346 0.41 0 C-N-CA 123.851 -1.312 . . . . 0.0 112.965 0.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -136.01 150.58 49.27 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.401 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 37.3 t -69.47 128.17 35.57 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.67 -18.39 62.84 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.398 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 28.1 mt -61.68 -62.13 2.02 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.66 -11.53 59.88 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.17 -40.66 10.35 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 21.3 m0 -125.06 -39.3 2.25 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 10.8 mmt -71.82 -20.0 61.9 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 78.95 25.68 59.57 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.45 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 9.9 m -113.97 93.22 28.79 Favored Pre-proline 0 C--N 1.326 -0.434 0 O-C-N 122.845 -0.209 . . . . 0.0 110.658 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -83.58 171.29 11.05 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.866 2.377 . . . . 0.0 112.124 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 8.4 m 53.64 72.15 0.46 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.088 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.476 -1.18 . . . . 0.0 111.551 -179.949 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.735 0 N-CA-C 111.776 -0.529 . . . . 0.0 111.776 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -87.26 146.48 7.48 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.614 2.21 . . . . 0.0 112.002 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.36 160.48 49.15 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.906 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.88 162.43 41.95 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.555 2.17 . . . . 0.0 111.445 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.09 -176.82 44.69 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.947 -0.644 . . . . 0.0 113.207 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -63.61 166.29 15.97 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.999 2.466 . . . . 0.0 111.865 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 130.66 -166.75 22.37 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.087 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.87 141.66 30.58 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 123.216 2.611 . . . . 0.0 112.304 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -68.59 147.65 51.62 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.09 147.58 34.2 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.361 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 6.6 mt -61.87 150.11 8.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.4 151.37 46.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.278 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.51 169.17 53.55 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.936 -0.65 . . . . 0.0 113.112 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -78.57 147.15 33.84 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -70.82 146.51 49.66 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.87 155.47 41.92 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.706 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 t -71.88 154.44 7.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.4 t -55.65 142.76 9.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 O-C-N 123.319 0.387 . . . . 0.0 110.874 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.64 163.54 51.67 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.788 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 97.1 mt -73.18 148.57 43.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.445 0.164 . . . . 0.0 110.693 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.79 156.26 53.43 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.788 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -70.56 158.77 54.95 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 122.868 2.378 . . . . 0.0 111.662 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.14 155.96 53.26 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.509 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.59 155.25 67.03 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.539 2.159 . . . . 0.0 111.73 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.68 178.16 48.59 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.203 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -73.33 165.33 32.84 Favored 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 123.336 2.691 . . . . 0.0 111.676 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.28 156.4 53.34 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.092 -0.575 . . . . 0.0 113.116 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.93 118.48 5.64 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.764 2.309 . . . . 0.0 111.748 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.399 0 CA-C-O 120.082 -0.288 . . . . 0.0 112.67 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -66.1 139.74 56.94 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 123.139 2.559 . . . . 0.0 112.444 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 102' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.76 161.26 49.5 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.132 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.22 153.52 36.18 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.78 2.32 . . . . 0.0 112.657 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 105' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -74.49 -178.61 40.16 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.81 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.54 154.62 21.02 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.865 2.377 . . . . 0.0 111.336 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 108' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -57.68 171.16 3.49 Favored Glycine 0 CA--C 1.519 0.338 0 CA-C-N 115.71 -0.677 . . . . 0.0 114.043 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.95 148.9 36.54 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 123.516 2.81 . . . . 0.0 113.286 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -59.34 140.52 56.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.842 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.47 161.88 38.11 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 116.01 -0.541 . . . . 0.0 113.354 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 42.0 mt -83.24 135.28 25.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.7 146.7 51.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.79 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -69.44 159.56 53.05 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.108 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -81.8 160.5 23.53 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.701 0.286 . . . . 0.0 110.742 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 42.8 ttm-85 -67.14 149.6 50.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.839 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.4 171.2 37.23 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.671 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 15.9 t -72.68 140.92 17.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 24.1 t -57.56 135.96 21.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.209 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.86 162.33 42.37 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.566 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 82.3 mt -78.39 139.92 38.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.607 0.242 . . . . 0.0 110.524 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 123' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -70.24 165.76 51.17 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.681 -0.691 . . . . 0.0 113.054 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -74.03 156.98 47.27 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.68 2.254 . . . . 0.0 111.19 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 126' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.63 162.85 37.21 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.778 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.56 161.0 34.63 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.555 2.17 . . . . 0.0 111.724 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -68.56 -173.33 8.06 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 121.192 -0.528 . . . . 0.0 113.461 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -72.45 157.53 52.85 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 123.141 2.561 . . . . 0.0 111.849 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 132' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -65.68 126.11 29.37 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.825 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -70.57 114.12 3.73 Favored 'Trans proline' 0 CA--C 1.531 0.375 0 C-N-CA 122.49 2.127 . . . . 0.0 111.614 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 135' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.451 0 N-CA-C 112.339 -0.304 . . . . 0.0 112.339 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.82 131.41 45.42 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.608 2.205 . . . . 0.0 111.384 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 202' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 82.21 -177.46 53.69 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.883 -0.675 . . . . 0.0 114.387 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.47 161.78 44.39 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 123.745 2.964 . . . . 0.0 112.168 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 205' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . 97.3 157.14 30.65 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.602 -0.808 . . . . 0.0 113.516 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -86.47 154.39 9.17 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 123.149 2.566 . . . . 0.0 112.727 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 208' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -81.35 171.64 53.31 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.503 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -69.11 148.45 69.32 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.957 2.438 . . . . 0.0 112.061 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -67.72 148.97 50.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.716 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -71.29 163.53 54.07 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.251 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 24.9 pt -69.55 165.38 2.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-O 120.65 0.262 . . . . 0.0 111.026 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -87.49 139.23 30.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.924 0.393 . . . . 0.0 110.842 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -61.49 161.76 26.05 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.67 -0.695 . . . . 0.0 113.525 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -73.27 160.36 32.0 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -66.63 155.64 37.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.17 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -61.98 158.21 34.08 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.878 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 25.8 t -61.74 141.88 17.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 24.6 t -62.48 138.51 22.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.206 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -58.12 154.11 24.98 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.613 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 7.2 mp -73.63 152.81 40.41 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.742 0.306 . . . . 0.0 111.044 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 223' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -61.7 153.46 40.69 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.685 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.84 143.24 72.69 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.697 2.265 . . . . 0.0 111.222 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 226' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -63.87 163.23 33.6 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.813 -0.631 . . . . 0.0 113.734 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -82.54 168.43 14.49 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 122.968 2.445 . . . . 0.0 111.474 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -74.38 179.73 42.58 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.02 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -69.21 146.42 63.55 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.952 2.435 . . . . 0.0 111.774 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 232' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo . . . . . 0 N--CA 1.479 0.674 0 N-CA-C 110.066 -0.782 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -109.34 145.39 36.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.425 0.155 . . . . 0.0 110.613 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 19.3 tt -81.05 -19.1 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 121.114 0.483 . . . . 0.0 111.349 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 7.9 m -95.68 12.59 29.28 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.094 0.473 . . . . 0.0 110.244 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -68.82 -33.77 74.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.445 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 82.48 179.85 52.91 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.624 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 5.5 t30 52.17 77.75 0.14 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.172 0.511 . . . . 0.0 111.448 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -98.75 157.53 16.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.235 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -68.48 -39.38 81.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.261 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 13.4 t -176.43 153.53 1.19 Allowed 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.79 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 60.6 t -135.84 123.53 35.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -144.3 178.1 8.15 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.963 0.411 . . . . 0.0 111.62 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 51.9 ttp -130.92 121.57 25.41 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 63.9 mt -114.9 122.09 45.23 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.012 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 64.1 mtp180 55.26 25.76 7.75 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 101.57 -8.67 56.77 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.509 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -105.79 127.92 53.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.993 0.396 . . . . 0.0 110.829 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 45.3 ttm -84.9 134.06 34.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.818 0.342 . . . . 0.0 111.633 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -126.49 128.39 46.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.64 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 35.6 t -108.31 119.37 57.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.43 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -99.85 131.76 45.62 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -141.51 106.01 4.86 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.723 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 63.03 -105.18 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.55 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -115.07 10.68 16.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.868 0.366 . . . . 0.0 111.32 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 10.1 m-90 -123.93 163.02 22.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.12 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -143.83 144.44 31.78 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.978 0.418 . . . . 0.0 110.923 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -108.41 146.52 32.94 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.818 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 23.9 ttt-85 -115.83 96.08 5.43 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 3.3 m -88.21 129.6 39.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.995 0.426 . . . . 0.0 111.184 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -142.87 122.44 13.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.853 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 14.3 m120 57.65 41.0 26.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.115 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 67.77 23.71 8.48 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.187 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -134.25 154.05 51.51 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 46.0 t -90.79 121.92 41.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 1.7 ttt -65.32 144.39 57.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.748 0.308 . . . . 0.0 111.133 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -66.87 147.1 53.68 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.546 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 100.94 -0.71 55.09 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.134 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -122.07 160.11 48.81 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.86 136.61 39.87 Favored 'Cis proline' 0 C--N 1.347 0.497 0 C-N-CA 123.736 -1.36 . . . . 0.0 113.025 0.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 47.2 ttm -116.59 141.95 28.84 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.448 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.62 135.27 68.5 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.262 1.975 . . . . 0.0 111.352 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 95.3 mt -54.21 -43.74 61.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.354 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -69.87 -6.44 56.01 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 121.028 -0.606 . . . . 0.0 114.606 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -86.24 -37.11 18.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.501 0.65 . . . . 0.0 110.208 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -95.11 -53.65 3.72 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -92.26 71.73 5.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 -59.99 101.71 0.13 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.135 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 131.06 -19.42 4.91 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.452 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 22.2 tp -91.14 131.95 35.5 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.681 0.276 . . . . 0.0 110.626 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -82.67 -173.76 1.83 Allowed 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.789 2.326 . . . . 0.0 112.269 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -90.01 154.75 19.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.212 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.7 m 56.37 93.47 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 21.5 pt -110.53 179.82 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.447 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -96.45 -55.81 2.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.949 0.404 . . . . 0.0 110.949 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.9 167.91 28.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.161 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -142.86 139.21 30.76 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -152.86 166.26 32.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.06 0.457 . . . . 0.0 111.913 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -100.77 141.13 34.08 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.19 -0.914 . . . . 0.0 108.64 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -100.77 -171.65 2.05 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.494 ' HZ3' ' CD ' ' A' ' 441' ' ' GLU . 39.3 tttt -72.46 -25.74 61.55 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -177.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.21 -17.38 32.76 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 113.49 -17.27 21.26 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.805 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 46.1 mttp -74.66 158.21 34.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.097 0.475 . . . . 0.0 111.521 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -98.46 134.76 40.99 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.444 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 21.9 t -116.58 121.08 66.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.023 0.439 . . . . 0.0 110.496 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -105.57 139.03 40.79 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -119.39 144.44 46.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.773 0.321 . . . . 0.0 111.702 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -155.51 98.89 1.99 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.954 178.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 71.52 -114.75 5.29 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.815 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -105.07 6.43 33.27 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -118.28 151.4 37.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.795 0.331 . . . . 0.0 111.793 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 37.0 p-80 -136.0 145.35 46.0 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.238 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 17.8 m-90 -118.27 133.09 56.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.654 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 60.0 t -111.78 113.4 44.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -107.66 127.52 53.74 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -92.7 88.92 6.45 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 69.02 -71.3 0.12 Allowed 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.721 0.638 . . . . 0.0 111.002 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -142.41 3.18 1.5 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.174 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.84 126.48 54.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.729 0.3 . . . . 0.0 111.582 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 47.8 tp -74.09 135.21 42.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.654 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -75.63 134.78 72.23 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.859 0.362 . . . . 0.0 111.068 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -58.74 142.53 98.79 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.199 2.599 . . . . 0.0 112.28 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 104.23 -25.1 27.17 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.309 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -89.64 161.24 39.71 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 110.561 -0.163 . . . . 0.0 110.561 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.03 152.84 98.68 Favored 'Cis proline' 0 C--N 1.345 0.355 0 C-N-CA 123.77 -1.346 . . . . 0.0 113.394 0.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -126.39 169.78 12.62 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.491 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -71.75 158.09 36.74 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.656 0.265 . . . . 0.0 111.236 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 22.4 mt -59.22 -35.54 58.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.18 0.514 . . . . 0.0 110.03 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 44.1 pttt -67.05 -15.04 63.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.803 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -82.27 -28.66 31.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.851 0.357 . . . . 0.0 110.549 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 41.1 tp -72.14 -53.34 13.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.29 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -153.9 159.68 28.89 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.618 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -89.69 127.37 35.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.719 0.295 . . . . 0.0 110.533 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 106.31 -0.92 37.52 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.226 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 95.1 mt -79.0 156.51 76.91 Favored Pre-proline 0 C--N 1.32 -0.691 0 O-C-N 122.878 -0.189 . . . . 0.0 110.663 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -53.34 138.62 64.83 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.677 2.252 . . . . 0.0 112.013 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.01 -15.97 28.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.723 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -86.41 -61.01 1.84 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 10.0 pttp -175.33 179.15 1.55 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 33.4 mm -117.98 147.93 21.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -100.15 -49.54 4.25 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -157.65 156.15 31.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.258 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -136.78 120.03 16.76 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 21.9 tp -108.94 124.53 50.83 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.058 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -97.57 114.13 25.98 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 10.9 t-105 -83.6 94.81 8.16 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 10.1 mmt -49.8 -52.84 48.07 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -47.55 -42.41 29.1 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 123.036 2.491 . . . . 0.0 115.177 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 36.0 p30 -104.64 -19.36 13.99 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 78.56 34.89 34.14 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.209 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 37.4 mmtt -117.0 147.48 42.27 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.6 m -107.53 126.64 52.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.771 0.32 . . . . 0.0 110.491 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -104.04 110.61 22.84 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.862 0.363 . . . . 0.0 110.74 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -92.46 120.78 33.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.781 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -97.01 132.26 43.0 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.751 0.31 . . . . 0.0 111.183 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -144.41 104.9 4.13 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.066 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 67.15 -111.66 4.27 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.591 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -109.3 10.64 25.59 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -130.94 152.44 50.26 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.805 0.336 . . . . 0.0 111.681 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -125.87 142.65 51.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.504 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -109.43 136.11 49.37 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.671 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -97.31 99.48 10.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.161 0.505 . . . . 0.0 109.651 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -89.94 134.81 34.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.748 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -110.56 106.6 15.93 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.354 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.7 -47.23 59.08 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -178.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' GLU . . . . . 0.494 ' CD ' ' HZ3' ' A' ' 375' ' ' LYS . 2.5 mp0 -59.3 -35.85 74.54 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 67.1 mt -98.63 -15.81 19.3 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 60.96 40.09 15.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.635 0.731 . . . . 0.0 110.992 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -150.97 168.24 25.15 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.458 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 87.6 t -92.01 141.58 14.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.553 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -62.13 163.39 8.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.161 0.505 . . . . 0.0 111.514 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 20.0 m -76.71 157.6 31.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.59 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 72.69 23.43 2.97 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.532 0.682 . . . . 0.0 111.01 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -122.37 164.13 28.03 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.119 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.61 161.29 92.21 Favored 'Cis proline' 0 C--N 1.345 0.378 0 C-N-CA 123.678 -1.384 . . . . 0.0 112.697 0.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -111.77 161.32 16.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.726 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 -66.08 140.06 58.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.821 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.4 tt -64.27 -13.07 13.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.427 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 36.9 mttm -61.46 -11.99 12.91 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 79.8 t -61.53 -34.79 63.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -89.05 95.53 10.36 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -56.6 107.72 0.42 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 105.05 -1.73 40.97 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.698 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 20.1 mm -88.92 129.01 49.97 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.978 0.389 . . . . 0.0 111.335 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.26 149.07 19.27 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 123.063 2.509 . . . . 0.0 112.904 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -71.4 146.27 48.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.379 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 4.2 m 55.08 71.39 1.3 Allowed Pre-proline 0 N--CA 1.467 0.412 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -85.84 178.49 4.24 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.711 2.274 . . . . 0.0 111.745 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.6 8.44 6.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.042 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -177.23 147.57 8.35 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.824 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 19.4 p -164.19 98.17 0.82 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -128.61 140.35 51.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.925 0.393 . . . . 0.0 111.31 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 39.2 ttm -84.78 138.82 32.37 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.965 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -72.33 160.04 53.91 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.467 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -15.45 57.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.969 0.414 . . . . 0.0 111.385 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -79.14 -18.53 53.01 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.222 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 69.21 1.77 3.38 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.22 -38.21 7.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.836 0.35 . . . . 0.0 111.458 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -120.84 143.69 48.76 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 55.3 m -115.88 139.97 49.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.32 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -106.18 123.6 48.28 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -107.18 144.99 33.13 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 94.1 t80 -129.02 134.7 48.24 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 59.7 tttt -170.81 134.35 1.01 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.991 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 60.11 43.37 98.38 Favored Glycine 0 N--CA 1.454 -0.125 0 CA-C-N 115.979 -0.555 . . . . 0.0 114.039 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 39.9 t30 67.07 3.58 3.21 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -118.22 157.13 27.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.733 0.301 . . . . 0.0 110.741 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -127.07 149.62 49.84 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.499 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 19.2 m-90 -117.82 138.67 51.93 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.529 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -101.42 93.95 5.66 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 486' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -85.21 130.12 34.67 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.394 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -86.65 121.53 29.29 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -65.94 -52.25 51.42 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.25 -40.39 86.26 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -178.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -78.26 -26.16 47.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.548 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 6.1 tp 63.24 38.78 10.18 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.572 0.701 . . . . 0.0 110.222 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -153.53 148.72 26.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.438 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 77.8 t -75.83 131.27 35.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -59.45 137.35 89.15 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.836 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.28 143.1 99.86 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.912 2.408 . . . . 0.0 112.261 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 103.76 5.39 44.86 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.278 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -114.03 166.27 11.81 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.554 -0.323 . . . . 0.0 110.349 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.75 178.67 32.41 Favored 'Cis proline' 0 C--N 1.349 0.557 0 C-N-CA 123.752 -1.353 . . . . 0.0 113.075 0.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -135.23 160.12 39.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.277 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 42.4 t -69.66 125.92 28.16 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.812 0.339 . . . . 0.0 110.977 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -71.64 -22.9 61.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.284 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 26.4 mt -69.55 -47.34 64.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.53 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -75.9 -35.08 59.95 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -88.69 -46.86 8.68 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 36.1 m0 -92.72 -56.73 2.9 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -177.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 11.4 mmt -64.08 -45.43 88.74 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 105.85 29.63 4.87 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.398 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 15.1 m -106.45 105.38 54.23 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -81.11 160.92 20.6 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 123.289 2.66 . . . . 0.0 112.087 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 18.6 m 61.15 68.14 0.75 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.574 0.702 . . . . 0.0 111.653 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.388 -1.229 . . . . 0.0 111.474 -179.7 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.608 0 N-CA-C 111.893 -0.483 . . . . 0.0 111.893 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -79.56 151.66 22.54 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.621 2.214 . . . . 0.0 111.985 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -62.33 160.54 31.73 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.664 -0.698 . . . . 0.0 113.46 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -68.03 163.49 35.63 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 123.002 2.468 . . . . 0.0 111.797 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.46 178.64 53.77 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.458 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.82 161.59 18.06 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.553 2.168 . . . . 0.0 111.26 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 138.66 -179.92 17.95 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.198 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.51 147.59 71.07 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.837 2.358 . . . . 0.0 111.575 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -68.71 150.41 47.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.971 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.48 154.7 29.95 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.129 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 mt -65.24 152.57 8.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.42 145.91 47.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.371 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.48 159.57 53.64 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 121.144 -0.551 . . . . 0.0 112.633 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -72.34 146.23 47.24 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -69.89 146.67 51.08 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.2 150.97 43.18 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.76 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 4.6 t -67.11 146.34 13.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.0 t -53.76 144.94 4.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.33 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.86 167.16 54.12 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.87 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 96.0 mt -92.55 153.12 19.25 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 121.987 0.115 . . . . 0.0 110.746 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.45 170.45 54.91 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.252 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.54 149.24 84.34 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.597 2.198 . . . . 0.0 111.275 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.18 161.52 47.66 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.994 -0.622 . . . . 0.0 113.551 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.13 155.9 47.12 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.835 2.357 . . . . 0.0 111.486 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.08 166.43 40.91 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.127 -0.558 . . . . 0.0 113.458 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -67.2 161.8 41.34 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.158 2.572 . . . . 0.0 111.731 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.75 156.2 53.4 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.765 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . 0.464 ' O ' ' C ' ' B' ' 35' ' ' HYP . 73.3 Cg_endo -75.25 154.97 41.71 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.695 2.263 . . . . 0.0 111.924 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' HYP . . . . . 0.464 ' C ' ' O ' ' B' ' 34' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.348 0 CA-C-O 120.086 -0.286 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -68.33 144.89 63.79 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 122.963 2.442 . . . . 0.0 111.875 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 102' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -82.05 175.84 53.89 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.851 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -87.07 158.01 8.52 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.592 2.862 . . . . 0.0 112.11 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 105' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -71.6 169.3 50.29 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.299 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.64 145.46 57.88 Favored 'Trans proline' 0 CA--C 1.528 0.209 0 C-N-CA 122.664 2.242 . . . . 0.0 111.353 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 108' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -54.83 166.18 2.78 Favored Glycine 0 CA--C 1.521 0.423 0 O-C-N 123.696 0.623 . . . . 0.0 113.915 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -65.14 163.97 26.97 Favored 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 122.841 2.361 . . . . 0.0 112.417 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -62.16 144.45 55.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.318 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -75.51 163.65 53.83 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.98 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 21.7 mt -65.14 136.61 26.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.17 148.14 50.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.254 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.36 154.43 37.87 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.117 -0.564 . . . . 0.0 112.873 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -83.51 163.25 20.58 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 43.5 ttm-85 -68.13 148.99 50.16 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.687 0.279 . . . . 0.0 110.357 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.93 175.35 38.6 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.06 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 25.3 t -73.49 140.24 18.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 90.4 t -63.27 136.07 26.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.105 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.18 157.62 46.54 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.269 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 74.4 mt -73.04 146.5 45.83 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.658 0.266 . . . . 0.0 111.103 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 123' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -69.02 165.34 48.99 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.504 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.2 157.83 45.77 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.55 2.166 . . . . 0.0 111.737 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 126' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -68.19 160.64 50.72 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.818 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.55 160.0 50.94 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 122.494 2.129 . . . . 0.0 111.321 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -69.66 171.69 40.68 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.494 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -68.7 142.61 53.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.822 2.348 . . . . 0.0 111.353 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 132' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.23 113.53 5.21 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.699 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -77.05 111.33 3.2 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.667 2.245 . . . . 0.0 111.891 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 135' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 201' ' ' PRO . . . . . 0.405 ' C ' ' H ' ' D' ' 203' ' ' GLY . 78.1 Cg_exo -54.23 139.69 72.45 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.014 2.476 . . . . 0.0 111.651 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 202' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 203' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' D' ' 201' ' ' PRO . . . 77.08 165.59 23.84 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 121.311 -0.471 . . . . 0.0 114.236 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -72.94 162.93 39.77 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.473 2.782 . . . . 0.0 111.965 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 205' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . 97.19 174.11 34.37 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.824 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -94.25 156.44 2.1 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.475 2.783 . . . . 0.0 112.636 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 208' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -81.34 171.13 53.02 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.842 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -71.85 141.85 37.96 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 123.02 2.48 . . . . 0.0 111.949 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -65.84 146.42 54.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.943 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -70.05 162.97 52.66 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.897 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 39.4 pt -69.84 166.85 2.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.606 0.241 . . . . 0.0 110.971 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -83.15 144.44 29.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.884 0.373 . . . . 0.0 110.882 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -65.95 168.14 33.4 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.8 -0.636 . . . . 0.0 114.054 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 -75.95 155.77 34.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.698 0.285 . . . . 0.0 110.955 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -66.14 153.06 43.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.5 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -59.83 150.25 39.54 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.086 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 13.8 t -61.2 143.12 15.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.61 142.16 16.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.888 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -59.88 154.79 31.41 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.358 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 5.2 mp -71.19 151.35 44.43 Favored 'General case' 0 C--N 1.32 -0.68 0 O-C-N 122.843 -0.21 . . . . 0.0 110.795 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 223' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -58.19 150.22 33.56 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.806 -0.634 . . . . 0.0 113.575 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.79 156.78 51.46 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 123.213 2.608 . . . . 0.0 112.09 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 226' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -68.18 160.06 51.08 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.516 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.92 156.11 34.45 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 122.702 2.268 . . . . 0.0 111.809 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -68.71 168.98 42.52 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.699 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -71.62 163.32 39.36 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 123.214 2.61 . . . . 0.0 111.263 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 232' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo . . . . . 0 N--CA 1.479 0.62 0 N-CA-C 110.477 -0.624 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -105.76 158.25 16.87 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 15.0 tt -75.39 -19.13 15.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.41 0.624 . . . . 0.0 110.046 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 69.5 m -85.7 -1.31 57.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.717 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -74.15 -23.59 59.28 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.366 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 74.46 -172.32 52.41 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.607 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 2.1 t30 54.6 81.7 0.1 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.113 0.565 . . . . 0.0 111.942 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -104.65 164.43 11.77 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.709 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -73.32 -41.26 63.73 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 9.4 t -172.78 152.5 2.49 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.535 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 97.6 t -133.0 118.28 32.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -141.58 172.94 12.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.063 0.459 . . . . 0.0 111.473 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 31.9 ttp -121.77 123.39 41.71 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.624 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 59.3 mt -116.6 118.43 32.59 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.933 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 43.7 mtp180 56.49 28.04 13.15 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 98.76 -11.86 62.69 Favored Glycine 0 CA--C 1.517 0.193 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.225 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -98.52 128.23 44.77 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.823 0.344 . . . . 0.0 110.875 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 48.7 ttm -87.39 119.9 28.13 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.504 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -112.04 128.4 56.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.055 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 26.1 t -106.8 119.91 57.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.434 -0.803 . . . . 0.0 108.913 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -107.87 130.11 55.03 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -153.44 108.24 3.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.75 177.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 69.89 -129.67 0.08 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.034 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 12.8 ptm85 -94.94 2.63 55.4 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -123.61 154.85 38.72 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.784 0.326 . . . . 0.0 111.053 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -134.16 149.76 51.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.568 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 26.2 m-90 -119.65 167.56 11.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.634 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.13 114.27 6.21 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 10.5 m -102.78 143.99 14.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.165 0.507 . . . . 0.0 112.238 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 29.1 ttm-85 -150.79 126.91 10.52 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.924 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 22.7 m120 68.55 30.89 5.0 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.203 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 39.6 t30 66.06 24.23 11.0 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.224 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -136.45 146.27 46.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.339 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 32.8 t -79.0 124.69 37.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 60.4 mtp -71.15 160.55 32.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.774 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -72.32 153.61 41.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.118 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 98.64 -4.41 59.68 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.517 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -118.6 152.6 51.42 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -73.94 149.12 93.54 Favored 'Cis proline' 0 C--O 1.234 0.315 0 C-N-CA 123.356 -1.518 . . . . 0.0 112.884 0.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 55.1 ttm -129.57 139.68 36.39 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.42 -0.809 . . . . 0.0 108.949 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.88 131.26 44.96 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.211 1.941 . . . . 0.0 111.213 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 65.6 mt -52.02 -46.21 41.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.047 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -65.05 -16.07 61.48 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 121.267 -0.492 . . . . 0.0 114.128 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -34.2 61.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.141 0.471 . . . . 0.0 110.574 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -101.25 -51.5 3.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.165 0.507 . . . . 0.0 110.062 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -87.8 85.68 7.07 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.371 0.605 . . . . 0.0 109.571 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -65.63 83.41 0.06 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.859 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 133.54 -3.6 4.7 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.164 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 22.9 tp -98.83 131.72 25.11 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 120.616 0.246 . . . . 0.0 110.858 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.55 -174.83 2.43 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.715 2.277 . . . . 0.0 111.598 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -91.35 151.34 20.9 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.938 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 18.1 m 57.45 93.52 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.483 0.919 . . . . 0.0 113.483 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 24.1 pt -107.19 172.39 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.409 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -96.64 -40.57 8.94 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -162.7 171.88 16.16 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.773 0.32 . . . . 0.0 111.347 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -162.06 144.44 11.39 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -157.35 164.16 37.87 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -95.5 122.05 37.82 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -75.57 -175.7 2.96 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -67.46 -33.18 74.59 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.988 0.423 . . . . 0.0 111.375 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.75 -50.62 19.79 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.825 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 147.63 -29.76 1.43 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.214 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -59.13 150.49 25.07 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.91 0.386 . . . . 0.0 111.088 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -95.73 136.09 36.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.612 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 3.8 t -113.86 113.96 45.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.094 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -100.52 144.78 29.11 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -126.63 141.51 51.83 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.848 0.356 . . . . 0.0 111.632 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -152.99 105.48 2.93 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 177.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 72.49 -117.07 6.04 Favored Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -109.85 10.51 24.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.848 0.356 . . . . 0.0 110.946 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -118.75 151.08 38.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.878 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 27.8 p-80 -131.38 153.28 49.82 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.028 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 26.7 m-90 -127.97 131.87 49.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.238 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 78.8 t -111.02 122.78 66.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -113.57 122.41 47.15 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -85.03 82.42 8.45 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 177.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 71.92 -68.93 0.2 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.489 -177.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -143.8 7.52 1.45 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.93 0.395 . . . . 0.0 110.915 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 2.0 m -113.76 125.01 53.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.02 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 52.3 tp -76.52 128.22 34.34 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.533 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -64.42 136.54 96.8 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.985 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.95 143.22 99.3 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.168 2.579 . . . . 0.0 112.447 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 96.51 -15.01 63.52 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.543 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -83.72 156.56 64.76 Favored Pre-proline 0 C--N 1.323 -0.577 0 O-C-N 122.672 -0.311 . . . . 0.0 110.782 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.51 156.38 97.04 Favored 'Cis proline' 0 C--N 1.349 0.593 0 C-N-CA 123.963 -1.266 . . . . 0.0 113.522 0.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -128.19 159.6 34.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.0 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -69.75 153.09 43.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.245 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 64.9 mt -56.52 -33.51 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -65.14 -12.53 51.97 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -80.91 -26.58 36.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.876 0.37 . . . . 0.0 110.772 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 32.2 tp -75.0 -47.14 30.67 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -169.37 147.82 11.44 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.759 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 33.0 ttt180 -84.68 132.96 34.41 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.745 0.307 . . . . 0.0 110.315 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 114.14 -14.77 21.1 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.551 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.17 152.9 84.29 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.571 -0.314 . . . . 0.0 110.563 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.46 130.19 38.75 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.922 2.414 . . . . 0.0 111.545 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.11 3.82 55.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.985 0.421 . . . . 0.0 111.482 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -95.52 -57.53 2.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.579 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 5.1 ptmt -172.38 171.64 4.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.919 0.39 . . . . 0.0 110.858 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 49.2 mm -120.92 127.52 75.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -86.49 -48.01 8.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.935 0.398 . . . . 0.0 110.55 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -153.87 154.38 33.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.295 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -135.1 107.27 7.18 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 40.5 tp -99.14 117.21 33.11 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.281 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -89.0 115.44 26.57 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.035 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -84.26 90.44 7.53 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 62.9 mtt -47.97 -48.73 61.95 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -48.87 -35.47 31.35 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 122.862 2.375 . . . . 0.0 114.787 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 38.3 p30 -113.29 -35.47 5.31 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 104.62 10.44 33.17 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.617 -0.802 . . . . 0.0 113.367 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -97.88 155.41 17.08 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.418 -0.46 . . . . 0.0 110.605 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 7.4 m -113.16 130.36 56.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.994 0.426 . . . . 0.0 111.568 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -100.85 108.17 19.89 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.742 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -91.47 124.57 35.74 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.226 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -99.57 132.24 45.03 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.094 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -144.4 108.08 4.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.171 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 70.14 -110.22 3.21 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.774 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 28.1 p30 -117.71 17.69 14.3 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.837 0.351 . . . . 0.0 111.158 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 52.5 mttt -133.86 158.22 43.97 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.725 0.298 . . . . 0.0 110.959 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -128.99 144.5 51.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.211 0.529 . . . . 0.0 110.984 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -110.53 133.74 53.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.596 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 19.2 ttp180 -94.86 92.14 6.78 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -84.34 129.04 34.91 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.131 0.491 . . . . 0.0 111.642 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -99.39 108.89 21.49 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -58.57 -43.04 89.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.947 0.403 . . . . 0.0 110.621 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -84.24 48.65 1.52 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.797 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -169.6 -35.03 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.706 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 37.6 mtp-105 69.58 36.94 2.04 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.429 0.633 . . . . 0.0 111.199 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -155.72 167.37 30.61 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.925 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 59.7 t -87.74 141.06 14.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.966 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -62.09 155.44 24.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.998 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.85 157.73 27.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.849 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 76.04 5.93 3.75 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.259 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -112.63 163.36 18.05 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.762 -0.199 . . . . 0.0 111.329 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.87 155.65 98.87 Favored 'Cis proline' 0 C--N 1.349 0.57 0 C-N-CA 123.624 -1.407 . . . . 0.0 112.967 0.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -116.84 162.3 17.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.305 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -65.53 139.94 58.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.718 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.1 tt -67.48 -9.6 10.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.094 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -63.47 -7.35 6.6 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 95.7 t -65.94 -37.17 79.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -88.43 93.68 9.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.94 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . 0.426 ' CD ' ' HZ2' ' A' ' 492' ' ' LYS . 0.2 OUTLIER -62.28 116.32 4.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.149 0.5 . . . . 0.0 112.072 -178.78 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 107.3 -15.57 39.02 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.716 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 33.6 mm -83.59 125.9 72.52 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 120.857 0.36 . . . . 0.0 111.304 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.44 152.93 30.55 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.758 2.306 . . . . 0.0 111.719 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -73.42 147.36 44.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.473 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 2.0 m 54.89 75.85 0.57 Allowed Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -83.5 -176.59 2.81 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.156 2.571 . . . . 0.0 112.173 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -134.81 18.96 3.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.207 0.527 . . . . 0.0 110.405 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 166.15 142.9 3.56 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 11.4 p -157.54 108.23 2.25 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -134.23 146.14 49.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.881 0.372 . . . . 0.0 111.507 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 48.0 ttm -99.03 141.06 32.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.167 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -67.69 166.74 42.5 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.179 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 2.7 m -68.74 -8.26 41.3 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.34 -14.27 27.1 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.969 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 65.39 12.17 7.9 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.241 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.7 -45.05 12.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.941 0.4 . . . . 0.0 110.682 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -114.07 141.56 47.31 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.208 0.528 . . . . 0.0 112.0 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 91.9 m -119.42 138.8 52.86 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.685 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -112.51 131.06 55.78 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.292 0.568 . . . . 0.0 112.506 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -114.65 142.78 46.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.215 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -123.75 136.84 54.67 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 111.526 0.195 . . . . 0.0 111.526 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -167.43 126.11 1.31 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.001 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 57.92 46.83 92.0 Favored Glycine 0 CA--C 1.519 0.341 0 CA-C-N 116.003 -0.544 . . . . 0.0 114.356 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 68.65 -2.25 1.72 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.775 0.658 . . . . 0.0 112.775 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -106.39 151.42 24.91 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -126.89 138.84 53.37 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.031 0.443 . . . . 0.0 111.332 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 15.1 m-90 -108.33 145.65 34.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.23 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 53.5 tttt -111.86 100.45 8.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.075 0.464 . . . . 0.0 109.927 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 486' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -89.1 130.61 35.52 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.945 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -96.82 112.38 24.16 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -64.72 -23.43 67.25 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 31.3 tp60 -78.57 -24.5 45.52 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -114.1 -6.26 13.08 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 15.3 tp 58.02 34.22 24.01 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.525 0.679 . . . . 0.0 110.375 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 492' ' ' LYS . . . . . 0.426 ' HZ2' ' CD ' ' A' ' 457' ' ' GLU . 39.3 tttp -152.46 152.71 32.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.703 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 66.7 t -76.1 133.36 31.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.696 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -61.38 148.22 86.1 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.386 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.23 149.56 85.27 Favored 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 122.743 2.295 . . . . 0.0 112.457 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 96.25 13.25 49.44 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.751 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -121.08 164.5 23.36 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.874 -0.163 . . . . 0.0 110.783 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.65 164.23 79.32 Favored 'Cis proline' 0 C--N 1.344 0.337 0 C-N-CA 123.806 -1.331 . . . . 0.0 113.647 0.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -118.68 160.77 21.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.651 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 30.1 t -71.97 115.47 11.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.946 0.403 . . . . 0.0 110.978 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -69.99 -23.67 63.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.61 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 83.5 mt -67.02 -32.0 72.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.074 0.464 . . . . 0.0 110.862 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -96.68 -35.08 11.14 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -89.65 -17.64 28.01 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 13.0 m0 -121.37 -52.63 2.04 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 11.2 mmt -67.95 -29.33 68.36 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 88.84 30.72 14.06 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.032 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 31.7 m -101.93 114.23 65.61 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.0 124.34 11.7 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.968 2.445 . . . . 0.0 112.652 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 3.9 m 68.28 153.68 0.1 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.482 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.188 -1.34 . . . . 0.0 111.19 179.957 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.771 0 N-CA-C 112.048 -0.421 . . . . 0.0 112.048 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -68.8 137.51 38.55 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 122.722 2.281 . . . . 0.0 112.01 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -64.37 158.54 42.61 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.175 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.77 166.78 28.43 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.764 2.309 . . . . 0.0 111.415 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.99 -171.98 43.44 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.318 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -64.41 162.64 29.78 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.617 2.211 . . . . 0.0 111.361 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.32 175.61 20.31 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.887 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.64 143.6 68.88 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.88 2.387 . . . . 0.0 111.514 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -64.89 150.82 47.08 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.99 154.72 31.96 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.345 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 6.5 mt -59.58 150.38 5.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.891 0.377 . . . . 0.0 110.924 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.59 145.27 56.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.127 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.32 153.85 45.54 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.903 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -69.27 148.59 49.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.756 0.312 . . . . 0.0 110.612 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -66.34 138.64 57.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.715 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.51 145.13 49.77 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.637 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 t -63.8 149.22 10.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.496 0.148 . . . . 0.0 110.766 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 11.0 t -52.13 146.05 2.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.262 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.54 165.08 52.45 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 121.187 -0.53 . . . . 0.0 113.4 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 81.2 mt -77.54 151.67 34.4 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.639 -0.28 . . . . 0.0 110.342 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.79 152.23 43.94 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.226 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -71.01 153.07 63.33 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.756 2.304 . . . . 0.0 111.698 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.01 169.07 53.9 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.748 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -80.71 160.56 21.75 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 123.043 2.495 . . . . 0.0 112.031 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.01 177.23 39.05 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.52 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.77 157.34 56.71 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.308 2.672 . . . . 0.0 112.455 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -55.57 128.76 45.44 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.665 -0.698 . . . . 0.0 113.8 -178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -57.21 114.01 1.74 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.952 2.435 . . . . 0.0 111.397 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.35 0 CA-C-O 120.019 -0.323 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -62.98 132.59 37.54 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.823 2.349 . . . . 0.0 111.63 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 102' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.6 159.55 52.12 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.519 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -81.84 160.62 18.73 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 123.074 2.516 . . . . 0.0 111.97 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 105' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -79.79 -167.7 35.47 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.504 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.32 154.12 45.8 Favored 'Trans proline' 0 N--CA 1.466 -0.142 0 C-N-CA 122.676 2.251 . . . . 0.0 110.743 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 108' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -55.23 160.6 5.79 Favored Glycine 0 CA--C 1.522 0.479 0 CA-C-N 115.953 -0.567 . . . . 0.0 113.282 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.26 160.07 32.48 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 123.216 2.611 . . . . 0.0 112.525 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -62.03 134.23 56.35 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.794 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -65.39 162.02 41.26 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.441 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 53.5 mt -72.94 138.72 20.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.8 153.09 37.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.306 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -66.56 159.39 48.29 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.351 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -88.94 150.53 22.8 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.617 0.246 . . . . 0.0 110.594 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 19.5 ttm-85 -60.97 142.11 56.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.323 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.24 167.12 49.79 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.41 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 86.0 t -66.73 142.28 16.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.675 0.274 . . . . 0.0 111.014 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 94.4 t -61.6 143.39 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.122 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.89 163.61 36.94 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.726 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 87.3 mt -76.72 147.1 37.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.49 0.186 . . . . 0.0 110.755 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 123' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -64.72 164.33 35.1 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.462 -179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.71 151.95 74.44 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.709 2.273 . . . . 0.0 111.629 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 126' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -65.81 162.67 41.71 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.318 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -80.86 159.86 21.3 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.666 2.244 . . . . 0.0 111.223 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -68.45 -178.32 15.7 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.997 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -76.33 153.02 35.32 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.921 2.414 . . . . 0.0 111.691 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 132' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.11 121.41 9.14 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.958 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.82 113.4 3.2 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.823 2.349 . . . . 0.0 111.463 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 135' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.287 0 CA-C-O 120.056 -0.302 . . . . 0.0 112.437 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -61.59 120.1 7.57 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.789 2.326 . . . . 0.0 111.034 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 202' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 66.92 166.0 2.43 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 114.72 0.648 . . . . 0.0 114.72 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -77.84 166.76 24.79 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 123.528 2.819 . . . . 0.0 110.411 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 205' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . 95.01 167.64 36.05 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.454 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -90.57 155.79 4.33 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 123.33 2.686 . . . . 0.0 112.803 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 208' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -84.72 -178.85 51.24 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.319 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.89 152.89 32.58 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 123.044 2.496 . . . . 0.0 111.786 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -73.91 149.32 41.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.774 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -68.02 159.45 51.2 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.486 -0.645 . . . . 0.0 111.486 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 42.1 pt -64.4 163.48 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-O 120.891 0.376 . . . . 0.0 111.484 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -74.56 145.16 43.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.333 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -67.42 158.02 51.34 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.518 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 -76.19 151.33 36.93 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -64.58 153.04 40.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.337 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -61.86 157.03 35.5 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.269 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 12.3 t -70.91 147.52 11.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.59 136.85 25.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.99 162.82 26.36 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.292 -0.48 . . . . 0.0 113.127 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 64.5 mt -69.36 154.04 42.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.846 -0.177 . . . . 0.0 110.795 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 223' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -66.19 147.54 50.15 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.276 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.53 152.75 78.01 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.602 2.202 . . . . 0.0 111.903 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 226' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -64.56 169.18 25.43 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.135 -0.555 . . . . 0.0 114.087 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -75.88 163.35 33.54 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 123.418 2.745 . . . . 0.0 111.485 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -67.96 170.01 37.82 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.268 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -72.16 145.52 44.26 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 123.002 2.468 . . . . 0.0 111.394 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 232' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo . . . . . 0 N--CA 1.477 0.54 0 N-CA-C 109.8 -0.885 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -110.42 -173.98 2.38 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 15.4 tt -117.46 -6.24 11.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.247 0.546 . . . . 0.0 110.54 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 99.6 m -100.11 -0.61 38.64 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -94.02 -9.17 37.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.81 0.338 . . . . 0.0 110.598 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 84.22 -149.05 24.7 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.808 -0.711 . . . . 0.0 111.843 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 2.8 t30 55.13 68.57 0.84 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.116 0.484 . . . . 0.0 111.756 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -100.99 152.17 20.89 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.547 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -80.31 -47.09 15.05 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 4.4 t -167.33 149.67 6.0 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.021 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 47.8 t -128.49 122.29 57.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -140.44 -177.98 5.29 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.065 0.459 . . . . 0.0 111.778 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 12.8 ttp -132.02 131.17 42.26 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 51.2 mt -127.58 116.86 20.99 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 123.295 0.372 . . . . 0.0 110.397 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . 0.43 ' H ' ' CD ' ' A' ' 373' ' ' GLU . 0.9 OUTLIER 64.83 20.84 12.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.822 179.203 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 102.85 -18.59 49.54 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.347 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -89.47 135.03 33.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.669 0.271 . . . . 0.0 110.475 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 48.4 ttm -87.03 126.61 34.86 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.907 0.384 . . . . 0.0 110.632 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -116.87 122.32 44.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.32 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.72 112.46 37.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -95.3 130.4 42.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.792 0.33 . . . . 0.0 111.578 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -147.98 108.82 4.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.244 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 63.34 -113.2 0.4 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.632 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -110.23 10.35 23.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.053 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -126.19 157.47 38.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.908 0.385 . . . . 0.0 110.591 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -141.31 141.57 33.89 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.563 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -107.21 150.46 26.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.92 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 14.5 ttt85 -125.5 106.32 9.7 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 3.7 m -92.79 129.01 43.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.409 0.623 . . . . 0.0 111.485 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.43 111.89 13.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.082 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 27.9 t30 55.69 52.06 11.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.031 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 68.14 7.07 5.62 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -122.38 158.06 30.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.724 0.297 . . . . 0.0 110.881 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 38.5 t -94.26 130.32 43.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 120.681 0.276 . . . . 0.0 110.475 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 4.0 mtp -72.04 156.72 38.9 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.204 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -79.08 150.55 31.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.81 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 99.69 -6.03 58.67 Favored Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -112.64 157.69 39.61 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.55 131.7 15.38 Favored 'Cis proline' 0 C--N 1.347 0.466 0 C-N-CA 123.713 -1.369 . . . . 0.0 112.693 0.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 52.6 ttm -104.38 136.08 19.23 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.24 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.18 131.84 38.6 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.256 1.971 . . . . 0.0 111.058 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 66.5 mt -54.96 -44.1 71.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.179 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -67.99 -14.22 65.43 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 121.19 -0.529 . . . . 0.0 113.718 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -79.55 -45.79 18.57 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 117.182 0.491 . . . . 0.0 110.622 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -88.38 -53.11 4.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.591 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -88.12 74.67 8.79 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.242 0.544 . . . . 0.0 109.536 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -60.66 94.83 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.865 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 130.91 -17.31 5.2 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.264 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 19.4 tp -85.31 132.59 44.64 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.647 0.261 . . . . 0.0 111.138 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.59 178.81 6.92 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.817 2.345 . . . . 0.0 111.651 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -86.56 151.57 23.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.421 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 44.6 m 55.98 83.99 0.09 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 19.9 pt -95.56 172.86 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.924 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.42 -42.05 6.42 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.708 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.23 159.2 44.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.85 0.357 . . . . 0.0 111.513 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -149.93 140.1 22.14 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -163.88 166.79 21.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.768 0.318 . . . . 0.0 111.42 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' A' ' 330' ' ' ARG . 33.5 mt-10 -97.56 138.38 35.07 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -89.41 -173.03 3.84 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.959 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -70.42 -19.51 62.99 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.67 -23.05 17.76 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.377 -0.529 . . . . 0.0 112.422 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 124.9 -18.99 7.01 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.603 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -70.45 152.0 44.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.842 0.353 . . . . 0.0 110.605 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -96.23 133.54 40.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.269 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 14.5 t -114.56 121.31 66.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 120.796 0.332 . . . . 0.0 110.276 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -107.65 138.62 43.55 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -121.3 137.7 54.57 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -155.25 103.54 2.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.408 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 76.61 -122.38 6.33 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.606 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -106.52 4.87 28.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.884 0.373 . . . . 0.0 111.098 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -114.62 150.01 35.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.217 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 32.5 p-80 -131.78 148.79 52.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.019 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 27.1 m-90 -123.6 132.81 53.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.066 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 21.8 t -112.86 124.6 69.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -117.48 128.68 55.23 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -94.73 89.21 5.63 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 68.98 -80.41 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.409 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -136.05 11.47 3.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.089 0.471 . . . . 0.0 110.902 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 19.3 m -120.82 129.29 53.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.876 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 33.8 tp -76.07 142.04 41.87 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.961 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -69.14 148.49 97.65 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.392 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.41 133.64 19.47 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.9 2.4 . . . . 0.0 112.584 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 87.29 52.81 2.95 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.4 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -143.62 162.66 40.59 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -80.4 165.32 77.96 Favored 'Cis proline' 0 C--N 1.347 0.489 0 C-N-CA 123.633 -1.403 . . . . 0.0 112.934 0.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -132.48 168.11 18.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.987 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -68.82 156.36 38.53 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 123.236 0.335 . . . . 0.0 110.499 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 52.8 mt -55.84 -36.53 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.111 0.482 . . . . 0.0 110.879 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -65.43 -14.48 61.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.127 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -80.62 -22.06 40.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.318 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 40.6 tp -82.69 -48.21 11.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.99 0.424 . . . . 0.0 110.234 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -151.18 140.54 7.93 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.919 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.67 126.32 30.77 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.0 0.429 . . . . 0.0 110.714 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 110.77 -1.83 28.89 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.052 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 88.6 mt -83.72 150.18 58.75 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.496 0.189 . . . . 0.0 110.562 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.0 140.86 92.35 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.697 2.265 . . . . 0.0 111.871 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.14 -5.94 39.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.812 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -79.27 -57.69 3.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.494 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -179.39 176.68 0.81 Allowed 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.823 0.344 . . . . 0.0 110.421 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 44.7 mm -124.55 134.64 66.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -89.4 -54.31 4.15 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.283 0.563 . . . . 0.0 110.206 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -150.84 155.93 40.2 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.978 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -139.14 121.51 16.03 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 35.2 tp -113.97 123.8 50.6 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.421 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -90.97 113.38 25.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.67 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -80.42 99.04 7.78 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 67.0 mtt -54.62 -49.41 91.4 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -47.54 -61.41 0.6 Allowed 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 122.557 2.171 . . . . 0.0 114.501 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 52.0 p30 -85.8 -24.9 26.61 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 83.56 47.43 5.67 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.514 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -131.49 152.58 50.6 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.8 m -106.24 126.55 52.36 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.141 0.496 . . . . 0.0 111.754 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -100.65 113.15 25.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.019 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -94.93 121.79 36.9 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.394 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -99.88 130.38 46.06 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.783 0.325 . . . . 0.0 110.929 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -141.75 98.7 3.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.829 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 67.79 -116.81 8.1 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.561 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -101.64 8.45 41.7 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -128.72 149.38 50.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.815 0.341 . . . . 0.0 111.195 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -126.43 144.41 50.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.468 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -109.5 143.41 39.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.879 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -103.84 93.77 5.06 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -82.79 129.57 35.0 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.533 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -103.65 108.3 19.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.102 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -54.98 -47.59 74.38 Favored 'General case' 0 C--O 1.231 0.115 0 O-C-N 123.486 0.491 . . . . 0.0 112.159 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -62.55 -32.71 73.71 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 68.2 mt -94.99 -10.94 29.46 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 58.07 29.32 17.64 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 123.32 0.387 . . . . 0.0 111.523 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -154.38 174.12 15.28 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.331 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.8 t -90.31 144.11 9.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.863 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -67.8 164.16 20.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.894 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.38 163.96 26.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.047 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 71.83 8.93 6.15 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.167 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -113.71 163.63 18.1 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.693 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -72.32 157.06 98.15 Favored 'Cis proline' 0 C--N 1.348 0.514 0 C-N-CA 123.631 -1.404 . . . . 0.0 112.301 -0.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -115.32 170.19 8.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.907 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -60.75 128.22 35.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.316 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 11.6 tt -66.74 -14.58 18.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.113 0.482 . . . . 0.0 111.347 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -69.89 3.7 2.47 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 39.1 t -66.6 -32.55 58.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 16.7 m95 -88.27 84.06 6.89 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.32 110.21 0.38 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.718 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 119.42 -23.67 8.4 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.173 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 43.7 mm -86.07 127.87 60.12 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.845 0.355 . . . . 0.0 111.383 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -85.49 162.49 11.01 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.809 2.339 . . . . 0.0 111.421 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -71.11 153.94 42.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.533 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 10.5 m 58.1 72.68 0.84 Allowed Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 115.591 -0.732 . . . . 0.0 112.942 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -82.52 176.51 7.83 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.093 2.529 . . . . 0.0 111.859 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 8.7 tpp85 -142.51 23.24 1.97 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.318 0.58 . . . . 0.0 110.472 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 172.97 142.03 3.68 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 12.3 p -165.43 101.42 0.72 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.728 0.299 . . . . 0.0 110.686 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -132.96 138.42 46.89 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.079 0.466 . . . . 0.0 111.656 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 40.0 ttm -93.65 135.9 34.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.526 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -68.2 163.62 48.2 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.391 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.93 -9.13 26.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.169 0.509 . . . . 0.0 111.605 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -84.99 -15.24 44.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.144 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 64.47 11.57 6.67 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 57.8 t -110.48 -40.69 4.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.921 0.391 . . . . 0.0 110.908 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -105.26 126.51 52.17 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 93.7 m -114.2 130.71 56.62 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -105.55 124.35 49.4 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.228 0.537 . . . . 0.0 112.389 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -105.55 152.35 23.17 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.971 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -131.82 137.59 48.17 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.514 0.197 . . . . 0.0 111.306 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -168.61 120.04 0.78 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.65 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 64.17 48.0 79.36 Favored Glycine 0 N--CA 1.453 -0.226 0 N-CA-C 114.561 0.584 . . . . 0.0 114.561 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 66.5 t30 67.94 0.93 2.53 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -115.9 152.37 33.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.173 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -126.12 152.23 46.19 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.892 0.377 . . . . 0.0 111.523 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 18.5 m-90 -117.98 140.43 49.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.757 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -100.38 94.59 6.25 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 486' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -88.59 123.57 33.2 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.054 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -91.99 114.16 26.63 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -62.21 -33.02 73.76 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -76.06 -26.66 56.75 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -101.3 -16.91 16.78 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 10.7 tp 58.56 38.53 25.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.726 0.774 . . . . 0.0 110.25 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -156.41 152.6 27.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.595 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 75.4 t -77.95 136.65 23.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.802 0.334 . . . . 0.0 110.585 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -62.93 146.35 95.47 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.284 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.98 155.68 66.77 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.571 2.18 . . . . 0.0 112.129 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 89.57 14.43 59.87 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.273 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -121.18 167.07 14.06 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -75.64 168.32 77.69 Favored 'Cis proline' 0 C--N 1.349 0.589 0 C-N-CA 123.905 -1.29 . . . . 0.0 113.016 0.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -123.39 169.67 11.11 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.945 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 39.9 t -79.24 117.57 20.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.777 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.02 -27.04 64.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.917 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 14.2 mt -65.0 -48.33 74.34 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.195 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -79.68 -42.98 23.58 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -76.45 -54.31 6.91 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -177.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -79.36 -61.03 2.13 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 7.2 mmt -66.57 -37.68 85.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.976 0.417 . . . . 0.0 111.479 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 94.63 22.68 23.29 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.705 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 18.8 m -83.48 124.18 75.9 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-O 120.614 0.245 . . . . 0.0 110.465 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.86 156.04 61.19 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.812 2.342 . . . . 0.0 112.842 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 4.0 m 70.77 -70.23 0.16 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.466 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.327 0 CA-C-O 118.365 -1.241 . . . . 0.0 111.23 -179.487 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.731 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.48 153.32 44.46 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.673 2.249 . . . . 0.0 112.256 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.18 174.12 53.52 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.947 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.33 164.86 30.31 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.782 2.321 . . . . 0.0 111.237 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.79 -176.31 39.96 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.467 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.51 163.27 7.01 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 122.979 2.452 . . . . 0.0 111.675 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 149.58 175.87 22.26 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.094 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.78 141.47 65.74 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.848 2.366 . . . . 0.0 111.545 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -68.47 144.7 54.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.213 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.24 154.16 37.9 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.806 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.59 148.94 11.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.34 151.23 46.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.362 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.84 157.03 53.54 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.332 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -72.51 148.44 45.04 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -66.08 148.34 51.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 0.0 110.825 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.44 159.88 49.84 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.996 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.6 t -70.78 153.72 8.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.626 0.251 . . . . 0.0 110.481 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 11.9 t -58.95 145.47 10.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.454 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.87 161.51 52.89 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.127 -0.559 . . . . 0.0 113.062 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 95.9 mt -73.49 152.16 40.8 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.573 -0.158 . . . . 0.0 110.573 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.9 158.99 51.72 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.233 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.63 153.54 49.1 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 122.653 2.236 . . . . 0.0 111.709 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.07 161.24 50.0 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.444 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.68 155.42 66.25 Favored 'Trans proline' 0 C--O 1.237 0.441 0 C-N-CA 122.515 2.143 . . . . 0.0 111.482 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.03 168.61 36.9 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.982 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -73.58 166.55 29.53 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 123.053 2.502 . . . . 0.0 111.507 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.73 178.24 50.83 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.94 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -79.23 154.18 24.88 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 123.162 2.575 . . . . 0.0 111.804 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.659 -0.176 . . . . 0.0 112.659 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -71.74 124.94 10.63 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.932 2.421 . . . . 0.0 111.931 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 102' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.43 173.28 46.75 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.206 -0.521 . . . . 0.0 113.281 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -88.5 163.87 6.59 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 123.156 2.57 . . . . 0.0 112.367 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 105' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -77.9 -175.92 45.0 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.22 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.93 152.76 28.62 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.647 2.232 . . . . 0.0 111.052 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 108' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -60.48 172.18 6.29 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.388 -0.824 . . . . 0.0 113.567 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -61.5 154.1 61.76 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 123.042 2.495 . . . . 0.0 113.109 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -62.79 137.52 58.29 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.617 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.24 154.74 44.23 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.34 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 41.4 mt -70.4 137.56 23.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 122.762 -0.258 . . . . 0.0 110.363 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.1 147.48 47.3 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.526 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -65.19 155.95 48.53 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.843 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -82.72 158.67 22.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.651 0.262 . . . . 0.0 110.573 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -64.69 145.18 56.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.399 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.59 172.78 34.87 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.669 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 30.3 t -67.78 141.78 17.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.642 0.258 . . . . 0.0 110.81 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 60.5 t -62.69 139.08 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.967 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.18 158.06 39.05 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 121.203 -0.523 . . . . 0.0 112.68 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 97.1 mt -77.28 142.1 39.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.553 0.216 . . . . 0.0 110.546 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 123' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -65.1 165.41 34.75 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.455 -0.793 . . . . 0.0 113.252 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -74.98 158.17 42.42 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.8 2.333 . . . . 0.0 111.832 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 126' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -68.02 162.82 48.47 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.525 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.61 159.4 51.19 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.523 2.149 . . . . 0.0 110.742 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -67.48 -178.16 11.55 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.983 -0.627 . . . . 0.0 114.34 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -71.7 153.71 59.44 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 123.611 2.874 . . . . 0.0 111.926 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 132' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.04 115.68 7.74 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 121.14 -0.553 . . . . 0.0 112.113 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -67.11 112.08 2.42 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 123.104 2.536 . . . . 0.0 112.061 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 135' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.49 0 CA-C-O 120.01 -0.328 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -55.45 151.19 38.61 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.302 2.668 . . . . 0.0 112.069 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 202' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 79.84 -177.6 54.21 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.013 -0.613 . . . . 0.0 114.102 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -74.94 169.28 22.96 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.907 3.072 . . . . 0.0 112.172 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 205' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . 92.89 170.73 40.19 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.404 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -90.61 156.74 4.3 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.905 3.07 . . . . 0.0 112.281 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 208' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -82.88 167.6 46.2 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.715 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.04 156.42 62.66 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 122.762 2.308 . . . . 0.0 112.341 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -76.61 147.15 37.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.441 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -69.2 165.31 49.4 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.35 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 10.8 pt -69.34 168.19 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 120.775 0.322 . . . . 0.0 111.141 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -83.18 146.46 28.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.951 0.405 . . . . 0.0 111.043 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -66.12 160.66 45.48 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.908 -0.587 . . . . 0.0 113.453 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -75.75 160.48 29.98 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -71.52 152.68 42.79 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -62.42 154.67 41.44 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.01 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 10.7 t -62.28 142.43 16.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 30.8 t -61.45 137.91 22.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.258 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -59.37 154.56 29.81 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.673 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 5.6 mp -75.2 158.19 33.37 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.479 0.181 . . . . 0.0 110.813 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 223' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -71.81 156.3 52.51 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.652 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.8 154.58 67.42 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.796 2.33 . . . . 0.0 111.811 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 226' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.96 163.31 29.85 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.705 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.97 160.21 33.78 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.64 2.226 . . . . 0.0 111.34 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -67.54 -176.72 9.57 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.881 -0.6 . . . . 0.0 113.973 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.26 168.98 22.16 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.937 2.424 . . . . 0.0 112.145 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 232' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo . . . . . 0 N--CA 1.48 0.727 0 N-CA-C 109.68 -0.931 . . . . 0.0 109.68 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -133.44 159.46 40.29 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 13.8 tt -78.71 -17.62 13.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.263 0.554 . . . . 0.0 110.923 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 6.8 m -95.8 14.98 21.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.669 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -60.42 -40.55 91.42 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.039 0.447 . . . . 0.0 111.072 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 98.85 146.92 21.28 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.084 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 23.9 t30 54.81 91.87 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -91.74 165.59 13.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.289 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -71.45 -41.56 69.28 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 1.2 t -167.6 149.77 5.76 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.354 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 90.6 t -134.33 123.98 44.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -147.88 176.53 10.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.812 0.339 . . . . 0.0 110.903 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 38.3 ttp -128.96 119.98 25.28 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 41.6 mt -119.98 125.89 49.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.301 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? 64.1 20.56 12.24 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.521 0.513 . . . . 0.0 111.183 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 91.31 1.44 72.05 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.875 -0.678 . . . . 0.0 111.857 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -105.97 124.78 50.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.75 0.31 . . . . 0.0 110.597 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 36.4 ttm -78.67 114.87 17.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.855 0.359 . . . . 0.0 111.109 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -106.37 126.57 52.41 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.14 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 39.2 t -109.48 118.88 57.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.441 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -104.29 130.54 52.1 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.809 0.338 . . . . 0.0 111.548 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 17.7 ttpp -150.94 116.19 5.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.055 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 65.28 -119.96 0.39 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.14 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.3 ptm85 -109.56 13.61 23.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.962 0.411 . . . . 0.0 111.847 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 17.2 m-90 -129.62 152.7 48.85 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.588 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -129.77 147.49 51.55 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.973 0.416 . . . . 0.0 110.866 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 26.5 m-90 -119.2 169.26 10.11 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.263 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.45 109.48 4.48 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 1.1 m -99.94 122.88 52.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.105 -178.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 21.1 ttm-85 -117.94 102.12 8.81 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 66.6 t30 66.72 51.87 1.02 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.5 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 9.1 m120 69.2 1.7 3.34 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.242 -0.89 . . . . 0.0 113.317 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -118.71 127.73 53.84 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.963 0.411 . . . . 0.0 112.019 -179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 20.0 t -74.24 123.68 30.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.218 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 72.3 mtp -68.29 167.4 14.5 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -74.73 153.64 38.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.712 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 95.23 7.47 59.43 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.887 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -122.71 153.93 63.36 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.3 143.32 74.52 Favored 'Cis proline' 0 C--N 1.345 0.349 0 C-N-CA 123.545 -1.44 . . . . 0.0 112.598 0.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 58.0 ttm -116.68 131.83 23.7 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.554 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.7 138.39 82.87 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.588 2.192 . . . . 0.0 111.41 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 78.4 mt -56.57 -46.6 82.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.34 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -73.07 3.04 31.61 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 121.175 -0.536 . . . . 0.0 113.85 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.38 -37.2 17.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.326 0.563 . . . . 0.0 110.42 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -106.67 -44.86 4.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.446 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 62.2 m95 -89.8 74.22 7.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.315 0.578 . . . . 0.0 110.122 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -62.23 103.63 0.41 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.173 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 120.98 -14.24 9.64 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.103 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 24.0 tp -93.38 133.85 27.75 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.744 0.306 . . . . 0.0 110.562 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -82.85 177.62 6.66 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.642 2.228 . . . . 0.0 111.585 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -86.86 160.61 18.68 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.781 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 54.8 m 53.57 79.87 0.12 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 23.0 pt -94.86 -178.63 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.496 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -105.63 -47.0 4.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.724 0.297 . . . . 0.0 111.658 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.85 163.45 39.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.746 0.308 . . . . 0.0 111.591 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -152.11 142.32 22.36 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -165.07 168.69 17.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.638 0.256 . . . . 0.0 111.546 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -95.09 126.51 40.47 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -84.7 171.96 11.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.66 0.267 . . . . 0.0 111.005 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.499 ' HZ1' ' CD ' ' A' ' 441' ' ' GLU . 84.1 tttt -66.8 -32.33 73.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.999 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -33.16 71.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.407 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 124.57 -20.92 6.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.476 -0.869 . . . . 0.0 113.928 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 19.8 mttp -90.32 175.27 7.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 117.196 0.498 . . . . 0.0 112.27 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -99.2 140.29 33.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.318 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 5.9 t -120.23 122.03 67.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.199 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -108.45 144.55 35.91 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -127.5 141.16 51.73 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -151.76 103.56 2.95 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 76.12 -115.27 4.42 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.268 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -113.95 10.59 17.63 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.791 0.329 . . . . 0.0 111.125 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -116.27 151.46 35.78 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.691 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 -132.88 150.46 52.16 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.604 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 18.6 m-90 -123.36 137.3 54.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.938 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 69.7 t -117.45 117.37 54.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.049 0.452 . . . . 0.0 109.883 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -113.48 124.68 52.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.731 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -91.48 84.62 5.57 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 70.19 -70.25 0.15 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.995 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -143.39 16.06 1.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.921 0.391 . . . . 0.0 110.787 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 1.1 m -126.25 121.07 31.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.787 0.327 . . . . 0.0 111.359 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 52.7 tp -75.34 127.84 34.06 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -61.65 127.35 88.6 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.655 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.44 141.04 90.07 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.059 2.506 . . . . 0.0 112.368 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 92.53 16.26 49.99 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.252 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -112.66 163.21 18.46 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 110.712 -0.107 . . . . 0.0 110.712 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.47 169.43 74.48 Favored 'Cis proline' 0 C--N 1.347 0.491 0 C-N-CA 123.682 -1.382 . . . . 0.0 112.678 0.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -131.6 166.6 21.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.492 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -71.47 154.79 41.25 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 68.9 mt -60.98 -38.2 78.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.205 0.526 . . . . 0.0 109.799 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -66.7 -17.2 64.73 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.676 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -81.14 -23.79 38.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.921 0.391 . . . . 0.0 110.659 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 49.0 tp -77.0 -43.87 33.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.08 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -155.91 146.23 13.73 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.852 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -77.24 126.31 30.73 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.625 0.25 . . . . 0.0 110.537 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.31 -0.93 46.76 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.383 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 40.6 mt -77.27 149.65 79.36 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 120.399 0.142 . . . . 0.0 111.025 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.96 112.53 1.24 Allowed 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.987 2.458 . . . . 0.0 112.201 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.4 37.59 0.74 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.058 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -134.58 -56.7 0.84 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.271 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 10.8 ptmt -173.32 166.41 4.8 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 122.335 0.254 . . . . 0.0 110.506 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 38.9 mm -121.85 130.37 74.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -86.47 -45.39 11.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.367 0.604 . . . . 0.0 109.678 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -158.15 157.57 32.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.745 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -141.64 123.61 15.38 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 28.2 tp -120.62 134.67 55.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.297 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -106.46 117.11 33.17 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.359 -0.382 . . . . 0.0 109.982 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 4.5 t-105 -86.09 98.91 11.13 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 66.8 mtt -57.31 -52.49 73.87 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -53.23 -27.88 39.9 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.839 2.359 . . . . 0.0 115.301 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -112.93 -24.49 9.5 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 83.49 38.15 11.2 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.213 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -122.95 146.68 47.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.756 0.313 . . . . 0.0 110.737 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 7.1 m -107.05 129.35 54.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.513 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -108.36 117.47 34.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.911 0.386 . . . . 0.0 111.02 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -101.79 122.47 44.03 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.745 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -98.94 129.03 45.24 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.973 0.416 . . . . 0.0 111.535 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -139.2 103.71 4.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.409 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 67.21 -110.76 3.65 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.124 -0.791 . . . . 0.0 111.124 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -115.89 16.25 16.22 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.098 0.475 . . . . 0.0 110.236 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -119.17 145.96 45.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.115 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -125.48 131.44 52.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.966 0.412 . . . . 0.0 110.679 178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -102.71 148.1 26.01 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.947 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -114.19 98.0 6.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.313 0.578 . . . . 0.0 109.457 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -81.73 134.32 35.44 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.649 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -104.72 103.49 13.13 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.882 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -48.94 -45.33 41.62 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' GLU . . . . . 0.499 ' CD ' ' HZ1' ' A' ' 375' ' ' LYS . 15.9 mp0 -53.85 -66.26 0.42 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 74.2 mt -75.72 -14.83 60.34 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 60.37 48.41 7.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.695 0.76 . . . . 0.0 110.782 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -156.43 161.7 40.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.105 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 74.4 t -81.81 141.85 14.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -60.12 160.85 7.58 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.373 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.3 m -68.32 151.81 46.36 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.671 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 69.06 30.81 4.31 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.064 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -125.43 159.12 61.76 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.645 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -80.43 166.8 75.22 Favored 'Cis proline' 0 C--N 1.342 0.23 0 C-N-CA 123.504 -1.457 . . . . 0.0 112.592 0.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -116.42 171.32 7.91 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.338 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -71.68 146.68 48.08 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.643 0.259 . . . . 0.0 110.651 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.1 tt -70.44 -8.41 10.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.83 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -60.68 -12.08 9.31 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.76 -31.96 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 24.4 m95 -89.36 95.34 10.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.026 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.49 105.75 1.26 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 110.9 -4.31 28.91 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.044 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 30.6 mm -91.93 128.03 47.36 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-O 121.096 0.474 . . . . 0.0 111.391 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.08 158.19 26.84 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.853 2.369 . . . . 0.0 111.699 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 30.0 mp0 -80.1 148.62 30.93 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.425 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.9 m 55.45 69.4 1.97 Allowed Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.1 -175.9 2.6 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.339 2.026 . . . . 0.0 111.773 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 7.2 tpp85 -144.65 32.63 1.16 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.338 0.589 . . . . 0.0 110.328 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 167.51 140.7 2.97 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 5.7 p -161.94 101.22 1.13 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.948 0.404 . . . . 0.0 109.959 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -130.19 135.56 48.3 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.047 0.451 . . . . 0.0 111.344 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 47.3 ttm -86.96 142.3 28.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.954 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -71.8 164.59 54.13 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.911 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.54 -12.66 54.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.09 0.471 . . . . 0.0 111.587 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -83.17 -17.07 44.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.637 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 68.05 5.74 4.78 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 122.9 0.48 . . . . 0.0 111.911 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 35.1 t -104.5 -32.71 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.877 0.37 . . . . 0.0 111.13 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -117.8 138.05 52.33 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 90.6 m -120.82 133.08 55.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.409 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -104.8 129.58 53.06 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.197 0.522 . . . . 0.0 112.117 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -110.99 146.72 36.17 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.316 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -126.74 137.83 53.29 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -162.16 107.03 1.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.964 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 480' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 482' ' ' LYS . . . 60.0 57.66 18.17 Favored Glycine 0 C--N 1.331 0.258 0 CA-C-N 115.998 -0.547 . . . . 0.0 113.401 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 18.3 t30 73.24 -33.72 0.27 Allowed 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 482' ' ' LYS . . . . . 0.413 ' H ' ' C ' ' A' ' 480' ' ' GLY . 24.1 mtmt -78.66 136.54 37.49 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.048 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -121.5 149.03 43.68 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.079 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 23.0 m-90 -117.82 149.39 40.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.46 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -115.25 99.92 7.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.202 0.525 . . . . 0.0 109.787 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 486' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -88.54 127.57 35.54 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.26 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -88.1 111.93 22.11 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -66.17 -23.94 66.56 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 36.4 tp60 -86.04 -25.95 25.63 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.902 0.382 . . . . 0.0 111.614 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -104.72 -14.47 15.55 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.0 tp 61.77 39.85 13.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.478 0.656 . . . . 0.0 110.189 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 51.3 tttt -154.23 148.97 26.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.589 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 69.9 t -79.26 138.43 20.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.666 0.27 . . . . 0.0 110.401 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -62.21 153.03 76.83 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.161 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -75.56 150.94 36.5 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.749 2.3 . . . . 0.0 113.024 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 98.14 5.06 57.39 Favored Glycine 0 C--N 1.331 0.282 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.327 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -106.55 167.24 9.84 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 110.666 -0.124 . . . . 0.0 110.666 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.26 167.71 75.72 Favored 'Cis proline' 0 C--N 1.345 0.38 0 C-N-CA 123.72 -1.367 . . . . 0.0 112.756 0.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -125.73 154.82 41.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.988 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 2.7 m -72.36 111.95 8.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.494 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -62.23 -27.06 68.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.521 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 36.3 mt -56.07 -44.23 78.72 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.58 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -89.28 -37.79 14.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.354 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.01 -39.51 83.18 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 15.4 m0 -122.02 -45.69 2.24 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 10.5 mmt -64.87 -29.01 69.94 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 86.98 28.21 26.5 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.898 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 32.4 m -103.01 106.63 51.72 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.72 171.93 14.94 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 123.074 2.516 . . . . 0.0 111.59 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 5.3 m 60.55 52.1 4.76 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.375 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.369 -1.239 . . . . 0.0 111.562 179.783 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.611 0 N-CA-C 111.864 -0.494 . . . . 0.0 111.864 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.09 154.0 62.55 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.769 2.313 . . . . 0.0 111.793 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.84 172.49 38.83 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.333 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.21 162.24 39.03 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.799 2.333 . . . . 0.0 111.782 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.15 173.02 46.3 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.367 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.78 162.7 15.07 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.784 2.322 . . . . 0.0 111.484 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 130.63 -175.02 19.55 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.395 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.54 144.32 31.91 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.183 2.589 . . . . 0.0 111.785 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -73.6 148.79 42.57 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.72 153.52 40.66 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.459 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 13.1 mt -70.88 150.06 9.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.29 149.2 46.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.378 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.67 170.26 32.36 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.219 -0.515 . . . . 0.0 113.293 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -72.62 141.78 48.35 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.58 141.18 58.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.645 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.02 150.3 40.12 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.763 -0.653 . . . . 0.0 113.139 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 5.3 t -71.65 146.29 11.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 45.6 t -55.43 144.95 6.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.09 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.1 162.86 51.31 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.159 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 86.1 mt -77.28 154.38 32.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.619 -0.291 . . . . 0.0 110.429 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.22 157.55 52.57 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.508 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -69.68 154.13 68.43 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.722 2.281 . . . . 0.0 111.835 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.42 156.11 51.86 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.532 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.32 157.11 60.33 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.695 2.263 . . . . 0.0 112.06 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.27 178.09 51.89 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.959 -0.638 . . . . 0.0 113.164 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -72.53 155.95 54.44 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.217 2.611 . . . . 0.0 111.493 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.37 154.15 50.46 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.769 -0.65 . . . . 0.0 114.217 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.84 116.1 4.55 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 123.413 2.742 . . . . 0.0 111.303 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 CA-C-O 119.999 -0.334 . . . . 0.0 112.666 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.82 132.24 50.47 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.047 2.498 . . . . 0.0 112.357 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 102' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.71 163.67 44.31 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.127 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -81.18 157.07 19.98 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 123.488 2.792 . . . . 0.0 112.313 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 105' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -82.79 175.98 53.31 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.476 -0.868 . . . . 0.0 111.53 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.09 130.12 14.99 Favored 'Trans proline' 0 CA--C 1.528 0.203 0 C-N-CA 122.553 2.168 . . . . 0.0 110.65 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 108' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -53.13 167.31 1.23 Allowed Glycine 0 CA--C 1.522 0.53 0 CA-C-N 115.426 -0.806 . . . . 0.0 114.779 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.93 167.6 25.51 Favored 'Trans proline' 0 C--O 1.238 0.475 0 C-N-CA 122.958 2.438 . . . . 0.0 112.345 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -60.76 142.25 56.12 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.124 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -73.74 160.88 53.8 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.892 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 33.0 mt -68.45 141.15 17.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.733 0.301 . . . . 0.0 110.713 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.19 153.73 41.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.681 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -63.29 161.18 34.63 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.574 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -84.11 153.83 23.51 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -65.55 141.44 58.45 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.81 168.33 32.47 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.179 -0.534 . . . . 0.0 113.035 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 24.1 t -71.0 140.12 18.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 24.2 t -65.77 131.79 31.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.095 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.84 158.73 36.7 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.883 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 13.4 mt -73.55 148.99 42.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.473 0.178 . . . . 0.0 110.885 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 123' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -72.05 164.39 54.33 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.548 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.08 149.98 37.16 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.532 2.155 . . . . 0.0 111.459 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 126' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.93 163.98 36.48 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.627 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -74.86 156.17 43.61 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.551 2.168 . . . . 0.0 111.452 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -66.97 168.88 36.19 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.862 -0.685 . . . . 0.0 113.139 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.47 153.69 75.69 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.77 2.313 . . . . 0.0 111.306 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 132' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -83.13 118.76 4.7 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.354 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -70.72 113.93 3.69 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 122.563 2.175 . . . . 0.0 111.361 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 135' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -58.49 146.97 88.63 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.092 2.528 . . . . 0.0 111.774 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 202' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 68.82 -178.7 24.51 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 114.713 0.645 . . . . 0.0 114.713 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -74.6 166.73 28.72 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 123.593 2.862 . . . . 0.0 111.599 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 205' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . 98.69 161.99 30.04 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.476 -0.868 . . . . 0.0 113.219 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.8 154.47 11.59 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 123.51 2.806 . . . . 0.0 112.453 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 208' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -77.82 173.97 54.94 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.345 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -72.71 155.22 54.27 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.875 2.383 . . . . 0.0 112.005 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -75.46 146.52 40.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.504 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -66.79 163.56 43.96 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.757 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 44.2 pt -69.94 168.47 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 120.858 0.361 . . . . 0.0 111.236 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -74.82 153.6 38.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.478 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -79.68 155.43 39.27 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.907 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -72.3 146.62 47.04 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.573 0.225 . . . . 0.0 110.41 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -65.1 155.47 34.72 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.739 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -65.75 153.99 51.11 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.793 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 14.6 t -69.07 149.39 11.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 48.4 t -68.66 141.31 17.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -62.06 161.35 29.22 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.854 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 5.8 mp -67.4 158.0 32.76 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 223' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -61.02 148.7 45.72 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.89 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -62.98 143.3 90.81 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.626 2.217 . . . . 0.0 111.061 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 226' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -60.84 158.64 28.73 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.985 -0.552 . . . . 0.0 113.747 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -72.37 159.67 48.81 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.14 2.56 . . . . 0.0 111.271 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -67.04 168.9 36.41 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.988 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -86.59 160.14 9.33 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.869 2.379 . . . . 0.0 111.689 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 232' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo . . . . . 0 N--CA 1.479 0.655 0 N-CA-C 110.045 -0.79 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -105.82 151.98 23.81 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 21.1 tt -66.58 -31.74 54.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.822 0.344 . . . . 0.0 110.808 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 57.7 m -75.72 -0.53 21.17 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.056 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -69.51 -27.24 65.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.87 0.367 . . . . 0.0 110.686 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 84.62 -176.6 51.16 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.951 -0.643 . . . . 0.0 113.121 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 6.4 t30 57.22 77.37 0.27 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.44 0.696 . . . . 0.0 112.671 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -96.9 148.32 23.07 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.661 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -70.55 -42.4 71.21 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 1.9 t -167.95 155.16 8.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.687 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 72.9 t -133.62 127.89 53.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -144.18 164.75 29.81 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.683 0.278 . . . . 0.0 110.9 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 36.4 ttp -122.14 105.55 10.36 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 28.8 mt -103.5 128.01 50.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.183 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.54 17.59 7.51 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.706 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 95.59 -4.54 66.51 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.184 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -97.49 126.9 43.04 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.613 0.244 . . . . 0.0 110.415 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 39.1 tpp -77.56 117.3 18.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.062 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -113.33 119.95 39.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.047 0.451 . . . . 0.0 110.974 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 21.1 t -103.24 117.44 48.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -103.99 129.82 51.61 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -147.13 122.12 10.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.268 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 60.12 -105.82 0.24 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.274 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 10.0 ptm85 -125.58 18.63 8.08 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.019 0.437 . . . . 0.0 111.401 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 20.3 m-90 -130.3 152.92 49.19 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.888 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -132.77 141.95 48.77 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.208 0.527 . . . . 0.0 111.62 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 24.9 m-90 -111.17 159.54 17.77 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.902 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.37 106.25 6.6 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 6.7 m -101.08 142.58 15.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.343 0.592 . . . . 0.0 111.667 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -133.11 100.57 4.91 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.478 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 59.04 67.06 0.96 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.698 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 54.54 43.77 29.77 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -162.54 140.5 8.46 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 26.3 t -91.28 135.04 27.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 24.9 ttt -75.79 151.45 37.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.222 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.94 159.88 32.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.025 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 90.7 2.82 71.94 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -123.5 162.94 37.46 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.723 -0.239 . . . . 0.0 110.369 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.5 150.94 92.89 Favored 'Cis proline' 0 C--N 1.346 0.412 0 C-N-CA 123.764 -1.348 . . . . 0.0 112.675 -0.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 56.2 ttm -123.29 135.99 26.59 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.66 139.9 88.17 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.45 2.1 . . . . 0.0 110.982 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 77.8 mt -57.14 -45.18 84.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.549 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -70.39 -8.0 61.67 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 121.188 -0.53 . . . . 0.0 114.15 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.61 -24.07 25.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.363 0.581 . . . . 0.0 110.646 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -113.28 -54.4 2.62 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.228 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 68.0 m95 -85.34 79.08 9.62 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.979 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -60.37 101.47 0.13 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.241 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 122.42 -13.07 8.89 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.431 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 14.8 tp -90.0 131.41 39.24 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.783 0.325 . . . . 0.0 111.067 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -84.13 -167.18 0.42 Allowed 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.937 2.424 . . . . 0.0 112.478 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -93.27 149.15 21.44 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.825 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 8.3 m 58.34 93.92 0.03 OUTLIER 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 22.0 pt -105.54 172.09 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.57 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -98.95 -52.4 3.57 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.673 0.273 . . . . 0.0 111.583 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.3 165.85 31.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.614 0.245 . . . . 0.0 111.238 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -152.59 141.44 21.08 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -156.85 153.26 27.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.885 0.374 . . . . 0.0 111.818 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -96.2 115.38 27.34 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -82.01 172.26 13.46 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -58.29 -30.49 66.68 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.902 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -69.03 -5.94 24.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.567 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 76.94 33.73 44.87 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.06 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -126.82 150.43 49.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.675 0.274 . . . . 0.0 110.865 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -94.62 117.37 30.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.082 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 10.9 t -102.88 120.73 53.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.427 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -109.71 133.59 52.96 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -112.83 141.51 46.56 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.095 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -149.23 98.78 2.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.758 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 71.64 -111.09 3.48 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.417 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -111.39 4.99 19.4 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.972 0.415 . . . . 0.0 111.193 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -114.76 152.2 32.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.68 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 36.9 p-80 -135.54 149.57 49.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.582 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 21.8 m-90 -124.87 137.1 54.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.708 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 87.7 t -119.75 117.3 53.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.008 0.432 . . . . 0.0 110.624 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -103.33 119.82 39.61 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.593 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -94.78 102.92 14.81 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 68.25 -72.04 0.1 Allowed 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.684 0.615 . . . . 0.0 111.615 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -153.78 21.8 0.52 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.922 0.391 . . . . 0.0 110.551 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 57.9 m -137.83 132.93 33.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.981 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 30.3 tp -75.41 130.3 38.75 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -56.07 144.11 60.48 Favored Pre-proline 0 C--O 1.234 0.289 0 CA-C-O 120.746 0.307 . . . . 0.0 111.003 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.19 125.79 10.58 Favored 'Trans proline' 0 CA--C 1.528 0.216 0 C-N-CA 122.81 2.34 . . . . 0.0 111.868 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 114.16 14.32 9.24 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.994 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -109.6 163.28 17.44 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.529 0.165 . . . . 0.0 110.611 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.92 157.88 97.09 Favored 'Cis proline' 0 C--N 1.346 0.398 0 C-N-CA 123.522 -1.449 . . . . 0.0 112.861 0.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -121.13 164.35 17.0 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.071 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -76.01 149.64 37.53 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 59.7 mt -55.14 -34.1 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 121.285 0.564 . . . . 0.0 110.775 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -68.34 -12.43 61.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.616 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -86.53 -19.2 29.83 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.065 0.459 . . . . 0.0 110.359 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 40.2 tp -80.39 -39.48 28.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.961 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -160.51 153.79 24.73 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.146 -1.026 . . . . 0.0 113.204 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.52 124.88 31.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.336 -0.432 . . . . 0.0 110.1 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.8 14.63 39.48 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 121.067 -0.587 . . . . 0.0 111.928 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 23.3 mt -89.67 147.29 37.38 Favored Pre-proline 0 C--N 1.322 -0.604 0 O-C-N 122.716 -0.285 . . . . 0.0 111.6 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -52.92 114.24 1.63 Allowed 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.146 2.564 . . . . 0.0 111.637 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.38 33.69 0.89 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.419 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -130.74 -52.67 1.07 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.868 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -176.31 172.94 2.2 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.374 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 38.0 mm -124.87 130.82 73.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -89.87 -52.52 4.94 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.234 0.54 . . . . 0.0 109.577 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -140.74 154.08 46.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.052 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -139.84 102.83 4.51 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 45.1 tp -108.04 128.57 54.79 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.829 0.347 . . . . 0.0 111.629 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -99.41 117.09 33.05 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 8.5 t-105 -87.27 97.75 10.96 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 60.8 mtt -56.59 -50.76 85.98 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -49.44 -33.29 29.36 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.717 2.278 . . . . 0.0 114.97 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 41.5 p30 -111.62 -24.64 9.98 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 85.57 34.51 13.62 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.757 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 55.3 mttt -125.98 154.49 42.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.957 0.378 . . . . 0.0 110.777 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 15.4 m -105.97 135.03 48.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.018 0.437 . . . . 0.0 111.343 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -108.8 112.94 25.48 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.833 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -99.37 126.52 45.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.161 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -103.58 135.98 44.16 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.941 0.4 . . . . 0.0 111.212 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -146.0 107.01 4.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.863 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 70.11 -104.16 1.29 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.734 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -120.91 7.74 10.43 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.895 0.379 . . . . 0.0 110.683 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 48.9 mttm -120.72 153.2 37.28 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.676 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -130.98 141.18 50.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.933 179.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -109.95 147.55 33.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.807 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -109.5 99.36 8.58 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -93.63 134.99 35.36 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.207 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -101.35 122.97 44.68 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.53 -31.19 72.3 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -80.81 -37.08 30.75 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 16.0 mt -89.1 -16.86 30.48 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 4.7 mtp-105 57.52 37.94 27.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.392 0.615 . . . . 0.0 111.299 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -153.31 167.53 29.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.329 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 88.5 t -90.1 144.22 9.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.913 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -64.55 153.17 39.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.261 0.553 . . . . 0.0 111.915 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.3 m -64.07 156.05 29.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.7 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 77.69 -5.59 2.1 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.636 0.585 . . . . 0.0 111.891 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -98.41 161.05 26.57 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.361 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.42 160.43 95.32 Favored 'Cis proline' 0 C--O 1.234 0.304 0 C-N-CA 123.617 -1.409 . . . . 0.0 113.474 0.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -112.46 169.75 8.66 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.563 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -73.03 140.69 47.44 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.9 tt -66.69 -13.39 16.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.091 0.472 . . . . 0.0 110.912 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -63.53 -11.08 21.34 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 82.1 t -65.32 -31.26 53.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 29.0 m95 -87.69 87.34 7.35 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -58.42 109.36 0.76 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.888 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 110.04 -14.86 31.21 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.737 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 46.6 mm -88.76 125.93 61.26 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 120.722 0.296 . . . . 0.0 110.537 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.28 160.66 20.17 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.536 2.157 . . . . 0.0 111.704 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -71.67 149.52 45.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.096 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 2.2 m 54.96 62.14 8.22 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -96.04 100.93 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.966 2.444 . . . . 0.0 110.495 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -77.17 78.24 3.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.225 0.536 . . . . 0.0 111.501 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 149.55 120.22 1.02 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 26.2 p -154.88 127.48 7.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.726 0.298 . . . . 0.0 110.791 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -155.22 146.21 22.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.772 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 47.6 ttm -98.07 142.64 29.52 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.933 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -69.5 162.36 52.11 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.065 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.86 0.37 5.89 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.41 -15.34 21.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.922 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 69.11 6.63 5.76 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 123.753 0.658 . . . . 0.0 111.869 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 58.3 t -104.51 -39.4 5.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.931 0.396 . . . . 0.0 111.166 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -110.91 135.49 51.36 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 66.4 m -118.02 137.49 52.85 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.749 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -113.51 139.88 48.6 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.11 0.481 . . . . 0.0 112.133 -178.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -121.14 148.04 44.75 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.927 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -127.87 131.5 49.44 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.773 0.32 . . . . 0.0 111.371 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -157.62 117.06 3.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.513 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 61.6 47.7 88.95 Favored Glycine 0 CA--C 1.518 0.241 0 CA-C-N 115.878 -0.601 . . . . 0.0 113.667 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 52.0 t30 70.81 -2.94 2.11 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -105.56 142.74 34.78 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -118.65 146.27 44.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.93 0.395 . . . . 0.0 111.587 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 19.2 m-90 -117.7 148.27 42.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.465 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 54.0 tttt -115.67 105.0 12.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.211 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 486' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -97.1 129.58 44.49 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.679 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -91.45 114.31 26.81 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -63.71 -29.22 70.47 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -84.68 -11.63 55.5 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -118.76 -14.2 9.53 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 92.2 mt 59.4 36.04 23.17 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.314 0.578 . . . . 0.0 110.45 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 9.9 tttp -149.74 154.75 39.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.893 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 38.8 t -85.1 142.49 13.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -64.13 132.89 95.44 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.621 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.32 151.59 72.97 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.968 2.445 . . . . 0.0 112.363 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 92.6 16.03 50.66 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.208 -0.52 . . . . 0.0 111.977 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -115.42 166.03 12.96 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.832 -0.184 . . . . 0.0 110.814 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -84.66 176.9 29.77 Favored 'Cis proline' 0 C--N 1.347 0.499 0 C-N-CA 123.827 -1.322 . . . . 0.0 112.94 0.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -133.2 156.54 47.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.057 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 23.0 t -72.07 123.63 23.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.864 0.364 . . . . 0.0 110.843 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -65.21 -27.12 68.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.53 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 14.0 mt -62.28 -46.54 88.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.662 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -79.39 -40.22 30.63 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.493 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.98 -40.95 37.6 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -177.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -110.93 -49.13 3.05 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 9.4 mmt -64.97 -28.19 69.35 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -177.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 84.74 32.91 20.4 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.162 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 42.8 m -106.67 104.94 53.3 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.77 146.66 48.79 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.767 2.311 . . . . 0.0 111.713 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 8.0 m 54.34 76.82 0.22 Allowed 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.654 0.596 . . . . 0.0 111.031 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.135 0 CA-C-O 118.794 -1.004 . . . . 0.0 112.314 -179.143 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.871 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.31 141.76 32.56 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.673 2.249 . . . . 0.0 112.316 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -68.86 162.43 51.03 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.986 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.73 166.28 29.67 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.849 2.366 . . . . 0.0 111.126 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.13 -168.38 41.5 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.335 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.56 168.86 23.26 Favored 'Trans proline' 0 CA--C 1.528 0.181 0 C-N-CA 122.905 2.403 . . . . 0.0 111.322 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 134.27 -159.5 23.83 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 119.677 -1.249 . . . . 0.0 113.415 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -74.37 138.12 24.22 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.027 2.485 . . . . 0.0 112.001 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -67.18 152.14 46.29 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.16 148.58 32.71 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.519 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 18.2 mt -64.02 148.03 11.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.58 141.75 57.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.851 0.358 . . . . 0.0 110.14 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.38 158.99 48.24 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.196 -0.526 . . . . 0.0 113.223 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -67.75 148.5 51.18 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -72.94 146.78 45.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.799 0.333 . . . . 0.0 110.4 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.74 157.01 39.02 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.819 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 3.8 t -73.91 152.87 7.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 12.8 t -55.41 142.92 9.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.915 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.98 162.23 48.88 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.859 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.46 148.1 47.18 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.537 0.208 . . . . 0.0 111.165 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.96 155.81 33.97 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.797 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.51 155.03 50.47 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.711 2.274 . . . . 0.0 111.917 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.09 162.14 53.58 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.24 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.22 157.59 45.9 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.747 2.298 . . . . 0.0 112.003 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.21 172.08 54.5 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.716 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -67.29 161.52 42.7 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 123.289 2.659 . . . . 0.0 111.59 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.22 160.47 54.06 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.872 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.65 151.08 31.95 Favored 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 122.779 2.319 . . . . 0.0 112.109 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.47 0 CA-C-O 120.323 -0.154 . . . . 0.0 113.189 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -72.18 156.26 55.59 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.302 2.668 . . . . 0.0 111.735 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 102' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.03 171.32 48.44 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.458 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.81 161.25 21.42 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.984 2.456 . . . . 0.0 112.04 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 105' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -73.59 178.63 41.94 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.419 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.2 157.69 33.63 Favored 'Trans proline' 0 C--O 1.223 -0.254 0 C-N-CA 122.745 2.296 . . . . 0.0 110.762 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 108' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -57.61 165.68 6.27 Favored Glycine 0 CA--C 1.52 0.384 0 CA-C-N 115.663 -0.699 . . . . 0.0 113.484 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.57 159.93 42.34 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 123.118 2.545 . . . . 0.0 112.324 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -58.23 136.68 57.35 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.035 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -66.86 160.05 48.43 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.726 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 62.3 mt -72.8 131.21 35.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.55 151.67 28.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.137 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -69.58 155.53 53.36 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.492 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -76.75 157.43 31.67 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -65.22 150.25 48.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.285 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.47 167.34 44.3 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.935 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 21.5 t -67.02 139.38 21.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.572 0.225 . . . . 0.0 110.474 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 28.6 t -64.46 138.18 23.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.372 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.27 159.44 40.97 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.99 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 81.2 mt -79.36 153.67 29.61 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.519 -0.178 . . . . 0.0 110.519 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 123' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -65.83 171.16 27.15 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.889 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.3 147.81 37.75 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.466 2.11 . . . . 0.0 111.906 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 126' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.47 159.09 50.62 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.783 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.93 164.58 34.19 Favored 'Trans proline' 0 C--O 1.237 0.465 0 C-N-CA 122.671 2.247 . . . . 0.0 111.58 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -72.7 -172.51 21.34 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.718 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -78.74 148.65 22.8 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.628 2.219 . . . . 0.0 112.099 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 132' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -62.3 126.28 37.72 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.418 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.52 110.75 2.37 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.195 2.597 . . . . 0.0 112.368 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 135' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.286 0 N-CA-C 112.405 -0.278 . . . . 0.0 112.405 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.8 143.12 91.26 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.869 2.379 . . . . 0.0 111.502 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 202' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 84.89 -176.77 50.89 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.83 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -69.12 161.02 47.54 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 123.823 3.015 . . . . 0.0 112.67 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 205' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . 90.09 178.59 44.53 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.73 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -97.9 160.49 0.86 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.889 3.059 . . . . 0.0 112.682 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 208' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -79.13 171.81 55.09 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.723 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -71.96 155.99 56.81 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.731 2.288 . . . . 0.0 112.014 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -73.22 147.92 44.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.301 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -68.17 158.75 51.89 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.186 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 20.5 mt -60.05 142.67 15.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.786 0.327 . . . . 0.0 110.948 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -65.26 139.94 58.67 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.582 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -60.37 156.04 31.12 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.11 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -78.56 159.25 28.24 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -67.75 154.33 41.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.783 0.325 . . . . 0.0 110.784 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -64.47 160.12 40.72 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.913 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 15.9 t -70.02 144.15 14.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 39.3 t -61.55 142.7 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.95 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.84 160.7 37.5 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.757 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 82.1 mt -73.79 153.55 39.93 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.823 -0.189 . . . . 0.0 110.741 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 223' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -59.59 149.4 40.14 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.505 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.03 137.47 79.33 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.841 2.361 . . . . 0.0 111.595 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 226' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -64.92 164.13 36.23 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.939 -0.573 . . . . 0.0 113.971 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -89.03 166.03 5.71 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 123.339 2.692 . . . . 0.0 111.339 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -62.94 159.27 36.25 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.896 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.93 140.38 54.72 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.614 2.209 . . . . 0.0 110.679 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 232' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo . . . . . 0 N--CA 1.474 0.361 0 N-CA-C 110.733 -0.526 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -128.81 154.85 46.03 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 11.2 tt -73.65 -19.54 17.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.999 0.428 . . . . 0.0 112.08 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 62.1 m -90.94 1.72 56.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.724 0.297 . . . . 0.0 111.51 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.3 -44.68 74.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.191 0.519 . . . . 0.0 110.451 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 93.28 -177.65 38.06 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.096 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 52.59 69.82 0.64 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.299 0.571 . . . . 0.0 111.634 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -87.24 156.36 19.69 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.682 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -65.35 -41.19 94.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.019 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 5.7 t -173.4 149.88 1.77 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.156 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 60.7 t -134.24 118.12 26.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -140.17 -172.18 3.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.843 0.354 . . . . 0.0 111.412 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 44.6 ttp -136.96 126.71 25.53 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.824 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 42.5 mt -120.92 119.93 34.01 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.313 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.17 17.82 9.54 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.14 0.576 . . . . 0.0 111.918 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 102.73 -9.2 55.28 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.154 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -99.5 127.69 45.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.637 0.256 . . . . 0.0 110.66 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 44.5 ttm -77.28 137.23 38.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.95 0.405 . . . . 0.0 111.424 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -125.42 117.05 22.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.618 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 33.3 t -107.7 114.61 46.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -99.15 129.33 45.39 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -139.27 102.47 4.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.774 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 63.33 -99.14 0.07 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.493 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -116.27 -0.56 12.58 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 18.3 m0 -119.27 154.86 32.8 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.323 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -129.05 133.98 47.93 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.104 0.478 . . . . 0.0 110.83 178.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 5.6 m-90 -102.28 153.48 19.95 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.686 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -129.49 105.77 8.31 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.17 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -102.36 123.99 56.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.738 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -118.57 107.16 13.4 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.01 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 63.45 45.25 4.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.26 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 45.1 t30 66.34 32.54 7.64 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.075 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -139.64 142.8 37.0 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 24.7 t -81.79 130.65 35.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 74.7 mtp -74.97 166.32 23.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.034 0.445 . . . . 0.0 112.073 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -83.75 154.93 23.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.762 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 80.76 26.16 54.45 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.329 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -135.22 162.57 56.7 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 122.97 -0.135 . . . . 0.0 110.644 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -75.23 146.23 85.76 Favored 'Cis proline' 0 C--N 1.346 0.408 0 C-N-CA 123.754 -1.353 . . . . 0.0 112.948 0.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 56.3 ttm -114.57 140.96 25.92 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.188 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.32 140.94 90.99 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.275 1.983 . . . . 0.0 111.02 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 91.8 mt -55.7 -43.95 75.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.225 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -72.02 -6.71 64.85 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 121.052 -0.594 . . . . 0.0 113.434 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.39 -21.53 30.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.239 0.52 . . . . 0.0 110.087 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -111.6 -55.42 2.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.789 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 65.1 m95 -91.27 83.62 5.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.366 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -63.32 105.35 0.73 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.264 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 116.55 -6.65 18.39 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.552 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 18.3 tp -91.68 131.4 35.92 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.703 0.287 . . . . 0.0 110.596 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -81.3 170.9 14.34 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.778 2.319 . . . . 0.0 111.371 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -80.59 153.49 28.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.704 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 15.7 m 56.68 84.07 0.09 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 16.8 pt -98.97 -174.07 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -134.29 -24.14 1.63 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 4.8 m -141.83 145.92 35.25 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.555 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -153.58 131.46 11.67 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -163.53 165.28 23.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.888 0.375 . . . . 0.0 111.496 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -94.23 141.63 28.34 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -97.2 -169.4 1.85 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.385 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.467 ' HZ3' ' CD ' ' A' ' 441' ' ' GLU . 34.9 tttt -69.39 -34.43 74.51 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.645 0.979 . . . . 0.0 113.645 -177.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 44.7 p30 -83.02 -10.37 58.79 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 107.83 -6.2 35.12 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.669 -0.776 . . . . 0.0 113.241 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 17.4 mttp -76.54 164.24 26.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.906 0.353 . . . . 0.0 110.879 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -107.82 123.32 48.4 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -178.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 12.2 t -105.98 119.82 55.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.036 0.446 . . . . 0.0 110.446 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -106.18 143.38 34.38 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.508 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -124.1 138.26 54.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.069 0.461 . . . . 0.0 111.897 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -150.69 98.24 2.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.78 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 77.58 -111.94 3.38 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.618 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -113.09 6.9 17.81 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.685 0.278 . . . . 0.0 111.345 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -114.61 148.97 37.33 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.514 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -128.86 146.0 51.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.218 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 -120.21 131.75 55.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.09 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 99.2 t -115.52 110.44 31.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.059 0.456 . . . . 0.0 109.972 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -102.68 128.18 49.49 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.613 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -99.35 103.15 14.94 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 71.89 -53.36 0.69 Allowed 'General case' 0 N--CA 1.469 0.519 0 O-C-N 123.663 0.602 . . . . 0.0 111.298 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -166.27 -29.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.844 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.37 138.8 32.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.814 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 27.9 tp -78.29 139.84 38.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.803 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -67.21 140.75 95.72 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.443 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -67.77 147.4 75.22 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.715 2.276 . . . . 0.0 111.238 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 89.18 15.04 59.55 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.718 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -117.99 162.58 28.77 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -76.74 164.44 87.43 Favored 'Cis proline' 0 C--N 1.345 0.375 0 C-N-CA 123.634 -1.402 . . . . 0.0 113.306 0.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -130.68 163.41 27.29 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.167 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -73.22 159.87 32.8 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 33.0 mt -59.61 -31.78 47.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.344 0.592 . . . . 0.0 110.222 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -69.38 -12.03 61.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.183 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -85.58 -21.95 28.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.971 0.415 . . . . 0.0 111.253 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 47.8 tp -76.51 -53.95 7.38 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.126 0.488 . . . . 0.0 110.25 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -151.54 157.64 27.32 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.127 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 38.2 ttt180 -86.68 130.18 34.58 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.798 0.333 . . . . 0.0 110.676 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 106.34 -5.93 38.78 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.797 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 66.7 mt -76.98 151.44 81.94 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 120.633 0.254 . . . . 0.0 111.235 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.27 131.44 44.96 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.907 2.404 . . . . 0.0 111.633 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.74 -7.45 33.83 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.848 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -87.12 -56.59 3.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.197 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 8.4 ptmt -175.42 173.74 2.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.955 0.407 . . . . 0.0 111.224 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 34.6 mm -125.4 130.67 72.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.341 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -89.11 -41.95 11.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.165 0.507 . . . . 0.0 110.532 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -163.64 164.4 24.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.903 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -148.73 127.25 12.36 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 24.9 tp -118.47 119.83 35.74 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.06 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -87.81 113.91 23.93 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 4.2 t-105 -81.81 96.36 7.58 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 58.2 mtt -52.09 -51.21 73.62 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -49.29 -57.25 2.47 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.681 2.254 . . . . 0.0 114.383 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 37.1 p30 -84.29 -24.72 29.75 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 82.92 37.44 13.03 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 121.009 -0.615 . . . . 0.0 113.438 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -128.08 150.39 49.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 117.031 0.416 . . . . 0.0 110.913 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 2.0 m -101.04 127.01 47.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.035 0.445 . . . . 0.0 111.753 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -101.85 111.62 23.94 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.556 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -94.45 137.42 33.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.124 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -113.08 129.89 56.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.003 0.43 . . . . 0.0 111.321 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -141.26 105.01 4.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.23 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 67.47 -108.88 2.62 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.073 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -114.39 13.09 17.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.835 0.35 . . . . 0.0 110.763 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -123.62 151.46 42.98 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.276 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -126.95 138.92 53.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.435 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -110.58 143.78 40.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.716 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -109.35 99.5 8.74 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -92.25 132.55 36.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.521 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -106.8 113.38 26.83 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.621 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -50.89 -52.43 41.93 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' GLU . . . . . 0.467 ' CD ' ' HZ3' ' A' ' 375' ' ' LYS . 11.6 mp0 -64.89 -14.35 59.43 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -178.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 47.9 mt -113.86 -7.77 13.18 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 47.3 40.67 10.92 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.599 0.714 . . . . 0.0 112.472 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -154.73 171.32 19.75 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.505 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.5 t -96.81 142.8 13.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.278 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.55 153.0 10.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.64 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 11.1 m -70.48 155.26 40.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.365 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 71.41 26.97 3.18 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.483 0.658 . . . . 0.0 110.918 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -123.72 164.47 28.64 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.094 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -79.85 155.68 88.2 Favored 'Cis proline' 0 C--N 1.344 0.34 0 C-N-CA 123.637 -1.401 . . . . 0.0 112.631 0.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -106.78 171.84 7.14 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.853 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -68.85 136.93 53.44 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.556 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 12.9 tt -67.72 -15.73 20.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.079 0.466 . . . . 0.0 111.381 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -67.07 -2.3 5.33 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 71.6 t -62.62 -34.96 68.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -88.34 90.05 8.24 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -53.02 114.62 1.51 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.606 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 113.25 -15.96 22.57 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.347 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 45.8 mm -89.68 117.61 68.29 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.694 0.283 . . . . 0.0 111.083 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -79.2 153.24 24.49 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 123.088 2.525 . . . . 0.0 111.374 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -67.54 149.6 49.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.601 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.3 m 60.58 78.08 0.34 Allowed Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -88.05 -174.98 1.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.966 2.444 . . . . 0.0 111.481 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.79 9.6 3.34 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.108 0.48 . . . . 0.0 110.856 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 169.94 141.83 3.38 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 6.3 p -152.73 106.15 3.04 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -128.26 142.15 51.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.057 0.456 . . . . 0.0 111.605 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 47.9 ttm -95.44 134.63 38.05 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.556 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -67.08 163.22 45.39 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.018 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 1.4 m -66.46 -7.33 18.82 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.911 0.386 . . . . 0.0 111.346 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -84.94 -15.09 45.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.069 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 65.77 6.76 4.11 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 46.6 t -109.62 -40.09 4.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.738 0.304 . . . . 0.0 111.362 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -105.02 123.0 47.04 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 90.9 m -111.16 138.06 48.08 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -113.4 128.3 56.41 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -110.22 125.92 53.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.298 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -106.25 136.33 46.16 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -158.19 102.89 1.8 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.814 0.34 . . . . 0.0 111.89 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 57.63 72.33 0.61 Allowed Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 114.823 0.689 . . . . 0.0 114.823 178.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 69.62 -24.87 0.15 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -104.32 156.05 18.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.885 0.374 . . . . 0.0 111.63 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -133.29 147.04 51.89 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.107 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 10.5 m-90 -109.93 148.27 31.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.782 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -107.23 97.13 6.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.823 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 486' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -91.61 124.81 36.04 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.973 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -92.52 117.36 29.86 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -68.15 -32.15 72.22 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -76.4 -26.44 55.56 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -102.92 -15.98 16.0 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.423 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 4.1 tp 60.09 39.28 19.85 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.565 0.698 . . . . 0.0 110.641 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 31.2 tttp -159.31 149.19 18.85 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.255 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 54.9 t -73.03 134.76 29.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.114 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -70.55 146.97 94.51 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.286 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.4 160.25 40.13 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.938 2.425 . . . . 0.0 112.781 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 87.21 17.25 59.4 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -128.4 166.82 21.72 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.431 -0.385 . . . . 0.0 110.39 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.5 167.94 78.51 Favored 'Cis proline' 0 C--N 1.346 0.425 0 C-N-CA 123.857 -1.309 . . . . 0.0 113.102 0.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -121.99 164.94 16.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.155 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 22.5 t -77.56 109.35 11.44 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.94 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -68.46 -25.37 64.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.988 0.423 . . . . 0.0 110.429 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 74.1 mt -65.57 -26.74 67.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.747 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 30.2 ttm105 -99.74 -40.82 7.56 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.091 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.96 -23.57 36.03 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -177.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -114.1 -48.09 2.91 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 11.5 mmt -77.53 -26.52 51.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.026 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 83.15 26.42 44.37 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.208 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 60.4 m -98.21 110.42 56.12 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-O 120.719 0.295 . . . . 0.0 110.698 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.07 175.71 10.61 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.895 2.396 . . . . 0.0 112.07 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 6.9 m 66.55 15.63 10.17 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 CA-C-O 118.163 -1.354 . . . . 0.0 110.929 179.833 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.8 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.89 140.37 34.99 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.503 2.135 . . . . 0.0 111.903 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.35 171.65 51.13 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.439 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -81.33 176.63 8.52 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.967 2.444 . . . . 0.0 110.331 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.65 -160.5 20.31 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.35 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.27 164.72 6.41 Favored 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 122.961 2.441 . . . . 0.0 111.183 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.35 152.47 7.66 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.712 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -58.07 135.4 68.3 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.804 2.336 . . . . 0.0 111.735 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -61.28 147.0 46.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.611 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.23 153.48 42.51 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.261 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 2.4 mt -67.0 150.63 11.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 122.669 0.388 . . . . 0.0 110.577 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.21 145.39 49.68 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.29 156.04 50.91 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.766 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -66.25 141.72 57.93 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 15.1 ttt180 -65.61 148.5 51.64 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.656 0.265 . . . . 0.0 110.967 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.78 150.56 45.34 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 116.001 -0.545 . . . . 0.0 113.447 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 8.2 t -65.9 147.53 12.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.684 -0.258 . . . . 0.0 110.513 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 6.6 t -53.42 145.1 3.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.401 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.25 165.41 46.38 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.243 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 69.2 mt -84.92 149.89 25.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.793 -0.204 . . . . 0.0 110.969 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -72.58 164.77 54.65 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.411 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.74 152.9 64.62 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.54 2.16 . . . . 0.0 111.668 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.19 153.1 44.51 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.824 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.33 162.17 42.32 Favored 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 122.944 2.429 . . . . 0.0 111.823 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.16 171.46 53.98 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.302 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -65.24 158.21 53.47 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 123.134 2.556 . . . . 0.0 112.076 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.07 139.63 32.88 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.787 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -70.3 144.63 51.72 Favored 'Trans proline' 0 CA--C 1.529 0.251 0 C-N-CA 122.766 2.311 . . . . 0.0 110.909 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.507 0 N-CA-C 112.278 -0.329 . . . . 0.0 112.278 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -75.05 150.46 37.97 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 123.211 2.608 . . . . 0.0 111.738 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 102' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.79 175.9 54.11 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.559 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -85.88 161.95 10.44 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.114 2.543 . . . . 0.0 112.361 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 105' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -71.13 173.48 42.5 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.565 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.12 150.5 37.75 Favored 'Trans proline' 0 CA--C 1.528 0.185 0 C-N-CA 122.674 2.249 . . . . 0.0 111.549 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 108' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -57.9 163.33 8.44 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-N 115.662 -0.699 . . . . 0.0 113.687 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.44 150.04 88.78 Favored 'Trans proline' 0 C--O 1.237 0.425 0 C-N-CA 122.883 2.388 . . . . 0.0 112.524 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -55.84 134.72 52.02 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.951 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.23 160.77 26.74 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.799 -0.637 . . . . 0.0 113.277 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 53.4 mt -74.03 138.43 21.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 120.755 0.312 . . . . 0.0 110.231 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.19 146.39 55.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.899 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -63.79 156.08 44.04 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.448 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -75.04 159.06 32.19 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.64 0.257 . . . . 0.0 110.577 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 14.6 ttm-85 -68.72 146.65 52.76 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.67 168.21 36.2 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.024 -0.608 . . . . 0.0 113.158 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 4.3 t -75.51 144.98 11.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 92.6 t -61.57 139.11 21.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.516 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.28 167.3 40.15 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.701 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 82.5 mt -76.9 142.24 40.22 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.478 0.18 . . . . 0.0 111.033 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 123' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -68.63 169.2 41.84 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.75 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -75.51 158.37 40.25 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.685 2.257 . . . . 0.0 111.592 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 126' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.75 163.76 32.17 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.913 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -80.29 162.14 22.7 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.673 2.249 . . . . 0.0 111.427 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -66.89 177.09 19.85 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.972 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.47 147.97 90.58 Favored 'Trans proline' 0 C--O 1.237 0.454 0 C-N-CA 122.739 2.293 . . . . 0.0 111.868 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 132' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -62.18 129.04 42.88 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.072 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -75.4 110.98 3.21 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.65 2.234 . . . . 0.0 111.78 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 135' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 112.173 -0.371 . . . . 0.0 112.173 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -58.19 142.9 97.51 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.935 2.423 . . . . 0.0 111.743 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 202' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 99.75 -160.62 19.54 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.344 178.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.82 157.35 58.56 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 123.551 2.834 . . . . 0.0 112.824 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 205' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . 88.05 164.32 40.1 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.394 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -90.98 148.17 3.8 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.743 2.962 . . . . 0.0 112.137 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 208' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -72.2 167.84 52.74 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.887 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.6 160.0 48.19 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.785 2.323 . . . . 0.0 112.456 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -77.22 143.87 38.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.416 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -65.57 158.76 46.2 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.683 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 38.3 pt -67.01 151.42 10.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.893 0.377 . . . . 0.0 111.033 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -66.81 149.37 50.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.917 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -67.49 172.04 32.25 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 116.05 -0.523 . . . . 0.0 113.285 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 51.3 mm-40 -87.95 154.32 20.6 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -62.88 151.98 37.64 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.763 0.316 . . . . 0.0 111.191 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -64.23 156.81 44.53 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.324 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 6.4 t -67.43 147.2 12.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 50.5 t -63.71 143.01 16.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.98 162.05 23.27 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.225 -0.512 . . . . 0.0 112.687 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 5.9 mp -75.3 154.02 37.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.872 -0.164 . . . . 0.0 110.914 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 223' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -59.26 150.67 36.81 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.674 -0.694 . . . . 0.0 113.055 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.43 139.72 82.12 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 123.208 2.605 . . . . 0.0 111.843 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 226' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -64.6 158.39 43.65 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.369 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -83.42 162.37 14.9 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.897 2.398 . . . . 0.0 111.362 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -66.53 164.52 41.71 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.799 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -83.36 145.24 11.9 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.577 2.185 . . . . 0.0 111.195 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 232' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo . . . . . 0 N--CA 1.477 0.508 0 N-CA-C 109.776 -0.894 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -119.84 155.51 32.47 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 10.5 tt -69.84 -17.93 21.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.007 0.432 . . . . 0.0 111.517 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 61.3 m -88.94 3.7 50.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.243 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -72.66 -38.71 67.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.016 0.436 . . . . 0.0 110.747 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 80.5 -164.85 47.61 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.309 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 51.51 56.18 8.29 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.211 0.529 . . . . 0.0 110.877 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -79.31 160.46 26.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.412 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -73.17 -36.25 66.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.897 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 8.9 t -177.62 149.22 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.207 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 91.4 t -129.4 124.19 59.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -148.6 -176.32 5.27 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.942 0.401 . . . . 0.0 111.299 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 24.3 ttp -128.89 133.88 48.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.801 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 79.7 mt -125.91 111.24 14.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.376 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 58.24 33.06 22.79 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 102.82 -32.86 7.09 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.334 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -81.92 135.81 35.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.807 0.304 . . . . 0.0 111.24 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 44.9 ttm -90.54 124.53 35.09 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -114.49 129.85 56.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.091 0.472 . . . . 0.0 111.809 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 13.7 t -114.56 128.45 71.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -109.63 139.46 44.63 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 12.8 tptp -144.23 100.07 3.49 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.63 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 60.27 -104.46 0.19 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.13 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -110.47 8.77 23.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.588 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 15.3 m-90 -122.43 157.8 31.11 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -139.01 148.24 43.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.013 0.435 . . . . 0.0 111.351 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 4.2 m-90 -120.29 160.52 22.84 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.008 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.32 108.81 6.53 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 2.3 m -97.02 139.31 19.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.407 0.622 . . . . 0.0 111.96 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 7.6 mmt180 -138.87 111.96 7.96 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.943 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 62.87 46.5 4.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.585 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 48.5 t30 63.81 27.56 14.61 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.758 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -136.28 142.81 43.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.359 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 21.9 t -90.13 124.11 42.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 49.6 mtp -70.41 157.22 38.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.704 0.288 . . . . 0.0 111.035 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.32 158.76 34.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.024 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 95.16 -2.78 66.1 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.456 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -118.17 156.25 50.72 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.07 137.6 47.74 Favored 'Cis proline' 0 C--N 1.345 0.389 0 C-N-CA 123.504 -1.457 . . . . 0.0 112.536 0.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 59.6 ttm -114.69 135.56 22.36 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.422 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -58.86 138.0 83.16 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.369 2.046 . . . . 0.0 111.08 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 74.3 mt -52.27 -40.36 30.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.257 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -66.55 -12.66 59.4 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 121.087 -0.577 . . . . 0.0 114.255 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -79.94 -17.37 53.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.037 0.419 . . . . 0.0 111.541 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -126.82 -55.36 1.39 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.006 0.432 . . . . 0.0 110.453 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -86.99 76.82 9.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.319 0.581 . . . . 0.0 110.136 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -65.72 94.74 0.21 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.491 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 129.47 -12.68 5.97 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.162 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 21.3 tp -88.81 127.5 55.83 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.805 0.336 . . . . 0.0 111.117 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -78.81 167.89 21.68 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.096 2.531 . . . . 0.0 111.793 179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -73.18 152.86 40.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.223 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 5.7 m 57.65 86.88 0.07 Allowed 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 22.9 pt -95.44 179.97 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.329 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.36 -45.3 4.12 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 121.146 -0.222 . . . . 0.0 111.525 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.73 172.32 18.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.969 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -162.67 138.04 6.97 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -150.47 162.29 40.87 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -96.78 117.69 31.6 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -87.62 175.95 7.67 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -66.69 -16.97 64.6 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.616 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.22 -26.78 30.47 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.7 0.286 . . . . 0.0 111.675 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 114.87 -9.03 21.43 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.689 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -94.98 164.88 12.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.908 0.385 . . . . 0.0 111.427 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -99.0 127.38 44.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.591 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 15.7 t -107.57 113.6 44.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.126 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -99.27 145.1 27.64 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.803 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -124.79 143.55 50.74 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.419 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 44.3 tttp -155.21 99.28 2.07 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 75.08 -105.6 1.93 Allowed Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.539 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -119.42 7.74 11.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.937 0.399 . . . . 0.0 110.87 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -114.44 152.74 31.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.959 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -132.47 150.49 52.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.645 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 24.6 m-90 -127.53 138.96 53.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.105 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 75.3 t -117.38 115.67 49.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -106.49 126.04 51.76 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -91.88 84.68 5.4 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 177.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 69.85 -64.15 0.36 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.316 -178.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -145.51 -3.93 0.7 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 11.6 m -111.43 135.39 52.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.711 0.291 . . . . 0.0 111.284 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 62.3 tp -81.07 138.96 35.95 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.129 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -65.39 146.71 98.93 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.63 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -65.48 148.11 87.47 Favored 'Trans proline' 0 C--O 1.238 0.496 0 C-N-CA 123.036 2.491 . . . . 0.0 112.663 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 73.19 45.08 32.65 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.626 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -128.25 159.04 69.27 Favored Pre-proline 0 C--N 1.321 -0.649 0 O-C-N 122.859 -0.201 . . . . 0.0 110.811 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.6 156.61 95.78 Favored 'Cis proline' 0 C--O 1.236 0.397 0 C-N-CA 123.568 -1.43 . . . . 0.0 113.577 0.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -112.58 156.48 22.59 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -72.11 156.96 38.62 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 78.2 mt -57.33 -39.28 67.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.943 0.401 . . . . 0.0 111.087 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -69.58 -7.53 39.44 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -87.32 -15.04 39.15 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 48.8 tp -86.36 -36.83 18.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.888 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -169.65 156.09 26.7 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.731 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -90.65 136.14 33.25 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.722 0.296 . . . . 0.0 110.75 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 102.18 4.83 50.39 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.426 -0.669 . . . . 0.0 111.426 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 88.9 mt -89.79 148.51 40.04 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 120.47 0.176 . . . . 0.0 111.014 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -58.0 119.24 6.37 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.696 2.264 . . . . 0.0 111.075 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.96 7.37 31.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.58 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -99.2 -54.99 2.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.82 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 15.6 ptmt -175.53 169.69 3.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.561 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 46.2 mm -121.82 126.23 74.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -82.38 -43.7 17.04 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.895 0.378 . . . . 0.0 110.698 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -157.65 154.8 28.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.301 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -134.83 119.32 17.99 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 42.0 tp -115.17 117.97 32.03 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.872 0.368 . . . . 0.0 111.778 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -91.24 118.25 30.31 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.208 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 15.6 t-105 -87.67 99.02 11.76 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 63.3 mtt -52.44 -52.57 62.12 Favored Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -48.23 -40.34 35.01 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.898 2.399 . . . . 0.0 114.913 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 39.6 p30 -103.09 -28.79 11.75 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 88.24 29.49 19.65 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.612 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -122.29 141.61 51.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.833 0.349 . . . . 0.0 110.589 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 60.1 m -103.17 130.03 50.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.419 0.628 . . . . 0.0 111.646 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -98.64 122.79 42.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.839 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -98.54 121.73 40.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.653 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -98.6 132.31 44.11 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.473 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -145.07 107.14 4.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.205 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 69.71 -117.41 7.58 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -113.22 16.28 19.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.258 0.551 . . . . 0.0 110.712 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -125.89 150.51 47.86 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.366 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -129.85 142.7 50.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.063 0.459 . . . . 0.0 111.457 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -109.09 147.57 32.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.428 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -107.14 94.74 5.26 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -81.49 119.59 23.93 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.414 0.626 . . . . 0.0 112.068 -178.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -86.33 94.93 9.48 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -54.8 -30.74 57.83 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -82.89 -10.74 58.68 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 50.3 mt -119.28 -12.41 9.42 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 52.9 mtm180 61.24 44.39 9.88 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.443 0.639 . . . . 0.0 111.858 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -163.24 154.95 17.52 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.769 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 93.9 t -80.99 137.56 21.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.048 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -62.79 163.47 9.34 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.306 0.574 . . . . 0.0 111.883 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.99 161.93 30.19 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.283 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 72.03 20.85 4.22 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.188 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -125.0 158.97 61.15 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.999 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.0 161.16 91.5 Favored 'Cis proline' 0 C--N 1.345 0.386 0 C-N-CA 123.766 -1.347 . . . . 0.0 112.574 1.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -114.24 172.51 6.96 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.78 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -72.42 140.99 48.67 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.2 tt -67.51 -12.04 14.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.078 0.466 . . . . 0.0 110.772 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -65.84 -10.16 35.46 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 81.2 t -61.34 -34.51 61.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 177.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -88.1 84.39 6.93 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.48 115.67 2.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.763 -178.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 103.24 -11.59 55.05 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.833 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 27.5 mm -89.36 126.09 59.62 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 120.808 0.337 . . . . 0.0 111.188 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.91 152.26 21.86 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.827 2.351 . . . . 0.0 111.41 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.64 157.6 33.52 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.84 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.5 m 56.86 69.43 1.72 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.577 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -87.91 -179.29 2.47 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.04 2.493 . . . . 0.0 111.637 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 7.7 tpp85 -144.46 36.11 1.2 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.519 0.676 . . . . 0.0 110.08 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 161.81 132.8 1.38 Allowed Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.342 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 6.0 p -155.56 106.32 2.51 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -133.35 142.67 48.53 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.028 0.442 . . . . 0.0 111.782 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 42.2 ttm -92.61 140.31 29.67 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.542 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -69.32 166.95 47.59 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.274 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 1.5 m -68.03 -7.41 28.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.15 0.5 . . . . 0.0 111.681 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -86.27 -20.87 27.79 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.756 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 70.34 13.65 7.54 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.748 0.655 . . . . 0.0 112.27 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 19.4 t -114.82 -34.3 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 120.781 0.324 . . . . 0.0 111.343 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -113.76 133.79 55.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.209 0.528 . . . . 0.0 111.986 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 84.9 m -119.03 140.07 50.65 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.936 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -110.32 134.38 52.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.882 0.372 . . . . 0.0 111.782 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -116.08 141.66 47.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.47 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -120.69 134.92 55.25 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.994 0.184 . . . . 0.0 111.27 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -168.52 126.68 1.1 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.443 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 63.63 42.6 98.71 Favored Glycine 0 N--CA 1.454 -0.154 0 CA-C-N 116.086 -0.506 . . . . 0.0 113.751 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 54.6 t30 68.29 3.19 3.59 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 25.6 mtmt -116.24 157.89 24.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.048 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -130.57 146.7 52.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.023 0.44 . . . . 0.0 111.695 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 16.8 m-90 -114.62 151.25 33.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.615 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -110.76 98.65 7.75 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 486' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -90.96 131.65 36.44 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.768 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -96.02 120.42 36.27 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -66.91 -29.49 69.38 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 52.0 tp60 -83.16 -39.35 21.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.827 0.346 . . . . 0.0 111.726 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -83.53 -19.87 34.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.484 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 18.3 tp 61.22 34.02 18.93 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.481 0.658 . . . . 0.0 110.036 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 25.8 tttp -156.03 150.2 25.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.567 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 56.8 t -70.19 137.79 23.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.42 138.71 86.5 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.821 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -60.08 145.01 99.42 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 123.156 2.571 . . . . 0.0 112.644 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 109.61 -6.69 31.63 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -109.75 169.1 6.77 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -76.85 171.53 67.64 Favored 'Cis proline' 0 C--N 1.35 0.647 0 C-N-CA 124.022 -1.241 . . . . 0.0 113.083 0.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -131.83 164.28 26.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.97 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 48.1 t -72.72 122.27 21.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.512 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -67.98 -29.76 68.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.068 0.461 . . . . 0.0 110.605 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 63.6 mt -68.01 -41.58 82.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.354 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -77.75 -37.33 49.35 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -93.58 -27.49 16.59 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -176.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 36.6 m0 -109.56 -50.7 2.96 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 11.3 mmt -73.02 -26.57 61.36 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -178.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 88.77 25.91 28.49 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.813 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 21.7 m -106.03 105.74 54.58 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 120.627 0.251 . . . . 0.0 110.743 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -84.61 176.15 6.5 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.867 2.378 . . . . 0.0 111.82 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 40.2 m 62.14 46.83 6.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.468 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.421 -1.211 . . . . 0.0 110.589 179.561 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.897 0 N-CA-C 112.295 -0.322 . . . . 0.0 112.295 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.05 156.56 47.3 Favored 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 122.821 2.347 . . . . 0.0 111.777 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.04 169.05 51.48 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.52 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -82.32 174.27 10.04 Favored 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 122.88 2.387 . . . . 0.0 111.021 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.04 -157.59 17.46 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.326 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -58.55 159.48 19.96 Favored 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 122.973 2.449 . . . . 0.0 111.866 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 160.57 155.49 7.8 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.687 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -63.19 137.28 60.39 Favored 'Trans proline' 0 C--O 1.238 0.498 0 C-N-CA 122.87 2.38 . . . . 0.0 111.839 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -65.47 143.35 57.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.133 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.63 153.2 24.99 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.987 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 mt -72.62 150.85 8.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.73 142.45 58.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.226 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.03 168.49 33.1 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.886 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -74.36 145.09 44.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.678 0.275 . . . . 0.0 110.782 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.55 136.18 54.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.973 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.8 144.34 34.79 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.985 -0.552 . . . . 0.0 113.687 -179.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 4.1 t -64.39 147.11 12.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 9.7 t -54.57 147.13 3.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.05 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.55 177.82 46.16 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.639 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 86.7 mt -87.96 153.45 21.28 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.418 0.151 . . . . 0.0 110.648 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.4 154.16 48.22 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.993 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -69.2 151.99 72.24 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.772 2.314 . . . . 0.0 112.154 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.88 165.07 34.52 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.212 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.05 171.42 17.19 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.187 2.591 . . . . 0.0 111.627 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.49 174.75 53.59 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.76 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -72.48 148.97 49.16 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 123.153 2.569 . . . . 0.0 111.643 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.28 139.13 47.43 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.783 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -69.72 130.74 19.91 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.487 2.124 . . . . 0.0 111.098 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.433 0 N-CA-C 112.29 -0.324 . . . . 0.0 112.29 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -69.96 130.7 19.53 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.898 2.399 . . . . 0.0 111.9 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 102' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -78.08 164.49 51.46 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.834 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -80.95 158.21 20.84 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.895 2.396 . . . . 0.0 112.528 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 105' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.61 -178.69 43.7 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.297 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -80.1 165.28 21.7 Favored 'Trans proline' 0 CA--C 1.528 0.18 0 C-N-CA 123.213 2.608 . . . . 0.0 110.886 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 108' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -65.99 165.98 37.32 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.811 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.85 157.45 61.31 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.749 2.299 . . . . 0.0 112.552 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -60.78 139.0 58.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.815 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -67.61 168.33 39.54 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.029 -0.605 . . . . 0.0 113.256 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 28.4 mt -68.6 138.18 22.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.86 147.58 51.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.966 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.54 149.27 48.72 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 116.058 -0.519 . . . . 0.0 113.196 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -78.27 143.61 36.89 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 122.283 0.233 . . . . 0.0 110.617 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 52.9 ttm-85 -62.19 145.25 54.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.632 0.253 . . . . 0.0 110.742 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.45 168.9 37.92 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.691 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -77.26 149.15 6.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.521 0.2 . . . . 0.0 110.475 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 63.4 t -64.61 137.55 24.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.982 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.36 161.78 50.24 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 121.11 -0.566 . . . . 0.0 112.42 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 88.9 mt -71.64 136.97 47.56 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 123' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -63.81 162.86 33.95 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.737 -0.665 . . . . 0.0 113.595 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.18 152.52 50.65 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.916 2.411 . . . . 0.0 111.647 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 126' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.79 163.55 32.7 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.365 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.38 160.64 44.35 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.632 2.222 . . . . 0.0 111.484 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -69.41 171.12 40.95 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.653 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -62.58 151.38 83.67 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.795 2.33 . . . . 0.0 111.59 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 132' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.11 123.38 12.46 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.551 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -77.28 107.96 2.51 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 123.005 2.47 . . . . 0.0 111.88 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 135' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.387 0 N-CA-C 112.17 -0.372 . . . . 0.0 112.17 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -62.2 144.98 96.33 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.783 2.322 . . . . 0.0 111.488 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 202' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 94.18 -175.86 35.27 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.253 -0.975 . . . . 0.0 114.346 178.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -64.13 156.43 59.17 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.896 3.064 . . . . 0.0 113.265 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 205' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . 91.28 170.16 42.37 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.988 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -89.15 151.32 5.65 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.187 2.591 . . . . 0.0 112.326 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 208' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -78.59 166.61 52.39 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.086 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -68.12 158.35 57.85 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.643 2.229 . . . . 0.0 112.237 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -79.49 147.31 32.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.886 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.97 161.49 36.78 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.167 -0.54 . . . . 0.0 112.286 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 40.5 pt -66.79 166.92 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.63 0.252 . . . . 0.0 111.168 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -80.64 138.99 36.45 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.912 0.387 . . . . 0.0 110.685 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -63.15 156.08 41.98 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.017 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -71.0 150.18 45.9 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -62.29 152.25 34.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.45 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -58.97 154.2 28.87 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.667 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 15.8 t -66.74 143.15 15.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 21.9 t -63.01 143.26 15.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.047 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.22 162.66 31.98 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.777 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 7.3 mp -76.15 157.33 32.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.489 0.185 . . . . 0.0 110.778 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 223' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -65.52 148.22 51.08 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.339 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -62.27 148.28 93.52 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.837 2.358 . . . . 0.0 111.506 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 226' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -64.11 159.61 40.12 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.999 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.87 162.26 29.61 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.03 2.487 . . . . 0.0 111.443 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -73.2 167.3 54.29 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.561 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -83.39 157.79 14.67 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.654 2.236 . . . . 0.0 110.816 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 232' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 N--CA 1.479 0.65 0 N-CA-C 110.06 -0.785 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -115.27 161.2 18.8 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 17.6 tt -70.42 -23.42 24.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.08 0.467 . . . . 0.0 110.875 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 59.0 m -80.9 -1.1 42.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.227 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -71.33 -20.98 62.11 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.13 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 76.22 -177.31 50.83 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.822 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 24.4 m120 48.79 83.52 0.04 OUTLIER 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -100.62 168.67 9.55 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.222 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -77.35 -40.73 43.02 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 7.0 t -171.46 154.72 3.92 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.928 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 67.7 t -130.5 125.71 59.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -136.89 170.47 16.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.006 0.431 . . . . 0.0 110.898 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 41.4 ttp -130.08 87.06 2.47 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.568 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 45.5 mt -85.7 123.8 31.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.48 -178.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 31.5 mmt-85 63.71 19.37 11.69 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.203 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 93.2 -3.61 73.04 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.631 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -95.45 128.44 42.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.853 0.359 . . . . 0.0 110.356 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 38.5 ttm -77.03 110.92 12.07 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.251 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -110.29 122.83 48.61 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.988 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 27.2 t -109.73 122.34 64.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.47 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -106.21 132.04 52.75 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.731 0.3 . . . . 0.0 111.46 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -148.37 112.38 5.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.42 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 64.76 -113.01 0.31 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.922 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 15.4 ptt-85 -114.63 11.78 17.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.857 0.361 . . . . 0.0 111.107 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 15.0 m-90 -122.99 155.07 37.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.933 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -135.85 148.69 48.76 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.686 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 29.2 m-90 -124.47 162.5 23.82 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.462 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.13 114.99 9.07 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 2.5 m -103.3 136.86 34.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.262 0.553 . . . . 0.0 112.083 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -135.84 123.26 22.0 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 5.6 m120 66.14 35.21 6.27 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 123.564 0.54 . . . . 0.0 110.614 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 17.5 t30 63.14 33.12 14.71 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.048 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -143.03 143.52 31.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.563 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 14.0 t -83.65 131.39 33.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 91.1 mtp -84.44 172.57 11.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.904 0.383 . . . . 0.0 111.513 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -77.47 158.38 30.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.23 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 98.02 -5.47 61.48 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.045 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -117.64 152.72 50.08 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.58 140.01 63.1 Favored 'Cis proline' 0 C--N 1.343 0.286 0 C-N-CA 123.215 -1.577 . . . . 0.0 112.834 0.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 57.1 ttm -119.85 135.94 24.56 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.94 134.77 64.59 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.327 2.018 . . . . 0.0 110.931 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 94.0 mt -51.91 -42.32 33.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.814 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -67.83 -8.11 51.61 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 116.029 -0.532 . . . . 0.0 114.271 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.72 -32.87 27.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.259 0.529 . . . . 0.0 110.447 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -104.47 -56.32 2.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.966 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -86.13 74.95 9.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.712 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -63.45 100.92 0.28 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.896 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 129.31 -16.7 5.68 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.299 -0.721 . . . . 0.0 111.299 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 22.6 tp -92.38 134.05 28.82 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -82.87 -167.08 0.43 Allowed 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 123.033 2.488 . . . . 0.0 112.258 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -96.94 157.81 15.72 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.051 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 27.7 m 54.73 80.31 0.13 Allowed 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 17.9 pt -93.57 170.26 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.013 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.93 -39.25 7.02 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -178.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.13 160.45 42.89 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.657 0.265 . . . . 0.0 111.288 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -153.08 138.2 17.35 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -166.09 174.66 9.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.683 0.278 . . . . 0.0 111.076 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -104.92 131.51 52.33 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -88.61 -177.99 5.7 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.404 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.438 ' HZ3' ' CD ' ' A' ' 441' ' ' GLU . 7.6 tttp -65.64 -34.23 77.75 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -21.82 64.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.98 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 109.77 -10.99 32.45 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.962 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 19.8 mttp -86.06 160.28 19.34 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 117.266 0.533 . . . . 0.0 111.409 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -88.35 130.57 35.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.181 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 8.9 t -113.86 119.7 61.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.004 0.431 . . . . 0.0 110.194 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -107.37 140.16 40.73 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.67 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -121.49 139.91 52.87 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.983 0.421 . . . . 0.0 111.603 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -154.2 114.05 3.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.744 178.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 66.76 -107.24 1.92 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.692 -0.765 . . . . 0.0 111.481 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -122.62 8.82 9.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.21 0.529 . . . . 0.0 110.165 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -114.84 152.37 32.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.795 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 -134.27 150.93 51.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.394 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 16.7 m-90 -122.64 142.58 50.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.186 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 85.6 t -124.38 119.13 55.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -118.62 126.79 52.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.977 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -93.79 95.08 8.9 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 177.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 69.96 -78.32 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.812 0.695 . . . . 0.0 110.273 -178.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -140.87 16.87 2.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.965 0.412 . . . . 0.0 111.05 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 9.1 m -123.24 126.9 47.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.956 0.407 . . . . 0.0 111.723 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 46.6 tp -76.54 140.19 41.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.428 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -71.6 136.63 83.31 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.307 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.0 131.99 32.83 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.81 2.34 . . . . 0.0 112.096 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 108.07 -11.44 37.42 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.841 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -93.5 161.01 31.85 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 110.543 -0.169 . . . . 0.0 110.543 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.96 160.33 85.77 Favored 'Cis proline' 0 C--N 1.348 0.537 0 C-N-CA 123.909 -1.288 . . . . 0.0 113.205 0.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -135.45 161.93 34.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.819 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 -70.37 153.91 42.48 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 77.6 mt -57.61 -37.81 60.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.099 0.476 . . . . 0.0 111.095 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -68.1 -10.08 51.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.99 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -79.65 -20.6 46.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.809 0.337 . . . . 0.0 110.767 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 36.9 tp -80.15 -61.81 1.87 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.264 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -143.21 154.91 25.74 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.063 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -79.61 132.06 36.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.667 -0.266 . . . . 0.0 110.336 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 102.29 -4.3 51.5 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.317 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 50.2 mt -77.33 146.0 73.46 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 120.63 0.252 . . . . 0.0 110.976 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -57.07 131.91 48.22 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.734 2.289 . . . . 0.0 112.075 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.69 -0.5 37.24 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.293 0.568 . . . . 0.0 110.42 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -90.13 -53.13 4.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.941 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -179.15 170.9 1.39 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.826 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 42.6 mm -124.61 133.01 70.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -90.63 -47.15 7.85 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.117 0.485 . . . . 0.0 110.234 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -155.26 159.68 40.23 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.339 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -142.45 113.68 7.7 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 35.1 tp -109.61 123.2 49.04 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.407 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -88.36 114.64 25.18 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.062 0.458 . . . . 0.0 110.086 178.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 15.3 t-105 -83.63 94.23 8.06 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.509 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 62.6 mtt -50.74 -50.72 71.69 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -43.01 -48.97 7.32 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 123.011 2.474 . . . . 0.0 114.867 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -105.07 -13.8 15.62 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 75.23 33.7 53.23 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.162 -0.542 . . . . 0.0 113.204 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -116.38 149.22 39.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.796 0.298 . . . . 0.0 110.456 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 6.4 m -98.23 128.0 44.47 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.203 0.525 . . . . 0.0 112.218 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -102.78 109.08 20.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.948 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -91.89 129.68 37.81 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.461 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -106.18 129.62 54.2 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.004 0.431 . . . . 0.0 110.988 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -139.21 102.98 4.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.336 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 63.44 -109.5 2.78 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.318 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -110.82 11.96 22.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.031 0.443 . . . . 0.0 110.62 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -122.91 152.38 40.86 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.966 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -133.82 139.2 46.11 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.383 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -111.62 145.2 39.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.829 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 20.9 ttp180 -106.01 100.62 10.16 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -85.06 120.41 26.54 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.235 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -95.61 106.79 18.93 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.537 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -58.16 -39.06 77.85 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.597 0.56 . . . . 0.0 111.48 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' GLU . . . . . 0.438 ' CD ' ' HZ3' ' A' ' 375' ' ' LYS . 1.9 mp0 -61.16 -20.56 62.85 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 13.8 mt -127.72 3.5 6.09 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 43.03 47.37 5.03 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.493 0.663 . . . . 0.0 112.315 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -154.51 172.65 17.45 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.132 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.6 t -88.24 138.94 18.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.149 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.32 160.81 15.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.525 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.7 m -67.13 151.96 46.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.446 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 78.45 -6.68 1.9 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.51 0.724 . . . . 0.0 111.786 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -98.23 154.68 37.55 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.702 -0.227 . . . . 0.0 111.418 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.4 162.71 91.94 Favored 'Cis proline' 0 C--N 1.345 0.364 0 C-N-CA 123.439 -1.484 . . . . 0.0 112.998 0.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -121.94 178.17 5.0 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -78.07 137.01 38.01 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.721 0.296 . . . . 0.0 110.298 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.5 tt -63.97 -17.48 20.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -63.48 -9.16 11.53 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 53.7 t -63.07 -33.9 63.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -91.5 94.76 9.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.362 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -56.08 105.2 0.17 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 114.25 -7.8 22.95 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.515 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 24.7 mm -84.58 127.44 65.56 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 121.006 0.431 . . . . 0.0 111.065 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -77.99 138.93 16.87 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.893 2.395 . . . . 0.0 113.042 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -66.66 140.81 57.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.293 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 2.7 m 57.74 71.44 1.07 Allowed Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -87.28 -171.28 0.7 Allowed 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.423 2.082 . . . . 0.0 111.632 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -143.63 20.55 1.84 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.212 0.529 . . . . 0.0 110.891 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 177.92 142.0 4.44 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 13.0 p -162.65 110.65 1.31 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.6 0.238 . . . . 0.0 110.731 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -138.98 144.44 38.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.866 0.365 . . . . 0.0 111.251 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 48.7 ttm -95.47 143.05 27.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.022 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . 0.481 ' C ' ' H ' ' A' ' 471' ' ' ASP . . . -72.67 163.91 54.76 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.962 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.94 30.25 0.09 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.167 0.508 . . . . 0.0 111.901 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . 0.481 ' H ' ' C ' ' A' ' 469' ' ' GLY . 1.0 OUTLIER -126.73 -14.28 5.71 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.294 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 67.24 9.44 6.96 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.3 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 40.2 t -106.71 -45.25 7.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.859 0.361 . . . . 0.0 111.133 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -108.09 132.13 53.89 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 97.0 m -116.79 138.95 51.13 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.689 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -114.15 126.52 55.17 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -110.08 141.78 42.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.145 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -123.04 135.0 54.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.705 0.288 . . . . 0.0 111.566 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 61.8 tttt -166.87 128.25 1.66 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.078 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 59.56 43.18 97.82 Favored Glycine 0 CA--C 1.516 0.148 0 N-CA-C 114.667 0.627 . . . . 0.0 114.667 178.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 58.4 t30 68.92 3.94 4.25 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 178.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -116.84 152.19 34.95 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -128.12 145.17 51.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.114 0.483 . . . . 0.0 111.813 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 16.8 m-90 -112.77 138.09 50.11 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.499 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -101.88 96.12 6.84 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 486' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -87.77 133.26 33.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.566 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -100.32 117.13 33.89 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -66.55 -34.44 77.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.768 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -68.76 -32.93 73.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.68 -178.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -98.5 -20.54 17.02 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 1.3 tp 66.11 39.26 4.4 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.795 0.807 . . . . 0.0 109.814 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 31.5 tttp -160.17 153.36 21.88 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.386 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 52.8 t -78.04 133.5 30.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 178.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -59.42 137.46 89.04 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.41 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -61.85 152.01 77.39 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.979 2.453 . . . . 0.0 112.284 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 94.37 9.48 59.07 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.684 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -117.43 170.17 6.49 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -78.29 -178.72 24.76 Favored 'Cis proline' 0 C--N 1.348 0.53 0 C-N-CA 124.104 -1.207 . . . . 0.0 112.865 0.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -135.29 155.25 50.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.176 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.29 116.33 10.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.565 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -63.47 -23.6 67.47 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 13.4 mt -61.15 -49.65 76.35 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -83.05 -29.08 29.12 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.05 -35.73 21.69 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 44.3 m0 -116.29 -45.07 2.85 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -177.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 9.7 mmt -75.5 -17.77 60.01 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -177.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 76.41 21.95 74.15 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.742 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 16.9 m -104.38 111.07 65.11 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 120.754 0.311 . . . . 0.0 110.898 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -86.27 -167.47 0.38 Allowed 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.873 2.382 . . . . 0.0 111.525 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 16.2 m 60.34 37.63 20.08 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.046 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.386 -1.23 . . . . 0.0 111.832 -179.506 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.669 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -80.06 150.3 20.44 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 122.543 2.162 . . . . 0.0 111.433 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -60.71 164.37 16.73 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.9 -0.591 . . . . 0.0 113.661 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.34 171.1 17.48 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.874 2.383 . . . . 0.0 110.966 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.6 -164.67 35.47 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.768 -0.73 . . . . 0.0 111.913 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -63.07 165.81 15.89 Favored 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 122.678 2.252 . . . . 0.0 111.463 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 149.24 176.2 22.29 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.65 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.11 138.33 51.56 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.769 2.312 . . . . 0.0 111.561 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -66.67 150.27 49.3 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.084 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.18 143.07 46.24 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.355 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 mp -64.86 137.93 24.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.01 143.41 22.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.129 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.64 164.77 41.8 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.106 -0.568 . . . . 0.0 113.17 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -75.11 150.34 38.83 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -70.22 146.49 50.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.525 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.95 155.24 48.84 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.492 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.2 t -66.3 149.76 11.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.554 0.216 . . . . 0.0 110.667 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 6.0 t -53.92 145.71 3.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.24 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.99 161.25 52.08 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 116.035 -0.529 . . . . 0.0 113.153 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 87.4 mt -76.78 147.22 37.38 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.703 -0.248 . . . . 0.0 110.756 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.12 157.11 52.69 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.847 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.42 158.54 51.12 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.609 2.206 . . . . 0.0 111.412 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.96 164.61 49.6 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.864 -0.607 . . . . 0.0 113.153 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -74.62 157.39 44.38 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.798 2.332 . . . . 0.0 111.864 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.2 174.14 52.2 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.168 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -74.71 152.95 42.96 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.29 2.66 . . . . 0.0 111.766 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.62 137.46 42.11 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.596 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -63.64 117.21 4.19 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.759 2.306 . . . . 0.0 111.033 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.506 0 CA-C-O 119.952 -0.36 . . . . 0.0 112.586 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.72 124.49 15.12 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.952 2.435 . . . . 0.0 112.084 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 102' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -67.97 160.08 50.67 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.446 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -84.05 162.91 13.62 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.957 2.438 . . . . 0.0 111.95 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 105' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -74.68 176.79 48.1 Favored Glycine 0 C--O 1.24 0.511 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.52 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.8 148.32 36.11 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.961 2.44 . . . . 0.0 110.742 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 108' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -67.91 172.88 32.21 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.615 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.27 163.98 37.01 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.886 2.391 . . . . 0.0 112.116 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -65.6 137.63 57.49 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.15 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.48 166.63 30.02 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.841 -0.618 . . . . 0.0 113.562 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 79.9 mt -63.8 137.72 24.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.752 0.31 . . . . 0.0 110.847 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.11 145.15 54.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.538 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -59.16 148.37 40.4 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.627 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -75.2 156.8 35.44 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.673 0.273 . . . . 0.0 110.464 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 38.0 ttm-85 -69.67 147.34 50.74 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.302 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.9 170.0 52.13 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.485 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 21.6 t -69.23 138.95 21.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.606 0.241 . . . . 0.0 110.651 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 58.0 t -62.42 137.33 24.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.661 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.31 158.62 30.77 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.26 -0.495 . . . . 0.0 112.851 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 95.7 mt -75.91 152.55 37.1 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.391 0.138 . . . . 0.0 110.922 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 123' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -70.46 165.41 51.99 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.496 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.53 155.15 55.17 Favored 'Trans proline' 0 CA--C 1.529 0.233 0 C-N-CA 122.691 2.261 . . . . 0.0 111.581 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 126' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -66.0 166.75 36.09 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.902 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -69.37 148.91 68.64 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.579 2.186 . . . . 0.0 111.562 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.3 156.72 29.6 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.885 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -70.73 158.49 55.56 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.913 2.409 . . . . 0.0 111.696 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 132' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -74.89 127.23 9.32 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.925 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.83 114.95 3.72 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 122.881 2.387 . . . . 0.0 111.889 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 135' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.335 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.98 156.64 63.45 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 122.946 2.431 . . . . 0.0 111.807 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 202' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 89.94 -172.29 38.42 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.993 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -65.64 155.64 68.01 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 123.454 2.769 . . . . 0.0 112.722 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 205' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . 91.05 171.82 43.36 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.965 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -96.05 160.43 1.36 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.424 2.75 . . . . 0.0 112.519 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 208' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -77.16 169.09 54.88 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.05 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.26 141.1 73.97 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.471 2.114 . . . . 0.0 112.23 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -65.87 150.93 47.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.929 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -67.46 160.33 49.47 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.357 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 45.6 pt -69.21 174.11 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 120.819 0.343 . . . . 0.0 111.439 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -77.67 147.86 35.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.499 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -74.48 158.02 51.28 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.773 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -77.52 151.6 34.48 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.623 0.249 . . . . 0.0 110.488 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -66.58 156.23 35.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.989 0.424 . . . . 0.0 110.571 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -66.23 151.37 52.09 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.185 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 11.5 t -65.82 148.77 11.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 61.6 t -63.03 139.1 21.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-O 120.725 0.297 . . . . 0.0 110.425 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.33 157.22 28.86 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.516 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 9.2 mp -65.03 149.2 50.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.751 -0.224 . . . . 0.0 110.889 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 223' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -60.04 153.26 34.91 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.855 -0.612 . . . . 0.0 113.175 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -69.98 148.85 64.58 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 123.031 2.487 . . . . 0.0 111.466 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 226' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -64.45 158.7 42.65 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.773 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.93 161.45 33.05 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 122.701 2.267 . . . . 0.0 111.954 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -78.32 -175.74 45.68 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.444 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -92.82 155.04 2.79 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.298 2.665 . . . . 0.0 112.511 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 232' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo . . . . . 0 N--CA 1.479 0.665 0 N-CA-C 110.26 -0.708 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -110.79 166.3 11.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.423 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 8.5 tp -72.78 -31.04 34.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.051 0.453 . . . . 0.0 110.64 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 59.0 m -82.77 10.24 8.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.94 0.4 . . . . 0.0 111.457 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.72 -32.02 70.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.437 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 79.96 -176.81 54.57 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.481 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 3.5 t30 53.9 78.79 0.15 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.046 0.45 . . . . 0.0 111.218 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -96.04 154.79 17.05 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.902 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.25 -40.53 62.31 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.221 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 1.8 t -170.86 146.54 2.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.448 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 60.6 t -131.97 126.25 56.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -149.33 176.81 10.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.053 0.454 . . . . 0.0 111.231 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 41.3 ttp -127.16 122.37 33.93 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 54.3 mt -114.64 119.75 37.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.902 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 55.82 26.04 9.14 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 101.96 -10.63 57.17 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.684 -0.77 . . . . 0.0 113.356 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -100.25 130.01 46.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.929 0.395 . . . . 0.0 111.306 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 45.2 ttm -84.05 124.43 31.08 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -119.56 120.5 36.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.132 0.492 . . . . 0.0 111.572 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 23.1 t -105.31 115.22 46.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -99.74 131.67 45.58 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -144.18 109.25 5.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.174 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 61.31 -102.39 0.12 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.894 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.7 ptm85 -119.48 12.97 12.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.878 0.37 . . . . 0.0 111.361 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 13.3 m-90 -125.71 153.73 43.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.71 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -136.35 141.76 43.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.863 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 21.0 m-90 -115.59 147.09 41.15 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.882 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -116.48 92.81 3.99 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 10.2 m -91.42 128.39 43.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.619 -179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 42.5 ttm-85 -131.82 118.85 20.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.428 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 63.03 41.42 8.29 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.869 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 34.9 t30 68.29 15.37 9.3 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.353 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -126.58 129.26 48.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.72 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.57 121.98 29.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.661 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 26.0 ttp -66.94 151.57 47.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.788 0.327 . . . . 0.0 110.501 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -69.51 161.08 30.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.195 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 90.21 7.07 68.13 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.06 -0.591 . . . . 0.0 111.908 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -128.78 162.22 52.88 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.37 144.04 76.77 Favored 'Cis proline' 0 C--N 1.346 0.396 0 C-N-CA 123.815 -1.327 . . . . 0.0 112.943 0.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.23 144.36 31.04 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.36 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -68.2 129.65 19.74 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.541 2.16 . . . . 0.0 111.358 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 85.3 mt -56.53 -41.6 73.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.479 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -65.7 -17.57 64.99 Favored Glycine 0 CA--C 1.518 0.25 0 N-CA-C 114.603 0.601 . . . . 0.0 114.603 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -84.65 -45.11 12.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.237 0.519 . . . . 0.0 111.063 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -82.72 -53.92 5.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.189 0.519 . . . . 0.0 110.555 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -92.61 70.24 4.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.553 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -59.41 101.88 0.12 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.208 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 128.95 -20.79 5.35 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 18.8 tp -85.7 134.61 39.39 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -82.43 -175.17 2.36 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.813 2.342 . . . . 0.0 112.145 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -91.06 153.0 20.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.502 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.0 m 57.12 83.06 0.11 Allowed 'General case' 0 C--O 1.233 0.232 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 13.7 pt -94.9 176.19 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.898 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -111.55 -38.2 4.99 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 1.6 m -149.97 156.23 41.36 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.798 0.332 . . . . 0.0 111.54 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -149.15 135.82 19.54 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -158.48 165.08 35.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.117 0.484 . . . . 0.0 112.191 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 62.5 tt0 -99.14 133.92 42.73 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -95.44 -170.69 2.21 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -77.17 -23.56 51.55 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -177.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.63 -11.05 57.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 104.23 -14.37 51.51 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.854 -0.689 . . . . 0.0 113.949 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 25.2 mttp -82.05 163.66 21.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.305 0.553 . . . . 0.0 111.867 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -99.96 135.56 41.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.351 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 12.2 t -116.43 122.02 68.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.254 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -108.2 139.8 42.35 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.56 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -122.01 140.15 52.83 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.71 0.291 . . . . 0.0 111.163 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -154.69 114.13 3.72 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.741 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 67.24 -110.25 3.37 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.833 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -119.32 12.96 12.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.941 0.401 . . . . 0.0 111.185 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -122.14 152.96 39.35 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.894 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -133.9 148.31 51.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.22 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 21.5 m-90 -122.4 140.41 52.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.149 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 69.5 t -120.34 120.2 62.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -115.8 127.77 55.33 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -90.79 86.26 6.28 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 176.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 69.52 -71.47 0.12 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.402 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -142.56 4.56 1.55 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.546 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 13.3 m -106.45 129.05 54.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.713 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 65.1 tp -84.16 133.75 34.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -66.1 135.34 95.08 Favored Pre-proline 0 C--O 1.238 0.489 0 CA-C-O 120.823 0.344 . . . . 0.0 111.039 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.81 128.82 21.78 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 123.152 2.568 . . . . 0.0 112.192 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 108.02 -5.27 34.17 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.836 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -94.0 159.56 34.12 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 111.526 0.195 . . . . 0.0 111.526 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.44 162.5 92.4 Favored 'Cis proline' 0 C--N 1.344 0.314 0 C-N-CA 123.477 -1.468 . . . . 0.0 112.939 0.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -125.59 161.39 27.32 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -69.9 155.89 39.89 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 67.5 mt -56.33 -40.98 69.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.368 . . . . 0.0 111.481 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.55 -12.18 59.77 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -78.93 -18.39 53.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.87 0.367 . . . . 0.0 110.946 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 38.5 tp -79.5 -31.97 42.36 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.268 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -176.82 165.77 36.12 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.261 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -90.33 132.87 35.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.572 0.225 . . . . 0.0 110.804 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.16 12.85 47.73 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.193 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 61.3 mt -92.25 146.31 32.38 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.638 0.256 . . . . 0.0 111.372 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.65 115.65 2.55 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.036 2.49 . . . . 0.0 111.232 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 1.1 m -84.49 1.88 43.56 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.505 -179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -97.24 -59.78 1.72 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.305 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -174.48 173.03 3.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.872 0.368 . . . . 0.0 110.933 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 43.9 mm -122.41 136.23 59.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.599 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -94.54 -43.31 8.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.202 0.525 . . . . 0.0 110.154 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -156.8 163.24 39.45 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.844 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -149.32 127.0 11.69 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 36.4 tp -121.88 128.86 52.07 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.028 0.442 . . . . 0.0 111.16 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -92.39 119.39 31.89 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 18.3 t-105 -85.21 91.65 8.2 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.341 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 13.9 mmt -47.28 -49.9 50.54 Favored Pre-proline 0 N--CA 1.47 0.533 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -45.93 -41.98 20.41 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.02 2.48 . . . . 0.0 115.476 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -115.34 -28.53 6.85 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 98.85 16.59 30.47 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.498 -0.858 . . . . 0.0 113.151 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -92.5 147.3 23.01 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 3.0 m -104.9 122.73 46.41 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.92 0.391 . . . . 0.0 110.867 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -99.35 111.79 24.09 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.946 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -95.69 137.37 34.84 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.876 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -112.69 127.58 56.16 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.976 0.417 . . . . 0.0 111.504 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -134.51 98.29 4.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.776 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 67.0 -107.37 1.98 Allowed Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.872 -0.603 . . . . 0.0 112.285 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -112.59 15.65 19.99 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.96 0.409 . . . . 0.0 111.278 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -128.77 141.39 51.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.823 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -120.86 142.69 49.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.031 0.443 . . . . 0.0 110.659 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -112.84 148.48 34.81 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.506 -178.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 19.7 ttp180 -112.5 91.43 3.65 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -85.14 134.99 34.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.143 0.497 . . . . 0.0 111.144 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -107.35 118.61 37.17 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.791 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.52 -57.05 13.52 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.37 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -80.12 54.52 1.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.908 0.385 . . . . 0.0 110.951 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 29.4 tp -168.35 -33.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.098 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 64.45 31.96 12.18 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.551 0.691 . . . . 0.0 111.055 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -152.36 163.83 38.69 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.454 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 86.8 t -89.37 143.0 12.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.025 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.63 156.83 18.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.462 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.5 m -69.01 151.13 46.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.343 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 85.03 -6.53 0.92 Allowed 'General case' 0 N--CA 1.471 0.575 0 O-C-N 124.269 0.981 . . . . 0.0 112.01 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -100.12 157.94 32.93 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.796 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.07 155.22 98.34 Favored 'Cis proline' 0 C--N 1.345 0.39 0 C-N-CA 123.585 -1.423 . . . . 0.0 112.797 0.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -118.88 165.71 13.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.682 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -61.06 128.07 34.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.446 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 10.7 tt -65.03 -17.23 21.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.799 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -67.73 -2.79 7.62 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 50.4 t -65.24 -33.38 63.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -83.23 90.85 7.16 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.68 108.82 0.3 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -178.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 108.32 -17.34 34.33 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.935 -0.65 . . . . 0.0 113.818 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 29.8 mm -79.32 122.93 84.64 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.98 0.419 . . . . 0.0 111.694 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.33 155.22 36.83 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.865 2.377 . . . . 0.0 111.778 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.77 144.97 43.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.679 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 2.9 m 57.03 75.28 0.58 Allowed Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.913 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.27 -176.8 3.39 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 123.011 2.474 . . . . 0.0 111.868 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.87 27.44 3.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.248 0.547 . . . . 0.0 110.327 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 153.22 144.62 3.95 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.432 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 4.1 p -156.25 123.41 5.34 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -144.43 149.61 36.32 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.721 0.296 . . . . 0.0 111.128 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 49.5 ttm -103.68 141.66 35.68 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -69.0 168.76 43.96 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.677 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 4.9 m -72.23 -10.89 60.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.084 0.469 . . . . 0.0 110.919 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -83.36 -17.15 43.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.007 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 68.22 7.92 6.22 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 48.8 t -105.8 -35.39 3.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.766 0.317 . . . . 0.0 111.443 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -110.55 131.02 55.41 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 94.1 m -114.7 141.87 47.25 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.593 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -118.97 134.49 55.15 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -117.84 134.8 54.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.232 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -109.45 133.7 52.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.562 0.22 . . . . 0.0 111.154 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -170.07 133.88 1.2 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.594 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 64.27 35.21 91.69 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 121.311 -0.471 . . . . 0.0 113.603 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 58.1 t30 67.21 10.92 8.08 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.589 0.709 . . . . 0.0 111.442 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -125.97 161.54 27.28 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.525 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -129.83 151.65 50.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.845 0.355 . . . . 0.0 111.571 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 12.4 m-90 -112.51 145.84 39.54 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.149 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 18.2 tttt -107.25 98.2 7.87 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 486' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -90.35 125.16 35.44 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.264 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -90.21 115.08 27.16 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -63.7 -33.21 75.13 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -71.17 -40.88 71.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.928 0.394 . . . . 0.0 111.725 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 490' ' ' LYS . . . . . 0.443 ' HZ1' ' CD ' ' A' ' 494' ' ' GLU . 46.1 mtpt -91.02 -14.28 31.68 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -178.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.4 tp 59.68 37.32 22.35 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.434 0.635 . . . . 0.0 110.618 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -154.37 151.78 29.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.888 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 58.5 t -74.52 132.77 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . 0.443 ' CD ' ' HZ1' ' A' ' 490' ' ' LYS . 5.0 mm-40 -67.53 143.56 97.13 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.549 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -61.18 149.92 86.98 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.257 2.638 . . . . 0.0 112.919 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 97.76 17.34 30.86 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -126.59 167.56 16.96 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -76.91 169.75 73.57 Favored 'Cis proline' 0 C--N 1.344 0.331 0 C-N-CA 124.001 -1.25 . . . . 0.0 112.962 0.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -124.97 150.35 46.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.537 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 37.4 t -64.4 119.76 10.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.257 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -64.83 -32.75 74.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.892 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 20.5 mt -62.81 -47.45 83.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.146 0.498 . . . . 0.0 111.16 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -75.48 -31.9 60.38 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.51 -33.47 17.76 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -177.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 15.9 m0 -127.64 -27.75 2.82 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -177.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 14.6 mmt -85.64 -6.46 59.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -177.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 71.2 42.87 57.11 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.937 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 59.9 m -120.55 93.57 48.46 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-O 120.707 0.289 . . . . 0.0 110.939 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -73.23 134.26 20.76 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.009 2.472 . . . . 0.0 111.814 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 5.1 m 55.53 68.9 0.79 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.341 0.591 . . . . 0.0 111.725 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.536 -1.146 . . . . 0.0 112.401 -179.626 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.598 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -74.97 149.88 37.48 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.468 2.112 . . . . 0.0 111.304 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.94 167.52 34.49 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.275 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -78.36 172.42 15.36 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.939 2.426 . . . . 0.0 111.635 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -74.2 -169.4 20.59 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.722 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.23 172.41 5.23 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.133 2.556 . . . . 0.0 112.755 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.69 158.95 21.7 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.598 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -64.76 140.91 69.7 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.987 2.458 . . . . 0.0 112.022 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -69.64 149.48 48.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.414 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.9 153.42 47.6 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.231 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 8.9 mt -67.64 149.3 11.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.66 152.89 37.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.882 0.372 . . . . 0.0 111.282 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.76 166.03 54.81 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.343 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -80.54 148.74 30.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.733 0.301 . . . . 0.0 110.353 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -76.4 141.56 41.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.356 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.28 150.85 46.43 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.787 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.9 t -69.68 155.46 7.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 3.1 t -52.89 146.6 2.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.454 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.81 168.64 54.81 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.747 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 96.5 mt -77.8 148.85 34.57 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.39 161.91 44.74 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.238 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -71.02 154.47 62.71 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.652 2.235 . . . . 0.0 111.576 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.24 154.09 53.07 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.517 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -74.17 157.56 46.11 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.828 2.352 . . . . 0.0 111.802 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.15 176.4 53.82 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.377 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -74.44 155.37 45.7 Favored 'Trans proline' 0 CA--C 1.53 0.308 0 C-N-CA 123.356 2.704 . . . . 0.0 111.734 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.93 154.28 52.67 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.665 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -77.67 125.81 7.76 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.909 2.406 . . . . 0.0 111.794 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 112.733 -0.147 . . . . 0.0 112.733 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.72 147.19 21.69 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 122.909 2.406 . . . . 0.0 112.769 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 102' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.65 173.18 49.99 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.824 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -80.14 158.25 23.44 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 122.803 2.335 . . . . 0.0 112.296 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 105' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.16 169.37 43.37 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.787 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -79.72 177.97 7.83 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.115 2.543 . . . . 0.0 110.437 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 108' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -64.41 179.03 7.76 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.171 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.03 150.06 89.16 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.872 2.381 . . . . 0.0 112.021 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -61.61 140.91 58.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.261 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -66.81 152.27 52.57 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.016 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 23.3 mt -65.57 137.11 25.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.7 149.98 38.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.889 0.376 . . . . 0.0 111.123 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -65.44 162.34 40.94 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.972 -0.632 . . . . 0.0 111.909 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -85.21 153.58 22.54 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.906 -0.317 . . . . 0.0 110.604 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 35.7 ttm-85 -61.74 144.77 54.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.329 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.08 169.56 27.2 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.545 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.33 142.12 14.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.821 0.343 . . . . 0.0 110.324 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 24.8 t -62.48 143.48 15.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.427 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.02 161.05 54.23 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.406 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 67.8 mt -75.97 150.13 37.51 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 123' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -67.1 166.6 40.69 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.956 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.1 149.71 85.6 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.565 2.177 . . . . 0.0 111.409 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 126' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.76 158.41 44.2 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.903 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.3 158.62 29.69 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.672 2.248 . . . . 0.0 111.332 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -67.39 179.13 16.22 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.123 -0.561 . . . . 0.0 113.557 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -71.36 160.09 49.75 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 123.141 2.561 . . . . 0.0 111.687 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 132' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -74.73 134.11 16.84 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.294 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.99 111.69 2.92 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 123.287 2.658 . . . . 0.0 112.14 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 135' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 N-CA-C 112.553 -0.219 . . . . 0.0 112.553 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.95 146.72 85.66 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.15 2.567 . . . . 0.0 112.074 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 202' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 86.07 169.46 45.96 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.725 -0.75 . . . . 0.0 113.978 178.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -75.12 159.64 40.7 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 123.53 2.82 . . . . 0.0 111.952 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 205' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . 98.34 -175.81 29.72 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.61 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -85.35 156.45 10.89 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.078 2.519 . . . . 0.0 112.137 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 208' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -73.4 164.82 54.88 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.988 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.42 141.14 73.06 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.589 2.193 . . . . 0.0 111.797 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -63.88 145.05 56.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.004 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -66.76 159.84 48.39 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.758 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 47.4 pt -74.35 164.75 3.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.774 0.321 . . . . 0.0 111.02 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -82.25 137.46 34.86 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.918 0.39 . . . . 0.0 110.725 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -65.3 164.87 36.47 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.853 -0.612 . . . . 0.0 113.039 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -68.81 156.46 38.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.675 0.274 . . . . 0.0 110.323 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -70.75 162.03 29.82 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -60.41 154.02 34.94 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.526 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 21.0 t -70.78 149.4 10.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 42.9 t -64.41 140.45 19.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.56 167.69 13.85 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.299 -0.477 . . . . 0.0 113.318 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 4.2 mp -78.84 155.43 29.16 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 223' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -62.32 150.97 46.41 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.139 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.38 139.89 88.93 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.877 2.385 . . . . 0.0 111.577 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 226' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -64.49 155.53 47.05 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.946 -0.57 . . . . 0.0 113.323 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -80.51 170.21 16.14 Favored 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 123.054 2.502 . . . . 0.0 111.475 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -76.88 -179.4 48.18 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.94 -0.647 . . . . 0.0 113.286 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.87 156.26 48.21 Favored 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 123.182 2.588 . . . . 0.0 111.928 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 232' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo . . . . . 0 N--CA 1.478 0.588 0 N-CA-C 109.714 -0.918 . . . . 0.0 109.714 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -102.69 148.61 25.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.663 0.268 . . . . 0.0 110.775 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 8.1 tp -73.57 -26.71 22.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.383 0.611 . . . . 0.0 110.681 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 37.3 m -88.74 26.33 1.54 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.81 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -76.77 -41.83 43.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.306 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 83.37 170.68 46.6 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.205 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 50.3 t30 50.65 68.97 0.69 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.198 0.523 . . . . 0.0 111.125 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -87.17 175.49 8.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.47 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -74.62 -46.96 34.95 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 14.5 t -171.34 153.95 3.75 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.518 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 57.0 t -131.39 124.42 54.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -141.59 169.04 18.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.009 0.433 . . . . 0.0 111.832 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 39.3 ttp -120.84 121.0 37.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.358 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 58.9 mt -112.18 115.7 29.26 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.666 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 44.9 mtp180 57.16 22.31 7.4 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 109.85 -14.77 31.73 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.85 -0.69 . . . . 0.0 113.656 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -99.84 129.46 45.94 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.938 0.369 . . . . 0.0 111.324 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 47.1 ttm -89.1 126.18 35.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.923 0.392 . . . . 0.0 111.082 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -119.68 132.86 55.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.114 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 23.9 t -107.02 117.33 52.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.502 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -100.68 126.62 47.21 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -139.71 102.78 4.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.157 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 63.92 -102.25 0.1 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.66 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.5 ptm85 -117.49 8.09 12.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.917 0.389 . . . . 0.0 111.962 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 3.0 m-90 -127.01 146.03 50.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.048 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -128.66 146.1 50.97 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.966 0.412 . . . . 0.0 110.985 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 20.4 m-90 -108.66 150.87 26.93 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.425 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 24.1 ttt-85 -113.8 100.89 8.79 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 3.1 m -93.49 129.43 43.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.137 0.494 . . . . 0.0 111.386 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.15 109.87 6.68 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.536 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 63.66 47.01 3.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.774 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 7.2 m120 64.68 27.96 13.13 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.185 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -142.06 150.17 40.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.952 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 47.4 t -91.76 129.19 42.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 89.5 mtp -77.23 165.44 24.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.026 0.441 . . . . 0.0 111.78 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -77.72 154.51 32.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.696 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 94.76 -5.8 69.75 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 111.701 -0.56 . . . . 0.0 111.701 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -118.85 159.0 46.25 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 110.448 -0.205 . . . . 0.0 110.448 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.67 137.88 34.4 Favored 'Cis proline' 0 C--N 1.348 0.542 0 C-N-CA 123.966 -1.264 . . . . 0.0 112.564 0.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 10.6 ttt -112.72 141.34 25.21 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.429 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.19 127.3 24.39 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.574 2.183 . . . . 0.0 111.204 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 66.8 mt -56.11 -42.42 72.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.942 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -70.3 -16.38 73.31 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.794 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -82.51 -28.28 31.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.046 0.451 . . . . 0.0 110.791 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -98.66 -53.0 3.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.239 0.543 . . . . 0.0 109.725 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -93.32 71.15 4.43 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -56.93 99.44 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.672 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 128.27 -17.09 5.95 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.969 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 30.9 tp -91.84 125.52 56.91 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-O 120.561 0.22 . . . . 0.0 110.764 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.38 170.19 19.85 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 123.06 2.507 . . . . 0.0 111.774 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -77.26 159.41 29.64 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.654 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 16.6 m 57.92 82.95 0.12 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.41 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 27.9 pt -100.38 173.23 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.911 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -95.79 -55.84 2.87 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.49 164.13 39.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.575 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -147.75 149.02 31.61 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -164.64 166.35 20.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.867 0.365 . . . . 0.0 111.768 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -97.3 125.53 41.94 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -84.44 -172.05 3.96 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -63.5 -40.72 97.81 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.01 -30.09 58.37 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 127.17 -14.7 6.54 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.731 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 38.2 mttp -70.45 149.13 47.55 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.746 0.307 . . . . 0.0 110.798 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -95.65 126.71 41.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.058 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 17.1 t -106.31 115.49 48.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.981 0.419 . . . . 0.0 110.558 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -102.72 128.95 49.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.531 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -107.77 143.32 36.49 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.398 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -152.01 92.93 1.77 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 75.71 -113.09 3.8 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -108.11 -0.73 20.94 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.032 0.444 . . . . 0.0 110.772 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -109.3 147.3 32.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.977 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 37.3 p-80 -132.64 147.87 52.35 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.357 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 20.9 m-90 -121.28 131.17 54.05 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.169 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 55.9 t -107.0 114.64 46.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -106.41 125.48 51.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.645 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -97.43 89.25 4.64 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 67.82 -85.98 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.308 -178.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -130.65 21.13 5.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.21 0.529 . . . . 0.0 110.886 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 10.2 m -133.83 135.29 43.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.02 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 57.3 tp -80.97 136.92 36.09 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.442 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.25 143.16 97.35 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.388 179.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.01 140.83 28.94 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 122.602 2.201 . . . . 0.0 112.581 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 91.24 26.26 21.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.542 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -118.88 163.54 25.59 Favored Pre-proline 0 C--N 1.324 -0.534 0 O-C-N 122.679 -0.307 . . . . 0.0 111.081 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.44 162.87 89.8 Favored 'Cis proline' 0 C--N 1.345 0.38 0 C-N-CA 123.529 -1.446 . . . . 0.0 113.067 0.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -121.0 161.46 21.59 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -74.84 153.54 38.66 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 71.2 mt -57.75 -38.62 66.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.27 0.557 . . . . 0.0 109.845 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.9 -10.74 58.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.469 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -84.45 -30.8 24.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.861 0.363 . . . . 0.0 110.435 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 47.6 tp -63.81 -51.88 62.74 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.859 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -152.69 162.45 29.99 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.296 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -86.85 129.05 35.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.592 0.234 . . . . 0.0 110.404 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.57 6.79 43.55 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.32 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 65.6 mt -86.95 156.05 55.24 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 122.961 -0.141 . . . . 0.0 110.624 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -65.13 144.47 81.78 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.626 2.217 . . . . 0.0 112.371 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.24 25.17 9.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.031 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -119.42 -76.03 0.58 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.606 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 7.8 ptmt -160.61 -176.75 5.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.82 0.343 . . . . 0.0 110.445 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 34.4 mm -125.59 135.61 63.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -94.48 -52.19 4.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.325 0.583 . . . . 0.0 110.062 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -147.13 145.63 29.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.946 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -129.01 117.18 20.5 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 57.8 tp -114.09 147.96 37.89 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.051 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -120.65 119.42 32.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.617 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 7.0 t-105 -86.85 94.8 9.66 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 64.1 mtt -51.42 -51.71 66.56 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -47.18 -33.82 16.54 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 123.029 2.486 . . . . 0.0 115.278 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 33.0 p30 -115.06 -24.54 8.52 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 87.47 23.02 41.39 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.403 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -108.21 149.9 27.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 117.131 0.465 . . . . 0.0 111.169 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.45 146.16 25.49 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.436 -178.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -124.9 110.16 13.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.498 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -98.98 123.14 43.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.797 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -98.79 130.28 45.23 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.608 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -140.05 106.81 5.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.163 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 66.72 -102.62 0.78 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.742 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -123.67 14.44 9.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.068 0.461 . . . . 0.0 110.154 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 52.0 mmtt -122.46 156.29 34.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.067 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -135.3 139.36 44.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.928 0.394 . . . . 0.0 110.573 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -108.07 143.72 36.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.699 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -106.79 103.4 12.83 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -92.42 135.23 34.22 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.482 -178.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -107.86 107.74 18.61 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -49.39 -51.3 35.93 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -54.76 -48.71 72.28 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 52.5 mt -86.45 -18.05 32.69 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 61.36 39.45 15.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.631 0.729 . . . . 0.0 110.57 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -148.79 155.07 40.45 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.497 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 97.8 t -80.31 140.13 17.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.845 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -62.49 156.95 21.48 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.4 m -66.71 152.43 45.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.82 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 72.34 29.4 2.19 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.272 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -126.39 160.9 55.5 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.192 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.81 160.77 95.51 Favored 'Cis proline' 0 C--N 1.347 0.479 0 C-N-CA 123.728 -1.363 . . . . 0.0 112.337 -0.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -109.71 176.76 4.95 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.106 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -76.8 139.82 40.49 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.518 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.4 tt -66.83 -11.99 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.109 0.48 . . . . 0.0 110.709 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 48.5 mmtt -68.69 -7.0 29.48 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.151 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 76.7 t -66.21 -30.95 51.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 6.7 m95 -97.72 85.59 3.6 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.545 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -54.43 114.78 1.79 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.62 -178.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 108.0 -21.16 29.98 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.065 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 19.1 mm -71.04 127.15 91.94 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 120.868 0.366 . . . . 0.0 111.077 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.25 139.51 32.32 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.925 2.417 . . . . 0.0 112.603 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -68.34 138.78 55.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.002 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.3 m 59.33 70.31 1.14 Allowed Pre-proline 0 C--O 1.234 0.288 0 O-C-N 123.58 0.55 . . . . 0.0 112.177 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -85.95 -179.53 3.31 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.013 2.476 . . . . 0.0 111.164 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.39 29.21 1.61 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.439 0.638 . . . . 0.0 110.738 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 174.05 135.15 1.97 Allowed Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 5.3 p -158.49 114.38 2.69 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.706 0.289 . . . . 0.0 110.236 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -145.14 140.7 28.17 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.696 0.284 . . . . 0.0 111.215 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 46.5 ttm -89.93 141.14 28.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.244 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -70.38 166.16 51.1 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.769 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.36 -14.62 57.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.895 0.378 . . . . 0.0 111.906 -179.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -81.43 -18.39 45.53 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.391 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 68.09 11.96 8.58 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.015 0.526 . . . . 0.0 112.254 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 49.1 t -110.46 -36.12 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.891 0.377 . . . . 0.0 111.057 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -111.53 133.68 53.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.275 0.559 . . . . 0.0 111.996 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 88.3 m -116.54 133.03 56.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.381 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -101.42 135.93 42.11 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.967 0.413 . . . . 0.0 111.807 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -122.2 138.49 54.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.422 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -121.74 134.36 54.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.803 0.335 . . . . 0.0 111.524 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 48.0 tttt -166.06 131.94 2.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.222 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 56.12 44.74 88.54 Favored Glycine 0 C--N 1.33 0.227 0 CA-C-N 115.944 -0.571 . . . . 0.0 114.307 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 23.0 t30 65.47 8.49 5.07 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -118.28 158.35 25.35 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -131.7 147.6 52.52 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.989 0.424 . . . . 0.0 111.934 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 11.3 m-90 -116.36 157.21 25.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.133 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -120.45 99.38 6.53 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 486' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -86.28 127.41 34.77 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.941 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -93.18 112.81 24.86 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -63.68 -26.99 68.91 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -76.6 -30.85 57.13 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -99.2 -21.02 16.31 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.8 tp 66.17 33.4 7.4 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -177.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -152.45 159.92 43.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.044 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 77.8 t -79.29 139.55 18.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.643 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -65.98 138.44 96.3 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.322 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.19 138.36 80.96 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 123.225 2.617 . . . . 0.0 112.59 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 111.21 -1.61 28.25 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -108.87 164.49 14.6 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.825 -0.187 . . . . 0.0 111.226 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -75.98 174.75 51.27 Favored 'Cis proline' 0 C--N 1.351 0.666 0 C-N-CA 124.058 -1.226 . . . . 0.0 113.045 0.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -134.41 166.61 22.44 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.991 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 44.3 t -71.54 118.07 13.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.597 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.7 -24.26 62.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.83 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 16.8 mt -70.96 -38.81 72.82 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.974 0.416 . . . . 0.0 110.652 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 8.7 ttm180 -84.37 -55.31 4.23 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -73.14 -18.02 61.32 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 9.5 m0 -111.95 -69.79 0.85 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 9.6 mmt -59.33 -44.54 92.61 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.976 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 109.85 14.03 14.77 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.51 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 35.1 m -81.87 113.6 44.16 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -83.29 153.57 14.12 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.576 2.184 . . . . 0.0 111.903 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 16.4 m 64.34 92.33 0.07 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.722 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.155 0 CA-C-O 118.166 -1.352 . . . . 0.0 110.796 -179.917 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.758 0 N-CA-C 111.531 -0.627 . . . . 0.0 111.531 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.34 144.0 22.65 Favored 'Trans proline' 0 CA--C 1.529 0.246 0 C-N-CA 122.613 2.209 . . . . 0.0 111.477 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.07 168.71 44.24 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.466 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -73.44 163.5 37.51 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 123.0 2.467 . . . . 0.0 112.025 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.04 175.42 54.55 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.698 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -59.27 167.28 6.24 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 122.803 2.335 . . . . 0.0 111.429 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 133.57 174.51 13.58 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.642 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -62.59 139.18 74.39 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.859 2.373 . . . . 0.0 111.869 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -64.97 150.04 48.7 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.27 157.3 24.07 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.198 -0.525 . . . . 0.0 113.198 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 mt -71.21 153.93 8.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.47 150.47 47.17 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.384 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.72 160.03 53.88 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.15 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -71.49 145.29 49.29 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -68.76 140.65 55.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.794 0.331 . . . . 0.0 110.608 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.22 154.98 36.4 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.834 -0.621 . . . . 0.0 113.16 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 8.0 t -65.72 147.94 12.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.665 0.269 . . . . 0.0 110.6 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 3.9 t -54.32 148.69 2.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.335 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.36 154.46 53.19 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.31 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 71.7 mt -76.56 152.21 36.06 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.482 0.182 . . . . 0.0 110.78 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.05 170.41 44.27 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.663 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.02 151.4 30.69 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.638 2.225 . . . . 0.0 111.645 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.72 160.72 53.85 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.868 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.72 149.88 49.35 Favored 'Trans proline' 0 C--O 1.237 0.453 0 C-N-CA 122.492 2.128 . . . . 0.0 111.432 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.5 170.19 48.77 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.935 -0.65 . . . . 0.0 113.174 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -73.79 163.4 37.25 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.969 2.446 . . . . 0.0 111.567 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.5 119.71 18.76 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.253 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -64.19 114.6 2.72 Favored 'Trans proline' 0 CA--C 1.528 0.207 0 C-N-CA 122.917 2.412 . . . . 0.0 111.786 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.565 0 CA-C-O 119.985 -0.342 . . . . 0.0 112.865 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -70.15 151.66 66.92 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.498 2.798 . . . . 0.0 112.604 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 102' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.41 166.66 53.66 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.552 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.06 158.45 20.55 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 123.216 2.611 . . . . 0.0 113.066 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 105' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.65 178.69 47.72 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.083 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -85.49 138.05 6.17 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.648 2.232 . . . . 0.0 111.324 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 108' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -61.94 176.2 6.02 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.698 -0.683 . . . . 0.0 113.125 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.58 162.91 34.82 Favored 'Trans proline' 0 C--O 1.238 0.519 0 C-N-CA 122.577 2.185 . . . . 0.0 112.514 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -64.5 151.38 44.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.737 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -69.76 166.3 49.47 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.438 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 2.7 mt -67.11 144.34 14.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.01 140.73 58.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.408 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -59.38 147.68 42.07 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.277 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -69.73 153.59 43.16 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 122.47 0.308 . . . . 0.0 110.336 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 53.9 ttm-85 -71.77 150.51 44.34 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.83 164.05 46.63 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.26 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 8.8 t -68.97 144.32 14.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 32.3 t -62.23 134.56 27.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.988 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.26 160.78 45.79 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.995 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 75.2 mt -78.11 145.05 35.96 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 123' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -63.29 161.12 34.74 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.695 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.72 151.13 85.47 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.68 2.253 . . . . 0.0 111.854 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 126' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -74.08 158.69 52.2 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.954 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -75.54 160.8 38.02 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.506 2.137 . . . . 0.0 111.105 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -73.55 -178.31 36.38 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.289 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -74.82 145.28 31.98 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.912 2.408 . . . . 0.0 111.275 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 132' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -57.52 125.12 38.21 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.917 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.41 112.48 3.37 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.922 2.415 . . . . 0.0 112.06 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 135' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.504 0 CA-C-O 119.939 -0.367 . . . . 0.0 112.239 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -53.72 140.95 66.08 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.148 2.566 . . . . 0.0 111.354 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 202' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 66.6 172.66 5.04 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 114.667 0.627 . . . . 0.0 114.667 178.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -76.82 166.17 27.4 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.673 2.915 . . . . 0.0 111.084 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 205' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . 99.55 168.92 30.07 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.879 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -87.95 158.2 7.31 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 123.891 3.061 . . . . 0.0 112.182 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 208' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.4 166.82 54.4 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.061 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.73 147.15 68.79 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.627 2.218 . . . . 0.0 112.088 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -65.24 151.41 46.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.629 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -71.79 169.44 50.47 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.358 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 32.3 pt -71.54 162.41 4.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 120.91 0.386 . . . . 0.0 111.052 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -79.76 142.21 35.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.084 0.469 . . . . 0.0 110.709 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -62.65 160.94 32.41 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.369 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -81.08 155.94 26.05 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -66.1 151.44 46.9 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.806 0.336 . . . . 0.0 110.815 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -62.4 157.4 37.07 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.862 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 16.3 t -65.25 138.83 22.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 33.1 t -60.74 142.3 16.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.941 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.12 157.95 26.65 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.238 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 9.2 mp -72.43 157.83 36.9 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.782 -0.209 . . . . 0.0 110.585 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 223' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -61.92 153.66 41.15 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.066 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.99 142.78 57.8 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.856 2.371 . . . . 0.0 111.352 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 226' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -67.74 167.66 41.18 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.892 -0.595 . . . . 0.0 113.142 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -84.44 164.32 12.66 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.906 2.404 . . . . 0.0 111.606 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -70.81 -179.21 28.22 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.08 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -61.76 133.28 44.17 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.945 2.43 . . . . 0.0 111.777 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 232' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo . . . . . 0 N--CA 1.478 0.559 0 N-CA-C 110.241 -0.715 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 317' ' ' ASN . . . . . 0.594 ' O ' ' HB2' ' A' ' 320' ' ' ASP . 20.1 t-20 -110.82 163.36 13.86 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 18.8 tt -68.59 -23.13 27.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.372 0.606 . . . . 0.0 110.698 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 45.2 m -88.51 5.52 42.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.972 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.594 ' HB2' ' O ' ' A' ' 317' ' ' ASN . 0.2 OUTLIER -68.07 -37.42 81.24 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.058 0.456 . . . . 0.0 110.696 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 85.8 174.95 50.02 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.766 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 5.4 t30 58.86 76.48 0.35 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.207 0.527 . . . . 0.0 111.304 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -95.08 174.34 7.12 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.66 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -90.25 -39.03 13.02 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.528 HG22 ' HB2' ' A' ' 336' ' ' PHE . 4.5 t -170.1 152.19 4.19 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.507 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.427 HG22 HG13 ' A' ' 335' ' ' VAL . 82.0 t -136.19 120.76 26.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -144.49 -179.96 6.88 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.993 0.425 . . . . 0.0 111.547 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 48.7 ttp -126.59 128.64 47.14 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 80.1 mt -122.27 112.1 17.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.938 0.399 . . . . 0.0 110.705 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 62.58 28.41 16.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.421 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 101.6 -20.22 47.28 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.333 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' GLU . . . . . 0.583 ' HG3' HH22 ' A' ' 343' ' ' ARG . 4.8 mm-40 -94.87 136.8 34.75 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.701 0.251 . . . . 0.0 110.567 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 333' ' ' MET . . . . . 0.553 ' HB3' HG23 ' A' ' 344' ' ' VAL . 47.0 ttm -87.86 134.39 33.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.884 0.373 . . . . 0.0 111.377 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -122.86 121.79 37.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.657 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 335' ' ' VAL . . . . . 0.427 HG13 HG22 ' A' ' 326' ' ' VAL . 46.8 t -106.63 111.64 36.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 336' ' ' PHE . . . . . 0.528 ' HB2' HG22 ' A' ' 325' ' ' THR . 78.6 m-85 -96.47 130.02 43.71 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.772 0.32 . . . . 0.0 111.73 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 0.668 ' HB3' ' HZ3' ' A' ' 342' ' ' TRP . 38.9 tttp -144.11 112.91 6.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.672 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 62.2 -105.21 0.17 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.315 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -116.56 9.43 14.2 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.814 0.34 . . . . 0.0 111.567 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 8.2 m-90 -129.72 161.22 31.16 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.364 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -137.94 140.75 40.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.946 0.403 . . . . 0.0 111.064 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 342' ' ' TRP . . . . . 0.668 ' HZ3' ' HB3' ' A' ' 337' ' ' LYS . 10.6 m-90 -102.7 144.38 31.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.472 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.583 HH22 ' HG3' ' A' ' 332' ' ' GLU . 25.1 ttt-85 -115.76 106.07 13.44 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.553 HG23 ' HB3' ' A' ' 333' ' ' MET . 1.3 m -101.43 132.44 47.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.18 0.514 . . . . 0.0 111.531 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.63 111.48 9.44 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.936 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 14.1 m120 61.18 50.17 5.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.843 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 66.73 9.23 6.54 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.452 -0.795 . . . . 0.0 113.096 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -121.45 137.87 54.53 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 122.391 -0.193 . . . . 0.0 111.058 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 38.4 t -79.58 123.82 36.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 350' ' ' MET . . . . . 0.453 ' SD ' ' HD3' ' A' ' 343' ' ' ARG . 83.5 mtp -66.34 148.84 51.28 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -66.98 153.05 44.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.56 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 84.83 10.11 79.62 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.672 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 353' ' ' TYR . . . . . 0.434 ' HB3' ' HA ' ' A' ' 354' ' ' PRO . 83.7 m-85 -123.74 158.83 58.34 Favored Pre-proline 0 C--N 1.326 -0.422 0 O-C-N 122.86 -0.2 . . . . 0.0 110.629 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.434 ' HA ' ' HB3' ' A' ' 353' ' ' TYR . 57.7 Cg_endo -70.51 149.67 90.78 Favored 'Cis proline' 0 C--N 1.349 0.569 0 C-N-CA 123.656 -1.393 . . . . 0.0 112.955 0.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 59.8 ttm -121.83 139.82 30.85 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.445 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -55.59 138.35 80.52 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.596 2.197 . . . . 0.0 111.406 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 89.4 mt -56.46 -40.58 68.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.597 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -70.46 -2.47 42.68 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 121.251 -0.499 . . . . 0.0 114.149 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.25 -39.8 14.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.125 0.488 . . . . 0.0 109.877 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -97.62 -56.33 2.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.266 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 51.9 m95 -93.73 73.91 4.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.691 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 33.7 ttp-105 -62.37 107.9 1.0 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.012 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 123.92 -18.65 7.49 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.558 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.601 HD12 ' HD2' ' A' ' 365' ' ' PRO . 29.8 tp -88.67 128.25 53.31 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.681 0.277 . . . . 0.0 110.552 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 365' ' ' PRO . . . . . 0.601 ' HD2' HD12 ' A' ' 364' ' ' LEU . 92.0 Cg_endo -79.91 -175.07 2.53 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.751 2.301 . . . . 0.0 112.277 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -87.89 160.3 18.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.328 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.1 m 55.31 87.22 0.05 Allowed 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 23.0 pt -105.8 163.91 4.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.174 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 369' ' ' ASN . . . . . 0.419 HD22 ' HA ' ' A' ' 369' ' ' ASN . 8.3 m120 -85.99 -56.7 3.34 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.677 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 370' ' ' THR . . . . . 0.746 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.1 OUTLIER -155.23 171.22 20.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.073 -179.542 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -153.39 144.39 22.88 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -164.55 164.49 21.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.635 0.255 . . . . 0.0 111.039 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -89.77 130.77 35.98 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 374' ' ' ARG . . . . . 0.524 ' HB2' ' OE2' ' A' ' 440' ' ' GLU . 13.2 ptm180 -83.58 -174.92 5.56 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.699 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -68.22 -23.47 64.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.988 0.423 . . . . 0.0 111.473 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 376' ' ' ASP . . . . . 0.452 ' H ' ' HG3' ' A' ' 374' ' ' ARG . 0.0 OUTLIER -86.68 -24.32 25.28 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.553 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 121.25 -26.53 6.67 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.318 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 378' ' ' LYS . . . . . 0.44 ' HG2' ' HA ' ' A' ' 391' ' ' ASP . 32.8 mttp -63.85 154.86 32.34 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.094 0.473 . . . . 0.0 111.731 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -96.31 123.57 39.99 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.656 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 7.9 t -102.19 114.62 42.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.312 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 381' ' ' PHE . . . . . 0.529 ' HB2' ' HB2' ' A' ' 388' ' ' TRP . 87.5 m-85 -100.34 144.61 29.14 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -124.18 149.12 46.69 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.869 0.366 . . . . 0.0 111.87 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.483 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 85.5 tttt -157.42 97.27 1.61 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 384' ' ' GLY . . . . . 0.676 ' O ' ' HA ' ' A' ' 414' ' ' LYS . . . 73.73 -108.45 2.51 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.211 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -114.91 7.74 15.73 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.931 0.396 . . . . 0.0 111.142 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -111.22 149.47 30.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.649 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 387' ' ' HIS . . . . . 0.416 ' NE2' ' HE1' ' A' ' 399' ' ' TYR . 28.9 p-80 -131.69 146.68 52.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.385 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 388' ' ' TRP . . . . . 0.529 ' HB2' ' HB2' ' A' ' 381' ' ' PHE . 17.4 m-90 -119.44 137.56 53.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.17 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 88.4 t -116.49 112.38 39.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -111.0 123.72 50.73 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.847 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.44 ' HA ' ' HG2' ' A' ' 378' ' ' LYS . 34.0 t70 -92.88 93.14 8.24 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 71.76 -79.43 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 O-C-N 123.695 0.622 . . . . 0.0 110.954 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -141.07 13.93 2.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.911 0.386 . . . . 0.0 110.648 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 5.5 m -123.48 131.8 53.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.267 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 58.4 tp -78.35 135.96 37.59 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.111 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 396' ' ' GLU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 1.5 mt-10 -74.69 148.8 85.52 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.73 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 397' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 12.3 Cg_exo -72.58 143.32 37.9 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.928 2.418 . . . . 0.0 111.751 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 89.8 32.45 10.04 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.991 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 399' ' ' TYR . . . . . 0.512 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 80.3 m-85 -138.57 161.05 60.9 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.512 ' HA ' ' HB3' ' A' ' 399' ' ' TYR . 66.8 Cg_endo -74.13 154.7 99.76 Favored 'Cis proline' 0 C--N 1.346 0.409 0 C-N-CA 123.715 -1.369 . . . . 0.0 112.998 0.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 53.3 mttt -125.93 170.29 11.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.233 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 0.528 ' HB3' ' HG2' ' A' ' 404' ' ' LYS . 3.8 m-70 -73.0 155.64 39.63 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.971 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 41.5 mt -59.22 -34.23 53.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.196 0.522 . . . . 0.0 110.658 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 404' ' ' LYS . . . . . 0.528 ' HG2' ' HB3' ' A' ' 402' ' ' HIS . 47.3 pttt -66.74 -17.59 64.94 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.013 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -78.02 -25.47 47.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.055 0.455 . . . . 0.0 110.111 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 49.9 tp -74.7 -45.33 45.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.567 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.73 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -164.76 147.7 13.06 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.505 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -81.34 140.94 34.47 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.918 0.389 . . . . 0.0 111.0 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 101.36 -3.28 54.26 Favored Glycine 0 CA--C 1.517 0.184 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.737 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 83.7 mt -85.48 149.04 50.94 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.472 0.177 . . . . 0.0 110.732 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.31 145.16 98.67 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.008 2.472 . . . . 0.0 111.863 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.79 11.14 22.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.059 0.457 . . . . 0.0 111.255 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -94.17 -56.34 2.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.672 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 414' ' ' LYS . . . . . 0.676 ' HA ' ' O ' ' A' ' 384' ' ' GLY . 18.1 ptmt -176.47 173.96 1.98 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.465 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 46.6 mm -123.17 135.04 64.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.866 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 416' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 430' ' ' PHE . 4.0 m-20 -89.14 -59.12 2.31 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 417' ' ' ALA . . . . . 0.746 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -153.72 153.72 32.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.896 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -132.47 116.69 17.08 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 37.1 tp -107.64 125.61 51.55 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.377 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -96.67 113.3 24.85 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 421' ' ' TRP . . . . . 0.491 ' HB2' ' HE2' ' A' ' 428' ' ' TYR . 11.9 t-105 -82.17 99.3 9.17 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.517 ' HB2' ' HD3' ' A' ' 423' ' ' PRO . 66.5 mtt -53.37 -52.96 61.59 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.517 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 82.0 Cg_exo -47.22 -44.58 23.78 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.758 2.305 . . . . 0.0 115.319 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 424' ' ' ASN . . . . . 0.473 ' OD1' ' HB3' ' A' ' 421' ' ' TRP . 35.3 p30 -101.25 -21.58 14.86 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 78.4 37.03 28.76 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.693 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 23.4 mmtt -121.24 144.85 48.39 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 427' ' ' THR . . . . . 0.628 ' HB ' ' HB3' ' A' ' 438' ' ' PHE . 15.0 m -97.95 132.17 43.75 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.045 0.45 . . . . 0.0 111.249 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 428' ' ' TYR . . . . . 0.491 ' HE2' ' HB2' ' A' ' 421' ' ' TRP . 83.0 m-85 -107.41 109.9 21.73 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -91.38 122.38 33.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.407 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 430' ' ' PHE . . . . . 0.439 ' O ' ' HB2' ' A' ' 416' ' ' ASP . 89.4 m-85 -100.36 131.82 46.08 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.737 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.402 ' HA ' ' HE ' ' A' ' 431' ' ' ARG . 3.1 tpm_? -144.0 108.95 4.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.893 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 66.05 -108.38 2.36 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -121.85 19.93 10.92 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.274 0.559 . . . . 0.0 110.668 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 42.3 mmtt -127.53 152.87 47.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.761 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 435' ' ' TYR . . . . . 0.505 ' CE1' ' HB2' ' A' ' 451' ' ' LYS . 3.9 p90 -132.76 139.86 47.76 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.825 0.345 . . . . 0.0 111.389 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -107.6 149.98 27.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.202 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -108.04 98.82 8.33 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 438' ' ' PHE . . . . . 0.73 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 69.5 t80 -81.31 124.63 29.51 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.782 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -93.73 104.85 16.93 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 440' ' ' GLU . . . . . 0.524 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 0.1 OUTLIER -58.09 -48.19 80.91 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.315 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.48 -50.66 72.34 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 88.4 mt -84.62 -12.95 52.98 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 23.6 mtp180 57.05 50.84 11.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.467 0.651 . . . . 0.0 111.704 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -159.65 169.63 23.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.684 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 86.5 t -89.19 133.13 32.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -64.34 161.63 16.46 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.368 0.417 . . . . 0.0 111.017 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 2.6 m -69.48 161.88 28.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.863 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 70.87 33.21 2.23 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.353 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 449' ' ' TYR . . . . . 0.404 ' HB3' ' HA ' ' A' ' 450' ' ' PRO . 32.2 m-85 -137.75 161.53 59.64 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.067 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 450' ' ' PRO . . . . . 0.404 ' HA ' ' HB3' ' A' ' 449' ' ' TYR . 85.0 Cg_endo -79.7 155.55 88.74 Favored 'Cis proline' 0 C--N 1.346 0.404 0 C-N-CA 123.477 -1.468 . . . . 0.0 112.522 0.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 451' ' ' LYS . . . . . 0.505 ' HB2' ' CE1' ' A' ' 435' ' ' TYR . 51.9 mttm -105.66 176.96 4.99 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.625 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 452' ' ' ASN . . . . . 0.401 ' O ' HG23 ' A' ' 455' ' ' VAL . 17.3 t-20 -75.2 140.73 43.47 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.0 tt -68.16 -14.62 18.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.94 0.4 . . . . 0.0 110.593 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -69.74 -1.62 9.67 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.302 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 455' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 452' ' ' ASN . 38.1 t -60.87 -37.71 77.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 456' ' ' TRP . . . . . 0.491 ' HB3' ' CE1' ' A' ' 486' ' ' PHE . 15.1 m95 -91.16 93.64 9.22 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 457' ' ' GLU . . . . . 0.434 ' HB3' ' HG3' ' A' ' 492' ' ' LYS . 3.2 tt0 -56.44 121.13 8.9 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 105.63 -15.03 45.94 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.722 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 25.6 mm -80.67 130.46 64.27 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 121.084 0.469 . . . . 0.0 111.245 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.04 158.24 30.59 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.733 2.289 . . . . 0.0 111.284 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -82.93 141.11 32.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.217 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.6 m 57.8 75.57 0.54 Allowed Pre-proline 0 N--CA 1.464 0.239 0 O-C-N 123.868 0.73 . . . . 0.0 112.855 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -90.5 179.86 1.77 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.689 2.259 . . . . 0.0 111.235 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 464' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 464' ' ' ARG . 0.0 OUTLIER -134.76 26.71 3.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.312 0.577 . . . . 0.0 110.42 179.692 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 175.01 137.96 2.63 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.38 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 20.9 p -161.04 99.77 1.22 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -128.99 143.9 51.02 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.839 0.352 . . . . 0.0 111.294 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 468' ' ' MET . . . . . 0.407 ' HA ' ' HA ' ' A' ' 475' ' ' THR . 34.7 ttm -86.33 143.21 27.98 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.853 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -72.81 163.77 54.85 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.511 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.44 -7.59 20.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.053 0.454 . . . . 0.0 111.648 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -90.9 -13.24 33.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.403 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 66.87 0.04 1.81 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 55.4 t -98.2 -36.38 5.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.845 0.355 . . . . 0.0 111.264 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -112.16 144.73 41.05 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 475' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 468' ' ' MET . 60.8 m -122.32 137.53 54.82 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -112.95 122.62 48.17 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.148 0.499 . . . . 0.0 112.29 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -101.97 150.57 23.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.645 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -130.07 133.37 46.65 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 44.1 tttt -170.51 140.91 1.85 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.86 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 60.14 32.62 76.73 Favored Glycine 0 C--N 1.328 0.104 0 C-N-CA 121.245 -0.502 . . . . 0.0 112.609 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 481' ' ' ASN . . . . . 0.525 ' OD1' ' HG ' ' A' ' 502' ' ' LEU . 2.0 t-20 64.53 17.67 10.97 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.344 0.592 . . . . 0.0 111.785 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -122.81 158.48 30.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.485 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 483' ' ' TYR . . . . . 0.504 ' CE1' ' HB2' ' A' ' 499' ' ' LYS . 4.7 p90 -123.98 149.53 45.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.915 0.388 . . . . 0.0 111.93 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 20.1 m-90 -118.21 138.56 52.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.452 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -99.89 93.62 5.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.089 0.471 . . . . 0.0 109.746 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 486' ' ' PHE . . . . . 0.491 ' CE1' ' HB3' ' A' ' 456' ' ' TRP . 81.6 t80 -86.45 131.2 34.25 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.738 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 487' ' ' ASN . . . . . 0.432 ' HB3' ' HB2' ' A' ' 490' ' ' LYS . 36.1 t-20 -97.17 114.67 26.39 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -65.15 -28.69 69.59 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -178.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -84.29 -14.61 49.27 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 490' ' ' LYS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 487' ' ' ASN . 93.1 mttt -109.35 -26.3 10.1 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 68.86 30.8 4.56 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.857 0.837 . . . . 0.0 110.373 -178.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 492' ' ' LYS . . . . . 0.434 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 62.6 tttp -150.06 154.43 38.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.048 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 55.9 t -79.17 133.54 29.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -59.91 147.19 80.14 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.459 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -62.96 157.15 50.22 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 123.246 2.631 . . . . 0.0 112.972 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 83.91 27.19 38.65 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.874 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 497' ' ' TYR . . . . . 0.523 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 27.7 m-85 -129.75 165.87 30.1 Favored Pre-proline 0 C--N 1.327 -0.393 0 O-C-N 122.877 -0.19 . . . . 0.0 111.13 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 498' ' ' PRO . . . . . 0.523 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 87.4 Cg_endo -82.41 175.25 40.4 Favored 'Cis proline' 0 C--N 1.346 0.433 0 C-N-CA 123.74 -1.358 . . . . 0.0 112.871 0.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 499' ' ' LYS . . . . . 0.504 ' HB2' ' CE1' ' A' ' 483' ' ' TYR . 97.8 mttt -129.7 153.98 47.62 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.406 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 41.4 t -69.36 123.92 22.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.905 0.383 . . . . 0.0 110.484 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -67.75 -18.49 64.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.885 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 502' ' ' LEU . . . . . 0.525 ' HG ' ' OD1' ' A' ' 481' ' ' ASN . 13.7 mt -66.8 -46.32 75.6 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.921 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -80.94 -41.27 23.17 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.2 -45.2 34.32 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -177.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 35.0 m0 -100.12 -58.55 1.89 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 10.8 mmt -60.64 -41.28 94.62 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 98.5 25.62 9.91 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.611 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 3.5 m -110.62 103.4 54.27 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -81.32 178.59 6.59 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.509 2.139 . . . . 0.0 111.693 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 3.9 m 67.12 13.88 9.59 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.73 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.396 -1.225 . . . . 0.0 111.087 179.699 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.809 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo . . . . . 0 N--CA 1.462 -0.37 0 C-N-CA 123.277 2.651 . . . . 0.0 111.397 179.599 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.654 0 N-CA-C 112.71 -0.156 . . . . 0.0 112.71 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo . . . . . 0 CA--C 1.529 0.269 0 C-N-CA 122.986 2.458 . . . . 0.0 111.689 -179.934 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 120.144 -0.253 . . . . 0.0 112.77 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.405 ' HD2' ' O ' ' D' ' 204' ' ' PRO . 52.9 Cg_exo . . . . . 0 CA--C 1.529 0.27 0 C-N-CA 122.86 2.373 . . . . 0.0 111.22 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.787 0 N-CA-C 112.019 -0.433 . . . . 0.0 112.019 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.76 142.99 95.72 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.855 2.37 . . . . 0.0 111.867 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -67.89 142.86 55.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.935 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' D' ' 210' ' ' PRO . . . -60.55 150.49 41.67 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.736 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.414 ' O ' ' HG3' ' D' ' 211' ' ' GLN . 17.4 mt -68.28 147.8 12.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.74 151.57 46.48 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.837 0.351 . . . . 0.0 110.447 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' D' ' 213' ' ' ILE . . . -66.35 162.46 43.88 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.299 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -68.94 148.72 49.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.771 0.319 . . . . 0.0 110.426 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.18 145.0 54.74 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.216 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.2 143.43 47.45 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.948 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.459 ' HB ' ' HG2' ' D' ' 217' ' ' ARG . 2.5 t -69.49 159.24 5.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 4.6 t -55.79 143.27 9.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.901 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.53 171.48 54.86 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.498 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 97.2 mt . . . . . 0 C--N 1.325 -0.458 0 CA-C-O 120.599 0.238 . . . . 0.0 110.686 -179.853 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.59 0 CA-C-O 120.473 -0.07 . . . . 0.0 113.22 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 CA--C 1.529 0.265 0 C-N-CA 122.921 2.414 . . . . 0.0 111.859 -179.94 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.624 0 N-CA-C 112.431 -0.268 . . . . 0.0 112.431 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo . . . . . 0 C--O 1.236 0.388 0 C-N-CA 122.886 2.39 . . . . 0.0 111.512 179.219 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.648 0 CA-C-O 120.197 -0.224 . . . . 0.0 112.641 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 CA--C 1.531 0.365 0 C-N-CA 123.056 2.504 . . . . 0.0 112.213 179.592 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.512 0 CA-C-O 120.456 -0.08 . . . . 0.0 113.237 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 C--O 1.235 0.345 0 C-N-CA 122.88 2.387 . . . . 0.0 111.193 179.373 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.461 0 CA-C-O 120.109 -0.273 . . . . 0.0 112.637 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo . . . . . 0 C--O 1.235 0.36 0 C-N-CA 123.369 2.712 . . . . 0.0 112.702 -179.82 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 103' ' ' GLY . . . . . 0.44 ' O ' ' HD3' ' D' ' 204' ' ' PRO . . . . . . . . 0 N--CA 1.449 -0.46 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo . . . . . 0 CA--C 1.536 0.588 0 C-N-CA 122.861 2.374 . . . . 0.0 112.449 -179.837 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.51 0 N-CA-C 112.425 -0.27 . . . . 0.0 112.425 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo . . . . . 0 C--N 1.342 0.223 0 C-N-CA 122.776 2.317 . . . . 0.0 111.197 179.44 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.429 0 N-CA-C 113.465 0.146 . . . . 0.0 113.465 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.03 157.34 62.2 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.814 2.343 . . . . 0.0 112.576 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -60.02 137.69 58.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.529 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -67.53 164.11 45.64 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.88 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 40.5 mt -67.22 144.46 14.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.42 148.04 50.15 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -63.17 147.22 50.56 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.119 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -75.17 149.97 38.84 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 122.753 -0.263 . . . . 0.0 110.366 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 9.5 ttm-85 -59.09 141.06 55.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.935 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.95 170.47 33.15 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.973 -0.558 . . . . 0.0 113.428 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 119' ' ' VAL . . . . . 0.452 ' O ' ' HA3' ' D' ' 218' ' ' GLY . 23.5 t -71.85 139.88 19.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.563 -0.319 . . . . 0.0 110.514 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 21.4 t -60.22 141.8 16.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.507 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.51 163.9 34.97 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.446 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 67.3 mt . . . . . 0 C--N 1.323 -0.545 0 O-C-N 122.895 -0.179 . . . . 0.0 110.722 -179.637 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 CA-C-O 120.288 -0.173 . . . . 0.0 112.849 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 C--O 1.236 0.405 0 C-N-CA 122.661 2.241 . . . . 0.0 112.369 -179.499 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.554 0 N-CA-C 112.705 -0.158 . . . . 0.0 112.705 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo . . . . . 0 C--O 1.237 0.438 0 C-N-CA 122.758 2.305 . . . . 0.0 112.046 -179.995 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.38 0 CA-C-O 120.571 -0.016 . . . . 0.0 113.134 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo . . . . . 0 C--O 1.235 0.371 0 C-N-CA 123.098 2.532 . . . . 0.0 111.855 -179.657 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.538 0 CA-C-O 120.273 -0.182 . . . . 0.0 112.955 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo . . . . . 0 CA--C 1.53 0.296 0 C-N-CA 122.971 2.448 . . . . 0.0 112.132 179.868 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 N-CA-C 112.205 -0.358 . . . . 0.0 112.205 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 C--N 1.348 0.516 0 C-N-CA 122.893 2.395 . . . . 0.0 111.412 179.841 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 203' ' ' GLY . . . . . 0.409 ' HA2' ' HD3' ' D' ' 204' ' ' PRO . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 114.381 0.512 . . . . 0.0 114.381 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 204' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' C' ' 103' ' ' GLY . 17.0 Cg_exo . . . . . 0 CA--C 1.53 0.316 0 C-N-CA 123.174 2.582 . . . . 0.0 110.99 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.268 0 N-CA-C 113.492 0.157 . . . . 0.0 113.492 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo . . . . . 0 CA--C 1.534 0.48 0 C-N-CA 123.516 2.811 . . . . 0.0 112.208 179.637 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.591 0 N-CA-C 112.425 -0.27 . . . . 0.0 112.425 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 210' ' ' PRO . . . . . 0.461 ' O ' ' HA3' ' B' ' 12' ' ' GLY . 58.8 Cg_endo -73.78 157.35 47.97 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.549 2.166 . . . . 0.0 112.273 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 211' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' B' ' 13' ' ' ILE . 34.9 tt0 -78.1 144.33 36.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.595 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -68.08 166.32 44.49 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.824 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 213' ' ' ILE . . . . . 0.485 ' O ' ' HA3' ' B' ' 15' ' ' GLY . 45.4 pt -68.29 164.73 2.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 120.835 0.35 . . . . 0.0 110.984 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -81.06 147.58 30.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.108 0.48 . . . . 0.0 111.381 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -71.89 153.02 49.59 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.411 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 48.8 mm-40 -71.55 150.6 44.61 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 217' ' ' ARG . . . . . 0.459 ' HG2' ' HB ' ' B' ' 19' ' ' VAL . 60.0 mtp180 -64.63 160.18 20.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.185 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 218' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' C' ' 119' ' ' VAL . . . -62.14 156.85 36.93 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.206 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.15 152.28 9.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.5 137.25 25.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -56.68 166.63 4.51 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.918 -0.583 . . . . 0.0 114.237 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 8.6 mp . . . . . 0 C--N 1.325 -0.498 0 CA-C-N 115.719 -0.241 . . . . 0.0 110.736 -179.84 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.646 0 N-CA-C 113.299 0.08 . . . . 0.0 113.299 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo . . . . . 0 C--O 1.233 0.268 0 C-N-CA 122.838 2.359 . . . . 0.0 111.109 179.311 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 113.158 0.023 . . . . 0.0 113.158 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo . . . . . 0 C--O 1.235 0.36 0 C-N-CA 122.682 2.255 . . . . 0.0 111.716 179.833 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.766 0 N-CA-C 112.86 -0.096 . . . . 0.0 112.86 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo . . . . . 0 N--CA 1.46 -0.495 0 C-N-CA 122.642 2.228 . . . . 0.0 111.079 179.382 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.478 0.6 0 N-CA-C 110.378 -0.662 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -106.48 160.03 15.72 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.975 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 318' ' ' ILE . . . . . 0.4 ' O ' ' HZ ' ' A' ' 323' ' ' PHE . 19.8 tt -75.9 -23.59 16.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.003 0.43 . . . . 0.0 111.474 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 21.4 m -80.52 0.18 34.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.283 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -67.6 -34.48 77.1 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.948 0.404 . . . . 0.0 111.178 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 321' ' ' GLY . . . . . 0.434 ' HA2' HD21 ' A' ' 502' ' ' LEU . . . 82.55 -171.66 51.53 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.213 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 5.0 t30 52.41 74.04 0.3 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.18 0.514 . . . . 0.0 111.139 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' PHE . . . . . 0.491 ' HD1' ' HB2' ' A' ' 337' ' ' LYS . 73.6 m-85 -95.67 162.76 13.48 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.427 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -77.0 -35.25 57.28 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.244 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 6.7 t -178.33 155.68 0.91 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.528 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.553 HG22 HG13 ' A' ' 335' ' ' VAL . 48.4 t -133.96 127.14 51.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -144.27 172.08 13.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.997 0.427 . . . . 0.0 111.67 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 38.6 ttp -126.28 113.74 17.36 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 50.9 mt -106.88 116.53 32.08 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.567 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.494 ' NH1' ' HB3' ' D' ' 214' ' ' ALA . 69.3 mtp180 57.9 27.45 14.65 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 98.18 -5.75 61.3 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.923 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -101.52 122.43 43.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.902 0.382 . . . . 0.0 111.131 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 56.7 ttm -81.45 120.81 25.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.194 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -119.24 126.76 52.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.756 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 335' ' ' VAL . . . . . 0.553 HG13 HG22 ' A' ' 326' ' ' VAL . 25.5 t -107.73 119.78 57.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.434 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -95.35 121.13 36.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.012 0.434 . . . . 0.0 112.145 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 0.491 ' HB2' ' HD1' ' A' ' 323' ' ' PHE . 52.4 tptt -130.18 99.56 5.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.686 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 62.4 -102.9 0.12 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.02 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -116.77 13.69 15.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.1 0.476 . . . . 0.0 111.026 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 20.1 m-90 -128.88 142.9 50.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.544 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.502 ' CE2' ' HE2' ' A' ' 353' ' ' TYR . 12.6 p90 -122.35 135.49 54.72 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.937 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 342' ' ' TRP . . . . . 0.436 ' HZ3' ' HB3' ' A' ' 337' ' ' LYS . 1.9 m-90 -100.15 151.95 20.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.572 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.515 ' HD2' ' CE1' ' A' ' 353' ' ' TYR . 14.8 ttt-85 -120.78 100.47 7.12 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 5.2 m -112.52 131.45 64.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.204 0.526 . . . . 0.0 112.09 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 6.3 ttm-85 -139.33 112.63 8.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.337 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 1.5 m120 72.97 49.78 0.15 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 61.67 24.46 14.56 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.487 178.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -143.45 145.75 32.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.053 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 22.2 t -83.41 135.75 24.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 350' ' ' MET . . . . . 0.454 ' SD ' ' HD3' ' A' ' 343' ' ' ARG . 87.9 mtp -83.2 156.07 23.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.995 0.426 . . . . 0.0 111.418 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -69.92 150.12 47.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.407 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 352' ' ' GLY . . . . . 0.665 ' HA3' HD11 ' B' ' 13' ' ' ILE . . . 95.04 -8.51 70.13 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.268 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 353' ' ' TYR . . . . . 0.569 ' HB3' ' HA ' ' A' ' 354' ' ' PRO . 32.8 m-85 -119.21 164.01 23.65 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.569 ' HA ' ' HB3' ' A' ' 353' ' ' TYR . 59.1 Cg_endo -70.58 159.82 91.55 Favored 'Cis proline' 0 C--N 1.348 0.501 0 C-N-CA 123.856 -1.31 . . . . 0.0 112.813 0.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 42.5 ttm -134.68 141.78 40.02 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.232 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -60.93 140.09 88.41 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.416 2.077 . . . . 0.0 111.165 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 78.7 mt -56.95 -44.15 81.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.605 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -69.86 3.04 10.38 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 114.283 0.473 . . . . 0.0 114.283 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.09 -46.5 7.41 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -93.79 -53.55 3.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.132 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -84.77 73.19 10.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.831 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 30.4 ttp-105 -64.46 93.88 0.11 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.187 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 129.72 -7.28 6.17 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.035 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.681 HD12 ' HD2' ' A' ' 365' ' ' PRO . 33.8 tp -99.41 126.37 37.85 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-O 120.57 0.224 . . . . 0.0 110.533 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 365' ' ' PRO . . . . . 0.681 ' HD2' HD12 ' A' ' 364' ' ' LEU . 73.9 Cg_endo -74.62 175.09 11.56 Favored 'Trans proline' 0 CA--C 1.528 0.216 0 C-N-CA 122.624 2.216 . . . . 0.0 111.961 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -85.8 154.91 21.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.494 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 35.0 m 55.5 82.41 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 22.7 pt -95.17 -171.22 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.29 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 369' ' ' ASN . . . . . 0.432 HD22 ' HA ' ' A' ' 369' ' ' ASN . 8.1 m120 -108.99 -47.7 3.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.724 0.297 . . . . 0.0 111.193 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 370' ' ' THR . . . . . 0.876 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.3 OUTLIER -156.44 166.34 33.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.848 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -153.4 145.51 23.77 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 372' ' ' TYR . . . . . 0.442 ' HD2' ' HB2' ' A' ' 420' ' ' PHE . 2.0 p90 -161.42 159.94 28.8 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.129 0.49 . . . . 0.0 112.221 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -89.63 121.18 31.57 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 374' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 378' ' ' LYS . 6.2 ptm180 -78.1 177.97 7.91 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.434 ' HE3' ' HA3' ' A' ' 425' ' ' GLY . 70.2 tttt -68.3 -38.2 81.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.863 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -31.63 71.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.632 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 129.66 -32.82 3.11 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.51 -0.852 . . . . 0.0 113.043 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 378' ' ' LYS . . . . . 0.49 ' O ' ' HG2' ' A' ' 374' ' ' ARG . 35.6 mttm -65.66 157.56 29.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.073 0.463 . . . . 0.0 111.696 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 379' ' ' PHE . . . . . 0.449 ' HE1' ' HG3' ' A' ' 330' ' ' ARG . 16.4 m-85 -98.67 135.04 40.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.993 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 4.7 t -113.24 121.65 65.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.842 0.353 . . . . 0.0 110.668 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -108.51 138.26 45.11 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.436 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -120.29 143.5 48.3 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.826 0.346 . . . . 0.0 111.584 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.515 ' HB3' ' CZ3' ' A' ' 388' ' ' TRP . 83.6 tttt -158.34 105.75 1.91 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.517 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 76.33 -114.84 4.26 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.556 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -114.19 4.0 15.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.932 0.396 . . . . 0.0 110.7 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -112.6 155.92 23.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.847 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -136.3 146.78 47.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.944 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 388' ' ' TRP . . . . . 0.515 ' CZ3' ' HB3' ' A' ' 383' ' ' LYS . 20.5 m-90 -121.88 132.51 54.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.061 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 95.0 t -111.88 119.49 60.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -111.21 130.96 55.48 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.342 0.591 . . . . 0.0 112.211 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -95.31 87.82 4.94 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 392' ' ' GLU . . . . . 0.53 ' OE1' ' HB ' ' D' ' 213' ' ' ILE . 38.1 mm-40 67.35 -79.54 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.604 0.565 . . . . 0.0 110.539 -178.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -137.7 19.32 2.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.234 0.54 . . . . 0.0 109.991 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 8.1 m -121.12 157.79 29.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.782 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 64.9 tp -104.43 135.95 44.92 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.629 0.252 . . . . 0.0 110.829 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 396' ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 24.9 mm-40 -70.57 125.89 92.11 Favored Pre-proline 0 C--O 1.232 0.184 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.047 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 397' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 31.9 Cg_exo -59.92 136.35 69.2 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.873 2.382 . . . . 0.0 111.842 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 101.04 -8.37 57.52 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.716 -0.755 . . . . 0.0 111.798 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 399' ' ' TYR . . . . . 0.402 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 22.6 m-85 -93.89 161.02 31.26 Favored Pre-proline 0 C--N 1.321 -0.659 0 O-C-N 122.85 -0.206 . . . . 0.0 110.815 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.458 ' HB3' ' NE1' ' A' ' 388' ' ' TRP . 74.0 Cg_endo -75.04 166.55 82.96 Favored 'Cis proline' 0 C--N 1.346 0.434 0 C-N-CA 123.819 -1.325 . . . . 0.0 112.943 0.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -137.66 163.04 32.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.388 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 0.517 ' HB2' ' HG2' ' A' ' 404' ' ' LYS . 8.6 m-70 -71.01 150.6 45.47 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 79.2 mt -54.61 -33.5 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 120.887 0.375 . . . . 0.0 111.33 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 404' ' ' LYS . . . . . 0.517 ' HG2' ' HB2' ' A' ' 402' ' ' HIS . 19.4 pttp -64.22 -15.13 59.38 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.193 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -81.93 -20.22 39.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.911 0.386 . . . . 0.0 111.102 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 38.3 tp -74.94 -48.85 22.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.084 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.739 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -162.82 155.74 27.19 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.687 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -81.58 130.92 35.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.791 0.329 . . . . 0.0 110.939 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 102.29 1.76 50.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.308 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 51.3 mt -79.46 156.34 75.9 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 120.49 0.186 . . . . 0.0 111.026 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 411' ' ' PRO . . . . . 0.469 ' HG3' ' CE1' ' A' ' 436' ' ' TYR . 30.6 Cg_exo -61.51 118.14 5.0 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.614 2.209 . . . . 0.0 111.525 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.04 -3.5 59.09 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.99 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -92.3 -56.67 2.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.448 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 9.5 ptmt -176.38 171.8 2.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.863 0.363 . . . . 0.0 110.723 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 39.6 mm -117.16 133.09 65.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.694 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 416' ' ' ASP . . . . . 0.503 ' HB3' ' HD2' ' A' ' 463' ' ' PRO . 14.7 m-20 -90.79 -48.85 6.78 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 417' ' ' ALA . . . . . 0.876 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -156.43 154.28 30.2 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.138 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -135.19 113.55 11.46 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 42.3 tp -107.94 132.69 53.22 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.269 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 420' ' ' PHE . . . . . 0.442 ' HB2' ' HD2' ' A' ' 372' ' ' TYR . 29.2 t80 -98.12 116.67 30.82 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.966 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 421' ' ' TRP . . . . . 0.409 ' HB2' ' CE1' ' A' ' 428' ' ' TYR . 9.4 t-105 -89.5 97.05 10.97 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.417 ' HB2' ' HD3' ' A' ' 423' ' ' PRO . 62.7 mtt -55.31 -50.81 84.56 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.417 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 81.7 Cg_exo -45.78 -53.33 5.78 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 123.151 2.567 . . . . 0.0 114.662 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 42.4 p30 -95.62 -10.67 28.84 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 425' ' ' GLY . . . . . 0.434 ' HA3' ' HE3' ' A' ' 375' ' ' LYS . . . 66.89 51.99 36.36 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.921 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -138.42 160.94 38.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.671 0.272 . . . . 0.0 111.03 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 427' ' ' THR . . . . . 0.492 ' HB ' ' HB3' ' A' ' 438' ' ' PHE . 26.5 m -105.7 133.26 50.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.067 0.461 . . . . 0.0 111.525 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 428' ' ' TYR . . . . . 0.409 ' CE1' ' HB2' ' A' ' 421' ' ' TRP . 17.0 m-85 -110.31 110.77 21.69 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -93.97 138.97 31.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.509 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 430' ' ' PHE . . . . . 0.455 ' O ' ' HB2' ' A' ' 416' ' ' ASP . 95.0 m-85 -114.1 136.73 52.61 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.331 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.466 ' HA ' ' HE ' ' A' ' 431' ' ' ARG . 2.6 tpm_? -148.27 105.18 3.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.809 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 68.1 -109.89 3.14 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -115.12 11.4 16.35 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.23 0.538 . . . . 0.0 110.009 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 434' ' ' LYS . . . . . 0.622 ' HD2' ' HG2' ' A' ' 450' ' ' PRO . 19.6 mmtt -117.01 150.48 38.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.156 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 435' ' ' TYR . . . . . 0.447 ' CE2' ' HE1' ' A' ' 449' ' ' TYR . 5.1 p90 -131.41 140.26 49.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.589 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 436' ' ' TYR . . . . . 0.469 ' CE1' ' HG3' ' A' ' 411' ' ' PRO . 2.3 m-85 -110.5 144.38 39.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.497 -178.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -106.14 96.65 6.63 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 438' ' ' PHE . . . . . 0.739 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 79.5 t80 -80.85 128.49 33.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.125 -177.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -96.74 97.87 9.69 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 440' ' ' GLU . . . . . 0.445 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 1.3 mm-40 -44.95 -60.61 1.98 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -56.23 -36.35 68.4 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 67.1 mt -88.73 -20.56 24.65 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 67.0 mtp180 61.96 48.55 5.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.557 0.694 . . . . 0.0 110.847 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -162.03 164.53 28.17 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.749 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.0 t -88.62 138.74 18.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -61.97 166.4 4.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.201 0.524 . . . . 0.0 112.147 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.46 152.0 46.04 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 68.81 22.74 7.15 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.668 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 449' ' ' TYR . . . . . 0.447 ' HE1' ' CE2' ' A' ' 435' ' ' TYR . 31.2 m-85 -118.21 158.26 46.89 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.114 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 450' ' ' PRO . . . . . 0.622 ' HG2' ' HD2' ' A' ' 434' ' ' LYS . 91.9 Cg_endo -77.75 151.71 91.89 Favored 'Cis proline' 0 C--N 1.344 0.332 0 C-N-CA 123.643 -1.399 . . . . 0.0 113.521 0.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -102.38 177.09 4.97 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.847 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -75.24 140.93 43.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.573 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.2 tt -69.79 -11.5 14.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.909 0.385 . . . . 0.0 110.974 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -63.84 -6.31 5.68 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 70.7 t -67.54 -33.6 63.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 10.0 m95 -95.46 84.84 4.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.253 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -57.4 115.71 2.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.187 0.518 . . . . 0.0 112.358 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 115.17 -26.47 9.2 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.097 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.452 HD11 ' HB2' ' A' ' 486' ' ' PHE . 31.7 mm -73.47 130.48 83.96 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.714 0.292 . . . . 0.0 111.067 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.0 156.15 23.32 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.825 2.35 . . . . 0.0 111.869 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -77.57 141.09 39.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.412 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 5.2 m 58.0 74.59 0.62 Allowed Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 463' ' ' PRO . . . . . 0.503 ' HD2' ' HB3' ' A' ' 416' ' ' ASP . 2.4 Cg_endo -81.84 -173.87 1.94 Allowed 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.866 2.378 . . . . 0.0 112.017 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.87 20.37 3.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.239 0.542 . . . . 0.0 110.528 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 161.36 142.48 3.4 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.592 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 7.8 p -156.75 106.77 2.3 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -127.48 138.34 52.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.923 0.392 . . . . 0.0 111.613 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 46.2 ttm -90.31 142.06 28.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.291 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -71.18 162.26 54.16 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.917 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.7 -12.46 46.86 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 16.9 p30 -85.27 -13.2 50.52 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.623 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 66.98 10.84 7.99 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.14 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 40.1 t -104.43 -42.9 7.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.601 0.239 . . . . 0.0 111.44 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 474' ' ' PHE . . . . . 0.411 ' CD1' ' HE2' ' A' ' 485' ' ' LYS . 80.9 m-85 -112.05 144.84 40.74 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 97.8 m -126.99 134.31 50.38 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.316 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -101.82 124.89 48.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.954 0.407 . . . . 0.0 111.716 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 477' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 483' ' ' TYR . 14.6 m-85 -110.22 131.41 55.08 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -115.26 137.76 51.68 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.665 0.269 . . . . 0.0 111.669 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 479' ' ' LYS . . . . . 0.467 ' HB3' ' CZ3' ' A' ' 484' ' ' TRP . 79.5 tttt -163.01 104.1 1.0 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.961 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 65.94 66.03 2.6 Favored Glycine 0 CA--C 1.518 0.268 0 N-CA-C 114.828 0.691 . . . . 0.0 114.828 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 61.84 -1.2 0.37 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 482' ' ' LYS . . . . . 0.441 ' HB2' ' HE2' ' A' ' 482' ' ' LYS . 30.3 mtmm -119.56 148.02 43.8 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 122.291 -0.256 . . . . 0.0 110.526 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 483' ' ' TYR . . . . . 0.543 ' CE2' ' HE2' ' A' ' 497' ' ' TYR . 11.0 p90 -127.95 147.55 50.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.174 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 484' ' ' TRP . . . . . 0.467 ' CZ3' ' HB3' ' A' ' 479' ' ' LYS . 17.4 m-90 -113.04 143.84 43.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.879 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 485' ' ' LYS . . . . . 0.411 ' HE2' ' CD1' ' A' ' 474' ' ' PHE . 74.0 tttt -104.35 97.08 7.07 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 486' ' ' PHE . . . . . 0.452 ' HB2' HD11 ' A' ' 459' ' ' ILE . 89.4 t80 -90.68 134.54 34.33 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.477 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -98.63 119.27 37.06 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -68.52 -32.93 73.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.199 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -74.84 -43.14 56.16 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.701 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -85.24 -22.56 28.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.131 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 3.7 tp 65.56 42.67 3.6 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.525 0.679 . . . . 0.0 109.889 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 492' ' ' LYS . . . . . 0.412 ' HG2' ' N ' ' A' ' 493' ' ' VAL . 16.1 tttp -156.96 153.89 28.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.61 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 493' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 486' ' ' PHE . 69.9 t -85.15 140.18 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -61.48 131.46 92.54 Favored Pre-proline 0 C--O 1.234 0.278 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.264 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -62.11 141.84 90.04 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.669 2.246 . . . . 0.0 111.682 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 109.56 -10.24 32.83 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 497' ' ' TYR . . . . . 0.613 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 14.0 m-85 -94.73 170.46 8.02 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.61 -0.295 . . . . 0.0 110.333 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 498' ' ' PRO . . . . . 0.613 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 91.9 Cg_endo -78.88 169.5 72.11 Favored 'Cis proline' 0 C--N 1.349 0.604 0 C-N-CA 123.978 -1.259 . . . . 0.0 113.253 0.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -120.85 157.65 29.34 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.774 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 47.6 t -69.84 112.91 6.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.973 0.416 . . . . 0.0 110.263 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -66.55 -23.73 66.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.074 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 502' ' ' LEU . . . . . 0.485 ' HA ' ' HG2' ' A' ' 506' ' ' MET . 79.1 mt -65.94 -39.25 90.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.114 0.483 . . . . 0.0 110.711 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -89.06 -39.69 13.47 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.587 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.0 -36.67 61.97 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 42.9 m0 -106.37 -57.44 2.05 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 506' ' ' MET . . . . . 0.485 ' HG2' ' HA ' ' A' ' 502' ' ' LEU . 7.1 mmt -65.84 -35.42 80.63 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 91.67 38.03 5.95 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.218 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 23.0 m -115.74 86.95 16.75 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.3 160.69 48.06 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.475 2.117 . . . . 0.0 111.737 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 5.7 m 66.4 69.71 0.42 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.166 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.23 0 CA-C-O 118.306 -1.274 . . . . 0.0 111.258 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.766 0 N-CA-C 112.429 -0.268 . . . . 0.0 112.429 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo . . . . . 0 C--N 1.345 0.394 0 C-N-CA 122.745 2.297 . . . . 0.0 112.471 -179.346 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.736 0 N-CA-C 112.181 -0.368 . . . . 0.0 112.181 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo . . . . . 0 N--CA 1.459 -0.521 0 C-N-CA 122.488 2.126 . . . . 0.0 110.404 178.97 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.563 0 CA-C-O 120.365 -0.131 . . . . 0.0 112.887 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo . . . . . 0 CA--C 1.527 0.154 0 C-N-CA 122.943 2.428 . . . . 0.0 111.766 179.915 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.744 0 N-CA-C 112.062 -0.415 . . . . 0.0 112.062 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.35 149.77 69.89 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 123.006 2.471 . . . . 0.0 112.061 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -65.17 145.56 56.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.494 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.41 155.96 46.21 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.249 -0.5 . . . . 0.0 112.318 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.665 HD11 ' HA3' ' A' ' 352' ' ' GLY . 6.9 mt -67.44 147.28 12.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.572 0.225 . . . . 0.0 110.778 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.41 147.29 53.09 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.797 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' D' ' 213' ' ' ILE . . . -75.77 162.08 52.79 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.0 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -72.94 150.47 42.51 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -75.16 152.41 38.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.191 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' D' ' 216' ' ' GLN . . . -67.84 154.23 53.01 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.648 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 3.2 t -71.99 152.32 8.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 2.9 t -51.33 145.24 2.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 O-C-N 123.499 0.499 . . . . 0.0 110.948 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.39 160.12 53.99 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.739 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 94.0 mt . . . . . 0 C--N 1.321 -0.654 0 CA-C-O 120.479 0.181 . . . . 0.0 110.604 179.978 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.612 0 N-CA-C 112.451 -0.26 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo . . . . . 0 CA--C 1.529 0.258 0 C-N-CA 122.752 2.301 . . . . 0.0 111.764 179.742 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 113.399 0.12 . . . . 0.0 113.399 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 CA--C 1.532 0.409 0 C-N-CA 123.244 2.629 . . . . 0.0 112.035 179.969 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 112.878 -0.089 . . . . 0.0 112.878 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo . . . . . 0 CA--C 1.528 0.224 0 C-N-CA 123.176 2.584 . . . . 0.0 111.853 179.702 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.514 0 N-CA-C 112.333 -0.307 . . . . 0.0 112.333 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo . . . . . 0 N--CA 1.464 -0.228 0 C-N-CA 122.685 2.256 . . . . 0.0 111.479 179.562 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.402 0 CA-C-O 120.224 -0.209 . . . . 0.0 112.64 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo . . . . . 0 C--O 1.234 0.282 0 C-N-CA 123.057 2.505 . . . . 0.0 111.142 -179.893 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 103' ' ' GLY . . . . . 0.417 ' HA2' ' HD3' ' C' ' 104' ' ' PRO . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 113.689 0.236 . . . . 0.0 113.689 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 104' ' ' PRO . . . . . 0.417 ' HD3' ' HA2' ' C' ' 103' ' ' GLY . 2.8 Cg_exo . . . . . 0 CA--C 1.533 0.44 0 C-N-CA 123.528 2.819 . . . . 0.0 112.413 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.394 0 N-CA-C 112.421 -0.272 . . . . 0.0 112.421 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo . . . . . 0 CA--C 1.531 0.34 0 C-N-CA 122.981 2.454 . . . . 0.0 111.756 -179.885 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.243 0 N-CA-C 113.553 0.181 . . . . 0.0 113.553 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.19 156.82 64.36 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.66 2.24 . . . . 0.0 112.085 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -59.33 135.86 57.78 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.06 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -62.01 162.16 27.63 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.563 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 16.3 mt -69.3 134.73 29.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.621 0.248 . . . . 0.0 110.68 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.26 146.52 47.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.679 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -64.94 157.04 46.62 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 121.205 -0.521 . . . . 0.0 113.002 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -84.3 152.4 24.16 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 117' ' ' ARG . . . . . 0.412 ' HE ' ' HB2' ' C' ' 117' ' ' ARG . 4.6 ttm180 -66.5 148.52 51.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.328 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.07 171.91 41.65 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.027 -0.606 . . . . 0.0 113.053 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 15.9 t -72.85 142.49 15.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 97.3 t -62.9 138.39 22.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.954 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.46 158.52 39.32 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 116.081 -0.508 . . . . 0.0 112.538 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 59.1 mt . . . . . 0 C--N 1.323 -0.551 0 CA-C-N 115.852 -0.174 . . . . 0.0 110.642 -179.777 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.615 0 N-CA-C 112.673 -0.171 . . . . 0.0 112.673 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 N--CA 1.464 -0.209 0 C-N-CA 122.475 2.117 . . . . 0.0 111.116 179.833 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.523 0 N-CA-C 112.774 -0.13 . . . . 0.0 112.774 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo . . . . . 0 C--O 1.236 0.381 0 C-N-CA 122.82 2.347 . . . . 0.0 111.552 179.839 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.434 0 N-CA-C 113.451 0.14 . . . . 0.0 113.451 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo . . . . . 0 C--O 1.235 0.328 0 C-N-CA 122.985 2.457 . . . . 0.0 111.731 -179.948 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 133' ' ' GLY . . . . . 0.407 ' HA2' ' HD3' ' C' ' 134' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.608 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 134' ' ' PRO . . . . . 0.407 ' HD3' ' HA2' ' C' ' 133' ' ' GLY . 17.2 Cg_exo . . . . . 0 C--N 1.345 0.375 0 C-N-CA 123.107 2.538 . . . . 0.0 111.968 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.387 0 CA-C-O 120.197 -0.224 . . . . 0.0 112.712 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo . . . . . 0 C--N 1.347 0.492 0 C-N-CA 123.153 2.569 . . . . 0.0 111.115 179.276 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 CA-C-O 120.138 -0.257 . . . . 0.0 113.606 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo . . . . . 0 C--N 1.348 0.522 0 C-N-CA 123.735 2.956 . . . . 0.0 113.04 -179.151 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.429 0 CA-C-O 120.429 -0.095 . . . . 0.0 113.033 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo . . . . . 0 N--CA 1.457 -0.64 0 C-N-CA 123.466 2.777 . . . . 0.0 111.995 179.948 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.574 0 N-CA-C 112.428 -0.269 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.06 158.48 57.25 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.502 2.134 . . . . 0.0 111.773 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -78.29 144.08 36.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.653 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -67.43 159.53 50.14 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.87 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 213' ' ' ILE . . . . . 0.53 ' HB ' ' OE1' ' A' ' 392' ' ' GLU . 15.2 pt -70.76 168.85 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.655 0.264 . . . . 0.0 111.026 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 214' ' ' ALA . . . . . 0.494 ' HB3' ' NH1' ' A' ' 330' ' ' ARG . . . -87.37 143.15 27.38 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.863 0.363 . . . . 0.0 110.595 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -65.99 162.25 42.93 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 116.02 -0.536 . . . . 0.0 113.216 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 216' ' ' GLN . . . . . 0.447 ' O ' ' HA3' ' B' ' 18' ' ' GLY . 68.0 mm-40 -71.08 158.94 35.62 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.783 0.325 . . . . 0.0 110.899 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -68.5 152.57 45.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.0 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -59.96 151.09 38.6 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.301 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 12.4 t -61.33 144.44 13.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 46.7 t -63.18 139.42 21.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -56.66 158.23 10.03 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.962 -0.563 . . . . 0.0 113.621 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 C--N 1.323 -0.587 0 CA-C-N 115.656 -0.272 . . . . 0.0 110.668 -179.589 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 224' ' ' GLY . . . . . 0.423 ' HA2' ' HD3' ' D' ' 225' ' ' PRO . . . . . . . . 0 N--CA 1.449 -0.475 0 CA-C-O 120.495 -0.058 . . . . 0.0 112.96 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 225' ' ' PRO . . . . . 0.423 ' HD3' ' HA2' ' D' ' 224' ' ' GLY . 24.2 Cg_exo . . . . . 0 CA--C 1.528 0.177 0 C-N-CA 123.092 2.528 . . . . 0.0 111.223 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.538 0 N-CA-C 112.638 -0.185 . . . . 0.0 112.638 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo . . . . . 0 N--CA 1.46 -0.481 0 C-N-CA 122.93 2.42 . . . . 0.0 111.643 179.503 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 113.816 0.286 . . . . 0.0 113.816 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo . . . . . 0 C--N 1.342 0.219 0 C-N-CA 123.206 2.604 . . . . 0.0 111.995 179.919 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo . . . . . 0 N--CA 1.479 0.63 0 N-CA-C 110.238 -0.716 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 317' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 320' ' ' ASP . 20.7 t-20 -114.1 164.62 13.6 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 19.5 tt -71.37 -23.44 22.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.948 0.404 . . . . 0.0 111.036 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 31.2 m -87.68 6.07 36.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.727 0.299 . . . . 0.0 111.574 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 317' ' ' ASN . 0.2 OUTLIER -63.15 -50.5 70.16 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.132 0.491 . . . . 0.0 110.438 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 97.13 175.59 34.7 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 51.03 73.43 0.29 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.172 0.511 . . . . 0.0 112.172 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' PHE . . . . . 0.609 ' HD1' ' HD3' ' A' ' 337' ' ' LYS . 60.7 m-85 -88.62 173.3 8.7 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.03 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.37 -51.75 27.55 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 14.5 t -170.51 147.67 2.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.435 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 76.8 t -112.71 126.62 70.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -131.67 166.7 20.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.01 0.433 . . . . 0.0 111.151 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 42.2 ttp -136.36 108.18 7.08 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 45.3 mt -106.25 127.2 53.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.574 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.06 14.85 5.71 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.55 0.531 . . . . 0.0 112.13 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 102.99 -9.29 54.92 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.23 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -93.94 129.67 40.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.631 0.253 . . . . 0.0 110.738 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 45.6 ttm -82.59 123.07 28.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.228 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -114.86 123.22 48.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.355 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 9.2 t -103.49 109.75 27.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.954 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -92.16 125.41 36.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.457 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 0.609 ' HD3' ' HD1' ' A' ' 323' ' ' PHE . 22.0 tptp -136.5 95.5 3.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.656 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 62.7 -100.5 0.09 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.411 ' H ' ' HG2' ' A' ' 339' ' ' ARG . 7.7 ptm85 -104.22 -5.25 22.09 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -177.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 7.6 m0 -124.69 159.89 29.8 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.974 0.416 . . . . 0.0 111.425 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -135.93 138.2 42.13 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.372 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -108.39 152.78 24.21 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.954 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.513 ' HD3' ' SD ' ' A' ' 350' ' ' MET . 16.4 ttt180 -127.07 113.4 16.38 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -101.78 113.09 37.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.175 0.512 . . . . 0.0 111.206 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.23 120.18 40.87 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 5.5 m120 61.83 32.94 17.94 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.437 0.46 . . . . 0.0 110.577 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 70.89 16.22 6.62 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.192 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -121.51 137.64 54.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.251 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 22.9 t -73.47 120.74 22.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.044 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 350' ' ' MET . . . . . 0.513 ' SD ' ' HD3' ' A' ' 343' ' ' ARG . 79.0 mtp -70.45 167.93 17.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.987 0.422 . . . . 0.0 111.542 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -85.81 163.71 17.98 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.371 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 91.54 -1.55 76.01 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.772 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 353' ' ' TYR . . . . . 0.56 ' HB3' ' HA ' ' A' ' 354' ' ' PRO . 63.4 m-85 -113.78 160.99 29.93 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.56 ' HA ' ' HB3' ' A' ' 353' ' ' TYR . 56.3 Cg_endo -72.55 128.49 15.18 Favored 'Cis proline' 0 C--N 1.347 0.493 0 C-N-CA 123.505 -1.456 . . . . 0.0 112.519 0.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 54.2 ttm -102.87 133.52 20.35 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.711 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.76 136.09 68.1 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.398 2.065 . . . . 0.0 111.158 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 77.4 mt -53.0 -45.47 52.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.835 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -68.18 -13.55 64.85 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 121.145 -0.55 . . . . 0.0 114.04 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.51 -29.45 61.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.954 0.377 . . . . 0.0 110.202 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -112.38 -53.91 2.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.556 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -86.91 73.72 9.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.962 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -64.69 103.64 0.72 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.008 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 127.55 -13.3 6.55 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.416 HD12 ' HD2' ' A' ' 365' ' ' PRO . 20.0 tp -97.9 129.23 31.63 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 365' ' ' PRO . . . . . 0.416 ' HD2' HD12 ' A' ' 364' ' ' LEU . 94.3 Cg_endo -81.62 -178.72 4.39 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.782 2.321 . . . . 0.0 112.067 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -82.93 149.19 27.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.502 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 39.3 m 58.5 90.11 0.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.752 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 30.3 pt -95.62 168.59 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.965 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 369' ' ' ASN . . . . . 0.535 ' HB2' ' HA ' ' A' ' 383' ' ' LYS . 0.1 OUTLIER -92.81 -45.54 7.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.902 -179.289 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 370' ' ' THR . . . . . 0.792 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.2 OUTLIER -157.38 168.08 28.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.741 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -157.37 141.14 15.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 372' ' ' TYR . . . . . 0.448 ' CE1' ' HB ' ' A' ' 380' ' ' VAL . 27.6 p90 -160.02 161.01 33.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.065 0.46 . . . . 0.0 111.859 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -94.99 125.68 39.81 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 374' ' ' ARG . . . . . 0.512 ' HB2' ' OE2' ' A' ' 440' ' ' GLU . 2.4 ptm180 -82.87 179.71 7.69 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -178.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.509 ' HD2' ' O ' ' A' ' 425' ' ' GLY . 71.4 tttt -64.46 -29.24 70.29 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 376' ' ' ASP . . . . . 0.443 ' OD2' ' HE2' ' A' ' 378' ' ' LYS . 0.0 OUTLIER -85.79 -17.21 36.41 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.07 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 116.53 -18.57 13.28 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.799 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 378' ' ' LYS . . . . . 0.443 ' HE2' ' OD2' ' A' ' 376' ' ' ASP . 44.4 mttm -72.48 156.05 39.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.195 0.497 . . . . 0.0 111.077 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -100.03 125.65 46.12 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.187 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 380' ' ' VAL . . . . . 0.448 ' HB ' ' CE1' ' A' ' 372' ' ' TYR . 15.4 t -108.25 116.3 51.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.041 0.448 . . . . 0.0 110.726 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -104.5 138.21 41.21 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.45 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -118.25 145.81 44.74 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.804 0.335 . . . . 0.0 111.233 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.668 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 64.4 tttp -155.0 99.55 2.12 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.957 178.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 71.56 -106.28 1.87 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.8 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -114.17 5.9 16.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.732 0.301 . . . . 0.0 111.432 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -116.95 154.52 30.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.91 0.386 . . . . 0.0 111.438 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 387' ' ' HIS . . . . . 0.401 ' NE2' ' HE2' ' A' ' 399' ' ' TYR . 23.9 p-80 -136.99 144.9 43.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.849 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 388' ' ' TRP . . . . . 0.668 ' HZ3' ' HB3' ' A' ' 383' ' ' LYS . 22.3 m-90 -118.8 135.13 54.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.964 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 53.3 t -113.37 114.55 47.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -107.06 121.6 44.81 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.411 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -91.5 100.13 12.94 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 69.0 -68.99 0.17 Allowed 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.722 0.639 . . . . 0.0 110.707 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -156.11 16.51 0.35 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.658 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.11 127.25 49.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.92 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 60.5 tp -75.14 131.51 40.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.218 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 396' ' ' GLU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 20.1 mm-40 -66.87 133.21 93.94 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.956 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 397' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 39.3 Cg_exo -62.24 123.62 12.82 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.997 2.465 . . . . 0.0 112.361 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 113.82 -1.84 24.47 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.413 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 399' ' ' TYR . . . . . 0.406 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 31.0 m-85 -100.17 161.64 23.52 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.464 ' HB3' ' CE2' ' A' ' 388' ' ' TRP . 75.7 Cg_endo -76.35 160.53 95.27 Favored 'Cis proline' 0 C--N 1.345 0.365 0 C-N-CA 123.797 -1.335 . . . . 0.0 113.269 0.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 28.6 mttm -125.41 165.44 18.4 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.262 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -71.53 158.33 36.43 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 47.5 mt -57.78 -36.54 55.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.045 0.45 . . . . 0.0 111.374 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -66.52 -15.56 63.48 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.265 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -78.66 -25.02 44.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.887 0.375 . . . . 0.0 110.896 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 39.6 tp -74.83 -45.38 43.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.122 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.612 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -164.21 154.81 25.86 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.764 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 52.1 ttt85 -79.66 135.89 36.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.7 0.286 . . . . 0.0 110.51 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.08 -4.59 62.83 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.84 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 46.8 mt -72.66 151.32 91.33 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.858 0.329 . . . . 0.0 111.121 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.02 129.07 33.33 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.869 2.38 . . . . 0.0 112.123 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.59 -8.6 52.28 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -91.51 -54.37 3.93 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -176.95 -179.66 0.95 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.337 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 37.6 mm -124.24 137.18 58.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 416' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 430' ' ' PHE . 1.4 m-20 -88.52 -57.94 2.73 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 417' ' ' ALA . . . . . 0.792 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -152.8 161.54 42.42 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.794 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -137.61 128.36 27.01 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 40.6 tp -118.92 122.17 41.65 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.824 0.345 . . . . 0.0 111.237 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -88.14 111.58 21.75 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.188 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 13.1 t-105 -80.24 96.25 6.54 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 67.9 mtt -51.35 -51.84 65.02 Favored Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -40.47 -54.52 2.25 Favored 'Trans proline' 0 C--N 1.358 1.067 0 C-N-CA 123.388 2.725 . . . . 0.0 115.139 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -104.24 -16.84 15.07 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 425' ' ' GLY . . . . . 0.509 ' O ' ' HD2' ' A' ' 375' ' ' LYS . . . 79.58 53.77 4.22 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.666 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -133.4 136.95 45.59 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.718 0.294 . . . . 0.0 110.436 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 17.6 m -91.65 127.42 37.1 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -99.56 114.69 27.85 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.631 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -96.17 123.31 39.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.658 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 430' ' ' PHE . . . . . 0.42 ' O ' ' HB2' ' A' ' 416' ' ' ASP . 86.9 m-85 -99.12 135.92 39.83 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.186 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.413 ' HA ' ' HE ' ' A' ' 431' ' ' ARG . 3.0 tpm_? -148.84 101.74 3.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.651 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 73.54 -116.71 5.53 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.737 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -110.08 14.38 22.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.99 0.424 . . . . 0.0 110.651 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 434' ' ' LYS . . . . . 0.521 ' HB3' ' HB2' ' A' ' 450' ' ' PRO . 33.7 mmtp -127.44 151.94 48.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.983 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 435' ' ' TYR . . . . . 0.506 ' CE2' ' HE2' ' A' ' 449' ' ' TYR . 30.8 p90 -130.09 143.43 50.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.657 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -111.05 151.21 28.29 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.211 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -111.6 99.57 8.28 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 438' ' ' PHE . . . . . 0.612 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 72.9 t80 -79.76 116.82 20.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.84 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -83.47 102.13 11.87 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.211 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 440' ' ' GLU . . . . . 0.512 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 4.1 mm-40 -56.93 -26.39 59.37 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -87.05 -14.37 41.7 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 93.0 mt -120.14 -11.65 9.2 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 443' ' ' ARG . . . . . 0.442 HH11 ' HD3' ' A' ' 443' ' ' ARG . 25.6 mtp180 58.69 45.01 16.47 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.323 0.583 . . . . 0.0 111.177 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -162.24 157.0 22.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.989 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 96.3 t -76.71 133.53 30.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -60.57 164.38 4.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.032 0.444 . . . . 0.0 111.731 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 74.4 m -70.64 159.16 34.92 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.768 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 72.62 20.25 3.86 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.126 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 449' ' ' TYR . . . . . 0.506 ' HE2' ' CE2' ' A' ' 435' ' ' TYR . 32.1 m-85 -120.41 159.08 49.37 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.5 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 450' ' ' PRO . . . . . 0.521 ' HB2' ' HB3' ' A' ' 434' ' ' LYS . 72.3 Cg_endo -75.04 165.52 85.71 Favored 'Cis proline' 0 C--N 1.344 0.34 0 C-N-CA 123.608 -1.413 . . . . 0.0 112.95 0.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 57.6 mttm -117.64 160.65 20.94 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.664 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 452' ' ' ASN . . . . . 0.437 ' HA ' ' HD3' ' A' ' 434' ' ' LYS . 30.9 t-20 -67.37 135.43 53.21 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.272 0.357 . . . . 0.0 110.453 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.4 tt -64.0 -12.91 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.075 0.464 . . . . 0.0 111.323 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -62.5 -15.21 48.98 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 75.7 t -58.75 -36.94 63.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 456' ' ' TRP . . . . . 0.445 ' HB2' ' HB ' ' A' ' 459' ' ' ILE . 17.4 m95 -86.06 88.53 7.6 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.11 109.04 0.38 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 107.89 -13.11 38.16 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.027 -0.606 . . . . 0.0 113.312 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.445 ' HB ' ' HB2' ' A' ' 456' ' ' TRP . 40.0 mm -83.33 126.24 72.27 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.81 0.305 . . . . 0.0 111.298 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.85 156.16 30.87 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.036 2.49 . . . . 0.0 111.983 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -73.04 149.55 43.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.177 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 3.5 m 51.64 69.46 2.49 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 114.484 1.291 . . . . 0.0 114.484 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -91.47 172.62 2.78 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.55 2.167 . . . . 0.0 109.956 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -142.91 74.56 1.45 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.542 0.686 . . . . 0.0 111.219 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 135.79 97.63 0.53 Allowed Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.345 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 466' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 476' ' ' TYR . 2.9 p -130.13 108.34 9.99 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -130.06 144.03 51.12 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.945 0.402 . . . . 0.0 111.475 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 43.1 ttm -97.11 133.87 41.2 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.521 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -65.31 164.69 36.79 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.379 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 2.4 m -65.5 -8.03 17.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.941 0.4 . . . . 0.0 111.825 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -87.89 -13.04 43.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.517 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 64.02 11.11 5.87 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.624 -0.717 . . . . 0.0 112.509 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 98.1 t -110.79 -41.5 4.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.845 0.355 . . . . 0.0 111.403 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -105.68 123.17 47.5 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 85.6 m -111.81 141.09 45.88 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 476' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 466' ' ' SER . 89.7 m-85 -113.52 135.0 54.37 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -118.66 127.27 53.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.415 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -109.27 133.85 52.52 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 56.6 tttt -165.66 127.69 2.01 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.223 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 61.98 38.19 95.65 Favored Glycine 0 N--CA 1.454 -0.118 0 CA-C-N 116.035 -0.53 . . . . 0.0 113.449 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 481' ' ' ASN . . . . . 0.511 HD21 HD12 ' A' ' 502' ' ' LEU . 53.7 t30 74.15 -4.79 2.21 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -106.85 155.29 19.9 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -127.26 139.35 52.97 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.137 0.494 . . . . 0.0 111.563 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 17.9 m-90 -108.84 133.28 53.09 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.742 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -99.03 100.81 12.02 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.958 0.408 . . . . 0.0 110.034 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 486' ' ' PHE . . . . . 0.497 ' HZ ' HD12 ' A' ' 491' ' ' LEU . 88.9 t80 -89.65 132.63 35.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.155 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 487' ' ' ASN . . . . . 0.414 ' HB3' ' HB3' ' A' ' 490' ' ' LYS . 32.6 t-20 -96.66 112.42 24.18 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -59.38 -47.8 84.08 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 41.3 tp60 -85.13 37.51 0.67 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.326 0.584 . . . . 0.0 111.41 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 490' ' ' LYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 487' ' ' ASN . 19.8 ttpt -153.33 -27.85 0.14 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.912 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.497 HD12 ' HZ ' ' A' ' 486' ' ' PHE . 14.7 tp 61.76 40.17 13.26 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.867 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -159.66 148.0 17.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.628 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 69.5 t -75.78 142.93 13.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -63.97 142.67 98.18 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.379 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -65.5 146.0 83.87 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.725 2.283 . . . . 0.0 111.753 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 96.12 1.75 61.05 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.21 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 497' ' ' TYR . . . . . 0.722 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 72.3 m-85 -108.87 167.39 9.23 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 498' ' ' PRO . . . . . 0.722 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 91.9 Cg_endo -76.46 176.75 42.48 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 124.037 -1.235 . . . . 0.0 113.42 0.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -133.12 166.0 23.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.939 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 500' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 504' ' ' ASP . 4.8 t -75.49 122.14 23.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.852 0.358 . . . . 0.0 110.849 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -73.92 -21.17 60.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.86 0.362 . . . . 0.0 110.866 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 502' ' ' LEU . . . . . 0.511 HD12 HD21 ' A' ' 481' ' ' ASN . 10.3 mt -70.96 -48.72 51.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.881 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -78.18 -40.18 38.53 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.999 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 504' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 500' ' ' SER . 0.6 OUTLIER -76.79 -56.33 4.69 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -177.899 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -85.17 -58.51 2.65 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -177.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 506' ' ' MET . . . . . 0.467 ' HG3' HD23 ' A' ' 502' ' ' LEU . 11.6 mmt -63.86 -32.51 74.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 87.82 38.01 7.67 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.938 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 59.9 m -121.29 90.8 47.84 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.01 166.2 30.31 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.804 2.336 . . . . 0.0 111.721 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 11.9 m 65.91 101.36 0.04 OUTLIER 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.459 0.647 . . . . 0.0 111.793 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.865 0 CA-C-O 118.361 -1.244 . . . . 0.0 111.473 179.914 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.889 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 CA--C 1.528 0.186 0 C-N-CA 122.421 2.081 . . . . 0.0 111.369 179.642 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 3' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' D' ' 201' ' ' PRO . . . . . . . . 0 N--CA 1.448 -0.559 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo . . . . . 0 CA--C 1.529 0.261 0 C-N-CA 122.683 2.255 . . . . 0.0 111.253 179.912 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.429 0 CA-C-O 120.34 -0.144 . . . . 0.0 112.969 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo . . . . . 0 CA--C 1.531 0.372 0 C-N-CA 122.995 2.463 . . . . 0.0 111.978 179.766 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.757 0 N-CA-C 112.538 -0.225 . . . . 0.0 112.538 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.91 144.55 96.68 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.119 2.546 . . . . 0.0 112.106 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -64.12 140.39 58.86 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.669 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.74 144.02 47.62 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.517 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 32.5 mt -63.67 144.69 14.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.592 0.234 . . . . 0.0 110.548 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.03 157.93 20.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.043 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' D' ' 213' ' ' ILE . . . -71.13 165.76 52.99 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.471 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -72.29 149.02 44.86 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.66 142.08 57.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.436 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' D' ' 216' ' ' GLN . . . -61.63 148.37 47.34 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.293 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.432 ' HB ' ' HG2' ' D' ' 217' ' ' ARG . 3.1 t -68.3 154.27 8.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.753 0.311 . . . . 0.0 110.502 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 14.7 t -58.33 141.4 15.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.689 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.46 168.37 53.92 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.567 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 C--N 1.324 -0.524 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 -179.815 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.572 0 CA-C-O 120.436 -0.091 . . . . 0.0 112.903 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo . . . . . 0 CA--C 1.53 0.299 0 C-N-CA 122.831 2.354 . . . . 0.0 111.798 179.836 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo . . . . . 0 C--O 1.237 0.459 0 C-N-CA 122.584 2.189 . . . . 0.0 111.924 179.93 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.816 0 CA-C-O 120.356 -0.136 . . . . 0.0 112.789 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo . . . . . 0 N--CA 1.465 -0.176 0 C-N-CA 122.915 2.41 . . . . 0.0 111.1 179.281 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 33' ' ' GLY . . . . . 0.415 ' HA2' ' HD3' ' B' ' 34' ' ' PRO . . . . . . . . 0 N--CA 1.45 -0.395 0 CA-C-O 120.428 -0.096 . . . . 0.0 113.138 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' PRO . . . . . 0.415 ' HD3' ' HA2' ' B' ' 33' ' ' GLY . 14.8 Cg_endo . . . . . 0 N--CA 1.455 -0.781 0 C-N-CA 123.419 2.746 . . . . 0.0 111.749 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.428 0 CA-C-O 120.077 -0.291 . . . . 0.0 112.665 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo . . . . . 0 C--N 1.344 0.301 0 C-N-CA 122.929 2.42 . . . . 0.0 111.679 179.614 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.425 0 N-CA-C 113.191 0.036 . . . . 0.0 113.191 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo . . . . . 0 CA--C 1.53 0.297 0 C-N-CA 123.48 2.787 . . . . 0.0 111.739 179.712 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.583 0 N-CA-C 112.095 -0.402 . . . . 0.0 112.095 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo . . . . . 0 N--CA 1.463 -0.27 0 C-N-CA 122.926 2.417 . . . . 0.0 110.83 179.479 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.292 0 N-CA-C 113.537 0.175 . . . . 0.0 113.537 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.97 169.98 13.84 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 122.85 2.366 . . . . 0.0 112.553 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 111' ' ' GLN . . . . . 0.444 ' OE1' ' HB2' ' D' ' 210' ' ' PRO . 5.6 tp60 -64.75 137.78 58.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.548 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -62.23 161.35 29.95 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 116.02 -0.536 . . . . 0.0 113.095 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 113' ' ' ILE . . . . . 0.497 ' H ' HG13 ' C' ' 113' ' ' ILE . 2.3 mt -62.73 144.0 14.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.695 -0.252 . . . . 0.0 110.393 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.97 152.8 44.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.539 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -70.43 145.81 41.29 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.477 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -72.82 147.02 45.87 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 35.1 ttm-85 -62.45 145.81 53.14 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.758 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.18 177.39 32.34 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.806 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 61.9 t -72.84 137.48 23.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.466 -0.367 . . . . 0.0 110.365 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 93.7 t -63.94 139.25 21.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.983 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.22 157.41 28.01 Favored Glycine 0 N--CA 1.45 -0.424 0 O-C-N 123.51 0.506 . . . . 0.0 112.886 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 31.8 mt . . . . . 0 C--N 1.325 -0.481 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 -179.706 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 113.237 0.055 . . . . 0.0 113.237 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo . . . . . 0 C--O 1.234 0.294 0 C-N-CA 122.684 2.256 . . . . 0.0 111.47 179.69 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.446 0 N-CA-C 112.961 -0.055 . . . . 0.0 112.961 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 C--O 1.237 0.454 0 C-N-CA 122.595 2.196 . . . . 0.0 111.514 179.807 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.391 0 N-CA-C 113.489 0.156 . . . . 0.0 113.489 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo . . . . . 0 C--N 1.34 0.114 0 C-N-CA 123.038 2.492 . . . . 0.0 111.287 179.711 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 133' ' ' GLY . . . . . 0.503 ' HA2' ' HD3' ' C' ' 134' ' ' PRO . . . . . . . . 0 N--CA 1.45 -0.373 0 N-CA-C 112.112 -0.395 . . . . 0.0 112.112 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 134' ' ' PRO . . . . . 0.503 ' HD3' ' HA2' ' C' ' 133' ' ' GLY . 7.6 Cg_exo . . . . . 0 C--O 1.233 0.259 0 C-N-CA 123.084 2.523 . . . . 0.0 112.143 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 CA-C-O 120.043 -0.309 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 201' ' ' PRO . . . . . 0.452 ' O ' ' HA3' ' B' ' 3' ' ' GLY . 35.4 Cg_exo . . . . . 0 C--N 1.345 0.382 0 C-N-CA 122.985 2.457 . . . . 0.0 111.724 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.462 0 CA-C-O 120.402 -0.11 . . . . 0.0 113.032 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo . . . . . 0 N--CA 1.461 -0.398 0 C-N-CA 123.903 3.068 . . . . 0.0 112.148 -179.805 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.342 0 N-CA-C 113.567 0.187 . . . . 0.0 113.567 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo . . . . . 0 N--CA 1.457 -0.647 0 C-N-CA 123.656 2.904 . . . . 0.0 112.46 179.742 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.514 0 N-CA-C 112.011 -0.436 . . . . 0.0 112.011 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 210' ' ' PRO . . . . . 0.444 ' HB2' ' OE1' ' C' ' 111' ' ' GLN . 12.4 Cg_exo -70.21 157.76 58.5 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.766 2.31 . . . . 0.0 111.901 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -82.56 142.33 31.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.988 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -64.74 162.66 37.92 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 116.08 -0.509 . . . . 0.0 113.295 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 213' ' ' ILE . . . . . 0.446 ' O ' ' HA3' ' B' ' 15' ' ' GLY . 42.2 pt -71.68 159.35 5.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.926 0.393 . . . . 0.0 111.403 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -71.27 139.1 49.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.081 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -64.37 165.6 31.45 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 116.01 -0.541 . . . . 0.0 113.864 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 216' ' ' GLN . . . . . 0.407 ' O ' ' HA3' ' B' ' 18' ' ' GLY . 91.0 mm-40 -78.58 153.42 31.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.794 0.33 . . . . 0.0 110.486 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 217' ' ' ARG . . . . . 0.432 ' HG2' ' HB ' ' B' ' 19' ' ' VAL . 33.8 mtp180 -69.79 156.23 39.34 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.543 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -64.36 154.52 47.79 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.735 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 24.5 t -65.31 144.53 14.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.98 135.98 25.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.887 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -54.15 161.22 4.16 Favored Glycine 0 N--CA 1.453 -0.216 0 O-C-N 123.799 0.687 . . . . 0.0 114.364 -178.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 10.8 mp . . . . . 0 C--N 1.322 -0.592 0 CA-C-N 115.659 -0.271 . . . . 0.0 110.587 179.988 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 224' ' ' GLY . . . . . 0.445 ' HA2' ' HD3' ' D' ' 225' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.597 0 CA-C-O 120.522 -0.043 . . . . 0.0 113.102 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 225' ' ' PRO . . . . . 0.445 ' HD3' ' HA2' ' D' ' 224' ' ' GLY . 21.7 Cg_exo . . . . . 0 C--O 1.235 0.343 0 C-N-CA 122.925 2.417 . . . . 0.0 111.692 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.436 0 N-CA-C 113.25 0.06 . . . . 0.0 113.25 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo . . . . . 0 C--O 1.236 0.405 0 C-N-CA 122.835 2.356 . . . . 0.0 111.645 179.774 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.598 0 CA-C-O 120.719 0.066 . . . . 0.0 113.096 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 CA--C 1.532 0.385 0 C-N-CA 123.077 2.518 . . . . 0.0 111.926 179.682 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo . . . . . 0 N--CA 1.477 0.558 0 N-CA-C 109.922 -0.838 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -113.25 149.15 34.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.308 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 16.1 tt -72.89 -18.63 18.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 20.6 m -91.76 0.25 57.5 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 121.152 -0.219 . . . . 0.0 111.263 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -67.86 -48.04 67.23 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.102 0.477 . . . . 0.0 110.288 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 321' ' ' GLY . . . . . 0.571 ' HA2' HD21 ' A' ' 502' ' ' LEU . . . 102.74 172.08 26.66 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.439 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 64.3 t30 55.56 85.73 0.06 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.468 0.651 . . . . 0.0 112.465 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' PHE . . . . . 0.567 ' HD1' ' HB2' ' A' ' 337' ' ' LYS . 92.9 m-85 -105.26 168.0 9.36 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.702 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.57 -46.87 83.92 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 6.6 t -175.43 160.75 2.62 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.472 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 49.0 t -127.56 127.51 68.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -135.23 167.93 20.1 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.007 0.432 . . . . 0.0 111.845 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 328' ' ' MET . . . . . 0.426 ' HA ' ' O ' ' A' ' 332' ' ' GLU . 53.1 ttm -129.75 115.11 16.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.786 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 56.8 mt -111.28 117.05 32.1 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.182 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.408 ' HD3' ' OE2' ' A' ' 373' ' ' GLU . 0.0 OUTLIER 59.13 20.26 8.21 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.957 -179.48 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 105.69 -18.24 41.13 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.609 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' GLU . . . . . 0.457 ' OE1' ' HD3' ' A' ' 343' ' ' ARG . 35.3 mm-40 -82.75 131.24 35.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.633 0.254 . . . . 0.0 110.676 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 50.2 ttm -88.23 117.74 27.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.794 0.33 . . . . 0.0 110.975 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -109.12 122.8 48.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.264 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 37.5 t -108.46 114.74 47.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -100.46 130.37 46.54 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 0.567 ' HB2' ' HD1' ' A' ' 323' ' ' PHE . 13.0 tptt -138.19 101.81 4.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.298 178.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 61.49 -95.3 0.05 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.0 ptm85 -121.06 7.08 10.29 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 340' ' ' TRP . . . . . 0.405 ' HB3' ' HB2' ' A' ' 354' ' ' PRO . 5.6 m-90 -129.03 152.43 48.64 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -137.69 153.95 49.73 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.121 0.486 . . . . 0.0 111.76 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 24.5 m-90 -121.8 160.91 23.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.363 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.457 ' HD3' ' OE1' ' A' ' 332' ' ' GLU . 18.1 ttm-85 -124.38 112.18 16.64 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 91.6 t -90.71 122.66 42.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.889 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 345' ' ' ARG . . . . . 0.431 ' HD3' ' HA ' ' A' ' 345' ' ' ARG . 2.2 mmt180 -132.71 100.92 5.09 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.553 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 66.5 54.79 0.86 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.817 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 29.2 t30 62.09 12.92 5.34 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -133.41 146.7 51.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.665 0.269 . . . . 0.0 110.61 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 39.0 t -96.71 127.88 48.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 86.2 mtp -68.28 159.84 30.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.531 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -76.65 167.74 21.3 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.679 0.276 . . . . 0.0 110.9 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 94.98 -21.77 42.02 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -178.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 353' ' ' TYR . . . . . 0.464 ' HB3' ' HA ' ' A' ' 354' ' ' PRO . 87.9 m-85 -101.5 158.94 30.83 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.464 ' HA ' ' HB3' ' A' ' 353' ' ' TYR . 58.1 Cg_endo -71.16 139.21 57.13 Favored 'Cis proline' 0 C--N 1.346 0.424 0 C-N-CA 123.484 -1.465 . . . . 0.0 112.561 0.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 55.3 ttm -114.33 138.8 23.2 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 356' ' ' PRO . . . . . 0.442 ' HB2' ' HB2' ' A' ' 359' ' ' GLN . 52.3 Cg_exo -55.43 130.33 39.97 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.382 2.054 . . . . 0.0 111.175 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 76.8 mt -55.02 -45.51 76.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.987 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -71.35 -12.78 73.21 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.95 -0.643 . . . . 0.0 113.707 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 359' ' ' GLN . . . . . 0.442 ' HB2' ' HB2' ' A' ' 356' ' ' PRO . 23.0 tt0 -82.32 -34.32 28.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.034 0.445 . . . . 0.0 110.454 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -94.1 -55.21 3.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.357 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -90.28 74.39 7.02 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -58.29 95.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.925 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 135.37 -17.3 4.04 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.503 ' HA ' ' HD3' ' A' ' 365' ' ' PRO . 29.6 tp -94.37 125.16 53.14 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 365' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 364' ' ' LEU . 4.2 Cg_exo -77.21 -174.02 2.02 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.017 2.478 . . . . 0.0 111.84 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -87.8 153.96 20.93 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.08 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 72.1 m 59.23 94.92 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 27.1 pt -106.87 -166.24 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.403 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.09 -47.06 1.22 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 370' ' ' THR . . . . . 0.643 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.2 OUTLIER -146.04 162.82 37.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.648 0.261 . . . . 0.0 111.178 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -158.35 138.48 12.37 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 372' ' ' TYR . . . . . 0.593 ' HE1' ' HE2' ' A' ' 382' ' ' PHE . 14.7 p90 -160.25 162.71 33.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.903 0.382 . . . . 0.0 111.532 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.408 ' OE2' ' HD3' ' A' ' 330' ' ' ARG . 64.9 tt0 -98.65 122.03 41.35 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 374' ' ' ARG . . . . . 0.568 ' HB2' ' OE2' ' A' ' 440' ' ' GLU . 5.2 ptm180 -78.76 -179.66 6.66 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -178.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -67.61 -34.52 77.15 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.908 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -37.29 85.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.68 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 129.27 -16.19 5.74 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.421 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 378' ' ' LYS . . . . . 0.625 ' HG2' ' HA ' ' A' ' 391' ' ' ASP . 72.8 mttt -80.46 166.16 21.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.881 0.372 . . . . 0.0 111.575 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -106.71 127.64 53.54 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.752 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 13.4 t -109.19 122.16 63.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.007 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -106.56 138.11 43.34 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.212 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.593 ' HE2' ' HE1' ' A' ' 372' ' ' TYR . 55.9 m-85 -117.83 141.69 48.14 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.61 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 83.0 tttt -154.14 107.6 2.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.6 177.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 384' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 414' ' ' LYS . . . 70.27 -112.2 4.21 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.566 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 385' ' ' ASP . . . . . 0.432 ' O ' HG13 ' A' ' 403' ' ' ILE . 3.7 p-10 -115.29 4.38 14.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.914 0.388 . . . . 0.0 110.606 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 386' ' ' LYS . . . . . 0.42 ' HB3' ' HB2' ' A' ' 400' ' ' PRO . 48.4 mmtm -112.07 150.79 30.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -131.97 147.94 52.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.176 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 388' ' ' TRP . . . . . 0.61 ' HZ3' ' HB3' ' A' ' 383' ' ' LYS . 22.5 m-90 -121.7 125.62 47.05 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.82 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 85.5 t -109.42 119.96 59.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.897 0.38 . . . . 0.0 110.32 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -104.87 123.66 48.1 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.932 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.625 ' HA ' ' HG2' ' A' ' 378' ' ' LYS . 21.8 t0 -92.71 95.05 9.33 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 67.52 -73.2 0.08 Allowed 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.727 0.642 . . . . 0.0 111.021 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -146.18 11.83 1.2 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.986 0.422 . . . . 0.0 110.41 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 1.7 m -125.51 127.09 45.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.253 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 55.9 tp -71.77 132.04 43.92 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.035 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -62.96 147.01 94.94 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.651 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -74.08 144.59 34.08 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.544 2.163 . . . . 0.0 113.038 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 90.37 18.15 50.3 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.459 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 399' ' ' TYR . . . . . 0.496 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 39.1 m-85 -109.13 162.16 21.12 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-O 120.292 0.091 . . . . 0.0 110.774 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.496 ' HA ' ' HB3' ' A' ' 399' ' ' TYR . 71.8 Cg_endo -77.07 157.81 96.84 Favored 'Cis proline' 0 C--N 1.346 0.442 0 C-N-CA 123.529 -1.446 . . . . 0.0 112.562 0.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -116.48 157.82 24.58 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -73.21 151.19 41.56 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 403' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 385' ' ' ASP . 61.2 mt -56.64 -32.75 38.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.325 0.583 . . . . 0.0 110.603 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -65.97 -20.71 66.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.485 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -84.18 -10.52 57.68 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 50.7 tp -85.32 -55.16 4.16 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.9 0.381 . . . . 0.0 110.12 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.639 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -149.08 150.9 23.1 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.798 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -77.68 126.46 30.9 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.57 0.224 . . . . 0.0 110.495 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 99.27 14.01 37.11 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.599 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 38.7 mt -92.83 147.31 33.78 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 122.794 -0.239 . . . . 0.0 111.093 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.09 124.66 16.8 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.848 2.365 . . . . 0.0 111.26 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.44 -3.93 57.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.055 0.455 . . . . 0.0 111.273 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -87.53 -55.73 3.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.315 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 414' ' ' LYS . . . . . 0.493 ' HB2' ' HE3' ' A' ' 414' ' ' LYS . 6.4 ptmt -177.57 176.37 1.28 Allowed 'General case' 0 C--N 1.332 -0.196 0 O-C-N 123.306 0.378 . . . . 0.0 110.791 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 38.3 mm -127.47 133.23 68.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -87.76 -47.68 8.44 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 417' ' ' ALA . . . . . 0.643 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -154.6 165.25 37.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.945 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -147.21 113.8 6.01 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.207 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 55.4 tp -106.98 124.95 50.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.932 0.396 . . . . 0.0 111.795 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -90.32 116.12 28.04 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.802 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 11.9 t-105 -86.26 94.4 9.31 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.443 ' HB2' ' HD3' ' A' ' 423' ' ' PRO . 61.5 mtt -51.19 -48.82 84.5 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.443 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 83.8 Cg_exo -50.02 -24.12 10.31 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.817 2.345 . . . . 0.0 115.269 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 26.0 p30 -125.51 -37.73 2.32 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 108.63 2.48 32.64 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.709 -0.757 . . . . 0.0 113.457 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -91.62 154.18 19.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 117.036 0.418 . . . . 0.0 111.271 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 7.0 m -108.4 128.17 54.53 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.517 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -98.84 108.96 21.77 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 429' ' ' PHE . . . . . 0.448 ' HB2' ' HB2' ' A' ' 436' ' ' TYR . 60.3 m-85 -90.48 136.74 32.87 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.21 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -112.57 132.74 54.98 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.85 0.357 . . . . 0.0 111.059 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -145.32 110.64 5.28 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.831 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 64.65 -102.66 0.65 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.694 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -127.61 20.78 6.6 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.158 0.504 . . . . 0.0 110.046 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 434' ' ' LYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 450' ' ' PRO . 63.3 mmtt -124.0 142.16 51.41 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.552 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 435' ' ' TYR . . . . . 0.523 ' CE1' ' HB2' ' A' ' 451' ' ' LYS . 4.1 p90 -119.02 137.9 53.21 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.748 0.309 . . . . 0.0 110.383 178.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 436' ' ' TYR . . . . . 0.448 ' HB2' ' HB2' ' A' ' 429' ' ' PHE . 23.4 m-85 -110.27 144.4 39.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.908 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 0.411 ' HB3' ' HB2' ' A' ' 446' ' ' ASP . 36.1 ttp180 -107.29 95.74 5.92 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 438' ' ' PHE . . . . . 0.639 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 83.7 t80 -84.95 129.42 34.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.117 0.484 . . . . 0.0 112.169 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -99.57 111.99 24.26 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.011 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 440' ' ' GLU . . . . . 0.568 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 2.4 mm-40 -61.08 -39.74 91.06 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -67.71 -38.5 83.7 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 94.8 mt -94.1 -10.42 33.38 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 6.8 mtt-85 56.48 41.12 29.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.195 0.521 . . . . 0.0 111.027 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -157.46 166.72 32.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.219 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 88.9 t -89.3 140.05 16.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 446' ' ' ASP . . . . . 0.411 ' HB2' ' HB3' ' A' ' 437' ' ' ARG . 0.5 OUTLIER -55.9 153.5 8.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.437 179.862 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 10.9 m -69.11 158.27 35.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.04 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 70.19 24.49 4.88 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.326 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -122.75 163.19 34.46 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.018 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 450' ' ' PRO . . . . . 0.433 ' HB2' ' HB3' ' A' ' 434' ' ' LYS . 96.8 Cg_endo -77.38 172.1 64.35 Favored 'Cis proline' 0 C--N 1.346 0.437 0 C-N-CA 123.653 -1.395 . . . . 0.0 112.673 0.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 451' ' ' LYS . . . . . 0.523 ' HB2' ' CE1' ' A' ' 435' ' ' TYR . 60.2 mttm -124.75 172.45 9.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.028 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -63.76 136.07 57.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.175 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.0 tt -71.8 -11.97 15.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.261 0.553 . . . . 0.0 110.565 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -71.18 -0.01 8.81 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 64.1 t -67.2 -32.75 59.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 456' ' ' TRP . . . . . 0.469 ' HE3' ' CZ ' ' A' ' 486' ' ' PHE . 8.2 m95 -86.75 85.49 7.28 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.08 108.78 0.35 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 118.34 -25.23 8.3 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.054 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.423 ' HB ' ' HB2' ' A' ' 456' ' ' TRP . 32.1 mm -77.08 130.18 76.15 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 120.86 0.362 . . . . 0.0 111.175 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 460' ' ' PRO . . . . . 0.414 ' HG3' ' CZ2' ' A' ' 484' ' ' TRP . 85.3 Cg_endo -81.96 166.3 16.93 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.887 2.391 . . . . 0.0 111.711 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 35.3 mp0 -80.52 136.89 36.37 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.04 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.4 m 61.13 65.4 1.94 Allowed Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 463' ' ' PRO . . . . . 0.491 ' O ' ' HB2' ' A' ' 417' ' ' ALA . 35.7 Cg_endo -96.43 118.34 0.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.184 2.589 . . . . 0.0 110.269 178.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 464' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 464' ' ' ARG . 3.1 ttm105 -89.59 68.55 7.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.087 0.47 . . . . 0.0 112.17 -178.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 158.55 124.92 0.79 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 25.3 p -158.81 120.7 3.49 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.493 -0.188 . . . . 0.0 110.493 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -150.13 147.35 27.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.715 0.293 . . . . 0.0 111.315 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 43.6 ttm -98.57 140.76 32.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.069 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -70.0 169.52 45.69 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.179 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 1.5 m -73.36 -0.17 13.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.001 0.429 . . . . 0.0 111.339 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.65 -17.64 24.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.156 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 67.88 8.05 6.18 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.878 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 43.6 t -109.73 -37.66 3.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.887 0.375 . . . . 0.0 111.458 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -107.0 129.06 54.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.19 0.519 . . . . 0.0 111.911 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 475' ' ' THR . . . . . 0.421 ' HB ' ' HB3' ' A' ' 486' ' ' PHE . 95.1 m -113.92 135.32 54.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.488 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -107.24 137.58 45.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.175 0.512 . . . . 0.0 112.195 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 477' ' ' PHE . . . . . 0.618 ' HB2' ' HB2' ' A' ' 484' ' ' TRP . 38.2 m-85 -121.16 145.34 47.92 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.682 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -127.34 131.95 50.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.861 0.363 . . . . 0.0 111.607 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 479' ' ' LYS . . . . . 0.466 ' HB3' ' CZ3' ' A' ' 484' ' ' TRP . 69.7 tttt -158.54 107.68 1.98 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.472 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 60.77 60.92 7.63 Favored Glycine 0 CA--C 1.518 0.238 0 N-CA-C 114.373 0.509 . . . . 0.0 114.373 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 69.44 -15.06 0.3 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 482' ' ' LYS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 498' ' ' PRO . 52.2 mtmt -99.39 144.58 28.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.828 0.346 . . . . 0.0 111.435 -178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 483' ' ' TYR . . . . . 0.49 ' CZ ' ' HE2' ' A' ' 497' ' ' TYR . 6.5 p90 -120.35 142.64 48.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.161 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 484' ' ' TRP . . . . . 0.618 ' HB2' ' HB2' ' A' ' 477' ' ' PHE . 11.8 m-90 -110.85 146.95 35.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.506 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -114.04 99.97 8.05 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 486' ' ' PHE . . . . . 0.469 ' CZ ' ' HE3' ' A' ' 456' ' ' TRP . 51.2 t80 -91.26 132.26 36.25 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.307 -178.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -95.5 112.12 23.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -64.86 -19.12 65.72 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -93.85 -14.43 26.12 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -112.5 -16.64 12.83 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.6 tp 61.91 34.85 16.67 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.653 0.74 . . . . 0.0 109.899 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 492' ' ' LYS . . . . . 0.442 ' HG2' ' N ' ' A' ' 493' ' ' VAL . 36.4 tttp -151.98 156.12 39.38 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.515 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 493' ' ' VAL . . . . . 0.442 ' N ' ' HG2' ' A' ' 492' ' ' LYS . 71.6 t -81.81 139.6 17.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.697 0.284 . . . . 0.0 110.623 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -62.49 147.39 92.28 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.566 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.64 152.1 81.38 Favored 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 122.6 2.2 . . . . 0.0 111.957 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 85.65 27.86 31.12 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 497' ' ' TYR . . . . . 0.493 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 42.6 m-85 -134.06 163.58 50.12 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.609 -0.295 . . . . 0.0 110.428 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 498' ' ' PRO . . . . . 0.493 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 89.8 Cg_endo -76.25 174.87 50.71 Favored 'Cis proline' 0 C--N 1.346 0.408 0 C-N-CA 123.979 -1.259 . . . . 0.0 112.849 0.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -133.99 164.21 27.81 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.596 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.81 110.54 6.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.519 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 501' ' ' ALA . . . . . 0.447 ' HB2' ' HB3' ' A' ' 483' ' ' TYR . . . -66.03 -24.08 66.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.152 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 502' ' ' LEU . . . . . 0.571 HD21 ' HA2' ' A' ' 321' ' ' GLY . 76.0 mt -62.47 -39.41 93.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.857 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -85.46 -42.67 14.26 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.744 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -43.04 57.35 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 47.9 m0 -98.27 -60.41 1.56 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 10.9 mmt -62.85 -25.81 68.46 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 81.42 30.17 37.79 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.14 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 30.4 m -116.35 95.29 44.98 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 120.758 0.313 . . . . 0.0 110.567 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.32 -167.53 0.52 Allowed 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.967 2.444 . . . . 0.0 111.363 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 57.01 59.82 3.28 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.089 0.471 . . . . 0.0 110.941 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.503 -1.165 . . . . 0.0 112.185 -179.326 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.598 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo . . . . . 0 N--CA 1.461 -0.437 0 C-N-CA 122.778 2.319 . . . . 0.0 111.964 179.953 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.55 0 N-CA-C 112.983 -0.047 . . . . 0.0 112.983 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo . . . . . 0 CA--C 1.532 0.386 0 C-N-CA 123.042 2.495 . . . . 0.0 112.253 179.88 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.802 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 CA--C 1.53 0.319 0 C-N-CA 122.732 2.288 . . . . 0.0 111.456 179.435 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.93 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.11 150.48 15.76 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.65 2.233 . . . . 0.0 112.223 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -71.73 151.83 43.26 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.87 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.573 ' HA3' ' O ' ' D' ' 210' ' ' PRO . . . -60.1 151.5 38.35 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.25 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.512 ' O ' ' HG3' ' D' ' 211' ' ' GLN . 8.4 mt -66.73 150.01 11.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.23 151.36 31.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.369 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.41 163.73 53.05 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.937 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -70.63 141.21 51.73 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -67.47 144.5 55.67 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.314 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' D' ' 216' ' ' GLN . . . -57.16 151.6 26.65 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.925 -0.58 . . . . 0.0 113.154 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 12.1 t -69.85 147.15 11.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 19.9 t -53.31 145.01 3.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 O-C-N 123.326 0.391 . . . . 0.0 111.033 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.79 177.7 30.35 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.991 -0.549 . . . . 0.0 113.511 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 C--N 1.325 -0.487 0 C-N-CA 122.234 0.213 . . . . 0.0 110.629 -179.526 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.677 0 N-CA-C 112.011 -0.436 . . . . 0.0 112.011 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo . . . . . 0 C--N 1.343 0.254 0 C-N-CA 122.501 2.134 . . . . 0.0 111.106 179.202 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.389 0 N-CA-C 113.704 0.242 . . . . 0.0 113.704 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo . . . . . 0 N--CA 1.462 -0.377 0 C-N-CA 123.035 2.49 . . . . 0.0 111.419 179.557 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.434 0 CA-C-O 120.446 -0.085 . . . . 0.0 113.205 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo . . . . . 0 CA--C 1.531 0.346 0 C-N-CA 123.423 2.748 . . . . 0.0 112.255 179.983 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.515 0 CA-C-O 120.231 -0.205 . . . . 0.0 112.632 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo . . . . . 0 C--N 1.343 0.245 0 C-N-CA 122.957 2.438 . . . . 0.0 111.735 179.875 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.345 0 CA-C-O 120.029 -0.317 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 C--N 1.35 0.63 0 C-N-CA 123.051 2.5 . . . . 0.0 111.83 179.661 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.343 0 CA-C-O 120.227 -0.207 . . . . 0.0 112.703 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo . . . . . 0 CA--C 1.533 0.459 0 C-N-CA 123.126 2.551 . . . . 0.0 112.542 -179.684 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.458 0 N-CA-C 112.215 -0.354 . . . . 0.0 112.215 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo . . . . . 0 C--O 1.223 -0.233 0 C-N-CA 122.638 2.226 . . . . 0.0 110.533 179.271 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.398 0 CA-C-O 120.699 0.055 . . . . 0.0 113.064 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.21 160.38 38.77 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.692 2.262 . . . . 0.0 112.753 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -57.91 135.14 56.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.997 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -68.42 154.15 53.12 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.876 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 50.2 mt -68.41 133.75 31.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.686 0.279 . . . . 0.0 110.421 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.79 153.43 24.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.331 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -65.87 151.29 51.93 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.402 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 116' ' ' GLN . . . . . 0.413 ' HG2' ' N ' ' C' ' 117' ' ' ARG . 4.6 tt0 -71.18 159.12 35.23 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 117' ' ' ARG . . . . . 0.413 ' N ' ' HG2' ' C' ' 116' ' ' GLN . 11.3 ttm-85 -67.55 144.71 55.48 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.87 165.6 41.44 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.962 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 5.2 t -70.05 142.43 15.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 39.2 t -61.31 142.7 15.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.275 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.51 164.98 40.99 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.518 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 86.2 mt . . . . . 0 C--N 1.322 -0.628 0 CA-C-O 120.586 0.231 . . . . 0.0 111.13 -179.658 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.658 0 N-CA-C 112.884 -0.086 . . . . 0.0 112.884 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 C--O 1.236 0.399 0 C-N-CA 122.722 2.281 . . . . 0.0 111.501 179.822 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.57 0 N-CA-C 113.305 0.082 . . . . 0.0 113.305 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo . . . . . 0 C--O 1.235 0.352 0 C-N-CA 122.677 2.252 . . . . 0.0 111.423 179.436 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.528 0 CA-C-O 120.767 0.093 . . . . 0.0 112.929 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo . . . . . 0 C--O 1.232 0.184 0 C-N-CA 122.921 2.414 . . . . 0.0 111.411 179.859 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 133' ' ' GLY . . . . . 0.42 ' HA2' ' HD3' ' C' ' 134' ' ' PRO . . . . . . . . 0 N--CA 1.451 -0.352 0 CA-C-O 120.309 -0.162 . . . . 0.0 112.976 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 134' ' ' PRO . . . . . 0.42 ' HD3' ' HA2' ' C' ' 133' ' ' GLY . 17.0 Cg_exo . . . . . 0 C--N 1.343 0.277 0 C-N-CA 123.002 2.468 . . . . 0.0 111.541 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.29 0 CA-C-O 120.031 -0.316 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo . . . . . 0 C--N 1.348 0.523 0 C-N-CA 123.364 2.709 . . . . 0.0 112.304 179.962 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 203' ' ' GLY . . . . . 0.407 ' HA2' ' HD3' ' D' ' 204' ' ' PRO . . . . . . . . 0 CA--C 1.522 0.511 0 N-CA-C 114.938 0.735 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 204' ' ' PRO . . . . . 0.407 ' HD3' ' HA2' ' D' ' 203' ' ' GLY . 10.8 Cg_exo . . . . . 0 CA--C 1.539 0.74 0 C-N-CA 123.934 3.09 . . . . 0.0 111.752 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 CA-C-O 120.171 -0.239 . . . . 0.0 112.72 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo . . . . . 0 CA--C 1.534 0.5 0 C-N-CA 123.177 2.584 . . . . 0.0 112.706 -179.94 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.564 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 210' ' ' PRO . . . . . 0.573 ' O ' ' HA3' ' B' ' 12' ' ' GLY . 34.5 Cg_endo -65.96 146.66 83.3 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.764 2.309 . . . . 0.0 111.969 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 211' ' ' GLN . . . . . 0.512 ' HG3' ' O ' ' B' ' 13' ' ' ILE . 24.8 tt0 -77.13 147.04 36.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.199 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -65.43 158.28 46.4 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.923 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 41.3 pt -73.98 162.83 4.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.897 0.38 . . . . 0.0 111.324 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -70.83 137.39 49.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.347 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -63.43 164.54 29.56 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.904 -0.589 . . . . 0.0 113.146 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 216' ' ' GLN . . . . . 0.479 ' O ' ' HA3' ' B' ' 18' ' ' GLY . 35.7 mm-40 -75.44 151.34 38.1 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 26.4 mtp180 -67.72 153.75 43.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.829 0.347 . . . . 0.0 110.933 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -62.98 151.96 47.05 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.49 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 8.9 t -65.47 146.92 12.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 91.4 t -61.65 138.32 22.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -56.32 160.78 7.38 Favored Glycine 0 N--CA 1.451 -0.332 0 O-C-N 123.55 0.531 . . . . 0.0 113.502 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 7.3 mp . . . . . 0 C--N 1.324 -0.534 0 CA-C-N 115.636 -0.282 . . . . 0.0 110.409 -179.822 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 224' ' ' GLY . . . . . 0.459 ' HA2' ' HD3' ' D' ' 225' ' ' PRO . . . . . . . . 0 N--CA 1.445 -0.722 0 N-CA-C 112.166 -0.374 . . . . 0.0 112.166 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 225' ' ' PRO . . . . . 0.459 ' HD3' ' HA2' ' D' ' 224' ' ' GLY . 17.0 Cg_exo . . . . . 0 C--O 1.238 0.476 0 C-N-CA 122.594 2.196 . . . . 0.0 111.568 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.711 0 N-CA-C 113.033 -0.027 . . . . 0.0 113.033 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo . . . . . 0 C--O 1.235 0.35 0 C-N-CA 122.874 2.383 . . . . 0.0 111.617 179.76 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.718 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo . . . . . 0 C--O 1.233 0.273 0 C-N-CA 122.832 2.355 . . . . 0.0 111.586 179.794 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.478 0.57 0 N-CA-C 110.533 -0.603 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -118.4 166.83 12.18 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 19.1 tt -79.68 -30.81 13.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.899 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 57.4 m -71.18 -7.48 46.99 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -76.75 -14.06 59.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.365 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 76.44 -148.73 36.02 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 5.9 m120 51.51 68.45 0.8 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.042 0.449 . . . . 0.0 111.737 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -97.16 143.48 27.92 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.381 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -72.53 -43.08 64.02 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 1.3 t -170.18 150.43 3.68 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.553 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 48.3 t -128.25 124.11 61.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -147.57 166.73 26.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.277 0.561 . . . . 0.0 111.955 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 328' ' ' MET . . . . . 0.439 ' HA ' ' HA ' ' A' ' 333' ' ' MET . 33.2 ttp -121.16 119.07 31.31 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 61.7 mt -112.56 119.76 39.28 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.464 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.733 ' HG3' ' HE1' ' A' ' 379' ' ' PHE . 57.0 mtp180 54.98 28.18 10.31 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 104.4 -24.97 27.37 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.593 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 332' ' ' GLU . . . . . 0.579 ' HG3' HH22 ' A' ' 343' ' ' ARG . 38.4 mm-40 -94.22 130.49 40.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.954 0.377 . . . . 0.0 111.163 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 333' ' ' MET . . . . . 0.439 ' HA ' ' HA ' ' A' ' 328' ' ' MET . 39.5 ttm -90.93 131.07 36.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.114 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -123.87 128.93 50.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.652 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 43.7 t -103.84 108.56 24.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -89.35 129.85 35.82 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.77 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -149.62 111.76 4.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.99 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 63.62 -110.54 0.3 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.784 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -113.18 9.96 18.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.03 0.443 . . . . 0.0 111.207 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -129.63 160.19 34.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.664 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.487 ' CE2' ' HE2' ' A' ' 353' ' ' TYR . 38.6 p90 -140.64 139.81 34.92 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.106 177.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 -102.41 151.14 22.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.656 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.61 ' HD3' ' SD ' ' A' ' 350' ' ' MET . 16.2 ttt-85 -111.24 95.24 5.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.678 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 2.3 m -93.37 110.7 23.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.355 0.598 . . . . 0.0 111.143 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.63 92.01 3.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.161 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 9.3 m120 60.42 58.45 2.53 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.623 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 7.0 t30 63.85 17.33 10.45 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.288 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -124.44 130.1 51.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.561 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 39.4 t -87.72 121.13 37.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 350' ' ' MET . . . . . 0.61 ' SD ' ' HD3' ' A' ' 343' ' ' ARG . 90.7 mtp -77.55 148.72 35.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.978 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.46 164.02 22.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.789 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 85.12 4.04 87.0 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 353' ' ' TYR . . . . . 0.538 ' CE1' ' HD2' ' A' ' 343' ' ' ARG . 76.5 m-85 -123.73 157.7 61.92 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.584 -0.308 . . . . 0.0 110.748 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 353' ' ' TYR . 42.9 Cg_endo -66.17 140.69 48.92 Favored 'Cis proline' 0 C--N 1.347 0.492 0 C-N-CA 123.646 -1.398 . . . . 0.0 113.012 0.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 355' ' ' MET . . . . . 0.422 ' HA ' ' HD3' ' A' ' 356' ' ' PRO . 52.7 ttm -105.01 137.42 19.21 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.094 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 356' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 355' ' ' MET . 33.5 Cg_exo -60.83 133.31 47.11 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.446 2.098 . . . . 0.0 111.587 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 78.4 mt -59.15 -41.16 82.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -67.91 -16.63 68.58 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 121.104 -0.569 . . . . 0.0 113.88 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 359' ' ' GLN . . . . . 0.415 ' HG2' ' HG3' ' D' ' 210' ' ' PRO . 28.8 tt0 -81.25 -54.4 5.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.095 0.447 . . . . 0.0 110.796 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 360' ' ' PHE . . . . . 0.747 ' HE2' ' HB3' ' D' ' 211' ' ' GLN . 24.1 t80 -77.38 -58.89 3.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.178 0.513 . . . . 0.0 110.261 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -88.48 63.17 6.92 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -57.04 103.43 0.11 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.91 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 126.85 -19.65 6.12 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.62 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.624 HD12 ' HD2' ' A' ' 365' ' ' PRO . 27.1 tp -88.72 129.76 47.58 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.69 0.281 . . . . 0.0 110.458 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 365' ' ' PRO . . . . . 0.624 ' HD2' HD12 ' A' ' 364' ' ' LEU . 73.5 Cg_endo -75.29 169.71 21.91 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.726 2.284 . . . . 0.0 112.029 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -77.96 150.13 34.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.186 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 60.2 m 59.9 94.94 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 21.1 pt -107.96 173.83 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.53 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -97.85 -47.93 5.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.254 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 370' ' ' THR . . . . . 0.857 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.2 OUTLIER -155.65 165.51 36.33 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.856 0.36 . . . . 0.0 111.489 -179.608 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -153.23 141.69 20.73 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 372' ' ' TYR . . . . . 0.577 ' HE1' ' HE2' ' A' ' 382' ' ' PHE . 13.2 p90 -156.12 162.69 40.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.169 0.509 . . . . 0.0 112.276 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -90.89 124.3 35.08 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 374' ' ' ARG . . . . . 0.559 ' HG2' ' O ' ' A' ' 378' ' ' LYS . 11.6 ptm180 -85.92 174.53 9.2 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -65.64 -36.26 83.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.142 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -31.92 73.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.393 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 124.93 -28.03 5.26 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.678 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 378' ' ' LYS . . . . . 0.685 ' HG2' ' HA ' ' A' ' 391' ' ' ASP . 31.0 mttt -77.12 174.97 10.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.162 0.506 . . . . 0.0 112.217 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 379' ' ' PHE . . . . . 0.733 ' HE1' ' HG3' ' A' ' 330' ' ' ARG . 9.5 m-85 -106.47 134.71 49.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.4 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 380' ' ' VAL . . . . . 0.48 ' HB ' ' CE1' ' A' ' 372' ' ' TYR . 13.2 t -112.34 120.31 62.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.901 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -105.29 137.91 42.32 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.956 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.577 ' HE2' ' HE1' ' A' ' 372' ' ' TYR . 78.0 m-85 -119.07 138.1 53.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.92 0.391 . . . . 0.0 111.576 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.517 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 26.5 tttp -150.47 101.6 2.97 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 384' ' ' GLY . . . . . 0.553 ' O ' ' HA ' ' A' ' 414' ' ' LYS . . . 74.15 -113.99 4.34 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.274 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -111.51 4.04 18.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.667 0.27 . . . . 0.0 111.17 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -113.68 148.94 35.45 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.248 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 387' ' ' HIS . . . . . 0.422 ' NE2' ' HE2' ' A' ' 399' ' ' TYR . 33.0 p-80 -130.32 147.43 52.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.222 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 388' ' ' TRP . . . . . 0.517 ' HZ3' ' HB3' ' A' ' 383' ' ' LYS . 23.3 m-90 -122.66 133.02 54.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.123 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 96.5 t -109.71 116.76 53.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -110.9 122.77 48.69 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.812 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.685 ' HA ' ' HG2' ' A' ' 378' ' ' LYS . 14.3 t70 -91.12 91.45 8.26 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 67.02 -77.51 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 O-C-N 123.874 0.734 . . . . 0.0 110.716 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -141.25 14.66 2.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.248 0.547 . . . . 0.0 109.912 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.57 118.9 28.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.91 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 47.5 tp -69.91 133.42 47.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.409 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -71.75 123.42 89.39 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -59.17 137.72 80.78 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.944 2.429 . . . . 0.0 112.257 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 108.94 6.5 30.08 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.352 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 399' ' ' TYR . . . . . 0.699 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 65.6 m-85 -113.43 167.12 9.84 Favored Pre-proline 0 C--N 1.323 -0.578 0 O-C-N 122.982 -0.128 . . . . 0.0 111.077 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.699 ' HA ' ' HB3' ' A' ' 399' ' ' TYR . 71.9 Cg_endo -77.68 161.73 91.27 Favored 'Cis proline' 0 C--N 1.348 0.541 0 C-N-CA 123.708 -1.372 . . . . 0.0 113.165 0.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -128.39 162.62 26.69 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.072 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -70.29 157.83 37.0 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 47.8 mt -57.16 -33.49 43.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.894 0.378 . . . . 0.0 110.971 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 404' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 404' ' ' LYS . 18.1 ptmt -67.88 -16.66 64.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.844 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -78.77 -15.52 58.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.898 0.38 . . . . 0.0 110.821 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 51.7 tp -83.44 -48.78 9.97 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -159.7 166.16 34.82 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.761 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -95.46 131.1 41.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.998 0.428 . . . . 0.0 110.999 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 106.83 5.87 35.39 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.586 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 411' ' ' PRO . 95.8 mt -92.39 148.97 37.52 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 411' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 410' ' ' LEU . 52.1 Cg_exo -56.1 135.41 69.75 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.185 2.59 . . . . 0.0 111.919 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.47 1.36 51.49 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.669 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -95.27 -56.41 2.73 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.733 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 414' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 384' ' ' GLY . 11.9 ptmt -174.85 173.59 2.72 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.752 0.311 . . . . 0.0 110.584 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 46.6 mm -121.84 132.93 69.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -87.68 -54.08 4.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.248 0.547 . . . . 0.0 109.8 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 417' ' ' ALA . . . . . 0.857 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -149.83 150.95 32.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.368 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -132.54 120.92 22.5 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 61.8 tp -115.73 127.13 54.9 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.024 0.44 . . . . 0.0 111.686 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -94.85 114.31 26.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.719 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 421' ' ' TRP . . . . . 0.436 ' HB3' ' OD1' ' A' ' 424' ' ' ASN . 4.5 t-105 -84.98 94.82 8.89 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.432 ' HB2' ' HD3' ' A' ' 423' ' ' PRO . 66.5 mtt -53.84 -50.15 85.41 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.432 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 97.5 Cg_exo -46.1 -43.37 20.59 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 122.77 2.313 . . . . 0.0 114.867 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 424' ' ' ASN . . . . . 0.436 ' OD1' ' HB3' ' A' ' 421' ' ' TRP . 30.4 p30 -107.04 -23.06 12.45 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 87.05 26.8 30.26 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.036 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 38.6 mmtt -108.22 155.22 20.71 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 9.2 m -112.1 125.88 54.58 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.853 0.359 . . . . 0.0 110.828 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -103.47 119.54 39.1 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.001 0.429 . . . . 0.0 110.634 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -102.15 131.95 48.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.239 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -110.96 132.42 54.22 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.949 0.404 . . . . 0.0 111.444 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -145.29 108.39 4.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 70.54 -105.23 1.54 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.525 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -124.91 11.67 8.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.073 0.463 . . . . 0.0 110.498 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -121.38 143.02 49.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.523 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 435' ' ' TYR . . . . . 0.618 ' CE2' ' HE2' ' A' ' 449' ' ' TYR . 20.4 p90 -123.36 141.13 52.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.03 0.443 . . . . 0.0 111.43 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -110.75 152.38 26.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.573 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 26.7 ttp180 -113.43 96.89 6.13 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -89.52 134.01 34.32 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.387 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 439' ' ' ASN . . . . . 0.453 ' HB3' ' HB2' ' A' ' 442' ' ' LEU . 2.6 t-20 -108.57 119.58 39.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.371 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.44 -45.49 73.09 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -66.55 -49.79 65.29 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 442' ' ' LEU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 439' ' ' ASN . 49.9 mt -71.76 -22.02 61.66 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 60.47 33.49 20.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.369 0.604 . . . . 0.0 111.31 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -156.67 173.2 17.3 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.251 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 98.1 t -89.12 137.87 20.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.114 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.25 156.48 21.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.415 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 447' ' ' SER . . . . . 0.558 ' O ' ' HB2' ' A' ' 448' ' ' GLU . 16.4 m -69.94 159.61 33.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.397 179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 448' ' ' GLU . . . . . 0.558 ' HB2' ' O ' ' A' ' 447' ' ' SER . 5.4 mm-40 80.15 6.06 1.73 Allowed 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.817 0.698 . . . . 0.0 111.067 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 449' ' ' TYR . . . . . 0.618 ' HE2' ' CE2' ' A' ' 435' ' ' TYR . 63.7 m-85 -117.13 162.73 26.36 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.089 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 450' ' ' PRO . . . . . 0.524 ' HA ' ' HB3' ' A' ' 449' ' ' TYR . 73.7 Cg_endo -74.2 156.19 99.78 Favored 'Cis proline' 0 C--N 1.347 0.493 0 C-N-CA 123.698 -1.376 . . . . 0.0 112.431 0.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -114.68 161.63 17.87 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.172 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -65.71 135.95 55.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.456 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.7 tt -64.63 -13.14 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.107 0.48 . . . . 0.0 111.153 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 454' ' ' LYS . . . . . 0.477 ' HD3' ' HA ' ' A' ' 454' ' ' LYS . 66.4 mmtt -62.88 -13.08 29.7 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.877 -0.602 . . . . 0.0 112.533 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 76.0 t -60.85 -37.82 77.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 456' ' ' TRP . . . . . 0.494 ' HZ3' HD11 ' A' ' 491' ' ' LEU . 26.4 m95 -86.72 91.42 8.61 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.171 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -61.46 112.25 2.12 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 115.29 -21.25 13.24 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.811 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 39.3 mm -81.08 125.77 78.82 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-O 120.815 0.34 . . . . 0.0 110.495 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 460' ' ' PRO . . . . . 0.405 ' HG3' ' CH2' ' A' ' 484' ' ' TRP . 97.7 Cg_endo -77.47 157.38 32.65 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.799 2.333 . . . . 0.0 111.686 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -78.46 145.06 35.23 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.36 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.9 m 57.68 70.44 1.3 Allowed Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -90.36 179.88 1.82 Allowed 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.68 2.253 . . . . 0.0 110.614 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 464' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 464' ' ' ARG . 0.3 OUTLIER -149.42 68.46 1.03 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.396 0.617 . . . . 0.0 110.801 179.363 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 137.34 111.7 1.07 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 3.2 p -137.96 115.3 11.09 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.791 0.329 . . . . 0.0 110.177 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -136.58 145.46 44.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 468' ' ' MET . . . . . 0.413 ' HA ' ' HA ' ' A' ' 475' ' ' THR . 46.4 ttm -101.33 142.53 32.61 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -68.99 163.21 50.86 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.514 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.99 9.29 0.57 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.08 -10.02 16.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.941 0.401 . . . . 0.0 110.8 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 69.42 5.07 4.95 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 43.9 t -111.85 -36.58 2.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 O-C-N 122.18 -0.325 . . . . 0.0 111.68 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -100.79 117.52 35.04 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 475' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 468' ' ' MET . 52.0 m -109.53 144.26 38.06 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.398 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 476' ' ' TYR . . . . . 0.55 ' CE1' ' HG3' ' A' ' 485' ' ' LYS . 92.9 m-85 -121.07 134.48 55.27 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -120.4 134.37 55.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.739 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -113.3 137.6 51.25 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.772 0.32 . . . . 0.0 111.807 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 479' ' ' LYS . . . . . 0.41 ' HB3' ' CZ3' ' A' ' 484' ' ' TRP . 77.1 tttt -161.98 109.77 1.4 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.424 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 65.12 58.94 8.58 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 114.614 0.606 . . . . 0.0 114.614 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 41.3 t30 62.89 4.19 1.41 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -121.99 151.07 41.19 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -130.0 152.8 49.07 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.936 0.398 . . . . 0.0 111.428 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 484' ' ' TRP . . . . . 0.5 ' CE2' ' HB3' ' A' ' 498' ' ' PRO . 15.1 m-90 -116.78 148.61 41.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.082 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 485' ' ' LYS . . . . . 0.55 ' HG3' ' CE1' ' A' ' 476' ' ' TYR . 24.1 tttp -106.86 100.59 10.09 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 486' ' ' PHE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 493' ' ' VAL . 62.4 t80 -93.12 125.36 37.68 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.297 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -94.9 115.14 27.1 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -66.92 -29.93 69.94 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -64.85 -53.7 42.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.991 0.424 . . . . 0.0 111.405 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -83.1 -14.22 54.14 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.983 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.494 HD11 ' HZ3' ' A' ' 456' ' ' TRP . 11.2 tp 63.6 42.26 6.59 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.448 0.642 . . . . 0.0 109.814 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 47.0 tttt -156.66 156.52 33.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.289 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 493' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 486' ' ' PHE . 53.5 t -79.96 139.81 17.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.149 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -69.82 146.12 95.19 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.025 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.45 153.6 73.56 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.651 2.234 . . . . 0.0 111.552 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 97.51 15.73 36.69 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 497' ' ' TYR . . . . . 0.623 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 24.6 m-85 -123.88 169.01 11.21 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.511 -0.344 . . . . 0.0 110.254 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 498' ' ' PRO . . . . . 0.623 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 72.4 Cg_endo -75.7 178.68 33.86 Favored 'Cis proline' 0 C--N 1.346 0.41 0 C-N-CA 123.851 -1.312 . . . . 0.0 112.965 0.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -136.01 150.58 49.27 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.401 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 37.3 t -69.47 128.17 35.57 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.67 -18.39 62.84 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.398 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 28.1 mt -61.68 -62.13 2.02 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.66 -11.53 59.88 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.17 -40.66 10.35 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 21.3 m0 -125.06 -39.3 2.25 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 10.8 mmt -71.82 -20.0 61.9 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 78.95 25.68 59.57 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.45 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 9.9 m -113.97 93.22 28.79 Favored Pre-proline 0 C--N 1.326 -0.434 0 O-C-N 122.845 -0.209 . . . . 0.0 110.658 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -83.58 171.29 11.05 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.866 2.377 . . . . 0.0 112.124 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 8.4 m 53.64 72.15 0.46 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.088 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.476 -1.18 . . . . 0.0 111.551 -179.949 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.735 0 N-CA-C 111.776 -0.529 . . . . 0.0 111.776 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo . . . . . 0 N--CA 1.46 -0.458 0 C-N-CA 122.614 2.21 . . . . 0.0 112.002 179.549 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 3' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' D' ' 201' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.621 0 N-CA-C 112.906 -0.078 . . . . 0.0 112.906 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo . . . . . 0 CA--C 1.531 0.373 0 C-N-CA 122.555 2.17 . . . . 0.0 111.445 179.77 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.455 0 CA-C-O 120.411 -0.105 . . . . 0.0 113.207 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo . . . . . 0 CA--C 1.531 0.368 0 C-N-CA 122.999 2.466 . . . . 0.0 111.865 179.375 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.768 0 CA-C-O 120.468 -0.073 . . . . 0.0 113.087 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.87 141.66 30.58 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 123.216 2.611 . . . . 0.0 112.304 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' GLN . . . . . 0.5 ' HB2' ' HG2' ' C' ' 110' ' ' PRO . 45.9 tt0 -68.59 147.65 51.62 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' D' ' 210' ' ' PRO . . . -57.09 147.58 34.2 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.361 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.452 ' H ' HG13 ' B' ' 13' ' ' ILE . 6.6 mt -61.87 150.11 8.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.4 151.37 46.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.278 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.51 169.17 53.55 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.936 -0.65 . . . . 0.0 113.112 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -78.57 147.15 33.84 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -70.82 146.51 49.66 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' D' ' 216' ' ' GLN . . . -62.87 155.47 41.92 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.706 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 t -71.88 154.44 7.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.4 t -55.65 142.76 9.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 O-C-N 123.319 0.387 . . . . 0.0 110.874 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.64 163.54 51.67 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.788 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 97.1 mt . . . . . 0 C--N 1.326 -0.435 0 CA-C-O 120.445 0.164 . . . . 0.0 110.693 -179.816 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.473 0 CA-C-O 120.281 -0.177 . . . . 0.0 112.788 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo . . . . . 0 CA--C 1.53 0.314 0 C-N-CA 122.868 2.378 . . . . 0.0 111.662 179.757 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.665 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo . . . . . 0 CA--C 1.529 0.268 0 C-N-CA 122.539 2.159 . . . . 0.0 111.73 179.858 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.445 0 N-CA-C 113.203 0.041 . . . . 0.0 113.203 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo . . . . . 0 CA--C 1.529 0.259 0 C-N-CA 123.336 2.691 . . . . 0.0 111.676 179.965 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 CA-C-O 120.331 -0.149 . . . . 0.0 113.116 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo . . . . . 0 C--N 1.345 0.367 0 C-N-CA 122.764 2.309 . . . . 0.0 111.748 179.671 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.399 0 CA-C-O 120.082 -0.288 . . . . 0.0 112.67 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo . . . . . 0 CA--C 1.53 0.305 0 C-N-CA 123.139 2.559 . . . . 0.0 112.444 -179.893 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.399 0 N-CA-C 112.132 -0.387 . . . . 0.0 112.132 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 CA--C 1.532 0.419 0 C-N-CA 122.78 2.32 . . . . 0.0 112.657 -179.576 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.584 0 N-CA-C 112.81 -0.116 . . . . 0.0 112.81 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo . . . . . 0 N--CA 1.464 -0.22 0 C-N-CA 122.865 2.377 . . . . 0.0 111.336 179.835 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.338 0 N-CA-C 114.043 0.377 . . . . 0.0 114.043 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 110' ' ' PRO . . . . . 0.5 ' HG2' ' HB2' ' B' ' 11' ' ' GLN . 10.4 Cg_endo -53.95 148.9 36.54 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 123.516 2.81 . . . . 0.0 113.286 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -59.34 140.52 56.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.842 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.47 161.88 38.11 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 116.01 -0.541 . . . . 0.0 113.354 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 42.0 mt -83.24 135.28 25.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.7 146.7 51.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.79 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -69.44 159.56 53.05 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.108 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 116' ' ' GLN . . . . . 0.441 ' HG2' ' H ' ' C' ' 117' ' ' ARG . 4.6 tt0 -81.8 160.5 23.53 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.701 0.286 . . . . 0.0 110.742 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 117' ' ' ARG . . . . . 0.441 ' H ' ' HG2' ' C' ' 116' ' ' GLN . 42.8 ttm-85 -67.14 149.6 50.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.839 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.4 171.2 37.23 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.671 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 15.9 t -72.68 140.92 17.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 120' ' ' VAL . . . . . 0.594 HG13 ' HB ' ' D' ' 219' ' ' VAL . 24.1 t -57.56 135.96 21.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.209 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.86 162.33 42.37 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.566 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 82.3 mt . . . . . 0 C--N 1.322 -0.59 0 CA-C-O 120.607 0.242 . . . . 0.0 110.524 -179.894 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.698 0 CA-C-O 120.532 -0.038 . . . . 0.0 113.054 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo . . . . . 0 C--O 1.235 0.35 0 C-N-CA 122.68 2.254 . . . . 0.0 111.19 179.842 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.556 0 N-CA-C 112.778 -0.129 . . . . 0.0 112.778 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 N--CA 1.459 -0.505 0 C-N-CA 122.555 2.17 . . . . 0.0 111.724 179.868 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.465 0 N-CA-C 113.461 0.144 . . . . 0.0 113.461 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo . . . . . 0 C--O 1.233 0.254 0 C-N-CA 123.141 2.561 . . . . 0.0 111.849 -179.74 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.538 0 CA-C-O 120.33 -0.15 . . . . 0.0 112.825 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 CA--C 1.531 0.375 0 C-N-CA 122.49 2.127 . . . . 0.0 111.614 179.211 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.451 0 N-CA-C 112.339 -0.304 . . . . 0.0 112.339 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 201' ' ' PRO . . . . . 0.556 ' O ' ' HA3' ' B' ' 3' ' ' GLY . 52.0 Cg_exo . . . . . 0 C--N 1.348 0.546 0 C-N-CA 122.608 2.205 . . . . 0.0 111.384 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 114.387 0.515 . . . . 0.0 114.387 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo . . . . . 0 CA--C 1.531 0.372 0 C-N-CA 123.745 2.964 . . . . 0.0 112.168 -179.984 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.382 0 N-CA-C 113.516 0.166 . . . . 0.0 113.516 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo . . . . . 0 CA--C 1.535 0.542 0 C-N-CA 123.149 2.566 . . . . 0.0 112.727 -179.917 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.556 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 210' ' ' PRO . . . . . 0.415 ' HG3' ' HG2' ' A' ' 359' ' ' GLN . 16.4 Cg_exo -69.11 148.45 69.32 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.957 2.438 . . . . 0.0 112.061 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 211' ' ' GLN . . . . . 0.747 ' HB3' ' HE2' ' A' ' 360' ' ' PHE . 60.0 tt0 -67.72 148.97 50.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.716 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -71.29 163.53 54.07 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.251 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 24.9 pt -69.55 165.38 2.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-O 120.65 0.262 . . . . 0.0 111.026 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 214' ' ' ALA . . . . . 0.496 ' HB3' ' NH1' ' A' ' 330' ' ' ARG . . . -87.49 139.23 30.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.924 0.393 . . . . 0.0 110.842 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -61.49 161.76 26.05 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.67 -0.695 . . . . 0.0 113.525 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 216' ' ' GLN . . . . . 0.443 ' O ' ' HA3' ' B' ' 18' ' ' GLY . 35.4 mm-40 -73.27 160.36 32.0 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -66.63 155.64 37.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.17 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -61.98 158.21 34.08 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.878 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 219' ' ' VAL . . . . . 0.594 ' HB ' HG13 ' C' ' 120' ' ' VAL . 25.8 t -61.74 141.88 17.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 24.6 t -62.48 138.51 22.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.206 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -58.12 154.11 24.98 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.613 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 7.2 mp . . . . . 0 C--N 1.323 -0.583 0 CA-C-O 120.742 0.306 . . . . 0.0 111.044 -179.517 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 224' ' ' GLY . . . . . 0.423 ' HA2' ' HD3' ' D' ' 225' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.58 0 N-CA-C 112.685 -0.166 . . . . 0.0 112.685 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 225' ' ' PRO . . . . . 0.423 ' HD3' ' HA2' ' D' ' 224' ' ' GLY . 24.0 Cg_exo . . . . . 0 N--CA 1.463 -0.277 0 C-N-CA 122.697 2.265 . . . . 0.0 111.222 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.57 0 N-CA-C 113.734 0.253 . . . . 0.0 113.734 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo . . . . . 0 CA--C 1.532 0.407 0 C-N-CA 122.968 2.445 . . . . 0.0 111.474 179.6 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.495 0 CA-C-O 120.523 -0.043 . . . . 0.0 113.02 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo . . . . . 0 N--CA 1.464 -0.231 0 C-N-CA 122.952 2.435 . . . . 0.0 111.774 -179.919 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo . . . . . 0 N--CA 1.479 0.674 0 N-CA-C 110.066 -0.782 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -109.34 145.39 36.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.425 0.155 . . . . 0.0 110.613 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 318' ' ' ILE . . . . . 0.448 ' O ' ' HZ ' ' A' ' 323' ' ' PHE . 19.3 tt -81.05 -19.1 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 121.114 0.483 . . . . 0.0 111.349 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 7.9 m -95.68 12.59 29.28 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.094 0.473 . . . . 0.0 110.244 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -68.82 -33.77 74.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.445 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 82.48 179.85 52.91 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.624 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 5.5 t30 52.17 77.75 0.14 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.172 0.511 . . . . 0.0 111.448 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' PHE . . . . . 0.448 ' HZ ' ' O ' ' A' ' 318' ' ' ILE . 72.1 m-85 -98.75 157.53 16.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.235 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -68.48 -39.38 81.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.261 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 13.4 t -176.43 153.53 1.19 Allowed 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.79 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.506 HG22 HG13 ' A' ' 335' ' ' VAL . 60.6 t -135.84 123.53 35.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -144.3 178.1 8.15 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.963 0.411 . . . . 0.0 111.62 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 51.9 ttp -130.92 121.57 25.41 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 63.9 mt -114.9 122.09 45.23 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.012 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.695 ' HG3' ' HE1' ' A' ' 379' ' ' PHE . 64.1 mtp180 55.26 25.76 7.75 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 101.57 -8.67 56.77 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.509 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -105.79 127.92 53.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.993 0.396 . . . . 0.0 110.829 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 45.3 ttm -84.9 134.06 34.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.818 0.342 . . . . 0.0 111.633 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -126.49 128.39 46.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.64 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 335' ' ' VAL . . . . . 0.506 HG13 HG22 ' A' ' 326' ' ' VAL . 35.6 t -108.31 119.37 57.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.43 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -99.85 131.76 45.62 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 0.426 ' HB2' ' HD1' ' A' ' 323' ' ' PHE . 41.4 tptt -141.51 106.01 4.86 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.723 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 63.03 -105.18 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.55 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -115.07 10.68 16.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.868 0.366 . . . . 0.0 111.32 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 10.1 m-90 -123.93 163.02 22.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.12 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -143.83 144.44 31.78 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.978 0.418 . . . . 0.0 110.923 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -108.41 146.52 32.94 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.818 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.628 ' HD3' ' SD ' ' A' ' 350' ' ' MET . 23.9 ttt-85 -115.83 96.08 5.43 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 3.3 m -88.21 129.6 39.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.995 0.426 . . . . 0.0 111.184 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -142.87 122.44 13.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.853 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 14.3 m120 57.65 41.0 26.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.115 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 67.77 23.71 8.48 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.187 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -134.25 154.05 51.51 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 46.0 t -90.79 121.92 41.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 350' ' ' MET . . . . . 0.628 ' SD ' ' HD3' ' A' ' 343' ' ' ARG . 1.7 ttt -65.32 144.39 57.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.748 0.308 . . . . 0.0 111.133 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -66.87 147.1 53.68 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.546 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 100.94 -0.71 55.09 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.134 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 353' ' ' TYR . . . . . 0.514 ' HB3' ' HA ' ' A' ' 354' ' ' PRO . 80.3 m-85 -122.07 160.11 48.81 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.514 ' HA ' ' HB3' ' A' ' 353' ' ' TYR . 55.2 Cg_endo -69.86 136.61 39.87 Favored 'Cis proline' 0 C--N 1.347 0.497 0 C-N-CA 123.736 -1.36 . . . . 0.0 113.025 0.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 47.2 ttm -116.59 141.95 28.84 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.448 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.62 135.27 68.5 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.262 1.975 . . . . 0.0 111.352 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 95.3 mt -54.21 -43.74 61.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.354 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -69.87 -6.44 56.01 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 121.028 -0.606 . . . . 0.0 114.606 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -86.24 -37.11 18.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.501 0.65 . . . . 0.0 110.208 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -95.11 -53.65 3.72 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -92.26 71.73 5.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 -59.99 101.71 0.13 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.135 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 131.06 -19.42 4.91 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.452 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.518 HD12 ' HD2' ' A' ' 365' ' ' PRO . 22.2 tp -91.14 131.95 35.5 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.681 0.276 . . . . 0.0 110.626 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 365' ' ' PRO . . . . . 0.518 ' HD2' HD12 ' A' ' 364' ' ' LEU . 92.2 Cg_endo -82.67 -173.76 1.83 Allowed 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.789 2.326 . . . . 0.0 112.269 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -90.01 154.75 19.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.212 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.7 m 56.37 93.47 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 21.5 pt -110.53 179.82 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.447 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 369' ' ' ASN . . . . . 0.423 HD22 ' HA ' ' A' ' 369' ' ' ASN . 4.3 m120 -96.45 -55.81 2.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.949 0.404 . . . . 0.0 110.949 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 370' ' ' THR . . . . . 0.919 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.2 OUTLIER -155.9 167.91 28.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.161 -179.668 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -142.86 139.21 30.76 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -152.86 166.26 32.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.06 0.457 . . . . 0.0 111.913 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -100.77 141.13 34.08 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.19 -0.914 . . . . 0.0 108.64 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 374' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 378' ' ' LYS . 7.1 ptm180 -100.77 -171.65 2.05 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 39.3 tttt -72.46 -25.74 61.55 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -177.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.21 -17.38 32.76 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 113.49 -17.27 21.26 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.805 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 378' ' ' LYS . . . . . 0.519 ' O ' ' HG2' ' A' ' 374' ' ' ARG . 46.1 mttp -74.66 158.21 34.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.097 0.475 . . . . 0.0 111.521 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 379' ' ' PHE . . . . . 0.695 ' HE1' ' HG3' ' A' ' 330' ' ' ARG . 9.7 m-85 -98.46 134.76 40.99 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.444 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 21.9 t -116.58 121.08 66.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.023 0.439 . . . . 0.0 110.496 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -105.57 139.03 40.79 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.451 ' HE1' HG12 ' A' ' 403' ' ' ILE . 3.8 m-85 -119.39 144.44 46.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.773 0.321 . . . . 0.0 111.702 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.461 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 83.5 tttt -155.51 98.89 1.99 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.954 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 384' ' ' GLY . . . . . 0.471 ' O ' HD11 ' A' ' 403' ' ' ILE . . . 71.52 -114.75 5.29 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.815 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 385' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 402' ' ' HIS . 13.1 p-10 -105.07 6.43 33.27 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -118.28 151.4 37.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.795 0.331 . . . . 0.0 111.793 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 37.0 p-80 -136.0 145.35 46.0 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.238 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 388' ' ' TRP . . . . . 0.461 ' HZ3' ' HB3' ' A' ' 383' ' ' LYS . 17.8 m-90 -118.27 133.09 56.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.654 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 60.0 t -111.78 113.4 44.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -107.66 127.52 53.74 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -92.7 88.92 6.45 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 392' ' ' GLU . . . . . 0.459 ' OE1' ' HB ' ' D' ' 213' ' ' ILE . 59.5 mm-40 69.02 -71.3 0.12 Allowed 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.721 0.638 . . . . 0.0 111.002 -178.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -142.41 3.18 1.5 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.174 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.84 126.48 54.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.729 0.3 . . . . 0.0 111.582 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 47.8 tp -74.09 135.21 42.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.654 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 396' ' ' GLU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 13.6 mt-10 -75.63 134.78 72.23 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.859 0.362 . . . . 0.0 111.068 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 397' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 45.2 Cg_exo -58.74 142.53 98.79 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.199 2.599 . . . . 0.0 112.28 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 104.23 -25.1 27.17 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.309 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 399' ' ' TYR . . . . . 0.602 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 95.2 m-85 -89.64 161.24 39.71 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 110.561 -0.163 . . . . 0.0 110.561 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.602 ' HA ' ' HB3' ' A' ' 399' ' ' TYR . 72.0 Cg_endo -75.03 152.84 98.68 Favored 'Cis proline' 0 C--N 1.345 0.355 0 C-N-CA 123.77 -1.346 . . . . 0.0 113.394 0.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -126.39 169.78 12.62 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.491 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 0.496 ' HA ' ' O ' ' A' ' 385' ' ' ASP . 76.3 m80 -71.75 158.09 36.74 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.656 0.265 . . . . 0.0 111.236 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 403' ' ' ILE . . . . . 0.471 HD11 ' O ' ' A' ' 384' ' ' GLY . 22.4 mt -59.22 -35.54 58.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.18 0.514 . . . . 0.0 110.03 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 44.1 pttt -67.05 -15.04 63.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.803 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.451 ' HG2' ' HB2' ' A' ' 402' ' ' HIS . 38.1 mm-40 -82.27 -28.66 31.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.851 0.357 . . . . 0.0 110.549 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 41.1 tp -72.14 -53.34 13.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.29 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.625 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -153.9 159.68 28.89 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.618 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -89.69 127.37 35.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.719 0.295 . . . . 0.0 110.533 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 106.31 -0.92 37.52 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.226 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 95.1 mt -79.0 156.51 76.91 Favored Pre-proline 0 C--N 1.32 -0.691 0 O-C-N 122.878 -0.189 . . . . 0.0 110.663 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -53.34 138.62 64.83 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.677 2.252 . . . . 0.0 112.013 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.01 -15.97 28.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.723 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -86.41 -61.01 1.84 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 414' ' ' LYS . . . . . 0.467 ' O ' ' HD2' ' A' ' 431' ' ' ARG . 10.0 pttp -175.33 179.15 1.55 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 33.4 mm -117.98 147.93 21.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -100.15 -49.54 4.25 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 417' ' ' ALA . . . . . 0.919 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -157.65 156.15 31.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.258 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -136.78 120.03 16.76 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 21.9 tp -108.94 124.53 50.83 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.058 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -97.57 114.13 25.98 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 421' ' ' TRP . . . . . 0.886 ' HB2' ' HE2' ' A' ' 428' ' ' TYR . 10.9 t-105 -83.6 94.81 8.16 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 10.1 mmt -49.8 -52.84 48.07 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -47.55 -42.41 29.1 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 123.036 2.491 . . . . 0.0 115.177 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 424' ' ' ASN . . . . . 0.446 ' OD1' ' HB3' ' A' ' 421' ' ' TRP . 36.0 p30 -104.64 -19.36 13.99 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 78.56 34.89 34.14 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.209 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 37.4 mmtt -117.0 147.48 42.27 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.6 m -107.53 126.64 52.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.771 0.32 . . . . 0.0 110.491 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 428' ' ' TYR . . . . . 0.886 ' HE2' ' HB2' ' A' ' 421' ' ' TRP . 71.3 m-85 -104.04 110.61 22.84 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.862 0.363 . . . . 0.0 110.74 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -92.46 120.78 33.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.781 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -97.01 132.26 43.0 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.751 0.31 . . . . 0.0 111.183 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.467 ' HD2' ' O ' ' A' ' 414' ' ' LYS . 2.5 tpm_? -144.41 104.9 4.13 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.066 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 432' ' ' GLY . . . . . 0.41 ' HA2' ' OG ' ' A' ' 462' ' ' SER . . . 67.15 -111.66 4.27 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.591 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -109.3 10.64 25.59 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 434' ' ' LYS . . . . . 0.656 ' HD3' ' HG2' ' A' ' 450' ' ' PRO . 89.8 mttt -130.94 152.44 50.26 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.805 0.336 . . . . 0.0 111.681 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 435' ' ' TYR . . . . . 0.421 ' CE2' ' HE2' ' A' ' 449' ' ' TYR . 11.7 p90 -125.87 142.65 51.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.504 178.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -109.43 136.11 49.37 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.671 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -97.31 99.48 10.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.161 0.505 . . . . 0.0 109.651 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 438' ' ' PHE . . . . . 0.625 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 91.4 t80 -89.94 134.81 34.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.748 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -110.56 106.6 15.93 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.354 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 440' ' ' GLU . . . . . 0.41 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 0.6 OUTLIER -50.7 -47.23 59.08 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -178.404 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -59.3 -35.85 74.54 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 67.1 mt -98.63 -15.81 19.3 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 60.96 40.09 15.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.635 0.731 . . . . 0.0 110.992 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -150.97 168.24 25.15 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.458 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 87.6 t -92.01 141.58 14.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.553 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -62.13 163.39 8.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.161 0.505 . . . . 0.0 111.514 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 20.0 m -76.71 157.6 31.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.59 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 72.69 23.43 2.97 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.532 0.682 . . . . 0.0 111.01 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 449' ' ' TYR . . . . . 0.421 ' HE2' ' CE2' ' A' ' 435' ' ' TYR . 17.1 m-85 -122.37 164.13 28.03 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.119 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 450' ' ' PRO . . . . . 0.656 ' HG2' ' HD3' ' A' ' 434' ' ' LYS . 83.4 Cg_endo -77.61 161.29 92.21 Favored 'Cis proline' 0 C--N 1.345 0.378 0 C-N-CA 123.678 -1.384 . . . . 0.0 112.697 0.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -111.77 161.32 16.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.726 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 -66.08 140.06 58.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.821 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.4 tt -64.27 -13.07 13.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.427 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 36.9 mttm -61.46 -11.99 12.91 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 79.8 t -61.53 -34.79 63.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 456' ' ' TRP . . . . . 0.482 ' HB2' ' HB ' ' A' ' 459' ' ' ILE . 8.1 m95 -89.05 95.53 10.36 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -56.6 107.72 0.42 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 105.05 -1.73 40.97 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.698 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.482 ' HB ' ' HB2' ' A' ' 456' ' ' TRP . 20.1 mm -88.92 129.01 49.97 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.978 0.389 . . . . 0.0 111.335 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.26 149.07 19.27 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 123.063 2.509 . . . . 0.0 112.904 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -71.4 146.27 48.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.379 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 462' ' ' SER . . . . . 0.41 ' OG ' ' HA2' ' A' ' 432' ' ' GLY . 4.2 m 55.08 71.39 1.3 Allowed Pre-proline 0 N--CA 1.467 0.412 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -85.84 178.49 4.24 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.711 2.274 . . . . 0.0 111.745 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.6 8.44 6.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.042 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -177.23 147.57 8.35 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.824 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 19.4 p -164.19 98.17 0.82 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -128.61 140.35 51.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.925 0.393 . . . . 0.0 111.31 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 468' ' ' MET . . . . . 0.404 ' HA ' ' HA ' ' A' ' 475' ' ' THR . 39.2 ttm -84.78 138.82 32.37 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.965 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -72.33 160.04 53.91 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.467 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -15.45 57.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.969 0.414 . . . . 0.0 111.385 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -79.14 -18.53 53.01 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.222 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 69.21 1.77 3.38 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.22 -38.21 7.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.836 0.35 . . . . 0.0 111.458 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -120.84 143.69 48.76 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 475' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 468' ' ' MET . 55.3 m -115.88 139.97 49.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.32 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -106.18 123.6 48.28 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -107.18 144.99 33.13 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 94.1 t80 -129.02 134.7 48.24 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 59.7 tttt -170.81 134.35 1.01 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.991 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 60.11 43.37 98.38 Favored Glycine 0 N--CA 1.454 -0.125 0 CA-C-N 115.979 -0.555 . . . . 0.0 114.039 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 39.9 t30 67.07 3.58 3.21 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -118.22 157.13 27.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.733 0.301 . . . . 0.0 110.741 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -127.07 149.62 49.84 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.499 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 484' ' ' TRP . . . . . 0.423 ' CE2' ' HB3' ' A' ' 498' ' ' PRO . 19.2 m-90 -117.82 138.67 51.93 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.529 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -101.42 93.95 5.66 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 486' ' ' PHE . . . . . 0.465 ' CZ ' ' HE3' ' A' ' 456' ' ' TRP . 82.6 t80 -85.21 130.12 34.67 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.394 -178.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 487' ' ' ASN . . . . . 0.504 ' HB3' ' HB3' ' A' ' 490' ' ' LYS . 36.6 t-20 -86.65 121.53 29.29 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -65.94 -52.25 51.42 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.25 -40.39 86.26 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -178.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 490' ' ' LYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 487' ' ' ASN . 37.5 ttmt -78.26 -26.16 47.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.548 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 6.1 tp 63.24 38.78 10.18 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.572 0.701 . . . . 0.0 110.222 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -153.53 148.72 26.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.438 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 493' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 486' ' ' PHE . 77.8 t -75.83 131.27 35.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -59.45 137.35 89.15 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.836 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.28 143.1 99.86 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.912 2.408 . . . . 0.0 112.261 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 103.76 5.39 44.86 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.278 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 497' ' ' TYR . . . . . 0.51 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 18.6 m-85 -114.03 166.27 11.81 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.554 -0.323 . . . . 0.0 110.349 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 498' ' ' PRO . . . . . 0.51 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 88.3 Cg_endo -79.75 178.67 32.41 Favored 'Cis proline' 0 C--N 1.349 0.557 0 C-N-CA 123.752 -1.353 . . . . 0.0 113.075 0.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -135.23 160.12 39.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.277 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 42.4 t -69.66 125.92 28.16 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.812 0.339 . . . . 0.0 110.977 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -71.64 -22.9 61.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.284 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 502' ' ' LEU . . . . . 0.404 ' HA ' ' HG2' ' A' ' 506' ' ' MET . 26.4 mt -69.55 -47.34 64.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.53 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -75.9 -35.08 59.95 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -88.69 -46.86 8.68 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 36.1 m0 -92.72 -56.73 2.9 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -177.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 506' ' ' MET . . . . . 0.404 ' HG2' ' HA ' ' A' ' 502' ' ' LEU . 11.4 mmt -64.08 -45.43 88.74 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 105.85 29.63 4.87 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.398 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 15.1 m -106.45 105.38 54.23 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -81.11 160.92 20.6 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 123.289 2.66 . . . . 0.0 112.087 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 18.6 m 61.15 68.14 0.75 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.574 0.702 . . . . 0.0 111.653 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.388 -1.229 . . . . 0.0 111.474 -179.7 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.608 0 N-CA-C 111.893 -0.483 . . . . 0.0 111.893 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo . . . . . 0 CA--C 1.53 0.306 0 C-N-CA 122.621 2.214 . . . . 0.0 111.985 179.966 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 3' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' D' ' 201' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.571 0 N-CA-C 113.46 0.144 . . . . 0.0 113.46 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 CA--C 1.531 0.331 0 C-N-CA 123.002 2.468 . . . . 0.0 111.797 179.89 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.608 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo . . . . . 0 CA--C 1.531 0.368 0 C-N-CA 122.553 2.168 . . . . 0.0 111.26 179.26 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.81 0 N-CA-C 112.198 -0.361 . . . . 0.0 112.198 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.51 147.59 71.07 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.837 2.358 . . . . 0.0 111.575 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -68.71 150.41 47.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.971 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.48 154.7 29.95 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.129 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.435 HG13 ' H ' ' B' ' 13' ' ' ILE . 5.2 mt -65.24 152.57 8.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.42 145.91 47.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.371 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.48 159.57 53.64 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 121.144 -0.551 . . . . 0.0 112.633 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -72.34 146.23 47.24 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -69.89 146.67 51.08 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.517 ' HA3' ' O ' ' D' ' 216' ' ' GLN . . . -61.2 150.97 43.18 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.76 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 4.6 t -67.11 146.34 13.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.0 t -53.76 144.94 4.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.33 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.86 167.16 54.12 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.87 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 C--N 1.322 -0.587 0 C-N-CA 121.987 0.115 . . . . 0.0 110.746 -179.755 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.649 0 N-CA-C 112.252 -0.339 . . . . 0.0 112.252 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 C--O 1.232 0.195 0 C-N-CA 122.597 2.198 . . . . 0.0 111.275 179.637 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 113.551 0.181 . . . . 0.0 113.551 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 C--O 1.235 0.351 0 C-N-CA 122.835 2.357 . . . . 0.0 111.486 179.442 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 113.458 0.143 . . . . 0.0 113.458 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo . . . . . 0 CA--C 1.531 0.358 0 C-N-CA 123.158 2.572 . . . . 0.0 111.731 179.674 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.508 0 CA-C-O 120.357 -0.135 . . . . 0.0 112.765 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 N--CA 1.462 -0.362 0 C-N-CA 122.695 2.263 . . . . 0.0 111.924 179.813 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.348 0 CA-C-O 120.086 -0.286 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo . . . . . 0 CA--C 1.53 0.283 0 C-N-CA 122.963 2.442 . . . . 0.0 111.875 179.735 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.413 0 N-CA-C 112.851 -0.1 . . . . 0.0 112.851 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo . . . . . 0 CA--C 1.531 0.373 0 C-N-CA 123.592 2.862 . . . . 0.0 112.11 -179.694 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.41 0 N-CA-C 112.299 -0.32 . . . . 0.0 112.299 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo . . . . . 0 CA--C 1.528 0.209 0 C-N-CA 122.664 2.242 . . . . 0.0 111.353 179.84 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.423 0 N-CA-C 113.915 0.326 . . . . 0.0 113.915 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -65.14 163.97 26.97 Favored 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 122.841 2.361 . . . . 0.0 112.417 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -62.16 144.45 55.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.318 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -75.51 163.65 53.83 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.98 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 21.7 mt -65.14 136.61 26.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.17 148.14 50.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.254 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.36 154.43 37.87 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.117 -0.564 . . . . 0.0 112.873 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -83.51 163.25 20.58 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 43.5 ttm-85 -68.13 148.99 50.16 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.687 0.279 . . . . 0.0 110.357 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.93 175.35 38.6 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.06 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 25.3 t -73.49 140.24 18.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 90.4 t -63.27 136.07 26.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.105 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.18 157.62 46.54 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.269 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 74.4 mt . . . . . 0 C--N 1.324 -0.526 0 CA-C-O 120.658 0.266 . . . . 0.0 111.103 -179.657 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 C--O 1.236 0.4 0 C-N-CA 122.55 2.166 . . . . 0.0 111.737 179.904 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.61 0 N-CA-C 112.818 -0.113 . . . . 0.0 112.818 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 C--O 1.237 0.462 0 C-N-CA 122.494 2.129 . . . . 0.0 111.321 179.554 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.604 0 N-CA-C 112.494 -0.243 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo . . . . . 0 N--CA 1.463 -0.293 0 C-N-CA 122.822 2.348 . . . . 0.0 111.353 179.837 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.426 0 CA-C-O 120.186 -0.23 . . . . 0.0 112.699 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo . . . . . 0 N--CA 1.462 -0.37 0 C-N-CA 122.667 2.245 . . . . 0.0 111.891 -179.706 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 201' ' ' PRO . . . . . 0.435 ' O ' ' HA3' ' B' ' 3' ' ' GLY . 78.1 Cg_exo . . . . . 0 C--N 1.346 0.408 0 C-N-CA 123.014 2.476 . . . . 0.0 111.651 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.435 0 N-CA-C 114.236 0.455 . . . . 0.0 114.236 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo . . . . . 0 CA--C 1.536 0.605 0 C-N-CA 123.473 2.782 . . . . 0.0 111.965 179.213 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 CA-C-O 120.342 -0.144 . . . . 0.0 112.824 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 N--CA 1.458 -0.599 0 C-N-CA 123.475 2.783 . . . . 0.0 112.636 179.972 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 112.842 -0.103 . . . . 0.0 112.842 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -71.85 141.85 37.96 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 123.02 2.48 . . . . 0.0 111.949 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -65.84 146.42 54.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.943 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -70.05 162.97 52.66 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.897 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 213' ' ' ILE . . . . . 0.459 ' HB ' ' OE1' ' A' ' 392' ' ' GLU . 39.4 pt -69.84 166.85 2.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.606 0.241 . . . . 0.0 110.971 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 214' ' ' ALA . . . . . 0.558 ' HB3' ' NH1' ' A' ' 330' ' ' ARG . . . -83.15 144.44 29.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.884 0.373 . . . . 0.0 110.882 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -65.95 168.14 33.4 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.8 -0.636 . . . . 0.0 114.054 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 216' ' ' GLN . . . . . 0.517 ' O ' ' HA3' ' B' ' 18' ' ' GLY . 89.7 mm-40 -75.95 155.77 34.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.698 0.285 . . . . 0.0 110.955 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -66.14 153.06 43.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.5 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -59.83 150.25 39.54 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.086 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 13.8 t -61.2 143.12 15.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.61 142.16 16.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.888 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -59.88 154.79 31.41 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.358 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 C--N 1.32 -0.68 0 O-C-N 122.843 -0.21 . . . . 0.0 110.795 -179.8 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 224' ' ' GLY . . . . . 0.442 ' HA2' ' HD3' ' D' ' 225' ' ' PRO . . . . . . . . 0 N--CA 1.45 -0.407 0 N-CA-C 113.575 0.19 . . . . 0.0 113.575 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 225' ' ' PRO . . . . . 0.442 ' HD3' ' HA2' ' D' ' 224' ' ' GLY . 31.4 Cg_exo . . . . . 0 CA--C 1.531 0.327 0 C-N-CA 123.213 2.608 . . . . 0.0 112.09 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.709 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 C--O 1.238 0.478 0 C-N-CA 122.702 2.268 . . . . 0.0 111.809 179.903 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.697 0 N-CA-C 113.699 0.24 . . . . 0.0 113.699 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo . . . . . 0 N--CA 1.464 -0.243 0 C-N-CA 123.214 2.61 . . . . 0.0 111.263 179.567 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.418 ' HD2' ' CZ3' ' A' ' 340' ' ' TRP . 4.8 Cg_endo . . . . . 0 N--CA 1.479 0.62 0 N-CA-C 110.477 -0.624 . . . . 0.0 110.477 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -105.76 158.25 16.87 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 318' ' ' ILE . . . . . 0.404 ' O ' ' HZ ' ' A' ' 323' ' ' PHE . 15.0 tt -75.39 -19.13 15.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.41 0.624 . . . . 0.0 110.046 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 69.5 m -85.7 -1.31 57.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.717 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -74.15 -23.59 59.28 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.366 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 74.46 -172.32 52.41 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.607 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 2.1 t30 54.6 81.7 0.1 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.113 0.565 . . . . 0.0 111.942 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' PHE . . . . . 0.469 ' HD1' ' HB2' ' A' ' 337' ' ' LYS . 50.8 m-85 -104.65 164.43 11.77 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.709 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -73.32 -41.26 63.73 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 9.4 t -172.78 152.5 2.49 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.535 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 97.6 t -133.0 118.28 32.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -141.58 172.94 12.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.063 0.459 . . . . 0.0 111.473 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 31.9 ttp -121.77 123.39 41.71 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.624 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 59.3 mt -116.6 118.43 32.59 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.933 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.404 ' HG3' ' CE1' ' A' ' 379' ' ' PHE . 43.7 mtp180 56.49 28.04 13.15 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 98.76 -11.86 62.69 Favored Glycine 0 CA--C 1.517 0.193 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.225 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -98.52 128.23 44.77 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.823 0.344 . . . . 0.0 110.875 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 48.7 ttm -87.39 119.9 28.13 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.504 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -112.04 128.4 56.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.055 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 335' ' ' VAL . . . . . 0.442 ' HB ' ' HB2' ' A' ' 342' ' ' TRP . 26.1 t -106.8 119.91 57.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.434 -0.803 . . . . 0.0 108.913 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -107.87 130.11 55.03 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 0.691 ' HB3' ' HZ3' ' A' ' 342' ' ' TRP . 87.7 tttt -153.44 108.24 3.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.75 177.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 69.89 -129.67 0.08 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.034 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 339' ' ' ARG . 12.8 ptm85 -94.94 2.63 55.4 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 340' ' ' TRP . . . . . 0.418 ' CZ3' ' HD2' ' A' ' 316' ' ' PRO . 6.9 m-90 -123.61 154.85 38.72 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.784 0.326 . . . . 0.0 111.053 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -134.16 149.76 51.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.568 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 342' ' ' TRP . . . . . 0.691 ' HZ3' ' HB3' ' A' ' 337' ' ' LYS . 26.2 m-90 -119.65 167.56 11.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.634 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.13 114.27 6.21 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.417 HG11 ' HA ' ' A' ' 506' ' ' MET . 10.5 m -102.78 143.99 14.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.165 0.507 . . . . 0.0 112.238 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 29.1 ttm-85 -150.79 126.91 10.52 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.924 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 22.7 m120 68.55 30.89 5.0 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.203 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 39.6 t30 66.06 24.23 11.0 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.224 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -136.45 146.27 46.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.339 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 32.8 t -79.0 124.69 37.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 60.4 mtp -71.15 160.55 32.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.774 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -72.32 153.61 41.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.118 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 98.64 -4.41 59.68 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.517 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -118.6 152.6 51.42 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -73.94 149.12 93.54 Favored 'Cis proline' 0 C--O 1.234 0.315 0 C-N-CA 123.356 -1.518 . . . . 0.0 112.884 0.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 55.1 ttm -129.57 139.68 36.39 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.42 -0.809 . . . . 0.0 108.949 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.88 131.26 44.96 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.211 1.941 . . . . 0.0 111.213 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 357' ' ' ILE . . . . . 0.475 HG23 ' HD1' ' A' ' 361' ' ' TRP . 65.6 mt -52.02 -46.21 41.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.047 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -65.05 -16.07 61.48 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 121.267 -0.492 . . . . 0.0 114.128 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -34.2 61.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.141 0.471 . . . . 0.0 110.574 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -101.25 -51.5 3.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.165 0.507 . . . . 0.0 110.062 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 361' ' ' TRP . . . . . 0.475 ' HD1' HG23 ' A' ' 357' ' ' ILE . 71.4 m95 -87.8 85.68 7.07 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.371 0.605 . . . . 0.0 109.571 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 362' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 362' ' ' ARG . 38.4 ttp180 -65.63 83.41 0.06 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.859 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.582 ' HA3' HD22 ' A' ' 395' ' ' LEU . . . 133.54 -3.6 4.7 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.164 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.583 HD12 ' HD2' ' A' ' 365' ' ' PRO . 22.9 tp -98.83 131.72 25.11 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 120.616 0.246 . . . . 0.0 110.858 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 365' ' ' PRO . . . . . 0.583 ' HD2' HD12 ' A' ' 364' ' ' LEU . 98.3 Cg_endo -79.55 -174.83 2.43 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.715 2.277 . . . . 0.0 111.598 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -91.35 151.34 20.9 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.938 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 18.1 m 57.45 93.52 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.483 0.919 . . . . 0.0 113.483 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 24.1 pt -107.19 172.39 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.409 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -96.64 -40.57 8.94 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 370' ' ' THR . . . . . 0.86 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.1 OUTLIER -162.7 171.88 16.16 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.773 0.32 . . . . 0.0 111.347 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 371' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 380' ' ' VAL . . . -162.06 144.44 11.39 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -157.35 164.16 37.87 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -95.5 122.05 37.82 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 374' ' ' ARG . . . . . 0.549 ' HG2' ' O ' ' A' ' 378' ' ' LYS . 9.3 ptm180 -75.57 -175.7 2.96 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.478 ' HD2' ' HA3' ' A' ' 425' ' ' GLY . 77.6 tttt -67.46 -33.18 74.59 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.988 0.423 . . . . 0.0 111.375 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.75 -50.62 19.79 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.825 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 147.63 -29.76 1.43 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.214 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 378' ' ' LYS . . . . . 0.731 ' HG2' ' HA ' ' A' ' 391' ' ' ASP . 91.5 mttt -59.13 150.49 25.07 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.91 0.386 . . . . 0.0 111.088 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 379' ' ' PHE . . . . . 0.404 ' CE1' ' HG3' ' A' ' 330' ' ' ARG . 18.2 m-85 -95.73 136.09 36.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.612 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 380' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 371' ' ' ALA . 3.8 t -113.86 113.96 45.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.094 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -100.52 144.78 29.11 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -126.63 141.51 51.83 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.848 0.356 . . . . 0.0 111.632 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.56 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 84.2 tttt -152.99 105.48 2.93 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 177.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 72.49 -117.07 6.04 Favored Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -109.85 10.51 24.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.848 0.356 . . . . 0.0 110.946 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -118.75 151.08 38.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.878 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 27.8 p-80 -131.38 153.28 49.82 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.028 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 388' ' ' TRP . . . . . 0.575 ' CE2' ' HB3' ' A' ' 400' ' ' PRO . 26.7 m-90 -127.97 131.87 49.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.238 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 389' ' ' VAL . . . . . 0.409 HG12 ' HG3' ' A' ' 396' ' ' GLU . 78.8 t -111.02 122.78 66.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -113.57 122.41 47.15 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.731 ' HA ' ' HG2' ' A' ' 378' ' ' LYS . 32.8 t70 -85.03 82.42 8.45 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 177.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 392' ' ' GLU . . . . . 0.451 ' OE1' ' HB ' ' D' ' 213' ' ' ILE . 35.7 mm-40 71.92 -68.93 0.2 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.489 -177.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -143.8 7.52 1.45 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.93 0.395 . . . . 0.0 110.915 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 2.0 m -113.76 125.01 53.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.02 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 395' ' ' LEU . . . . . 0.582 HD22 ' HA3' ' A' ' 363' ' ' GLY . 52.3 tp -76.52 128.22 34.34 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.533 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 396' ' ' GLU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 1.4 mt-10 -64.42 136.54 96.8 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.985 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 397' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 31.5 Cg_exo -60.95 143.22 99.3 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.168 2.579 . . . . 0.0 112.447 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 96.51 -15.01 63.52 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.543 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -83.72 156.56 64.76 Favored Pre-proline 0 C--N 1.323 -0.577 0 O-C-N 122.672 -0.311 . . . . 0.0 110.782 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.575 ' HB3' ' CE2' ' A' ' 388' ' ' TRP . 59.9 Cg_endo -71.51 156.38 97.04 Favored 'Cis proline' 0 C--N 1.349 0.593 0 C-N-CA 123.963 -1.266 . . . . 0.0 113.522 0.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -128.19 159.6 34.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.0 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 0.545 ' ND1' ' HG2' ' A' ' 404' ' ' LYS . 5.4 t-80 -69.75 153.09 43.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.245 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 64.9 mt -56.52 -33.51 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 404' ' ' LYS . . . . . 0.545 ' HG2' ' ND1' ' A' ' 402' ' ' HIS . 20.7 pttm -65.14 -12.53 51.97 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -80.91 -26.58 36.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.876 0.37 . . . . 0.0 110.772 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 32.2 tp -75.0 -47.14 30.67 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.477 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -169.37 147.82 11.44 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.759 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 33.0 ttt180 -84.68 132.96 34.41 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.745 0.307 . . . . 0.0 110.315 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 114.14 -14.77 21.1 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.551 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.443 HD21 ' HB2' ' A' ' 438' ' ' PHE . 96.0 mt -76.17 152.9 84.29 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.571 -0.314 . . . . 0.0 110.563 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.46 130.19 38.75 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.922 2.414 . . . . 0.0 111.545 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.11 3.82 55.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.985 0.421 . . . . 0.0 111.482 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -95.52 -57.53 2.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.579 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 5.1 ptmt -172.38 171.64 4.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.919 0.39 . . . . 0.0 110.858 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 49.2 mm -120.92 127.52 75.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -86.49 -48.01 8.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.935 0.398 . . . . 0.0 110.55 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 417' ' ' ALA . . . . . 0.86 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -153.87 154.38 33.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.295 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -135.1 107.27 7.18 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 40.5 tp -99.14 117.21 33.11 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.281 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 420' ' ' PHE . . . . . 0.417 ' CZ ' ' HA ' ' A' ' 375' ' ' LYS . 44.7 t80 -89.0 115.44 26.57 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.035 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 421' ' ' TRP . . . . . 0.494 ' HB2' ' HE2' ' A' ' 428' ' ' TYR . 22.0 t-105 -84.26 90.44 7.53 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.463 ' HB2' ' HG2' ' A' ' 472' ' ' GLU . 62.9 mtt -47.97 -48.73 61.95 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.422 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 79.8 Cg_exo -48.87 -35.47 31.35 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 122.862 2.375 . . . . 0.0 114.787 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 38.3 p30 -113.29 -35.47 5.31 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 425' ' ' GLY . . . . . 0.478 ' HA3' ' HD2' ' A' ' 375' ' ' LYS . . . 104.62 10.44 33.17 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.617 -0.802 . . . . 0.0 113.367 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -97.88 155.41 17.08 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.418 -0.46 . . . . 0.0 110.605 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 7.4 m -113.16 130.36 56.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.994 0.426 . . . . 0.0 111.568 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 428' ' ' TYR . . . . . 0.494 ' HE2' ' HB2' ' A' ' 421' ' ' TRP . 99.4 m-85 -100.85 108.17 19.89 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.742 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -91.47 124.57 35.74 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.226 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -99.57 132.24 45.03 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.094 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.41 ' HA ' ' HE ' ' A' ' 431' ' ' ARG . 2.9 tpm_? -144.4 108.08 4.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.171 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 70.14 -110.22 3.21 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.774 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 28.1 p30 -117.71 17.69 14.3 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.837 0.351 . . . . 0.0 111.158 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 52.5 mttt -133.86 158.22 43.97 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.725 0.298 . . . . 0.0 110.959 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 435' ' ' TYR . . . . . 0.46 ' CE2' ' HE2' ' A' ' 449' ' ' TYR . 7.1 p90 -128.99 144.5 51.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.211 0.529 . . . . 0.0 110.984 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -110.53 133.74 53.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.596 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 19.2 ttp180 -94.86 92.14 6.78 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 438' ' ' PHE . . . . . 0.477 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 67.8 t80 -84.34 129.04 34.91 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.131 0.491 . . . . 0.0 111.642 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -99.39 108.89 21.49 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 440' ' ' GLU . . . . . 0.524 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 1.7 tt0 -58.57 -43.04 89.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.947 0.403 . . . . 0.0 110.621 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -84.24 48.65 1.52 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.797 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -169.6 -35.03 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.706 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 443' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 443' ' ' ARG . 37.6 mtp-105 69.58 36.94 2.04 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.429 0.633 . . . . 0.0 111.199 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -155.72 167.37 30.61 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.925 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 59.7 t -87.74 141.06 14.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.966 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -62.09 155.44 24.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.998 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 447' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 448' ' ' GLU . 0.9 OUTLIER -64.85 157.73 27.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.849 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 448' ' ' GLU . . . . . 0.577 ' HB3' ' HE2' ' A' ' 451' ' ' LYS . 8.3 mm-40 76.04 5.93 3.75 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.259 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 449' ' ' TYR . . . . . 0.524 ' HB3' ' HA ' ' A' ' 450' ' ' PRO . 42.6 m-85 -112.63 163.36 18.05 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.762 -0.199 . . . . 0.0 111.329 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 450' ' ' PRO . . . . . 0.524 ' HA ' ' HB3' ' A' ' 449' ' ' TYR . 73.1 Cg_endo -75.87 155.65 98.87 Favored 'Cis proline' 0 C--N 1.349 0.57 0 C-N-CA 123.624 -1.407 . . . . 0.0 112.967 0.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 451' ' ' LYS . . . . . 0.577 ' HE2' ' HB3' ' A' ' 448' ' ' GLU . 63.0 mttm -116.84 162.3 17.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.305 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -65.53 139.94 58.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.718 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.1 tt -67.48 -9.6 10.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.094 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -63.47 -7.35 6.6 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 95.7 t -65.94 -37.17 79.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 456' ' ' TRP . . . . . 0.563 ' HE3' ' CZ ' ' A' ' 486' ' ' PHE . 5.7 m95 -88.43 93.68 9.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.94 179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.28 116.32 4.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.149 0.5 . . . . 0.0 112.072 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 107.3 -15.57 39.02 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.716 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.424 ' HB ' ' HB2' ' A' ' 456' ' ' TRP . 33.6 mm -83.59 125.9 72.52 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 120.857 0.36 . . . . 0.0 111.304 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.44 152.93 30.55 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.758 2.306 . . . . 0.0 111.719 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -73.42 147.36 44.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.473 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 2.0 m 54.89 75.85 0.57 Allowed Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -83.5 -176.59 2.81 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.156 2.571 . . . . 0.0 112.173 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -134.81 18.96 3.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.207 0.527 . . . . 0.0 110.405 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 166.15 142.9 3.56 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 11.4 p -157.54 108.23 2.25 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -134.23 146.14 49.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.881 0.372 . . . . 0.0 111.507 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 48.0 ttm -99.03 141.06 32.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.167 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -67.69 166.74 42.5 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.179 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 2.7 m -68.74 -8.26 41.3 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.34 -14.27 27.1 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.969 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 472' ' ' GLU . . . . . 0.463 ' HG2' ' HB2' ' A' ' 422' ' ' MET . 36.4 mt-10 65.39 12.17 7.9 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.241 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.7 -45.05 12.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.941 0.4 . . . . 0.0 110.682 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -114.07 141.56 47.31 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.208 0.528 . . . . 0.0 112.0 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 475' ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' A' ' 486' ' ' PHE . 91.9 m -119.42 138.8 52.86 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.685 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -112.51 131.06 55.78 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.292 0.568 . . . . 0.0 112.506 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -114.65 142.78 46.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.215 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -123.75 136.84 54.67 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 111.526 0.195 . . . . 0.0 111.526 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -167.43 126.11 1.31 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.001 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 57.92 46.83 92.0 Favored Glycine 0 CA--C 1.519 0.341 0 CA-C-N 116.003 -0.544 . . . . 0.0 114.356 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 68.65 -2.25 1.72 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.775 0.658 . . . . 0.0 112.775 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 482' ' ' LYS . . . . . 0.436 ' HB3' ' HB2' ' A' ' 498' ' ' PRO . 34.7 mtmt -106.39 151.42 24.91 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 483' ' ' TYR . . . . . 0.5 ' CZ ' ' HE2' ' A' ' 497' ' ' TYR . 3.3 p90 -126.89 138.84 53.37 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.031 0.443 . . . . 0.0 111.332 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 15.1 m-90 -108.33 145.65 34.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.23 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 53.5 tttt -111.86 100.45 8.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.075 0.464 . . . . 0.0 109.927 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 486' ' ' PHE . . . . . 0.563 ' CZ ' ' HE3' ' A' ' 456' ' ' TRP . 67.1 t80 -89.1 130.61 35.52 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.945 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -96.82 112.38 24.16 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -64.72 -23.43 67.25 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 31.3 tp60 -78.57 -24.5 45.52 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -114.1 -6.26 13.08 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 15.3 tp 58.02 34.22 24.01 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.525 0.679 . . . . 0.0 110.375 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 492' ' ' LYS . . . . . 0.432 ' HG2' ' N ' ' A' ' 493' ' ' VAL . 39.3 tttp -152.46 152.71 32.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.703 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 493' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 486' ' ' PHE . 66.7 t -76.1 133.36 31.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.696 178.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -61.38 148.22 86.1 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.386 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.23 149.56 85.27 Favored 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 122.743 2.295 . . . . 0.0 112.457 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 96.25 13.25 49.44 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.751 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 497' ' ' TYR . . . . . 0.567 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 51.1 m-85 -121.08 164.5 23.36 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.874 -0.163 . . . . 0.0 110.783 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 498' ' ' PRO . . . . . 0.567 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 95.8 Cg_endo -80.65 164.23 79.32 Favored 'Cis proline' 0 C--N 1.344 0.337 0 C-N-CA 123.806 -1.331 . . . . 0.0 113.647 0.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -118.68 160.77 21.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.651 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 30.1 t -71.97 115.47 11.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.946 0.403 . . . . 0.0 110.978 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -69.99 -23.67 63.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.61 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 502' ' ' LEU . . . . . 0.472 ' HA ' ' HG2' ' A' ' 506' ' ' MET . 83.5 mt -67.02 -32.0 72.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.074 0.464 . . . . 0.0 110.862 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -96.68 -35.08 11.14 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -89.65 -17.64 28.01 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 13.0 m0 -121.37 -52.63 2.04 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 506' ' ' MET . . . . . 0.472 ' HG2' ' HA ' ' A' ' 502' ' ' LEU . 11.2 mmt -67.95 -29.33 68.36 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 88.84 30.72 14.06 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.032 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 31.7 m -101.93 114.23 65.61 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.0 124.34 11.7 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.968 2.445 . . . . 0.0 112.652 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 3.9 m 68.28 153.68 0.1 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.482 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.188 -1.34 . . . . 0.0 111.19 179.957 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.771 0 N-CA-C 112.048 -0.421 . . . . 0.0 112.048 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 CA--C 1.53 0.321 0 C-N-CA 122.722 2.281 . . . . 0.0 112.01 179.916 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 3' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' D' ' 201' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.61 0 N-CA-C 112.175 -0.37 . . . . 0.0 112.175 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo . . . . . 0 C--O 1.232 0.21 0 C-N-CA 122.764 2.309 . . . . 0.0 111.415 179.773 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.683 0 N-CA-C 112.318 -0.313 . . . . 0.0 112.318 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo . . . . . 0 N--CA 1.463 -0.303 0 C-N-CA 122.617 2.211 . . . . 0.0 111.361 179.085 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.673 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.64 143.6 68.88 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.88 2.387 . . . . 0.0 111.514 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -64.89 150.82 47.08 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.607 ' HA3' ' O ' ' D' ' 210' ' ' PRO . . . -59.99 154.72 31.96 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.345 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.486 ' O ' ' HG3' ' D' ' 211' ' ' GLN . 6.5 mt -59.58 150.38 5.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.891 0.377 . . . . 0.0 110.924 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.59 145.27 56.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.127 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.32 153.85 45.54 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.903 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -69.27 148.59 49.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.756 0.312 . . . . 0.0 110.612 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -66.34 138.64 57.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.715 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.51 145.13 49.77 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.637 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 t -63.8 149.22 10.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.496 0.148 . . . . 0.0 110.766 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 11.0 t -52.13 146.05 2.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.262 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.54 165.08 52.45 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 121.187 -0.53 . . . . 0.0 113.4 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 81.2 mt . . . . . 0 C--N 1.322 -0.598 0 CA-C-N 115.639 -0.28 . . . . 0.0 110.342 179.946 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.586 0 N-CA-C 112.226 -0.349 . . . . 0.0 112.226 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo . . . . . 0 C--O 1.234 0.314 0 C-N-CA 122.756 2.304 . . . . 0.0 111.698 179.662 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.51 0 N-CA-C 112.748 -0.141 . . . . 0.0 112.748 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo . . . . . 0 CA--C 1.532 0.423 0 C-N-CA 123.043 2.495 . . . . 0.0 112.031 -179.997 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 113.52 0.168 . . . . 0.0 113.52 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo . . . . . 0 C--N 1.345 0.392 0 C-N-CA 123.308 2.672 . . . . 0.0 112.455 -179.803 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.459 0 N-CA-C 113.8 0.28 . . . . 0.0 113.8 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo . . . . . 0 C--N 1.346 0.406 0 C-N-CA 122.952 2.435 . . . . 0.0 111.397 179.257 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.35 0 CA-C-O 120.019 -0.323 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo . . . . . 0 C--O 1.235 0.359 0 C-N-CA 122.823 2.349 . . . . 0.0 111.63 179.54 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo . . . . . 0 N--CA 1.463 -0.319 0 C-N-CA 123.074 2.516 . . . . 0.0 111.97 179.862 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.513 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo . . . . . 0 N--CA 1.466 -0.142 0 C-N-CA 122.676 2.251 . . . . 0.0 110.743 179.621 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.479 0 CA-C-O 120.454 -0.081 . . . . 0.0 113.282 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.26 160.07 32.48 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 123.216 2.611 . . . . 0.0 112.525 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -62.03 134.23 56.35 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.794 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -65.39 162.02 41.26 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.441 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 53.5 mt -72.94 138.72 20.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.8 153.09 37.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.306 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -66.56 159.39 48.29 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.351 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -88.94 150.53 22.8 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.617 0.246 . . . . 0.0 110.594 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 19.5 ttm-85 -60.97 142.11 56.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.323 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.24 167.12 49.79 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.41 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 86.0 t -66.73 142.28 16.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.675 0.274 . . . . 0.0 111.014 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 94.4 t -61.6 143.39 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.122 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.89 163.61 36.94 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.726 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 87.3 mt . . . . . 0 C--N 1.324 -0.519 0 CA-C-O 120.49 0.186 . . . . 0.0 110.755 -179.959 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.512 0 N-CA-C 113.462 0.145 . . . . 0.0 113.462 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 C--O 1.234 0.312 0 C-N-CA 122.709 2.273 . . . . 0.0 111.629 -179.918 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.565 0 N-CA-C 112.318 -0.313 . . . . 0.0 112.318 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo . . . . . 0 N--CA 1.459 -0.516 0 C-N-CA 122.666 2.244 . . . . 0.0 111.223 179.479 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.62 0 CA-C-O 120.694 0.052 . . . . 0.0 112.997 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo . . . . . 0 C--O 1.235 0.348 0 C-N-CA 122.921 2.414 . . . . 0.0 111.691 -179.94 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.555 0 CA-C-O 120.211 -0.216 . . . . 0.0 112.958 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo . . . . . 0 C--N 1.345 0.369 0 C-N-CA 122.823 2.349 . . . . 0.0 111.463 179.509 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.287 0 CA-C-O 120.056 -0.302 . . . . 0.0 112.437 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 201' ' ' PRO . . . . . 0.446 ' O ' ' HA3' ' B' ' 3' ' ' GLY . 31.9 Cg_exo . . . . . 0 C--N 1.345 0.366 0 C-N-CA 122.789 2.326 . . . . 0.0 111.034 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.418 0 N-CA-C 114.72 0.648 . . . . 0.0 114.72 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo . . . . . 0 CA--C 1.531 0.339 0 C-N-CA 123.528 2.819 . . . . 0.0 110.411 178.307 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.287 0 N-CA-C 113.454 0.141 . . . . 0.0 113.454 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo . . . . . 0 CA--C 1.533 0.454 0 C-N-CA 123.33 2.686 . . . . 0.0 112.803 -179.87 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.456 0 N-CA-C 112.319 -0.312 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 210' ' ' PRO . . . . . 0.607 ' O ' ' HA3' ' B' ' 12' ' ' GLY . 2.6 Cg_exo -76.89 152.89 32.58 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 123.044 2.496 . . . . 0.0 111.786 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 211' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' B' ' 13' ' ' ILE . 57.0 tt0 -73.91 149.32 41.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.774 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -68.02 159.45 51.2 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.486 -0.645 . . . . 0.0 111.486 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 213' ' ' ILE . . . . . 0.451 ' HB ' ' OE1' ' A' ' 392' ' ' GLU . 42.1 pt -64.4 163.48 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-O 120.891 0.376 . . . . 0.0 111.484 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -74.56 145.16 43.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.333 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -67.42 158.02 51.34 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.518 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 -76.19 151.33 36.93 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -64.58 153.04 40.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.337 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -61.86 157.03 35.5 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.269 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 12.3 t -70.91 147.52 11.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.59 136.85 25.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.99 162.82 26.36 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.292 -0.48 . . . . 0.0 113.127 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 64.5 mt . . . . . 0 C--N 1.325 -0.485 0 CA-C-N 115.846 -0.177 . . . . 0.0 110.795 -179.982 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 224' ' ' GLY . . . . . 0.447 ' HA2' ' HD3' ' D' ' 225' ' ' PRO . . . . . . . . 0 N--CA 1.446 -0.658 0 N-CA-C 112.276 -0.33 . . . . 0.0 112.276 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 225' ' ' PRO . . . . . 0.447 ' HD3' ' HA2' ' D' ' 224' ' ' GLY . 17.3 Cg_exo . . . . . 0 C--O 1.236 0.406 0 C-N-CA 122.602 2.202 . . . . 0.0 111.903 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.449 0 N-CA-C 114.087 0.395 . . . . 0.0 114.087 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 CA--C 1.531 0.35 0 C-N-CA 123.418 2.745 . . . . 0.0 111.485 179.587 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.506 0 N-CA-C 113.268 0.067 . . . . 0.0 113.268 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo . . . . . 0 N--CA 1.463 -0.319 0 C-N-CA 123.002 2.468 . . . . 0.0 111.394 179.519 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo . . . . . 0 N--CA 1.477 0.54 0 N-CA-C 109.8 -0.885 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -110.42 -173.98 2.38 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 15.4 tt -117.46 -6.24 11.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.247 0.546 . . . . 0.0 110.54 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 99.6 m -100.11 -0.61 38.64 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -94.02 -9.17 37.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.81 0.338 . . . . 0.0 110.598 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 84.22 -149.05 24.7 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.808 -0.711 . . . . 0.0 111.843 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 2.8 t30 55.13 68.57 0.84 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.116 0.484 . . . . 0.0 111.756 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -100.99 152.17 20.89 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.547 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -80.31 -47.09 15.05 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 4.4 t -167.33 149.67 6.0 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.021 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 47.8 t -128.49 122.29 57.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -140.44 -177.98 5.29 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.065 0.459 . . . . 0.0 111.778 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 12.8 ttp -132.02 131.17 42.26 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 51.2 mt -127.58 116.86 20.99 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 123.295 0.372 . . . . 0.0 110.397 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.451 ' H ' ' CD ' ' A' ' 373' ' ' GLU . 0.9 OUTLIER 64.83 20.84 12.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.822 179.203 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 102.85 -18.59 49.54 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.347 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -89.47 135.03 33.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.669 0.271 . . . . 0.0 110.475 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 48.4 ttm -87.03 126.61 34.86 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.907 0.384 . . . . 0.0 110.632 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -116.87 122.32 44.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.32 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.72 112.46 37.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -95.3 130.4 42.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.792 0.33 . . . . 0.0 111.578 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -147.98 108.82 4.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.244 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 63.34 -113.2 0.4 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.632 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.456 HH11 ' HD2' ' A' ' 339' ' ' ARG . 13.3 ptm180 -110.23 10.35 23.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.053 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -126.19 157.47 38.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.908 0.385 . . . . 0.0 110.591 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -141.31 141.57 33.89 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.563 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -107.21 150.46 26.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.92 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.454 ' HD3' ' SD ' ' A' ' 350' ' ' MET . 14.5 ttt85 -125.5 106.32 9.7 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 3.7 m -92.79 129.01 43.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.409 0.623 . . . . 0.0 111.485 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.43 111.89 13.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.082 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 27.9 t30 55.69 52.06 11.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.031 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 68.14 7.07 5.62 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -122.38 158.06 30.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.724 0.297 . . . . 0.0 110.881 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 38.5 t -94.26 130.32 43.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 120.681 0.276 . . . . 0.0 110.475 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 350' ' ' MET . . . . . 0.454 ' SD ' ' HD3' ' A' ' 343' ' ' ARG . 4.0 mtp -72.04 156.72 38.9 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.204 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -79.08 150.55 31.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.81 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 99.69 -6.03 58.67 Favored Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 353' ' ' TYR . . . . . 0.459 ' HA ' ' C ' ' A' ' 354' ' ' PRO . 86.7 m-85 -112.64 157.69 39.61 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.459 ' C ' ' HA ' ' A' ' 353' ' ' TYR . 38.1 Cg_endo -66.55 131.7 15.38 Favored 'Cis proline' 0 C--N 1.347 0.466 0 C-N-CA 123.713 -1.369 . . . . 0.0 112.693 0.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 355' ' ' MET . . . . . 0.441 ' HA ' ' HD3' ' A' ' 356' ' ' PRO . 52.6 ttm -104.38 136.08 19.23 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.24 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 356' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 355' ' ' MET . 31.4 Cg_exo -61.18 131.84 38.6 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.256 1.971 . . . . 0.0 111.058 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 66.5 mt -54.96 -44.1 71.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.179 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -67.99 -14.22 65.43 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 121.19 -0.529 . . . . 0.0 113.718 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -79.55 -45.79 18.57 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 117.182 0.491 . . . . 0.0 110.622 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -88.38 -53.11 4.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.591 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -88.12 74.67 8.79 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.242 0.544 . . . . 0.0 109.536 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -60.66 94.83 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.865 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 130.91 -17.31 5.2 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.264 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.55 HD12 ' HD2' ' A' ' 365' ' ' PRO . 19.4 tp -85.31 132.59 44.64 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.647 0.261 . . . . 0.0 111.138 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 365' ' ' PRO . . . . . 0.55 ' HD2' HD12 ' A' ' 364' ' ' LEU . 94.2 Cg_endo -79.59 178.81 6.92 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.817 2.345 . . . . 0.0 111.651 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -86.56 151.57 23.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.421 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 44.6 m 55.98 83.99 0.09 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 19.9 pt -95.56 172.86 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.924 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.42 -42.05 6.42 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.708 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 370' ' ' THR . . . . . 0.729 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.2 OUTLIER -151.23 159.2 44.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.85 0.357 . . . . 0.0 111.513 -179.6 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -149.93 140.1 22.14 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -163.88 166.79 21.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.768 0.318 . . . . 0.0 111.42 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.52 ' HG2' ' HD1' ' A' ' 379' ' ' PHE . 33.5 mt-10 -97.56 138.38 35.07 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 374' ' ' ARG . . . . . 0.628 ' HG3' ' H ' ' A' ' 376' ' ' ASP . 10.0 ptm180 -89.41 -173.03 3.84 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.959 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.482 ' HB2' ' HG3' ' A' ' 440' ' ' GLU . 67.8 tttt -70.42 -19.51 62.99 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -177.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 376' ' ' ASP . . . . . 0.628 ' H ' ' HG3' ' A' ' 374' ' ' ARG . 0.4 OUTLIER -94.67 -23.05 17.76 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.377 -0.529 . . . . 0.0 112.422 -179.341 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 124.9 -18.99 7.01 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.603 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -70.45 152.0 44.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.842 0.353 . . . . 0.0 110.605 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 379' ' ' PHE . . . . . 0.52 ' HD1' ' HG2' ' A' ' 373' ' ' GLU . 21.5 m-85 -96.23 133.54 40.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.269 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 14.5 t -114.56 121.31 66.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 120.796 0.332 . . . . 0.0 110.276 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -107.65 138.62 43.55 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -121.3 137.7 54.57 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.461 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 79.0 tttt -155.25 103.54 2.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.408 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 76.61 -122.38 6.33 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.606 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 385' ' ' ASP . . . . . 0.52 ' O ' ' HA ' ' A' ' 402' ' ' HIS . 2.3 p-10 -106.52 4.87 28.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.884 0.373 . . . . 0.0 111.098 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 386' ' ' LYS . . . . . 0.4 ' HB3' ' HB2' ' A' ' 400' ' ' PRO . 46.3 mmtm -114.62 150.01 35.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.217 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 32.5 p-80 -131.78 148.79 52.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.019 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 388' ' ' TRP . . . . . 0.461 ' HZ3' ' HB3' ' A' ' 383' ' ' LYS . 27.1 m-90 -123.6 132.81 53.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.066 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 21.8 t -112.86 124.6 69.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -117.48 128.68 55.23 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -94.73 89.21 5.63 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 392' ' ' GLU . . . . . 0.46 ' HA ' ' HE2' ' A' ' 379' ' ' PHE . 76.9 mm-40 68.98 -80.41 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.409 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -136.05 11.47 3.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.089 0.471 . . . . 0.0 110.902 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 19.3 m -120.82 129.29 53.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.876 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 33.8 tp -76.07 142.04 41.87 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.961 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -69.14 148.49 97.65 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.392 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.41 133.64 19.47 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.9 2.4 . . . . 0.0 112.584 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 87.29 52.81 2.95 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.4 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 399' ' ' TYR . . . . . 0.432 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 25.4 m-85 -143.62 162.66 40.59 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.432 ' HA ' ' HB3' ' A' ' 399' ' ' TYR . 83.3 Cg_endo -80.4 165.32 77.96 Favored 'Cis proline' 0 C--N 1.347 0.489 0 C-N-CA 123.633 -1.403 . . . . 0.0 112.934 0.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -132.48 168.11 18.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.987 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 0.52 ' HA ' ' O ' ' A' ' 385' ' ' ASP . 5.4 m80 -68.82 156.36 38.53 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 123.236 0.335 . . . . 0.0 110.499 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 52.8 mt -55.84 -36.53 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.111 0.482 . . . . 0.0 110.879 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 404' ' ' LYS . . . . . 0.416 ' HG2' ' HB2' ' A' ' 402' ' ' HIS . 22.8 pttp -65.43 -14.48 61.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.127 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -80.62 -22.06 40.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.318 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 40.6 tp -82.69 -48.21 11.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.99 0.424 . . . . 0.0 110.234 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.531 ' HA3' ' CE1' ' A' ' 438' ' ' PHE . . . -151.18 140.54 7.93 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.919 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 408' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 408' ' ' ARG . 0.1 OUTLIER -79.67 126.32 30.77 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.0 0.429 . . . . 0.0 110.714 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 110.77 -1.83 28.89 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.052 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 88.6 mt -83.72 150.18 58.75 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.496 0.189 . . . . 0.0 110.562 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.0 140.86 92.35 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.697 2.265 . . . . 0.0 111.871 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.14 -5.94 39.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.812 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 413' ' ' ASP . . . . . 0.499 ' OD2' ' HD3' ' A' ' 431' ' ' ARG . 8.5 p-10 -79.27 -57.69 3.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.494 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -179.39 176.68 0.81 Allowed 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.823 0.344 . . . . 0.0 110.421 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 44.7 mm -124.55 134.64 66.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -89.4 -54.31 4.15 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.283 0.563 . . . . 0.0 110.206 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 417' ' ' ALA . . . . . 0.729 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -150.84 155.93 40.2 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.978 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -139.14 121.51 16.03 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 35.2 tp -113.97 123.8 50.6 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.421 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -90.97 113.38 25.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.67 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 421' ' ' TRP . . . . . 0.487 ' HB2' ' HE2' ' A' ' 428' ' ' TYR . 19.2 t-105 -80.42 99.04 7.78 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 67.0 mtt -54.62 -49.41 91.4 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -47.54 -61.41 0.6 Allowed 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 122.557 2.171 . . . . 0.0 114.501 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 424' ' ' ASN . . . . . 0.428 ' H ' ' HD1' ' A' ' 421' ' ' TRP . 52.0 p30 -85.8 -24.9 26.61 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 83.56 47.43 5.67 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.514 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -131.49 152.58 50.6 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.8 m -106.24 126.55 52.36 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.141 0.496 . . . . 0.0 111.754 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 428' ' ' TYR . . . . . 0.487 ' HE2' ' HB2' ' A' ' 421' ' ' TRP . 95.6 m-85 -100.65 113.15 25.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.019 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 429' ' ' PHE . . . . . 0.448 ' HB2' ' HB2' ' A' ' 436' ' ' TYR . 46.4 m-85 -94.93 121.79 36.9 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.394 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -99.88 130.38 46.06 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.783 0.325 . . . . 0.0 110.929 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.499 ' HD3' ' OD2' ' A' ' 413' ' ' ASP . 3.1 tpm_? -141.75 98.7 3.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.829 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 67.79 -116.81 8.1 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.561 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -101.64 8.45 41.7 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 434' ' ' LYS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 450' ' ' PRO . 65.9 mmtt -128.72 149.38 50.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.815 0.341 . . . . 0.0 111.195 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 435' ' ' TYR . . . . . 0.437 ' CE2' ' HE2' ' A' ' 449' ' ' TYR . 9.1 p90 -126.43 144.41 50.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.468 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 436' ' ' TYR . . . . . 0.448 ' HB2' ' HB2' ' A' ' 429' ' ' PHE . 26.6 m-85 -109.5 143.41 39.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.879 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -103.84 93.77 5.06 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 438' ' ' PHE . . . . . 0.531 ' CE1' ' HA3' ' A' ' 407' ' ' GLY . 76.5 t80 -82.79 129.57 35.0 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.533 -178.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -103.65 108.3 19.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.102 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 440' ' ' GLU . . . . . 0.507 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 4.1 mm-40 -54.98 -47.59 74.38 Favored 'General case' 0 C--O 1.231 0.115 0 O-C-N 123.486 0.491 . . . . 0.0 112.159 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -62.55 -32.71 73.71 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 68.2 mt -94.99 -10.94 29.46 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 443' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 443' ' ' ARG . 3.5 mmm180 58.07 29.32 17.64 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 123.32 0.387 . . . . 0.0 111.523 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -154.38 174.12 15.28 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.331 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.8 t -90.31 144.11 9.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.863 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -67.8 164.16 20.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.894 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.38 163.96 26.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.047 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 71.83 8.93 6.15 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.167 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 449' ' ' TYR . . . . . 0.449 ' HB3' ' HA ' ' A' ' 450' ' ' PRO . 31.6 m-85 -113.71 163.63 18.1 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.693 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 450' ' ' PRO . . . . . 0.473 ' HB2' ' HB3' ' A' ' 434' ' ' LYS . 66.1 Cg_endo -72.32 157.06 98.15 Favored 'Cis proline' 0 C--N 1.348 0.514 0 C-N-CA 123.631 -1.404 . . . . 0.0 112.301 -0.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -115.32 170.19 8.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.907 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -60.75 128.22 35.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.316 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 11.6 tt -66.74 -14.58 18.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.113 0.482 . . . . 0.0 111.347 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -69.89 3.7 2.47 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 39.1 t -66.6 -32.55 58.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 456' ' ' TRP . . . . . 0.412 ' HE3' ' CZ ' ' A' ' 486' ' ' PHE . 16.7 m95 -88.27 84.06 6.89 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.32 110.21 0.38 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.718 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 119.42 -23.67 8.4 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.173 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 43.7 mm -86.07 127.87 60.12 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.845 0.355 . . . . 0.0 111.383 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -85.49 162.49 11.01 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.809 2.339 . . . . 0.0 111.421 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -71.11 153.94 42.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.533 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 10.5 m 58.1 72.68 0.84 Allowed Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 115.591 -0.732 . . . . 0.0 112.942 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -82.52 176.51 7.83 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.093 2.529 . . . . 0.0 111.859 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 8.7 tpp85 -142.51 23.24 1.97 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.318 0.58 . . . . 0.0 110.472 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 172.97 142.03 3.68 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 12.3 p -165.43 101.42 0.72 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.728 0.299 . . . . 0.0 110.686 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -132.96 138.42 46.89 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.079 0.466 . . . . 0.0 111.656 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 40.0 ttm -93.65 135.9 34.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.526 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -68.2 163.62 48.2 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.391 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.93 -9.13 26.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.169 0.509 . . . . 0.0 111.605 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -84.99 -15.24 44.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.144 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 64.47 11.57 6.67 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 57.8 t -110.48 -40.69 4.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.921 0.391 . . . . 0.0 110.908 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -105.26 126.51 52.17 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 93.7 m -114.2 130.71 56.62 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -105.55 124.35 49.4 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.228 0.537 . . . . 0.0 112.389 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -105.55 152.35 23.17 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.971 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -131.82 137.59 48.17 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.514 0.197 . . . . 0.0 111.306 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 479' ' ' LYS . . . . . 0.403 ' HB3' ' CZ3' ' A' ' 484' ' ' TRP . 58.7 tttt -168.61 120.04 0.78 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.65 178.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 64.17 48.0 79.36 Favored Glycine 0 N--CA 1.453 -0.226 0 N-CA-C 114.561 0.584 . . . . 0.0 114.561 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 481' ' ' ASN . . . . . 0.568 ' OD1' ' HG ' ' A' ' 502' ' ' LEU . 66.5 t30 67.94 0.93 2.53 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 482' ' ' LYS . . . . . 0.543 ' HB3' ' HB2' ' A' ' 498' ' ' PRO . 41.5 mtmt -115.9 152.37 33.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.173 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 483' ' ' TYR . . . . . 0.475 ' CE2' ' HE2' ' A' ' 497' ' ' TYR . 32.6 p90 -126.12 152.23 46.19 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.892 0.377 . . . . 0.0 111.523 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 484' ' ' TRP . . . . . 0.494 ' HD1' HG11 ' A' ' 493' ' ' VAL . 18.5 m-90 -117.98 140.43 49.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.757 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -100.38 94.59 6.25 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 486' ' ' PHE . . . . . 0.412 ' CZ ' ' HE3' ' A' ' 456' ' ' TRP . 68.1 t80 -88.59 123.57 33.2 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.054 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 487' ' ' ASN . . . . . 0.407 ' ND2' ' HD3' ' A' ' 490' ' ' LYS . 40.1 t-20 -91.99 114.16 26.63 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -62.21 -33.02 73.76 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -76.06 -26.66 56.75 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 490' ' ' LYS . . . . . 0.407 ' HD3' ' ND2' ' A' ' 487' ' ' ASN . 55.4 mtpt -101.3 -16.91 16.78 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 10.7 tp 58.56 38.53 25.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.726 0.774 . . . . 0.0 110.25 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -156.41 152.6 27.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.595 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 493' ' ' VAL . . . . . 0.494 HG11 ' HD1' ' A' ' 484' ' ' TRP . 75.4 t -77.95 136.65 23.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.802 0.334 . . . . 0.0 110.585 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -62.93 146.35 95.47 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.284 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.98 155.68 66.77 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.571 2.18 . . . . 0.0 112.129 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 89.57 14.43 59.87 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.273 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 497' ' ' TYR . . . . . 0.686 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 66.3 m-85 -121.18 167.07 14.06 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 498' ' ' PRO . . . . . 0.686 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 76.8 Cg_endo -75.64 168.32 77.69 Favored 'Cis proline' 0 C--N 1.349 0.589 0 C-N-CA 123.905 -1.29 . . . . 0.0 113.016 0.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -123.39 169.67 11.11 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.945 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 39.9 t -79.24 117.57 20.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.777 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.02 -27.04 64.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.917 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 502' ' ' LEU . . . . . 0.568 ' HG ' ' OD1' ' A' ' 481' ' ' ASN . 14.2 mt -65.0 -48.33 74.34 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.195 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -79.68 -42.98 23.58 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -76.45 -54.31 6.91 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -177.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -79.36 -61.03 2.13 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 7.2 mmt -66.57 -37.68 85.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.976 0.417 . . . . 0.0 111.479 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 94.63 22.68 23.29 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.705 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 18.8 m -83.48 124.18 75.9 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-O 120.614 0.245 . . . . 0.0 110.465 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.86 156.04 61.19 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.812 2.342 . . . . 0.0 112.842 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 4.0 m 70.77 -70.23 0.16 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.466 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.327 0 CA-C-O 118.365 -1.241 . . . . 0.0 111.23 -179.487 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.731 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo . . . . . 0 C--O 1.236 0.406 0 C-N-CA 122.673 2.249 . . . . 0.0 112.256 -179.877 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.601 0 N-CA-C 112.947 -0.061 . . . . 0.0 112.947 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 N--CA 1.462 -0.337 0 C-N-CA 122.782 2.321 . . . . 0.0 111.237 179.575 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 6' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' D' ' 204' ' ' PRO . . . . . . . . 0 N--CA 1.449 -0.491 0 CA-C-O 120.143 -0.254 . . . . 0.0 112.467 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo . . . . . 0 CA--C 1.53 0.315 0 C-N-CA 122.979 2.452 . . . . 0.0 111.675 179.287 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.785 0 N-CA-C 112.094 -0.403 . . . . 0.0 112.094 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.78 141.47 65.74 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.848 2.366 . . . . 0.0 111.545 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -68.47 144.7 54.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.213 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' D' ' 210' ' ' PRO . . . -61.24 154.16 37.9 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.806 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.463 ' O ' ' HG3' ' D' ' 211' ' ' GLN . 1.4 mp -67.59 148.94 11.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.34 151.23 46.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.362 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' D' ' 213' ' ' ILE . . . -69.84 157.03 53.54 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.332 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -72.51 148.44 45.04 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -66.08 148.34 51.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 0.0 110.825 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' D' ' 216' ' ' GLN . . . -67.44 159.88 49.84 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.996 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.6 t -70.78 153.72 8.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.626 0.251 . . . . 0.0 110.481 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 11.9 t -58.95 145.47 10.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.454 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.87 161.51 52.89 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.127 -0.559 . . . . 0.0 113.062 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 C--N 1.326 -0.455 0 N-CA-C 110.573 -0.158 . . . . 0.0 110.573 179.859 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.652 0 N-CA-C 112.233 -0.347 . . . . 0.0 112.233 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 C--O 1.238 0.484 0 C-N-CA 122.653 2.236 . . . . 0.0 111.709 179.952 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.62 0 N-CA-C 112.444 -0.262 . . . . 0.0 112.444 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 C--O 1.237 0.441 0 C-N-CA 122.515 2.143 . . . . 0.0 111.482 179.65 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.467 0 N-CA-C 113.982 0.353 . . . . 0.0 113.982 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo . . . . . 0 CA--C 1.533 0.432 0 C-N-CA 123.053 2.502 . . . . 0.0 111.507 179.472 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.554 0 N-CA-C 112.94 -0.064 . . . . 0.0 112.94 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 N--CA 1.463 -0.285 0 C-N-CA 123.162 2.575 . . . . 0.0 111.804 179.93 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.659 -0.176 . . . . 0.0 112.659 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo . . . . . 0 C--O 1.236 0.386 0 C-N-CA 122.932 2.421 . . . . 0.0 111.931 179.712 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 113.281 0.072 . . . . 0.0 113.281 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo . . . . . 0 CA--C 1.533 0.434 0 C-N-CA 123.156 2.57 . . . . 0.0 112.367 -179.866 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.444 0 N-CA-C 112.22 -0.352 . . . . 0.0 112.22 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 N--CA 1.464 -0.223 0 C-N-CA 122.647 2.232 . . . . 0.0 111.052 179.543 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 113.567 0.187 . . . . 0.0 113.567 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -61.5 154.1 61.76 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 123.042 2.495 . . . . 0.0 113.109 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -62.79 137.52 58.29 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.617 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.24 154.74 44.23 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.34 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 41.4 mt -70.4 137.56 23.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 122.762 -0.258 . . . . 0.0 110.363 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.1 147.48 47.3 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.526 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -65.19 155.95 48.53 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.843 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -82.72 158.67 22.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.651 0.262 . . . . 0.0 110.573 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -64.69 145.18 56.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.399 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.59 172.78 34.87 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.669 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 30.3 t -67.78 141.78 17.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.642 0.258 . . . . 0.0 110.81 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 120' ' ' VAL . . . . . 0.41 HG13 ' HB ' ' D' ' 219' ' ' VAL . 60.5 t -62.69 139.08 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.967 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.18 158.06 39.05 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 121.203 -0.523 . . . . 0.0 112.68 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 97.1 mt . . . . . 0 C--N 1.323 -0.557 0 CA-C-O 120.553 0.216 . . . . 0.0 110.546 -179.914 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 113.252 0.061 . . . . 0.0 113.252 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo . . . . . 0 C--O 1.236 0.415 0 C-N-CA 122.8 2.333 . . . . 0.0 111.832 179.949 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.676 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 N--CA 1.462 -0.336 0 C-N-CA 122.523 2.149 . . . . 0.0 110.742 179.34 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.425 0 N-CA-C 114.34 0.496 . . . . 0.0 114.34 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo . . . . . 0 C--O 1.233 0.233 0 C-N-CA 123.611 2.874 . . . . 0.0 111.926 179.995 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 133' ' ' GLY . . . . . 0.429 ' HA2' ' HD3' ' C' ' 134' ' ' PRO . . . . . . . . 0 CA--C 1.519 0.286 0 N-CA-C 112.113 -0.395 . . . . 0.0 112.113 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 134' ' ' PRO . . . . . 0.429 ' HD3' ' HA2' ' C' ' 133' ' ' GLY . 20.6 Cg_exo . . . . . 0 C--O 1.235 0.332 0 C-N-CA 123.104 2.536 . . . . 0.0 112.061 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.49 0 CA-C-O 120.01 -0.328 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo . . . . . 0 C--N 1.346 0.419 0 C-N-CA 123.302 2.668 . . . . 0.0 112.069 178.902 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 114.102 0.401 . . . . 0.0 114.102 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 204' ' ' PRO . . . . . 0.47 ' O ' ' HA3' ' B' ' 6' ' ' GLY . 11.3 Cg_exo . . . . . 0 CA--C 1.534 0.497 0 C-N-CA 123.907 3.072 . . . . 0.0 112.172 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 113.404 0.122 . . . . 0.0 113.404 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo . . . . . 0 N--CA 1.458 -0.617 0 C-N-CA 123.905 3.07 . . . . 0.0 112.281 179.939 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.575 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 210' ' ' PRO . . . . . 0.502 ' O ' ' HA3' ' B' ' 12' ' ' GLY . 11.6 Cg_exo -70.04 156.42 62.66 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 122.762 2.308 . . . . 0.0 112.341 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 211' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' B' ' 13' ' ' ILE . 24.8 tt0 -76.61 147.15 37.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.441 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -69.2 165.31 49.4 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.35 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 213' ' ' ILE . . . . . 0.505 ' O ' ' HA3' ' B' ' 15' ' ' GLY . 10.8 pt -69.34 168.19 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 120.775 0.322 . . . . 0.0 111.141 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -83.18 146.46 28.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.951 0.405 . . . . 0.0 111.043 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -66.12 160.66 45.48 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.908 -0.587 . . . . 0.0 113.453 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 216' ' ' GLN . . . . . 0.481 ' O ' ' HA3' ' B' ' 18' ' ' GLY . 39.9 mm-40 -75.75 160.48 29.98 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -71.52 152.68 42.79 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -62.42 154.67 41.44 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.01 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 219' ' ' VAL . . . . . 0.41 ' HB ' HG13 ' C' ' 120' ' ' VAL . 10.7 t -62.28 142.43 16.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 30.8 t -61.45 137.91 22.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.258 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -59.37 154.56 29.81 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.673 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 5.6 mp . . . . . 0 C--N 1.321 -0.672 0 CA-C-O 120.479 0.181 . . . . 0.0 110.813 -179.594 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.84 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo . . . . . 0 C--O 1.236 0.391 0 C-N-CA 122.796 2.33 . . . . 0.0 111.811 179.661 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 112.705 -0.158 . . . . 0.0 112.705 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo . . . . . 0 C--O 1.236 0.408 0 C-N-CA 122.64 2.226 . . . . 0.0 111.34 179.688 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.404 0 N-CA-C 113.973 0.349 . . . . 0.0 113.973 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 CA--C 1.533 0.43 0 C-N-CA 122.937 2.424 . . . . 0.0 112.145 179.752 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo . . . . . 0 N--CA 1.48 0.727 0 N-CA-C 109.68 -0.931 . . . . 0.0 109.68 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -133.44 159.46 40.29 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 13.8 tt -78.71 -17.62 13.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.263 0.554 . . . . 0.0 110.923 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 319' ' ' CYS . . . . . 0.508 ' HA ' HD22 ' A' ' 502' ' ' LEU . 6.8 m -95.8 14.98 21.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.669 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -60.42 -40.55 91.42 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.039 0.447 . . . . 0.0 111.072 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 98.85 146.92 21.28 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.084 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 23.9 t30 54.81 91.87 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' PHE . . . . . 0.418 ' HD1' ' HD3' ' A' ' 337' ' ' LYS . 47.4 m-85 -91.74 165.59 13.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.289 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -71.45 -41.56 69.28 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.579 HG22 ' HB2' ' A' ' 336' ' ' PHE . 1.2 t -167.6 149.77 5.76 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.354 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 90.6 t -134.33 123.98 44.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -147.88 176.53 10.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.812 0.339 . . . . 0.0 110.903 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 38.3 ttp -128.96 119.98 25.28 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 41.6 mt -119.98 125.89 49.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.301 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 330' ' ' ARG . 5.9 mmp_? 64.1 20.56 12.24 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.521 0.513 . . . . 0.0 111.183 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 91.31 1.44 72.05 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.875 -0.678 . . . . 0.0 111.857 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 332' ' ' GLU . . . . . 0.431 ' CD ' ' HE ' ' A' ' 343' ' ' ARG . 12.0 mm-40 -105.97 124.78 50.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.75 0.31 . . . . 0.0 110.597 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 36.4 ttm -78.67 114.87 17.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.855 0.359 . . . . 0.0 111.109 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -106.37 126.57 52.41 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.14 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 39.2 t -109.48 118.88 57.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.441 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 336' ' ' PHE . . . . . 0.579 ' HB2' HG22 ' A' ' 325' ' ' THR . 81.3 m-85 -104.29 130.54 52.1 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.809 0.338 . . . . 0.0 111.548 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 0.703 ' HB3' ' HZ3' ' A' ' 342' ' ' TRP . 17.7 ttpp -150.94 116.19 5.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.055 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 65.28 -119.96 0.39 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.14 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.3 ptm85 -109.56 13.61 23.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.962 0.411 . . . . 0.0 111.847 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 17.2 m-90 -129.62 152.7 48.85 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.588 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -129.77 147.49 51.55 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.973 0.416 . . . . 0.0 110.866 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 342' ' ' TRP . . . . . 0.703 ' HZ3' ' HB3' ' A' ' 337' ' ' LYS . 26.5 m-90 -119.2 169.26 10.11 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.263 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.431 ' HE ' ' CD ' ' A' ' 332' ' ' GLU . 0.0 OUTLIER -147.45 109.48 4.48 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.111 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.54 HG11 ' HA ' ' A' ' 506' ' ' MET . 1.1 m -99.94 122.88 52.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.105 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 21.1 ttm-85 -117.94 102.12 8.81 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 66.6 t30 66.72 51.87 1.02 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.5 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 347' ' ' ASN . . . . . 0.537 ' HA ' ' O ' ' A' ' 505' ' ' TRP . 29.8 m-80 69.2 1.7 3.34 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.242 -0.89 . . . . 0.0 113.317 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -118.71 127.73 53.84 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.963 0.411 . . . . 0.0 112.019 -179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 20.0 t -74.24 123.68 30.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.218 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 72.3 mtp -68.29 167.4 14.5 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -74.73 153.64 38.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.712 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 95.23 7.47 59.43 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.887 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 353' ' ' TYR . . . . . 0.43 ' HA ' ' C ' ' A' ' 354' ' ' PRO . 85.8 m-85 -122.71 153.93 63.36 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.43 ' C ' ' HA ' ' A' ' 353' ' ' TYR . 55.2 Cg_endo -70.3 143.32 74.52 Favored 'Cis proline' 0 C--N 1.345 0.349 0 C-N-CA 123.545 -1.44 . . . . 0.0 112.598 0.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 58.0 ttm -116.68 131.83 23.7 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.554 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.7 138.39 82.87 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.588 2.192 . . . . 0.0 111.41 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 78.4 mt -56.57 -46.6 82.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.34 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -73.07 3.04 31.61 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 121.175 -0.536 . . . . 0.0 113.85 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -87.38 -37.2 17.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.326 0.563 . . . . 0.0 110.42 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -106.67 -44.86 4.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.446 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 62.2 m95 -89.8 74.22 7.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.315 0.578 . . . . 0.0 110.122 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -62.23 103.63 0.41 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.173 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 120.98 -14.24 9.64 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.103 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.559 HD12 ' HD2' ' A' ' 365' ' ' PRO . 24.0 tp -93.38 133.85 27.75 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.744 0.306 . . . . 0.0 110.562 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 365' ' ' PRO . . . . . 0.559 ' HD2' HD12 ' A' ' 364' ' ' LEU . 93.9 Cg_endo -82.85 177.62 6.66 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.642 2.228 . . . . 0.0 111.585 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -86.86 160.61 18.68 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.781 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 54.8 m 53.57 79.87 0.12 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 23.0 pt -94.86 -178.63 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.496 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -105.63 -47.0 4.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.724 0.297 . . . . 0.0 111.658 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 370' ' ' THR . . . . . 0.728 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.2 OUTLIER -152.85 163.45 39.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.746 0.308 . . . . 0.0 111.591 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -152.11 142.32 22.36 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 372' ' ' TYR . . . . . 0.636 ' HE1' ' HE1' ' A' ' 382' ' ' PHE . 17.5 p90 -165.07 168.69 17.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.638 0.256 . . . . 0.0 111.546 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -95.09 126.51 40.47 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 374' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 378' ' ' LYS . 13.5 ptm180 -84.7 171.96 11.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.66 0.267 . . . . 0.0 111.005 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.616 ' HB3' ' HG2' ' A' ' 440' ' ' GLU . 84.1 tttt -66.8 -32.33 73.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.999 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -33.16 71.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.407 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 124.57 -20.92 6.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.476 -0.869 . . . . 0.0 113.928 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 378' ' ' LYS . . . . . 0.57 ' HD3' ' HB2' ' A' ' 391' ' ' ASP . 19.8 mttp -90.32 175.27 7.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 117.196 0.498 . . . . 0.0 112.27 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 379' ' ' PHE . . . . . 0.508 ' HE2' ' HA ' ' A' ' 392' ' ' GLU . 22.1 m-85 -99.2 140.29 33.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.318 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 380' ' ' VAL . . . . . 0.477 ' HB ' ' CE1' ' A' ' 372' ' ' TYR . 5.9 t -120.23 122.03 67.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.199 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -108.45 144.55 35.91 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.636 ' HE1' ' HE1' ' A' ' 372' ' ' TYR . 53.6 m-85 -127.5 141.16 51.73 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -151.76 103.56 2.95 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 384' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 414' ' ' LYS . . . 76.12 -115.27 4.42 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.268 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -113.95 10.59 17.63 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.791 0.329 . . . . 0.0 111.125 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -116.27 151.46 35.78 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.691 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 387' ' ' HIS . . . . . 0.431 ' CE1' ' HB2' ' A' ' 406' ' ' LEU . 29.8 p-80 -132.88 150.46 52.16 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.604 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 388' ' ' TRP . . . . . 0.438 ' CE2' ' HB3' ' A' ' 400' ' ' PRO . 18.6 m-90 -123.36 137.3 54.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.938 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 69.7 t -117.45 117.37 54.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.049 0.452 . . . . 0.0 109.883 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -113.48 124.68 52.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.731 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.57 ' HB2' ' HD3' ' A' ' 378' ' ' LYS . 24.8 t0 -91.48 84.62 5.57 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 392' ' ' GLU . . . . . 0.508 ' HA ' ' HE2' ' A' ' 379' ' ' PHE . 57.7 mm-40 70.19 -70.25 0.15 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.995 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -143.39 16.06 1.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.921 0.391 . . . . 0.0 110.787 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 1.1 m -126.25 121.07 31.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.787 0.327 . . . . 0.0 111.359 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 52.7 tp -75.34 127.84 34.06 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 396' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 2.4 mt-10 -61.65 127.35 88.6 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.655 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 397' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 50.1 Cg_exo -56.44 141.04 90.07 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.059 2.506 . . . . 0.0 112.368 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 92.53 16.26 49.99 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.252 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 399' ' ' TYR . . . . . 0.444 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 19.4 m-85 -112.66 163.21 18.46 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 110.712 -0.107 . . . . 0.0 110.712 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.444 ' HA ' ' HB3' ' A' ' 399' ' ' TYR . 74.5 Cg_endo -76.47 169.43 74.48 Favored 'Cis proline' 0 C--N 1.347 0.491 0 C-N-CA 123.682 -1.382 . . . . 0.0 112.678 0.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -131.6 166.6 21.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.492 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 0.739 ' HB2' ' HG2' ' A' ' 405' ' ' GLU . 16.9 m-70 -71.47 154.79 41.25 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 68.9 mt -60.98 -38.2 78.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.205 0.526 . . . . 0.0 109.799 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 404' ' ' LYS . . . . . 0.549 ' HB3' HG23 ' A' ' 412' ' ' THR . 50.2 pttt -66.7 -17.2 64.73 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.676 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.739 ' HG2' ' HB2' ' A' ' 402' ' ' HIS . 22.1 mm-40 -81.14 -23.79 38.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.921 0.391 . . . . 0.0 110.659 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 406' ' ' LEU . . . . . 0.431 ' HB2' ' CE1' ' A' ' 387' ' ' HIS . 49.0 tp -77.0 -43.87 33.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.08 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.444 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -155.91 146.23 13.73 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.852 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -77.24 126.31 30.73 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.625 0.25 . . . . 0.0 110.537 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.31 -0.93 46.76 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.383 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 40.6 mt -77.27 149.65 79.36 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 120.399 0.142 . . . . 0.0 111.025 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 411' ' ' PRO . . . . . 0.451 ' HG3' ' CE1' ' A' ' 436' ' ' TYR . 32.0 Cg_exo -58.96 112.53 1.24 Allowed 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.987 2.458 . . . . 0.0 112.201 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 412' ' ' THR . . . . . 0.549 HG23 ' HB3' ' A' ' 404' ' ' LYS . 0.0 OUTLIER -86.4 37.59 0.74 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.058 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -134.58 -56.7 0.84 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.271 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 414' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 384' ' ' GLY . 10.8 ptmt -173.32 166.41 4.8 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 122.335 0.254 . . . . 0.0 110.506 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 38.9 mm -121.85 130.37 74.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -86.47 -45.39 11.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.367 0.604 . . . . 0.0 109.678 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 417' ' ' ALA . . . . . 0.728 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -158.15 157.57 32.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.745 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -141.64 123.61 15.38 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 419' ' ' LEU . . . . . 0.444 ' HB2' ' HB2' ' A' ' 466' ' ' SER . 28.2 tp -120.62 134.67 55.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.297 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -106.46 117.11 33.17 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.359 -0.382 . . . . 0.0 109.982 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 421' ' ' TRP . . . . . 0.714 ' HB2' ' HE1' ' A' ' 428' ' ' TYR . 4.5 t-105 -86.09 98.91 11.13 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.545 ' HB2' ' HD3' ' A' ' 423' ' ' PRO . 66.8 mtt -57.31 -52.49 73.87 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -178.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.545 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 68.2 Cg_exo -53.23 -27.88 39.9 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.839 2.359 . . . . 0.0 115.301 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 424' ' ' ASN . . . . . 0.626 ' OD1' ' HB3' ' A' ' 421' ' ' TRP . 23.1 p-10 -112.93 -24.49 9.5 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 83.49 38.15 11.2 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.213 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -122.95 146.68 47.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.756 0.313 . . . . 0.0 110.737 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 427' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' A' ' 438' ' ' PHE . 7.1 m -107.05 129.35 54.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.513 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 428' ' ' TYR . . . . . 0.714 ' HE1' ' HB2' ' A' ' 421' ' ' TRP . 86.0 m-85 -108.36 117.47 34.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.911 0.386 . . . . 0.0 111.02 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 429' ' ' PHE . . . . . 0.448 ' HB2' ' HB2' ' A' ' 436' ' ' TYR . 53.4 m-85 -101.79 122.47 44.03 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.745 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -98.94 129.03 45.24 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.973 0.416 . . . . 0.0 111.535 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -139.2 103.71 4.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.409 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 67.21 -110.76 3.65 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.124 -0.791 . . . . 0.0 111.124 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -115.89 16.25 16.22 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.098 0.475 . . . . 0.0 110.236 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -119.17 145.96 45.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.115 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 435' ' ' TYR . . . . . 0.481 ' CE1' ' HB2' ' A' ' 451' ' ' LYS . 5.4 p90 -125.48 131.44 52.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.966 0.412 . . . . 0.0 110.679 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 436' ' ' TYR . . . . . 0.451 ' CE1' ' HG3' ' A' ' 411' ' ' PRO . 14.3 m-85 -102.71 148.1 26.01 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.947 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -114.19 98.0 6.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.313 0.578 . . . . 0.0 109.457 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 438' ' ' PHE . . . . . 0.556 ' HB3' ' HB ' ' A' ' 427' ' ' THR . 78.8 t80 -81.73 134.32 35.44 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.649 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -104.72 103.49 13.13 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.882 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 440' ' ' GLU . . . . . 0.616 ' HG2' ' HB3' ' A' ' 375' ' ' LYS . 5.4 tp10 -48.94 -45.33 41.62 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -179.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -53.85 -66.26 0.42 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 74.2 mt -75.72 -14.83 60.34 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 443' ' ' ARG . . . . . 0.425 ' O ' ' HA2' ' A' ' 407' ' ' GLY . 22.6 mtp180 60.37 48.41 7.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.695 0.76 . . . . 0.0 110.782 -178.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -156.43 161.7 40.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.105 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 74.4 t -81.81 141.85 14.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -60.12 160.85 7.58 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.373 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.3 m -68.32 151.81 46.36 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.671 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 69.06 30.81 4.31 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.064 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -125.43 159.12 61.76 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.645 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -80.43 166.8 75.22 Favored 'Cis proline' 0 C--N 1.342 0.23 0 C-N-CA 123.504 -1.457 . . . . 0.0 112.592 0.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 451' ' ' LYS . . . . . 0.481 ' HB2' ' CE1' ' A' ' 435' ' ' TYR . 64.5 mttm -116.42 171.32 7.91 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.338 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -71.68 146.68 48.08 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.643 0.259 . . . . 0.0 110.651 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.1 tt -70.44 -8.41 10.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.83 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 454' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 454' ' ' LYS . 66.1 mmtt -60.68 -12.08 9.31 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.76 -31.96 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 456' ' ' TRP . . . . . 0.431 ' HB2' ' HB ' ' A' ' 459' ' ' ILE . 24.4 m95 -89.36 95.34 10.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.026 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.49 105.75 1.26 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 110.9 -4.31 28.91 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.044 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 456' ' ' TRP . 30.6 mm -91.93 128.03 47.36 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-O 121.096 0.474 . . . . 0.0 111.391 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 460' ' ' PRO . . . . . 0.451 ' HG3' ' CH2' ' A' ' 484' ' ' TRP . 88.5 Cg_endo -79.08 158.19 26.84 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.853 2.369 . . . . 0.0 111.699 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 30.0 mp0 -80.1 148.62 30.93 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.425 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.9 m 55.45 69.4 1.97 Allowed Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.1 -175.9 2.6 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.339 2.026 . . . . 0.0 111.773 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 7.2 tpp85 -144.65 32.63 1.16 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.338 0.589 . . . . 0.0 110.328 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 167.51 140.7 2.97 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 466' ' ' SER . . . . . 0.444 ' HB2' ' HB2' ' A' ' 419' ' ' LEU . 5.7 p -161.94 101.22 1.13 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.948 0.404 . . . . 0.0 109.959 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -130.19 135.56 48.3 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.047 0.451 . . . . 0.0 111.344 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 468' ' ' MET . . . . . 0.47 ' HA ' ' HA ' ' A' ' 475' ' ' THR . 47.3 ttm -86.96 142.3 28.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.954 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -71.8 164.59 54.13 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.911 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.54 -12.66 54.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.09 0.471 . . . . 0.0 111.587 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -83.17 -17.07 44.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.637 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 68.05 5.74 4.78 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 122.9 0.48 . . . . 0.0 111.911 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 35.1 t -104.5 -32.71 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.877 0.37 . . . . 0.0 111.13 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -117.8 138.05 52.33 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 475' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 468' ' ' MET . 90.6 m -120.82 133.08 55.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.409 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -104.8 129.58 53.06 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.197 0.522 . . . . 0.0 112.117 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -110.99 146.72 36.17 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.316 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -126.74 137.83 53.29 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -162.16 107.03 1.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.964 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 60.0 57.66 18.17 Favored Glycine 0 C--N 1.331 0.258 0 CA-C-N 115.998 -0.547 . . . . 0.0 113.401 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 481' ' ' ASN . . . . . 0.417 ' OD1' ' HG ' ' A' ' 502' ' ' LEU . 18.3 t30 73.24 -33.72 0.27 Allowed 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 482' ' ' LYS . . . . . 0.629 ' HB3' ' HB2' ' A' ' 498' ' ' PRO . 24.1 mtmt -78.66 136.54 37.49 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.048 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 483' ' ' TYR . . . . . 0.48 ' CE1' ' HB2' ' A' ' 499' ' ' LYS . 5.4 p90 -121.5 149.03 43.68 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.079 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 484' ' ' TRP . . . . . 0.471 ' CE2' ' HB3' ' A' ' 498' ' ' PRO . 23.0 m-90 -117.82 149.39 40.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.46 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -115.25 99.92 7.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.202 0.525 . . . . 0.0 109.787 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 486' ' ' PHE . . . . . 0.432 ' HA ' ' HA ' ' A' ' 493' ' ' VAL . 58.2 t80 -88.54 127.57 35.54 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.26 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -88.1 111.93 22.11 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -66.17 -23.94 66.56 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 36.4 tp60 -86.04 -25.95 25.63 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.902 0.382 . . . . 0.0 111.614 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -104.72 -14.47 15.55 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.0 tp 61.77 39.85 13.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.478 0.656 . . . . 0.0 110.189 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 51.3 tttt -154.23 148.97 26.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.589 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 493' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 486' ' ' PHE . 69.9 t -79.26 138.43 20.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.666 0.27 . . . . 0.0 110.401 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -62.21 153.03 76.83 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.161 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -75.56 150.94 36.5 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.749 2.3 . . . . 0.0 113.024 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 98.14 5.06 57.39 Favored Glycine 0 C--N 1.331 0.282 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.327 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 497' ' ' TYR . . . . . 0.737 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 67.6 m-85 -106.55 167.24 9.84 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 110.666 -0.124 . . . . 0.0 110.666 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 498' ' ' PRO . . . . . 0.737 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 87.6 Cg_endo -79.26 167.71 75.72 Favored 'Cis proline' 0 C--N 1.345 0.38 0 C-N-CA 123.72 -1.367 . . . . 0.0 112.756 0.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 499' ' ' LYS . . . . . 0.48 ' HB2' ' CE1' ' A' ' 483' ' ' TYR . 33.0 mtpt -125.73 154.82 41.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.988 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 2.7 m -72.36 111.95 8.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.494 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -62.23 -27.06 68.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.521 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 502' ' ' LEU . . . . . 0.508 HD22 ' HA ' ' A' ' 319' ' ' CYS . 36.3 mt -56.07 -44.23 78.72 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.58 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -89.28 -37.79 14.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.354 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.01 -39.51 83.18 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 505' ' ' TRP . . . . . 0.537 ' O ' ' HA ' ' A' ' 347' ' ' ASN . 15.4 m0 -122.02 -45.69 2.24 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 506' ' ' MET . . . . . 0.54 ' HA ' HG11 ' A' ' 344' ' ' VAL . 10.5 mmt -64.87 -29.01 69.94 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 86.98 28.21 26.5 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.898 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 508' ' ' CYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 509' ' ' PRO . 32.4 m -103.01 106.63 51.72 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 509' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 508' ' ' CYS . 6.2 Cg_exo -79.72 171.93 14.94 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 123.074 2.516 . . . . 0.0 111.59 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 5.3 m 60.55 52.1 4.76 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.375 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.369 -1.239 . . . . 0.0 111.562 179.783 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.611 0 N-CA-C 111.864 -0.494 . . . . 0.0 111.864 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo . . . . . 0 C--O 1.232 0.181 0 C-N-CA 122.769 2.313 . . . . 0.0 111.793 179.937 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 3' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' D' ' 201' ' ' PRO . . . . . . . . 0 N--CA 1.446 -0.675 0 N-CA-C 112.333 -0.307 . . . . 0.0 112.333 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 C--O 1.233 0.244 0 C-N-CA 122.799 2.333 . . . . 0.0 111.782 179.664 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 6' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' D' ' 204' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.572 0 N-CA-C 112.367 -0.293 . . . . 0.0 112.367 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo . . . . . 0 CA--C 1.532 0.404 0 C-N-CA 122.784 2.322 . . . . 0.0 111.484 179.372 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.791 0 N-CA-C 112.395 -0.282 . . . . 0.0 112.395 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.54 144.32 31.91 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.183 2.589 . . . . 0.0 111.785 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -73.6 148.79 42.57 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' D' ' 210' ' ' PRO . . . -61.72 153.52 40.66 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.459 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.521 ' O ' ' HG3' ' D' ' 211' ' ' GLN . 13.1 mt -70.88 150.06 9.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' C' ' 113' ' ' ILE . . . -63.29 149.2 46.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.378 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 15' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' D' ' 213' ' ' ILE . . . -66.67 170.26 32.36 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.219 -0.515 . . . . 0.0 113.293 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -72.62 141.78 48.35 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' B' ' 17' ' ' ARG . 0.0 OUTLIER -65.58 141.18 58.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.645 -179.69 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.02 150.3 40.12 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.763 -0.653 . . . . 0.0 113.139 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 5.3 t -71.65 146.29 11.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 45.6 t -55.43 144.95 6.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.09 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.1 162.86 51.31 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.159 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 86.1 mt . . . . . 0 C--N 1.323 -0.56 0 CA-C-N 115.619 -0.291 . . . . 0.0 110.429 -179.869 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.503 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo . . . . . 0 C--O 1.234 0.297 0 C-N-CA 122.722 2.281 . . . . 0.0 111.835 179.843 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.593 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 C--O 1.235 0.359 0 C-N-CA 122.695 2.263 . . . . 0.0 112.06 179.905 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.414 0 CA-C-O 120.528 -0.04 . . . . 0.0 113.164 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.501 ' O ' ' HA3' ' C' ' 130' ' ' GLY . 11.8 Cg_exo . . . . . 0 C--O 1.234 0.321 0 C-N-CA 123.217 2.611 . . . . 0.0 111.493 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' GLY . . . . . 0.472 ' HA2' ' HD3' ' B' ' 34' ' ' PRO . . . . . . . . 0 N--CA 1.449 -0.448 0 N-CA-C 114.217 0.447 . . . . 0.0 114.217 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' PRO . . . . . 0.472 ' HD3' ' HA2' ' B' ' 33' ' ' GLY . 7.0 Cg_exo . . . . . 0 N--CA 1.461 -0.391 0 C-N-CA 123.413 2.742 . . . . 0.0 111.303 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 CA-C-O 119.999 -0.334 . . . . 0.0 112.666 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo . . . . . 0 C--N 1.345 0.389 0 C-N-CA 123.047 2.498 . . . . 0.0 112.357 179.928 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 112.127 -0.389 . . . . 0.0 112.127 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo . . . . . 0 CA--C 1.531 0.343 0 C-N-CA 123.488 2.792 . . . . 0.0 112.313 -179.78 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.597 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 CA--C 1.528 0.203 0 C-N-CA 122.553 2.168 . . . . 0.0 110.65 179.201 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.53 0 N-CA-C 114.779 0.672 . . . . 0.0 114.779 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.93 167.6 25.51 Favored 'Trans proline' 0 C--O 1.238 0.475 0 C-N-CA 122.958 2.438 . . . . 0.0 112.345 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -60.76 142.25 56.12 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.124 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -73.74 160.88 53.8 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.892 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 113' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' B' ' 14' ' ' ALA . 33.0 mt -68.45 141.15 17.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.733 0.301 . . . . 0.0 110.713 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.19 153.73 41.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.681 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -63.29 161.18 34.63 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.574 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -84.11 153.83 23.51 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 117' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' C' ' 117' ' ' ARG . 11.8 ttm180 -65.55 141.44 58.45 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.81 168.33 32.47 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.179 -0.534 . . . . 0.0 113.035 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 24.1 t -71.0 140.12 18.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 120' ' ' VAL . . . . . 0.435 HG13 ' HB ' ' D' ' 219' ' ' VAL . 24.2 t -65.77 131.79 31.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.095 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.84 158.73 36.7 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.883 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 13.4 mt . . . . . 0 C--N 1.326 -0.418 0 CA-C-O 120.473 0.178 . . . . 0.0 110.885 -179.748 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.626 0 N-CA-C 112.548 -0.221 . . . . 0.0 112.548 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo . . . . . 0 C--O 1.236 0.392 0 C-N-CA 122.532 2.155 . . . . 0.0 111.459 179.528 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.456 0 N-CA-C 112.627 -0.189 . . . . 0.0 112.627 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo . . . . . 0 C--O 1.234 0.304 0 C-N-CA 122.551 2.168 . . . . 0.0 111.452 -179.865 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 130' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' B' ' 31' ' ' PRO . . . . . . . . 0 N--CA 1.45 -0.388 0 CA-C-O 120.69 0.05 . . . . 0.0 113.139 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo . . . . . 0 C--N 1.343 0.256 0 C-N-CA 122.77 2.313 . . . . 0.0 111.306 179.776 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 112.354 -0.298 . . . . 0.0 112.354 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo . . . . . 0 CA--C 1.53 0.321 0 C-N-CA 122.563 2.175 . . . . 0.0 111.361 179.683 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 201' ' ' PRO . . . . . 0.476 ' O ' ' HA3' ' B' ' 3' ' ' GLY . 42.2 Cg_exo . . . . . 0 C--N 1.345 0.365 0 C-N-CA 123.092 2.528 . . . . 0.0 111.774 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.405 0 N-CA-C 114.713 0.645 . . . . 0.0 114.713 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 204' ' ' PRO . . . . . 0.439 ' O ' ' HA3' ' B' ' 6' ' ' GLY . 11.6 Cg_exo . . . . . 0 CA--C 1.53 0.29 0 C-N-CA 123.593 2.862 . . . . 0.0 111.599 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 206' ' ' GLY . . . . . 0.4 ' HA2' ' HD3' ' D' ' 207' ' ' PRO . . . . . . . . 0 N--CA 1.449 -0.441 0 N-CA-C 113.219 0.048 . . . . 0.0 113.219 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 207' ' ' PRO . . . . . 0.4 ' HD3' ' HA2' ' D' ' 206' ' ' GLY . 1.2 Cg_endo . . . . . 0 CA--C 1.533 0.453 0 C-N-CA 123.51 2.806 . . . . 0.0 112.453 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.506 0 N-CA-C 112.345 -0.302 . . . . 0.0 112.345 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 210' ' ' PRO . . . . . 0.536 ' O ' ' HA3' ' B' ' 12' ' ' GLY . 7.1 Cg_exo -72.71 155.22 54.27 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.875 2.383 . . . . 0.0 112.005 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 211' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' B' ' 13' ' ' ILE . 27.3 tt0 -75.46 146.52 40.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.504 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -66.79 163.56 43.96 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.757 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 213' ' ' ILE . . . . . 0.444 ' O ' ' HA3' ' B' ' 15' ' ' GLY . 44.2 pt -69.94 168.47 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 120.858 0.361 . . . . 0.0 111.236 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -74.82 153.6 38.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.478 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -79.68 155.43 39.27 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.907 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -72.3 146.62 47.04 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.573 0.225 . . . . 0.0 110.41 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -65.1 155.47 34.72 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.739 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -65.75 153.99 51.11 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.793 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 219' ' ' VAL . . . . . 0.435 ' HB ' HG13 ' C' ' 120' ' ' VAL . 14.6 t -69.07 149.39 11.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 48.4 t -68.66 141.31 17.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -62.06 161.35 29.22 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.854 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 C--N 1.327 -0.371 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.88 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.51 0 CA-C-O 120.316 -0.158 . . . . 0.0 112.89 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo . . . . . 0 C--O 1.234 0.322 0 C-N-CA 122.626 2.217 . . . . 0.0 111.061 179.418 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 227' ' ' GLY . . . . . 0.412 ' HA2' ' HD3' ' D' ' 228' ' ' PRO . . . . . . . . 0 N--CA 1.45 -0.383 0 N-CA-C 113.747 0.259 . . . . 0.0 113.747 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 228' ' ' PRO . . . . . 0.412 ' HD3' ' HA2' ' D' ' 227' ' ' GLY . 13.6 Cg_exo . . . . . 0 C--O 1.234 0.294 0 C-N-CA 123.14 2.56 . . . . 0.0 111.271 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.669 0 N-CA-C 112.988 -0.045 . . . . 0.0 112.988 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo . . . . . 0 N--CA 1.459 -0.544 0 C-N-CA 122.869 2.379 . . . . 0.0 111.689 179.55 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo . . . . . 0 N--CA 1.479 0.655 0 N-CA-C 110.045 -0.79 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -105.82 151.98 23.81 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 21.1 tt -66.58 -31.74 54.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.822 0.344 . . . . 0.0 110.808 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 319' ' ' CYS . . . . . 0.427 ' HA ' HD22 ' A' ' 502' ' ' LEU . 57.7 m -75.72 -0.53 21.17 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.056 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -69.51 -27.24 65.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.87 0.367 . . . . 0.0 110.686 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 84.62 -176.6 51.16 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.951 -0.643 . . . . 0.0 113.121 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 6.4 t30 57.22 77.37 0.27 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.44 0.696 . . . . 0.0 112.671 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -96.9 148.32 23.07 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.661 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 324' ' ' ASP . . . . . 0.411 ' OD1' ' HA ' ' A' ' 337' ' ' LYS . 2.5 m-20 -70.55 -42.4 71.21 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 1.9 t -167.95 155.16 8.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.687 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 72.9 t -133.62 127.89 53.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -144.18 164.75 29.81 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.683 0.278 . . . . 0.0 110.9 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 36.4 ttp -122.14 105.55 10.36 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 28.8 mt -103.5 128.01 50.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.183 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.54 17.59 7.51 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.706 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 95.59 -4.54 66.51 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.184 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -97.49 126.9 43.04 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.613 0.244 . . . . 0.0 110.415 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 39.1 tpp -77.56 117.3 18.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.062 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -113.33 119.95 39.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.047 0.451 . . . . 0.0 110.974 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 335' ' ' VAL . . . . . 0.435 ' HB ' ' HB2' ' A' ' 342' ' ' TRP . 21.1 t -103.24 117.44 48.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -103.99 129.82 51.61 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 0.635 ' HB3' ' HZ3' ' A' ' 342' ' ' TRP . 83.3 tttt -147.13 122.12 10.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.268 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 60.12 -105.82 0.24 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.274 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 339' ' ' ARG . 10.0 ptm85 -125.58 18.63 8.08 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.019 0.437 . . . . 0.0 111.401 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 20.3 m-90 -130.3 152.92 49.19 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.888 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -132.77 141.95 48.77 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.208 0.527 . . . . 0.0 111.62 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 342' ' ' TRP . . . . . 0.635 ' HZ3' ' HB3' ' A' ' 337' ' ' LYS . 24.9 m-90 -111.17 159.54 17.77 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.902 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.37 106.25 6.6 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.428 HG11 ' HA ' ' A' ' 506' ' ' MET . 6.7 m -101.08 142.58 15.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.343 0.592 . . . . 0.0 111.667 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -133.11 100.57 4.91 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.478 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 59.04 67.06 0.96 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.698 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 347' ' ' ASN . . . . . 0.493 ' HA ' ' O ' ' A' ' 505' ' ' TRP . 4.8 t-20 54.54 43.77 29.77 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -162.54 140.5 8.46 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 26.3 t -91.28 135.04 27.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 24.9 ttt -75.79 151.45 37.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.222 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.94 159.88 32.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.025 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 90.7 2.82 71.94 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 353' ' ' TYR . . . . . 0.566 ' HB3' ' HA ' ' A' ' 354' ' ' PRO . 96.9 m-85 -123.5 162.94 37.46 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.723 -0.239 . . . . 0.0 110.369 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.566 ' HA ' ' HB3' ' A' ' 353' ' ' TYR . 56.6 Cg_endo -70.5 150.94 92.89 Favored 'Cis proline' 0 C--N 1.346 0.412 0 C-N-CA 123.764 -1.348 . . . . 0.0 112.675 -0.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 56.2 ttm -123.29 135.99 26.59 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.66 139.9 88.17 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.45 2.1 . . . . 0.0 110.982 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 77.8 mt -57.14 -45.18 84.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.549 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -70.39 -8.0 61.67 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 121.188 -0.53 . . . . 0.0 114.15 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -86.61 -24.07 25.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.363 0.581 . . . . 0.0 110.646 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -113.28 -54.4 2.62 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.228 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 68.0 m95 -85.34 79.08 9.62 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.979 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 362' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' A' ' 362' ' ' ARG . 37.3 ttp180 -60.37 101.47 0.13 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.241 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 122.42 -13.07 8.89 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.431 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 14.8 tp -90.0 131.41 39.24 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.783 0.325 . . . . 0.0 111.067 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 365' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -84.13 -167.18 0.42 Allowed 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.937 2.424 . . . . 0.0 112.478 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -93.27 149.15 21.44 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.825 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 8.3 m 58.34 93.92 0.03 OUTLIER 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 22.0 pt -105.54 172.09 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.57 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -98.95 -52.4 3.57 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.673 0.273 . . . . 0.0 111.583 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 370' ' ' THR . . . . . 0.737 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.2 OUTLIER -150.3 165.85 31.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.614 0.245 . . . . 0.0 111.238 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 371' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 380' ' ' VAL . . . -152.59 141.44 21.08 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -156.85 153.26 27.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.885 0.374 . . . . 0.0 111.818 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -96.2 115.38 27.34 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -82.01 172.26 13.46 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -58.29 -30.49 66.68 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.902 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -69.03 -5.94 24.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.567 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 76.94 33.73 44.87 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.06 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 378' ' ' LYS . . . . . 0.614 ' HG2' ' HA ' ' A' ' 391' ' ' ASP . 82.3 mttt -126.82 150.43 49.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.675 0.274 . . . . 0.0 110.865 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -94.62 117.37 30.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.082 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 380' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 371' ' ' ALA . 10.9 t -102.88 120.73 53.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.427 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -109.71 133.59 52.96 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -112.83 141.51 46.56 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.095 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.644 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 59.6 tttp -149.23 98.78 2.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.758 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 384' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 414' ' ' LYS . . . 71.64 -111.09 3.48 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.417 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -111.39 4.99 19.4 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.972 0.415 . . . . 0.0 111.193 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -114.76 152.2 32.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.68 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -135.54 149.57 49.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.582 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 388' ' ' TRP . . . . . 0.644 ' HZ3' ' HB3' ' A' ' 383' ' ' LYS . 21.8 m-90 -124.87 137.1 54.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.708 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 87.7 t -119.75 117.3 53.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.008 0.432 . . . . 0.0 110.624 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -103.33 119.82 39.61 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.593 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.614 ' HA ' ' HG2' ' A' ' 378' ' ' LYS . 14.0 t70 -94.78 102.92 14.81 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 68.25 -72.04 0.1 Allowed 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.684 0.615 . . . . 0.0 111.615 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -153.78 21.8 0.52 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.922 0.391 . . . . 0.0 110.551 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 57.9 m -137.83 132.93 33.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.981 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 30.3 tp -75.41 130.3 38.75 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 396' ' ' GLU . . . . . 0.494 ' HB2' ' CE1' ' A' ' 399' ' ' TYR . 50.3 mt-10 -56.07 144.11 60.48 Favored Pre-proline 0 C--O 1.234 0.289 0 CA-C-O 120.746 0.307 . . . . 0.0 111.003 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 397' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 8.2 Cg_exo -73.19 125.79 10.58 Favored 'Trans proline' 0 CA--C 1.528 0.216 0 C-N-CA 122.81 2.34 . . . . 0.0 111.868 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 114.16 14.32 9.24 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.994 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 399' ' ' TYR . . . . . 0.614 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 38.7 m-85 -109.6 163.28 17.44 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.529 0.165 . . . . 0.0 110.611 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.614 ' HA ' ' HB3' ' A' ' 399' ' ' TYR . 71.7 Cg_endo -76.92 157.88 97.09 Favored 'Cis proline' 0 C--N 1.346 0.398 0 C-N-CA 123.522 -1.449 . . . . 0.0 112.861 0.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -121.13 164.35 17.0 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.071 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 0.567 ' HB3' ' HG2' ' A' ' 404' ' ' LYS . 1.9 m-70 -76.01 149.64 37.53 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 59.7 mt -55.14 -34.1 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 121.285 0.564 . . . . 0.0 110.775 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 404' ' ' LYS . . . . . 0.567 ' HG2' ' HB3' ' A' ' 402' ' ' HIS . 19.8 pttp -68.34 -12.43 61.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.616 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.43 ' OE2' ' HG3' ' A' ' 404' ' ' LYS . 18.0 mm-40 -86.53 -19.2 29.83 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.065 0.459 . . . . 0.0 110.359 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 40.2 tp -80.39 -39.48 28.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.961 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -160.51 153.79 24.73 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.146 -1.026 . . . . 0.0 113.204 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.52 124.88 31.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.336 -0.432 . . . . 0.0 110.1 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.8 14.63 39.48 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 121.067 -0.587 . . . . 0.0 111.928 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 23.3 mt -89.67 147.29 37.38 Favored Pre-proline 0 C--N 1.322 -0.604 0 O-C-N 122.716 -0.285 . . . . 0.0 111.6 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -52.92 114.24 1.63 Allowed 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.146 2.564 . . . . 0.0 111.637 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.38 33.69 0.89 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.419 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -130.74 -52.67 1.07 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.868 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 414' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 384' ' ' GLY . 18.5 ptmt -176.31 172.94 2.2 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.374 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 38.0 mm -124.87 130.82 73.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 416' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 464' ' ' ARG . 14.6 m-20 -89.87 -52.52 4.94 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.234 0.54 . . . . 0.0 109.577 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 417' ' ' ALA . . . . . 0.737 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -140.74 154.08 46.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.052 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -139.84 102.83 4.51 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 45.1 tp -108.04 128.57 54.79 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.829 0.347 . . . . 0.0 111.629 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -99.41 117.09 33.05 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 421' ' ' TRP . . . . . 0.429 ' HB3' ' OD1' ' A' ' 424' ' ' ASN . 8.5 t-105 -87.27 97.75 10.96 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.491 ' HB2' ' HD3' ' A' ' 423' ' ' PRO . 60.8 mtt -56.59 -50.76 85.98 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.491 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 84.7 Cg_exo -49.44 -33.29 29.36 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.717 2.278 . . . . 0.0 114.97 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 424' ' ' ASN . . . . . 0.429 ' OD1' ' HB3' ' A' ' 421' ' ' TRP . 41.5 p30 -111.62 -24.64 9.98 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 85.57 34.51 13.62 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.757 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 55.3 mttt -125.98 154.49 42.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.957 0.378 . . . . 0.0 110.777 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 15.4 m -105.97 135.03 48.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.018 0.437 . . . . 0.0 111.343 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -108.8 112.94 25.48 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.833 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -99.37 126.52 45.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.161 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 430' ' ' PHE . . . . . 0.595 ' HB2' ' HB3' ' A' ' 417' ' ' ALA . 64.4 m-85 -103.58 135.98 44.16 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.941 0.4 . . . . 0.0 111.212 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.406 ' HA ' ' HE ' ' A' ' 431' ' ' ARG . 2.8 tpm_? -146.0 107.01 4.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.863 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 70.11 -104.16 1.29 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.734 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -120.91 7.74 10.43 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.895 0.379 . . . . 0.0 110.683 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 48.9 mttm -120.72 153.2 37.28 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.676 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 435' ' ' TYR . . . . . 0.48 ' CE1' ' HB2' ' A' ' 451' ' ' LYS . 11.7 p90 -130.98 141.18 50.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.933 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -109.95 147.55 33.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.807 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -109.5 99.36 8.58 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -93.63 134.99 35.36 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.207 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -101.35 122.97 44.68 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.53 -31.19 72.3 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -80.81 -37.08 30.75 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 16.0 mt -89.1 -16.86 30.48 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 4.7 mtp-105 57.52 37.94 27.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.392 0.615 . . . . 0.0 111.299 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -153.31 167.53 29.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.329 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 88.5 t -90.1 144.22 9.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.913 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -64.55 153.17 39.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.261 0.553 . . . . 0.0 111.915 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 447' ' ' SER . . . . . 0.519 ' O ' ' HB2' ' A' ' 448' ' ' GLU . 1.3 m -64.07 156.05 29.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.7 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 448' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 447' ' ' SER . 2.2 mm-40 77.69 -5.59 2.1 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.636 0.585 . . . . 0.0 111.891 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 449' ' ' TYR . . . . . 0.472 ' HE2' ' CE2' ' A' ' 435' ' ' TYR . 29.5 m-85 -98.41 161.05 26.57 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.361 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.42 160.43 95.32 Favored 'Cis proline' 0 C--O 1.234 0.304 0 C-N-CA 123.617 -1.409 . . . . 0.0 113.474 0.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 451' ' ' LYS . . . . . 0.497 ' HE2' ' O ' ' A' ' 448' ' ' GLU . 63.5 mmtt -112.46 169.75 8.66 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.563 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -73.03 140.69 47.44 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 453' ' ' ILE . . . . . 0.492 HG21 ' HG3' ' A' ' 461' ' ' GLU . 15.9 tt -66.69 -13.39 16.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.091 0.472 . . . . 0.0 110.912 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -63.53 -11.08 21.34 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 82.1 t -65.32 -31.26 53.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 29.0 m95 -87.69 87.34 7.35 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -58.42 109.36 0.76 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.888 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 110.04 -14.86 31.21 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.737 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 46.6 mm -88.76 125.93 61.26 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 120.722 0.296 . . . . 0.0 110.537 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.28 160.66 20.17 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.536 2.157 . . . . 0.0 111.704 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 461' ' ' GLU . . . . . 0.492 ' HG3' HG21 ' A' ' 453' ' ' ILE . 3.5 mp0 -71.67 149.52 45.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.096 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 462' ' ' SER . . . . . 0.442 ' N ' ' HD3' ' A' ' 463' ' ' PRO . 2.2 m 54.96 62.14 8.22 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 463' ' ' PRO . . . . . 0.591 ' O ' ' HB2' ' A' ' 417' ' ' ALA . 35.8 Cg_endo -96.04 100.93 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.966 2.444 . . . . 0.0 110.495 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 464' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 416' ' ' ASP . 7.4 ttm180 -77.17 78.24 3.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.225 0.536 . . . . 0.0 111.501 -179.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 149.55 120.22 1.02 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 466' ' ' SER . . . . . 0.414 ' OG ' ' HB1' ' A' ' 417' ' ' ALA . 26.2 p -154.88 127.48 7.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.726 0.298 . . . . 0.0 110.791 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 467' ' ' PHE . . . . . 0.486 ' CE2' ' HB2' ' A' ' 476' ' ' TYR . 14.7 p90 -155.22 146.21 22.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.772 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 47.6 ttm -98.07 142.64 29.52 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.933 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -69.5 162.36 52.11 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.065 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.86 0.37 5.89 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.41 -15.34 21.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.922 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 69.11 6.63 5.76 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 123.753 0.658 . . . . 0.0 111.869 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 58.3 t -104.51 -39.4 5.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.931 0.396 . . . . 0.0 111.166 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -110.91 135.49 51.36 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 66.4 m -118.02 137.49 52.85 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.749 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 476' ' ' TYR . . . . . 0.486 ' HB2' ' CE2' ' A' ' 467' ' ' PHE . 82.4 m-85 -113.51 139.88 48.6 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.11 0.481 . . . . 0.0 112.133 -178.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -121.14 148.04 44.75 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.927 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 478' ' ' TYR . . . . . 0.421 ' CE1' ' HA ' ' A' ' 481' ' ' ASN . 73.0 t80 -127.87 131.5 49.44 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.773 0.32 . . . . 0.0 111.371 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 479' ' ' LYS . . . . . 0.42 ' HB3' ' CZ3' ' A' ' 484' ' ' TRP . 77.7 tttt -157.62 117.06 3.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.513 178.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 61.6 47.7 88.95 Favored Glycine 0 CA--C 1.518 0.241 0 CA-C-N 115.878 -0.601 . . . . 0.0 113.667 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 481' ' ' ASN . . . . . 0.421 ' HA ' ' CE1' ' A' ' 478' ' ' TYR . 52.0 t30 70.81 -2.94 2.11 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -105.56 142.74 34.78 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -118.65 146.27 44.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.93 0.395 . . . . 0.0 111.587 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 484' ' ' TRP . . . . . 0.438 ' CE2' ' HB3' ' A' ' 498' ' ' PRO . 19.2 m-90 -117.7 148.27 42.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.465 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 54.0 tttt -115.67 105.0 12.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.211 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 486' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -97.1 129.58 44.49 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.679 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -91.45 114.31 26.81 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -63.71 -29.22 70.47 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -84.68 -11.63 55.5 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -118.76 -14.2 9.53 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 92.2 mt 59.4 36.04 23.17 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.314 0.578 . . . . 0.0 110.45 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 9.9 tttp -149.74 154.75 39.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.893 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 38.8 t -85.1 142.49 13.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -64.13 132.89 95.44 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.621 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.32 151.59 72.97 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.968 2.445 . . . . 0.0 112.363 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 92.6 16.03 50.66 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.208 -0.52 . . . . 0.0 111.977 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 497' ' ' TYR . . . . . 0.496 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 22.6 m-85 -115.42 166.03 12.96 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.832 -0.184 . . . . 0.0 110.814 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 498' ' ' PRO . . . . . 0.496 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 66.5 Cg_endo -84.66 176.9 29.77 Favored 'Cis proline' 0 C--N 1.347 0.499 0 C-N-CA 123.827 -1.322 . . . . 0.0 112.94 0.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -133.2 156.54 47.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.057 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 23.0 t -72.07 123.63 23.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.864 0.364 . . . . 0.0 110.843 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -65.21 -27.12 68.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.53 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 502' ' ' LEU . . . . . 0.467 HD23 ' HG3' ' A' ' 506' ' ' MET . 14.0 mt -62.28 -46.54 88.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.662 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -79.39 -40.22 30.63 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.493 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.98 -40.95 37.6 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -177.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 505' ' ' TRP . . . . . 0.493 ' O ' ' HA ' ' A' ' 347' ' ' ASN . 11.8 m0 -110.93 -49.13 3.05 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 506' ' ' MET . . . . . 0.467 ' HG3' HD23 ' A' ' 502' ' ' LEU . 9.4 mmt -64.97 -28.19 69.35 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -177.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 84.74 32.91 20.4 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.162 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 42.8 m -106.67 104.94 53.3 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.77 146.66 48.79 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.767 2.311 . . . . 0.0 111.713 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 8.0 m 54.34 76.82 0.22 Allowed 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.654 0.596 . . . . 0.0 111.031 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.135 0 CA-C-O 118.794 -1.004 . . . . 0.0 112.314 -179.143 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.871 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo . . . . . 0 C--N 1.344 0.34 0 C-N-CA 122.673 2.249 . . . . 0.0 112.316 179.87 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 3' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' D' ' 201' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.606 0 CA-C-O 120.47 -0.072 . . . . 0.0 112.986 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo . . . . . 0 CA--C 1.528 0.217 0 C-N-CA 122.849 2.366 . . . . 0.0 111.126 179.425 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.66 0 N-CA-C 112.335 -0.306 . . . . 0.0 112.335 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo . . . . . 0 CA--C 1.528 0.181 0 C-N-CA 122.905 2.403 . . . . 0.0 111.322 179.685 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.769 0 N-CA-C 113.415 0.126 . . . . 0.0 113.415 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -74.37 138.12 24.22 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.027 2.485 . . . . 0.0 112.001 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' GLN . . . . . 0.453 ' HG3' ' HG2' ' C' ' 110' ' ' PRO . 50.2 tt0 -67.18 152.14 46.29 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' D' ' 210' ' ' PRO . . . -57.16 148.58 32.71 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.519 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 18.2 mt -64.02 148.03 11.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.58 141.75 57.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.851 0.358 . . . . 0.0 110.14 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.38 158.99 48.24 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.196 -0.526 . . . . 0.0 113.223 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -67.75 148.5 51.18 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -72.94 146.78 45.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.799 0.333 . . . . 0.0 110.4 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' D' ' 216' ' ' GLN . . . -62.74 157.01 39.02 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.819 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 3.8 t -73.91 152.87 7.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 12.8 t -55.41 142.92 9.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.915 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.98 162.23 48.88 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.859 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 C--N 1.324 -0.531 0 CA-C-O 120.537 0.208 . . . . 0.0 111.165 -179.747 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 112.797 -0.121 . . . . 0.0 112.797 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo . . . . . 0 C--O 1.235 0.35 0 C-N-CA 122.711 2.274 . . . . 0.0 111.917 179.936 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.62 0 N-CA-C 112.24 -0.344 . . . . 0.0 112.24 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo . . . . . 0 C--O 1.235 0.352 0 C-N-CA 122.747 2.298 . . . . 0.0 112.003 -179.606 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 30' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' D' ' 228' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 113.716 0.246 . . . . 0.0 113.716 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo . . . . . 0 C--O 1.234 0.276 0 C-N-CA 123.289 2.659 . . . . 0.0 111.59 179.363 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.458 0 CA-C-O 120.417 -0.101 . . . . 0.0 112.872 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 CA--C 1.531 0.355 0 C-N-CA 122.779 2.319 . . . . 0.0 112.109 179.867 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.47 0 CA-C-O 120.323 -0.154 . . . . 0.0 113.189 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo . . . . . 0 C--N 1.343 0.287 0 C-N-CA 123.302 2.668 . . . . 0.0 111.735 179.867 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.655 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo . . . . . 0 N--CA 1.463 -0.303 0 C-N-CA 122.984 2.456 . . . . 0.0 112.04 -179.903 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.423 0 N-CA-C 112.419 -0.273 . . . . 0.0 112.419 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 C--O 1.223 -0.254 0 C-N-CA 122.745 2.296 . . . . 0.0 110.762 179.507 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.384 0 N-CA-C 113.484 0.154 . . . . 0.0 113.484 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 110' ' ' PRO . . . . . 0.453 ' HG2' ' HG3' ' B' ' 11' ' ' GLN . 34.4 Cg_endo -64.57 159.93 42.34 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 123.118 2.545 . . . . 0.0 112.324 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 111' ' ' GLN . . . . . 0.405 ' OE1' ' HG2' ' D' ' 210' ' ' PRO . 5.8 tp60 -58.23 136.68 57.35 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.035 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -66.86 160.05 48.43 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.726 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 62.3 mt -72.8 131.21 35.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.55 151.67 28.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.137 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -69.58 155.53 53.36 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.492 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -76.75 157.43 31.67 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -65.22 150.25 48.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.285 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.47 167.34 44.3 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.935 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 21.5 t -67.02 139.38 21.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.572 0.225 . . . . 0.0 110.474 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 28.6 t -64.46 138.18 23.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.372 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.27 159.44 40.97 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.99 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 81.2 mt . . . . . 0 C--N 1.322 -0.598 0 N-CA-C 110.519 -0.178 . . . . 0.0 110.519 179.921 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.415 0 N-CA-C 112.889 -0.085 . . . . 0.0 112.889 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 C--O 1.236 0.391 0 C-N-CA 122.466 2.11 . . . . 0.0 111.906 179.94 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.502 0 N-CA-C 112.783 -0.127 . . . . 0.0 112.783 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo . . . . . 0 C--O 1.237 0.465 0 C-N-CA 122.671 2.247 . . . . 0.0 111.58 179.584 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.475 0 N-CA-C 112.718 -0.153 . . . . 0.0 112.718 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo . . . . . 0 C--O 1.234 0.318 0 C-N-CA 122.628 2.219 . . . . 0.0 112.099 179.907 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 CA-C-O 120.105 -0.275 . . . . 0.0 112.418 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 CA--C 1.534 0.518 0 C-N-CA 123.195 2.597 . . . . 0.0 112.368 179.802 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.286 0 N-CA-C 112.405 -0.278 . . . . 0.0 112.405 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 201' ' ' PRO . . . . . 0.44 ' O ' ' HA3' ' B' ' 3' ' ' GLY . 38.1 Cg_exo . . . . . 0 C--N 1.345 0.35 0 C-N-CA 122.869 2.379 . . . . 0.0 111.502 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.505 0 N-CA-C 113.83 0.292 . . . . 0.0 113.83 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo . . . . . 0 CA--C 1.532 0.388 0 C-N-CA 123.823 3.015 . . . . 0.0 112.67 -179.936 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.373 0 N-CA-C 113.73 0.252 . . . . 0.0 113.73 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 N--CA 1.455 -0.782 0 C-N-CA 123.889 3.059 . . . . 0.0 112.682 179.8 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.385 0 CA-C-O 120.321 -0.155 . . . . 0.0 112.723 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 210' ' ' PRO . . . . . 0.561 ' O ' ' HA3' ' B' ' 12' ' ' GLY . 50.5 Cg_endo -71.96 155.99 56.81 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.731 2.288 . . . . 0.0 112.014 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -73.22 147.92 44.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.301 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -68.17 158.75 51.89 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.186 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 213' ' ' ILE . . . . . 0.446 ' H ' HG13 ' D' ' 213' ' ' ILE . 20.5 mt -60.05 142.67 15.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.786 0.327 . . . . 0.0 110.948 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -65.26 139.94 58.67 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.582 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -60.37 156.04 31.12 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.11 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 216' ' ' GLN . . . . . 0.488 ' O ' ' HA3' ' B' ' 18' ' ' GLY . 9.5 mm-40 -78.56 159.25 28.24 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -67.75 154.33 41.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.783 0.325 . . . . 0.0 110.784 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -64.47 160.12 40.72 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.913 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 15.9 t -70.02 144.15 14.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 39.3 t -61.55 142.7 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.95 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.84 160.7 37.5 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.757 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 82.1 mt . . . . . 0 C--N 1.322 -0.628 0 CA-C-N 115.823 -0.189 . . . . 0.0 110.741 179.938 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.668 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 C--O 1.235 0.337 0 C-N-CA 122.841 2.361 . . . . 0.0 111.595 179.576 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.461 0 N-CA-C 113.971 0.349 . . . . 0.0 113.971 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 228' ' ' PRO . . . . . 0.409 ' O ' ' HA3' ' B' ' 30' ' ' GLY . 97.3 Cg_endo . . . . . 0 N--CA 1.461 -0.388 0 C-N-CA 123.339 2.692 . . . . 0.0 111.339 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.652 0 N-CA-C 112.896 -0.082 . . . . 0.0 112.896 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo . . . . . 0 N--CA 1.462 -0.341 0 C-N-CA 122.614 2.209 . . . . 0.0 110.679 179.645 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.615 ' HB2' ' HH2' ' A' ' 342' ' ' TRP . 4.3 Cg_exo . . . . . 0 N--CA 1.474 0.361 0 N-CA-C 110.733 -0.526 . . . . 0.0 110.733 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -128.81 154.85 46.03 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 318' ' ' ILE . . . . . 0.419 HG12 ' HB3' ' A' ' 506' ' ' MET . 11.2 tt -73.65 -19.54 17.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.999 0.428 . . . . 0.0 112.08 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 62.1 m -90.94 1.72 56.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.724 0.297 . . . . 0.0 111.51 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.3 -44.68 74.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.191 0.519 . . . . 0.0 110.451 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 321' ' ' GLY . . . . . 0.533 ' HA2' HD21 ' A' ' 502' ' ' LEU . . . 93.28 -177.65 38.06 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.096 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 52.59 69.82 0.64 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.299 0.571 . . . . 0.0 111.634 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 323' ' ' PHE . . . . . 0.485 ' HD1' ' HB2' ' A' ' 337' ' ' LYS . 85.0 m-85 -87.24 156.36 19.69 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.682 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -65.35 -41.19 94.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.019 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 5.7 t -173.4 149.88 1.77 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.156 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.452 HG22 HG13 ' A' ' 335' ' ' VAL . 60.7 t -134.24 118.12 26.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -140.17 -172.18 3.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.843 0.354 . . . . 0.0 111.412 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 44.6 ttp -136.96 126.71 25.53 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.824 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 42.5 mt -120.92 119.93 34.01 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.313 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.17 17.82 9.54 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.14 0.576 . . . . 0.0 111.918 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 102.73 -9.2 55.28 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.154 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 332' ' ' GLU . . . . . 0.5 ' HB3' ' NH1' ' A' ' 343' ' ' ARG . 70.1 mm-40 -99.5 127.69 45.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.637 0.256 . . . . 0.0 110.66 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 44.5 ttm -77.28 137.23 38.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.95 0.405 . . . . 0.0 111.424 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -125.42 117.05 22.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.618 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 335' ' ' VAL . . . . . 0.452 HG13 HG22 ' A' ' 326' ' ' VAL . 33.3 t -107.7 114.61 46.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -99.15 129.33 45.39 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 0.485 ' HB2' ' HD1' ' A' ' 323' ' ' PHE . 50.9 tptt -139.27 102.47 4.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.774 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 63.33 -99.14 0.07 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.493 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -116.27 -0.56 12.58 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 340' ' ' TRP . . . . . 0.646 ' HD1' ' HA ' ' A' ' 356' ' ' PRO . 18.3 m0 -119.27 154.86 32.8 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.323 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -129.05 133.98 47.93 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.104 0.478 . . . . 0.0 110.83 178.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 342' ' ' TRP . . . . . 0.615 ' HH2' ' HB2' ' A' ' 316' ' ' PRO . 5.6 m-90 -102.28 153.48 19.95 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.686 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.597 ' HG3' ' CZ ' ' A' ' 353' ' ' TYR . 6.3 mmm180 -129.49 105.77 8.31 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.17 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -102.36 123.99 56.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.738 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -118.57 107.16 13.4 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.01 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 63.45 45.25 4.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.26 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 45.1 t30 66.34 32.54 7.64 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.075 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -139.64 142.8 37.0 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 24.7 t -81.79 130.65 35.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 74.7 mtp -74.97 166.32 23.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.034 0.445 . . . . 0.0 112.073 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -83.75 154.93 23.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.762 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 80.76 26.16 54.45 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.329 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 353' ' ' TYR . . . . . 0.597 ' CZ ' ' HG3' ' A' ' 343' ' ' ARG . 73.4 m-85 -135.22 162.57 56.7 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 122.97 -0.135 . . . . 0.0 110.644 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.583 ' HA ' ' HB3' ' A' ' 353' ' ' TYR . 70.7 Cg_endo -75.23 146.23 85.76 Favored 'Cis proline' 0 C--N 1.346 0.408 0 C-N-CA 123.754 -1.353 . . . . 0.0 112.948 0.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 56.3 ttm -114.57 140.96 25.92 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.188 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 356' ' ' PRO . . . . . 0.646 ' HA ' ' HD1' ' A' ' 340' ' ' TRP . 32.2 Cg_exo -61.32 140.94 90.99 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.275 1.983 . . . . 0.0 111.02 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 91.8 mt -55.7 -43.95 75.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.225 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -72.02 -6.71 64.85 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 121.052 -0.594 . . . . 0.0 113.434 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -84.39 -21.53 30.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.239 0.52 . . . . 0.0 110.087 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 360' ' ' PHE . . . . . 0.496 ' HE2' ' HB3' ' D' ' 211' ' ' GLN . 8.9 t80 -111.6 -55.42 2.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.789 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 65.1 m95 -91.27 83.62 5.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.366 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -63.32 105.35 0.73 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.264 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 116.55 -6.65 18.39 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.552 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.534 HD12 ' HD2' ' A' ' 365' ' ' PRO . 18.3 tp -91.68 131.4 35.92 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.703 0.287 . . . . 0.0 110.596 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 365' ' ' PRO . . . . . 0.534 ' HD2' HD12 ' A' ' 364' ' ' LEU . 86.4 Cg_endo -81.3 170.9 14.34 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.778 2.319 . . . . 0.0 111.371 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -80.59 153.49 28.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.704 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 15.7 m 56.68 84.07 0.09 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 16.8 pt -98.97 -174.07 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -134.29 -24.14 1.63 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 370' ' ' THR . . . . . 0.931 ' HB ' ' HB2' ' A' ' 382' ' ' PHE . 4.8 m -141.83 145.92 35.25 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.555 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -153.58 131.46 11.67 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -163.53 165.28 23.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.888 0.375 . . . . 0.0 111.496 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -94.23 141.63 28.34 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 374' ' ' ARG . . . . . 0.534 ' HB2' ' OE2' ' A' ' 440' ' ' GLU . 12.2 ptm180 -97.2 -169.4 1.85 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.385 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -69.39 -34.43 74.51 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.645 0.979 . . . . 0.0 113.645 -177.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 44.7 p30 -83.02 -10.37 58.79 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 107.83 -6.2 35.12 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.669 -0.776 . . . . 0.0 113.241 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 17.4 mttp -76.54 164.24 26.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.906 0.353 . . . . 0.0 110.879 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -107.82 123.32 48.4 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -178.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 12.2 t -105.98 119.82 55.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.036 0.446 . . . . 0.0 110.446 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -106.18 143.38 34.38 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.508 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.931 ' HB2' ' HB ' ' A' ' 370' ' ' THR . 23.2 m-85 -124.1 138.26 54.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.069 0.461 . . . . 0.0 111.897 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -150.69 98.24 2.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.78 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 77.58 -111.94 3.38 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.618 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 385' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 402' ' ' HIS . 4.3 p-10 -113.09 6.9 17.81 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.685 0.278 . . . . 0.0 111.345 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -114.61 148.97 37.33 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.514 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -128.86 146.0 51.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.218 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 388' ' ' TRP . . . . . 0.407 ' CE2' ' HB3' ' A' ' 400' ' ' PRO . 16.4 m-90 -120.21 131.75 55.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.09 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 99.2 t -115.52 110.44 31.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.059 0.456 . . . . 0.0 109.972 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -102.68 128.18 49.49 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.613 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -99.35 103.15 14.94 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 71.89 -53.36 0.69 Allowed 'General case' 0 N--CA 1.469 0.519 0 O-C-N 123.663 0.602 . . . . 0.0 111.298 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -166.27 -29.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.844 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.37 138.8 32.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.814 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 27.9 tp -78.29 139.84 38.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.803 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 396' ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 3.3 mt-10 -67.21 140.75 95.72 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.443 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 397' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 21.6 Cg_exo -67.77 147.4 75.22 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.715 2.276 . . . . 0.0 111.238 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 89.18 15.04 59.55 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.718 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 399' ' ' TYR . . . . . 0.502 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 50.1 m-85 -117.99 162.58 28.77 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.502 ' HA ' ' HB3' ' A' ' 399' ' ' TYR . 84.0 Cg_endo -76.74 164.44 87.43 Favored 'Cis proline' 0 C--N 1.345 0.375 0 C-N-CA 123.634 -1.402 . . . . 0.0 113.306 0.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 401' ' ' LYS . . . . . 0.402 ' HD3' ' HB3' ' A' ' 405' ' ' GLU . 39.3 mttp -130.68 163.41 27.29 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.167 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 0.585 ' HB2' ' HG2' ' A' ' 404' ' ' LYS . 4.6 m80 -73.22 159.87 32.8 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 33.0 mt -59.61 -31.78 47.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.344 0.592 . . . . 0.0 110.222 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 404' ' ' LYS . . . . . 0.585 ' HG2' ' HB2' ' A' ' 402' ' ' HIS . 20.4 pttp -69.38 -12.03 61.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.183 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.402 ' HB3' ' HD3' ' A' ' 401' ' ' LYS . 10.2 mm-40 -85.58 -21.95 28.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.971 0.415 . . . . 0.0 111.253 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 47.8 tp -76.51 -53.95 7.38 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.126 0.488 . . . . 0.0 110.25 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.466 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -151.54 157.64 27.32 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.127 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 38.2 ttt180 -86.68 130.18 34.58 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.798 0.333 . . . . 0.0 110.676 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 106.34 -5.93 38.78 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.797 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 66.7 mt -76.98 151.44 81.94 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 120.633 0.254 . . . . 0.0 111.235 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.27 131.44 44.96 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.907 2.404 . . . . 0.0 111.633 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.74 -7.45 33.83 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.848 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -87.12 -56.59 3.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.197 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 414' ' ' LYS . . . . . 0.477 ' O ' ' HD2' ' A' ' 431' ' ' ARG . 8.4 ptmt -175.42 173.74 2.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.955 0.407 . . . . 0.0 111.224 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 34.6 mm -125.4 130.67 72.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.341 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -89.11 -41.95 11.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.165 0.507 . . . . 0.0 110.532 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -163.64 164.4 24.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.903 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -148.73 127.25 12.36 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 419' ' ' LEU . . . . . 0.434 HD11 ' HB2' ' A' ' 468' ' ' MET . 24.9 tp -118.47 119.83 35.74 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.06 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -87.81 113.91 23.93 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 421' ' ' TRP . . . . . 0.507 ' HB3' ' OD1' ' A' ' 424' ' ' ASN . 4.2 t-105 -81.81 96.36 7.58 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.414 ' HB2' ' HD3' ' A' ' 423' ' ' PRO . 58.2 mtt -52.09 -51.21 73.62 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 86.5 Cg_exo -49.29 -57.25 2.47 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.681 2.254 . . . . 0.0 114.383 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 424' ' ' ASN . . . . . 0.507 ' OD1' ' HB3' ' A' ' 421' ' ' TRP . 37.1 p30 -84.29 -24.72 29.75 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 82.92 37.44 13.03 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 121.009 -0.615 . . . . 0.0 113.438 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -128.08 150.39 49.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 117.031 0.416 . . . . 0.0 110.913 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 2.0 m -101.04 127.01 47.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.035 0.445 . . . . 0.0 111.753 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -101.85 111.62 23.94 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.556 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 429' ' ' PHE . . . . . 0.408 ' HB2' ' HB2' ' A' ' 436' ' ' TYR . 69.3 m-85 -94.45 137.42 33.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.124 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -113.08 129.89 56.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.003 0.43 . . . . 0.0 111.321 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.477 ' HD2' ' O ' ' A' ' 414' ' ' LYS . 2.8 tpm_? -141.26 105.01 4.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.23 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 67.47 -108.88 2.62 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.073 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -114.39 13.09 17.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.835 0.35 . . . . 0.0 110.763 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 434' ' ' LYS . . . . . 0.524 ' HD3' ' HG2' ' A' ' 450' ' ' PRO . 97.2 mttt -123.62 151.46 42.98 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.276 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 435' ' ' TYR . . . . . 0.476 ' CE1' ' HB2' ' A' ' 451' ' ' LYS . 9.0 p90 -126.95 138.92 53.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.435 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 436' ' ' TYR . . . . . 0.408 ' HB2' ' HB2' ' A' ' 429' ' ' PHE . 9.5 m-85 -110.58 143.78 40.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.716 -178.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -109.35 99.5 8.74 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 438' ' ' PHE . . . . . 0.466 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 75.4 t80 -92.25 132.55 36.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.521 -178.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -106.8 113.38 26.83 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.621 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 440' ' ' GLU . . . . . 0.534 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 3.3 mm-40 -50.89 -52.43 41.93 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 -64.89 -14.35 59.43 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -178.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 47.9 mt -113.86 -7.77 13.18 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 47.3 40.67 10.92 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.599 0.714 . . . . 0.0 112.472 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -154.73 171.32 19.75 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.505 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.5 t -96.81 142.8 13.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.278 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.55 153.0 10.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.64 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 11.1 m -70.48 155.26 40.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.365 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 71.41 26.97 3.18 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.483 0.658 . . . . 0.0 110.918 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -123.72 164.47 28.64 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.094 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 450' ' ' PRO . . . . . 0.524 ' HG2' ' HD3' ' A' ' 434' ' ' LYS . 86.5 Cg_endo -79.85 155.68 88.2 Favored 'Cis proline' 0 C--N 1.344 0.34 0 C-N-CA 123.637 -1.401 . . . . 0.0 112.631 0.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 451' ' ' LYS . . . . . 0.476 ' HB2' ' CE1' ' A' ' 435' ' ' TYR . 64.6 mttm -106.78 171.84 7.14 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.853 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 452' ' ' ASN . . . . . 0.464 ' O ' HG23 ' A' ' 455' ' ' VAL . 18.3 t-20 -68.85 136.93 53.44 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.556 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 12.9 tt -67.72 -15.73 20.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.079 0.466 . . . . 0.0 111.381 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -67.07 -2.3 5.33 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 455' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 452' ' ' ASN . 71.6 t -62.62 -34.96 68.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 456' ' ' TRP . . . . . 0.474 ' HZ3' HD11 ' A' ' 491' ' ' LEU . 14.0 m95 -88.34 90.05 8.24 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -53.02 114.62 1.51 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.606 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 458' ' ' GLY . . . . . 0.403 ' HA3' ' HB ' ' A' ' 493' ' ' VAL . . . 113.25 -15.96 22.57 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.347 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 460' ' ' PRO . 45.8 mm -89.68 117.61 68.29 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.694 0.283 . . . . 0.0 111.083 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 460' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 459' ' ' ILE . 4.9 Cg_exo -79.2 153.24 24.49 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 123.088 2.525 . . . . 0.0 111.374 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -67.54 149.6 49.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.601 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.3 m 60.58 78.08 0.34 Allowed Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -88.05 -174.98 1.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.966 2.444 . . . . 0.0 111.481 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.79 9.6 3.34 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.108 0.48 . . . . 0.0 110.856 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 169.94 141.83 3.38 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 6.3 p -152.73 106.15 3.04 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -128.26 142.15 51.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.057 0.456 . . . . 0.0 111.605 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 468' ' ' MET . . . . . 0.434 ' HB2' HD11 ' A' ' 419' ' ' LEU . 47.9 ttm -95.44 134.63 38.05 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.556 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -67.08 163.22 45.39 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.018 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 1.4 m -66.46 -7.33 18.82 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.911 0.386 . . . . 0.0 111.346 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -84.94 -15.09 45.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.069 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 65.77 6.76 4.11 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 46.6 t -109.62 -40.09 4.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.738 0.304 . . . . 0.0 111.362 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -105.02 123.0 47.04 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 90.9 m -111.16 138.06 48.08 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -113.4 128.3 56.41 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -110.22 125.92 53.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.298 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -106.25 136.33 46.16 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 479' ' ' LYS . . . . . 0.519 ' HB3' ' CZ3' ' A' ' 484' ' ' TRP . 78.6 tttt -158.19 102.89 1.8 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.814 0.34 . . . . 0.0 111.89 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 57.63 72.33 0.61 Allowed Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 114.823 0.689 . . . . 0.0 114.823 178.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 69.62 -24.87 0.15 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -104.32 156.05 18.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.885 0.374 . . . . 0.0 111.63 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -133.29 147.04 51.89 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.107 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 484' ' ' TRP . . . . . 0.519 ' CZ3' ' HB3' ' A' ' 479' ' ' LYS . 10.5 m-90 -109.93 148.27 31.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.782 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -107.23 97.13 6.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.823 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 486' ' ' PHE . . . . . 0.409 ' CE1' ' HB3' ' A' ' 456' ' ' TRP . 88.1 t80 -91.61 124.81 36.04 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.973 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -92.52 117.36 29.86 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -68.15 -32.15 72.22 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -76.4 -26.44 55.56 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -102.92 -15.98 16.0 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.423 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.474 HD11 ' HZ3' ' A' ' 456' ' ' TRP . 4.1 tp 60.09 39.28 19.85 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.565 0.698 . . . . 0.0 110.641 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 31.2 tttp -159.31 149.19 18.85 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.255 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 493' ' ' VAL . . . . . 0.403 ' HB ' ' HA3' ' A' ' 458' ' ' GLY . 54.9 t -73.03 134.76 29.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.114 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -70.55 146.97 94.51 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.286 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.4 160.25 40.13 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.938 2.425 . . . . 0.0 112.781 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 87.21 17.25 59.4 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 497' ' ' TYR . . . . . 0.536 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 20.5 m-85 -128.4 166.82 21.72 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.431 -0.385 . . . . 0.0 110.39 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 498' ' ' PRO . . . . . 0.536 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 72.0 Cg_endo -74.5 167.94 78.51 Favored 'Cis proline' 0 C--N 1.346 0.425 0 C-N-CA 123.857 -1.309 . . . . 0.0 113.102 0.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -121.99 164.94 16.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.155 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 22.5 t -77.56 109.35 11.44 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.94 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -68.46 -25.37 64.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.988 0.423 . . . . 0.0 110.429 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 502' ' ' LEU . . . . . 0.533 HD21 ' HA2' ' A' ' 321' ' ' GLY . 74.1 mt -65.57 -26.74 67.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.747 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 503' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 503' ' ' ARG . 30.2 ttm105 -99.74 -40.82 7.56 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.091 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.96 -23.57 36.03 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -177.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -114.1 -48.09 2.91 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 506' ' ' MET . . . . . 0.419 ' HB3' HG12 ' A' ' 318' ' ' ILE . 11.5 mmt -77.53 -26.52 51.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.026 -178.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 83.15 26.42 44.37 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.208 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 60.4 m -98.21 110.42 56.12 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-O 120.719 0.295 . . . . 0.0 110.698 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.07 175.71 10.61 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.895 2.396 . . . . 0.0 112.07 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 6.9 m 66.55 15.63 10.17 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 CA-C-O 118.163 -1.354 . . . . 0.0 110.929 179.833 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.8 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo . . . . . 0 C--O 1.234 0.302 0 C-N-CA 122.503 2.135 . . . . 0.0 111.903 179.989 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.618 0 N-CA-C 112.439 -0.264 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo . . . . . 0 CA--C 1.53 0.297 0 C-N-CA 122.967 2.444 . . . . 0.0 110.331 179.673 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.47 0 N-CA-C 112.35 -0.3 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 CA--C 1.53 0.323 0 C-N-CA 122.961 2.441 . . . . 0.0 111.183 178.803 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.793 0 N-CA-C 111.712 -0.555 . . . . 0.0 111.712 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -58.07 135.4 68.3 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.804 2.336 . . . . 0.0 111.735 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 11' ' ' GLN . . . . . 0.419 ' HG3' ' HG2' ' C' ' 110' ' ' PRO . 62.0 tt0 -61.28 147.0 46.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.611 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' D' ' 210' ' ' PRO . . . -62.23 153.48 42.51 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.261 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.491 ' H ' HG13 ' B' ' 13' ' ' ILE . 2.4 mt -67.0 150.63 11.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 122.669 0.388 . . . . 0.0 110.577 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.21 145.39 49.68 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.29 156.04 50.91 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.766 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -66.25 141.72 57.93 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.456 ' HG3' ' HB3' ' C' ' 116' ' ' GLN . 15.1 ttt180 -65.61 148.5 51.64 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.656 0.265 . . . . 0.0 110.967 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' D' ' 216' ' ' GLN . . . -61.78 150.56 45.34 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 116.001 -0.545 . . . . 0.0 113.447 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.41 ' HB ' ' HG2' ' D' ' 217' ' ' ARG . 8.2 t -65.9 147.53 12.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.684 -0.258 . . . . 0.0 110.513 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 6.6 t -53.42 145.1 3.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.401 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.25 165.41 46.38 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.243 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 69.2 mt . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 115.793 -0.204 . . . . 0.0 110.969 -179.789 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.628 0 N-CA-C 112.411 -0.276 . . . . 0.0 112.411 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 C--O 1.234 0.313 0 C-N-CA 122.54 2.16 . . . . 0.0 111.668 179.713 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.584 0 CA-C-O 120.356 -0.135 . . . . 0.0 112.824 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 CA--C 1.533 0.428 0 C-N-CA 122.944 2.429 . . . . 0.0 111.823 179.609 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 113.302 0.081 . . . . 0.0 113.302 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo . . . . . 0 C--O 1.236 0.381 0 C-N-CA 123.134 2.556 . . . . 0.0 112.076 179.666 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 33' ' ' GLY . . . . . 0.465 ' HA2' ' HD3' ' B' ' 34' ' ' PRO . . . . . . . . 0 N--CA 1.445 -0.744 0 N-CA-C 112.787 -0.125 . . . . 0.0 112.787 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 34' ' ' PRO . . . . . 0.465 ' HD3' ' HA2' ' B' ' 33' ' ' GLY . 16.4 Cg_exo . . . . . 0 CA--C 1.529 0.251 0 C-N-CA 122.766 2.311 . . . . 0.0 110.909 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 100' ' ' GLY . . . . . 0.451 ' HA3' ' HD3' ' C' ' 101' ' ' PRO . . . . . . . . 0 N--CA 1.448 -0.507 0 N-CA-C 112.278 -0.329 . . . . 0.0 112.278 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 101' ' ' PRO . . . . . 0.451 ' HD3' ' HA3' ' C' ' 100' ' ' GLY . 6.9 Cg_exo . . . . . 0 N--CA 1.465 -0.189 0 C-N-CA 123.211 2.608 . . . . 0.0 111.738 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.449 0 N-CA-C 112.559 -0.216 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo . . . . . 0 C--O 1.235 0.33 0 C-N-CA 123.114 2.543 . . . . 0.0 112.361 -179.973 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.565 -0.214 . . . . 0.0 112.565 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo . . . . . 0 CA--C 1.528 0.185 0 C-N-CA 122.674 2.249 . . . . 0.0 111.549 179.934 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.382 0 N-CA-C 113.687 0.235 . . . . 0.0 113.687 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 110' ' ' PRO . . . . . 0.419 ' HG2' ' HG3' ' B' ' 11' ' ' GLN . 28.5 Cg_endo -62.44 150.04 88.78 Favored 'Trans proline' 0 C--O 1.237 0.425 0 C-N-CA 122.883 2.388 . . . . 0.0 112.524 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -55.84 134.72 52.02 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.951 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.23 160.77 26.74 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.799 -0.637 . . . . 0.0 113.277 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 53.4 mt -74.03 138.43 21.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 120.755 0.312 . . . . 0.0 110.231 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.19 146.39 55.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.899 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -63.79 156.08 44.04 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.448 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 116' ' ' GLN . . . . . 0.456 ' HB3' ' HG3' ' B' ' 17' ' ' ARG . 40.7 tt0 -75.04 159.06 32.19 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.64 0.257 . . . . 0.0 110.577 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 14.6 ttm-85 -68.72 146.65 52.76 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.67 168.21 36.2 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.024 -0.608 . . . . 0.0 113.158 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 4.3 t -75.51 144.98 11.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 92.6 t -61.57 139.11 21.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.516 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.28 167.3 40.15 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.701 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 82.5 mt . . . . . 0 C--N 1.322 -0.589 0 CA-C-O 120.478 0.18 . . . . 0.0 111.033 -179.717 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.612 0 N-CA-C 112.75 -0.14 . . . . 0.0 112.75 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo . . . . . 0 C--O 1.234 0.309 0 C-N-CA 122.685 2.257 . . . . 0.0 111.592 179.697 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.466 0 N-CA-C 112.913 -0.075 . . . . 0.0 112.913 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo . . . . . 0 C--O 1.236 0.412 0 C-N-CA 122.673 2.249 . . . . 0.0 111.427 -179.894 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 112.972 -0.051 . . . . 0.0 112.972 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo . . . . . 0 C--O 1.237 0.454 0 C-N-CA 122.739 2.293 . . . . 0.0 111.868 179.963 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 CA-C-O 120.13 -0.261 . . . . 0.0 113.072 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo . . . . . 0 C--N 1.343 0.282 0 C-N-CA 122.65 2.234 . . . . 0.0 111.78 179.563 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 112.173 -0.371 . . . . 0.0 112.173 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo . . . . . 0 C--N 1.347 0.461 0 C-N-CA 122.935 2.423 . . . . 0.0 111.743 179.954 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.497 0 CA-C-O 120.221 -0.211 . . . . 0.0 113.344 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo . . . . . 0 CA--C 1.532 0.407 0 C-N-CA 123.551 2.834 . . . . 0.0 112.824 -179.423 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.376 0 N-CA-C 113.394 0.118 . . . . 0.0 113.394 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo . . . . . 0 N--CA 1.456 -0.694 0 C-N-CA 123.743 2.962 . . . . 0.0 112.137 -179.834 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 CA-C-O 120.354 -0.136 . . . . 0.0 112.887 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 210' ' ' PRO . . . . . 0.408 ' O ' ' HA3' ' B' ' 12' ' ' GLY . 37.2 Cg_endo -66.6 160.0 48.19 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.785 2.323 . . . . 0.0 112.456 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 211' ' ' GLN . . . . . 0.496 ' HB3' ' HE2' ' A' ' 360' ' ' PHE . 62.5 tt0 -77.22 143.87 38.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.416 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -65.57 158.76 46.2 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.683 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 38.3 pt -67.01 151.42 10.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.893 0.377 . . . . 0.0 111.033 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -66.81 149.37 50.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.917 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -67.49 172.04 32.25 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 116.05 -0.523 . . . . 0.0 113.285 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 216' ' ' GLN . . . . . 0.481 ' O ' ' HA3' ' B' ' 18' ' ' GLY . 51.3 mm-40 -87.95 154.32 20.6 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 217' ' ' ARG . . . . . 0.41 ' HG2' ' HB ' ' B' ' 19' ' ' VAL . 27.5 mtp180 -62.88 151.98 37.64 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.763 0.316 . . . . 0.0 111.191 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -64.23 156.81 44.53 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.324 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 6.4 t -67.43 147.2 12.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 50.5 t -63.71 143.01 16.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.98 162.05 23.27 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.225 -0.512 . . . . 0.0 112.687 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 5.9 mp . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.872 -0.164 . . . . 0.0 110.914 -179.578 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.669 0 CA-C-O 120.298 -0.168 . . . . 0.0 113.055 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo . . . . . 0 C--O 1.232 0.18 0 C-N-CA 123.208 2.605 . . . . 0.0 111.843 179.698 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.614 0 N-CA-C 113.369 0.108 . . . . 0.0 113.369 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo . . . . . 0 N--CA 1.461 -0.4 0 C-N-CA 122.897 2.398 . . . . 0.0 111.362 179.603 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.662 0 N-CA-C 112.799 -0.12 . . . . 0.0 112.799 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo . . . . . 0 N--CA 1.458 -0.609 0 C-N-CA 122.577 2.185 . . . . 0.0 111.195 179.323 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo . . . . . 0 N--CA 1.477 0.508 0 N-CA-C 109.776 -0.894 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -119.84 155.51 32.47 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 10.5 tt -69.84 -17.93 21.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.007 0.432 . . . . 0.0 111.517 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 61.3 m -88.94 3.7 50.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.243 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -72.66 -38.71 67.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.016 0.436 . . . . 0.0 110.747 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 321' ' ' GLY . . . . . 0.465 ' O ' ' HE2' ' A' ' 337' ' ' LYS . . . 80.5 -164.85 47.61 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.309 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 51.51 56.18 8.29 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.211 0.529 . . . . 0.0 110.877 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -79.31 160.46 26.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.412 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -73.17 -36.25 66.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.897 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 8.9 t -177.62 149.22 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.207 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.507 HG22 HG13 ' A' ' 335' ' ' VAL . 91.4 t -129.4 124.19 59.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -148.6 -176.32 5.27 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.942 0.401 . . . . 0.0 111.299 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 24.3 ttp -128.89 133.88 48.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.801 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 79.7 mt -125.91 111.24 14.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.376 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.773 ' HG3' ' HE1' ' A' ' 379' ' ' PHE . 60.7 mtp180 58.24 33.06 22.79 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 102.82 -32.86 7.09 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.334 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -81.92 135.81 35.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.807 0.304 . . . . 0.0 111.24 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 44.9 ttm -90.54 124.53 35.09 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -114.49 129.85 56.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.091 0.472 . . . . 0.0 111.809 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 335' ' ' VAL . . . . . 0.507 HG13 HG22 ' A' ' 326' ' ' VAL . 13.7 t -114.56 128.45 71.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -109.63 139.46 44.63 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 0.465 ' HE2' ' O ' ' A' ' 321' ' ' GLY . 12.8 tptp -144.23 100.07 3.49 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.63 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 60.27 -104.46 0.19 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.13 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -110.47 8.77 23.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.588 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 15.3 m-90 -122.43 157.8 31.11 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -139.01 148.24 43.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.013 0.435 . . . . 0.0 111.351 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 4.2 m-90 -120.29 160.52 22.84 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.008 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.32 108.81 6.53 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 2.3 m -97.02 139.31 19.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.407 0.622 . . . . 0.0 111.96 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 345' ' ' ARG . . . . . 0.407 ' HD3' ' HA ' ' A' ' 345' ' ' ARG . 7.6 mmt180 -138.87 111.96 7.96 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.943 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 62.87 46.5 4.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.585 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 48.5 t30 63.81 27.56 14.61 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.758 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -136.28 142.81 43.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.359 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 21.9 t -90.13 124.11 42.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 49.6 mtp -70.41 157.22 38.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.704 0.288 . . . . 0.0 111.035 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.32 158.76 34.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.024 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 95.16 -2.78 66.1 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.456 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 353' ' ' TYR . . . . . 0.416 ' HB3' ' HA ' ' A' ' 354' ' ' PRO . 70.1 m-85 -118.17 156.25 50.72 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.416 ' HA ' ' HB3' ' A' ' 353' ' ' TYR . 57.0 Cg_endo -71.07 137.6 47.74 Favored 'Cis proline' 0 C--N 1.345 0.389 0 C-N-CA 123.504 -1.457 . . . . 0.0 112.536 0.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 355' ' ' MET . . . . . 0.413 ' HA ' ' HD3' ' A' ' 356' ' ' PRO . 59.6 ttm -114.69 135.56 22.36 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.422 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 356' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 355' ' ' MET . 47.2 Cg_exo -58.86 138.0 83.16 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.369 2.046 . . . . 0.0 111.08 178.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 357' ' ' ILE . . . . . 0.403 HG23 ' HD1' ' A' ' 361' ' ' TRP . 74.3 mt -52.27 -40.36 30.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.257 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -66.55 -12.66 59.4 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 121.087 -0.577 . . . . 0.0 114.255 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -79.94 -17.37 53.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.037 0.419 . . . . 0.0 111.541 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -126.82 -55.36 1.39 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.006 0.432 . . . . 0.0 110.453 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 361' ' ' TRP . . . . . 0.403 ' HD1' HG23 ' A' ' 357' ' ' ILE . 48.4 m95 -86.99 76.82 9.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.319 0.581 . . . . 0.0 110.136 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -65.72 94.74 0.21 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.491 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 129.47 -12.68 5.97 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.162 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 365' ' ' PRO . 21.3 tp -88.81 127.5 55.83 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.805 0.336 . . . . 0.0 111.117 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 365' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 364' ' ' LEU . 3.3 Cg_exo -78.81 167.89 21.68 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.096 2.531 . . . . 0.0 111.793 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -73.18 152.86 40.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.223 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 5.7 m 57.65 86.88 0.07 Allowed 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 22.9 pt -95.44 179.97 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.329 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.36 -45.3 4.12 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 121.146 -0.222 . . . . 0.0 111.525 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 370' ' ' THR . . . . . 0.771 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.0 OUTLIER -158.73 172.32 18.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.969 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -162.67 138.04 6.97 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 372' ' ' TYR . . . . . 0.454 ' CE1' ' HB ' ' A' ' 380' ' ' VAL . 11.2 p90 -150.47 162.29 40.87 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -96.78 117.69 31.6 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 374' ' ' ARG . . . . . 0.593 HH21 ' HB3' ' A' ' 440' ' ' GLU . 7.6 ptm180 -87.62 175.95 7.67 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -66.69 -16.97 64.6 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.616 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.22 -26.78 30.47 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.7 0.286 . . . . 0.0 111.675 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 114.87 -9.03 21.43 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.689 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 378' ' ' LYS . . . . . 0.525 ' HG2' ' HA ' ' A' ' 391' ' ' ASP . 76.6 mttt -94.98 164.88 12.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.908 0.385 . . . . 0.0 111.427 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 379' ' ' PHE . . . . . 0.773 ' HE1' ' HG3' ' A' ' 330' ' ' ARG . 10.9 m-85 -99.0 127.38 44.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.591 -179.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 380' ' ' VAL . . . . . 0.454 ' HB ' ' CE1' ' A' ' 372' ' ' TYR . 15.7 t -107.57 113.6 44.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.126 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 381' ' ' PHE . . . . . 0.402 ' HB2' ' HB2' ' A' ' 388' ' ' TRP . 61.9 m-85 -99.27 145.1 27.64 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.803 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -124.79 143.55 50.74 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.419 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.648 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 44.3 tttp -155.21 99.28 2.07 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 384' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 414' ' ' LYS . . . 75.08 -105.6 1.93 Allowed Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.539 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -119.42 7.74 11.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.937 0.399 . . . . 0.0 110.87 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -114.44 152.74 31.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.959 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -132.47 150.49 52.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.645 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 388' ' ' TRP . . . . . 0.648 ' HZ3' ' HB3' ' A' ' 383' ' ' LYS . 24.6 m-90 -127.53 138.96 53.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.105 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 75.3 t -117.38 115.67 49.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -106.49 126.04 51.76 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.525 ' HA ' ' HG2' ' A' ' 378' ' ' LYS . 21.2 t70 -91.88 84.68 5.4 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 177.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 69.85 -64.15 0.36 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.316 -178.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -145.51 -3.93 0.7 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 11.6 m -111.43 135.39 52.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.711 0.291 . . . . 0.0 111.284 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 62.3 tp -81.07 138.96 35.95 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.129 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 396' ' ' GLU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 2.2 mm-40 -65.39 146.71 98.93 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.63 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 397' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 24.7 Cg_exo -65.48 148.11 87.47 Favored 'Trans proline' 0 C--O 1.238 0.496 0 C-N-CA 123.036 2.491 . . . . 0.0 112.663 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 73.19 45.08 32.65 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.626 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -128.25 159.04 69.27 Favored Pre-proline 0 C--N 1.321 -0.649 0 O-C-N 122.859 -0.201 . . . . 0.0 110.811 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.6 ' HB3' ' CE2' ' A' ' 388' ' ' TRP . 92.2 Cg_endo -77.6 156.61 95.78 Favored 'Cis proline' 0 C--O 1.236 0.397 0 C-N-CA 123.568 -1.43 . . . . 0.0 113.577 0.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -112.58 156.48 22.59 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 0.425 ' HB2' ' HG2' ' A' ' 405' ' ' GLU . 19.1 m-70 -72.11 156.96 38.62 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 78.2 mt -57.33 -39.28 67.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.943 0.401 . . . . 0.0 111.087 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -69.58 -7.53 39.44 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.425 ' HG2' ' HB2' ' A' ' 402' ' ' HIS . 10.8 mm-40 -87.32 -15.04 39.15 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 48.8 tp -86.36 -36.83 18.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.888 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.689 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -169.65 156.09 26.7 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.731 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -90.65 136.14 33.25 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.722 0.296 . . . . 0.0 110.75 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 102.18 4.83 50.39 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.426 -0.669 . . . . 0.0 111.426 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 88.9 mt -89.79 148.51 40.04 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 120.47 0.176 . . . . 0.0 111.014 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -58.0 119.24 6.37 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.696 2.264 . . . . 0.0 111.075 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.96 7.37 31.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.58 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -99.2 -54.99 2.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.82 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 414' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 384' ' ' GLY . 15.6 ptmt -175.53 169.69 3.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.561 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.448 HD12 ' HD2' ' A' ' 429' ' ' PHE . 46.2 mm -121.82 126.23 74.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 416' ' ' ASP . . . . . 0.424 ' HB3' ' HD2' ' A' ' 463' ' ' PRO . 15.4 m-20 -82.38 -43.7 17.04 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.895 0.378 . . . . 0.0 110.698 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 417' ' ' ALA . . . . . 0.771 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -157.65 154.8 28.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.301 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -134.83 119.32 17.99 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 42.0 tp -115.17 117.97 32.03 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.872 0.368 . . . . 0.0 111.778 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -91.24 118.25 30.31 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.208 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 421' ' ' TRP . . . . . 0.731 ' HB2' ' HE2' ' A' ' 428' ' ' TYR . 15.6 t-105 -87.67 99.02 11.76 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.486 ' HB2' ' HD3' ' A' ' 423' ' ' PRO . 63.3 mtt -52.44 -52.57 62.12 Favored Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.486 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 86.6 Cg_exo -48.23 -40.34 35.01 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.898 2.399 . . . . 0.0 114.913 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 424' ' ' ASN . . . . . 0.514 ' OD1' ' HB3' ' A' ' 421' ' ' TRP . 39.6 p30 -103.09 -28.79 11.75 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 88.24 29.49 19.65 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.612 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -122.29 141.61 51.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.833 0.349 . . . . 0.0 110.589 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 60.1 m -103.17 130.03 50.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.419 0.628 . . . . 0.0 111.646 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 428' ' ' TYR . . . . . 0.731 ' HE2' ' HB2' ' A' ' 421' ' ' TRP . 65.7 m-85 -98.64 122.79 42.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.839 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 429' ' ' PHE . . . . . 0.448 ' HD2' HD12 ' A' ' 415' ' ' ILE . 43.1 m-85 -98.54 121.73 40.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.653 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -98.6 132.31 44.11 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.473 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.404 ' HD2' ' O ' ' A' ' 414' ' ' LYS . 3.4 tpm_? -145.07 107.14 4.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.205 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 69.71 -117.41 7.58 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 433' ' ' ASN . . . . . 0.51 ' HA ' ' HB3' ' A' ' 461' ' ' GLU . 24.6 p-10 -113.22 16.28 19.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.258 0.551 . . . . 0.0 110.712 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -125.89 150.51 47.86 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.366 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 435' ' ' TYR . . . . . 0.492 ' CE1' ' HB2' ' A' ' 451' ' ' LYS . 6.7 p90 -129.85 142.7 50.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.063 0.459 . . . . 0.0 111.457 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 436' ' ' TYR . . . . . 0.747 ' HD1' HG11 ' A' ' 445' ' ' VAL . 53.5 m-85 -109.09 147.57 32.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.428 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -107.14 94.74 5.26 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 438' ' ' PHE . . . . . 0.689 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 71.8 t80 -81.49 119.59 23.93 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.414 0.626 . . . . 0.0 112.068 -178.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -86.33 94.93 9.48 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 440' ' ' GLU . . . . . 0.593 ' HB3' HH21 ' A' ' 374' ' ' ARG . 8.8 mt-10 -54.8 -30.74 57.83 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -82.89 -10.74 58.68 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 50.3 mt -119.28 -12.41 9.42 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 52.9 mtm180 61.24 44.39 9.88 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.443 0.639 . . . . 0.0 111.858 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -163.24 154.95 17.52 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.769 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 445' ' ' VAL . . . . . 0.747 HG11 ' HD1' ' A' ' 436' ' ' TYR . 93.9 t -80.99 137.56 21.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.048 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -62.79 163.47 9.34 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.306 0.574 . . . . 0.0 111.883 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.99 161.93 30.19 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.283 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 72.03 20.85 4.22 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.188 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 449' ' ' TYR . . . . . 0.425 ' HE2' ' CE2' ' A' ' 435' ' ' TYR . 29.0 m-85 -125.0 158.97 61.15 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.999 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.0 161.16 91.5 Favored 'Cis proline' 0 C--N 1.345 0.386 0 C-N-CA 123.766 -1.347 . . . . 0.0 112.574 1.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 451' ' ' LYS . . . . . 0.492 ' HB2' ' CE1' ' A' ' 435' ' ' TYR . 68.0 mttm -114.24 172.51 6.96 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.78 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -72.42 140.99 48.67 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 453' ' ' ILE . . . . . 0.667 HD13 ' HA ' ' A' ' 461' ' ' GLU . 13.2 tt -67.51 -12.04 14.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.078 0.466 . . . . 0.0 110.772 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 454' ' ' LYS . . . . . 0.481 ' HD3' ' HA ' ' A' ' 454' ' ' LYS . 27.6 mmtp -65.84 -10.16 35.46 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 81.2 t -61.34 -34.51 61.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 177.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 456' ' ' TRP . . . . . 0.505 ' HB2' ' HB ' ' A' ' 459' ' ' ILE . 9.8 m95 -88.1 84.39 6.93 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.48 115.67 2.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.763 -178.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 103.24 -11.59 55.05 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.833 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 456' ' ' TRP . 27.5 mm -89.36 126.09 59.62 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 120.808 0.337 . . . . 0.0 111.188 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 460' ' ' PRO . . . . . 0.426 ' HG3' ' CZ2' ' A' ' 484' ' ' TRP . 94.2 Cg_endo -79.91 152.26 21.86 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.827 2.351 . . . . 0.0 111.41 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 461' ' ' GLU . . . . . 0.667 ' HA ' HD13 ' A' ' 453' ' ' ILE . 0.1 OUTLIER -75.64 157.6 33.52 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.84 -179.773 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.5 m 56.86 69.43 1.72 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.577 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 463' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 416' ' ' ASP . 4.6 Cg_endo -87.91 -179.29 2.47 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.04 2.493 . . . . 0.0 111.637 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 7.7 tpp85 -144.46 36.11 1.2 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.519 0.676 . . . . 0.0 110.08 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 161.81 132.8 1.38 Allowed Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.342 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 6.0 p -155.56 106.32 2.51 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -133.35 142.67 48.53 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.028 0.442 . . . . 0.0 111.782 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 42.2 ttm -92.61 140.31 29.67 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.542 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -69.32 166.95 47.59 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.274 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 1.5 m -68.03 -7.41 28.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.15 0.5 . . . . 0.0 111.681 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -86.27 -20.87 27.79 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.756 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 70.34 13.65 7.54 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.748 0.655 . . . . 0.0 112.27 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 19.4 t -114.82 -34.3 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 120.781 0.324 . . . . 0.0 111.343 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -113.76 133.79 55.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.209 0.528 . . . . 0.0 111.986 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 84.9 m -119.03 140.07 50.65 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.936 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -110.32 134.38 52.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.882 0.372 . . . . 0.0 111.782 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -116.08 141.66 47.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.47 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -120.69 134.92 55.25 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.994 0.184 . . . . 0.0 111.27 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -168.52 126.68 1.1 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.443 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 63.63 42.6 98.71 Favored Glycine 0 N--CA 1.454 -0.154 0 CA-C-N 116.086 -0.506 . . . . 0.0 113.751 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 54.6 t30 68.29 3.19 3.59 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 25.6 mtmt -116.24 157.89 24.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.048 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 483' ' ' TYR . . . . . 0.53 ' CE2' ' HE2' ' A' ' 497' ' ' TYR . 24.5 p90 -130.57 146.7 52.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.023 0.44 . . . . 0.0 111.695 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 484' ' ' TRP . . . . . 0.426 ' CZ2' ' HG3' ' A' ' 460' ' ' PRO . 16.8 m-90 -114.62 151.25 33.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.615 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -110.76 98.65 7.75 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 486' ' ' PHE . . . . . 0.548 ' HZ ' HD12 ' A' ' 491' ' ' LEU . 82.4 t80 -90.96 131.65 36.44 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.768 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -96.02 120.42 36.27 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -66.91 -29.49 69.38 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 52.0 tp60 -83.16 -39.35 21.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.827 0.346 . . . . 0.0 111.726 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -83.53 -19.87 34.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.484 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.548 HD12 ' HZ ' ' A' ' 486' ' ' PHE . 18.3 tp 61.22 34.02 18.93 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.481 0.658 . . . . 0.0 110.036 -179.215 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 25.8 tttp -156.03 150.2 25.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.567 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 493' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 486' ' ' PHE . 56.8 t -70.19 137.79 23.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.42 138.71 86.5 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.821 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -60.08 145.01 99.42 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 123.156 2.571 . . . . 0.0 112.644 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 109.61 -6.69 31.63 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 497' ' ' TYR . . . . . 0.744 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 57.0 m-85 -109.75 169.1 6.77 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 498' ' ' PRO . . . . . 0.744 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 96.6 Cg_endo -76.85 171.53 67.64 Favored 'Cis proline' 0 C--N 1.35 0.647 0 C-N-CA 124.022 -1.241 . . . . 0.0 113.083 0.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -131.83 164.28 26.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.97 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 48.1 t -72.72 122.27 21.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.512 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -67.98 -29.76 68.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.068 0.461 . . . . 0.0 110.605 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 502' ' ' LEU . . . . . 0.44 ' HA ' ' HG2' ' A' ' 506' ' ' MET . 63.6 mt -68.01 -41.58 82.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.354 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -77.75 -37.33 49.35 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -93.58 -27.49 16.59 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -176.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 36.6 m0 -109.56 -50.7 2.96 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 506' ' ' MET . . . . . 0.44 ' HG2' ' HA ' ' A' ' 502' ' ' LEU . 11.3 mmt -73.02 -26.57 61.36 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -178.125 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 88.77 25.91 28.49 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.813 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 21.7 m -106.03 105.74 54.58 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 120.627 0.251 . . . . 0.0 110.743 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -84.61 176.15 6.5 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.867 2.378 . . . . 0.0 111.82 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 40.2 m 62.14 46.83 6.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.468 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.421 -1.211 . . . . 0.0 110.589 179.561 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.897 0 N-CA-C 112.295 -0.322 . . . . 0.0 112.295 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 CA--C 1.53 0.288 0 C-N-CA 122.821 2.347 . . . . 0.0 111.777 179.845 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.717 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo . . . . . 0 CA--C 1.531 0.357 0 C-N-CA 122.88 2.387 . . . . 0.0 111.021 179.454 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 N-CA-C 112.326 -0.31 . . . . 0.0 112.326 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo . . . . . 0 CA--C 1.531 0.355 0 C-N-CA 122.973 2.449 . . . . 0.0 111.866 179.434 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.712 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -63.19 137.28 60.39 Favored 'Trans proline' 0 C--O 1.238 0.498 0 C-N-CA 122.87 2.38 . . . . 0.0 111.839 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -65.47 143.35 57.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.133 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' D' ' 210' ' ' PRO . . . -57.63 153.2 24.99 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.987 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 mt -72.62 150.85 8.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.73 142.45 58.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.226 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.03 168.49 33.1 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.886 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -74.36 145.09 44.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.678 0.275 . . . . 0.0 110.782 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.55 136.18 54.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.973 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.8 144.34 34.79 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.985 -0.552 . . . . 0.0 113.687 -179.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 4.1 t -64.39 147.11 12.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 9.7 t -54.57 147.13 3.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.05 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.55 177.82 46.16 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.639 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 86.7 mt . . . . . 0 C--N 1.323 -0.571 0 CA-C-O 120.418 0.151 . . . . 0.0 110.648 -179.665 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.503 0 CA-C-O 120.405 -0.108 . . . . 0.0 112.993 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo . . . . . 0 C--O 1.234 0.313 0 C-N-CA 122.772 2.314 . . . . 0.0 112.154 179.846 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.567 0 N-CA-C 113.212 0.045 . . . . 0.0 113.212 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo . . . . . 0 CA--C 1.534 0.501 0 C-N-CA 123.187 2.591 . . . . 0.0 111.627 179.689 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.637 0 N-CA-C 112.76 -0.136 . . . . 0.0 112.76 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo . . . . . 0 C--O 1.236 0.399 0 C-N-CA 123.153 2.569 . . . . 0.0 111.643 179.392 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.943 0 N-CA-C 112.783 -0.127 . . . . 0.0 112.783 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo . . . . . 0 N--CA 1.46 -0.488 0 C-N-CA 122.487 2.124 . . . . 0.0 111.098 179.403 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 100' ' ' GLY . . . . . 0.479 ' HA3' ' HD3' ' C' ' 101' ' ' PRO . . . . . . . . 0 N--CA 1.449 -0.433 0 N-CA-C 112.29 -0.324 . . . . 0.0 112.29 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 101' ' ' PRO . . . . . 0.479 ' HD3' ' HA3' ' C' ' 100' ' ' GLY . 14.5 Cg_exo . . . . . 0 CA--C 1.528 0.217 0 C-N-CA 122.898 2.399 . . . . 0.0 111.9 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 111.834 -0.507 . . . . 0.0 111.834 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo . . . . . 0 C--O 1.236 0.379 0 C-N-CA 122.895 2.396 . . . . 0.0 112.528 -179.576 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.383 0 N-CA-C 112.297 -0.321 . . . . 0.0 112.297 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 CA--C 1.528 0.18 0 C-N-CA 123.213 2.608 . . . . 0.0 110.886 179.513 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.417 0 N-CA-C 112.811 -0.115 . . . . 0.0 112.811 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.85 157.45 61.31 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.749 2.299 . . . . 0.0 112.552 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -60.78 139.0 58.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.815 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -67.61 168.33 39.54 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.029 -0.605 . . . . 0.0 113.256 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 28.4 mt -68.6 138.18 22.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.86 147.58 51.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.966 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.54 149.27 48.72 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 116.058 -0.519 . . . . 0.0 113.196 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -78.27 143.61 36.89 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 122.283 0.233 . . . . 0.0 110.617 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 52.9 ttm-85 -62.19 145.25 54.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.632 0.253 . . . . 0.0 110.742 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.45 168.9 37.92 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.691 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -77.26 149.15 6.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.521 0.2 . . . . 0.0 110.475 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 120' ' ' VAL . . . . . 0.611 HG22 ' HB ' ' D' ' 219' ' ' VAL . 63.4 t -64.61 137.55 24.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.982 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.36 161.78 50.24 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 121.11 -0.566 . . . . 0.0 112.42 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 88.9 mt . . . . . 0 C--N 1.325 -0.464 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.92 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.442 0 N-CA-C 113.595 0.198 . . . . 0.0 113.595 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 C--O 1.235 0.356 0 C-N-CA 122.916 2.411 . . . . 0.0 111.647 179.587 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 113.365 0.106 . . . . 0.0 113.365 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo . . . . . 0 C--O 1.236 0.414 0 C-N-CA 122.632 2.222 . . . . 0.0 111.484 179.634 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 112.653 -0.179 . . . . 0.0 112.653 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo . . . . . 0 C--N 1.342 0.233 0 C-N-CA 122.795 2.33 . . . . 0.0 111.59 179.754 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.521 0 CA-C-O 119.927 -0.374 . . . . 0.0 112.551 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo . . . . . 0 CA--C 1.53 0.302 0 C-N-CA 123.005 2.47 . . . . 0.0 111.88 -179.991 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.387 0 N-CA-C 112.17 -0.372 . . . . 0.0 112.17 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo . . . . . 0 C--N 1.344 0.32 0 C-N-CA 122.783 2.322 . . . . 0.0 111.488 179.77 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.329 0 N-CA-C 114.346 0.498 . . . . 0.0 114.346 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo . . . . . 0 C--N 1.347 0.459 0 C-N-CA 123.896 3.064 . . . . 0.0 113.265 -179.394 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.421 0 CA-C-O 120.456 -0.08 . . . . 0.0 112.988 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo . . . . . 0 N--CA 1.459 -0.506 0 C-N-CA 123.187 2.591 . . . . 0.0 112.326 179.898 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.697 0 N-CA-C 112.086 -0.406 . . . . 0.0 112.086 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 210' ' ' PRO . . . . . 0.452 ' O ' ' HA3' ' B' ' 12' ' ' GLY . 38.9 Cg_endo -68.12 158.35 57.85 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.643 2.229 . . . . 0.0 112.237 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -79.49 147.31 32.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.886 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.97 161.49 36.78 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.167 -0.54 . . . . 0.0 112.286 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 40.5 pt -66.79 166.92 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.63 0.252 . . . . 0.0 111.168 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 214' ' ' ALA . . . . . 0.432 ' HB3' ' NH1' ' A' ' 330' ' ' ARG . . . -80.64 138.99 36.45 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.912 0.387 . . . . 0.0 110.685 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -63.15 156.08 41.98 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.017 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -71.0 150.18 45.9 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -62.29 152.25 34.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.45 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -58.97 154.2 28.87 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.667 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 219' ' ' VAL . . . . . 0.611 ' HB ' HG22 ' C' ' 120' ' ' VAL . 15.8 t -66.74 143.15 15.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 21.9 t -63.01 143.26 15.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.047 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.22 162.66 31.98 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.777 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 7.3 mp . . . . . 0 C--N 1.323 -0.547 0 CA-C-O 120.489 0.185 . . . . 0.0 110.778 -179.8 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.805 0 N-CA-C 112.339 -0.304 . . . . 0.0 112.339 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo . . . . . 0 C--O 1.233 0.229 0 C-N-CA 122.837 2.358 . . . . 0.0 111.506 179.746 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 227' ' ' GLY . . . . . 0.419 ' HA2' ' HD3' ' D' ' 228' ' ' PRO . . . . . . . . 0 N--CA 1.448 -0.528 0 CA-C-O 120.466 -0.075 . . . . 0.0 112.999 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 228' ' ' PRO . . . . . 0.419 ' HD3' ' HA2' ' D' ' 227' ' ' GLY . 2.7 Cg_exo . . . . . 0 N--CA 1.462 -0.33 0 C-N-CA 123.03 2.487 . . . . 0.0 111.443 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.581 0 N-CA-C 112.561 -0.215 . . . . 0.0 112.561 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo . . . . . 0 N--CA 1.462 -0.34 0 C-N-CA 122.654 2.236 . . . . 0.0 110.816 179.02 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 N--CA 1.479 0.65 0 N-CA-C 110.06 -0.785 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 317' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 320' ' ' ASP . 18.2 t-20 -115.27 161.2 18.8 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 17.6 tt -70.42 -23.42 24.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.08 0.467 . . . . 0.0 110.875 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 59.0 m -80.9 -1.1 42.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.227 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 317' ' ' ASN . 3.5 m-20 -71.33 -20.98 62.11 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.13 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 76.22 -177.31 50.83 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.822 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 24.4 m120 48.79 83.52 0.04 OUTLIER 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 323' ' ' PHE . . . . . 0.417 ' HD2' ' HH ' ' A' ' 478' ' ' TYR . 23.4 m-85 -100.62 168.67 9.55 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.222 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -77.35 -40.73 43.02 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 7.0 t -171.46 154.72 3.92 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.928 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 67.7 t -130.5 125.71 59.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -136.89 170.47 16.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.006 0.431 . . . . 0.0 110.898 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 328' ' ' MET . . . . . 0.433 ' HA ' ' O ' ' A' ' 332' ' ' GLU . 41.4 ttp -130.08 87.06 2.47 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.568 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.426 ' HB3' ' CE1' ' A' ' 379' ' ' PHE . 45.5 mt -85.7 123.8 31.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.48 -178.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 330' ' ' ARG . 31.5 mmt-85 63.71 19.37 11.69 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.203 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 93.2 -3.61 73.04 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.631 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 332' ' ' GLU . . . . . 0.451 ' HA ' ' NH2' ' A' ' 345' ' ' ARG . 15.4 mm-40 -95.45 128.44 42.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.853 0.359 . . . . 0.0 110.356 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 38.5 ttm -77.03 110.92 12.07 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.251 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -110.29 122.83 48.61 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.988 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 27.2 t -109.73 122.34 64.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.47 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -106.21 132.04 52.75 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.731 0.3 . . . . 0.0 111.46 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 0.783 ' HB3' ' HZ3' ' A' ' 342' ' ' TRP . 61.2 tttp -148.37 112.38 5.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.42 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 64.76 -113.01 0.31 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.922 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 15.4 ptt-85 -114.63 11.78 17.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.857 0.361 . . . . 0.0 111.107 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 15.0 m-90 -122.99 155.07 37.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.933 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -135.85 148.69 48.76 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.686 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 342' ' ' TRP . . . . . 0.783 ' HZ3' ' HB3' ' A' ' 337' ' ' LYS . 29.2 m-90 -124.47 162.5 23.82 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.462 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.13 114.99 9.07 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 2.5 m -103.3 136.86 34.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.262 0.553 . . . . 0.0 112.083 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 345' ' ' ARG . . . . . 0.451 ' NH2' ' HA ' ' A' ' 332' ' ' GLU . 18.0 tpp180 -135.84 123.26 22.0 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 5.6 m120 66.14 35.21 6.27 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 123.564 0.54 . . . . 0.0 110.614 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 17.5 t30 63.14 33.12 14.71 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.048 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -143.03 143.52 31.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.563 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 14.0 t -83.65 131.39 33.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 91.1 mtp -84.44 172.57 11.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.904 0.383 . . . . 0.0 111.513 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -77.47 158.38 30.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.23 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 98.02 -5.47 61.48 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.045 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -117.64 152.72 50.08 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.406 ' HB3' ' CE2' ' A' ' 342' ' ' TRP . 74.0 Cg_endo -76.58 140.01 63.1 Favored 'Cis proline' 0 C--N 1.343 0.286 0 C-N-CA 123.215 -1.577 . . . . 0.0 112.834 0.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 57.1 ttm -119.85 135.94 24.56 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.94 134.77 64.59 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.327 2.018 . . . . 0.0 110.931 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 94.0 mt -51.91 -42.32 33.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.814 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -67.83 -8.11 51.61 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 116.029 -0.532 . . . . 0.0 114.271 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.72 -32.87 27.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.259 0.529 . . . . 0.0 110.447 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -104.47 -56.32 2.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.966 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -86.13 74.95 9.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.712 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 362' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 362' ' ' ARG . 25.6 ttp180 -63.45 100.92 0.28 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.896 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 129.31 -16.7 5.68 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.299 -0.721 . . . . 0.0 111.299 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.555 HD12 ' HD2' ' A' ' 365' ' ' PRO . 22.6 tp -92.38 134.05 28.82 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 365' ' ' PRO . . . . . 0.555 ' HD2' HD12 ' A' ' 364' ' ' LEU . 96.3 Cg_endo -82.87 -167.08 0.43 Allowed 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 123.033 2.488 . . . . 0.0 112.258 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -96.94 157.81 15.72 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.051 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 27.7 m 54.73 80.31 0.13 Allowed 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 17.9 pt -93.57 170.26 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.013 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.93 -39.25 7.02 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -178.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 370' ' ' THR . . . . . 0.532 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.2 OUTLIER -153.13 160.45 42.89 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.657 0.265 . . . . 0.0 111.288 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -153.08 138.2 17.35 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 372' ' ' TYR . . . . . 0.474 ' HE1' ' HE2' ' A' ' 382' ' ' PHE . 11.8 p90 -166.09 174.66 9.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.683 0.278 . . . . 0.0 111.076 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.418 ' OE1' ' HD3' ' A' ' 330' ' ' ARG . 33.4 mt-10 -104.92 131.51 52.33 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 374' ' ' ARG . . . . . 0.492 ' HB2' ' OE2' ' A' ' 440' ' ' GLU . 6.3 ptm180 -88.61 -177.99 5.7 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.404 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.449 ' HZ3' ' CD ' ' A' ' 441' ' ' GLU . 7.6 tttp -65.64 -34.23 77.75 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -21.82 64.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.98 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 109.77 -10.99 32.45 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.962 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 19.8 mttp -86.06 160.28 19.34 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 117.266 0.533 . . . . 0.0 111.409 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 379' ' ' PHE . . . . . 0.426 ' CE1' ' HB3' ' A' ' 329' ' ' LEU . 45.6 m-85 -88.35 130.57 35.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.181 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 380' ' ' VAL . . . . . 0.448 ' HB ' ' CE1' ' A' ' 372' ' ' TYR . 8.9 t -113.86 119.7 61.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.004 0.431 . . . . 0.0 110.194 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 381' ' ' PHE . . . . . 0.444 ' HB2' ' HB2' ' A' ' 388' ' ' TRP . 94.5 m-85 -107.37 140.16 40.73 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.67 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.474 ' HE2' ' HE1' ' A' ' 372' ' ' TYR . 32.9 m-85 -121.49 139.91 52.87 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.983 0.421 . . . . 0.0 111.603 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.456 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 86.1 tttt -154.2 114.05 3.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.744 178.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 66.76 -107.24 1.92 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.692 -0.765 . . . . 0.0 111.481 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -122.62 8.82 9.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.21 0.529 . . . . 0.0 110.165 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -114.84 152.37 32.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.795 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 387' ' ' HIS . . . . . 0.407 ' NE2' ' HE2' ' A' ' 399' ' ' TYR . 25.8 p-80 -134.27 150.93 51.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.394 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 388' ' ' TRP . . . . . 0.535 ' CE2' ' HB3' ' A' ' 400' ' ' PRO . 16.7 m-90 -122.64 142.58 50.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.186 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 85.6 t -124.38 119.13 55.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -118.62 126.79 52.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.977 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -93.79 95.08 8.9 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 177.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 392' ' ' GLU . . . . . 0.416 ' HA ' ' HE2' ' A' ' 379' ' ' PHE . 72.2 mm-40 69.96 -78.32 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.812 0.695 . . . . 0.0 110.273 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -140.87 16.87 2.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.965 0.412 . . . . 0.0 111.05 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 9.1 m -123.24 126.9 47.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.956 0.407 . . . . 0.0 111.723 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 46.6 tp -76.54 140.19 41.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.428 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 396' ' ' GLU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 5.5 mm-40 -71.6 136.63 83.31 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.307 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 397' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 24.6 Cg_exo -64.0 131.99 32.83 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.81 2.34 . . . . 0.0 112.096 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 108.07 -11.44 37.42 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.841 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 399' ' ' TYR . . . . . 0.505 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 58.2 m-85 -93.5 161.01 31.85 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 110.543 -0.169 . . . . 0.0 110.543 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.535 ' HB3' ' CE2' ' A' ' 388' ' ' TRP . 55.3 Cg_endo -68.96 160.33 85.77 Favored 'Cis proline' 0 C--N 1.348 0.537 0 C-N-CA 123.909 -1.288 . . . . 0.0 113.205 0.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -135.45 161.93 34.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.819 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 0.501 ' HB2' ' HG2' ' A' ' 405' ' ' GLU . 30.5 m-70 -70.37 153.91 42.48 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 77.6 mt -57.61 -37.81 60.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.099 0.476 . . . . 0.0 111.095 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -68.1 -10.08 51.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.99 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.501 ' HG2' ' HB2' ' A' ' 402' ' ' HIS . 65.3 mm-40 -79.65 -20.6 46.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.809 0.337 . . . . 0.0 110.767 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 36.9 tp -80.15 -61.81 1.87 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.264 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.845 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -143.21 154.91 25.74 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.063 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -79.61 132.06 36.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.667 -0.266 . . . . 0.0 110.336 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 102.29 -4.3 51.5 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.317 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 410' ' ' LEU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 411' ' ' PRO . 50.2 mt -77.33 146.0 73.46 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 120.63 0.252 . . . . 0.0 110.976 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 411' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 410' ' ' LEU . 47.8 Cg_exo -57.07 131.91 48.22 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.734 2.289 . . . . 0.0 112.075 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.69 -0.5 37.24 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.293 0.568 . . . . 0.0 110.42 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -90.13 -53.13 4.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.941 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -179.15 170.9 1.39 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.826 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 42.6 mm -124.61 133.01 70.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -90.63 -47.15 7.85 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.117 0.485 . . . . 0.0 110.234 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 417' ' ' ALA . . . . . 0.532 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -155.26 159.68 40.23 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.339 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -142.45 113.68 7.7 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 35.1 tp -109.61 123.2 49.04 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.407 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -88.36 114.64 25.18 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.062 0.458 . . . . 0.0 110.086 178.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 15.3 t-105 -83.63 94.23 8.06 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.509 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 62.6 mtt -50.74 -50.72 71.69 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -43.01 -48.97 7.32 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 123.011 2.474 . . . . 0.0 114.867 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -105.07 -13.8 15.62 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 75.23 33.7 53.23 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.162 -0.542 . . . . 0.0 113.204 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -116.38 149.22 39.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.796 0.298 . . . . 0.0 110.456 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 6.4 m -98.23 128.0 44.47 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.203 0.525 . . . . 0.0 112.218 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -102.78 109.08 20.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.948 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -91.89 129.68 37.81 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.461 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -106.18 129.62 54.2 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.004 0.431 . . . . 0.0 110.988 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.562 ' HB3' ' HE1' ' A' ' 436' ' ' TYR . 3.1 tpm_? -139.21 102.98 4.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.336 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 63.44 -109.5 2.78 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.318 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -110.82 11.96 22.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.031 0.443 . . . . 0.0 110.62 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -122.91 152.38 40.86 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.966 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 435' ' ' TYR . . . . . 0.551 ' CE2' ' HE2' ' A' ' 449' ' ' TYR . 8.2 p90 -133.82 139.2 46.11 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.383 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 436' ' ' TYR . . . . . 0.562 ' HE1' ' HB3' ' A' ' 431' ' ' ARG . 4.2 m-85 -111.62 145.2 39.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.829 -178.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 20.9 ttp180 -106.01 100.62 10.16 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 438' ' ' PHE . . . . . 0.845 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 83.2 t80 -85.06 120.41 26.54 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.235 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -95.61 106.79 18.93 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.537 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 440' ' ' GLU . . . . . 0.492 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 4.5 mm-40 -58.16 -39.06 77.85 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.597 0.56 . . . . 0.0 111.48 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 441' ' ' GLU . . . . . 0.449 ' CD ' ' HZ3' ' A' ' 375' ' ' LYS . 1.9 mp0 -61.16 -20.56 62.85 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 13.8 mt -127.72 3.5 6.09 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 43.03 47.37 5.03 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.493 0.663 . . . . 0.0 112.315 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -154.51 172.65 17.45 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.132 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.6 t -88.24 138.94 18.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.149 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.32 160.81 15.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.525 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 447' ' ' SER . . . . . 0.543 ' O ' ' HB2' ' A' ' 448' ' ' GLU . 1.7 m -67.13 151.96 46.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.446 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 448' ' ' GLU . . . . . 0.543 ' HB2' ' O ' ' A' ' 447' ' ' SER . 26.7 mt-10 78.45 -6.68 1.9 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.51 0.724 . . . . 0.0 111.786 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 449' ' ' TYR . . . . . 0.551 ' HE2' ' CE2' ' A' ' 435' ' ' TYR . 54.2 m-85 -98.23 154.68 37.55 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.702 -0.227 . . . . 0.0 111.418 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.4 162.71 91.94 Favored 'Cis proline' 0 C--N 1.345 0.364 0 C-N-CA 123.439 -1.484 . . . . 0.0 112.998 0.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -121.94 178.17 5.0 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -78.07 137.01 38.01 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.721 0.296 . . . . 0.0 110.298 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.5 tt -63.97 -17.48 20.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -63.48 -9.16 11.53 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 53.7 t -63.07 -33.9 63.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -91.5 94.76 9.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.362 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 457' ' ' GLU . . . . . 0.722 ' HB3' ' HG3' ' A' ' 492' ' ' LYS . 13.3 mm-40 -56.08 105.2 0.17 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 114.25 -7.8 22.95 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.515 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 24.7 mm -84.58 127.44 65.56 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 121.006 0.431 . . . . 0.0 111.065 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -77.99 138.93 16.87 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.893 2.395 . . . . 0.0 113.042 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -66.66 140.81 57.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.293 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 2.7 m 57.74 71.44 1.07 Allowed Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -87.28 -171.28 0.7 Allowed 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.423 2.082 . . . . 0.0 111.632 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -143.63 20.55 1.84 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.212 0.529 . . . . 0.0 110.891 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 177.92 142.0 4.44 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 13.0 p -162.65 110.65 1.31 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.6 0.238 . . . . 0.0 110.731 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -138.98 144.44 38.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.866 0.365 . . . . 0.0 111.251 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 48.7 ttm -95.47 143.05 27.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.022 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 469' ' ' GLY . . . . . 0.442 ' C ' ' H ' ' A' ' 471' ' ' ASP . . . -72.67 163.91 54.76 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.962 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.94 30.25 0.09 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.167 0.508 . . . . 0.0 111.901 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 471' ' ' ASP . . . . . 0.442 ' H ' ' C ' ' A' ' 469' ' ' GLY . 1.0 OUTLIER -126.73 -14.28 5.71 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.294 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 67.24 9.44 6.96 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.3 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 40.2 t -106.71 -45.25 7.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.859 0.361 . . . . 0.0 111.133 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -108.09 132.13 53.89 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 97.0 m -116.79 138.95 51.13 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.689 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 476' ' ' TYR . . . . . 0.491 ' HE1' ' HE2' ' A' ' 485' ' ' LYS . 28.3 m-85 -114.15 126.52 55.17 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -110.08 141.78 42.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.145 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 478' ' ' TYR . . . . . 0.417 ' HH ' ' HD2' ' A' ' 323' ' ' PHE . 76.8 t80 -123.04 135.0 54.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.705 0.288 . . . . 0.0 111.566 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 479' ' ' LYS . . . . . 0.4 ' HB3' ' CZ3' ' A' ' 484' ' ' TRP . 61.8 tttt -166.87 128.25 1.66 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.078 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 59.56 43.18 97.82 Favored Glycine 0 CA--C 1.516 0.148 0 N-CA-C 114.667 0.627 . . . . 0.0 114.667 178.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 58.4 t30 68.92 3.94 4.25 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 178.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -116.84 152.19 34.95 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 483' ' ' TYR . . . . . 0.481 ' CE2' ' HE2' ' A' ' 497' ' ' TYR . 7.3 p90 -128.12 145.17 51.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.114 0.483 . . . . 0.0 111.813 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 484' ' ' TRP . . . . . 0.4 ' CZ3' ' HB3' ' A' ' 479' ' ' LYS . 16.8 m-90 -112.77 138.09 50.11 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.499 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 485' ' ' LYS . . . . . 0.491 ' HE2' ' HE1' ' A' ' 476' ' ' TYR . 32.6 ttmt -101.88 96.12 6.84 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 486' ' ' PHE . . . . . 0.552 ' HA ' ' HA ' ' A' ' 493' ' ' VAL . 90.0 t80 -87.77 133.26 33.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.566 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -100.32 117.13 33.89 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -66.55 -34.44 77.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.768 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -68.76 -32.93 73.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.68 -178.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -98.5 -20.54 17.02 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 1.3 tp 66.11 39.26 4.4 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.795 0.807 . . . . 0.0 109.814 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 492' ' ' LYS . . . . . 0.722 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 31.5 tttp -160.17 153.36 21.88 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.386 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 493' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 486' ' ' PHE . 52.8 t -78.04 133.5 30.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 178.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -59.42 137.46 89.04 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.41 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -61.85 152.01 77.39 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.979 2.453 . . . . 0.0 112.284 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 94.37 9.48 59.07 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.684 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 497' ' ' TYR . . . . . 0.633 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 21.7 m-85 -117.43 170.17 6.49 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 498' ' ' PRO . . . . . 0.633 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 87.4 Cg_endo -78.29 -178.72 24.76 Favored 'Cis proline' 0 C--N 1.348 0.53 0 C-N-CA 124.104 -1.207 . . . . 0.0 112.865 0.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -135.29 155.25 50.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.176 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.29 116.33 10.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.565 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -63.47 -23.6 67.47 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 502' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 502' ' ' LEU . 13.4 mt -61.15 -49.65 76.35 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -83.05 -29.08 29.12 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.05 -35.73 21.69 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 44.3 m0 -116.29 -45.07 2.85 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -177.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 9.7 mmt -75.5 -17.77 60.01 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -177.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 76.41 21.95 74.15 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.742 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 16.9 m -104.38 111.07 65.11 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 120.754 0.311 . . . . 0.0 110.898 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -86.27 -167.47 0.38 Allowed 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.873 2.382 . . . . 0.0 111.525 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 16.2 m 60.34 37.63 20.08 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.046 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.386 -1.23 . . . . 0.0 111.832 -179.506 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.669 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo . . . . . 0 CA--C 1.53 0.305 0 C-N-CA 122.543 2.162 . . . . 0.0 111.433 179.683 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 113.661 0.224 . . . . 0.0 113.661 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo . . . . . 0 CA--C 1.532 0.382 0 C-N-CA 122.874 2.383 . . . . 0.0 110.966 179.586 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.612 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo . . . . . 0 CA--C 1.532 0.412 0 C-N-CA 122.678 2.252 . . . . 0.0 111.463 179.263 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.912 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.11 138.33 51.56 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.769 2.312 . . . . 0.0 111.561 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 11' ' ' GLN . . . . . 0.664 ' HG3' ' HG2' ' C' ' 110' ' ' PRO . 27.2 tt0 -66.67 150.27 49.3 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.084 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.18 143.07 46.24 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.355 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.475 ' H ' HD12 ' B' ' 13' ' ' ILE . 4.0 mp -64.86 137.93 24.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.01 143.41 22.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.129 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.64 164.77 41.8 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.106 -0.568 . . . . 0.0 113.17 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -75.11 150.34 38.83 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -70.22 146.49 50.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.525 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' D' ' 216' ' ' GLN . . . -64.95 155.24 48.84 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.492 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.42 ' H ' HG23 ' B' ' 19' ' ' VAL . 2.2 t -66.3 149.76 11.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.554 0.216 . . . . 0.0 110.667 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 6.0 t -53.92 145.71 3.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.24 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.99 161.25 52.08 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 116.035 -0.529 . . . . 0.0 113.153 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 87.4 mt . . . . . 0 C--N 1.323 -0.583 0 CA-C-N 115.703 -0.248 . . . . 0.0 110.756 -179.71 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.544 0 N-CA-C 112.847 -0.101 . . . . 0.0 112.847 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo . . . . . 0 C--O 1.235 0.33 0 C-N-CA 122.609 2.206 . . . . 0.0 111.412 179.565 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.575 0 N-CA-C 113.153 0.021 . . . . 0.0 113.153 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo . . . . . 0 C--O 1.235 0.355 0 C-N-CA 122.798 2.332 . . . . 0.0 111.864 179.867 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.58 0 N-CA-C 113.168 0.027 . . . . 0.0 113.168 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo . . . . . 0 C--O 1.234 0.302 0 C-N-CA 123.29 2.66 . . . . 0.0 111.766 179.516 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 113.596 0.198 . . . . 0.0 113.596 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo . . . . . 0 C--N 1.344 0.335 0 C-N-CA 122.759 2.306 . . . . 0.0 111.033 179.304 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.506 0 CA-C-O 119.952 -0.36 . . . . 0.0 112.586 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo . . . . . 0 C--N 1.345 0.364 0 C-N-CA 122.952 2.435 . . . . 0.0 112.084 179.716 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.552 0 N-CA-C 112.446 -0.261 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo . . . . . 0 N--CA 1.462 -0.375 0 C-N-CA 122.957 2.438 . . . . 0.0 111.95 179.773 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.511 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.465 -0.172 0 C-N-CA 122.961 2.44 . . . . 0.0 110.742 179.528 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.498 0 N-CA-C 112.615 -0.194 . . . . 0.0 112.615 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 110' ' ' PRO . . . . . 0.664 ' HG2' ' HG3' ' B' ' 11' ' ' GLN . 59.1 Cg_endo -72.27 163.98 37.01 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.886 2.391 . . . . 0.0 112.116 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -65.6 137.63 57.49 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.15 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.48 166.63 30.02 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.841 -0.618 . . . . 0.0 113.562 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 79.9 mt -63.8 137.72 24.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.752 0.31 . . . . 0.0 110.847 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.11 145.15 54.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.538 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -59.16 148.37 40.4 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.627 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -75.2 156.8 35.44 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.673 0.273 . . . . 0.0 110.464 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 38.0 ttm-85 -69.67 147.34 50.74 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.302 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.9 170.0 52.13 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.485 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 21.6 t -69.23 138.95 21.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.606 0.241 . . . . 0.0 110.651 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 58.0 t -62.42 137.33 24.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.661 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.31 158.62 30.77 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.26 -0.495 . . . . 0.0 112.851 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 95.7 mt . . . . . 0 C--N 1.324 -0.508 0 CA-C-O 120.391 0.138 . . . . 0.0 110.922 -179.92 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.643 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo . . . . . 0 CA--C 1.529 0.233 0 C-N-CA 122.691 2.261 . . . . 0.0 111.581 179.534 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.523 0 CA-C-O 120.407 -0.107 . . . . 0.0 112.902 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo . . . . . 0 C--O 1.236 0.376 0 C-N-CA 122.579 2.186 . . . . 0.0 111.562 179.551 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 130' ' ' GLY . . . . . 0.408 ' HA2' ' HD3' ' C' ' 131' ' ' PRO . . . . . . . . 0 N--CA 1.446 -0.669 0 N-CA-C 112.885 -0.086 . . . . 0.0 112.885 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 131' ' ' PRO . . . . . 0.408 ' HD3' ' HA2' ' C' ' 130' ' ' GLY . 14.0 Cg_exo . . . . . 0 C--O 1.236 0.376 0 C-N-CA 122.913 2.409 . . . . 0.0 111.696 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.542 0 CA-C-O 120.257 -0.19 . . . . 0.0 112.925 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 CA--C 1.531 0.325 0 C-N-CA 122.881 2.387 . . . . 0.0 111.889 179.763 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.335 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo . . . . . 0 CA--C 1.531 0.359 0 C-N-CA 122.946 2.431 . . . . 0.0 111.807 179.964 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.406 0 CA-C-O 120.341 -0.144 . . . . 0.0 112.993 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo . . . . . 0 CA--C 1.531 0.343 0 C-N-CA 123.454 2.769 . . . . 0.0 112.722 -179.805 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.391 0 N-CA-C 112.965 -0.054 . . . . 0.0 112.965 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo . . . . . 0 N--CA 1.456 -0.696 0 C-N-CA 123.424 2.75 . . . . 0.0 112.519 -179.768 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.67 0 N-CA-C 112.05 -0.42 . . . . 0.0 112.05 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.26 141.1 73.97 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.471 2.114 . . . . 0.0 112.23 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 211' ' ' GLN . . . . . 0.451 ' HG3' ' N ' ' D' ' 212' ' ' GLY . 1.4 tt0 -65.87 150.93 47.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.929 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 212' ' ' GLY . . . . . 0.451 ' N ' ' HG3' ' D' ' 211' ' ' GLN . . . -67.46 160.33 49.47 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.357 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 45.6 pt -69.21 174.11 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 120.819 0.343 . . . . 0.0 111.439 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -77.67 147.86 35.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.499 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -74.48 158.02 51.28 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.773 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 216' ' ' GLN . . . . . 0.453 ' O ' ' HA3' ' B' ' 18' ' ' GLY . 33.4 mm-40 -77.52 151.6 34.48 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.623 0.249 . . . . 0.0 110.488 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 217' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' D' ' 217' ' ' ARG . 8.8 mtp180 -66.58 156.23 35.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.989 0.424 . . . . 0.0 110.571 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -66.23 151.37 52.09 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.185 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 11.5 t -65.82 148.77 11.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 61.6 t -63.03 139.1 21.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-O 120.725 0.297 . . . . 0.0 110.425 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.33 157.22 28.86 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.516 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 115.751 -0.224 . . . . 0.0 110.889 -179.893 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 224' ' ' GLY . . . . . 0.418 ' HA2' ' HD3' ' D' ' 225' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.613 0 CA-C-O 120.47 -0.072 . . . . 0.0 113.175 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 225' ' ' PRO . . . . . 0.418 ' HD3' ' HA2' ' D' ' 224' ' ' GLY . 15.5 Cg_exo . . . . . 0 C--O 1.236 0.382 0 C-N-CA 123.031 2.487 . . . . 0.0 111.466 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.502 0 N-CA-C 112.773 -0.131 . . . . 0.0 112.773 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 CA--C 1.53 0.314 0 C-N-CA 122.701 2.267 . . . . 0.0 111.954 -179.929 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.468 0 N-CA-C 113.444 0.137 . . . . 0.0 113.444 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo . . . . . 0 N--CA 1.458 -0.594 0 C-N-CA 123.298 2.665 . . . . 0.0 112.511 -179.982 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo . . . . . 0 N--CA 1.479 0.665 0 N-CA-C 110.26 -0.708 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 317' ' ' ASN . . . . . 0.534 ' O ' ' HB2' ' A' ' 320' ' ' ASP . 14.3 t-20 -110.79 166.3 11.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.423 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 318' ' ' ILE . . . . . 0.466 HG13 ' HB3' ' A' ' 506' ' ' MET . 8.5 tp -72.78 -31.04 34.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.051 0.453 . . . . 0.0 110.64 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 59.0 m -82.77 10.24 8.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.94 0.4 . . . . 0.0 111.457 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.534 ' HB2' ' O ' ' A' ' 317' ' ' ASN . 0.1 OUTLIER -69.72 -32.02 70.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.437 179.626 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 79.96 -176.81 54.57 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.481 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 3.5 t30 53.9 78.79 0.15 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.046 0.45 . . . . 0.0 111.218 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -96.04 154.79 17.05 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.902 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 324' ' ' ASP . . . . . 0.418 ' OD1' ' HA ' ' A' ' 337' ' ' LYS . 3.0 m-20 -74.25 -40.53 62.31 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.221 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 1.8 t -170.86 146.54 2.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.448 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.431 HG22 HG13 ' A' ' 335' ' ' VAL . 60.6 t -131.97 126.25 56.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -149.33 176.81 10.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.053 0.454 . . . . 0.0 111.231 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 41.3 ttp -127.16 122.37 33.93 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.419 ' HB3' ' CE1' ' A' ' 379' ' ' PHE . 54.3 mt -114.64 119.75 37.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.902 -179.015 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.609 ' HG3' ' HE1' ' A' ' 379' ' ' PHE . 63.6 mtp180 55.82 26.04 9.14 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 101.96 -10.63 57.17 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.684 -0.77 . . . . 0.0 113.356 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -100.25 130.01 46.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.929 0.395 . . . . 0.0 111.306 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 45.2 ttm -84.05 124.43 31.08 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -119.56 120.5 36.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.132 0.492 . . . . 0.0 111.572 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 335' ' ' VAL . . . . . 0.431 HG13 HG22 ' A' ' 326' ' ' VAL . 23.1 t -105.31 115.22 46.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -99.74 131.67 45.58 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 0.695 ' HB3' ' HZ3' ' A' ' 342' ' ' TRP . 38.7 tttp -144.18 109.25 5.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.174 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 61.31 -102.39 0.12 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.894 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 339' ' ' ARG . 11.7 ptm85 -119.48 12.97 12.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.878 0.37 . . . . 0.0 111.361 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 13.3 m-90 -125.71 153.73 43.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.71 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -136.35 141.76 43.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.863 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 342' ' ' TRP . . . . . 0.695 ' HZ3' ' HB3' ' A' ' 337' ' ' LYS . 21.0 m-90 -115.59 147.09 41.15 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.882 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -116.48 92.81 3.99 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.476 HG12 HG22 ' A' ' 349' ' ' VAL . 10.2 m -91.42 128.39 43.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.619 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 42.5 ttm-85 -131.82 118.85 20.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.428 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 63.03 41.42 8.29 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.869 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 34.9 t30 68.29 15.37 9.3 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.353 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -126.58 129.26 48.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.72 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.476 HG22 HG12 ' A' ' 344' ' ' VAL . 21.7 t -76.57 121.98 29.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.661 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 26.0 ttp -66.94 151.57 47.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.788 0.327 . . . . 0.0 110.501 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -69.51 161.08 30.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.195 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 90.21 7.07 68.13 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.06 -0.591 . . . . 0.0 111.908 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 353' ' ' TYR . . . . . 0.561 ' HB3' ' HA ' ' A' ' 354' ' ' PRO . 80.5 m-85 -128.78 162.22 52.88 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.561 ' HA ' ' HB3' ' A' ' 353' ' ' TYR . 56.8 Cg_endo -70.37 144.04 76.77 Favored 'Cis proline' 0 C--N 1.346 0.396 0 C-N-CA 123.815 -1.327 . . . . 0.0 112.943 0.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 355' ' ' MET . . . . . 0.502 ' HB2' ' CD1' ' A' ' 353' ' ' TYR . 0.0 OUTLIER -113.23 144.36 31.04 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.36 179.528 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 356' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 355' ' ' MET . 17.5 Cg_exo -68.2 129.65 19.74 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.541 2.16 . . . . 0.0 111.358 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 85.3 mt -56.53 -41.6 73.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.479 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -65.7 -17.57 64.99 Favored Glycine 0 CA--C 1.518 0.25 0 N-CA-C 114.603 0.601 . . . . 0.0 114.603 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -84.65 -45.11 12.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.237 0.519 . . . . 0.0 111.063 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -82.72 -53.92 5.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.189 0.519 . . . . 0.0 110.555 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -92.61 70.24 4.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.553 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -59.41 101.88 0.12 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.208 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 128.95 -20.79 5.35 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.464 HD12 ' HD2' ' A' ' 365' ' ' PRO . 18.8 tp -85.7 134.61 39.39 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 365' ' ' PRO . . . . . 0.464 ' HD2' HD12 ' A' ' 364' ' ' LEU . 97.5 Cg_endo -82.43 -175.17 2.36 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.813 2.342 . . . . 0.0 112.145 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -91.06 153.0 20.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.502 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.0 m 57.12 83.06 0.11 Allowed 'General case' 0 C--O 1.233 0.232 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 13.7 pt -94.9 176.19 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.898 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -111.55 -38.2 4.99 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 1.6 m -149.97 156.23 41.36 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.798 0.332 . . . . 0.0 111.54 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -149.15 135.82 19.54 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 372' ' ' TYR . . . . . 0.459 ' CE1' ' HB ' ' A' ' 380' ' ' VAL . 33.6 p90 -158.48 165.08 35.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.117 0.484 . . . . 0.0 112.191 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 62.5 tt0 -99.14 133.92 42.73 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 374' ' ' ARG . . . . . 0.469 ' HB2' ' OE2' ' A' ' 440' ' ' GLU . 15.2 ptm180 -95.44 -170.69 2.21 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -77.17 -23.56 51.55 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -177.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.63 -11.05 57.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 104.23 -14.37 51.51 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.854 -0.689 . . . . 0.0 113.949 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 378' ' ' LYS . . . . . 0.513 ' HD3' ' HB2' ' A' ' 391' ' ' ASP . 25.2 mttp -82.05 163.66 21.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.305 0.553 . . . . 0.0 111.867 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 379' ' ' PHE . . . . . 0.609 ' HE1' ' HG3' ' A' ' 330' ' ' ARG . 10.5 m-85 -99.96 135.56 41.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.351 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 380' ' ' VAL . . . . . 0.459 ' HB ' ' CE1' ' A' ' 372' ' ' TYR . 12.2 t -116.43 122.02 68.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.254 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -108.2 139.8 42.35 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.56 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.437 ' HE2' HG23 ' A' ' 403' ' ' ILE . 17.6 m-85 -122.01 140.15 52.83 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.71 0.291 . . . . 0.0 111.163 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -154.69 114.13 3.72 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.741 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 67.24 -110.25 3.37 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.833 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -119.32 12.96 12.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.941 0.401 . . . . 0.0 111.185 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -122.14 152.96 39.35 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.894 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -133.9 148.31 51.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.22 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 388' ' ' TRP . . . . . 0.453 ' CE2' ' HB3' ' A' ' 400' ' ' PRO . 21.5 m-90 -122.4 140.41 52.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.149 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 69.5 t -120.34 120.2 62.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -115.8 127.77 55.33 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.513 ' HB2' ' HD3' ' A' ' 378' ' ' LYS . 19.7 t70 -90.79 86.26 6.28 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 176.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 392' ' ' GLU . . . . . 0.418 ' OE1' ' HB ' ' D' ' 213' ' ' ILE . 57.0 mm-40 69.52 -71.47 0.12 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.402 -177.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -142.56 4.56 1.55 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.546 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 13.3 m -106.45 129.05 54.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.713 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 65.1 tp -84.16 133.75 34.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 396' ' ' GLU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 4.0 mt-10 -66.1 135.34 95.08 Favored Pre-proline 0 C--O 1.238 0.489 0 CA-C-O 120.823 0.344 . . . . 0.0 111.039 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 397' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 23.7 Cg_exo -64.81 128.82 21.78 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 123.152 2.568 . . . . 0.0 112.192 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 108.02 -5.27 34.17 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.836 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 399' ' ' TYR . . . . . 0.411 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 33.9 m-85 -94.0 159.56 34.12 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 111.526 0.195 . . . . 0.0 111.526 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.453 ' HB3' ' CE2' ' A' ' 388' ' ' TRP . 71.9 Cg_endo -74.44 162.5 92.4 Favored 'Cis proline' 0 C--N 1.344 0.314 0 C-N-CA 123.477 -1.468 . . . . 0.0 112.939 0.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -125.59 161.39 27.32 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 0.452 ' ND1' ' HG3' ' A' ' 404' ' ' LYS . 23.7 t-80 -69.9 155.89 39.89 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 403' ' ' ILE . . . . . 0.437 HG23 ' HE2' ' A' ' 382' ' ' PHE . 67.5 mt -56.33 -40.98 69.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.368 . . . . 0.0 111.481 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 404' ' ' LYS . . . . . 0.452 ' HG3' ' ND1' ' A' ' 402' ' ' HIS . 0.0 OUTLIER -67.55 -12.18 59.77 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -179.441 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -78.93 -18.39 53.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.87 0.367 . . . . 0.0 110.946 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 38.5 tp -79.5 -31.97 42.36 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.268 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.519 ' HA2' ' HG2' ' A' ' 443' ' ' ARG . . . -176.82 165.77 36.12 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.261 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -90.33 132.87 35.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.572 0.225 . . . . 0.0 110.804 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.16 12.85 47.73 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.193 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 61.3 mt -92.25 146.31 32.38 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.638 0.256 . . . . 0.0 111.372 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.65 115.65 2.55 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.036 2.49 . . . . 0.0 111.232 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 1.1 m -84.49 1.88 43.56 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.505 -179.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -97.24 -59.78 1.72 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.305 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -174.48 173.03 3.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.872 0.368 . . . . 0.0 110.933 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 43.9 mm -122.41 136.23 59.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.599 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -94.54 -43.31 8.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.202 0.525 . . . . 0.0 110.154 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -156.8 163.24 39.45 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.844 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -149.32 127.0 11.69 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 36.4 tp -121.88 128.86 52.07 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.028 0.442 . . . . 0.0 111.16 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -92.39 119.39 31.89 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 18.3 t-105 -85.21 91.65 8.2 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.341 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 13.9 mmt -47.28 -49.9 50.54 Favored Pre-proline 0 N--CA 1.47 0.533 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -45.93 -41.98 20.41 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.02 2.48 . . . . 0.0 115.476 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -115.34 -28.53 6.85 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 98.85 16.59 30.47 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.498 -0.858 . . . . 0.0 113.151 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -92.5 147.3 23.01 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 3.0 m -104.9 122.73 46.41 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.92 0.391 . . . . 0.0 110.867 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -99.35 111.79 24.09 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.946 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -95.69 137.37 34.84 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.876 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -112.69 127.58 56.16 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.976 0.417 . . . . 0.0 111.504 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.486 ' HB3' ' HE1' ' A' ' 436' ' ' TYR . 2.9 tpm_? -134.51 98.29 4.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.776 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 67.0 -107.37 1.98 Allowed Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.872 -0.603 . . . . 0.0 112.285 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 433' ' ' ASN . . . . . 0.597 ' HB3' ' HG2' ' A' ' 461' ' ' GLU . 4.9 p30 -112.59 15.65 19.99 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.96 0.409 . . . . 0.0 111.278 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 434' ' ' LYS . . . . . 0.516 ' HB3' ' HB2' ' A' ' 450' ' ' PRO . 68.0 mmtt -128.77 141.39 51.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.823 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 435' ' ' TYR . . . . . 0.538 ' CE2' ' HE2' ' A' ' 449' ' ' TYR . 14.3 p90 -120.86 142.69 49.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.031 0.443 . . . . 0.0 110.659 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 436' ' ' TYR . . . . . 0.486 ' HE1' ' HB3' ' A' ' 431' ' ' ARG . 4.3 m-85 -112.84 148.48 34.81 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.506 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 19.7 ttp180 -112.5 91.43 3.65 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 438' ' ' PHE . . . . . 0.412 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 81.3 t80 -85.14 134.99 34.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.143 0.497 . . . . 0.0 111.144 -178.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 439' ' ' ASN . . . . . 0.552 ' HB3' ' HB3' ' A' ' 442' ' ' LEU . 3.8 t30 -107.35 118.61 37.17 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.791 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 440' ' ' GLU . . . . . 0.469 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 0.4 OUTLIER -55.52 -57.05 13.52 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.37 -179.502 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -80.12 54.52 1.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.908 0.385 . . . . 0.0 110.951 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 442' ' ' LEU . . . . . 0.552 ' HB3' ' HB3' ' A' ' 439' ' ' ASN . 29.4 tp -168.35 -33.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.098 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 443' ' ' ARG . . . . . 0.519 ' HG2' ' HA2' ' A' ' 407' ' ' GLY . 20.8 ttt180 64.45 31.96 12.18 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.551 0.691 . . . . 0.0 111.055 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -152.36 163.83 38.69 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.454 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 86.8 t -89.37 143.0 12.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.025 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.63 156.83 18.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.462 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 447' ' ' SER . . . . . 0.592 ' O ' ' HB2' ' A' ' 448' ' ' GLU . 1.5 m -69.01 151.13 46.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.343 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 448' ' ' GLU . . . . . 0.736 ' HB3' ' HE2' ' A' ' 451' ' ' LYS . 6.8 mt-10 85.03 -6.53 0.92 Allowed 'General case' 0 N--CA 1.471 0.575 0 O-C-N 124.269 0.981 . . . . 0.0 112.01 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 449' ' ' TYR . . . . . 0.538 ' HE2' ' CE2' ' A' ' 435' ' ' TYR . 92.3 m-85 -100.12 157.94 32.93 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.796 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 450' ' ' PRO . . . . . 0.516 ' HB2' ' HB3' ' A' ' 434' ' ' LYS . 61.2 Cg_endo -72.07 155.22 98.34 Favored 'Cis proline' 0 C--N 1.345 0.39 0 C-N-CA 123.585 -1.423 . . . . 0.0 112.797 0.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 451' ' ' LYS . . . . . 0.736 ' HE2' ' HB3' ' A' ' 448' ' ' GLU . 51.4 mttm -118.88 165.71 13.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.682 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 452' ' ' ASN . . . . . 0.557 ' ND2' ' HB2' ' A' ' 454' ' ' LYS . 38.9 t30 -61.06 128.07 34.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.446 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 453' ' ' ILE . . . . . 0.501 HG21 ' HG3' ' A' ' 461' ' ' GLU . 10.7 tt -65.03 -17.23 21.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.799 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 454' ' ' LYS . . . . . 0.557 ' HB2' ' ND2' ' A' ' 452' ' ' ASN . 67.1 mttm -67.73 -2.79 7.62 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 50.4 t -65.24 -33.38 63.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 456' ' ' TRP . . . . . 0.419 ' HE3' ' CZ ' ' A' ' 486' ' ' PHE . 26.4 m95 -83.23 90.85 7.16 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 457' ' ' GLU . . . . . 0.636 ' HB3' ' HG3' ' A' ' 492' ' ' LYS . 0.3 OUTLIER -51.68 108.82 0.3 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -178.61 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 108.32 -17.34 34.33 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.935 -0.65 . . . . 0.0 113.818 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.414 ' HB ' ' HB2' ' A' ' 456' ' ' TRP . 29.8 mm -79.32 122.93 84.64 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.98 0.419 . . . . 0.0 111.694 -179.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.33 155.22 36.83 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.865 2.377 . . . . 0.0 111.778 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 461' ' ' GLU . . . . . 0.597 ' HG2' ' HB3' ' A' ' 433' ' ' ASN . 0.9 OUTLIER -74.77 144.97 43.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.679 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 2.9 m 57.03 75.28 0.58 Allowed Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.913 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.27 -176.8 3.39 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 123.011 2.474 . . . . 0.0 111.868 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 464' ' ' ARG . . . . . 0.489 ' HA ' ' HE ' ' A' ' 464' ' ' ARG . 0.2 OUTLIER -135.87 27.44 3.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.248 0.547 . . . . 0.0 110.327 179.602 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 153.22 144.62 3.95 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.432 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 4.1 p -156.25 123.41 5.34 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -144.43 149.61 36.32 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.721 0.296 . . . . 0.0 111.128 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 468' ' ' MET . . . . . 0.412 ' HA ' ' HA ' ' A' ' 475' ' ' THR . 49.5 ttm -103.68 141.66 35.68 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -69.0 168.76 43.96 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.677 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 4.9 m -72.23 -10.89 60.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.084 0.469 . . . . 0.0 110.919 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 471' ' ' ASP . . . . . 0.465 ' OD2' ' HB ' ' A' ' 473' ' ' VAL . 11.9 p-10 -83.36 -17.15 43.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.007 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 68.22 7.92 6.22 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 473' ' ' VAL . . . . . 0.465 ' HB ' ' OD2' ' A' ' 471' ' ' ASP . 48.8 t -105.8 -35.39 3.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.766 0.317 . . . . 0.0 111.443 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -110.55 131.02 55.41 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 475' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 468' ' ' MET . 94.1 m -114.7 141.87 47.25 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.593 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 476' ' ' TYR . . . . . 0.418 ' HE1' ' HD2' ' A' ' 485' ' ' LYS . 73.0 m-85 -118.97 134.49 55.15 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 477' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 483' ' ' TYR . 20.0 m-85 -117.84 134.8 54.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.232 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -109.45 133.7 52.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.562 0.22 . . . . 0.0 111.154 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 479' ' ' LYS . . . . . 0.437 ' HB3' ' CZ3' ' A' ' 484' ' ' TRP . 54.4 tttp -170.07 133.88 1.2 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.594 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 64.27 35.21 91.69 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 121.311 -0.471 . . . . 0.0 113.603 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 481' ' ' ASN . . . . . 0.4 HD21 ' CD1' ' A' ' 502' ' ' LEU . 58.1 t30 67.21 10.92 8.08 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.589 0.709 . . . . 0.0 111.442 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -125.97 161.54 27.28 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.525 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 483' ' ' TYR . . . . . 0.413 ' CE2' ' HE2' ' A' ' 497' ' ' TYR . 15.4 p90 -129.83 151.65 50.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.845 0.355 . . . . 0.0 111.571 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 484' ' ' TRP . . . . . 0.437 ' CZ3' ' HB3' ' A' ' 479' ' ' LYS . 12.4 m-90 -112.51 145.84 39.54 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.149 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 485' ' ' LYS . . . . . 0.418 ' HD2' ' HE1' ' A' ' 476' ' ' TYR . 18.2 tttt -107.25 98.2 7.87 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 486' ' ' PHE . . . . . 0.458 ' HA ' ' HA ' ' A' ' 493' ' ' VAL . 51.8 t80 -90.35 125.16 35.44 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.264 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -90.21 115.08 27.16 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -63.7 -33.21 75.13 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -71.17 -40.88 71.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.928 0.394 . . . . 0.0 111.725 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -91.02 -14.28 31.68 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.4 tp 59.68 37.32 22.35 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.434 0.635 . . . . 0.0 110.618 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 492' ' ' LYS . . . . . 0.636 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 59.1 tttp -154.37 151.78 29.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.888 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 493' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 486' ' ' PHE . 58.5 t -74.52 132.77 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -67.53 143.56 97.13 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.549 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -61.18 149.92 86.98 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.257 2.638 . . . . 0.0 112.919 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 97.76 17.34 30.86 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 497' ' ' TYR . . . . . 0.546 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 19.2 m-85 -126.59 167.56 16.96 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 498' ' ' PRO . . . . . 0.546 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 94.3 Cg_endo -76.91 169.75 73.57 Favored 'Cis proline' 0 C--N 1.344 0.331 0 C-N-CA 124.001 -1.25 . . . . 0.0 112.962 0.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -124.97 150.35 46.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.537 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 37.4 t -64.4 119.76 10.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.257 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -64.83 -32.75 74.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.892 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 502' ' ' LEU . . . . . 0.571 HD23 ' HG3' ' A' ' 506' ' ' MET . 20.5 mt -62.81 -47.45 83.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.146 0.498 . . . . 0.0 111.16 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -75.48 -31.9 60.38 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.51 -33.47 17.76 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -177.035 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 15.9 m0 -127.64 -27.75 2.82 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -177.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 506' ' ' MET . . . . . 0.571 ' HG3' HD23 ' A' ' 502' ' ' LEU . 14.6 mmt -85.64 -6.46 59.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -177.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 71.2 42.87 57.11 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.937 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 508' ' ' CYS . . . . . 0.562 ' HB2' ' HB3' ' A' ' 502' ' ' LEU . 59.9 m -120.55 93.57 48.46 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-O 120.707 0.289 . . . . 0.0 110.939 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -73.23 134.26 20.76 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.009 2.472 . . . . 0.0 111.814 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 5.1 m 55.53 68.9 0.79 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.341 0.591 . . . . 0.0 111.725 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.536 -1.146 . . . . 0.0 112.401 -179.626 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.598 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo . . . . . 0 N--CA 1.464 -0.233 0 C-N-CA 122.468 2.112 . . . . 0.0 111.304 179.565 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.46 0 N-CA-C 113.275 0.07 . . . . 0.0 113.275 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo . . . . . 0 CA--C 1.532 0.377 0 C-N-CA 122.939 2.426 . . . . 0.0 111.635 179.838 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.427 0 CA-C-O 120.308 -0.162 . . . . 0.0 112.722 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo . . . . . 0 CA--C 1.539 0.728 0 C-N-CA 123.133 2.556 . . . . 0.0 112.755 179.527 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.618 0 N-CA-C 112.598 -0.201 . . . . 0.0 112.598 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -64.76 140.91 69.7 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.987 2.458 . . . . 0.0 112.022 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 11' ' ' GLN . . . . . 0.596 ' HG3' ' HG2' ' C' ' 110' ' ' PRO . 61.1 tt0 -69.64 149.48 48.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.414 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.9 153.42 47.6 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.231 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 8.9 mt -67.64 149.3 11.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.66 152.89 37.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.882 0.372 . . . . 0.0 111.282 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 15' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' D' ' 213' ' ' ILE . . . -74.76 166.03 54.81 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.343 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -80.54 148.74 30.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.733 0.301 . . . . 0.0 110.353 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -76.4 141.56 41.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.356 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.28 150.85 46.43 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.787 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.9 t -69.68 155.46 7.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.402 HG23 ' H ' ' B' ' 20' ' ' VAL . 3.1 t -52.89 146.6 2.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.454 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.81 168.64 54.81 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.747 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 C--N 1.32 -0.676 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 -179.823 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.534 0 CA-C-O 120.493 -0.06 . . . . 0.0 113.238 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo . . . . . 0 CA--C 1.53 0.276 0 C-N-CA 122.652 2.235 . . . . 0.0 111.576 179.252 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.509 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo . . . . . 0 C--O 1.236 0.379 0 C-N-CA 122.828 2.352 . . . . 0.0 111.802 -179.972 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.457 0 N-CA-C 113.377 0.111 . . . . 0.0 113.377 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo . . . . . 0 CA--C 1.53 0.308 0 C-N-CA 123.356 2.704 . . . . 0.0 111.734 179.659 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 33' ' ' GLY . . . . . 0.429 ' HA2' ' HD3' ' B' ' 34' ' ' PRO . . . . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 112.665 -0.174 . . . . 0.0 112.665 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 34' ' ' PRO . . . . . 0.429 ' HD3' ' HA2' ' B' ' 33' ' ' GLY . 3.2 Cg_exo . . . . . 0 N--CA 1.463 -0.268 0 C-N-CA 122.909 2.406 . . . . 0.0 111.794 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 112.733 -0.147 . . . . 0.0 112.733 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 CA--C 1.534 0.521 0 C-N-CA 122.909 2.406 . . . . 0.0 112.769 -179.414 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 CA-C-O 120.393 -0.115 . . . . 0.0 112.824 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo . . . . . 0 CA--C 1.532 0.411 0 C-N-CA 122.803 2.335 . . . . 0.0 112.296 -179.634 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.635 0 N-CA-C 111.787 -0.525 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo . . . . . 0 CA--C 1.531 0.328 0 C-N-CA 123.115 2.543 . . . . 0.0 110.437 179.303 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 120.742 0.079 . . . . 0.0 113.171 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 110' ' ' PRO . . . . . 0.596 ' HG2' ' HG3' ' B' ' 11' ' ' GLN . 32.3 Cg_endo -64.03 150.06 89.16 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.872 2.381 . . . . 0.0 112.021 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -61.61 140.91 58.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.261 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -66.81 152.27 52.57 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.016 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 23.3 mt -65.57 137.11 25.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.7 149.98 38.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.889 0.376 . . . . 0.0 111.123 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -65.44 162.34 40.94 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.972 -0.632 . . . . 0.0 111.909 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -85.21 153.58 22.54 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.906 -0.317 . . . . 0.0 110.604 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 35.7 ttm-85 -61.74 144.77 54.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.329 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.08 169.56 27.2 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.545 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.33 142.12 14.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.821 0.343 . . . . 0.0 110.324 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 120' ' ' VAL . . . . . 0.496 HG13 ' HB ' ' D' ' 219' ' ' VAL . 24.8 t -62.48 143.48 15.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.427 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.02 161.05 54.23 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.406 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--N 1.322 -0.598 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 179.804 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.598 0 CA-C-O 120.372 -0.127 . . . . 0.0 112.956 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 C--O 1.236 0.379 0 C-N-CA 122.565 2.177 . . . . 0.0 111.409 179.66 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.635 0 N-CA-C 112.903 -0.079 . . . . 0.0 112.903 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 C--O 1.236 0.398 0 C-N-CA 122.672 2.248 . . . . 0.0 111.332 179.624 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 113.557 0.183 . . . . 0.0 113.557 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo . . . . . 0 CA--C 1.529 0.273 0 C-N-CA 123.141 2.561 . . . . 0.0 111.687 179.691 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 133' ' ' GLY . . . . . 0.44 ' HA2' ' HD3' ' C' ' 134' ' ' PRO . . . . . . . . 0 N--CA 1.45 -0.42 0 CA-C-O 119.896 -0.391 . . . . 0.0 112.294 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 134' ' ' PRO . . . . . 0.44 ' HD3' ' HA2' ' C' ' 133' ' ' GLY . 14.7 Cg_exo . . . . . 0 C--O 1.235 0.337 0 C-N-CA 123.287 2.658 . . . . 0.0 112.14 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 N-CA-C 112.553 -0.219 . . . . 0.0 112.553 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo . . . . . 0 C--N 1.346 0.416 0 C-N-CA 123.15 2.567 . . . . 0.0 112.074 179.381 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.257 0 N-CA-C 113.978 0.351 . . . . 0.0 113.978 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo . . . . . 0 CA--C 1.532 0.376 0 C-N-CA 123.53 2.82 . . . . 0.0 111.952 179.835 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.413 0 N-CA-C 112.61 -0.196 . . . . 0.0 112.61 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo . . . . . 0 N--CA 1.461 -0.429 0 C-N-CA 123.078 2.519 . . . . 0.0 112.137 179.95 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.545 0 N-CA-C 111.988 -0.445 . . . . 0.0 111.988 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.42 141.14 73.06 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.589 2.193 . . . . 0.0 111.797 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -63.88 145.05 56.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.004 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -66.76 159.84 48.39 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.758 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 213' ' ' ILE . . . . . 0.418 ' HB ' ' OE1' ' A' ' 392' ' ' GLU . 47.4 pt -74.35 164.75 3.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.774 0.321 . . . . 0.0 111.02 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 214' ' ' ALA . . . . . 0.477 ' HB3' ' NH1' ' A' ' 330' ' ' ARG . . . -82.25 137.46 34.86 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.918 0.39 . . . . 0.0 110.725 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -65.3 164.87 36.47 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.853 -0.612 . . . . 0.0 113.039 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -68.81 156.46 38.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.675 0.274 . . . . 0.0 110.323 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -70.75 162.03 29.82 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -60.41 154.02 34.94 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.526 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 219' ' ' VAL . . . . . 0.496 ' HB ' HG13 ' C' ' 120' ' ' VAL . 21.0 t -70.78 149.4 10.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 42.9 t -64.41 140.45 19.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.56 167.69 13.85 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.299 -0.477 . . . . 0.0 113.318 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 C--N 1.324 -0.542 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 -179.921 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 112.139 -0.384 . . . . 0.0 112.139 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo . . . . . 0 C--O 1.232 0.197 0 C-N-CA 122.877 2.385 . . . . 0.0 111.577 179.923 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.524 0 N-CA-C 113.323 0.089 . . . . 0.0 113.323 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo . . . . . 0 CA--C 1.531 0.346 0 C-N-CA 123.054 2.502 . . . . 0.0 111.475 179.743 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.551 0 N-CA-C 113.286 0.075 . . . . 0.0 113.286 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 CA--C 1.529 0.24 0 C-N-CA 123.182 2.588 . . . . 0.0 111.928 -179.996 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.425 ' HB2' ' HH2' ' A' ' 342' ' ' TRP . 6.0 Cg_exo . . . . . 0 N--CA 1.478 0.588 0 N-CA-C 109.714 -0.918 . . . . 0.0 109.714 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -102.69 148.61 25.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.663 0.268 . . . . 0.0 110.775 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 8.1 tp -73.57 -26.71 22.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.383 0.611 . . . . 0.0 110.681 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 37.3 m -88.74 26.33 1.54 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.81 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -76.77 -41.83 43.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.306 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 83.37 170.68 46.6 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.205 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 50.3 t30 50.65 68.97 0.69 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.198 0.523 . . . . 0.0 111.125 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -87.17 175.49 8.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.47 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 324' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 464' ' ' ARG . 4.7 m-20 -74.62 -46.96 34.95 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 14.5 t -171.34 153.95 3.75 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.518 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 57.0 t -131.39 124.42 54.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 327' ' ' ALA . . . . . 0.446 ' HA ' ' CD1' ' A' ' 467' ' ' PHE . . . -141.59 169.04 18.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.009 0.433 . . . . 0.0 111.832 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 39.3 ttp -120.84 121.0 37.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.358 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 58.9 mt -112.18 115.7 29.26 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.666 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 330' ' ' ARG . . . . . 0.464 ' HG3' ' HE1' ' A' ' 379' ' ' PHE . 44.9 mtp180 57.16 22.31 7.4 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 109.85 -14.77 31.73 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.85 -0.69 . . . . 0.0 113.656 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -99.84 129.46 45.94 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.938 0.369 . . . . 0.0 111.324 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 47.1 ttm -89.1 126.18 35.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.923 0.392 . . . . 0.0 111.082 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -119.68 132.86 55.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.114 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 23.9 t -107.02 117.33 52.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.502 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -100.68 126.62 47.21 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 0.794 ' HB3' ' HZ3' ' A' ' 342' ' ' TRP . 27.5 tptt -139.71 102.78 4.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.157 178.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 63.92 -102.25 0.1 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.66 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.5 ptm85 -117.49 8.09 12.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.917 0.389 . . . . 0.0 111.962 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 3.0 m-90 -127.01 146.03 50.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.048 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -128.66 146.1 50.97 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.966 0.412 . . . . 0.0 110.985 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 342' ' ' TRP . . . . . 0.794 ' HZ3' ' HB3' ' A' ' 337' ' ' LYS . 20.4 m-90 -108.66 150.87 26.93 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.425 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.637 ' HD3' ' SD ' ' A' ' 350' ' ' MET . 24.1 ttt-85 -113.8 100.89 8.79 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 3.1 m -93.49 129.43 43.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.137 0.494 . . . . 0.0 111.386 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.15 109.87 6.68 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.536 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 63.66 47.01 3.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.774 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 7.2 m120 64.68 27.96 13.13 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.185 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -142.06 150.17 40.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.952 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 47.4 t -91.76 129.19 42.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 350' ' ' MET . . . . . 0.637 ' SD ' ' HD3' ' A' ' 343' ' ' ARG . 89.5 mtp -77.23 165.44 24.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.026 0.441 . . . . 0.0 111.78 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -77.72 154.51 32.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.696 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 94.76 -5.8 69.75 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 111.701 -0.56 . . . . 0.0 111.701 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 353' ' ' TYR . . . . . 0.494 ' CE1' ' HD2' ' A' ' 343' ' ' ARG . 83.1 m-85 -118.85 159.0 46.25 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 110.448 -0.205 . . . . 0.0 110.448 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.478 ' C ' ' HA ' ' A' ' 353' ' ' TYR . 37.9 Cg_endo -65.67 137.88 34.4 Favored 'Cis proline' 0 C--N 1.348 0.542 0 C-N-CA 123.966 -1.264 . . . . 0.0 112.564 0.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 355' ' ' MET . . . . . 0.42 ' HA ' ' HD3' ' A' ' 356' ' ' PRO . 10.6 ttt -112.72 141.34 25.21 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.429 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 356' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 355' ' ' MET . 50.7 Cg_exo -58.19 127.3 24.39 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.574 2.183 . . . . 0.0 111.204 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 66.8 mt -56.11 -42.42 72.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.942 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -70.3 -16.38 73.31 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.794 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -82.51 -28.28 31.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.046 0.451 . . . . 0.0 110.791 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -98.66 -53.0 3.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.239 0.543 . . . . 0.0 109.725 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -93.32 71.15 4.43 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -56.93 99.44 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.672 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 128.27 -17.09 5.95 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.969 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.475 ' HA ' ' HD3' ' A' ' 365' ' ' PRO . 30.9 tp -91.84 125.52 56.91 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-O 120.561 0.22 . . . . 0.0 110.764 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 365' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 364' ' ' LEU . 3.0 Cg_exo -77.38 170.19 19.85 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 123.06 2.507 . . . . 0.0 111.774 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -77.26 159.41 29.64 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.654 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 16.6 m 57.92 82.95 0.12 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.41 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 27.9 pt -100.38 173.23 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.911 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 369' ' ' ASN . . . . . 0.418 HD22 ' HA ' ' A' ' 369' ' ' ASN . 1.5 m120 -95.79 -55.84 2.87 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 370' ' ' THR . . . . . 0.7 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.2 OUTLIER -155.49 164.13 39.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.575 -179.838 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -147.75 149.02 31.61 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 372' ' ' TYR . . . . . 0.61 ' HE1' ' HE2' ' A' ' 382' ' ' PHE . 19.3 p90 -164.64 166.35 20.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.867 0.365 . . . . 0.0 111.768 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -97.3 125.53 41.94 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 374' ' ' ARG . . . . . 0.498 ' HB2' ' OE2' ' A' ' 440' ' ' GLU . 10.6 ptm180 -84.44 -172.05 3.96 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.576 ' HB2' ' HG3' ' A' ' 440' ' ' GLU . 4.7 tttp -63.5 -40.72 97.81 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.01 -30.09 58.37 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 127.17 -14.7 6.54 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.731 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 38.2 mttp -70.45 149.13 47.55 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.746 0.307 . . . . 0.0 110.798 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 379' ' ' PHE . . . . . 0.464 ' HE1' ' HG3' ' A' ' 330' ' ' ARG . 16.0 m-85 -95.65 126.71 41.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.058 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 380' ' ' VAL . . . . . 0.513 ' HB ' ' CE1' ' A' ' 372' ' ' TYR . 17.1 t -106.31 115.49 48.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.981 0.419 . . . . 0.0 110.558 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -102.72 128.95 49.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.531 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.61 ' HE2' ' HE1' ' A' ' 372' ' ' TYR . 59.1 m-85 -107.77 143.32 36.49 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.398 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.699 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 60.5 tttp -152.01 92.93 1.77 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 384' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 414' ' ' LYS . . . 75.71 -113.09 3.8 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -108.11 -0.73 20.94 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.032 0.444 . . . . 0.0 110.772 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -109.3 147.3 32.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.977 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -132.64 147.87 52.35 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.357 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 388' ' ' TRP . . . . . 0.699 ' HZ3' ' HB3' ' A' ' 383' ' ' LYS . 20.9 m-90 -121.28 131.17 54.05 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.169 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 55.9 t -107.0 114.64 46.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -106.41 125.48 51.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.645 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -97.43 89.25 4.64 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 67.82 -85.98 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.308 -178.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -130.65 21.13 5.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.21 0.529 . . . . 0.0 110.886 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 10.2 m -133.83 135.29 43.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.02 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 57.3 tp -80.97 136.92 36.09 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.442 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 396' ' ' GLU . . . . . 0.648 ' HB3' ' CE1' ' A' ' 399' ' ' TYR . 0.0 OUTLIER -67.25 143.16 97.35 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.388 179.221 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.01 140.83 28.94 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 122.602 2.201 . . . . 0.0 112.581 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 91.24 26.26 21.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.542 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 399' ' ' TYR . . . . . 0.657 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 42.8 m-85 -118.88 163.54 25.59 Favored Pre-proline 0 C--N 1.324 -0.534 0 O-C-N 122.679 -0.307 . . . . 0.0 111.081 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.657 ' HA ' ' HB3' ' A' ' 399' ' ' TYR . 84.1 Cg_endo -77.44 162.87 89.8 Favored 'Cis proline' 0 C--N 1.345 0.38 0 C-N-CA 123.529 -1.446 . . . . 0.0 113.067 0.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -121.0 161.46 21.59 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 0.668 ' HB2' ' HG2' ' A' ' 405' ' ' GLU . 7.6 m-70 -74.84 153.54 38.66 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 71.2 mt -57.75 -38.62 66.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.27 0.557 . . . . 0.0 109.845 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 404' ' ' LYS . . . . . 0.417 ' HG3' ' HB3' ' A' ' 402' ' ' HIS . 0.0 OUTLIER -68.9 -10.74 58.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.469 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.668 ' HG2' ' HB2' ' A' ' 402' ' ' HIS . 78.4 mm-40 -84.45 -30.8 24.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.861 0.363 . . . . 0.0 110.435 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 47.6 tp -63.81 -51.88 62.74 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.859 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 407' ' ' GLY . . . . . 0.816 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -152.69 162.45 29.99 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.296 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -86.85 129.05 35.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.592 0.234 . . . . 0.0 110.404 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.57 6.79 43.55 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.32 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 65.6 mt -86.95 156.05 55.24 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 122.961 -0.141 . . . . 0.0 110.624 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -65.13 144.47 81.78 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.626 2.217 . . . . 0.0 112.371 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.24 25.17 9.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.031 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 413' ' ' ASP . . . . . 0.479 ' OD2' ' HD3' ' A' ' 431' ' ' ARG . 1.7 p-10 -119.42 -76.03 0.58 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.606 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 414' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 384' ' ' GLY . 7.8 ptmt -160.61 -176.75 5.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.82 0.343 . . . . 0.0 110.445 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 34.4 mm -125.59 135.61 63.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -94.48 -52.19 4.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.325 0.583 . . . . 0.0 110.062 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 417' ' ' ALA . . . . . 0.7 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -147.13 145.63 29.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.946 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -129.01 117.18 20.5 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 57.8 tp -114.09 147.96 37.89 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.051 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -120.65 119.42 32.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.617 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 421' ' ' TRP . . . . . 0.466 ' HB2' ' HE2' ' A' ' 428' ' ' TYR . 7.0 t-105 -86.85 94.8 9.66 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.446 ' HB2' ' HD3' ' A' ' 423' ' ' PRO . 64.1 mtt -51.42 -51.71 66.56 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 92.5 Cg_exo -47.18 -33.82 16.54 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 123.029 2.486 . . . . 0.0 115.278 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 424' ' ' ASN . . . . . 0.408 ' OD1' ' HB3' ' A' ' 421' ' ' TRP . 33.0 p30 -115.06 -24.54 8.52 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 87.47 23.02 41.39 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.403 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -108.21 149.9 27.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 117.131 0.465 . . . . 0.0 111.169 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.45 146.16 25.49 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.436 -178.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 428' ' ' TYR . . . . . 0.466 ' HE2' ' HB2' ' A' ' 421' ' ' TRP . 81.8 m-85 -124.9 110.16 13.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.498 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -98.98 123.14 43.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.797 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 430' ' ' PHE . . . . . 0.442 ' HB2' ' HB3' ' A' ' 417' ' ' ALA . 89.8 m-85 -98.79 130.28 45.23 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.608 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 431' ' ' ARG . . . . . 0.479 ' HD3' ' OD2' ' A' ' 413' ' ' ASP . 2.0 tpm_? -140.05 106.81 5.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.163 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 66.72 -102.62 0.78 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.742 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -123.67 14.44 9.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.068 0.461 . . . . 0.0 110.154 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 52.0 mmtt -122.46 156.29 34.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.067 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 435' ' ' TYR . . . . . 0.537 ' CE2' ' HE1' ' A' ' 449' ' ' TYR . 7.8 p90 -135.3 139.36 44.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.928 0.394 . . . . 0.0 110.573 178.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -108.07 143.72 36.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.699 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -106.79 103.4 12.83 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 438' ' ' PHE . . . . . 0.816 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 66.6 t80 -92.42 135.23 34.22 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.482 -178.102 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -107.86 107.74 18.61 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 440' ' ' GLU . . . . . 0.576 ' HG3' ' HB2' ' A' ' 375' ' ' LYS . 4.9 mm-40 -49.39 -51.3 35.93 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -54.76 -48.71 72.28 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 52.5 mt -86.45 -18.05 32.69 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 61.36 39.45 15.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.631 0.729 . . . . 0.0 110.57 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -148.79 155.07 40.45 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.497 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 97.8 t -80.31 140.13 17.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.845 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -62.49 156.95 21.48 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.4 m -66.71 152.43 45.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.82 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 72.34 29.4 2.19 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.272 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 449' ' ' TYR . . . . . 0.537 ' HE1' ' CE2' ' A' ' 435' ' ' TYR . 27.5 m-85 -126.39 160.9 55.5 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.192 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.81 160.77 95.51 Favored 'Cis proline' 0 C--N 1.347 0.479 0 C-N-CA 123.728 -1.363 . . . . 0.0 112.337 -0.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 451' ' ' LYS . . . . . 0.506 ' HB2' ' CE1' ' A' ' 435' ' ' TYR . 60.4 mttm -109.71 176.76 4.95 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.106 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -76.8 139.82 40.49 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.518 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 453' ' ' ILE . . . . . 0.438 HD13 ' HA ' ' A' ' 461' ' ' GLU . 15.4 tt -66.83 -11.99 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.109 0.48 . . . . 0.0 110.709 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 454' ' ' LYS . . . . . 0.446 ' HD3' ' HA ' ' A' ' 454' ' ' LYS . 48.5 mmtt -68.69 -7.0 29.48 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.151 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 76.7 t -66.21 -30.95 51.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 456' ' ' TRP . . . . . 0.477 ' HE3' ' CZ ' ' A' ' 486' ' ' PHE . 6.7 m95 -97.72 85.59 3.6 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.545 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 457' ' ' GLU . . . . . 0.467 ' HB3' ' HG3' ' A' ' 492' ' ' LYS . 1.6 tm-20 -54.43 114.78 1.79 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.62 -178.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 108.0 -21.16 29.98 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.065 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 19.1 mm -71.04 127.15 91.94 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 120.868 0.366 . . . . 0.0 111.077 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.25 139.51 32.32 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.925 2.417 . . . . 0.0 112.603 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 461' ' ' GLU . . . . . 0.438 ' HA ' HD13 ' A' ' 453' ' ' ILE . 27.6 mp0 -68.34 138.78 55.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.002 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.3 m 59.33 70.31 1.14 Allowed Pre-proline 0 C--O 1.234 0.288 0 O-C-N 123.58 0.55 . . . . 0.0 112.177 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -85.95 -179.53 3.31 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.013 2.476 . . . . 0.0 111.164 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 464' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 324' ' ' ASP . 0.0 OUTLIER -142.39 29.21 1.61 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.439 0.638 . . . . 0.0 110.738 179.768 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 174.05 135.15 1.97 Allowed Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 5.3 p -158.49 114.38 2.69 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.706 0.289 . . . . 0.0 110.236 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 467' ' ' PHE . . . . . 0.446 ' CD1' ' HA ' ' A' ' 327' ' ' ALA . 30.3 p90 -145.14 140.7 28.17 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.696 0.284 . . . . 0.0 111.215 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 468' ' ' MET . . . . . 0.434 ' HA ' ' HA ' ' A' ' 475' ' ' THR . 46.5 ttm -89.93 141.14 28.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.244 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -70.38 166.16 51.1 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.769 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.36 -14.62 57.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.895 0.378 . . . . 0.0 111.906 -179.187 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -81.43 -18.39 45.53 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.391 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 68.09 11.96 8.58 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.015 0.526 . . . . 0.0 112.254 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 49.1 t -110.46 -36.12 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.891 0.377 . . . . 0.0 111.057 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -111.53 133.68 53.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.275 0.559 . . . . 0.0 111.996 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 475' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 468' ' ' MET . 88.3 m -116.54 133.03 56.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.381 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -101.42 135.93 42.11 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.967 0.413 . . . . 0.0 111.807 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -122.2 138.49 54.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.422 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -121.74 134.36 54.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.803 0.335 . . . . 0.0 111.524 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 48.0 tttt -166.06 131.94 2.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.222 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 56.12 44.74 88.54 Favored Glycine 0 C--N 1.33 0.227 0 CA-C-N 115.944 -0.571 . . . . 0.0 114.307 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 23.0 t30 65.47 8.49 5.07 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -118.28 158.35 25.35 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 483' ' ' TYR . . . . . 0.458 ' CE2' ' HE2' ' A' ' 497' ' ' TYR . 3.5 p90 -131.7 147.6 52.52 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.989 0.424 . . . . 0.0 111.934 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 484' ' ' TRP . . . . . 0.548 ' CE2' ' HB3' ' A' ' 498' ' ' PRO . 11.3 m-90 -116.36 157.21 25.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.133 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -120.45 99.38 6.53 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 486' ' ' PHE . . . . . 0.477 ' CZ ' ' HE3' ' A' ' 456' ' ' TRP . 77.4 t80 -86.28 127.41 34.77 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.941 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -93.18 112.81 24.86 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -63.68 -26.99 68.91 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -76.6 -30.85 57.13 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -99.2 -21.02 16.31 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.8 tp 66.17 33.4 7.4 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -177.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 492' ' ' LYS . . . . . 0.467 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 6.0 tttp -152.45 159.92 43.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.044 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 493' ' ' VAL . . . . . 0.429 ' N ' ' HG2' ' A' ' 492' ' ' LYS . 77.8 t -79.29 139.55 18.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.643 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -65.98 138.44 96.3 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.322 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.19 138.36 80.96 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 123.225 2.617 . . . . 0.0 112.59 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 111.21 -1.61 28.25 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 497' ' ' TYR . . . . . 0.526 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 37.5 m-85 -108.87 164.49 14.6 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.825 -0.187 . . . . 0.0 111.226 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 498' ' ' PRO . . . . . 0.548 ' HB3' ' CE2' ' A' ' 484' ' ' TRP . 83.2 Cg_endo -75.98 174.75 51.27 Favored 'Cis proline' 0 C--N 1.351 0.666 0 C-N-CA 124.058 -1.226 . . . . 0.0 113.045 0.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -134.41 166.61 22.44 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.991 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 44.3 t -71.54 118.07 13.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.597 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 501' ' ' ALA . . . . . 0.624 ' O ' ' HB2' ' A' ' 505' ' ' TRP . . . -70.7 -24.26 62.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.83 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 16.8 mt -70.96 -38.81 72.82 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.974 0.416 . . . . 0.0 110.652 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 8.7 ttm180 -84.37 -55.31 4.23 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -73.14 -18.02 61.32 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 505' ' ' TRP . . . . . 0.624 ' HB2' ' O ' ' A' ' 501' ' ' ALA . 9.5 m0 -111.95 -69.79 0.85 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 9.6 mmt -59.33 -44.54 92.61 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.976 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 109.85 14.03 14.77 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.51 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 35.1 m -81.87 113.6 44.16 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -83.29 153.57 14.12 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.576 2.184 . . . . 0.0 111.903 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 16.4 m 64.34 92.33 0.07 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.722 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.155 0 CA-C-O 118.166 -1.352 . . . . 0.0 110.796 -179.917 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.758 0 N-CA-C 111.531 -0.627 . . . . 0.0 111.531 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 CA--C 1.529 0.246 0 C-N-CA 122.613 2.209 . . . . 0.0 111.477 179.796 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.563 0 N-CA-C 112.466 -0.253 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo . . . . . 0 CA--C 1.529 0.254 0 C-N-CA 123.0 2.467 . . . . 0.0 112.025 -179.953 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.778 0 N-CA-C 111.698 -0.561 . . . . 0.0 111.698 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo . . . . . 0 CA--C 1.535 0.55 0 C-N-CA 122.803 2.335 . . . . 0.0 111.429 179.135 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.974 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -62.59 139.18 74.39 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.859 2.373 . . . . 0.0 111.869 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 11' ' ' GLN . . . . . 0.882 ' HG3' ' HG2' ' C' ' 110' ' ' PRO . 34.0 tt0 -64.97 150.04 48.7 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.27 157.3 24.07 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.198 -0.525 . . . . 0.0 113.198 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.499 ' H ' HG13 ' B' ' 13' ' ' ILE . 2.7 mt -71.21 153.93 8.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.47 150.47 47.17 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.384 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 15' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' D' ' 213' ' ' ILE . . . -72.72 160.03 53.88 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.15 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -71.49 145.29 49.29 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -68.76 140.65 55.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.794 0.331 . . . . 0.0 110.608 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.22 154.98 36.4 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.834 -0.621 . . . . 0.0 113.16 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 8.0 t -65.72 147.94 12.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.665 0.269 . . . . 0.0 110.6 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 3.9 t -54.32 148.69 2.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.335 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.36 154.46 53.19 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.31 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 71.7 mt . . . . . 0 C--N 1.32 -0.695 0 CA-C-O 120.482 0.182 . . . . 0.0 110.78 -179.834 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.643 0 N-CA-C 112.663 -0.175 . . . . 0.0 112.663 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 N--CA 1.461 -0.407 0 C-N-CA 122.638 2.225 . . . . 0.0 111.645 179.746 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.571 0 N-CA-C 112.868 -0.093 . . . . 0.0 112.868 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo . . . . . 0 C--O 1.237 0.453 0 C-N-CA 122.492 2.128 . . . . 0.0 111.432 179.639 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.565 0 CA-C-O 120.476 -0.069 . . . . 0.0 113.174 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo . . . . . 0 C--O 1.236 0.385 0 C-N-CA 122.969 2.446 . . . . 0.0 111.567 179.098 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.508 0 N-CA-C 112.253 -0.339 . . . . 0.0 112.253 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo . . . . . 0 CA--C 1.528 0.207 0 C-N-CA 122.917 2.412 . . . . 0.0 111.786 -179.783 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.565 0 CA-C-O 119.985 -0.342 . . . . 0.0 112.865 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo . . . . . 0 C--N 1.345 0.361 0 C-N-CA 123.498 2.798 . . . . 0.0 112.604 179.974 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.392 0 N-CA-C 112.552 -0.219 . . . . 0.0 112.552 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo . . . . . 0 CA--C 1.537 0.652 0 C-N-CA 123.216 2.611 . . . . 0.0 113.066 -179.421 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.633 0 N-CA-C 112.083 -0.407 . . . . 0.0 112.083 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo . . . . . 0 N--CA 1.461 -0.427 0 C-N-CA 122.648 2.232 . . . . 0.0 111.324 179.45 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.425 0 CA-C-O 120.704 0.058 . . . . 0.0 113.125 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 110' ' ' PRO . . . . . 0.882 ' HG2' ' HG3' ' B' ' 11' ' ' GLN . 37.4 Cg_endo -66.58 162.91 34.82 Favored 'Trans proline' 0 C--O 1.238 0.519 0 C-N-CA 122.577 2.185 . . . . 0.0 112.514 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -64.5 151.38 44.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.737 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 112' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' B' ' 13' ' ' ILE . . . -69.76 166.3 49.47 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.438 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 113' ' ' ILE . . . . . 0.468 ' H ' HG13 ' C' ' 113' ' ' ILE . 2.7 mt -67.11 144.34 14.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.01 140.73 58.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.408 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -59.38 147.68 42.07 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.277 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -69.73 153.59 43.16 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 122.47 0.308 . . . . 0.0 110.336 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 53.9 ttm-85 -71.77 150.51 44.34 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.83 164.05 46.63 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.26 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 8.8 t -68.97 144.32 14.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 120' ' ' VAL . . . . . 0.442 HG13 ' HB ' ' D' ' 219' ' ' VAL . 32.3 t -62.23 134.56 27.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.988 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.26 160.78 45.79 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.995 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 75.2 mt . . . . . 0 C--N 1.324 -0.536 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.682 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.617 0 N-CA-C 112.695 -0.162 . . . . 0.0 112.695 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo . . . . . 0 C--O 1.235 0.363 0 C-N-CA 122.68 2.253 . . . . 0.0 111.854 179.961 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 112.954 -0.059 . . . . 0.0 112.954 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo . . . . . 0 C--O 1.234 0.298 0 C-N-CA 122.506 2.137 . . . . 0.0 111.105 179.326 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.457 0 N-CA-C 113.289 0.075 . . . . 0.0 113.289 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.46 -0.489 0 C-N-CA 122.912 2.408 . . . . 0.0 111.275 179.903 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 CA-C-O 120.223 -0.209 . . . . 0.0 112.917 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo . . . . . 0 CA--C 1.532 0.39 0 C-N-CA 122.922 2.415 . . . . 0.0 112.06 179.804 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.504 0 CA-C-O 119.939 -0.367 . . . . 0.0 112.239 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo . . . . . 0 C--N 1.347 0.481 0 C-N-CA 123.148 2.566 . . . . 0.0 111.354 179.267 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.448 0 N-CA-C 114.667 0.627 . . . . 0.0 114.667 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo . . . . . 0 C--N 1.344 0.338 0 C-N-CA 123.673 2.915 . . . . 0.0 111.084 178.916 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 CA-C-O 120.385 -0.119 . . . . 0.0 112.879 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo . . . . . 0 N--CA 1.46 -0.482 0 C-N-CA 123.891 3.061 . . . . 0.0 112.182 179.843 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.571 0 N-CA-C 112.061 -0.416 . . . . 0.0 112.061 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.73 147.15 68.79 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.627 2.218 . . . . 0.0 112.088 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -65.24 151.41 46.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.629 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -71.79 169.44 50.47 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.358 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 213' ' ' ILE . . . . . 0.414 ' O ' ' HA3' ' B' ' 15' ' ' GLY . 32.3 pt -71.54 162.41 4.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 120.91 0.386 . . . . 0.0 111.052 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -79.76 142.21 35.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.084 0.469 . . . . 0.0 110.709 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -62.65 160.94 32.41 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.369 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -81.08 155.94 26.05 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -66.1 151.44 46.9 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.806 0.336 . . . . 0.0 110.815 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -62.4 157.4 37.07 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.862 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 219' ' ' VAL . . . . . 0.442 ' HB ' HG13 ' C' ' 120' ' ' VAL . 16.3 t -65.25 138.83 22.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 33.1 t -60.74 142.3 16.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.941 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.12 157.95 26.65 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.238 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.782 -0.209 . . . . 0.0 110.585 -179.952 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 224' ' ' GLY . . . . . 0.437 ' HA2' ' HD3' ' D' ' 225' ' ' PRO . . . . . . . . 0 N--CA 1.451 -0.349 0 CA-C-O 120.423 -0.098 . . . . 0.0 113.066 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 225' ' ' PRO . . . . . 0.437 ' HD3' ' HA2' ' D' ' 224' ' ' GLY . 17.7 Cg_exo . . . . . 0 C--O 1.236 0.382 0 C-N-CA 122.856 2.371 . . . . 0.0 111.352 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.534 0 CA-C-O 120.55 -0.028 . . . . 0.0 113.142 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo . . . . . 0 N--CA 1.461 -0.427 0 C-N-CA 122.906 2.404 . . . . 0.0 111.606 179.845 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.431 0 CA-C-O 120.378 -0.123 . . . . 0.0 113.08 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo . . . . . 0 C--N 1.341 0.175 0 C-N-CA 122.945 2.43 . . . . 0.0 111.777 179.844 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo . . . . . 0 N--CA 1.478 0.559 0 N-CA-C 110.241 -0.715 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 317' ' ' ASN . . . . . 0.594 ' O ' ' HB2' ' A' ' 320' ' ' ASP . 20.1 t-20 -110.82 163.36 13.86 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 18.8 tt -68.59 -23.13 27.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.372 0.606 . . . . 0.0 110.698 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 45.2 m -88.51 5.52 42.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.972 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.594 ' HB2' ' O ' ' A' ' 317' ' ' ASN . 0.2 OUTLIER -68.07 -37.42 81.24 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.058 0.456 . . . . 0.0 110.696 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 85.8 174.95 50.02 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.766 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 5.4 t30 58.86 76.48 0.35 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.207 0.527 . . . . 0.0 111.304 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -95.08 174.34 7.12 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.66 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -90.25 -39.03 13.02 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.528 HG22 ' HB2' ' A' ' 336' ' ' PHE . 4.5 t -170.1 152.19 4.19 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.507 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.427 HG22 HG13 ' A' ' 335' ' ' VAL . 82.0 t -136.19 120.76 26.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -144.49 -179.96 6.88 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.993 0.425 . . . . 0.0 111.547 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 48.7 ttp -126.59 128.64 47.14 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 80.1 mt -122.27 112.1 17.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.938 0.399 . . . . 0.0 110.705 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 62.58 28.41 16.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.421 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 101.6 -20.22 47.28 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.333 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' GLU . . . . . 0.583 ' HG3' HH22 ' A' ' 343' ' ' ARG . 4.8 mm-40 -94.87 136.8 34.75 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.701 0.251 . . . . 0.0 110.567 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 333' ' ' MET . . . . . 0.553 ' HB3' HG23 ' A' ' 344' ' ' VAL . 47.0 ttm -87.86 134.39 33.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.884 0.373 . . . . 0.0 111.377 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -122.86 121.79 37.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.657 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' VAL . . . . . 0.427 HG13 HG22 ' A' ' 326' ' ' VAL . 46.8 t -106.63 111.64 36.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 336' ' ' PHE . . . . . 0.528 ' HB2' HG22 ' A' ' 325' ' ' THR . 78.6 m-85 -96.47 130.02 43.71 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.772 0.32 . . . . 0.0 111.73 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 0.668 ' HB3' ' HZ3' ' A' ' 342' ' ' TRP . 38.9 tttp -144.11 112.91 6.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.672 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 62.2 -105.21 0.17 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.315 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -116.56 9.43 14.2 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.814 0.34 . . . . 0.0 111.567 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 8.2 m-90 -129.72 161.22 31.16 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.364 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -137.94 140.75 40.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.946 0.403 . . . . 0.0 111.064 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' TRP . . . . . 0.668 ' HZ3' ' HB3' ' A' ' 337' ' ' LYS . 10.6 m-90 -102.7 144.38 31.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.472 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.583 HH22 ' HG3' ' A' ' 332' ' ' GLU . 25.1 ttt-85 -115.76 106.07 13.44 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.553 HG23 ' HB3' ' A' ' 333' ' ' MET . 1.3 m -101.43 132.44 47.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.18 0.514 . . . . 0.0 111.531 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.63 111.48 9.44 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.936 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 14.1 m120 61.18 50.17 5.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.843 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 66.73 9.23 6.54 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.452 -0.795 . . . . 0.0 113.096 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -121.45 137.87 54.53 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 122.391 -0.193 . . . . 0.0 111.058 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 38.4 t -79.58 123.82 36.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 350' ' ' MET . . . . . 0.453 ' SD ' ' HD3' ' A' ' 343' ' ' ARG . 83.5 mtp -66.34 148.84 51.28 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -66.98 153.05 44.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.56 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 84.83 10.11 79.62 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.672 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' TYR . . . . . 0.434 ' HB3' ' HA ' ' A' ' 354' ' ' PRO . 83.7 m-85 -123.74 158.83 58.34 Favored Pre-proline 0 C--N 1.326 -0.422 0 O-C-N 122.86 -0.2 . . . . 0.0 110.629 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.434 ' HA ' ' HB3' ' A' ' 353' ' ' TYR . 57.7 Cg_endo -70.51 149.67 90.78 Favored 'Cis proline' 0 C--N 1.349 0.569 0 C-N-CA 123.656 -1.393 . . . . 0.0 112.955 0.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 59.8 ttm -121.83 139.82 30.85 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.445 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -55.59 138.35 80.52 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.596 2.197 . . . . 0.0 111.406 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 89.4 mt -56.46 -40.58 68.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.597 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -70.46 -2.47 42.68 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 121.251 -0.499 . . . . 0.0 114.149 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.25 -39.8 14.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.125 0.488 . . . . 0.0 109.877 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -97.62 -56.33 2.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.266 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 51.9 m95 -93.73 73.91 4.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.691 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 33.7 ttp-105 -62.37 107.9 1.0 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.012 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 123.92 -18.65 7.49 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.558 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.601 HD12 ' HD2' ' A' ' 365' ' ' PRO . 29.8 tp -88.67 128.25 53.31 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.681 0.277 . . . . 0.0 110.552 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 365' ' ' PRO . . . . . 0.601 ' HD2' HD12 ' A' ' 364' ' ' LEU . 92.0 Cg_endo -79.91 -175.07 2.53 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.751 2.301 . . . . 0.0 112.277 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -87.89 160.3 18.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.328 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.1 m 55.31 87.22 0.05 Allowed 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 23.0 pt -105.8 163.91 4.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.174 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' ASN . . . . . 0.419 HD22 ' HA ' ' A' ' 369' ' ' ASN . 8.3 m120 -85.99 -56.7 3.34 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.677 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 370' ' ' THR . . . . . 0.746 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.1 OUTLIER -155.23 171.22 20.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.073 -179.542 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -153.39 144.39 22.88 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -164.55 164.49 21.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.635 0.255 . . . . 0.0 111.039 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -89.77 130.77 35.98 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' ARG . . . . . 0.524 ' HB2' ' OE2' ' A' ' 440' ' ' GLU . 13.2 ptm180 -83.58 -174.92 5.56 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.699 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -68.22 -23.47 64.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.988 0.423 . . . . 0.0 111.473 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' ASP . . . . . 0.452 ' H ' ' HG3' ' A' ' 374' ' ' ARG . 0.0 OUTLIER -86.68 -24.32 25.28 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.553 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 121.25 -26.53 6.67 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.318 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' LYS . . . . . 0.44 ' HG2' ' HA ' ' A' ' 391' ' ' ASP . 32.8 mttp -63.85 154.86 32.34 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.094 0.473 . . . . 0.0 111.731 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -96.31 123.57 39.99 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.656 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 7.9 t -102.19 114.62 42.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.312 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' PHE . . . . . 0.529 ' HB2' ' HB2' ' A' ' 388' ' ' TRP . 87.5 m-85 -100.34 144.61 29.14 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -124.18 149.12 46.69 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.869 0.366 . . . . 0.0 111.87 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.483 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 85.5 tttt -157.42 97.27 1.61 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.676 ' O ' ' HA ' ' A' ' 414' ' ' LYS . . . 73.73 -108.45 2.51 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.211 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -114.91 7.74 15.73 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.931 0.396 . . . . 0.0 111.142 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -111.22 149.47 30.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.649 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' HIS . . . . . 0.416 ' NE2' ' HE1' ' A' ' 399' ' ' TYR . 28.9 p-80 -131.69 146.68 52.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.385 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 388' ' ' TRP . . . . . 0.529 ' HB2' ' HB2' ' A' ' 381' ' ' PHE . 17.4 m-90 -119.44 137.56 53.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.17 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 88.4 t -116.49 112.38 39.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -111.0 123.72 50.73 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.847 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.44 ' HA ' ' HG2' ' A' ' 378' ' ' LYS . 34.0 t70 -92.88 93.14 8.24 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 71.76 -79.43 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 O-C-N 123.695 0.622 . . . . 0.0 110.954 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -141.07 13.93 2.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.911 0.386 . . . . 0.0 110.648 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 5.5 m -123.48 131.8 53.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.267 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 58.4 tp -78.35 135.96 37.59 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.111 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 396' ' ' GLU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 1.5 mt-10 -74.69 148.8 85.52 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.73 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 397' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 12.3 Cg_exo -72.58 143.32 37.9 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.928 2.418 . . . . 0.0 111.751 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 89.8 32.45 10.04 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.991 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' TYR . . . . . 0.512 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 80.3 m-85 -138.57 161.05 60.9 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.512 ' HA ' ' HB3' ' A' ' 399' ' ' TYR . 66.8 Cg_endo -74.13 154.7 99.76 Favored 'Cis proline' 0 C--N 1.346 0.409 0 C-N-CA 123.715 -1.369 . . . . 0.0 112.998 0.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 53.3 mttt -125.93 170.29 11.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.233 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 0.528 ' HB3' ' HG2' ' A' ' 404' ' ' LYS . 3.8 m-70 -73.0 155.64 39.63 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.971 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 41.5 mt -59.22 -34.23 53.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.196 0.522 . . . . 0.0 110.658 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.528 ' HG2' ' HB3' ' A' ' 402' ' ' HIS . 47.3 pttt -66.74 -17.59 64.94 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.013 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -78.02 -25.47 47.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.055 0.455 . . . . 0.0 110.111 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 49.9 tp -74.7 -45.33 45.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.567 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.73 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -164.76 147.7 13.06 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.505 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -81.34 140.94 34.47 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.918 0.389 . . . . 0.0 111.0 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 101.36 -3.28 54.26 Favored Glycine 0 CA--C 1.517 0.184 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.737 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 83.7 mt -85.48 149.04 50.94 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.472 0.177 . . . . 0.0 110.732 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.31 145.16 98.67 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.008 2.472 . . . . 0.0 111.863 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.79 11.14 22.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.059 0.457 . . . . 0.0 111.255 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -94.17 -56.34 2.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.672 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 414' ' ' LYS . . . . . 0.676 ' HA ' ' O ' ' A' ' 384' ' ' GLY . 18.1 ptmt -176.47 173.96 1.98 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.465 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 46.6 mm -123.17 135.04 64.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.866 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 416' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 430' ' ' PHE . 4.0 m-20 -89.14 -59.12 2.31 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 417' ' ' ALA . . . . . 0.746 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -153.72 153.72 32.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.896 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -132.47 116.69 17.08 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 37.1 tp -107.64 125.61 51.55 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.377 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -96.67 113.3 24.85 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 421' ' ' TRP . . . . . 0.491 ' HB2' ' HE2' ' A' ' 428' ' ' TYR . 11.9 t-105 -82.17 99.3 9.17 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.517 ' HB2' ' HD3' ' A' ' 423' ' ' PRO . 66.5 mtt -53.37 -52.96 61.59 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.517 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 82.0 Cg_exo -47.22 -44.58 23.78 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.758 2.305 . . . . 0.0 115.319 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 424' ' ' ASN . . . . . 0.473 ' OD1' ' HB3' ' A' ' 421' ' ' TRP . 35.3 p30 -101.25 -21.58 14.86 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 78.4 37.03 28.76 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.693 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 23.4 mmtt -121.24 144.85 48.39 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 427' ' ' THR . . . . . 0.628 ' HB ' ' HB3' ' A' ' 438' ' ' PHE . 15.0 m -97.95 132.17 43.75 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.045 0.45 . . . . 0.0 111.249 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 428' ' ' TYR . . . . . 0.491 ' HE2' ' HB2' ' A' ' 421' ' ' TRP . 83.0 m-85 -107.41 109.9 21.73 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -91.38 122.38 33.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.407 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 430' ' ' PHE . . . . . 0.439 ' O ' ' HB2' ' A' ' 416' ' ' ASP . 89.4 m-85 -100.36 131.82 46.08 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.737 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.402 ' HA ' ' HE ' ' A' ' 431' ' ' ARG . 3.1 tpm_? -144.0 108.95 4.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.893 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 66.05 -108.38 2.36 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -121.85 19.93 10.92 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.274 0.559 . . . . 0.0 110.668 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 42.3 mmtt -127.53 152.87 47.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.761 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 435' ' ' TYR . . . . . 0.505 ' CE1' ' HB2' ' A' ' 451' ' ' LYS . 3.9 p90 -132.76 139.86 47.76 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.825 0.345 . . . . 0.0 111.389 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -107.6 149.98 27.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.202 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -108.04 98.82 8.33 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 438' ' ' PHE . . . . . 0.73 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 69.5 t80 -81.31 124.63 29.51 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.782 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -93.73 104.85 16.93 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 440' ' ' GLU . . . . . 0.524 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 0.1 OUTLIER -58.09 -48.19 80.91 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.315 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.48 -50.66 72.34 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 88.4 mt -84.62 -12.95 52.98 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 23.6 mtp180 57.05 50.84 11.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.467 0.651 . . . . 0.0 111.704 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -159.65 169.63 23.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.684 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 86.5 t -89.19 133.13 32.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -64.34 161.63 16.46 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.368 0.417 . . . . 0.0 111.017 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 2.6 m -69.48 161.88 28.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.863 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 70.87 33.21 2.23 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.353 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 449' ' ' TYR . . . . . 0.404 ' HB3' ' HA ' ' A' ' 450' ' ' PRO . 32.2 m-85 -137.75 161.53 59.64 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.067 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 450' ' ' PRO . . . . . 0.404 ' HA ' ' HB3' ' A' ' 449' ' ' TYR . 85.0 Cg_endo -79.7 155.55 88.74 Favored 'Cis proline' 0 C--N 1.346 0.404 0 C-N-CA 123.477 -1.468 . . . . 0.0 112.522 0.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 451' ' ' LYS . . . . . 0.505 ' HB2' ' CE1' ' A' ' 435' ' ' TYR . 51.9 mttm -105.66 176.96 4.99 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.625 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 452' ' ' ASN . . . . . 0.401 ' O ' HG23 ' A' ' 455' ' ' VAL . 17.3 t-20 -75.2 140.73 43.47 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.0 tt -68.16 -14.62 18.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.94 0.4 . . . . 0.0 110.593 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -69.74 -1.62 9.67 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.302 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 455' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 452' ' ' ASN . 38.1 t -60.87 -37.71 77.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 456' ' ' TRP . . . . . 0.491 ' HB3' ' CE1' ' A' ' 486' ' ' PHE . 15.1 m95 -91.16 93.64 9.22 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 457' ' ' GLU . . . . . 0.434 ' HB3' ' HG3' ' A' ' 492' ' ' LYS . 3.2 tt0 -56.44 121.13 8.9 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 105.63 -15.03 45.94 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.722 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 25.6 mm -80.67 130.46 64.27 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 121.084 0.469 . . . . 0.0 111.245 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.04 158.24 30.59 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.733 2.289 . . . . 0.0 111.284 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -82.93 141.11 32.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.217 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.6 m 57.8 75.57 0.54 Allowed Pre-proline 0 N--CA 1.464 0.239 0 O-C-N 123.868 0.73 . . . . 0.0 112.855 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -90.5 179.86 1.77 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.689 2.259 . . . . 0.0 111.235 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 464' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 464' ' ' ARG . 0.0 OUTLIER -134.76 26.71 3.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.312 0.577 . . . . 0.0 110.42 179.692 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 175.01 137.96 2.63 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.38 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 20.9 p -161.04 99.77 1.22 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -128.99 143.9 51.02 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.839 0.352 . . . . 0.0 111.294 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 468' ' ' MET . . . . . 0.407 ' HA ' ' HA ' ' A' ' 475' ' ' THR . 34.7 ttm -86.33 143.21 27.98 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.853 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -72.81 163.77 54.85 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.511 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.44 -7.59 20.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.053 0.454 . . . . 0.0 111.648 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -90.9 -13.24 33.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.403 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 66.87 0.04 1.81 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 55.4 t -98.2 -36.38 5.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.845 0.355 . . . . 0.0 111.264 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -112.16 144.73 41.05 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 475' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 468' ' ' MET . 60.8 m -122.32 137.53 54.82 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -112.95 122.62 48.17 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.148 0.499 . . . . 0.0 112.29 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -101.97 150.57 23.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.645 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -130.07 133.37 46.65 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 44.1 tttt -170.51 140.91 1.85 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.86 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 60.14 32.62 76.73 Favored Glycine 0 C--N 1.328 0.104 0 C-N-CA 121.245 -0.502 . . . . 0.0 112.609 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 481' ' ' ASN . . . . . 0.525 ' OD1' ' HG ' ' A' ' 502' ' ' LEU . 2.0 t-20 64.53 17.67 10.97 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.344 0.592 . . . . 0.0 111.785 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -122.81 158.48 30.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.485 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 483' ' ' TYR . . . . . 0.504 ' CE1' ' HB2' ' A' ' 499' ' ' LYS . 4.7 p90 -123.98 149.53 45.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.915 0.388 . . . . 0.0 111.93 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 20.1 m-90 -118.21 138.56 52.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.452 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -99.89 93.62 5.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.089 0.471 . . . . 0.0 109.746 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 486' ' ' PHE . . . . . 0.491 ' CE1' ' HB3' ' A' ' 456' ' ' TRP . 81.6 t80 -86.45 131.2 34.25 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.738 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 487' ' ' ASN . . . . . 0.432 ' HB3' ' HB2' ' A' ' 490' ' ' LYS . 36.1 t-20 -97.17 114.67 26.39 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -65.15 -28.69 69.59 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -178.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -84.29 -14.61 49.27 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 490' ' ' LYS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 487' ' ' ASN . 93.1 mttt -109.35 -26.3 10.1 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 68.86 30.8 4.56 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.857 0.837 . . . . 0.0 110.373 -178.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 492' ' ' LYS . . . . . 0.434 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 62.6 tttp -150.06 154.43 38.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.048 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 55.9 t -79.17 133.54 29.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -59.91 147.19 80.14 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.459 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -62.96 157.15 50.22 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 123.246 2.631 . . . . 0.0 112.972 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 83.91 27.19 38.65 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.874 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 497' ' ' TYR . . . . . 0.523 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 27.7 m-85 -129.75 165.87 30.1 Favored Pre-proline 0 C--N 1.327 -0.393 0 O-C-N 122.877 -0.19 . . . . 0.0 111.13 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 498' ' ' PRO . . . . . 0.523 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 87.4 Cg_endo -82.41 175.25 40.4 Favored 'Cis proline' 0 C--N 1.346 0.433 0 C-N-CA 123.74 -1.358 . . . . 0.0 112.871 0.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 499' ' ' LYS . . . . . 0.504 ' HB2' ' CE1' ' A' ' 483' ' ' TYR . 97.8 mttt -129.7 153.98 47.62 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.406 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 41.4 t -69.36 123.92 22.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.905 0.383 . . . . 0.0 110.484 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -67.75 -18.49 64.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.885 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 502' ' ' LEU . . . . . 0.525 ' HG ' ' OD1' ' A' ' 481' ' ' ASN . 13.7 mt -66.8 -46.32 75.6 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.921 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -80.94 -41.27 23.17 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.2 -45.2 34.32 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -177.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 35.0 m0 -100.12 -58.55 1.89 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 10.8 mmt -60.64 -41.28 94.62 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 98.5 25.62 9.91 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.611 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 3.5 m -110.62 103.4 54.27 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -81.32 178.59 6.59 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.509 2.139 . . . . 0.0 111.693 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 3.9 m 67.12 13.88 9.59 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.73 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.396 -1.225 . . . . 0.0 111.087 179.699 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.809 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' PRO . . . . . 0.435 ' HA ' HD23 ' B' ' 2' ' ' HYP . 1.8 Cg_endo -84.16 153.31 12.58 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 123.277 2.651 . . . . 0.0 111.397 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 2' ' ' HYP . . . . . 0.435 HD23 ' HA ' ' B' ' 1' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.76 169.31 38.38 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.71 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -72.34 163.93 37.17 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 122.986 2.458 . . . . 0.0 111.689 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 6' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' D' ' 202' ' ' HYP . . . -73.62 179.6 40.35 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.77 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.405 ' HD2' ' O ' ' D' ' 204' ' ' PRO . 52.9 Cg_exo -57.52 165.2 6.25 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 122.86 2.373 . . . . 0.0 111.22 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 151.39 170.63 18.48 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.019 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.76 142.99 95.72 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.855 2.37 . . . . 0.0 111.867 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -67.89 142.86 55.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.935 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' D' ' 210' ' ' PRO . . . -60.55 150.49 41.67 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.736 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.414 ' O ' ' HG3' ' D' ' 211' ' ' GLN . 17.4 mt -68.28 147.8 12.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.74 151.57 46.48 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.837 0.351 . . . . 0.0 110.447 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' D' ' 213' ' ' ILE . . . -66.35 162.46 43.88 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.299 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -68.94 148.72 49.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.771 0.319 . . . . 0.0 110.426 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.18 145.0 54.74 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.216 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.2 143.43 47.45 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.948 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.459 ' HB ' ' HG2' ' D' ' 217' ' ' ARG . 2.5 t -69.49 159.24 5.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 4.6 t -55.79 143.27 9.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.901 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.53 171.48 54.86 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.498 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 97.2 mt -81.0 142.91 32.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.599 0.238 . . . . 0.0 110.686 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.32 163.78 48.4 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.874 -0.603 . . . . 0.0 113.22 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.46 154.81 31.78 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 122.921 2.414 . . . . 0.0 111.859 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.11 162.98 41.03 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.431 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.94 165.82 31.74 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.886 2.39 . . . . 0.0 111.512 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.44 168.17 53.62 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.641 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.98 155.98 52.1 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 123.056 2.504 . . . . 0.0 112.213 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.13 133.16 45.88 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.943 -0.571 . . . . 0.0 113.237 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' PRO . . . . . 0.473 ' HA ' HD23 ' B' ' 35' ' ' HYP . 40.2 Cg_endo -67.66 116.12 4.09 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.88 2.387 . . . . 0.0 111.193 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' HYP . . . . . 0.473 HD23 ' HA ' ' B' ' 34' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.461 0 CA-C-O 120.109 -0.273 . . . . 0.0 112.637 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 101' ' ' PRO . . . . . 0.503 ' HA ' HD23 ' C' ' 102' ' ' HYP . 39.1 Cg_exo -59.55 135.95 67.93 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 123.369 2.712 . . . . 0.0 112.702 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 102' ' ' HYP . . . . . 0.689 ' HA ' ' HD2' ' D' ' 201' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 103' ' ' GLY . . . . . 0.44 ' O ' ' HD3' ' D' ' 204' ' ' PRO . . . -75.44 161.26 52.71 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.465 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -83.18 160.49 15.38 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.861 2.374 . . . . 0.0 112.449 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 105' ' ' HYP . . . . . 0.469 ' OD1' ' HG2' ' D' ' 204' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -83.62 -170.91 47.06 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.425 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -74.72 154.45 43.95 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.776 2.317 . . . . 0.0 111.197 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 108' ' ' HYP . . . . . 0.443 ' HA ' ' HG2' ' D' ' 207' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -57.87 167.04 5.82 Favored Glycine 0 CA--C 1.521 0.429 0 CA-C-N 115.832 -0.622 . . . . 0.0 113.465 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.03 157.34 62.2 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.814 2.343 . . . . 0.0 112.576 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -60.02 137.69 58.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.529 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -67.53 164.11 45.64 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.88 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 40.5 mt -67.22 144.46 14.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.42 148.04 50.15 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -63.17 147.22 50.56 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.119 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -75.17 149.97 38.84 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 122.753 -0.263 . . . . 0.0 110.366 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 9.5 ttm-85 -59.09 141.06 55.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.935 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.95 170.47 33.15 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.973 -0.558 . . . . 0.0 113.428 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 119' ' ' VAL . . . . . 0.452 ' O ' ' HA3' ' D' ' 218' ' ' GLY . 23.5 t -71.85 139.88 19.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.563 -0.319 . . . . 0.0 110.514 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 21.4 t -60.22 141.8 16.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.507 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.51 163.9 34.97 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.446 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 122' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' C' ' 123' ' ' HYP . 67.3 mt -77.21 141.53 40.02 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.895 -0.179 . . . . 0.0 110.722 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 123' ' ' HYP . . . . . 0.405 HD23 ' HA ' ' C' ' 122' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -64.6 161.24 39.62 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.849 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.49 154.73 35.84 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 122.661 2.241 . . . . 0.0 112.369 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 126' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -72.51 169.34 52.03 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.705 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 128' ' ' PRO . . . . . 0.444 ' HA ' HD23 ' C' ' 129' ' ' HYP . 70.8 Cg_endo -75.66 152.13 37.41 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.758 2.305 . . . . 0.0 112.046 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 129' ' ' HYP . . . . . 0.444 HD23 ' HA ' ' C' ' 128' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -62.52 167.46 19.26 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 116.057 -0.52 . . . . 0.0 113.134 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 131' ' ' PRO . . . . . 0.404 ' HA ' HD23 ' C' ' 132' ' ' HYP . 5.6 Cg_exo -75.36 154.55 40.9 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 123.098 2.532 . . . . 0.0 111.855 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 132' ' ' HYP . . . . . 0.563 ' HA ' ' O ' ' D' ' 231' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.03 136.52 18.32 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.955 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 134' ' ' PRO . . . . . 0.432 ' HA ' HD23 ' C' ' 135' ' ' HYP . 23.0 Cg_endo -61.87 114.8 2.44 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.971 2.448 . . . . 0.0 112.132 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 135' ' ' HYP . . . . . 0.432 HD23 ' HA ' ' C' ' 134' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 N-CA-C 112.205 -0.358 . . . . 0.0 112.205 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 201' ' ' PRO . . . . . 0.689 ' HD2' ' HA ' ' C' ' 102' ' ' HYP . 52.3 Cg_exo -57.92 138.52 86.42 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.893 2.395 . . . . 0.0 111.412 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 202' ' ' HYP . . . . . 0.486 ' O ' ' HA2' ' B' ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 203' ' ' GLY . . . . . 0.409 ' HA2' ' HD3' ' D' ' 204' ' ' PRO . . . 72.41 155.57 2.7 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 114.381 0.512 . . . . 0.0 114.381 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 204' ' ' PRO . . . . . 0.469 ' HG2' ' OD1' ' C' ' 105' ' ' HYP . 17.0 Cg_exo -71.25 162.89 40.98 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.174 2.582 . . . . 0.0 110.99 178.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 205' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . 97.83 173.64 33.35 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.492 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 207' ' ' PRO . . . . . 0.443 ' HG2' ' HA ' ' C' ' 108' ' ' HYP . 94.6 Cg_endo -90.8 156.65 4.12 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 123.516 2.811 . . . . 0.0 112.208 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 208' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -75.78 169.95 54.7 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.425 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 210' ' ' PRO . . . . . 0.461 ' O ' ' HA3' ' B' ' 12' ' ' GLY . 58.8 Cg_endo -73.78 157.35 47.97 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.549 2.166 . . . . 0.0 112.273 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 211' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' B' ' 13' ' ' ILE . 34.9 tt0 -78.1 144.33 36.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.595 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -68.08 166.32 44.49 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.824 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 213' ' ' ILE . . . . . 0.485 ' O ' ' HA3' ' B' ' 15' ' ' GLY . 45.4 pt -68.29 164.73 2.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 120.835 0.35 . . . . 0.0 110.984 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -81.06 147.58 30.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.108 0.48 . . . . 0.0 111.381 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -71.89 153.02 49.59 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.411 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 48.8 mm-40 -71.55 150.6 44.61 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 217' ' ' ARG . . . . . 0.459 ' HG2' ' HB ' ' B' ' 19' ' ' VAL . 60.0 mtp180 -64.63 160.18 20.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.185 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 218' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' C' ' 119' ' ' VAL . . . -62.14 156.85 36.93 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.206 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.15 152.28 9.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.5 137.25 25.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -56.68 166.63 4.51 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.918 -0.583 . . . . 0.0 114.237 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 8.6 mp -72.25 153.32 41.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.719 -0.241 . . . . 0.0 110.736 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 223' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -60.81 153.51 37.44 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 116.113 -0.494 . . . . 0.0 113.299 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -70.17 147.99 61.44 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.838 2.359 . . . . 0.0 111.109 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 226' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -63.18 166.37 24.96 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.062 -0.59 . . . . 0.0 113.158 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -79.2 160.79 26.33 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.682 2.255 . . . . 0.0 111.716 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -64.99 167.45 30.78 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.86 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 231' ' ' PRO . . . . . 0.563 ' O ' ' HA ' ' C' ' 132' ' ' HYP . 96.3 Cg_endo -82.74 156.84 15.93 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.642 2.228 . . . . 0.0 111.079 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 232' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.478 0.6 0 N-CA-C 110.378 -0.662 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -106.48 160.03 15.72 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.975 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.4 ' O ' ' HZ ' ' A' ' 323' ' ' PHE . 19.8 tt -75.9 -23.59 16.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.003 0.43 . . . . 0.0 111.474 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 21.4 m -80.52 0.18 34.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.283 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -67.6 -34.48 77.1 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.948 0.404 . . . . 0.0 111.178 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' GLY . . . . . 0.434 ' HA2' HD21 ' A' ' 502' ' ' LEU . . . 82.55 -171.66 51.53 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.213 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 5.0 t30 52.41 74.04 0.3 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.18 0.514 . . . . 0.0 111.139 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' PHE . . . . . 0.491 ' HD1' ' HB2' ' A' ' 337' ' ' LYS . 73.6 m-85 -95.67 162.76 13.48 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.427 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -77.0 -35.25 57.28 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.244 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 6.7 t -178.33 155.68 0.91 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.528 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.553 HG22 HG13 ' A' ' 335' ' ' VAL . 48.4 t -133.96 127.14 51.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -144.27 172.08 13.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.997 0.427 . . . . 0.0 111.67 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 38.6 ttp -126.28 113.74 17.36 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 50.9 mt -106.88 116.53 32.08 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.567 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.494 ' NH1' ' HB3' ' D' ' 214' ' ' ALA . 69.3 mtp180 57.9 27.45 14.65 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 98.18 -5.75 61.3 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.923 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -101.52 122.43 43.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.902 0.382 . . . . 0.0 111.131 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 56.7 ttm -81.45 120.81 25.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.194 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -119.24 126.76 52.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.756 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' VAL . . . . . 0.553 HG13 HG22 ' A' ' 326' ' ' VAL . 25.5 t -107.73 119.78 57.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.434 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -95.35 121.13 36.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.012 0.434 . . . . 0.0 112.145 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 0.491 ' HB2' ' HD1' ' A' ' 323' ' ' PHE . 52.4 tptt -130.18 99.56 5.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.686 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 62.4 -102.9 0.12 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.02 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -116.77 13.69 15.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.1 0.476 . . . . 0.0 111.026 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 20.1 m-90 -128.88 142.9 50.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.544 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.502 ' CE2' ' HE2' ' A' ' 353' ' ' TYR . 12.6 p90 -122.35 135.49 54.72 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.937 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 342' ' ' TRP . . . . . 0.436 ' HZ3' ' HB3' ' A' ' 337' ' ' LYS . 1.9 m-90 -100.15 151.95 20.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.572 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.515 ' HD2' ' CE1' ' A' ' 353' ' ' TYR . 14.8 ttt-85 -120.78 100.47 7.12 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 5.2 m -112.52 131.45 64.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.204 0.526 . . . . 0.0 112.09 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 6.3 ttm-85 -139.33 112.63 8.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.337 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 1.5 m120 72.97 49.78 0.15 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 61.67 24.46 14.56 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.487 178.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -143.45 145.75 32.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.053 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 22.2 t -83.41 135.75 24.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 350' ' ' MET . . . . . 0.454 ' SD ' ' HD3' ' A' ' 343' ' ' ARG . 87.9 mtp -83.2 156.07 23.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.995 0.426 . . . . 0.0 111.418 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -69.92 150.12 47.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.407 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' GLY . . . . . 0.665 ' HA3' HD11 ' B' ' 13' ' ' ILE . . . 95.04 -8.51 70.13 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.268 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 353' ' ' TYR . . . . . 0.569 ' HB3' ' HA ' ' A' ' 354' ' ' PRO . 32.8 m-85 -119.21 164.01 23.65 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.569 ' HA ' ' HB3' ' A' ' 353' ' ' TYR . 59.1 Cg_endo -70.58 159.82 91.55 Favored 'Cis proline' 0 C--N 1.348 0.501 0 C-N-CA 123.856 -1.31 . . . . 0.0 112.813 0.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 42.5 ttm -134.68 141.78 40.02 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.232 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -60.93 140.09 88.41 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.416 2.077 . . . . 0.0 111.165 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 78.7 mt -56.95 -44.15 81.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.605 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -69.86 3.04 10.38 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 114.283 0.473 . . . . 0.0 114.283 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.09 -46.5 7.41 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -93.79 -53.55 3.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.132 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -84.77 73.19 10.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.831 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 30.4 ttp-105 -64.46 93.88 0.11 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.187 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 129.72 -7.28 6.17 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.035 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.681 HD12 ' HD2' ' A' ' 365' ' ' PRO . 33.8 tp -99.41 126.37 37.85 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-O 120.57 0.224 . . . . 0.0 110.533 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 365' ' ' PRO . . . . . 0.681 ' HD2' HD12 ' A' ' 364' ' ' LEU . 73.9 Cg_endo -74.62 175.09 11.56 Favored 'Trans proline' 0 CA--C 1.528 0.216 0 C-N-CA 122.624 2.216 . . . . 0.0 111.961 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -85.8 154.91 21.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.494 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 35.0 m 55.5 82.41 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 22.7 pt -95.17 -171.22 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.29 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' ASN . . . . . 0.432 HD22 ' HA ' ' A' ' 369' ' ' ASN . 8.1 m120 -108.99 -47.7 3.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.724 0.297 . . . . 0.0 111.193 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 370' ' ' THR . . . . . 0.876 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.3 OUTLIER -156.44 166.34 33.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.848 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -153.4 145.51 23.77 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 372' ' ' TYR . . . . . 0.442 ' HD2' ' HB2' ' A' ' 420' ' ' PHE . 2.0 p90 -161.42 159.94 28.8 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.129 0.49 . . . . 0.0 112.221 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -89.63 121.18 31.57 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 378' ' ' LYS . 6.2 ptm180 -78.1 177.97 7.91 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.434 ' HE3' ' HA3' ' A' ' 425' ' ' GLY . 70.2 tttt -68.3 -38.2 81.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.863 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -31.63 71.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.632 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 129.66 -32.82 3.11 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.51 -0.852 . . . . 0.0 113.043 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' LYS . . . . . 0.49 ' O ' ' HG2' ' A' ' 374' ' ' ARG . 35.6 mttm -65.66 157.56 29.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.073 0.463 . . . . 0.0 111.696 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 379' ' ' PHE . . . . . 0.449 ' HE1' ' HG3' ' A' ' 330' ' ' ARG . 16.4 m-85 -98.67 135.04 40.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.993 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 4.7 t -113.24 121.65 65.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.842 0.353 . . . . 0.0 110.668 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -108.51 138.26 45.11 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.436 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -120.29 143.5 48.3 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.826 0.346 . . . . 0.0 111.584 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.515 ' HB3' ' CZ3' ' A' ' 388' ' ' TRP . 83.6 tttt -158.34 105.75 1.91 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.517 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 76.33 -114.84 4.26 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.556 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -114.19 4.0 15.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.932 0.396 . . . . 0.0 110.7 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -112.6 155.92 23.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.847 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -136.3 146.78 47.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.944 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' TRP . . . . . 0.515 ' CZ3' ' HB3' ' A' ' 383' ' ' LYS . 20.5 m-90 -121.88 132.51 54.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.061 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 95.0 t -111.88 119.49 60.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -111.21 130.96 55.48 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.342 0.591 . . . . 0.0 112.211 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -95.31 87.82 4.94 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 392' ' ' GLU . . . . . 0.53 ' OE1' ' HB ' ' D' ' 213' ' ' ILE . 38.1 mm-40 67.35 -79.54 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.604 0.565 . . . . 0.0 110.539 -178.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -137.7 19.32 2.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.234 0.54 . . . . 0.0 109.991 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 8.1 m -121.12 157.79 29.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.782 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 64.9 tp -104.43 135.95 44.92 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.629 0.252 . . . . 0.0 110.829 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 396' ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 24.9 mm-40 -70.57 125.89 92.11 Favored Pre-proline 0 C--O 1.232 0.184 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.047 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 397' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 31.9 Cg_exo -59.92 136.35 69.2 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.873 2.382 . . . . 0.0 111.842 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 101.04 -8.37 57.52 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.716 -0.755 . . . . 0.0 111.798 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 399' ' ' TYR . . . . . 0.402 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 22.6 m-85 -93.89 161.02 31.26 Favored Pre-proline 0 C--N 1.321 -0.659 0 O-C-N 122.85 -0.206 . . . . 0.0 110.815 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.458 ' HB3' ' NE1' ' A' ' 388' ' ' TRP . 74.0 Cg_endo -75.04 166.55 82.96 Favored 'Cis proline' 0 C--N 1.346 0.434 0 C-N-CA 123.819 -1.325 . . . . 0.0 112.943 0.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -137.66 163.04 32.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.388 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 0.517 ' HB2' ' HG2' ' A' ' 404' ' ' LYS . 8.6 m-70 -71.01 150.6 45.47 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 79.2 mt -54.61 -33.5 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 120.887 0.375 . . . . 0.0 111.33 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.517 ' HG2' ' HB2' ' A' ' 402' ' ' HIS . 19.4 pttp -64.22 -15.13 59.38 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.193 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -81.93 -20.22 39.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.911 0.386 . . . . 0.0 111.102 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 38.3 tp -74.94 -48.85 22.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.084 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.739 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -162.82 155.74 27.19 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.687 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -81.58 130.92 35.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.791 0.329 . . . . 0.0 110.939 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 102.29 1.76 50.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.308 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 51.3 mt -79.46 156.34 75.9 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 120.49 0.186 . . . . 0.0 111.026 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 411' ' ' PRO . . . . . 0.469 ' HG3' ' CE1' ' A' ' 436' ' ' TYR . 30.6 Cg_exo -61.51 118.14 5.0 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.614 2.209 . . . . 0.0 111.525 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.04 -3.5 59.09 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.99 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -92.3 -56.67 2.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.448 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 9.5 ptmt -176.38 171.8 2.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.863 0.363 . . . . 0.0 110.723 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 39.6 mm -117.16 133.09 65.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.694 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 416' ' ' ASP . . . . . 0.503 ' HB3' ' HD2' ' A' ' 463' ' ' PRO . 14.7 m-20 -90.79 -48.85 6.78 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 417' ' ' ALA . . . . . 0.876 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -156.43 154.28 30.2 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.138 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -135.19 113.55 11.46 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 42.3 tp -107.94 132.69 53.22 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.269 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 420' ' ' PHE . . . . . 0.442 ' HB2' ' HD2' ' A' ' 372' ' ' TYR . 29.2 t80 -98.12 116.67 30.82 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.966 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 421' ' ' TRP . . . . . 0.409 ' HB2' ' CE1' ' A' ' 428' ' ' TYR . 9.4 t-105 -89.5 97.05 10.97 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.417 ' HB2' ' HD3' ' A' ' 423' ' ' PRO . 62.7 mtt -55.31 -50.81 84.56 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.417 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 81.7 Cg_exo -45.78 -53.33 5.78 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 123.151 2.567 . . . . 0.0 114.662 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 42.4 p30 -95.62 -10.67 28.84 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 425' ' ' GLY . . . . . 0.434 ' HA3' ' HE3' ' A' ' 375' ' ' LYS . . . 66.89 51.99 36.36 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.921 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -138.42 160.94 38.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.671 0.272 . . . . 0.0 111.03 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 427' ' ' THR . . . . . 0.492 ' HB ' ' HB3' ' A' ' 438' ' ' PHE . 26.5 m -105.7 133.26 50.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.067 0.461 . . . . 0.0 111.525 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 428' ' ' TYR . . . . . 0.409 ' CE1' ' HB2' ' A' ' 421' ' ' TRP . 17.0 m-85 -110.31 110.77 21.69 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -93.97 138.97 31.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.509 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 430' ' ' PHE . . . . . 0.455 ' O ' ' HB2' ' A' ' 416' ' ' ASP . 95.0 m-85 -114.1 136.73 52.61 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.331 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.466 ' HA ' ' HE ' ' A' ' 431' ' ' ARG . 2.6 tpm_? -148.27 105.18 3.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.809 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 68.1 -109.89 3.14 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -115.12 11.4 16.35 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.23 0.538 . . . . 0.0 110.009 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 434' ' ' LYS . . . . . 0.622 ' HD2' ' HG2' ' A' ' 450' ' ' PRO . 19.6 mmtt -117.01 150.48 38.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.156 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 435' ' ' TYR . . . . . 0.447 ' CE2' ' HE1' ' A' ' 449' ' ' TYR . 5.1 p90 -131.41 140.26 49.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.589 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 436' ' ' TYR . . . . . 0.469 ' CE1' ' HG3' ' A' ' 411' ' ' PRO . 2.3 m-85 -110.5 144.38 39.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.497 -178.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -106.14 96.65 6.63 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 438' ' ' PHE . . . . . 0.739 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 79.5 t80 -80.85 128.49 33.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.125 -177.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -96.74 97.87 9.69 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 440' ' ' GLU . . . . . 0.445 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 1.3 mm-40 -44.95 -60.61 1.98 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -56.23 -36.35 68.4 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 67.1 mt -88.73 -20.56 24.65 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 67.0 mtp180 61.96 48.55 5.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.557 0.694 . . . . 0.0 110.847 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -162.03 164.53 28.17 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.749 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.0 t -88.62 138.74 18.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -61.97 166.4 4.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.201 0.524 . . . . 0.0 112.147 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.46 152.0 46.04 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 68.81 22.74 7.15 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.668 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 449' ' ' TYR . . . . . 0.447 ' HE1' ' CE2' ' A' ' 435' ' ' TYR . 31.2 m-85 -118.21 158.26 46.89 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.114 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 450' ' ' PRO . . . . . 0.622 ' HG2' ' HD2' ' A' ' 434' ' ' LYS . 91.9 Cg_endo -77.75 151.71 91.89 Favored 'Cis proline' 0 C--N 1.344 0.332 0 C-N-CA 123.643 -1.399 . . . . 0.0 113.521 0.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -102.38 177.09 4.97 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.847 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -75.24 140.93 43.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.573 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.2 tt -69.79 -11.5 14.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.909 0.385 . . . . 0.0 110.974 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -63.84 -6.31 5.68 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 70.7 t -67.54 -33.6 63.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 10.0 m95 -95.46 84.84 4.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.253 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -57.4 115.71 2.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.187 0.518 . . . . 0.0 112.358 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 115.17 -26.47 9.2 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.097 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.452 HD11 ' HB2' ' A' ' 486' ' ' PHE . 31.7 mm -73.47 130.48 83.96 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.714 0.292 . . . . 0.0 111.067 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.0 156.15 23.32 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.825 2.35 . . . . 0.0 111.869 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -77.57 141.09 39.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.412 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 5.2 m 58.0 74.59 0.62 Allowed Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 463' ' ' PRO . . . . . 0.503 ' HD2' ' HB3' ' A' ' 416' ' ' ASP . 2.4 Cg_endo -81.84 -173.87 1.94 Allowed 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.866 2.378 . . . . 0.0 112.017 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.87 20.37 3.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.239 0.542 . . . . 0.0 110.528 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 161.36 142.48 3.4 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.592 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 7.8 p -156.75 106.77 2.3 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -127.48 138.34 52.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.923 0.392 . . . . 0.0 111.613 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 46.2 ttm -90.31 142.06 28.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.291 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -71.18 162.26 54.16 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.917 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.7 -12.46 46.86 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 16.9 p30 -85.27 -13.2 50.52 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.623 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 66.98 10.84 7.99 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.14 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 40.1 t -104.43 -42.9 7.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.601 0.239 . . . . 0.0 111.44 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 474' ' ' PHE . . . . . 0.411 ' CD1' ' HE2' ' A' ' 485' ' ' LYS . 80.9 m-85 -112.05 144.84 40.74 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 97.8 m -126.99 134.31 50.38 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.316 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -101.82 124.89 48.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.954 0.407 . . . . 0.0 111.716 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 477' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 483' ' ' TYR . 14.6 m-85 -110.22 131.41 55.08 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -115.26 137.76 51.68 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.665 0.269 . . . . 0.0 111.669 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 479' ' ' LYS . . . . . 0.467 ' HB3' ' CZ3' ' A' ' 484' ' ' TRP . 79.5 tttt -163.01 104.1 1.0 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.961 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 65.94 66.03 2.6 Favored Glycine 0 CA--C 1.518 0.268 0 N-CA-C 114.828 0.691 . . . . 0.0 114.828 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 61.84 -1.2 0.37 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 482' ' ' LYS . . . . . 0.441 ' HB2' ' HE2' ' A' ' 482' ' ' LYS . 30.3 mtmm -119.56 148.02 43.8 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 122.291 -0.256 . . . . 0.0 110.526 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 483' ' ' TYR . . . . . 0.543 ' CE2' ' HE2' ' A' ' 497' ' ' TYR . 11.0 p90 -127.95 147.55 50.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.174 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 484' ' ' TRP . . . . . 0.467 ' CZ3' ' HB3' ' A' ' 479' ' ' LYS . 17.4 m-90 -113.04 143.84 43.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.879 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 485' ' ' LYS . . . . . 0.411 ' HE2' ' CD1' ' A' ' 474' ' ' PHE . 74.0 tttt -104.35 97.08 7.07 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 486' ' ' PHE . . . . . 0.452 ' HB2' HD11 ' A' ' 459' ' ' ILE . 89.4 t80 -90.68 134.54 34.33 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.477 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -98.63 119.27 37.06 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -68.52 -32.93 73.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.199 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -74.84 -43.14 56.16 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.701 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -85.24 -22.56 28.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.131 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 3.7 tp 65.56 42.67 3.6 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.525 0.679 . . . . 0.0 109.889 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 492' ' ' LYS . . . . . 0.412 ' HG2' ' N ' ' A' ' 493' ' ' VAL . 16.1 tttp -156.96 153.89 28.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.61 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 493' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 486' ' ' PHE . 69.9 t -85.15 140.18 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -61.48 131.46 92.54 Favored Pre-proline 0 C--O 1.234 0.278 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.264 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -62.11 141.84 90.04 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.669 2.246 . . . . 0.0 111.682 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 109.56 -10.24 32.83 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 497' ' ' TYR . . . . . 0.613 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 14.0 m-85 -94.73 170.46 8.02 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.61 -0.295 . . . . 0.0 110.333 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 498' ' ' PRO . . . . . 0.613 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 91.9 Cg_endo -78.88 169.5 72.11 Favored 'Cis proline' 0 C--N 1.349 0.604 0 C-N-CA 123.978 -1.259 . . . . 0.0 113.253 0.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -120.85 157.65 29.34 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.774 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 47.6 t -69.84 112.91 6.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.973 0.416 . . . . 0.0 110.263 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -66.55 -23.73 66.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.074 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 502' ' ' LEU . . . . . 0.485 ' HA ' ' HG2' ' A' ' 506' ' ' MET . 79.1 mt -65.94 -39.25 90.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.114 0.483 . . . . 0.0 110.711 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -89.06 -39.69 13.47 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.587 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.0 -36.67 61.97 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 42.9 m0 -106.37 -57.44 2.05 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 506' ' ' MET . . . . . 0.485 ' HG2' ' HA ' ' A' ' 502' ' ' LEU . 7.1 mmt -65.84 -35.42 80.63 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 91.67 38.03 5.95 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.218 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 23.0 m -115.74 86.95 16.75 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.3 160.69 48.06 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.475 2.117 . . . . 0.0 111.737 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 5.7 m 66.4 69.71 0.42 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.166 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.23 0 CA-C-O 118.306 -1.274 . . . . 0.0 111.258 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.766 0 N-CA-C 112.429 -0.268 . . . . 0.0 112.429 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' PRO . . . . . 0.443 ' HA ' HD23 ' B' ' 2' ' ' HYP . 60.0 Cg_endo -72.7 143.63 37.98 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.745 2.297 . . . . 0.0 112.471 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 2' ' ' HYP . . . . . 0.443 HD23 ' HA ' ' B' ' 1' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -85.76 161.15 34.74 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.181 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -80.77 161.57 21.45 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.488 2.126 . . . . 0.0 110.404 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.27 -136.02 1.23 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.887 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.422 ' HA ' HD23 ' B' ' 8' ' ' HYP . 34.4 Cg_exo -61.55 154.16 61.6 Favored 'Trans proline' 0 CA--C 1.527 0.154 0 C-N-CA 122.943 2.428 . . . . 0.0 111.766 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 8' ' ' HYP . . . . . 0.629 ' HA ' ' HD2' ' C' ' 107' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.03 160.23 17.84 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.062 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.35 149.77 69.89 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 123.006 2.471 . . . . 0.0 112.061 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -65.17 145.56 56.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.494 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.41 155.96 46.21 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.249 -0.5 . . . . 0.0 112.318 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.665 HD11 ' HA3' ' A' ' 352' ' ' GLY . 6.9 mt -67.44 147.28 12.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.572 0.225 . . . . 0.0 110.778 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.41 147.29 53.09 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.797 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' D' ' 213' ' ' ILE . . . -75.77 162.08 52.79 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.0 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -72.94 150.47 42.51 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -75.16 152.41 38.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.191 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' D' ' 216' ' ' GLN . . . -67.84 154.23 53.01 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.648 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 3.2 t -71.99 152.32 8.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 2.9 t -51.33 145.24 2.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 O-C-N 123.499 0.499 . . . . 0.0 110.948 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.39 160.12 53.99 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.739 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' B' ' 23' ' ' HYP . 94.0 mt -71.82 148.13 46.52 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.479 0.181 . . . . 0.0 110.604 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' HYP . . . . . 0.402 HD23 ' HA ' ' B' ' 22' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.73 154.66 48.76 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.451 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.439 ' HA ' HD23 ' B' ' 26' ' ' HYP . 38.3 Cg_endo -67.22 153.23 77.93 Favored 'Trans proline' 0 CA--C 1.529 0.258 0 C-N-CA 122.752 2.301 . . . . 0.0 111.764 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' HYP . . . . . 0.439 HD23 ' HA ' ' B' ' 25' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.93 155.38 53.2 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.723 -0.672 . . . . 0.0 113.399 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.3 166.95 26.72 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 123.244 2.629 . . . . 0.0 112.035 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.34 173.11 51.48 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.878 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.448 ' HA ' HD23 ' B' ' 32' ' ' HYP . 30.1 Cg_exo -64.07 157.52 52.86 Favored 'Trans proline' 0 CA--C 1.528 0.224 0 C-N-CA 123.176 2.584 . . . . 0.0 111.853 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' HYP . . . . . 0.448 HD23 ' HA ' ' B' ' 31' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.4 155.1 53.39 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.333 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' PRO . . . . . 0.403 ' HG2' ' HB2' ' D' ' 232' ' ' HYP . 69.2 Cg_endo -75.21 156.49 42.09 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.685 2.256 . . . . 0.0 111.479 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.402 0 CA-C-O 120.224 -0.209 . . . . 0.0 112.64 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 101' ' ' PRO . . . . . 0.408 ' HA ' HD23 ' C' ' 102' ' ' HYP . 11.5 Cg_exo -72.25 133.18 20.63 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 123.057 2.505 . . . . 0.0 111.142 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 102' ' ' HYP . . . . . 0.524 ' HA ' ' HD2' ' D' ' 201' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 103' ' ' GLY . . . . . 0.417 ' HA2' ' HD3' ' C' ' 104' ' ' PRO . . . -61.63 160.85 28.28 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.832 -0.622 . . . . 0.0 113.689 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 104' ' ' PRO . . . . . 0.417 ' HD3' ' HA2' ' C' ' 103' ' ' GLY . 2.8 Cg_exo -77.47 164.79 28.21 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 123.528 2.819 . . . . 0.0 112.413 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 105' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -84.22 -176.05 50.99 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.421 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 107' ' ' PRO . . . . . 0.629 ' HD2' ' HA ' ' B' ' 8' ' ' HYP . 83.1 Cg_endo -82.14 158.09 17.71 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 122.981 2.454 . . . . 0.0 111.756 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 108' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -58.22 167.47 6.04 Favored Glycine 0 N--CA 1.452 -0.243 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.553 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.19 156.82 64.36 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.66 2.24 . . . . 0.0 112.085 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -59.33 135.86 57.78 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.06 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -62.01 162.16 27.63 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.563 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 16.3 mt -69.3 134.73 29.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.621 0.248 . . . . 0.0 110.68 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.26 146.52 47.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.679 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -64.94 157.04 46.62 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 121.205 -0.521 . . . . 0.0 113.002 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -84.3 152.4 24.16 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 117' ' ' ARG . . . . . 0.412 ' HE ' ' HB2' ' C' ' 117' ' ' ARG . 4.6 ttm180 -66.5 148.52 51.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.328 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.07 171.91 41.65 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.027 -0.606 . . . . 0.0 113.053 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 15.9 t -72.85 142.49 15.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 97.3 t -62.9 138.39 22.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.954 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.46 158.52 39.32 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 116.081 -0.508 . . . . 0.0 112.538 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 59.1 mt -73.62 142.02 46.53 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.852 -0.174 . . . . 0.0 110.642 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 123' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -64.74 158.41 44.13 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.673 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 125' ' ' PRO . . . . . 0.423 ' HA ' HD23 ' C' ' 126' ' ' HYP . 36.4 Cg_endo -65.59 146.39 84.39 Favored 'Trans proline' 0 N--CA 1.464 -0.209 0 C-N-CA 122.475 2.117 . . . . 0.0 111.116 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 126' ' ' HYP . . . . . 0.423 HD23 ' HA ' ' C' ' 125' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -66.06 156.05 50.25 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.774 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.08 166.27 26.86 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.82 2.347 . . . . 0.0 111.552 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -70.58 -177.87 24.15 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.451 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 131' ' ' PRO . . . . . 0.429 ' HA ' HD23 ' C' ' 132' ' ' HYP . 13.1 Cg_exo -70.95 151.65 62.47 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.985 2.457 . . . . 0.0 111.731 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 132' ' ' HYP . . . . . 0.525 ' HA ' ' O ' ' D' ' 231' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 133' ' ' GLY . . . . . 0.407 ' HA2' ' HD3' ' C' ' 134' ' ' PRO . . . -78.92 119.87 5.17 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.805 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 134' ' ' PRO . . . . . 0.499 ' HA ' HD23 ' C' ' 135' ' ' HYP . 17.2 Cg_exo -67.45 110.84 2.15 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.107 2.538 . . . . 0.0 111.968 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 135' ' ' HYP . . . . . 0.499 HD23 ' HA ' ' C' ' 134' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.387 0 CA-C-O 120.197 -0.224 . . . . 0.0 112.712 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 201' ' ' PRO . . . . . 0.524 ' HD2' ' HA ' ' C' ' 102' ' ' HYP . 24.8 Cg_exo -65.85 155.45 69.26 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.153 2.569 . . . . 0.0 111.115 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 202' ' ' HYP . . . . . 0.428 HD23 ' HA ' ' D' ' 201' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 117.51 -156.6 15.55 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.071 -1.061 . . . . 0.0 113.606 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 204' ' ' PRO . . . . . 0.402 ' HA ' HD23 ' D' ' 205' ' ' HYP . 15.3 Cg_exo -69.57 159.95 51.62 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.735 2.956 . . . . 0.0 113.04 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 205' ' ' HYP . . . . . 0.402 HD23 ' HA ' ' D' ' 204' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 206' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' B' ' 8' ' ' HYP . . . 95.26 162.93 34.45 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.033 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 207' ' ' PRO . . . . . 0.401 ' HA ' HD23 ' D' ' 208' ' ' HYP . 3.1 Cg_endo -86.85 148.6 8.32 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.466 2.777 . . . . 0.0 111.995 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 208' ' ' HYP . . . . . 0.401 HD23 ' HA ' ' D' ' 207' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.95 169.9 55.05 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.428 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.06 158.48 57.25 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.502 2.134 . . . . 0.0 111.773 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -78.29 144.08 36.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.653 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -67.43 159.53 50.14 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.87 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 213' ' ' ILE . . . . . 0.53 ' HB ' ' OE1' ' A' ' 392' ' ' GLU . 15.2 pt -70.76 168.85 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.655 0.264 . . . . 0.0 111.026 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 214' ' ' ALA . . . . . 0.494 ' HB3' ' NH1' ' A' ' 330' ' ' ARG . . . -87.37 143.15 27.38 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.863 0.363 . . . . 0.0 110.595 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -65.99 162.25 42.93 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 116.02 -0.536 . . . . 0.0 113.216 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 216' ' ' GLN . . . . . 0.447 ' O ' ' HA3' ' B' ' 18' ' ' GLY . 68.0 mm-40 -71.08 158.94 35.62 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.783 0.325 . . . . 0.0 110.899 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -68.5 152.57 45.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.0 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -59.96 151.09 38.6 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.301 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 12.4 t -61.33 144.44 13.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 46.7 t -63.18 139.42 21.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -56.66 158.23 10.03 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.962 -0.563 . . . . 0.0 113.621 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 222' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' D' ' 223' ' ' HYP . 7.1 mp -71.09 150.8 45.14 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.656 -0.272 . . . . 0.0 110.668 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 223' ' ' HYP . . . . . 0.42 HD23 ' HA ' ' D' ' 222' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 224' ' ' GLY . . . . . 0.423 ' HA2' ' HD3' ' D' ' 225' ' ' PRO . . . -57.57 145.6 39.02 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.96 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 225' ' ' PRO . . . . . 0.433 ' HA ' HD23 ' D' ' 226' ' ' HYP . 24.2 Cg_exo -66.05 152.79 80.4 Favored 'Trans proline' 0 CA--C 1.528 0.177 0 C-N-CA 123.092 2.528 . . . . 0.0 111.223 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 226' ' ' HYP . . . . . 0.433 HD23 ' HA ' ' D' ' 225' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -74.56 171.08 53.46 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.638 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -87.36 163.59 8.27 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.93 2.42 . . . . 0.0 111.643 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 229' ' ' HYP . . . . . 0.434 ' HA ' ' O ' ' B' ' 31' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -67.68 174.68 27.94 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.219 -0.515 . . . . 0.0 113.816 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 231' ' ' PRO . . . . . 0.525 ' O ' ' HA ' ' C' ' 132' ' ' HYP . 35.1 Cg_exo -60.41 140.29 90.9 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 123.206 2.604 . . . . 0.0 111.995 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 232' ' ' HYP . . . . . 0.467 HD23 ' HA ' ' D' ' 231' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo . . . . . 0 N--CA 1.479 0.63 0 N-CA-C 110.238 -0.716 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 317' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 320' ' ' ASP . 20.7 t-20 -114.1 164.62 13.6 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 19.5 tt -71.37 -23.44 22.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.948 0.404 . . . . 0.0 111.036 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 31.2 m -87.68 6.07 36.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.727 0.299 . . . . 0.0 111.574 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 317' ' ' ASN . 0.2 OUTLIER -63.15 -50.5 70.16 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.132 0.491 . . . . 0.0 110.438 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 97.13 175.59 34.7 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 51.03 73.43 0.29 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.172 0.511 . . . . 0.0 112.172 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' PHE . . . . . 0.609 ' HD1' ' HD3' ' A' ' 337' ' ' LYS . 60.7 m-85 -88.62 173.3 8.7 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.03 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.37 -51.75 27.55 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 14.5 t -170.51 147.67 2.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.435 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 76.8 t -112.71 126.62 70.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -131.67 166.7 20.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.01 0.433 . . . . 0.0 111.151 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 42.2 ttp -136.36 108.18 7.08 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 45.3 mt -106.25 127.2 53.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.574 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.06 14.85 5.71 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.55 0.531 . . . . 0.0 112.13 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 102.99 -9.29 54.92 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.23 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -93.94 129.67 40.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.631 0.253 . . . . 0.0 110.738 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 45.6 ttm -82.59 123.07 28.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.228 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -114.86 123.22 48.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.355 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 9.2 t -103.49 109.75 27.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.954 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -92.16 125.41 36.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.457 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 0.609 ' HD3' ' HD1' ' A' ' 323' ' ' PHE . 22.0 tptp -136.5 95.5 3.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.656 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 62.7 -100.5 0.09 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.411 ' H ' ' HG2' ' A' ' 339' ' ' ARG . 7.7 ptm85 -104.22 -5.25 22.09 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -177.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 7.6 m0 -124.69 159.89 29.8 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.974 0.416 . . . . 0.0 111.425 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -135.93 138.2 42.13 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.372 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -108.39 152.78 24.21 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.954 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.513 ' HD3' ' SD ' ' A' ' 350' ' ' MET . 16.4 ttt180 -127.07 113.4 16.38 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -101.78 113.09 37.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.175 0.512 . . . . 0.0 111.206 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.23 120.18 40.87 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 5.5 m120 61.83 32.94 17.94 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.437 0.46 . . . . 0.0 110.577 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 70.89 16.22 6.62 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.192 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -121.51 137.64 54.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.251 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 22.9 t -73.47 120.74 22.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.044 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 350' ' ' MET . . . . . 0.513 ' SD ' ' HD3' ' A' ' 343' ' ' ARG . 79.0 mtp -70.45 167.93 17.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.987 0.422 . . . . 0.0 111.542 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -85.81 163.71 17.98 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.371 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 91.54 -1.55 76.01 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.772 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' TYR . . . . . 0.56 ' HB3' ' HA ' ' A' ' 354' ' ' PRO . 63.4 m-85 -113.78 160.99 29.93 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.56 ' HA ' ' HB3' ' A' ' 353' ' ' TYR . 56.3 Cg_endo -72.55 128.49 15.18 Favored 'Cis proline' 0 C--N 1.347 0.493 0 C-N-CA 123.505 -1.456 . . . . 0.0 112.519 0.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 54.2 ttm -102.87 133.52 20.35 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.711 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.76 136.09 68.1 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.398 2.065 . . . . 0.0 111.158 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 77.4 mt -53.0 -45.47 52.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.835 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -68.18 -13.55 64.85 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 121.145 -0.55 . . . . 0.0 114.04 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.51 -29.45 61.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.954 0.377 . . . . 0.0 110.202 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -112.38 -53.91 2.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.556 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -86.91 73.72 9.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.962 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -64.69 103.64 0.72 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.008 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 127.55 -13.3 6.55 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.416 HD12 ' HD2' ' A' ' 365' ' ' PRO . 20.0 tp -97.9 129.23 31.63 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 365' ' ' PRO . . . . . 0.416 ' HD2' HD12 ' A' ' 364' ' ' LEU . 94.3 Cg_endo -81.62 -178.72 4.39 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.782 2.321 . . . . 0.0 112.067 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -82.93 149.19 27.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.502 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 39.3 m 58.5 90.11 0.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.752 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 30.3 pt -95.62 168.59 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.965 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' ASN . . . . . 0.535 ' HB2' ' HA ' ' A' ' 383' ' ' LYS . 0.1 OUTLIER -92.81 -45.54 7.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.902 -179.289 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 370' ' ' THR . . . . . 0.792 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.2 OUTLIER -157.38 168.08 28.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.741 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -157.37 141.14 15.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 372' ' ' TYR . . . . . 0.448 ' CE1' ' HB ' ' A' ' 380' ' ' VAL . 27.6 p90 -160.02 161.01 33.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.065 0.46 . . . . 0.0 111.859 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -94.99 125.68 39.81 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 374' ' ' ARG . . . . . 0.512 ' HB2' ' OE2' ' A' ' 440' ' ' GLU . 2.4 ptm180 -82.87 179.71 7.69 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -178.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.509 ' HD2' ' O ' ' A' ' 425' ' ' GLY . 71.4 tttt -64.46 -29.24 70.29 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 376' ' ' ASP . . . . . 0.443 ' OD2' ' HE2' ' A' ' 378' ' ' LYS . 0.0 OUTLIER -85.79 -17.21 36.41 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.07 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 116.53 -18.57 13.28 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.799 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 378' ' ' LYS . . . . . 0.443 ' HE2' ' OD2' ' A' ' 376' ' ' ASP . 44.4 mttm -72.48 156.05 39.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.195 0.497 . . . . 0.0 111.077 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -100.03 125.65 46.12 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.187 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' VAL . . . . . 0.448 ' HB ' ' CE1' ' A' ' 372' ' ' TYR . 15.4 t -108.25 116.3 51.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.041 0.448 . . . . 0.0 110.726 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -104.5 138.21 41.21 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.45 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -118.25 145.81 44.74 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.804 0.335 . . . . 0.0 111.233 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.668 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 64.4 tttp -155.0 99.55 2.12 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.957 178.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 71.56 -106.28 1.87 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.8 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -114.17 5.9 16.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.732 0.301 . . . . 0.0 111.432 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -116.95 154.52 30.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.91 0.386 . . . . 0.0 111.438 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' HIS . . . . . 0.401 ' NE2' ' HE2' ' A' ' 399' ' ' TYR . 23.9 p-80 -136.99 144.9 43.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.849 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 388' ' ' TRP . . . . . 0.668 ' HZ3' ' HB3' ' A' ' 383' ' ' LYS . 22.3 m-90 -118.8 135.13 54.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.964 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 53.3 t -113.37 114.55 47.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -107.06 121.6 44.81 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.411 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -91.5 100.13 12.94 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 69.0 -68.99 0.17 Allowed 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.722 0.639 . . . . 0.0 110.707 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -156.11 16.51 0.35 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.658 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.11 127.25 49.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.92 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 60.5 tp -75.14 131.51 40.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.218 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' GLU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 20.1 mm-40 -66.87 133.21 93.94 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.956 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 397' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 39.3 Cg_exo -62.24 123.62 12.82 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.997 2.465 . . . . 0.0 112.361 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 113.82 -1.84 24.47 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.413 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 399' ' ' TYR . . . . . 0.406 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 31.0 m-85 -100.17 161.64 23.52 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.464 ' HB3' ' CE2' ' A' ' 388' ' ' TRP . 75.7 Cg_endo -76.35 160.53 95.27 Favored 'Cis proline' 0 C--N 1.345 0.365 0 C-N-CA 123.797 -1.335 . . . . 0.0 113.269 0.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 28.6 mttm -125.41 165.44 18.4 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.262 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -71.53 158.33 36.43 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 47.5 mt -57.78 -36.54 55.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.045 0.45 . . . . 0.0 111.374 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -66.52 -15.56 63.48 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.265 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -78.66 -25.02 44.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.887 0.375 . . . . 0.0 110.896 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 39.6 tp -74.83 -45.38 43.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.122 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.612 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -164.21 154.81 25.86 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.764 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 52.1 ttt85 -79.66 135.89 36.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.7 0.286 . . . . 0.0 110.51 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.08 -4.59 62.83 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.84 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 46.8 mt -72.66 151.32 91.33 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.858 0.329 . . . . 0.0 111.121 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.02 129.07 33.33 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.869 2.38 . . . . 0.0 112.123 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.59 -8.6 52.28 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -91.51 -54.37 3.93 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -176.95 -179.66 0.95 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.337 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 37.6 mm -124.24 137.18 58.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 416' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 430' ' ' PHE . 1.4 m-20 -88.52 -57.94 2.73 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 417' ' ' ALA . . . . . 0.792 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -152.8 161.54 42.42 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.794 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -137.61 128.36 27.01 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 40.6 tp -118.92 122.17 41.65 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.824 0.345 . . . . 0.0 111.237 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -88.14 111.58 21.75 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.188 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 13.1 t-105 -80.24 96.25 6.54 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 67.9 mtt -51.35 -51.84 65.02 Favored Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -40.47 -54.52 2.25 Favored 'Trans proline' 0 C--N 1.358 1.067 0 C-N-CA 123.388 2.725 . . . . 0.0 115.139 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -104.24 -16.84 15.07 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 425' ' ' GLY . . . . . 0.509 ' O ' ' HD2' ' A' ' 375' ' ' LYS . . . 79.58 53.77 4.22 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.666 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -133.4 136.95 45.59 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.718 0.294 . . . . 0.0 110.436 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 17.6 m -91.65 127.42 37.1 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -99.56 114.69 27.85 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.631 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -96.17 123.31 39.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.658 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 430' ' ' PHE . . . . . 0.42 ' O ' ' HB2' ' A' ' 416' ' ' ASP . 86.9 m-85 -99.12 135.92 39.83 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.186 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.413 ' HA ' ' HE ' ' A' ' 431' ' ' ARG . 3.0 tpm_? -148.84 101.74 3.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.651 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 73.54 -116.71 5.53 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.737 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -110.08 14.38 22.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.99 0.424 . . . . 0.0 110.651 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 434' ' ' LYS . . . . . 0.521 ' HB3' ' HB2' ' A' ' 450' ' ' PRO . 33.7 mmtp -127.44 151.94 48.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.983 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 435' ' ' TYR . . . . . 0.506 ' CE2' ' HE2' ' A' ' 449' ' ' TYR . 30.8 p90 -130.09 143.43 50.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.657 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -111.05 151.21 28.29 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.211 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -111.6 99.57 8.28 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 438' ' ' PHE . . . . . 0.612 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 72.9 t80 -79.76 116.82 20.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.84 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -83.47 102.13 11.87 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.211 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 440' ' ' GLU . . . . . 0.512 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 4.1 mm-40 -56.93 -26.39 59.37 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -87.05 -14.37 41.7 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 93.0 mt -120.14 -11.65 9.2 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 443' ' ' ARG . . . . . 0.442 HH11 ' HD3' ' A' ' 443' ' ' ARG . 25.6 mtp180 58.69 45.01 16.47 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.323 0.583 . . . . 0.0 111.177 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -162.24 157.0 22.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.989 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 96.3 t -76.71 133.53 30.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -60.57 164.38 4.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.032 0.444 . . . . 0.0 111.731 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 74.4 m -70.64 159.16 34.92 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.768 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 72.62 20.25 3.86 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.126 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 449' ' ' TYR . . . . . 0.506 ' HE2' ' CE2' ' A' ' 435' ' ' TYR . 32.1 m-85 -120.41 159.08 49.37 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.5 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 450' ' ' PRO . . . . . 0.521 ' HB2' ' HB3' ' A' ' 434' ' ' LYS . 72.3 Cg_endo -75.04 165.52 85.71 Favored 'Cis proline' 0 C--N 1.344 0.34 0 C-N-CA 123.608 -1.413 . . . . 0.0 112.95 0.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 57.6 mttm -117.64 160.65 20.94 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.664 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 452' ' ' ASN . . . . . 0.437 ' HA ' ' HD3' ' A' ' 434' ' ' LYS . 30.9 t-20 -67.37 135.43 53.21 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.272 0.357 . . . . 0.0 110.453 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.4 tt -64.0 -12.91 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.075 0.464 . . . . 0.0 111.323 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -62.5 -15.21 48.98 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 75.7 t -58.75 -36.94 63.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 456' ' ' TRP . . . . . 0.445 ' HB2' ' HB ' ' A' ' 459' ' ' ILE . 17.4 m95 -86.06 88.53 7.6 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.11 109.04 0.38 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 107.89 -13.11 38.16 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.027 -0.606 . . . . 0.0 113.312 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.445 ' HB ' ' HB2' ' A' ' 456' ' ' TRP . 40.0 mm -83.33 126.24 72.27 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.81 0.305 . . . . 0.0 111.298 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.85 156.16 30.87 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.036 2.49 . . . . 0.0 111.983 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -73.04 149.55 43.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.177 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 3.5 m 51.64 69.46 2.49 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 114.484 1.291 . . . . 0.0 114.484 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -91.47 172.62 2.78 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.55 2.167 . . . . 0.0 109.956 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -142.91 74.56 1.45 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.542 0.686 . . . . 0.0 111.219 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 135.79 97.63 0.53 Allowed Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.345 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 466' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 476' ' ' TYR . 2.9 p -130.13 108.34 9.99 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -130.06 144.03 51.12 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.945 0.402 . . . . 0.0 111.475 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 43.1 ttm -97.11 133.87 41.2 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.521 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -65.31 164.69 36.79 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.379 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 2.4 m -65.5 -8.03 17.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.941 0.4 . . . . 0.0 111.825 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -87.89 -13.04 43.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.517 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 64.02 11.11 5.87 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.624 -0.717 . . . . 0.0 112.509 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 98.1 t -110.79 -41.5 4.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.845 0.355 . . . . 0.0 111.403 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -105.68 123.17 47.5 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 85.6 m -111.81 141.09 45.88 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 476' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 466' ' ' SER . 89.7 m-85 -113.52 135.0 54.37 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -118.66 127.27 53.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.415 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -109.27 133.85 52.52 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 56.6 tttt -165.66 127.69 2.01 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.223 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 61.98 38.19 95.65 Favored Glycine 0 N--CA 1.454 -0.118 0 CA-C-N 116.035 -0.53 . . . . 0.0 113.449 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 481' ' ' ASN . . . . . 0.511 HD21 HD12 ' A' ' 502' ' ' LEU . 53.7 t30 74.15 -4.79 2.21 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -106.85 155.29 19.9 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -127.26 139.35 52.97 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.137 0.494 . . . . 0.0 111.563 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 17.9 m-90 -108.84 133.28 53.09 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.742 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -99.03 100.81 12.02 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.958 0.408 . . . . 0.0 110.034 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 486' ' ' PHE . . . . . 0.497 ' HZ ' HD12 ' A' ' 491' ' ' LEU . 88.9 t80 -89.65 132.63 35.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.155 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 487' ' ' ASN . . . . . 0.414 ' HB3' ' HB3' ' A' ' 490' ' ' LYS . 32.6 t-20 -96.66 112.42 24.18 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -59.38 -47.8 84.08 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 41.3 tp60 -85.13 37.51 0.67 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.326 0.584 . . . . 0.0 111.41 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 490' ' ' LYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 487' ' ' ASN . 19.8 ttpt -153.33 -27.85 0.14 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.912 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.497 HD12 ' HZ ' ' A' ' 486' ' ' PHE . 14.7 tp 61.76 40.17 13.26 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.867 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -159.66 148.0 17.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.628 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 69.5 t -75.78 142.93 13.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -63.97 142.67 98.18 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.379 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -65.5 146.0 83.87 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.725 2.283 . . . . 0.0 111.753 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 96.12 1.75 61.05 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.21 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 497' ' ' TYR . . . . . 0.722 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 72.3 m-85 -108.87 167.39 9.23 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 498' ' ' PRO . . . . . 0.722 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 91.9 Cg_endo -76.46 176.75 42.48 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 124.037 -1.235 . . . . 0.0 113.42 0.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -133.12 166.0 23.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.939 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 500' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 504' ' ' ASP . 4.8 t -75.49 122.14 23.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.852 0.358 . . . . 0.0 110.849 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -73.92 -21.17 60.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.86 0.362 . . . . 0.0 110.866 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 502' ' ' LEU . . . . . 0.511 HD12 HD21 ' A' ' 481' ' ' ASN . 10.3 mt -70.96 -48.72 51.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.881 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -78.18 -40.18 38.53 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.999 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 504' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 500' ' ' SER . 0.6 OUTLIER -76.79 -56.33 4.69 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -177.899 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -85.17 -58.51 2.65 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -177.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 506' ' ' MET . . . . . 0.467 ' HG3' HD23 ' A' ' 502' ' ' LEU . 11.6 mmt -63.86 -32.51 74.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 87.82 38.01 7.67 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.938 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 59.9 m -121.29 90.8 47.84 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.01 166.2 30.31 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.804 2.336 . . . . 0.0 111.721 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 11.9 m 65.91 101.36 0.04 OUTLIER 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.459 0.647 . . . . 0.0 111.793 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.865 0 CA-C-O 118.361 -1.244 . . . . 0.0 111.473 179.914 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.889 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' PRO . . . . . 0.48 ' HA ' HD23 ' B' ' 2' ' ' HYP . 72.8 Cg_endo -78.77 142.68 18.04 Favored 'Trans proline' 0 CA--C 1.528 0.186 0 C-N-CA 122.421 2.081 . . . . 0.0 111.369 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 2' ' ' HYP . . . . . 0.48 HD23 ' HA ' ' B' ' 1' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' D' ' 201' ' ' PRO . . . -65.72 155.48 50.09 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.489 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.21 160.49 29.58 Favored 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.683 2.255 . . . . 0.0 111.253 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.06 -147.87 14.39 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.969 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.996 ' HG2' ' HA ' ' D' ' 205' ' ' HYP . 19.7 Cg_endo -62.01 163.01 20.65 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.995 2.463 . . . . 0.0 111.978 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' HYP . . . . . 0.509 ' O ' ' HA3' ' D' ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' D' ' 205' ' ' HYP . . . 161.61 170.15 25.91 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.538 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.91 144.55 96.68 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.119 2.546 . . . . 0.0 112.106 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -64.12 140.39 58.86 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.669 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.74 144.02 47.62 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.517 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 32.5 mt -63.67 144.69 14.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.592 0.234 . . . . 0.0 110.548 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.03 157.93 20.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.043 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' D' ' 213' ' ' ILE . . . -71.13 165.76 52.99 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.471 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -72.29 149.02 44.86 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.66 142.08 57.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.436 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' D' ' 216' ' ' GLN . . . -61.63 148.37 47.34 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.293 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.432 ' HB ' ' HG2' ' D' ' 217' ' ' ARG . 3.1 t -68.3 154.27 8.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.753 0.311 . . . . 0.0 110.502 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 14.7 t -58.33 141.4 15.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.689 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.46 168.37 53.92 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.567 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.429 ' HA ' HD23 ' B' ' 23' ' ' HYP . 79.8 mt -81.38 145.95 30.56 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' HYP . . . . . 0.429 HD23 ' HA ' ' B' ' 22' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.29 159.01 53.79 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.903 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.9 162.35 42.19 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.831 2.354 . . . . 0.0 111.798 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.95 154.17 46.32 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.991 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.22 152.67 79.14 Favored 'Trans proline' 0 C--O 1.237 0.459 0 C-N-CA 122.584 2.189 . . . . 0.0 111.924 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.19 169.19 54.72 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.789 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.461 ' HA ' HD23 ' B' ' 32' ' ' HYP . 23.9 Cg_exo -66.85 153.62 77.3 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.915 2.41 . . . . 0.0 111.1 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' HYP . . . . . 0.461 HD23 ' HA ' ' B' ' 31' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' GLY . . . . . 0.415 ' HA2' ' HD3' ' B' ' 34' ' ' PRO . . . -61.39 156.45 34.61 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.99 -0.55 . . . . 0.0 113.138 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' PRO . . . . . 0.462 ' HA ' HD22 ' B' ' 35' ' ' HYP . 14.8 Cg_endo -91.61 105.99 0.25 Allowed 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.419 2.746 . . . . 0.0 111.749 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' HYP . . . . . 0.462 HD22 ' HA ' ' B' ' 34' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.428 0 CA-C-O 120.077 -0.291 . . . . 0.0 112.665 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 101' ' ' PRO . . . . . 0.491 ' HA ' HD23 ' C' ' 102' ' ' HYP . 17.1 Cg_exo -69.17 139.22 41.72 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.929 2.42 . . . . 0.0 111.679 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 102' ' ' HYP . . . . . 0.491 HD23 ' HA ' ' C' ' 101' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.52 161.29 54.34 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.191 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -79.43 162.89 24.87 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 123.48 2.787 . . . . 0.0 111.739 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 105' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -77.89 178.72 52.02 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.095 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -77.21 145.01 23.91 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.926 2.417 . . . . 0.0 110.83 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 108' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -62.7 172.75 9.84 Favored Glycine 0 CA--C 1.519 0.292 0 CA-C-N 115.636 -0.711 . . . . 0.0 113.537 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.97 169.98 13.84 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 122.85 2.366 . . . . 0.0 112.553 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 111' ' ' GLN . . . . . 0.444 ' OE1' ' HB2' ' D' ' 210' ' ' PRO . 5.6 tp60 -64.75 137.78 58.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.548 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -62.23 161.35 29.95 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 116.02 -0.536 . . . . 0.0 113.095 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 113' ' ' ILE . . . . . 0.497 ' H ' HG13 ' C' ' 113' ' ' ILE . 2.3 mt -62.73 144.0 14.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.695 -0.252 . . . . 0.0 110.393 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.97 152.8 44.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.539 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -70.43 145.81 41.29 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.477 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -72.82 147.02 45.87 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 35.1 ttm-85 -62.45 145.81 53.14 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.758 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.18 177.39 32.34 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.806 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 61.9 t -72.84 137.48 23.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.466 -0.367 . . . . 0.0 110.365 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 93.7 t -63.94 139.25 21.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.983 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.22 157.41 28.01 Favored Glycine 0 N--CA 1.45 -0.424 0 O-C-N 123.51 0.506 . . . . 0.0 112.886 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 31.8 mt -73.2 151.19 41.56 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 123' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -67.13 162.43 46.47 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.237 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 125' ' ' PRO . . . . . 0.421 ' HA ' HD23 ' C' ' 126' ' ' HYP . 54.9 Cg_endo -70.39 150.5 64.44 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.684 2.256 . . . . 0.0 111.47 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 126' ' ' HYP . . . . . 0.421 HD23 ' HA ' ' C' ' 125' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -69.67 160.44 52.99 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.961 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.08 158.92 37.82 Favored 'Trans proline' 0 C--O 1.237 0.454 0 C-N-CA 122.595 2.196 . . . . 0.0 111.514 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -65.19 175.25 14.64 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.489 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 131' ' ' PRO . . . . . 0.433 ' HA ' HD23 ' C' ' 132' ' ' HYP . 24.0 Cg_exo -65.96 147.4 84.71 Favored 'Trans proline' 0 C--N 1.34 0.114 0 C-N-CA 123.038 2.492 . . . . 0.0 111.287 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 132' ' ' HYP . . . . . 0.433 HD23 ' HA ' ' C' ' 131' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 133' ' ' GLY . . . . . 0.503 ' HA2' ' HD3' ' C' ' 134' ' ' PRO . . . -70.65 132.86 22.78 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.112 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 134' ' ' PRO . . . . . 0.503 ' HD3' ' HA2' ' C' ' 133' ' ' GLY . 7.6 Cg_exo -73.42 111.61 3.33 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 123.084 2.523 . . . . 0.0 112.143 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 135' ' ' HYP . . . . . 0.438 HD23 ' HA ' ' C' ' 134' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 CA-C-O 120.043 -0.309 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 201' ' ' PRO . . . . . 0.502 ' HA ' HD23 ' D' ' 202' ' ' HYP . 35.4 Cg_exo -62.51 146.87 95.5 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.985 2.457 . . . . 0.0 111.724 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 202' ' ' HYP . . . . . 0.502 HD23 ' HA ' ' D' ' 201' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 83.42 -161.19 38.78 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.032 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 204' ' ' PRO . . . . . 0.419 ' HA ' HD23 ' D' ' 205' ' ' HYP . 4.4 Cg_endo -88.48 161.54 6.66 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 123.903 3.068 . . . . 0.0 112.148 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 205' ' ' HYP . . . . . 0.996 ' HA ' ' HG2' ' B' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 206' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' B' ' 8' ' ' HYP . . . 77.14 -177.07 52.84 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.993 -0.623 . . . . 0.0 113.567 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 207' ' ' PRO . . . . . 0.404 ' HA ' HD23 ' D' ' 208' ' ' HYP . 95.5 Cg_endo -98.27 160.86 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.656 2.904 . . . . 0.0 112.46 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 208' ' ' HYP . . . . . 0.404 HD23 ' HA ' ' D' ' 207' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.44 171.55 54.79 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.011 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 210' ' ' PRO . . . . . 0.444 ' HB2' ' OE1' ' C' ' 111' ' ' GLN . 12.4 Cg_exo -70.21 157.76 58.5 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.766 2.31 . . . . 0.0 111.901 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -82.56 142.33 31.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.988 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -64.74 162.66 37.92 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 116.08 -0.509 . . . . 0.0 113.295 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 213' ' ' ILE . . . . . 0.446 ' O ' ' HA3' ' B' ' 15' ' ' GLY . 42.2 pt -71.68 159.35 5.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.926 0.393 . . . . 0.0 111.403 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -71.27 139.1 49.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.081 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -64.37 165.6 31.45 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 116.01 -0.541 . . . . 0.0 113.864 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 216' ' ' GLN . . . . . 0.407 ' O ' ' HA3' ' B' ' 18' ' ' GLY . 91.0 mm-40 -78.58 153.42 31.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.794 0.33 . . . . 0.0 110.486 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 217' ' ' ARG . . . . . 0.432 ' HG2' ' HB ' ' B' ' 19' ' ' VAL . 33.8 mtp180 -69.79 156.23 39.34 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.543 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -64.36 154.52 47.79 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.735 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 24.5 t -65.31 144.53 14.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.98 135.98 25.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.887 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -54.15 161.22 4.16 Favored Glycine 0 N--CA 1.453 -0.216 0 O-C-N 123.799 0.687 . . . . 0.0 114.364 -178.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 10.8 mp -76.65 146.76 37.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.659 -0.271 . . . . 0.0 110.587 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 223' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 224' ' ' GLY . . . . . 0.445 ' HA2' ' HD3' ' D' ' 225' ' ' PRO . . . -60.83 154.13 36.42 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.102 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 225' ' ' PRO . . . . . 0.445 ' HD3' ' HA2' ' D' ' 224' ' ' GLY . 21.7 Cg_exo -66.43 146.16 79.4 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.925 2.417 . . . . 0.0 111.692 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 226' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.93 162.25 31.48 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.974 -0.631 . . . . 0.0 113.25 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -79.61 163.2 24.22 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 122.835 2.356 . . . . 0.0 111.645 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -69.11 174.2 34.18 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.954 -0.566 . . . . 0.0 113.096 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 231' ' ' PRO . . . . . 0.415 ' HA ' HD23 ' D' ' 232' ' ' HYP . 3.0 Cg_exo -76.69 154.8 34.97 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.077 2.518 . . . . 0.0 111.926 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 232' ' ' HYP . . . . . 0.415 HD23 ' HA ' ' D' ' 231' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo . . . . . 0 N--CA 1.477 0.558 0 N-CA-C 109.922 -0.838 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -113.25 149.15 34.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.308 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 16.1 tt -72.89 -18.63 18.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 20.6 m -91.76 0.25 57.5 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 121.152 -0.219 . . . . 0.0 111.263 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -67.86 -48.04 67.23 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.102 0.477 . . . . 0.0 110.288 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' GLY . . . . . 0.571 ' HA2' HD21 ' A' ' 502' ' ' LEU . . . 102.74 172.08 26.66 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.439 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 64.3 t30 55.56 85.73 0.06 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.468 0.651 . . . . 0.0 112.465 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' PHE . . . . . 0.567 ' HD1' ' HB2' ' A' ' 337' ' ' LYS . 92.9 m-85 -105.26 168.0 9.36 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.702 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.57 -46.87 83.92 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 6.6 t -175.43 160.75 2.62 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.472 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 49.0 t -127.56 127.51 68.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -135.23 167.93 20.1 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.007 0.432 . . . . 0.0 111.845 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' MET . . . . . 0.426 ' HA ' ' O ' ' A' ' 332' ' ' GLU . 53.1 ttm -129.75 115.11 16.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.786 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 56.8 mt -111.28 117.05 32.1 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.182 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.408 ' HD3' ' OE2' ' A' ' 373' ' ' GLU . 0.0 OUTLIER 59.13 20.26 8.21 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.957 -179.48 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 105.69 -18.24 41.13 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.609 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' GLU . . . . . 0.457 ' OE1' ' HD3' ' A' ' 343' ' ' ARG . 35.3 mm-40 -82.75 131.24 35.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.633 0.254 . . . . 0.0 110.676 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 50.2 ttm -88.23 117.74 27.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.794 0.33 . . . . 0.0 110.975 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -109.12 122.8 48.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.264 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 37.5 t -108.46 114.74 47.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -100.46 130.37 46.54 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 0.567 ' HB2' ' HD1' ' A' ' 323' ' ' PHE . 13.0 tptt -138.19 101.81 4.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.298 178.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 61.49 -95.3 0.05 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.0 ptm85 -121.06 7.08 10.29 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 340' ' ' TRP . . . . . 0.405 ' HB3' ' HB2' ' A' ' 354' ' ' PRO . 5.6 m-90 -129.03 152.43 48.64 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -137.69 153.95 49.73 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.121 0.486 . . . . 0.0 111.76 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 24.5 m-90 -121.8 160.91 23.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.363 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.457 ' HD3' ' OE1' ' A' ' 332' ' ' GLU . 18.1 ttm-85 -124.38 112.18 16.64 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 91.6 t -90.71 122.66 42.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.889 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 345' ' ' ARG . . . . . 0.431 ' HD3' ' HA ' ' A' ' 345' ' ' ARG . 2.2 mmt180 -132.71 100.92 5.09 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.553 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 66.5 54.79 0.86 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.817 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 29.2 t30 62.09 12.92 5.34 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -133.41 146.7 51.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.665 0.269 . . . . 0.0 110.61 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 39.0 t -96.71 127.88 48.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 86.2 mtp -68.28 159.84 30.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.531 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -76.65 167.74 21.3 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.679 0.276 . . . . 0.0 110.9 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 94.98 -21.77 42.02 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -178.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 353' ' ' TYR . . . . . 0.464 ' HB3' ' HA ' ' A' ' 354' ' ' PRO . 87.9 m-85 -101.5 158.94 30.83 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.464 ' HA ' ' HB3' ' A' ' 353' ' ' TYR . 58.1 Cg_endo -71.16 139.21 57.13 Favored 'Cis proline' 0 C--N 1.346 0.424 0 C-N-CA 123.484 -1.465 . . . . 0.0 112.561 0.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 55.3 ttm -114.33 138.8 23.2 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 356' ' ' PRO . . . . . 0.442 ' HB2' ' HB2' ' A' ' 359' ' ' GLN . 52.3 Cg_exo -55.43 130.33 39.97 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.382 2.054 . . . . 0.0 111.175 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 76.8 mt -55.02 -45.51 76.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.987 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -71.35 -12.78 73.21 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.95 -0.643 . . . . 0.0 113.707 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' GLN . . . . . 0.442 ' HB2' ' HB2' ' A' ' 356' ' ' PRO . 3.7 tt0 -82.32 -34.32 28.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.034 0.445 . . . . 0.0 110.454 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -94.1 -55.21 3.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.357 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -90.28 74.39 7.02 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -58.29 95.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.925 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 135.37 -17.3 4.04 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.503 ' HA ' ' HD3' ' A' ' 365' ' ' PRO . 29.6 tp -94.37 125.16 53.14 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 365' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 364' ' ' LEU . 4.2 Cg_exo -77.21 -174.02 2.02 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.017 2.478 . . . . 0.0 111.84 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -87.8 153.96 20.93 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.08 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 72.1 m 59.23 94.92 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 27.1 pt -106.87 -166.24 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.403 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.09 -47.06 1.22 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 370' ' ' THR . . . . . 0.643 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.2 OUTLIER -146.04 162.82 37.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.648 0.261 . . . . 0.0 111.178 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -158.35 138.48 12.37 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' TYR . . . . . 0.593 ' HE1' ' HE2' ' A' ' 382' ' ' PHE . 14.7 p90 -160.25 162.71 33.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.903 0.382 . . . . 0.0 111.532 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.408 ' OE2' ' HD3' ' A' ' 330' ' ' ARG . 64.9 tt0 -98.65 122.03 41.35 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 374' ' ' ARG . . . . . 0.568 ' HB2' ' OE2' ' A' ' 440' ' ' GLU . 5.2 ptm180 -78.76 -179.66 6.66 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -178.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -67.61 -34.52 77.15 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.908 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -37.29 85.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.68 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 129.27 -16.19 5.74 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.421 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 378' ' ' LYS . . . . . 0.625 ' HG2' ' HA ' ' A' ' 391' ' ' ASP . 72.8 mttt -80.46 166.16 21.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.881 0.372 . . . . 0.0 111.575 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -106.71 127.64 53.54 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.752 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 13.4 t -109.19 122.16 63.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.007 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -106.56 138.11 43.34 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.212 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.593 ' HE2' ' HE1' ' A' ' 372' ' ' TYR . 55.9 m-85 -117.83 141.69 48.14 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.61 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 83.0 tttt -154.14 107.6 2.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.6 177.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 414' ' ' LYS . . . 70.27 -112.2 4.21 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.566 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 385' ' ' ASP . . . . . 0.432 ' O ' HG13 ' A' ' 403' ' ' ILE . 3.7 p-10 -115.29 4.38 14.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.914 0.388 . . . . 0.0 110.606 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 386' ' ' LYS . . . . . 0.42 ' HB3' ' HB2' ' A' ' 400' ' ' PRO . 48.4 mmtm -112.07 150.79 30.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -131.97 147.94 52.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.176 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' TRP . . . . . 0.61 ' HZ3' ' HB3' ' A' ' 383' ' ' LYS . 22.5 m-90 -121.7 125.62 47.05 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.82 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 85.5 t -109.42 119.96 59.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.897 0.38 . . . . 0.0 110.32 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -104.87 123.66 48.1 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.932 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.625 ' HA ' ' HG2' ' A' ' 378' ' ' LYS . 21.8 t0 -92.71 95.05 9.33 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 67.52 -73.2 0.08 Allowed 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.727 0.642 . . . . 0.0 111.021 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -146.18 11.83 1.2 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.986 0.422 . . . . 0.0 110.41 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 1.7 m -125.51 127.09 45.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.253 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 55.9 tp -71.77 132.04 43.92 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.035 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -62.96 147.01 94.94 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.651 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -74.08 144.59 34.08 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.544 2.163 . . . . 0.0 113.038 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 90.37 18.15 50.3 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.459 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' TYR . . . . . 0.496 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 39.1 m-85 -109.13 162.16 21.12 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-O 120.292 0.091 . . . . 0.0 110.774 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.496 ' HA ' ' HB3' ' A' ' 399' ' ' TYR . 71.8 Cg_endo -77.07 157.81 96.84 Favored 'Cis proline' 0 C--N 1.346 0.442 0 C-N-CA 123.529 -1.446 . . . . 0.0 112.562 0.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -116.48 157.82 24.58 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -73.21 151.19 41.56 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 403' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 385' ' ' ASP . 61.2 mt -56.64 -32.75 38.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.325 0.583 . . . . 0.0 110.603 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -65.97 -20.71 66.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.485 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -84.18 -10.52 57.68 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 50.7 tp -85.32 -55.16 4.16 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.9 0.381 . . . . 0.0 110.12 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.639 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -149.08 150.9 23.1 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.798 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -77.68 126.46 30.9 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.57 0.224 . . . . 0.0 110.495 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 99.27 14.01 37.11 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.599 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 38.7 mt -92.83 147.31 33.78 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 122.794 -0.239 . . . . 0.0 111.093 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.09 124.66 16.8 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.848 2.365 . . . . 0.0 111.26 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.44 -3.93 57.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.055 0.455 . . . . 0.0 111.273 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -87.53 -55.73 3.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.315 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 414' ' ' LYS . . . . . 0.493 ' HB2' ' HE3' ' A' ' 414' ' ' LYS . 6.4 ptmt -177.57 176.37 1.28 Allowed 'General case' 0 C--N 1.332 -0.196 0 O-C-N 123.306 0.378 . . . . 0.0 110.791 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 38.3 mm -127.47 133.23 68.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -87.76 -47.68 8.44 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 417' ' ' ALA . . . . . 0.643 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -154.6 165.25 37.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.945 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -147.21 113.8 6.01 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.207 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 55.4 tp -106.98 124.95 50.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.932 0.396 . . . . 0.0 111.795 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -90.32 116.12 28.04 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.802 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 11.9 t-105 -86.26 94.4 9.31 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.443 ' HB2' ' HD3' ' A' ' 423' ' ' PRO . 61.5 mtt -51.19 -48.82 84.5 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.443 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 83.8 Cg_exo -50.02 -24.12 10.31 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.817 2.345 . . . . 0.0 115.269 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 26.0 p30 -125.51 -37.73 2.32 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 108.63 2.48 32.64 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.709 -0.757 . . . . 0.0 113.457 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -91.62 154.18 19.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 117.036 0.418 . . . . 0.0 111.271 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 7.0 m -108.4 128.17 54.53 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.517 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -98.84 108.96 21.77 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 429' ' ' PHE . . . . . 0.448 ' HB2' ' HB2' ' A' ' 436' ' ' TYR . 60.3 m-85 -90.48 136.74 32.87 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.21 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -112.57 132.74 54.98 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.85 0.357 . . . . 0.0 111.059 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -145.32 110.64 5.28 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.831 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 64.65 -102.66 0.65 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.694 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -127.61 20.78 6.6 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.158 0.504 . . . . 0.0 110.046 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 434' ' ' LYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 450' ' ' PRO . 63.3 mmtt -124.0 142.16 51.41 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.552 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 435' ' ' TYR . . . . . 0.523 ' CE1' ' HB2' ' A' ' 451' ' ' LYS . 4.1 p90 -119.02 137.9 53.21 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.748 0.309 . . . . 0.0 110.383 178.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 436' ' ' TYR . . . . . 0.448 ' HB2' ' HB2' ' A' ' 429' ' ' PHE . 23.4 m-85 -110.27 144.4 39.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.908 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.411 ' HB3' ' HB2' ' A' ' 446' ' ' ASP . 36.1 ttp180 -107.29 95.74 5.92 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 438' ' ' PHE . . . . . 0.639 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 83.7 t80 -84.95 129.42 34.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.117 0.484 . . . . 0.0 112.169 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -99.57 111.99 24.26 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.011 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 440' ' ' GLU . . . . . 0.568 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 2.4 mm-40 -61.08 -39.74 91.06 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -67.71 -38.5 83.7 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 94.8 mt -94.1 -10.42 33.38 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 6.8 mtt-85 56.48 41.12 29.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.195 0.521 . . . . 0.0 111.027 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -157.46 166.72 32.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.219 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 88.9 t -89.3 140.05 16.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 446' ' ' ASP . . . . . 0.411 ' HB2' ' HB3' ' A' ' 437' ' ' ARG . 0.5 OUTLIER -55.9 153.5 8.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.437 179.862 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 10.9 m -69.11 158.27 35.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.04 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 70.19 24.49 4.88 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.326 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -122.75 163.19 34.46 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.018 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 450' ' ' PRO . . . . . 0.433 ' HB2' ' HB3' ' A' ' 434' ' ' LYS . 96.8 Cg_endo -77.38 172.1 64.35 Favored 'Cis proline' 0 C--N 1.346 0.437 0 C-N-CA 123.653 -1.395 . . . . 0.0 112.673 0.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 451' ' ' LYS . . . . . 0.523 ' HB2' ' CE1' ' A' ' 435' ' ' TYR . 60.2 mttm -124.75 172.45 9.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.028 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -63.76 136.07 57.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.175 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.0 tt -71.8 -11.97 15.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.261 0.553 . . . . 0.0 110.565 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -71.18 -0.01 8.81 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 64.1 t -67.2 -32.75 59.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 456' ' ' TRP . . . . . 0.469 ' HE3' ' CZ ' ' A' ' 486' ' ' PHE . 8.2 m95 -86.75 85.49 7.28 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.08 108.78 0.35 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 118.34 -25.23 8.3 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.054 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.423 ' HB ' ' HB2' ' A' ' 456' ' ' TRP . 32.1 mm -77.08 130.18 76.15 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 120.86 0.362 . . . . 0.0 111.175 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 460' ' ' PRO . . . . . 0.414 ' HG3' ' CZ2' ' A' ' 484' ' ' TRP . 85.3 Cg_endo -81.96 166.3 16.93 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.887 2.391 . . . . 0.0 111.711 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 35.3 mp0 -80.52 136.89 36.37 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.04 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.4 m 61.13 65.4 1.94 Allowed Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 463' ' ' PRO . . . . . 0.491 ' O ' ' HB2' ' A' ' 417' ' ' ALA . 35.7 Cg_endo -96.43 118.34 0.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.184 2.589 . . . . 0.0 110.269 178.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 464' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 464' ' ' ARG . 3.1 ttm105 -89.59 68.55 7.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.087 0.47 . . . . 0.0 112.17 -178.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 158.55 124.92 0.79 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 25.3 p -158.81 120.7 3.49 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.493 -0.188 . . . . 0.0 110.493 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -150.13 147.35 27.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.715 0.293 . . . . 0.0 111.315 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 43.6 ttm -98.57 140.76 32.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.069 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -70.0 169.52 45.69 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.179 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 1.5 m -73.36 -0.17 13.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.001 0.429 . . . . 0.0 111.339 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.65 -17.64 24.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.156 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 67.88 8.05 6.18 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.878 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 43.6 t -109.73 -37.66 3.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.887 0.375 . . . . 0.0 111.458 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -107.0 129.06 54.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.19 0.519 . . . . 0.0 111.911 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 475' ' ' THR . . . . . 0.421 ' HB ' ' HB3' ' A' ' 486' ' ' PHE . 95.1 m -113.92 135.32 54.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.488 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -107.24 137.58 45.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.175 0.512 . . . . 0.0 112.195 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 477' ' ' PHE . . . . . 0.618 ' HB2' ' HB2' ' A' ' 484' ' ' TRP . 38.2 m-85 -121.16 145.34 47.92 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.682 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -127.34 131.95 50.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.861 0.363 . . . . 0.0 111.607 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 479' ' ' LYS . . . . . 0.466 ' HB3' ' CZ3' ' A' ' 484' ' ' TRP . 69.7 tttt -158.54 107.68 1.98 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.472 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 60.77 60.92 7.63 Favored Glycine 0 CA--C 1.518 0.238 0 N-CA-C 114.373 0.509 . . . . 0.0 114.373 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 69.44 -15.06 0.3 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 482' ' ' LYS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 498' ' ' PRO . 52.2 mtmt -99.39 144.58 28.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.828 0.346 . . . . 0.0 111.435 -178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 483' ' ' TYR . . . . . 0.49 ' CZ ' ' HE2' ' A' ' 497' ' ' TYR . 6.5 p90 -120.35 142.64 48.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.161 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 484' ' ' TRP . . . . . 0.618 ' HB2' ' HB2' ' A' ' 477' ' ' PHE . 11.8 m-90 -110.85 146.95 35.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.506 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -114.04 99.97 8.05 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 486' ' ' PHE . . . . . 0.469 ' CZ ' ' HE3' ' A' ' 456' ' ' TRP . 51.2 t80 -91.26 132.26 36.25 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.307 -178.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -95.5 112.12 23.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -64.86 -19.12 65.72 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -93.85 -14.43 26.12 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -112.5 -16.64 12.83 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.6 tp 61.91 34.85 16.67 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.653 0.74 . . . . 0.0 109.899 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 492' ' ' LYS . . . . . 0.442 ' HG2' ' N ' ' A' ' 493' ' ' VAL . 36.4 tttp -151.98 156.12 39.38 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.515 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 493' ' ' VAL . . . . . 0.442 ' N ' ' HG2' ' A' ' 492' ' ' LYS . 71.6 t -81.81 139.6 17.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.697 0.284 . . . . 0.0 110.623 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -62.49 147.39 92.28 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.566 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.64 152.1 81.38 Favored 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 122.6 2.2 . . . . 0.0 111.957 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 85.65 27.86 31.12 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 497' ' ' TYR . . . . . 0.493 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 42.6 m-85 -134.06 163.58 50.12 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.609 -0.295 . . . . 0.0 110.428 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 498' ' ' PRO . . . . . 0.493 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 89.8 Cg_endo -76.25 174.87 50.71 Favored 'Cis proline' 0 C--N 1.346 0.408 0 C-N-CA 123.979 -1.259 . . . . 0.0 112.849 0.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -133.99 164.21 27.81 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.596 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.81 110.54 6.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.519 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 501' ' ' ALA . . . . . 0.447 ' HB2' ' HB3' ' A' ' 483' ' ' TYR . . . -66.03 -24.08 66.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.152 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 502' ' ' LEU . . . . . 0.571 HD21 ' HA2' ' A' ' 321' ' ' GLY . 76.0 mt -62.47 -39.41 93.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.857 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -85.46 -42.67 14.26 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.744 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -43.04 57.35 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 47.9 m0 -98.27 -60.41 1.56 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 10.9 mmt -62.85 -25.81 68.46 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 81.42 30.17 37.79 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.14 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 30.4 m -116.35 95.29 44.98 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 120.758 0.313 . . . . 0.0 110.567 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.32 -167.53 0.52 Allowed 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.967 2.444 . . . . 0.0 111.363 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 57.01 59.82 3.28 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.089 0.471 . . . . 0.0 110.941 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.503 -1.165 . . . . 0.0 112.185 -179.326 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.598 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' PRO . . . . . 0.485 ' HA ' HD23 ' B' ' 2' ' ' HYP . 88.2 Cg_endo -84.1 146.38 11.37 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.778 2.319 . . . . 0.0 111.964 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 2' ' ' HYP . . . . . 0.691 ' HA ' ' HB2' ' C' ' 101' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.71 170.65 45.96 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.983 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.7 163.42 38.29 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 123.042 2.495 . . . . 0.0 112.253 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 6' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' D' ' 202' ' ' HYP . . . -71.5 170.59 48.18 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.805 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.47 161.08 21.59 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.732 2.288 . . . . 0.0 111.456 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' HYP . . . . . 0.44 ' O ' ' HD2' ' D' ' 207' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 135.29 -168.64 23.7 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.785 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.11 150.48 15.76 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.65 2.233 . . . . 0.0 112.223 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -71.73 151.83 43.26 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.87 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.573 ' HA3' ' O ' ' D' ' 210' ' ' PRO . . . -60.1 151.5 38.35 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.25 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.512 ' O ' ' HG3' ' D' ' 211' ' ' GLN . 8.4 mt -66.73 150.01 11.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.23 151.36 31.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.369 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.41 163.73 53.05 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.937 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -70.63 141.21 51.73 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -67.47 144.5 55.67 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.314 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' D' ' 216' ' ' GLN . . . -57.16 151.6 26.65 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.925 -0.58 . . . . 0.0 113.154 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 12.1 t -69.85 147.15 11.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 19.9 t -53.31 145.01 3.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 O-C-N 123.326 0.391 . . . . 0.0 111.033 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.79 177.7 30.35 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.991 -0.549 . . . . 0.0 113.511 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 96.6 mt -90.77 160.65 15.68 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 122.234 0.213 . . . . 0.0 110.629 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -73.01 150.79 44.74 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.011 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.481 ' HA ' HD23 ' B' ' 26' ' ' HYP . 12.7 Cg_endo -57.43 137.72 82.84 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.501 2.134 . . . . 0.0 111.106 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' HYP . . . . . 0.481 HD23 ' HA ' ' B' ' 25' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.55 160.22 47.33 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.687 -0.688 . . . . 0.0 113.704 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' D' ' 226' ' ' HYP . 83.9 Cg_endo -82.84 163.88 15.91 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 123.035 2.49 . . . . 0.0 111.419 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.73 -179.1 44.73 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.205 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -70.9 165.16 33.17 Favored 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 123.423 2.748 . . . . 0.0 112.255 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.93 134.67 37.41 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.632 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -65.33 114.51 2.89 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.957 2.438 . . . . 0.0 111.735 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.345 0 CA-C-O 120.029 -0.317 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 101' ' ' PRO . . . . . 0.691 ' HB2' ' HA ' ' B' ' 2' ' ' HYP . 51.1 Cg_exo -55.14 114.62 1.95 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.051 2.5 . . . . 0.0 111.83 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 102' ' ' HYP . . . . . 0.477 HD23 ' HA ' ' C' ' 101' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.41 164.92 54.51 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.703 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -85.71 164.28 10.58 Favored 'Trans proline' 0 CA--C 1.533 0.459 0 C-N-CA 123.126 2.551 . . . . 0.0 112.542 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 105' ' ' HYP . . . . . 0.484 ' OD1' ' HG2' ' D' ' 204' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -82.68 -163.2 33.08 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.215 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -78.44 153.2 27.1 Favored 'Trans proline' 0 C--O 1.223 -0.233 0 C-N-CA 122.638 2.226 . . . . 0.0 110.533 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 108' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -58.63 165.17 8.2 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.89 -0.595 . . . . 0.0 113.064 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.21 160.38 38.77 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.692 2.262 . . . . 0.0 112.753 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -57.91 135.14 56.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.997 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -68.42 154.15 53.12 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.876 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 50.2 mt -68.41 133.75 31.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.686 0.279 . . . . 0.0 110.421 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.79 153.43 24.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.331 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -65.87 151.29 51.93 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.402 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 116' ' ' GLN . . . . . 0.413 ' HG2' ' N ' ' C' ' 117' ' ' ARG . 4.6 tt0 -71.18 159.12 35.23 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 117' ' ' ARG . . . . . 0.413 ' N ' ' HG2' ' C' ' 116' ' ' GLN . 11.3 ttm-85 -67.55 144.71 55.48 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.87 165.6 41.44 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.962 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 5.2 t -70.05 142.43 15.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 39.2 t -61.31 142.7 15.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.275 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.51 164.98 40.99 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.518 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 86.2 mt -79.84 141.73 35.92 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.586 0.231 . . . . 0.0 111.13 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 123' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -66.56 160.24 47.35 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.884 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.32 156.36 62.04 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.722 2.281 . . . . 0.0 111.501 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 126' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.74 162.71 37.85 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.878 -0.601 . . . . 0.0 113.305 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.37 162.12 36.66 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.677 2.252 . . . . 0.0 111.423 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -70.92 -176.08 21.7 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.929 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 131' ' ' PRO . . . . . 0.478 ' HA ' HD23 ' C' ' 132' ' ' HYP . 15.5 Cg_exo -69.95 150.66 67.33 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.921 2.414 . . . . 0.0 111.411 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 132' ' ' HYP . . . . . 0.478 HD23 ' HA ' ' C' ' 131' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 133' ' ' GLY . . . . . 0.42 ' HA2' ' HD3' ' C' ' 134' ' ' PRO . . . -71.88 120.47 8.04 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.976 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 134' ' ' PRO . . . . . 0.487 ' HA ' HD23 ' C' ' 135' ' ' HYP . 17.0 Cg_exo -68.19 111.96 2.63 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.002 2.468 . . . . 0.0 111.541 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 135' ' ' HYP . . . . . 0.487 HD23 ' HA ' ' C' ' 134' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.29 0 CA-C-O 120.031 -0.316 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 201' ' ' PRO . . . . . 0.453 ' HA ' HD23 ' D' ' 202' ' ' HYP . 74.3 Cg_exo -52.79 138.21 60.04 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.364 2.709 . . . . 0.0 112.304 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 202' ' ' HYP . . . . . 0.453 HD23 ' HA ' ' D' ' 201' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 203' ' ' GLY . . . . . 0.407 ' HA2' ' HD3' ' D' ' 204' ' ' PRO . . . 69.16 165.5 4.23 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 114.938 0.735 . . . . 0.0 114.938 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 204' ' ' PRO . . . . . 0.484 ' HG2' ' OD1' ' C' ' 105' ' ' HYP . 10.8 Cg_exo -75.58 172.28 16.62 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.934 3.09 . . . . 0.0 111.752 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 205' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . 105.0 169.5 24.18 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.72 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 207' ' ' PRO . . . . . 0.49 ' HA ' HD23 ' D' ' 208' ' ' HYP . 96.2 Cg_endo -88.42 150.29 6.49 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 123.177 2.584 . . . . 0.0 112.706 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 208' ' ' HYP . . . . . 0.49 HD23 ' HA ' ' D' ' 207' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -82.37 167.4 46.95 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.45 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 210' ' ' PRO . . . . . 0.573 ' O ' ' HA3' ' B' ' 12' ' ' GLY . 34.5 Cg_endo -65.96 146.66 83.3 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.764 2.309 . . . . 0.0 111.969 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 211' ' ' GLN . . . . . 0.512 ' HG3' ' O ' ' B' ' 13' ' ' ILE . 24.8 tt0 -77.13 147.04 36.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.199 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -65.43 158.28 46.4 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.923 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 41.3 pt -73.98 162.83 4.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.897 0.38 . . . . 0.0 111.324 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -70.83 137.39 49.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.347 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -63.43 164.54 29.56 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.904 -0.589 . . . . 0.0 113.146 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 216' ' ' GLN . . . . . 0.479 ' O ' ' HA3' ' B' ' 18' ' ' GLY . 35.7 mm-40 -75.44 151.34 38.1 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 26.4 mtp180 -67.72 153.75 43.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.829 0.347 . . . . 0.0 110.933 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -62.98 151.96 47.05 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.49 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 8.9 t -65.47 146.92 12.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 91.4 t -61.65 138.32 22.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -56.32 160.78 7.38 Favored Glycine 0 N--CA 1.451 -0.332 0 O-C-N 123.55 0.531 . . . . 0.0 113.502 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 7.3 mp -66.94 150.48 49.16 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.636 -0.282 . . . . 0.0 110.409 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 223' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 224' ' ' GLY . . . . . 0.459 ' HA2' ' HD3' ' D' ' 225' ' ' PRO . . . -64.03 146.91 50.65 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.993 -0.623 . . . . 0.0 112.166 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 225' ' ' PRO . . . . . 0.459 ' HD3' ' HA2' ' D' ' 224' ' ' GLY . 17.0 Cg_exo -69.14 150.49 72.05 Favored 'Trans proline' 0 C--O 1.238 0.476 0 C-N-CA 122.594 2.196 . . . . 0.0 111.568 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 226' ' ' HYP . . . . . 0.43 ' HA ' ' HD2' ' B' ' 28' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -73.48 170.71 52.26 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.033 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -78.95 163.46 25.79 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.874 2.383 . . . . 0.0 111.617 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -70.1 169.08 46.77 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.487 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 231' ' ' PRO . . . . . 0.455 ' HA ' HD23 ' D' ' 232' ' ' HYP . 27.6 Cg_exo -63.85 139.54 68.94 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.832 2.355 . . . . 0.0 111.586 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 232' ' ' HYP . . . . . 0.455 HD23 ' HA ' ' D' ' 231' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.478 0.57 0 N-CA-C 110.533 -0.603 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -118.4 166.83 12.18 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 19.1 tt -79.68 -30.81 13.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.899 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 57.4 m -71.18 -7.48 46.99 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -76.75 -14.06 59.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.365 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 76.44 -148.73 36.02 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 5.9 m120 51.51 68.45 0.8 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.042 0.449 . . . . 0.0 111.737 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -97.16 143.48 27.92 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.381 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -72.53 -43.08 64.02 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 1.3 t -170.18 150.43 3.68 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.553 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 48.3 t -128.25 124.11 61.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -147.57 166.73 26.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.277 0.561 . . . . 0.0 111.955 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' MET . . . . . 0.439 ' HA ' ' HA ' ' A' ' 333' ' ' MET . 33.2 ttp -121.16 119.07 31.31 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 61.7 mt -112.56 119.76 39.28 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.464 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.733 ' HG3' ' HE1' ' A' ' 379' ' ' PHE . 57.0 mtp180 54.98 28.18 10.31 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 104.4 -24.97 27.37 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.593 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' GLU . . . . . 0.579 ' HG3' HH22 ' A' ' 343' ' ' ARG . 38.4 mm-40 -94.22 130.49 40.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.954 0.377 . . . . 0.0 111.163 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 333' ' ' MET . . . . . 0.439 ' HA ' ' HA ' ' A' ' 328' ' ' MET . 39.5 ttm -90.93 131.07 36.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.114 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -123.87 128.93 50.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.652 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 43.7 t -103.84 108.56 24.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -89.35 129.85 35.82 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.77 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -149.62 111.76 4.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.99 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 63.62 -110.54 0.3 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.784 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -113.18 9.96 18.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.03 0.443 . . . . 0.0 111.207 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -129.63 160.19 34.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.664 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.487 ' CE2' ' HE2' ' A' ' 353' ' ' TYR . 38.6 p90 -140.64 139.81 34.92 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.106 177.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 -102.41 151.14 22.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.656 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.61 ' HD3' ' SD ' ' A' ' 350' ' ' MET . 16.2 ttt-85 -111.24 95.24 5.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.678 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 2.3 m -93.37 110.7 23.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.355 0.598 . . . . 0.0 111.143 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.63 92.01 3.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.161 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 9.3 m120 60.42 58.45 2.53 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.623 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 7.0 t30 63.85 17.33 10.45 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.288 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -124.44 130.1 51.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.561 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 39.4 t -87.72 121.13 37.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 350' ' ' MET . . . . . 0.61 ' SD ' ' HD3' ' A' ' 343' ' ' ARG . 90.7 mtp -77.55 148.72 35.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.978 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.46 164.02 22.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.789 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 85.12 4.04 87.0 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' TYR . . . . . 0.538 ' CE1' ' HD2' ' A' ' 343' ' ' ARG . 76.5 m-85 -123.73 157.7 61.92 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.584 -0.308 . . . . 0.0 110.748 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 353' ' ' TYR . 42.9 Cg_endo -66.17 140.69 48.92 Favored 'Cis proline' 0 C--N 1.347 0.492 0 C-N-CA 123.646 -1.398 . . . . 0.0 113.012 0.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 355' ' ' MET . . . . . 0.422 ' HA ' ' HD3' ' A' ' 356' ' ' PRO . 52.7 ttm -105.01 137.42 19.21 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.094 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 356' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 355' ' ' MET . 33.5 Cg_exo -60.83 133.31 47.11 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.446 2.098 . . . . 0.0 111.587 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 78.4 mt -59.15 -41.16 82.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -67.91 -16.63 68.58 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 121.104 -0.569 . . . . 0.0 113.88 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 359' ' ' GLN . . . . . 0.415 ' HG2' ' HG3' ' D' ' 210' ' ' PRO . 28.8 tt0 -81.25 -54.4 5.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.095 0.447 . . . . 0.0 110.796 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.747 ' HE2' ' HB3' ' D' ' 211' ' ' GLN . 24.1 t80 -77.38 -58.89 3.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.178 0.513 . . . . 0.0 110.261 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -88.48 63.17 6.92 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -57.04 103.43 0.11 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.91 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 126.85 -19.65 6.12 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.62 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.624 HD12 ' HD2' ' A' ' 365' ' ' PRO . 27.1 tp -88.72 129.76 47.58 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.69 0.281 . . . . 0.0 110.458 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 365' ' ' PRO . . . . . 0.624 ' HD2' HD12 ' A' ' 364' ' ' LEU . 73.5 Cg_endo -75.29 169.71 21.91 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.726 2.284 . . . . 0.0 112.029 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -77.96 150.13 34.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.186 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 60.2 m 59.9 94.94 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 21.1 pt -107.96 173.83 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.53 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -97.85 -47.93 5.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.254 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' THR . . . . . 0.857 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.2 OUTLIER -155.65 165.51 36.33 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.856 0.36 . . . . 0.0 111.489 -179.608 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -153.23 141.69 20.73 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 372' ' ' TYR . . . . . 0.577 ' HE1' ' HE2' ' A' ' 382' ' ' PHE . 13.2 p90 -156.12 162.69 40.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.169 0.509 . . . . 0.0 112.276 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -90.89 124.3 35.08 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 374' ' ' ARG . . . . . 0.559 ' HG2' ' O ' ' A' ' 378' ' ' LYS . 11.6 ptm180 -85.92 174.53 9.2 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -65.64 -36.26 83.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.142 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -31.92 73.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.393 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 124.93 -28.03 5.26 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.678 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' LYS . . . . . 0.685 ' HG2' ' HA ' ' A' ' 391' ' ' ASP . 31.0 mttt -77.12 174.97 10.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.162 0.506 . . . . 0.0 112.217 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 379' ' ' PHE . . . . . 0.733 ' HE1' ' HG3' ' A' ' 330' ' ' ARG . 9.5 m-85 -106.47 134.71 49.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.4 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 380' ' ' VAL . . . . . 0.48 ' HB ' ' CE1' ' A' ' 372' ' ' TYR . 13.2 t -112.34 120.31 62.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.901 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -105.29 137.91 42.32 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.956 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.577 ' HE2' ' HE1' ' A' ' 372' ' ' TYR . 78.0 m-85 -119.07 138.1 53.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.92 0.391 . . . . 0.0 111.576 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.517 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 26.5 tttp -150.47 101.6 2.97 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.553 ' O ' ' HA ' ' A' ' 414' ' ' LYS . . . 74.15 -113.99 4.34 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.274 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -111.51 4.04 18.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.667 0.27 . . . . 0.0 111.17 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -113.68 148.94 35.45 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.248 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' HIS . . . . . 0.422 ' NE2' ' HE2' ' A' ' 399' ' ' TYR . 33.0 p-80 -130.32 147.43 52.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.222 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 388' ' ' TRP . . . . . 0.517 ' HZ3' ' HB3' ' A' ' 383' ' ' LYS . 23.3 m-90 -122.66 133.02 54.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.123 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 96.5 t -109.71 116.76 53.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -110.9 122.77 48.69 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.812 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.685 ' HA ' ' HG2' ' A' ' 378' ' ' LYS . 14.3 t70 -91.12 91.45 8.26 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 67.02 -77.51 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 O-C-N 123.874 0.734 . . . . 0.0 110.716 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -141.25 14.66 2.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.248 0.547 . . . . 0.0 109.912 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.57 118.9 28.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.91 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 47.5 tp -69.91 133.42 47.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.409 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -71.75 123.42 89.39 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -59.17 137.72 80.78 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.944 2.429 . . . . 0.0 112.257 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 108.94 6.5 30.08 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.352 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' TYR . . . . . 0.699 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 65.6 m-85 -113.43 167.12 9.84 Favored Pre-proline 0 C--N 1.323 -0.578 0 O-C-N 122.982 -0.128 . . . . 0.0 111.077 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.699 ' HA ' ' HB3' ' A' ' 399' ' ' TYR . 71.9 Cg_endo -77.68 161.73 91.27 Favored 'Cis proline' 0 C--N 1.348 0.541 0 C-N-CA 123.708 -1.372 . . . . 0.0 113.165 0.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -128.39 162.62 26.69 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.072 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -70.29 157.83 37.0 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 47.8 mt -57.16 -33.49 43.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.894 0.378 . . . . 0.0 110.971 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 404' ' ' LYS . 18.1 ptmt -67.88 -16.66 64.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.844 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -78.77 -15.52 58.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.898 0.38 . . . . 0.0 110.821 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 51.7 tp -83.44 -48.78 9.97 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -159.7 166.16 34.82 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.761 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -95.46 131.1 41.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.998 0.428 . . . . 0.0 110.999 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 106.83 5.87 35.39 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.586 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 411' ' ' PRO . 95.8 mt -92.39 148.97 37.52 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 411' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 410' ' ' LEU . 52.1 Cg_exo -56.1 135.41 69.75 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.185 2.59 . . . . 0.0 111.919 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.47 1.36 51.49 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.669 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -95.27 -56.41 2.73 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.733 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 414' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 384' ' ' GLY . 11.9 ptmt -174.85 173.59 2.72 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.752 0.311 . . . . 0.0 110.584 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 46.6 mm -121.84 132.93 69.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -87.68 -54.08 4.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.248 0.547 . . . . 0.0 109.8 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 417' ' ' ALA . . . . . 0.857 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -149.83 150.95 32.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.368 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -132.54 120.92 22.5 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 61.8 tp -115.73 127.13 54.9 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.024 0.44 . . . . 0.0 111.686 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -94.85 114.31 26.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.719 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 421' ' ' TRP . . . . . 0.436 ' HB3' ' OD1' ' A' ' 424' ' ' ASN . 4.5 t-105 -84.98 94.82 8.89 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.432 ' HB2' ' HD3' ' A' ' 423' ' ' PRO . 66.5 mtt -53.84 -50.15 85.41 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.432 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 97.5 Cg_exo -46.1 -43.37 20.59 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 122.77 2.313 . . . . 0.0 114.867 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 424' ' ' ASN . . . . . 0.436 ' OD1' ' HB3' ' A' ' 421' ' ' TRP . 30.4 p30 -107.04 -23.06 12.45 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 87.05 26.8 30.26 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.036 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 38.6 mmtt -108.22 155.22 20.71 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 9.2 m -112.1 125.88 54.58 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.853 0.359 . . . . 0.0 110.828 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -103.47 119.54 39.1 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.001 0.429 . . . . 0.0 110.634 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -102.15 131.95 48.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.239 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -110.96 132.42 54.22 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.949 0.404 . . . . 0.0 111.444 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -145.29 108.39 4.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 70.54 -105.23 1.54 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.525 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -124.91 11.67 8.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.073 0.463 . . . . 0.0 110.498 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -121.38 143.02 49.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.523 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 435' ' ' TYR . . . . . 0.618 ' CE2' ' HE2' ' A' ' 449' ' ' TYR . 20.4 p90 -123.36 141.13 52.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.03 0.443 . . . . 0.0 111.43 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -110.75 152.38 26.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.573 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 26.7 ttp180 -113.43 96.89 6.13 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -89.52 134.01 34.32 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.387 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 439' ' ' ASN . . . . . 0.453 ' HB3' ' HB2' ' A' ' 442' ' ' LEU . 2.6 t-20 -108.57 119.58 39.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.371 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.44 -45.49 73.09 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -66.55 -49.79 65.29 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 442' ' ' LEU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 439' ' ' ASN . 49.9 mt -71.76 -22.02 61.66 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 60.47 33.49 20.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.369 0.604 . . . . 0.0 111.31 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -156.67 173.2 17.3 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.251 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 98.1 t -89.12 137.87 20.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.114 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.25 156.48 21.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.415 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 447' ' ' SER . . . . . 0.558 ' O ' ' HB2' ' A' ' 448' ' ' GLU . 16.4 m -69.94 159.61 33.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.397 179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 448' ' ' GLU . . . . . 0.558 ' HB2' ' O ' ' A' ' 447' ' ' SER . 5.4 mm-40 80.15 6.06 1.73 Allowed 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.817 0.698 . . . . 0.0 111.067 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 449' ' ' TYR . . . . . 0.618 ' HE2' ' CE2' ' A' ' 435' ' ' TYR . 63.7 m-85 -117.13 162.73 26.36 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.089 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 450' ' ' PRO . . . . . 0.524 ' HA ' ' HB3' ' A' ' 449' ' ' TYR . 73.7 Cg_endo -74.2 156.19 99.78 Favored 'Cis proline' 0 C--N 1.347 0.493 0 C-N-CA 123.698 -1.376 . . . . 0.0 112.431 0.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -114.68 161.63 17.87 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.172 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -65.71 135.95 55.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.456 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.7 tt -64.63 -13.14 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.107 0.48 . . . . 0.0 111.153 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 454' ' ' LYS . . . . . 0.477 ' HD3' ' HA ' ' A' ' 454' ' ' LYS . 66.4 mmtt -62.88 -13.08 29.7 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.877 -0.602 . . . . 0.0 112.533 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 76.0 t -60.85 -37.82 77.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 456' ' ' TRP . . . . . 0.494 ' HZ3' HD11 ' A' ' 491' ' ' LEU . 26.4 m95 -86.72 91.42 8.61 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.171 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -61.46 112.25 2.12 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 115.29 -21.25 13.24 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.811 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 39.3 mm -81.08 125.77 78.82 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-O 120.815 0.34 . . . . 0.0 110.495 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 460' ' ' PRO . . . . . 0.405 ' HG3' ' CH2' ' A' ' 484' ' ' TRP . 97.7 Cg_endo -77.47 157.38 32.65 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.799 2.333 . . . . 0.0 111.686 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -78.46 145.06 35.23 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.36 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.9 m 57.68 70.44 1.3 Allowed Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -90.36 179.88 1.82 Allowed 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.68 2.253 . . . . 0.0 110.614 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 464' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 464' ' ' ARG . 0.3 OUTLIER -149.42 68.46 1.03 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.396 0.617 . . . . 0.0 110.801 179.363 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 137.34 111.7 1.07 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 3.2 p -137.96 115.3 11.09 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.791 0.329 . . . . 0.0 110.177 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -136.58 145.46 44.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 468' ' ' MET . . . . . 0.413 ' HA ' ' HA ' ' A' ' 475' ' ' THR . 46.4 ttm -101.33 142.53 32.61 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -68.99 163.21 50.86 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.514 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.99 9.29 0.57 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.08 -10.02 16.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.941 0.401 . . . . 0.0 110.8 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 69.42 5.07 4.95 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 43.9 t -111.85 -36.58 2.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 O-C-N 122.18 -0.325 . . . . 0.0 111.68 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -100.79 117.52 35.04 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 475' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 468' ' ' MET . 52.0 m -109.53 144.26 38.06 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.398 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 476' ' ' TYR . . . . . 0.55 ' CE1' ' HG3' ' A' ' 485' ' ' LYS . 92.9 m-85 -121.07 134.48 55.27 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -120.4 134.37 55.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.739 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -113.3 137.6 51.25 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.772 0.32 . . . . 0.0 111.807 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 479' ' ' LYS . . . . . 0.41 ' HB3' ' CZ3' ' A' ' 484' ' ' TRP . 77.1 tttt -161.98 109.77 1.4 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.424 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 65.12 58.94 8.58 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 114.614 0.606 . . . . 0.0 114.614 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 41.3 t30 62.89 4.19 1.41 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -121.99 151.07 41.19 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -130.0 152.8 49.07 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.936 0.398 . . . . 0.0 111.428 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 484' ' ' TRP . . . . . 0.5 ' CE2' ' HB3' ' A' ' 498' ' ' PRO . 15.1 m-90 -116.78 148.61 41.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.082 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 485' ' ' LYS . . . . . 0.55 ' HG3' ' CE1' ' A' ' 476' ' ' TYR . 24.1 tttp -106.86 100.59 10.09 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 486' ' ' PHE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 493' ' ' VAL . 62.4 t80 -93.12 125.36 37.68 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.297 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -94.9 115.14 27.1 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -66.92 -29.93 69.94 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -64.85 -53.7 42.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.991 0.424 . . . . 0.0 111.405 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -83.1 -14.22 54.14 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.983 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.494 HD11 ' HZ3' ' A' ' 456' ' ' TRP . 11.2 tp 63.6 42.26 6.59 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.448 0.642 . . . . 0.0 109.814 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 47.0 tttt -156.66 156.52 33.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.289 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 493' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 486' ' ' PHE . 53.5 t -79.96 139.81 17.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.149 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -69.82 146.12 95.19 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.025 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.45 153.6 73.56 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.651 2.234 . . . . 0.0 111.552 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 97.51 15.73 36.69 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 497' ' ' TYR . . . . . 0.623 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 24.6 m-85 -123.88 169.01 11.21 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.511 -0.344 . . . . 0.0 110.254 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 498' ' ' PRO . . . . . 0.623 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 72.4 Cg_endo -75.7 178.68 33.86 Favored 'Cis proline' 0 C--N 1.346 0.41 0 C-N-CA 123.851 -1.312 . . . . 0.0 112.965 0.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -136.01 150.58 49.27 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.401 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 37.3 t -69.47 128.17 35.57 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.67 -18.39 62.84 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.398 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 28.1 mt -61.68 -62.13 2.02 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.66 -11.53 59.88 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.17 -40.66 10.35 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 21.3 m0 -125.06 -39.3 2.25 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 10.8 mmt -71.82 -20.0 61.9 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 78.95 25.68 59.57 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.45 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 9.9 m -113.97 93.22 28.79 Favored Pre-proline 0 C--N 1.326 -0.434 0 O-C-N 122.845 -0.209 . . . . 0.0 110.658 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -83.58 171.29 11.05 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.866 2.377 . . . . 0.0 112.124 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 8.4 m 53.64 72.15 0.46 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.088 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.476 -1.18 . . . . 0.0 111.551 -179.949 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.735 0 N-CA-C 111.776 -0.529 . . . . 0.0 111.776 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' PRO . . . . . 0.48 ' HA ' HD23 ' B' ' 2' ' ' HYP . 83.5 Cg_endo -87.26 146.48 7.48 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.614 2.21 . . . . 0.0 112.002 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 2' ' ' HYP . . . . . 0.48 HD23 ' HA ' ' B' ' 1' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' D' ' 201' ' ' PRO . . . -67.36 160.48 49.15 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.906 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.88 162.43 41.95 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.555 2.17 . . . . 0.0 111.445 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.09 -176.82 44.69 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.947 -0.644 . . . . 0.0 113.207 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.576 ' HG2' ' HA ' ' D' ' 205' ' ' HYP . 26.2 Cg_endo -63.61 166.29 15.97 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.999 2.466 . . . . 0.0 111.865 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' HYP . . . . . 0.415 ' O ' ' HA3' ' D' ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 130.66 -166.75 22.37 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.087 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.87 141.66 30.58 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 123.216 2.611 . . . . 0.0 112.304 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' GLN . . . . . 0.5 ' HB2' ' HG2' ' C' ' 110' ' ' PRO . 45.9 tt0 -68.59 147.65 51.62 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' D' ' 210' ' ' PRO . . . -57.09 147.58 34.2 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.361 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.452 ' H ' HG13 ' B' ' 13' ' ' ILE . 6.6 mt -61.87 150.11 8.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.4 151.37 46.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.278 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.51 169.17 53.55 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.936 -0.65 . . . . 0.0 113.112 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -78.57 147.15 33.84 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -70.82 146.51 49.66 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' D' ' 216' ' ' GLN . . . -62.87 155.47 41.92 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.706 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 t -71.88 154.44 7.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.4 t -55.65 142.76 9.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 O-C-N 123.319 0.387 . . . . 0.0 110.874 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.64 163.54 51.67 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.788 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 97.1 mt -73.18 148.57 43.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.445 0.164 . . . . 0.0 110.693 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.79 156.26 53.43 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.788 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -70.56 158.77 54.95 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 122.868 2.378 . . . . 0.0 111.662 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.14 155.96 53.26 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.509 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.445 ' HA ' HD23 ' B' ' 29' ' ' HYP . 43.6 Cg_endo -69.59 155.25 67.03 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.539 2.159 . . . . 0.0 111.73 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' HYP . . . . . 0.445 HD23 ' HA ' ' B' ' 28' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.68 178.16 48.59 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.203 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -73.33 165.33 32.84 Favored 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 123.336 2.691 . . . . 0.0 111.676 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.28 156.4 53.34 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.092 -0.575 . . . . 0.0 113.116 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' PRO . . . . . 0.486 ' HA ' HD23 ' B' ' 35' ' ' HYP . 38.2 Cg_endo -67.93 118.48 5.64 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.764 2.309 . . . . 0.0 111.748 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' HYP . . . . . 0.486 HD23 ' HA ' ' B' ' 34' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.399 0 CA-C-O 120.082 -0.288 . . . . 0.0 112.67 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 101' ' ' PRO . . . . . 0.503 ' HA ' HD23 ' C' ' 102' ' ' HYP . 23.4 Cg_exo -66.1 139.74 56.94 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 123.139 2.559 . . . . 0.0 112.444 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 102' ' ' HYP . . . . . 0.503 HD23 ' HA ' ' C' ' 101' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.76 161.26 49.5 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.132 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.22 153.52 36.18 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.78 2.32 . . . . 0.0 112.657 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 105' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -74.49 -178.61 40.16 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.81 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.54 154.62 21.02 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.865 2.377 . . . . 0.0 111.336 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 108' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -57.68 171.16 3.49 Favored Glycine 0 CA--C 1.519 0.338 0 CA-C-N 115.71 -0.677 . . . . 0.0 114.043 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 110' ' ' PRO . . . . . 0.5 ' HG2' ' HB2' ' B' ' 11' ' ' GLN . 10.4 Cg_endo -53.95 148.9 36.54 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 123.516 2.81 . . . . 0.0 113.286 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -59.34 140.52 56.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.842 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.47 161.88 38.11 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 116.01 -0.541 . . . . 0.0 113.354 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 42.0 mt -83.24 135.28 25.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.7 146.7 51.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.79 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -69.44 159.56 53.05 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.108 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 116' ' ' GLN . . . . . 0.441 ' HG2' ' H ' ' C' ' 117' ' ' ARG . 4.6 tt0 -81.8 160.5 23.53 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.701 0.286 . . . . 0.0 110.742 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 117' ' ' ARG . . . . . 0.441 ' H ' ' HG2' ' C' ' 116' ' ' GLN . 42.8 ttm-85 -67.14 149.6 50.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.839 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.4 171.2 37.23 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.671 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 15.9 t -72.68 140.92 17.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 120' ' ' VAL . . . . . 0.594 HG13 ' HB ' ' D' ' 219' ' ' VAL . 24.1 t -57.56 135.96 21.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.209 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.86 162.33 42.37 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.566 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 122' ' ' LEU . . . . . 0.448 ' HA ' HD23 ' C' ' 123' ' ' HYP . 82.3 mt -78.39 139.92 38.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.607 0.242 . . . . 0.0 110.524 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 123' ' ' HYP . . . . . 0.448 HD23 ' HA ' ' C' ' 122' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -70.24 165.76 51.17 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.681 -0.691 . . . . 0.0 113.054 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -74.03 156.98 47.27 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.68 2.254 . . . . 0.0 111.19 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 126' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.63 162.85 37.21 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.778 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.56 161.0 34.63 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.555 2.17 . . . . 0.0 111.724 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -68.56 -173.33 8.06 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 121.192 -0.528 . . . . 0.0 113.461 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -72.45 157.53 52.85 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 123.141 2.561 . . . . 0.0 111.849 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 132' ' ' HYP . . . . . 0.499 ' HA ' ' O ' ' D' ' 231' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -65.68 126.11 29.37 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.825 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 134' ' ' PRO . . . . . 0.417 ' HD2' ' OD1' ' B' ' 35' ' ' HYP . 53.1 Cg_endo -70.57 114.12 3.73 Favored 'Trans proline' 0 CA--C 1.531 0.375 0 C-N-CA 122.49 2.127 . . . . 0.0 111.614 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 135' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.451 0 N-CA-C 112.339 -0.304 . . . . 0.0 112.339 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 201' ' ' PRO . . . . . 0.556 ' O ' ' HA3' ' B' ' 3' ' ' GLY . 52.0 Cg_exo -56.82 131.41 45.42 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.608 2.205 . . . . 0.0 111.384 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 202' ' ' HYP . . . . . 0.491 HD23 ' HA ' ' D' ' 201' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 82.21 -177.46 53.69 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.883 -0.675 . . . . 0.0 114.387 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 204' ' ' PRO . . . . . 0.411 ' HA ' HD23 ' D' ' 205' ' ' HYP . 13.6 Cg_exo -71.47 161.78 44.39 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 123.745 2.964 . . . . 0.0 112.168 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 205' ' ' HYP . . . . . 0.576 ' HA ' ' HG2' ' B' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 206' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' B' ' 8' ' ' HYP . . . 97.3 157.14 30.65 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.602 -0.808 . . . . 0.0 113.516 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -86.47 154.39 9.17 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 123.149 2.566 . . . . 0.0 112.727 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 208' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -81.35 171.64 53.31 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.503 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 210' ' ' PRO . . . . . 0.415 ' HG3' ' HG2' ' A' ' 359' ' ' GLN . 16.4 Cg_exo -69.11 148.45 69.32 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.957 2.438 . . . . 0.0 112.061 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 211' ' ' GLN . . . . . 0.747 ' HB3' ' HE2' ' A' ' 360' ' ' PHE . 60.0 tt0 -67.72 148.97 50.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.716 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -71.29 163.53 54.07 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.251 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 24.9 pt -69.55 165.38 2.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-O 120.65 0.262 . . . . 0.0 111.026 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 214' ' ' ALA . . . . . 0.496 ' HB3' ' NH1' ' A' ' 330' ' ' ARG . . . -87.49 139.23 30.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.924 0.393 . . . . 0.0 110.842 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -61.49 161.76 26.05 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.67 -0.695 . . . . 0.0 113.525 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 216' ' ' GLN . . . . . 0.443 ' O ' ' HA3' ' B' ' 18' ' ' GLY . 35.4 mm-40 -73.27 160.36 32.0 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -66.63 155.64 37.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.17 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -61.98 158.21 34.08 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.878 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 219' ' ' VAL . . . . . 0.594 ' HB ' HG13 ' C' ' 120' ' ' VAL . 25.8 t -61.74 141.88 17.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 24.6 t -62.48 138.51 22.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.206 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -58.12 154.11 24.98 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.613 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 222' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' D' ' 223' ' ' HYP . 7.2 mp -73.63 152.81 40.41 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.742 0.306 . . . . 0.0 111.044 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 223' ' ' HYP . . . . . 0.403 HD23 ' HA ' ' D' ' 222' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 224' ' ' GLY . . . . . 0.423 ' HA2' ' HD3' ' D' ' 225' ' ' PRO . . . -61.7 153.46 40.69 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.685 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 225' ' ' PRO . . . . . 0.423 ' HD3' ' HA2' ' D' ' 224' ' ' GLY . 24.0 Cg_exo -65.84 143.24 72.69 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.697 2.265 . . . . 0.0 111.222 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 226' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -63.87 163.23 33.6 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.813 -0.631 . . . . 0.0 113.734 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -82.54 168.43 14.49 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 122.968 2.445 . . . . 0.0 111.474 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -74.38 179.73 42.58 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.02 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 231' ' ' PRO . . . . . 0.499 ' O ' ' HA ' ' C' ' 132' ' ' HYP . 15.7 Cg_exo -69.21 146.42 63.55 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.952 2.435 . . . . 0.0 111.774 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 232' ' ' HYP . . . . . 0.457 HD23 ' HA ' ' D' ' 231' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo . . . . . 0 N--CA 1.479 0.674 0 N-CA-C 110.066 -0.782 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -109.34 145.39 36.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.425 0.155 . . . . 0.0 110.613 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.448 ' O ' ' HZ ' ' A' ' 323' ' ' PHE . 19.3 tt -81.05 -19.1 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 121.114 0.483 . . . . 0.0 111.349 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 7.9 m -95.68 12.59 29.28 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.094 0.473 . . . . 0.0 110.244 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -68.82 -33.77 74.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.445 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 82.48 179.85 52.91 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.624 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 5.5 t30 52.17 77.75 0.14 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.172 0.511 . . . . 0.0 111.448 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' PHE . . . . . 0.448 ' HZ ' ' O ' ' A' ' 318' ' ' ILE . 72.1 m-85 -98.75 157.53 16.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.235 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -68.48 -39.38 81.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.261 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 13.4 t -176.43 153.53 1.19 Allowed 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.79 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.506 HG22 HG13 ' A' ' 335' ' ' VAL . 60.6 t -135.84 123.53 35.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -144.3 178.1 8.15 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.963 0.411 . . . . 0.0 111.62 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 51.9 ttp -130.92 121.57 25.41 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 63.9 mt -114.9 122.09 45.23 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.012 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.695 ' HG3' ' HE1' ' A' ' 379' ' ' PHE . 64.1 mtp180 55.26 25.76 7.75 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 101.57 -8.67 56.77 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.509 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -105.79 127.92 53.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.993 0.396 . . . . 0.0 110.829 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 45.3 ttm -84.9 134.06 34.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.818 0.342 . . . . 0.0 111.633 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -126.49 128.39 46.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.64 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 335' ' ' VAL . . . . . 0.506 HG13 HG22 ' A' ' 326' ' ' VAL . 35.6 t -108.31 119.37 57.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.43 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -99.85 131.76 45.62 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 0.426 ' HB2' ' HD1' ' A' ' 323' ' ' PHE . 41.4 tptt -141.51 106.01 4.86 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.723 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 63.03 -105.18 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.55 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -115.07 10.68 16.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.868 0.366 . . . . 0.0 111.32 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 10.1 m-90 -123.93 163.02 22.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.12 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -143.83 144.44 31.78 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.978 0.418 . . . . 0.0 110.923 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -108.41 146.52 32.94 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.818 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.628 ' HD3' ' SD ' ' A' ' 350' ' ' MET . 23.9 ttt-85 -115.83 96.08 5.43 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 3.3 m -88.21 129.6 39.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.995 0.426 . . . . 0.0 111.184 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -142.87 122.44 13.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.853 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 14.3 m120 57.65 41.0 26.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.115 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 67.77 23.71 8.48 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.187 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -134.25 154.05 51.51 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 46.0 t -90.79 121.92 41.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 350' ' ' MET . . . . . 0.628 ' SD ' ' HD3' ' A' ' 343' ' ' ARG . 1.7 ttt -65.32 144.39 57.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.748 0.308 . . . . 0.0 111.133 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -66.87 147.1 53.68 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.546 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 100.94 -0.71 55.09 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.134 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' TYR . . . . . 0.514 ' HB3' ' HA ' ' A' ' 354' ' ' PRO . 80.3 m-85 -122.07 160.11 48.81 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.514 ' HA ' ' HB3' ' A' ' 353' ' ' TYR . 55.2 Cg_endo -69.86 136.61 39.87 Favored 'Cis proline' 0 C--N 1.347 0.497 0 C-N-CA 123.736 -1.36 . . . . 0.0 113.025 0.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 47.2 ttm -116.59 141.95 28.84 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.448 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.62 135.27 68.5 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.262 1.975 . . . . 0.0 111.352 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 95.3 mt -54.21 -43.74 61.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.354 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -69.87 -6.44 56.01 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 121.028 -0.606 . . . . 0.0 114.606 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -86.24 -37.11 18.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.501 0.65 . . . . 0.0 110.208 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -95.11 -53.65 3.72 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -92.26 71.73 5.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 -59.99 101.71 0.13 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.135 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 131.06 -19.42 4.91 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.452 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.518 HD12 ' HD2' ' A' ' 365' ' ' PRO . 22.2 tp -91.14 131.95 35.5 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.681 0.276 . . . . 0.0 110.626 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 365' ' ' PRO . . . . . 0.518 ' HD2' HD12 ' A' ' 364' ' ' LEU . 92.2 Cg_endo -82.67 -173.76 1.83 Allowed 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.789 2.326 . . . . 0.0 112.269 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -90.01 154.75 19.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.212 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.7 m 56.37 93.47 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 21.5 pt -110.53 179.82 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.447 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' ASN . . . . . 0.423 HD22 ' HA ' ' A' ' 369' ' ' ASN . 4.3 m120 -96.45 -55.81 2.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.949 0.404 . . . . 0.0 110.949 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 370' ' ' THR . . . . . 0.919 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.2 OUTLIER -155.9 167.91 28.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.161 -179.668 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -142.86 139.21 30.76 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -152.86 166.26 32.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.06 0.457 . . . . 0.0 111.913 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -100.77 141.13 34.08 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.19 -0.914 . . . . 0.0 108.64 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 374' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 378' ' ' LYS . 7.1 ptm180 -100.77 -171.65 2.05 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 39.3 tttt -72.46 -25.74 61.55 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -177.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.21 -17.38 32.76 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 113.49 -17.27 21.26 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.805 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' LYS . . . . . 0.519 ' O ' ' HG2' ' A' ' 374' ' ' ARG . 46.1 mttp -74.66 158.21 34.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.097 0.475 . . . . 0.0 111.521 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 379' ' ' PHE . . . . . 0.695 ' HE1' ' HG3' ' A' ' 330' ' ' ARG . 9.7 m-85 -98.46 134.76 40.99 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.444 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 21.9 t -116.58 121.08 66.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.023 0.439 . . . . 0.0 110.496 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -105.57 139.03 40.79 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.451 ' HE1' HG12 ' A' ' 403' ' ' ILE . 3.8 m-85 -119.39 144.44 46.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.773 0.321 . . . . 0.0 111.702 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.461 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 83.5 tttt -155.51 98.89 1.99 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.954 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.471 ' O ' HD11 ' A' ' 403' ' ' ILE . . . 71.52 -114.75 5.29 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.815 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 385' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 402' ' ' HIS . 13.1 p-10 -105.07 6.43 33.27 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -118.28 151.4 37.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.795 0.331 . . . . 0.0 111.793 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 37.0 p-80 -136.0 145.35 46.0 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.238 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' TRP . . . . . 0.461 ' HZ3' ' HB3' ' A' ' 383' ' ' LYS . 17.8 m-90 -118.27 133.09 56.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.654 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 60.0 t -111.78 113.4 44.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -107.66 127.52 53.74 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -92.7 88.92 6.45 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 392' ' ' GLU . . . . . 0.459 ' OE1' ' HB ' ' D' ' 213' ' ' ILE . 59.5 mm-40 69.02 -71.3 0.12 Allowed 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.721 0.638 . . . . 0.0 111.002 -178.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -142.41 3.18 1.5 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.174 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.84 126.48 54.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.729 0.3 . . . . 0.0 111.582 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 47.8 tp -74.09 135.21 42.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.654 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' GLU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 13.6 mt-10 -75.63 134.78 72.23 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.859 0.362 . . . . 0.0 111.068 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 397' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 45.2 Cg_exo -58.74 142.53 98.79 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.199 2.599 . . . . 0.0 112.28 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 104.23 -25.1 27.17 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.309 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 399' ' ' TYR . . . . . 0.602 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 95.2 m-85 -89.64 161.24 39.71 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 110.561 -0.163 . . . . 0.0 110.561 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.602 ' HA ' ' HB3' ' A' ' 399' ' ' TYR . 72.0 Cg_endo -75.03 152.84 98.68 Favored 'Cis proline' 0 C--N 1.345 0.355 0 C-N-CA 123.77 -1.346 . . . . 0.0 113.394 0.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -126.39 169.78 12.62 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.491 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 0.496 ' HA ' ' O ' ' A' ' 385' ' ' ASP . 76.3 m80 -71.75 158.09 36.74 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.656 0.265 . . . . 0.0 111.236 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 403' ' ' ILE . . . . . 0.471 HD11 ' O ' ' A' ' 384' ' ' GLY . 22.4 mt -59.22 -35.54 58.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.18 0.514 . . . . 0.0 110.03 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 44.1 pttt -67.05 -15.04 63.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.803 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.451 ' HG2' ' HB2' ' A' ' 402' ' ' HIS . 38.1 mm-40 -82.27 -28.66 31.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.851 0.357 . . . . 0.0 110.549 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 41.1 tp -72.14 -53.34 13.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.29 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.625 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -153.9 159.68 28.89 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.618 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -89.69 127.37 35.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.719 0.295 . . . . 0.0 110.533 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 106.31 -0.92 37.52 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.226 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 95.1 mt -79.0 156.51 76.91 Favored Pre-proline 0 C--N 1.32 -0.691 0 O-C-N 122.878 -0.189 . . . . 0.0 110.663 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -53.34 138.62 64.83 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.677 2.252 . . . . 0.0 112.013 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.01 -15.97 28.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.723 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -86.41 -61.01 1.84 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 414' ' ' LYS . . . . . 0.467 ' O ' ' HD2' ' A' ' 431' ' ' ARG . 10.0 pttp -175.33 179.15 1.55 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 33.4 mm -117.98 147.93 21.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -100.15 -49.54 4.25 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 417' ' ' ALA . . . . . 0.919 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -157.65 156.15 31.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.258 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -136.78 120.03 16.76 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 21.9 tp -108.94 124.53 50.83 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.058 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -97.57 114.13 25.98 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 421' ' ' TRP . . . . . 0.886 ' HB2' ' HE2' ' A' ' 428' ' ' TYR . 10.9 t-105 -83.6 94.81 8.16 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 10.1 mmt -49.8 -52.84 48.07 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -47.55 -42.41 29.1 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 123.036 2.491 . . . . 0.0 115.177 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 424' ' ' ASN . . . . . 0.446 ' OD1' ' HB3' ' A' ' 421' ' ' TRP . 36.0 p30 -104.64 -19.36 13.99 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 78.56 34.89 34.14 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.209 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 37.4 mmtt -117.0 147.48 42.27 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.6 m -107.53 126.64 52.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.771 0.32 . . . . 0.0 110.491 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 428' ' ' TYR . . . . . 0.886 ' HE2' ' HB2' ' A' ' 421' ' ' TRP . 71.3 m-85 -104.04 110.61 22.84 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.862 0.363 . . . . 0.0 110.74 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -92.46 120.78 33.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.781 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -97.01 132.26 43.0 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.751 0.31 . . . . 0.0 111.183 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.467 ' HD2' ' O ' ' A' ' 414' ' ' LYS . 2.5 tpm_? -144.41 104.9 4.13 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.066 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 432' ' ' GLY . . . . . 0.41 ' HA2' ' OG ' ' A' ' 462' ' ' SER . . . 67.15 -111.66 4.27 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.591 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -109.3 10.64 25.59 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 434' ' ' LYS . . . . . 0.656 ' HD3' ' HG2' ' A' ' 450' ' ' PRO . 89.8 mttt -130.94 152.44 50.26 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.805 0.336 . . . . 0.0 111.681 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 435' ' ' TYR . . . . . 0.421 ' CE2' ' HE2' ' A' ' 449' ' ' TYR . 11.7 p90 -125.87 142.65 51.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.504 178.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -109.43 136.11 49.37 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.671 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -97.31 99.48 10.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.161 0.505 . . . . 0.0 109.651 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 438' ' ' PHE . . . . . 0.625 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 91.4 t80 -89.94 134.81 34.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.748 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -110.56 106.6 15.93 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.354 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 440' ' ' GLU . . . . . 0.41 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 0.6 OUTLIER -50.7 -47.23 59.08 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -178.404 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -59.3 -35.85 74.54 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 67.1 mt -98.63 -15.81 19.3 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 60.96 40.09 15.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.635 0.731 . . . . 0.0 110.992 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -150.97 168.24 25.15 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.458 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 87.6 t -92.01 141.58 14.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.553 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -62.13 163.39 8.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.161 0.505 . . . . 0.0 111.514 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 20.0 m -76.71 157.6 31.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.59 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 72.69 23.43 2.97 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.532 0.682 . . . . 0.0 111.01 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 449' ' ' TYR . . . . . 0.421 ' HE2' ' CE2' ' A' ' 435' ' ' TYR . 17.1 m-85 -122.37 164.13 28.03 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.119 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 450' ' ' PRO . . . . . 0.656 ' HG2' ' HD3' ' A' ' 434' ' ' LYS . 83.4 Cg_endo -77.61 161.29 92.21 Favored 'Cis proline' 0 C--N 1.345 0.378 0 C-N-CA 123.678 -1.384 . . . . 0.0 112.697 0.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -111.77 161.32 16.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.726 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 -66.08 140.06 58.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.821 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.4 tt -64.27 -13.07 13.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.427 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 36.9 mttm -61.46 -11.99 12.91 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 79.8 t -61.53 -34.79 63.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 456' ' ' TRP . . . . . 0.482 ' HB2' ' HB ' ' A' ' 459' ' ' ILE . 8.1 m95 -89.05 95.53 10.36 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -56.6 107.72 0.42 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 105.05 -1.73 40.97 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.698 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.482 ' HB ' ' HB2' ' A' ' 456' ' ' TRP . 20.1 mm -88.92 129.01 49.97 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.978 0.389 . . . . 0.0 111.335 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.26 149.07 19.27 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 123.063 2.509 . . . . 0.0 112.904 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -71.4 146.27 48.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.379 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 462' ' ' SER . . . . . 0.41 ' OG ' ' HA2' ' A' ' 432' ' ' GLY . 4.2 m 55.08 71.39 1.3 Allowed Pre-proline 0 N--CA 1.467 0.412 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -85.84 178.49 4.24 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.711 2.274 . . . . 0.0 111.745 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.6 8.44 6.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.042 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -177.23 147.57 8.35 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.824 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 19.4 p -164.19 98.17 0.82 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -128.61 140.35 51.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.925 0.393 . . . . 0.0 111.31 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 468' ' ' MET . . . . . 0.404 ' HA ' ' HA ' ' A' ' 475' ' ' THR . 39.2 ttm -84.78 138.82 32.37 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.965 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -72.33 160.04 53.91 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.467 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -15.45 57.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.969 0.414 . . . . 0.0 111.385 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -79.14 -18.53 53.01 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.222 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 69.21 1.77 3.38 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.22 -38.21 7.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.836 0.35 . . . . 0.0 111.458 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -120.84 143.69 48.76 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 475' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 468' ' ' MET . 55.3 m -115.88 139.97 49.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.32 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -106.18 123.6 48.28 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -107.18 144.99 33.13 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 94.1 t80 -129.02 134.7 48.24 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 59.7 tttt -170.81 134.35 1.01 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.991 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 60.11 43.37 98.38 Favored Glycine 0 N--CA 1.454 -0.125 0 CA-C-N 115.979 -0.555 . . . . 0.0 114.039 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 39.9 t30 67.07 3.58 3.21 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -118.22 157.13 27.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.733 0.301 . . . . 0.0 110.741 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -127.07 149.62 49.84 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.499 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 484' ' ' TRP . . . . . 0.423 ' CE2' ' HB3' ' A' ' 498' ' ' PRO . 19.2 m-90 -117.82 138.67 51.93 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.529 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -101.42 93.95 5.66 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 486' ' ' PHE . . . . . 0.465 ' CZ ' ' HE3' ' A' ' 456' ' ' TRP . 82.6 t80 -85.21 130.12 34.67 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.394 -178.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 487' ' ' ASN . . . . . 0.504 ' HB3' ' HB3' ' A' ' 490' ' ' LYS . 36.6 t-20 -86.65 121.53 29.29 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -65.94 -52.25 51.42 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.25 -40.39 86.26 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -178.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 490' ' ' LYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 487' ' ' ASN . 37.5 ttmt -78.26 -26.16 47.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.548 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 6.1 tp 63.24 38.78 10.18 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.572 0.701 . . . . 0.0 110.222 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -153.53 148.72 26.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.438 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 493' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 486' ' ' PHE . 77.8 t -75.83 131.27 35.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -59.45 137.35 89.15 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.836 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.28 143.1 99.86 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.912 2.408 . . . . 0.0 112.261 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 103.76 5.39 44.86 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.278 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 497' ' ' TYR . . . . . 0.51 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 18.6 m-85 -114.03 166.27 11.81 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.554 -0.323 . . . . 0.0 110.349 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 498' ' ' PRO . . . . . 0.51 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 88.3 Cg_endo -79.75 178.67 32.41 Favored 'Cis proline' 0 C--N 1.349 0.557 0 C-N-CA 123.752 -1.353 . . . . 0.0 113.075 0.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -135.23 160.12 39.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.277 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 42.4 t -69.66 125.92 28.16 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.812 0.339 . . . . 0.0 110.977 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -71.64 -22.9 61.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.284 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 502' ' ' LEU . . . . . 0.404 ' HA ' ' HG2' ' A' ' 506' ' ' MET . 26.4 mt -69.55 -47.34 64.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.53 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -75.9 -35.08 59.95 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -88.69 -46.86 8.68 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 36.1 m0 -92.72 -56.73 2.9 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -177.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 506' ' ' MET . . . . . 0.404 ' HG2' ' HA ' ' A' ' 502' ' ' LEU . 11.4 mmt -64.08 -45.43 88.74 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 105.85 29.63 4.87 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.398 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 15.1 m -106.45 105.38 54.23 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -81.11 160.92 20.6 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 123.289 2.66 . . . . 0.0 112.087 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 18.6 m 61.15 68.14 0.75 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.574 0.702 . . . . 0.0 111.653 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.388 -1.229 . . . . 0.0 111.474 -179.7 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.608 0 N-CA-C 111.893 -0.483 . . . . 0.0 111.893 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' PRO . . . . . 0.422 ' HA ' HD23 ' B' ' 2' ' ' HYP . 93.2 Cg_endo -79.56 151.66 22.54 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.621 2.214 . . . . 0.0 111.985 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 2' ' ' HYP . . . . . 0.422 HD23 ' HA ' ' B' ' 1' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' D' ' 201' ' ' PRO . . . -62.33 160.54 31.73 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.664 -0.698 . . . . 0.0 113.46 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.511 ' HG2' ' HA ' ' D' ' 202' ' ' HYP . 53.8 Cg_endo -68.03 163.49 35.63 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 123.002 2.468 . . . . 0.0 111.797 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' HYP . . . . . 0.532 ' HA ' ' HD2' ' C' ' 104' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.46 178.64 53.77 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.458 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.772 ' HG2' ' HA ' ' D' ' 205' ' ' HYP . 18.8 Cg_endo -59.82 161.59 18.06 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.553 2.168 . . . . 0.0 111.26 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 8' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 138.66 -179.92 17.95 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.198 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.51 147.59 71.07 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.837 2.358 . . . . 0.0 111.575 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -68.71 150.41 47.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.971 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.48 154.7 29.95 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.129 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.435 HG13 ' H ' ' B' ' 13' ' ' ILE . 5.2 mt -65.24 152.57 8.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.42 145.91 47.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.371 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.48 159.57 53.64 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 121.144 -0.551 . . . . 0.0 112.633 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -72.34 146.23 47.24 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -69.89 146.67 51.08 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.517 ' HA3' ' O ' ' D' ' 216' ' ' GLN . . . -61.2 150.97 43.18 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.76 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 4.6 t -67.11 146.34 13.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.0 t -53.76 144.94 4.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.33 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.86 167.16 54.12 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.87 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 96.0 mt -92.55 153.12 19.25 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 121.987 0.115 . . . . 0.0 110.746 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.45 170.45 54.91 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.252 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.46 ' HA ' HD23 ' B' ' 26' ' ' HYP . 36.8 Cg_endo -66.54 149.24 84.34 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.597 2.198 . . . . 0.0 111.275 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' HYP . . . . . 0.46 HD23 ' HA ' ' B' ' 25' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.18 161.52 47.66 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.994 -0.622 . . . . 0.0 113.551 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.13 155.9 47.12 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.835 2.357 . . . . 0.0 111.486 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.08 166.43 40.91 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.127 -0.558 . . . . 0.0 113.458 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -67.2 161.8 41.34 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.158 2.572 . . . . 0.0 111.731 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.75 156.2 53.4 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.765 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' PRO . . . . . 0.464 ' O ' ' C ' ' B' ' 35' ' ' HYP . 73.3 Cg_endo -75.25 154.97 41.71 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.695 2.263 . . . . 0.0 111.924 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' HYP . . . . . 0.464 ' C ' ' O ' ' B' ' 34' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.348 0 CA-C-O 120.086 -0.286 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 101' ' ' PRO . . . . . 0.463 ' HA ' HD23 ' C' ' 102' ' ' HYP . 17.4 Cg_exo -68.33 144.89 63.79 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 122.963 2.442 . . . . 0.0 111.875 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 102' ' ' HYP . . . . . 0.463 HD23 ' HA ' ' C' ' 101' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -82.05 175.84 53.89 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.851 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 104' ' ' PRO . . . . . 0.532 ' HD2' ' HA ' ' B' ' 5' ' ' HYP . 3.7 Cg_endo -87.07 158.01 8.52 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.592 2.862 . . . . 0.0 112.11 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 105' ' ' HYP . . . . . 0.441 HD23 ' HA ' ' C' ' 104' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -71.6 169.3 50.29 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.299 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.64 145.46 57.88 Favored 'Trans proline' 0 CA--C 1.528 0.209 0 C-N-CA 122.664 2.242 . . . . 0.0 111.353 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 108' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -54.83 166.18 2.78 Favored Glycine 0 CA--C 1.521 0.423 0 O-C-N 123.696 0.623 . . . . 0.0 113.915 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -65.14 163.97 26.97 Favored 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 122.841 2.361 . . . . 0.0 112.417 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -62.16 144.45 55.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.318 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -75.51 163.65 53.83 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.98 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 21.7 mt -65.14 136.61 26.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.17 148.14 50.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.254 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.36 154.43 37.87 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.117 -0.564 . . . . 0.0 112.873 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -83.51 163.25 20.58 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 43.5 ttm-85 -68.13 148.99 50.16 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.687 0.279 . . . . 0.0 110.357 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.93 175.35 38.6 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.06 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 25.3 t -73.49 140.24 18.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 90.4 t -63.27 136.07 26.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.105 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.18 157.62 46.54 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.269 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 122' ' ' LEU . . . . . 0.445 ' HA ' HD23 ' C' ' 123' ' ' HYP . 74.4 mt -73.04 146.5 45.83 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.658 0.266 . . . . 0.0 111.103 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 123' ' ' HYP . . . . . 0.445 HD23 ' HA ' ' C' ' 122' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -69.02 165.34 48.99 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.504 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 125' ' ' PRO . . . . . 0.413 ' HA ' HD23 ' C' ' 126' ' ' HYP . 73.6 Cg_endo -74.2 157.83 45.77 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.55 2.166 . . . . 0.0 111.737 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 126' ' ' HYP . . . . . 0.413 HD23 ' HA ' ' C' ' 125' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -68.19 160.64 50.72 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.818 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.55 160.0 50.94 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 122.494 2.129 . . . . 0.0 111.321 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -69.66 171.69 40.68 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.494 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 131' ' ' PRO . . . . . 0.477 ' HA ' HD23 ' C' ' 132' ' ' HYP . 17.1 Cg_exo -68.7 142.61 53.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.822 2.348 . . . . 0.0 111.353 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 132' ' ' HYP . . . . . 0.57 ' HA ' ' O ' ' D' ' 231' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.23 113.53 5.21 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.699 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 134' ' ' PRO . . . . . 0.474 ' HA ' HD23 ' C' ' 135' ' ' HYP . 68.0 Cg_endo -77.05 111.33 3.2 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.667 2.245 . . . . 0.0 111.891 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 135' ' ' HYP . . . . . 0.474 HD23 ' HA ' ' C' ' 134' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 201' ' ' PRO . . . . . 0.511 ' HA ' HD23 ' D' ' 202' ' ' HYP . 78.1 Cg_exo -54.23 139.69 72.45 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.014 2.476 . . . . 0.0 111.651 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 202' ' ' HYP . . . . . 0.511 ' HA ' ' HG2' ' B' ' 4' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 77.08 165.59 23.84 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 121.311 -0.471 . . . . 0.0 114.236 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 204' ' ' PRO . . . . . 0.439 ' HG2' ' OD1' ' C' ' 105' ' ' HYP . 13.3 Cg_exo -72.94 162.93 39.77 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.473 2.782 . . . . 0.0 111.965 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 205' ' ' HYP . . . . . 0.772 ' HA ' ' HG2' ' B' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . 97.19 174.11 34.37 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.824 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 207' ' ' PRO . . . . . 0.402 ' HA ' HD23 ' D' ' 208' ' ' HYP . 73.2 Cg_endo -94.25 156.44 2.1 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.475 2.783 . . . . 0.0 112.636 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 208' ' ' HYP . . . . . 0.402 HD23 ' HA ' ' D' ' 207' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -81.34 171.13 53.02 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.842 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -71.85 141.85 37.96 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 123.02 2.48 . . . . 0.0 111.949 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -65.84 146.42 54.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.943 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -70.05 162.97 52.66 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.897 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 213' ' ' ILE . . . . . 0.459 ' HB ' ' OE1' ' A' ' 392' ' ' GLU . 39.4 pt -69.84 166.85 2.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.606 0.241 . . . . 0.0 110.971 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 214' ' ' ALA . . . . . 0.558 ' HB3' ' NH1' ' A' ' 330' ' ' ARG . . . -83.15 144.44 29.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.884 0.373 . . . . 0.0 110.882 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -65.95 168.14 33.4 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.8 -0.636 . . . . 0.0 114.054 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 216' ' ' GLN . . . . . 0.517 ' O ' ' HA3' ' B' ' 18' ' ' GLY . 89.7 mm-40 -75.95 155.77 34.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.698 0.285 . . . . 0.0 110.955 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -66.14 153.06 43.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.5 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -59.83 150.25 39.54 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.086 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 13.8 t -61.2 143.12 15.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.61 142.16 16.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.888 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -59.88 154.79 31.41 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.358 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 5.2 mp -71.19 151.35 44.43 Favored 'General case' 0 C--N 1.32 -0.68 0 O-C-N 122.843 -0.21 . . . . 0.0 110.795 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 223' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 224' ' ' GLY . . . . . 0.442 ' HA2' ' HD3' ' D' ' 225' ' ' PRO . . . -58.19 150.22 33.56 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.806 -0.634 . . . . 0.0 113.575 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 225' ' ' PRO . . . . . 0.442 ' HD3' ' HA2' ' D' ' 224' ' ' GLY . 31.4 Cg_exo -62.79 156.78 51.46 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 123.213 2.608 . . . . 0.0 112.09 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 226' ' ' HYP . . . . . 0.432 HD23 ' HA ' ' D' ' 225' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -68.18 160.06 51.08 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.516 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.92 156.11 34.45 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 122.702 2.268 . . . . 0.0 111.809 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -68.71 168.98 42.52 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.699 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 231' ' ' PRO . . . . . 0.57 ' O ' ' HA ' ' C' ' 132' ' ' HYP . 14.7 Cg_exo -71.62 163.32 39.36 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 123.214 2.61 . . . . 0.0 111.263 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 232' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.418 ' HD2' ' CZ3' ' A' ' 340' ' ' TRP . 4.8 Cg_endo . . . . . 0 N--CA 1.479 0.62 0 N-CA-C 110.477 -0.624 . . . . 0.0 110.477 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -105.76 158.25 16.87 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.404 ' O ' ' HZ ' ' A' ' 323' ' ' PHE . 15.0 tt -75.39 -19.13 15.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.41 0.624 . . . . 0.0 110.046 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 69.5 m -85.7 -1.31 57.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.717 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -74.15 -23.59 59.28 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.366 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 74.46 -172.32 52.41 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.607 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 2.1 t30 54.6 81.7 0.1 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.113 0.565 . . . . 0.0 111.942 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' PHE . . . . . 0.469 ' HD1' ' HB2' ' A' ' 337' ' ' LYS . 50.8 m-85 -104.65 164.43 11.77 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.709 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -73.32 -41.26 63.73 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 9.4 t -172.78 152.5 2.49 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.535 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 97.6 t -133.0 118.28 32.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -141.58 172.94 12.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.063 0.459 . . . . 0.0 111.473 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 31.9 ttp -121.77 123.39 41.71 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.624 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 59.3 mt -116.6 118.43 32.59 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.933 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.404 ' HG3' ' CE1' ' A' ' 379' ' ' PHE . 43.7 mtp180 56.49 28.04 13.15 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 98.76 -11.86 62.69 Favored Glycine 0 CA--C 1.517 0.193 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.225 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -98.52 128.23 44.77 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.823 0.344 . . . . 0.0 110.875 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 48.7 ttm -87.39 119.9 28.13 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.504 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -112.04 128.4 56.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.055 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 335' ' ' VAL . . . . . 0.442 ' HB ' ' HB2' ' A' ' 342' ' ' TRP . 26.1 t -106.8 119.91 57.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.434 -0.803 . . . . 0.0 108.913 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -107.87 130.11 55.03 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 0.691 ' HB3' ' HZ3' ' A' ' 342' ' ' TRP . 87.7 tttt -153.44 108.24 3.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.75 177.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 69.89 -129.67 0.08 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.034 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 339' ' ' ARG . 12.8 ptm85 -94.94 2.63 55.4 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 340' ' ' TRP . . . . . 0.418 ' CZ3' ' HD2' ' A' ' 316' ' ' PRO . 6.9 m-90 -123.61 154.85 38.72 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.784 0.326 . . . . 0.0 111.053 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -134.16 149.76 51.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.568 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' TRP . . . . . 0.691 ' HZ3' ' HB3' ' A' ' 337' ' ' LYS . 26.2 m-90 -119.65 167.56 11.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.634 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.13 114.27 6.21 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.417 HG11 ' HA ' ' A' ' 506' ' ' MET . 10.5 m -102.78 143.99 14.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.165 0.507 . . . . 0.0 112.238 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 29.1 ttm-85 -150.79 126.91 10.52 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.924 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 22.7 m120 68.55 30.89 5.0 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.203 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 39.6 t30 66.06 24.23 11.0 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.224 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -136.45 146.27 46.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.339 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 32.8 t -79.0 124.69 37.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 60.4 mtp -71.15 160.55 32.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.774 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -72.32 153.61 41.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.118 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 98.64 -4.41 59.68 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.517 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -118.6 152.6 51.42 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -73.94 149.12 93.54 Favored 'Cis proline' 0 C--O 1.234 0.315 0 C-N-CA 123.356 -1.518 . . . . 0.0 112.884 0.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 55.1 ttm -129.57 139.68 36.39 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.42 -0.809 . . . . 0.0 108.949 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.88 131.26 44.96 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.211 1.941 . . . . 0.0 111.213 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' ILE . . . . . 0.475 HG23 ' HD1' ' A' ' 361' ' ' TRP . 65.6 mt -52.02 -46.21 41.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.047 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -65.05 -16.07 61.48 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 121.267 -0.492 . . . . 0.0 114.128 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -34.2 61.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.141 0.471 . . . . 0.0 110.574 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -101.25 -51.5 3.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.165 0.507 . . . . 0.0 110.062 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' TRP . . . . . 0.475 ' HD1' HG23 ' A' ' 357' ' ' ILE . 71.4 m95 -87.8 85.68 7.07 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.371 0.605 . . . . 0.0 109.571 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 362' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 362' ' ' ARG . 38.4 ttp180 -65.63 83.41 0.06 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.859 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.582 ' HA3' HD22 ' A' ' 395' ' ' LEU . . . 133.54 -3.6 4.7 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.164 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.583 HD12 ' HD2' ' A' ' 365' ' ' PRO . 22.9 tp -98.83 131.72 25.11 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 120.616 0.246 . . . . 0.0 110.858 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 365' ' ' PRO . . . . . 0.583 ' HD2' HD12 ' A' ' 364' ' ' LEU . 98.3 Cg_endo -79.55 -174.83 2.43 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.715 2.277 . . . . 0.0 111.598 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -91.35 151.34 20.9 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.938 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 18.1 m 57.45 93.52 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.483 0.919 . . . . 0.0 113.483 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 24.1 pt -107.19 172.39 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.409 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -96.64 -40.57 8.94 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 370' ' ' THR . . . . . 0.86 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.1 OUTLIER -162.7 171.88 16.16 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.773 0.32 . . . . 0.0 111.347 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 371' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 380' ' ' VAL . . . -162.06 144.44 11.39 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -157.35 164.16 37.87 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -95.5 122.05 37.82 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 374' ' ' ARG . . . . . 0.549 ' HG2' ' O ' ' A' ' 378' ' ' LYS . 9.3 ptm180 -75.57 -175.7 2.96 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.478 ' HD2' ' HA3' ' A' ' 425' ' ' GLY . 77.6 tttt -67.46 -33.18 74.59 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.988 0.423 . . . . 0.0 111.375 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.75 -50.62 19.79 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.825 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 147.63 -29.76 1.43 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.214 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 378' ' ' LYS . . . . . 0.731 ' HG2' ' HA ' ' A' ' 391' ' ' ASP . 91.5 mttt -59.13 150.49 25.07 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.91 0.386 . . . . 0.0 111.088 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 379' ' ' PHE . . . . . 0.404 ' CE1' ' HG3' ' A' ' 330' ' ' ARG . 18.2 m-85 -95.73 136.09 36.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.612 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 380' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 371' ' ' ALA . 3.8 t -113.86 113.96 45.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.094 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -100.52 144.78 29.11 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -126.63 141.51 51.83 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.848 0.356 . . . . 0.0 111.632 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.56 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 84.2 tttt -152.99 105.48 2.93 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 177.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 72.49 -117.07 6.04 Favored Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -109.85 10.51 24.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.848 0.356 . . . . 0.0 110.946 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -118.75 151.08 38.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.878 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 27.8 p-80 -131.38 153.28 49.82 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.028 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' TRP . . . . . 0.575 ' CE2' ' HB3' ' A' ' 400' ' ' PRO . 26.7 m-90 -127.97 131.87 49.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.238 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 389' ' ' VAL . . . . . 0.409 HG12 ' HG3' ' A' ' 396' ' ' GLU . 78.8 t -111.02 122.78 66.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -113.57 122.41 47.15 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.731 ' HA ' ' HG2' ' A' ' 378' ' ' LYS . 32.8 t70 -85.03 82.42 8.45 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 177.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 392' ' ' GLU . . . . . 0.451 ' OE1' ' HB ' ' D' ' 213' ' ' ILE . 35.7 mm-40 71.92 -68.93 0.2 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.489 -177.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -143.8 7.52 1.45 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.93 0.395 . . . . 0.0 110.915 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 2.0 m -113.76 125.01 53.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.02 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.582 HD22 ' HA3' ' A' ' 363' ' ' GLY . 52.3 tp -76.52 128.22 34.34 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.533 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 396' ' ' GLU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 1.4 mt-10 -64.42 136.54 96.8 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.985 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 397' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 31.5 Cg_exo -60.95 143.22 99.3 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.168 2.579 . . . . 0.0 112.447 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 96.51 -15.01 63.52 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.543 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -83.72 156.56 64.76 Favored Pre-proline 0 C--N 1.323 -0.577 0 O-C-N 122.672 -0.311 . . . . 0.0 110.782 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.575 ' HB3' ' CE2' ' A' ' 388' ' ' TRP . 59.9 Cg_endo -71.51 156.38 97.04 Favored 'Cis proline' 0 C--N 1.349 0.593 0 C-N-CA 123.963 -1.266 . . . . 0.0 113.522 0.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -128.19 159.6 34.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.0 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 0.545 ' ND1' ' HG2' ' A' ' 404' ' ' LYS . 5.4 t-80 -69.75 153.09 43.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.245 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 64.9 mt -56.52 -33.51 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.545 ' HG2' ' ND1' ' A' ' 402' ' ' HIS . 20.7 pttm -65.14 -12.53 51.97 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -80.91 -26.58 36.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.876 0.37 . . . . 0.0 110.772 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 32.2 tp -75.0 -47.14 30.67 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.477 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -169.37 147.82 11.44 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.759 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 33.0 ttt180 -84.68 132.96 34.41 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.745 0.307 . . . . 0.0 110.315 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 114.14 -14.77 21.1 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.551 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.443 HD21 ' HB2' ' A' ' 438' ' ' PHE . 96.0 mt -76.17 152.9 84.29 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.571 -0.314 . . . . 0.0 110.563 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.46 130.19 38.75 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.922 2.414 . . . . 0.0 111.545 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.11 3.82 55.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.985 0.421 . . . . 0.0 111.482 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -95.52 -57.53 2.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.579 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 5.1 ptmt -172.38 171.64 4.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.919 0.39 . . . . 0.0 110.858 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 49.2 mm -120.92 127.52 75.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -86.49 -48.01 8.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.935 0.398 . . . . 0.0 110.55 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 417' ' ' ALA . . . . . 0.86 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -153.87 154.38 33.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.295 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -135.1 107.27 7.18 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 40.5 tp -99.14 117.21 33.11 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.281 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 420' ' ' PHE . . . . . 0.417 ' CZ ' ' HA ' ' A' ' 375' ' ' LYS . 44.7 t80 -89.0 115.44 26.57 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.035 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 421' ' ' TRP . . . . . 0.494 ' HB2' ' HE2' ' A' ' 428' ' ' TYR . 22.0 t-105 -84.26 90.44 7.53 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.463 ' HB2' ' HG2' ' A' ' 472' ' ' GLU . 62.9 mtt -47.97 -48.73 61.95 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.422 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 79.8 Cg_exo -48.87 -35.47 31.35 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 122.862 2.375 . . . . 0.0 114.787 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 38.3 p30 -113.29 -35.47 5.31 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 425' ' ' GLY . . . . . 0.478 ' HA3' ' HD2' ' A' ' 375' ' ' LYS . . . 104.62 10.44 33.17 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.617 -0.802 . . . . 0.0 113.367 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -97.88 155.41 17.08 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.418 -0.46 . . . . 0.0 110.605 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 7.4 m -113.16 130.36 56.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.994 0.426 . . . . 0.0 111.568 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 428' ' ' TYR . . . . . 0.494 ' HE2' ' HB2' ' A' ' 421' ' ' TRP . 99.4 m-85 -100.85 108.17 19.89 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.742 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -91.47 124.57 35.74 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.226 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -99.57 132.24 45.03 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.094 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.41 ' HA ' ' HE ' ' A' ' 431' ' ' ARG . 2.9 tpm_? -144.4 108.08 4.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.171 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 70.14 -110.22 3.21 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.774 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 28.1 p30 -117.71 17.69 14.3 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.837 0.351 . . . . 0.0 111.158 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 52.5 mttt -133.86 158.22 43.97 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.725 0.298 . . . . 0.0 110.959 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 435' ' ' TYR . . . . . 0.46 ' CE2' ' HE2' ' A' ' 449' ' ' TYR . 7.1 p90 -128.99 144.5 51.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.211 0.529 . . . . 0.0 110.984 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -110.53 133.74 53.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.596 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 19.2 ttp180 -94.86 92.14 6.78 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 438' ' ' PHE . . . . . 0.477 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 67.8 t80 -84.34 129.04 34.91 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.131 0.491 . . . . 0.0 111.642 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -99.39 108.89 21.49 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 440' ' ' GLU . . . . . 0.524 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 1.7 tt0 -58.57 -43.04 89.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.947 0.403 . . . . 0.0 110.621 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -84.24 48.65 1.52 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.797 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -169.6 -35.03 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.706 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 443' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 443' ' ' ARG . 37.6 mtp-105 69.58 36.94 2.04 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.429 0.633 . . . . 0.0 111.199 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -155.72 167.37 30.61 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.925 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 59.7 t -87.74 141.06 14.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.966 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -62.09 155.44 24.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.998 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 447' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 448' ' ' GLU . 0.9 OUTLIER -64.85 157.73 27.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.849 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 448' ' ' GLU . . . . . 0.577 ' HB3' ' HE2' ' A' ' 451' ' ' LYS . 8.3 mm-40 76.04 5.93 3.75 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.259 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 449' ' ' TYR . . . . . 0.524 ' HB3' ' HA ' ' A' ' 450' ' ' PRO . 42.6 m-85 -112.63 163.36 18.05 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.762 -0.199 . . . . 0.0 111.329 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 450' ' ' PRO . . . . . 0.524 ' HA ' ' HB3' ' A' ' 449' ' ' TYR . 73.1 Cg_endo -75.87 155.65 98.87 Favored 'Cis proline' 0 C--N 1.349 0.57 0 C-N-CA 123.624 -1.407 . . . . 0.0 112.967 0.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 451' ' ' LYS . . . . . 0.577 ' HE2' ' HB3' ' A' ' 448' ' ' GLU . 63.0 mttm -116.84 162.3 17.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.305 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -65.53 139.94 58.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.718 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.1 tt -67.48 -9.6 10.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.094 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -63.47 -7.35 6.6 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 95.7 t -65.94 -37.17 79.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 456' ' ' TRP . . . . . 0.563 ' HE3' ' CZ ' ' A' ' 486' ' ' PHE . 5.7 m95 -88.43 93.68 9.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.94 179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.28 116.32 4.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.149 0.5 . . . . 0.0 112.072 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 107.3 -15.57 39.02 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.716 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.424 ' HB ' ' HB2' ' A' ' 456' ' ' TRP . 33.6 mm -83.59 125.9 72.52 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 120.857 0.36 . . . . 0.0 111.304 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.44 152.93 30.55 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.758 2.306 . . . . 0.0 111.719 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -73.42 147.36 44.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.473 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 2.0 m 54.89 75.85 0.57 Allowed Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -83.5 -176.59 2.81 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.156 2.571 . . . . 0.0 112.173 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -134.81 18.96 3.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.207 0.527 . . . . 0.0 110.405 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 166.15 142.9 3.56 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 11.4 p -157.54 108.23 2.25 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -134.23 146.14 49.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.881 0.372 . . . . 0.0 111.507 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 48.0 ttm -99.03 141.06 32.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.167 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -67.69 166.74 42.5 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.179 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 2.7 m -68.74 -8.26 41.3 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.34 -14.27 27.1 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.969 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 472' ' ' GLU . . . . . 0.463 ' HG2' ' HB2' ' A' ' 422' ' ' MET . 36.4 mt-10 65.39 12.17 7.9 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.241 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.7 -45.05 12.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.941 0.4 . . . . 0.0 110.682 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -114.07 141.56 47.31 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.208 0.528 . . . . 0.0 112.0 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 475' ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' A' ' 486' ' ' PHE . 91.9 m -119.42 138.8 52.86 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.685 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -112.51 131.06 55.78 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.292 0.568 . . . . 0.0 112.506 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -114.65 142.78 46.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.215 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -123.75 136.84 54.67 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 111.526 0.195 . . . . 0.0 111.526 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -167.43 126.11 1.31 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.001 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 57.92 46.83 92.0 Favored Glycine 0 CA--C 1.519 0.341 0 CA-C-N 116.003 -0.544 . . . . 0.0 114.356 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 68.65 -2.25 1.72 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.775 0.658 . . . . 0.0 112.775 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 482' ' ' LYS . . . . . 0.436 ' HB3' ' HB2' ' A' ' 498' ' ' PRO . 34.7 mtmt -106.39 151.42 24.91 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 483' ' ' TYR . . . . . 0.5 ' CZ ' ' HE2' ' A' ' 497' ' ' TYR . 3.3 p90 -126.89 138.84 53.37 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.031 0.443 . . . . 0.0 111.332 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 15.1 m-90 -108.33 145.65 34.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.23 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 53.5 tttt -111.86 100.45 8.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.075 0.464 . . . . 0.0 109.927 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 486' ' ' PHE . . . . . 0.563 ' CZ ' ' HE3' ' A' ' 456' ' ' TRP . 67.1 t80 -89.1 130.61 35.52 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.945 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -96.82 112.38 24.16 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -64.72 -23.43 67.25 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 31.3 tp60 -78.57 -24.5 45.52 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -114.1 -6.26 13.08 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 15.3 tp 58.02 34.22 24.01 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.525 0.679 . . . . 0.0 110.375 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 492' ' ' LYS . . . . . 0.432 ' HG2' ' N ' ' A' ' 493' ' ' VAL . 39.3 tttp -152.46 152.71 32.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.703 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 493' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 486' ' ' PHE . 66.7 t -76.1 133.36 31.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.696 178.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -61.38 148.22 86.1 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.386 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.23 149.56 85.27 Favored 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 122.743 2.295 . . . . 0.0 112.457 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 96.25 13.25 49.44 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.751 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 497' ' ' TYR . . . . . 0.567 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 51.1 m-85 -121.08 164.5 23.36 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.874 -0.163 . . . . 0.0 110.783 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 498' ' ' PRO . . . . . 0.567 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 95.8 Cg_endo -80.65 164.23 79.32 Favored 'Cis proline' 0 C--N 1.344 0.337 0 C-N-CA 123.806 -1.331 . . . . 0.0 113.647 0.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -118.68 160.77 21.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.651 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 30.1 t -71.97 115.47 11.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.946 0.403 . . . . 0.0 110.978 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -69.99 -23.67 63.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.61 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 502' ' ' LEU . . . . . 0.472 ' HA ' ' HG2' ' A' ' 506' ' ' MET . 83.5 mt -67.02 -32.0 72.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.074 0.464 . . . . 0.0 110.862 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -96.68 -35.08 11.14 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -89.65 -17.64 28.01 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 13.0 m0 -121.37 -52.63 2.04 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 506' ' ' MET . . . . . 0.472 ' HG2' ' HA ' ' A' ' 502' ' ' LEU . 11.2 mmt -67.95 -29.33 68.36 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 88.84 30.72 14.06 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.032 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 31.7 m -101.93 114.23 65.61 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.0 124.34 11.7 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.968 2.445 . . . . 0.0 112.652 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 3.9 m 68.28 153.68 0.1 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.482 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.188 -1.34 . . . . 0.0 111.19 179.957 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.771 0 N-CA-C 112.048 -0.421 . . . . 0.0 112.048 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' PRO . . . . . 0.461 ' HA ' HD23 ' B' ' 2' ' ' HYP . 50.1 Cg_endo -68.8 137.51 38.55 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 122.722 2.281 . . . . 0.0 112.01 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 2' ' ' HYP . . . . . 0.522 ' HA ' ' HB2' ' C' ' 101' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' D' ' 201' ' ' PRO . . . -64.37 158.54 42.61 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.175 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.77 166.78 28.43 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.764 2.309 . . . . 0.0 111.415 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.99 -171.98 43.44 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.318 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.834 ' HG2' ' HA ' ' D' ' 205' ' ' HYP . 29.1 Cg_endo -64.41 162.64 29.78 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.617 2.211 . . . . 0.0 111.361 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' HYP . . . . . 0.427 ' O ' ' HA3' ' D' ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.32 175.61 20.31 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.887 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.64 143.6 68.88 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.88 2.387 . . . . 0.0 111.514 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -64.89 150.82 47.08 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.607 ' HA3' ' O ' ' D' ' 210' ' ' PRO . . . -59.99 154.72 31.96 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.345 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.486 ' O ' ' HG3' ' D' ' 211' ' ' GLN . 6.5 mt -59.58 150.38 5.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.891 0.377 . . . . 0.0 110.924 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.59 145.27 56.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.127 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.32 153.85 45.54 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.903 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -69.27 148.59 49.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.756 0.312 . . . . 0.0 110.612 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -66.34 138.64 57.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.715 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.51 145.13 49.77 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.637 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 t -63.8 149.22 10.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.496 0.148 . . . . 0.0 110.766 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 11.0 t -52.13 146.05 2.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.262 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.54 165.08 52.45 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 121.187 -0.53 . . . . 0.0 113.4 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 81.2 mt -77.54 151.67 34.4 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.639 -0.28 . . . . 0.0 110.342 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.79 152.23 43.94 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.226 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.43 ' HA ' HD23 ' B' ' 26' ' ' HYP . 55.0 Cg_endo -71.01 153.07 63.33 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.756 2.304 . . . . 0.0 111.698 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' HYP . . . . . 0.43 HD23 ' HA ' ' B' ' 25' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.01 169.07 53.9 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.748 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -80.71 160.56 21.75 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 123.043 2.495 . . . . 0.0 112.031 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.01 177.23 39.05 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.52 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.434 ' HA ' HD23 ' B' ' 32' ' ' HYP . 24.4 Cg_exo -64.77 157.34 56.71 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.308 2.672 . . . . 0.0 112.455 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' HYP . . . . . 0.434 HD23 ' HA ' ' B' ' 31' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -55.57 128.76 45.44 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.665 -0.698 . . . . 0.0 113.8 -178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' PRO . . . . . 0.459 ' HA ' HD23 ' B' ' 35' ' ' HYP . 11.4 Cg_endo -57.21 114.01 1.74 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.952 2.435 . . . . 0.0 111.397 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' HYP . . . . . 0.459 HD23 ' HA ' ' B' ' 34' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.35 0 CA-C-O 120.019 -0.323 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 101' ' ' PRO . . . . . 0.522 ' HB2' ' HA ' ' B' ' 2' ' ' HYP . 36.9 Cg_exo -62.98 132.59 37.54 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.823 2.349 . . . . 0.0 111.63 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 102' ' ' HYP . . . . . 0.496 HD23 ' HA ' ' C' ' 101' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.6 159.55 52.12 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.519 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 104' ' ' PRO . . . . . 0.417 ' HA ' HD23 ' C' ' 105' ' ' HYP . 86.4 Cg_endo -81.84 160.62 18.73 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 123.074 2.516 . . . . 0.0 111.97 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 105' ' ' HYP . . . . . 0.572 ' OD1' ' HG2' ' D' ' 204' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -79.79 -167.7 35.47 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.504 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.32 154.12 45.8 Favored 'Trans proline' 0 N--CA 1.466 -0.142 0 C-N-CA 122.676 2.251 . . . . 0.0 110.743 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 108' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -55.23 160.6 5.79 Favored Glycine 0 CA--C 1.522 0.479 0 CA-C-N 115.953 -0.567 . . . . 0.0 113.282 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.26 160.07 32.48 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 123.216 2.611 . . . . 0.0 112.525 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -62.03 134.23 56.35 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.794 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -65.39 162.02 41.26 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.441 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 53.5 mt -72.94 138.72 20.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.8 153.09 37.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.306 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -66.56 159.39 48.29 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.351 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -88.94 150.53 22.8 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.617 0.246 . . . . 0.0 110.594 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 19.5 ttm-85 -60.97 142.11 56.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.323 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.24 167.12 49.79 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.41 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 86.0 t -66.73 142.28 16.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.675 0.274 . . . . 0.0 111.014 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 94.4 t -61.6 143.39 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.122 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.89 163.61 36.94 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.726 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 122' ' ' LEU . . . . . 0.423 ' HA ' HD23 ' C' ' 123' ' ' HYP . 87.3 mt -76.72 147.1 37.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.49 0.186 . . . . 0.0 110.755 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 123' ' ' HYP . . . . . 0.423 HD23 ' HA ' ' C' ' 122' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -64.72 164.33 35.1 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.462 -179.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 125' ' ' PRO . . . . . 0.432 ' HA ' HD23 ' C' ' 126' ' ' HYP . 45.7 Cg_endo -68.71 151.95 74.44 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.709 2.273 . . . . 0.0 111.629 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 126' ' ' HYP . . . . . 0.432 HD23 ' HA ' ' C' ' 125' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -65.81 162.67 41.71 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.318 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -80.86 159.86 21.3 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.666 2.244 . . . . 0.0 111.223 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -68.45 -178.32 15.7 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.997 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 131' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' B' ' 32' ' ' HYP . 3.6 Cg_exo -76.33 153.02 35.32 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.921 2.414 . . . . 0.0 111.691 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 132' ' ' HYP . . . . . 0.54 ' HA ' ' O ' ' D' ' 231' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.11 121.41 9.14 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.958 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 134' ' ' PRO . . . . . 0.409 ' HA ' HD23 ' C' ' 135' ' ' HYP . 43.1 Cg_endo -68.82 113.4 3.2 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.823 2.349 . . . . 0.0 111.463 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 135' ' ' HYP . . . . . 0.409 HD23 ' HA ' ' C' ' 134' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.287 0 CA-C-O 120.056 -0.302 . . . . 0.0 112.437 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 201' ' ' PRO . . . . . 0.446 ' O ' ' HA3' ' B' ' 3' ' ' GLY . 31.9 Cg_exo -61.59 120.1 7.57 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.789 2.326 . . . . 0.0 111.034 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 202' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 66.92 166.0 2.43 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 114.72 0.648 . . . . 0.0 114.72 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 204' ' ' PRO . . . . . 0.572 ' HG2' ' OD1' ' C' ' 105' ' ' HYP . 7.9 Cg_exo -77.84 166.76 24.79 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 123.528 2.819 . . . . 0.0 110.411 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 205' ' ' HYP . . . . . 0.834 ' HA ' ' HG2' ' B' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 206' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' B' ' 8' ' ' HYP . . . 95.01 167.64 36.05 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.454 178.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -90.57 155.79 4.33 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 123.33 2.686 . . . . 0.0 112.803 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 208' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -84.72 -178.85 51.24 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.319 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 210' ' ' PRO . . . . . 0.607 ' O ' ' HA3' ' B' ' 12' ' ' GLY . 2.6 Cg_exo -76.89 152.89 32.58 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 123.044 2.496 . . . . 0.0 111.786 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 211' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' B' ' 13' ' ' ILE . 57.0 tt0 -73.91 149.32 41.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.774 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -68.02 159.45 51.2 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.486 -0.645 . . . . 0.0 111.486 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 213' ' ' ILE . . . . . 0.451 ' HB ' ' OE1' ' A' ' 392' ' ' GLU . 42.1 pt -64.4 163.48 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-O 120.891 0.376 . . . . 0.0 111.484 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -74.56 145.16 43.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.333 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -67.42 158.02 51.34 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.518 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 -76.19 151.33 36.93 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -64.58 153.04 40.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.337 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -61.86 157.03 35.5 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.269 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 12.3 t -70.91 147.52 11.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.59 136.85 25.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.99 162.82 26.36 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.292 -0.48 . . . . 0.0 113.127 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 64.5 mt -69.36 154.04 42.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.846 -0.177 . . . . 0.0 110.795 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 223' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 224' ' ' GLY . . . . . 0.447 ' HA2' ' HD3' ' D' ' 225' ' ' PRO . . . -66.19 147.54 50.15 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.276 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 225' ' ' PRO . . . . . 0.447 ' HD3' ' HA2' ' D' ' 224' ' ' GLY . 17.3 Cg_exo -67.53 152.75 78.01 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.602 2.202 . . . . 0.0 111.903 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 226' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -64.56 169.18 25.43 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.135 -0.555 . . . . 0.0 114.087 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -75.88 163.35 33.54 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 123.418 2.745 . . . . 0.0 111.485 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -67.96 170.01 37.82 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.268 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 231' ' ' PRO . . . . . 0.54 ' O ' ' HA ' ' C' ' 132' ' ' HYP . 10.8 Cg_exo -72.16 145.52 44.26 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 123.002 2.468 . . . . 0.0 111.394 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 232' ' ' HYP . . . . . 0.433 HD23 ' HA ' ' D' ' 231' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo . . . . . 0 N--CA 1.477 0.54 0 N-CA-C 109.8 -0.885 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -110.42 -173.98 2.38 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 15.4 tt -117.46 -6.24 11.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.247 0.546 . . . . 0.0 110.54 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 99.6 m -100.11 -0.61 38.64 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -94.02 -9.17 37.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.81 0.338 . . . . 0.0 110.598 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 84.22 -149.05 24.7 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.808 -0.711 . . . . 0.0 111.843 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 2.8 t30 55.13 68.57 0.84 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.116 0.484 . . . . 0.0 111.756 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -100.99 152.17 20.89 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.547 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -80.31 -47.09 15.05 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 4.4 t -167.33 149.67 6.0 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.021 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 47.8 t -128.49 122.29 57.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -140.44 -177.98 5.29 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.065 0.459 . . . . 0.0 111.778 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 12.8 ttp -132.02 131.17 42.26 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 51.2 mt -127.58 116.86 20.99 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 123.295 0.372 . . . . 0.0 110.397 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.451 ' H ' ' CD ' ' A' ' 373' ' ' GLU . 0.9 OUTLIER 64.83 20.84 12.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.822 179.203 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 102.85 -18.59 49.54 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.347 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -89.47 135.03 33.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.669 0.271 . . . . 0.0 110.475 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 48.4 ttm -87.03 126.61 34.86 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.907 0.384 . . . . 0.0 110.632 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -116.87 122.32 44.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.32 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.72 112.46 37.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -95.3 130.4 42.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.792 0.33 . . . . 0.0 111.578 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -147.98 108.82 4.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.244 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 63.34 -113.2 0.4 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.632 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.456 HH11 ' HD2' ' A' ' 339' ' ' ARG . 13.3 ptm180 -110.23 10.35 23.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.053 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -126.19 157.47 38.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.908 0.385 . . . . 0.0 110.591 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -141.31 141.57 33.89 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.563 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -107.21 150.46 26.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.92 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.454 ' HD3' ' SD ' ' A' ' 350' ' ' MET . 14.5 ttt85 -125.5 106.32 9.7 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 3.7 m -92.79 129.01 43.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.409 0.623 . . . . 0.0 111.485 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.43 111.89 13.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.082 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 27.9 t30 55.69 52.06 11.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.031 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 68.14 7.07 5.62 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -122.38 158.06 30.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.724 0.297 . . . . 0.0 110.881 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 38.5 t -94.26 130.32 43.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 120.681 0.276 . . . . 0.0 110.475 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 350' ' ' MET . . . . . 0.454 ' SD ' ' HD3' ' A' ' 343' ' ' ARG . 4.0 mtp -72.04 156.72 38.9 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.204 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -79.08 150.55 31.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.81 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 99.69 -6.03 58.67 Favored Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 353' ' ' TYR . . . . . 0.459 ' HA ' ' C ' ' A' ' 354' ' ' PRO . 86.7 m-85 -112.64 157.69 39.61 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.459 ' C ' ' HA ' ' A' ' 353' ' ' TYR . 38.1 Cg_endo -66.55 131.7 15.38 Favored 'Cis proline' 0 C--N 1.347 0.466 0 C-N-CA 123.713 -1.369 . . . . 0.0 112.693 0.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 355' ' ' MET . . . . . 0.441 ' HA ' ' HD3' ' A' ' 356' ' ' PRO . 52.6 ttm -104.38 136.08 19.23 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.24 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 356' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 355' ' ' MET . 31.4 Cg_exo -61.18 131.84 38.6 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.256 1.971 . . . . 0.0 111.058 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 66.5 mt -54.96 -44.1 71.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.179 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -67.99 -14.22 65.43 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 121.19 -0.529 . . . . 0.0 113.718 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -79.55 -45.79 18.57 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 117.182 0.491 . . . . 0.0 110.622 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -88.38 -53.11 4.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.591 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -88.12 74.67 8.79 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.242 0.544 . . . . 0.0 109.536 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -60.66 94.83 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.865 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 130.91 -17.31 5.2 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.264 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.55 HD12 ' HD2' ' A' ' 365' ' ' PRO . 19.4 tp -85.31 132.59 44.64 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.647 0.261 . . . . 0.0 111.138 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 365' ' ' PRO . . . . . 0.55 ' HD2' HD12 ' A' ' 364' ' ' LEU . 94.2 Cg_endo -79.59 178.81 6.92 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.817 2.345 . . . . 0.0 111.651 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -86.56 151.57 23.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.421 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 44.6 m 55.98 83.99 0.09 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 19.9 pt -95.56 172.86 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.924 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.42 -42.05 6.42 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.708 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 370' ' ' THR . . . . . 0.729 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.2 OUTLIER -151.23 159.2 44.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.85 0.357 . . . . 0.0 111.513 -179.6 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -149.93 140.1 22.14 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -163.88 166.79 21.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.768 0.318 . . . . 0.0 111.42 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.52 ' HG2' ' HD1' ' A' ' 379' ' ' PHE . 33.5 mt-10 -97.56 138.38 35.07 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 374' ' ' ARG . . . . . 0.628 ' HG3' ' H ' ' A' ' 376' ' ' ASP . 10.0 ptm180 -89.41 -173.03 3.84 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.959 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.482 ' HB2' ' HG3' ' A' ' 440' ' ' GLU . 67.8 tttt -70.42 -19.51 62.99 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -177.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 376' ' ' ASP . . . . . 0.628 ' H ' ' HG3' ' A' ' 374' ' ' ARG . 0.4 OUTLIER -94.67 -23.05 17.76 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.377 -0.529 . . . . 0.0 112.422 -179.341 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 124.9 -18.99 7.01 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.603 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -70.45 152.0 44.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.842 0.353 . . . . 0.0 110.605 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' PHE . . . . . 0.52 ' HD1' ' HG2' ' A' ' 373' ' ' GLU . 21.5 m-85 -96.23 133.54 40.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.269 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 14.5 t -114.56 121.31 66.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 120.796 0.332 . . . . 0.0 110.276 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -107.65 138.62 43.55 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -121.3 137.7 54.57 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.461 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 79.0 tttt -155.25 103.54 2.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.408 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 76.61 -122.38 6.33 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.606 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 385' ' ' ASP . . . . . 0.52 ' O ' ' HA ' ' A' ' 402' ' ' HIS . 2.3 p-10 -106.52 4.87 28.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.884 0.373 . . . . 0.0 111.098 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 386' ' ' LYS . . . . . 0.4 ' HB3' ' HB2' ' A' ' 400' ' ' PRO . 46.3 mmtm -114.62 150.01 35.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.217 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 32.5 p-80 -131.78 148.79 52.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.019 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' TRP . . . . . 0.461 ' HZ3' ' HB3' ' A' ' 383' ' ' LYS . 27.1 m-90 -123.6 132.81 53.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.066 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 21.8 t -112.86 124.6 69.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -117.48 128.68 55.23 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -94.73 89.21 5.63 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 392' ' ' GLU . . . . . 0.46 ' HA ' ' HE2' ' A' ' 379' ' ' PHE . 76.9 mm-40 68.98 -80.41 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.409 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -136.05 11.47 3.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.089 0.471 . . . . 0.0 110.902 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 19.3 m -120.82 129.29 53.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.876 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 33.8 tp -76.07 142.04 41.87 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.961 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -69.14 148.49 97.65 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.392 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.41 133.64 19.47 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.9 2.4 . . . . 0.0 112.584 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 87.29 52.81 2.95 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.4 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' TYR . . . . . 0.432 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 25.4 m-85 -143.62 162.66 40.59 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.432 ' HA ' ' HB3' ' A' ' 399' ' ' TYR . 83.3 Cg_endo -80.4 165.32 77.96 Favored 'Cis proline' 0 C--N 1.347 0.489 0 C-N-CA 123.633 -1.403 . . . . 0.0 112.934 0.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -132.48 168.11 18.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.987 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 0.52 ' HA ' ' O ' ' A' ' 385' ' ' ASP . 5.4 m80 -68.82 156.36 38.53 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 123.236 0.335 . . . . 0.0 110.499 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 52.8 mt -55.84 -36.53 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.111 0.482 . . . . 0.0 110.879 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.416 ' HG2' ' HB2' ' A' ' 402' ' ' HIS . 22.8 pttp -65.43 -14.48 61.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.127 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -80.62 -22.06 40.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.318 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 40.6 tp -82.69 -48.21 11.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.99 0.424 . . . . 0.0 110.234 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.531 ' HA3' ' CE1' ' A' ' 438' ' ' PHE . . . -151.18 140.54 7.93 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.919 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 408' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 408' ' ' ARG . 0.1 OUTLIER -79.67 126.32 30.77 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.0 0.429 . . . . 0.0 110.714 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 110.77 -1.83 28.89 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.052 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 88.6 mt -83.72 150.18 58.75 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.496 0.189 . . . . 0.0 110.562 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.0 140.86 92.35 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.697 2.265 . . . . 0.0 111.871 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.14 -5.94 39.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.812 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.499 ' OD2' ' HD3' ' A' ' 431' ' ' ARG . 8.5 p-10 -79.27 -57.69 3.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.494 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -179.39 176.68 0.81 Allowed 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.823 0.344 . . . . 0.0 110.421 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 44.7 mm -124.55 134.64 66.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -89.4 -54.31 4.15 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.283 0.563 . . . . 0.0 110.206 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 417' ' ' ALA . . . . . 0.729 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -150.84 155.93 40.2 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.978 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -139.14 121.51 16.03 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 35.2 tp -113.97 123.8 50.6 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.421 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -90.97 113.38 25.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.67 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 421' ' ' TRP . . . . . 0.487 ' HB2' ' HE2' ' A' ' 428' ' ' TYR . 19.2 t-105 -80.42 99.04 7.78 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 67.0 mtt -54.62 -49.41 91.4 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -47.54 -61.41 0.6 Allowed 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 122.557 2.171 . . . . 0.0 114.501 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 424' ' ' ASN . . . . . 0.428 ' H ' ' HD1' ' A' ' 421' ' ' TRP . 52.0 p30 -85.8 -24.9 26.61 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 83.56 47.43 5.67 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.514 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -131.49 152.58 50.6 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.8 m -106.24 126.55 52.36 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.141 0.496 . . . . 0.0 111.754 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 428' ' ' TYR . . . . . 0.487 ' HE2' ' HB2' ' A' ' 421' ' ' TRP . 95.6 m-85 -100.65 113.15 25.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.019 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 429' ' ' PHE . . . . . 0.448 ' HB2' ' HB2' ' A' ' 436' ' ' TYR . 46.4 m-85 -94.93 121.79 36.9 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.394 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -99.88 130.38 46.06 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.783 0.325 . . . . 0.0 110.929 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.499 ' HD3' ' OD2' ' A' ' 413' ' ' ASP . 3.1 tpm_? -141.75 98.7 3.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.829 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 67.79 -116.81 8.1 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.561 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -101.64 8.45 41.7 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 434' ' ' LYS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 450' ' ' PRO . 65.9 mmtt -128.72 149.38 50.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.815 0.341 . . . . 0.0 111.195 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 435' ' ' TYR . . . . . 0.437 ' CE2' ' HE2' ' A' ' 449' ' ' TYR . 9.1 p90 -126.43 144.41 50.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.468 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 436' ' ' TYR . . . . . 0.448 ' HB2' ' HB2' ' A' ' 429' ' ' PHE . 26.6 m-85 -109.5 143.41 39.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.879 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -103.84 93.77 5.06 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 438' ' ' PHE . . . . . 0.531 ' CE1' ' HA3' ' A' ' 407' ' ' GLY . 76.5 t80 -82.79 129.57 35.0 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.533 -178.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -103.65 108.3 19.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.102 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 440' ' ' GLU . . . . . 0.507 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 4.1 mm-40 -54.98 -47.59 74.38 Favored 'General case' 0 C--O 1.231 0.115 0 O-C-N 123.486 0.491 . . . . 0.0 112.159 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -62.55 -32.71 73.71 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 68.2 mt -94.99 -10.94 29.46 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 443' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 443' ' ' ARG . 3.5 mmm180 58.07 29.32 17.64 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 123.32 0.387 . . . . 0.0 111.523 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -154.38 174.12 15.28 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.331 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.8 t -90.31 144.11 9.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.863 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -67.8 164.16 20.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.894 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.38 163.96 26.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.047 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 71.83 8.93 6.15 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.167 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 449' ' ' TYR . . . . . 0.449 ' HB3' ' HA ' ' A' ' 450' ' ' PRO . 31.6 m-85 -113.71 163.63 18.1 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.693 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 450' ' ' PRO . . . . . 0.473 ' HB2' ' HB3' ' A' ' 434' ' ' LYS . 66.1 Cg_endo -72.32 157.06 98.15 Favored 'Cis proline' 0 C--N 1.348 0.514 0 C-N-CA 123.631 -1.404 . . . . 0.0 112.301 -0.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -115.32 170.19 8.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.907 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -60.75 128.22 35.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.316 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 11.6 tt -66.74 -14.58 18.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.113 0.482 . . . . 0.0 111.347 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -69.89 3.7 2.47 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 39.1 t -66.6 -32.55 58.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 456' ' ' TRP . . . . . 0.412 ' HE3' ' CZ ' ' A' ' 486' ' ' PHE . 16.7 m95 -88.27 84.06 6.89 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.32 110.21 0.38 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.718 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 119.42 -23.67 8.4 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.173 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 43.7 mm -86.07 127.87 60.12 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.845 0.355 . . . . 0.0 111.383 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -85.49 162.49 11.01 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.809 2.339 . . . . 0.0 111.421 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -71.11 153.94 42.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.533 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 10.5 m 58.1 72.68 0.84 Allowed Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 115.591 -0.732 . . . . 0.0 112.942 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -82.52 176.51 7.83 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.093 2.529 . . . . 0.0 111.859 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 8.7 tpp85 -142.51 23.24 1.97 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.318 0.58 . . . . 0.0 110.472 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 172.97 142.03 3.68 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 12.3 p -165.43 101.42 0.72 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.728 0.299 . . . . 0.0 110.686 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -132.96 138.42 46.89 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.079 0.466 . . . . 0.0 111.656 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 40.0 ttm -93.65 135.9 34.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.526 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -68.2 163.62 48.2 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.391 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.93 -9.13 26.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.169 0.509 . . . . 0.0 111.605 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -84.99 -15.24 44.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.144 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 64.47 11.57 6.67 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 57.8 t -110.48 -40.69 4.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.921 0.391 . . . . 0.0 110.908 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -105.26 126.51 52.17 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 93.7 m -114.2 130.71 56.62 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -105.55 124.35 49.4 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.228 0.537 . . . . 0.0 112.389 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -105.55 152.35 23.17 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.971 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -131.82 137.59 48.17 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.514 0.197 . . . . 0.0 111.306 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 479' ' ' LYS . . . . . 0.403 ' HB3' ' CZ3' ' A' ' 484' ' ' TRP . 58.7 tttt -168.61 120.04 0.78 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.65 178.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 64.17 48.0 79.36 Favored Glycine 0 N--CA 1.453 -0.226 0 N-CA-C 114.561 0.584 . . . . 0.0 114.561 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 481' ' ' ASN . . . . . 0.568 ' OD1' ' HG ' ' A' ' 502' ' ' LEU . 66.5 t30 67.94 0.93 2.53 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 482' ' ' LYS . . . . . 0.543 ' HB3' ' HB2' ' A' ' 498' ' ' PRO . 41.5 mtmt -115.9 152.37 33.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.173 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 483' ' ' TYR . . . . . 0.475 ' CE2' ' HE2' ' A' ' 497' ' ' TYR . 32.6 p90 -126.12 152.23 46.19 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.892 0.377 . . . . 0.0 111.523 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 484' ' ' TRP . . . . . 0.494 ' HD1' HG11 ' A' ' 493' ' ' VAL . 18.5 m-90 -117.98 140.43 49.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.757 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -100.38 94.59 6.25 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 486' ' ' PHE . . . . . 0.412 ' CZ ' ' HE3' ' A' ' 456' ' ' TRP . 68.1 t80 -88.59 123.57 33.2 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.054 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 487' ' ' ASN . . . . . 0.407 ' ND2' ' HD3' ' A' ' 490' ' ' LYS . 40.1 t-20 -91.99 114.16 26.63 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -62.21 -33.02 73.76 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -76.06 -26.66 56.75 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 490' ' ' LYS . . . . . 0.407 ' HD3' ' ND2' ' A' ' 487' ' ' ASN . 55.4 mtpt -101.3 -16.91 16.78 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 10.7 tp 58.56 38.53 25.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.726 0.774 . . . . 0.0 110.25 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -156.41 152.6 27.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.595 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 493' ' ' VAL . . . . . 0.494 HG11 ' HD1' ' A' ' 484' ' ' TRP . 75.4 t -77.95 136.65 23.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.802 0.334 . . . . 0.0 110.585 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -62.93 146.35 95.47 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.284 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.98 155.68 66.77 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.571 2.18 . . . . 0.0 112.129 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 89.57 14.43 59.87 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.273 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 497' ' ' TYR . . . . . 0.686 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 66.3 m-85 -121.18 167.07 14.06 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 498' ' ' PRO . . . . . 0.686 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 76.8 Cg_endo -75.64 168.32 77.69 Favored 'Cis proline' 0 C--N 1.349 0.589 0 C-N-CA 123.905 -1.29 . . . . 0.0 113.016 0.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -123.39 169.67 11.11 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.945 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 39.9 t -79.24 117.57 20.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.777 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.02 -27.04 64.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.917 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 502' ' ' LEU . . . . . 0.568 ' HG ' ' OD1' ' A' ' 481' ' ' ASN . 14.2 mt -65.0 -48.33 74.34 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.195 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -79.68 -42.98 23.58 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -76.45 -54.31 6.91 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -177.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -79.36 -61.03 2.13 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 7.2 mmt -66.57 -37.68 85.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.976 0.417 . . . . 0.0 111.479 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 94.63 22.68 23.29 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.705 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 18.8 m -83.48 124.18 75.9 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-O 120.614 0.245 . . . . 0.0 110.465 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.86 156.04 61.19 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.812 2.342 . . . . 0.0 112.842 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 4.0 m 70.77 -70.23 0.16 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.466 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.327 0 CA-C-O 118.365 -1.241 . . . . 0.0 111.23 -179.487 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.731 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' PRO . . . . . 0.415 ' HA ' HD23 ' B' ' 2' ' ' HYP . 66.8 Cg_endo -74.48 153.32 44.46 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.673 2.249 . . . . 0.0 112.256 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 2' ' ' HYP . . . . . 0.415 HD23 ' HA ' ' B' ' 1' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.18 174.12 53.52 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.947 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.33 164.86 30.31 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.782 2.321 . . . . 0.0 111.237 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 6' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' D' ' 204' ' ' PRO . . . -75.79 -176.31 39.96 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.467 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.706 ' HG2' ' HA ' ' D' ' 205' ' ' HYP . 12.0 Cg_endo -56.51 163.27 7.01 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 122.979 2.452 . . . . 0.0 111.675 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' HYP . . . . . 0.443 ' O ' ' HA3' ' D' ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 149.58 175.87 22.26 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.094 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.78 141.47 65.74 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.848 2.366 . . . . 0.0 111.545 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -68.47 144.7 54.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.213 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' D' ' 210' ' ' PRO . . . -61.24 154.16 37.9 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.806 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.463 ' O ' ' HG3' ' D' ' 211' ' ' GLN . 1.4 mp -67.59 148.94 11.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.34 151.23 46.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.362 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' D' ' 213' ' ' ILE . . . -69.84 157.03 53.54 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.332 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -72.51 148.44 45.04 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -66.08 148.34 51.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 0.0 110.825 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' D' ' 216' ' ' GLN . . . -67.44 159.88 49.84 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.996 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.6 t -70.78 153.72 8.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.626 0.251 . . . . 0.0 110.481 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 11.9 t -58.95 145.47 10.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.454 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.87 161.51 52.89 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.127 -0.559 . . . . 0.0 113.062 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 95.9 mt -73.49 152.16 40.8 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.573 -0.158 . . . . 0.0 110.573 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.9 158.99 51.72 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.233 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.414 ' HA ' HD23 ' B' ' 26' ' ' HYP . 60.8 Cg_endo -73.63 153.54 49.1 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 122.653 2.236 . . . . 0.0 111.709 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' HYP . . . . . 0.414 HD23 ' HA ' ' B' ' 25' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.07 161.24 50.0 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.444 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.453 ' HA ' HD23 ' B' ' 29' ' ' HYP . 49.8 Cg_endo -69.68 155.42 66.25 Favored 'Trans proline' 0 C--O 1.237 0.441 0 C-N-CA 122.515 2.143 . . . . 0.0 111.482 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' HYP . . . . . 0.453 HD23 ' HA ' ' B' ' 28' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.03 168.61 36.9 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.982 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -73.58 166.55 29.53 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 123.053 2.502 . . . . 0.0 111.507 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.73 178.24 50.83 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.94 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -79.23 154.18 24.88 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 123.162 2.575 . . . . 0.0 111.804 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.659 -0.176 . . . . 0.0 112.659 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 101' ' ' PRO . . . . . 0.469 ' HA ' HD23 ' C' ' 102' ' ' HYP . 12.8 Cg_exo -71.74 124.94 10.63 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.932 2.421 . . . . 0.0 111.931 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 102' ' ' HYP . . . . . 0.469 HD23 ' HA ' ' C' ' 101' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.43 173.28 46.75 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.206 -0.521 . . . . 0.0 113.281 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -88.5 163.87 6.59 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 123.156 2.57 . . . . 0.0 112.367 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 105' ' ' HYP . . . . . 0.476 ' OD1' ' HG2' ' D' ' 204' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -77.9 -175.92 45.0 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.22 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.93 152.76 28.62 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.647 2.232 . . . . 0.0 111.052 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 108' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -60.48 172.18 6.29 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.388 -0.824 . . . . 0.0 113.567 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -61.5 154.1 61.76 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 123.042 2.495 . . . . 0.0 113.109 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -62.79 137.52 58.29 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.617 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.24 154.74 44.23 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.34 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 41.4 mt -70.4 137.56 23.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 122.762 -0.258 . . . . 0.0 110.363 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.1 147.48 47.3 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.526 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -65.19 155.95 48.53 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.843 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -82.72 158.67 22.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.651 0.262 . . . . 0.0 110.573 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -64.69 145.18 56.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.399 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.59 172.78 34.87 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.669 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 30.3 t -67.78 141.78 17.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.642 0.258 . . . . 0.0 110.81 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 120' ' ' VAL . . . . . 0.41 HG13 ' HB ' ' D' ' 219' ' ' VAL . 60.5 t -62.69 139.08 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.967 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.18 158.06 39.05 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 121.203 -0.523 . . . . 0.0 112.68 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 122' ' ' LEU . . . . . 0.47 ' HA ' HD23 ' C' ' 123' ' ' HYP . 97.1 mt -77.28 142.1 39.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.553 0.216 . . . . 0.0 110.546 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 123' ' ' HYP . . . . . 0.47 HD23 ' HA ' ' C' ' 122' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -65.1 165.41 34.75 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.455 -0.793 . . . . 0.0 113.252 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -74.98 158.17 42.42 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.8 2.333 . . . . 0.0 111.832 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 126' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -68.02 162.82 48.47 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.525 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.61 159.4 51.19 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.523 2.149 . . . . 0.0 110.742 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -67.48 -178.16 11.55 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.983 -0.627 . . . . 0.0 114.34 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 131' ' ' PRO . . . . . 0.452 ' HA ' HD23 ' C' ' 132' ' ' HYP . 14.4 Cg_exo -71.7 153.71 59.44 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 123.611 2.874 . . . . 0.0 111.926 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 132' ' ' HYP . . . . . 0.452 HD23 ' HA ' ' C' ' 131' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 133' ' ' GLY . . . . . 0.429 ' HA2' ' HD3' ' C' ' 134' ' ' PRO . . . -66.04 115.68 7.74 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 121.14 -0.553 . . . . 0.0 112.113 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 134' ' ' PRO . . . . . 0.469 ' HA ' HD23 ' C' ' 135' ' ' HYP . 20.6 Cg_exo -67.11 112.08 2.42 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 123.104 2.536 . . . . 0.0 112.061 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 135' ' ' HYP . . . . . 0.469 HD23 ' HA ' ' C' ' 134' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.49 0 CA-C-O 120.01 -0.328 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 201' ' ' PRO . . . . . 0.487 ' HA ' HD23 ' D' ' 202' ' ' HYP . 64.9 Cg_exo -55.45 151.19 38.61 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.302 2.668 . . . . 0.0 112.069 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 202' ' ' HYP . . . . . 0.487 HD23 ' HA ' ' D' ' 201' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 79.84 -177.6 54.21 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.013 -0.613 . . . . 0.0 114.102 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 204' ' ' PRO . . . . . 0.476 ' HG2' ' OD1' ' C' ' 105' ' ' HYP . 11.3 Cg_exo -74.94 169.28 22.96 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.907 3.072 . . . . 0.0 112.172 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 205' ' ' HYP . . . . . 0.706 ' HA ' ' HG2' ' B' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 206' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' B' ' 8' ' ' HYP . . . 92.89 170.73 40.19 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.404 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -90.61 156.74 4.3 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.905 3.07 . . . . 0.0 112.281 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 208' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -82.88 167.6 46.2 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.715 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 210' ' ' PRO . . . . . 0.502 ' O ' ' HA3' ' B' ' 12' ' ' GLY . 11.6 Cg_exo -70.04 156.42 62.66 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 122.762 2.308 . . . . 0.0 112.341 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 211' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' B' ' 13' ' ' ILE . 24.8 tt0 -76.61 147.15 37.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.441 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -69.2 165.31 49.4 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.35 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 213' ' ' ILE . . . . . 0.505 ' O ' ' HA3' ' B' ' 15' ' ' GLY . 10.8 pt -69.34 168.19 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 120.775 0.322 . . . . 0.0 111.141 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -83.18 146.46 28.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.951 0.405 . . . . 0.0 111.043 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -66.12 160.66 45.48 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.908 -0.587 . . . . 0.0 113.453 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 216' ' ' GLN . . . . . 0.481 ' O ' ' HA3' ' B' ' 18' ' ' GLY . 39.9 mm-40 -75.75 160.48 29.98 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -71.52 152.68 42.79 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -62.42 154.67 41.44 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.01 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 219' ' ' VAL . . . . . 0.41 ' HB ' HG13 ' C' ' 120' ' ' VAL . 10.7 t -62.28 142.43 16.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 30.8 t -61.45 137.91 22.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.258 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -59.37 154.56 29.81 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.673 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 5.6 mp -75.2 158.19 33.37 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.479 0.181 . . . . 0.0 110.813 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 223' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -71.81 156.3 52.51 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.652 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 225' ' ' PRO . . . . . 0.407 ' HA ' HD23 ' D' ' 226' ' ' HYP . 15.4 Cg_exo -69.8 154.58 67.42 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.796 2.33 . . . . 0.0 111.811 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 226' ' ' HYP . . . . . 0.407 HD23 ' HA ' ' D' ' 225' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.96 163.31 29.85 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.705 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.97 160.21 33.78 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.64 2.226 . . . . 0.0 111.34 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -67.54 -176.72 9.57 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.881 -0.6 . . . . 0.0 113.973 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.26 168.98 22.16 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.937 2.424 . . . . 0.0 112.145 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 232' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo . . . . . 0 N--CA 1.48 0.727 0 N-CA-C 109.68 -0.931 . . . . 0.0 109.68 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -133.44 159.46 40.29 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 13.8 tt -78.71 -17.62 13.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.263 0.554 . . . . 0.0 110.923 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' CYS . . . . . 0.508 ' HA ' HD22 ' A' ' 502' ' ' LEU . 6.8 m -95.8 14.98 21.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.669 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -60.42 -40.55 91.42 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.039 0.447 . . . . 0.0 111.072 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 98.85 146.92 21.28 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.084 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 23.9 t30 54.81 91.87 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' PHE . . . . . 0.418 ' HD1' ' HD3' ' A' ' 337' ' ' LYS . 47.4 m-85 -91.74 165.59 13.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.289 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -71.45 -41.56 69.28 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.579 HG22 ' HB2' ' A' ' 336' ' ' PHE . 1.2 t -167.6 149.77 5.76 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.354 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 90.6 t -134.33 123.98 44.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -147.88 176.53 10.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.812 0.339 . . . . 0.0 110.903 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 38.3 ttp -128.96 119.98 25.28 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 41.6 mt -119.98 125.89 49.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.301 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 330' ' ' ARG . 5.9 mmp_? 64.1 20.56 12.24 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.521 0.513 . . . . 0.0 111.183 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 91.31 1.44 72.05 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.875 -0.678 . . . . 0.0 111.857 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' GLU . . . . . 0.431 ' CD ' ' HE ' ' A' ' 343' ' ' ARG . 12.0 mm-40 -105.97 124.78 50.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.75 0.31 . . . . 0.0 110.597 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 36.4 ttm -78.67 114.87 17.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.855 0.359 . . . . 0.0 111.109 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -106.37 126.57 52.41 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.14 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 39.2 t -109.48 118.88 57.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.441 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 336' ' ' PHE . . . . . 0.579 ' HB2' HG22 ' A' ' 325' ' ' THR . 81.3 m-85 -104.29 130.54 52.1 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.809 0.338 . . . . 0.0 111.548 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 0.703 ' HB3' ' HZ3' ' A' ' 342' ' ' TRP . 17.7 ttpp -150.94 116.19 5.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.055 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 65.28 -119.96 0.39 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.14 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.3 ptm85 -109.56 13.61 23.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.962 0.411 . . . . 0.0 111.847 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 17.2 m-90 -129.62 152.7 48.85 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.588 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -129.77 147.49 51.55 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.973 0.416 . . . . 0.0 110.866 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 342' ' ' TRP . . . . . 0.703 ' HZ3' ' HB3' ' A' ' 337' ' ' LYS . 26.5 m-90 -119.2 169.26 10.11 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.263 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.431 ' HE ' ' CD ' ' A' ' 332' ' ' GLU . 0.0 OUTLIER -147.45 109.48 4.48 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.111 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.54 HG11 ' HA ' ' A' ' 506' ' ' MET . 1.1 m -99.94 122.88 52.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.105 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 21.1 ttm-85 -117.94 102.12 8.81 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 66.6 t30 66.72 51.87 1.02 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.5 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.537 ' HA ' ' O ' ' A' ' 505' ' ' TRP . 29.8 m-80 69.2 1.7 3.34 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.242 -0.89 . . . . 0.0 113.317 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -118.71 127.73 53.84 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.963 0.411 . . . . 0.0 112.019 -179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 20.0 t -74.24 123.68 30.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.218 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 72.3 mtp -68.29 167.4 14.5 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -74.73 153.64 38.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.712 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 95.23 7.47 59.43 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.887 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 353' ' ' TYR . . . . . 0.43 ' HA ' ' C ' ' A' ' 354' ' ' PRO . 85.8 m-85 -122.71 153.93 63.36 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.43 ' C ' ' HA ' ' A' ' 353' ' ' TYR . 55.2 Cg_endo -70.3 143.32 74.52 Favored 'Cis proline' 0 C--N 1.345 0.349 0 C-N-CA 123.545 -1.44 . . . . 0.0 112.598 0.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 58.0 ttm -116.68 131.83 23.7 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.554 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.7 138.39 82.87 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.588 2.192 . . . . 0.0 111.41 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 78.4 mt -56.57 -46.6 82.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.34 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -73.07 3.04 31.61 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 121.175 -0.536 . . . . 0.0 113.85 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -87.38 -37.2 17.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.326 0.563 . . . . 0.0 110.42 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -106.67 -44.86 4.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.446 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 62.2 m95 -89.8 74.22 7.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.315 0.578 . . . . 0.0 110.122 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -62.23 103.63 0.41 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.173 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 120.98 -14.24 9.64 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.103 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.559 HD12 ' HD2' ' A' ' 365' ' ' PRO . 24.0 tp -93.38 133.85 27.75 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.744 0.306 . . . . 0.0 110.562 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 365' ' ' PRO . . . . . 0.559 ' HD2' HD12 ' A' ' 364' ' ' LEU . 93.9 Cg_endo -82.85 177.62 6.66 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.642 2.228 . . . . 0.0 111.585 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -86.86 160.61 18.68 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.781 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 54.8 m 53.57 79.87 0.12 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 23.0 pt -94.86 -178.63 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.496 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -105.63 -47.0 4.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.724 0.297 . . . . 0.0 111.658 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 370' ' ' THR . . . . . 0.728 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.2 OUTLIER -152.85 163.45 39.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.746 0.308 . . . . 0.0 111.591 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -152.11 142.32 22.36 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 372' ' ' TYR . . . . . 0.636 ' HE1' ' HE1' ' A' ' 382' ' ' PHE . 17.5 p90 -165.07 168.69 17.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.638 0.256 . . . . 0.0 111.546 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -95.09 126.51 40.47 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 374' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 378' ' ' LYS . 13.5 ptm180 -84.7 171.96 11.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.66 0.267 . . . . 0.0 111.005 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.616 ' HB3' ' HG2' ' A' ' 440' ' ' GLU . 84.1 tttt -66.8 -32.33 73.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.999 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -33.16 71.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.407 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 124.57 -20.92 6.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.476 -0.869 . . . . 0.0 113.928 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 378' ' ' LYS . . . . . 0.57 ' HD3' ' HB2' ' A' ' 391' ' ' ASP . 19.8 mttp -90.32 175.27 7.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 117.196 0.498 . . . . 0.0 112.27 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 379' ' ' PHE . . . . . 0.508 ' HE2' ' HA ' ' A' ' 392' ' ' GLU . 22.1 m-85 -99.2 140.29 33.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.318 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 380' ' ' VAL . . . . . 0.477 ' HB ' ' CE1' ' A' ' 372' ' ' TYR . 5.9 t -120.23 122.03 67.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.199 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -108.45 144.55 35.91 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.636 ' HE1' ' HE1' ' A' ' 372' ' ' TYR . 53.6 m-85 -127.5 141.16 51.73 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -151.76 103.56 2.95 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 414' ' ' LYS . . . 76.12 -115.27 4.42 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.268 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -113.95 10.59 17.63 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.791 0.329 . . . . 0.0 111.125 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -116.27 151.46 35.78 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.691 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' HIS . . . . . 0.431 ' CE1' ' HB2' ' A' ' 406' ' ' LEU . 29.8 p-80 -132.88 150.46 52.16 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.604 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 388' ' ' TRP . . . . . 0.438 ' CE2' ' HB3' ' A' ' 400' ' ' PRO . 18.6 m-90 -123.36 137.3 54.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.938 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 69.7 t -117.45 117.37 54.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.049 0.452 . . . . 0.0 109.883 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -113.48 124.68 52.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.731 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.57 ' HB2' ' HD3' ' A' ' 378' ' ' LYS . 24.8 t0 -91.48 84.62 5.57 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 392' ' ' GLU . . . . . 0.508 ' HA ' ' HE2' ' A' ' 379' ' ' PHE . 57.7 mm-40 70.19 -70.25 0.15 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.995 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -143.39 16.06 1.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.921 0.391 . . . . 0.0 110.787 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 1.1 m -126.25 121.07 31.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.787 0.327 . . . . 0.0 111.359 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 52.7 tp -75.34 127.84 34.06 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 2.4 mt-10 -61.65 127.35 88.6 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.655 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 397' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 50.1 Cg_exo -56.44 141.04 90.07 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.059 2.506 . . . . 0.0 112.368 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 92.53 16.26 49.99 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.252 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 399' ' ' TYR . . . . . 0.444 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 19.4 m-85 -112.66 163.21 18.46 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 110.712 -0.107 . . . . 0.0 110.712 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.444 ' HA ' ' HB3' ' A' ' 399' ' ' TYR . 74.5 Cg_endo -76.47 169.43 74.48 Favored 'Cis proline' 0 C--N 1.347 0.491 0 C-N-CA 123.682 -1.382 . . . . 0.0 112.678 0.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -131.6 166.6 21.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.492 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 0.739 ' HB2' ' HG2' ' A' ' 405' ' ' GLU . 16.9 m-70 -71.47 154.79 41.25 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 68.9 mt -60.98 -38.2 78.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.205 0.526 . . . . 0.0 109.799 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.549 ' HB3' HG23 ' A' ' 412' ' ' THR . 50.2 pttt -66.7 -17.2 64.73 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.676 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.739 ' HG2' ' HB2' ' A' ' 402' ' ' HIS . 22.1 mm-40 -81.14 -23.79 38.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.921 0.391 . . . . 0.0 110.659 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 406' ' ' LEU . . . . . 0.431 ' HB2' ' CE1' ' A' ' 387' ' ' HIS . 49.0 tp -77.0 -43.87 33.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.08 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.444 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -155.91 146.23 13.73 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.852 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -77.24 126.31 30.73 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.625 0.25 . . . . 0.0 110.537 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.31 -0.93 46.76 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.383 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 40.6 mt -77.27 149.65 79.36 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 120.399 0.142 . . . . 0.0 111.025 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 411' ' ' PRO . . . . . 0.451 ' HG3' ' CE1' ' A' ' 436' ' ' TYR . 32.0 Cg_exo -58.96 112.53 1.24 Allowed 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.987 2.458 . . . . 0.0 112.201 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 412' ' ' THR . . . . . 0.549 HG23 ' HB3' ' A' ' 404' ' ' LYS . 0.0 OUTLIER -86.4 37.59 0.74 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.058 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -134.58 -56.7 0.84 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.271 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 414' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 384' ' ' GLY . 10.8 ptmt -173.32 166.41 4.8 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 122.335 0.254 . . . . 0.0 110.506 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 38.9 mm -121.85 130.37 74.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -86.47 -45.39 11.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.367 0.604 . . . . 0.0 109.678 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 417' ' ' ALA . . . . . 0.728 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -158.15 157.57 32.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.745 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -141.64 123.61 15.38 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.444 ' HB2' ' HB2' ' A' ' 466' ' ' SER . 28.2 tp -120.62 134.67 55.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.297 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -106.46 117.11 33.17 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.359 -0.382 . . . . 0.0 109.982 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 421' ' ' TRP . . . . . 0.714 ' HB2' ' HE1' ' A' ' 428' ' ' TYR . 4.5 t-105 -86.09 98.91 11.13 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.545 ' HB2' ' HD3' ' A' ' 423' ' ' PRO . 66.8 mtt -57.31 -52.49 73.87 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -178.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.545 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 68.2 Cg_exo -53.23 -27.88 39.9 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.839 2.359 . . . . 0.0 115.301 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 424' ' ' ASN . . . . . 0.626 ' OD1' ' HB3' ' A' ' 421' ' ' TRP . 23.1 p-10 -112.93 -24.49 9.5 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 83.49 38.15 11.2 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.213 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -122.95 146.68 47.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.756 0.313 . . . . 0.0 110.737 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 427' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' A' ' 438' ' ' PHE . 7.1 m -107.05 129.35 54.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.513 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 428' ' ' TYR . . . . . 0.714 ' HE1' ' HB2' ' A' ' 421' ' ' TRP . 86.0 m-85 -108.36 117.47 34.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.911 0.386 . . . . 0.0 111.02 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 429' ' ' PHE . . . . . 0.448 ' HB2' ' HB2' ' A' ' 436' ' ' TYR . 53.4 m-85 -101.79 122.47 44.03 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.745 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -98.94 129.03 45.24 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.973 0.416 . . . . 0.0 111.535 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -139.2 103.71 4.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.409 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 67.21 -110.76 3.65 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.124 -0.791 . . . . 0.0 111.124 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -115.89 16.25 16.22 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.098 0.475 . . . . 0.0 110.236 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -119.17 145.96 45.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.115 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 435' ' ' TYR . . . . . 0.481 ' CE1' ' HB2' ' A' ' 451' ' ' LYS . 5.4 p90 -125.48 131.44 52.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.966 0.412 . . . . 0.0 110.679 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 436' ' ' TYR . . . . . 0.451 ' CE1' ' HG3' ' A' ' 411' ' ' PRO . 14.3 m-85 -102.71 148.1 26.01 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.947 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -114.19 98.0 6.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.313 0.578 . . . . 0.0 109.457 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 438' ' ' PHE . . . . . 0.556 ' HB3' ' HB ' ' A' ' 427' ' ' THR . 78.8 t80 -81.73 134.32 35.44 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.649 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -104.72 103.49 13.13 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.882 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 440' ' ' GLU . . . . . 0.616 ' HG2' ' HB3' ' A' ' 375' ' ' LYS . 5.4 tp10 -48.94 -45.33 41.62 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -179.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -53.85 -66.26 0.42 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 74.2 mt -75.72 -14.83 60.34 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 443' ' ' ARG . . . . . 0.425 ' O ' ' HA2' ' A' ' 407' ' ' GLY . 22.6 mtp180 60.37 48.41 7.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.695 0.76 . . . . 0.0 110.782 -178.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -156.43 161.7 40.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.105 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 74.4 t -81.81 141.85 14.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -60.12 160.85 7.58 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.373 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.3 m -68.32 151.81 46.36 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.671 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 69.06 30.81 4.31 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.064 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -125.43 159.12 61.76 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.645 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -80.43 166.8 75.22 Favored 'Cis proline' 0 C--N 1.342 0.23 0 C-N-CA 123.504 -1.457 . . . . 0.0 112.592 0.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 451' ' ' LYS . . . . . 0.481 ' HB2' ' CE1' ' A' ' 435' ' ' TYR . 64.5 mttm -116.42 171.32 7.91 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.338 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -71.68 146.68 48.08 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.643 0.259 . . . . 0.0 110.651 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.1 tt -70.44 -8.41 10.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.83 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 454' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 454' ' ' LYS . 66.1 mmtt -60.68 -12.08 9.31 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.76 -31.96 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 456' ' ' TRP . . . . . 0.431 ' HB2' ' HB ' ' A' ' 459' ' ' ILE . 24.4 m95 -89.36 95.34 10.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.026 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.49 105.75 1.26 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 110.9 -4.31 28.91 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.044 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 456' ' ' TRP . 30.6 mm -91.93 128.03 47.36 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-O 121.096 0.474 . . . . 0.0 111.391 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 460' ' ' PRO . . . . . 0.451 ' HG3' ' CH2' ' A' ' 484' ' ' TRP . 88.5 Cg_endo -79.08 158.19 26.84 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.853 2.369 . . . . 0.0 111.699 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 30.0 mp0 -80.1 148.62 30.93 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.425 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.9 m 55.45 69.4 1.97 Allowed Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.1 -175.9 2.6 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.339 2.026 . . . . 0.0 111.773 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 7.2 tpp85 -144.65 32.63 1.16 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.338 0.589 . . . . 0.0 110.328 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 167.51 140.7 2.97 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 466' ' ' SER . . . . . 0.444 ' HB2' ' HB2' ' A' ' 419' ' ' LEU . 5.7 p -161.94 101.22 1.13 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.948 0.404 . . . . 0.0 109.959 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -130.19 135.56 48.3 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.047 0.451 . . . . 0.0 111.344 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 468' ' ' MET . . . . . 0.47 ' HA ' ' HA ' ' A' ' 475' ' ' THR . 47.3 ttm -86.96 142.3 28.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.954 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -71.8 164.59 54.13 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.911 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.54 -12.66 54.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.09 0.471 . . . . 0.0 111.587 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -83.17 -17.07 44.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.637 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 68.05 5.74 4.78 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 122.9 0.48 . . . . 0.0 111.911 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 35.1 t -104.5 -32.71 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.877 0.37 . . . . 0.0 111.13 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -117.8 138.05 52.33 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 475' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 468' ' ' MET . 90.6 m -120.82 133.08 55.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.409 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -104.8 129.58 53.06 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.197 0.522 . . . . 0.0 112.117 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -110.99 146.72 36.17 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.316 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -126.74 137.83 53.29 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -162.16 107.03 1.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.964 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 60.0 57.66 18.17 Favored Glycine 0 C--N 1.331 0.258 0 CA-C-N 115.998 -0.547 . . . . 0.0 113.401 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 481' ' ' ASN . . . . . 0.417 ' OD1' ' HG ' ' A' ' 502' ' ' LEU . 18.3 t30 73.24 -33.72 0.27 Allowed 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 482' ' ' LYS . . . . . 0.629 ' HB3' ' HB2' ' A' ' 498' ' ' PRO . 24.1 mtmt -78.66 136.54 37.49 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.048 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 483' ' ' TYR . . . . . 0.48 ' CE1' ' HB2' ' A' ' 499' ' ' LYS . 5.4 p90 -121.5 149.03 43.68 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.079 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 484' ' ' TRP . . . . . 0.471 ' CE2' ' HB3' ' A' ' 498' ' ' PRO . 23.0 m-90 -117.82 149.39 40.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.46 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -115.25 99.92 7.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.202 0.525 . . . . 0.0 109.787 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 486' ' ' PHE . . . . . 0.432 ' HA ' ' HA ' ' A' ' 493' ' ' VAL . 58.2 t80 -88.54 127.57 35.54 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.26 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -88.1 111.93 22.11 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -66.17 -23.94 66.56 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 36.4 tp60 -86.04 -25.95 25.63 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.902 0.382 . . . . 0.0 111.614 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -104.72 -14.47 15.55 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.0 tp 61.77 39.85 13.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.478 0.656 . . . . 0.0 110.189 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 51.3 tttt -154.23 148.97 26.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.589 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 493' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 486' ' ' PHE . 69.9 t -79.26 138.43 20.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.666 0.27 . . . . 0.0 110.401 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -62.21 153.03 76.83 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.161 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -75.56 150.94 36.5 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.749 2.3 . . . . 0.0 113.024 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 98.14 5.06 57.39 Favored Glycine 0 C--N 1.331 0.282 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.327 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 497' ' ' TYR . . . . . 0.737 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 67.6 m-85 -106.55 167.24 9.84 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 110.666 -0.124 . . . . 0.0 110.666 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 498' ' ' PRO . . . . . 0.737 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 87.6 Cg_endo -79.26 167.71 75.72 Favored 'Cis proline' 0 C--N 1.345 0.38 0 C-N-CA 123.72 -1.367 . . . . 0.0 112.756 0.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 499' ' ' LYS . . . . . 0.48 ' HB2' ' CE1' ' A' ' 483' ' ' TYR . 33.0 mtpt -125.73 154.82 41.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.988 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 2.7 m -72.36 111.95 8.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.494 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -62.23 -27.06 68.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.521 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 502' ' ' LEU . . . . . 0.508 HD22 ' HA ' ' A' ' 319' ' ' CYS . 36.3 mt -56.07 -44.23 78.72 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.58 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -89.28 -37.79 14.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.354 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.01 -39.51 83.18 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 505' ' ' TRP . . . . . 0.537 ' O ' ' HA ' ' A' ' 347' ' ' ASN . 15.4 m0 -122.02 -45.69 2.24 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 506' ' ' MET . . . . . 0.54 ' HA ' HG11 ' A' ' 344' ' ' VAL . 10.5 mmt -64.87 -29.01 69.94 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 86.98 28.21 26.5 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.898 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 508' ' ' CYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 509' ' ' PRO . 32.4 m -103.01 106.63 51.72 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 508' ' ' CYS . 6.2 Cg_exo -79.72 171.93 14.94 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 123.074 2.516 . . . . 0.0 111.59 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 5.3 m 60.55 52.1 4.76 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.375 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.369 -1.239 . . . . 0.0 111.562 179.783 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.611 0 N-CA-C 111.864 -0.494 . . . . 0.0 111.864 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' PRO . . . . . 0.454 ' HA ' HD23 ' B' ' 2' ' ' HYP . 56.9 Cg_endo -71.09 154.0 62.55 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.769 2.313 . . . . 0.0 111.793 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 2' ' ' HYP . . . . . 0.576 ' HA ' ' HB2' ' C' ' 101' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' D' ' 201' ' ' PRO . . . -89.84 172.49 38.83 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.333 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.584 ' HG2' ' HA ' ' D' ' 202' ' ' HYP . 73.5 Cg_endo -74.21 162.24 39.03 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.799 2.333 . . . . 0.0 111.782 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 6' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' D' ' 204' ' ' PRO . . . -72.15 173.02 46.3 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.367 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.577 ' HG2' ' HA ' ' D' ' 205' ' ' HYP . 19.0 Cg_endo -59.78 162.7 15.07 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.784 2.322 . . . . 0.0 111.484 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 8' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 130.63 -175.02 19.55 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.395 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' D' ' 208' ' ' HYP . 8.0 Cg_exo -74.54 144.32 31.91 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.183 2.589 . . . . 0.0 111.785 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -73.6 148.79 42.57 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' D' ' 210' ' ' PRO . . . -61.72 153.52 40.66 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.459 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.521 ' O ' ' HG3' ' D' ' 211' ' ' GLN . 13.1 mt -70.88 150.06 9.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' C' ' 113' ' ' ILE . . . -63.29 149.2 46.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.378 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 15' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' D' ' 213' ' ' ILE . . . -66.67 170.26 32.36 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.219 -0.515 . . . . 0.0 113.293 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -72.62 141.78 48.35 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' B' ' 17' ' ' ARG . 0.0 OUTLIER -65.58 141.18 58.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.645 -179.69 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.02 150.3 40.12 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.763 -0.653 . . . . 0.0 113.139 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 5.3 t -71.65 146.29 11.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 45.6 t -55.43 144.95 6.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.09 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.1 162.86 51.31 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.159 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 86.1 mt -77.28 154.38 32.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.619 -0.291 . . . . 0.0 110.429 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.22 157.55 52.57 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.508 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.412 ' HA ' HD23 ' B' ' 26' ' ' HYP . 46.6 Cg_endo -69.68 154.13 68.43 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.722 2.281 . . . . 0.0 111.835 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' HYP . . . . . 0.412 HD23 ' HA ' ' B' ' 25' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.42 156.11 51.86 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.532 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.418 ' HA ' HD23 ' B' ' 29' ' ' HYP . 55.2 Cg_endo -70.32 157.11 60.33 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.695 2.263 . . . . 0.0 112.06 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' HYP . . . . . 0.418 HD23 ' HA ' ' B' ' 28' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.27 178.09 51.89 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.959 -0.638 . . . . 0.0 113.164 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.51 ' HD2' ' HA ' ' D' ' 229' ' ' HYP . 11.8 Cg_exo -72.53 155.95 54.44 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.217 2.611 . . . . 0.0 111.493 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 32' ' ' HYP . . . . . 0.443 HD23 ' HA ' ' B' ' 31' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' GLY . . . . . 0.472 ' HA2' ' HD3' ' B' ' 34' ' ' PRO . . . -65.37 154.15 50.46 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.769 -0.65 . . . . 0.0 114.217 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' PRO . . . . . 0.472 ' HD3' ' HA2' ' B' ' 33' ' ' GLY . 7.0 Cg_exo -73.84 116.1 4.55 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 123.413 2.742 . . . . 0.0 111.303 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 CA-C-O 119.999 -0.334 . . . . 0.0 112.666 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 101' ' ' PRO . . . . . 0.576 ' HB2' ' HA ' ' B' ' 2' ' ' HYP . 52.2 Cg_exo -56.82 132.24 50.47 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.047 2.498 . . . . 0.0 112.357 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 102' ' ' HYP . . . . . 0.466 ' HA ' ' HD2' ' D' ' 201' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.71 163.67 44.31 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.127 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -81.18 157.07 19.98 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 123.488 2.792 . . . . 0.0 112.313 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 105' ' ' HYP . . . . . 0.423 ' OD1' ' HG2' ' D' ' 204' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -82.79 175.98 53.31 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.476 -0.868 . . . . 0.0 111.53 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 107' ' ' PRO . . . . . 0.429 ' HA ' HD22 ' C' ' 108' ' ' HYP . 55.5 Cg_endo -73.09 130.12 14.99 Favored 'Trans proline' 0 CA--C 1.528 0.203 0 C-N-CA 122.553 2.168 . . . . 0.0 110.65 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 108' ' ' HYP . . . . . 0.429 HD22 ' HA ' ' C' ' 107' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -53.13 167.31 1.23 Allowed Glycine 0 CA--C 1.522 0.53 0 CA-C-N 115.426 -0.806 . . . . 0.0 114.779 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.93 167.6 25.51 Favored 'Trans proline' 0 C--O 1.238 0.475 0 C-N-CA 122.958 2.438 . . . . 0.0 112.345 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -60.76 142.25 56.12 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.124 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -73.74 160.88 53.8 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.892 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 113' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' B' ' 14' ' ' ALA . 33.0 mt -68.45 141.15 17.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.733 0.301 . . . . 0.0 110.713 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.19 153.73 41.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.681 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -63.29 161.18 34.63 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.574 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -84.11 153.83 23.51 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 117' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' C' ' 117' ' ' ARG . 11.8 ttm180 -65.55 141.44 58.45 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.81 168.33 32.47 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.179 -0.534 . . . . 0.0 113.035 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 24.1 t -71.0 140.12 18.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 120' ' ' VAL . . . . . 0.435 HG13 ' HB ' ' D' ' 219' ' ' VAL . 24.2 t -65.77 131.79 31.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.095 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.84 158.73 36.7 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.883 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 13.4 mt -73.55 148.99 42.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.473 0.178 . . . . 0.0 110.885 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 123' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -72.05 164.39 54.33 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.548 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 125' ' ' PRO . . . . . 0.448 ' HA ' HD23 ' C' ' 126' ' ' HYP . 71.5 Cg_endo -75.08 149.98 37.16 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.532 2.155 . . . . 0.0 111.459 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 126' ' ' HYP . . . . . 0.448 HD23 ' HA ' ' C' ' 125' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.93 163.98 36.48 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.627 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -74.86 156.17 43.61 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.551 2.168 . . . . 0.0 111.452 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 130' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' B' ' 31' ' ' PRO . . . -66.97 168.88 36.19 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.862 -0.685 . . . . 0.0 113.139 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 131' ' ' PRO . . . . . 0.422 ' HA ' HD23 ' C' ' 132' ' ' HYP . 24.7 Cg_exo -64.47 153.69 75.69 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.77 2.313 . . . . 0.0 111.306 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 132' ' ' HYP . . . . . 0.491 ' HA ' ' O ' ' D' ' 231' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -83.13 118.76 4.7 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.354 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 134' ' ' PRO . . . . . 0.454 ' HA ' HD23 ' C' ' 135' ' ' HYP . 45.1 Cg_endo -70.72 113.93 3.69 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 122.563 2.175 . . . . 0.0 111.361 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 135' ' ' HYP . . . . . 0.454 HD23 ' HA ' ' C' ' 134' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 201' ' ' PRO . . . . . 0.476 ' O ' ' HA3' ' B' ' 3' ' ' GLY . 42.2 Cg_exo -58.49 146.97 88.63 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.092 2.528 . . . . 0.0 111.774 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 202' ' ' HYP . . . . . 0.584 ' HA ' ' HG2' ' B' ' 4' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 68.82 -178.7 24.51 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 114.713 0.645 . . . . 0.0 114.713 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 204' ' ' PRO . . . . . 0.439 ' O ' ' HA3' ' B' ' 6' ' ' GLY . 11.6 Cg_exo -74.6 166.73 28.72 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 123.593 2.862 . . . . 0.0 111.599 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 205' ' ' HYP . . . . . 0.577 ' HA ' ' HG2' ' B' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 206' ' ' GLY . . . . . 0.4 ' HA2' ' HD3' ' D' ' 207' ' ' PRO . . . 98.69 161.99 30.04 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.476 -0.868 . . . . 0.0 113.219 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 207' ' ' PRO . . . . . 0.454 ' HA ' HD23 ' D' ' 208' ' ' HYP . 1.2 Cg_endo -84.8 154.47 11.59 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 123.51 2.806 . . . . 0.0 112.453 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 208' ' ' HYP . . . . . 0.454 HD23 ' HA ' ' D' ' 207' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -77.82 173.97 54.94 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.345 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 210' ' ' PRO . . . . . 0.536 ' O ' ' HA3' ' B' ' 12' ' ' GLY . 7.1 Cg_exo -72.71 155.22 54.27 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.875 2.383 . . . . 0.0 112.005 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 211' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' B' ' 13' ' ' ILE . 27.3 tt0 -75.46 146.52 40.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.504 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -66.79 163.56 43.96 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.757 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 213' ' ' ILE . . . . . 0.444 ' O ' ' HA3' ' B' ' 15' ' ' GLY . 44.2 pt -69.94 168.47 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 120.858 0.361 . . . . 0.0 111.236 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -74.82 153.6 38.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.478 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -79.68 155.43 39.27 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.907 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -72.3 146.62 47.04 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.573 0.225 . . . . 0.0 110.41 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -65.1 155.47 34.72 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.739 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -65.75 153.99 51.11 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.793 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 219' ' ' VAL . . . . . 0.435 ' HB ' HG13 ' C' ' 120' ' ' VAL . 14.6 t -69.07 149.39 11.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 48.4 t -68.66 141.31 17.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -62.06 161.35 29.22 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.854 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 5.8 mp -67.4 158.0 32.76 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 223' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -61.02 148.7 45.72 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.89 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 225' ' ' PRO . . . . . 0.438 ' HA ' HD23 ' D' ' 226' ' ' HYP . 37.9 Cg_exo -62.98 143.3 90.81 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.626 2.217 . . . . 0.0 111.061 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 226' ' ' HYP . . . . . 0.438 HD23 ' HA ' ' D' ' 225' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 227' ' ' GLY . . . . . 0.412 ' HA2' ' HD3' ' D' ' 228' ' ' PRO . . . -60.84 158.64 28.73 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.985 -0.552 . . . . 0.0 113.747 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 228' ' ' PRO . . . . . 0.412 ' HD3' ' HA2' ' D' ' 227' ' ' GLY . 13.6 Cg_exo -72.37 159.67 48.81 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.14 2.56 . . . . 0.0 111.271 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 229' ' ' HYP . . . . . 0.51 ' HA ' ' HD2' ' B' ' 31' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -67.04 168.9 36.41 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.988 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 231' ' ' PRO . . . . . 0.491 ' O ' ' HA ' ' C' ' 132' ' ' HYP . 92.5 Cg_endo -86.59 160.14 9.33 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.869 2.379 . . . . 0.0 111.689 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 232' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo . . . . . 0 N--CA 1.479 0.655 0 N-CA-C 110.045 -0.79 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -105.82 151.98 23.81 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 21.1 tt -66.58 -31.74 54.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.822 0.344 . . . . 0.0 110.808 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' CYS . . . . . 0.427 ' HA ' HD22 ' A' ' 502' ' ' LEU . 57.7 m -75.72 -0.53 21.17 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.056 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -69.51 -27.24 65.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.87 0.367 . . . . 0.0 110.686 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 84.62 -176.6 51.16 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.951 -0.643 . . . . 0.0 113.121 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 6.4 t30 57.22 77.37 0.27 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.44 0.696 . . . . 0.0 112.671 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -96.9 148.32 23.07 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.661 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 324' ' ' ASP . . . . . 0.411 ' OD1' ' HA ' ' A' ' 337' ' ' LYS . 2.5 m-20 -70.55 -42.4 71.21 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 1.9 t -167.95 155.16 8.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.687 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 72.9 t -133.62 127.89 53.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -144.18 164.75 29.81 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.683 0.278 . . . . 0.0 110.9 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 36.4 ttp -122.14 105.55 10.36 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 28.8 mt -103.5 128.01 50.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.183 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.54 17.59 7.51 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.706 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 95.59 -4.54 66.51 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.184 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -97.49 126.9 43.04 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.613 0.244 . . . . 0.0 110.415 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 39.1 tpp -77.56 117.3 18.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.062 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -113.33 119.95 39.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.047 0.451 . . . . 0.0 110.974 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' VAL . . . . . 0.435 ' HB ' ' HB2' ' A' ' 342' ' ' TRP . 21.1 t -103.24 117.44 48.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -103.99 129.82 51.61 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 0.635 ' HB3' ' HZ3' ' A' ' 342' ' ' TRP . 83.3 tttt -147.13 122.12 10.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.268 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 60.12 -105.82 0.24 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.274 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 339' ' ' ARG . 10.0 ptm85 -125.58 18.63 8.08 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.019 0.437 . . . . 0.0 111.401 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 20.3 m-90 -130.3 152.92 49.19 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.888 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -132.77 141.95 48.77 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.208 0.527 . . . . 0.0 111.62 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 342' ' ' TRP . . . . . 0.635 ' HZ3' ' HB3' ' A' ' 337' ' ' LYS . 24.9 m-90 -111.17 159.54 17.77 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.902 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.37 106.25 6.6 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.428 HG11 ' HA ' ' A' ' 506' ' ' MET . 6.7 m -101.08 142.58 15.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.343 0.592 . . . . 0.0 111.667 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -133.11 100.57 4.91 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.478 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 59.04 67.06 0.96 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.698 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.493 ' HA ' ' O ' ' A' ' 505' ' ' TRP . 4.8 t-20 54.54 43.77 29.77 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -162.54 140.5 8.46 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 26.3 t -91.28 135.04 27.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 24.9 ttt -75.79 151.45 37.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.222 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.94 159.88 32.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.025 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 90.7 2.82 71.94 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' TYR . . . . . 0.566 ' HB3' ' HA ' ' A' ' 354' ' ' PRO . 96.9 m-85 -123.5 162.94 37.46 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.723 -0.239 . . . . 0.0 110.369 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.566 ' HA ' ' HB3' ' A' ' 353' ' ' TYR . 56.6 Cg_endo -70.5 150.94 92.89 Favored 'Cis proline' 0 C--N 1.346 0.412 0 C-N-CA 123.764 -1.348 . . . . 0.0 112.675 -0.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 56.2 ttm -123.29 135.99 26.59 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.66 139.9 88.17 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.45 2.1 . . . . 0.0 110.982 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 77.8 mt -57.14 -45.18 84.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.549 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -70.39 -8.0 61.67 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 121.188 -0.53 . . . . 0.0 114.15 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.61 -24.07 25.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.363 0.581 . . . . 0.0 110.646 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -113.28 -54.4 2.62 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.228 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 68.0 m95 -85.34 79.08 9.62 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.979 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 362' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' A' ' 362' ' ' ARG . 37.3 ttp180 -60.37 101.47 0.13 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.241 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 122.42 -13.07 8.89 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.431 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 14.8 tp -90.0 131.41 39.24 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.783 0.325 . . . . 0.0 111.067 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 365' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -84.13 -167.18 0.42 Allowed 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.937 2.424 . . . . 0.0 112.478 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -93.27 149.15 21.44 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.825 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 8.3 m 58.34 93.92 0.03 OUTLIER 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 22.0 pt -105.54 172.09 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.57 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -98.95 -52.4 3.57 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.673 0.273 . . . . 0.0 111.583 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 370' ' ' THR . . . . . 0.737 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.2 OUTLIER -150.3 165.85 31.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.614 0.245 . . . . 0.0 111.238 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 371' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 380' ' ' VAL . . . -152.59 141.44 21.08 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -156.85 153.26 27.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.885 0.374 . . . . 0.0 111.818 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -96.2 115.38 27.34 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -82.01 172.26 13.46 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -58.29 -30.49 66.68 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.902 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -69.03 -5.94 24.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.567 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 76.94 33.73 44.87 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.06 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 378' ' ' LYS . . . . . 0.614 ' HG2' ' HA ' ' A' ' 391' ' ' ASP . 82.3 mttt -126.82 150.43 49.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.675 0.274 . . . . 0.0 110.865 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -94.62 117.37 30.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.082 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 371' ' ' ALA . 10.9 t -102.88 120.73 53.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.427 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -109.71 133.59 52.96 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -112.83 141.51 46.56 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.095 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.644 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 59.6 tttp -149.23 98.78 2.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.758 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 414' ' ' LYS . . . 71.64 -111.09 3.48 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.417 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -111.39 4.99 19.4 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.972 0.415 . . . . 0.0 111.193 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -114.76 152.2 32.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.68 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -135.54 149.57 49.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.582 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' TRP . . . . . 0.644 ' HZ3' ' HB3' ' A' ' 383' ' ' LYS . 21.8 m-90 -124.87 137.1 54.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.708 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 87.7 t -119.75 117.3 53.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.008 0.432 . . . . 0.0 110.624 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -103.33 119.82 39.61 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.593 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.614 ' HA ' ' HG2' ' A' ' 378' ' ' LYS . 14.0 t70 -94.78 102.92 14.81 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 68.25 -72.04 0.1 Allowed 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.684 0.615 . . . . 0.0 111.615 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -153.78 21.8 0.52 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.922 0.391 . . . . 0.0 110.551 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 57.9 m -137.83 132.93 33.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.981 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 30.3 tp -75.41 130.3 38.75 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' GLU . . . . . 0.494 ' HB2' ' CE1' ' A' ' 399' ' ' TYR . 50.3 mt-10 -56.07 144.11 60.48 Favored Pre-proline 0 C--O 1.234 0.289 0 CA-C-O 120.746 0.307 . . . . 0.0 111.003 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 397' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 8.2 Cg_exo -73.19 125.79 10.58 Favored 'Trans proline' 0 CA--C 1.528 0.216 0 C-N-CA 122.81 2.34 . . . . 0.0 111.868 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 114.16 14.32 9.24 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.994 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 399' ' ' TYR . . . . . 0.614 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 38.7 m-85 -109.6 163.28 17.44 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.529 0.165 . . . . 0.0 110.611 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.614 ' HA ' ' HB3' ' A' ' 399' ' ' TYR . 71.7 Cg_endo -76.92 157.88 97.09 Favored 'Cis proline' 0 C--N 1.346 0.398 0 C-N-CA 123.522 -1.449 . . . . 0.0 112.861 0.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -121.13 164.35 17.0 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.071 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 0.567 ' HB3' ' HG2' ' A' ' 404' ' ' LYS . 1.9 m-70 -76.01 149.64 37.53 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 59.7 mt -55.14 -34.1 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 121.285 0.564 . . . . 0.0 110.775 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.567 ' HG2' ' HB3' ' A' ' 402' ' ' HIS . 19.8 pttp -68.34 -12.43 61.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.616 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.43 ' OE2' ' HG3' ' A' ' 404' ' ' LYS . 18.0 mm-40 -86.53 -19.2 29.83 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.065 0.459 . . . . 0.0 110.359 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 40.2 tp -80.39 -39.48 28.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.961 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -160.51 153.79 24.73 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.146 -1.026 . . . . 0.0 113.204 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.52 124.88 31.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.336 -0.432 . . . . 0.0 110.1 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.8 14.63 39.48 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 121.067 -0.587 . . . . 0.0 111.928 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 23.3 mt -89.67 147.29 37.38 Favored Pre-proline 0 C--N 1.322 -0.604 0 O-C-N 122.716 -0.285 . . . . 0.0 111.6 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -52.92 114.24 1.63 Allowed 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.146 2.564 . . . . 0.0 111.637 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.38 33.69 0.89 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.419 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -130.74 -52.67 1.07 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.868 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 414' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 384' ' ' GLY . 18.5 ptmt -176.31 172.94 2.2 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.374 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 38.0 mm -124.87 130.82 73.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 416' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 464' ' ' ARG . 14.6 m-20 -89.87 -52.52 4.94 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.234 0.54 . . . . 0.0 109.577 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 417' ' ' ALA . . . . . 0.737 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -140.74 154.08 46.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.052 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -139.84 102.83 4.51 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 45.1 tp -108.04 128.57 54.79 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.829 0.347 . . . . 0.0 111.629 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -99.41 117.09 33.05 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 421' ' ' TRP . . . . . 0.429 ' HB3' ' OD1' ' A' ' 424' ' ' ASN . 8.5 t-105 -87.27 97.75 10.96 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.491 ' HB2' ' HD3' ' A' ' 423' ' ' PRO . 60.8 mtt -56.59 -50.76 85.98 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.491 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 84.7 Cg_exo -49.44 -33.29 29.36 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.717 2.278 . . . . 0.0 114.97 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 424' ' ' ASN . . . . . 0.429 ' OD1' ' HB3' ' A' ' 421' ' ' TRP . 41.5 p30 -111.62 -24.64 9.98 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 85.57 34.51 13.62 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.757 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 55.3 mttt -125.98 154.49 42.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.957 0.378 . . . . 0.0 110.777 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 15.4 m -105.97 135.03 48.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.018 0.437 . . . . 0.0 111.343 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -108.8 112.94 25.48 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.833 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -99.37 126.52 45.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.161 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 430' ' ' PHE . . . . . 0.595 ' HB2' ' HB3' ' A' ' 417' ' ' ALA . 64.4 m-85 -103.58 135.98 44.16 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.941 0.4 . . . . 0.0 111.212 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.406 ' HA ' ' HE ' ' A' ' 431' ' ' ARG . 2.8 tpm_? -146.0 107.01 4.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.863 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 70.11 -104.16 1.29 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.734 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -120.91 7.74 10.43 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.895 0.379 . . . . 0.0 110.683 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 48.9 mttm -120.72 153.2 37.28 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.676 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 435' ' ' TYR . . . . . 0.48 ' CE1' ' HB2' ' A' ' 451' ' ' LYS . 11.7 p90 -130.98 141.18 50.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.933 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -109.95 147.55 33.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.807 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -109.5 99.36 8.58 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -93.63 134.99 35.36 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.207 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -101.35 122.97 44.68 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.53 -31.19 72.3 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -80.81 -37.08 30.75 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 16.0 mt -89.1 -16.86 30.48 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 4.7 mtp-105 57.52 37.94 27.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.392 0.615 . . . . 0.0 111.299 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -153.31 167.53 29.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.329 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 88.5 t -90.1 144.22 9.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.913 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -64.55 153.17 39.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.261 0.553 . . . . 0.0 111.915 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 447' ' ' SER . . . . . 0.519 ' O ' ' HB2' ' A' ' 448' ' ' GLU . 1.3 m -64.07 156.05 29.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.7 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 448' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 447' ' ' SER . 2.2 mm-40 77.69 -5.59 2.1 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.636 0.585 . . . . 0.0 111.891 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 449' ' ' TYR . . . . . 0.472 ' HE2' ' CE2' ' A' ' 435' ' ' TYR . 29.5 m-85 -98.41 161.05 26.57 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.361 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.42 160.43 95.32 Favored 'Cis proline' 0 C--O 1.234 0.304 0 C-N-CA 123.617 -1.409 . . . . 0.0 113.474 0.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 451' ' ' LYS . . . . . 0.497 ' HE2' ' O ' ' A' ' 448' ' ' GLU . 63.5 mmtt -112.46 169.75 8.66 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.563 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -73.03 140.69 47.44 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 453' ' ' ILE . . . . . 0.492 HG21 ' HG3' ' A' ' 461' ' ' GLU . 15.9 tt -66.69 -13.39 16.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.091 0.472 . . . . 0.0 110.912 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -63.53 -11.08 21.34 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 82.1 t -65.32 -31.26 53.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 29.0 m95 -87.69 87.34 7.35 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -58.42 109.36 0.76 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.888 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 110.04 -14.86 31.21 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.737 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 46.6 mm -88.76 125.93 61.26 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 120.722 0.296 . . . . 0.0 110.537 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.28 160.66 20.17 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.536 2.157 . . . . 0.0 111.704 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 461' ' ' GLU . . . . . 0.492 ' HG3' HG21 ' A' ' 453' ' ' ILE . 3.5 mp0 -71.67 149.52 45.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.096 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 462' ' ' SER . . . . . 0.442 ' N ' ' HD3' ' A' ' 463' ' ' PRO . 2.2 m 54.96 62.14 8.22 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 463' ' ' PRO . . . . . 0.591 ' O ' ' HB2' ' A' ' 417' ' ' ALA . 35.8 Cg_endo -96.04 100.93 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.966 2.444 . . . . 0.0 110.495 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 464' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 416' ' ' ASP . 7.4 ttm180 -77.17 78.24 3.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.225 0.536 . . . . 0.0 111.501 -179.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 149.55 120.22 1.02 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 466' ' ' SER . . . . . 0.414 ' OG ' ' HB1' ' A' ' 417' ' ' ALA . 26.2 p -154.88 127.48 7.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.726 0.298 . . . . 0.0 110.791 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 467' ' ' PHE . . . . . 0.486 ' CE2' ' HB2' ' A' ' 476' ' ' TYR . 14.7 p90 -155.22 146.21 22.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.772 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 47.6 ttm -98.07 142.64 29.52 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.933 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -69.5 162.36 52.11 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.065 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.86 0.37 5.89 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.41 -15.34 21.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.922 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 69.11 6.63 5.76 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 123.753 0.658 . . . . 0.0 111.869 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 58.3 t -104.51 -39.4 5.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.931 0.396 . . . . 0.0 111.166 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -110.91 135.49 51.36 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 66.4 m -118.02 137.49 52.85 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.749 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 476' ' ' TYR . . . . . 0.486 ' HB2' ' CE2' ' A' ' 467' ' ' PHE . 82.4 m-85 -113.51 139.88 48.6 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.11 0.481 . . . . 0.0 112.133 -178.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -121.14 148.04 44.75 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.927 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 478' ' ' TYR . . . . . 0.421 ' CE1' ' HA ' ' A' ' 481' ' ' ASN . 73.0 t80 -127.87 131.5 49.44 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.773 0.32 . . . . 0.0 111.371 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 479' ' ' LYS . . . . . 0.42 ' HB3' ' CZ3' ' A' ' 484' ' ' TRP . 77.7 tttt -157.62 117.06 3.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.513 178.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 61.6 47.7 88.95 Favored Glycine 0 CA--C 1.518 0.241 0 CA-C-N 115.878 -0.601 . . . . 0.0 113.667 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 481' ' ' ASN . . . . . 0.421 ' HA ' ' CE1' ' A' ' 478' ' ' TYR . 52.0 t30 70.81 -2.94 2.11 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -105.56 142.74 34.78 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -118.65 146.27 44.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.93 0.395 . . . . 0.0 111.587 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 484' ' ' TRP . . . . . 0.438 ' CE2' ' HB3' ' A' ' 498' ' ' PRO . 19.2 m-90 -117.7 148.27 42.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.465 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 54.0 tttt -115.67 105.0 12.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.211 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 486' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -97.1 129.58 44.49 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.679 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -91.45 114.31 26.81 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -63.71 -29.22 70.47 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -84.68 -11.63 55.5 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -118.76 -14.2 9.53 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 92.2 mt 59.4 36.04 23.17 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.314 0.578 . . . . 0.0 110.45 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 9.9 tttp -149.74 154.75 39.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.893 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 38.8 t -85.1 142.49 13.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -64.13 132.89 95.44 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.621 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.32 151.59 72.97 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.968 2.445 . . . . 0.0 112.363 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 92.6 16.03 50.66 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.208 -0.52 . . . . 0.0 111.977 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 497' ' ' TYR . . . . . 0.496 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 22.6 m-85 -115.42 166.03 12.96 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.832 -0.184 . . . . 0.0 110.814 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 498' ' ' PRO . . . . . 0.496 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 66.5 Cg_endo -84.66 176.9 29.77 Favored 'Cis proline' 0 C--N 1.347 0.499 0 C-N-CA 123.827 -1.322 . . . . 0.0 112.94 0.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -133.2 156.54 47.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.057 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 23.0 t -72.07 123.63 23.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.864 0.364 . . . . 0.0 110.843 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -65.21 -27.12 68.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.53 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 502' ' ' LEU . . . . . 0.467 HD23 ' HG3' ' A' ' 506' ' ' MET . 14.0 mt -62.28 -46.54 88.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.662 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -79.39 -40.22 30.63 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.493 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.98 -40.95 37.6 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -177.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 505' ' ' TRP . . . . . 0.493 ' O ' ' HA ' ' A' ' 347' ' ' ASN . 11.8 m0 -110.93 -49.13 3.05 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 506' ' ' MET . . . . . 0.467 ' HG3' HD23 ' A' ' 502' ' ' LEU . 9.4 mmt -64.97 -28.19 69.35 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -177.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 84.74 32.91 20.4 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.162 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 42.8 m -106.67 104.94 53.3 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.77 146.66 48.79 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.767 2.311 . . . . 0.0 111.713 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 8.0 m 54.34 76.82 0.22 Allowed 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.654 0.596 . . . . 0.0 111.031 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.135 0 CA-C-O 118.794 -1.004 . . . . 0.0 112.314 -179.143 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.871 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' PRO . . . . . 0.515 ' HA ' HD23 ' B' ' 2' ' ' HYP . 64.1 Cg_endo -73.31 141.76 32.56 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.673 2.249 . . . . 0.0 112.316 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 2' ' ' HYP . . . . . 0.515 HD23 ' HA ' ' B' ' 1' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' D' ' 201' ' ' PRO . . . -68.86 162.43 51.03 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.986 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.73 166.28 29.67 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.849 2.366 . . . . 0.0 111.126 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.13 -168.38 41.5 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.335 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.56 168.86 23.26 Favored 'Trans proline' 0 CA--C 1.528 0.181 0 C-N-CA 122.905 2.403 . . . . 0.0 111.322 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 134.27 -159.5 23.83 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 119.677 -1.249 . . . . 0.0 113.415 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -74.37 138.12 24.22 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.027 2.485 . . . . 0.0 112.001 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' GLN . . . . . 0.453 ' HG3' ' HG2' ' C' ' 110' ' ' PRO . 50.2 tt0 -67.18 152.14 46.29 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' D' ' 210' ' ' PRO . . . -57.16 148.58 32.71 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.519 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 18.2 mt -64.02 148.03 11.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.58 141.75 57.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.851 0.358 . . . . 0.0 110.14 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.38 158.99 48.24 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.196 -0.526 . . . . 0.0 113.223 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -67.75 148.5 51.18 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -72.94 146.78 45.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.799 0.333 . . . . 0.0 110.4 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' D' ' 216' ' ' GLN . . . -62.74 157.01 39.02 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.819 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 3.8 t -73.91 152.87 7.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 12.8 t -55.41 142.92 9.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.915 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.98 162.23 48.88 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.859 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.427 ' HA ' HD23 ' B' ' 23' ' ' HYP . 96.0 mt -71.46 148.1 47.18 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.537 0.208 . . . . 0.0 111.165 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' HYP . . . . . 0.427 HD23 ' HA ' ' B' ' 22' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.96 155.81 33.97 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.797 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.51 155.03 50.47 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.711 2.274 . . . . 0.0 111.917 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.09 162.14 53.58 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.24 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.435 ' HA ' HD23 ' B' ' 29' ' ' HYP . 67.5 Cg_endo -74.22 157.59 45.9 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.747 2.298 . . . . 0.0 112.003 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' HYP . . . . . 0.435 HD23 ' HA ' ' B' ' 28' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' D' ' 228' ' ' PRO . . . -76.21 172.08 54.5 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.716 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.402 ' HA ' HD23 ' B' ' 32' ' ' HYP . 22.8 Cg_exo -67.29 161.52 42.7 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 123.289 2.659 . . . . 0.0 111.59 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' HYP . . . . . 0.402 HD23 ' HA ' ' B' ' 31' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.22 160.47 54.06 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.872 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' PRO . . . . . 0.617 ' HG2' ' HB2' ' D' ' 232' ' ' HYP . 72.0 Cg_endo -76.65 151.08 31.95 Favored 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 122.779 2.319 . . . . 0.0 112.109 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.47 0 CA-C-O 120.323 -0.154 . . . . 0.0 113.189 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -72.18 156.26 55.59 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.302 2.668 . . . . 0.0 111.735 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 102' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.03 171.32 48.44 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.458 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.81 161.25 21.42 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.984 2.456 . . . . 0.0 112.04 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 105' ' ' HYP . . . . . 0.434 ' OD1' ' HG2' ' D' ' 204' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -73.59 178.63 41.94 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.419 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.2 157.69 33.63 Favored 'Trans proline' 0 C--O 1.223 -0.254 0 C-N-CA 122.745 2.296 . . . . 0.0 110.762 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 108' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -57.61 165.68 6.27 Favored Glycine 0 CA--C 1.52 0.384 0 CA-C-N 115.663 -0.699 . . . . 0.0 113.484 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 110' ' ' PRO . . . . . 0.453 ' HG2' ' HG3' ' B' ' 11' ' ' GLN . 34.4 Cg_endo -64.57 159.93 42.34 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 123.118 2.545 . . . . 0.0 112.324 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 111' ' ' GLN . . . . . 0.405 ' OE1' ' HG2' ' D' ' 210' ' ' PRO . 5.8 tp60 -58.23 136.68 57.35 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.035 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -66.86 160.05 48.43 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.726 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 62.3 mt -72.8 131.21 35.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.55 151.67 28.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.137 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -69.58 155.53 53.36 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.492 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -76.75 157.43 31.67 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -65.22 150.25 48.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.285 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.47 167.34 44.3 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.935 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 21.5 t -67.02 139.38 21.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.572 0.225 . . . . 0.0 110.474 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 28.6 t -64.46 138.18 23.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.372 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.27 159.44 40.97 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.99 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 81.2 mt -79.36 153.67 29.61 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.519 -0.178 . . . . 0.0 110.519 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 123' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -65.83 171.16 27.15 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.889 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 125' ' ' PRO . . . . . 0.442 ' HA ' HD23 ' C' ' 126' ' ' HYP . 60.2 Cg_endo -74.3 147.81 37.75 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.466 2.11 . . . . 0.0 111.906 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 126' ' ' HYP . . . . . 0.442 HD23 ' HA ' ' C' ' 125' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.47 159.09 50.62 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.783 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.93 164.58 34.19 Favored 'Trans proline' 0 C--O 1.237 0.465 0 C-N-CA 122.671 2.247 . . . . 0.0 111.58 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -72.7 -172.51 21.34 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.718 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -78.74 148.65 22.8 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.628 2.219 . . . . 0.0 112.099 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 132' ' ' HYP . . . . . 0.693 ' HA ' ' O ' ' D' ' 231' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -62.3 126.28 37.72 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.418 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 134' ' ' PRO . . . . . 0.465 ' HA ' HD23 ' C' ' 135' ' ' HYP . 44.9 Cg_endo -68.52 110.75 2.37 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.195 2.597 . . . . 0.0 112.368 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 135' ' ' HYP . . . . . 0.465 HD23 ' HA ' ' C' ' 134' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.286 0 N-CA-C 112.405 -0.278 . . . . 0.0 112.405 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 201' ' ' PRO . . . . . 0.486 ' HA ' HD23 ' D' ' 202' ' ' HYP . 38.1 Cg_exo -62.8 143.12 91.26 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.869 2.379 . . . . 0.0 111.502 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 202' ' ' HYP . . . . . 0.486 HD23 ' HA ' ' D' ' 201' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 84.89 -176.77 50.89 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.83 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 204' ' ' PRO . . . . . 0.434 ' HG2' ' OD1' ' C' ' 105' ' ' HYP . 19.0 Cg_exo -69.12 161.02 47.54 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 123.823 3.015 . . . . 0.0 112.67 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 205' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . 90.09 178.59 44.53 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.73 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 207' ' ' PRO . . . . . 0.442 ' HA ' HD23 ' D' ' 208' ' ' HYP . 72.7 Cg_endo -97.9 160.49 0.86 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.889 3.059 . . . . 0.0 112.682 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 208' ' ' HYP . . . . . 0.442 HD23 ' HA ' ' D' ' 207' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -79.13 171.81 55.09 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.723 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 210' ' ' PRO . . . . . 0.561 ' O ' ' HA3' ' B' ' 12' ' ' GLY . 50.5 Cg_endo -71.96 155.99 56.81 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.731 2.288 . . . . 0.0 112.014 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -73.22 147.92 44.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.301 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -68.17 158.75 51.89 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.186 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 213' ' ' ILE . . . . . 0.446 ' H ' HG13 ' D' ' 213' ' ' ILE . 20.5 mt -60.05 142.67 15.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.786 0.327 . . . . 0.0 110.948 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -65.26 139.94 58.67 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.582 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -60.37 156.04 31.12 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.11 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 216' ' ' GLN . . . . . 0.488 ' O ' ' HA3' ' B' ' 18' ' ' GLY . 9.5 mm-40 -78.56 159.25 28.24 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -67.75 154.33 41.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.783 0.325 . . . . 0.0 110.784 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -64.47 160.12 40.72 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.913 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 15.9 t -70.02 144.15 14.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 39.3 t -61.55 142.7 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.95 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.84 160.7 37.5 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.757 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 82.1 mt -73.79 153.55 39.93 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.823 -0.189 . . . . 0.0 110.741 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 223' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -59.59 149.4 40.14 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.505 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 225' ' ' PRO . . . . . 0.473 ' HA ' HD23 ' D' ' 226' ' ' HYP . 51.7 Cg_exo -56.03 137.47 79.33 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.841 2.361 . . . . 0.0 111.595 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 226' ' ' HYP . . . . . 0.473 HD23 ' HA ' ' D' ' 225' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -64.92 164.13 36.23 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.939 -0.573 . . . . 0.0 113.971 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 228' ' ' PRO . . . . . 0.409 ' O ' ' HA3' ' B' ' 30' ' ' GLY . 97.3 Cg_endo -89.03 166.03 5.71 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 123.339 2.692 . . . . 0.0 111.339 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -62.94 159.27 36.25 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.896 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 231' ' ' PRO . . . . . 0.693 ' O ' ' HA ' ' C' ' 132' ' ' HYP . 21.3 Cg_exo -66.93 140.38 54.72 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.614 2.209 . . . . 0.0 110.679 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 232' ' ' HYP . . . . . 0.617 ' HB2' ' HG2' ' B' ' 34' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.615 ' HB2' ' HH2' ' A' ' 342' ' ' TRP . 4.3 Cg_exo . . . . . 0 N--CA 1.474 0.361 0 N-CA-C 110.733 -0.526 . . . . 0.0 110.733 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -128.81 154.85 46.03 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.419 HG12 ' HB3' ' A' ' 506' ' ' MET . 11.2 tt -73.65 -19.54 17.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.999 0.428 . . . . 0.0 112.08 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 62.1 m -90.94 1.72 56.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.724 0.297 . . . . 0.0 111.51 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.3 -44.68 74.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.191 0.519 . . . . 0.0 110.451 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 321' ' ' GLY . . . . . 0.533 ' HA2' HD21 ' A' ' 502' ' ' LEU . . . 93.28 -177.65 38.06 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.096 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 52.59 69.82 0.64 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.299 0.571 . . . . 0.0 111.634 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 323' ' ' PHE . . . . . 0.485 ' HD1' ' HB2' ' A' ' 337' ' ' LYS . 85.0 m-85 -87.24 156.36 19.69 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.682 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -65.35 -41.19 94.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.019 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 5.7 t -173.4 149.88 1.77 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.156 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.452 HG22 HG13 ' A' ' 335' ' ' VAL . 60.7 t -134.24 118.12 26.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -140.17 -172.18 3.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.843 0.354 . . . . 0.0 111.412 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 44.6 ttp -136.96 126.71 25.53 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.824 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 42.5 mt -120.92 119.93 34.01 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.313 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.17 17.82 9.54 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.14 0.576 . . . . 0.0 111.918 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 102.73 -9.2 55.28 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.154 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 332' ' ' GLU . . . . . 0.5 ' HB3' ' NH1' ' A' ' 343' ' ' ARG . 70.1 mm-40 -99.5 127.69 45.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.637 0.256 . . . . 0.0 110.66 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 44.5 ttm -77.28 137.23 38.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.95 0.405 . . . . 0.0 111.424 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -125.42 117.05 22.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.618 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 335' ' ' VAL . . . . . 0.452 HG13 HG22 ' A' ' 326' ' ' VAL . 33.3 t -107.7 114.61 46.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -99.15 129.33 45.39 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 0.485 ' HB2' ' HD1' ' A' ' 323' ' ' PHE . 50.9 tptt -139.27 102.47 4.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.774 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 63.33 -99.14 0.07 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.493 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -116.27 -0.56 12.58 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 340' ' ' TRP . . . . . 0.646 ' HD1' ' HA ' ' A' ' 356' ' ' PRO . 18.3 m0 -119.27 154.86 32.8 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.323 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -129.05 133.98 47.93 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.104 0.478 . . . . 0.0 110.83 178.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 342' ' ' TRP . . . . . 0.615 ' HH2' ' HB2' ' A' ' 316' ' ' PRO . 5.6 m-90 -102.28 153.48 19.95 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.686 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.597 ' HG3' ' CZ ' ' A' ' 353' ' ' TYR . 6.3 mmm180 -129.49 105.77 8.31 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.17 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -102.36 123.99 56.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.738 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -118.57 107.16 13.4 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.01 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 63.45 45.25 4.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.26 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 45.1 t30 66.34 32.54 7.64 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.075 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -139.64 142.8 37.0 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 24.7 t -81.79 130.65 35.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 74.7 mtp -74.97 166.32 23.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.034 0.445 . . . . 0.0 112.073 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -83.75 154.93 23.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.762 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 80.76 26.16 54.45 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.329 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 353' ' ' TYR . . . . . 0.597 ' CZ ' ' HG3' ' A' ' 343' ' ' ARG . 73.4 m-85 -135.22 162.57 56.7 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 122.97 -0.135 . . . . 0.0 110.644 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.583 ' HA ' ' HB3' ' A' ' 353' ' ' TYR . 70.7 Cg_endo -75.23 146.23 85.76 Favored 'Cis proline' 0 C--N 1.346 0.408 0 C-N-CA 123.754 -1.353 . . . . 0.0 112.948 0.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 56.3 ttm -114.57 140.96 25.92 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.188 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 356' ' ' PRO . . . . . 0.646 ' HA ' ' HD1' ' A' ' 340' ' ' TRP . 32.2 Cg_exo -61.32 140.94 90.99 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.275 1.983 . . . . 0.0 111.02 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 91.8 mt -55.7 -43.95 75.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.225 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -72.02 -6.71 64.85 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 121.052 -0.594 . . . . 0.0 113.434 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.39 -21.53 30.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.239 0.52 . . . . 0.0 110.087 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.496 ' HE2' ' HB3' ' D' ' 211' ' ' GLN . 8.9 t80 -111.6 -55.42 2.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.789 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 65.1 m95 -91.27 83.62 5.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.366 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -63.32 105.35 0.73 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.264 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 116.55 -6.65 18.39 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.552 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.534 HD12 ' HD2' ' A' ' 365' ' ' PRO . 18.3 tp -91.68 131.4 35.92 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.703 0.287 . . . . 0.0 110.596 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 365' ' ' PRO . . . . . 0.534 ' HD2' HD12 ' A' ' 364' ' ' LEU . 86.4 Cg_endo -81.3 170.9 14.34 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.778 2.319 . . . . 0.0 111.371 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -80.59 153.49 28.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.704 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 15.7 m 56.68 84.07 0.09 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 16.8 pt -98.97 -174.07 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -134.29 -24.14 1.63 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 370' ' ' THR . . . . . 0.931 ' HB ' ' HB2' ' A' ' 382' ' ' PHE . 4.8 m -141.83 145.92 35.25 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.555 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -153.58 131.46 11.67 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -163.53 165.28 23.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.888 0.375 . . . . 0.0 111.496 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -94.23 141.63 28.34 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 374' ' ' ARG . . . . . 0.534 ' HB2' ' OE2' ' A' ' 440' ' ' GLU . 12.2 ptm180 -97.2 -169.4 1.85 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.385 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -69.39 -34.43 74.51 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.645 0.979 . . . . 0.0 113.645 -177.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 44.7 p30 -83.02 -10.37 58.79 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 107.83 -6.2 35.12 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.669 -0.776 . . . . 0.0 113.241 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 17.4 mttp -76.54 164.24 26.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.906 0.353 . . . . 0.0 110.879 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -107.82 123.32 48.4 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -178.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 12.2 t -105.98 119.82 55.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.036 0.446 . . . . 0.0 110.446 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -106.18 143.38 34.38 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.508 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.931 ' HB2' ' HB ' ' A' ' 370' ' ' THR . 23.2 m-85 -124.1 138.26 54.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.069 0.461 . . . . 0.0 111.897 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -150.69 98.24 2.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.78 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 77.58 -111.94 3.38 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.618 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 385' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 402' ' ' HIS . 4.3 p-10 -113.09 6.9 17.81 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.685 0.278 . . . . 0.0 111.345 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -114.61 148.97 37.33 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.514 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -128.86 146.0 51.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.218 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 388' ' ' TRP . . . . . 0.407 ' CE2' ' HB3' ' A' ' 400' ' ' PRO . 16.4 m-90 -120.21 131.75 55.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.09 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 99.2 t -115.52 110.44 31.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.059 0.456 . . . . 0.0 109.972 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -102.68 128.18 49.49 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.613 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -99.35 103.15 14.94 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 71.89 -53.36 0.69 Allowed 'General case' 0 N--CA 1.469 0.519 0 O-C-N 123.663 0.602 . . . . 0.0 111.298 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -166.27 -29.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.844 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.37 138.8 32.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.814 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 27.9 tp -78.29 139.84 38.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.803 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 396' ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 3.3 mt-10 -67.21 140.75 95.72 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.443 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 397' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 21.6 Cg_exo -67.77 147.4 75.22 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.715 2.276 . . . . 0.0 111.238 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 89.18 15.04 59.55 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.718 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 399' ' ' TYR . . . . . 0.502 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 50.1 m-85 -117.99 162.58 28.77 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.502 ' HA ' ' HB3' ' A' ' 399' ' ' TYR . 84.0 Cg_endo -76.74 164.44 87.43 Favored 'Cis proline' 0 C--N 1.345 0.375 0 C-N-CA 123.634 -1.402 . . . . 0.0 113.306 0.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 401' ' ' LYS . . . . . 0.402 ' HD3' ' HB3' ' A' ' 405' ' ' GLU . 39.3 mttp -130.68 163.41 27.29 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.167 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 0.585 ' HB2' ' HG2' ' A' ' 404' ' ' LYS . 4.6 m80 -73.22 159.87 32.8 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 33.0 mt -59.61 -31.78 47.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.344 0.592 . . . . 0.0 110.222 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.585 ' HG2' ' HB2' ' A' ' 402' ' ' HIS . 20.4 pttp -69.38 -12.03 61.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.183 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.402 ' HB3' ' HD3' ' A' ' 401' ' ' LYS . 10.2 mm-40 -85.58 -21.95 28.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.971 0.415 . . . . 0.0 111.253 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 47.8 tp -76.51 -53.95 7.38 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.126 0.488 . . . . 0.0 110.25 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.466 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -151.54 157.64 27.32 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.127 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 38.2 ttt180 -86.68 130.18 34.58 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.798 0.333 . . . . 0.0 110.676 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 106.34 -5.93 38.78 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.797 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 66.7 mt -76.98 151.44 81.94 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 120.633 0.254 . . . . 0.0 111.235 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.27 131.44 44.96 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.907 2.404 . . . . 0.0 111.633 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.74 -7.45 33.83 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.848 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -87.12 -56.59 3.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.197 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 414' ' ' LYS . . . . . 0.477 ' O ' ' HD2' ' A' ' 431' ' ' ARG . 8.4 ptmt -175.42 173.74 2.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.955 0.407 . . . . 0.0 111.224 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 34.6 mm -125.4 130.67 72.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.341 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -89.11 -41.95 11.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.165 0.507 . . . . 0.0 110.532 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -163.64 164.4 24.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.903 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -148.73 127.25 12.36 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.434 HD11 ' HB2' ' A' ' 468' ' ' MET . 24.9 tp -118.47 119.83 35.74 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.06 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -87.81 113.91 23.93 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 421' ' ' TRP . . . . . 0.507 ' HB3' ' OD1' ' A' ' 424' ' ' ASN . 4.2 t-105 -81.81 96.36 7.58 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.414 ' HB2' ' HD3' ' A' ' 423' ' ' PRO . 58.2 mtt -52.09 -51.21 73.62 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 86.5 Cg_exo -49.29 -57.25 2.47 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.681 2.254 . . . . 0.0 114.383 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 424' ' ' ASN . . . . . 0.507 ' OD1' ' HB3' ' A' ' 421' ' ' TRP . 37.1 p30 -84.29 -24.72 29.75 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 82.92 37.44 13.03 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 121.009 -0.615 . . . . 0.0 113.438 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -128.08 150.39 49.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 117.031 0.416 . . . . 0.0 110.913 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 2.0 m -101.04 127.01 47.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.035 0.445 . . . . 0.0 111.753 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -101.85 111.62 23.94 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.556 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 429' ' ' PHE . . . . . 0.408 ' HB2' ' HB2' ' A' ' 436' ' ' TYR . 69.3 m-85 -94.45 137.42 33.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.124 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -113.08 129.89 56.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.003 0.43 . . . . 0.0 111.321 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.477 ' HD2' ' O ' ' A' ' 414' ' ' LYS . 2.8 tpm_? -141.26 105.01 4.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.23 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 67.47 -108.88 2.62 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.073 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -114.39 13.09 17.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.835 0.35 . . . . 0.0 110.763 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 434' ' ' LYS . . . . . 0.524 ' HD3' ' HG2' ' A' ' 450' ' ' PRO . 97.2 mttt -123.62 151.46 42.98 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.276 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 435' ' ' TYR . . . . . 0.476 ' CE1' ' HB2' ' A' ' 451' ' ' LYS . 9.0 p90 -126.95 138.92 53.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.435 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 436' ' ' TYR . . . . . 0.408 ' HB2' ' HB2' ' A' ' 429' ' ' PHE . 9.5 m-85 -110.58 143.78 40.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.716 -178.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -109.35 99.5 8.74 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 438' ' ' PHE . . . . . 0.466 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 75.4 t80 -92.25 132.55 36.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.521 -178.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -106.8 113.38 26.83 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.621 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 440' ' ' GLU . . . . . 0.534 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 3.3 mm-40 -50.89 -52.43 41.93 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 -64.89 -14.35 59.43 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -178.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 47.9 mt -113.86 -7.77 13.18 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 47.3 40.67 10.92 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.599 0.714 . . . . 0.0 112.472 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -154.73 171.32 19.75 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.505 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.5 t -96.81 142.8 13.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.278 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.55 153.0 10.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.64 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 11.1 m -70.48 155.26 40.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.365 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 71.41 26.97 3.18 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.483 0.658 . . . . 0.0 110.918 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -123.72 164.47 28.64 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.094 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 450' ' ' PRO . . . . . 0.524 ' HG2' ' HD3' ' A' ' 434' ' ' LYS . 86.5 Cg_endo -79.85 155.68 88.2 Favored 'Cis proline' 0 C--N 1.344 0.34 0 C-N-CA 123.637 -1.401 . . . . 0.0 112.631 0.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 451' ' ' LYS . . . . . 0.476 ' HB2' ' CE1' ' A' ' 435' ' ' TYR . 64.6 mttm -106.78 171.84 7.14 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.853 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 452' ' ' ASN . . . . . 0.464 ' O ' HG23 ' A' ' 455' ' ' VAL . 18.3 t-20 -68.85 136.93 53.44 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.556 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 12.9 tt -67.72 -15.73 20.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.079 0.466 . . . . 0.0 111.381 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -67.07 -2.3 5.33 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 455' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 452' ' ' ASN . 71.6 t -62.62 -34.96 68.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 456' ' ' TRP . . . . . 0.474 ' HZ3' HD11 ' A' ' 491' ' ' LEU . 14.0 m95 -88.34 90.05 8.24 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -53.02 114.62 1.51 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.606 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 458' ' ' GLY . . . . . 0.403 ' HA3' ' HB ' ' A' ' 493' ' ' VAL . . . 113.25 -15.96 22.57 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.347 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 460' ' ' PRO . 45.8 mm -89.68 117.61 68.29 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.694 0.283 . . . . 0.0 111.083 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 460' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 459' ' ' ILE . 4.9 Cg_exo -79.2 153.24 24.49 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 123.088 2.525 . . . . 0.0 111.374 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -67.54 149.6 49.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.601 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.3 m 60.58 78.08 0.34 Allowed Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -88.05 -174.98 1.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.966 2.444 . . . . 0.0 111.481 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.79 9.6 3.34 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.108 0.48 . . . . 0.0 110.856 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 169.94 141.83 3.38 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 6.3 p -152.73 106.15 3.04 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -128.26 142.15 51.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.057 0.456 . . . . 0.0 111.605 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 468' ' ' MET . . . . . 0.434 ' HB2' HD11 ' A' ' 419' ' ' LEU . 47.9 ttm -95.44 134.63 38.05 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.556 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -67.08 163.22 45.39 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.018 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 1.4 m -66.46 -7.33 18.82 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.911 0.386 . . . . 0.0 111.346 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -84.94 -15.09 45.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.069 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 65.77 6.76 4.11 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 46.6 t -109.62 -40.09 4.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.738 0.304 . . . . 0.0 111.362 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -105.02 123.0 47.04 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 90.9 m -111.16 138.06 48.08 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -113.4 128.3 56.41 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -110.22 125.92 53.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.298 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -106.25 136.33 46.16 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 479' ' ' LYS . . . . . 0.519 ' HB3' ' CZ3' ' A' ' 484' ' ' TRP . 78.6 tttt -158.19 102.89 1.8 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.814 0.34 . . . . 0.0 111.89 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 57.63 72.33 0.61 Allowed Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 114.823 0.689 . . . . 0.0 114.823 178.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 69.62 -24.87 0.15 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -104.32 156.05 18.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.885 0.374 . . . . 0.0 111.63 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -133.29 147.04 51.89 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.107 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 484' ' ' TRP . . . . . 0.519 ' CZ3' ' HB3' ' A' ' 479' ' ' LYS . 10.5 m-90 -109.93 148.27 31.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.782 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -107.23 97.13 6.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.823 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 486' ' ' PHE . . . . . 0.409 ' CE1' ' HB3' ' A' ' 456' ' ' TRP . 88.1 t80 -91.61 124.81 36.04 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.973 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -92.52 117.36 29.86 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -68.15 -32.15 72.22 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -76.4 -26.44 55.56 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -102.92 -15.98 16.0 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.423 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.474 HD11 ' HZ3' ' A' ' 456' ' ' TRP . 4.1 tp 60.09 39.28 19.85 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.565 0.698 . . . . 0.0 110.641 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 31.2 tttp -159.31 149.19 18.85 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.255 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 493' ' ' VAL . . . . . 0.403 ' HB ' ' HA3' ' A' ' 458' ' ' GLY . 54.9 t -73.03 134.76 29.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.114 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -70.55 146.97 94.51 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.286 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.4 160.25 40.13 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.938 2.425 . . . . 0.0 112.781 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 87.21 17.25 59.4 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 497' ' ' TYR . . . . . 0.536 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 20.5 m-85 -128.4 166.82 21.72 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.431 -0.385 . . . . 0.0 110.39 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 498' ' ' PRO . . . . . 0.536 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 72.0 Cg_endo -74.5 167.94 78.51 Favored 'Cis proline' 0 C--N 1.346 0.425 0 C-N-CA 123.857 -1.309 . . . . 0.0 113.102 0.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -121.99 164.94 16.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.155 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 22.5 t -77.56 109.35 11.44 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.94 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -68.46 -25.37 64.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.988 0.423 . . . . 0.0 110.429 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 502' ' ' LEU . . . . . 0.533 HD21 ' HA2' ' A' ' 321' ' ' GLY . 74.1 mt -65.57 -26.74 67.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.747 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 503' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 503' ' ' ARG . 30.2 ttm105 -99.74 -40.82 7.56 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.091 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.96 -23.57 36.03 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -177.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -114.1 -48.09 2.91 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 506' ' ' MET . . . . . 0.419 ' HB3' HG12 ' A' ' 318' ' ' ILE . 11.5 mmt -77.53 -26.52 51.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.026 -178.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 83.15 26.42 44.37 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.208 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 60.4 m -98.21 110.42 56.12 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-O 120.719 0.295 . . . . 0.0 110.698 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.07 175.71 10.61 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.895 2.396 . . . . 0.0 112.07 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 6.9 m 66.55 15.63 10.17 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 CA-C-O 118.163 -1.354 . . . . 0.0 110.929 179.833 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.8 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' PRO . . . . . 0.464 ' HA ' HD23 ' B' ' 2' ' ' HYP . 59.6 Cg_endo -71.89 140.37 34.99 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.503 2.135 . . . . 0.0 111.903 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 2' ' ' HYP . . . . . 0.464 HD23 ' HA ' ' B' ' 1' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.35 171.65 51.13 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.439 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -81.33 176.63 8.52 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.967 2.444 . . . . 0.0 110.331 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.65 -160.5 20.31 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.35 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.612 ' HD2' ' HA ' ' D' ' 205' ' ' HYP . 51.1 Cg_exo -57.27 164.72 6.41 Favored 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 122.961 2.441 . . . . 0.0 111.183 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 8' ' ' HYP . . . . . 0.505 ' O ' ' HA3' ' D' ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.35 152.47 7.66 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.712 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -58.07 135.4 68.3 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.804 2.336 . . . . 0.0 111.735 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' GLN . . . . . 0.419 ' HG3' ' HG2' ' C' ' 110' ' ' PRO . 62.0 tt0 -61.28 147.0 46.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.611 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' D' ' 210' ' ' PRO . . . -62.23 153.48 42.51 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.261 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.491 ' H ' HG13 ' B' ' 13' ' ' ILE . 2.4 mt -67.0 150.63 11.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 122.669 0.388 . . . . 0.0 110.577 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.21 145.39 49.68 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.29 156.04 50.91 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.766 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -66.25 141.72 57.93 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.456 ' HG3' ' HB3' ' C' ' 116' ' ' GLN . 15.1 ttt180 -65.61 148.5 51.64 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.656 0.265 . . . . 0.0 110.967 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' D' ' 216' ' ' GLN . . . -61.78 150.56 45.34 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 116.001 -0.545 . . . . 0.0 113.447 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.41 ' HB ' ' HG2' ' D' ' 217' ' ' ARG . 8.2 t -65.9 147.53 12.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.684 -0.258 . . . . 0.0 110.513 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 6.6 t -53.42 145.1 3.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.401 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.25 165.41 46.38 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.243 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.43 ' HA ' HD23 ' B' ' 23' ' ' HYP . 69.2 mt -84.92 149.89 25.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.793 -0.204 . . . . 0.0 110.969 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 23' ' ' HYP . . . . . 0.43 HD23 ' HA ' ' B' ' 22' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -72.58 164.77 54.65 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.411 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.406 ' HA ' HD23 ' B' ' 26' ' ' HYP . 57.0 Cg_endo -70.74 152.9 64.62 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.54 2.16 . . . . 0.0 111.668 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 26' ' ' HYP . . . . . 0.406 HD23 ' HA ' ' B' ' 25' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.19 153.1 44.51 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.824 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.33 162.17 42.32 Favored 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 122.944 2.429 . . . . 0.0 111.823 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 29' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.16 171.46 53.98 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.302 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -65.24 158.21 53.47 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 123.134 2.556 . . . . 0.0 112.076 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 32' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 33' ' ' GLY . . . . . 0.465 ' HA2' ' HD3' ' B' ' 34' ' ' PRO . . . -69.07 139.63 32.88 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.787 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 34' ' ' PRO . . . . . 0.465 ' HD3' ' HA2' ' B' ' 33' ' ' GLY . 16.4 Cg_exo -70.3 144.63 51.72 Favored 'Trans proline' 0 CA--C 1.529 0.251 0 C-N-CA 122.766 2.311 . . . . 0.0 110.909 179.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 35' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 100' ' ' GLY . . . . . 0.451 ' HA3' ' HD3' ' C' ' 101' ' ' PRO . . . . . . . . 0 N--CA 1.448 -0.507 0 N-CA-C 112.278 -0.329 . . . . 0.0 112.278 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 101' ' ' PRO . . . . . 0.451 ' HD3' ' HA3' ' C' ' 100' ' ' GLY . 6.9 Cg_exo -75.05 150.46 37.97 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 123.211 2.608 . . . . 0.0 111.738 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 102' ' ' HYP . . . . . 0.402 HD23 ' HA ' ' C' ' 101' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.79 175.9 54.11 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.559 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -85.88 161.95 10.44 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.114 2.543 . . . . 0.0 112.361 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 105' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -71.13 173.48 42.5 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.565 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 107' ' ' PRO . . . . . 0.403 ' HA ' HD23 ' C' ' 108' ' ' HYP . 73.0 Cg_endo -75.12 150.5 37.75 Favored 'Trans proline' 0 CA--C 1.528 0.185 0 C-N-CA 122.674 2.249 . . . . 0.0 111.549 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 108' ' ' HYP . . . . . 0.403 HD23 ' HA ' ' C' ' 107' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -57.9 163.33 8.44 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-N 115.662 -0.699 . . . . 0.0 113.687 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 110' ' ' PRO . . . . . 0.419 ' HG2' ' HG3' ' B' ' 11' ' ' GLN . 28.5 Cg_endo -62.44 150.04 88.78 Favored 'Trans proline' 0 C--O 1.237 0.425 0 C-N-CA 122.883 2.388 . . . . 0.0 112.524 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -55.84 134.72 52.02 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.951 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.23 160.77 26.74 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.799 -0.637 . . . . 0.0 113.277 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 53.4 mt -74.03 138.43 21.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 120.755 0.312 . . . . 0.0 110.231 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.19 146.39 55.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.899 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -63.79 156.08 44.04 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.448 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 116' ' ' GLN . . . . . 0.456 ' HB3' ' HG3' ' B' ' 17' ' ' ARG . 40.7 tt0 -75.04 159.06 32.19 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.64 0.257 . . . . 0.0 110.577 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 14.6 ttm-85 -68.72 146.65 52.76 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.67 168.21 36.2 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.024 -0.608 . . . . 0.0 113.158 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 4.3 t -75.51 144.98 11.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 92.6 t -61.57 139.11 21.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.516 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.28 167.3 40.15 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.701 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 122' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' C' ' 123' ' ' HYP . 82.5 mt -76.9 142.24 40.22 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.478 0.18 . . . . 0.0 111.033 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 123' ' ' HYP . . . . . 0.457 HD23 ' HA ' ' C' ' 122' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -68.63 169.2 41.84 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.75 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -75.51 158.37 40.25 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.685 2.257 . . . . 0.0 111.592 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 126' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.75 163.76 32.17 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.913 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -80.29 162.14 22.7 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.673 2.249 . . . . 0.0 111.427 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -66.89 177.09 19.85 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.972 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.47 147.97 90.58 Favored 'Trans proline' 0 C--O 1.237 0.454 0 C-N-CA 122.739 2.293 . . . . 0.0 111.868 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 132' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -62.18 129.04 42.88 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.072 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 134' ' ' PRO . . . . . 0.461 ' HA ' HD23 ' C' ' 135' ' ' HYP . 59.0 Cg_endo -75.4 110.98 3.21 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.65 2.234 . . . . 0.0 111.78 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 135' ' ' HYP . . . . . 0.461 HD23 ' HA ' ' C' ' 134' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 112.173 -0.371 . . . . 0.0 112.173 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' D' D ' 201' ' ' PRO . . . . . 0.46 ' HA ' HD23 ' D' ' 202' ' ' HYP . 43.7 Cg_exo -58.19 142.9 97.51 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.935 2.423 . . . . 0.0 111.743 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 202' ' ' HYP . . . . . 0.46 HD23 ' HA ' ' D' ' 201' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 99.75 -160.62 19.54 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.344 178.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 204' ' ' PRO . . . . . 0.4 ' HA ' HD23 ' D' ' 205' ' ' HYP . 13.8 Cg_exo -70.82 157.35 58.56 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 123.551 2.834 . . . . 0.0 112.824 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 205' ' ' HYP . . . . . 0.612 ' HA ' ' HD2' ' B' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 206' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' B' ' 8' ' ' HYP . . . 88.05 164.32 40.1 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.394 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -90.98 148.17 3.8 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.743 2.962 . . . . 0.0 112.137 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 208' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -72.2 167.84 52.74 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.887 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 210' ' ' PRO . . . . . 0.408 ' O ' ' HA3' ' B' ' 12' ' ' GLY . 37.2 Cg_endo -66.6 160.0 48.19 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.785 2.323 . . . . 0.0 112.456 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 211' ' ' GLN . . . . . 0.496 ' HB3' ' HE2' ' A' ' 360' ' ' PHE . 62.5 tt0 -77.22 143.87 38.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.416 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -65.57 158.76 46.2 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.683 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 38.3 pt -67.01 151.42 10.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.893 0.377 . . . . 0.0 111.033 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -66.81 149.37 50.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.917 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -67.49 172.04 32.25 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 116.05 -0.523 . . . . 0.0 113.285 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 216' ' ' GLN . . . . . 0.481 ' O ' ' HA3' ' B' ' 18' ' ' GLY . 51.3 mm-40 -87.95 154.32 20.6 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 217' ' ' ARG . . . . . 0.41 ' HG2' ' HB ' ' B' ' 19' ' ' VAL . 27.5 mtp180 -62.88 151.98 37.64 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.763 0.316 . . . . 0.0 111.191 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -64.23 156.81 44.53 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.324 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 6.4 t -67.43 147.2 12.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 50.5 t -63.71 143.01 16.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.98 162.05 23.27 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.225 -0.512 . . . . 0.0 112.687 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 5.9 mp -75.3 154.02 37.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.872 -0.164 . . . . 0.0 110.914 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 223' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -59.26 150.67 36.81 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.674 -0.694 . . . . 0.0 113.055 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 225' ' ' PRO . . . . . 0.435 ' HA ' HD23 ' D' ' 226' ' ' HYP . 52.0 Cg_exo -55.43 139.72 82.12 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 123.208 2.605 . . . . 0.0 111.843 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 226' ' ' HYP . . . . . 0.435 HD23 ' HA ' ' D' ' 225' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -64.6 158.39 43.65 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.369 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -83.42 162.37 14.9 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.897 2.398 . . . . 0.0 111.362 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -66.53 164.52 41.71 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.799 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 231' ' ' PRO . . . . . 0.46 ' HA ' HD23 ' D' ' 232' ' ' HYP . 91.3 Cg_endo -83.36 145.24 11.9 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.577 2.185 . . . . 0.0 111.195 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 232' ' ' HYP . . . . . 0.46 HD23 ' HA ' ' D' ' 231' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo . . . . . 0 N--CA 1.477 0.508 0 N-CA-C 109.776 -0.894 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -119.84 155.51 32.47 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 10.5 tt -69.84 -17.93 21.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.007 0.432 . . . . 0.0 111.517 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 61.3 m -88.94 3.7 50.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.243 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -72.66 -38.71 67.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.016 0.436 . . . . 0.0 110.747 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 321' ' ' GLY . . . . . 0.465 ' O ' ' HE2' ' A' ' 337' ' ' LYS . . . 80.5 -164.85 47.61 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.309 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 51.51 56.18 8.29 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.211 0.529 . . . . 0.0 110.877 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -79.31 160.46 26.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.412 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -73.17 -36.25 66.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.897 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 8.9 t -177.62 149.22 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.207 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.507 HG22 HG13 ' A' ' 335' ' ' VAL . 91.4 t -129.4 124.19 59.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -148.6 -176.32 5.27 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.942 0.401 . . . . 0.0 111.299 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 24.3 ttp -128.89 133.88 48.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.801 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 79.7 mt -125.91 111.24 14.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.376 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.773 ' HG3' ' HE1' ' A' ' 379' ' ' PHE . 60.7 mtp180 58.24 33.06 22.79 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 102.82 -32.86 7.09 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.334 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -81.92 135.81 35.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.807 0.304 . . . . 0.0 111.24 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 44.9 ttm -90.54 124.53 35.09 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -114.49 129.85 56.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.091 0.472 . . . . 0.0 111.809 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 335' ' ' VAL . . . . . 0.507 HG13 HG22 ' A' ' 326' ' ' VAL . 13.7 t -114.56 128.45 71.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -109.63 139.46 44.63 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 0.465 ' HE2' ' O ' ' A' ' 321' ' ' GLY . 12.8 tptp -144.23 100.07 3.49 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.63 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 60.27 -104.46 0.19 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.13 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -110.47 8.77 23.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.588 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 15.3 m-90 -122.43 157.8 31.11 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -139.01 148.24 43.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.013 0.435 . . . . 0.0 111.351 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 4.2 m-90 -120.29 160.52 22.84 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.008 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.32 108.81 6.53 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 2.3 m -97.02 139.31 19.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.407 0.622 . . . . 0.0 111.96 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 345' ' ' ARG . . . . . 0.407 ' HD3' ' HA ' ' A' ' 345' ' ' ARG . 7.6 mmt180 -138.87 111.96 7.96 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.943 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 62.87 46.5 4.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.585 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 48.5 t30 63.81 27.56 14.61 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.758 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -136.28 142.81 43.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.359 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 21.9 t -90.13 124.11 42.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 49.6 mtp -70.41 157.22 38.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.704 0.288 . . . . 0.0 111.035 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.32 158.76 34.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.024 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 95.16 -2.78 66.1 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.456 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 353' ' ' TYR . . . . . 0.416 ' HB3' ' HA ' ' A' ' 354' ' ' PRO . 70.1 m-85 -118.17 156.25 50.72 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.416 ' HA ' ' HB3' ' A' ' 353' ' ' TYR . 57.0 Cg_endo -71.07 137.6 47.74 Favored 'Cis proline' 0 C--N 1.345 0.389 0 C-N-CA 123.504 -1.457 . . . . 0.0 112.536 0.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 355' ' ' MET . . . . . 0.413 ' HA ' ' HD3' ' A' ' 356' ' ' PRO . 59.6 ttm -114.69 135.56 22.36 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.422 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 356' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 355' ' ' MET . 47.2 Cg_exo -58.86 138.0 83.16 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.369 2.046 . . . . 0.0 111.08 178.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 357' ' ' ILE . . . . . 0.403 HG23 ' HD1' ' A' ' 361' ' ' TRP . 74.3 mt -52.27 -40.36 30.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.257 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -66.55 -12.66 59.4 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 121.087 -0.577 . . . . 0.0 114.255 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -79.94 -17.37 53.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.037 0.419 . . . . 0.0 111.541 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -126.82 -55.36 1.39 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.006 0.432 . . . . 0.0 110.453 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 361' ' ' TRP . . . . . 0.403 ' HD1' HG23 ' A' ' 357' ' ' ILE . 48.4 m95 -86.99 76.82 9.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.319 0.581 . . . . 0.0 110.136 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -65.72 94.74 0.21 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.491 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 129.47 -12.68 5.97 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.162 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 365' ' ' PRO . 21.3 tp -88.81 127.5 55.83 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.805 0.336 . . . . 0.0 111.117 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 365' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 364' ' ' LEU . 3.3 Cg_exo -78.81 167.89 21.68 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.096 2.531 . . . . 0.0 111.793 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -73.18 152.86 40.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.223 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 5.7 m 57.65 86.88 0.07 Allowed 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 22.9 pt -95.44 179.97 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.329 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.36 -45.3 4.12 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 121.146 -0.222 . . . . 0.0 111.525 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 370' ' ' THR . . . . . 0.771 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.0 OUTLIER -158.73 172.32 18.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.969 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -162.67 138.04 6.97 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 372' ' ' TYR . . . . . 0.454 ' CE1' ' HB ' ' A' ' 380' ' ' VAL . 11.2 p90 -150.47 162.29 40.87 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -96.78 117.69 31.6 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 374' ' ' ARG . . . . . 0.593 HH21 ' HB3' ' A' ' 440' ' ' GLU . 7.6 ptm180 -87.62 175.95 7.67 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -66.69 -16.97 64.6 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.616 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.22 -26.78 30.47 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.7 0.286 . . . . 0.0 111.675 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 114.87 -9.03 21.43 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.689 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 378' ' ' LYS . . . . . 0.525 ' HG2' ' HA ' ' A' ' 391' ' ' ASP . 76.6 mttt -94.98 164.88 12.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.908 0.385 . . . . 0.0 111.427 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 379' ' ' PHE . . . . . 0.773 ' HE1' ' HG3' ' A' ' 330' ' ' ARG . 10.9 m-85 -99.0 127.38 44.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.591 -179.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 380' ' ' VAL . . . . . 0.454 ' HB ' ' CE1' ' A' ' 372' ' ' TYR . 15.7 t -107.57 113.6 44.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.126 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 381' ' ' PHE . . . . . 0.402 ' HB2' ' HB2' ' A' ' 388' ' ' TRP . 61.9 m-85 -99.27 145.1 27.64 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.803 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -124.79 143.55 50.74 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.419 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.648 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 44.3 tttp -155.21 99.28 2.07 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 414' ' ' LYS . . . 75.08 -105.6 1.93 Allowed Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.539 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -119.42 7.74 11.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.937 0.399 . . . . 0.0 110.87 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -114.44 152.74 31.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.959 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -132.47 150.49 52.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.645 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 388' ' ' TRP . . . . . 0.648 ' HZ3' ' HB3' ' A' ' 383' ' ' LYS . 24.6 m-90 -127.53 138.96 53.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.105 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 75.3 t -117.38 115.67 49.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -106.49 126.04 51.76 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.525 ' HA ' ' HG2' ' A' ' 378' ' ' LYS . 21.2 t70 -91.88 84.68 5.4 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 177.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 69.85 -64.15 0.36 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.316 -178.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -145.51 -3.93 0.7 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 11.6 m -111.43 135.39 52.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.711 0.291 . . . . 0.0 111.284 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 62.3 tp -81.07 138.96 35.95 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.129 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' GLU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 2.2 mm-40 -65.39 146.71 98.93 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.63 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 397' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 24.7 Cg_exo -65.48 148.11 87.47 Favored 'Trans proline' 0 C--O 1.238 0.496 0 C-N-CA 123.036 2.491 . . . . 0.0 112.663 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 73.19 45.08 32.65 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.626 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -128.25 159.04 69.27 Favored Pre-proline 0 C--N 1.321 -0.649 0 O-C-N 122.859 -0.201 . . . . 0.0 110.811 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.6 ' HB3' ' CE2' ' A' ' 388' ' ' TRP . 92.2 Cg_endo -77.6 156.61 95.78 Favored 'Cis proline' 0 C--O 1.236 0.397 0 C-N-CA 123.568 -1.43 . . . . 0.0 113.577 0.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -112.58 156.48 22.59 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 0.425 ' HB2' ' HG2' ' A' ' 405' ' ' GLU . 19.1 m-70 -72.11 156.96 38.62 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 78.2 mt -57.33 -39.28 67.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.943 0.401 . . . . 0.0 111.087 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -69.58 -7.53 39.44 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.425 ' HG2' ' HB2' ' A' ' 402' ' ' HIS . 10.8 mm-40 -87.32 -15.04 39.15 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 48.8 tp -86.36 -36.83 18.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.888 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.689 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -169.65 156.09 26.7 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.731 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -90.65 136.14 33.25 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.722 0.296 . . . . 0.0 110.75 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 102.18 4.83 50.39 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.426 -0.669 . . . . 0.0 111.426 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 88.9 mt -89.79 148.51 40.04 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 120.47 0.176 . . . . 0.0 111.014 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -58.0 119.24 6.37 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.696 2.264 . . . . 0.0 111.075 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.96 7.37 31.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.58 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -99.2 -54.99 2.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.82 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 414' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 384' ' ' GLY . 15.6 ptmt -175.53 169.69 3.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.561 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.448 HD12 ' HD2' ' A' ' 429' ' ' PHE . 46.2 mm -121.82 126.23 74.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 416' ' ' ASP . . . . . 0.424 ' HB3' ' HD2' ' A' ' 463' ' ' PRO . 15.4 m-20 -82.38 -43.7 17.04 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.895 0.378 . . . . 0.0 110.698 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 417' ' ' ALA . . . . . 0.771 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -157.65 154.8 28.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.301 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -134.83 119.32 17.99 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 42.0 tp -115.17 117.97 32.03 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.872 0.368 . . . . 0.0 111.778 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -91.24 118.25 30.31 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.208 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 421' ' ' TRP . . . . . 0.731 ' HB2' ' HE2' ' A' ' 428' ' ' TYR . 15.6 t-105 -87.67 99.02 11.76 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.486 ' HB2' ' HD3' ' A' ' 423' ' ' PRO . 63.3 mtt -52.44 -52.57 62.12 Favored Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.486 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 86.6 Cg_exo -48.23 -40.34 35.01 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.898 2.399 . . . . 0.0 114.913 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 424' ' ' ASN . . . . . 0.514 ' OD1' ' HB3' ' A' ' 421' ' ' TRP . 39.6 p30 -103.09 -28.79 11.75 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 88.24 29.49 19.65 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.612 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -122.29 141.61 51.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.833 0.349 . . . . 0.0 110.589 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 60.1 m -103.17 130.03 50.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.419 0.628 . . . . 0.0 111.646 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 428' ' ' TYR . . . . . 0.731 ' HE2' ' HB2' ' A' ' 421' ' ' TRP . 65.7 m-85 -98.64 122.79 42.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.839 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 429' ' ' PHE . . . . . 0.448 ' HD2' HD12 ' A' ' 415' ' ' ILE . 43.1 m-85 -98.54 121.73 40.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.653 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -98.6 132.31 44.11 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.473 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.404 ' HD2' ' O ' ' A' ' 414' ' ' LYS . 3.4 tpm_? -145.07 107.14 4.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.205 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 69.71 -117.41 7.58 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 433' ' ' ASN . . . . . 0.51 ' HA ' ' HB3' ' A' ' 461' ' ' GLU . 24.6 p-10 -113.22 16.28 19.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.258 0.551 . . . . 0.0 110.712 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -125.89 150.51 47.86 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.366 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 435' ' ' TYR . . . . . 0.492 ' CE1' ' HB2' ' A' ' 451' ' ' LYS . 6.7 p90 -129.85 142.7 50.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.063 0.459 . . . . 0.0 111.457 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 436' ' ' TYR . . . . . 0.747 ' HD1' HG11 ' A' ' 445' ' ' VAL . 53.5 m-85 -109.09 147.57 32.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.428 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -107.14 94.74 5.26 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 438' ' ' PHE . . . . . 0.689 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 71.8 t80 -81.49 119.59 23.93 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.414 0.626 . . . . 0.0 112.068 -178.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -86.33 94.93 9.48 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 440' ' ' GLU . . . . . 0.593 ' HB3' HH21 ' A' ' 374' ' ' ARG . 8.8 mt-10 -54.8 -30.74 57.83 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -82.89 -10.74 58.68 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 50.3 mt -119.28 -12.41 9.42 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 52.9 mtm180 61.24 44.39 9.88 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.443 0.639 . . . . 0.0 111.858 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -163.24 154.95 17.52 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.769 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 445' ' ' VAL . . . . . 0.747 HG11 ' HD1' ' A' ' 436' ' ' TYR . 93.9 t -80.99 137.56 21.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.048 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -62.79 163.47 9.34 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.306 0.574 . . . . 0.0 111.883 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.99 161.93 30.19 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.283 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 72.03 20.85 4.22 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.188 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 449' ' ' TYR . . . . . 0.425 ' HE2' ' CE2' ' A' ' 435' ' ' TYR . 29.0 m-85 -125.0 158.97 61.15 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.999 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.0 161.16 91.5 Favored 'Cis proline' 0 C--N 1.345 0.386 0 C-N-CA 123.766 -1.347 . . . . 0.0 112.574 1.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 451' ' ' LYS . . . . . 0.492 ' HB2' ' CE1' ' A' ' 435' ' ' TYR . 68.0 mttm -114.24 172.51 6.96 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.78 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -72.42 140.99 48.67 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 453' ' ' ILE . . . . . 0.667 HD13 ' HA ' ' A' ' 461' ' ' GLU . 13.2 tt -67.51 -12.04 14.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.078 0.466 . . . . 0.0 110.772 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 454' ' ' LYS . . . . . 0.481 ' HD3' ' HA ' ' A' ' 454' ' ' LYS . 27.6 mmtp -65.84 -10.16 35.46 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 81.2 t -61.34 -34.51 61.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 177.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 456' ' ' TRP . . . . . 0.505 ' HB2' ' HB ' ' A' ' 459' ' ' ILE . 9.8 m95 -88.1 84.39 6.93 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.48 115.67 2.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.763 -178.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 103.24 -11.59 55.05 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.833 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 456' ' ' TRP . 27.5 mm -89.36 126.09 59.62 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 120.808 0.337 . . . . 0.0 111.188 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 460' ' ' PRO . . . . . 0.426 ' HG3' ' CZ2' ' A' ' 484' ' ' TRP . 94.2 Cg_endo -79.91 152.26 21.86 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.827 2.351 . . . . 0.0 111.41 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 461' ' ' GLU . . . . . 0.667 ' HA ' HD13 ' A' ' 453' ' ' ILE . 0.1 OUTLIER -75.64 157.6 33.52 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.84 -179.773 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.5 m 56.86 69.43 1.72 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.577 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 463' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 416' ' ' ASP . 4.6 Cg_endo -87.91 -179.29 2.47 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.04 2.493 . . . . 0.0 111.637 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 7.7 tpp85 -144.46 36.11 1.2 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.519 0.676 . . . . 0.0 110.08 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 161.81 132.8 1.38 Allowed Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.342 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 6.0 p -155.56 106.32 2.51 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -133.35 142.67 48.53 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.028 0.442 . . . . 0.0 111.782 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 42.2 ttm -92.61 140.31 29.67 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.542 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -69.32 166.95 47.59 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.274 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 1.5 m -68.03 -7.41 28.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.15 0.5 . . . . 0.0 111.681 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -86.27 -20.87 27.79 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.756 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 70.34 13.65 7.54 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.748 0.655 . . . . 0.0 112.27 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 19.4 t -114.82 -34.3 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 120.781 0.324 . . . . 0.0 111.343 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -113.76 133.79 55.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.209 0.528 . . . . 0.0 111.986 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 84.9 m -119.03 140.07 50.65 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.936 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -110.32 134.38 52.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.882 0.372 . . . . 0.0 111.782 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -116.08 141.66 47.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.47 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -120.69 134.92 55.25 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.994 0.184 . . . . 0.0 111.27 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -168.52 126.68 1.1 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.443 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 63.63 42.6 98.71 Favored Glycine 0 N--CA 1.454 -0.154 0 CA-C-N 116.086 -0.506 . . . . 0.0 113.751 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 54.6 t30 68.29 3.19 3.59 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 25.6 mtmt -116.24 157.89 24.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.048 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 483' ' ' TYR . . . . . 0.53 ' CE2' ' HE2' ' A' ' 497' ' ' TYR . 24.5 p90 -130.57 146.7 52.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.023 0.44 . . . . 0.0 111.695 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 484' ' ' TRP . . . . . 0.426 ' CZ2' ' HG3' ' A' ' 460' ' ' PRO . 16.8 m-90 -114.62 151.25 33.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.615 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -110.76 98.65 7.75 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 486' ' ' PHE . . . . . 0.548 ' HZ ' HD12 ' A' ' 491' ' ' LEU . 82.4 t80 -90.96 131.65 36.44 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.768 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -96.02 120.42 36.27 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -66.91 -29.49 69.38 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 52.0 tp60 -83.16 -39.35 21.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.827 0.346 . . . . 0.0 111.726 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -83.53 -19.87 34.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.484 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.548 HD12 ' HZ ' ' A' ' 486' ' ' PHE . 18.3 tp 61.22 34.02 18.93 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.481 0.658 . . . . 0.0 110.036 -179.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 25.8 tttp -156.03 150.2 25.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.567 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 493' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 486' ' ' PHE . 56.8 t -70.19 137.79 23.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.42 138.71 86.5 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.821 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -60.08 145.01 99.42 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 123.156 2.571 . . . . 0.0 112.644 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 109.61 -6.69 31.63 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 497' ' ' TYR . . . . . 0.744 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 57.0 m-85 -109.75 169.1 6.77 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 498' ' ' PRO . . . . . 0.744 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 96.6 Cg_endo -76.85 171.53 67.64 Favored 'Cis proline' 0 C--N 1.35 0.647 0 C-N-CA 124.022 -1.241 . . . . 0.0 113.083 0.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -131.83 164.28 26.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.97 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 48.1 t -72.72 122.27 21.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.512 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -67.98 -29.76 68.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.068 0.461 . . . . 0.0 110.605 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 502' ' ' LEU . . . . . 0.44 ' HA ' ' HG2' ' A' ' 506' ' ' MET . 63.6 mt -68.01 -41.58 82.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.354 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -77.75 -37.33 49.35 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -93.58 -27.49 16.59 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -176.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 36.6 m0 -109.56 -50.7 2.96 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 506' ' ' MET . . . . . 0.44 ' HG2' ' HA ' ' A' ' 502' ' ' LEU . 11.3 mmt -73.02 -26.57 61.36 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -178.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 88.77 25.91 28.49 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.813 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 21.7 m -106.03 105.74 54.58 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 120.627 0.251 . . . . 0.0 110.743 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -84.61 176.15 6.5 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.867 2.378 . . . . 0.0 111.82 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 40.2 m 62.14 46.83 6.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.468 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.421 -1.211 . . . . 0.0 110.589 179.561 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.897 0 N-CA-C 112.295 -0.322 . . . . 0.0 112.295 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' PRO . . . . . 0.444 ' HA ' HD23 ' B' ' 2' ' ' HYP . 72.4 Cg_endo -74.05 156.56 47.3 Favored 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 122.821 2.347 . . . . 0.0 111.777 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 2' ' ' HYP . . . . . 0.444 HD23 ' HA ' ' B' ' 1' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.04 169.05 51.48 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.52 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -82.32 174.27 10.04 Favored 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 122.88 2.387 . . . . 0.0 111.021 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.04 -157.59 17.46 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.326 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.684 ' HD2' ' HA ' ' D' ' 205' ' ' HYP . 48.1 Cg_exo -58.55 159.48 19.96 Favored 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 122.973 2.449 . . . . 0.0 111.866 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 8' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 160.57 155.49 7.8 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.687 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -63.19 137.28 60.39 Favored 'Trans proline' 0 C--O 1.238 0.498 0 C-N-CA 122.87 2.38 . . . . 0.0 111.839 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -65.47 143.35 57.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.133 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' D' ' 210' ' ' PRO . . . -57.63 153.2 24.99 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.987 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 mt -72.62 150.85 8.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.73 142.45 58.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.226 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.03 168.49 33.1 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.886 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -74.36 145.09 44.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.678 0.275 . . . . 0.0 110.782 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.55 136.18 54.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.973 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.8 144.34 34.79 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.985 -0.552 . . . . 0.0 113.687 -179.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 4.1 t -64.39 147.11 12.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 9.7 t -54.57 147.13 3.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.05 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.55 177.82 46.16 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.639 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 86.7 mt -87.96 153.45 21.28 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.418 0.151 . . . . 0.0 110.648 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 23' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.4 154.16 48.22 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.993 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.452 ' HA ' HD23 ' B' ' 26' ' ' HYP . 42.1 Cg_endo -69.2 151.99 72.24 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.772 2.314 . . . . 0.0 112.154 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 26' ' ' HYP . . . . . 0.452 HD23 ' HA ' ' B' ' 25' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.88 165.07 34.52 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.212 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.05 171.42 17.19 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.187 2.591 . . . . 0.0 111.627 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 29' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.49 174.75 53.59 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.76 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.401 ' HA ' HD23 ' B' ' 32' ' ' HYP . 14.2 Cg_exo -72.48 148.97 49.16 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 123.153 2.569 . . . . 0.0 111.643 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 32' ' ' HYP . . . . . 0.401 HD23 ' HA ' ' B' ' 31' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.28 139.13 47.43 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.783 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -69.72 130.74 19.91 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.487 2.124 . . . . 0.0 111.098 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 35' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 100' ' ' GLY . . . . . 0.479 ' HA3' ' HD3' ' C' ' 101' ' ' PRO . . . . . . . . 0 N--CA 1.449 -0.433 0 N-CA-C 112.29 -0.324 . . . . 0.0 112.29 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 101' ' ' PRO . . . . . 0.479 ' HD3' ' HA3' ' C' ' 100' ' ' GLY . 14.5 Cg_exo -69.96 130.7 19.53 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.898 2.399 . . . . 0.0 111.9 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 102' ' ' HYP . . . . . 0.455 HD23 ' HA ' ' C' ' 101' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -78.08 164.49 51.46 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.834 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 104' ' ' PRO . . . . . 0.421 ' HA ' HD23 ' C' ' 105' ' ' HYP . 94.1 Cg_endo -80.95 158.21 20.84 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.895 2.396 . . . . 0.0 112.528 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 105' ' ' HYP . . . . . 0.455 ' OD1' ' HG2' ' D' ' 204' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.61 -178.69 43.7 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.297 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -80.1 165.28 21.7 Favored 'Trans proline' 0 CA--C 1.528 0.18 0 C-N-CA 123.213 2.608 . . . . 0.0 110.886 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 108' ' ' HYP . . . . . 0.491 ' HA ' ' HG2' ' D' ' 207' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -65.99 165.98 37.32 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.811 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.85 157.45 61.31 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.749 2.299 . . . . 0.0 112.552 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -60.78 139.0 58.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.815 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -67.61 168.33 39.54 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.029 -0.605 . . . . 0.0 113.256 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 28.4 mt -68.6 138.18 22.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.86 147.58 51.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.966 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.54 149.27 48.72 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 116.058 -0.519 . . . . 0.0 113.196 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -78.27 143.61 36.89 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 122.283 0.233 . . . . 0.0 110.617 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 52.9 ttm-85 -62.19 145.25 54.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.632 0.253 . . . . 0.0 110.742 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.45 168.9 37.92 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.691 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -77.26 149.15 6.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.521 0.2 . . . . 0.0 110.475 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 120' ' ' VAL . . . . . 0.611 HG22 ' HB ' ' D' ' 219' ' ' VAL . 63.4 t -64.61 137.55 24.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.982 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.36 161.78 50.24 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 121.11 -0.566 . . . . 0.0 112.42 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 122' ' ' LEU . . . . . 0.429 ' HA ' HD23 ' C' ' 123' ' ' HYP . 88.9 mt -71.64 136.97 47.56 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 123' ' ' HYP . . . . . 0.429 HD23 ' HA ' ' C' ' 122' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -63.81 162.86 33.95 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.737 -0.665 . . . . 0.0 113.595 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.18 152.52 50.65 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.916 2.411 . . . . 0.0 111.647 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 126' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.79 163.55 32.7 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.365 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.38 160.64 44.35 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.632 2.222 . . . . 0.0 111.484 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -69.41 171.12 40.95 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.653 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -62.58 151.38 83.67 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.795 2.33 . . . . 0.0 111.59 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 132' ' ' HYP . . . . . 0.494 ' HA ' ' O ' ' D' ' 231' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.11 123.38 12.46 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.551 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -77.28 107.96 2.51 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 123.005 2.47 . . . . 0.0 111.88 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 135' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.387 0 N-CA-C 112.17 -0.372 . . . . 0.0 112.17 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' D' D ' 201' ' ' PRO . . . . . 0.461 ' HA ' HD23 ' D' ' 202' ' ' HYP . 36.0 Cg_exo -62.2 144.98 96.33 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.783 2.322 . . . . 0.0 111.488 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 202' ' ' HYP . . . . . 0.461 HD23 ' HA ' ' D' ' 201' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 94.18 -175.86 35.27 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.253 -0.975 . . . . 0.0 114.346 178.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 204' ' ' PRO . . . . . 0.455 ' HG2' ' OD1' ' C' ' 105' ' ' HYP . 28.4 Cg_exo -64.13 156.43 59.17 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.896 3.064 . . . . 0.0 113.265 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 205' ' ' HYP . . . . . 0.684 ' HA ' ' HD2' ' B' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . 91.28 170.16 42.37 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.988 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 207' ' ' PRO . . . . . 0.491 ' HG2' ' HA ' ' C' ' 108' ' ' HYP . 86.5 Cg_endo -89.15 151.32 5.65 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.187 2.591 . . . . 0.0 112.326 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 208' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -78.59 166.61 52.39 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.086 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 210' ' ' PRO . . . . . 0.452 ' O ' ' HA3' ' B' ' 12' ' ' GLY . 38.9 Cg_endo -68.12 158.35 57.85 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.643 2.229 . . . . 0.0 112.237 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -79.49 147.31 32.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.886 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.97 161.49 36.78 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.167 -0.54 . . . . 0.0 112.286 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 40.5 pt -66.79 166.92 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.63 0.252 . . . . 0.0 111.168 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 214' ' ' ALA . . . . . 0.432 ' HB3' ' NH1' ' A' ' 330' ' ' ARG . . . -80.64 138.99 36.45 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.912 0.387 . . . . 0.0 110.685 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -63.15 156.08 41.98 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.017 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -71.0 150.18 45.9 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -62.29 152.25 34.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.45 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -58.97 154.2 28.87 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.667 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 219' ' ' VAL . . . . . 0.611 ' HB ' HG22 ' C' ' 120' ' ' VAL . 15.8 t -66.74 143.15 15.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 21.9 t -63.01 143.26 15.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.047 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.22 162.66 31.98 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.777 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 7.3 mp -76.15 157.33 32.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.489 0.185 . . . . 0.0 110.778 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 223' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -65.52 148.22 51.08 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.339 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 225' ' ' PRO . . . . . 0.48 ' HA ' HD23 ' D' ' 226' ' ' HYP . 38.9 Cg_exo -62.27 148.28 93.52 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.837 2.358 . . . . 0.0 111.506 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 226' ' ' HYP . . . . . 0.48 HD23 ' HA ' ' D' ' 225' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 227' ' ' GLY . . . . . 0.419 ' HA2' ' HD3' ' D' ' 228' ' ' PRO . . . -64.11 159.61 40.12 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.999 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 228' ' ' PRO . . . . . 0.419 ' HD3' ' HA2' ' D' ' 227' ' ' GLY . 2.7 Cg_exo -77.87 162.26 29.61 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.03 2.487 . . . . 0.0 111.443 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -73.2 167.3 54.29 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.561 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 231' ' ' PRO . . . . . 0.494 ' O ' ' HA ' ' C' ' 132' ' ' HYP . 90.5 Cg_endo -83.39 157.79 14.67 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.654 2.236 . . . . 0.0 110.816 179.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 232' ' ' HYP . . . . . 0.411 HD23 ' HA ' ' D' ' 231' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 N--CA 1.479 0.65 0 N-CA-C 110.06 -0.785 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 317' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 320' ' ' ASP . 18.2 t-20 -115.27 161.2 18.8 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 17.6 tt -70.42 -23.42 24.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.08 0.467 . . . . 0.0 110.875 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 59.0 m -80.9 -1.1 42.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.227 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 317' ' ' ASN . 3.5 m-20 -71.33 -20.98 62.11 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.13 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 76.22 -177.31 50.83 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.822 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 24.4 m120 48.79 83.52 0.04 OUTLIER 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 323' ' ' PHE . . . . . 0.417 ' HD2' ' HH ' ' A' ' 478' ' ' TYR . 23.4 m-85 -100.62 168.67 9.55 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.222 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -77.35 -40.73 43.02 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 7.0 t -171.46 154.72 3.92 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.928 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 67.7 t -130.5 125.71 59.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -136.89 170.47 16.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.006 0.431 . . . . 0.0 110.898 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 328' ' ' MET . . . . . 0.433 ' HA ' ' O ' ' A' ' 332' ' ' GLU . 41.4 ttp -130.08 87.06 2.47 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.568 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.426 ' HB3' ' CE1' ' A' ' 379' ' ' PHE . 45.5 mt -85.7 123.8 31.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.48 -178.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 330' ' ' ARG . 31.5 mmt-85 63.71 19.37 11.69 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.203 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 93.2 -3.61 73.04 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.631 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 332' ' ' GLU . . . . . 0.451 ' HA ' ' NH2' ' A' ' 345' ' ' ARG . 15.4 mm-40 -95.45 128.44 42.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.853 0.359 . . . . 0.0 110.356 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 38.5 ttm -77.03 110.92 12.07 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.251 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -110.29 122.83 48.61 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.988 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 27.2 t -109.73 122.34 64.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.47 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -106.21 132.04 52.75 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.731 0.3 . . . . 0.0 111.46 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 0.783 ' HB3' ' HZ3' ' A' ' 342' ' ' TRP . 61.2 tttp -148.37 112.38 5.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.42 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 64.76 -113.01 0.31 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.922 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 15.4 ptt-85 -114.63 11.78 17.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.857 0.361 . . . . 0.0 111.107 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 15.0 m-90 -122.99 155.07 37.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.933 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -135.85 148.69 48.76 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.686 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 342' ' ' TRP . . . . . 0.783 ' HZ3' ' HB3' ' A' ' 337' ' ' LYS . 29.2 m-90 -124.47 162.5 23.82 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.462 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.13 114.99 9.07 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 2.5 m -103.3 136.86 34.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.262 0.553 . . . . 0.0 112.083 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 345' ' ' ARG . . . . . 0.451 ' NH2' ' HA ' ' A' ' 332' ' ' GLU . 18.0 tpp180 -135.84 123.26 22.0 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 5.6 m120 66.14 35.21 6.27 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 123.564 0.54 . . . . 0.0 110.614 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 17.5 t30 63.14 33.12 14.71 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.048 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -143.03 143.52 31.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.563 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 14.0 t -83.65 131.39 33.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 91.1 mtp -84.44 172.57 11.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.904 0.383 . . . . 0.0 111.513 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -77.47 158.38 30.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.23 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 98.02 -5.47 61.48 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.045 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -117.64 152.72 50.08 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.406 ' HB3' ' CE2' ' A' ' 342' ' ' TRP . 74.0 Cg_endo -76.58 140.01 63.1 Favored 'Cis proline' 0 C--N 1.343 0.286 0 C-N-CA 123.215 -1.577 . . . . 0.0 112.834 0.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 57.1 ttm -119.85 135.94 24.56 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.94 134.77 64.59 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.327 2.018 . . . . 0.0 110.931 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 94.0 mt -51.91 -42.32 33.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.814 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -67.83 -8.11 51.61 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 116.029 -0.532 . . . . 0.0 114.271 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.72 -32.87 27.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.259 0.529 . . . . 0.0 110.447 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -104.47 -56.32 2.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.966 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -86.13 74.95 9.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.712 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 362' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 362' ' ' ARG . 25.6 ttp180 -63.45 100.92 0.28 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.896 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 129.31 -16.7 5.68 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.299 -0.721 . . . . 0.0 111.299 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.555 HD12 ' HD2' ' A' ' 365' ' ' PRO . 22.6 tp -92.38 134.05 28.82 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 365' ' ' PRO . . . . . 0.555 ' HD2' HD12 ' A' ' 364' ' ' LEU . 96.3 Cg_endo -82.87 -167.08 0.43 Allowed 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 123.033 2.488 . . . . 0.0 112.258 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -96.94 157.81 15.72 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.051 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 27.7 m 54.73 80.31 0.13 Allowed 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 17.9 pt -93.57 170.26 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.013 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.93 -39.25 7.02 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -178.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 370' ' ' THR . . . . . 0.532 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.2 OUTLIER -153.13 160.45 42.89 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.657 0.265 . . . . 0.0 111.288 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -153.08 138.2 17.35 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 372' ' ' TYR . . . . . 0.474 ' HE1' ' HE2' ' A' ' 382' ' ' PHE . 11.8 p90 -166.09 174.66 9.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.683 0.278 . . . . 0.0 111.076 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.418 ' OE1' ' HD3' ' A' ' 330' ' ' ARG . 33.4 mt-10 -104.92 131.51 52.33 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 374' ' ' ARG . . . . . 0.492 ' HB2' ' OE2' ' A' ' 440' ' ' GLU . 6.3 ptm180 -88.61 -177.99 5.7 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.404 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.449 ' HZ3' ' CD ' ' A' ' 441' ' ' GLU . 7.6 tttp -65.64 -34.23 77.75 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -21.82 64.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.98 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 109.77 -10.99 32.45 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.962 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 19.8 mttp -86.06 160.28 19.34 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 117.266 0.533 . . . . 0.0 111.409 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 379' ' ' PHE . . . . . 0.426 ' CE1' ' HB3' ' A' ' 329' ' ' LEU . 45.6 m-85 -88.35 130.57 35.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.181 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 380' ' ' VAL . . . . . 0.448 ' HB ' ' CE1' ' A' ' 372' ' ' TYR . 8.9 t -113.86 119.7 61.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.004 0.431 . . . . 0.0 110.194 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 381' ' ' PHE . . . . . 0.444 ' HB2' ' HB2' ' A' ' 388' ' ' TRP . 94.5 m-85 -107.37 140.16 40.73 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.67 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.474 ' HE2' ' HE1' ' A' ' 372' ' ' TYR . 32.9 m-85 -121.49 139.91 52.87 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.983 0.421 . . . . 0.0 111.603 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.456 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 86.1 tttt -154.2 114.05 3.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.744 178.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 66.76 -107.24 1.92 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.692 -0.765 . . . . 0.0 111.481 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -122.62 8.82 9.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.21 0.529 . . . . 0.0 110.165 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -114.84 152.37 32.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.795 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 387' ' ' HIS . . . . . 0.407 ' NE2' ' HE2' ' A' ' 399' ' ' TYR . 25.8 p-80 -134.27 150.93 51.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.394 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 388' ' ' TRP . . . . . 0.535 ' CE2' ' HB3' ' A' ' 400' ' ' PRO . 16.7 m-90 -122.64 142.58 50.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.186 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 85.6 t -124.38 119.13 55.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -118.62 126.79 52.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.977 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -93.79 95.08 8.9 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 177.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 392' ' ' GLU . . . . . 0.416 ' HA ' ' HE2' ' A' ' 379' ' ' PHE . 72.2 mm-40 69.96 -78.32 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.812 0.695 . . . . 0.0 110.273 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -140.87 16.87 2.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.965 0.412 . . . . 0.0 111.05 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 9.1 m -123.24 126.9 47.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.956 0.407 . . . . 0.0 111.723 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 46.6 tp -76.54 140.19 41.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.428 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 396' ' ' GLU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 5.5 mm-40 -71.6 136.63 83.31 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.307 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 397' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 24.6 Cg_exo -64.0 131.99 32.83 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.81 2.34 . . . . 0.0 112.096 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 108.07 -11.44 37.42 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.841 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 399' ' ' TYR . . . . . 0.505 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 58.2 m-85 -93.5 161.01 31.85 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 110.543 -0.169 . . . . 0.0 110.543 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.535 ' HB3' ' CE2' ' A' ' 388' ' ' TRP . 55.3 Cg_endo -68.96 160.33 85.77 Favored 'Cis proline' 0 C--N 1.348 0.537 0 C-N-CA 123.909 -1.288 . . . . 0.0 113.205 0.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -135.45 161.93 34.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.819 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 0.501 ' HB2' ' HG2' ' A' ' 405' ' ' GLU . 30.5 m-70 -70.37 153.91 42.48 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 77.6 mt -57.61 -37.81 60.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.099 0.476 . . . . 0.0 111.095 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -68.1 -10.08 51.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.99 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.501 ' HG2' ' HB2' ' A' ' 402' ' ' HIS . 65.3 mm-40 -79.65 -20.6 46.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.809 0.337 . . . . 0.0 110.767 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 36.9 tp -80.15 -61.81 1.87 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.264 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.845 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -143.21 154.91 25.74 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.063 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -79.61 132.06 36.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.667 -0.266 . . . . 0.0 110.336 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 102.29 -4.3 51.5 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.317 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 410' ' ' LEU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 411' ' ' PRO . 50.2 mt -77.33 146.0 73.46 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 120.63 0.252 . . . . 0.0 110.976 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 411' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 410' ' ' LEU . 47.8 Cg_exo -57.07 131.91 48.22 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.734 2.289 . . . . 0.0 112.075 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.69 -0.5 37.24 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.293 0.568 . . . . 0.0 110.42 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -90.13 -53.13 4.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.941 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -179.15 170.9 1.39 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.826 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 42.6 mm -124.61 133.01 70.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -90.63 -47.15 7.85 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.117 0.485 . . . . 0.0 110.234 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 417' ' ' ALA . . . . . 0.532 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -155.26 159.68 40.23 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.339 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -142.45 113.68 7.7 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 35.1 tp -109.61 123.2 49.04 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.407 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -88.36 114.64 25.18 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.062 0.458 . . . . 0.0 110.086 178.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 15.3 t-105 -83.63 94.23 8.06 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.509 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 62.6 mtt -50.74 -50.72 71.69 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -43.01 -48.97 7.32 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 123.011 2.474 . . . . 0.0 114.867 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -105.07 -13.8 15.62 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 75.23 33.7 53.23 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.162 -0.542 . . . . 0.0 113.204 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -116.38 149.22 39.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.796 0.298 . . . . 0.0 110.456 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 6.4 m -98.23 128.0 44.47 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.203 0.525 . . . . 0.0 112.218 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -102.78 109.08 20.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.948 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -91.89 129.68 37.81 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.461 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -106.18 129.62 54.2 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.004 0.431 . . . . 0.0 110.988 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.562 ' HB3' ' HE1' ' A' ' 436' ' ' TYR . 3.1 tpm_? -139.21 102.98 4.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.336 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 63.44 -109.5 2.78 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.318 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -110.82 11.96 22.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.031 0.443 . . . . 0.0 110.62 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -122.91 152.38 40.86 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.966 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 435' ' ' TYR . . . . . 0.551 ' CE2' ' HE2' ' A' ' 449' ' ' TYR . 8.2 p90 -133.82 139.2 46.11 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.383 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 436' ' ' TYR . . . . . 0.562 ' HE1' ' HB3' ' A' ' 431' ' ' ARG . 4.2 m-85 -111.62 145.2 39.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.829 -178.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 20.9 ttp180 -106.01 100.62 10.16 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 438' ' ' PHE . . . . . 0.845 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 83.2 t80 -85.06 120.41 26.54 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.235 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -95.61 106.79 18.93 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.537 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 440' ' ' GLU . . . . . 0.492 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 4.5 mm-40 -58.16 -39.06 77.85 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.597 0.56 . . . . 0.0 111.48 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 441' ' ' GLU . . . . . 0.449 ' CD ' ' HZ3' ' A' ' 375' ' ' LYS . 1.9 mp0 -61.16 -20.56 62.85 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 13.8 mt -127.72 3.5 6.09 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 43.03 47.37 5.03 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.493 0.663 . . . . 0.0 112.315 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -154.51 172.65 17.45 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.132 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.6 t -88.24 138.94 18.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.149 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.32 160.81 15.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.525 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 447' ' ' SER . . . . . 0.543 ' O ' ' HB2' ' A' ' 448' ' ' GLU . 1.7 m -67.13 151.96 46.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.446 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 448' ' ' GLU . . . . . 0.543 ' HB2' ' O ' ' A' ' 447' ' ' SER . 26.7 mt-10 78.45 -6.68 1.9 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.51 0.724 . . . . 0.0 111.786 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 449' ' ' TYR . . . . . 0.551 ' HE2' ' CE2' ' A' ' 435' ' ' TYR . 54.2 m-85 -98.23 154.68 37.55 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.702 -0.227 . . . . 0.0 111.418 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.4 162.71 91.94 Favored 'Cis proline' 0 C--N 1.345 0.364 0 C-N-CA 123.439 -1.484 . . . . 0.0 112.998 0.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -121.94 178.17 5.0 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -78.07 137.01 38.01 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.721 0.296 . . . . 0.0 110.298 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.5 tt -63.97 -17.48 20.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -63.48 -9.16 11.53 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 53.7 t -63.07 -33.9 63.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -91.5 94.76 9.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.362 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 457' ' ' GLU . . . . . 0.722 ' HB3' ' HG3' ' A' ' 492' ' ' LYS . 13.3 mm-40 -56.08 105.2 0.17 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 114.25 -7.8 22.95 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.515 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 24.7 mm -84.58 127.44 65.56 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 121.006 0.431 . . . . 0.0 111.065 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -77.99 138.93 16.87 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.893 2.395 . . . . 0.0 113.042 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -66.66 140.81 57.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.293 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 2.7 m 57.74 71.44 1.07 Allowed Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -87.28 -171.28 0.7 Allowed 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.423 2.082 . . . . 0.0 111.632 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -143.63 20.55 1.84 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.212 0.529 . . . . 0.0 110.891 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 177.92 142.0 4.44 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 13.0 p -162.65 110.65 1.31 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.6 0.238 . . . . 0.0 110.731 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -138.98 144.44 38.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.866 0.365 . . . . 0.0 111.251 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 48.7 ttm -95.47 143.05 27.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.022 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 469' ' ' GLY . . . . . 0.442 ' C ' ' H ' ' A' ' 471' ' ' ASP . . . -72.67 163.91 54.76 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.962 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.94 30.25 0.09 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.167 0.508 . . . . 0.0 111.901 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 471' ' ' ASP . . . . . 0.442 ' H ' ' C ' ' A' ' 469' ' ' GLY . 1.0 OUTLIER -126.73 -14.28 5.71 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.294 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 67.24 9.44 6.96 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.3 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 40.2 t -106.71 -45.25 7.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.859 0.361 . . . . 0.0 111.133 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -108.09 132.13 53.89 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 97.0 m -116.79 138.95 51.13 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.689 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 476' ' ' TYR . . . . . 0.491 ' HE1' ' HE2' ' A' ' 485' ' ' LYS . 28.3 m-85 -114.15 126.52 55.17 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -110.08 141.78 42.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.145 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 478' ' ' TYR . . . . . 0.417 ' HH ' ' HD2' ' A' ' 323' ' ' PHE . 76.8 t80 -123.04 135.0 54.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.705 0.288 . . . . 0.0 111.566 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 479' ' ' LYS . . . . . 0.4 ' HB3' ' CZ3' ' A' ' 484' ' ' TRP . 61.8 tttt -166.87 128.25 1.66 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.078 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 59.56 43.18 97.82 Favored Glycine 0 CA--C 1.516 0.148 0 N-CA-C 114.667 0.627 . . . . 0.0 114.667 178.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 58.4 t30 68.92 3.94 4.25 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 178.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -116.84 152.19 34.95 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 483' ' ' TYR . . . . . 0.481 ' CE2' ' HE2' ' A' ' 497' ' ' TYR . 7.3 p90 -128.12 145.17 51.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.114 0.483 . . . . 0.0 111.813 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 484' ' ' TRP . . . . . 0.4 ' CZ3' ' HB3' ' A' ' 479' ' ' LYS . 16.8 m-90 -112.77 138.09 50.11 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.499 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 485' ' ' LYS . . . . . 0.491 ' HE2' ' HE1' ' A' ' 476' ' ' TYR . 32.6 ttmt -101.88 96.12 6.84 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 486' ' ' PHE . . . . . 0.552 ' HA ' ' HA ' ' A' ' 493' ' ' VAL . 90.0 t80 -87.77 133.26 33.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.566 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -100.32 117.13 33.89 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -66.55 -34.44 77.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.768 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -68.76 -32.93 73.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.68 -178.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -98.5 -20.54 17.02 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 1.3 tp 66.11 39.26 4.4 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.795 0.807 . . . . 0.0 109.814 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 492' ' ' LYS . . . . . 0.722 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 31.5 tttp -160.17 153.36 21.88 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.386 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 493' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 486' ' ' PHE . 52.8 t -78.04 133.5 30.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 178.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -59.42 137.46 89.04 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.41 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -61.85 152.01 77.39 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.979 2.453 . . . . 0.0 112.284 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 94.37 9.48 59.07 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.684 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 497' ' ' TYR . . . . . 0.633 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 21.7 m-85 -117.43 170.17 6.49 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 498' ' ' PRO . . . . . 0.633 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 87.4 Cg_endo -78.29 -178.72 24.76 Favored 'Cis proline' 0 C--N 1.348 0.53 0 C-N-CA 124.104 -1.207 . . . . 0.0 112.865 0.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -135.29 155.25 50.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.176 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.29 116.33 10.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.565 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -63.47 -23.6 67.47 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 502' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 502' ' ' LEU . 13.4 mt -61.15 -49.65 76.35 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -83.05 -29.08 29.12 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.05 -35.73 21.69 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 44.3 m0 -116.29 -45.07 2.85 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -177.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 9.7 mmt -75.5 -17.77 60.01 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -177.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 76.41 21.95 74.15 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.742 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 16.9 m -104.38 111.07 65.11 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 120.754 0.311 . . . . 0.0 110.898 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -86.27 -167.47 0.38 Allowed 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.873 2.382 . . . . 0.0 111.525 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 16.2 m 60.34 37.63 20.08 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.046 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.386 -1.23 . . . . 0.0 111.832 -179.506 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.669 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -80.06 150.3 20.44 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 122.543 2.162 . . . . 0.0 111.433 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 2' ' ' HYP . . . . . 0.516 ' HA ' ' HB2' ' C' ' 101' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -60.71 164.37 16.73 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.9 -0.591 . . . . 0.0 113.661 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.34 171.1 17.48 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.874 2.383 . . . . 0.0 110.966 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.6 -164.67 35.47 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.768 -0.73 . . . . 0.0 111.913 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.703 ' HG2' ' HA ' ' D' ' 205' ' ' HYP . 22.3 Cg_endo -63.07 165.81 15.89 Favored 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 122.678 2.252 . . . . 0.0 111.463 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 8' ' ' HYP . . . . . 0.539 ' O ' ' HA3' ' D' ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 149.24 176.2 22.29 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.65 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.11 138.33 51.56 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.769 2.312 . . . . 0.0 111.561 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' GLN . . . . . 0.664 ' HG3' ' HG2' ' C' ' 110' ' ' PRO . 27.2 tt0 -66.67 150.27 49.3 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.084 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.18 143.07 46.24 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.355 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.475 ' H ' HD12 ' B' ' 13' ' ' ILE . 4.0 mp -64.86 137.93 24.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.01 143.41 22.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.129 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.64 164.77 41.8 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.106 -0.568 . . . . 0.0 113.17 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -75.11 150.34 38.83 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -70.22 146.49 50.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.525 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' D' ' 216' ' ' GLN . . . -64.95 155.24 48.84 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.492 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.42 ' H ' HG23 ' B' ' 19' ' ' VAL . 2.2 t -66.3 149.76 11.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.554 0.216 . . . . 0.0 110.667 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 6.0 t -53.92 145.71 3.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.24 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.99 161.25 52.08 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 116.035 -0.529 . . . . 0.0 113.153 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 87.4 mt -76.78 147.22 37.38 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.703 -0.248 . . . . 0.0 110.756 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 23' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.12 157.11 52.69 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.847 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.42 158.54 51.12 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.609 2.206 . . . . 0.0 111.412 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.96 164.61 49.6 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.864 -0.607 . . . . 0.0 113.153 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.418 ' HA ' HD23 ' B' ' 29' ' ' HYP . 68.0 Cg_endo -74.62 157.39 44.38 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.798 2.332 . . . . 0.0 111.864 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 29' ' ' HYP . . . . . 0.418 HD23 ' HA ' ' B' ' 28' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.2 174.14 52.2 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.168 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.403 ' HA ' HD23 ' B' ' 32' ' ' HYP . 9.1 Cg_exo -74.71 152.95 42.96 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.29 2.66 . . . . 0.0 111.766 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 32' ' ' HYP . . . . . 0.403 HD23 ' HA ' ' B' ' 31' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.62 137.46 42.11 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.596 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' PRO . . . . . 0.499 ' HA ' HD23 ' B' ' 35' ' ' HYP . 25.1 Cg_endo -63.64 117.21 4.19 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.759 2.306 . . . . 0.0 111.033 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 35' ' ' HYP . . . . . 0.499 HD23 ' HA ' ' B' ' 34' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.506 0 CA-C-O 119.952 -0.36 . . . . 0.0 112.586 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 101' ' ' PRO . . . . . 0.516 ' HB2' ' HA ' ' B' ' 2' ' ' HYP . 31.5 Cg_exo -60.72 124.49 15.12 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.952 2.435 . . . . 0.0 112.084 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 102' ' ' HYP . . . . . 0.511 HD23 ' HA ' ' C' ' 101' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -67.97 160.08 50.67 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.446 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -84.05 162.91 13.62 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.957 2.438 . . . . 0.0 111.95 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 105' ' ' HYP . . . . . 0.465 ' OD1' ' HG2' ' D' ' 204' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -74.68 176.79 48.1 Favored Glycine 0 C--O 1.24 0.511 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.52 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.8 148.32 36.11 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.961 2.44 . . . . 0.0 110.742 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 108' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -67.91 172.88 32.21 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.615 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 110' ' ' PRO . . . . . 0.664 ' HG2' ' HG3' ' B' ' 11' ' ' GLN . 59.1 Cg_endo -72.27 163.98 37.01 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.886 2.391 . . . . 0.0 112.116 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -65.6 137.63 57.49 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.15 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.48 166.63 30.02 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.841 -0.618 . . . . 0.0 113.562 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 79.9 mt -63.8 137.72 24.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.752 0.31 . . . . 0.0 110.847 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.11 145.15 54.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.538 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -59.16 148.37 40.4 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.627 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -75.2 156.8 35.44 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.673 0.273 . . . . 0.0 110.464 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 38.0 ttm-85 -69.67 147.34 50.74 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.302 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.9 170.0 52.13 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.485 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 21.6 t -69.23 138.95 21.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.606 0.241 . . . . 0.0 110.651 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 58.0 t -62.42 137.33 24.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.661 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.31 158.62 30.77 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.26 -0.495 . . . . 0.0 112.851 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 95.7 mt -75.91 152.55 37.1 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.391 0.138 . . . . 0.0 110.922 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 123' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -70.46 165.41 51.99 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.496 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.53 155.15 55.17 Favored 'Trans proline' 0 CA--C 1.529 0.233 0 C-N-CA 122.691 2.261 . . . . 0.0 111.581 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 126' ' ' HYP . . . . . 0.405 ' HA ' ' HD2' ' D' ' 225' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -66.0 166.75 36.09 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.902 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 128' ' ' PRO . . . . . 0.455 ' HA ' HD23 ' C' ' 129' ' ' HYP . 46.9 Cg_endo -69.37 148.91 68.64 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.579 2.186 . . . . 0.0 111.562 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 129' ' ' HYP . . . . . 0.455 HD23 ' HA ' ' C' ' 128' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 130' ' ' GLY . . . . . 0.408 ' HA2' ' HD3' ' C' ' 131' ' ' PRO . . . -60.3 156.72 29.6 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.885 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 131' ' ' PRO . . . . . 0.418 ' HA ' HD23 ' C' ' 132' ' ' HYP . 14.0 Cg_exo -70.73 158.49 55.56 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.913 2.409 . . . . 0.0 111.696 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 132' ' ' HYP . . . . . 0.418 HD23 ' HA ' ' C' ' 131' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -74.89 127.23 9.32 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.925 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 134' ' ' PRO . . . . . 0.485 ' HA ' HD23 ' C' ' 135' ' ' HYP . 40.8 Cg_endo -68.83 114.95 3.72 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 122.881 2.387 . . . . 0.0 111.889 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 135' ' ' HYP . . . . . 0.485 HD23 ' HA ' ' C' ' 134' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.335 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' 201' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' C' ' 102' ' ' HYP . 24.0 Cg_exo -65.98 156.64 63.45 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 122.946 2.431 . . . . 0.0 111.807 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 202' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 89.94 -172.29 38.42 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.993 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 204' ' ' PRO . . . . . 0.465 ' HG2' ' OD1' ' C' ' 105' ' ' HYP . 25.5 Cg_exo -65.64 155.64 68.01 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 123.454 2.769 . . . . 0.0 112.722 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 205' ' ' HYP . . . . . 0.703 ' HA ' ' HG2' ' B' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 206' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' B' ' 8' ' ' HYP . . . 91.05 171.82 43.36 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.965 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 207' ' ' PRO . . . . . 0.415 ' HA ' HD23 ' D' ' 208' ' ' HYP . 81.7 Cg_endo -96.05 160.43 1.36 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.424 2.75 . . . . 0.0 112.519 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 208' ' ' HYP . . . . . 0.415 HD23 ' HA ' ' D' ' 207' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -77.16 169.09 54.88 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.05 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.26 141.1 73.97 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.471 2.114 . . . . 0.0 112.23 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 211' ' ' GLN . . . . . 0.451 ' HG3' ' N ' ' D' ' 212' ' ' GLY . 1.4 tt0 -65.87 150.93 47.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.929 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 212' ' ' GLY . . . . . 0.451 ' N ' ' HG3' ' D' ' 211' ' ' GLN . . . -67.46 160.33 49.47 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.357 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 45.6 pt -69.21 174.11 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 120.819 0.343 . . . . 0.0 111.439 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -77.67 147.86 35.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.499 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -74.48 158.02 51.28 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.773 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 216' ' ' GLN . . . . . 0.453 ' O ' ' HA3' ' B' ' 18' ' ' GLY . 33.4 mm-40 -77.52 151.6 34.48 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.623 0.249 . . . . 0.0 110.488 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 217' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' D' ' 217' ' ' ARG . 8.8 mtp180 -66.58 156.23 35.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.989 0.424 . . . . 0.0 110.571 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -66.23 151.37 52.09 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.185 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 11.5 t -65.82 148.77 11.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 61.6 t -63.03 139.1 21.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-O 120.725 0.297 . . . . 0.0 110.425 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.33 157.22 28.86 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.516 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 222' ' ' LEU . . . . . 0.409 ' HA ' HD23 ' D' ' 223' ' ' HYP . 9.2 mp -65.03 149.2 50.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.751 -0.224 . . . . 0.0 110.889 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 223' ' ' HYP . . . . . 0.409 HD23 ' HA ' ' D' ' 222' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 224' ' ' GLY . . . . . 0.418 ' HA2' ' HD3' ' D' ' 225' ' ' PRO . . . -60.04 153.26 34.91 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.855 -0.612 . . . . 0.0 113.175 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 225' ' ' PRO . . . . . 0.433 ' HA ' HD23 ' D' ' 226' ' ' HYP . 15.5 Cg_exo -69.98 148.85 64.58 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 123.031 2.487 . . . . 0.0 111.466 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 226' ' ' HYP . . . . . 0.433 HD23 ' HA ' ' D' ' 225' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -64.45 158.7 42.65 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.773 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.93 161.45 33.05 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 122.701 2.267 . . . . 0.0 111.954 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -78.32 -175.74 45.68 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.444 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 231' ' ' PRO . . . . . 0.418 ' HA ' HD23 ' D' ' 232' ' ' HYP . 95.2 Cg_endo -92.82 155.04 2.79 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.298 2.665 . . . . 0.0 112.511 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 232' ' ' HYP . . . . . 0.418 HD23 ' HA ' ' D' ' 231' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo . . . . . 0 N--CA 1.479 0.665 0 N-CA-C 110.26 -0.708 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 317' ' ' ASN . . . . . 0.534 ' O ' ' HB2' ' A' ' 320' ' ' ASP . 14.3 t-20 -110.79 166.3 11.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.423 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.466 HG13 ' HB3' ' A' ' 506' ' ' MET . 8.5 tp -72.78 -31.04 34.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.051 0.453 . . . . 0.0 110.64 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 59.0 m -82.77 10.24 8.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.94 0.4 . . . . 0.0 111.457 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.534 ' HB2' ' O ' ' A' ' 317' ' ' ASN . 0.1 OUTLIER -69.72 -32.02 70.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.437 179.626 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 79.96 -176.81 54.57 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.481 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 3.5 t30 53.9 78.79 0.15 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.046 0.45 . . . . 0.0 111.218 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -96.04 154.79 17.05 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.902 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 324' ' ' ASP . . . . . 0.418 ' OD1' ' HA ' ' A' ' 337' ' ' LYS . 3.0 m-20 -74.25 -40.53 62.31 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.221 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 1.8 t -170.86 146.54 2.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.448 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.431 HG22 HG13 ' A' ' 335' ' ' VAL . 60.6 t -131.97 126.25 56.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -149.33 176.81 10.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.053 0.454 . . . . 0.0 111.231 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 41.3 ttp -127.16 122.37 33.93 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.419 ' HB3' ' CE1' ' A' ' 379' ' ' PHE . 54.3 mt -114.64 119.75 37.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.902 -179.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.609 ' HG3' ' HE1' ' A' ' 379' ' ' PHE . 63.6 mtp180 55.82 26.04 9.14 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 101.96 -10.63 57.17 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.684 -0.77 . . . . 0.0 113.356 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -100.25 130.01 46.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.929 0.395 . . . . 0.0 111.306 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 45.2 ttm -84.05 124.43 31.08 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -119.56 120.5 36.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.132 0.492 . . . . 0.0 111.572 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 335' ' ' VAL . . . . . 0.431 HG13 HG22 ' A' ' 326' ' ' VAL . 23.1 t -105.31 115.22 46.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -99.74 131.67 45.58 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 0.695 ' HB3' ' HZ3' ' A' ' 342' ' ' TRP . 38.7 tttp -144.18 109.25 5.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.174 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 61.31 -102.39 0.12 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.894 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 339' ' ' ARG . 11.7 ptm85 -119.48 12.97 12.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.878 0.37 . . . . 0.0 111.361 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 13.3 m-90 -125.71 153.73 43.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.71 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -136.35 141.76 43.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.863 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 342' ' ' TRP . . . . . 0.695 ' HZ3' ' HB3' ' A' ' 337' ' ' LYS . 21.0 m-90 -115.59 147.09 41.15 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.882 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -116.48 92.81 3.99 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.476 HG12 HG22 ' A' ' 349' ' ' VAL . 10.2 m -91.42 128.39 43.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.619 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 42.5 ttm-85 -131.82 118.85 20.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.428 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 63.03 41.42 8.29 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.869 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 34.9 t30 68.29 15.37 9.3 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.353 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -126.58 129.26 48.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.72 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.476 HG22 HG12 ' A' ' 344' ' ' VAL . 21.7 t -76.57 121.98 29.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.661 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 26.0 ttp -66.94 151.57 47.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.788 0.327 . . . . 0.0 110.501 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -69.51 161.08 30.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.195 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 90.21 7.07 68.13 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.06 -0.591 . . . . 0.0 111.908 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 353' ' ' TYR . . . . . 0.561 ' HB3' ' HA ' ' A' ' 354' ' ' PRO . 80.5 m-85 -128.78 162.22 52.88 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.561 ' HA ' ' HB3' ' A' ' 353' ' ' TYR . 56.8 Cg_endo -70.37 144.04 76.77 Favored 'Cis proline' 0 C--N 1.346 0.396 0 C-N-CA 123.815 -1.327 . . . . 0.0 112.943 0.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 355' ' ' MET . . . . . 0.502 ' HB2' ' CD1' ' A' ' 353' ' ' TYR . 0.0 OUTLIER -113.23 144.36 31.04 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.36 179.528 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 356' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 355' ' ' MET . 17.5 Cg_exo -68.2 129.65 19.74 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.541 2.16 . . . . 0.0 111.358 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 85.3 mt -56.53 -41.6 73.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.479 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -65.7 -17.57 64.99 Favored Glycine 0 CA--C 1.518 0.25 0 N-CA-C 114.603 0.601 . . . . 0.0 114.603 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -84.65 -45.11 12.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.237 0.519 . . . . 0.0 111.063 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -82.72 -53.92 5.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.189 0.519 . . . . 0.0 110.555 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -92.61 70.24 4.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.553 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -59.41 101.88 0.12 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.208 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 128.95 -20.79 5.35 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.464 HD12 ' HD2' ' A' ' 365' ' ' PRO . 18.8 tp -85.7 134.61 39.39 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 365' ' ' PRO . . . . . 0.464 ' HD2' HD12 ' A' ' 364' ' ' LEU . 97.5 Cg_endo -82.43 -175.17 2.36 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.813 2.342 . . . . 0.0 112.145 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -91.06 153.0 20.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.502 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.0 m 57.12 83.06 0.11 Allowed 'General case' 0 C--O 1.233 0.232 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 13.7 pt -94.9 176.19 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.898 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -111.55 -38.2 4.99 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 1.6 m -149.97 156.23 41.36 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.798 0.332 . . . . 0.0 111.54 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -149.15 135.82 19.54 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 372' ' ' TYR . . . . . 0.459 ' CE1' ' HB ' ' A' ' 380' ' ' VAL . 33.6 p90 -158.48 165.08 35.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.117 0.484 . . . . 0.0 112.191 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 62.5 tt0 -99.14 133.92 42.73 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 374' ' ' ARG . . . . . 0.469 ' HB2' ' OE2' ' A' ' 440' ' ' GLU . 15.2 ptm180 -95.44 -170.69 2.21 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -77.17 -23.56 51.55 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -177.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.63 -11.05 57.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 104.23 -14.37 51.51 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.854 -0.689 . . . . 0.0 113.949 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 378' ' ' LYS . . . . . 0.513 ' HD3' ' HB2' ' A' ' 391' ' ' ASP . 25.2 mttp -82.05 163.66 21.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.305 0.553 . . . . 0.0 111.867 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 379' ' ' PHE . . . . . 0.609 ' HE1' ' HG3' ' A' ' 330' ' ' ARG . 10.5 m-85 -99.96 135.56 41.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.351 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 380' ' ' VAL . . . . . 0.459 ' HB ' ' CE1' ' A' ' 372' ' ' TYR . 12.2 t -116.43 122.02 68.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.254 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -108.2 139.8 42.35 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.56 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.437 ' HE2' HG23 ' A' ' 403' ' ' ILE . 17.6 m-85 -122.01 140.15 52.83 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.71 0.291 . . . . 0.0 111.163 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -154.69 114.13 3.72 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.741 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 67.24 -110.25 3.37 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.833 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -119.32 12.96 12.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.941 0.401 . . . . 0.0 111.185 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -122.14 152.96 39.35 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.894 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -133.9 148.31 51.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.22 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 388' ' ' TRP . . . . . 0.453 ' CE2' ' HB3' ' A' ' 400' ' ' PRO . 21.5 m-90 -122.4 140.41 52.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.149 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 69.5 t -120.34 120.2 62.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -115.8 127.77 55.33 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.513 ' HB2' ' HD3' ' A' ' 378' ' ' LYS . 19.7 t70 -90.79 86.26 6.28 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 176.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 392' ' ' GLU . . . . . 0.418 ' OE1' ' HB ' ' D' ' 213' ' ' ILE . 57.0 mm-40 69.52 -71.47 0.12 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.402 -177.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -142.56 4.56 1.55 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.546 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 13.3 m -106.45 129.05 54.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.713 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 65.1 tp -84.16 133.75 34.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 396' ' ' GLU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 4.0 mt-10 -66.1 135.34 95.08 Favored Pre-proline 0 C--O 1.238 0.489 0 CA-C-O 120.823 0.344 . . . . 0.0 111.039 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 397' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 23.7 Cg_exo -64.81 128.82 21.78 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 123.152 2.568 . . . . 0.0 112.192 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 108.02 -5.27 34.17 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.836 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 399' ' ' TYR . . . . . 0.411 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 33.9 m-85 -94.0 159.56 34.12 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 111.526 0.195 . . . . 0.0 111.526 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.453 ' HB3' ' CE2' ' A' ' 388' ' ' TRP . 71.9 Cg_endo -74.44 162.5 92.4 Favored 'Cis proline' 0 C--N 1.344 0.314 0 C-N-CA 123.477 -1.468 . . . . 0.0 112.939 0.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -125.59 161.39 27.32 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 0.452 ' ND1' ' HG3' ' A' ' 404' ' ' LYS . 23.7 t-80 -69.9 155.89 39.89 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 403' ' ' ILE . . . . . 0.437 HG23 ' HE2' ' A' ' 382' ' ' PHE . 67.5 mt -56.33 -40.98 69.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.368 . . . . 0.0 111.481 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.452 ' HG3' ' ND1' ' A' ' 402' ' ' HIS . 0.0 OUTLIER -67.55 -12.18 59.77 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -179.441 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -78.93 -18.39 53.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.87 0.367 . . . . 0.0 110.946 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 38.5 tp -79.5 -31.97 42.36 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.268 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.519 ' HA2' ' HG2' ' A' ' 443' ' ' ARG . . . -176.82 165.77 36.12 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.261 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -90.33 132.87 35.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.572 0.225 . . . . 0.0 110.804 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.16 12.85 47.73 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.193 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 61.3 mt -92.25 146.31 32.38 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.638 0.256 . . . . 0.0 111.372 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.65 115.65 2.55 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.036 2.49 . . . . 0.0 111.232 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 1.1 m -84.49 1.88 43.56 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.505 -179.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -97.24 -59.78 1.72 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.305 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -174.48 173.03 3.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.872 0.368 . . . . 0.0 110.933 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 43.9 mm -122.41 136.23 59.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.599 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -94.54 -43.31 8.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.202 0.525 . . . . 0.0 110.154 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -156.8 163.24 39.45 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.844 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -149.32 127.0 11.69 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 36.4 tp -121.88 128.86 52.07 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.028 0.442 . . . . 0.0 111.16 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -92.39 119.39 31.89 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 18.3 t-105 -85.21 91.65 8.2 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.341 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 13.9 mmt -47.28 -49.9 50.54 Favored Pre-proline 0 N--CA 1.47 0.533 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -45.93 -41.98 20.41 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.02 2.48 . . . . 0.0 115.476 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -115.34 -28.53 6.85 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 98.85 16.59 30.47 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.498 -0.858 . . . . 0.0 113.151 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -92.5 147.3 23.01 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 3.0 m -104.9 122.73 46.41 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.92 0.391 . . . . 0.0 110.867 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -99.35 111.79 24.09 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.946 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -95.69 137.37 34.84 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.876 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -112.69 127.58 56.16 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.976 0.417 . . . . 0.0 111.504 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.486 ' HB3' ' HE1' ' A' ' 436' ' ' TYR . 2.9 tpm_? -134.51 98.29 4.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.776 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 67.0 -107.37 1.98 Allowed Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.872 -0.603 . . . . 0.0 112.285 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 433' ' ' ASN . . . . . 0.597 ' HB3' ' HG2' ' A' ' 461' ' ' GLU . 4.9 p30 -112.59 15.65 19.99 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.96 0.409 . . . . 0.0 111.278 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 434' ' ' LYS . . . . . 0.516 ' HB3' ' HB2' ' A' ' 450' ' ' PRO . 68.0 mmtt -128.77 141.39 51.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.823 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 435' ' ' TYR . . . . . 0.538 ' CE2' ' HE2' ' A' ' 449' ' ' TYR . 14.3 p90 -120.86 142.69 49.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.031 0.443 . . . . 0.0 110.659 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 436' ' ' TYR . . . . . 0.486 ' HE1' ' HB3' ' A' ' 431' ' ' ARG . 4.3 m-85 -112.84 148.48 34.81 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.506 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 19.7 ttp180 -112.5 91.43 3.65 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 438' ' ' PHE . . . . . 0.412 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 81.3 t80 -85.14 134.99 34.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.143 0.497 . . . . 0.0 111.144 -178.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 439' ' ' ASN . . . . . 0.552 ' HB3' ' HB3' ' A' ' 442' ' ' LEU . 3.8 t30 -107.35 118.61 37.17 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.791 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 440' ' ' GLU . . . . . 0.469 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 0.4 OUTLIER -55.52 -57.05 13.52 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.37 -179.502 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -80.12 54.52 1.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.908 0.385 . . . . 0.0 110.951 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 442' ' ' LEU . . . . . 0.552 ' HB3' ' HB3' ' A' ' 439' ' ' ASN . 29.4 tp -168.35 -33.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.098 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 443' ' ' ARG . . . . . 0.519 ' HG2' ' HA2' ' A' ' 407' ' ' GLY . 20.8 ttt180 64.45 31.96 12.18 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.551 0.691 . . . . 0.0 111.055 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -152.36 163.83 38.69 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.454 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 86.8 t -89.37 143.0 12.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.025 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.63 156.83 18.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.462 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 447' ' ' SER . . . . . 0.592 ' O ' ' HB2' ' A' ' 448' ' ' GLU . 1.5 m -69.01 151.13 46.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.343 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 448' ' ' GLU . . . . . 0.736 ' HB3' ' HE2' ' A' ' 451' ' ' LYS . 6.8 mt-10 85.03 -6.53 0.92 Allowed 'General case' 0 N--CA 1.471 0.575 0 O-C-N 124.269 0.981 . . . . 0.0 112.01 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 449' ' ' TYR . . . . . 0.538 ' HE2' ' CE2' ' A' ' 435' ' ' TYR . 92.3 m-85 -100.12 157.94 32.93 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.796 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 450' ' ' PRO . . . . . 0.516 ' HB2' ' HB3' ' A' ' 434' ' ' LYS . 61.2 Cg_endo -72.07 155.22 98.34 Favored 'Cis proline' 0 C--N 1.345 0.39 0 C-N-CA 123.585 -1.423 . . . . 0.0 112.797 0.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 451' ' ' LYS . . . . . 0.736 ' HE2' ' HB3' ' A' ' 448' ' ' GLU . 51.4 mttm -118.88 165.71 13.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.682 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 452' ' ' ASN . . . . . 0.557 ' ND2' ' HB2' ' A' ' 454' ' ' LYS . 38.9 t30 -61.06 128.07 34.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.446 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 453' ' ' ILE . . . . . 0.501 HG21 ' HG3' ' A' ' 461' ' ' GLU . 10.7 tt -65.03 -17.23 21.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.799 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 454' ' ' LYS . . . . . 0.557 ' HB2' ' ND2' ' A' ' 452' ' ' ASN . 67.1 mttm -67.73 -2.79 7.62 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 50.4 t -65.24 -33.38 63.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 456' ' ' TRP . . . . . 0.419 ' HE3' ' CZ ' ' A' ' 486' ' ' PHE . 26.4 m95 -83.23 90.85 7.16 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 457' ' ' GLU . . . . . 0.636 ' HB3' ' HG3' ' A' ' 492' ' ' LYS . 0.3 OUTLIER -51.68 108.82 0.3 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -178.61 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 108.32 -17.34 34.33 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.935 -0.65 . . . . 0.0 113.818 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.414 ' HB ' ' HB2' ' A' ' 456' ' ' TRP . 29.8 mm -79.32 122.93 84.64 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.98 0.419 . . . . 0.0 111.694 -179.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.33 155.22 36.83 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.865 2.377 . . . . 0.0 111.778 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 461' ' ' GLU . . . . . 0.597 ' HG2' ' HB3' ' A' ' 433' ' ' ASN . 0.9 OUTLIER -74.77 144.97 43.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.679 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 2.9 m 57.03 75.28 0.58 Allowed Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.913 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.27 -176.8 3.39 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 123.011 2.474 . . . . 0.0 111.868 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 464' ' ' ARG . . . . . 0.489 ' HA ' ' HE ' ' A' ' 464' ' ' ARG . 0.2 OUTLIER -135.87 27.44 3.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.248 0.547 . . . . 0.0 110.327 179.602 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 153.22 144.62 3.95 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.432 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 4.1 p -156.25 123.41 5.34 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -144.43 149.61 36.32 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.721 0.296 . . . . 0.0 111.128 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 468' ' ' MET . . . . . 0.412 ' HA ' ' HA ' ' A' ' 475' ' ' THR . 49.5 ttm -103.68 141.66 35.68 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -69.0 168.76 43.96 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.677 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 4.9 m -72.23 -10.89 60.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.084 0.469 . . . . 0.0 110.919 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 471' ' ' ASP . . . . . 0.465 ' OD2' ' HB ' ' A' ' 473' ' ' VAL . 11.9 p-10 -83.36 -17.15 43.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.007 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 68.22 7.92 6.22 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 473' ' ' VAL . . . . . 0.465 ' HB ' ' OD2' ' A' ' 471' ' ' ASP . 48.8 t -105.8 -35.39 3.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.766 0.317 . . . . 0.0 111.443 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -110.55 131.02 55.41 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 475' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 468' ' ' MET . 94.1 m -114.7 141.87 47.25 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.593 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 476' ' ' TYR . . . . . 0.418 ' HE1' ' HD2' ' A' ' 485' ' ' LYS . 73.0 m-85 -118.97 134.49 55.15 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 477' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 483' ' ' TYR . 20.0 m-85 -117.84 134.8 54.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.232 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -109.45 133.7 52.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.562 0.22 . . . . 0.0 111.154 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 479' ' ' LYS . . . . . 0.437 ' HB3' ' CZ3' ' A' ' 484' ' ' TRP . 54.4 tttp -170.07 133.88 1.2 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.594 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 64.27 35.21 91.69 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 121.311 -0.471 . . . . 0.0 113.603 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 481' ' ' ASN . . . . . 0.4 HD21 ' CD1' ' A' ' 502' ' ' LEU . 58.1 t30 67.21 10.92 8.08 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.589 0.709 . . . . 0.0 111.442 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -125.97 161.54 27.28 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.525 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 483' ' ' TYR . . . . . 0.413 ' CE2' ' HE2' ' A' ' 497' ' ' TYR . 15.4 p90 -129.83 151.65 50.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.845 0.355 . . . . 0.0 111.571 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 484' ' ' TRP . . . . . 0.437 ' CZ3' ' HB3' ' A' ' 479' ' ' LYS . 12.4 m-90 -112.51 145.84 39.54 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.149 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 485' ' ' LYS . . . . . 0.418 ' HD2' ' HE1' ' A' ' 476' ' ' TYR . 18.2 tttt -107.25 98.2 7.87 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 486' ' ' PHE . . . . . 0.458 ' HA ' ' HA ' ' A' ' 493' ' ' VAL . 51.8 t80 -90.35 125.16 35.44 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.264 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -90.21 115.08 27.16 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -63.7 -33.21 75.13 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -71.17 -40.88 71.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.928 0.394 . . . . 0.0 111.725 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -91.02 -14.28 31.68 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.4 tp 59.68 37.32 22.35 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.434 0.635 . . . . 0.0 110.618 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 492' ' ' LYS . . . . . 0.636 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 59.1 tttp -154.37 151.78 29.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.888 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 493' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 486' ' ' PHE . 58.5 t -74.52 132.77 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -67.53 143.56 97.13 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.549 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -61.18 149.92 86.98 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.257 2.638 . . . . 0.0 112.919 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 97.76 17.34 30.86 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 497' ' ' TYR . . . . . 0.546 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 19.2 m-85 -126.59 167.56 16.96 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 498' ' ' PRO . . . . . 0.546 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 94.3 Cg_endo -76.91 169.75 73.57 Favored 'Cis proline' 0 C--N 1.344 0.331 0 C-N-CA 124.001 -1.25 . . . . 0.0 112.962 0.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -124.97 150.35 46.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.537 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 37.4 t -64.4 119.76 10.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.257 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -64.83 -32.75 74.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.892 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 502' ' ' LEU . . . . . 0.571 HD23 ' HG3' ' A' ' 506' ' ' MET . 20.5 mt -62.81 -47.45 83.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.146 0.498 . . . . 0.0 111.16 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -75.48 -31.9 60.38 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.51 -33.47 17.76 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -177.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 15.9 m0 -127.64 -27.75 2.82 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -177.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 506' ' ' MET . . . . . 0.571 ' HG3' HD23 ' A' ' 502' ' ' LEU . 14.6 mmt -85.64 -6.46 59.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -177.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 71.2 42.87 57.11 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.937 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 508' ' ' CYS . . . . . 0.562 ' HB2' ' HB3' ' A' ' 502' ' ' LEU . 59.9 m -120.55 93.57 48.46 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-O 120.707 0.289 . . . . 0.0 110.939 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -73.23 134.26 20.76 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.009 2.472 . . . . 0.0 111.814 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 5.1 m 55.53 68.9 0.79 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.341 0.591 . . . . 0.0 111.725 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.536 -1.146 . . . . 0.0 112.401 -179.626 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.598 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' PRO . . . . . 0.476 ' HA ' HD23 ' B' ' 2' ' ' HYP . 66.3 Cg_endo -74.97 149.88 37.48 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.468 2.112 . . . . 0.0 111.304 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 2' ' ' HYP . . . . . 0.538 ' HA ' ' HG2' ' C' ' 101' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.94 167.52 34.49 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.275 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -78.36 172.42 15.36 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.939 2.426 . . . . 0.0 111.635 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -74.2 -169.4 20.59 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.722 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.669 ' HG2' ' HA ' ' D' ' 205' ' ' HYP . 28.9 Cg_endo -63.23 172.41 5.23 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.133 2.556 . . . . 0.0 112.755 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 8' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.69 158.95 21.7 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.598 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -64.76 140.91 69.7 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.987 2.458 . . . . 0.0 112.022 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' GLN . . . . . 0.596 ' HG3' ' HG2' ' C' ' 110' ' ' PRO . 61.1 tt0 -69.64 149.48 48.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.414 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.9 153.42 47.6 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.231 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 8.9 mt -67.64 149.3 11.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.66 152.89 37.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.882 0.372 . . . . 0.0 111.282 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' D' ' 213' ' ' ILE . . . -74.76 166.03 54.81 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.343 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -80.54 148.74 30.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.733 0.301 . . . . 0.0 110.353 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -76.4 141.56 41.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.356 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.28 150.85 46.43 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.787 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.9 t -69.68 155.46 7.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.402 HG23 ' H ' ' B' ' 20' ' ' VAL . 3.1 t -52.89 146.6 2.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.454 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.81 168.64 54.81 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.747 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 96.5 mt -77.8 148.85 34.57 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 23' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.39 161.91 44.74 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.238 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -71.02 154.47 62.71 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.652 2.235 . . . . 0.0 111.576 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 26' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.24 154.09 53.07 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.517 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -74.17 157.56 46.11 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.828 2.352 . . . . 0.0 111.802 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 29' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.15 176.4 53.82 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.377 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.436 ' HA ' HD23 ' B' ' 32' ' ' HYP . 8.1 Cg_exo -74.44 155.37 45.7 Favored 'Trans proline' 0 CA--C 1.53 0.308 0 C-N-CA 123.356 2.704 . . . . 0.0 111.734 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 32' ' ' HYP . . . . . 0.436 HD23 ' HA ' ' B' ' 31' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 33' ' ' GLY . . . . . 0.429 ' HA2' ' HD3' ' B' ' 34' ' ' PRO . . . -69.93 154.28 52.67 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.665 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 34' ' ' PRO . . . . . 0.429 ' HD3' ' HA2' ' B' ' 33' ' ' GLY . 3.2 Cg_exo -77.67 125.81 7.76 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.909 2.406 . . . . 0.0 111.794 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 35' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 112.733 -0.147 . . . . 0.0 112.733 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 101' ' ' PRO . . . . . 0.538 ' HG2' ' HA ' ' B' ' 2' ' ' HYP . 72.6 Cg_endo -78.72 147.19 21.69 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 122.909 2.406 . . . . 0.0 112.769 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 102' ' ' HYP . . . . . 0.565 ' HA ' ' HD2' ' D' ' 201' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.65 173.18 49.99 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.824 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -80.14 158.25 23.44 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 122.803 2.335 . . . . 0.0 112.296 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 105' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.16 169.37 43.37 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.787 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -79.72 177.97 7.83 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.115 2.543 . . . . 0.0 110.437 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 108' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -64.41 179.03 7.76 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.171 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 110' ' ' PRO . . . . . 0.596 ' HG2' ' HG3' ' B' ' 11' ' ' GLN . 32.3 Cg_endo -64.03 150.06 89.16 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.872 2.381 . . . . 0.0 112.021 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -61.61 140.91 58.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.261 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -66.81 152.27 52.57 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.016 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 23.3 mt -65.57 137.11 25.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.7 149.98 38.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.889 0.376 . . . . 0.0 111.123 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -65.44 162.34 40.94 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.972 -0.632 . . . . 0.0 111.909 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -85.21 153.58 22.54 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.906 -0.317 . . . . 0.0 110.604 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 35.7 ttm-85 -61.74 144.77 54.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.329 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.08 169.56 27.2 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.545 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.33 142.12 14.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.821 0.343 . . . . 0.0 110.324 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 120' ' ' VAL . . . . . 0.496 HG13 ' HB ' ' D' ' 219' ' ' VAL . 24.8 t -62.48 143.48 15.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.427 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.02 161.05 54.23 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.406 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 122' ' ' LEU . . . . . 0.429 ' HA ' HD23 ' C' ' 123' ' ' HYP . 67.8 mt -75.97 150.13 37.51 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 123' ' ' HYP . . . . . 0.429 HD23 ' HA ' ' C' ' 122' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -67.1 166.6 40.69 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.956 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 125' ' ' PRO . . . . . 0.412 ' HA ' HD23 ' C' ' 126' ' ' HYP . 36.4 Cg_endo -66.1 149.71 85.6 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.565 2.177 . . . . 0.0 111.409 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 126' ' ' HYP . . . . . 0.412 HD23 ' HA ' ' C' ' 125' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.76 158.41 44.2 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.903 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.3 158.62 29.69 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.672 2.248 . . . . 0.0 111.332 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -67.39 179.13 16.22 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.123 -0.561 . . . . 0.0 113.557 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -71.36 160.09 49.75 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 123.141 2.561 . . . . 0.0 111.687 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 132' ' ' HYP . . . . . 0.427 ' HA ' ' O ' ' D' ' 231' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 133' ' ' GLY . . . . . 0.44 ' HA2' ' HD3' ' C' ' 134' ' ' PRO . . . -74.73 134.11 16.84 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.294 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 134' ' ' PRO . . . . . 0.458 ' HA ' HD23 ' C' ' 135' ' ' HYP . 14.7 Cg_exo -69.99 111.69 2.92 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 123.287 2.658 . . . . 0.0 112.14 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 135' ' ' HYP . . . . . 0.458 HD23 ' HA ' ' C' ' 134' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 N-CA-C 112.553 -0.219 . . . . 0.0 112.553 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 201' ' ' PRO . . . . . 0.565 ' HD2' ' HA ' ' C' ' 102' ' ' HYP . 52.4 Cg_exo -57.95 146.72 85.66 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.15 2.567 . . . . 0.0 112.074 179.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 202' ' ' HYP . . . . . 0.514 HD23 ' HA ' ' D' ' 201' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 86.07 169.46 45.96 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.725 -0.75 . . . . 0.0 113.978 178.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -75.12 159.64 40.7 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 123.53 2.82 . . . . 0.0 111.952 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 205' ' ' HYP . . . . . 0.669 ' HA ' ' HG2' ' B' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . 98.34 -175.81 29.72 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.61 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -85.35 156.45 10.89 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.078 2.519 . . . . 0.0 112.137 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 208' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -73.4 164.82 54.88 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.988 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.42 141.14 73.06 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.589 2.193 . . . . 0.0 111.797 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -63.88 145.05 56.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.004 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -66.76 159.84 48.39 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.758 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 213' ' ' ILE . . . . . 0.418 ' HB ' ' OE1' ' A' ' 392' ' ' GLU . 47.4 pt -74.35 164.75 3.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.774 0.321 . . . . 0.0 111.02 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 214' ' ' ALA . . . . . 0.477 ' HB3' ' NH1' ' A' ' 330' ' ' ARG . . . -82.25 137.46 34.86 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.918 0.39 . . . . 0.0 110.725 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -65.3 164.87 36.47 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.853 -0.612 . . . . 0.0 113.039 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -68.81 156.46 38.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.675 0.274 . . . . 0.0 110.323 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -70.75 162.03 29.82 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -60.41 154.02 34.94 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.526 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 219' ' ' VAL . . . . . 0.496 ' HB ' HG13 ' C' ' 120' ' ' VAL . 21.0 t -70.78 149.4 10.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 42.9 t -64.41 140.45 19.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.56 167.69 13.85 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.299 -0.477 . . . . 0.0 113.318 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 4.2 mp -78.84 155.43 29.16 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 223' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -62.32 150.97 46.41 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.139 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 225' ' ' PRO . . . . . 0.423 ' HA ' HD23 ' D' ' 226' ' ' HYP . 31.8 Cg_exo -60.38 139.89 88.93 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.877 2.385 . . . . 0.0 111.577 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 226' ' ' HYP . . . . . 0.423 HD23 ' HA ' ' D' ' 225' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -64.49 155.53 47.05 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.946 -0.57 . . . . 0.0 113.323 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -80.51 170.21 16.14 Favored 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 123.054 2.502 . . . . 0.0 111.475 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -76.88 -179.4 48.18 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.94 -0.647 . . . . 0.0 113.286 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 231' ' ' PRO . . . . . 0.453 ' HA ' HD23 ' D' ' 232' ' ' HYP . 60.2 Cg_endo -73.87 156.26 48.21 Favored 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 123.182 2.588 . . . . 0.0 111.928 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 232' ' ' HYP . . . . . 0.453 HD23 ' HA ' ' D' ' 231' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.425 ' HB2' ' HH2' ' A' ' 342' ' ' TRP . 6.0 Cg_exo . . . . . 0 N--CA 1.478 0.588 0 N-CA-C 109.714 -0.918 . . . . 0.0 109.714 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -102.69 148.61 25.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.663 0.268 . . . . 0.0 110.775 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 8.1 tp -73.57 -26.71 22.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.383 0.611 . . . . 0.0 110.681 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 37.3 m -88.74 26.33 1.54 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.81 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -76.77 -41.83 43.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.306 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 83.37 170.68 46.6 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.205 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 50.3 t30 50.65 68.97 0.69 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.198 0.523 . . . . 0.0 111.125 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -87.17 175.49 8.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.47 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 324' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 464' ' ' ARG . 4.7 m-20 -74.62 -46.96 34.95 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 14.5 t -171.34 153.95 3.75 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.518 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 57.0 t -131.39 124.42 54.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 327' ' ' ALA . . . . . 0.446 ' HA ' ' CD1' ' A' ' 467' ' ' PHE . . . -141.59 169.04 18.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.009 0.433 . . . . 0.0 111.832 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 39.3 ttp -120.84 121.0 37.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.358 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 58.9 mt -112.18 115.7 29.26 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.666 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 330' ' ' ARG . . . . . 0.464 ' HG3' ' HE1' ' A' ' 379' ' ' PHE . 44.9 mtp180 57.16 22.31 7.4 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 109.85 -14.77 31.73 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.85 -0.69 . . . . 0.0 113.656 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -99.84 129.46 45.94 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.938 0.369 . . . . 0.0 111.324 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 47.1 ttm -89.1 126.18 35.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.923 0.392 . . . . 0.0 111.082 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -119.68 132.86 55.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.114 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 23.9 t -107.02 117.33 52.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.502 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -100.68 126.62 47.21 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 0.794 ' HB3' ' HZ3' ' A' ' 342' ' ' TRP . 27.5 tptt -139.71 102.78 4.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.157 178.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 63.92 -102.25 0.1 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.66 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.5 ptm85 -117.49 8.09 12.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.917 0.389 . . . . 0.0 111.962 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 3.0 m-90 -127.01 146.03 50.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.048 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -128.66 146.1 50.97 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.966 0.412 . . . . 0.0 110.985 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 342' ' ' TRP . . . . . 0.794 ' HZ3' ' HB3' ' A' ' 337' ' ' LYS . 20.4 m-90 -108.66 150.87 26.93 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.425 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.637 ' HD3' ' SD ' ' A' ' 350' ' ' MET . 24.1 ttt-85 -113.8 100.89 8.79 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 3.1 m -93.49 129.43 43.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.137 0.494 . . . . 0.0 111.386 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.15 109.87 6.68 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.536 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 63.66 47.01 3.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.774 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 7.2 m120 64.68 27.96 13.13 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.185 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -142.06 150.17 40.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.952 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 47.4 t -91.76 129.19 42.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 350' ' ' MET . . . . . 0.637 ' SD ' ' HD3' ' A' ' 343' ' ' ARG . 89.5 mtp -77.23 165.44 24.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.026 0.441 . . . . 0.0 111.78 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -77.72 154.51 32.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.696 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 94.76 -5.8 69.75 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 111.701 -0.56 . . . . 0.0 111.701 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 353' ' ' TYR . . . . . 0.494 ' CE1' ' HD2' ' A' ' 343' ' ' ARG . 83.1 m-85 -118.85 159.0 46.25 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 110.448 -0.205 . . . . 0.0 110.448 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.478 ' C ' ' HA ' ' A' ' 353' ' ' TYR . 37.9 Cg_endo -65.67 137.88 34.4 Favored 'Cis proline' 0 C--N 1.348 0.542 0 C-N-CA 123.966 -1.264 . . . . 0.0 112.564 0.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 355' ' ' MET . . . . . 0.42 ' HA ' ' HD3' ' A' ' 356' ' ' PRO . 10.6 ttt -112.72 141.34 25.21 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.429 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 356' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 355' ' ' MET . 50.7 Cg_exo -58.19 127.3 24.39 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.574 2.183 . . . . 0.0 111.204 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 66.8 mt -56.11 -42.42 72.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.942 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -70.3 -16.38 73.31 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.794 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -82.51 -28.28 31.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.046 0.451 . . . . 0.0 110.791 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -98.66 -53.0 3.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.239 0.543 . . . . 0.0 109.725 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -93.32 71.15 4.43 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -56.93 99.44 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.672 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 128.27 -17.09 5.95 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.969 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.475 ' HA ' ' HD3' ' A' ' 365' ' ' PRO . 30.9 tp -91.84 125.52 56.91 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-O 120.561 0.22 . . . . 0.0 110.764 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 365' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 364' ' ' LEU . 3.0 Cg_exo -77.38 170.19 19.85 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 123.06 2.507 . . . . 0.0 111.774 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -77.26 159.41 29.64 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.654 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 16.6 m 57.92 82.95 0.12 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.41 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 27.9 pt -100.38 173.23 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.911 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 369' ' ' ASN . . . . . 0.418 HD22 ' HA ' ' A' ' 369' ' ' ASN . 1.5 m120 -95.79 -55.84 2.87 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 370' ' ' THR . . . . . 0.7 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.2 OUTLIER -155.49 164.13 39.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.575 -179.838 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -147.75 149.02 31.61 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 372' ' ' TYR . . . . . 0.61 ' HE1' ' HE2' ' A' ' 382' ' ' PHE . 19.3 p90 -164.64 166.35 20.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.867 0.365 . . . . 0.0 111.768 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -97.3 125.53 41.94 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 374' ' ' ARG . . . . . 0.498 ' HB2' ' OE2' ' A' ' 440' ' ' GLU . 10.6 ptm180 -84.44 -172.05 3.96 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.576 ' HB2' ' HG3' ' A' ' 440' ' ' GLU . 4.7 tttp -63.5 -40.72 97.81 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.01 -30.09 58.37 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 127.17 -14.7 6.54 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.731 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 38.2 mttp -70.45 149.13 47.55 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.746 0.307 . . . . 0.0 110.798 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 379' ' ' PHE . . . . . 0.464 ' HE1' ' HG3' ' A' ' 330' ' ' ARG . 16.0 m-85 -95.65 126.71 41.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.058 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 380' ' ' VAL . . . . . 0.513 ' HB ' ' CE1' ' A' ' 372' ' ' TYR . 17.1 t -106.31 115.49 48.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.981 0.419 . . . . 0.0 110.558 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -102.72 128.95 49.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.531 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.61 ' HE2' ' HE1' ' A' ' 372' ' ' TYR . 59.1 m-85 -107.77 143.32 36.49 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.398 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.699 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 60.5 tttp -152.01 92.93 1.77 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 414' ' ' LYS . . . 75.71 -113.09 3.8 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -108.11 -0.73 20.94 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.032 0.444 . . . . 0.0 110.772 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -109.3 147.3 32.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.977 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -132.64 147.87 52.35 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.357 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 388' ' ' TRP . . . . . 0.699 ' HZ3' ' HB3' ' A' ' 383' ' ' LYS . 20.9 m-90 -121.28 131.17 54.05 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.169 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 55.9 t -107.0 114.64 46.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -106.41 125.48 51.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.645 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -97.43 89.25 4.64 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 67.82 -85.98 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.308 -178.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -130.65 21.13 5.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.21 0.529 . . . . 0.0 110.886 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 10.2 m -133.83 135.29 43.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.02 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 57.3 tp -80.97 136.92 36.09 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.442 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 396' ' ' GLU . . . . . 0.648 ' HB3' ' CE1' ' A' ' 399' ' ' TYR . 0.0 OUTLIER -67.25 143.16 97.35 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.388 179.221 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.01 140.83 28.94 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 122.602 2.201 . . . . 0.0 112.581 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 91.24 26.26 21.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.542 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 399' ' ' TYR . . . . . 0.657 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 42.8 m-85 -118.88 163.54 25.59 Favored Pre-proline 0 C--N 1.324 -0.534 0 O-C-N 122.679 -0.307 . . . . 0.0 111.081 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.657 ' HA ' ' HB3' ' A' ' 399' ' ' TYR . 84.1 Cg_endo -77.44 162.87 89.8 Favored 'Cis proline' 0 C--N 1.345 0.38 0 C-N-CA 123.529 -1.446 . . . . 0.0 113.067 0.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -121.0 161.46 21.59 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 0.668 ' HB2' ' HG2' ' A' ' 405' ' ' GLU . 7.6 m-70 -74.84 153.54 38.66 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 71.2 mt -57.75 -38.62 66.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.27 0.557 . . . . 0.0 109.845 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.417 ' HG3' ' HB3' ' A' ' 402' ' ' HIS . 0.0 OUTLIER -68.9 -10.74 58.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.469 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.668 ' HG2' ' HB2' ' A' ' 402' ' ' HIS . 78.4 mm-40 -84.45 -30.8 24.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.861 0.363 . . . . 0.0 110.435 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 47.6 tp -63.81 -51.88 62.74 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.859 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.816 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -152.69 162.45 29.99 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.296 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -86.85 129.05 35.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.592 0.234 . . . . 0.0 110.404 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.57 6.79 43.55 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.32 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 65.6 mt -86.95 156.05 55.24 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 122.961 -0.141 . . . . 0.0 110.624 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -65.13 144.47 81.78 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.626 2.217 . . . . 0.0 112.371 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.24 25.17 9.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.031 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.479 ' OD2' ' HD3' ' A' ' 431' ' ' ARG . 1.7 p-10 -119.42 -76.03 0.58 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.606 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 414' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 384' ' ' GLY . 7.8 ptmt -160.61 -176.75 5.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.82 0.343 . . . . 0.0 110.445 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 34.4 mm -125.59 135.61 63.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -94.48 -52.19 4.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.325 0.583 . . . . 0.0 110.062 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 417' ' ' ALA . . . . . 0.7 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -147.13 145.63 29.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.946 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -129.01 117.18 20.5 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 57.8 tp -114.09 147.96 37.89 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.051 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -120.65 119.42 32.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.617 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 421' ' ' TRP . . . . . 0.466 ' HB2' ' HE2' ' A' ' 428' ' ' TYR . 7.0 t-105 -86.85 94.8 9.66 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.446 ' HB2' ' HD3' ' A' ' 423' ' ' PRO . 64.1 mtt -51.42 -51.71 66.56 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 92.5 Cg_exo -47.18 -33.82 16.54 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 123.029 2.486 . . . . 0.0 115.278 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 424' ' ' ASN . . . . . 0.408 ' OD1' ' HB3' ' A' ' 421' ' ' TRP . 33.0 p30 -115.06 -24.54 8.52 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 87.47 23.02 41.39 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.403 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -108.21 149.9 27.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 117.131 0.465 . . . . 0.0 111.169 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.45 146.16 25.49 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.436 -178.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 428' ' ' TYR . . . . . 0.466 ' HE2' ' HB2' ' A' ' 421' ' ' TRP . 81.8 m-85 -124.9 110.16 13.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.498 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -98.98 123.14 43.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.797 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 430' ' ' PHE . . . . . 0.442 ' HB2' ' HB3' ' A' ' 417' ' ' ALA . 89.8 m-85 -98.79 130.28 45.23 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.608 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 431' ' ' ARG . . . . . 0.479 ' HD3' ' OD2' ' A' ' 413' ' ' ASP . 2.0 tpm_? -140.05 106.81 5.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.163 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 66.72 -102.62 0.78 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.742 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -123.67 14.44 9.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.068 0.461 . . . . 0.0 110.154 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 52.0 mmtt -122.46 156.29 34.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.067 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 435' ' ' TYR . . . . . 0.537 ' CE2' ' HE1' ' A' ' 449' ' ' TYR . 7.8 p90 -135.3 139.36 44.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.928 0.394 . . . . 0.0 110.573 178.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -108.07 143.72 36.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.699 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -106.79 103.4 12.83 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 438' ' ' PHE . . . . . 0.816 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 66.6 t80 -92.42 135.23 34.22 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.482 -178.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -107.86 107.74 18.61 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 440' ' ' GLU . . . . . 0.576 ' HG3' ' HB2' ' A' ' 375' ' ' LYS . 4.9 mm-40 -49.39 -51.3 35.93 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -54.76 -48.71 72.28 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 52.5 mt -86.45 -18.05 32.69 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 61.36 39.45 15.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.631 0.729 . . . . 0.0 110.57 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -148.79 155.07 40.45 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.497 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 97.8 t -80.31 140.13 17.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.845 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -62.49 156.95 21.48 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.4 m -66.71 152.43 45.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.82 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 72.34 29.4 2.19 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.272 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 449' ' ' TYR . . . . . 0.537 ' HE1' ' CE2' ' A' ' 435' ' ' TYR . 27.5 m-85 -126.39 160.9 55.5 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.192 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.81 160.77 95.51 Favored 'Cis proline' 0 C--N 1.347 0.479 0 C-N-CA 123.728 -1.363 . . . . 0.0 112.337 -0.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 451' ' ' LYS . . . . . 0.506 ' HB2' ' CE1' ' A' ' 435' ' ' TYR . 60.4 mttm -109.71 176.76 4.95 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.106 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -76.8 139.82 40.49 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.518 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 453' ' ' ILE . . . . . 0.438 HD13 ' HA ' ' A' ' 461' ' ' GLU . 15.4 tt -66.83 -11.99 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.109 0.48 . . . . 0.0 110.709 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 454' ' ' LYS . . . . . 0.446 ' HD3' ' HA ' ' A' ' 454' ' ' LYS . 48.5 mmtt -68.69 -7.0 29.48 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.151 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 76.7 t -66.21 -30.95 51.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 456' ' ' TRP . . . . . 0.477 ' HE3' ' CZ ' ' A' ' 486' ' ' PHE . 6.7 m95 -97.72 85.59 3.6 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.545 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 457' ' ' GLU . . . . . 0.467 ' HB3' ' HG3' ' A' ' 492' ' ' LYS . 1.6 tm-20 -54.43 114.78 1.79 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.62 -178.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 108.0 -21.16 29.98 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.065 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 19.1 mm -71.04 127.15 91.94 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 120.868 0.366 . . . . 0.0 111.077 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.25 139.51 32.32 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.925 2.417 . . . . 0.0 112.603 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 461' ' ' GLU . . . . . 0.438 ' HA ' HD13 ' A' ' 453' ' ' ILE . 27.6 mp0 -68.34 138.78 55.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.002 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.3 m 59.33 70.31 1.14 Allowed Pre-proline 0 C--O 1.234 0.288 0 O-C-N 123.58 0.55 . . . . 0.0 112.177 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -85.95 -179.53 3.31 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.013 2.476 . . . . 0.0 111.164 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 464' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 324' ' ' ASP . 0.0 OUTLIER -142.39 29.21 1.61 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.439 0.638 . . . . 0.0 110.738 179.768 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 174.05 135.15 1.97 Allowed Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 5.3 p -158.49 114.38 2.69 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.706 0.289 . . . . 0.0 110.236 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 467' ' ' PHE . . . . . 0.446 ' CD1' ' HA ' ' A' ' 327' ' ' ALA . 30.3 p90 -145.14 140.7 28.17 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.696 0.284 . . . . 0.0 111.215 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 468' ' ' MET . . . . . 0.434 ' HA ' ' HA ' ' A' ' 475' ' ' THR . 46.5 ttm -89.93 141.14 28.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.244 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -70.38 166.16 51.1 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.769 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.36 -14.62 57.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.895 0.378 . . . . 0.0 111.906 -179.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -81.43 -18.39 45.53 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.391 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 68.09 11.96 8.58 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.015 0.526 . . . . 0.0 112.254 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 49.1 t -110.46 -36.12 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.891 0.377 . . . . 0.0 111.057 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -111.53 133.68 53.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.275 0.559 . . . . 0.0 111.996 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 475' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 468' ' ' MET . 88.3 m -116.54 133.03 56.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.381 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -101.42 135.93 42.11 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.967 0.413 . . . . 0.0 111.807 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -122.2 138.49 54.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.422 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -121.74 134.36 54.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.803 0.335 . . . . 0.0 111.524 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 48.0 tttt -166.06 131.94 2.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.222 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 56.12 44.74 88.54 Favored Glycine 0 C--N 1.33 0.227 0 CA-C-N 115.944 -0.571 . . . . 0.0 114.307 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 23.0 t30 65.47 8.49 5.07 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -118.28 158.35 25.35 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 483' ' ' TYR . . . . . 0.458 ' CE2' ' HE2' ' A' ' 497' ' ' TYR . 3.5 p90 -131.7 147.6 52.52 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.989 0.424 . . . . 0.0 111.934 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 484' ' ' TRP . . . . . 0.548 ' CE2' ' HB3' ' A' ' 498' ' ' PRO . 11.3 m-90 -116.36 157.21 25.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.133 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -120.45 99.38 6.53 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 486' ' ' PHE . . . . . 0.477 ' CZ ' ' HE3' ' A' ' 456' ' ' TRP . 77.4 t80 -86.28 127.41 34.77 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.941 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -93.18 112.81 24.86 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -63.68 -26.99 68.91 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -76.6 -30.85 57.13 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -99.2 -21.02 16.31 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.8 tp 66.17 33.4 7.4 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -177.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 492' ' ' LYS . . . . . 0.467 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 6.0 tttp -152.45 159.92 43.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.044 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 493' ' ' VAL . . . . . 0.429 ' N ' ' HG2' ' A' ' 492' ' ' LYS . 77.8 t -79.29 139.55 18.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.643 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -65.98 138.44 96.3 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.322 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.19 138.36 80.96 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 123.225 2.617 . . . . 0.0 112.59 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 111.21 -1.61 28.25 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 497' ' ' TYR . . . . . 0.526 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 37.5 m-85 -108.87 164.49 14.6 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.825 -0.187 . . . . 0.0 111.226 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 498' ' ' PRO . . . . . 0.548 ' HB3' ' CE2' ' A' ' 484' ' ' TRP . 83.2 Cg_endo -75.98 174.75 51.27 Favored 'Cis proline' 0 C--N 1.351 0.666 0 C-N-CA 124.058 -1.226 . . . . 0.0 113.045 0.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -134.41 166.61 22.44 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.991 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 44.3 t -71.54 118.07 13.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.597 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 501' ' ' ALA . . . . . 0.624 ' O ' ' HB2' ' A' ' 505' ' ' TRP . . . -70.7 -24.26 62.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.83 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 16.8 mt -70.96 -38.81 72.82 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.974 0.416 . . . . 0.0 110.652 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 8.7 ttm180 -84.37 -55.31 4.23 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -73.14 -18.02 61.32 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 505' ' ' TRP . . . . . 0.624 ' HB2' ' O ' ' A' ' 501' ' ' ALA . 9.5 m0 -111.95 -69.79 0.85 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 9.6 mmt -59.33 -44.54 92.61 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.976 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 109.85 14.03 14.77 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.51 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 35.1 m -81.87 113.6 44.16 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -83.29 153.57 14.12 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.576 2.184 . . . . 0.0 111.903 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 16.4 m 64.34 92.33 0.07 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.722 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.155 0 CA-C-O 118.166 -1.352 . . . . 0.0 110.796 -179.917 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.758 0 N-CA-C 111.531 -0.627 . . . . 0.0 111.531 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' PRO . . . . . 0.464 ' HA ' HD23 ' B' ' 2' ' ' HYP . 72.2 Cg_endo -77.34 144.0 22.65 Favored 'Trans proline' 0 CA--C 1.529 0.246 0 C-N-CA 122.613 2.209 . . . . 0.0 111.477 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 2' ' ' HYP . . . . . 0.464 HD23 ' HA ' ' B' ' 1' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.07 168.71 44.24 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.466 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -73.44 163.5 37.51 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 123.0 2.467 . . . . 0.0 112.025 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.04 175.42 54.55 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.698 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.788 ' HG2' ' HA ' ' D' ' 205' ' ' HYP . 15.3 Cg_endo -59.27 167.28 6.24 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 122.803 2.335 . . . . 0.0 111.429 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 8' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 133.57 174.51 13.58 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.642 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -62.59 139.18 74.39 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.859 2.373 . . . . 0.0 111.869 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' GLN . . . . . 0.882 ' HG3' ' HG2' ' C' ' 110' ' ' PRO . 34.0 tt0 -64.97 150.04 48.7 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.27 157.3 24.07 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.198 -0.525 . . . . 0.0 113.198 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.499 ' H ' HG13 ' B' ' 13' ' ' ILE . 2.7 mt -71.21 153.93 8.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.47 150.47 47.17 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.384 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 15' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' D' ' 213' ' ' ILE . . . -72.72 160.03 53.88 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.15 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -71.49 145.29 49.29 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -68.76 140.65 55.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.794 0.331 . . . . 0.0 110.608 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.22 154.98 36.4 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.834 -0.621 . . . . 0.0 113.16 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 8.0 t -65.72 147.94 12.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.665 0.269 . . . . 0.0 110.6 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 3.9 t -54.32 148.69 2.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.335 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.36 154.46 53.19 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.31 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 71.7 mt -76.56 152.21 36.06 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.482 0.182 . . . . 0.0 110.78 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 23' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.05 170.41 44.27 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.663 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.417 ' HA ' HD23 ' B' ' 26' ' ' HYP . 73.2 Cg_endo -77.02 151.4 30.69 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.638 2.225 . . . . 0.0 111.645 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 26' ' ' HYP . . . . . 0.417 HD23 ' HA ' ' B' ' 25' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.72 160.72 53.85 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.868 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.419 ' HG2' ' HB2' ' D' ' 226' ' ' HYP . 55.9 Cg_endo -72.72 149.88 49.35 Favored 'Trans proline' 0 C--O 1.237 0.453 0 C-N-CA 122.492 2.128 . . . . 0.0 111.432 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 29' ' ' HYP . . . . . 0.412 HD23 ' HA ' ' B' ' 28' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.5 170.19 48.77 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.935 -0.65 . . . . 0.0 113.174 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -73.79 163.4 37.25 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.969 2.446 . . . . 0.0 111.567 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 32' ' ' HYP . . . . . 0.474 ' HA ' ' HD2' ' C' ' 131' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.5 119.71 18.76 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.253 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 34' ' ' PRO . . . . . 0.491 ' O ' ' HB2' ' D' ' 232' ' ' HYP . 28.0 Cg_endo -64.19 114.6 2.72 Favored 'Trans proline' 0 CA--C 1.528 0.207 0 C-N-CA 122.917 2.412 . . . . 0.0 111.786 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 35' ' ' HYP . . . . . 0.44 HD23 ' HA ' ' B' ' 34' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.565 0 CA-C-O 119.985 -0.342 . . . . 0.0 112.865 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 101' ' ' PRO . . . . . 0.471 ' HA ' HD23 ' C' ' 102' ' ' HYP . 16.3 Cg_exo -70.15 151.66 66.92 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.498 2.798 . . . . 0.0 112.604 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 102' ' ' HYP . . . . . 0.504 ' HA ' ' HD2' ' D' ' 201' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.41 166.66 53.66 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.552 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 104' ' ' PRO . . . . . 0.402 ' HA ' HD23 ' C' ' 105' ' ' HYP . 90.7 Cg_endo -81.06 158.45 20.55 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 123.216 2.611 . . . . 0.0 113.066 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 105' ' ' HYP . . . . . 0.517 ' HA ' ' HD2' ' D' ' 204' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.65 178.69 47.72 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.083 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -85.49 138.05 6.17 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.648 2.232 . . . . 0.0 111.324 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 108' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -61.94 176.2 6.02 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.698 -0.683 . . . . 0.0 113.125 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 110' ' ' PRO . . . . . 0.882 ' HG2' ' HG3' ' B' ' 11' ' ' GLN . 37.4 Cg_endo -66.58 162.91 34.82 Favored 'Trans proline' 0 C--O 1.238 0.519 0 C-N-CA 122.577 2.185 . . . . 0.0 112.514 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -64.5 151.38 44.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.737 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 112' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' B' ' 13' ' ' ILE . . . -69.76 166.3 49.47 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.438 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 113' ' ' ILE . . . . . 0.468 ' H ' HG13 ' C' ' 113' ' ' ILE . 2.7 mt -67.11 144.34 14.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.01 140.73 58.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.408 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -59.38 147.68 42.07 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.277 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -69.73 153.59 43.16 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 122.47 0.308 . . . . 0.0 110.336 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 53.9 ttm-85 -71.77 150.51 44.34 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.83 164.05 46.63 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.26 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 8.8 t -68.97 144.32 14.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 120' ' ' VAL . . . . . 0.442 HG13 ' HB ' ' D' ' 219' ' ' VAL . 32.3 t -62.23 134.56 27.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.988 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.26 160.78 45.79 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.995 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 122' ' ' LEU . . . . . 0.43 ' HA ' HD23 ' C' ' 123' ' ' HYP . 75.2 mt -78.11 145.05 35.96 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 123' ' ' HYP . . . . . 0.43 HD23 ' HA ' ' C' ' 122' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -63.29 161.12 34.74 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.695 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 125' ' ' PRO . . . . . 0.401 ' HA ' HD23 ' C' ' 126' ' ' HYP . 29.2 Cg_endo -62.72 151.13 85.47 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.68 2.253 . . . . 0.0 111.854 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 126' ' ' HYP . . . . . 0.401 HD23 ' HA ' ' C' ' 125' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -74.08 158.69 52.2 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.954 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -75.54 160.8 38.02 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.506 2.137 . . . . 0.0 111.105 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -73.55 -178.31 36.38 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.289 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 131' ' ' PRO . . . . . 0.474 ' HD2' ' HA ' ' B' ' 32' ' ' HYP . 3.1 Cg_exo -74.82 145.28 31.98 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.912 2.408 . . . . 0.0 111.275 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 132' ' ' HYP . . . . . 0.535 ' HA ' ' O ' ' D' ' 231' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -57.52 125.12 38.21 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.917 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 134' ' ' PRO . . . . . 0.506 ' HA ' HD23 ' C' ' 135' ' ' HYP . 74.1 Cg_endo -77.41 112.48 3.37 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.922 2.415 . . . . 0.0 112.06 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 135' ' ' HYP . . . . . 0.506 HD23 ' HA ' ' C' ' 134' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.504 0 CA-C-O 119.939 -0.367 . . . . 0.0 112.239 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' D' D ' 201' ' ' PRO . . . . . 0.504 ' HD2' ' HA ' ' C' ' 102' ' ' HYP . 74.5 Cg_exo -53.72 140.95 66.08 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.148 2.566 . . . . 0.0 111.354 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 202' ' ' HYP . . . . . 0.439 HD23 ' HA ' ' D' ' 201' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 66.6 172.66 5.04 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 114.667 0.627 . . . . 0.0 114.667 178.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 204' ' ' PRO . . . . . 0.517 ' HD2' ' HA ' ' C' ' 105' ' ' HYP . 6.7 Cg_exo -76.82 166.17 27.4 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.673 2.915 . . . . 0.0 111.084 178.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 205' ' ' HYP . . . . . 0.788 ' HA ' ' HG2' ' B' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . 99.55 168.92 30.07 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.879 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -87.95 158.2 7.31 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 123.891 3.061 . . . . 0.0 112.182 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 208' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.4 166.82 54.4 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.061 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.73 147.15 68.79 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.627 2.218 . . . . 0.0 112.088 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -65.24 151.41 46.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.629 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -71.79 169.44 50.47 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.358 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 213' ' ' ILE . . . . . 0.414 ' O ' ' HA3' ' B' ' 15' ' ' GLY . 32.3 pt -71.54 162.41 4.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 120.91 0.386 . . . . 0.0 111.052 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -79.76 142.21 35.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.084 0.469 . . . . 0.0 110.709 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -62.65 160.94 32.41 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.369 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -81.08 155.94 26.05 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -66.1 151.44 46.9 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.806 0.336 . . . . 0.0 110.815 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -62.4 157.4 37.07 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.862 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 219' ' ' VAL . . . . . 0.442 ' HB ' HG13 ' C' ' 120' ' ' VAL . 16.3 t -65.25 138.83 22.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 33.1 t -60.74 142.3 16.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.941 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.12 157.95 26.65 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.238 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 9.2 mp -72.43 157.83 36.9 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.782 -0.209 . . . . 0.0 110.585 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 223' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' D' D ' 224' ' ' GLY . . . . . 0.437 ' HA2' ' HD3' ' D' ' 225' ' ' PRO . . . -61.92 153.66 41.15 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.066 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 225' ' ' PRO . . . . . 0.437 ' HD3' ' HA2' ' D' ' 224' ' ' GLY . 17.7 Cg_exo -67.99 142.78 57.8 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.856 2.371 . . . . 0.0 111.352 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 226' ' ' HYP . . . . . 0.419 ' HB2' ' HG2' ' B' ' 28' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -67.74 167.66 41.18 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.892 -0.595 . . . . 0.0 113.142 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -84.44 164.32 12.66 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.906 2.404 . . . . 0.0 111.606 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -70.81 -179.21 28.22 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.08 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 231' ' ' PRO . . . . . 0.535 ' O ' ' HA ' ' C' ' 132' ' ' HYP . 35.1 Cg_exo -61.76 133.28 44.17 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.945 2.43 . . . . 0.0 111.777 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 232' ' ' HYP . . . . . 0.491 ' HB2' ' O ' ' B' ' 34' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo . . . . . 0 N--CA 1.478 0.559 0 N-CA-C 110.241 -0.715 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' ASN . . . . . 0.594 ' O ' ' HB2' ' A' ' 320' ' ' ASP . 20.1 t-20 -110.82 163.36 13.86 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 18.8 tt -68.59 -23.13 27.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.372 0.606 . . . . 0.0 110.698 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 45.2 m -88.51 5.52 42.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.972 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.594 ' HB2' ' O ' ' A' ' 317' ' ' ASN . 0.2 OUTLIER -68.07 -37.42 81.24 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.058 0.456 . . . . 0.0 110.696 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 85.8 174.95 50.02 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.766 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 5.4 t30 58.86 76.48 0.35 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.207 0.527 . . . . 0.0 111.304 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -95.08 174.34 7.12 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.66 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -90.25 -39.03 13.02 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.528 HG22 ' HB2' ' A' ' 336' ' ' PHE . 4.5 t -170.1 152.19 4.19 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.507 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.427 HG22 HG13 ' A' ' 335' ' ' VAL . 82.0 t -136.19 120.76 26.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -144.49 -179.96 6.88 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.993 0.425 . . . . 0.0 111.547 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 48.7 ttp -126.59 128.64 47.14 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 80.1 mt -122.27 112.1 17.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.938 0.399 . . . . 0.0 110.705 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 62.58 28.41 16.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.421 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 101.6 -20.22 47.28 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.333 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . 0.583 ' HG3' HH22 ' A' ' 343' ' ' ARG . 4.8 mm-40 -94.87 136.8 34.75 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.701 0.251 . . . . 0.0 110.567 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' MET . . . . . 0.553 ' HB3' HG23 ' A' ' 344' ' ' VAL . 47.0 ttm -87.86 134.39 33.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.884 0.373 . . . . 0.0 111.377 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -122.86 121.79 37.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.657 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . 0.427 HG13 HG22 ' A' ' 326' ' ' VAL . 46.8 t -106.63 111.64 36.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' PHE . . . . . 0.528 ' HB2' HG22 ' A' ' 325' ' ' THR . 78.6 m-85 -96.47 130.02 43.71 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.772 0.32 . . . . 0.0 111.73 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 0.668 ' HB3' ' HZ3' ' A' ' 342' ' ' TRP . 38.9 tttp -144.11 112.91 6.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.672 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 62.2 -105.21 0.17 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.315 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -116.56 9.43 14.2 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.814 0.34 . . . . 0.0 111.567 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 8.2 m-90 -129.72 161.22 31.16 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.364 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -137.94 140.75 40.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.946 0.403 . . . . 0.0 111.064 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' TRP . . . . . 0.668 ' HZ3' ' HB3' ' A' ' 337' ' ' LYS . 10.6 m-90 -102.7 144.38 31.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.472 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.583 HH22 ' HG3' ' A' ' 332' ' ' GLU . 25.1 ttt-85 -115.76 106.07 13.44 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.553 HG23 ' HB3' ' A' ' 333' ' ' MET . 1.3 m -101.43 132.44 47.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.18 0.514 . . . . 0.0 111.531 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.63 111.48 9.44 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.936 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 14.1 m120 61.18 50.17 5.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.843 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 66.73 9.23 6.54 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.452 -0.795 . . . . 0.0 113.096 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . 0.434 HE21 ' HB2' ' A' ' 348' ' ' GLN . 3.3 mt-30 -121.45 137.87 54.53 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 122.391 -0.193 . . . . 0.0 111.058 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 38.4 t -79.58 123.82 36.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' MET . . . . . 0.453 ' SD ' ' HD3' ' A' ' 343' ' ' ARG . 83.5 mtp -66.34 148.84 51.28 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -66.98 153.05 44.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.56 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 84.83 10.11 79.62 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.672 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' TYR . . . . . 0.434 ' HB3' ' HA ' ' A' ' 354' ' ' PRO . 83.7 m-85 -123.74 158.83 58.34 Favored Pre-proline 0 C--N 1.326 -0.422 0 O-C-N 122.86 -0.2 . . . . 0.0 110.629 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.434 ' HA ' ' HB3' ' A' ' 353' ' ' TYR . 57.7 Cg_endo -70.51 149.67 90.78 Favored 'Cis proline' 0 C--N 1.349 0.569 0 C-N-CA 123.656 -1.393 . . . . 0.0 112.955 0.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 59.8 ttm -121.83 139.82 30.85 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.445 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -55.59 138.35 80.52 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.596 2.197 . . . . 0.0 111.406 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 89.4 mt -56.46 -40.58 68.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.597 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -70.46 -2.47 42.68 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 121.251 -0.499 . . . . 0.0 114.149 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.25 -39.8 14.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.125 0.488 . . . . 0.0 109.877 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -97.62 -56.33 2.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.266 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 51.9 m95 -93.73 73.91 4.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.691 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 33.7 ttp-105 -62.37 107.9 1.0 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.012 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 123.92 -18.65 7.49 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.558 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.601 HD12 ' HD2' ' A' ' 365' ' ' PRO . 29.8 tp -88.67 128.25 53.31 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.681 0.277 . . . . 0.0 110.552 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' PRO . . . . . 0.601 ' HD2' HD12 ' A' ' 364' ' ' LEU . 92.0 Cg_endo -79.91 -175.07 2.53 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.751 2.301 . . . . 0.0 112.277 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -87.89 160.3 18.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.328 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.1 m 55.31 87.22 0.05 Allowed 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 23.0 pt -105.8 163.91 4.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.174 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . 0.419 HD22 ' HA ' ' A' ' 369' ' ' ASN . 8.3 m120 -85.99 -56.7 3.34 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.677 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . 0.746 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.1 OUTLIER -155.23 171.22 20.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.073 -179.542 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -153.39 144.39 22.88 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -164.55 164.49 21.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.635 0.255 . . . . 0.0 111.039 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -89.77 130.77 35.98 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' ARG . . . . . 0.524 ' HB2' ' OE2' ' A' ' 440' ' ' GLU . 13.2 ptm180 -83.58 -174.92 5.56 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.699 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -68.22 -23.47 64.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.988 0.423 . . . . 0.0 111.473 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . 0.452 ' H ' ' HG3' ' A' ' 374' ' ' ARG . 0.0 OUTLIER -86.68 -24.32 25.28 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.553 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 121.25 -26.53 6.67 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.318 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' LYS . . . . . 0.44 ' HG2' ' HA ' ' A' ' 391' ' ' ASP . 32.8 mttp -63.85 154.86 32.34 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.094 0.473 . . . . 0.0 111.731 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -96.31 123.57 39.99 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.656 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 7.9 t -102.19 114.62 42.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.312 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . 0.529 ' HB2' ' HB2' ' A' ' 388' ' ' TRP . 87.5 m-85 -100.34 144.61 29.14 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -124.18 149.12 46.69 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.869 0.366 . . . . 0.0 111.87 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.483 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 85.5 tttt -157.42 97.27 1.61 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . 0.676 ' O ' ' HA ' ' A' ' 414' ' ' LYS . . . 73.73 -108.45 2.51 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.211 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -114.91 7.74 15.73 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.931 0.396 . . . . 0.0 111.142 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -111.22 149.47 30.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.649 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' HIS . . . . . 0.416 ' NE2' ' HE1' ' A' ' 399' ' ' TYR . 28.9 p-80 -131.69 146.68 52.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.385 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' TRP . . . . . 0.529 ' HB2' ' HB2' ' A' ' 381' ' ' PHE . 17.4 m-90 -119.44 137.56 53.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.17 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 88.4 t -116.49 112.38 39.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -111.0 123.72 50.73 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.847 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.44 ' HA ' ' HG2' ' A' ' 378' ' ' LYS . 34.0 t70 -92.88 93.14 8.24 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 71.76 -79.43 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 O-C-N 123.695 0.622 . . . . 0.0 110.954 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -141.07 13.93 2.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.911 0.386 . . . . 0.0 110.648 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 5.5 m -123.48 131.8 53.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.267 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 58.4 tp -78.35 135.96 37.59 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.111 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 1.5 mt-10 -74.69 148.8 85.52 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.73 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 12.3 Cg_exo -72.58 143.32 37.9 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.928 2.418 . . . . 0.0 111.751 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 89.8 32.45 10.04 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.991 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' TYR . . . . . 0.512 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 80.3 m-85 -138.57 161.05 60.9 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.512 ' HA ' ' HB3' ' A' ' 399' ' ' TYR . 66.8 Cg_endo -74.13 154.7 99.76 Favored 'Cis proline' 0 C--N 1.346 0.409 0 C-N-CA 123.715 -1.369 . . . . 0.0 112.998 0.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 53.3 mttt -125.93 170.29 11.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.233 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 0.528 ' HB3' ' HG2' ' A' ' 404' ' ' LYS . 3.8 m-70 -73.0 155.64 39.63 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.971 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 41.5 mt -59.22 -34.23 53.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.196 0.522 . . . . 0.0 110.658 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . 0.528 ' HG2' ' HB3' ' A' ' 402' ' ' HIS . 47.3 pttt -66.74 -17.59 64.94 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.013 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -78.02 -25.47 47.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.055 0.455 . . . . 0.0 110.111 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 49.9 tp -74.7 -45.33 45.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.567 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.73 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -164.76 147.7 13.06 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.505 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -81.34 140.94 34.47 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.918 0.389 . . . . 0.0 111.0 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 101.36 -3.28 54.26 Favored Glycine 0 CA--C 1.517 0.184 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.737 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 83.7 mt -85.48 149.04 50.94 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.472 0.177 . . . . 0.0 110.732 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.31 145.16 98.67 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.008 2.472 . . . . 0.0 111.863 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.79 11.14 22.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.059 0.457 . . . . 0.0 111.255 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -94.17 -56.34 2.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.672 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . 0.676 ' HA ' ' O ' ' A' ' 384' ' ' GLY . 18.1 ptmt -176.47 173.96 1.98 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.465 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 46.6 mm -123.17 135.04 64.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.866 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 430' ' ' PHE . 4.0 m-20 -89.14 -59.12 2.31 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.746 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -153.72 153.72 32.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.896 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -132.47 116.69 17.08 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 37.1 tp -107.64 125.61 51.55 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.377 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -96.67 113.3 24.85 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' TRP . . . . . 0.491 ' HB2' ' HE2' ' A' ' 428' ' ' TYR . 11.9 t-105 -82.17 99.3 9.17 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.517 ' HB2' ' HD3' ' A' ' 423' ' ' PRO . 66.5 mtt -53.37 -52.96 61.59 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.517 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 82.0 Cg_exo -47.22 -44.58 23.78 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.758 2.305 . . . . 0.0 115.319 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' ASN . . . . . 0.473 ' OD1' ' HB3' ' A' ' 421' ' ' TRP . 35.3 p30 -101.25 -21.58 14.86 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 78.4 37.03 28.76 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.693 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 23.4 mmtt -121.24 144.85 48.39 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . 0.628 ' HB ' ' HB3' ' A' ' 438' ' ' PHE . 15.0 m -97.95 132.17 43.75 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.045 0.45 . . . . 0.0 111.249 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' TYR . . . . . 0.491 ' HE2' ' HB2' ' A' ' 421' ' ' TRP . 83.0 m-85 -107.41 109.9 21.73 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -91.38 122.38 33.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.407 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' PHE . . . . . 0.439 ' O ' ' HB2' ' A' ' 416' ' ' ASP . 89.4 m-85 -100.36 131.82 46.08 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.737 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.402 ' HA ' ' HE ' ' A' ' 431' ' ' ARG . 3.1 tpm_? -144.0 108.95 4.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.893 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 66.05 -108.38 2.36 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -121.85 19.93 10.92 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.274 0.559 . . . . 0.0 110.668 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 42.3 mmtt -127.53 152.87 47.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.761 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' TYR . . . . . 0.505 ' CE1' ' HB2' ' A' ' 451' ' ' LYS . 3.9 p90 -132.76 139.86 47.76 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.825 0.345 . . . . 0.0 111.389 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -107.6 149.98 27.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.202 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -108.04 98.82 8.33 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' PHE . . . . . 0.73 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 69.5 t80 -81.31 124.63 29.51 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.782 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -93.73 104.85 16.93 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' GLU . . . . . 0.524 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 0.1 OUTLIER -58.09 -48.19 80.91 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.315 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.48 -50.66 72.34 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 88.4 mt -84.62 -12.95 52.98 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 23.6 mtp180 57.05 50.84 11.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.467 0.651 . . . . 0.0 111.704 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -159.65 169.63 23.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.684 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 86.5 t -89.19 133.13 32.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -64.34 161.63 16.46 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.368 0.417 . . . . 0.0 111.017 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 2.6 m -69.48 161.88 28.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.863 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 70.87 33.21 2.23 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.353 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . 0.404 ' HB3' ' HA ' ' A' ' 450' ' ' PRO . 32.2 m-85 -137.75 161.53 59.64 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.067 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . 0.404 ' HA ' ' HB3' ' A' ' 449' ' ' TYR . 85.0 Cg_endo -79.7 155.55 88.74 Favored 'Cis proline' 0 C--N 1.346 0.404 0 C-N-CA 123.477 -1.468 . . . . 0.0 112.522 0.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . 0.505 ' HB2' ' CE1' ' A' ' 435' ' ' TYR . 51.9 mttm -105.66 176.96 4.99 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.625 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 452' ' ' ASN . . . . . 0.401 ' O ' HG23 ' A' ' 455' ' ' VAL . 17.3 t-20 -75.2 140.73 43.47 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.0 tt -68.16 -14.62 18.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.94 0.4 . . . . 0.0 110.593 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -69.74 -1.62 9.67 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.302 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 455' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 452' ' ' ASN . 38.1 t -60.87 -37.71 77.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 456' ' ' TRP . . . . . 0.491 ' HB3' ' CE1' ' A' ' 486' ' ' PHE . 15.1 m95 -91.16 93.64 9.22 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . 0.434 ' HB3' ' HG3' ' A' ' 492' ' ' LYS . 3.2 tt0 -56.44 121.13 8.9 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 105.63 -15.03 45.94 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.722 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 25.6 mm -80.67 130.46 64.27 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 121.084 0.469 . . . . 0.0 111.245 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.04 158.24 30.59 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.733 2.289 . . . . 0.0 111.284 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -82.93 141.11 32.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.217 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.6 m 57.8 75.57 0.54 Allowed Pre-proline 0 N--CA 1.464 0.239 0 O-C-N 123.868 0.73 . . . . 0.0 112.855 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -90.5 179.86 1.77 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.689 2.259 . . . . 0.0 111.235 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 464' ' ' ARG . 0.0 OUTLIER -134.76 26.71 3.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.312 0.577 . . . . 0.0 110.42 179.692 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 175.01 137.96 2.63 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.38 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 20.9 p -161.04 99.77 1.22 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -128.99 143.9 51.02 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.839 0.352 . . . . 0.0 111.294 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 468' ' ' MET . . . . . 0.407 ' HA ' ' HA ' ' A' ' 475' ' ' THR . 34.7 ttm -86.33 143.21 27.98 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.853 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -72.81 163.77 54.85 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.511 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.44 -7.59 20.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.053 0.454 . . . . 0.0 111.648 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -90.9 -13.24 33.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.403 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 66.87 0.04 1.81 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 55.4 t -98.2 -36.38 5.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.845 0.355 . . . . 0.0 111.264 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -112.16 144.73 41.05 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 475' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 468' ' ' MET . 60.8 m -122.32 137.53 54.82 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -112.95 122.62 48.17 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.148 0.499 . . . . 0.0 112.29 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -101.97 150.57 23.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.645 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -130.07 133.37 46.65 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 44.1 tttt -170.51 140.91 1.85 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.86 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 60.14 32.62 76.73 Favored Glycine 0 C--N 1.328 0.104 0 C-N-CA 121.245 -0.502 . . . . 0.0 112.609 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 481' ' ' ASN . . . . . 0.92 HD21 ' HG ' ' A' ' 502' ' ' LEU . 1.7 t30 64.53 17.67 10.97 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.344 0.592 . . . . 0.0 111.785 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -122.81 158.48 30.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.485 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 483' ' ' TYR . . . . . 0.504 ' CE1' ' HB2' ' A' ' 499' ' ' LYS . 4.7 p90 -123.98 149.53 45.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.915 0.388 . . . . 0.0 111.93 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 20.1 m-90 -118.21 138.56 52.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.452 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -99.89 93.62 5.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.089 0.471 . . . . 0.0 109.746 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 486' ' ' PHE . . . . . 0.491 ' CE1' ' HB3' ' A' ' 456' ' ' TRP . 81.6 t80 -86.45 131.2 34.25 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.738 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . 0.432 ' HB3' ' HB2' ' A' ' 490' ' ' LYS . 36.1 t-20 -97.17 114.67 26.39 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -65.15 -28.69 69.59 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -178.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -84.29 -14.61 49.27 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 490' ' ' LYS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 487' ' ' ASN . 93.1 mttt -109.35 -26.3 10.1 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 68.86 30.8 4.56 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.857 0.837 . . . . 0.0 110.373 -178.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 492' ' ' LYS . . . . . 0.434 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 62.6 tttp -150.06 154.43 38.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.048 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 55.9 t -79.17 133.54 29.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -59.91 147.19 80.14 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.459 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -62.96 157.15 50.22 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 123.246 2.631 . . . . 0.0 112.972 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 83.91 27.19 38.65 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.874 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . 0.523 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 27.7 m-85 -129.75 165.87 30.1 Favored Pre-proline 0 C--N 1.327 -0.393 0 O-C-N 122.877 -0.19 . . . . 0.0 111.13 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . 0.523 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 87.4 Cg_endo -82.41 175.25 40.4 Favored 'Cis proline' 0 C--N 1.346 0.433 0 C-N-CA 123.74 -1.358 . . . . 0.0 112.871 0.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 499' ' ' LYS . . . . . 0.504 ' HB2' ' CE1' ' A' ' 483' ' ' TYR . 97.8 mttt -129.7 153.98 47.62 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.406 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 41.4 t -69.36 123.92 22.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.905 0.383 . . . . 0.0 110.484 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -67.75 -18.49 64.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.885 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 502' ' ' LEU . . . . . 0.92 ' HG ' HD21 ' A' ' 481' ' ' ASN . 13.7 mt -66.8 -46.32 75.6 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.921 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -80.94 -41.27 23.17 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.2 -45.2 34.32 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -177.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 35.0 m0 -100.12 -58.55 1.89 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 10.8 mmt -60.64 -41.28 94.62 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 98.5 25.62 9.91 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.611 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 3.5 m -110.62 103.4 54.27 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -81.32 178.59 6.59 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.509 2.139 . . . . 0.0 111.693 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 3.9 m 67.12 13.88 9.59 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.73 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.396 -1.225 . . . . 0.0 111.087 179.699 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.809 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo . . . . . 0 N--CA 1.462 -0.37 0 C-N-CA 123.277 2.651 . . . . 0.0 111.397 179.599 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.654 0 N-CA-C 112.71 -0.156 . . . . 0.0 112.71 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo . . . . . 0 CA--C 1.529 0.269 0 C-N-CA 122.986 2.458 . . . . 0.0 111.689 -179.934 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 120.144 -0.253 . . . . 0.0 112.77 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.405 ' HD2' ' O ' ' D' ' 204' ' ' PRO . 52.9 Cg_exo . . . . . 0 CA--C 1.529 0.27 0 C-N-CA 122.86 2.373 . . . . 0.0 111.22 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.787 0 N-CA-C 112.019 -0.433 . . . . 0.0 112.019 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.76 142.99 95.72 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.855 2.37 . . . . 0.0 111.867 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -67.89 142.86 55.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.935 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' D' ' 210' ' ' PRO . . . -60.55 150.49 41.67 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.736 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.414 ' O ' ' HG3' ' D' ' 211' ' ' GLN . 17.4 mt -68.28 147.8 12.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.74 151.57 46.48 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.837 0.351 . . . . 0.0 110.447 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' D' ' 213' ' ' ILE . . . -66.35 162.46 43.88 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.299 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -68.94 148.72 49.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.771 0.319 . . . . 0.0 110.426 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.18 145.0 54.74 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.216 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.2 143.43 47.45 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.948 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.459 ' HB ' ' HG2' ' D' ' 217' ' ' ARG . 2.5 t -69.49 159.24 5.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 4.6 t -55.79 143.27 9.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.901 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.53 171.48 54.86 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.498 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 97.2 mt . . . . . 0 C--N 1.325 -0.458 0 CA-C-O 120.599 0.238 . . . . 0.0 110.686 -179.853 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.59 0 CA-C-O 120.473 -0.07 . . . . 0.0 113.22 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 CA--C 1.529 0.265 0 C-N-CA 122.921 2.414 . . . . 0.0 111.859 -179.94 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.624 0 N-CA-C 112.431 -0.268 . . . . 0.0 112.431 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo . . . . . 0 C--O 1.236 0.388 0 C-N-CA 122.886 2.39 . . . . 0.0 111.512 179.219 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.648 0 CA-C-O 120.197 -0.224 . . . . 0.0 112.641 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 CA--C 1.531 0.365 0 C-N-CA 123.056 2.504 . . . . 0.0 112.213 179.592 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.512 0 CA-C-O 120.456 -0.08 . . . . 0.0 113.237 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 C--O 1.235 0.345 0 C-N-CA 122.88 2.387 . . . . 0.0 111.193 179.373 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.461 0 CA-C-O 120.109 -0.273 . . . . 0.0 112.637 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo . . . . . 0 C--O 1.235 0.36 0 C-N-CA 123.369 2.712 . . . . 0.0 112.702 -179.82 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 103' ' ' GLY . . . . . 0.44 ' O ' ' HD3' ' D' ' 204' ' ' PRO . . . . . . . . 0 N--CA 1.449 -0.46 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo . . . . . 0 CA--C 1.536 0.588 0 C-N-CA 122.861 2.374 . . . . 0.0 112.449 -179.837 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.51 0 N-CA-C 112.425 -0.27 . . . . 0.0 112.425 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo . . . . . 0 C--N 1.342 0.223 0 C-N-CA 122.776 2.317 . . . . 0.0 111.197 179.44 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.429 0 N-CA-C 113.465 0.146 . . . . 0.0 113.465 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.03 157.34 62.2 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.814 2.343 . . . . 0.0 112.576 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -60.02 137.69 58.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.529 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -67.53 164.11 45.64 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.88 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 40.5 mt -67.22 144.46 14.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.42 148.04 50.15 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -63.17 147.22 50.56 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.119 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -75.17 149.97 38.84 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 122.753 -0.263 . . . . 0.0 110.366 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 9.5 ttm-85 -59.09 141.06 55.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.935 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.95 170.47 33.15 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.973 -0.558 . . . . 0.0 113.428 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 119' ' ' VAL . . . . . 0.452 ' O ' ' HA3' ' D' ' 218' ' ' GLY . 23.5 t -71.85 139.88 19.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.563 -0.319 . . . . 0.0 110.514 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 21.4 t -60.22 141.8 16.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.507 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.51 163.9 34.97 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.446 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 67.3 mt . . . . . 0 C--N 1.323 -0.545 0 O-C-N 122.895 -0.179 . . . . 0.0 110.722 -179.637 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 CA-C-O 120.288 -0.173 . . . . 0.0 112.849 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 C--O 1.236 0.405 0 C-N-CA 122.661 2.241 . . . . 0.0 112.369 -179.499 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.554 0 N-CA-C 112.705 -0.158 . . . . 0.0 112.705 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo . . . . . 0 C--O 1.237 0.438 0 C-N-CA 122.758 2.305 . . . . 0.0 112.046 -179.995 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.38 0 CA-C-O 120.571 -0.016 . . . . 0.0 113.134 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo . . . . . 0 C--O 1.235 0.371 0 C-N-CA 123.098 2.532 . . . . 0.0 111.855 -179.657 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.538 0 CA-C-O 120.273 -0.182 . . . . 0.0 112.955 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo . . . . . 0 CA--C 1.53 0.296 0 C-N-CA 122.971 2.448 . . . . 0.0 112.132 179.868 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 N-CA-C 112.205 -0.358 . . . . 0.0 112.205 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 C--N 1.348 0.516 0 C-N-CA 122.893 2.395 . . . . 0.0 111.412 179.841 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 203' ' ' GLY . . . . . 0.409 ' HA2' ' HD3' ' D' ' 204' ' ' PRO . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 114.381 0.512 . . . . 0.0 114.381 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 204' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' C' ' 103' ' ' GLY . 17.0 Cg_exo . . . . . 0 CA--C 1.53 0.316 0 C-N-CA 123.174 2.582 . . . . 0.0 110.99 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.268 0 N-CA-C 113.492 0.157 . . . . 0.0 113.492 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo . . . . . 0 CA--C 1.534 0.48 0 C-N-CA 123.516 2.811 . . . . 0.0 112.208 179.637 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.591 0 N-CA-C 112.425 -0.27 . . . . 0.0 112.425 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 210' ' ' PRO . . . . . 0.461 ' O ' ' HA3' ' B' ' 12' ' ' GLY . 58.8 Cg_endo -73.78 157.35 47.97 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.549 2.166 . . . . 0.0 112.273 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 211' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' B' ' 13' ' ' ILE . 34.9 tt0 -78.1 144.33 36.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.595 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -68.08 166.32 44.49 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.824 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 213' ' ' ILE . . . . . 0.485 ' O ' ' HA3' ' B' ' 15' ' ' GLY . 45.4 pt -68.29 164.73 2.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 120.835 0.35 . . . . 0.0 110.984 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -81.06 147.58 30.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.108 0.48 . . . . 0.0 111.381 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -71.89 153.02 49.59 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.411 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 48.8 mm-40 -71.55 150.6 44.61 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 217' ' ' ARG . . . . . 0.459 ' HG2' ' HB ' ' B' ' 19' ' ' VAL . 60.0 mtp180 -64.63 160.18 20.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.185 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 218' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' C' ' 119' ' ' VAL . . . -62.14 156.85 36.93 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.206 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.15 152.28 9.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.5 137.25 25.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -56.68 166.63 4.51 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.918 -0.583 . . . . 0.0 114.237 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 8.6 mp . . . . . 0 C--N 1.325 -0.498 0 CA-C-N 115.719 -0.241 . . . . 0.0 110.736 -179.84 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.646 0 N-CA-C 113.299 0.08 . . . . 0.0 113.299 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo . . . . . 0 C--O 1.233 0.268 0 C-N-CA 122.838 2.359 . . . . 0.0 111.109 179.311 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 113.158 0.023 . . . . 0.0 113.158 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo . . . . . 0 C--O 1.235 0.36 0 C-N-CA 122.682 2.255 . . . . 0.0 111.716 179.833 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.766 0 N-CA-C 112.86 -0.096 . . . . 0.0 112.86 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo . . . . . 0 N--CA 1.46 -0.495 0 C-N-CA 122.642 2.228 . . . . 0.0 111.079 179.382 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.478 0.6 0 N-CA-C 110.378 -0.662 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -106.48 160.03 15.72 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.975 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . 0.4 ' O ' ' HZ ' ' A' ' 323' ' ' PHE . 19.8 tt -75.9 -23.59 16.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.003 0.43 . . . . 0.0 111.474 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 21.4 m -80.52 0.18 34.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.283 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -67.6 -34.48 77.1 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.948 0.404 . . . . 0.0 111.178 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' GLY . . . . . 0.434 ' HA2' HD21 ' A' ' 502' ' ' LEU . . . 82.55 -171.66 51.53 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.213 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 5.0 t30 52.41 74.04 0.3 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.18 0.514 . . . . 0.0 111.139 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' PHE . . . . . 0.491 ' HD1' ' HB2' ' A' ' 337' ' ' LYS . 73.6 m-85 -95.67 162.76 13.48 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.427 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -77.0 -35.25 57.28 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.244 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 6.7 t -178.33 155.68 0.91 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.528 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.553 HG22 HG13 ' A' ' 335' ' ' VAL . 48.4 t -133.96 127.14 51.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -144.27 172.08 13.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.997 0.427 . . . . 0.0 111.67 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 38.6 ttp -126.28 113.74 17.36 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 50.9 mt -106.88 116.53 32.08 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.567 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.494 ' NH1' ' HB3' ' D' ' 214' ' ' ALA . 69.3 mtp180 57.9 27.45 14.65 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 98.18 -5.75 61.3 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.923 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -101.52 122.43 43.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.902 0.382 . . . . 0.0 111.131 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 56.7 ttm -81.45 120.81 25.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.194 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -119.24 126.76 52.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.756 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . 0.553 HG13 HG22 ' A' ' 326' ' ' VAL . 25.5 t -107.73 119.78 57.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.434 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -95.35 121.13 36.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.012 0.434 . . . . 0.0 112.145 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 0.491 ' HB2' ' HD1' ' A' ' 323' ' ' PHE . 52.4 tptt -130.18 99.56 5.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.686 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 62.4 -102.9 0.12 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.02 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -116.77 13.69 15.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.1 0.476 . . . . 0.0 111.026 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 20.1 m-90 -128.88 142.9 50.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.544 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.502 ' CE2' ' HE2' ' A' ' 353' ' ' TYR . 12.6 p90 -122.35 135.49 54.72 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.937 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' TRP . . . . . 0.436 ' HZ3' ' HB3' ' A' ' 337' ' ' LYS . 1.9 m-90 -100.15 151.95 20.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.572 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.515 ' HD2' ' CE1' ' A' ' 353' ' ' TYR . 14.8 ttt-85 -120.78 100.47 7.12 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 5.2 m -112.52 131.45 64.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.204 0.526 . . . . 0.0 112.09 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 6.3 ttm-85 -139.33 112.63 8.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.337 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 1.5 m120 72.97 49.78 0.15 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 61.67 24.46 14.56 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.487 178.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -143.45 145.75 32.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.053 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 22.2 t -83.41 135.75 24.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' MET . . . . . 0.454 ' SD ' ' HD3' ' A' ' 343' ' ' ARG . 87.9 mtp -83.2 156.07 23.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.995 0.426 . . . . 0.0 111.418 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -69.92 150.12 47.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.407 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . 0.665 ' HA3' HD11 ' B' ' 13' ' ' ILE . . . 95.04 -8.51 70.13 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.268 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' TYR . . . . . 0.569 ' HB3' ' HA ' ' A' ' 354' ' ' PRO . 32.8 m-85 -119.21 164.01 23.65 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.569 ' HA ' ' HB3' ' A' ' 353' ' ' TYR . 59.1 Cg_endo -70.58 159.82 91.55 Favored 'Cis proline' 0 C--N 1.348 0.501 0 C-N-CA 123.856 -1.31 . . . . 0.0 112.813 0.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 42.5 ttm -134.68 141.78 40.02 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.232 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -60.93 140.09 88.41 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.416 2.077 . . . . 0.0 111.165 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 78.7 mt -56.95 -44.15 81.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.605 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -69.86 3.04 10.38 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 114.283 0.473 . . . . 0.0 114.283 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.09 -46.5 7.41 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -93.79 -53.55 3.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.132 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -84.77 73.19 10.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.831 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 30.4 ttp-105 -64.46 93.88 0.11 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.187 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 129.72 -7.28 6.17 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.035 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.681 HD12 ' HD2' ' A' ' 365' ' ' PRO . 33.8 tp -99.41 126.37 37.85 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-O 120.57 0.224 . . . . 0.0 110.533 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' PRO . . . . . 0.681 ' HD2' HD12 ' A' ' 364' ' ' LEU . 73.9 Cg_endo -74.62 175.09 11.56 Favored 'Trans proline' 0 CA--C 1.528 0.216 0 C-N-CA 122.624 2.216 . . . . 0.0 111.961 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -85.8 154.91 21.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.494 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 35.0 m 55.5 82.41 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 22.7 pt -95.17 -171.22 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.29 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . 0.432 HD22 ' HA ' ' A' ' 369' ' ' ASN . 8.1 m120 -108.99 -47.7 3.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.724 0.297 . . . . 0.0 111.193 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . 0.876 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.3 OUTLIER -156.44 166.34 33.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.848 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -153.4 145.51 23.77 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . 0.442 ' HD2' ' HB2' ' A' ' 420' ' ' PHE . 2.0 p90 -161.42 159.94 28.8 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.129 0.49 . . . . 0.0 112.221 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -89.63 121.18 31.57 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 378' ' ' LYS . 6.2 ptm180 -78.1 177.97 7.91 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.434 ' HE3' ' HA3' ' A' ' 425' ' ' GLY . 70.2 tttt -68.3 -38.2 81.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.863 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -31.63 71.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.632 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 129.66 -32.82 3.11 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.51 -0.852 . . . . 0.0 113.043 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' LYS . . . . . 0.49 ' O ' ' HG2' ' A' ' 374' ' ' ARG . 35.6 mttm -65.66 157.56 29.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.073 0.463 . . . . 0.0 111.696 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' PHE . . . . . 0.449 ' HE1' ' HG3' ' A' ' 330' ' ' ARG . 16.4 m-85 -98.67 135.04 40.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.993 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 4.7 t -113.24 121.65 65.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.842 0.353 . . . . 0.0 110.668 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -108.51 138.26 45.11 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.436 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -120.29 143.5 48.3 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.826 0.346 . . . . 0.0 111.584 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.515 ' HB3' ' CZ3' ' A' ' 388' ' ' TRP . 83.6 tttt -158.34 105.75 1.91 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.517 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 76.33 -114.84 4.26 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.556 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -114.19 4.0 15.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.932 0.396 . . . . 0.0 110.7 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -112.6 155.92 23.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.847 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -136.3 146.78 47.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.944 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' TRP . . . . . 0.515 ' CZ3' ' HB3' ' A' ' 383' ' ' LYS . 20.5 m-90 -121.88 132.51 54.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.061 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 95.0 t -111.88 119.49 60.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -111.21 130.96 55.48 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.342 0.591 . . . . 0.0 112.211 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -95.31 87.82 4.94 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' GLU . . . . . 0.53 ' OE1' ' HB ' ' D' ' 213' ' ' ILE . 38.1 mm-40 67.35 -79.54 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.604 0.565 . . . . 0.0 110.539 -178.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -137.7 19.32 2.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.234 0.54 . . . . 0.0 109.991 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 8.1 m -121.12 157.79 29.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.782 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 64.9 tp -104.43 135.95 44.92 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.629 0.252 . . . . 0.0 110.829 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 24.9 mm-40 -70.57 125.89 92.11 Favored Pre-proline 0 C--O 1.232 0.184 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.047 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 31.9 Cg_exo -59.92 136.35 69.2 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.873 2.382 . . . . 0.0 111.842 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 101.04 -8.37 57.52 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.716 -0.755 . . . . 0.0 111.798 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' TYR . . . . . 0.402 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 22.6 m-85 -93.89 161.02 31.26 Favored Pre-proline 0 C--N 1.321 -0.659 0 O-C-N 122.85 -0.206 . . . . 0.0 110.815 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.458 ' HB3' ' NE1' ' A' ' 388' ' ' TRP . 74.0 Cg_endo -75.04 166.55 82.96 Favored 'Cis proline' 0 C--N 1.346 0.434 0 C-N-CA 123.819 -1.325 . . . . 0.0 112.943 0.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -137.66 163.04 32.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.388 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 0.517 ' HB2' ' HG2' ' A' ' 404' ' ' LYS . 8.6 m-70 -71.01 150.6 45.47 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 79.2 mt -54.61 -33.5 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 120.887 0.375 . . . . 0.0 111.33 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . 0.517 ' HG2' ' HB2' ' A' ' 402' ' ' HIS . 19.4 pttp -64.22 -15.13 59.38 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.193 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -81.93 -20.22 39.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.911 0.386 . . . . 0.0 111.102 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 38.3 tp -74.94 -48.85 22.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.084 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.739 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -162.82 155.74 27.19 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.687 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -81.58 130.92 35.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.791 0.329 . . . . 0.0 110.939 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 102.29 1.76 50.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.308 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 51.3 mt -79.46 156.34 75.9 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 120.49 0.186 . . . . 0.0 111.026 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' PRO . . . . . 0.469 ' HG3' ' CE1' ' A' ' 436' ' ' TYR . 30.6 Cg_exo -61.51 118.14 5.0 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.614 2.209 . . . . 0.0 111.525 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.04 -3.5 59.09 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.99 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -92.3 -56.67 2.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.448 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 9.5 ptmt -176.38 171.8 2.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.863 0.363 . . . . 0.0 110.723 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 39.6 mm -117.16 133.09 65.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.694 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . 0.503 ' HB3' ' HD2' ' A' ' 463' ' ' PRO . 14.7 m-20 -90.79 -48.85 6.78 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.876 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -156.43 154.28 30.2 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.138 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -135.19 113.55 11.46 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 42.3 tp -107.94 132.69 53.22 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.269 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . 0.442 ' HB2' ' HD2' ' A' ' 372' ' ' TYR . 29.2 t80 -98.12 116.67 30.82 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.966 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' TRP . . . . . 0.409 ' HB2' ' CE1' ' A' ' 428' ' ' TYR . 9.4 t-105 -89.5 97.05 10.97 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.417 ' HB2' ' HD3' ' A' ' 423' ' ' PRO . 62.7 mtt -55.31 -50.81 84.56 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.417 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 81.7 Cg_exo -45.78 -53.33 5.78 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 123.151 2.567 . . . . 0.0 114.662 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 42.4 p30 -95.62 -10.67 28.84 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . 0.434 ' HA3' ' HE3' ' A' ' 375' ' ' LYS . . . 66.89 51.99 36.36 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.921 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -138.42 160.94 38.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.671 0.272 . . . . 0.0 111.03 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . 0.492 ' HB ' ' HB3' ' A' ' 438' ' ' PHE . 26.5 m -105.7 133.26 50.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.067 0.461 . . . . 0.0 111.525 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' TYR . . . . . 0.409 ' CE1' ' HB2' ' A' ' 421' ' ' TRP . 17.0 m-85 -110.31 110.77 21.69 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -93.97 138.97 31.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.509 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' PHE . . . . . 0.455 ' O ' ' HB2' ' A' ' 416' ' ' ASP . 95.0 m-85 -114.1 136.73 52.61 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.331 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.466 ' HA ' ' HE ' ' A' ' 431' ' ' ARG . 2.6 tpm_? -148.27 105.18 3.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.809 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 68.1 -109.89 3.14 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -115.12 11.4 16.35 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.23 0.538 . . . . 0.0 110.009 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . 0.622 ' HD2' ' HG2' ' A' ' 450' ' ' PRO . 19.6 mmtt -117.01 150.48 38.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.156 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' TYR . . . . . 0.447 ' CE2' ' HE1' ' A' ' 449' ' ' TYR . 5.1 p90 -131.41 140.26 49.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.589 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' TYR . . . . . 0.469 ' CE1' ' HG3' ' A' ' 411' ' ' PRO . 2.3 m-85 -110.5 144.38 39.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.497 -178.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -106.14 96.65 6.63 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' PHE . . . . . 0.739 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 79.5 t80 -80.85 128.49 33.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.125 -177.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -96.74 97.87 9.69 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' GLU . . . . . 0.445 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 1.3 mm-40 -44.95 -60.61 1.98 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -56.23 -36.35 68.4 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 67.1 mt -88.73 -20.56 24.65 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 67.0 mtp180 61.96 48.55 5.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.557 0.694 . . . . 0.0 110.847 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -162.03 164.53 28.17 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.749 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.0 t -88.62 138.74 18.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -61.97 166.4 4.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.201 0.524 . . . . 0.0 112.147 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.46 152.0 46.04 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 68.81 22.74 7.15 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.668 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . 0.447 ' HE1' ' CE2' ' A' ' 435' ' ' TYR . 31.2 m-85 -118.21 158.26 46.89 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.114 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . 0.622 ' HG2' ' HD2' ' A' ' 434' ' ' LYS . 91.9 Cg_endo -77.75 151.71 91.89 Favored 'Cis proline' 0 C--N 1.344 0.332 0 C-N-CA 123.643 -1.399 . . . . 0.0 113.521 0.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -102.38 177.09 4.97 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.847 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -75.24 140.93 43.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.573 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.2 tt -69.79 -11.5 14.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.909 0.385 . . . . 0.0 110.974 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -63.84 -6.31 5.68 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 70.7 t -67.54 -33.6 63.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 10.0 m95 -95.46 84.84 4.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.253 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -57.4 115.71 2.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.187 0.518 . . . . 0.0 112.358 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 115.17 -26.47 9.2 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.097 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.452 HD11 ' HB2' ' A' ' 486' ' ' PHE . 31.7 mm -73.47 130.48 83.96 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.714 0.292 . . . . 0.0 111.067 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.0 156.15 23.32 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.825 2.35 . . . . 0.0 111.869 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -77.57 141.09 39.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.412 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 5.2 m 58.0 74.59 0.62 Allowed Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 463' ' ' PRO . . . . . 0.503 ' HD2' ' HB3' ' A' ' 416' ' ' ASP . 2.4 Cg_endo -81.84 -173.87 1.94 Allowed 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.866 2.378 . . . . 0.0 112.017 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.87 20.37 3.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.239 0.542 . . . . 0.0 110.528 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 161.36 142.48 3.4 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.592 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 7.8 p -156.75 106.77 2.3 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -127.48 138.34 52.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.923 0.392 . . . . 0.0 111.613 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 46.2 ttm -90.31 142.06 28.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.291 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -71.18 162.26 54.16 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.917 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.7 -12.46 46.86 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 16.9 p30 -85.27 -13.2 50.52 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.623 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 66.98 10.84 7.99 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.14 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 40.1 t -104.43 -42.9 7.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.601 0.239 . . . . 0.0 111.44 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 474' ' ' PHE . . . . . 0.411 ' CD1' ' HE2' ' A' ' 485' ' ' LYS . 80.9 m-85 -112.05 144.84 40.74 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 97.8 m -126.99 134.31 50.38 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.316 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -101.82 124.89 48.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.954 0.407 . . . . 0.0 111.716 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 477' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 483' ' ' TYR . 14.6 m-85 -110.22 131.41 55.08 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -115.26 137.76 51.68 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.665 0.269 . . . . 0.0 111.669 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 479' ' ' LYS . . . . . 0.467 ' HB3' ' CZ3' ' A' ' 484' ' ' TRP . 79.5 tttt -163.01 104.1 1.0 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.961 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 65.94 66.03 2.6 Favored Glycine 0 CA--C 1.518 0.268 0 N-CA-C 114.828 0.691 . . . . 0.0 114.828 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 61.84 -1.2 0.37 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 482' ' ' LYS . . . . . 0.441 ' HB2' ' HE2' ' A' ' 482' ' ' LYS . 30.3 mtmm -119.56 148.02 43.8 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 122.291 -0.256 . . . . 0.0 110.526 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 483' ' ' TYR . . . . . 0.543 ' CE2' ' HE2' ' A' ' 497' ' ' TYR . 11.0 p90 -127.95 147.55 50.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.174 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 484' ' ' TRP . . . . . 0.467 ' CZ3' ' HB3' ' A' ' 479' ' ' LYS . 17.4 m-90 -113.04 143.84 43.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.879 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . 0.411 ' HE2' ' CD1' ' A' ' 474' ' ' PHE . 74.0 tttt -104.35 97.08 7.07 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 486' ' ' PHE . . . . . 0.452 ' HB2' HD11 ' A' ' 459' ' ' ILE . 89.4 t80 -90.68 134.54 34.33 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.477 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -98.63 119.27 37.06 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -68.52 -32.93 73.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.199 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -74.84 -43.14 56.16 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.701 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -85.24 -22.56 28.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.131 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 3.7 tp 65.56 42.67 3.6 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.525 0.679 . . . . 0.0 109.889 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 492' ' ' LYS . . . . . 0.412 ' HG2' ' N ' ' A' ' 493' ' ' VAL . 16.1 tttp -156.96 153.89 28.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.61 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 486' ' ' PHE . 69.9 t -85.15 140.18 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -61.48 131.46 92.54 Favored Pre-proline 0 C--O 1.234 0.278 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.264 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -62.11 141.84 90.04 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.669 2.246 . . . . 0.0 111.682 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 109.56 -10.24 32.83 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . 0.613 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 14.0 m-85 -94.73 170.46 8.02 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.61 -0.295 . . . . 0.0 110.333 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . 0.613 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 91.9 Cg_endo -78.88 169.5 72.11 Favored 'Cis proline' 0 C--N 1.349 0.604 0 C-N-CA 123.978 -1.259 . . . . 0.0 113.253 0.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -120.85 157.65 29.34 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.774 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 47.6 t -69.84 112.91 6.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.973 0.416 . . . . 0.0 110.263 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -66.55 -23.73 66.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.074 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 502' ' ' LEU . . . . . 0.485 ' HA ' ' HG2' ' A' ' 506' ' ' MET . 79.1 mt -65.94 -39.25 90.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.114 0.483 . . . . 0.0 110.711 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -89.06 -39.69 13.47 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.587 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.0 -36.67 61.97 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 42.9 m0 -106.37 -57.44 2.05 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 506' ' ' MET . . . . . 0.485 ' HG2' ' HA ' ' A' ' 502' ' ' LEU . 7.1 mmt -65.84 -35.42 80.63 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 91.67 38.03 5.95 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.218 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 23.0 m -115.74 86.95 16.75 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.3 160.69 48.06 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.475 2.117 . . . . 0.0 111.737 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 5.7 m 66.4 69.71 0.42 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.166 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.23 0 CA-C-O 118.306 -1.274 . . . . 0.0 111.258 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.766 0 N-CA-C 112.429 -0.268 . . . . 0.0 112.429 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo . . . . . 0 C--N 1.345 0.394 0 C-N-CA 122.745 2.297 . . . . 0.0 112.471 -179.346 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.736 0 N-CA-C 112.181 -0.368 . . . . 0.0 112.181 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo . . . . . 0 N--CA 1.459 -0.521 0 C-N-CA 122.488 2.126 . . . . 0.0 110.404 178.97 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.563 0 CA-C-O 120.365 -0.131 . . . . 0.0 112.887 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo . . . . . 0 CA--C 1.527 0.154 0 C-N-CA 122.943 2.428 . . . . 0.0 111.766 179.915 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.744 0 N-CA-C 112.062 -0.415 . . . . 0.0 112.062 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.35 149.77 69.89 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 123.006 2.471 . . . . 0.0 112.061 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -65.17 145.56 56.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.494 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.41 155.96 46.21 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.249 -0.5 . . . . 0.0 112.318 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.665 HD11 ' HA3' ' A' ' 352' ' ' GLY . 6.9 mt -67.44 147.28 12.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.572 0.225 . . . . 0.0 110.778 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.41 147.29 53.09 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.797 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' D' ' 213' ' ' ILE . . . -75.77 162.08 52.79 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.0 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -72.94 150.47 42.51 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -75.16 152.41 38.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.191 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' D' ' 216' ' ' GLN . . . -67.84 154.23 53.01 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.648 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 3.2 t -71.99 152.32 8.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 2.9 t -51.33 145.24 2.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 O-C-N 123.499 0.499 . . . . 0.0 110.948 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.39 160.12 53.99 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.739 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 94.0 mt . . . . . 0 C--N 1.321 -0.654 0 CA-C-O 120.479 0.181 . . . . 0.0 110.604 179.978 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.612 0 N-CA-C 112.451 -0.26 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo . . . . . 0 CA--C 1.529 0.258 0 C-N-CA 122.752 2.301 . . . . 0.0 111.764 179.742 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 113.399 0.12 . . . . 0.0 113.399 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 CA--C 1.532 0.409 0 C-N-CA 123.244 2.629 . . . . 0.0 112.035 179.969 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 112.878 -0.089 . . . . 0.0 112.878 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo . . . . . 0 CA--C 1.528 0.224 0 C-N-CA 123.176 2.584 . . . . 0.0 111.853 179.702 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.514 0 N-CA-C 112.333 -0.307 . . . . 0.0 112.333 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo . . . . . 0 N--CA 1.464 -0.228 0 C-N-CA 122.685 2.256 . . . . 0.0 111.479 179.562 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.402 0 CA-C-O 120.224 -0.209 . . . . 0.0 112.64 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo . . . . . 0 C--O 1.234 0.282 0 C-N-CA 123.057 2.505 . . . . 0.0 111.142 -179.893 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 103' ' ' GLY . . . . . 0.417 ' HA2' ' HD3' ' C' ' 104' ' ' PRO . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 113.689 0.236 . . . . 0.0 113.689 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 104' ' ' PRO . . . . . 0.417 ' HD3' ' HA2' ' C' ' 103' ' ' GLY . 2.8 Cg_exo . . . . . 0 CA--C 1.533 0.44 0 C-N-CA 123.528 2.819 . . . . 0.0 112.413 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.394 0 N-CA-C 112.421 -0.272 . . . . 0.0 112.421 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo . . . . . 0 CA--C 1.531 0.34 0 C-N-CA 122.981 2.454 . . . . 0.0 111.756 -179.885 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.243 0 N-CA-C 113.553 0.181 . . . . 0.0 113.553 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.19 156.82 64.36 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.66 2.24 . . . . 0.0 112.085 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -59.33 135.86 57.78 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.06 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -62.01 162.16 27.63 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.563 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 16.3 mt -69.3 134.73 29.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.621 0.248 . . . . 0.0 110.68 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.26 146.52 47.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.679 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -64.94 157.04 46.62 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 121.205 -0.521 . . . . 0.0 113.002 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -84.3 152.4 24.16 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 117' ' ' ARG . . . . . 0.412 ' HE ' ' HB2' ' C' ' 117' ' ' ARG . 4.6 ttm180 -66.5 148.52 51.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.328 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.07 171.91 41.65 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.027 -0.606 . . . . 0.0 113.053 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 15.9 t -72.85 142.49 15.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 97.3 t -62.9 138.39 22.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.954 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.46 158.52 39.32 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 116.081 -0.508 . . . . 0.0 112.538 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 59.1 mt . . . . . 0 C--N 1.323 -0.551 0 CA-C-N 115.852 -0.174 . . . . 0.0 110.642 -179.777 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.615 0 N-CA-C 112.673 -0.171 . . . . 0.0 112.673 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 N--CA 1.464 -0.209 0 C-N-CA 122.475 2.117 . . . . 0.0 111.116 179.833 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.523 0 N-CA-C 112.774 -0.13 . . . . 0.0 112.774 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo . . . . . 0 C--O 1.236 0.381 0 C-N-CA 122.82 2.347 . . . . 0.0 111.552 179.839 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.434 0 N-CA-C 113.451 0.14 . . . . 0.0 113.451 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo . . . . . 0 C--O 1.235 0.328 0 C-N-CA 122.985 2.457 . . . . 0.0 111.731 -179.948 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 133' ' ' GLY . . . . . 0.407 ' HA2' ' HD3' ' C' ' 134' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.608 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 134' ' ' PRO . . . . . 0.407 ' HD3' ' HA2' ' C' ' 133' ' ' GLY . 17.2 Cg_exo . . . . . 0 C--N 1.345 0.375 0 C-N-CA 123.107 2.538 . . . . 0.0 111.968 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.387 0 CA-C-O 120.197 -0.224 . . . . 0.0 112.712 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo . . . . . 0 C--N 1.347 0.492 0 C-N-CA 123.153 2.569 . . . . 0.0 111.115 179.276 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 CA-C-O 120.138 -0.257 . . . . 0.0 113.606 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo . . . . . 0 C--N 1.348 0.522 0 C-N-CA 123.735 2.956 . . . . 0.0 113.04 -179.151 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.429 0 CA-C-O 120.429 -0.095 . . . . 0.0 113.033 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo . . . . . 0 N--CA 1.457 -0.64 0 C-N-CA 123.466 2.777 . . . . 0.0 111.995 179.948 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.574 0 N-CA-C 112.428 -0.269 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.06 158.48 57.25 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.502 2.134 . . . . 0.0 111.773 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -78.29 144.08 36.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.653 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -67.43 159.53 50.14 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.87 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 213' ' ' ILE . . . . . 0.53 ' HB ' ' OE1' ' A' ' 392' ' ' GLU . 15.2 pt -70.76 168.85 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.655 0.264 . . . . 0.0 111.026 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 214' ' ' ALA . . . . . 0.494 ' HB3' ' NH1' ' A' ' 330' ' ' ARG . . . -87.37 143.15 27.38 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.863 0.363 . . . . 0.0 110.595 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -65.99 162.25 42.93 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 116.02 -0.536 . . . . 0.0 113.216 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 216' ' ' GLN . . . . . 0.447 ' O ' ' HA3' ' B' ' 18' ' ' GLY . 68.0 mm-40 -71.08 158.94 35.62 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.783 0.325 . . . . 0.0 110.899 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -68.5 152.57 45.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.0 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -59.96 151.09 38.6 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.301 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 12.4 t -61.33 144.44 13.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 46.7 t -63.18 139.42 21.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -56.66 158.23 10.03 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.962 -0.563 . . . . 0.0 113.621 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 C--N 1.323 -0.587 0 CA-C-N 115.656 -0.272 . . . . 0.0 110.668 -179.589 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 224' ' ' GLY . . . . . 0.423 ' HA2' ' HD3' ' D' ' 225' ' ' PRO . . . . . . . . 0 N--CA 1.449 -0.475 0 CA-C-O 120.495 -0.058 . . . . 0.0 112.96 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 225' ' ' PRO . . . . . 0.423 ' HD3' ' HA2' ' D' ' 224' ' ' GLY . 24.2 Cg_exo . . . . . 0 CA--C 1.528 0.177 0 C-N-CA 123.092 2.528 . . . . 0.0 111.223 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.538 0 N-CA-C 112.638 -0.185 . . . . 0.0 112.638 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo . . . . . 0 N--CA 1.46 -0.481 0 C-N-CA 122.93 2.42 . . . . 0.0 111.643 179.503 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 113.816 0.286 . . . . 0.0 113.816 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo . . . . . 0 C--N 1.342 0.219 0 C-N-CA 123.206 2.604 . . . . 0.0 111.995 179.919 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo . . . . . 0 N--CA 1.479 0.63 0 N-CA-C 110.238 -0.716 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 320' ' ' ASP . 20.7 t-20 -114.1 164.62 13.6 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 19.5 tt -71.37 -23.44 22.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.948 0.404 . . . . 0.0 111.036 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 31.2 m -87.68 6.07 36.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.727 0.299 . . . . 0.0 111.574 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 317' ' ' ASN . 0.2 OUTLIER -63.15 -50.5 70.16 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.132 0.491 . . . . 0.0 110.438 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 97.13 175.59 34.7 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . 0.43 HD22 ' HA ' ' A' ' 322' ' ' ASN . 8.0 m120 51.03 73.43 0.29 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.172 0.511 . . . . 0.0 112.172 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' PHE . . . . . 0.609 ' HD1' ' HD3' ' A' ' 337' ' ' LYS . 60.7 m-85 -88.62 173.3 8.7 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.03 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.37 -51.75 27.55 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 14.5 t -170.51 147.67 2.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.435 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 76.8 t -112.71 126.62 70.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -131.67 166.7 20.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.01 0.433 . . . . 0.0 111.151 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 42.2 ttp -136.36 108.18 7.08 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 45.3 mt -106.25 127.2 53.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.574 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.06 14.85 5.71 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.55 0.531 . . . . 0.0 112.13 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 102.99 -9.29 54.92 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.23 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -93.94 129.67 40.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.631 0.253 . . . . 0.0 110.738 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 45.6 ttm -82.59 123.07 28.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.228 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -114.86 123.22 48.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.355 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 9.2 t -103.49 109.75 27.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.954 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -92.16 125.41 36.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.457 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 0.609 ' HD3' ' HD1' ' A' ' 323' ' ' PHE . 22.0 tptp -136.5 95.5 3.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.656 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 62.7 -100.5 0.09 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.411 ' H ' ' HG2' ' A' ' 339' ' ' ARG . 7.7 ptm85 -104.22 -5.25 22.09 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -177.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 7.6 m0 -124.69 159.89 29.8 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.974 0.416 . . . . 0.0 111.425 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -135.93 138.2 42.13 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.372 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -108.39 152.78 24.21 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.954 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.513 ' HD3' ' SD ' ' A' ' 350' ' ' MET . 16.4 ttt180 -127.07 113.4 16.38 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -101.78 113.09 37.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.175 0.512 . . . . 0.0 111.206 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.23 120.18 40.87 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 5.5 m120 61.83 32.94 17.94 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.437 0.46 . . . . 0.0 110.577 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 70.89 16.22 6.62 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.192 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -121.51 137.64 54.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.251 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 22.9 t -73.47 120.74 22.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.044 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' MET . . . . . 0.513 ' SD ' ' HD3' ' A' ' 343' ' ' ARG . 79.0 mtp -70.45 167.93 17.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.987 0.422 . . . . 0.0 111.542 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -85.81 163.71 17.98 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.371 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 91.54 -1.55 76.01 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.772 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' TYR . . . . . 0.56 ' HB3' ' HA ' ' A' ' 354' ' ' PRO . 63.4 m-85 -113.78 160.99 29.93 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.56 ' HA ' ' HB3' ' A' ' 353' ' ' TYR . 56.3 Cg_endo -72.55 128.49 15.18 Favored 'Cis proline' 0 C--N 1.347 0.493 0 C-N-CA 123.505 -1.456 . . . . 0.0 112.519 0.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 54.2 ttm -102.87 133.52 20.35 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.711 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.76 136.09 68.1 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.398 2.065 . . . . 0.0 111.158 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 77.4 mt -53.0 -45.47 52.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.835 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -68.18 -13.55 64.85 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 121.145 -0.55 . . . . 0.0 114.04 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.51 -29.45 61.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.954 0.377 . . . . 0.0 110.202 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -112.38 -53.91 2.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.556 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -86.91 73.72 9.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.962 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -64.69 103.64 0.72 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.008 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 127.55 -13.3 6.55 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.416 HD12 ' HD2' ' A' ' 365' ' ' PRO . 20.0 tp -97.9 129.23 31.63 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' PRO . . . . . 0.416 ' HD2' HD12 ' A' ' 364' ' ' LEU . 94.3 Cg_endo -81.62 -178.72 4.39 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.782 2.321 . . . . 0.0 112.067 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -82.93 149.19 27.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.502 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 39.3 m 58.5 90.11 0.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.752 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 30.3 pt -95.62 168.59 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.965 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . 0.535 ' HB2' ' HA ' ' A' ' 383' ' ' LYS . 0.1 OUTLIER -92.81 -45.54 7.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.902 -179.289 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . 0.792 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.2 OUTLIER -157.38 168.08 28.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.741 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -157.37 141.14 15.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . 0.448 ' CE1' ' HB ' ' A' ' 380' ' ' VAL . 27.6 p90 -160.02 161.01 33.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.065 0.46 . . . . 0.0 111.859 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -94.99 125.68 39.81 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' ARG . . . . . 0.512 ' HB2' ' OE2' ' A' ' 440' ' ' GLU . 2.4 ptm180 -82.87 179.71 7.69 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -178.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.509 ' HD2' ' O ' ' A' ' 425' ' ' GLY . 71.4 tttt -64.46 -29.24 70.29 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . 0.443 ' OD2' ' HE2' ' A' ' 378' ' ' LYS . 0.0 OUTLIER -85.79 -17.21 36.41 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.07 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 116.53 -18.57 13.28 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.799 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' LYS . . . . . 0.443 ' HE2' ' OD2' ' A' ' 376' ' ' ASP . 44.4 mttm -72.48 156.05 39.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.195 0.497 . . . . 0.0 111.077 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -100.03 125.65 46.12 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.187 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . 0.448 ' HB ' ' CE1' ' A' ' 372' ' ' TYR . 15.4 t -108.25 116.3 51.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.041 0.448 . . . . 0.0 110.726 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -104.5 138.21 41.21 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.45 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -118.25 145.81 44.74 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.804 0.335 . . . . 0.0 111.233 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.668 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 64.4 tttp -155.0 99.55 2.12 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.957 178.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 71.56 -106.28 1.87 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.8 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -114.17 5.9 16.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.732 0.301 . . . . 0.0 111.432 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -116.95 154.52 30.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.91 0.386 . . . . 0.0 111.438 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' HIS . . . . . 0.401 ' NE2' ' HE2' ' A' ' 399' ' ' TYR . 23.9 p-80 -136.99 144.9 43.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.849 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' TRP . . . . . 0.668 ' HZ3' ' HB3' ' A' ' 383' ' ' LYS . 22.3 m-90 -118.8 135.13 54.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.964 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 53.3 t -113.37 114.55 47.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -107.06 121.6 44.81 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.411 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -91.5 100.13 12.94 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 69.0 -68.99 0.17 Allowed 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.722 0.639 . . . . 0.0 110.707 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -156.11 16.51 0.35 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.658 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.11 127.25 49.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.92 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 60.5 tp -75.14 131.51 40.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.218 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 20.1 mm-40 -66.87 133.21 93.94 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.956 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 39.3 Cg_exo -62.24 123.62 12.82 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.997 2.465 . . . . 0.0 112.361 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 113.82 -1.84 24.47 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.413 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' TYR . . . . . 0.406 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 31.0 m-85 -100.17 161.64 23.52 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.464 ' HB3' ' CE2' ' A' ' 388' ' ' TRP . 75.7 Cg_endo -76.35 160.53 95.27 Favored 'Cis proline' 0 C--N 1.345 0.365 0 C-N-CA 123.797 -1.335 . . . . 0.0 113.269 0.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 28.6 mttm -125.41 165.44 18.4 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.262 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -71.53 158.33 36.43 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 47.5 mt -57.78 -36.54 55.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.045 0.45 . . . . 0.0 111.374 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -66.52 -15.56 63.48 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.265 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -78.66 -25.02 44.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.887 0.375 . . . . 0.0 110.896 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 39.6 tp -74.83 -45.38 43.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.122 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.612 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -164.21 154.81 25.86 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.764 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 52.1 ttt85 -79.66 135.89 36.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.7 0.286 . . . . 0.0 110.51 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.08 -4.59 62.83 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.84 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 46.8 mt -72.66 151.32 91.33 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.858 0.329 . . . . 0.0 111.121 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.02 129.07 33.33 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.869 2.38 . . . . 0.0 112.123 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.59 -8.6 52.28 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -91.51 -54.37 3.93 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -176.95 -179.66 0.95 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.337 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 37.6 mm -124.24 137.18 58.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 430' ' ' PHE . 1.4 m-20 -88.52 -57.94 2.73 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.792 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -152.8 161.54 42.42 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.794 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -137.61 128.36 27.01 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 40.6 tp -118.92 122.17 41.65 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.824 0.345 . . . . 0.0 111.237 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -88.14 111.58 21.75 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.188 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 13.1 t-105 -80.24 96.25 6.54 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 67.9 mtt -51.35 -51.84 65.02 Favored Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -40.47 -54.52 2.25 Favored 'Trans proline' 0 C--N 1.358 1.067 0 C-N-CA 123.388 2.725 . . . . 0.0 115.139 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -104.24 -16.84 15.07 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . 0.509 ' O ' ' HD2' ' A' ' 375' ' ' LYS . . . 79.58 53.77 4.22 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.666 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -133.4 136.95 45.59 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.718 0.294 . . . . 0.0 110.436 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 17.6 m -91.65 127.42 37.1 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -99.56 114.69 27.85 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.631 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -96.17 123.31 39.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.658 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' PHE . . . . . 0.42 ' O ' ' HB2' ' A' ' 416' ' ' ASP . 86.9 m-85 -99.12 135.92 39.83 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.186 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.413 ' HA ' ' HE ' ' A' ' 431' ' ' ARG . 3.0 tpm_? -148.84 101.74 3.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.651 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 73.54 -116.71 5.53 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.737 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -110.08 14.38 22.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.99 0.424 . . . . 0.0 110.651 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . 0.521 ' HB3' ' HB2' ' A' ' 450' ' ' PRO . 33.7 mmtp -127.44 151.94 48.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.983 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' TYR . . . . . 0.506 ' CE2' ' HE2' ' A' ' 449' ' ' TYR . 30.8 p90 -130.09 143.43 50.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.657 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -111.05 151.21 28.29 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.211 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -111.6 99.57 8.28 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' PHE . . . . . 0.612 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 72.9 t80 -79.76 116.82 20.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.84 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -83.47 102.13 11.87 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.211 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' GLU . . . . . 0.512 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 4.1 mm-40 -56.93 -26.39 59.37 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -87.05 -14.37 41.7 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 93.0 mt -120.14 -11.65 9.2 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' ARG . . . . . 0.442 HH11 ' HD3' ' A' ' 443' ' ' ARG . 25.6 mtp180 58.69 45.01 16.47 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.323 0.583 . . . . 0.0 111.177 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -162.24 157.0 22.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.989 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 96.3 t -76.71 133.53 30.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -60.57 164.38 4.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.032 0.444 . . . . 0.0 111.731 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 74.4 m -70.64 159.16 34.92 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.768 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 72.62 20.25 3.86 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.126 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . 0.506 ' HE2' ' CE2' ' A' ' 435' ' ' TYR . 32.1 m-85 -120.41 159.08 49.37 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.5 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . 0.521 ' HB2' ' HB3' ' A' ' 434' ' ' LYS . 72.3 Cg_endo -75.04 165.52 85.71 Favored 'Cis proline' 0 C--N 1.344 0.34 0 C-N-CA 123.608 -1.413 . . . . 0.0 112.95 0.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 57.6 mttm -117.64 160.65 20.94 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.664 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 452' ' ' ASN . . . . . 0.437 ' HA ' ' HD3' ' A' ' 434' ' ' LYS . 30.9 t-20 -67.37 135.43 53.21 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.272 0.357 . . . . 0.0 110.453 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.4 tt -64.0 -12.91 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.075 0.464 . . . . 0.0 111.323 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -62.5 -15.21 48.98 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 75.7 t -58.75 -36.94 63.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 456' ' ' TRP . . . . . 0.445 ' HB2' ' HB ' ' A' ' 459' ' ' ILE . 17.4 m95 -86.06 88.53 7.6 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.11 109.04 0.38 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 107.89 -13.11 38.16 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.027 -0.606 . . . . 0.0 113.312 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.445 ' HB ' ' HB2' ' A' ' 456' ' ' TRP . 40.0 mm -83.33 126.24 72.27 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.81 0.305 . . . . 0.0 111.298 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.85 156.16 30.87 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.036 2.49 . . . . 0.0 111.983 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -73.04 149.55 43.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.177 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 3.5 m 51.64 69.46 2.49 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 114.484 1.291 . . . . 0.0 114.484 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -91.47 172.62 2.78 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.55 2.167 . . . . 0.0 109.956 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -142.91 74.56 1.45 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.542 0.686 . . . . 0.0 111.219 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 135.79 97.63 0.53 Allowed Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.345 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 466' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 476' ' ' TYR . 2.9 p -130.13 108.34 9.99 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -130.06 144.03 51.12 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.945 0.402 . . . . 0.0 111.475 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 43.1 ttm -97.11 133.87 41.2 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.521 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -65.31 164.69 36.79 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.379 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 2.4 m -65.5 -8.03 17.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.941 0.4 . . . . 0.0 111.825 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -87.89 -13.04 43.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.517 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 64.02 11.11 5.87 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.624 -0.717 . . . . 0.0 112.509 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 98.1 t -110.79 -41.5 4.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.845 0.355 . . . . 0.0 111.403 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -105.68 123.17 47.5 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 85.6 m -111.81 141.09 45.88 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 476' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 466' ' ' SER . 89.7 m-85 -113.52 135.0 54.37 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -118.66 127.27 53.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.415 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -109.27 133.85 52.52 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 56.6 tttt -165.66 127.69 2.01 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.223 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 61.98 38.19 95.65 Favored Glycine 0 N--CA 1.454 -0.118 0 CA-C-N 116.035 -0.53 . . . . 0.0 113.449 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 481' ' ' ASN . . . . . 0.511 HD21 HD12 ' A' ' 502' ' ' LEU . 53.7 t30 74.15 -4.79 2.21 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -106.85 155.29 19.9 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -127.26 139.35 52.97 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.137 0.494 . . . . 0.0 111.563 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 17.9 m-90 -108.84 133.28 53.09 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.742 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -99.03 100.81 12.02 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.958 0.408 . . . . 0.0 110.034 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 486' ' ' PHE . . . . . 0.497 ' HZ ' HD12 ' A' ' 491' ' ' LEU . 88.9 t80 -89.65 132.63 35.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.155 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . 0.414 ' HB3' ' HB3' ' A' ' 490' ' ' LYS . 32.6 t-20 -96.66 112.42 24.18 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -59.38 -47.8 84.08 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 41.3 tp60 -85.13 37.51 0.67 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.326 0.584 . . . . 0.0 111.41 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 490' ' ' LYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 487' ' ' ASN . 19.8 ttpt -153.33 -27.85 0.14 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.912 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.497 HD12 ' HZ ' ' A' ' 486' ' ' PHE . 14.7 tp 61.76 40.17 13.26 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.867 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -159.66 148.0 17.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.628 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 69.5 t -75.78 142.93 13.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -63.97 142.67 98.18 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.379 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -65.5 146.0 83.87 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.725 2.283 . . . . 0.0 111.753 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 96.12 1.75 61.05 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.21 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . 0.722 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 72.3 m-85 -108.87 167.39 9.23 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . 0.722 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 91.9 Cg_endo -76.46 176.75 42.48 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 124.037 -1.235 . . . . 0.0 113.42 0.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -133.12 166.0 23.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.939 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 500' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 504' ' ' ASP . 4.8 t -75.49 122.14 23.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.852 0.358 . . . . 0.0 110.849 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -73.92 -21.17 60.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.86 0.362 . . . . 0.0 110.866 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 502' ' ' LEU . . . . . 0.511 HD12 HD21 ' A' ' 481' ' ' ASN . 10.3 mt -70.96 -48.72 51.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.881 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -78.18 -40.18 38.53 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.999 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 504' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 500' ' ' SER . 0.6 OUTLIER -76.79 -56.33 4.69 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -177.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -85.17 -58.51 2.65 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -177.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 506' ' ' MET . . . . . 0.467 ' HG3' HD23 ' A' ' 502' ' ' LEU . 11.6 mmt -63.86 -32.51 74.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 87.82 38.01 7.67 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.938 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 59.9 m -121.29 90.8 47.84 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.01 166.2 30.31 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.804 2.336 . . . . 0.0 111.721 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 11.9 m 65.91 101.36 0.04 OUTLIER 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.459 0.647 . . . . 0.0 111.793 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.865 0 CA-C-O 118.361 -1.244 . . . . 0.0 111.473 179.914 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.889 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 CA--C 1.528 0.186 0 C-N-CA 122.421 2.081 . . . . 0.0 111.369 179.642 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' D' ' 201' ' ' PRO . . . . . . . . 0 N--CA 1.448 -0.559 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo . . . . . 0 CA--C 1.529 0.261 0 C-N-CA 122.683 2.255 . . . . 0.0 111.253 179.912 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.429 0 CA-C-O 120.34 -0.144 . . . . 0.0 112.969 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo . . . . . 0 CA--C 1.531 0.372 0 C-N-CA 122.995 2.463 . . . . 0.0 111.978 179.766 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.757 0 N-CA-C 112.538 -0.225 . . . . 0.0 112.538 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.91 144.55 96.68 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.119 2.546 . . . . 0.0 112.106 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -64.12 140.39 58.86 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.669 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.74 144.02 47.62 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.517 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 32.5 mt -63.67 144.69 14.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.592 0.234 . . . . 0.0 110.548 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.03 157.93 20.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.043 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' D' ' 213' ' ' ILE . . . -71.13 165.76 52.99 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.471 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -72.29 149.02 44.86 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.66 142.08 57.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.436 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' D' ' 216' ' ' GLN . . . -61.63 148.37 47.34 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.293 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.432 ' HB ' ' HG2' ' D' ' 217' ' ' ARG . 3.1 t -68.3 154.27 8.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.753 0.311 . . . . 0.0 110.502 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 14.7 t -58.33 141.4 15.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.689 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.46 168.37 53.92 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.567 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 C--N 1.324 -0.524 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 -179.815 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.572 0 CA-C-O 120.436 -0.091 . . . . 0.0 112.903 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo . . . . . 0 CA--C 1.53 0.299 0 C-N-CA 122.831 2.354 . . . . 0.0 111.798 179.836 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo . . . . . 0 C--O 1.237 0.459 0 C-N-CA 122.584 2.189 . . . . 0.0 111.924 179.93 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.816 0 CA-C-O 120.356 -0.136 . . . . 0.0 112.789 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo . . . . . 0 N--CA 1.465 -0.176 0 C-N-CA 122.915 2.41 . . . . 0.0 111.1 179.281 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . 0.415 ' HA2' ' HD3' ' B' ' 34' ' ' PRO . . . . . . . . 0 N--CA 1.45 -0.395 0 CA-C-O 120.428 -0.096 . . . . 0.0 113.138 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . 0.415 ' HD3' ' HA2' ' B' ' 33' ' ' GLY . 14.8 Cg_endo . . . . . 0 N--CA 1.455 -0.781 0 C-N-CA 123.419 2.746 . . . . 0.0 111.749 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.428 0 CA-C-O 120.077 -0.291 . . . . 0.0 112.665 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo . . . . . 0 C--N 1.344 0.301 0 C-N-CA 122.929 2.42 . . . . 0.0 111.679 179.614 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.425 0 N-CA-C 113.191 0.036 . . . . 0.0 113.191 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo . . . . . 0 CA--C 1.53 0.297 0 C-N-CA 123.48 2.787 . . . . 0.0 111.739 179.712 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.583 0 N-CA-C 112.095 -0.402 . . . . 0.0 112.095 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo . . . . . 0 N--CA 1.463 -0.27 0 C-N-CA 122.926 2.417 . . . . 0.0 110.83 179.479 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.292 0 N-CA-C 113.537 0.175 . . . . 0.0 113.537 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.97 169.98 13.84 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 122.85 2.366 . . . . 0.0 112.553 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 111' ' ' GLN . . . . . 0.444 ' OE1' ' HB2' ' D' ' 210' ' ' PRO . 5.6 tp60 -64.75 137.78 58.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.548 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -62.23 161.35 29.95 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 116.02 -0.536 . . . . 0.0 113.095 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . 0.497 ' H ' HG13 ' C' ' 113' ' ' ILE . 2.3 mt -62.73 144.0 14.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.695 -0.252 . . . . 0.0 110.393 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.97 152.8 44.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.539 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -70.43 145.81 41.29 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.477 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -72.82 147.02 45.87 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 35.1 ttm-85 -62.45 145.81 53.14 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.758 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.18 177.39 32.34 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.806 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 61.9 t -72.84 137.48 23.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.466 -0.367 . . . . 0.0 110.365 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 93.7 t -63.94 139.25 21.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.983 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.22 157.41 28.01 Favored Glycine 0 N--CA 1.45 -0.424 0 O-C-N 123.51 0.506 . . . . 0.0 112.886 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 31.8 mt . . . . . 0 C--N 1.325 -0.481 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 -179.706 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 113.237 0.055 . . . . 0.0 113.237 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo . . . . . 0 C--O 1.234 0.294 0 C-N-CA 122.684 2.256 . . . . 0.0 111.47 179.69 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.446 0 N-CA-C 112.961 -0.055 . . . . 0.0 112.961 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 C--O 1.237 0.454 0 C-N-CA 122.595 2.196 . . . . 0.0 111.514 179.807 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.391 0 N-CA-C 113.489 0.156 . . . . 0.0 113.489 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo . . . . . 0 C--N 1.34 0.114 0 C-N-CA 123.038 2.492 . . . . 0.0 111.287 179.711 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 133' ' ' GLY . . . . . 0.503 ' HA2' ' HD3' ' C' ' 134' ' ' PRO . . . . . . . . 0 N--CA 1.45 -0.373 0 N-CA-C 112.112 -0.395 . . . . 0.0 112.112 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 134' ' ' PRO . . . . . 0.503 ' HD3' ' HA2' ' C' ' 133' ' ' GLY . 7.6 Cg_exo . . . . . 0 C--O 1.233 0.259 0 C-N-CA 123.084 2.523 . . . . 0.0 112.143 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 CA-C-O 120.043 -0.309 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 201' ' ' PRO . . . . . 0.452 ' O ' ' HA3' ' B' ' 3' ' ' GLY . 35.4 Cg_exo . . . . . 0 C--N 1.345 0.382 0 C-N-CA 122.985 2.457 . . . . 0.0 111.724 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.462 0 CA-C-O 120.402 -0.11 . . . . 0.0 113.032 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo . . . . . 0 N--CA 1.461 -0.398 0 C-N-CA 123.903 3.068 . . . . 0.0 112.148 -179.805 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.342 0 N-CA-C 113.567 0.187 . . . . 0.0 113.567 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo . . . . . 0 N--CA 1.457 -0.647 0 C-N-CA 123.656 2.904 . . . . 0.0 112.46 179.742 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.514 0 N-CA-C 112.011 -0.436 . . . . 0.0 112.011 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 210' ' ' PRO . . . . . 0.444 ' HB2' ' OE1' ' C' ' 111' ' ' GLN . 12.4 Cg_exo -70.21 157.76 58.5 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.766 2.31 . . . . 0.0 111.901 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -82.56 142.33 31.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.988 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -64.74 162.66 37.92 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 116.08 -0.509 . . . . 0.0 113.295 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 213' ' ' ILE . . . . . 0.446 ' O ' ' HA3' ' B' ' 15' ' ' GLY . 42.2 pt -71.68 159.35 5.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.926 0.393 . . . . 0.0 111.403 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -71.27 139.1 49.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.081 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -64.37 165.6 31.45 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 116.01 -0.541 . . . . 0.0 113.864 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 216' ' ' GLN . . . . . 0.407 ' O ' ' HA3' ' B' ' 18' ' ' GLY . 91.0 mm-40 -78.58 153.42 31.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.794 0.33 . . . . 0.0 110.486 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 217' ' ' ARG . . . . . 0.432 ' HG2' ' HB ' ' B' ' 19' ' ' VAL . 33.8 mtp180 -69.79 156.23 39.34 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.543 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -64.36 154.52 47.79 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.735 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 24.5 t -65.31 144.53 14.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.98 135.98 25.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.887 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -54.15 161.22 4.16 Favored Glycine 0 N--CA 1.453 -0.216 0 O-C-N 123.799 0.687 . . . . 0.0 114.364 -178.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 10.8 mp . . . . . 0 C--N 1.322 -0.592 0 CA-C-N 115.659 -0.271 . . . . 0.0 110.587 179.988 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 224' ' ' GLY . . . . . 0.445 ' HA2' ' HD3' ' D' ' 225' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.597 0 CA-C-O 120.522 -0.043 . . . . 0.0 113.102 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 225' ' ' PRO . . . . . 0.445 ' HD3' ' HA2' ' D' ' 224' ' ' GLY . 21.7 Cg_exo . . . . . 0 C--O 1.235 0.343 0 C-N-CA 122.925 2.417 . . . . 0.0 111.692 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.436 0 N-CA-C 113.25 0.06 . . . . 0.0 113.25 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo . . . . . 0 C--O 1.236 0.405 0 C-N-CA 122.835 2.356 . . . . 0.0 111.645 179.774 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.598 0 CA-C-O 120.719 0.066 . . . . 0.0 113.096 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 CA--C 1.532 0.385 0 C-N-CA 123.077 2.518 . . . . 0.0 111.926 179.682 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo . . . . . 0 N--CA 1.477 0.558 0 N-CA-C 109.922 -0.838 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -113.25 149.15 34.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.308 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 16.1 tt -72.89 -18.63 18.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 20.6 m -91.76 0.25 57.5 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 121.152 -0.219 . . . . 0.0 111.263 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -67.86 -48.04 67.23 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.102 0.477 . . . . 0.0 110.288 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' GLY . . . . . 0.571 ' HA2' HD21 ' A' ' 502' ' ' LEU . . . 102.74 172.08 26.66 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.439 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 64.3 t30 55.56 85.73 0.06 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.468 0.651 . . . . 0.0 112.465 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' PHE . . . . . 0.567 ' HD1' ' HB2' ' A' ' 337' ' ' LYS . 92.9 m-85 -105.26 168.0 9.36 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.702 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.57 -46.87 83.92 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 6.6 t -175.43 160.75 2.62 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.472 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 49.0 t -127.56 127.51 68.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -135.23 167.93 20.1 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.007 0.432 . . . . 0.0 111.845 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . 0.426 ' HA ' ' O ' ' A' ' 332' ' ' GLU . 53.1 ttm -129.75 115.11 16.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.786 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 56.8 mt -111.28 117.05 32.1 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.182 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.408 ' HD3' ' OE2' ' A' ' 373' ' ' GLU . 0.0 OUTLIER 59.13 20.26 8.21 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.957 -179.48 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 105.69 -18.24 41.13 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.609 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . 0.457 ' OE1' ' HD3' ' A' ' 343' ' ' ARG . 35.3 mm-40 -82.75 131.24 35.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.633 0.254 . . . . 0.0 110.676 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 50.2 ttm -88.23 117.74 27.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.794 0.33 . . . . 0.0 110.975 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -109.12 122.8 48.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.264 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 37.5 t -108.46 114.74 47.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -100.46 130.37 46.54 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 0.567 ' HB2' ' HD1' ' A' ' 323' ' ' PHE . 13.0 tptt -138.19 101.81 4.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.298 178.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 61.49 -95.3 0.05 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.0 ptm85 -121.06 7.08 10.29 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . 0.405 ' HB3' ' HB2' ' A' ' 354' ' ' PRO . 5.6 m-90 -129.03 152.43 48.64 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -137.69 153.95 49.73 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.121 0.486 . . . . 0.0 111.76 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 24.5 m-90 -121.8 160.91 23.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.363 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.457 ' HD3' ' OE1' ' A' ' 332' ' ' GLU . 18.1 ttm-85 -124.38 112.18 16.64 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 91.6 t -90.71 122.66 42.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.889 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . 0.431 ' HD3' ' HA ' ' A' ' 345' ' ' ARG . 2.2 mmt180 -132.71 100.92 5.09 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.553 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 66.5 54.79 0.86 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.817 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 29.2 t30 62.09 12.92 5.34 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -133.41 146.7 51.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.665 0.269 . . . . 0.0 110.61 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 39.0 t -96.71 127.88 48.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 86.2 mtp -68.28 159.84 30.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.531 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -76.65 167.74 21.3 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.679 0.276 . . . . 0.0 110.9 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 94.98 -21.77 42.02 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -178.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' TYR . . . . . 0.464 ' HB3' ' HA ' ' A' ' 354' ' ' PRO . 87.9 m-85 -101.5 158.94 30.83 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.464 ' HA ' ' HB3' ' A' ' 353' ' ' TYR . 58.1 Cg_endo -71.16 139.21 57.13 Favored 'Cis proline' 0 C--N 1.346 0.424 0 C-N-CA 123.484 -1.465 . . . . 0.0 112.561 0.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 55.3 ttm -114.33 138.8 23.2 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . 0.442 ' HB2' ' HB2' ' A' ' 359' ' ' GLN . 52.3 Cg_exo -55.43 130.33 39.97 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.382 2.054 . . . . 0.0 111.175 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 76.8 mt -55.02 -45.51 76.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.987 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -71.35 -12.78 73.21 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.95 -0.643 . . . . 0.0 113.707 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' GLN . . . . . 0.442 ' HB2' ' HB2' ' A' ' 356' ' ' PRO . 3.7 tt0 -82.32 -34.32 28.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.034 0.445 . . . . 0.0 110.454 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -94.1 -55.21 3.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.357 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -90.28 74.39 7.02 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -58.29 95.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.925 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 135.37 -17.3 4.04 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.503 ' HA ' ' HD3' ' A' ' 365' ' ' PRO . 29.6 tp -94.37 125.16 53.14 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 364' ' ' LEU . 4.2 Cg_exo -77.21 -174.02 2.02 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.017 2.478 . . . . 0.0 111.84 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -87.8 153.96 20.93 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.08 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 72.1 m 59.23 94.92 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 27.1 pt -106.87 -166.24 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.403 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.09 -47.06 1.22 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . 0.643 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.2 OUTLIER -146.04 162.82 37.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.648 0.261 . . . . 0.0 111.178 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -158.35 138.48 12.37 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . 0.593 ' HE1' ' HE2' ' A' ' 382' ' ' PHE . 14.7 p90 -160.25 162.71 33.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.903 0.382 . . . . 0.0 111.532 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.408 ' OE2' ' HD3' ' A' ' 330' ' ' ARG . 64.9 tt0 -98.65 122.03 41.35 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' ARG . . . . . 0.568 ' HB2' ' OE2' ' A' ' 440' ' ' GLU . 5.2 ptm180 -78.76 -179.66 6.66 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -178.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -67.61 -34.52 77.15 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.908 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -37.29 85.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.68 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 129.27 -16.19 5.74 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.421 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' LYS . . . . . 0.625 ' HG2' ' HA ' ' A' ' 391' ' ' ASP . 72.8 mttt -80.46 166.16 21.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.881 0.372 . . . . 0.0 111.575 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -106.71 127.64 53.54 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.752 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 13.4 t -109.19 122.16 63.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.007 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -106.56 138.11 43.34 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.212 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.593 ' HE2' ' HE1' ' A' ' 372' ' ' TYR . 55.9 m-85 -117.83 141.69 48.14 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.61 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 83.0 tttt -154.14 107.6 2.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.6 177.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 414' ' ' LYS . . . 70.27 -112.2 4.21 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.566 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . 0.432 ' O ' HG13 ' A' ' 403' ' ' ILE . 3.7 p-10 -115.29 4.38 14.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.914 0.388 . . . . 0.0 110.606 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . 0.42 ' HB3' ' HB2' ' A' ' 400' ' ' PRO . 48.4 mmtm -112.07 150.79 30.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 48.5 p-80 -131.97 147.94 52.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.176 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' TRP . . . . . 0.61 ' HZ3' ' HB3' ' A' ' 383' ' ' LYS . 22.5 m-90 -121.7 125.62 47.05 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.82 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 85.5 t -109.42 119.96 59.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.897 0.38 . . . . 0.0 110.32 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -104.87 123.66 48.1 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.932 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.625 ' HA ' ' HG2' ' A' ' 378' ' ' LYS . 21.8 t0 -92.71 95.05 9.33 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 67.52 -73.2 0.08 Allowed 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.727 0.642 . . . . 0.0 111.021 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -146.18 11.83 1.2 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.986 0.422 . . . . 0.0 110.41 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 1.7 m -125.51 127.09 45.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.253 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 55.9 tp -71.77 132.04 43.92 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.035 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -62.96 147.01 94.94 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.651 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -74.08 144.59 34.08 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.544 2.163 . . . . 0.0 113.038 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 90.37 18.15 50.3 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.459 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' TYR . . . . . 0.496 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 39.1 m-85 -109.13 162.16 21.12 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-O 120.292 0.091 . . . . 0.0 110.774 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.496 ' HA ' ' HB3' ' A' ' 399' ' ' TYR . 71.8 Cg_endo -77.07 157.81 96.84 Favored 'Cis proline' 0 C--N 1.346 0.442 0 C-N-CA 123.529 -1.446 . . . . 0.0 112.562 0.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -116.48 157.82 24.58 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -73.21 151.19 41.56 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 385' ' ' ASP . 61.2 mt -56.64 -32.75 38.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.325 0.583 . . . . 0.0 110.603 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -65.97 -20.71 66.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.485 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -84.18 -10.52 57.68 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 50.7 tp -85.32 -55.16 4.16 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.9 0.381 . . . . 0.0 110.12 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.639 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -149.08 150.9 23.1 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.798 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -77.68 126.46 30.9 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.57 0.224 . . . . 0.0 110.495 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 99.27 14.01 37.11 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.599 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 38.7 mt -92.83 147.31 33.78 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 122.794 -0.239 . . . . 0.0 111.093 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.09 124.66 16.8 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.848 2.365 . . . . 0.0 111.26 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.44 -3.93 57.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.055 0.455 . . . . 0.0 111.273 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -87.53 -55.73 3.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.315 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . 0.493 ' HB2' ' HE3' ' A' ' 414' ' ' LYS . 6.4 ptmt -177.57 176.37 1.28 Allowed 'General case' 0 C--N 1.332 -0.196 0 O-C-N 123.306 0.378 . . . . 0.0 110.791 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 38.3 mm -127.47 133.23 68.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -87.76 -47.68 8.44 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.643 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -154.6 165.25 37.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.945 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -147.21 113.8 6.01 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.207 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 55.4 tp -106.98 124.95 50.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.932 0.396 . . . . 0.0 111.795 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -90.32 116.12 28.04 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.802 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 11.9 t-105 -86.26 94.4 9.31 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.443 ' HB2' ' HD3' ' A' ' 423' ' ' PRO . 61.5 mtt -51.19 -48.82 84.5 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.443 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 83.8 Cg_exo -50.02 -24.12 10.31 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.817 2.345 . . . . 0.0 115.269 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 26.0 p30 -125.51 -37.73 2.32 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 108.63 2.48 32.64 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.709 -0.757 . . . . 0.0 113.457 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -91.62 154.18 19.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 117.036 0.418 . . . . 0.0 111.271 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 7.0 m -108.4 128.17 54.53 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.517 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -98.84 108.96 21.77 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . 0.448 ' HB2' ' HB2' ' A' ' 436' ' ' TYR . 60.3 m-85 -90.48 136.74 32.87 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.21 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -112.57 132.74 54.98 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.85 0.357 . . . . 0.0 111.059 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -145.32 110.64 5.28 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.831 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 64.65 -102.66 0.65 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.694 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -127.61 20.78 6.6 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.158 0.504 . . . . 0.0 110.046 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 450' ' ' PRO . 63.3 mmtt -124.0 142.16 51.41 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.552 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' TYR . . . . . 0.523 ' CE1' ' HB2' ' A' ' 451' ' ' LYS . 4.1 p90 -119.02 137.9 53.21 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.748 0.309 . . . . 0.0 110.383 178.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' TYR . . . . . 0.448 ' HB2' ' HB2' ' A' ' 429' ' ' PHE . 23.4 m-85 -110.27 144.4 39.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.908 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 0.411 ' HB3' ' HB2' ' A' ' 446' ' ' ASP . 36.1 ttp180 -107.29 95.74 5.92 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' PHE . . . . . 0.639 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 83.7 t80 -84.95 129.42 34.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.117 0.484 . . . . 0.0 112.169 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -99.57 111.99 24.26 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.011 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' GLU . . . . . 0.568 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 2.4 mm-40 -61.08 -39.74 91.06 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -67.71 -38.5 83.7 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 94.8 mt -94.1 -10.42 33.38 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 6.8 mtt-85 56.48 41.12 29.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.195 0.521 . . . . 0.0 111.027 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -157.46 166.72 32.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.219 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 88.9 t -89.3 140.05 16.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . 0.411 ' HB2' ' HB3' ' A' ' 437' ' ' ARG . 0.5 OUTLIER -55.9 153.5 8.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.437 179.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 10.9 m -69.11 158.27 35.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.04 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 70.19 24.49 4.88 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.326 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -122.75 163.19 34.46 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.018 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . 0.433 ' HB2' ' HB3' ' A' ' 434' ' ' LYS . 96.8 Cg_endo -77.38 172.1 64.35 Favored 'Cis proline' 0 C--N 1.346 0.437 0 C-N-CA 123.653 -1.395 . . . . 0.0 112.673 0.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . 0.523 ' HB2' ' CE1' ' A' ' 435' ' ' TYR . 60.2 mttm -124.75 172.45 9.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.028 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -63.76 136.07 57.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.175 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.0 tt -71.8 -11.97 15.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.261 0.553 . . . . 0.0 110.565 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -71.18 -0.01 8.81 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 64.1 t -67.2 -32.75 59.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 456' ' ' TRP . . . . . 0.469 ' HE3' ' CZ ' ' A' ' 486' ' ' PHE . 8.2 m95 -86.75 85.49 7.28 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.08 108.78 0.35 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 118.34 -25.23 8.3 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.054 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.423 ' HB ' ' HB2' ' A' ' 456' ' ' TRP . 32.1 mm -77.08 130.18 76.15 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 120.86 0.362 . . . . 0.0 111.175 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 460' ' ' PRO . . . . . 0.414 ' HG3' ' CZ2' ' A' ' 484' ' ' TRP . 85.3 Cg_endo -81.96 166.3 16.93 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.887 2.391 . . . . 0.0 111.711 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 35.3 mp0 -80.52 136.89 36.37 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.04 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.4 m 61.13 65.4 1.94 Allowed Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 463' ' ' PRO . . . . . 0.491 ' O ' ' HB2' ' A' ' 417' ' ' ALA . 35.7 Cg_endo -96.43 118.34 0.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.184 2.589 . . . . 0.0 110.269 178.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 464' ' ' ARG . 3.1 ttm105 -89.59 68.55 7.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.087 0.47 . . . . 0.0 112.17 -178.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 158.55 124.92 0.79 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 25.3 p -158.81 120.7 3.49 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.493 -0.188 . . . . 0.0 110.493 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -150.13 147.35 27.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.715 0.293 . . . . 0.0 111.315 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 43.6 ttm -98.57 140.76 32.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.069 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -70.0 169.52 45.69 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.179 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 1.5 m -73.36 -0.17 13.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.001 0.429 . . . . 0.0 111.339 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.65 -17.64 24.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.156 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 67.88 8.05 6.18 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.878 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 43.6 t -109.73 -37.66 3.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.887 0.375 . . . . 0.0 111.458 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -107.0 129.06 54.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.19 0.519 . . . . 0.0 111.911 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 475' ' ' THR . . . . . 0.421 ' HB ' ' HB3' ' A' ' 486' ' ' PHE . 95.1 m -113.92 135.32 54.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.488 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -107.24 137.58 45.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.175 0.512 . . . . 0.0 112.195 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 477' ' ' PHE . . . . . 0.618 ' HB2' ' HB2' ' A' ' 484' ' ' TRP . 38.2 m-85 -121.16 145.34 47.92 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.682 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -127.34 131.95 50.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.861 0.363 . . . . 0.0 111.607 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 479' ' ' LYS . . . . . 0.466 ' HB3' ' CZ3' ' A' ' 484' ' ' TRP . 69.7 tttt -158.54 107.68 1.98 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.472 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 60.77 60.92 7.63 Favored Glycine 0 CA--C 1.518 0.238 0 N-CA-C 114.373 0.509 . . . . 0.0 114.373 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 69.44 -15.06 0.3 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 482' ' ' LYS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 498' ' ' PRO . 52.2 mtmt -99.39 144.58 28.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.828 0.346 . . . . 0.0 111.435 -178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 483' ' ' TYR . . . . . 0.49 ' CZ ' ' HE2' ' A' ' 497' ' ' TYR . 6.5 p90 -120.35 142.64 48.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.161 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 484' ' ' TRP . . . . . 0.618 ' HB2' ' HB2' ' A' ' 477' ' ' PHE . 11.8 m-90 -110.85 146.95 35.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.506 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -114.04 99.97 8.05 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 486' ' ' PHE . . . . . 0.469 ' CZ ' ' HE3' ' A' ' 456' ' ' TRP . 51.2 t80 -91.26 132.26 36.25 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.307 -178.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -95.5 112.12 23.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -64.86 -19.12 65.72 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -93.85 -14.43 26.12 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -112.5 -16.64 12.83 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.6 tp 61.91 34.85 16.67 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.653 0.74 . . . . 0.0 109.899 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 492' ' ' LYS . . . . . 0.442 ' HG2' ' N ' ' A' ' 493' ' ' VAL . 36.4 tttp -151.98 156.12 39.38 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.515 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . 0.442 ' N ' ' HG2' ' A' ' 492' ' ' LYS . 71.6 t -81.81 139.6 17.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.697 0.284 . . . . 0.0 110.623 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -62.49 147.39 92.28 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.566 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.64 152.1 81.38 Favored 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 122.6 2.2 . . . . 0.0 111.957 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 85.65 27.86 31.12 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . 0.493 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 42.6 m-85 -134.06 163.58 50.12 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.609 -0.295 . . . . 0.0 110.428 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . 0.493 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 89.8 Cg_endo -76.25 174.87 50.71 Favored 'Cis proline' 0 C--N 1.346 0.408 0 C-N-CA 123.979 -1.259 . . . . 0.0 112.849 0.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -133.99 164.21 27.81 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.596 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.81 110.54 6.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.519 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . 0.447 ' HB2' ' HB3' ' A' ' 483' ' ' TYR . . . -66.03 -24.08 66.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.152 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 502' ' ' LEU . . . . . 0.571 HD21 ' HA2' ' A' ' 321' ' ' GLY . 76.0 mt -62.47 -39.41 93.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.857 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -85.46 -42.67 14.26 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.744 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -43.04 57.35 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 47.9 m0 -98.27 -60.41 1.56 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 10.9 mmt -62.85 -25.81 68.46 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 81.42 30.17 37.79 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.14 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 30.4 m -116.35 95.29 44.98 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 120.758 0.313 . . . . 0.0 110.567 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.32 -167.53 0.52 Allowed 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.967 2.444 . . . . 0.0 111.363 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 57.01 59.82 3.28 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.089 0.471 . . . . 0.0 110.941 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.503 -1.165 . . . . 0.0 112.185 -179.326 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.598 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo . . . . . 0 N--CA 1.461 -0.437 0 C-N-CA 122.778 2.319 . . . . 0.0 111.964 179.953 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.55 0 N-CA-C 112.983 -0.047 . . . . 0.0 112.983 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo . . . . . 0 CA--C 1.532 0.386 0 C-N-CA 123.042 2.495 . . . . 0.0 112.253 179.88 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.802 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 CA--C 1.53 0.319 0 C-N-CA 122.732 2.288 . . . . 0.0 111.456 179.435 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.93 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.11 150.48 15.76 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.65 2.233 . . . . 0.0 112.223 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -71.73 151.83 43.26 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.87 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.573 ' HA3' ' O ' ' D' ' 210' ' ' PRO . . . -60.1 151.5 38.35 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.25 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.512 ' O ' ' HG3' ' D' ' 211' ' ' GLN . 8.4 mt -66.73 150.01 11.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.23 151.36 31.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.369 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.41 163.73 53.05 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.937 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -70.63 141.21 51.73 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -67.47 144.5 55.67 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.314 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' D' ' 216' ' ' GLN . . . -57.16 151.6 26.65 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.925 -0.58 . . . . 0.0 113.154 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 12.1 t -69.85 147.15 11.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 19.9 t -53.31 145.01 3.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 O-C-N 123.326 0.391 . . . . 0.0 111.033 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.79 177.7 30.35 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.991 -0.549 . . . . 0.0 113.511 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 C--N 1.325 -0.487 0 C-N-CA 122.234 0.213 . . . . 0.0 110.629 -179.526 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.677 0 N-CA-C 112.011 -0.436 . . . . 0.0 112.011 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo . . . . . 0 C--N 1.343 0.254 0 C-N-CA 122.501 2.134 . . . . 0.0 111.106 179.202 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.389 0 N-CA-C 113.704 0.242 . . . . 0.0 113.704 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo . . . . . 0 N--CA 1.462 -0.377 0 C-N-CA 123.035 2.49 . . . . 0.0 111.419 179.557 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.434 0 CA-C-O 120.446 -0.085 . . . . 0.0 113.205 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo . . . . . 0 CA--C 1.531 0.346 0 C-N-CA 123.423 2.748 . . . . 0.0 112.255 179.983 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.515 0 CA-C-O 120.231 -0.205 . . . . 0.0 112.632 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo . . . . . 0 C--N 1.343 0.245 0 C-N-CA 122.957 2.438 . . . . 0.0 111.735 179.875 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.345 0 CA-C-O 120.029 -0.317 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 C--N 1.35 0.63 0 C-N-CA 123.051 2.5 . . . . 0.0 111.83 179.661 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.343 0 CA-C-O 120.227 -0.207 . . . . 0.0 112.703 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo . . . . . 0 CA--C 1.533 0.459 0 C-N-CA 123.126 2.551 . . . . 0.0 112.542 -179.684 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.458 0 N-CA-C 112.215 -0.354 . . . . 0.0 112.215 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo . . . . . 0 C--O 1.223 -0.233 0 C-N-CA 122.638 2.226 . . . . 0.0 110.533 179.271 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.398 0 CA-C-O 120.699 0.055 . . . . 0.0 113.064 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.21 160.38 38.77 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.692 2.262 . . . . 0.0 112.753 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -57.91 135.14 56.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.997 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -68.42 154.15 53.12 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.876 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 50.2 mt -68.41 133.75 31.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.686 0.279 . . . . 0.0 110.421 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.79 153.43 24.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.331 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -65.87 151.29 51.93 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.402 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 116' ' ' GLN . . . . . 0.413 ' HG2' ' N ' ' C' ' 117' ' ' ARG . 4.6 tt0 -71.18 159.12 35.23 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 117' ' ' ARG . . . . . 0.413 ' N ' ' HG2' ' C' ' 116' ' ' GLN . 11.3 ttm-85 -67.55 144.71 55.48 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.87 165.6 41.44 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.962 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 5.2 t -70.05 142.43 15.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 39.2 t -61.31 142.7 15.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.275 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.51 164.98 40.99 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.518 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 86.2 mt . . . . . 0 C--N 1.322 -0.628 0 CA-C-O 120.586 0.231 . . . . 0.0 111.13 -179.658 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.658 0 N-CA-C 112.884 -0.086 . . . . 0.0 112.884 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 C--O 1.236 0.399 0 C-N-CA 122.722 2.281 . . . . 0.0 111.501 179.822 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.57 0 N-CA-C 113.305 0.082 . . . . 0.0 113.305 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo . . . . . 0 C--O 1.235 0.352 0 C-N-CA 122.677 2.252 . . . . 0.0 111.423 179.436 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.528 0 CA-C-O 120.767 0.093 . . . . 0.0 112.929 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo . . . . . 0 C--O 1.232 0.184 0 C-N-CA 122.921 2.414 . . . . 0.0 111.411 179.859 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 133' ' ' GLY . . . . . 0.42 ' HA2' ' HD3' ' C' ' 134' ' ' PRO . . . . . . . . 0 N--CA 1.451 -0.352 0 CA-C-O 120.309 -0.162 . . . . 0.0 112.976 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 134' ' ' PRO . . . . . 0.42 ' HD3' ' HA2' ' C' ' 133' ' ' GLY . 17.0 Cg_exo . . . . . 0 C--N 1.343 0.277 0 C-N-CA 123.002 2.468 . . . . 0.0 111.541 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.29 0 CA-C-O 120.031 -0.316 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo . . . . . 0 C--N 1.348 0.523 0 C-N-CA 123.364 2.709 . . . . 0.0 112.304 179.962 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 203' ' ' GLY . . . . . 0.407 ' HA2' ' HD3' ' D' ' 204' ' ' PRO . . . . . . . . 0 CA--C 1.522 0.511 0 N-CA-C 114.938 0.735 . . . . 0.0 114.938 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 204' ' ' PRO . . . . . 0.407 ' HD3' ' HA2' ' D' ' 203' ' ' GLY . 10.8 Cg_exo . . . . . 0 CA--C 1.539 0.74 0 C-N-CA 123.934 3.09 . . . . 0.0 111.752 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 CA-C-O 120.171 -0.239 . . . . 0.0 112.72 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo . . . . . 0 CA--C 1.534 0.5 0 C-N-CA 123.177 2.584 . . . . 0.0 112.706 -179.94 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.564 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 210' ' ' PRO . . . . . 0.573 ' O ' ' HA3' ' B' ' 12' ' ' GLY . 34.5 Cg_endo -65.96 146.66 83.3 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.764 2.309 . . . . 0.0 111.969 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 211' ' ' GLN . . . . . 0.512 ' HG3' ' O ' ' B' ' 13' ' ' ILE . 24.8 tt0 -77.13 147.04 36.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.199 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -65.43 158.28 46.4 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.923 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 41.3 pt -73.98 162.83 4.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.897 0.38 . . . . 0.0 111.324 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -70.83 137.39 49.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.347 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -63.43 164.54 29.56 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.904 -0.589 . . . . 0.0 113.146 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 216' ' ' GLN . . . . . 0.479 ' O ' ' HA3' ' B' ' 18' ' ' GLY . 35.7 mm-40 -75.44 151.34 38.1 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 26.4 mtp180 -67.72 153.75 43.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.829 0.347 . . . . 0.0 110.933 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -62.98 151.96 47.05 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.49 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 8.9 t -65.47 146.92 12.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 91.4 t -61.65 138.32 22.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -56.32 160.78 7.38 Favored Glycine 0 N--CA 1.451 -0.332 0 O-C-N 123.55 0.531 . . . . 0.0 113.502 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 7.3 mp . . . . . 0 C--N 1.324 -0.534 0 CA-C-N 115.636 -0.282 . . . . 0.0 110.409 -179.822 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 224' ' ' GLY . . . . . 0.459 ' HA2' ' HD3' ' D' ' 225' ' ' PRO . . . . . . . . 0 N--CA 1.445 -0.722 0 N-CA-C 112.166 -0.374 . . . . 0.0 112.166 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 225' ' ' PRO . . . . . 0.459 ' HD3' ' HA2' ' D' ' 224' ' ' GLY . 17.0 Cg_exo . . . . . 0 C--O 1.238 0.476 0 C-N-CA 122.594 2.196 . . . . 0.0 111.568 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.711 0 N-CA-C 113.033 -0.027 . . . . 0.0 113.033 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo . . . . . 0 C--O 1.235 0.35 0 C-N-CA 122.874 2.383 . . . . 0.0 111.617 179.76 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.718 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo . . . . . 0 C--O 1.233 0.273 0 C-N-CA 122.832 2.355 . . . . 0.0 111.586 179.794 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.478 0.57 0 N-CA-C 110.533 -0.603 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -118.4 166.83 12.18 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 19.1 tt -79.68 -30.81 13.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.899 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 57.4 m -71.18 -7.48 46.99 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -76.75 -14.06 59.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.365 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 76.44 -148.73 36.02 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 5.9 m120 51.51 68.45 0.8 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.042 0.449 . . . . 0.0 111.737 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -97.16 143.48 27.92 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.381 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -72.53 -43.08 64.02 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 1.3 t -170.18 150.43 3.68 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.553 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 48.3 t -128.25 124.11 61.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -147.57 166.73 26.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.277 0.561 . . . . 0.0 111.955 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . 0.439 ' HA ' ' HA ' ' A' ' 333' ' ' MET . 33.2 ttp -121.16 119.07 31.31 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 61.7 mt -112.56 119.76 39.28 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.464 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.733 ' HG3' ' HE1' ' A' ' 379' ' ' PHE . 57.0 mtp180 54.98 28.18 10.31 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 104.4 -24.97 27.37 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.593 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . 0.579 ' HG3' HH22 ' A' ' 343' ' ' ARG . 38.4 mm-40 -94.22 130.49 40.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.954 0.377 . . . . 0.0 111.163 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' MET . . . . . 0.439 ' HA ' ' HA ' ' A' ' 328' ' ' MET . 39.5 ttm -90.93 131.07 36.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.114 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -123.87 128.93 50.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.652 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 43.7 t -103.84 108.56 24.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -89.35 129.85 35.82 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.77 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -149.62 111.76 4.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.99 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 63.62 -110.54 0.3 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.784 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -113.18 9.96 18.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.03 0.443 . . . . 0.0 111.207 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -129.63 160.19 34.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.664 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.487 ' CE2' ' HE2' ' A' ' 353' ' ' TYR . 38.6 p90 -140.64 139.81 34.92 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.106 177.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 -102.41 151.14 22.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.656 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.61 ' HD3' ' SD ' ' A' ' 350' ' ' MET . 16.2 ttt-85 -111.24 95.24 5.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.678 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 2.3 m -93.37 110.7 23.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.355 0.598 . . . . 0.0 111.143 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.63 92.01 3.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.161 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 9.3 m120 60.42 58.45 2.53 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.623 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 7.0 t30 63.85 17.33 10.45 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.288 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -124.44 130.1 51.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.561 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 39.4 t -87.72 121.13 37.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' MET . . . . . 0.61 ' SD ' ' HD3' ' A' ' 343' ' ' ARG . 90.7 mtp -77.55 148.72 35.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.978 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.46 164.02 22.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.789 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 85.12 4.04 87.0 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' TYR . . . . . 0.538 ' CE1' ' HD2' ' A' ' 343' ' ' ARG . 76.5 m-85 -123.73 157.7 61.92 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.584 -0.308 . . . . 0.0 110.748 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 353' ' ' TYR . 42.9 Cg_endo -66.17 140.69 48.92 Favored 'Cis proline' 0 C--N 1.347 0.492 0 C-N-CA 123.646 -1.398 . . . . 0.0 113.012 0.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' MET . . . . . 0.422 ' HA ' ' HD3' ' A' ' 356' ' ' PRO . 52.7 ttm -105.01 137.42 19.21 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.094 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 355' ' ' MET . 33.5 Cg_exo -60.83 133.31 47.11 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.446 2.098 . . . . 0.0 111.587 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 78.4 mt -59.15 -41.16 82.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -67.91 -16.63 68.58 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 121.104 -0.569 . . . . 0.0 113.88 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' GLN . . . . . 0.415 ' HG2' ' HG3' ' D' ' 210' ' ' PRO . 28.8 tt0 -81.25 -54.4 5.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.095 0.447 . . . . 0.0 110.796 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' PHE . . . . . 0.747 ' HE2' ' HB3' ' D' ' 211' ' ' GLN . 24.1 t80 -77.38 -58.89 3.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.178 0.513 . . . . 0.0 110.261 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -88.48 63.17 6.92 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -57.04 103.43 0.11 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.91 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 126.85 -19.65 6.12 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.62 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.624 HD12 ' HD2' ' A' ' 365' ' ' PRO . 27.1 tp -88.72 129.76 47.58 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.69 0.281 . . . . 0.0 110.458 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' PRO . . . . . 0.624 ' HD2' HD12 ' A' ' 364' ' ' LEU . 73.5 Cg_endo -75.29 169.71 21.91 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.726 2.284 . . . . 0.0 112.029 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -77.96 150.13 34.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.186 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 60.2 m 59.9 94.94 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 21.1 pt -107.96 173.83 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.53 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -97.85 -47.93 5.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.254 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . 0.857 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.2 OUTLIER -155.65 165.51 36.33 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.856 0.36 . . . . 0.0 111.489 -179.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -153.23 141.69 20.73 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . 0.577 ' HE1' ' HE2' ' A' ' 382' ' ' PHE . 13.2 p90 -156.12 162.69 40.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.169 0.509 . . . . 0.0 112.276 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -90.89 124.3 35.08 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' ARG . . . . . 0.559 ' HG2' ' O ' ' A' ' 378' ' ' LYS . 11.6 ptm180 -85.92 174.53 9.2 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -65.64 -36.26 83.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.142 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -31.92 73.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.393 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 124.93 -28.03 5.26 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.678 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' LYS . . . . . 0.685 ' HG2' ' HA ' ' A' ' 391' ' ' ASP . 31.0 mttt -77.12 174.97 10.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.162 0.506 . . . . 0.0 112.217 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' PHE . . . . . 0.733 ' HE1' ' HG3' ' A' ' 330' ' ' ARG . 9.5 m-85 -106.47 134.71 49.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.4 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . 0.48 ' HB ' ' CE1' ' A' ' 372' ' ' TYR . 13.2 t -112.34 120.31 62.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.901 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -105.29 137.91 42.32 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.956 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.577 ' HE2' ' HE1' ' A' ' 372' ' ' TYR . 78.0 m-85 -119.07 138.1 53.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.92 0.391 . . . . 0.0 111.576 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.517 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 26.5 tttp -150.47 101.6 2.97 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . 0.553 ' O ' ' HA ' ' A' ' 414' ' ' LYS . . . 74.15 -113.99 4.34 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.274 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -111.51 4.04 18.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.667 0.27 . . . . 0.0 111.17 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -113.68 148.94 35.45 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.248 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' HIS . . . . . 0.422 ' NE2' ' HE2' ' A' ' 399' ' ' TYR . 33.0 p-80 -130.32 147.43 52.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.222 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' TRP . . . . . 0.517 ' HZ3' ' HB3' ' A' ' 383' ' ' LYS . 23.3 m-90 -122.66 133.02 54.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.123 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 96.5 t -109.71 116.76 53.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -110.9 122.77 48.69 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.812 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.685 ' HA ' ' HG2' ' A' ' 378' ' ' LYS . 14.3 t70 -91.12 91.45 8.26 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 67.02 -77.51 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 O-C-N 123.874 0.734 . . . . 0.0 110.716 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -141.25 14.66 2.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.248 0.547 . . . . 0.0 109.912 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.57 118.9 28.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.91 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 47.5 tp -69.91 133.42 47.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.409 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -71.75 123.42 89.39 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -59.17 137.72 80.78 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.944 2.429 . . . . 0.0 112.257 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 108.94 6.5 30.08 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.352 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' TYR . . . . . 0.699 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 65.6 m-85 -113.43 167.12 9.84 Favored Pre-proline 0 C--N 1.323 -0.578 0 O-C-N 122.982 -0.128 . . . . 0.0 111.077 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.699 ' HA ' ' HB3' ' A' ' 399' ' ' TYR . 71.9 Cg_endo -77.68 161.73 91.27 Favored 'Cis proline' 0 C--N 1.348 0.541 0 C-N-CA 123.708 -1.372 . . . . 0.0 113.165 0.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -128.39 162.62 26.69 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.072 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -70.29 157.83 37.0 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 47.8 mt -57.16 -33.49 43.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.894 0.378 . . . . 0.0 110.971 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 404' ' ' LYS . 18.1 ptmt -67.88 -16.66 64.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.844 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -78.77 -15.52 58.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.898 0.38 . . . . 0.0 110.821 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 51.7 tp -83.44 -48.78 9.97 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -159.7 166.16 34.82 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.761 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -95.46 131.1 41.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.998 0.428 . . . . 0.0 110.999 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 106.83 5.87 35.39 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.586 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 411' ' ' PRO . 95.8 mt -92.39 148.97 37.52 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 410' ' ' LEU . 52.1 Cg_exo -56.1 135.41 69.75 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.185 2.59 . . . . 0.0 111.919 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.47 1.36 51.49 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.669 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -95.27 -56.41 2.73 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.733 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 384' ' ' GLY . 11.9 ptmt -174.85 173.59 2.72 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.752 0.311 . . . . 0.0 110.584 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 46.6 mm -121.84 132.93 69.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -87.68 -54.08 4.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.248 0.547 . . . . 0.0 109.8 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.857 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -149.83 150.95 32.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.368 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -132.54 120.92 22.5 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 61.8 tp -115.73 127.13 54.9 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.024 0.44 . . . . 0.0 111.686 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -94.85 114.31 26.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.719 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' TRP . . . . . 0.436 ' HB3' ' OD1' ' A' ' 424' ' ' ASN . 4.5 t-105 -84.98 94.82 8.89 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.432 ' HB2' ' HD3' ' A' ' 423' ' ' PRO . 66.5 mtt -53.84 -50.15 85.41 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.432 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 97.5 Cg_exo -46.1 -43.37 20.59 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 122.77 2.313 . . . . 0.0 114.867 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' ASN . . . . . 0.436 ' OD1' ' HB3' ' A' ' 421' ' ' TRP . 30.4 p30 -107.04 -23.06 12.45 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 87.05 26.8 30.26 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.036 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 38.6 mmtt -108.22 155.22 20.71 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 9.2 m -112.1 125.88 54.58 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.853 0.359 . . . . 0.0 110.828 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -103.47 119.54 39.1 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.001 0.429 . . . . 0.0 110.634 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -102.15 131.95 48.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.239 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -110.96 132.42 54.22 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.949 0.404 . . . . 0.0 111.444 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -145.29 108.39 4.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 70.54 -105.23 1.54 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.525 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -124.91 11.67 8.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.073 0.463 . . . . 0.0 110.498 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -121.38 143.02 49.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.523 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' TYR . . . . . 0.618 ' CE2' ' HE2' ' A' ' 449' ' ' TYR . 20.4 p90 -123.36 141.13 52.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.03 0.443 . . . . 0.0 111.43 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -110.75 152.38 26.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.573 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 26.7 ttp180 -113.43 96.89 6.13 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -89.52 134.01 34.32 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.387 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' ASN . . . . . 0.549 HD22 ' HG ' ' A' ' 442' ' ' LEU . 64.4 t30 -108.57 119.58 39.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.371 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.44 -45.49 73.09 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -66.55 -49.79 65.29 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' LEU . . . . . 0.549 ' HG ' HD22 ' A' ' 439' ' ' ASN . 49.9 mt -71.76 -22.02 61.66 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 60.47 33.49 20.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.369 0.604 . . . . 0.0 111.31 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -156.67 173.2 17.3 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.251 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 98.1 t -89.12 137.87 20.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.114 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.25 156.48 21.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.415 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . 0.558 ' O ' ' HB2' ' A' ' 448' ' ' GLU . 16.4 m -69.94 159.61 33.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.397 179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 448' ' ' GLU . . . . . 0.558 ' HB2' ' O ' ' A' ' 447' ' ' SER . 5.4 mm-40 80.15 6.06 1.73 Allowed 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.817 0.698 . . . . 0.0 111.067 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . 0.618 ' HE2' ' CE2' ' A' ' 435' ' ' TYR . 63.7 m-85 -117.13 162.73 26.36 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.089 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . 0.524 ' HA ' ' HB3' ' A' ' 449' ' ' TYR . 73.7 Cg_endo -74.2 156.19 99.78 Favored 'Cis proline' 0 C--N 1.347 0.493 0 C-N-CA 123.698 -1.376 . . . . 0.0 112.431 0.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -114.68 161.63 17.87 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.172 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -65.71 135.95 55.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.456 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.7 tt -64.63 -13.14 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.107 0.48 . . . . 0.0 111.153 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . 0.477 ' HD3' ' HA ' ' A' ' 454' ' ' LYS . 66.4 mmtt -62.88 -13.08 29.7 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.877 -0.602 . . . . 0.0 112.533 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 76.0 t -60.85 -37.82 77.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 456' ' ' TRP . . . . . 0.494 ' HZ3' HD11 ' A' ' 491' ' ' LEU . 26.4 m95 -86.72 91.42 8.61 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.171 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -61.46 112.25 2.12 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 115.29 -21.25 13.24 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.811 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 39.3 mm -81.08 125.77 78.82 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-O 120.815 0.34 . . . . 0.0 110.495 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 460' ' ' PRO . . . . . 0.405 ' HG3' ' CH2' ' A' ' 484' ' ' TRP . 97.7 Cg_endo -77.47 157.38 32.65 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.799 2.333 . . . . 0.0 111.686 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -78.46 145.06 35.23 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.36 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.9 m 57.68 70.44 1.3 Allowed Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -90.36 179.88 1.82 Allowed 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.68 2.253 . . . . 0.0 110.614 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 464' ' ' ARG . 0.3 OUTLIER -149.42 68.46 1.03 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.396 0.617 . . . . 0.0 110.801 179.363 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 137.34 111.7 1.07 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 3.2 p -137.96 115.3 11.09 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.791 0.329 . . . . 0.0 110.177 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -136.58 145.46 44.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 468' ' ' MET . . . . . 0.413 ' HA ' ' HA ' ' A' ' 475' ' ' THR . 46.4 ttm -101.33 142.53 32.61 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -68.99 163.21 50.86 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.514 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.99 9.29 0.57 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.08 -10.02 16.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.941 0.401 . . . . 0.0 110.8 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 69.42 5.07 4.95 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 43.9 t -111.85 -36.58 2.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 O-C-N 122.18 -0.325 . . . . 0.0 111.68 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -100.79 117.52 35.04 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 475' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 468' ' ' MET . 52.0 m -109.53 144.26 38.06 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.398 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 476' ' ' TYR . . . . . 0.55 ' CE1' ' HG3' ' A' ' 485' ' ' LYS . 92.9 m-85 -121.07 134.48 55.27 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -120.4 134.37 55.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.739 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -113.3 137.6 51.25 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.772 0.32 . . . . 0.0 111.807 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 479' ' ' LYS . . . . . 0.41 ' HB3' ' CZ3' ' A' ' 484' ' ' TRP . 77.1 tttt -161.98 109.77 1.4 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.424 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 65.12 58.94 8.58 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 114.614 0.606 . . . . 0.0 114.614 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 41.3 t30 62.89 4.19 1.41 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -121.99 151.07 41.19 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -130.0 152.8 49.07 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.936 0.398 . . . . 0.0 111.428 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 484' ' ' TRP . . . . . 0.5 ' CE2' ' HB3' ' A' ' 498' ' ' PRO . 15.1 m-90 -116.78 148.61 41.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.082 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . 0.55 ' HG3' ' CE1' ' A' ' 476' ' ' TYR . 24.1 tttp -106.86 100.59 10.09 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 486' ' ' PHE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 493' ' ' VAL . 62.4 t80 -93.12 125.36 37.68 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.297 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -94.9 115.14 27.1 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -66.92 -29.93 69.94 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -64.85 -53.7 42.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.991 0.424 . . . . 0.0 111.405 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -83.1 -14.22 54.14 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.983 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.494 HD11 ' HZ3' ' A' ' 456' ' ' TRP . 11.2 tp 63.6 42.26 6.59 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.448 0.642 . . . . 0.0 109.814 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 47.0 tttt -156.66 156.52 33.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.289 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 486' ' ' PHE . 53.5 t -79.96 139.81 17.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.149 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -69.82 146.12 95.19 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.025 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.45 153.6 73.56 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.651 2.234 . . . . 0.0 111.552 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 97.51 15.73 36.69 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . 0.623 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 24.6 m-85 -123.88 169.01 11.21 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.511 -0.344 . . . . 0.0 110.254 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . 0.623 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 72.4 Cg_endo -75.7 178.68 33.86 Favored 'Cis proline' 0 C--N 1.346 0.41 0 C-N-CA 123.851 -1.312 . . . . 0.0 112.965 0.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -136.01 150.58 49.27 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.401 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 37.3 t -69.47 128.17 35.57 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.67 -18.39 62.84 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.398 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 28.1 mt -61.68 -62.13 2.02 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.66 -11.53 59.88 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.17 -40.66 10.35 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 21.3 m0 -125.06 -39.3 2.25 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 10.8 mmt -71.82 -20.0 61.9 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 78.95 25.68 59.57 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.45 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 9.9 m -113.97 93.22 28.79 Favored Pre-proline 0 C--N 1.326 -0.434 0 O-C-N 122.845 -0.209 . . . . 0.0 110.658 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -83.58 171.29 11.05 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.866 2.377 . . . . 0.0 112.124 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 8.4 m 53.64 72.15 0.46 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.088 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.476 -1.18 . . . . 0.0 111.551 -179.949 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.735 0 N-CA-C 111.776 -0.529 . . . . 0.0 111.776 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo . . . . . 0 N--CA 1.46 -0.458 0 C-N-CA 122.614 2.21 . . . . 0.0 112.002 179.549 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' D' ' 201' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.621 0 N-CA-C 112.906 -0.078 . . . . 0.0 112.906 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo . . . . . 0 CA--C 1.531 0.373 0 C-N-CA 122.555 2.17 . . . . 0.0 111.445 179.77 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.455 0 CA-C-O 120.411 -0.105 . . . . 0.0 113.207 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo . . . . . 0 CA--C 1.531 0.368 0 C-N-CA 122.999 2.466 . . . . 0.0 111.865 179.375 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.768 0 CA-C-O 120.468 -0.073 . . . . 0.0 113.087 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.87 141.66 30.58 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 123.216 2.611 . . . . 0.0 112.304 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . 0.5 ' HB2' ' HG2' ' C' ' 110' ' ' PRO . 45.9 tt0 -68.59 147.65 51.62 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' D' ' 210' ' ' PRO . . . -57.09 147.58 34.2 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.361 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.452 ' H ' HG13 ' B' ' 13' ' ' ILE . 6.6 mt -61.87 150.11 8.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.4 151.37 46.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.278 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.51 169.17 53.55 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.936 -0.65 . . . . 0.0 113.112 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -78.57 147.15 33.84 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -70.82 146.51 49.66 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' D' ' 216' ' ' GLN . . . -62.87 155.47 41.92 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.706 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 t -71.88 154.44 7.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.4 t -55.65 142.76 9.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 O-C-N 123.319 0.387 . . . . 0.0 110.874 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.64 163.54 51.67 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.788 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 97.1 mt . . . . . 0 C--N 1.326 -0.435 0 CA-C-O 120.445 0.164 . . . . 0.0 110.693 -179.816 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.473 0 CA-C-O 120.281 -0.177 . . . . 0.0 112.788 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo . . . . . 0 CA--C 1.53 0.314 0 C-N-CA 122.868 2.378 . . . . 0.0 111.662 179.757 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.665 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo . . . . . 0 CA--C 1.529 0.268 0 C-N-CA 122.539 2.159 . . . . 0.0 111.73 179.858 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.445 0 N-CA-C 113.203 0.041 . . . . 0.0 113.203 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo . . . . . 0 CA--C 1.529 0.259 0 C-N-CA 123.336 2.691 . . . . 0.0 111.676 179.965 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 CA-C-O 120.331 -0.149 . . . . 0.0 113.116 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo . . . . . 0 C--N 1.345 0.367 0 C-N-CA 122.764 2.309 . . . . 0.0 111.748 179.671 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.399 0 CA-C-O 120.082 -0.288 . . . . 0.0 112.67 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo . . . . . 0 CA--C 1.53 0.305 0 C-N-CA 123.139 2.559 . . . . 0.0 112.444 -179.893 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.399 0 N-CA-C 112.132 -0.387 . . . . 0.0 112.132 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 CA--C 1.532 0.419 0 C-N-CA 122.78 2.32 . . . . 0.0 112.657 -179.576 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.584 0 N-CA-C 112.81 -0.116 . . . . 0.0 112.81 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo . . . . . 0 N--CA 1.464 -0.22 0 C-N-CA 122.865 2.377 . . . . 0.0 111.336 179.835 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.338 0 N-CA-C 114.043 0.377 . . . . 0.0 114.043 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 110' ' ' PRO . . . . . 0.5 ' HG2' ' HB2' ' B' ' 11' ' ' GLN . 10.4 Cg_endo -53.95 148.9 36.54 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 123.516 2.81 . . . . 0.0 113.286 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -59.34 140.52 56.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.842 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.47 161.88 38.11 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 116.01 -0.541 . . . . 0.0 113.354 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 42.0 mt -83.24 135.28 25.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.7 146.7 51.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.79 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -69.44 159.56 53.05 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.108 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 116' ' ' GLN . . . . . 0.441 ' HG2' ' H ' ' C' ' 117' ' ' ARG . 4.6 tt0 -81.8 160.5 23.53 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.701 0.286 . . . . 0.0 110.742 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 117' ' ' ARG . . . . . 0.441 ' H ' ' HG2' ' C' ' 116' ' ' GLN . 42.8 ttm-85 -67.14 149.6 50.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.839 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.4 171.2 37.23 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.671 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 15.9 t -72.68 140.92 17.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 120' ' ' VAL . . . . . 0.594 HG13 ' HB ' ' D' ' 219' ' ' VAL . 24.1 t -57.56 135.96 21.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.209 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.86 162.33 42.37 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.566 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 82.3 mt . . . . . 0 C--N 1.322 -0.59 0 CA-C-O 120.607 0.242 . . . . 0.0 110.524 -179.894 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.698 0 CA-C-O 120.532 -0.038 . . . . 0.0 113.054 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo . . . . . 0 C--O 1.235 0.35 0 C-N-CA 122.68 2.254 . . . . 0.0 111.19 179.842 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.556 0 N-CA-C 112.778 -0.129 . . . . 0.0 112.778 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 N--CA 1.459 -0.505 0 C-N-CA 122.555 2.17 . . . . 0.0 111.724 179.868 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.465 0 N-CA-C 113.461 0.144 . . . . 0.0 113.461 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo . . . . . 0 C--O 1.233 0.254 0 C-N-CA 123.141 2.561 . . . . 0.0 111.849 -179.74 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.538 0 CA-C-O 120.33 -0.15 . . . . 0.0 112.825 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 CA--C 1.531 0.375 0 C-N-CA 122.49 2.127 . . . . 0.0 111.614 179.211 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.451 0 N-CA-C 112.339 -0.304 . . . . 0.0 112.339 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 201' ' ' PRO . . . . . 0.556 ' O ' ' HA3' ' B' ' 3' ' ' GLY . 52.0 Cg_exo . . . . . 0 C--N 1.348 0.546 0 C-N-CA 122.608 2.205 . . . . 0.0 111.384 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 114.387 0.515 . . . . 0.0 114.387 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo . . . . . 0 CA--C 1.531 0.372 0 C-N-CA 123.745 2.964 . . . . 0.0 112.168 -179.984 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.382 0 N-CA-C 113.516 0.166 . . . . 0.0 113.516 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo . . . . . 0 CA--C 1.535 0.542 0 C-N-CA 123.149 2.566 . . . . 0.0 112.727 -179.917 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.556 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 210' ' ' PRO . . . . . 0.415 ' HG3' ' HG2' ' A' ' 359' ' ' GLN . 16.4 Cg_exo -69.11 148.45 69.32 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.957 2.438 . . . . 0.0 112.061 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 211' ' ' GLN . . . . . 0.747 ' HB3' ' HE2' ' A' ' 360' ' ' PHE . 60.0 tt0 -67.72 148.97 50.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.716 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -71.29 163.53 54.07 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.251 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 24.9 pt -69.55 165.38 2.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-O 120.65 0.262 . . . . 0.0 111.026 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 214' ' ' ALA . . . . . 0.496 ' HB3' ' NH1' ' A' ' 330' ' ' ARG . . . -87.49 139.23 30.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.924 0.393 . . . . 0.0 110.842 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -61.49 161.76 26.05 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.67 -0.695 . . . . 0.0 113.525 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 216' ' ' GLN . . . . . 0.443 ' O ' ' HA3' ' B' ' 18' ' ' GLY . 35.4 mm-40 -73.27 160.36 32.0 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -66.63 155.64 37.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.17 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -61.98 158.21 34.08 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.878 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 219' ' ' VAL . . . . . 0.594 ' HB ' HG13 ' C' ' 120' ' ' VAL . 25.8 t -61.74 141.88 17.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 24.6 t -62.48 138.51 22.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.206 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -58.12 154.11 24.98 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.613 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 7.2 mp . . . . . 0 C--N 1.323 -0.583 0 CA-C-O 120.742 0.306 . . . . 0.0 111.044 -179.517 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 224' ' ' GLY . . . . . 0.423 ' HA2' ' HD3' ' D' ' 225' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.58 0 N-CA-C 112.685 -0.166 . . . . 0.0 112.685 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 225' ' ' PRO . . . . . 0.423 ' HD3' ' HA2' ' D' ' 224' ' ' GLY . 24.0 Cg_exo . . . . . 0 N--CA 1.463 -0.277 0 C-N-CA 122.697 2.265 . . . . 0.0 111.222 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.57 0 N-CA-C 113.734 0.253 . . . . 0.0 113.734 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo . . . . . 0 CA--C 1.532 0.407 0 C-N-CA 122.968 2.445 . . . . 0.0 111.474 179.6 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.495 0 CA-C-O 120.523 -0.043 . . . . 0.0 113.02 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo . . . . . 0 N--CA 1.464 -0.231 0 C-N-CA 122.952 2.435 . . . . 0.0 111.774 -179.919 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo . . . . . 0 N--CA 1.479 0.674 0 N-CA-C 110.066 -0.782 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -109.34 145.39 36.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.425 0.155 . . . . 0.0 110.613 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . 0.448 ' O ' ' HZ ' ' A' ' 323' ' ' PHE . 19.3 tt -81.05 -19.1 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 121.114 0.483 . . . . 0.0 111.349 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 7.9 m -95.68 12.59 29.28 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.094 0.473 . . . . 0.0 110.244 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -68.82 -33.77 74.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.445 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 82.48 179.85 52.91 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.624 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 5.5 t30 52.17 77.75 0.14 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.172 0.511 . . . . 0.0 111.448 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' PHE . . . . . 0.448 ' HZ ' ' O ' ' A' ' 318' ' ' ILE . 72.1 m-85 -98.75 157.53 16.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.235 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -68.48 -39.38 81.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.261 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 13.4 t -176.43 153.53 1.19 Allowed 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.79 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.506 HG22 HG13 ' A' ' 335' ' ' VAL . 60.6 t -135.84 123.53 35.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -144.3 178.1 8.15 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.963 0.411 . . . . 0.0 111.62 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 51.9 ttp -130.92 121.57 25.41 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 63.9 mt -114.9 122.09 45.23 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.012 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.695 ' HG3' ' HE1' ' A' ' 379' ' ' PHE . 64.1 mtp180 55.26 25.76 7.75 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 101.57 -8.67 56.77 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.509 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -105.79 127.92 53.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.993 0.396 . . . . 0.0 110.829 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 45.3 ttm -84.9 134.06 34.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.818 0.342 . . . . 0.0 111.633 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -126.49 128.39 46.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.64 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . 0.506 HG13 HG22 ' A' ' 326' ' ' VAL . 35.6 t -108.31 119.37 57.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.43 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -99.85 131.76 45.62 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 0.426 ' HB2' ' HD1' ' A' ' 323' ' ' PHE . 41.4 tptt -141.51 106.01 4.86 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.723 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 63.03 -105.18 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.55 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -115.07 10.68 16.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.868 0.366 . . . . 0.0 111.32 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 10.1 m-90 -123.93 163.02 22.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.12 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -143.83 144.44 31.78 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.978 0.418 . . . . 0.0 110.923 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -108.41 146.52 32.94 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.818 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.628 ' HD3' ' SD ' ' A' ' 350' ' ' MET . 23.9 ttt-85 -115.83 96.08 5.43 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 3.3 m -88.21 129.6 39.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.995 0.426 . . . . 0.0 111.184 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -142.87 122.44 13.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.853 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 14.3 m120 57.65 41.0 26.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.115 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 67.77 23.71 8.48 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.187 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -134.25 154.05 51.51 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 46.0 t -90.79 121.92 41.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' MET . . . . . 0.628 ' SD ' ' HD3' ' A' ' 343' ' ' ARG . 1.7 ttt -65.32 144.39 57.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.748 0.308 . . . . 0.0 111.133 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -66.87 147.1 53.68 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.546 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 100.94 -0.71 55.09 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.134 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' TYR . . . . . 0.514 ' HB3' ' HA ' ' A' ' 354' ' ' PRO . 80.3 m-85 -122.07 160.11 48.81 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.514 ' HA ' ' HB3' ' A' ' 353' ' ' TYR . 55.2 Cg_endo -69.86 136.61 39.87 Favored 'Cis proline' 0 C--N 1.347 0.497 0 C-N-CA 123.736 -1.36 . . . . 0.0 113.025 0.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 47.2 ttm -116.59 141.95 28.84 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.448 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.62 135.27 68.5 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.262 1.975 . . . . 0.0 111.352 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 95.3 mt -54.21 -43.74 61.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.354 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -69.87 -6.44 56.01 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 121.028 -0.606 . . . . 0.0 114.606 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -86.24 -37.11 18.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.501 0.65 . . . . 0.0 110.208 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -95.11 -53.65 3.72 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -92.26 71.73 5.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 -59.99 101.71 0.13 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.135 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 131.06 -19.42 4.91 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.452 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.518 HD12 ' HD2' ' A' ' 365' ' ' PRO . 22.2 tp -91.14 131.95 35.5 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.681 0.276 . . . . 0.0 110.626 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' PRO . . . . . 0.518 ' HD2' HD12 ' A' ' 364' ' ' LEU . 92.2 Cg_endo -82.67 -173.76 1.83 Allowed 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.789 2.326 . . . . 0.0 112.269 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -90.01 154.75 19.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.212 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.7 m 56.37 93.47 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 21.5 pt -110.53 179.82 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.447 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . 0.423 HD22 ' HA ' ' A' ' 369' ' ' ASN . 4.3 m120 -96.45 -55.81 2.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.949 0.404 . . . . 0.0 110.949 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . 0.919 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.2 OUTLIER -155.9 167.91 28.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.161 -179.668 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -142.86 139.21 30.76 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -152.86 166.26 32.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.06 0.457 . . . . 0.0 111.913 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -100.77 141.13 34.08 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.19 -0.914 . . . . 0.0 108.64 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 378' ' ' LYS . 7.1 ptm180 -100.77 -171.65 2.05 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 39.3 tttt -72.46 -25.74 61.55 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -177.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.21 -17.38 32.76 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 113.49 -17.27 21.26 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.805 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' LYS . . . . . 0.519 ' O ' ' HG2' ' A' ' 374' ' ' ARG . 46.1 mttp -74.66 158.21 34.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.097 0.475 . . . . 0.0 111.521 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' PHE . . . . . 0.695 ' HE1' ' HG3' ' A' ' 330' ' ' ARG . 9.7 m-85 -98.46 134.76 40.99 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.444 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 21.9 t -116.58 121.08 66.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.023 0.439 . . . . 0.0 110.496 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -105.57 139.03 40.79 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.451 ' HE1' HG12 ' A' ' 403' ' ' ILE . 3.8 m-85 -119.39 144.44 46.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.773 0.321 . . . . 0.0 111.702 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.461 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 83.5 tttt -155.51 98.89 1.99 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.954 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . 0.471 ' O ' HD11 ' A' ' 403' ' ' ILE . . . 71.52 -114.75 5.29 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.815 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 402' ' ' HIS . 13.1 p-10 -105.07 6.43 33.27 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -118.28 151.4 37.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.795 0.331 . . . . 0.0 111.793 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 37.0 p-80 -136.0 145.35 46.0 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.238 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' TRP . . . . . 0.461 ' HZ3' ' HB3' ' A' ' 383' ' ' LYS . 17.8 m-90 -118.27 133.09 56.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.654 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 60.0 t -111.78 113.4 44.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -107.66 127.52 53.74 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -92.7 88.92 6.45 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' GLU . . . . . 0.459 ' OE1' ' HB ' ' D' ' 213' ' ' ILE . 59.5 mm-40 69.02 -71.3 0.12 Allowed 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.721 0.638 . . . . 0.0 111.002 -178.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -142.41 3.18 1.5 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.174 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.84 126.48 54.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.729 0.3 . . . . 0.0 111.582 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 47.8 tp -74.09 135.21 42.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.654 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 13.6 mt-10 -75.63 134.78 72.23 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.859 0.362 . . . . 0.0 111.068 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 45.2 Cg_exo -58.74 142.53 98.79 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.199 2.599 . . . . 0.0 112.28 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 104.23 -25.1 27.17 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.309 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' TYR . . . . . 0.602 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 95.2 m-85 -89.64 161.24 39.71 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 110.561 -0.163 . . . . 0.0 110.561 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.602 ' HA ' ' HB3' ' A' ' 399' ' ' TYR . 72.0 Cg_endo -75.03 152.84 98.68 Favored 'Cis proline' 0 C--N 1.345 0.355 0 C-N-CA 123.77 -1.346 . . . . 0.0 113.394 0.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -126.39 169.78 12.62 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.491 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 0.496 ' HA ' ' O ' ' A' ' 385' ' ' ASP . 76.3 m80 -71.75 158.09 36.74 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.656 0.265 . . . . 0.0 111.236 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . 0.471 HD11 ' O ' ' A' ' 384' ' ' GLY . 22.4 mt -59.22 -35.54 58.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.18 0.514 . . . . 0.0 110.03 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 44.1 pttt -67.05 -15.04 63.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.803 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.451 ' HG2' ' HB2' ' A' ' 402' ' ' HIS . 38.1 mm-40 -82.27 -28.66 31.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.851 0.357 . . . . 0.0 110.549 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 41.1 tp -72.14 -53.34 13.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.29 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.625 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -153.9 159.68 28.89 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.618 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -89.69 127.37 35.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.719 0.295 . . . . 0.0 110.533 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 106.31 -0.92 37.52 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.226 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 95.1 mt -79.0 156.51 76.91 Favored Pre-proline 0 C--N 1.32 -0.691 0 O-C-N 122.878 -0.189 . . . . 0.0 110.663 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -53.34 138.62 64.83 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.677 2.252 . . . . 0.0 112.013 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.01 -15.97 28.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.723 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -86.41 -61.01 1.84 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . 0.467 ' O ' ' HD2' ' A' ' 431' ' ' ARG . 10.0 pttp -175.33 179.15 1.55 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 33.4 mm -117.98 147.93 21.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -100.15 -49.54 4.25 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.919 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -157.65 156.15 31.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.258 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -136.78 120.03 16.76 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 21.9 tp -108.94 124.53 50.83 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.058 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -97.57 114.13 25.98 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' TRP . . . . . 0.886 ' HB2' ' HE2' ' A' ' 428' ' ' TYR . 10.9 t-105 -83.6 94.81 8.16 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 10.1 mmt -49.8 -52.84 48.07 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -47.55 -42.41 29.1 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 123.036 2.491 . . . . 0.0 115.177 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' ASN . . . . . 0.446 ' OD1' ' HB3' ' A' ' 421' ' ' TRP . 36.0 p30 -104.64 -19.36 13.99 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 78.56 34.89 34.14 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.209 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 37.4 mmtt -117.0 147.48 42.27 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.6 m -107.53 126.64 52.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.771 0.32 . . . . 0.0 110.491 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' TYR . . . . . 0.886 ' HE2' ' HB2' ' A' ' 421' ' ' TRP . 71.3 m-85 -104.04 110.61 22.84 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.862 0.363 . . . . 0.0 110.74 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -92.46 120.78 33.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.781 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -97.01 132.26 43.0 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.751 0.31 . . . . 0.0 111.183 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.467 ' HD2' ' O ' ' A' ' 414' ' ' LYS . 2.5 tpm_? -144.41 104.9 4.13 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.066 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . 0.41 ' HA2' ' OG ' ' A' ' 462' ' ' SER . . . 67.15 -111.66 4.27 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.591 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -109.3 10.64 25.59 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . 0.656 ' HD3' ' HG2' ' A' ' 450' ' ' PRO . 89.8 mttt -130.94 152.44 50.26 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.805 0.336 . . . . 0.0 111.681 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' TYR . . . . . 0.421 ' CE2' ' HE2' ' A' ' 449' ' ' TYR . 11.7 p90 -125.87 142.65 51.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.504 178.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -109.43 136.11 49.37 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.671 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -97.31 99.48 10.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.161 0.505 . . . . 0.0 109.651 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' PHE . . . . . 0.625 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 91.4 t80 -89.94 134.81 34.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.748 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -110.56 106.6 15.93 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.354 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' GLU . . . . . 0.41 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 0.6 OUTLIER -50.7 -47.23 59.08 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -178.404 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -59.3 -35.85 74.54 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 67.1 mt -98.63 -15.81 19.3 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 60.96 40.09 15.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.635 0.731 . . . . 0.0 110.992 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -150.97 168.24 25.15 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.458 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 87.6 t -92.01 141.58 14.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.553 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -62.13 163.39 8.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.161 0.505 . . . . 0.0 111.514 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 20.0 m -76.71 157.6 31.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.59 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 72.69 23.43 2.97 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.532 0.682 . . . . 0.0 111.01 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . 0.421 ' HE2' ' CE2' ' A' ' 435' ' ' TYR . 17.1 m-85 -122.37 164.13 28.03 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.119 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . 0.656 ' HG2' ' HD3' ' A' ' 434' ' ' LYS . 83.4 Cg_endo -77.61 161.29 92.21 Favored 'Cis proline' 0 C--N 1.345 0.378 0 C-N-CA 123.678 -1.384 . . . . 0.0 112.697 0.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -111.77 161.32 16.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.726 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 -66.08 140.06 58.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.821 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.4 tt -64.27 -13.07 13.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.427 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 36.9 mttm -61.46 -11.99 12.91 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 79.8 t -61.53 -34.79 63.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 456' ' ' TRP . . . . . 0.482 ' HB2' ' HB ' ' A' ' 459' ' ' ILE . 8.1 m95 -89.05 95.53 10.36 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -56.6 107.72 0.42 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 105.05 -1.73 40.97 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.698 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.482 ' HB ' ' HB2' ' A' ' 456' ' ' TRP . 20.1 mm -88.92 129.01 49.97 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.978 0.389 . . . . 0.0 111.335 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.26 149.07 19.27 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 123.063 2.509 . . . . 0.0 112.904 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -71.4 146.27 48.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.379 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 462' ' ' SER . . . . . 0.41 ' OG ' ' HA2' ' A' ' 432' ' ' GLY . 4.2 m 55.08 71.39 1.3 Allowed Pre-proline 0 N--CA 1.467 0.412 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -85.84 178.49 4.24 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.711 2.274 . . . . 0.0 111.745 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.6 8.44 6.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.042 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -177.23 147.57 8.35 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.824 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 19.4 p -164.19 98.17 0.82 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -128.61 140.35 51.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.925 0.393 . . . . 0.0 111.31 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 468' ' ' MET . . . . . 0.404 ' HA ' ' HA ' ' A' ' 475' ' ' THR . 39.2 ttm -84.78 138.82 32.37 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.965 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -72.33 160.04 53.91 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.467 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -15.45 57.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.969 0.414 . . . . 0.0 111.385 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -79.14 -18.53 53.01 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.222 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 69.21 1.77 3.38 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.22 -38.21 7.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.836 0.35 . . . . 0.0 111.458 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -120.84 143.69 48.76 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 475' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 468' ' ' MET . 55.3 m -115.88 139.97 49.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.32 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -106.18 123.6 48.28 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -107.18 144.99 33.13 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 94.1 t80 -129.02 134.7 48.24 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 59.7 tttt -170.81 134.35 1.01 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.991 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 60.11 43.37 98.38 Favored Glycine 0 N--CA 1.454 -0.125 0 CA-C-N 115.979 -0.555 . . . . 0.0 114.039 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 39.9 t30 67.07 3.58 3.21 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -118.22 157.13 27.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.733 0.301 . . . . 0.0 110.741 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -127.07 149.62 49.84 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.499 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 484' ' ' TRP . . . . . 0.423 ' CE2' ' HB3' ' A' ' 498' ' ' PRO . 19.2 m-90 -117.82 138.67 51.93 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.529 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -101.42 93.95 5.66 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 486' ' ' PHE . . . . . 0.465 ' CZ ' ' HE3' ' A' ' 456' ' ' TRP . 82.6 t80 -85.21 130.12 34.67 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.394 -178.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . 0.504 ' HB3' ' HB3' ' A' ' 490' ' ' LYS . 36.6 t-20 -86.65 121.53 29.29 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -65.94 -52.25 51.42 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.25 -40.39 86.26 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -178.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 490' ' ' LYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 487' ' ' ASN . 37.5 ttmt -78.26 -26.16 47.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.548 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 6.1 tp 63.24 38.78 10.18 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.572 0.701 . . . . 0.0 110.222 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -153.53 148.72 26.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.438 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 486' ' ' PHE . 77.8 t -75.83 131.27 35.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -59.45 137.35 89.15 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.836 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.28 143.1 99.86 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.912 2.408 . . . . 0.0 112.261 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 103.76 5.39 44.86 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.278 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . 0.51 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 18.6 m-85 -114.03 166.27 11.81 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.554 -0.323 . . . . 0.0 110.349 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . 0.51 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 88.3 Cg_endo -79.75 178.67 32.41 Favored 'Cis proline' 0 C--N 1.349 0.557 0 C-N-CA 123.752 -1.353 . . . . 0.0 113.075 0.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -135.23 160.12 39.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.277 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 42.4 t -69.66 125.92 28.16 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.812 0.339 . . . . 0.0 110.977 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -71.64 -22.9 61.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.284 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 502' ' ' LEU . . . . . 0.404 ' HA ' ' HG2' ' A' ' 506' ' ' MET . 26.4 mt -69.55 -47.34 64.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.53 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -75.9 -35.08 59.95 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -88.69 -46.86 8.68 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 36.1 m0 -92.72 -56.73 2.9 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -177.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 506' ' ' MET . . . . . 0.404 ' HG2' ' HA ' ' A' ' 502' ' ' LEU . 11.4 mmt -64.08 -45.43 88.74 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 105.85 29.63 4.87 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.398 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 15.1 m -106.45 105.38 54.23 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -81.11 160.92 20.6 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 123.289 2.66 . . . . 0.0 112.087 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 18.6 m 61.15 68.14 0.75 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.574 0.702 . . . . 0.0 111.653 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.388 -1.229 . . . . 0.0 111.474 -179.7 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.608 0 N-CA-C 111.893 -0.483 . . . . 0.0 111.893 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo . . . . . 0 CA--C 1.53 0.306 0 C-N-CA 122.621 2.214 . . . . 0.0 111.985 179.966 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' D' ' 201' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.571 0 N-CA-C 113.46 0.144 . . . . 0.0 113.46 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 CA--C 1.531 0.331 0 C-N-CA 123.002 2.468 . . . . 0.0 111.797 179.89 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.608 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo . . . . . 0 CA--C 1.531 0.368 0 C-N-CA 122.553 2.168 . . . . 0.0 111.26 179.26 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.81 0 N-CA-C 112.198 -0.361 . . . . 0.0 112.198 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.51 147.59 71.07 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.837 2.358 . . . . 0.0 111.575 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -68.71 150.41 47.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.971 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.48 154.7 29.95 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.129 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.435 HG13 ' H ' ' B' ' 13' ' ' ILE . 5.2 mt -65.24 152.57 8.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.42 145.91 47.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.371 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.48 159.57 53.64 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 121.144 -0.551 . . . . 0.0 112.633 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -72.34 146.23 47.24 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -69.89 146.67 51.08 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.517 ' HA3' ' O ' ' D' ' 216' ' ' GLN . . . -61.2 150.97 43.18 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.76 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 4.6 t -67.11 146.34 13.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.0 t -53.76 144.94 4.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.33 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.86 167.16 54.12 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.87 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 C--N 1.322 -0.587 0 C-N-CA 121.987 0.115 . . . . 0.0 110.746 -179.755 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.649 0 N-CA-C 112.252 -0.339 . . . . 0.0 112.252 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 C--O 1.232 0.195 0 C-N-CA 122.597 2.198 . . . . 0.0 111.275 179.637 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 113.551 0.181 . . . . 0.0 113.551 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 C--O 1.235 0.351 0 C-N-CA 122.835 2.357 . . . . 0.0 111.486 179.442 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 113.458 0.143 . . . . 0.0 113.458 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo . . . . . 0 CA--C 1.531 0.358 0 C-N-CA 123.158 2.572 . . . . 0.0 111.731 179.674 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.508 0 CA-C-O 120.357 -0.135 . . . . 0.0 112.765 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 N--CA 1.462 -0.362 0 C-N-CA 122.695 2.263 . . . . 0.0 111.924 179.813 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.348 0 CA-C-O 120.086 -0.286 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo . . . . . 0 CA--C 1.53 0.283 0 C-N-CA 122.963 2.442 . . . . 0.0 111.875 179.735 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.413 0 N-CA-C 112.851 -0.1 . . . . 0.0 112.851 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo . . . . . 0 CA--C 1.531 0.373 0 C-N-CA 123.592 2.862 . . . . 0.0 112.11 -179.694 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.41 0 N-CA-C 112.299 -0.32 . . . . 0.0 112.299 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo . . . . . 0 CA--C 1.528 0.209 0 C-N-CA 122.664 2.242 . . . . 0.0 111.353 179.84 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.423 0 N-CA-C 113.915 0.326 . . . . 0.0 113.915 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -65.14 163.97 26.97 Favored 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 122.841 2.361 . . . . 0.0 112.417 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -62.16 144.45 55.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.318 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -75.51 163.65 53.83 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.98 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 21.7 mt -65.14 136.61 26.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.17 148.14 50.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.254 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.36 154.43 37.87 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.117 -0.564 . . . . 0.0 112.873 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -83.51 163.25 20.58 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 43.5 ttm-85 -68.13 148.99 50.16 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.687 0.279 . . . . 0.0 110.357 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.93 175.35 38.6 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.06 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 25.3 t -73.49 140.24 18.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 90.4 t -63.27 136.07 26.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.105 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.18 157.62 46.54 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.269 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 74.4 mt . . . . . 0 C--N 1.324 -0.526 0 CA-C-O 120.658 0.266 . . . . 0.0 111.103 -179.657 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 C--O 1.236 0.4 0 C-N-CA 122.55 2.166 . . . . 0.0 111.737 179.904 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.61 0 N-CA-C 112.818 -0.113 . . . . 0.0 112.818 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 C--O 1.237 0.462 0 C-N-CA 122.494 2.129 . . . . 0.0 111.321 179.554 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.604 0 N-CA-C 112.494 -0.243 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo . . . . . 0 N--CA 1.463 -0.293 0 C-N-CA 122.822 2.348 . . . . 0.0 111.353 179.837 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.426 0 CA-C-O 120.186 -0.23 . . . . 0.0 112.699 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo . . . . . 0 N--CA 1.462 -0.37 0 C-N-CA 122.667 2.245 . . . . 0.0 111.891 -179.706 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 201' ' ' PRO . . . . . 0.435 ' O ' ' HA3' ' B' ' 3' ' ' GLY . 78.1 Cg_exo . . . . . 0 C--N 1.346 0.408 0 C-N-CA 123.014 2.476 . . . . 0.0 111.651 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.435 0 N-CA-C 114.236 0.455 . . . . 0.0 114.236 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo . . . . . 0 CA--C 1.536 0.605 0 C-N-CA 123.473 2.782 . . . . 0.0 111.965 179.213 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 CA-C-O 120.342 -0.144 . . . . 0.0 112.824 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 N--CA 1.458 -0.599 0 C-N-CA 123.475 2.783 . . . . 0.0 112.636 179.972 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 112.842 -0.103 . . . . 0.0 112.842 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -71.85 141.85 37.96 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 123.02 2.48 . . . . 0.0 111.949 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -65.84 146.42 54.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.943 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -70.05 162.97 52.66 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.897 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 213' ' ' ILE . . . . . 0.459 ' HB ' ' OE1' ' A' ' 392' ' ' GLU . 39.4 pt -69.84 166.85 2.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.606 0.241 . . . . 0.0 110.971 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 214' ' ' ALA . . . . . 0.558 ' HB3' ' NH1' ' A' ' 330' ' ' ARG . . . -83.15 144.44 29.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.884 0.373 . . . . 0.0 110.882 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -65.95 168.14 33.4 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.8 -0.636 . . . . 0.0 114.054 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 216' ' ' GLN . . . . . 0.517 ' O ' ' HA3' ' B' ' 18' ' ' GLY . 89.7 mm-40 -75.95 155.77 34.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.698 0.285 . . . . 0.0 110.955 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -66.14 153.06 43.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.5 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -59.83 150.25 39.54 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.086 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 13.8 t -61.2 143.12 15.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.61 142.16 16.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.888 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -59.88 154.79 31.41 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.358 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 C--N 1.32 -0.68 0 O-C-N 122.843 -0.21 . . . . 0.0 110.795 -179.8 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 224' ' ' GLY . . . . . 0.442 ' HA2' ' HD3' ' D' ' 225' ' ' PRO . . . . . . . . 0 N--CA 1.45 -0.407 0 N-CA-C 113.575 0.19 . . . . 0.0 113.575 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 225' ' ' PRO . . . . . 0.442 ' HD3' ' HA2' ' D' ' 224' ' ' GLY . 31.4 Cg_exo . . . . . 0 CA--C 1.531 0.327 0 C-N-CA 123.213 2.608 . . . . 0.0 112.09 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.709 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 C--O 1.238 0.478 0 C-N-CA 122.702 2.268 . . . . 0.0 111.809 179.903 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.697 0 N-CA-C 113.699 0.24 . . . . 0.0 113.699 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo . . . . . 0 N--CA 1.464 -0.243 0 C-N-CA 123.214 2.61 . . . . 0.0 111.263 179.567 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.418 ' HD2' ' CZ3' ' A' ' 340' ' ' TRP . 4.8 Cg_endo . . . . . 0 N--CA 1.479 0.62 0 N-CA-C 110.477 -0.624 . . . . 0.0 110.477 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -105.76 158.25 16.87 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . 0.404 ' O ' ' HZ ' ' A' ' 323' ' ' PHE . 15.0 tt -75.39 -19.13 15.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.41 0.624 . . . . 0.0 110.046 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 69.5 m -85.7 -1.31 57.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.717 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -74.15 -23.59 59.28 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.366 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 74.46 -172.32 52.41 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.607 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 2.1 t30 54.6 81.7 0.1 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.113 0.565 . . . . 0.0 111.942 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' PHE . . . . . 0.469 ' HD1' ' HB2' ' A' ' 337' ' ' LYS . 50.8 m-85 -104.65 164.43 11.77 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.709 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -73.32 -41.26 63.73 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 9.4 t -172.78 152.5 2.49 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.535 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 97.6 t -133.0 118.28 32.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -141.58 172.94 12.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.063 0.459 . . . . 0.0 111.473 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 31.9 ttp -121.77 123.39 41.71 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.624 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 59.3 mt -116.6 118.43 32.59 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.933 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.404 ' HG3' ' CE1' ' A' ' 379' ' ' PHE . 43.7 mtp180 56.49 28.04 13.15 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 98.76 -11.86 62.69 Favored Glycine 0 CA--C 1.517 0.193 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.225 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -98.52 128.23 44.77 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.823 0.344 . . . . 0.0 110.875 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 48.7 ttm -87.39 119.9 28.13 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.504 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -112.04 128.4 56.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.055 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . 0.442 ' HB ' ' HB2' ' A' ' 342' ' ' TRP . 26.1 t -106.8 119.91 57.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.434 -0.803 . . . . 0.0 108.913 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -107.87 130.11 55.03 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 0.691 ' HB3' ' HZ3' ' A' ' 342' ' ' TRP . 87.7 tttt -153.44 108.24 3.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.75 177.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 69.89 -129.67 0.08 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.034 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 339' ' ' ARG . 12.8 ptm85 -94.94 2.63 55.4 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . 0.418 ' CZ3' ' HD2' ' A' ' 316' ' ' PRO . 6.9 m-90 -123.61 154.85 38.72 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.784 0.326 . . . . 0.0 111.053 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -134.16 149.76 51.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.568 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' TRP . . . . . 0.691 ' HZ3' ' HB3' ' A' ' 337' ' ' LYS . 26.2 m-90 -119.65 167.56 11.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.634 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.13 114.27 6.21 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.417 HG11 ' HA ' ' A' ' 506' ' ' MET . 10.5 m -102.78 143.99 14.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.165 0.507 . . . . 0.0 112.238 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 29.1 ttm-85 -150.79 126.91 10.52 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.924 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 22.7 m120 68.55 30.89 5.0 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.203 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 39.6 t30 66.06 24.23 11.0 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.224 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -136.45 146.27 46.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.339 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 32.8 t -79.0 124.69 37.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 60.4 mtp -71.15 160.55 32.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.774 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -72.32 153.61 41.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.118 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 98.64 -4.41 59.68 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.517 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -118.6 152.6 51.42 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -73.94 149.12 93.54 Favored 'Cis proline' 0 C--O 1.234 0.315 0 C-N-CA 123.356 -1.518 . . . . 0.0 112.884 0.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 55.1 ttm -129.57 139.68 36.39 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.42 -0.809 . . . . 0.0 108.949 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.88 131.26 44.96 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.211 1.941 . . . . 0.0 111.213 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' ILE . . . . . 0.475 HG23 ' HD1' ' A' ' 361' ' ' TRP . 65.6 mt -52.02 -46.21 41.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.047 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -65.05 -16.07 61.48 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 121.267 -0.492 . . . . 0.0 114.128 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -34.2 61.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.141 0.471 . . . . 0.0 110.574 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -101.25 -51.5 3.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.165 0.507 . . . . 0.0 110.062 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' TRP . . . . . 0.475 ' HD1' HG23 ' A' ' 357' ' ' ILE . 71.4 m95 -87.8 85.68 7.07 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.371 0.605 . . . . 0.0 109.571 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 362' ' ' ARG . 38.4 ttp180 -65.63 83.41 0.06 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.859 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.582 ' HA3' HD22 ' A' ' 395' ' ' LEU . . . 133.54 -3.6 4.7 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.164 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.583 HD12 ' HD2' ' A' ' 365' ' ' PRO . 22.9 tp -98.83 131.72 25.11 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 120.616 0.246 . . . . 0.0 110.858 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' PRO . . . . . 0.583 ' HD2' HD12 ' A' ' 364' ' ' LEU . 98.3 Cg_endo -79.55 -174.83 2.43 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.715 2.277 . . . . 0.0 111.598 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -91.35 151.34 20.9 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.938 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 18.1 m 57.45 93.52 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.483 0.919 . . . . 0.0 113.483 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 24.1 pt -107.19 172.39 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.409 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -96.64 -40.57 8.94 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . 0.86 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.1 OUTLIER -162.7 171.88 16.16 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.773 0.32 . . . . 0.0 111.347 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 380' ' ' VAL . . . -162.06 144.44 11.39 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -157.35 164.16 37.87 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -95.5 122.05 37.82 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' ARG . . . . . 0.549 ' HG2' ' O ' ' A' ' 378' ' ' LYS . 9.3 ptm180 -75.57 -175.7 2.96 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.478 ' HD2' ' HA3' ' A' ' 425' ' ' GLY . 77.6 tttt -67.46 -33.18 74.59 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.988 0.423 . . . . 0.0 111.375 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.75 -50.62 19.79 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.825 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 147.63 -29.76 1.43 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.214 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' LYS . . . . . 0.731 ' HG2' ' HA ' ' A' ' 391' ' ' ASP . 91.5 mttt -59.13 150.49 25.07 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.91 0.386 . . . . 0.0 111.088 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' PHE . . . . . 0.404 ' CE1' ' HG3' ' A' ' 330' ' ' ARG . 18.2 m-85 -95.73 136.09 36.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.612 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 371' ' ' ALA . 3.8 t -113.86 113.96 45.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.094 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -100.52 144.78 29.11 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -126.63 141.51 51.83 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.848 0.356 . . . . 0.0 111.632 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.56 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 84.2 tttt -152.99 105.48 2.93 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 177.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 72.49 -117.07 6.04 Favored Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -109.85 10.51 24.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.848 0.356 . . . . 0.0 110.946 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -118.75 151.08 38.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.878 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 27.8 p-80 -131.38 153.28 49.82 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.028 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' TRP . . . . . 0.575 ' CE2' ' HB3' ' A' ' 400' ' ' PRO . 26.7 m-90 -127.97 131.87 49.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.238 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . 0.409 HG12 ' HG3' ' A' ' 396' ' ' GLU . 78.8 t -111.02 122.78 66.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -113.57 122.41 47.15 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.731 ' HA ' ' HG2' ' A' ' 378' ' ' LYS . 32.8 t70 -85.03 82.42 8.45 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 177.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' GLU . . . . . 0.451 ' OE1' ' HB ' ' D' ' 213' ' ' ILE . 35.7 mm-40 71.92 -68.93 0.2 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.489 -177.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -143.8 7.52 1.45 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.93 0.395 . . . . 0.0 110.915 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 2.0 m -113.76 125.01 53.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.02 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . 0.582 HD22 ' HA3' ' A' ' 363' ' ' GLY . 52.3 tp -76.52 128.22 34.34 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.533 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 1.4 mt-10 -64.42 136.54 96.8 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.985 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 31.5 Cg_exo -60.95 143.22 99.3 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.168 2.579 . . . . 0.0 112.447 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 96.51 -15.01 63.52 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.543 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -83.72 156.56 64.76 Favored Pre-proline 0 C--N 1.323 -0.577 0 O-C-N 122.672 -0.311 . . . . 0.0 110.782 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.575 ' HB3' ' CE2' ' A' ' 388' ' ' TRP . 59.9 Cg_endo -71.51 156.38 97.04 Favored 'Cis proline' 0 C--N 1.349 0.593 0 C-N-CA 123.963 -1.266 . . . . 0.0 113.522 0.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -128.19 159.6 34.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.0 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 0.545 ' ND1' ' HG2' ' A' ' 404' ' ' LYS . 5.4 t-80 -69.75 153.09 43.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.245 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 64.9 mt -56.52 -33.51 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . 0.545 ' HG2' ' ND1' ' A' ' 402' ' ' HIS . 20.7 pttm -65.14 -12.53 51.97 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -80.91 -26.58 36.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.876 0.37 . . . . 0.0 110.772 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 32.2 tp -75.0 -47.14 30.67 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.477 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -169.37 147.82 11.44 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.759 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 33.0 ttt180 -84.68 132.96 34.41 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.745 0.307 . . . . 0.0 110.315 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 114.14 -14.77 21.1 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.551 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.443 HD21 ' HB2' ' A' ' 438' ' ' PHE . 96.0 mt -76.17 152.9 84.29 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.571 -0.314 . . . . 0.0 110.563 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.46 130.19 38.75 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.922 2.414 . . . . 0.0 111.545 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.11 3.82 55.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.985 0.421 . . . . 0.0 111.482 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -95.52 -57.53 2.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.579 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 5.1 ptmt -172.38 171.64 4.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.919 0.39 . . . . 0.0 110.858 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 49.2 mm -120.92 127.52 75.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -86.49 -48.01 8.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.935 0.398 . . . . 0.0 110.55 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.86 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -153.87 154.38 33.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.295 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -135.1 107.27 7.18 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 40.5 tp -99.14 117.21 33.11 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.281 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . 0.417 ' CZ ' ' HA ' ' A' ' 375' ' ' LYS . 44.7 t80 -89.0 115.44 26.57 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.035 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' TRP . . . . . 0.494 ' HB2' ' HE2' ' A' ' 428' ' ' TYR . 22.0 t-105 -84.26 90.44 7.53 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.463 ' HB2' ' HG2' ' A' ' 472' ' ' GLU . 62.9 mtt -47.97 -48.73 61.95 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.422 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 79.8 Cg_exo -48.87 -35.47 31.35 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 122.862 2.375 . . . . 0.0 114.787 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 38.3 p30 -113.29 -35.47 5.31 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . 0.478 ' HA3' ' HD2' ' A' ' 375' ' ' LYS . . . 104.62 10.44 33.17 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.617 -0.802 . . . . 0.0 113.367 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -97.88 155.41 17.08 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.418 -0.46 . . . . 0.0 110.605 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 7.4 m -113.16 130.36 56.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.994 0.426 . . . . 0.0 111.568 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' TYR . . . . . 0.494 ' HE2' ' HB2' ' A' ' 421' ' ' TRP . 99.4 m-85 -100.85 108.17 19.89 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.742 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -91.47 124.57 35.74 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.226 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -99.57 132.24 45.03 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.094 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.41 ' HA ' ' HE ' ' A' ' 431' ' ' ARG . 2.9 tpm_? -144.4 108.08 4.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.171 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 70.14 -110.22 3.21 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.774 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 28.1 p30 -117.71 17.69 14.3 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.837 0.351 . . . . 0.0 111.158 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 52.5 mttt -133.86 158.22 43.97 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.725 0.298 . . . . 0.0 110.959 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' TYR . . . . . 0.46 ' CE2' ' HE2' ' A' ' 449' ' ' TYR . 7.1 p90 -128.99 144.5 51.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.211 0.529 . . . . 0.0 110.984 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -110.53 133.74 53.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.596 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 19.2 ttp180 -94.86 92.14 6.78 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' PHE . . . . . 0.477 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 67.8 t80 -84.34 129.04 34.91 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.131 0.491 . . . . 0.0 111.642 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -99.39 108.89 21.49 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' GLU . . . . . 0.524 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 1.7 tt0 -58.57 -43.04 89.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.947 0.403 . . . . 0.0 110.621 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -84.24 48.65 1.52 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.797 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -169.6 -35.03 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.706 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 443' ' ' ARG . 37.6 mtp-105 69.58 36.94 2.04 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.429 0.633 . . . . 0.0 111.199 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -155.72 167.37 30.61 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.925 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 59.7 t -87.74 141.06 14.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.966 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -62.09 155.44 24.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.998 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 448' ' ' GLU . 0.9 OUTLIER -64.85 157.73 27.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.849 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 448' ' ' GLU . . . . . 0.577 ' HB3' ' HE2' ' A' ' 451' ' ' LYS . 8.3 mm-40 76.04 5.93 3.75 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.259 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . 0.524 ' HB3' ' HA ' ' A' ' 450' ' ' PRO . 42.6 m-85 -112.63 163.36 18.05 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.762 -0.199 . . . . 0.0 111.329 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . 0.524 ' HA ' ' HB3' ' A' ' 449' ' ' TYR . 73.1 Cg_endo -75.87 155.65 98.87 Favored 'Cis proline' 0 C--N 1.349 0.57 0 C-N-CA 123.624 -1.407 . . . . 0.0 112.967 0.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . 0.577 ' HE2' ' HB3' ' A' ' 448' ' ' GLU . 63.0 mttm -116.84 162.3 17.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.305 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -65.53 139.94 58.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.718 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.1 tt -67.48 -9.6 10.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.094 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -63.47 -7.35 6.6 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 95.7 t -65.94 -37.17 79.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 456' ' ' TRP . . . . . 0.563 ' HE3' ' CZ ' ' A' ' 486' ' ' PHE . 5.7 m95 -88.43 93.68 9.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.94 179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.28 116.32 4.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.149 0.5 . . . . 0.0 112.072 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 107.3 -15.57 39.02 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.716 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.424 ' HB ' ' HB2' ' A' ' 456' ' ' TRP . 33.6 mm -83.59 125.9 72.52 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 120.857 0.36 . . . . 0.0 111.304 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.44 152.93 30.55 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.758 2.306 . . . . 0.0 111.719 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -73.42 147.36 44.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.473 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 2.0 m 54.89 75.85 0.57 Allowed Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -83.5 -176.59 2.81 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.156 2.571 . . . . 0.0 112.173 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -134.81 18.96 3.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.207 0.527 . . . . 0.0 110.405 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 166.15 142.9 3.56 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 11.4 p -157.54 108.23 2.25 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -134.23 146.14 49.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.881 0.372 . . . . 0.0 111.507 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 48.0 ttm -99.03 141.06 32.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.167 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -67.69 166.74 42.5 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.179 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 2.7 m -68.74 -8.26 41.3 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.34 -14.27 27.1 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.969 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . 0.463 ' HG2' ' HB2' ' A' ' 422' ' ' MET . 36.4 mt-10 65.39 12.17 7.9 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.241 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.7 -45.05 12.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.941 0.4 . . . . 0.0 110.682 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -114.07 141.56 47.31 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.208 0.528 . . . . 0.0 112.0 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 475' ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' A' ' 486' ' ' PHE . 91.9 m -119.42 138.8 52.86 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.685 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -112.51 131.06 55.78 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.292 0.568 . . . . 0.0 112.506 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -114.65 142.78 46.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.215 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -123.75 136.84 54.67 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 111.526 0.195 . . . . 0.0 111.526 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -167.43 126.11 1.31 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.001 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 57.92 46.83 92.0 Favored Glycine 0 CA--C 1.519 0.341 0 CA-C-N 116.003 -0.544 . . . . 0.0 114.356 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 68.65 -2.25 1.72 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.775 0.658 . . . . 0.0 112.775 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 482' ' ' LYS . . . . . 0.436 ' HB3' ' HB2' ' A' ' 498' ' ' PRO . 34.7 mtmt -106.39 151.42 24.91 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 483' ' ' TYR . . . . . 0.5 ' CZ ' ' HE2' ' A' ' 497' ' ' TYR . 3.3 p90 -126.89 138.84 53.37 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.031 0.443 . . . . 0.0 111.332 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 15.1 m-90 -108.33 145.65 34.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.23 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 53.5 tttt -111.86 100.45 8.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.075 0.464 . . . . 0.0 109.927 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 486' ' ' PHE . . . . . 0.563 ' CZ ' ' HE3' ' A' ' 456' ' ' TRP . 67.1 t80 -89.1 130.61 35.52 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.945 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -96.82 112.38 24.16 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -64.72 -23.43 67.25 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 31.3 tp60 -78.57 -24.5 45.52 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -114.1 -6.26 13.08 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 15.3 tp 58.02 34.22 24.01 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.525 0.679 . . . . 0.0 110.375 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 492' ' ' LYS . . . . . 0.432 ' HG2' ' N ' ' A' ' 493' ' ' VAL . 39.3 tttp -152.46 152.71 32.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.703 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 486' ' ' PHE . 66.7 t -76.1 133.36 31.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.696 178.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -61.38 148.22 86.1 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.386 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.23 149.56 85.27 Favored 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 122.743 2.295 . . . . 0.0 112.457 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 96.25 13.25 49.44 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.751 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . 0.567 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 51.1 m-85 -121.08 164.5 23.36 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.874 -0.163 . . . . 0.0 110.783 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . 0.567 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 95.8 Cg_endo -80.65 164.23 79.32 Favored 'Cis proline' 0 C--N 1.344 0.337 0 C-N-CA 123.806 -1.331 . . . . 0.0 113.647 0.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -118.68 160.77 21.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.651 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 30.1 t -71.97 115.47 11.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.946 0.403 . . . . 0.0 110.978 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -69.99 -23.67 63.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.61 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 502' ' ' LEU . . . . . 0.472 ' HA ' ' HG2' ' A' ' 506' ' ' MET . 83.5 mt -67.02 -32.0 72.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.074 0.464 . . . . 0.0 110.862 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -96.68 -35.08 11.14 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -89.65 -17.64 28.01 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 13.0 m0 -121.37 -52.63 2.04 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 506' ' ' MET . . . . . 0.472 ' HG2' ' HA ' ' A' ' 502' ' ' LEU . 11.2 mmt -67.95 -29.33 68.36 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 88.84 30.72 14.06 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.032 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 31.7 m -101.93 114.23 65.61 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.0 124.34 11.7 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.968 2.445 . . . . 0.0 112.652 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 3.9 m 68.28 153.68 0.1 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.482 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.188 -1.34 . . . . 0.0 111.19 179.957 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.771 0 N-CA-C 112.048 -0.421 . . . . 0.0 112.048 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 CA--C 1.53 0.321 0 C-N-CA 122.722 2.281 . . . . 0.0 112.01 179.916 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' D' ' 201' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.61 0 N-CA-C 112.175 -0.37 . . . . 0.0 112.175 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo . . . . . 0 C--O 1.232 0.21 0 C-N-CA 122.764 2.309 . . . . 0.0 111.415 179.773 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.683 0 N-CA-C 112.318 -0.313 . . . . 0.0 112.318 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo . . . . . 0 N--CA 1.463 -0.303 0 C-N-CA 122.617 2.211 . . . . 0.0 111.361 179.085 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.673 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.64 143.6 68.88 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.88 2.387 . . . . 0.0 111.514 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -64.89 150.82 47.08 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.607 ' HA3' ' O ' ' D' ' 210' ' ' PRO . . . -59.99 154.72 31.96 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.345 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.486 ' O ' ' HG3' ' D' ' 211' ' ' GLN . 6.5 mt -59.58 150.38 5.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.891 0.377 . . . . 0.0 110.924 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.59 145.27 56.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.127 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.32 153.85 45.54 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.903 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -69.27 148.59 49.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.756 0.312 . . . . 0.0 110.612 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -66.34 138.64 57.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.715 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.51 145.13 49.77 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.637 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 t -63.8 149.22 10.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.496 0.148 . . . . 0.0 110.766 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 11.0 t -52.13 146.05 2.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.262 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.54 165.08 52.45 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 121.187 -0.53 . . . . 0.0 113.4 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 81.2 mt . . . . . 0 C--N 1.322 -0.598 0 CA-C-N 115.639 -0.28 . . . . 0.0 110.342 179.946 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.586 0 N-CA-C 112.226 -0.349 . . . . 0.0 112.226 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo . . . . . 0 C--O 1.234 0.314 0 C-N-CA 122.756 2.304 . . . . 0.0 111.698 179.662 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.51 0 N-CA-C 112.748 -0.141 . . . . 0.0 112.748 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo . . . . . 0 CA--C 1.532 0.423 0 C-N-CA 123.043 2.495 . . . . 0.0 112.031 -179.997 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 113.52 0.168 . . . . 0.0 113.52 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo . . . . . 0 C--N 1.345 0.392 0 C-N-CA 123.308 2.672 . . . . 0.0 112.455 -179.803 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.459 0 N-CA-C 113.8 0.28 . . . . 0.0 113.8 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo . . . . . 0 C--N 1.346 0.406 0 C-N-CA 122.952 2.435 . . . . 0.0 111.397 179.257 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.35 0 CA-C-O 120.019 -0.323 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo . . . . . 0 C--O 1.235 0.359 0 C-N-CA 122.823 2.349 . . . . 0.0 111.63 179.54 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo . . . . . 0 N--CA 1.463 -0.319 0 C-N-CA 123.074 2.516 . . . . 0.0 111.97 179.862 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.513 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo . . . . . 0 N--CA 1.466 -0.142 0 C-N-CA 122.676 2.251 . . . . 0.0 110.743 179.621 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.479 0 CA-C-O 120.454 -0.081 . . . . 0.0 113.282 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.26 160.07 32.48 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 123.216 2.611 . . . . 0.0 112.525 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -62.03 134.23 56.35 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.794 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -65.39 162.02 41.26 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.441 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 53.5 mt -72.94 138.72 20.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.8 153.09 37.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.306 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -66.56 159.39 48.29 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.351 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -88.94 150.53 22.8 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.617 0.246 . . . . 0.0 110.594 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 19.5 ttm-85 -60.97 142.11 56.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.323 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.24 167.12 49.79 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.41 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 86.0 t -66.73 142.28 16.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.675 0.274 . . . . 0.0 111.014 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 94.4 t -61.6 143.39 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.122 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.89 163.61 36.94 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.726 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 87.3 mt . . . . . 0 C--N 1.324 -0.519 0 CA-C-O 120.49 0.186 . . . . 0.0 110.755 -179.959 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.512 0 N-CA-C 113.462 0.145 . . . . 0.0 113.462 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 C--O 1.234 0.312 0 C-N-CA 122.709 2.273 . . . . 0.0 111.629 -179.918 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.565 0 N-CA-C 112.318 -0.313 . . . . 0.0 112.318 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo . . . . . 0 N--CA 1.459 -0.516 0 C-N-CA 122.666 2.244 . . . . 0.0 111.223 179.479 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.62 0 CA-C-O 120.694 0.052 . . . . 0.0 112.997 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo . . . . . 0 C--O 1.235 0.348 0 C-N-CA 122.921 2.414 . . . . 0.0 111.691 -179.94 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.555 0 CA-C-O 120.211 -0.216 . . . . 0.0 112.958 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo . . . . . 0 C--N 1.345 0.369 0 C-N-CA 122.823 2.349 . . . . 0.0 111.463 179.509 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.287 0 CA-C-O 120.056 -0.302 . . . . 0.0 112.437 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 201' ' ' PRO . . . . . 0.446 ' O ' ' HA3' ' B' ' 3' ' ' GLY . 31.9 Cg_exo . . . . . 0 C--N 1.345 0.366 0 C-N-CA 122.789 2.326 . . . . 0.0 111.034 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.418 0 N-CA-C 114.72 0.648 . . . . 0.0 114.72 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo . . . . . 0 CA--C 1.531 0.339 0 C-N-CA 123.528 2.819 . . . . 0.0 110.411 178.307 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.287 0 N-CA-C 113.454 0.141 . . . . 0.0 113.454 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo . . . . . 0 CA--C 1.533 0.454 0 C-N-CA 123.33 2.686 . . . . 0.0 112.803 -179.87 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.456 0 N-CA-C 112.319 -0.312 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 210' ' ' PRO . . . . . 0.607 ' O ' ' HA3' ' B' ' 12' ' ' GLY . 2.6 Cg_exo -76.89 152.89 32.58 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 123.044 2.496 . . . . 0.0 111.786 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 211' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' B' ' 13' ' ' ILE . 57.0 tt0 -73.91 149.32 41.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.774 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -68.02 159.45 51.2 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.486 -0.645 . . . . 0.0 111.486 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 213' ' ' ILE . . . . . 0.451 ' HB ' ' OE1' ' A' ' 392' ' ' GLU . 42.1 pt -64.4 163.48 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-O 120.891 0.376 . . . . 0.0 111.484 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -74.56 145.16 43.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.333 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -67.42 158.02 51.34 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.518 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 -76.19 151.33 36.93 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -64.58 153.04 40.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.337 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -61.86 157.03 35.5 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.269 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 12.3 t -70.91 147.52 11.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.59 136.85 25.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.99 162.82 26.36 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.292 -0.48 . . . . 0.0 113.127 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 64.5 mt . . . . . 0 C--N 1.325 -0.485 0 CA-C-N 115.846 -0.177 . . . . 0.0 110.795 -179.982 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 224' ' ' GLY . . . . . 0.447 ' HA2' ' HD3' ' D' ' 225' ' ' PRO . . . . . . . . 0 N--CA 1.446 -0.658 0 N-CA-C 112.276 -0.33 . . . . 0.0 112.276 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 225' ' ' PRO . . . . . 0.447 ' HD3' ' HA2' ' D' ' 224' ' ' GLY . 17.3 Cg_exo . . . . . 0 C--O 1.236 0.406 0 C-N-CA 122.602 2.202 . . . . 0.0 111.903 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.449 0 N-CA-C 114.087 0.395 . . . . 0.0 114.087 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 CA--C 1.531 0.35 0 C-N-CA 123.418 2.745 . . . . 0.0 111.485 179.587 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.506 0 N-CA-C 113.268 0.067 . . . . 0.0 113.268 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo . . . . . 0 N--CA 1.463 -0.319 0 C-N-CA 123.002 2.468 . . . . 0.0 111.394 179.519 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo . . . . . 0 N--CA 1.477 0.54 0 N-CA-C 109.8 -0.885 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -110.42 -173.98 2.38 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 15.4 tt -117.46 -6.24 11.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.247 0.546 . . . . 0.0 110.54 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 99.6 m -100.11 -0.61 38.64 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -94.02 -9.17 37.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.81 0.338 . . . . 0.0 110.598 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 84.22 -149.05 24.7 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.808 -0.711 . . . . 0.0 111.843 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 2.8 t30 55.13 68.57 0.84 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.116 0.484 . . . . 0.0 111.756 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -100.99 152.17 20.89 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.547 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -80.31 -47.09 15.05 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 4.4 t -167.33 149.67 6.0 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.021 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 47.8 t -128.49 122.29 57.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -140.44 -177.98 5.29 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.065 0.459 . . . . 0.0 111.778 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 12.8 ttp -132.02 131.17 42.26 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 51.2 mt -127.58 116.86 20.99 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 123.295 0.372 . . . . 0.0 110.397 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.451 ' H ' ' CD ' ' A' ' 373' ' ' GLU . 0.9 OUTLIER 64.83 20.84 12.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.822 179.203 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 102.85 -18.59 49.54 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.347 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -89.47 135.03 33.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.669 0.271 . . . . 0.0 110.475 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 48.4 ttm -87.03 126.61 34.86 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.907 0.384 . . . . 0.0 110.632 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -116.87 122.32 44.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.32 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.72 112.46 37.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -95.3 130.4 42.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.792 0.33 . . . . 0.0 111.578 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -147.98 108.82 4.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.244 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 63.34 -113.2 0.4 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.632 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.456 HH11 ' HD2' ' A' ' 339' ' ' ARG . 13.3 ptm180 -110.23 10.35 23.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.053 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -126.19 157.47 38.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.908 0.385 . . . . 0.0 110.591 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -141.31 141.57 33.89 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.563 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -107.21 150.46 26.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.92 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.454 ' HD3' ' SD ' ' A' ' 350' ' ' MET . 14.5 ttt85 -125.5 106.32 9.7 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 3.7 m -92.79 129.01 43.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.409 0.623 . . . . 0.0 111.485 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.43 111.89 13.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.082 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 27.9 t30 55.69 52.06 11.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.031 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 68.14 7.07 5.62 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -122.38 158.06 30.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.724 0.297 . . . . 0.0 110.881 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 38.5 t -94.26 130.32 43.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 120.681 0.276 . . . . 0.0 110.475 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' MET . . . . . 0.454 ' SD ' ' HD3' ' A' ' 343' ' ' ARG . 4.0 mtp -72.04 156.72 38.9 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.204 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -79.08 150.55 31.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.81 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 99.69 -6.03 58.67 Favored Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' TYR . . . . . 0.459 ' HA ' ' C ' ' A' ' 354' ' ' PRO . 86.7 m-85 -112.64 157.69 39.61 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.459 ' C ' ' HA ' ' A' ' 353' ' ' TYR . 38.1 Cg_endo -66.55 131.7 15.38 Favored 'Cis proline' 0 C--N 1.347 0.466 0 C-N-CA 123.713 -1.369 . . . . 0.0 112.693 0.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' MET . . . . . 0.441 ' HA ' ' HD3' ' A' ' 356' ' ' PRO . 52.6 ttm -104.38 136.08 19.23 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.24 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 355' ' ' MET . 31.4 Cg_exo -61.18 131.84 38.6 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.256 1.971 . . . . 0.0 111.058 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 66.5 mt -54.96 -44.1 71.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.179 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -67.99 -14.22 65.43 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 121.19 -0.529 . . . . 0.0 113.718 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -79.55 -45.79 18.57 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 117.182 0.491 . . . . 0.0 110.622 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -88.38 -53.11 4.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.591 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -88.12 74.67 8.79 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.242 0.544 . . . . 0.0 109.536 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -60.66 94.83 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.865 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 130.91 -17.31 5.2 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.264 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.55 HD12 ' HD2' ' A' ' 365' ' ' PRO . 19.4 tp -85.31 132.59 44.64 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.647 0.261 . . . . 0.0 111.138 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' PRO . . . . . 0.55 ' HD2' HD12 ' A' ' 364' ' ' LEU . 94.2 Cg_endo -79.59 178.81 6.92 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.817 2.345 . . . . 0.0 111.651 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -86.56 151.57 23.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.421 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 44.6 m 55.98 83.99 0.09 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 19.9 pt -95.56 172.86 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.924 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.42 -42.05 6.42 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.708 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . 0.729 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.2 OUTLIER -151.23 159.2 44.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.85 0.357 . . . . 0.0 111.513 -179.6 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -149.93 140.1 22.14 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -163.88 166.79 21.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.768 0.318 . . . . 0.0 111.42 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.52 ' HG2' ' HD1' ' A' ' 379' ' ' PHE . 33.5 mt-10 -97.56 138.38 35.07 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' ARG . . . . . 0.628 ' HG3' ' H ' ' A' ' 376' ' ' ASP . 10.0 ptm180 -89.41 -173.03 3.84 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.959 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.482 ' HB2' ' HG3' ' A' ' 440' ' ' GLU . 67.8 tttt -70.42 -19.51 62.99 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -177.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . 0.628 ' H ' ' HG3' ' A' ' 374' ' ' ARG . 0.4 OUTLIER -94.67 -23.05 17.76 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.377 -0.529 . . . . 0.0 112.422 -179.341 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 124.9 -18.99 7.01 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.603 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -70.45 152.0 44.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.842 0.353 . . . . 0.0 110.605 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' PHE . . . . . 0.52 ' HD1' ' HG2' ' A' ' 373' ' ' GLU . 21.5 m-85 -96.23 133.54 40.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.269 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 14.5 t -114.56 121.31 66.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 120.796 0.332 . . . . 0.0 110.276 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -107.65 138.62 43.55 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -121.3 137.7 54.57 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.461 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 79.0 tttt -155.25 103.54 2.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.408 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 76.61 -122.38 6.33 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.606 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . 0.52 ' O ' ' HA ' ' A' ' 402' ' ' HIS . 2.3 p-10 -106.52 4.87 28.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.884 0.373 . . . . 0.0 111.098 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . 0.4 ' HB3' ' HB2' ' A' ' 400' ' ' PRO . 46.3 mmtm -114.62 150.01 35.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.217 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 32.5 p-80 -131.78 148.79 52.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.019 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' TRP . . . . . 0.461 ' HZ3' ' HB3' ' A' ' 383' ' ' LYS . 27.1 m-90 -123.6 132.81 53.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.066 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 21.8 t -112.86 124.6 69.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -117.48 128.68 55.23 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -94.73 89.21 5.63 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' GLU . . . . . 0.46 ' HA ' ' HE2' ' A' ' 379' ' ' PHE . 76.9 mm-40 68.98 -80.41 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.409 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -136.05 11.47 3.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.089 0.471 . . . . 0.0 110.902 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 19.3 m -120.82 129.29 53.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.876 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 33.8 tp -76.07 142.04 41.87 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.961 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -69.14 148.49 97.65 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.392 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.41 133.64 19.47 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.9 2.4 . . . . 0.0 112.584 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 87.29 52.81 2.95 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.4 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' TYR . . . . . 0.432 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 25.4 m-85 -143.62 162.66 40.59 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.432 ' HA ' ' HB3' ' A' ' 399' ' ' TYR . 83.3 Cg_endo -80.4 165.32 77.96 Favored 'Cis proline' 0 C--N 1.347 0.489 0 C-N-CA 123.633 -1.403 . . . . 0.0 112.934 0.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -132.48 168.11 18.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.987 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 0.52 ' HA ' ' O ' ' A' ' 385' ' ' ASP . 5.4 m80 -68.82 156.36 38.53 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 123.236 0.335 . . . . 0.0 110.499 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 52.8 mt -55.84 -36.53 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.111 0.482 . . . . 0.0 110.879 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . 0.416 ' HG2' ' HB2' ' A' ' 402' ' ' HIS . 22.8 pttp -65.43 -14.48 61.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.127 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -80.62 -22.06 40.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.318 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 40.6 tp -82.69 -48.21 11.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.99 0.424 . . . . 0.0 110.234 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.531 ' HA3' ' CE1' ' A' ' 438' ' ' PHE . . . -151.18 140.54 7.93 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.919 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 408' ' ' ARG . 0.1 OUTLIER -79.67 126.32 30.77 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.0 0.429 . . . . 0.0 110.714 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 110.77 -1.83 28.89 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.052 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 88.6 mt -83.72 150.18 58.75 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.496 0.189 . . . . 0.0 110.562 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.0 140.86 92.35 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.697 2.265 . . . . 0.0 111.871 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.14 -5.94 39.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.812 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . 0.499 ' OD2' ' HD3' ' A' ' 431' ' ' ARG . 8.5 p-10 -79.27 -57.69 3.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.494 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -179.39 176.68 0.81 Allowed 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.823 0.344 . . . . 0.0 110.421 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 44.7 mm -124.55 134.64 66.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -89.4 -54.31 4.15 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.283 0.563 . . . . 0.0 110.206 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.729 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -150.84 155.93 40.2 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.978 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -139.14 121.51 16.03 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 35.2 tp -113.97 123.8 50.6 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.421 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -90.97 113.38 25.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.67 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' TRP . . . . . 0.487 ' HB2' ' HE2' ' A' ' 428' ' ' TYR . 19.2 t-105 -80.42 99.04 7.78 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 67.0 mtt -54.62 -49.41 91.4 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -47.54 -61.41 0.6 Allowed 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 122.557 2.171 . . . . 0.0 114.501 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' ASN . . . . . 0.428 ' H ' ' HD1' ' A' ' 421' ' ' TRP . 52.0 p30 -85.8 -24.9 26.61 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 83.56 47.43 5.67 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.514 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -131.49 152.58 50.6 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.8 m -106.24 126.55 52.36 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.141 0.496 . . . . 0.0 111.754 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' TYR . . . . . 0.487 ' HE2' ' HB2' ' A' ' 421' ' ' TRP . 95.6 m-85 -100.65 113.15 25.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.019 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . 0.448 ' HB2' ' HB2' ' A' ' 436' ' ' TYR . 46.4 m-85 -94.93 121.79 36.9 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.394 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -99.88 130.38 46.06 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.783 0.325 . . . . 0.0 110.929 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.499 ' HD3' ' OD2' ' A' ' 413' ' ' ASP . 3.1 tpm_? -141.75 98.7 3.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.829 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 67.79 -116.81 8.1 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.561 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -101.64 8.45 41.7 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 450' ' ' PRO . 65.9 mmtt -128.72 149.38 50.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.815 0.341 . . . . 0.0 111.195 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' TYR . . . . . 0.437 ' CE2' ' HE2' ' A' ' 449' ' ' TYR . 9.1 p90 -126.43 144.41 50.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.468 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' TYR . . . . . 0.448 ' HB2' ' HB2' ' A' ' 429' ' ' PHE . 26.6 m-85 -109.5 143.41 39.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.879 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -103.84 93.77 5.06 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' PHE . . . . . 0.531 ' CE1' ' HA3' ' A' ' 407' ' ' GLY . 76.5 t80 -82.79 129.57 35.0 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.533 -178.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -103.65 108.3 19.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.102 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' GLU . . . . . 0.507 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 4.1 mm-40 -54.98 -47.59 74.38 Favored 'General case' 0 C--O 1.231 0.115 0 O-C-N 123.486 0.491 . . . . 0.0 112.159 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -62.55 -32.71 73.71 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 68.2 mt -94.99 -10.94 29.46 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 443' ' ' ARG . 3.5 mmm180 58.07 29.32 17.64 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 123.32 0.387 . . . . 0.0 111.523 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -154.38 174.12 15.28 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.331 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.8 t -90.31 144.11 9.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.863 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -67.8 164.16 20.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.894 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.38 163.96 26.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.047 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 71.83 8.93 6.15 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.167 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . 0.449 ' HB3' ' HA ' ' A' ' 450' ' ' PRO . 31.6 m-85 -113.71 163.63 18.1 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.693 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . 0.473 ' HB2' ' HB3' ' A' ' 434' ' ' LYS . 66.1 Cg_endo -72.32 157.06 98.15 Favored 'Cis proline' 0 C--N 1.348 0.514 0 C-N-CA 123.631 -1.404 . . . . 0.0 112.301 -0.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -115.32 170.19 8.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.907 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -60.75 128.22 35.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.316 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 11.6 tt -66.74 -14.58 18.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.113 0.482 . . . . 0.0 111.347 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -69.89 3.7 2.47 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 39.1 t -66.6 -32.55 58.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 456' ' ' TRP . . . . . 0.412 ' HE3' ' CZ ' ' A' ' 486' ' ' PHE . 16.7 m95 -88.27 84.06 6.89 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.32 110.21 0.38 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.718 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 119.42 -23.67 8.4 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.173 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 43.7 mm -86.07 127.87 60.12 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.845 0.355 . . . . 0.0 111.383 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -85.49 162.49 11.01 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.809 2.339 . . . . 0.0 111.421 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -71.11 153.94 42.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.533 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 10.5 m 58.1 72.68 0.84 Allowed Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 115.591 -0.732 . . . . 0.0 112.942 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -82.52 176.51 7.83 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.093 2.529 . . . . 0.0 111.859 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 8.7 tpp85 -142.51 23.24 1.97 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.318 0.58 . . . . 0.0 110.472 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 172.97 142.03 3.68 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 12.3 p -165.43 101.42 0.72 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.728 0.299 . . . . 0.0 110.686 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -132.96 138.42 46.89 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.079 0.466 . . . . 0.0 111.656 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 40.0 ttm -93.65 135.9 34.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.526 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -68.2 163.62 48.2 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.391 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.93 -9.13 26.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.169 0.509 . . . . 0.0 111.605 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -84.99 -15.24 44.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.144 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 64.47 11.57 6.67 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 57.8 t -110.48 -40.69 4.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.921 0.391 . . . . 0.0 110.908 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -105.26 126.51 52.17 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 93.7 m -114.2 130.71 56.62 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -105.55 124.35 49.4 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.228 0.537 . . . . 0.0 112.389 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -105.55 152.35 23.17 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.971 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -131.82 137.59 48.17 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.514 0.197 . . . . 0.0 111.306 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 479' ' ' LYS . . . . . 0.403 ' HB3' ' CZ3' ' A' ' 484' ' ' TRP . 58.7 tttt -168.61 120.04 0.78 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.65 178.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 64.17 48.0 79.36 Favored Glycine 0 N--CA 1.453 -0.226 0 N-CA-C 114.561 0.584 . . . . 0.0 114.561 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 481' ' ' ASN . . . . . 0.568 ' OD1' ' HG ' ' A' ' 502' ' ' LEU . 66.5 t30 67.94 0.93 2.53 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 482' ' ' LYS . . . . . 0.543 ' HB3' ' HB2' ' A' ' 498' ' ' PRO . 41.5 mtmt -115.9 152.37 33.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.173 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 483' ' ' TYR . . . . . 0.475 ' CE2' ' HE2' ' A' ' 497' ' ' TYR . 32.6 p90 -126.12 152.23 46.19 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.892 0.377 . . . . 0.0 111.523 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 484' ' ' TRP . . . . . 0.494 ' HD1' HG11 ' A' ' 493' ' ' VAL . 18.5 m-90 -117.98 140.43 49.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.757 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -100.38 94.59 6.25 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 486' ' ' PHE . . . . . 0.412 ' CZ ' ' HE3' ' A' ' 456' ' ' TRP . 68.1 t80 -88.59 123.57 33.2 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.054 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . 0.407 ' ND2' ' HD3' ' A' ' 490' ' ' LYS . 40.1 t-20 -91.99 114.16 26.63 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -62.21 -33.02 73.76 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -76.06 -26.66 56.75 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 490' ' ' LYS . . . . . 0.407 ' HD3' ' ND2' ' A' ' 487' ' ' ASN . 55.4 mtpt -101.3 -16.91 16.78 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 10.7 tp 58.56 38.53 25.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.726 0.774 . . . . 0.0 110.25 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -156.41 152.6 27.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.595 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . 0.494 HG11 ' HD1' ' A' ' 484' ' ' TRP . 75.4 t -77.95 136.65 23.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.802 0.334 . . . . 0.0 110.585 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -62.93 146.35 95.47 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.284 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.98 155.68 66.77 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.571 2.18 . . . . 0.0 112.129 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 89.57 14.43 59.87 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.273 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . 0.686 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 66.3 m-85 -121.18 167.07 14.06 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . 0.686 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 76.8 Cg_endo -75.64 168.32 77.69 Favored 'Cis proline' 0 C--N 1.349 0.589 0 C-N-CA 123.905 -1.29 . . . . 0.0 113.016 0.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -123.39 169.67 11.11 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.945 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 39.9 t -79.24 117.57 20.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.777 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.02 -27.04 64.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.917 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 502' ' ' LEU . . . . . 0.568 ' HG ' ' OD1' ' A' ' 481' ' ' ASN . 14.2 mt -65.0 -48.33 74.34 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.195 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -79.68 -42.98 23.58 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -76.45 -54.31 6.91 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -177.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -79.36 -61.03 2.13 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 7.2 mmt -66.57 -37.68 85.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.976 0.417 . . . . 0.0 111.479 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 94.63 22.68 23.29 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.705 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 18.8 m -83.48 124.18 75.9 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-O 120.614 0.245 . . . . 0.0 110.465 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.86 156.04 61.19 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.812 2.342 . . . . 0.0 112.842 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 4.0 m 70.77 -70.23 0.16 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.466 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.327 0 CA-C-O 118.365 -1.241 . . . . 0.0 111.23 -179.487 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.731 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo . . . . . 0 C--O 1.236 0.406 0 C-N-CA 122.673 2.249 . . . . 0.0 112.256 -179.877 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.601 0 N-CA-C 112.947 -0.061 . . . . 0.0 112.947 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 N--CA 1.462 -0.337 0 C-N-CA 122.782 2.321 . . . . 0.0 111.237 179.575 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' D' ' 204' ' ' PRO . . . . . . . . 0 N--CA 1.449 -0.491 0 CA-C-O 120.143 -0.254 . . . . 0.0 112.467 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo . . . . . 0 CA--C 1.53 0.315 0 C-N-CA 122.979 2.452 . . . . 0.0 111.675 179.287 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.785 0 N-CA-C 112.094 -0.403 . . . . 0.0 112.094 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.78 141.47 65.74 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.848 2.366 . . . . 0.0 111.545 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -68.47 144.7 54.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.213 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' D' ' 210' ' ' PRO . . . -61.24 154.16 37.9 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.806 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.463 ' O ' ' HG3' ' D' ' 211' ' ' GLN . 1.4 mp -67.59 148.94 11.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.34 151.23 46.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.362 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' D' ' 213' ' ' ILE . . . -69.84 157.03 53.54 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.332 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -72.51 148.44 45.04 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -66.08 148.34 51.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 0.0 110.825 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' D' ' 216' ' ' GLN . . . -67.44 159.88 49.84 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.996 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.6 t -70.78 153.72 8.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.626 0.251 . . . . 0.0 110.481 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 11.9 t -58.95 145.47 10.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.454 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.87 161.51 52.89 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.127 -0.559 . . . . 0.0 113.062 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 C--N 1.326 -0.455 0 N-CA-C 110.573 -0.158 . . . . 0.0 110.573 179.859 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.652 0 N-CA-C 112.233 -0.347 . . . . 0.0 112.233 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 C--O 1.238 0.484 0 C-N-CA 122.653 2.236 . . . . 0.0 111.709 179.952 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.62 0 N-CA-C 112.444 -0.262 . . . . 0.0 112.444 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 C--O 1.237 0.441 0 C-N-CA 122.515 2.143 . . . . 0.0 111.482 179.65 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.467 0 N-CA-C 113.982 0.353 . . . . 0.0 113.982 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo . . . . . 0 CA--C 1.533 0.432 0 C-N-CA 123.053 2.502 . . . . 0.0 111.507 179.472 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.554 0 N-CA-C 112.94 -0.064 . . . . 0.0 112.94 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 N--CA 1.463 -0.285 0 C-N-CA 123.162 2.575 . . . . 0.0 111.804 179.93 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.659 -0.176 . . . . 0.0 112.659 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo . . . . . 0 C--O 1.236 0.386 0 C-N-CA 122.932 2.421 . . . . 0.0 111.931 179.712 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 113.281 0.072 . . . . 0.0 113.281 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo . . . . . 0 CA--C 1.533 0.434 0 C-N-CA 123.156 2.57 . . . . 0.0 112.367 -179.866 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.444 0 N-CA-C 112.22 -0.352 . . . . 0.0 112.22 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 N--CA 1.464 -0.223 0 C-N-CA 122.647 2.232 . . . . 0.0 111.052 179.543 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 113.567 0.187 . . . . 0.0 113.567 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -61.5 154.1 61.76 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 123.042 2.495 . . . . 0.0 113.109 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -62.79 137.52 58.29 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.617 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.24 154.74 44.23 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.34 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 41.4 mt -70.4 137.56 23.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 122.762 -0.258 . . . . 0.0 110.363 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.1 147.48 47.3 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.526 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -65.19 155.95 48.53 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.843 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -82.72 158.67 22.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.651 0.262 . . . . 0.0 110.573 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -64.69 145.18 56.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.399 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.59 172.78 34.87 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.669 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 30.3 t -67.78 141.78 17.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.642 0.258 . . . . 0.0 110.81 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 120' ' ' VAL . . . . . 0.41 HG13 ' HB ' ' D' ' 219' ' ' VAL . 60.5 t -62.69 139.08 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.967 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.18 158.06 39.05 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 121.203 -0.523 . . . . 0.0 112.68 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 97.1 mt . . . . . 0 C--N 1.323 -0.557 0 CA-C-O 120.553 0.216 . . . . 0.0 110.546 -179.914 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 113.252 0.061 . . . . 0.0 113.252 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo . . . . . 0 C--O 1.236 0.415 0 C-N-CA 122.8 2.333 . . . . 0.0 111.832 179.949 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.676 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 N--CA 1.462 -0.336 0 C-N-CA 122.523 2.149 . . . . 0.0 110.742 179.34 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.425 0 N-CA-C 114.34 0.496 . . . . 0.0 114.34 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo . . . . . 0 C--O 1.233 0.233 0 C-N-CA 123.611 2.874 . . . . 0.0 111.926 179.995 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 133' ' ' GLY . . . . . 0.429 ' HA2' ' HD3' ' C' ' 134' ' ' PRO . . . . . . . . 0 CA--C 1.519 0.286 0 N-CA-C 112.113 -0.395 . . . . 0.0 112.113 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 134' ' ' PRO . . . . . 0.429 ' HD3' ' HA2' ' C' ' 133' ' ' GLY . 20.6 Cg_exo . . . . . 0 C--O 1.235 0.332 0 C-N-CA 123.104 2.536 . . . . 0.0 112.061 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.49 0 CA-C-O 120.01 -0.328 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo . . . . . 0 C--N 1.346 0.419 0 C-N-CA 123.302 2.668 . . . . 0.0 112.069 178.902 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 114.102 0.401 . . . . 0.0 114.102 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 204' ' ' PRO . . . . . 0.47 ' O ' ' HA3' ' B' ' 6' ' ' GLY . 11.3 Cg_exo . . . . . 0 CA--C 1.534 0.497 0 C-N-CA 123.907 3.072 . . . . 0.0 112.172 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 113.404 0.122 . . . . 0.0 113.404 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo . . . . . 0 N--CA 1.458 -0.617 0 C-N-CA 123.905 3.07 . . . . 0.0 112.281 179.939 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.575 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 210' ' ' PRO . . . . . 0.502 ' O ' ' HA3' ' B' ' 12' ' ' GLY . 11.6 Cg_exo -70.04 156.42 62.66 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 122.762 2.308 . . . . 0.0 112.341 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 211' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' B' ' 13' ' ' ILE . 24.8 tt0 -76.61 147.15 37.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.441 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -69.2 165.31 49.4 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.35 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 213' ' ' ILE . . . . . 0.505 ' O ' ' HA3' ' B' ' 15' ' ' GLY . 10.8 pt -69.34 168.19 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 120.775 0.322 . . . . 0.0 111.141 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -83.18 146.46 28.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.951 0.405 . . . . 0.0 111.043 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -66.12 160.66 45.48 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.908 -0.587 . . . . 0.0 113.453 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 216' ' ' GLN . . . . . 0.481 ' O ' ' HA3' ' B' ' 18' ' ' GLY . 39.9 mm-40 -75.75 160.48 29.98 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -71.52 152.68 42.79 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -62.42 154.67 41.44 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.01 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 219' ' ' VAL . . . . . 0.41 ' HB ' HG13 ' C' ' 120' ' ' VAL . 10.7 t -62.28 142.43 16.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 30.8 t -61.45 137.91 22.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.258 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -59.37 154.56 29.81 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.673 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 5.6 mp . . . . . 0 C--N 1.321 -0.672 0 CA-C-O 120.479 0.181 . . . . 0.0 110.813 -179.594 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.84 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo . . . . . 0 C--O 1.236 0.391 0 C-N-CA 122.796 2.33 . . . . 0.0 111.811 179.661 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 112.705 -0.158 . . . . 0.0 112.705 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo . . . . . 0 C--O 1.236 0.408 0 C-N-CA 122.64 2.226 . . . . 0.0 111.34 179.688 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.404 0 N-CA-C 113.973 0.349 . . . . 0.0 113.973 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 CA--C 1.533 0.43 0 C-N-CA 122.937 2.424 . . . . 0.0 112.145 179.752 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo . . . . . 0 N--CA 1.48 0.727 0 N-CA-C 109.68 -0.931 . . . . 0.0 109.68 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -133.44 159.46 40.29 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 13.8 tt -78.71 -17.62 13.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.263 0.554 . . . . 0.0 110.923 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' CYS . . . . . 0.508 ' HA ' HD22 ' A' ' 502' ' ' LEU . 6.8 m -95.8 14.98 21.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.669 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -60.42 -40.55 91.42 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.039 0.447 . . . . 0.0 111.072 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 98.85 146.92 21.28 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.084 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 23.9 t30 54.81 91.87 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' PHE . . . . . 0.418 ' HD1' ' HD3' ' A' ' 337' ' ' LYS . 47.4 m-85 -91.74 165.59 13.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.289 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -71.45 -41.56 69.28 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.579 HG22 ' HB2' ' A' ' 336' ' ' PHE . 1.2 t -167.6 149.77 5.76 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.354 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 90.6 t -134.33 123.98 44.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -147.88 176.53 10.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.812 0.339 . . . . 0.0 110.903 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 38.3 ttp -128.96 119.98 25.28 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 41.6 mt -119.98 125.89 49.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.301 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 330' ' ' ARG . 5.9 mmp_? 64.1 20.56 12.24 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.521 0.513 . . . . 0.0 111.183 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 91.31 1.44 72.05 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.875 -0.678 . . . . 0.0 111.857 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . 0.431 ' CD ' ' HE ' ' A' ' 343' ' ' ARG . 12.0 mm-40 -105.97 124.78 50.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.75 0.31 . . . . 0.0 110.597 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 36.4 ttm -78.67 114.87 17.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.855 0.359 . . . . 0.0 111.109 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -106.37 126.57 52.41 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.14 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 39.2 t -109.48 118.88 57.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.441 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' PHE . . . . . 0.579 ' HB2' HG22 ' A' ' 325' ' ' THR . 81.3 m-85 -104.29 130.54 52.1 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.809 0.338 . . . . 0.0 111.548 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 0.703 ' HB3' ' HZ3' ' A' ' 342' ' ' TRP . 17.7 ttpp -150.94 116.19 5.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.055 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 65.28 -119.96 0.39 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.14 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.3 ptm85 -109.56 13.61 23.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.962 0.411 . . . . 0.0 111.847 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 17.2 m-90 -129.62 152.7 48.85 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.588 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -129.77 147.49 51.55 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.973 0.416 . . . . 0.0 110.866 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' TRP . . . . . 0.703 ' HZ3' ' HB3' ' A' ' 337' ' ' LYS . 26.5 m-90 -119.2 169.26 10.11 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.263 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.431 ' HE ' ' CD ' ' A' ' 332' ' ' GLU . 0.0 OUTLIER -147.45 109.48 4.48 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.111 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.54 HG11 ' HA ' ' A' ' 506' ' ' MET . 1.1 m -99.94 122.88 52.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.105 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 21.1 ttm-85 -117.94 102.12 8.81 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 66.6 t30 66.72 51.87 1.02 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.5 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . 0.537 ' HA ' ' O ' ' A' ' 505' ' ' TRP . 9.1 m120 69.2 1.7 3.34 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.242 -0.89 . . . . 0.0 113.317 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -118.71 127.73 53.84 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.963 0.411 . . . . 0.0 112.019 -179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 20.0 t -74.24 123.68 30.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.218 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 72.3 mtp -68.29 167.4 14.5 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -74.73 153.64 38.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.712 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 95.23 7.47 59.43 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.887 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' TYR . . . . . 0.43 ' HA ' ' C ' ' A' ' 354' ' ' PRO . 85.8 m-85 -122.71 153.93 63.36 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.43 ' C ' ' HA ' ' A' ' 353' ' ' TYR . 55.2 Cg_endo -70.3 143.32 74.52 Favored 'Cis proline' 0 C--N 1.345 0.349 0 C-N-CA 123.545 -1.44 . . . . 0.0 112.598 0.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 58.0 ttm -116.68 131.83 23.7 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.554 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.7 138.39 82.87 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.588 2.192 . . . . 0.0 111.41 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 78.4 mt -56.57 -46.6 82.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.34 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -73.07 3.04 31.61 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 121.175 -0.536 . . . . 0.0 113.85 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' GLN . . . . . 0.674 HE21 ' HA ' ' A' ' 359' ' ' GLN . 0.0 OUTLIER -87.38 -37.2 17.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.326 0.563 . . . . 0.0 110.42 179.386 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -106.67 -44.86 4.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.446 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 62.2 m95 -89.8 74.22 7.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.315 0.578 . . . . 0.0 110.122 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -62.23 103.63 0.41 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.173 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 120.98 -14.24 9.64 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.103 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.559 HD12 ' HD2' ' A' ' 365' ' ' PRO . 24.0 tp -93.38 133.85 27.75 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.744 0.306 . . . . 0.0 110.562 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' PRO . . . . . 0.559 ' HD2' HD12 ' A' ' 364' ' ' LEU . 93.9 Cg_endo -82.85 177.62 6.66 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.642 2.228 . . . . 0.0 111.585 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -86.86 160.61 18.68 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.781 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 54.8 m 53.57 79.87 0.12 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 23.0 pt -94.86 -178.63 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.496 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -105.63 -47.0 4.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.724 0.297 . . . . 0.0 111.658 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . 0.728 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.2 OUTLIER -152.85 163.45 39.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.746 0.308 . . . . 0.0 111.591 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -152.11 142.32 22.36 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . 0.636 ' HE1' ' HE1' ' A' ' 382' ' ' PHE . 17.5 p90 -165.07 168.69 17.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.638 0.256 . . . . 0.0 111.546 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -95.09 126.51 40.47 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 378' ' ' LYS . 13.5 ptm180 -84.7 171.96 11.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.66 0.267 . . . . 0.0 111.005 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.616 ' HB3' ' HG2' ' A' ' 440' ' ' GLU . 84.1 tttt -66.8 -32.33 73.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.999 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -33.16 71.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.407 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 124.57 -20.92 6.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.476 -0.869 . . . . 0.0 113.928 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' LYS . . . . . 0.57 ' HD3' ' HB2' ' A' ' 391' ' ' ASP . 19.8 mttp -90.32 175.27 7.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 117.196 0.498 . . . . 0.0 112.27 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' PHE . . . . . 0.508 ' HE2' ' HA ' ' A' ' 392' ' ' GLU . 22.1 m-85 -99.2 140.29 33.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.318 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . 0.477 ' HB ' ' CE1' ' A' ' 372' ' ' TYR . 5.9 t -120.23 122.03 67.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.199 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -108.45 144.55 35.91 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.636 ' HE1' ' HE1' ' A' ' 372' ' ' TYR . 53.6 m-85 -127.5 141.16 51.73 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -151.76 103.56 2.95 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 414' ' ' LYS . . . 76.12 -115.27 4.42 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.268 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -113.95 10.59 17.63 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.791 0.329 . . . . 0.0 111.125 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -116.27 151.46 35.78 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.691 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' HIS . . . . . 0.431 ' CE1' ' HB2' ' A' ' 406' ' ' LEU . 29.8 p-80 -132.88 150.46 52.16 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.604 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' TRP . . . . . 0.438 ' CE2' ' HB3' ' A' ' 400' ' ' PRO . 18.6 m-90 -123.36 137.3 54.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.938 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 69.7 t -117.45 117.37 54.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.049 0.452 . . . . 0.0 109.883 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -113.48 124.68 52.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.731 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.57 ' HB2' ' HD3' ' A' ' 378' ' ' LYS . 24.8 t0 -91.48 84.62 5.57 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' GLU . . . . . 0.508 ' HA ' ' HE2' ' A' ' 379' ' ' PHE . 57.7 mm-40 70.19 -70.25 0.15 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.995 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -143.39 16.06 1.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.921 0.391 . . . . 0.0 110.787 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 1.1 m -126.25 121.07 31.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.787 0.327 . . . . 0.0 111.359 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 52.7 tp -75.34 127.84 34.06 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 2.4 mt-10 -61.65 127.35 88.6 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.655 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 50.1 Cg_exo -56.44 141.04 90.07 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.059 2.506 . . . . 0.0 112.368 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 92.53 16.26 49.99 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.252 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' TYR . . . . . 0.444 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 19.4 m-85 -112.66 163.21 18.46 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 110.712 -0.107 . . . . 0.0 110.712 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.444 ' HA ' ' HB3' ' A' ' 399' ' ' TYR . 74.5 Cg_endo -76.47 169.43 74.48 Favored 'Cis proline' 0 C--N 1.347 0.491 0 C-N-CA 123.682 -1.382 . . . . 0.0 112.678 0.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -131.6 166.6 21.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.492 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 0.739 ' HB2' ' HG2' ' A' ' 405' ' ' GLU . 16.9 m-70 -71.47 154.79 41.25 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 68.9 mt -60.98 -38.2 78.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.205 0.526 . . . . 0.0 109.799 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . 0.549 ' HB3' HG23 ' A' ' 412' ' ' THR . 50.2 pttt -66.7 -17.2 64.73 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.676 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.739 ' HG2' ' HB2' ' A' ' 402' ' ' HIS . 22.1 mm-40 -81.14 -23.79 38.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.921 0.391 . . . . 0.0 110.659 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . 0.431 ' HB2' ' CE1' ' A' ' 387' ' ' HIS . 49.0 tp -77.0 -43.87 33.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.08 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.444 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -155.91 146.23 13.73 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.852 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -77.24 126.31 30.73 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.625 0.25 . . . . 0.0 110.537 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.31 -0.93 46.76 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.383 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 40.6 mt -77.27 149.65 79.36 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 120.399 0.142 . . . . 0.0 111.025 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' PRO . . . . . 0.451 ' HG3' ' CE1' ' A' ' 436' ' ' TYR . 32.0 Cg_exo -58.96 112.53 1.24 Allowed 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.987 2.458 . . . . 0.0 112.201 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' THR . . . . . 0.549 HG23 ' HB3' ' A' ' 404' ' ' LYS . 0.0 OUTLIER -86.4 37.59 0.74 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.058 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -134.58 -56.7 0.84 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.271 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 384' ' ' GLY . 10.8 ptmt -173.32 166.41 4.8 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 122.335 0.254 . . . . 0.0 110.506 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 38.9 mm -121.85 130.37 74.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -86.47 -45.39 11.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.367 0.604 . . . . 0.0 109.678 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.728 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -158.15 157.57 32.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.745 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -141.64 123.61 15.38 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . 0.444 ' HB2' ' HB2' ' A' ' 466' ' ' SER . 28.2 tp -120.62 134.67 55.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.297 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -106.46 117.11 33.17 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.359 -0.382 . . . . 0.0 109.982 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' TRP . . . . . 0.714 ' HB2' ' HE1' ' A' ' 428' ' ' TYR . 4.5 t-105 -86.09 98.91 11.13 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.545 ' HB2' ' HD3' ' A' ' 423' ' ' PRO . 66.8 mtt -57.31 -52.49 73.87 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -178.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.545 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 68.2 Cg_exo -53.23 -27.88 39.9 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.839 2.359 . . . . 0.0 115.301 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' ASN . . . . . 0.626 ' OD1' ' HB3' ' A' ' 421' ' ' TRP . 23.1 p-10 -112.93 -24.49 9.5 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 83.49 38.15 11.2 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.213 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -122.95 146.68 47.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.756 0.313 . . . . 0.0 110.737 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' A' ' 438' ' ' PHE . 7.1 m -107.05 129.35 54.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.513 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' TYR . . . . . 0.714 ' HE1' ' HB2' ' A' ' 421' ' ' TRP . 86.0 m-85 -108.36 117.47 34.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.911 0.386 . . . . 0.0 111.02 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . 0.448 ' HB2' ' HB2' ' A' ' 436' ' ' TYR . 53.4 m-85 -101.79 122.47 44.03 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.745 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -98.94 129.03 45.24 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.973 0.416 . . . . 0.0 111.535 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -139.2 103.71 4.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.409 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 67.21 -110.76 3.65 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.124 -0.791 . . . . 0.0 111.124 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -115.89 16.25 16.22 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.098 0.475 . . . . 0.0 110.236 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -119.17 145.96 45.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.115 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' TYR . . . . . 0.481 ' CE1' ' HB2' ' A' ' 451' ' ' LYS . 5.4 p90 -125.48 131.44 52.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.966 0.412 . . . . 0.0 110.679 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' TYR . . . . . 0.451 ' CE1' ' HG3' ' A' ' 411' ' ' PRO . 14.3 m-85 -102.71 148.1 26.01 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.947 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -114.19 98.0 6.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.313 0.578 . . . . 0.0 109.457 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' PHE . . . . . 0.556 ' HB3' ' HB ' ' A' ' 427' ' ' THR . 78.8 t80 -81.73 134.32 35.44 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.649 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -104.72 103.49 13.13 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.882 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' GLU . . . . . 0.616 ' HG2' ' HB3' ' A' ' 375' ' ' LYS . 5.4 tp10 -48.94 -45.33 41.62 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -179.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -53.85 -66.26 0.42 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 74.2 mt -75.72 -14.83 60.34 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' ARG . . . . . 0.425 ' O ' ' HA2' ' A' ' 407' ' ' GLY . 22.6 mtp180 60.37 48.41 7.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.695 0.76 . . . . 0.0 110.782 -178.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -156.43 161.7 40.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.105 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 74.4 t -81.81 141.85 14.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -60.12 160.85 7.58 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.373 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.3 m -68.32 151.81 46.36 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.671 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 69.06 30.81 4.31 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.064 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -125.43 159.12 61.76 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.645 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -80.43 166.8 75.22 Favored 'Cis proline' 0 C--N 1.342 0.23 0 C-N-CA 123.504 -1.457 . . . . 0.0 112.592 0.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . 0.481 ' HB2' ' CE1' ' A' ' 435' ' ' TYR . 64.5 mttm -116.42 171.32 7.91 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.338 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -71.68 146.68 48.08 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.643 0.259 . . . . 0.0 110.651 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.1 tt -70.44 -8.41 10.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.83 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 454' ' ' LYS . 66.1 mmtt -60.68 -12.08 9.31 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.76 -31.96 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 456' ' ' TRP . . . . . 0.431 ' HB2' ' HB ' ' A' ' 459' ' ' ILE . 24.4 m95 -89.36 95.34 10.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.026 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.49 105.75 1.26 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 110.9 -4.31 28.91 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.044 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 456' ' ' TRP . 30.6 mm -91.93 128.03 47.36 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-O 121.096 0.474 . . . . 0.0 111.391 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 460' ' ' PRO . . . . . 0.451 ' HG3' ' CH2' ' A' ' 484' ' ' TRP . 88.5 Cg_endo -79.08 158.19 26.84 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.853 2.369 . . . . 0.0 111.699 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 30.0 mp0 -80.1 148.62 30.93 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.425 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.9 m 55.45 69.4 1.97 Allowed Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.1 -175.9 2.6 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.339 2.026 . . . . 0.0 111.773 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 7.2 tpp85 -144.65 32.63 1.16 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.338 0.589 . . . . 0.0 110.328 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 167.51 140.7 2.97 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 466' ' ' SER . . . . . 0.444 ' HB2' ' HB2' ' A' ' 419' ' ' LEU . 5.7 p -161.94 101.22 1.13 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.948 0.404 . . . . 0.0 109.959 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -130.19 135.56 48.3 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.047 0.451 . . . . 0.0 111.344 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 468' ' ' MET . . . . . 0.47 ' HA ' ' HA ' ' A' ' 475' ' ' THR . 47.3 ttm -86.96 142.3 28.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.954 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -71.8 164.59 54.13 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.911 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.54 -12.66 54.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.09 0.471 . . . . 0.0 111.587 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -83.17 -17.07 44.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.637 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 68.05 5.74 4.78 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 122.9 0.48 . . . . 0.0 111.911 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 35.1 t -104.5 -32.71 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.877 0.37 . . . . 0.0 111.13 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -117.8 138.05 52.33 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 475' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 468' ' ' MET . 90.6 m -120.82 133.08 55.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.409 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -104.8 129.58 53.06 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.197 0.522 . . . . 0.0 112.117 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -110.99 146.72 36.17 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.316 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -126.74 137.83 53.29 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -162.16 107.03 1.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.964 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 60.0 57.66 18.17 Favored Glycine 0 C--N 1.331 0.258 0 CA-C-N 115.998 -0.547 . . . . 0.0 113.401 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 481' ' ' ASN . . . . . 0.417 ' OD1' ' HG ' ' A' ' 502' ' ' LEU . 18.3 t30 73.24 -33.72 0.27 Allowed 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 482' ' ' LYS . . . . . 0.629 ' HB3' ' HB2' ' A' ' 498' ' ' PRO . 24.1 mtmt -78.66 136.54 37.49 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.048 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 483' ' ' TYR . . . . . 0.48 ' CE1' ' HB2' ' A' ' 499' ' ' LYS . 5.4 p90 -121.5 149.03 43.68 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.079 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 484' ' ' TRP . . . . . 0.471 ' CE2' ' HB3' ' A' ' 498' ' ' PRO . 23.0 m-90 -117.82 149.39 40.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.46 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -115.25 99.92 7.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.202 0.525 . . . . 0.0 109.787 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 486' ' ' PHE . . . . . 0.432 ' HA ' ' HA ' ' A' ' 493' ' ' VAL . 58.2 t80 -88.54 127.57 35.54 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.26 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -88.1 111.93 22.11 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -66.17 -23.94 66.56 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 36.4 tp60 -86.04 -25.95 25.63 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.902 0.382 . . . . 0.0 111.614 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -104.72 -14.47 15.55 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.0 tp 61.77 39.85 13.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.478 0.656 . . . . 0.0 110.189 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 51.3 tttt -154.23 148.97 26.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.589 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 486' ' ' PHE . 69.9 t -79.26 138.43 20.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.666 0.27 . . . . 0.0 110.401 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -62.21 153.03 76.83 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.161 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -75.56 150.94 36.5 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.749 2.3 . . . . 0.0 113.024 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 98.14 5.06 57.39 Favored Glycine 0 C--N 1.331 0.282 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.327 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . 0.737 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 67.6 m-85 -106.55 167.24 9.84 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 110.666 -0.124 . . . . 0.0 110.666 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . 0.737 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 87.6 Cg_endo -79.26 167.71 75.72 Favored 'Cis proline' 0 C--N 1.345 0.38 0 C-N-CA 123.72 -1.367 . . . . 0.0 112.756 0.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 499' ' ' LYS . . . . . 0.48 ' HB2' ' CE1' ' A' ' 483' ' ' TYR . 33.0 mtpt -125.73 154.82 41.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.988 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 2.7 m -72.36 111.95 8.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.494 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -62.23 -27.06 68.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.521 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 502' ' ' LEU . . . . . 0.508 HD22 ' HA ' ' A' ' 319' ' ' CYS . 36.3 mt -56.07 -44.23 78.72 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.58 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -89.28 -37.79 14.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.354 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.01 -39.51 83.18 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 505' ' ' TRP . . . . . 0.537 ' O ' ' HA ' ' A' ' 347' ' ' ASN . 15.4 m0 -122.02 -45.69 2.24 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 506' ' ' MET . . . . . 0.54 ' HA ' HG11 ' A' ' 344' ' ' VAL . 10.5 mmt -64.87 -29.01 69.94 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 86.98 28.21 26.5 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.898 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 508' ' ' CYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 509' ' ' PRO . 32.4 m -103.01 106.63 51.72 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 508' ' ' CYS . 6.2 Cg_exo -79.72 171.93 14.94 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 123.074 2.516 . . . . 0.0 111.59 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 5.3 m 60.55 52.1 4.76 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.375 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.369 -1.239 . . . . 0.0 111.562 179.783 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.611 0 N-CA-C 111.864 -0.494 . . . . 0.0 111.864 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo . . . . . 0 C--O 1.232 0.181 0 C-N-CA 122.769 2.313 . . . . 0.0 111.793 179.937 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' D' ' 201' ' ' PRO . . . . . . . . 0 N--CA 1.446 -0.675 0 N-CA-C 112.333 -0.307 . . . . 0.0 112.333 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 C--O 1.233 0.244 0 C-N-CA 122.799 2.333 . . . . 0.0 111.782 179.664 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' D' ' 204' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.572 0 N-CA-C 112.367 -0.293 . . . . 0.0 112.367 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo . . . . . 0 CA--C 1.532 0.404 0 C-N-CA 122.784 2.322 . . . . 0.0 111.484 179.372 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.791 0 N-CA-C 112.395 -0.282 . . . . 0.0 112.395 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.54 144.32 31.91 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.183 2.589 . . . . 0.0 111.785 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -73.6 148.79 42.57 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' D' ' 210' ' ' PRO . . . -61.72 153.52 40.66 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.459 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.521 ' O ' ' HG3' ' D' ' 211' ' ' GLN . 13.1 mt -70.88 150.06 9.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' C' ' 113' ' ' ILE . . . -63.29 149.2 46.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.378 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' D' ' 213' ' ' ILE . . . -66.67 170.26 32.36 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.219 -0.515 . . . . 0.0 113.293 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -72.62 141.78 48.35 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' B' ' 17' ' ' ARG . 0.0 OUTLIER -65.58 141.18 58.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.645 -179.69 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.02 150.3 40.12 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.763 -0.653 . . . . 0.0 113.139 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 5.3 t -71.65 146.29 11.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 45.6 t -55.43 144.95 6.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.09 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.1 162.86 51.31 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.159 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 86.1 mt . . . . . 0 C--N 1.323 -0.56 0 CA-C-N 115.619 -0.291 . . . . 0.0 110.429 -179.869 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.503 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo . . . . . 0 C--O 1.234 0.297 0 C-N-CA 122.722 2.281 . . . . 0.0 111.835 179.843 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.593 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 C--O 1.235 0.359 0 C-N-CA 122.695 2.263 . . . . 0.0 112.06 179.905 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.414 0 CA-C-O 120.528 -0.04 . . . . 0.0 113.164 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.501 ' O ' ' HA3' ' C' ' 130' ' ' GLY . 11.8 Cg_exo . . . . . 0 C--O 1.234 0.321 0 C-N-CA 123.217 2.611 . . . . 0.0 111.493 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . 0.472 ' HA2' ' HD3' ' B' ' 34' ' ' PRO . . . . . . . . 0 N--CA 1.449 -0.448 0 N-CA-C 114.217 0.447 . . . . 0.0 114.217 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . 0.472 ' HD3' ' HA2' ' B' ' 33' ' ' GLY . 7.0 Cg_exo . . . . . 0 N--CA 1.461 -0.391 0 C-N-CA 123.413 2.742 . . . . 0.0 111.303 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 CA-C-O 119.999 -0.334 . . . . 0.0 112.666 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo . . . . . 0 C--N 1.345 0.389 0 C-N-CA 123.047 2.498 . . . . 0.0 112.357 179.928 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 112.127 -0.389 . . . . 0.0 112.127 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo . . . . . 0 CA--C 1.531 0.343 0 C-N-CA 123.488 2.792 . . . . 0.0 112.313 -179.78 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.597 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 CA--C 1.528 0.203 0 C-N-CA 122.553 2.168 . . . . 0.0 110.65 179.201 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.53 0 N-CA-C 114.779 0.672 . . . . 0.0 114.779 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.93 167.6 25.51 Favored 'Trans proline' 0 C--O 1.238 0.475 0 C-N-CA 122.958 2.438 . . . . 0.0 112.345 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -60.76 142.25 56.12 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.124 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -73.74 160.88 53.8 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.892 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' B' ' 14' ' ' ALA . 33.0 mt -68.45 141.15 17.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.733 0.301 . . . . 0.0 110.713 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.19 153.73 41.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.681 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -63.29 161.18 34.63 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.574 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -84.11 153.83 23.51 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 117' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' C' ' 117' ' ' ARG . 11.8 ttm180 -65.55 141.44 58.45 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.81 168.33 32.47 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.179 -0.534 . . . . 0.0 113.035 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 24.1 t -71.0 140.12 18.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 120' ' ' VAL . . . . . 0.435 HG13 ' HB ' ' D' ' 219' ' ' VAL . 24.2 t -65.77 131.79 31.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.095 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.84 158.73 36.7 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.883 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 13.4 mt . . . . . 0 C--N 1.326 -0.418 0 CA-C-O 120.473 0.178 . . . . 0.0 110.885 -179.748 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.626 0 N-CA-C 112.548 -0.221 . . . . 0.0 112.548 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo . . . . . 0 C--O 1.236 0.392 0 C-N-CA 122.532 2.155 . . . . 0.0 111.459 179.528 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.456 0 N-CA-C 112.627 -0.189 . . . . 0.0 112.627 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo . . . . . 0 C--O 1.234 0.304 0 C-N-CA 122.551 2.168 . . . . 0.0 111.452 -179.865 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 130' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' B' ' 31' ' ' PRO . . . . . . . . 0 N--CA 1.45 -0.388 0 CA-C-O 120.69 0.05 . . . . 0.0 113.139 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo . . . . . 0 C--N 1.343 0.256 0 C-N-CA 122.77 2.313 . . . . 0.0 111.306 179.776 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 112.354 -0.298 . . . . 0.0 112.354 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo . . . . . 0 CA--C 1.53 0.321 0 C-N-CA 122.563 2.175 . . . . 0.0 111.361 179.683 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 201' ' ' PRO . . . . . 0.476 ' O ' ' HA3' ' B' ' 3' ' ' GLY . 42.2 Cg_exo . . . . . 0 C--N 1.345 0.365 0 C-N-CA 123.092 2.528 . . . . 0.0 111.774 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.405 0 N-CA-C 114.713 0.645 . . . . 0.0 114.713 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 204' ' ' PRO . . . . . 0.439 ' O ' ' HA3' ' B' ' 6' ' ' GLY . 11.6 Cg_exo . . . . . 0 CA--C 1.53 0.29 0 C-N-CA 123.593 2.862 . . . . 0.0 111.599 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 206' ' ' GLY . . . . . 0.4 ' HA2' ' HD3' ' D' ' 207' ' ' PRO . . . . . . . . 0 N--CA 1.449 -0.441 0 N-CA-C 113.219 0.048 . . . . 0.0 113.219 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 207' ' ' PRO . . . . . 0.4 ' HD3' ' HA2' ' D' ' 206' ' ' GLY . 1.2 Cg_endo . . . . . 0 CA--C 1.533 0.453 0 C-N-CA 123.51 2.806 . . . . 0.0 112.453 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.506 0 N-CA-C 112.345 -0.302 . . . . 0.0 112.345 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 210' ' ' PRO . . . . . 0.536 ' O ' ' HA3' ' B' ' 12' ' ' GLY . 7.1 Cg_exo -72.71 155.22 54.27 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.875 2.383 . . . . 0.0 112.005 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 211' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' B' ' 13' ' ' ILE . 27.3 tt0 -75.46 146.52 40.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.504 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -66.79 163.56 43.96 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.757 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 213' ' ' ILE . . . . . 0.444 ' O ' ' HA3' ' B' ' 15' ' ' GLY . 44.2 pt -69.94 168.47 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 120.858 0.361 . . . . 0.0 111.236 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -74.82 153.6 38.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.478 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -79.68 155.43 39.27 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.907 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -72.3 146.62 47.04 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.573 0.225 . . . . 0.0 110.41 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -65.1 155.47 34.72 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.739 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -65.75 153.99 51.11 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.793 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 219' ' ' VAL . . . . . 0.435 ' HB ' HG13 ' C' ' 120' ' ' VAL . 14.6 t -69.07 149.39 11.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 48.4 t -68.66 141.31 17.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -62.06 161.35 29.22 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.854 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 C--N 1.327 -0.371 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.88 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.51 0 CA-C-O 120.316 -0.158 . . . . 0.0 112.89 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo . . . . . 0 C--O 1.234 0.322 0 C-N-CA 122.626 2.217 . . . . 0.0 111.061 179.418 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 227' ' ' GLY . . . . . 0.412 ' HA2' ' HD3' ' D' ' 228' ' ' PRO . . . . . . . . 0 N--CA 1.45 -0.383 0 N-CA-C 113.747 0.259 . . . . 0.0 113.747 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 228' ' ' PRO . . . . . 0.412 ' HD3' ' HA2' ' D' ' 227' ' ' GLY . 13.6 Cg_exo . . . . . 0 C--O 1.234 0.294 0 C-N-CA 123.14 2.56 . . . . 0.0 111.271 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.669 0 N-CA-C 112.988 -0.045 . . . . 0.0 112.988 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo . . . . . 0 N--CA 1.459 -0.544 0 C-N-CA 122.869 2.379 . . . . 0.0 111.689 179.55 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo . . . . . 0 N--CA 1.479 0.655 0 N-CA-C 110.045 -0.79 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -105.82 151.98 23.81 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 21.1 tt -66.58 -31.74 54.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.822 0.344 . . . . 0.0 110.808 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' CYS . . . . . 0.427 ' HA ' HD22 ' A' ' 502' ' ' LEU . 57.7 m -75.72 -0.53 21.17 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.056 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -69.51 -27.24 65.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.87 0.367 . . . . 0.0 110.686 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 84.62 -176.6 51.16 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.951 -0.643 . . . . 0.0 113.121 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 6.4 t30 57.22 77.37 0.27 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.44 0.696 . . . . 0.0 112.671 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -96.9 148.32 23.07 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.661 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . 0.411 ' OD1' ' HA ' ' A' ' 337' ' ' LYS . 2.5 m-20 -70.55 -42.4 71.21 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 1.9 t -167.95 155.16 8.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.687 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 72.9 t -133.62 127.89 53.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -144.18 164.75 29.81 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.683 0.278 . . . . 0.0 110.9 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 36.4 ttp -122.14 105.55 10.36 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 28.8 mt -103.5 128.01 50.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.183 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.54 17.59 7.51 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.706 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 95.59 -4.54 66.51 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.184 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -97.49 126.9 43.04 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.613 0.244 . . . . 0.0 110.415 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 39.1 tpp -77.56 117.3 18.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.062 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -113.33 119.95 39.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.047 0.451 . . . . 0.0 110.974 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . 0.435 ' HB ' ' HB2' ' A' ' 342' ' ' TRP . 21.1 t -103.24 117.44 48.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -103.99 129.82 51.61 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 0.635 ' HB3' ' HZ3' ' A' ' 342' ' ' TRP . 83.3 tttt -147.13 122.12 10.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.268 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 60.12 -105.82 0.24 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.274 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 339' ' ' ARG . 10.0 ptm85 -125.58 18.63 8.08 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.019 0.437 . . . . 0.0 111.401 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 20.3 m-90 -130.3 152.92 49.19 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.888 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -132.77 141.95 48.77 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.208 0.527 . . . . 0.0 111.62 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' TRP . . . . . 0.635 ' HZ3' ' HB3' ' A' ' 337' ' ' LYS . 24.9 m-90 -111.17 159.54 17.77 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.902 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.37 106.25 6.6 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.428 HG11 ' HA ' ' A' ' 506' ' ' MET . 6.7 m -101.08 142.58 15.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.343 0.592 . . . . 0.0 111.667 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -133.11 100.57 4.91 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.478 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 59.04 67.06 0.96 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.698 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . 0.493 ' HA ' ' O ' ' A' ' 505' ' ' TRP . 4.8 t-20 54.54 43.77 29.77 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -162.54 140.5 8.46 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 26.3 t -91.28 135.04 27.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 24.9 ttt -75.79 151.45 37.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.222 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.94 159.88 32.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.025 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 90.7 2.82 71.94 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' TYR . . . . . 0.566 ' HB3' ' HA ' ' A' ' 354' ' ' PRO . 96.9 m-85 -123.5 162.94 37.46 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.723 -0.239 . . . . 0.0 110.369 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.566 ' HA ' ' HB3' ' A' ' 353' ' ' TYR . 56.6 Cg_endo -70.5 150.94 92.89 Favored 'Cis proline' 0 C--N 1.346 0.412 0 C-N-CA 123.764 -1.348 . . . . 0.0 112.675 -0.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 56.2 ttm -123.29 135.99 26.59 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.66 139.9 88.17 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.45 2.1 . . . . 0.0 110.982 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 77.8 mt -57.14 -45.18 84.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.549 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -70.39 -8.0 61.67 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 121.188 -0.53 . . . . 0.0 114.15 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.61 -24.07 25.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.363 0.581 . . . . 0.0 110.646 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -113.28 -54.4 2.62 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.228 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 68.0 m95 -85.34 79.08 9.62 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.979 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' A' ' 362' ' ' ARG . 37.3 ttp180 -60.37 101.47 0.13 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.241 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 122.42 -13.07 8.89 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.431 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 14.8 tp -90.0 131.41 39.24 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.783 0.325 . . . . 0.0 111.067 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -84.13 -167.18 0.42 Allowed 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.937 2.424 . . . . 0.0 112.478 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -93.27 149.15 21.44 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.825 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 8.3 m 58.34 93.92 0.03 OUTLIER 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 22.0 pt -105.54 172.09 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.57 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -98.95 -52.4 3.57 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.673 0.273 . . . . 0.0 111.583 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . 0.737 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.2 OUTLIER -150.3 165.85 31.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.614 0.245 . . . . 0.0 111.238 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 380' ' ' VAL . . . -152.59 141.44 21.08 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -156.85 153.26 27.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.885 0.374 . . . . 0.0 111.818 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -96.2 115.38 27.34 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -82.01 172.26 13.46 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -58.29 -30.49 66.68 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.902 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -69.03 -5.94 24.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.567 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 76.94 33.73 44.87 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.06 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' LYS . . . . . 0.614 ' HG2' ' HA ' ' A' ' 391' ' ' ASP . 82.3 mttt -126.82 150.43 49.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.675 0.274 . . . . 0.0 110.865 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -94.62 117.37 30.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.082 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 371' ' ' ALA . 10.9 t -102.88 120.73 53.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.427 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -109.71 133.59 52.96 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -112.83 141.51 46.56 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.095 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.644 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 59.6 tttp -149.23 98.78 2.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.758 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 414' ' ' LYS . . . 71.64 -111.09 3.48 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.417 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -111.39 4.99 19.4 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.972 0.415 . . . . 0.0 111.193 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -114.76 152.2 32.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.68 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 36.9 p-80 -135.54 149.57 49.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.582 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' TRP . . . . . 0.644 ' HZ3' ' HB3' ' A' ' 383' ' ' LYS . 21.8 m-90 -124.87 137.1 54.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.708 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 87.7 t -119.75 117.3 53.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.008 0.432 . . . . 0.0 110.624 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -103.33 119.82 39.61 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.593 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.614 ' HA ' ' HG2' ' A' ' 378' ' ' LYS . 14.0 t70 -94.78 102.92 14.81 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 68.25 -72.04 0.1 Allowed 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.684 0.615 . . . . 0.0 111.615 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -153.78 21.8 0.52 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.922 0.391 . . . . 0.0 110.551 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 57.9 m -137.83 132.93 33.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.981 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 30.3 tp -75.41 130.3 38.75 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . 0.494 ' HB2' ' CE1' ' A' ' 399' ' ' TYR . 50.3 mt-10 -56.07 144.11 60.48 Favored Pre-proline 0 C--O 1.234 0.289 0 CA-C-O 120.746 0.307 . . . . 0.0 111.003 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 8.2 Cg_exo -73.19 125.79 10.58 Favored 'Trans proline' 0 CA--C 1.528 0.216 0 C-N-CA 122.81 2.34 . . . . 0.0 111.868 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 114.16 14.32 9.24 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.994 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' TYR . . . . . 0.614 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 38.7 m-85 -109.6 163.28 17.44 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.529 0.165 . . . . 0.0 110.611 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.614 ' HA ' ' HB3' ' A' ' 399' ' ' TYR . 71.7 Cg_endo -76.92 157.88 97.09 Favored 'Cis proline' 0 C--N 1.346 0.398 0 C-N-CA 123.522 -1.449 . . . . 0.0 112.861 0.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -121.13 164.35 17.0 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.071 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 0.567 ' HB3' ' HG2' ' A' ' 404' ' ' LYS . 1.9 m-70 -76.01 149.64 37.53 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 59.7 mt -55.14 -34.1 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 121.285 0.564 . . . . 0.0 110.775 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . 0.567 ' HG2' ' HB3' ' A' ' 402' ' ' HIS . 19.8 pttp -68.34 -12.43 61.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.616 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.43 ' OE2' ' HG3' ' A' ' 404' ' ' LYS . 18.0 mm-40 -86.53 -19.2 29.83 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.065 0.459 . . . . 0.0 110.359 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 40.2 tp -80.39 -39.48 28.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.961 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -160.51 153.79 24.73 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.146 -1.026 . . . . 0.0 113.204 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.52 124.88 31.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.336 -0.432 . . . . 0.0 110.1 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.8 14.63 39.48 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 121.067 -0.587 . . . . 0.0 111.928 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 23.3 mt -89.67 147.29 37.38 Favored Pre-proline 0 C--N 1.322 -0.604 0 O-C-N 122.716 -0.285 . . . . 0.0 111.6 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -52.92 114.24 1.63 Allowed 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.146 2.564 . . . . 0.0 111.637 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.38 33.69 0.89 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.419 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -130.74 -52.67 1.07 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.868 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 384' ' ' GLY . 18.5 ptmt -176.31 172.94 2.2 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.374 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 38.0 mm -124.87 130.82 73.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 464' ' ' ARG . 14.6 m-20 -89.87 -52.52 4.94 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.234 0.54 . . . . 0.0 109.577 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.737 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -140.74 154.08 46.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.052 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -139.84 102.83 4.51 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 45.1 tp -108.04 128.57 54.79 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.829 0.347 . . . . 0.0 111.629 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -99.41 117.09 33.05 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' TRP . . . . . 0.429 ' HB3' ' OD1' ' A' ' 424' ' ' ASN . 8.5 t-105 -87.27 97.75 10.96 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.491 ' HB2' ' HD3' ' A' ' 423' ' ' PRO . 60.8 mtt -56.59 -50.76 85.98 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.491 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 84.7 Cg_exo -49.44 -33.29 29.36 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.717 2.278 . . . . 0.0 114.97 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' ASN . . . . . 0.429 ' OD1' ' HB3' ' A' ' 421' ' ' TRP . 41.5 p30 -111.62 -24.64 9.98 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 85.57 34.51 13.62 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.757 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 55.3 mttt -125.98 154.49 42.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.957 0.378 . . . . 0.0 110.777 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 15.4 m -105.97 135.03 48.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.018 0.437 . . . . 0.0 111.343 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -108.8 112.94 25.48 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.833 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -99.37 126.52 45.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.161 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' PHE . . . . . 0.595 ' HB2' ' HB3' ' A' ' 417' ' ' ALA . 64.4 m-85 -103.58 135.98 44.16 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.941 0.4 . . . . 0.0 111.212 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.406 ' HA ' ' HE ' ' A' ' 431' ' ' ARG . 2.8 tpm_? -146.0 107.01 4.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.863 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 70.11 -104.16 1.29 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.734 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -120.91 7.74 10.43 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.895 0.379 . . . . 0.0 110.683 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 48.9 mttm -120.72 153.2 37.28 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.676 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' TYR . . . . . 0.48 ' CE1' ' HB2' ' A' ' 451' ' ' LYS . 11.7 p90 -130.98 141.18 50.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.933 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -109.95 147.55 33.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.807 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -109.5 99.36 8.58 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -93.63 134.99 35.36 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.207 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -101.35 122.97 44.68 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.53 -31.19 72.3 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -80.81 -37.08 30.75 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 16.0 mt -89.1 -16.86 30.48 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 4.7 mtp-105 57.52 37.94 27.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.392 0.615 . . . . 0.0 111.299 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -153.31 167.53 29.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.329 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 88.5 t -90.1 144.22 9.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.913 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -64.55 153.17 39.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.261 0.553 . . . . 0.0 111.915 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . 0.519 ' O ' ' HB2' ' A' ' 448' ' ' GLU . 1.3 m -64.07 156.05 29.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.7 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 448' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 447' ' ' SER . 2.2 mm-40 77.69 -5.59 2.1 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.636 0.585 . . . . 0.0 111.891 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . 0.472 ' HE2' ' CE2' ' A' ' 435' ' ' TYR . 29.5 m-85 -98.41 161.05 26.57 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.361 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.42 160.43 95.32 Favored 'Cis proline' 0 C--O 1.234 0.304 0 C-N-CA 123.617 -1.409 . . . . 0.0 113.474 0.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . 0.497 ' HE2' ' O ' ' A' ' 448' ' ' GLU . 63.5 mmtt -112.46 169.75 8.66 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.563 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -73.03 140.69 47.44 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . 0.492 HG21 ' HG3' ' A' ' 461' ' ' GLU . 15.9 tt -66.69 -13.39 16.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.091 0.472 . . . . 0.0 110.912 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -63.53 -11.08 21.34 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 82.1 t -65.32 -31.26 53.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 29.0 m95 -87.69 87.34 7.35 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -58.42 109.36 0.76 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.888 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 110.04 -14.86 31.21 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.737 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 46.6 mm -88.76 125.93 61.26 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 120.722 0.296 . . . . 0.0 110.537 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.28 160.66 20.17 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.536 2.157 . . . . 0.0 111.704 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 461' ' ' GLU . . . . . 0.492 ' HG3' HG21 ' A' ' 453' ' ' ILE . 3.5 mp0 -71.67 149.52 45.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.096 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 462' ' ' SER . . . . . 0.442 ' N ' ' HD3' ' A' ' 463' ' ' PRO . 2.2 m 54.96 62.14 8.22 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 463' ' ' PRO . . . . . 0.591 ' O ' ' HB2' ' A' ' 417' ' ' ALA . 35.8 Cg_endo -96.04 100.93 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.966 2.444 . . . . 0.0 110.495 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 416' ' ' ASP . 7.4 ttm180 -77.17 78.24 3.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.225 0.536 . . . . 0.0 111.501 -179.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 149.55 120.22 1.02 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 466' ' ' SER . . . . . 0.414 ' OG ' ' HB1' ' A' ' 417' ' ' ALA . 26.2 p -154.88 127.48 7.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.726 0.298 . . . . 0.0 110.791 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 467' ' ' PHE . . . . . 0.486 ' CE2' ' HB2' ' A' ' 476' ' ' TYR . 14.7 p90 -155.22 146.21 22.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.772 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 47.6 ttm -98.07 142.64 29.52 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.933 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -69.5 162.36 52.11 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.065 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.86 0.37 5.89 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.41 -15.34 21.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.922 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 69.11 6.63 5.76 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 123.753 0.658 . . . . 0.0 111.869 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 58.3 t -104.51 -39.4 5.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.931 0.396 . . . . 0.0 111.166 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -110.91 135.49 51.36 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 66.4 m -118.02 137.49 52.85 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.749 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 476' ' ' TYR . . . . . 0.486 ' HB2' ' CE2' ' A' ' 467' ' ' PHE . 82.4 m-85 -113.51 139.88 48.6 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.11 0.481 . . . . 0.0 112.133 -178.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -121.14 148.04 44.75 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.927 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . 0.421 ' CE1' ' HA ' ' A' ' 481' ' ' ASN . 73.0 t80 -127.87 131.5 49.44 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.773 0.32 . . . . 0.0 111.371 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 479' ' ' LYS . . . . . 0.42 ' HB3' ' CZ3' ' A' ' 484' ' ' TRP . 77.7 tttt -157.62 117.06 3.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.513 178.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 61.6 47.7 88.95 Favored Glycine 0 CA--C 1.518 0.241 0 CA-C-N 115.878 -0.601 . . . . 0.0 113.667 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 481' ' ' ASN . . . . . 0.421 ' HA ' ' CE1' ' A' ' 478' ' ' TYR . 52.0 t30 70.81 -2.94 2.11 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -105.56 142.74 34.78 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -118.65 146.27 44.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.93 0.395 . . . . 0.0 111.587 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 484' ' ' TRP . . . . . 0.438 ' CE2' ' HB3' ' A' ' 498' ' ' PRO . 19.2 m-90 -117.7 148.27 42.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.465 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 54.0 tttt -115.67 105.0 12.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.211 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 486' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -97.1 129.58 44.49 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.679 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -91.45 114.31 26.81 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -63.71 -29.22 70.47 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -84.68 -11.63 55.5 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -118.76 -14.2 9.53 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 92.2 mt 59.4 36.04 23.17 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.314 0.578 . . . . 0.0 110.45 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 9.9 tttp -149.74 154.75 39.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.893 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 38.8 t -85.1 142.49 13.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -64.13 132.89 95.44 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.621 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.32 151.59 72.97 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.968 2.445 . . . . 0.0 112.363 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 92.6 16.03 50.66 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.208 -0.52 . . . . 0.0 111.977 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . 0.496 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 22.6 m-85 -115.42 166.03 12.96 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.832 -0.184 . . . . 0.0 110.814 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . 0.496 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 66.5 Cg_endo -84.66 176.9 29.77 Favored 'Cis proline' 0 C--N 1.347 0.499 0 C-N-CA 123.827 -1.322 . . . . 0.0 112.94 0.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -133.2 156.54 47.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.057 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 23.0 t -72.07 123.63 23.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.864 0.364 . . . . 0.0 110.843 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -65.21 -27.12 68.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.53 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 502' ' ' LEU . . . . . 0.467 HD23 ' HG3' ' A' ' 506' ' ' MET . 14.0 mt -62.28 -46.54 88.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.662 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -79.39 -40.22 30.63 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.493 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.98 -40.95 37.6 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -177.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 505' ' ' TRP . . . . . 0.493 ' O ' ' HA ' ' A' ' 347' ' ' ASN . 11.8 m0 -110.93 -49.13 3.05 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 506' ' ' MET . . . . . 0.467 ' HG3' HD23 ' A' ' 502' ' ' LEU . 9.4 mmt -64.97 -28.19 69.35 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -177.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 84.74 32.91 20.4 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.162 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 42.8 m -106.67 104.94 53.3 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.77 146.66 48.79 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.767 2.311 . . . . 0.0 111.713 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 8.0 m 54.34 76.82 0.22 Allowed 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.654 0.596 . . . . 0.0 111.031 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.135 0 CA-C-O 118.794 -1.004 . . . . 0.0 112.314 -179.143 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.871 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo . . . . . 0 C--N 1.344 0.34 0 C-N-CA 122.673 2.249 . . . . 0.0 112.316 179.87 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' D' ' 201' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.606 0 CA-C-O 120.47 -0.072 . . . . 0.0 112.986 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo . . . . . 0 CA--C 1.528 0.217 0 C-N-CA 122.849 2.366 . . . . 0.0 111.126 179.425 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.66 0 N-CA-C 112.335 -0.306 . . . . 0.0 112.335 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo . . . . . 0 CA--C 1.528 0.181 0 C-N-CA 122.905 2.403 . . . . 0.0 111.322 179.685 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.769 0 N-CA-C 113.415 0.126 . . . . 0.0 113.415 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -74.37 138.12 24.22 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.027 2.485 . . . . 0.0 112.001 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . 0.453 ' HG3' ' HG2' ' C' ' 110' ' ' PRO . 50.2 tt0 -67.18 152.14 46.29 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' D' ' 210' ' ' PRO . . . -57.16 148.58 32.71 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.519 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 18.2 mt -64.02 148.03 11.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.58 141.75 57.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.851 0.358 . . . . 0.0 110.14 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.38 158.99 48.24 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.196 -0.526 . . . . 0.0 113.223 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -67.75 148.5 51.18 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -72.94 146.78 45.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.799 0.333 . . . . 0.0 110.4 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' D' ' 216' ' ' GLN . . . -62.74 157.01 39.02 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.819 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 3.8 t -73.91 152.87 7.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 12.8 t -55.41 142.92 9.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.915 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.98 162.23 48.88 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.859 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 C--N 1.324 -0.531 0 CA-C-O 120.537 0.208 . . . . 0.0 111.165 -179.747 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 112.797 -0.121 . . . . 0.0 112.797 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo . . . . . 0 C--O 1.235 0.35 0 C-N-CA 122.711 2.274 . . . . 0.0 111.917 179.936 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.62 0 N-CA-C 112.24 -0.344 . . . . 0.0 112.24 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo . . . . . 0 C--O 1.235 0.352 0 C-N-CA 122.747 2.298 . . . . 0.0 112.003 -179.606 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' D' ' 228' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 113.716 0.246 . . . . 0.0 113.716 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo . . . . . 0 C--O 1.234 0.276 0 C-N-CA 123.289 2.659 . . . . 0.0 111.59 179.363 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.458 0 CA-C-O 120.417 -0.101 . . . . 0.0 112.872 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 CA--C 1.531 0.355 0 C-N-CA 122.779 2.319 . . . . 0.0 112.109 179.867 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.47 0 CA-C-O 120.323 -0.154 . . . . 0.0 113.189 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo . . . . . 0 C--N 1.343 0.287 0 C-N-CA 123.302 2.668 . . . . 0.0 111.735 179.867 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.655 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo . . . . . 0 N--CA 1.463 -0.303 0 C-N-CA 122.984 2.456 . . . . 0.0 112.04 -179.903 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.423 0 N-CA-C 112.419 -0.273 . . . . 0.0 112.419 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 C--O 1.223 -0.254 0 C-N-CA 122.745 2.296 . . . . 0.0 110.762 179.507 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.384 0 N-CA-C 113.484 0.154 . . . . 0.0 113.484 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 110' ' ' PRO . . . . . 0.453 ' HG2' ' HG3' ' B' ' 11' ' ' GLN . 34.4 Cg_endo -64.57 159.93 42.34 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 123.118 2.545 . . . . 0.0 112.324 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 111' ' ' GLN . . . . . 0.405 ' OE1' ' HG2' ' D' ' 210' ' ' PRO . 5.8 tp60 -58.23 136.68 57.35 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.035 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -66.86 160.05 48.43 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.726 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 62.3 mt -72.8 131.21 35.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.55 151.67 28.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.137 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -69.58 155.53 53.36 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.492 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -76.75 157.43 31.67 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -65.22 150.25 48.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.285 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.47 167.34 44.3 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.935 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 21.5 t -67.02 139.38 21.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.572 0.225 . . . . 0.0 110.474 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 28.6 t -64.46 138.18 23.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.372 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.27 159.44 40.97 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.99 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 81.2 mt . . . . . 0 C--N 1.322 -0.598 0 N-CA-C 110.519 -0.178 . . . . 0.0 110.519 179.921 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.415 0 N-CA-C 112.889 -0.085 . . . . 0.0 112.889 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 C--O 1.236 0.391 0 C-N-CA 122.466 2.11 . . . . 0.0 111.906 179.94 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.502 0 N-CA-C 112.783 -0.127 . . . . 0.0 112.783 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo . . . . . 0 C--O 1.237 0.465 0 C-N-CA 122.671 2.247 . . . . 0.0 111.58 179.584 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.475 0 N-CA-C 112.718 -0.153 . . . . 0.0 112.718 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo . . . . . 0 C--O 1.234 0.318 0 C-N-CA 122.628 2.219 . . . . 0.0 112.099 179.907 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 CA-C-O 120.105 -0.275 . . . . 0.0 112.418 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 CA--C 1.534 0.518 0 C-N-CA 123.195 2.597 . . . . 0.0 112.368 179.802 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.286 0 N-CA-C 112.405 -0.278 . . . . 0.0 112.405 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 201' ' ' PRO . . . . . 0.44 ' O ' ' HA3' ' B' ' 3' ' ' GLY . 38.1 Cg_exo . . . . . 0 C--N 1.345 0.35 0 C-N-CA 122.869 2.379 . . . . 0.0 111.502 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.505 0 N-CA-C 113.83 0.292 . . . . 0.0 113.83 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo . . . . . 0 CA--C 1.532 0.388 0 C-N-CA 123.823 3.015 . . . . 0.0 112.67 -179.936 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.373 0 N-CA-C 113.73 0.252 . . . . 0.0 113.73 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 N--CA 1.455 -0.782 0 C-N-CA 123.889 3.059 . . . . 0.0 112.682 179.8 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.385 0 CA-C-O 120.321 -0.155 . . . . 0.0 112.723 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 210' ' ' PRO . . . . . 0.561 ' O ' ' HA3' ' B' ' 12' ' ' GLY . 50.5 Cg_endo -71.96 155.99 56.81 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.731 2.288 . . . . 0.0 112.014 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -73.22 147.92 44.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.301 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -68.17 158.75 51.89 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.186 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 213' ' ' ILE . . . . . 0.446 ' H ' HG13 ' D' ' 213' ' ' ILE . 20.5 mt -60.05 142.67 15.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.786 0.327 . . . . 0.0 110.948 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -65.26 139.94 58.67 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.582 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -60.37 156.04 31.12 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.11 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 216' ' ' GLN . . . . . 0.488 ' O ' ' HA3' ' B' ' 18' ' ' GLY . 9.5 mm-40 -78.56 159.25 28.24 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -67.75 154.33 41.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.783 0.325 . . . . 0.0 110.784 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -64.47 160.12 40.72 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.913 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 15.9 t -70.02 144.15 14.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 39.3 t -61.55 142.7 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.95 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.84 160.7 37.5 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.757 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 82.1 mt . . . . . 0 C--N 1.322 -0.628 0 CA-C-N 115.823 -0.189 . . . . 0.0 110.741 179.938 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.668 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 C--O 1.235 0.337 0 C-N-CA 122.841 2.361 . . . . 0.0 111.595 179.576 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.461 0 N-CA-C 113.971 0.349 . . . . 0.0 113.971 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 228' ' ' PRO . . . . . 0.409 ' O ' ' HA3' ' B' ' 30' ' ' GLY . 97.3 Cg_endo . . . . . 0 N--CA 1.461 -0.388 0 C-N-CA 123.339 2.692 . . . . 0.0 111.339 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.652 0 N-CA-C 112.896 -0.082 . . . . 0.0 112.896 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo . . . . . 0 N--CA 1.462 -0.341 0 C-N-CA 122.614 2.209 . . . . 0.0 110.679 179.645 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.615 ' HB2' ' HH2' ' A' ' 342' ' ' TRP . 4.3 Cg_exo . . . . . 0 N--CA 1.474 0.361 0 N-CA-C 110.733 -0.526 . . . . 0.0 110.733 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -128.81 154.85 46.03 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . 0.419 HG12 ' HB3' ' A' ' 506' ' ' MET . 11.2 tt -73.65 -19.54 17.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.999 0.428 . . . . 0.0 112.08 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 62.1 m -90.94 1.72 56.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.724 0.297 . . . . 0.0 111.51 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.3 -44.68 74.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.191 0.519 . . . . 0.0 110.451 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' GLY . . . . . 0.533 ' HA2' HD21 ' A' ' 502' ' ' LEU . . . 93.28 -177.65 38.06 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.096 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 52.59 69.82 0.64 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.299 0.571 . . . . 0.0 111.634 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' PHE . . . . . 0.485 ' HD1' ' HB2' ' A' ' 337' ' ' LYS . 85.0 m-85 -87.24 156.36 19.69 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.682 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -65.35 -41.19 94.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.019 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 5.7 t -173.4 149.88 1.77 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.156 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.452 HG22 HG13 ' A' ' 335' ' ' VAL . 60.7 t -134.24 118.12 26.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -140.17 -172.18 3.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.843 0.354 . . . . 0.0 111.412 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 44.6 ttp -136.96 126.71 25.53 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.824 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 42.5 mt -120.92 119.93 34.01 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.313 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.17 17.82 9.54 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.14 0.576 . . . . 0.0 111.918 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 102.73 -9.2 55.28 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.154 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . 0.5 ' HB3' ' NH1' ' A' ' 343' ' ' ARG . 70.1 mm-40 -99.5 127.69 45.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.637 0.256 . . . . 0.0 110.66 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 44.5 ttm -77.28 137.23 38.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.95 0.405 . . . . 0.0 111.424 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -125.42 117.05 22.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.618 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . 0.452 HG13 HG22 ' A' ' 326' ' ' VAL . 33.3 t -107.7 114.61 46.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -99.15 129.33 45.39 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 0.485 ' HB2' ' HD1' ' A' ' 323' ' ' PHE . 50.9 tptt -139.27 102.47 4.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.774 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 63.33 -99.14 0.07 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.493 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -116.27 -0.56 12.58 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . 0.646 ' HD1' ' HA ' ' A' ' 356' ' ' PRO . 18.3 m0 -119.27 154.86 32.8 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.323 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -129.05 133.98 47.93 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.104 0.478 . . . . 0.0 110.83 178.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' TRP . . . . . 0.615 ' HH2' ' HB2' ' A' ' 316' ' ' PRO . 5.6 m-90 -102.28 153.48 19.95 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.686 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.597 ' HG3' ' CZ ' ' A' ' 353' ' ' TYR . 6.3 mmm180 -129.49 105.77 8.31 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.17 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -102.36 123.99 56.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.738 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -118.57 107.16 13.4 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.01 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 63.45 45.25 4.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.26 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 45.1 t30 66.34 32.54 7.64 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.075 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -139.64 142.8 37.0 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 24.7 t -81.79 130.65 35.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 74.7 mtp -74.97 166.32 23.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.034 0.445 . . . . 0.0 112.073 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -83.75 154.93 23.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.762 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 80.76 26.16 54.45 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.329 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 353' ' ' TYR . . . . . 0.597 ' CZ ' ' HG3' ' A' ' 343' ' ' ARG . 73.4 m-85 -135.22 162.57 56.7 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 122.97 -0.135 . . . . 0.0 110.644 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.583 ' HA ' ' HB3' ' A' ' 353' ' ' TYR . 70.7 Cg_endo -75.23 146.23 85.76 Favored 'Cis proline' 0 C--N 1.346 0.408 0 C-N-CA 123.754 -1.353 . . . . 0.0 112.948 0.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 56.3 ttm -114.57 140.96 25.92 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.188 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . 0.646 ' HA ' ' HD1' ' A' ' 340' ' ' TRP . 32.2 Cg_exo -61.32 140.94 90.99 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.275 1.983 . . . . 0.0 111.02 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 91.8 mt -55.7 -43.95 75.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.225 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -72.02 -6.71 64.85 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 121.052 -0.594 . . . . 0.0 113.434 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.39 -21.53 30.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.239 0.52 . . . . 0.0 110.087 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 360' ' ' PHE . . . . . 0.496 ' HE2' ' HB3' ' D' ' 211' ' ' GLN . 8.9 t80 -111.6 -55.42 2.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.789 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 65.1 m95 -91.27 83.62 5.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.366 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -63.32 105.35 0.73 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.264 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 116.55 -6.65 18.39 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.552 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.534 HD12 ' HD2' ' A' ' 365' ' ' PRO . 18.3 tp -91.68 131.4 35.92 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.703 0.287 . . . . 0.0 110.596 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' PRO . . . . . 0.534 ' HD2' HD12 ' A' ' 364' ' ' LEU . 86.4 Cg_endo -81.3 170.9 14.34 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.778 2.319 . . . . 0.0 111.371 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -80.59 153.49 28.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.704 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 15.7 m 56.68 84.07 0.09 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 16.8 pt -98.97 -174.07 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -134.29 -24.14 1.63 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . 0.931 ' HB ' ' HB2' ' A' ' 382' ' ' PHE . 4.8 m -141.83 145.92 35.25 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.555 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -153.58 131.46 11.67 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -163.53 165.28 23.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.888 0.375 . . . . 0.0 111.496 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -94.23 141.63 28.34 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' ARG . . . . . 0.534 ' HB2' ' OE2' ' A' ' 440' ' ' GLU . 12.2 ptm180 -97.2 -169.4 1.85 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.385 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -69.39 -34.43 74.51 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.645 0.979 . . . . 0.0 113.645 -177.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 44.7 p30 -83.02 -10.37 58.79 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 107.83 -6.2 35.12 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.669 -0.776 . . . . 0.0 113.241 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 17.4 mttp -76.54 164.24 26.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.906 0.353 . . . . 0.0 110.879 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -107.82 123.32 48.4 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -178.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 12.2 t -105.98 119.82 55.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.036 0.446 . . . . 0.0 110.446 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -106.18 143.38 34.38 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.508 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.931 ' HB2' ' HB ' ' A' ' 370' ' ' THR . 23.2 m-85 -124.1 138.26 54.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.069 0.461 . . . . 0.0 111.897 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -150.69 98.24 2.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.78 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 77.58 -111.94 3.38 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.618 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 402' ' ' HIS . 4.3 p-10 -113.09 6.9 17.81 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.685 0.278 . . . . 0.0 111.345 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -114.61 148.97 37.33 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.514 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -128.86 146.0 51.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.218 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' TRP . . . . . 0.407 ' CE2' ' HB3' ' A' ' 400' ' ' PRO . 16.4 m-90 -120.21 131.75 55.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.09 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 99.2 t -115.52 110.44 31.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.059 0.456 . . . . 0.0 109.972 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -102.68 128.18 49.49 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.613 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -99.35 103.15 14.94 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 71.89 -53.36 0.69 Allowed 'General case' 0 N--CA 1.469 0.519 0 O-C-N 123.663 0.602 . . . . 0.0 111.298 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -166.27 -29.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.844 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.37 138.8 32.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.814 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 27.9 tp -78.29 139.84 38.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.803 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 3.3 mt-10 -67.21 140.75 95.72 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.443 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 21.6 Cg_exo -67.77 147.4 75.22 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.715 2.276 . . . . 0.0 111.238 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 89.18 15.04 59.55 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.718 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' TYR . . . . . 0.502 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 50.1 m-85 -117.99 162.58 28.77 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.502 ' HA ' ' HB3' ' A' ' 399' ' ' TYR . 84.0 Cg_endo -76.74 164.44 87.43 Favored 'Cis proline' 0 C--N 1.345 0.375 0 C-N-CA 123.634 -1.402 . . . . 0.0 113.306 0.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . 0.402 ' HD3' ' HB3' ' A' ' 405' ' ' GLU . 39.3 mttp -130.68 163.41 27.29 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.167 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 0.585 ' HB2' ' HG2' ' A' ' 404' ' ' LYS . 4.6 m80 -73.22 159.87 32.8 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 33.0 mt -59.61 -31.78 47.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.344 0.592 . . . . 0.0 110.222 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . 0.585 ' HG2' ' HB2' ' A' ' 402' ' ' HIS . 20.4 pttp -69.38 -12.03 61.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.183 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.402 ' HB3' ' HD3' ' A' ' 401' ' ' LYS . 10.2 mm-40 -85.58 -21.95 28.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.971 0.415 . . . . 0.0 111.253 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 47.8 tp -76.51 -53.95 7.38 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.126 0.488 . . . . 0.0 110.25 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.466 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -151.54 157.64 27.32 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.127 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 38.2 ttt180 -86.68 130.18 34.58 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.798 0.333 . . . . 0.0 110.676 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 106.34 -5.93 38.78 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.797 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 66.7 mt -76.98 151.44 81.94 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 120.633 0.254 . . . . 0.0 111.235 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.27 131.44 44.96 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.907 2.404 . . . . 0.0 111.633 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.74 -7.45 33.83 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.848 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -87.12 -56.59 3.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.197 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . 0.477 ' O ' ' HD2' ' A' ' 431' ' ' ARG . 8.4 ptmt -175.42 173.74 2.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.955 0.407 . . . . 0.0 111.224 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 34.6 mm -125.4 130.67 72.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.341 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -89.11 -41.95 11.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.165 0.507 . . . . 0.0 110.532 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -163.64 164.4 24.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.903 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -148.73 127.25 12.36 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . 0.434 HD11 ' HB2' ' A' ' 468' ' ' MET . 24.9 tp -118.47 119.83 35.74 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.06 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -87.81 113.91 23.93 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' TRP . . . . . 0.507 ' HB3' ' OD1' ' A' ' 424' ' ' ASN . 4.2 t-105 -81.81 96.36 7.58 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.414 ' HB2' ' HD3' ' A' ' 423' ' ' PRO . 58.2 mtt -52.09 -51.21 73.62 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 86.5 Cg_exo -49.29 -57.25 2.47 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.681 2.254 . . . . 0.0 114.383 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' ASN . . . . . 0.507 ' OD1' ' HB3' ' A' ' 421' ' ' TRP . 37.1 p30 -84.29 -24.72 29.75 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 82.92 37.44 13.03 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 121.009 -0.615 . . . . 0.0 113.438 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -128.08 150.39 49.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 117.031 0.416 . . . . 0.0 110.913 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 2.0 m -101.04 127.01 47.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.035 0.445 . . . . 0.0 111.753 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -101.85 111.62 23.94 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.556 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . 0.408 ' HB2' ' HB2' ' A' ' 436' ' ' TYR . 69.3 m-85 -94.45 137.42 33.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.124 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -113.08 129.89 56.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.003 0.43 . . . . 0.0 111.321 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.477 ' HD2' ' O ' ' A' ' 414' ' ' LYS . 2.8 tpm_? -141.26 105.01 4.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.23 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 67.47 -108.88 2.62 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.073 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -114.39 13.09 17.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.835 0.35 . . . . 0.0 110.763 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . 0.524 ' HD3' ' HG2' ' A' ' 450' ' ' PRO . 97.2 mttt -123.62 151.46 42.98 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.276 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 435' ' ' TYR . . . . . 0.476 ' CE1' ' HB2' ' A' ' 451' ' ' LYS . 9.0 p90 -126.95 138.92 53.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.435 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 436' ' ' TYR . . . . . 0.408 ' HB2' ' HB2' ' A' ' 429' ' ' PHE . 9.5 m-85 -110.58 143.78 40.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.716 -178.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -109.35 99.5 8.74 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' PHE . . . . . 0.466 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 75.4 t80 -92.25 132.55 36.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.521 -178.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -106.8 113.38 26.83 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.621 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' GLU . . . . . 0.534 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 3.3 mm-40 -50.89 -52.43 41.93 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 -64.89 -14.35 59.43 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -178.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 47.9 mt -113.86 -7.77 13.18 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 47.3 40.67 10.92 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.599 0.714 . . . . 0.0 112.472 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -154.73 171.32 19.75 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.505 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.5 t -96.81 142.8 13.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.278 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.55 153.0 10.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.64 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 11.1 m -70.48 155.26 40.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.365 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 71.41 26.97 3.18 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.483 0.658 . . . . 0.0 110.918 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -123.72 164.47 28.64 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.094 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . 0.524 ' HG2' ' HD3' ' A' ' 434' ' ' LYS . 86.5 Cg_endo -79.85 155.68 88.2 Favored 'Cis proline' 0 C--N 1.344 0.34 0 C-N-CA 123.637 -1.401 . . . . 0.0 112.631 0.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . 0.476 ' HB2' ' CE1' ' A' ' 435' ' ' TYR . 64.6 mttm -106.78 171.84 7.14 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.853 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 452' ' ' ASN . . . . . 0.464 ' O ' HG23 ' A' ' 455' ' ' VAL . 18.3 t-20 -68.85 136.93 53.44 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.556 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 12.9 tt -67.72 -15.73 20.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.079 0.466 . . . . 0.0 111.381 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -67.07 -2.3 5.33 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 455' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 452' ' ' ASN . 71.6 t -62.62 -34.96 68.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 456' ' ' TRP . . . . . 0.474 ' HZ3' HD11 ' A' ' 491' ' ' LEU . 14.0 m95 -88.34 90.05 8.24 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -53.02 114.62 1.51 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.606 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 458' ' ' GLY . . . . . 0.403 ' HA3' ' HB ' ' A' ' 493' ' ' VAL . . . 113.25 -15.96 22.57 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.347 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 460' ' ' PRO . 45.8 mm -89.68 117.61 68.29 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.694 0.283 . . . . 0.0 111.083 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 460' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 459' ' ' ILE . 4.9 Cg_exo -79.2 153.24 24.49 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 123.088 2.525 . . . . 0.0 111.374 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -67.54 149.6 49.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.601 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.3 m 60.58 78.08 0.34 Allowed Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -88.05 -174.98 1.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.966 2.444 . . . . 0.0 111.481 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.79 9.6 3.34 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.108 0.48 . . . . 0.0 110.856 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 169.94 141.83 3.38 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 6.3 p -152.73 106.15 3.04 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -128.26 142.15 51.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.057 0.456 . . . . 0.0 111.605 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 468' ' ' MET . . . . . 0.434 ' HB2' HD11 ' A' ' 419' ' ' LEU . 47.9 ttm -95.44 134.63 38.05 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.556 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -67.08 163.22 45.39 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.018 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 1.4 m -66.46 -7.33 18.82 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.911 0.386 . . . . 0.0 111.346 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -84.94 -15.09 45.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.069 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 65.77 6.76 4.11 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 46.6 t -109.62 -40.09 4.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.738 0.304 . . . . 0.0 111.362 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -105.02 123.0 47.04 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 90.9 m -111.16 138.06 48.08 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -113.4 128.3 56.41 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -110.22 125.92 53.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.298 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -106.25 136.33 46.16 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 479' ' ' LYS . . . . . 0.519 ' HB3' ' CZ3' ' A' ' 484' ' ' TRP . 78.6 tttt -158.19 102.89 1.8 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.814 0.34 . . . . 0.0 111.89 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 57.63 72.33 0.61 Allowed Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 114.823 0.689 . . . . 0.0 114.823 178.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 69.62 -24.87 0.15 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -104.32 156.05 18.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.885 0.374 . . . . 0.0 111.63 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -133.29 147.04 51.89 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.107 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 484' ' ' TRP . . . . . 0.519 ' CZ3' ' HB3' ' A' ' 479' ' ' LYS . 10.5 m-90 -109.93 148.27 31.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.782 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -107.23 97.13 6.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.823 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 486' ' ' PHE . . . . . 0.409 ' CE1' ' HB3' ' A' ' 456' ' ' TRP . 88.1 t80 -91.61 124.81 36.04 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.973 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -92.52 117.36 29.86 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -68.15 -32.15 72.22 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -76.4 -26.44 55.56 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -102.92 -15.98 16.0 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.423 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.474 HD11 ' HZ3' ' A' ' 456' ' ' TRP . 4.1 tp 60.09 39.28 19.85 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.565 0.698 . . . . 0.0 110.641 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 31.2 tttp -159.31 149.19 18.85 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.255 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . 0.403 ' HB ' ' HA3' ' A' ' 458' ' ' GLY . 54.9 t -73.03 134.76 29.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.114 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -70.55 146.97 94.51 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.286 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.4 160.25 40.13 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.938 2.425 . . . . 0.0 112.781 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 87.21 17.25 59.4 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . 0.536 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 20.5 m-85 -128.4 166.82 21.72 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.431 -0.385 . . . . 0.0 110.39 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . 0.536 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 72.0 Cg_endo -74.5 167.94 78.51 Favored 'Cis proline' 0 C--N 1.346 0.425 0 C-N-CA 123.857 -1.309 . . . . 0.0 113.102 0.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -121.99 164.94 16.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.155 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 22.5 t -77.56 109.35 11.44 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.94 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -68.46 -25.37 64.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.988 0.423 . . . . 0.0 110.429 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 502' ' ' LEU . . . . . 0.533 HD21 ' HA2' ' A' ' 321' ' ' GLY . 74.1 mt -65.57 -26.74 67.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.747 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 503' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 503' ' ' ARG . 30.2 ttm105 -99.74 -40.82 7.56 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.091 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.96 -23.57 36.03 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -177.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -114.1 -48.09 2.91 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 506' ' ' MET . . . . . 0.419 ' HB3' HG12 ' A' ' 318' ' ' ILE . 11.5 mmt -77.53 -26.52 51.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.026 -178.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 83.15 26.42 44.37 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.208 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 60.4 m -98.21 110.42 56.12 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-O 120.719 0.295 . . . . 0.0 110.698 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.07 175.71 10.61 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.895 2.396 . . . . 0.0 112.07 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 6.9 m 66.55 15.63 10.17 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 CA-C-O 118.163 -1.354 . . . . 0.0 110.929 179.833 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.8 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo . . . . . 0 C--O 1.234 0.302 0 C-N-CA 122.503 2.135 . . . . 0.0 111.903 179.989 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.618 0 N-CA-C 112.439 -0.264 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo . . . . . 0 CA--C 1.53 0.297 0 C-N-CA 122.967 2.444 . . . . 0.0 110.331 179.673 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.47 0 N-CA-C 112.35 -0.3 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 CA--C 1.53 0.323 0 C-N-CA 122.961 2.441 . . . . 0.0 111.183 178.803 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.793 0 N-CA-C 111.712 -0.555 . . . . 0.0 111.712 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -58.07 135.4 68.3 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.804 2.336 . . . . 0.0 111.735 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . 0.419 ' HG3' ' HG2' ' C' ' 110' ' ' PRO . 62.0 tt0 -61.28 147.0 46.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.611 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' D' ' 210' ' ' PRO . . . -62.23 153.48 42.51 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.261 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.491 ' H ' HG13 ' B' ' 13' ' ' ILE . 2.4 mt -67.0 150.63 11.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 122.669 0.388 . . . . 0.0 110.577 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.21 145.39 49.68 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.29 156.04 50.91 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.766 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -66.25 141.72 57.93 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.456 ' HG3' ' HB3' ' C' ' 116' ' ' GLN . 15.1 ttt180 -65.61 148.5 51.64 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.656 0.265 . . . . 0.0 110.967 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' D' ' 216' ' ' GLN . . . -61.78 150.56 45.34 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 116.001 -0.545 . . . . 0.0 113.447 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.41 ' HB ' ' HG2' ' D' ' 217' ' ' ARG . 8.2 t -65.9 147.53 12.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.684 -0.258 . . . . 0.0 110.513 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 6.6 t -53.42 145.1 3.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.401 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.25 165.41 46.38 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.243 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 69.2 mt . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 115.793 -0.204 . . . . 0.0 110.969 -179.789 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.628 0 N-CA-C 112.411 -0.276 . . . . 0.0 112.411 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 C--O 1.234 0.313 0 C-N-CA 122.54 2.16 . . . . 0.0 111.668 179.713 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.584 0 CA-C-O 120.356 -0.135 . . . . 0.0 112.824 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 CA--C 1.533 0.428 0 C-N-CA 122.944 2.429 . . . . 0.0 111.823 179.609 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 113.302 0.081 . . . . 0.0 113.302 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo . . . . . 0 C--O 1.236 0.381 0 C-N-CA 123.134 2.556 . . . . 0.0 112.076 179.666 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . 0.465 ' HA2' ' HD3' ' B' ' 34' ' ' PRO . . . . . . . . 0 N--CA 1.445 -0.744 0 N-CA-C 112.787 -0.125 . . . . 0.0 112.787 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . 0.465 ' HD3' ' HA2' ' B' ' 33' ' ' GLY . 16.4 Cg_exo . . . . . 0 CA--C 1.529 0.251 0 C-N-CA 122.766 2.311 . . . . 0.0 110.909 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 100' ' ' GLY . . . . . 0.451 ' HA3' ' HD3' ' C' ' 101' ' ' PRO . . . . . . . . 0 N--CA 1.448 -0.507 0 N-CA-C 112.278 -0.329 . . . . 0.0 112.278 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 101' ' ' PRO . . . . . 0.451 ' HD3' ' HA3' ' C' ' 100' ' ' GLY . 6.9 Cg_exo . . . . . 0 N--CA 1.465 -0.189 0 C-N-CA 123.211 2.608 . . . . 0.0 111.738 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.449 0 N-CA-C 112.559 -0.216 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo . . . . . 0 C--O 1.235 0.33 0 C-N-CA 123.114 2.543 . . . . 0.0 112.361 -179.973 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.565 -0.214 . . . . 0.0 112.565 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo . . . . . 0 CA--C 1.528 0.185 0 C-N-CA 122.674 2.249 . . . . 0.0 111.549 179.934 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.382 0 N-CA-C 113.687 0.235 . . . . 0.0 113.687 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 110' ' ' PRO . . . . . 0.419 ' HG2' ' HG3' ' B' ' 11' ' ' GLN . 28.5 Cg_endo -62.44 150.04 88.78 Favored 'Trans proline' 0 C--O 1.237 0.425 0 C-N-CA 122.883 2.388 . . . . 0.0 112.524 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -55.84 134.72 52.02 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.951 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.23 160.77 26.74 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.799 -0.637 . . . . 0.0 113.277 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 53.4 mt -74.03 138.43 21.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 120.755 0.312 . . . . 0.0 110.231 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.19 146.39 55.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.899 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -63.79 156.08 44.04 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.448 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 116' ' ' GLN . . . . . 0.456 ' HB3' ' HG3' ' B' ' 17' ' ' ARG . 7.8 tt0 -75.04 159.06 32.19 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.64 0.257 . . . . 0.0 110.577 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 14.6 ttm-85 -68.72 146.65 52.76 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.67 168.21 36.2 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.024 -0.608 . . . . 0.0 113.158 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 4.3 t -75.51 144.98 11.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 92.6 t -61.57 139.11 21.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.516 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.28 167.3 40.15 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.701 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 82.5 mt . . . . . 0 C--N 1.322 -0.589 0 CA-C-O 120.478 0.18 . . . . 0.0 111.033 -179.717 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.612 0 N-CA-C 112.75 -0.14 . . . . 0.0 112.75 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo . . . . . 0 C--O 1.234 0.309 0 C-N-CA 122.685 2.257 . . . . 0.0 111.592 179.697 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.466 0 N-CA-C 112.913 -0.075 . . . . 0.0 112.913 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo . . . . . 0 C--O 1.236 0.412 0 C-N-CA 122.673 2.249 . . . . 0.0 111.427 -179.894 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 112.972 -0.051 . . . . 0.0 112.972 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo . . . . . 0 C--O 1.237 0.454 0 C-N-CA 122.739 2.293 . . . . 0.0 111.868 179.963 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 CA-C-O 120.13 -0.261 . . . . 0.0 113.072 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo . . . . . 0 C--N 1.343 0.282 0 C-N-CA 122.65 2.234 . . . . 0.0 111.78 179.563 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 112.173 -0.371 . . . . 0.0 112.173 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo . . . . . 0 C--N 1.347 0.461 0 C-N-CA 122.935 2.423 . . . . 0.0 111.743 179.954 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.497 0 CA-C-O 120.221 -0.211 . . . . 0.0 113.344 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo . . . . . 0 CA--C 1.532 0.407 0 C-N-CA 123.551 2.834 . . . . 0.0 112.824 -179.423 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.376 0 N-CA-C 113.394 0.118 . . . . 0.0 113.394 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo . . . . . 0 N--CA 1.456 -0.694 0 C-N-CA 123.743 2.962 . . . . 0.0 112.137 -179.834 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 CA-C-O 120.354 -0.136 . . . . 0.0 112.887 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 210' ' ' PRO . . . . . 0.408 ' O ' ' HA3' ' B' ' 12' ' ' GLY . 37.2 Cg_endo -66.6 160.0 48.19 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.785 2.323 . . . . 0.0 112.456 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 211' ' ' GLN . . . . . 0.496 ' HB3' ' HE2' ' A' ' 360' ' ' PHE . 62.5 tt0 -77.22 143.87 38.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.416 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -65.57 158.76 46.2 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.683 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 38.3 pt -67.01 151.42 10.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.893 0.377 . . . . 0.0 111.033 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -66.81 149.37 50.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.917 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -67.49 172.04 32.25 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 116.05 -0.523 . . . . 0.0 113.285 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 216' ' ' GLN . . . . . 0.481 ' O ' ' HA3' ' B' ' 18' ' ' GLY . 51.3 mm-40 -87.95 154.32 20.6 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 217' ' ' ARG . . . . . 0.41 ' HG2' ' HB ' ' B' ' 19' ' ' VAL . 27.5 mtp180 -62.88 151.98 37.64 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.763 0.316 . . . . 0.0 111.191 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -64.23 156.81 44.53 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.324 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 6.4 t -67.43 147.2 12.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 50.5 t -63.71 143.01 16.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.98 162.05 23.27 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.225 -0.512 . . . . 0.0 112.687 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 5.9 mp . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.872 -0.164 . . . . 0.0 110.914 -179.578 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.669 0 CA-C-O 120.298 -0.168 . . . . 0.0 113.055 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo . . . . . 0 C--O 1.232 0.18 0 C-N-CA 123.208 2.605 . . . . 0.0 111.843 179.698 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.614 0 N-CA-C 113.369 0.108 . . . . 0.0 113.369 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo . . . . . 0 N--CA 1.461 -0.4 0 C-N-CA 122.897 2.398 . . . . 0.0 111.362 179.603 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.662 0 N-CA-C 112.799 -0.12 . . . . 0.0 112.799 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo . . . . . 0 N--CA 1.458 -0.609 0 C-N-CA 122.577 2.185 . . . . 0.0 111.195 179.323 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo . . . . . 0 N--CA 1.477 0.508 0 N-CA-C 109.776 -0.894 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -119.84 155.51 32.47 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 10.5 tt -69.84 -17.93 21.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.007 0.432 . . . . 0.0 111.517 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 61.3 m -88.94 3.7 50.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.243 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -72.66 -38.71 67.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.016 0.436 . . . . 0.0 110.747 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' GLY . . . . . 0.465 ' O ' ' HE2' ' A' ' 337' ' ' LYS . . . 80.5 -164.85 47.61 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.309 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 51.51 56.18 8.29 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.211 0.529 . . . . 0.0 110.877 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -79.31 160.46 26.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.412 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -73.17 -36.25 66.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.897 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 8.9 t -177.62 149.22 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.207 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.507 HG22 HG13 ' A' ' 335' ' ' VAL . 91.4 t -129.4 124.19 59.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -148.6 -176.32 5.27 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.942 0.401 . . . . 0.0 111.299 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 24.3 ttp -128.89 133.88 48.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.801 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 79.7 mt -125.91 111.24 14.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.376 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.773 ' HG3' ' HE1' ' A' ' 379' ' ' PHE . 60.7 mtp180 58.24 33.06 22.79 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 102.82 -32.86 7.09 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.334 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -81.92 135.81 35.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.807 0.304 . . . . 0.0 111.24 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 44.9 ttm -90.54 124.53 35.09 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -114.49 129.85 56.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.091 0.472 . . . . 0.0 111.809 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . 0.507 HG13 HG22 ' A' ' 326' ' ' VAL . 13.7 t -114.56 128.45 71.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -109.63 139.46 44.63 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 0.465 ' HE2' ' O ' ' A' ' 321' ' ' GLY . 12.8 tptp -144.23 100.07 3.49 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.63 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 60.27 -104.46 0.19 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.13 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -110.47 8.77 23.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.588 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 15.3 m-90 -122.43 157.8 31.11 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -139.01 148.24 43.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.013 0.435 . . . . 0.0 111.351 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 4.2 m-90 -120.29 160.52 22.84 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.008 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.32 108.81 6.53 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 2.3 m -97.02 139.31 19.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.407 0.622 . . . . 0.0 111.96 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . 0.407 ' HD3' ' HA ' ' A' ' 345' ' ' ARG . 7.6 mmt180 -138.87 111.96 7.96 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.943 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 62.87 46.5 4.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.585 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 48.5 t30 63.81 27.56 14.61 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.758 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . 0.483 HE21 ' HB2' ' A' ' 348' ' ' GLN . 10.1 mt-30 -136.28 142.81 43.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.359 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 21.9 t -90.13 124.11 42.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 49.6 mtp -70.41 157.22 38.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.704 0.288 . . . . 0.0 111.035 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.32 158.76 34.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.024 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 95.16 -2.78 66.1 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.456 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 353' ' ' TYR . . . . . 0.416 ' HB3' ' HA ' ' A' ' 354' ' ' PRO . 70.1 m-85 -118.17 156.25 50.72 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.416 ' HA ' ' HB3' ' A' ' 353' ' ' TYR . 57.0 Cg_endo -71.07 137.6 47.74 Favored 'Cis proline' 0 C--N 1.345 0.389 0 C-N-CA 123.504 -1.457 . . . . 0.0 112.536 0.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 355' ' ' MET . . . . . 0.413 ' HA ' ' HD3' ' A' ' 356' ' ' PRO . 59.6 ttm -114.69 135.56 22.36 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.422 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 355' ' ' MET . 47.2 Cg_exo -58.86 138.0 83.16 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.369 2.046 . . . . 0.0 111.08 178.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 357' ' ' ILE . . . . . 0.403 HG23 ' HD1' ' A' ' 361' ' ' TRP . 74.3 mt -52.27 -40.36 30.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.257 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -66.55 -12.66 59.4 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 121.087 -0.577 . . . . 0.0 114.255 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -79.94 -17.37 53.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.037 0.419 . . . . 0.0 111.541 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -126.82 -55.36 1.39 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.006 0.432 . . . . 0.0 110.453 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 361' ' ' TRP . . . . . 0.403 ' HD1' HG23 ' A' ' 357' ' ' ILE . 48.4 m95 -86.99 76.82 9.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.319 0.581 . . . . 0.0 110.136 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -65.72 94.74 0.21 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.491 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 129.47 -12.68 5.97 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.162 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 365' ' ' PRO . 21.3 tp -88.81 127.5 55.83 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.805 0.336 . . . . 0.0 111.117 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 364' ' ' LEU . 3.3 Cg_exo -78.81 167.89 21.68 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.096 2.531 . . . . 0.0 111.793 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -73.18 152.86 40.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.223 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 5.7 m 57.65 86.88 0.07 Allowed 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 22.9 pt -95.44 179.97 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.329 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.36 -45.3 4.12 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 121.146 -0.222 . . . . 0.0 111.525 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . 0.771 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.0 OUTLIER -158.73 172.32 18.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.969 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -162.67 138.04 6.97 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . 0.454 ' CE1' ' HB ' ' A' ' 380' ' ' VAL . 11.2 p90 -150.47 162.29 40.87 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -96.78 117.69 31.6 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' ARG . . . . . 0.593 HH21 ' HB3' ' A' ' 440' ' ' GLU . 7.6 ptm180 -87.62 175.95 7.67 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -66.69 -16.97 64.6 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.616 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.22 -26.78 30.47 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.7 0.286 . . . . 0.0 111.675 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 114.87 -9.03 21.43 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.689 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' LYS . . . . . 0.525 ' HG2' ' HA ' ' A' ' 391' ' ' ASP . 76.6 mttt -94.98 164.88 12.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.908 0.385 . . . . 0.0 111.427 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' PHE . . . . . 0.773 ' HE1' ' HG3' ' A' ' 330' ' ' ARG . 10.9 m-85 -99.0 127.38 44.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.591 -179.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . 0.454 ' HB ' ' CE1' ' A' ' 372' ' ' TYR . 15.7 t -107.57 113.6 44.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.126 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . 0.402 ' HB2' ' HB2' ' A' ' 388' ' ' TRP . 61.9 m-85 -99.27 145.1 27.64 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.803 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -124.79 143.55 50.74 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.419 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.648 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 44.3 tttp -155.21 99.28 2.07 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 414' ' ' LYS . . . 75.08 -105.6 1.93 Allowed Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.539 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -119.42 7.74 11.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.937 0.399 . . . . 0.0 110.87 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -114.44 152.74 31.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.959 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -132.47 150.49 52.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.645 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' TRP . . . . . 0.648 ' HZ3' ' HB3' ' A' ' 383' ' ' LYS . 24.6 m-90 -127.53 138.96 53.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.105 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 75.3 t -117.38 115.67 49.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -106.49 126.04 51.76 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.525 ' HA ' ' HG2' ' A' ' 378' ' ' LYS . 21.2 t70 -91.88 84.68 5.4 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 177.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 69.85 -64.15 0.36 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.316 -178.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -145.51 -3.93 0.7 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 11.6 m -111.43 135.39 52.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.711 0.291 . . . . 0.0 111.284 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 62.3 tp -81.07 138.96 35.95 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.129 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 2.2 mm-40 -65.39 146.71 98.93 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.63 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 24.7 Cg_exo -65.48 148.11 87.47 Favored 'Trans proline' 0 C--O 1.238 0.496 0 C-N-CA 123.036 2.491 . . . . 0.0 112.663 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 73.19 45.08 32.65 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.626 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -128.25 159.04 69.27 Favored Pre-proline 0 C--N 1.321 -0.649 0 O-C-N 122.859 -0.201 . . . . 0.0 110.811 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.6 ' HB3' ' CE2' ' A' ' 388' ' ' TRP . 92.2 Cg_endo -77.6 156.61 95.78 Favored 'Cis proline' 0 C--O 1.236 0.397 0 C-N-CA 123.568 -1.43 . . . . 0.0 113.577 0.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -112.58 156.48 22.59 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 0.425 ' HB2' ' HG2' ' A' ' 405' ' ' GLU . 19.1 m-70 -72.11 156.96 38.62 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 78.2 mt -57.33 -39.28 67.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.943 0.401 . . . . 0.0 111.087 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -69.58 -7.53 39.44 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.425 ' HG2' ' HB2' ' A' ' 402' ' ' HIS . 10.8 mm-40 -87.32 -15.04 39.15 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 48.8 tp -86.36 -36.83 18.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.888 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.689 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -169.65 156.09 26.7 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.731 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -90.65 136.14 33.25 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.722 0.296 . . . . 0.0 110.75 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 102.18 4.83 50.39 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.426 -0.669 . . . . 0.0 111.426 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 88.9 mt -89.79 148.51 40.04 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 120.47 0.176 . . . . 0.0 111.014 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -58.0 119.24 6.37 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.696 2.264 . . . . 0.0 111.075 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.96 7.37 31.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.58 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -99.2 -54.99 2.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.82 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 384' ' ' GLY . 15.6 ptmt -175.53 169.69 3.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.561 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.448 HD12 ' HD2' ' A' ' 429' ' ' PHE . 46.2 mm -121.82 126.23 74.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . 0.424 ' HB3' ' HD2' ' A' ' 463' ' ' PRO . 15.4 m-20 -82.38 -43.7 17.04 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.895 0.378 . . . . 0.0 110.698 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.771 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -157.65 154.8 28.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.301 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -134.83 119.32 17.99 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 42.0 tp -115.17 117.97 32.03 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.872 0.368 . . . . 0.0 111.778 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -91.24 118.25 30.31 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.208 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' TRP . . . . . 0.731 ' HB2' ' HE2' ' A' ' 428' ' ' TYR . 15.6 t-105 -87.67 99.02 11.76 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.486 ' HB2' ' HD3' ' A' ' 423' ' ' PRO . 63.3 mtt -52.44 -52.57 62.12 Favored Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.486 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 86.6 Cg_exo -48.23 -40.34 35.01 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.898 2.399 . . . . 0.0 114.913 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' ASN . . . . . 0.514 ' OD1' ' HB3' ' A' ' 421' ' ' TRP . 39.6 p30 -103.09 -28.79 11.75 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 88.24 29.49 19.65 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.612 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -122.29 141.61 51.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.833 0.349 . . . . 0.0 110.589 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 60.1 m -103.17 130.03 50.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.419 0.628 . . . . 0.0 111.646 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 428' ' ' TYR . . . . . 0.731 ' HE2' ' HB2' ' A' ' 421' ' ' TRP . 65.7 m-85 -98.64 122.79 42.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.839 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . 0.448 ' HD2' HD12 ' A' ' 415' ' ' ILE . 43.1 m-85 -98.54 121.73 40.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.653 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -98.6 132.31 44.11 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.473 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.404 ' HD2' ' O ' ' A' ' 414' ' ' LYS . 3.4 tpm_? -145.07 107.14 4.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.205 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 69.71 -117.41 7.58 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' ASN . . . . . 0.51 ' HA ' ' HB3' ' A' ' 461' ' ' GLU . 24.6 p-10 -113.22 16.28 19.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.258 0.551 . . . . 0.0 110.712 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -125.89 150.51 47.86 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.366 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 435' ' ' TYR . . . . . 0.492 ' CE1' ' HB2' ' A' ' 451' ' ' LYS . 6.7 p90 -129.85 142.7 50.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.063 0.459 . . . . 0.0 111.457 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 436' ' ' TYR . . . . . 0.747 ' HD1' HG11 ' A' ' 445' ' ' VAL . 53.5 m-85 -109.09 147.57 32.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.428 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -107.14 94.74 5.26 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' PHE . . . . . 0.689 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 71.8 t80 -81.49 119.59 23.93 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.414 0.626 . . . . 0.0 112.068 -178.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -86.33 94.93 9.48 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 440' ' ' GLU . . . . . 0.593 ' HB3' HH21 ' A' ' 374' ' ' ARG . 8.8 mt-10 -54.8 -30.74 57.83 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -82.89 -10.74 58.68 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 50.3 mt -119.28 -12.41 9.42 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 52.9 mtm180 61.24 44.39 9.88 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.443 0.639 . . . . 0.0 111.858 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -163.24 154.95 17.52 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.769 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . 0.747 HG11 ' HD1' ' A' ' 436' ' ' TYR . 93.9 t -80.99 137.56 21.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.048 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -62.79 163.47 9.34 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.306 0.574 . . . . 0.0 111.883 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.99 161.93 30.19 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.283 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 72.03 20.85 4.22 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.188 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . 0.425 ' HE2' ' CE2' ' A' ' 435' ' ' TYR . 29.0 m-85 -125.0 158.97 61.15 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.999 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.0 161.16 91.5 Favored 'Cis proline' 0 C--N 1.345 0.386 0 C-N-CA 123.766 -1.347 . . . . 0.0 112.574 1.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . 0.492 ' HB2' ' CE1' ' A' ' 435' ' ' TYR . 68.0 mttm -114.24 172.51 6.96 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.78 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -72.42 140.99 48.67 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . 0.667 HD13 ' HA ' ' A' ' 461' ' ' GLU . 13.2 tt -67.51 -12.04 14.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.078 0.466 . . . . 0.0 110.772 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . 0.481 ' HD3' ' HA ' ' A' ' 454' ' ' LYS . 27.6 mmtp -65.84 -10.16 35.46 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 81.2 t -61.34 -34.51 61.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 177.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 456' ' ' TRP . . . . . 0.505 ' HB2' ' HB ' ' A' ' 459' ' ' ILE . 9.8 m95 -88.1 84.39 6.93 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.48 115.67 2.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.763 -178.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 103.24 -11.59 55.05 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.833 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 456' ' ' TRP . 27.5 mm -89.36 126.09 59.62 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 120.808 0.337 . . . . 0.0 111.188 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 460' ' ' PRO . . . . . 0.426 ' HG3' ' CZ2' ' A' ' 484' ' ' TRP . 94.2 Cg_endo -79.91 152.26 21.86 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.827 2.351 . . . . 0.0 111.41 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 461' ' ' GLU . . . . . 0.667 ' HA ' HD13 ' A' ' 453' ' ' ILE . 0.1 OUTLIER -75.64 157.6 33.52 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.84 -179.773 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.5 m 56.86 69.43 1.72 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.577 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 463' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 416' ' ' ASP . 4.6 Cg_endo -87.91 -179.29 2.47 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.04 2.493 . . . . 0.0 111.637 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 7.7 tpp85 -144.46 36.11 1.2 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.519 0.676 . . . . 0.0 110.08 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 161.81 132.8 1.38 Allowed Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.342 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 6.0 p -155.56 106.32 2.51 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -133.35 142.67 48.53 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.028 0.442 . . . . 0.0 111.782 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 42.2 ttm -92.61 140.31 29.67 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.542 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -69.32 166.95 47.59 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.274 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 1.5 m -68.03 -7.41 28.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.15 0.5 . . . . 0.0 111.681 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -86.27 -20.87 27.79 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.756 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 70.34 13.65 7.54 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.748 0.655 . . . . 0.0 112.27 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 19.4 t -114.82 -34.3 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 120.781 0.324 . . . . 0.0 111.343 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -113.76 133.79 55.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.209 0.528 . . . . 0.0 111.986 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 84.9 m -119.03 140.07 50.65 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.936 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -110.32 134.38 52.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.882 0.372 . . . . 0.0 111.782 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -116.08 141.66 47.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.47 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -120.69 134.92 55.25 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.994 0.184 . . . . 0.0 111.27 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -168.52 126.68 1.1 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.443 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 63.63 42.6 98.71 Favored Glycine 0 N--CA 1.454 -0.154 0 CA-C-N 116.086 -0.506 . . . . 0.0 113.751 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 54.6 t30 68.29 3.19 3.59 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 25.6 mtmt -116.24 157.89 24.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.048 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 483' ' ' TYR . . . . . 0.53 ' CE2' ' HE2' ' A' ' 497' ' ' TYR . 24.5 p90 -130.57 146.7 52.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.023 0.44 . . . . 0.0 111.695 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 484' ' ' TRP . . . . . 0.426 ' CZ2' ' HG3' ' A' ' 460' ' ' PRO . 16.8 m-90 -114.62 151.25 33.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.615 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -110.76 98.65 7.75 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 486' ' ' PHE . . . . . 0.548 ' HZ ' HD12 ' A' ' 491' ' ' LEU . 82.4 t80 -90.96 131.65 36.44 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.768 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -96.02 120.42 36.27 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -66.91 -29.49 69.38 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 52.0 tp60 -83.16 -39.35 21.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.827 0.346 . . . . 0.0 111.726 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -83.53 -19.87 34.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.484 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.548 HD12 ' HZ ' ' A' ' 486' ' ' PHE . 18.3 tp 61.22 34.02 18.93 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.481 0.658 . . . . 0.0 110.036 -179.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 25.8 tttp -156.03 150.2 25.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.567 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 486' ' ' PHE . 56.8 t -70.19 137.79 23.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.42 138.71 86.5 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.821 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -60.08 145.01 99.42 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 123.156 2.571 . . . . 0.0 112.644 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 109.61 -6.69 31.63 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . 0.744 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 57.0 m-85 -109.75 169.1 6.77 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . 0.744 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 96.6 Cg_endo -76.85 171.53 67.64 Favored 'Cis proline' 0 C--N 1.35 0.647 0 C-N-CA 124.022 -1.241 . . . . 0.0 113.083 0.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -131.83 164.28 26.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.97 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 48.1 t -72.72 122.27 21.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.512 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -67.98 -29.76 68.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.068 0.461 . . . . 0.0 110.605 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 502' ' ' LEU . . . . . 0.44 ' HA ' ' HG2' ' A' ' 506' ' ' MET . 63.6 mt -68.01 -41.58 82.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.354 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -77.75 -37.33 49.35 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -93.58 -27.49 16.59 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -176.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 36.6 m0 -109.56 -50.7 2.96 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 506' ' ' MET . . . . . 0.44 ' HG2' ' HA ' ' A' ' 502' ' ' LEU . 11.3 mmt -73.02 -26.57 61.36 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -178.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 88.77 25.91 28.49 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.813 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 21.7 m -106.03 105.74 54.58 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 120.627 0.251 . . . . 0.0 110.743 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -84.61 176.15 6.5 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.867 2.378 . . . . 0.0 111.82 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 40.2 m 62.14 46.83 6.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.468 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.421 -1.211 . . . . 0.0 110.589 179.561 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.897 0 N-CA-C 112.295 -0.322 . . . . 0.0 112.295 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 CA--C 1.53 0.288 0 C-N-CA 122.821 2.347 . . . . 0.0 111.777 179.845 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.717 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo . . . . . 0 CA--C 1.531 0.357 0 C-N-CA 122.88 2.387 . . . . 0.0 111.021 179.454 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 N-CA-C 112.326 -0.31 . . . . 0.0 112.326 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo . . . . . 0 CA--C 1.531 0.355 0 C-N-CA 122.973 2.449 . . . . 0.0 111.866 179.434 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.712 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -63.19 137.28 60.39 Favored 'Trans proline' 0 C--O 1.238 0.498 0 C-N-CA 122.87 2.38 . . . . 0.0 111.839 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -65.47 143.35 57.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.133 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' D' ' 210' ' ' PRO . . . -57.63 153.2 24.99 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.987 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 mt -72.62 150.85 8.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.73 142.45 58.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.226 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.03 168.49 33.1 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.886 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -74.36 145.09 44.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.678 0.275 . . . . 0.0 110.782 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.55 136.18 54.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.973 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.8 144.34 34.79 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.985 -0.552 . . . . 0.0 113.687 -179.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 4.1 t -64.39 147.11 12.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 9.7 t -54.57 147.13 3.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.05 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.55 177.82 46.16 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.639 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 86.7 mt . . . . . 0 C--N 1.323 -0.571 0 CA-C-O 120.418 0.151 . . . . 0.0 110.648 -179.665 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.503 0 CA-C-O 120.405 -0.108 . . . . 0.0 112.993 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo . . . . . 0 C--O 1.234 0.313 0 C-N-CA 122.772 2.314 . . . . 0.0 112.154 179.846 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.567 0 N-CA-C 113.212 0.045 . . . . 0.0 113.212 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo . . . . . 0 CA--C 1.534 0.501 0 C-N-CA 123.187 2.591 . . . . 0.0 111.627 179.689 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.637 0 N-CA-C 112.76 -0.136 . . . . 0.0 112.76 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo . . . . . 0 C--O 1.236 0.399 0 C-N-CA 123.153 2.569 . . . . 0.0 111.643 179.392 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.943 0 N-CA-C 112.783 -0.127 . . . . 0.0 112.783 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo . . . . . 0 N--CA 1.46 -0.488 0 C-N-CA 122.487 2.124 . . . . 0.0 111.098 179.403 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 100' ' ' GLY . . . . . 0.479 ' HA3' ' HD3' ' C' ' 101' ' ' PRO . . . . . . . . 0 N--CA 1.449 -0.433 0 N-CA-C 112.29 -0.324 . . . . 0.0 112.29 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 101' ' ' PRO . . . . . 0.479 ' HD3' ' HA3' ' C' ' 100' ' ' GLY . 14.5 Cg_exo . . . . . 0 CA--C 1.528 0.217 0 C-N-CA 122.898 2.399 . . . . 0.0 111.9 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 111.834 -0.507 . . . . 0.0 111.834 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo . . . . . 0 C--O 1.236 0.379 0 C-N-CA 122.895 2.396 . . . . 0.0 112.528 -179.576 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.383 0 N-CA-C 112.297 -0.321 . . . . 0.0 112.297 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 CA--C 1.528 0.18 0 C-N-CA 123.213 2.608 . . . . 0.0 110.886 179.513 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.417 0 N-CA-C 112.811 -0.115 . . . . 0.0 112.811 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.85 157.45 61.31 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.749 2.299 . . . . 0.0 112.552 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -60.78 139.0 58.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.815 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -67.61 168.33 39.54 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.029 -0.605 . . . . 0.0 113.256 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 28.4 mt -68.6 138.18 22.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.86 147.58 51.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.966 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.54 149.27 48.72 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 116.058 -0.519 . . . . 0.0 113.196 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -78.27 143.61 36.89 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 122.283 0.233 . . . . 0.0 110.617 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 52.9 ttm-85 -62.19 145.25 54.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.632 0.253 . . . . 0.0 110.742 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.45 168.9 37.92 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.691 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -77.26 149.15 6.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.521 0.2 . . . . 0.0 110.475 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 120' ' ' VAL . . . . . 0.611 HG22 ' HB ' ' D' ' 219' ' ' VAL . 63.4 t -64.61 137.55 24.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.982 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.36 161.78 50.24 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 121.11 -0.566 . . . . 0.0 112.42 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 88.9 mt . . . . . 0 C--N 1.325 -0.464 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.92 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.442 0 N-CA-C 113.595 0.198 . . . . 0.0 113.595 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 C--O 1.235 0.356 0 C-N-CA 122.916 2.411 . . . . 0.0 111.647 179.587 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 113.365 0.106 . . . . 0.0 113.365 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo . . . . . 0 C--O 1.236 0.414 0 C-N-CA 122.632 2.222 . . . . 0.0 111.484 179.634 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 112.653 -0.179 . . . . 0.0 112.653 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo . . . . . 0 C--N 1.342 0.233 0 C-N-CA 122.795 2.33 . . . . 0.0 111.59 179.754 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.521 0 CA-C-O 119.927 -0.374 . . . . 0.0 112.551 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo . . . . . 0 CA--C 1.53 0.302 0 C-N-CA 123.005 2.47 . . . . 0.0 111.88 -179.991 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.387 0 N-CA-C 112.17 -0.372 . . . . 0.0 112.17 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo . . . . . 0 C--N 1.344 0.32 0 C-N-CA 122.783 2.322 . . . . 0.0 111.488 179.77 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.329 0 N-CA-C 114.346 0.498 . . . . 0.0 114.346 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo . . . . . 0 C--N 1.347 0.459 0 C-N-CA 123.896 3.064 . . . . 0.0 113.265 -179.394 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.421 0 CA-C-O 120.456 -0.08 . . . . 0.0 112.988 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo . . . . . 0 N--CA 1.459 -0.506 0 C-N-CA 123.187 2.591 . . . . 0.0 112.326 179.898 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.697 0 N-CA-C 112.086 -0.406 . . . . 0.0 112.086 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 210' ' ' PRO . . . . . 0.452 ' O ' ' HA3' ' B' ' 12' ' ' GLY . 38.9 Cg_endo -68.12 158.35 57.85 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.643 2.229 . . . . 0.0 112.237 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -79.49 147.31 32.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.886 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.97 161.49 36.78 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.167 -0.54 . . . . 0.0 112.286 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 40.5 pt -66.79 166.92 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.63 0.252 . . . . 0.0 111.168 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 214' ' ' ALA . . . . . 0.432 ' HB3' ' NH1' ' A' ' 330' ' ' ARG . . . -80.64 138.99 36.45 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.912 0.387 . . . . 0.0 110.685 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -63.15 156.08 41.98 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.017 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -71.0 150.18 45.9 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -62.29 152.25 34.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.45 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -58.97 154.2 28.87 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.667 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 219' ' ' VAL . . . . . 0.611 ' HB ' HG22 ' C' ' 120' ' ' VAL . 15.8 t -66.74 143.15 15.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 21.9 t -63.01 143.26 15.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.047 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.22 162.66 31.98 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.777 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 7.3 mp . . . . . 0 C--N 1.323 -0.547 0 CA-C-O 120.489 0.185 . . . . 0.0 110.778 -179.8 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.805 0 N-CA-C 112.339 -0.304 . . . . 0.0 112.339 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo . . . . . 0 C--O 1.233 0.229 0 C-N-CA 122.837 2.358 . . . . 0.0 111.506 179.746 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 227' ' ' GLY . . . . . 0.419 ' HA2' ' HD3' ' D' ' 228' ' ' PRO . . . . . . . . 0 N--CA 1.448 -0.528 0 CA-C-O 120.466 -0.075 . . . . 0.0 112.999 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 228' ' ' PRO . . . . . 0.419 ' HD3' ' HA2' ' D' ' 227' ' ' GLY . 2.7 Cg_exo . . . . . 0 N--CA 1.462 -0.33 0 C-N-CA 123.03 2.487 . . . . 0.0 111.443 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.581 0 N-CA-C 112.561 -0.215 . . . . 0.0 112.561 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo . . . . . 0 N--CA 1.462 -0.34 0 C-N-CA 122.654 2.236 . . . . 0.0 110.816 179.02 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 N--CA 1.479 0.65 0 N-CA-C 110.06 -0.785 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 320' ' ' ASP . 18.2 t-20 -115.27 161.2 18.8 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 17.6 tt -70.42 -23.42 24.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.08 0.467 . . . . 0.0 110.875 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 59.0 m -80.9 -1.1 42.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.227 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 317' ' ' ASN . 3.5 m-20 -71.33 -20.98 62.11 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.13 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 76.22 -177.31 50.83 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.822 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 24.4 m120 48.79 83.52 0.04 OUTLIER 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' PHE . . . . . 0.417 ' HD2' ' HH ' ' A' ' 478' ' ' TYR . 23.4 m-85 -100.62 168.67 9.55 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.222 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -77.35 -40.73 43.02 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 7.0 t -171.46 154.72 3.92 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.928 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 67.7 t -130.5 125.71 59.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -136.89 170.47 16.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.006 0.431 . . . . 0.0 110.898 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . 0.433 ' HA ' ' O ' ' A' ' 332' ' ' GLU . 41.4 ttp -130.08 87.06 2.47 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.568 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.426 ' HB3' ' CE1' ' A' ' 379' ' ' PHE . 45.5 mt -85.7 123.8 31.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.48 -178.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 330' ' ' ARG . 31.5 mmt-85 63.71 19.37 11.69 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.203 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 93.2 -3.61 73.04 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.631 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . 0.451 ' HA ' ' NH2' ' A' ' 345' ' ' ARG . 15.4 mm-40 -95.45 128.44 42.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.853 0.359 . . . . 0.0 110.356 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 38.5 ttm -77.03 110.92 12.07 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.251 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -110.29 122.83 48.61 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.988 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 27.2 t -109.73 122.34 64.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.47 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -106.21 132.04 52.75 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.731 0.3 . . . . 0.0 111.46 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 0.783 ' HB3' ' HZ3' ' A' ' 342' ' ' TRP . 61.2 tttp -148.37 112.38 5.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.42 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 64.76 -113.01 0.31 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.922 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 15.4 ptt-85 -114.63 11.78 17.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.857 0.361 . . . . 0.0 111.107 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 15.0 m-90 -122.99 155.07 37.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.933 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -135.85 148.69 48.76 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.686 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' TRP . . . . . 0.783 ' HZ3' ' HB3' ' A' ' 337' ' ' LYS . 29.2 m-90 -124.47 162.5 23.82 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.462 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.13 114.99 9.07 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 2.5 m -103.3 136.86 34.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.262 0.553 . . . . 0.0 112.083 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . 0.451 ' NH2' ' HA ' ' A' ' 332' ' ' GLU . 18.0 tpp180 -135.84 123.26 22.0 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 5.6 m120 66.14 35.21 6.27 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 123.564 0.54 . . . . 0.0 110.614 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 17.5 t30 63.14 33.12 14.71 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.048 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -143.03 143.52 31.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.563 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 14.0 t -83.65 131.39 33.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 91.1 mtp -84.44 172.57 11.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.904 0.383 . . . . 0.0 111.513 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -77.47 158.38 30.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.23 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 98.02 -5.47 61.48 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.045 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -117.64 152.72 50.08 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.406 ' HB3' ' CE2' ' A' ' 342' ' ' TRP . 74.0 Cg_endo -76.58 140.01 63.1 Favored 'Cis proline' 0 C--N 1.343 0.286 0 C-N-CA 123.215 -1.577 . . . . 0.0 112.834 0.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 57.1 ttm -119.85 135.94 24.56 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.94 134.77 64.59 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.327 2.018 . . . . 0.0 110.931 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 94.0 mt -51.91 -42.32 33.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.814 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -67.83 -8.11 51.61 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 116.029 -0.532 . . . . 0.0 114.271 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.72 -32.87 27.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.259 0.529 . . . . 0.0 110.447 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -104.47 -56.32 2.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.966 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -86.13 74.95 9.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.712 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 362' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 362' ' ' ARG . 25.6 ttp180 -63.45 100.92 0.28 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.896 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 129.31 -16.7 5.68 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.299 -0.721 . . . . 0.0 111.299 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.555 HD12 ' HD2' ' A' ' 365' ' ' PRO . 22.6 tp -92.38 134.05 28.82 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' PRO . . . . . 0.555 ' HD2' HD12 ' A' ' 364' ' ' LEU . 96.3 Cg_endo -82.87 -167.08 0.43 Allowed 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 123.033 2.488 . . . . 0.0 112.258 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -96.94 157.81 15.72 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.051 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 27.7 m 54.73 80.31 0.13 Allowed 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 17.9 pt -93.57 170.26 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.013 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.93 -39.25 7.02 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -178.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . 0.532 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.2 OUTLIER -153.13 160.45 42.89 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.657 0.265 . . . . 0.0 111.288 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -153.08 138.2 17.35 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . 0.474 ' HE1' ' HE2' ' A' ' 382' ' ' PHE . 11.8 p90 -166.09 174.66 9.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.683 0.278 . . . . 0.0 111.076 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.418 ' OE1' ' HD3' ' A' ' 330' ' ' ARG . 33.4 mt-10 -104.92 131.51 52.33 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' ARG . . . . . 0.492 ' HB2' ' OE2' ' A' ' 440' ' ' GLU . 6.3 ptm180 -88.61 -177.99 5.7 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.404 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.449 ' HZ3' ' CD ' ' A' ' 441' ' ' GLU . 7.6 tttp -65.64 -34.23 77.75 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -21.82 64.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.98 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 109.77 -10.99 32.45 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.962 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 19.8 mttp -86.06 160.28 19.34 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 117.266 0.533 . . . . 0.0 111.409 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' PHE . . . . . 0.426 ' CE1' ' HB3' ' A' ' 329' ' ' LEU . 45.6 m-85 -88.35 130.57 35.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.181 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . 0.448 ' HB ' ' CE1' ' A' ' 372' ' ' TYR . 8.9 t -113.86 119.7 61.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.004 0.431 . . . . 0.0 110.194 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . 0.444 ' HB2' ' HB2' ' A' ' 388' ' ' TRP . 94.5 m-85 -107.37 140.16 40.73 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.67 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.474 ' HE2' ' HE1' ' A' ' 372' ' ' TYR . 32.9 m-85 -121.49 139.91 52.87 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.983 0.421 . . . . 0.0 111.603 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.456 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 86.1 tttt -154.2 114.05 3.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.744 178.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 66.76 -107.24 1.92 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.692 -0.765 . . . . 0.0 111.481 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -122.62 8.82 9.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.21 0.529 . . . . 0.0 110.165 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -114.84 152.37 32.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.795 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' HIS . . . . . 0.407 ' NE2' ' HE2' ' A' ' 399' ' ' TYR . 25.8 p-80 -134.27 150.93 51.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.394 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' TRP . . . . . 0.535 ' CE2' ' HB3' ' A' ' 400' ' ' PRO . 16.7 m-90 -122.64 142.58 50.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.186 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 85.6 t -124.38 119.13 55.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -118.62 126.79 52.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.977 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -93.79 95.08 8.9 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 177.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' GLU . . . . . 0.416 ' HA ' ' HE2' ' A' ' 379' ' ' PHE . 72.2 mm-40 69.96 -78.32 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.812 0.695 . . . . 0.0 110.273 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -140.87 16.87 2.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.965 0.412 . . . . 0.0 111.05 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 9.1 m -123.24 126.9 47.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.956 0.407 . . . . 0.0 111.723 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 46.6 tp -76.54 140.19 41.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.428 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 5.5 mm-40 -71.6 136.63 83.31 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.307 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 24.6 Cg_exo -64.0 131.99 32.83 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.81 2.34 . . . . 0.0 112.096 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 108.07 -11.44 37.42 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.841 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' TYR . . . . . 0.505 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 58.2 m-85 -93.5 161.01 31.85 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 110.543 -0.169 . . . . 0.0 110.543 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.535 ' HB3' ' CE2' ' A' ' 388' ' ' TRP . 55.3 Cg_endo -68.96 160.33 85.77 Favored 'Cis proline' 0 C--N 1.348 0.537 0 C-N-CA 123.909 -1.288 . . . . 0.0 113.205 0.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -135.45 161.93 34.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.819 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 0.501 ' HB2' ' HG2' ' A' ' 405' ' ' GLU . 30.5 m-70 -70.37 153.91 42.48 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 77.6 mt -57.61 -37.81 60.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.099 0.476 . . . . 0.0 111.095 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -68.1 -10.08 51.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.99 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.501 ' HG2' ' HB2' ' A' ' 402' ' ' HIS . 65.3 mm-40 -79.65 -20.6 46.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.809 0.337 . . . . 0.0 110.767 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 36.9 tp -80.15 -61.81 1.87 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.264 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.845 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -143.21 154.91 25.74 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.063 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -79.61 132.06 36.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.667 -0.266 . . . . 0.0 110.336 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 102.29 -4.3 51.5 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.317 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 411' ' ' PRO . 50.2 mt -77.33 146.0 73.46 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 120.63 0.252 . . . . 0.0 110.976 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 410' ' ' LEU . 47.8 Cg_exo -57.07 131.91 48.22 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.734 2.289 . . . . 0.0 112.075 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.69 -0.5 37.24 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.293 0.568 . . . . 0.0 110.42 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -90.13 -53.13 4.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.941 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -179.15 170.9 1.39 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.826 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 42.6 mm -124.61 133.01 70.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -90.63 -47.15 7.85 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.117 0.485 . . . . 0.0 110.234 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.532 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -155.26 159.68 40.23 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.339 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -142.45 113.68 7.7 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 35.1 tp -109.61 123.2 49.04 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.407 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -88.36 114.64 25.18 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.062 0.458 . . . . 0.0 110.086 178.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 15.3 t-105 -83.63 94.23 8.06 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.509 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 62.6 mtt -50.74 -50.72 71.69 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -43.01 -48.97 7.32 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 123.011 2.474 . . . . 0.0 114.867 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -105.07 -13.8 15.62 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 75.23 33.7 53.23 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.162 -0.542 . . . . 0.0 113.204 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -116.38 149.22 39.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.796 0.298 . . . . 0.0 110.456 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 6.4 m -98.23 128.0 44.47 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.203 0.525 . . . . 0.0 112.218 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -102.78 109.08 20.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.948 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -91.89 129.68 37.81 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.461 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -106.18 129.62 54.2 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.004 0.431 . . . . 0.0 110.988 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.562 ' HB3' ' HE1' ' A' ' 436' ' ' TYR . 3.1 tpm_? -139.21 102.98 4.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.336 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 63.44 -109.5 2.78 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.318 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -110.82 11.96 22.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.031 0.443 . . . . 0.0 110.62 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -122.91 152.38 40.86 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.966 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 435' ' ' TYR . . . . . 0.551 ' CE2' ' HE2' ' A' ' 449' ' ' TYR . 8.2 p90 -133.82 139.2 46.11 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.383 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 436' ' ' TYR . . . . . 0.562 ' HE1' ' HB3' ' A' ' 431' ' ' ARG . 4.2 m-85 -111.62 145.2 39.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.829 -178.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 20.9 ttp180 -106.01 100.62 10.16 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' PHE . . . . . 0.845 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 83.2 t80 -85.06 120.41 26.54 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.235 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -95.61 106.79 18.93 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.537 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 440' ' ' GLU . . . . . 0.492 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 4.5 mm-40 -58.16 -39.06 77.85 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.597 0.56 . . . . 0.0 111.48 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 441' ' ' GLU . . . . . 0.449 ' CD ' ' HZ3' ' A' ' 375' ' ' LYS . 1.9 mp0 -61.16 -20.56 62.85 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 13.8 mt -127.72 3.5 6.09 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 43.03 47.37 5.03 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.493 0.663 . . . . 0.0 112.315 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -154.51 172.65 17.45 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.132 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.6 t -88.24 138.94 18.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.149 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.32 160.81 15.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.525 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . 0.543 ' O ' ' HB2' ' A' ' 448' ' ' GLU . 1.7 m -67.13 151.96 46.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.446 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 448' ' ' GLU . . . . . 0.543 ' HB2' ' O ' ' A' ' 447' ' ' SER . 26.7 mt-10 78.45 -6.68 1.9 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.51 0.724 . . . . 0.0 111.786 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . 0.551 ' HE2' ' CE2' ' A' ' 435' ' ' TYR . 54.2 m-85 -98.23 154.68 37.55 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.702 -0.227 . . . . 0.0 111.418 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.4 162.71 91.94 Favored 'Cis proline' 0 C--N 1.345 0.364 0 C-N-CA 123.439 -1.484 . . . . 0.0 112.998 0.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -121.94 178.17 5.0 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -78.07 137.01 38.01 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.721 0.296 . . . . 0.0 110.298 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.5 tt -63.97 -17.48 20.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -63.48 -9.16 11.53 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 53.7 t -63.07 -33.9 63.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -91.5 94.76 9.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.362 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . 0.722 ' HB3' ' HG3' ' A' ' 492' ' ' LYS . 13.3 mm-40 -56.08 105.2 0.17 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 114.25 -7.8 22.95 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.515 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 24.7 mm -84.58 127.44 65.56 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 121.006 0.431 . . . . 0.0 111.065 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -77.99 138.93 16.87 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.893 2.395 . . . . 0.0 113.042 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -66.66 140.81 57.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.293 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 2.7 m 57.74 71.44 1.07 Allowed Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -87.28 -171.28 0.7 Allowed 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.423 2.082 . . . . 0.0 111.632 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -143.63 20.55 1.84 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.212 0.529 . . . . 0.0 110.891 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 177.92 142.0 4.44 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 13.0 p -162.65 110.65 1.31 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.6 0.238 . . . . 0.0 110.731 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -138.98 144.44 38.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.866 0.365 . . . . 0.0 111.251 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 48.7 ttm -95.47 143.05 27.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.022 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . 0.442 ' C ' ' H ' ' A' ' 471' ' ' ASP . . . -72.67 163.91 54.76 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.962 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.94 30.25 0.09 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.167 0.508 . . . . 0.0 111.901 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . 0.442 ' H ' ' C ' ' A' ' 469' ' ' GLY . 1.0 OUTLIER -126.73 -14.28 5.71 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.294 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 67.24 9.44 6.96 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.3 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 40.2 t -106.71 -45.25 7.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.859 0.361 . . . . 0.0 111.133 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -108.09 132.13 53.89 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 97.0 m -116.79 138.95 51.13 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.689 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 476' ' ' TYR . . . . . 0.491 ' HE1' ' HE2' ' A' ' 485' ' ' LYS . 28.3 m-85 -114.15 126.52 55.17 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -110.08 141.78 42.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.145 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . 0.417 ' HH ' ' HD2' ' A' ' 323' ' ' PHE . 76.8 t80 -123.04 135.0 54.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.705 0.288 . . . . 0.0 111.566 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 479' ' ' LYS . . . . . 0.4 ' HB3' ' CZ3' ' A' ' 484' ' ' TRP . 61.8 tttt -166.87 128.25 1.66 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.078 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 59.56 43.18 97.82 Favored Glycine 0 CA--C 1.516 0.148 0 N-CA-C 114.667 0.627 . . . . 0.0 114.667 178.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 58.4 t30 68.92 3.94 4.25 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 178.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -116.84 152.19 34.95 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 483' ' ' TYR . . . . . 0.481 ' CE2' ' HE2' ' A' ' 497' ' ' TYR . 7.3 p90 -128.12 145.17 51.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.114 0.483 . . . . 0.0 111.813 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 484' ' ' TRP . . . . . 0.4 ' CZ3' ' HB3' ' A' ' 479' ' ' LYS . 16.8 m-90 -112.77 138.09 50.11 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.499 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . 0.491 ' HE2' ' HE1' ' A' ' 476' ' ' TYR . 32.6 ttmt -101.88 96.12 6.84 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 486' ' ' PHE . . . . . 0.552 ' HA ' ' HA ' ' A' ' 493' ' ' VAL . 90.0 t80 -87.77 133.26 33.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.566 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -100.32 117.13 33.89 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -66.55 -34.44 77.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.768 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -68.76 -32.93 73.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.68 -178.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -98.5 -20.54 17.02 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 1.3 tp 66.11 39.26 4.4 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.795 0.807 . . . . 0.0 109.814 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 492' ' ' LYS . . . . . 0.722 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 31.5 tttp -160.17 153.36 21.88 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.386 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 486' ' ' PHE . 52.8 t -78.04 133.5 30.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 178.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -59.42 137.46 89.04 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.41 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -61.85 152.01 77.39 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.979 2.453 . . . . 0.0 112.284 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 94.37 9.48 59.07 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.684 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . 0.633 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 21.7 m-85 -117.43 170.17 6.49 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . 0.633 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 87.4 Cg_endo -78.29 -178.72 24.76 Favored 'Cis proline' 0 C--N 1.348 0.53 0 C-N-CA 124.104 -1.207 . . . . 0.0 112.865 0.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -135.29 155.25 50.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.176 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.29 116.33 10.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.565 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -63.47 -23.6 67.47 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 502' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 502' ' ' LEU . 13.4 mt -61.15 -49.65 76.35 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -83.05 -29.08 29.12 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.05 -35.73 21.69 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 44.3 m0 -116.29 -45.07 2.85 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -177.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 9.7 mmt -75.5 -17.77 60.01 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -177.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 76.41 21.95 74.15 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.742 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 16.9 m -104.38 111.07 65.11 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 120.754 0.311 . . . . 0.0 110.898 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -86.27 -167.47 0.38 Allowed 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.873 2.382 . . . . 0.0 111.525 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 16.2 m 60.34 37.63 20.08 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.046 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.386 -1.23 . . . . 0.0 111.832 -179.506 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.669 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo . . . . . 0 CA--C 1.53 0.305 0 C-N-CA 122.543 2.162 . . . . 0.0 111.433 179.683 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 113.661 0.224 . . . . 0.0 113.661 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo . . . . . 0 CA--C 1.532 0.382 0 C-N-CA 122.874 2.383 . . . . 0.0 110.966 179.586 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.612 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo . . . . . 0 CA--C 1.532 0.412 0 C-N-CA 122.678 2.252 . . . . 0.0 111.463 179.263 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.912 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.11 138.33 51.56 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.769 2.312 . . . . 0.0 111.561 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . 0.664 ' HG3' ' HG2' ' C' ' 110' ' ' PRO . 27.2 tt0 -66.67 150.27 49.3 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.084 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.18 143.07 46.24 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.355 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.475 ' H ' HD12 ' B' ' 13' ' ' ILE . 4.0 mp -64.86 137.93 24.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.01 143.41 22.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.129 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.64 164.77 41.8 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.106 -0.568 . . . . 0.0 113.17 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -75.11 150.34 38.83 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -70.22 146.49 50.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.525 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' D' ' 216' ' ' GLN . . . -64.95 155.24 48.84 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.492 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.42 ' H ' HG23 ' B' ' 19' ' ' VAL . 2.2 t -66.3 149.76 11.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.554 0.216 . . . . 0.0 110.667 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 6.0 t -53.92 145.71 3.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.24 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.99 161.25 52.08 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 116.035 -0.529 . . . . 0.0 113.153 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 87.4 mt . . . . . 0 C--N 1.323 -0.583 0 CA-C-N 115.703 -0.248 . . . . 0.0 110.756 -179.71 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.544 0 N-CA-C 112.847 -0.101 . . . . 0.0 112.847 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo . . . . . 0 C--O 1.235 0.33 0 C-N-CA 122.609 2.206 . . . . 0.0 111.412 179.565 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.575 0 N-CA-C 113.153 0.021 . . . . 0.0 113.153 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo . . . . . 0 C--O 1.235 0.355 0 C-N-CA 122.798 2.332 . . . . 0.0 111.864 179.867 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.58 0 N-CA-C 113.168 0.027 . . . . 0.0 113.168 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo . . . . . 0 C--O 1.234 0.302 0 C-N-CA 123.29 2.66 . . . . 0.0 111.766 179.516 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 113.596 0.198 . . . . 0.0 113.596 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo . . . . . 0 C--N 1.344 0.335 0 C-N-CA 122.759 2.306 . . . . 0.0 111.033 179.304 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.506 0 CA-C-O 119.952 -0.36 . . . . 0.0 112.586 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo . . . . . 0 C--N 1.345 0.364 0 C-N-CA 122.952 2.435 . . . . 0.0 112.084 179.716 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.552 0 N-CA-C 112.446 -0.261 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo . . . . . 0 N--CA 1.462 -0.375 0 C-N-CA 122.957 2.438 . . . . 0.0 111.95 179.773 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.511 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.465 -0.172 0 C-N-CA 122.961 2.44 . . . . 0.0 110.742 179.528 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.498 0 N-CA-C 112.615 -0.194 . . . . 0.0 112.615 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 110' ' ' PRO . . . . . 0.664 ' HG2' ' HG3' ' B' ' 11' ' ' GLN . 59.1 Cg_endo -72.27 163.98 37.01 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.886 2.391 . . . . 0.0 112.116 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -65.6 137.63 57.49 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.15 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.48 166.63 30.02 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.841 -0.618 . . . . 0.0 113.562 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 79.9 mt -63.8 137.72 24.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.752 0.31 . . . . 0.0 110.847 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.11 145.15 54.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.538 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -59.16 148.37 40.4 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.627 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -75.2 156.8 35.44 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.673 0.273 . . . . 0.0 110.464 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 38.0 ttm-85 -69.67 147.34 50.74 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.302 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.9 170.0 52.13 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.485 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 21.6 t -69.23 138.95 21.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.606 0.241 . . . . 0.0 110.651 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 58.0 t -62.42 137.33 24.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.661 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.31 158.62 30.77 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.26 -0.495 . . . . 0.0 112.851 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 95.7 mt . . . . . 0 C--N 1.324 -0.508 0 CA-C-O 120.391 0.138 . . . . 0.0 110.922 -179.92 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.643 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo . . . . . 0 CA--C 1.529 0.233 0 C-N-CA 122.691 2.261 . . . . 0.0 111.581 179.534 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.523 0 CA-C-O 120.407 -0.107 . . . . 0.0 112.902 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo . . . . . 0 C--O 1.236 0.376 0 C-N-CA 122.579 2.186 . . . . 0.0 111.562 179.551 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 130' ' ' GLY . . . . . 0.408 ' HA2' ' HD3' ' C' ' 131' ' ' PRO . . . . . . . . 0 N--CA 1.446 -0.669 0 N-CA-C 112.885 -0.086 . . . . 0.0 112.885 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 131' ' ' PRO . . . . . 0.408 ' HD3' ' HA2' ' C' ' 130' ' ' GLY . 14.0 Cg_exo . . . . . 0 C--O 1.236 0.376 0 C-N-CA 122.913 2.409 . . . . 0.0 111.696 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.542 0 CA-C-O 120.257 -0.19 . . . . 0.0 112.925 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 CA--C 1.531 0.325 0 C-N-CA 122.881 2.387 . . . . 0.0 111.889 179.763 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.335 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo . . . . . 0 CA--C 1.531 0.359 0 C-N-CA 122.946 2.431 . . . . 0.0 111.807 179.964 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.406 0 CA-C-O 120.341 -0.144 . . . . 0.0 112.993 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo . . . . . 0 CA--C 1.531 0.343 0 C-N-CA 123.454 2.769 . . . . 0.0 112.722 -179.805 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.391 0 N-CA-C 112.965 -0.054 . . . . 0.0 112.965 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo . . . . . 0 N--CA 1.456 -0.696 0 C-N-CA 123.424 2.75 . . . . 0.0 112.519 -179.768 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.67 0 N-CA-C 112.05 -0.42 . . . . 0.0 112.05 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.26 141.1 73.97 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.471 2.114 . . . . 0.0 112.23 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 211' ' ' GLN . . . . . 0.451 ' HG3' ' N ' ' D' ' 212' ' ' GLY . 1.4 tt0 -65.87 150.93 47.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.929 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 212' ' ' GLY . . . . . 0.451 ' N ' ' HG3' ' D' ' 211' ' ' GLN . . . -67.46 160.33 49.47 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.357 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 45.6 pt -69.21 174.11 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 120.819 0.343 . . . . 0.0 111.439 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -77.67 147.86 35.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.499 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -74.48 158.02 51.28 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.773 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 216' ' ' GLN . . . . . 0.453 ' O ' ' HA3' ' B' ' 18' ' ' GLY . 33.4 mm-40 -77.52 151.6 34.48 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.623 0.249 . . . . 0.0 110.488 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 217' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' D' ' 217' ' ' ARG . 8.8 mtp180 -66.58 156.23 35.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.989 0.424 . . . . 0.0 110.571 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -66.23 151.37 52.09 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.185 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 11.5 t -65.82 148.77 11.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 61.6 t -63.03 139.1 21.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-O 120.725 0.297 . . . . 0.0 110.425 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.33 157.22 28.86 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.516 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 115.751 -0.224 . . . . 0.0 110.889 -179.893 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 224' ' ' GLY . . . . . 0.418 ' HA2' ' HD3' ' D' ' 225' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.613 0 CA-C-O 120.47 -0.072 . . . . 0.0 113.175 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 225' ' ' PRO . . . . . 0.418 ' HD3' ' HA2' ' D' ' 224' ' ' GLY . 15.5 Cg_exo . . . . . 0 C--O 1.236 0.382 0 C-N-CA 123.031 2.487 . . . . 0.0 111.466 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.502 0 N-CA-C 112.773 -0.131 . . . . 0.0 112.773 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 CA--C 1.53 0.314 0 C-N-CA 122.701 2.267 . . . . 0.0 111.954 -179.929 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.468 0 N-CA-C 113.444 0.137 . . . . 0.0 113.444 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo . . . . . 0 N--CA 1.458 -0.594 0 C-N-CA 123.298 2.665 . . . . 0.0 112.511 -179.982 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo . . . . . 0 N--CA 1.479 0.665 0 N-CA-C 110.26 -0.708 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' ASN . . . . . 0.534 ' O ' ' HB2' ' A' ' 320' ' ' ASP . 14.3 t-20 -110.79 166.3 11.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.423 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . 0.466 HG13 ' HB3' ' A' ' 506' ' ' MET . 8.5 tp -72.78 -31.04 34.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.051 0.453 . . . . 0.0 110.64 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 59.0 m -82.77 10.24 8.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.94 0.4 . . . . 0.0 111.457 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.534 ' HB2' ' O ' ' A' ' 317' ' ' ASN . 0.1 OUTLIER -69.72 -32.02 70.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.437 179.626 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 79.96 -176.81 54.57 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.481 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 3.5 t30 53.9 78.79 0.15 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.046 0.45 . . . . 0.0 111.218 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -96.04 154.79 17.05 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.902 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . 0.418 ' OD1' ' HA ' ' A' ' 337' ' ' LYS . 3.0 m-20 -74.25 -40.53 62.31 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.221 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 1.8 t -170.86 146.54 2.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.448 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.431 HG22 HG13 ' A' ' 335' ' ' VAL . 60.6 t -131.97 126.25 56.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -149.33 176.81 10.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.053 0.454 . . . . 0.0 111.231 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 41.3 ttp -127.16 122.37 33.93 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.419 ' HB3' ' CE1' ' A' ' 379' ' ' PHE . 54.3 mt -114.64 119.75 37.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.902 -179.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.609 ' HG3' ' HE1' ' A' ' 379' ' ' PHE . 63.6 mtp180 55.82 26.04 9.14 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 101.96 -10.63 57.17 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.684 -0.77 . . . . 0.0 113.356 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -100.25 130.01 46.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.929 0.395 . . . . 0.0 111.306 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 45.2 ttm -84.05 124.43 31.08 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -119.56 120.5 36.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.132 0.492 . . . . 0.0 111.572 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . 0.431 HG13 HG22 ' A' ' 326' ' ' VAL . 23.1 t -105.31 115.22 46.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -99.74 131.67 45.58 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 0.695 ' HB3' ' HZ3' ' A' ' 342' ' ' TRP . 38.7 tttp -144.18 109.25 5.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.174 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 61.31 -102.39 0.12 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.894 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 339' ' ' ARG . 11.7 ptm85 -119.48 12.97 12.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.878 0.37 . . . . 0.0 111.361 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 13.3 m-90 -125.71 153.73 43.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.71 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -136.35 141.76 43.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.863 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' TRP . . . . . 0.695 ' HZ3' ' HB3' ' A' ' 337' ' ' LYS . 21.0 m-90 -115.59 147.09 41.15 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.882 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -116.48 92.81 3.99 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.476 HG12 HG22 ' A' ' 349' ' ' VAL . 10.2 m -91.42 128.39 43.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.619 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 42.5 ttm-85 -131.82 118.85 20.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.428 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 63.03 41.42 8.29 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.869 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 34.9 t30 68.29 15.37 9.3 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.353 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -126.58 129.26 48.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.72 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.476 HG22 HG12 ' A' ' 344' ' ' VAL . 21.7 t -76.57 121.98 29.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.661 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 26.0 ttp -66.94 151.57 47.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.788 0.327 . . . . 0.0 110.501 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -69.51 161.08 30.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.195 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 90.21 7.07 68.13 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.06 -0.591 . . . . 0.0 111.908 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 353' ' ' TYR . . . . . 0.561 ' HB3' ' HA ' ' A' ' 354' ' ' PRO . 80.5 m-85 -128.78 162.22 52.88 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.561 ' HA ' ' HB3' ' A' ' 353' ' ' TYR . 56.8 Cg_endo -70.37 144.04 76.77 Favored 'Cis proline' 0 C--N 1.346 0.396 0 C-N-CA 123.815 -1.327 . . . . 0.0 112.943 0.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 355' ' ' MET . . . . . 0.502 ' HB2' ' CD1' ' A' ' 353' ' ' TYR . 0.0 OUTLIER -113.23 144.36 31.04 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.36 179.528 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 355' ' ' MET . 17.5 Cg_exo -68.2 129.65 19.74 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.541 2.16 . . . . 0.0 111.358 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 85.3 mt -56.53 -41.6 73.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.479 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -65.7 -17.57 64.99 Favored Glycine 0 CA--C 1.518 0.25 0 N-CA-C 114.603 0.601 . . . . 0.0 114.603 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -84.65 -45.11 12.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.237 0.519 . . . . 0.0 111.063 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -82.72 -53.92 5.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.189 0.519 . . . . 0.0 110.555 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -92.61 70.24 4.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.553 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -59.41 101.88 0.12 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.208 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 128.95 -20.79 5.35 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.464 HD12 ' HD2' ' A' ' 365' ' ' PRO . 18.8 tp -85.7 134.61 39.39 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' PRO . . . . . 0.464 ' HD2' HD12 ' A' ' 364' ' ' LEU . 97.5 Cg_endo -82.43 -175.17 2.36 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.813 2.342 . . . . 0.0 112.145 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -91.06 153.0 20.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.502 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.0 m 57.12 83.06 0.11 Allowed 'General case' 0 C--O 1.233 0.232 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 13.7 pt -94.9 176.19 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.898 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -111.55 -38.2 4.99 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 1.6 m -149.97 156.23 41.36 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.798 0.332 . . . . 0.0 111.54 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -149.15 135.82 19.54 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . 0.459 ' CE1' ' HB ' ' A' ' 380' ' ' VAL . 33.6 p90 -158.48 165.08 35.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.117 0.484 . . . . 0.0 112.191 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 62.5 tt0 -99.14 133.92 42.73 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' ARG . . . . . 0.469 ' HB2' ' OE2' ' A' ' 440' ' ' GLU . 15.2 ptm180 -95.44 -170.69 2.21 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -77.17 -23.56 51.55 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -177.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.63 -11.05 57.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 104.23 -14.37 51.51 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.854 -0.689 . . . . 0.0 113.949 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' LYS . . . . . 0.513 ' HD3' ' HB2' ' A' ' 391' ' ' ASP . 25.2 mttp -82.05 163.66 21.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.305 0.553 . . . . 0.0 111.867 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' PHE . . . . . 0.609 ' HE1' ' HG3' ' A' ' 330' ' ' ARG . 10.5 m-85 -99.96 135.56 41.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.351 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . 0.459 ' HB ' ' CE1' ' A' ' 372' ' ' TYR . 12.2 t -116.43 122.02 68.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.254 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -108.2 139.8 42.35 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.56 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.437 ' HE2' HG23 ' A' ' 403' ' ' ILE . 17.6 m-85 -122.01 140.15 52.83 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.71 0.291 . . . . 0.0 111.163 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -154.69 114.13 3.72 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.741 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 67.24 -110.25 3.37 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.833 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -119.32 12.96 12.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.941 0.401 . . . . 0.0 111.185 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -122.14 152.96 39.35 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.894 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -133.9 148.31 51.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.22 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' TRP . . . . . 0.453 ' CE2' ' HB3' ' A' ' 400' ' ' PRO . 21.5 m-90 -122.4 140.41 52.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.149 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 69.5 t -120.34 120.2 62.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -115.8 127.77 55.33 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.513 ' HB2' ' HD3' ' A' ' 378' ' ' LYS . 19.7 t70 -90.79 86.26 6.28 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 176.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' GLU . . . . . 0.418 ' OE1' ' HB ' ' D' ' 213' ' ' ILE . 57.0 mm-40 69.52 -71.47 0.12 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.402 -177.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -142.56 4.56 1.55 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.546 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 13.3 m -106.45 129.05 54.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.713 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 65.1 tp -84.16 133.75 34.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 4.0 mt-10 -66.1 135.34 95.08 Favored Pre-proline 0 C--O 1.238 0.489 0 CA-C-O 120.823 0.344 . . . . 0.0 111.039 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 23.7 Cg_exo -64.81 128.82 21.78 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 123.152 2.568 . . . . 0.0 112.192 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 108.02 -5.27 34.17 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.836 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' TYR . . . . . 0.411 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 33.9 m-85 -94.0 159.56 34.12 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 111.526 0.195 . . . . 0.0 111.526 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.453 ' HB3' ' CE2' ' A' ' 388' ' ' TRP . 71.9 Cg_endo -74.44 162.5 92.4 Favored 'Cis proline' 0 C--N 1.344 0.314 0 C-N-CA 123.477 -1.468 . . . . 0.0 112.939 0.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -125.59 161.39 27.32 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 0.452 ' ND1' ' HG3' ' A' ' 404' ' ' LYS . 23.7 t-80 -69.9 155.89 39.89 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . 0.437 HG23 ' HE2' ' A' ' 382' ' ' PHE . 67.5 mt -56.33 -40.98 69.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.368 . . . . 0.0 111.481 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . 0.452 ' HG3' ' ND1' ' A' ' 402' ' ' HIS . 0.0 OUTLIER -67.55 -12.18 59.77 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -179.441 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -78.93 -18.39 53.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.87 0.367 . . . . 0.0 110.946 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 38.5 tp -79.5 -31.97 42.36 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.268 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.519 ' HA2' ' HG2' ' A' ' 443' ' ' ARG . . . -176.82 165.77 36.12 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.261 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -90.33 132.87 35.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.572 0.225 . . . . 0.0 110.804 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.16 12.85 47.73 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.193 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 61.3 mt -92.25 146.31 32.38 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.638 0.256 . . . . 0.0 111.372 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.65 115.65 2.55 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.036 2.49 . . . . 0.0 111.232 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 1.1 m -84.49 1.88 43.56 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.505 -179.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -97.24 -59.78 1.72 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.305 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -174.48 173.03 3.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.872 0.368 . . . . 0.0 110.933 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 43.9 mm -122.41 136.23 59.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.599 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -94.54 -43.31 8.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.202 0.525 . . . . 0.0 110.154 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -156.8 163.24 39.45 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.844 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -149.32 127.0 11.69 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 36.4 tp -121.88 128.86 52.07 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.028 0.442 . . . . 0.0 111.16 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -92.39 119.39 31.89 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 18.3 t-105 -85.21 91.65 8.2 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.341 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 13.9 mmt -47.28 -49.9 50.54 Favored Pre-proline 0 N--CA 1.47 0.533 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -45.93 -41.98 20.41 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.02 2.48 . . . . 0.0 115.476 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -115.34 -28.53 6.85 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 98.85 16.59 30.47 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.498 -0.858 . . . . 0.0 113.151 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -92.5 147.3 23.01 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 3.0 m -104.9 122.73 46.41 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.92 0.391 . . . . 0.0 110.867 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -99.35 111.79 24.09 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.946 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -95.69 137.37 34.84 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.876 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -112.69 127.58 56.16 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.976 0.417 . . . . 0.0 111.504 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.486 ' HB3' ' HE1' ' A' ' 436' ' ' TYR . 2.9 tpm_? -134.51 98.29 4.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.776 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 67.0 -107.37 1.98 Allowed Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.872 -0.603 . . . . 0.0 112.285 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' ASN . . . . . 0.597 ' HB3' ' HG2' ' A' ' 461' ' ' GLU . 4.9 p30 -112.59 15.65 19.99 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.96 0.409 . . . . 0.0 111.278 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . 0.516 ' HB3' ' HB2' ' A' ' 450' ' ' PRO . 68.0 mmtt -128.77 141.39 51.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.823 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 435' ' ' TYR . . . . . 0.538 ' CE2' ' HE2' ' A' ' 449' ' ' TYR . 14.3 p90 -120.86 142.69 49.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.031 0.443 . . . . 0.0 110.659 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 436' ' ' TYR . . . . . 0.486 ' HE1' ' HB3' ' A' ' 431' ' ' ARG . 4.3 m-85 -112.84 148.48 34.81 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.506 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 19.7 ttp180 -112.5 91.43 3.65 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' PHE . . . . . 0.412 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 81.3 t80 -85.14 134.99 34.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.143 0.497 . . . . 0.0 111.144 -178.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' ASN . . . . . 0.552 ' HB3' ' HB3' ' A' ' 442' ' ' LEU . 3.8 t30 -107.35 118.61 37.17 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.791 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 440' ' ' GLU . . . . . 0.469 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 0.4 OUTLIER -55.52 -57.05 13.52 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.37 -179.502 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -80.12 54.52 1.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.908 0.385 . . . . 0.0 110.951 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' LEU . . . . . 0.552 ' HB3' ' HB3' ' A' ' 439' ' ' ASN . 29.4 tp -168.35 -33.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.098 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' ARG . . . . . 0.519 ' HG2' ' HA2' ' A' ' 407' ' ' GLY . 20.8 ttt180 64.45 31.96 12.18 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.551 0.691 . . . . 0.0 111.055 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -152.36 163.83 38.69 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.454 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 86.8 t -89.37 143.0 12.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.025 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.63 156.83 18.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.462 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . 0.592 ' O ' ' HB2' ' A' ' 448' ' ' GLU . 1.5 m -69.01 151.13 46.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.343 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 448' ' ' GLU . . . . . 0.736 ' HB3' ' HE2' ' A' ' 451' ' ' LYS . 6.8 mt-10 85.03 -6.53 0.92 Allowed 'General case' 0 N--CA 1.471 0.575 0 O-C-N 124.269 0.981 . . . . 0.0 112.01 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . 0.538 ' HE2' ' CE2' ' A' ' 435' ' ' TYR . 92.3 m-85 -100.12 157.94 32.93 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.796 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . 0.516 ' HB2' ' HB3' ' A' ' 434' ' ' LYS . 61.2 Cg_endo -72.07 155.22 98.34 Favored 'Cis proline' 0 C--N 1.345 0.39 0 C-N-CA 123.585 -1.423 . . . . 0.0 112.797 0.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . 0.736 ' HE2' ' HB3' ' A' ' 448' ' ' GLU . 51.4 mttm -118.88 165.71 13.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.682 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 452' ' ' ASN . . . . . 0.557 ' ND2' ' HB2' ' A' ' 454' ' ' LYS . 38.9 t30 -61.06 128.07 34.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.446 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . 0.501 HG21 ' HG3' ' A' ' 461' ' ' GLU . 10.7 tt -65.03 -17.23 21.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.799 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . 0.557 ' HB2' ' ND2' ' A' ' 452' ' ' ASN . 67.1 mttm -67.73 -2.79 7.62 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 50.4 t -65.24 -33.38 63.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 456' ' ' TRP . . . . . 0.419 ' HE3' ' CZ ' ' A' ' 486' ' ' PHE . 26.4 m95 -83.23 90.85 7.16 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . 0.636 ' HB3' ' HG3' ' A' ' 492' ' ' LYS . 0.3 OUTLIER -51.68 108.82 0.3 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -178.61 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 108.32 -17.34 34.33 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.935 -0.65 . . . . 0.0 113.818 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.414 ' HB ' ' HB2' ' A' ' 456' ' ' TRP . 29.8 mm -79.32 122.93 84.64 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.98 0.419 . . . . 0.0 111.694 -179.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.33 155.22 36.83 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.865 2.377 . . . . 0.0 111.778 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 461' ' ' GLU . . . . . 0.597 ' HG2' ' HB3' ' A' ' 433' ' ' ASN . 0.9 OUTLIER -74.77 144.97 43.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.679 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 2.9 m 57.03 75.28 0.58 Allowed Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.913 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.27 -176.8 3.39 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 123.011 2.474 . . . . 0.0 111.868 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . 0.489 ' HA ' ' HE ' ' A' ' 464' ' ' ARG . 0.2 OUTLIER -135.87 27.44 3.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.248 0.547 . . . . 0.0 110.327 179.602 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 153.22 144.62 3.95 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.432 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 4.1 p -156.25 123.41 5.34 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -144.43 149.61 36.32 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.721 0.296 . . . . 0.0 111.128 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 468' ' ' MET . . . . . 0.412 ' HA ' ' HA ' ' A' ' 475' ' ' THR . 49.5 ttm -103.68 141.66 35.68 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -69.0 168.76 43.96 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.677 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 4.9 m -72.23 -10.89 60.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.084 0.469 . . . . 0.0 110.919 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . 0.465 ' OD2' ' HB ' ' A' ' 473' ' ' VAL . 11.9 p-10 -83.36 -17.15 43.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.007 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 68.22 7.92 6.22 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 473' ' ' VAL . . . . . 0.465 ' HB ' ' OD2' ' A' ' 471' ' ' ASP . 48.8 t -105.8 -35.39 3.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.766 0.317 . . . . 0.0 111.443 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -110.55 131.02 55.41 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 475' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 468' ' ' MET . 94.1 m -114.7 141.87 47.25 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.593 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 476' ' ' TYR . . . . . 0.418 ' HE1' ' HD2' ' A' ' 485' ' ' LYS . 73.0 m-85 -118.97 134.49 55.15 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 477' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 483' ' ' TYR . 20.0 m-85 -117.84 134.8 54.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.232 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -109.45 133.7 52.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.562 0.22 . . . . 0.0 111.154 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 479' ' ' LYS . . . . . 0.437 ' HB3' ' CZ3' ' A' ' 484' ' ' TRP . 54.4 tttp -170.07 133.88 1.2 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.594 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 64.27 35.21 91.69 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 121.311 -0.471 . . . . 0.0 113.603 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 481' ' ' ASN . . . . . 0.4 HD21 ' CD1' ' A' ' 502' ' ' LEU . 58.1 t30 67.21 10.92 8.08 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.589 0.709 . . . . 0.0 111.442 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -125.97 161.54 27.28 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.525 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 483' ' ' TYR . . . . . 0.413 ' CE2' ' HE2' ' A' ' 497' ' ' TYR . 15.4 p90 -129.83 151.65 50.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.845 0.355 . . . . 0.0 111.571 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 484' ' ' TRP . . . . . 0.437 ' CZ3' ' HB3' ' A' ' 479' ' ' LYS . 12.4 m-90 -112.51 145.84 39.54 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.149 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . 0.418 ' HD2' ' HE1' ' A' ' 476' ' ' TYR . 18.2 tttt -107.25 98.2 7.87 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 486' ' ' PHE . . . . . 0.458 ' HA ' ' HA ' ' A' ' 493' ' ' VAL . 51.8 t80 -90.35 125.16 35.44 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.264 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -90.21 115.08 27.16 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -63.7 -33.21 75.13 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -71.17 -40.88 71.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.928 0.394 . . . . 0.0 111.725 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -91.02 -14.28 31.68 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.4 tp 59.68 37.32 22.35 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.434 0.635 . . . . 0.0 110.618 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 492' ' ' LYS . . . . . 0.636 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 59.1 tttp -154.37 151.78 29.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.888 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 486' ' ' PHE . 58.5 t -74.52 132.77 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -67.53 143.56 97.13 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.549 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -61.18 149.92 86.98 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.257 2.638 . . . . 0.0 112.919 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 97.76 17.34 30.86 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . 0.546 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 19.2 m-85 -126.59 167.56 16.96 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . 0.546 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 94.3 Cg_endo -76.91 169.75 73.57 Favored 'Cis proline' 0 C--N 1.344 0.331 0 C-N-CA 124.001 -1.25 . . . . 0.0 112.962 0.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -124.97 150.35 46.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.537 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 37.4 t -64.4 119.76 10.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.257 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -64.83 -32.75 74.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.892 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 502' ' ' LEU . . . . . 0.571 HD23 ' HG3' ' A' ' 506' ' ' MET . 20.5 mt -62.81 -47.45 83.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.146 0.498 . . . . 0.0 111.16 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -75.48 -31.9 60.38 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.51 -33.47 17.76 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -177.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 15.9 m0 -127.64 -27.75 2.82 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -177.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 506' ' ' MET . . . . . 0.571 ' HG3' HD23 ' A' ' 502' ' ' LEU . 14.6 mmt -85.64 -6.46 59.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -177.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 71.2 42.87 57.11 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.937 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 508' ' ' CYS . . . . . 0.562 ' HB2' ' HB3' ' A' ' 502' ' ' LEU . 59.9 m -120.55 93.57 48.46 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-O 120.707 0.289 . . . . 0.0 110.939 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -73.23 134.26 20.76 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.009 2.472 . . . . 0.0 111.814 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 5.1 m 55.53 68.9 0.79 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.341 0.591 . . . . 0.0 111.725 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.536 -1.146 . . . . 0.0 112.401 -179.626 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.598 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo . . . . . 0 N--CA 1.464 -0.233 0 C-N-CA 122.468 2.112 . . . . 0.0 111.304 179.565 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.46 0 N-CA-C 113.275 0.07 . . . . 0.0 113.275 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo . . . . . 0 CA--C 1.532 0.377 0 C-N-CA 122.939 2.426 . . . . 0.0 111.635 179.838 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.427 0 CA-C-O 120.308 -0.162 . . . . 0.0 112.722 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo . . . . . 0 CA--C 1.539 0.728 0 C-N-CA 123.133 2.556 . . . . 0.0 112.755 179.527 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.618 0 N-CA-C 112.598 -0.201 . . . . 0.0 112.598 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -64.76 140.91 69.7 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.987 2.458 . . . . 0.0 112.022 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . 0.596 ' HG3' ' HG2' ' C' ' 110' ' ' PRO . 61.1 tt0 -69.64 149.48 48.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.414 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.9 153.42 47.6 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.231 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 8.9 mt -67.64 149.3 11.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.66 152.89 37.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.882 0.372 . . . . 0.0 111.282 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' D' ' 213' ' ' ILE . . . -74.76 166.03 54.81 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.343 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -80.54 148.74 30.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.733 0.301 . . . . 0.0 110.353 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -76.4 141.56 41.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.356 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.28 150.85 46.43 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.787 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.9 t -69.68 155.46 7.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.402 HG23 ' H ' ' B' ' 20' ' ' VAL . 3.1 t -52.89 146.6 2.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.454 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.81 168.64 54.81 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.747 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 C--N 1.32 -0.676 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 -179.823 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.534 0 CA-C-O 120.493 -0.06 . . . . 0.0 113.238 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo . . . . . 0 CA--C 1.53 0.276 0 C-N-CA 122.652 2.235 . . . . 0.0 111.576 179.252 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.509 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo . . . . . 0 C--O 1.236 0.379 0 C-N-CA 122.828 2.352 . . . . 0.0 111.802 -179.972 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.457 0 N-CA-C 113.377 0.111 . . . . 0.0 113.377 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo . . . . . 0 CA--C 1.53 0.308 0 C-N-CA 123.356 2.704 . . . . 0.0 111.734 179.659 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . 0.429 ' HA2' ' HD3' ' B' ' 34' ' ' PRO . . . . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 112.665 -0.174 . . . . 0.0 112.665 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . 0.429 ' HD3' ' HA2' ' B' ' 33' ' ' GLY . 3.2 Cg_exo . . . . . 0 N--CA 1.463 -0.268 0 C-N-CA 122.909 2.406 . . . . 0.0 111.794 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 112.733 -0.147 . . . . 0.0 112.733 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 CA--C 1.534 0.521 0 C-N-CA 122.909 2.406 . . . . 0.0 112.769 -179.414 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 CA-C-O 120.393 -0.115 . . . . 0.0 112.824 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo . . . . . 0 CA--C 1.532 0.411 0 C-N-CA 122.803 2.335 . . . . 0.0 112.296 -179.634 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.635 0 N-CA-C 111.787 -0.525 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo . . . . . 0 CA--C 1.531 0.328 0 C-N-CA 123.115 2.543 . . . . 0.0 110.437 179.303 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 120.742 0.079 . . . . 0.0 113.171 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 110' ' ' PRO . . . . . 0.596 ' HG2' ' HG3' ' B' ' 11' ' ' GLN . 32.3 Cg_endo -64.03 150.06 89.16 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.872 2.381 . . . . 0.0 112.021 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -61.61 140.91 58.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.261 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -66.81 152.27 52.57 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.016 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 23.3 mt -65.57 137.11 25.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.7 149.98 38.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.889 0.376 . . . . 0.0 111.123 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -65.44 162.34 40.94 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.972 -0.632 . . . . 0.0 111.909 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -85.21 153.58 22.54 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.906 -0.317 . . . . 0.0 110.604 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 35.7 ttm-85 -61.74 144.77 54.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.329 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.08 169.56 27.2 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.545 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.33 142.12 14.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.821 0.343 . . . . 0.0 110.324 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 120' ' ' VAL . . . . . 0.496 HG13 ' HB ' ' D' ' 219' ' ' VAL . 24.8 t -62.48 143.48 15.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.427 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.02 161.05 54.23 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.406 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--N 1.322 -0.598 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 179.804 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.598 0 CA-C-O 120.372 -0.127 . . . . 0.0 112.956 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 C--O 1.236 0.379 0 C-N-CA 122.565 2.177 . . . . 0.0 111.409 179.66 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.635 0 N-CA-C 112.903 -0.079 . . . . 0.0 112.903 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 C--O 1.236 0.398 0 C-N-CA 122.672 2.248 . . . . 0.0 111.332 179.624 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 113.557 0.183 . . . . 0.0 113.557 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo . . . . . 0 CA--C 1.529 0.273 0 C-N-CA 123.141 2.561 . . . . 0.0 111.687 179.691 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 133' ' ' GLY . . . . . 0.44 ' HA2' ' HD3' ' C' ' 134' ' ' PRO . . . . . . . . 0 N--CA 1.45 -0.42 0 CA-C-O 119.896 -0.391 . . . . 0.0 112.294 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 134' ' ' PRO . . . . . 0.44 ' HD3' ' HA2' ' C' ' 133' ' ' GLY . 14.7 Cg_exo . . . . . 0 C--O 1.235 0.337 0 C-N-CA 123.287 2.658 . . . . 0.0 112.14 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 N-CA-C 112.553 -0.219 . . . . 0.0 112.553 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo . . . . . 0 C--N 1.346 0.416 0 C-N-CA 123.15 2.567 . . . . 0.0 112.074 179.381 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.257 0 N-CA-C 113.978 0.351 . . . . 0.0 113.978 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo . . . . . 0 CA--C 1.532 0.376 0 C-N-CA 123.53 2.82 . . . . 0.0 111.952 179.835 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.413 0 N-CA-C 112.61 -0.196 . . . . 0.0 112.61 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo . . . . . 0 N--CA 1.461 -0.429 0 C-N-CA 123.078 2.519 . . . . 0.0 112.137 179.95 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.545 0 N-CA-C 111.988 -0.445 . . . . 0.0 111.988 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.42 141.14 73.06 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.589 2.193 . . . . 0.0 111.797 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -63.88 145.05 56.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.004 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -66.76 159.84 48.39 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.758 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 213' ' ' ILE . . . . . 0.418 ' HB ' ' OE1' ' A' ' 392' ' ' GLU . 47.4 pt -74.35 164.75 3.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.774 0.321 . . . . 0.0 111.02 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 214' ' ' ALA . . . . . 0.477 ' HB3' ' NH1' ' A' ' 330' ' ' ARG . . . -82.25 137.46 34.86 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.918 0.39 . . . . 0.0 110.725 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -65.3 164.87 36.47 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.853 -0.612 . . . . 0.0 113.039 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -68.81 156.46 38.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.675 0.274 . . . . 0.0 110.323 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -70.75 162.03 29.82 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -60.41 154.02 34.94 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.526 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 219' ' ' VAL . . . . . 0.496 ' HB ' HG13 ' C' ' 120' ' ' VAL . 21.0 t -70.78 149.4 10.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 42.9 t -64.41 140.45 19.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.56 167.69 13.85 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.299 -0.477 . . . . 0.0 113.318 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 C--N 1.324 -0.542 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 -179.921 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 112.139 -0.384 . . . . 0.0 112.139 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo . . . . . 0 C--O 1.232 0.197 0 C-N-CA 122.877 2.385 . . . . 0.0 111.577 179.923 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.524 0 N-CA-C 113.323 0.089 . . . . 0.0 113.323 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo . . . . . 0 CA--C 1.531 0.346 0 C-N-CA 123.054 2.502 . . . . 0.0 111.475 179.743 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.551 0 N-CA-C 113.286 0.075 . . . . 0.0 113.286 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 CA--C 1.529 0.24 0 C-N-CA 123.182 2.588 . . . . 0.0 111.928 -179.996 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.425 ' HB2' ' HH2' ' A' ' 342' ' ' TRP . 6.0 Cg_exo . . . . . 0 N--CA 1.478 0.588 0 N-CA-C 109.714 -0.918 . . . . 0.0 109.714 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -102.69 148.61 25.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.663 0.268 . . . . 0.0 110.775 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 8.1 tp -73.57 -26.71 22.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.383 0.611 . . . . 0.0 110.681 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 37.3 m -88.74 26.33 1.54 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.81 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -76.77 -41.83 43.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.306 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 83.37 170.68 46.6 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.205 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 50.3 t30 50.65 68.97 0.69 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.198 0.523 . . . . 0.0 111.125 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -87.17 175.49 8.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.47 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 464' ' ' ARG . 4.7 m-20 -74.62 -46.96 34.95 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 14.5 t -171.34 153.95 3.75 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.518 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 57.0 t -131.39 124.42 54.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . 0.446 ' HA ' ' CD1' ' A' ' 467' ' ' PHE . . . -141.59 169.04 18.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.009 0.433 . . . . 0.0 111.832 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 39.3 ttp -120.84 121.0 37.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.358 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 58.9 mt -112.18 115.7 29.26 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.666 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 330' ' ' ARG . . . . . 0.464 ' HG3' ' HE1' ' A' ' 379' ' ' PHE . 44.9 mtp180 57.16 22.31 7.4 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 109.85 -14.77 31.73 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.85 -0.69 . . . . 0.0 113.656 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -99.84 129.46 45.94 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.938 0.369 . . . . 0.0 111.324 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 47.1 ttm -89.1 126.18 35.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.923 0.392 . . . . 0.0 111.082 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -119.68 132.86 55.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.114 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 23.9 t -107.02 117.33 52.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.502 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -100.68 126.62 47.21 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 0.794 ' HB3' ' HZ3' ' A' ' 342' ' ' TRP . 27.5 tptt -139.71 102.78 4.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.157 178.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 63.92 -102.25 0.1 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.66 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.5 ptm85 -117.49 8.09 12.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.917 0.389 . . . . 0.0 111.962 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 3.0 m-90 -127.01 146.03 50.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.048 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -128.66 146.1 50.97 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.966 0.412 . . . . 0.0 110.985 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' TRP . . . . . 0.794 ' HZ3' ' HB3' ' A' ' 337' ' ' LYS . 20.4 m-90 -108.66 150.87 26.93 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.425 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.637 ' HD3' ' SD ' ' A' ' 350' ' ' MET . 24.1 ttt-85 -113.8 100.89 8.79 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 3.1 m -93.49 129.43 43.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.137 0.494 . . . . 0.0 111.386 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.15 109.87 6.68 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.536 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 63.66 47.01 3.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.774 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 7.2 m120 64.68 27.96 13.13 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.185 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -142.06 150.17 40.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.952 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 47.4 t -91.76 129.19 42.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 350' ' ' MET . . . . . 0.637 ' SD ' ' HD3' ' A' ' 343' ' ' ARG . 89.5 mtp -77.23 165.44 24.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.026 0.441 . . . . 0.0 111.78 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -77.72 154.51 32.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.696 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 94.76 -5.8 69.75 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 111.701 -0.56 . . . . 0.0 111.701 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 353' ' ' TYR . . . . . 0.494 ' CE1' ' HD2' ' A' ' 343' ' ' ARG . 83.1 m-85 -118.85 159.0 46.25 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 110.448 -0.205 . . . . 0.0 110.448 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.478 ' C ' ' HA ' ' A' ' 353' ' ' TYR . 37.9 Cg_endo -65.67 137.88 34.4 Favored 'Cis proline' 0 C--N 1.348 0.542 0 C-N-CA 123.966 -1.264 . . . . 0.0 112.564 0.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 355' ' ' MET . . . . . 0.42 ' HA ' ' HD3' ' A' ' 356' ' ' PRO . 10.6 ttt -112.72 141.34 25.21 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.429 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 355' ' ' MET . 50.7 Cg_exo -58.19 127.3 24.39 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.574 2.183 . . . . 0.0 111.204 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 66.8 mt -56.11 -42.42 72.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.942 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -70.3 -16.38 73.31 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.794 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -82.51 -28.28 31.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.046 0.451 . . . . 0.0 110.791 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -98.66 -53.0 3.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.239 0.543 . . . . 0.0 109.725 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -93.32 71.15 4.43 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -56.93 99.44 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.672 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 128.27 -17.09 5.95 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.969 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.475 ' HA ' ' HD3' ' A' ' 365' ' ' PRO . 30.9 tp -91.84 125.52 56.91 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-O 120.561 0.22 . . . . 0.0 110.764 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 364' ' ' LEU . 3.0 Cg_exo -77.38 170.19 19.85 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 123.06 2.507 . . . . 0.0 111.774 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -77.26 159.41 29.64 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.654 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 16.6 m 57.92 82.95 0.12 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.41 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 27.9 pt -100.38 173.23 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.911 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . 0.418 HD22 ' HA ' ' A' ' 369' ' ' ASN . 1.5 m120 -95.79 -55.84 2.87 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 370' ' ' THR . . . . . 0.7 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.2 OUTLIER -155.49 164.13 39.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.575 -179.838 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -147.75 149.02 31.61 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . 0.61 ' HE1' ' HE2' ' A' ' 382' ' ' PHE . 19.3 p90 -164.64 166.35 20.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.867 0.365 . . . . 0.0 111.768 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -97.3 125.53 41.94 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' ARG . . . . . 0.498 ' HB2' ' OE2' ' A' ' 440' ' ' GLU . 10.6 ptm180 -84.44 -172.05 3.96 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.576 ' HB2' ' HG3' ' A' ' 440' ' ' GLU . 4.7 tttp -63.5 -40.72 97.81 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.01 -30.09 58.37 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 127.17 -14.7 6.54 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.731 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 38.2 mttp -70.45 149.13 47.55 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.746 0.307 . . . . 0.0 110.798 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' PHE . . . . . 0.464 ' HE1' ' HG3' ' A' ' 330' ' ' ARG . 16.0 m-85 -95.65 126.71 41.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.058 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . 0.513 ' HB ' ' CE1' ' A' ' 372' ' ' TYR . 17.1 t -106.31 115.49 48.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.981 0.419 . . . . 0.0 110.558 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -102.72 128.95 49.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.531 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.61 ' HE2' ' HE1' ' A' ' 372' ' ' TYR . 59.1 m-85 -107.77 143.32 36.49 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.398 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.699 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 60.5 tttp -152.01 92.93 1.77 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 414' ' ' LYS . . . 75.71 -113.09 3.8 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -108.11 -0.73 20.94 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.032 0.444 . . . . 0.0 110.772 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -109.3 147.3 32.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.977 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 37.3 p-80 -132.64 147.87 52.35 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.357 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' TRP . . . . . 0.699 ' HZ3' ' HB3' ' A' ' 383' ' ' LYS . 20.9 m-90 -121.28 131.17 54.05 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.169 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 55.9 t -107.0 114.64 46.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -106.41 125.48 51.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.645 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -97.43 89.25 4.64 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 67.82 -85.98 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.308 -178.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -130.65 21.13 5.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.21 0.529 . . . . 0.0 110.886 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 10.2 m -133.83 135.29 43.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.02 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 57.3 tp -80.97 136.92 36.09 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.442 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . 0.648 ' HB3' ' CE1' ' A' ' 399' ' ' TYR . 0.0 OUTLIER -67.25 143.16 97.35 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.388 179.221 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.01 140.83 28.94 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 122.602 2.201 . . . . 0.0 112.581 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 91.24 26.26 21.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.542 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' TYR . . . . . 0.657 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 42.8 m-85 -118.88 163.54 25.59 Favored Pre-proline 0 C--N 1.324 -0.534 0 O-C-N 122.679 -0.307 . . . . 0.0 111.081 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.657 ' HA ' ' HB3' ' A' ' 399' ' ' TYR . 84.1 Cg_endo -77.44 162.87 89.8 Favored 'Cis proline' 0 C--N 1.345 0.38 0 C-N-CA 123.529 -1.446 . . . . 0.0 113.067 0.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -121.0 161.46 21.59 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 0.668 ' HB2' ' HG2' ' A' ' 405' ' ' GLU . 7.6 m-70 -74.84 153.54 38.66 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 71.2 mt -57.75 -38.62 66.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.27 0.557 . . . . 0.0 109.845 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . 0.417 ' HG3' ' HB3' ' A' ' 402' ' ' HIS . 0.0 OUTLIER -68.9 -10.74 58.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.469 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.668 ' HG2' ' HB2' ' A' ' 402' ' ' HIS . 78.4 mm-40 -84.45 -30.8 24.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.861 0.363 . . . . 0.0 110.435 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 47.6 tp -63.81 -51.88 62.74 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.859 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' GLY . . . . . 0.816 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -152.69 162.45 29.99 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.296 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -86.85 129.05 35.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.592 0.234 . . . . 0.0 110.404 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.57 6.79 43.55 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.32 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 65.6 mt -86.95 156.05 55.24 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 122.961 -0.141 . . . . 0.0 110.624 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -65.13 144.47 81.78 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.626 2.217 . . . . 0.0 112.371 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.24 25.17 9.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.031 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . 0.479 ' OD2' ' HD3' ' A' ' 431' ' ' ARG . 1.7 p-10 -119.42 -76.03 0.58 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.606 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 384' ' ' GLY . 7.8 ptmt -160.61 -176.75 5.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.82 0.343 . . . . 0.0 110.445 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 34.4 mm -125.59 135.61 63.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -94.48 -52.19 4.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.325 0.583 . . . . 0.0 110.062 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.7 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -147.13 145.63 29.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.946 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -129.01 117.18 20.5 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 57.8 tp -114.09 147.96 37.89 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.051 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -120.65 119.42 32.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.617 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' TRP . . . . . 0.466 ' HB2' ' HE2' ' A' ' 428' ' ' TYR . 7.0 t-105 -86.85 94.8 9.66 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.446 ' HB2' ' HD3' ' A' ' 423' ' ' PRO . 64.1 mtt -51.42 -51.71 66.56 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 92.5 Cg_exo -47.18 -33.82 16.54 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 123.029 2.486 . . . . 0.0 115.278 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' ASN . . . . . 0.408 ' OD1' ' HB3' ' A' ' 421' ' ' TRP . 33.0 p30 -115.06 -24.54 8.52 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 87.47 23.02 41.39 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.403 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -108.21 149.9 27.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 117.131 0.465 . . . . 0.0 111.169 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.45 146.16 25.49 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.436 -178.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 428' ' ' TYR . . . . . 0.466 ' HE2' ' HB2' ' A' ' 421' ' ' TRP . 81.8 m-85 -124.9 110.16 13.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.498 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -98.98 123.14 43.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.797 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' PHE . . . . . 0.442 ' HB2' ' HB3' ' A' ' 417' ' ' ALA . 89.8 m-85 -98.79 130.28 45.23 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.608 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' ARG . . . . . 0.479 ' HD3' ' OD2' ' A' ' 413' ' ' ASP . 2.0 tpm_? -140.05 106.81 5.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.163 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 66.72 -102.62 0.78 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.742 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -123.67 14.44 9.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.068 0.461 . . . . 0.0 110.154 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 52.0 mmtt -122.46 156.29 34.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.067 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 435' ' ' TYR . . . . . 0.537 ' CE2' ' HE1' ' A' ' 449' ' ' TYR . 7.8 p90 -135.3 139.36 44.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.928 0.394 . . . . 0.0 110.573 178.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -108.07 143.72 36.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.699 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -106.79 103.4 12.83 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' PHE . . . . . 0.816 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 66.6 t80 -92.42 135.23 34.22 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.482 -178.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -107.86 107.74 18.61 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 440' ' ' GLU . . . . . 0.576 ' HG3' ' HB2' ' A' ' 375' ' ' LYS . 4.9 mm-40 -49.39 -51.3 35.93 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -54.76 -48.71 72.28 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 52.5 mt -86.45 -18.05 32.69 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 61.36 39.45 15.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.631 0.729 . . . . 0.0 110.57 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -148.79 155.07 40.45 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.497 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 97.8 t -80.31 140.13 17.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.845 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -62.49 156.95 21.48 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.4 m -66.71 152.43 45.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.82 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 72.34 29.4 2.19 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.272 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . 0.537 ' HE1' ' CE2' ' A' ' 435' ' ' TYR . 27.5 m-85 -126.39 160.9 55.5 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.192 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.81 160.77 95.51 Favored 'Cis proline' 0 C--N 1.347 0.479 0 C-N-CA 123.728 -1.363 . . . . 0.0 112.337 -0.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . 0.506 ' HB2' ' CE1' ' A' ' 435' ' ' TYR . 60.4 mttm -109.71 176.76 4.95 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.106 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -76.8 139.82 40.49 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.518 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . 0.438 HD13 ' HA ' ' A' ' 461' ' ' GLU . 15.4 tt -66.83 -11.99 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.109 0.48 . . . . 0.0 110.709 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . 0.446 ' HD3' ' HA ' ' A' ' 454' ' ' LYS . 48.5 mmtt -68.69 -7.0 29.48 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.151 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 76.7 t -66.21 -30.95 51.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 456' ' ' TRP . . . . . 0.477 ' HE3' ' CZ ' ' A' ' 486' ' ' PHE . 6.7 m95 -97.72 85.59 3.6 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.545 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . 0.467 ' HB3' ' HG3' ' A' ' 492' ' ' LYS . 1.6 tm-20 -54.43 114.78 1.79 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.62 -178.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 108.0 -21.16 29.98 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.065 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 19.1 mm -71.04 127.15 91.94 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 120.868 0.366 . . . . 0.0 111.077 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.25 139.51 32.32 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.925 2.417 . . . . 0.0 112.603 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 461' ' ' GLU . . . . . 0.438 ' HA ' HD13 ' A' ' 453' ' ' ILE . 27.6 mp0 -68.34 138.78 55.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.002 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.3 m 59.33 70.31 1.14 Allowed Pre-proline 0 C--O 1.234 0.288 0 O-C-N 123.58 0.55 . . . . 0.0 112.177 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -85.95 -179.53 3.31 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.013 2.476 . . . . 0.0 111.164 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 324' ' ' ASP . 0.0 OUTLIER -142.39 29.21 1.61 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.439 0.638 . . . . 0.0 110.738 179.768 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 174.05 135.15 1.97 Allowed Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 5.3 p -158.49 114.38 2.69 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.706 0.289 . . . . 0.0 110.236 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 467' ' ' PHE . . . . . 0.446 ' CD1' ' HA ' ' A' ' 327' ' ' ALA . 30.3 p90 -145.14 140.7 28.17 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.696 0.284 . . . . 0.0 111.215 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 468' ' ' MET . . . . . 0.434 ' HA ' ' HA ' ' A' ' 475' ' ' THR . 46.5 ttm -89.93 141.14 28.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.244 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -70.38 166.16 51.1 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.769 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.36 -14.62 57.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.895 0.378 . . . . 0.0 111.906 -179.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -81.43 -18.39 45.53 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.391 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 68.09 11.96 8.58 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.015 0.526 . . . . 0.0 112.254 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 49.1 t -110.46 -36.12 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.891 0.377 . . . . 0.0 111.057 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -111.53 133.68 53.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.275 0.559 . . . . 0.0 111.996 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 475' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 468' ' ' MET . 88.3 m -116.54 133.03 56.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.381 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -101.42 135.93 42.11 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.967 0.413 . . . . 0.0 111.807 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -122.2 138.49 54.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.422 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -121.74 134.36 54.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.803 0.335 . . . . 0.0 111.524 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 48.0 tttt -166.06 131.94 2.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.222 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 56.12 44.74 88.54 Favored Glycine 0 C--N 1.33 0.227 0 CA-C-N 115.944 -0.571 . . . . 0.0 114.307 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 23.0 t30 65.47 8.49 5.07 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -118.28 158.35 25.35 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 483' ' ' TYR . . . . . 0.458 ' CE2' ' HE2' ' A' ' 497' ' ' TYR . 3.5 p90 -131.7 147.6 52.52 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.989 0.424 . . . . 0.0 111.934 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 484' ' ' TRP . . . . . 0.548 ' CE2' ' HB3' ' A' ' 498' ' ' PRO . 11.3 m-90 -116.36 157.21 25.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.133 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -120.45 99.38 6.53 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 486' ' ' PHE . . . . . 0.477 ' CZ ' ' HE3' ' A' ' 456' ' ' TRP . 77.4 t80 -86.28 127.41 34.77 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.941 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -93.18 112.81 24.86 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -63.68 -26.99 68.91 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -76.6 -30.85 57.13 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -99.2 -21.02 16.31 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.8 tp 66.17 33.4 7.4 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -177.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 492' ' ' LYS . . . . . 0.467 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 6.0 tttp -152.45 159.92 43.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.044 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . 0.429 ' N ' ' HG2' ' A' ' 492' ' ' LYS . 77.8 t -79.29 139.55 18.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.643 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -65.98 138.44 96.3 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.322 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.19 138.36 80.96 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 123.225 2.617 . . . . 0.0 112.59 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 111.21 -1.61 28.25 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . 0.526 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 37.5 m-85 -108.87 164.49 14.6 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.825 -0.187 . . . . 0.0 111.226 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . 0.548 ' HB3' ' CE2' ' A' ' 484' ' ' TRP . 83.2 Cg_endo -75.98 174.75 51.27 Favored 'Cis proline' 0 C--N 1.351 0.666 0 C-N-CA 124.058 -1.226 . . . . 0.0 113.045 0.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -134.41 166.61 22.44 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.991 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 44.3 t -71.54 118.07 13.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.597 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . 0.624 ' O ' ' HB2' ' A' ' 505' ' ' TRP . . . -70.7 -24.26 62.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.83 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 16.8 mt -70.96 -38.81 72.82 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.974 0.416 . . . . 0.0 110.652 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 8.7 ttm180 -84.37 -55.31 4.23 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -73.14 -18.02 61.32 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 505' ' ' TRP . . . . . 0.624 ' HB2' ' O ' ' A' ' 501' ' ' ALA . 9.5 m0 -111.95 -69.79 0.85 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 9.6 mmt -59.33 -44.54 92.61 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.976 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 109.85 14.03 14.77 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.51 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 35.1 m -81.87 113.6 44.16 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -83.29 153.57 14.12 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.576 2.184 . . . . 0.0 111.903 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 16.4 m 64.34 92.33 0.07 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.722 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.155 0 CA-C-O 118.166 -1.352 . . . . 0.0 110.796 -179.917 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.758 0 N-CA-C 111.531 -0.627 . . . . 0.0 111.531 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 CA--C 1.529 0.246 0 C-N-CA 122.613 2.209 . . . . 0.0 111.477 179.796 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.563 0 N-CA-C 112.466 -0.253 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo . . . . . 0 CA--C 1.529 0.254 0 C-N-CA 123.0 2.467 . . . . 0.0 112.025 -179.953 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.778 0 N-CA-C 111.698 -0.561 . . . . 0.0 111.698 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo . . . . . 0 CA--C 1.535 0.55 0 C-N-CA 122.803 2.335 . . . . 0.0 111.429 179.135 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.974 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -62.59 139.18 74.39 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.859 2.373 . . . . 0.0 111.869 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . 0.882 ' HG3' ' HG2' ' C' ' 110' ' ' PRO . 34.0 tt0 -64.97 150.04 48.7 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.27 157.3 24.07 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.198 -0.525 . . . . 0.0 113.198 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.499 ' H ' HG13 ' B' ' 13' ' ' ILE . 2.7 mt -71.21 153.93 8.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.47 150.47 47.17 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.384 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' D' ' 213' ' ' ILE . . . -72.72 160.03 53.88 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.15 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -71.49 145.29 49.29 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -68.76 140.65 55.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.794 0.331 . . . . 0.0 110.608 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.22 154.98 36.4 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.834 -0.621 . . . . 0.0 113.16 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 8.0 t -65.72 147.94 12.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.665 0.269 . . . . 0.0 110.6 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 3.9 t -54.32 148.69 2.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.335 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.36 154.46 53.19 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.31 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 71.7 mt . . . . . 0 C--N 1.32 -0.695 0 CA-C-O 120.482 0.182 . . . . 0.0 110.78 -179.834 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.643 0 N-CA-C 112.663 -0.175 . . . . 0.0 112.663 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 N--CA 1.461 -0.407 0 C-N-CA 122.638 2.225 . . . . 0.0 111.645 179.746 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.571 0 N-CA-C 112.868 -0.093 . . . . 0.0 112.868 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo . . . . . 0 C--O 1.237 0.453 0 C-N-CA 122.492 2.128 . . . . 0.0 111.432 179.639 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.565 0 CA-C-O 120.476 -0.069 . . . . 0.0 113.174 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo . . . . . 0 C--O 1.236 0.385 0 C-N-CA 122.969 2.446 . . . . 0.0 111.567 179.098 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.508 0 N-CA-C 112.253 -0.339 . . . . 0.0 112.253 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo . . . . . 0 CA--C 1.528 0.207 0 C-N-CA 122.917 2.412 . . . . 0.0 111.786 -179.783 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.565 0 CA-C-O 119.985 -0.342 . . . . 0.0 112.865 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo . . . . . 0 C--N 1.345 0.361 0 C-N-CA 123.498 2.798 . . . . 0.0 112.604 179.974 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.392 0 N-CA-C 112.552 -0.219 . . . . 0.0 112.552 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo . . . . . 0 CA--C 1.537 0.652 0 C-N-CA 123.216 2.611 . . . . 0.0 113.066 -179.421 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.633 0 N-CA-C 112.083 -0.407 . . . . 0.0 112.083 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo . . . . . 0 N--CA 1.461 -0.427 0 C-N-CA 122.648 2.232 . . . . 0.0 111.324 179.45 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.425 0 CA-C-O 120.704 0.058 . . . . 0.0 113.125 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 110' ' ' PRO . . . . . 0.882 ' HG2' ' HG3' ' B' ' 11' ' ' GLN . 37.4 Cg_endo -66.58 162.91 34.82 Favored 'Trans proline' 0 C--O 1.238 0.519 0 C-N-CA 122.577 2.185 . . . . 0.0 112.514 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -64.5 151.38 44.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.737 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 112' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' B' ' 13' ' ' ILE . . . -69.76 166.3 49.47 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.438 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . 0.468 ' H ' HG13 ' C' ' 113' ' ' ILE . 2.7 mt -67.11 144.34 14.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.01 140.73 58.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.408 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -59.38 147.68 42.07 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.277 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -69.73 153.59 43.16 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 122.47 0.308 . . . . 0.0 110.336 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 53.9 ttm-85 -71.77 150.51 44.34 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.83 164.05 46.63 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.26 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 8.8 t -68.97 144.32 14.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 120' ' ' VAL . . . . . 0.442 HG13 ' HB ' ' D' ' 219' ' ' VAL . 32.3 t -62.23 134.56 27.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.988 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.26 160.78 45.79 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.995 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 75.2 mt . . . . . 0 C--N 1.324 -0.536 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.682 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.617 0 N-CA-C 112.695 -0.162 . . . . 0.0 112.695 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo . . . . . 0 C--O 1.235 0.363 0 C-N-CA 122.68 2.253 . . . . 0.0 111.854 179.961 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 112.954 -0.059 . . . . 0.0 112.954 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo . . . . . 0 C--O 1.234 0.298 0 C-N-CA 122.506 2.137 . . . . 0.0 111.105 179.326 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.457 0 N-CA-C 113.289 0.075 . . . . 0.0 113.289 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.46 -0.489 0 C-N-CA 122.912 2.408 . . . . 0.0 111.275 179.903 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 CA-C-O 120.223 -0.209 . . . . 0.0 112.917 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo . . . . . 0 CA--C 1.532 0.39 0 C-N-CA 122.922 2.415 . . . . 0.0 112.06 179.804 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.504 0 CA-C-O 119.939 -0.367 . . . . 0.0 112.239 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 201' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo . . . . . 0 C--N 1.347 0.481 0 C-N-CA 123.148 2.566 . . . . 0.0 111.354 179.267 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.448 0 N-CA-C 114.667 0.627 . . . . 0.0 114.667 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo . . . . . 0 C--N 1.344 0.338 0 C-N-CA 123.673 2.915 . . . . 0.0 111.084 178.916 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 CA-C-O 120.385 -0.119 . . . . 0.0 112.879 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo . . . . . 0 N--CA 1.46 -0.482 0 C-N-CA 123.891 3.061 . . . . 0.0 112.182 179.843 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.571 0 N-CA-C 112.061 -0.416 . . . . 0.0 112.061 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.73 147.15 68.79 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.627 2.218 . . . . 0.0 112.088 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -65.24 151.41 46.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.629 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -71.79 169.44 50.47 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.358 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 213' ' ' ILE . . . . . 0.414 ' O ' ' HA3' ' B' ' 15' ' ' GLY . 32.3 pt -71.54 162.41 4.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 120.91 0.386 . . . . 0.0 111.052 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -79.76 142.21 35.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.084 0.469 . . . . 0.0 110.709 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -62.65 160.94 32.41 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.369 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -81.08 155.94 26.05 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -66.1 151.44 46.9 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.806 0.336 . . . . 0.0 110.815 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -62.4 157.4 37.07 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.862 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 219' ' ' VAL . . . . . 0.442 ' HB ' HG13 ' C' ' 120' ' ' VAL . 16.3 t -65.25 138.83 22.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 33.1 t -60.74 142.3 16.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.941 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.12 157.95 26.65 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.238 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.782 -0.209 . . . . 0.0 110.585 -179.952 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 224' ' ' GLY . . . . . 0.437 ' HA2' ' HD3' ' D' ' 225' ' ' PRO . . . . . . . . 0 N--CA 1.451 -0.349 0 CA-C-O 120.423 -0.098 . . . . 0.0 113.066 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 225' ' ' PRO . . . . . 0.437 ' HD3' ' HA2' ' D' ' 224' ' ' GLY . 17.7 Cg_exo . . . . . 0 C--O 1.236 0.382 0 C-N-CA 122.856 2.371 . . . . 0.0 111.352 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.534 0 CA-C-O 120.55 -0.028 . . . . 0.0 113.142 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo . . . . . 0 N--CA 1.461 -0.427 0 C-N-CA 122.906 2.404 . . . . 0.0 111.606 179.845 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.431 0 CA-C-O 120.378 -0.123 . . . . 0.0 113.08 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo . . . . . 0 C--N 1.341 0.175 0 C-N-CA 122.945 2.43 . . . . 0.0 111.777 179.844 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo . . . . . 0 N--CA 1.478 0.559 0 N-CA-C 110.241 -0.715 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' ASN . . . . . 0.594 ' O ' ' HB2' ' A' ' 320' ' ' ASP . 20.1 t-20 -110.82 163.36 13.86 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 18.8 tt -68.59 -23.13 27.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.372 0.606 . . . . 0.0 110.698 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 45.2 m -88.51 5.52 42.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.972 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.594 ' HB2' ' O ' ' A' ' 317' ' ' ASN . 0.2 OUTLIER -68.07 -37.42 81.24 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.058 0.456 . . . . 0.0 110.696 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 85.8 174.95 50.02 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.766 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 5.4 t30 58.86 76.48 0.35 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.207 0.527 . . . . 0.0 111.304 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -95.08 174.34 7.12 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.66 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -90.25 -39.03 13.02 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.528 HG22 ' HB2' ' A' ' 336' ' ' PHE . 4.5 t -170.1 152.19 4.19 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.507 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.427 HG22 HG13 ' A' ' 335' ' ' VAL . 82.0 t -136.19 120.76 26.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -144.49 -179.96 6.88 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.993 0.425 . . . . 0.0 111.547 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 48.7 ttp -126.59 128.64 47.14 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 80.1 mt -122.27 112.1 17.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.938 0.399 . . . . 0.0 110.705 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 62.58 28.41 16.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.421 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 101.6 -20.22 47.28 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.333 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . 0.583 ' HG3' HH22 ' A' ' 343' ' ' ARG . 4.8 mm-40 -94.87 136.8 34.75 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.701 0.251 . . . . 0.0 110.567 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' MET . . . . . 0.553 ' HB3' HG23 ' A' ' 344' ' ' VAL . 47.0 ttm -87.86 134.39 33.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.884 0.373 . . . . 0.0 111.377 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -122.86 121.79 37.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.657 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . 0.427 HG13 HG22 ' A' ' 326' ' ' VAL . 46.8 t -106.63 111.64 36.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' PHE . . . . . 0.528 ' HB2' HG22 ' A' ' 325' ' ' THR . 78.6 m-85 -96.47 130.02 43.71 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.772 0.32 . . . . 0.0 111.73 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 0.668 ' HB3' ' HZ3' ' A' ' 342' ' ' TRP . 38.9 tttp -144.11 112.91 6.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.672 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 62.2 -105.21 0.17 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.315 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -116.56 9.43 14.2 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.814 0.34 . . . . 0.0 111.567 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 8.2 m-90 -129.72 161.22 31.16 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.364 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -137.94 140.75 40.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.946 0.403 . . . . 0.0 111.064 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' TRP . . . . . 0.668 ' HZ3' ' HB3' ' A' ' 337' ' ' LYS . 10.6 m-90 -102.7 144.38 31.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.472 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.583 HH22 ' HG3' ' A' ' 332' ' ' GLU . 25.1 ttt-85 -115.76 106.07 13.44 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.553 HG23 ' HB3' ' A' ' 333' ' ' MET . 1.3 m -101.43 132.44 47.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.18 0.514 . . . . 0.0 111.531 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.63 111.48 9.44 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.936 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 14.1 m120 61.18 50.17 5.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.843 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 66.73 9.23 6.54 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.452 -0.795 . . . . 0.0 113.096 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . 0.434 HE21 ' HB2' ' A' ' 348' ' ' GLN . 3.3 mt-30 -121.45 137.87 54.53 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 122.391 -0.193 . . . . 0.0 111.058 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 38.4 t -79.58 123.82 36.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' MET . . . . . 0.453 ' SD ' ' HD3' ' A' ' 343' ' ' ARG . 83.5 mtp -66.34 148.84 51.28 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -66.98 153.05 44.59 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.56 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 84.83 10.11 79.62 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.672 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' TYR . . . . . 0.434 ' HB3' ' HA ' ' A' ' 354' ' ' PRO . 83.7 m-85 -123.74 158.83 58.34 Favored Pre-proline 0 C--N 1.326 -0.422 0 O-C-N 122.86 -0.2 . . . . 0.0 110.629 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.434 ' HA ' ' HB3' ' A' ' 353' ' ' TYR . 57.7 Cg_endo -70.51 149.67 90.78 Favored 'Cis proline' 0 C--N 1.349 0.569 0 C-N-CA 123.656 -1.393 . . . . 0.0 112.955 0.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 59.8 ttm -121.83 139.82 30.85 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.445 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -55.59 138.35 80.52 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.596 2.197 . . . . 0.0 111.406 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 89.4 mt -56.46 -40.58 68.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.597 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -70.46 -2.47 42.68 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 121.251 -0.499 . . . . 0.0 114.149 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.25 -39.8 14.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.125 0.488 . . . . 0.0 109.877 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -97.62 -56.33 2.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.266 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 51.9 m95 -93.73 73.91 4.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.691 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 33.7 ttp-105 -62.37 107.9 1.0 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.012 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 123.92 -18.65 7.49 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.558 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.601 HD12 ' HD2' ' A' ' 365' ' ' PRO . 29.8 tp -88.67 128.25 53.31 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.681 0.277 . . . . 0.0 110.552 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' PRO . . . . . 0.601 ' HD2' HD12 ' A' ' 364' ' ' LEU . 92.0 Cg_endo -79.91 -175.07 2.53 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.751 2.301 . . . . 0.0 112.277 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -87.89 160.3 18.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.328 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.1 m 55.31 87.22 0.05 Allowed 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 23.0 pt -105.8 163.91 4.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.174 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . 0.419 HD22 ' HA ' ' A' ' 369' ' ' ASN . 8.3 m120 -85.99 -56.7 3.34 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.677 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . 0.746 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.1 OUTLIER -155.23 171.22 20.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.073 -179.542 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -153.39 144.39 22.88 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -164.55 164.49 21.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.635 0.255 . . . . 0.0 111.039 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -89.77 130.77 35.98 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . 0.524 ' HB2' ' OE2' ' A' ' 440' ' ' GLU . 13.2 ptm180 -83.58 -174.92 5.56 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.699 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -68.22 -23.47 64.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.988 0.423 . . . . 0.0 111.473 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . 0.452 ' H ' ' HG3' ' A' ' 374' ' ' ARG . 0.0 OUTLIER -86.68 -24.32 25.28 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.553 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 121.25 -26.53 6.67 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.318 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' LYS . . . . . 0.44 ' HG2' ' HA ' ' A' ' 391' ' ' ASP . 32.8 mttp -63.85 154.86 32.34 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.094 0.473 . . . . 0.0 111.731 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -96.31 123.57 39.99 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.656 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 7.9 t -102.19 114.62 42.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.312 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . 0.529 ' HB2' ' HB2' ' A' ' 388' ' ' TRP . 87.5 m-85 -100.34 144.61 29.14 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -124.18 149.12 46.69 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.869 0.366 . . . . 0.0 111.87 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.483 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 85.5 tttt -157.42 97.27 1.61 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.676 ' O ' ' HA ' ' A' ' 414' ' ' LYS . . . 73.73 -108.45 2.51 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.211 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -114.91 7.74 15.73 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.931 0.396 . . . . 0.0 111.142 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -111.22 149.47 30.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.649 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . 0.416 ' NE2' ' HE1' ' A' ' 399' ' ' TYR . 28.9 p-80 -131.69 146.68 52.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.385 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' TRP . . . . . 0.529 ' HB2' ' HB2' ' A' ' 381' ' ' PHE . 17.4 m-90 -119.44 137.56 53.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.17 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 88.4 t -116.49 112.38 39.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -111.0 123.72 50.73 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.847 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.44 ' HA ' ' HG2' ' A' ' 378' ' ' LYS . 34.0 t70 -92.88 93.14 8.24 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 71.76 -79.43 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 O-C-N 123.695 0.622 . . . . 0.0 110.954 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -141.07 13.93 2.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.911 0.386 . . . . 0.0 110.648 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 5.5 m -123.48 131.8 53.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.267 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 58.4 tp -78.35 135.96 37.59 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.111 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 1.5 mt-10 -74.69 148.8 85.52 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.73 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 12.3 Cg_exo -72.58 143.32 37.9 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.928 2.418 . . . . 0.0 111.751 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 89.8 32.45 10.04 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.991 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' TYR . . . . . 0.512 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 80.3 m-85 -138.57 161.05 60.9 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.512 ' HA ' ' HB3' ' A' ' 399' ' ' TYR . 66.8 Cg_endo -74.13 154.7 99.76 Favored 'Cis proline' 0 C--N 1.346 0.409 0 C-N-CA 123.715 -1.369 . . . . 0.0 112.998 0.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 53.3 mttt -125.93 170.29 11.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.233 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 0.528 ' HB3' ' HG2' ' A' ' 404' ' ' LYS . 3.8 m-70 -73.0 155.64 39.63 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.971 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 41.5 mt -59.22 -34.23 53.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.196 0.522 . . . . 0.0 110.658 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.528 ' HG2' ' HB3' ' A' ' 402' ' ' HIS . 47.3 pttt -66.74 -17.59 64.94 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.013 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -78.02 -25.47 47.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.055 0.455 . . . . 0.0 110.111 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 49.9 tp -74.7 -45.33 45.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.567 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.73 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -164.76 147.7 13.06 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.505 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -81.34 140.94 34.47 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.918 0.389 . . . . 0.0 111.0 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 101.36 -3.28 54.26 Favored Glycine 0 CA--C 1.517 0.184 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.737 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 83.7 mt -85.48 149.04 50.94 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.472 0.177 . . . . 0.0 110.732 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.31 145.16 98.67 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.008 2.472 . . . . 0.0 111.863 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.79 11.14 22.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.059 0.457 . . . . 0.0 111.255 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -94.17 -56.34 2.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.672 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . 0.676 ' HA ' ' O ' ' A' ' 384' ' ' GLY . 18.1 ptmt -176.47 173.96 1.98 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.465 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 46.6 mm -123.17 135.04 64.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.866 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 430' ' ' PHE . 4.0 m-20 -89.14 -59.12 2.31 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.746 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -153.72 153.72 32.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.896 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -132.47 116.69 17.08 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 37.1 tp -107.64 125.61 51.55 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.377 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -96.67 113.3 24.85 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' TRP . . . . . 0.491 ' HB2' ' HE2' ' A' ' 428' ' ' TYR . 11.9 t-105 -82.17 99.3 9.17 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.517 ' HB2' ' HD3' ' A' ' 423' ' ' PRO . 66.5 mtt -53.37 -52.96 61.59 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.517 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 82.0 Cg_exo -47.22 -44.58 23.78 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.758 2.305 . . . . 0.0 115.319 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' ASN . . . . . 0.473 ' OD1' ' HB3' ' A' ' 421' ' ' TRP . 35.3 p30 -101.25 -21.58 14.86 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 78.4 37.03 28.76 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.693 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 23.4 mmtt -121.24 144.85 48.39 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . 0.628 ' HB ' ' HB3' ' A' ' 438' ' ' PHE . 15.0 m -97.95 132.17 43.75 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.045 0.45 . . . . 0.0 111.249 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' TYR . . . . . 0.491 ' HE2' ' HB2' ' A' ' 421' ' ' TRP . 83.0 m-85 -107.41 109.9 21.73 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -91.38 122.38 33.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.407 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' PHE . . . . . 0.439 ' O ' ' HB2' ' A' ' 416' ' ' ASP . 89.4 m-85 -100.36 131.82 46.08 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.737 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.402 ' HA ' ' HE ' ' A' ' 431' ' ' ARG . 3.1 tpm_? -144.0 108.95 4.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.893 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 66.05 -108.38 2.36 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -121.85 19.93 10.92 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.274 0.559 . . . . 0.0 110.668 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 42.3 mmtt -127.53 152.87 47.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.761 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' TYR . . . . . 0.505 ' CE1' ' HB2' ' A' ' 451' ' ' LYS . 3.9 p90 -132.76 139.86 47.76 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.825 0.345 . . . . 0.0 111.389 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -107.6 149.98 27.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.202 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -108.04 98.82 8.33 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . 0.73 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 69.5 t80 -81.31 124.63 29.51 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.782 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -93.73 104.85 16.93 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' GLU . . . . . 0.524 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 0.1 OUTLIER -58.09 -48.19 80.91 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.315 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.48 -50.66 72.34 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 88.4 mt -84.62 -12.95 52.98 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 23.6 mtp180 57.05 50.84 11.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.467 0.651 . . . . 0.0 111.704 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -159.65 169.63 23.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.684 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 86.5 t -89.19 133.13 32.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -64.34 161.63 16.46 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.368 0.417 . . . . 0.0 111.017 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 2.6 m -69.48 161.88 28.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.863 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 70.87 33.21 2.23 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.353 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . 0.404 ' HB3' ' HA ' ' A' ' 450' ' ' PRO . 32.2 m-85 -137.75 161.53 59.64 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.067 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . 0.404 ' HA ' ' HB3' ' A' ' 449' ' ' TYR . 85.0 Cg_endo -79.7 155.55 88.74 Favored 'Cis proline' 0 C--N 1.346 0.404 0 C-N-CA 123.477 -1.468 . . . . 0.0 112.522 0.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . 0.505 ' HB2' ' CE1' ' A' ' 435' ' ' TYR . 51.9 mttm -105.66 176.96 4.99 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.625 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . 0.401 ' O ' HG23 ' A' ' 455' ' ' VAL . 17.3 t-20 -75.2 140.73 43.47 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.0 tt -68.16 -14.62 18.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.94 0.4 . . . . 0.0 110.593 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -69.74 -1.62 9.67 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.302 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 452' ' ' ASN . 38.1 t -60.87 -37.71 77.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' TRP . . . . . 0.491 ' HB3' ' CE1' ' A' ' 486' ' ' PHE . 15.1 m95 -91.16 93.64 9.22 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . 0.434 ' HB3' ' HG3' ' A' ' 492' ' ' LYS . 3.2 tt0 -56.44 121.13 8.9 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 105.63 -15.03 45.94 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.722 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 25.6 mm -80.67 130.46 64.27 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 121.084 0.469 . . . . 0.0 111.245 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.04 158.24 30.59 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.733 2.289 . . . . 0.0 111.284 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -82.93 141.11 32.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.217 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.6 m 57.8 75.57 0.54 Allowed Pre-proline 0 N--CA 1.464 0.239 0 O-C-N 123.868 0.73 . . . . 0.0 112.855 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -90.5 179.86 1.77 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.689 2.259 . . . . 0.0 111.235 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 464' ' ' ARG . 0.0 OUTLIER -134.76 26.71 3.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.312 0.577 . . . . 0.0 110.42 179.692 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 175.01 137.96 2.63 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.38 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 20.9 p -161.04 99.77 1.22 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -128.99 143.9 51.02 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.839 0.352 . . . . 0.0 111.294 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 468' ' ' MET . . . . . 0.407 ' HA ' ' HA ' ' A' ' 475' ' ' THR . 34.7 ttm -86.33 143.21 27.98 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.853 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -72.81 163.77 54.85 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.511 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.44 -7.59 20.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.053 0.454 . . . . 0.0 111.648 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -90.9 -13.24 33.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.403 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 66.87 0.04 1.81 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 55.4 t -98.2 -36.38 5.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.845 0.355 . . . . 0.0 111.264 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -112.16 144.73 41.05 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 475' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 468' ' ' MET . 60.8 m -122.32 137.53 54.82 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -112.95 122.62 48.17 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.148 0.499 . . . . 0.0 112.29 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -101.97 150.57 23.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.645 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -130.07 133.37 46.65 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 44.1 tttt -170.51 140.91 1.85 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.86 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 60.14 32.62 76.73 Favored Glycine 0 C--N 1.328 0.104 0 C-N-CA 121.245 -0.502 . . . . 0.0 112.609 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . 0.92 HD21 ' HG ' ' A' ' 502' ' ' LEU . 1.7 t30 64.53 17.67 10.97 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.344 0.592 . . . . 0.0 111.785 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -122.81 158.48 30.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.485 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 483' ' ' TYR . . . . . 0.504 ' CE1' ' HB2' ' A' ' 499' ' ' LYS . 4.7 p90 -123.98 149.53 45.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.915 0.388 . . . . 0.0 111.93 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 20.1 m-90 -118.21 138.56 52.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.452 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -99.89 93.62 5.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.089 0.471 . . . . 0.0 109.746 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 486' ' ' PHE . . . . . 0.491 ' CE1' ' HB3' ' A' ' 456' ' ' TRP . 81.6 t80 -86.45 131.2 34.25 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.738 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . 0.432 ' HB3' ' HB2' ' A' ' 490' ' ' LYS . 36.1 t-20 -97.17 114.67 26.39 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -65.15 -28.69 69.59 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -178.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -84.29 -14.61 49.27 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 490' ' ' LYS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 487' ' ' ASN . 93.1 mttt -109.35 -26.3 10.1 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 68.86 30.8 4.56 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.857 0.837 . . . . 0.0 110.373 -178.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 492' ' ' LYS . . . . . 0.434 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 62.6 tttp -150.06 154.43 38.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.048 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 55.9 t -79.17 133.54 29.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -59.91 147.19 80.14 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.459 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -62.96 157.15 50.22 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 123.246 2.631 . . . . 0.0 112.972 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 83.91 27.19 38.65 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.874 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . 0.523 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 27.7 m-85 -129.75 165.87 30.1 Favored Pre-proline 0 C--N 1.327 -0.393 0 O-C-N 122.877 -0.19 . . . . 0.0 111.13 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . 0.523 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 87.4 Cg_endo -82.41 175.25 40.4 Favored 'Cis proline' 0 C--N 1.346 0.433 0 C-N-CA 123.74 -1.358 . . . . 0.0 112.871 0.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 499' ' ' LYS . . . . . 0.504 ' HB2' ' CE1' ' A' ' 483' ' ' TYR . 97.8 mttt -129.7 153.98 47.62 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.406 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 41.4 t -69.36 123.92 22.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.905 0.383 . . . . 0.0 110.484 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -67.75 -18.49 64.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.885 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 502' ' ' LEU . . . . . 0.92 ' HG ' HD21 ' A' ' 481' ' ' ASN . 13.7 mt -66.8 -46.32 75.6 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.921 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -80.94 -41.27 23.17 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.2 -45.2 34.32 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -177.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 35.0 m0 -100.12 -58.55 1.89 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 10.8 mmt -60.64 -41.28 94.62 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 98.5 25.62 9.91 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.611 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 3.5 m -110.62 103.4 54.27 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -81.32 178.59 6.59 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.509 2.139 . . . . 0.0 111.693 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 3.9 m 67.12 13.88 9.59 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.73 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.396 -1.225 . . . . 0.0 111.087 179.699 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.809 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' PRO . . . . . 0.435 ' HA ' HD23 ' B' ' 2' ' ' HYP . 1.8 Cg_endo -84.16 153.31 12.58 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 123.277 2.651 . . . . 0.0 111.397 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' HYP . . . . . 0.435 HD23 ' HA ' ' B' ' 1' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.76 169.31 38.38 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.71 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -72.34 163.93 37.17 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 122.986 2.458 . . . . 0.0 111.689 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' D' ' 202' ' ' HYP . . . -73.62 179.6 40.35 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.77 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.405 ' HD2' ' O ' ' D' ' 204' ' ' PRO . 52.9 Cg_exo -57.52 165.2 6.25 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 122.86 2.373 . . . . 0.0 111.22 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 151.39 170.63 18.48 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.019 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.76 142.99 95.72 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.855 2.37 . . . . 0.0 111.867 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -67.89 142.86 55.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.935 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' D' ' 210' ' ' PRO . . . -60.55 150.49 41.67 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.736 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.414 ' O ' ' HG3' ' D' ' 211' ' ' GLN . 17.4 mt -68.28 147.8 12.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.74 151.57 46.48 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.837 0.351 . . . . 0.0 110.447 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' D' ' 213' ' ' ILE . . . -66.35 162.46 43.88 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.299 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -68.94 148.72 49.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.771 0.319 . . . . 0.0 110.426 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.18 145.0 54.74 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.216 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.2 143.43 47.45 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.948 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.459 ' HB ' ' HG2' ' D' ' 217' ' ' ARG . 2.5 t -69.49 159.24 5.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 4.6 t -55.79 143.27 9.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.901 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.53 171.48 54.86 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.498 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 97.2 mt -81.0 142.91 32.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.599 0.238 . . . . 0.0 110.686 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.32 163.78 48.4 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.874 -0.603 . . . . 0.0 113.22 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.46 154.81 31.78 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 122.921 2.414 . . . . 0.0 111.859 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.11 162.98 41.03 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.431 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.94 165.82 31.74 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.886 2.39 . . . . 0.0 111.512 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.44 168.17 53.62 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.641 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.98 155.98 52.1 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 123.056 2.504 . . . . 0.0 112.213 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.13 133.16 45.88 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.943 -0.571 . . . . 0.0 113.237 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . 0.473 ' HA ' HD23 ' B' ' 35' ' ' HYP . 40.2 Cg_endo -67.66 116.12 4.09 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.88 2.387 . . . . 0.0 111.193 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' HYP . . . . . 0.473 HD23 ' HA ' ' B' ' 34' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.461 0 CA-C-O 120.109 -0.273 . . . . 0.0 112.637 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 101' ' ' PRO . . . . . 0.503 ' HA ' HD23 ' C' ' 102' ' ' HYP . 39.1 Cg_exo -59.55 135.95 67.93 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 123.369 2.712 . . . . 0.0 112.702 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 102' ' ' HYP . . . . . 0.689 ' HA ' ' HD2' ' D' ' 201' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 103' ' ' GLY . . . . . 0.44 ' O ' ' HD3' ' D' ' 204' ' ' PRO . . . -75.44 161.26 52.71 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.465 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -83.18 160.49 15.38 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.861 2.374 . . . . 0.0 112.449 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 105' ' ' HYP . . . . . 0.469 ' OD1' ' HG2' ' D' ' 204' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -83.62 -170.91 47.06 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.425 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -74.72 154.45 43.95 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.776 2.317 . . . . 0.0 111.197 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 108' ' ' HYP . . . . . 0.443 ' HA ' ' HG2' ' D' ' 207' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -57.87 167.04 5.82 Favored Glycine 0 CA--C 1.521 0.429 0 CA-C-N 115.832 -0.622 . . . . 0.0 113.465 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.03 157.34 62.2 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.814 2.343 . . . . 0.0 112.576 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -60.02 137.69 58.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.529 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -67.53 164.11 45.64 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.88 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 40.5 mt -67.22 144.46 14.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.42 148.04 50.15 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -63.17 147.22 50.56 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.119 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -75.17 149.97 38.84 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 122.753 -0.263 . . . . 0.0 110.366 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 9.5 ttm-85 -59.09 141.06 55.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.935 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.95 170.47 33.15 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.973 -0.558 . . . . 0.0 113.428 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 119' ' ' VAL . . . . . 0.452 ' O ' ' HA3' ' D' ' 218' ' ' GLY . 23.5 t -71.85 139.88 19.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.563 -0.319 . . . . 0.0 110.514 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 21.4 t -60.22 141.8 16.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.507 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.51 163.9 34.97 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.446 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 122' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' C' ' 123' ' ' HYP . 67.3 mt -77.21 141.53 40.02 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.895 -0.179 . . . . 0.0 110.722 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 123' ' ' HYP . . . . . 0.405 HD23 ' HA ' ' C' ' 122' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -64.6 161.24 39.62 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.849 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.49 154.73 35.84 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 122.661 2.241 . . . . 0.0 112.369 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 126' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -72.51 169.34 52.03 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.705 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 128' ' ' PRO . . . . . 0.444 ' HA ' HD23 ' C' ' 129' ' ' HYP . 70.8 Cg_endo -75.66 152.13 37.41 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.758 2.305 . . . . 0.0 112.046 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 129' ' ' HYP . . . . . 0.444 HD23 ' HA ' ' C' ' 128' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -62.52 167.46 19.26 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 116.057 -0.52 . . . . 0.0 113.134 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 131' ' ' PRO . . . . . 0.404 ' HA ' HD23 ' C' ' 132' ' ' HYP . 5.6 Cg_exo -75.36 154.55 40.9 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 123.098 2.532 . . . . 0.0 111.855 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 132' ' ' HYP . . . . . 0.563 ' HA ' ' O ' ' D' ' 231' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.03 136.52 18.32 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.955 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 134' ' ' PRO . . . . . 0.432 ' HA ' HD23 ' C' ' 135' ' ' HYP . 23.0 Cg_endo -61.87 114.8 2.44 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.971 2.448 . . . . 0.0 112.132 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 135' ' ' HYP . . . . . 0.432 HD23 ' HA ' ' C' ' 134' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 N-CA-C 112.205 -0.358 . . . . 0.0 112.205 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 201' ' ' PRO . . . . . 0.689 ' HD2' ' HA ' ' C' ' 102' ' ' HYP . 52.3 Cg_exo -57.92 138.52 86.42 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.893 2.395 . . . . 0.0 111.412 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 202' ' ' HYP . . . . . 0.486 ' O ' ' HA2' ' B' ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 203' ' ' GLY . . . . . 0.409 ' HA2' ' HD3' ' D' ' 204' ' ' PRO . . . 72.41 155.57 2.7 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 114.381 0.512 . . . . 0.0 114.381 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 204' ' ' PRO . . . . . 0.469 ' HG2' ' OD1' ' C' ' 105' ' ' HYP . 17.0 Cg_exo -71.25 162.89 40.98 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.174 2.582 . . . . 0.0 110.99 178.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 205' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . 97.83 173.64 33.35 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.492 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 207' ' ' PRO . . . . . 0.443 ' HG2' ' HA ' ' C' ' 108' ' ' HYP . 94.6 Cg_endo -90.8 156.65 4.12 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 123.516 2.811 . . . . 0.0 112.208 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 208' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -75.78 169.95 54.7 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.425 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 210' ' ' PRO . . . . . 0.461 ' O ' ' HA3' ' B' ' 12' ' ' GLY . 58.8 Cg_endo -73.78 157.35 47.97 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.549 2.166 . . . . 0.0 112.273 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 211' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' B' ' 13' ' ' ILE . 34.9 tt0 -78.1 144.33 36.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.595 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -68.08 166.32 44.49 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.824 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 213' ' ' ILE . . . . . 0.485 ' O ' ' HA3' ' B' ' 15' ' ' GLY . 45.4 pt -68.29 164.73 2.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 120.835 0.35 . . . . 0.0 110.984 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -81.06 147.58 30.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.108 0.48 . . . . 0.0 111.381 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -71.89 153.02 49.59 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.411 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 48.8 mm-40 -71.55 150.6 44.61 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 217' ' ' ARG . . . . . 0.459 ' HG2' ' HB ' ' B' ' 19' ' ' VAL . 60.0 mtp180 -64.63 160.18 20.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.185 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 218' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' C' ' 119' ' ' VAL . . . -62.14 156.85 36.93 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.206 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.15 152.28 9.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.5 137.25 25.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -56.68 166.63 4.51 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.918 -0.583 . . . . 0.0 114.237 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 8.6 mp -72.25 153.32 41.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.719 -0.241 . . . . 0.0 110.736 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 223' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -60.81 153.51 37.44 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 116.113 -0.494 . . . . 0.0 113.299 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 225' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -70.17 147.99 61.44 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.838 2.359 . . . . 0.0 111.109 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 226' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -63.18 166.37 24.96 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.062 -0.59 . . . . 0.0 113.158 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -79.2 160.79 26.33 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.682 2.255 . . . . 0.0 111.716 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -64.99 167.45 30.78 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.86 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 231' ' ' PRO . . . . . 0.563 ' O ' ' HA ' ' C' ' 132' ' ' HYP . 96.3 Cg_endo -82.74 156.84 15.93 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.642 2.228 . . . . 0.0 111.079 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 232' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.478 0.6 0 N-CA-C 110.378 -0.662 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -106.48 160.03 15.72 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.975 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.4 ' O ' ' HZ ' ' A' ' 323' ' ' PHE . 19.8 tt -75.9 -23.59 16.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.003 0.43 . . . . 0.0 111.474 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 21.4 m -80.52 0.18 34.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.283 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -67.6 -34.48 77.1 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.948 0.404 . . . . 0.0 111.178 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . 0.434 ' HA2' HD21 ' A' ' 502' ' ' LEU . . . 82.55 -171.66 51.53 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.213 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 5.0 t30 52.41 74.04 0.3 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.18 0.514 . . . . 0.0 111.139 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' PHE . . . . . 0.491 ' HD1' ' HB2' ' A' ' 337' ' ' LYS . 73.6 m-85 -95.67 162.76 13.48 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.427 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -77.0 -35.25 57.28 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.244 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 6.7 t -178.33 155.68 0.91 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.528 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.553 HG22 HG13 ' A' ' 335' ' ' VAL . 48.4 t -133.96 127.14 51.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -144.27 172.08 13.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.997 0.427 . . . . 0.0 111.67 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 38.6 ttp -126.28 113.74 17.36 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 50.9 mt -106.88 116.53 32.08 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.567 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.494 ' NH1' ' HB3' ' D' ' 214' ' ' ALA . 69.3 mtp180 57.9 27.45 14.65 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 98.18 -5.75 61.3 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.923 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -101.52 122.43 43.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.902 0.382 . . . . 0.0 111.131 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 56.7 ttm -81.45 120.81 25.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.194 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -119.24 126.76 52.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.756 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . 0.553 HG13 HG22 ' A' ' 326' ' ' VAL . 25.5 t -107.73 119.78 57.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.434 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -95.35 121.13 36.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.012 0.434 . . . . 0.0 112.145 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 0.491 ' HB2' ' HD1' ' A' ' 323' ' ' PHE . 52.4 tptt -130.18 99.56 5.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.686 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 62.4 -102.9 0.12 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.02 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -116.77 13.69 15.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.1 0.476 . . . . 0.0 111.026 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 20.1 m-90 -128.88 142.9 50.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.544 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.502 ' CE2' ' HE2' ' A' ' 353' ' ' TYR . 12.6 p90 -122.35 135.49 54.72 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.937 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' TRP . . . . . 0.436 ' HZ3' ' HB3' ' A' ' 337' ' ' LYS . 1.9 m-90 -100.15 151.95 20.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.572 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.515 ' HD2' ' CE1' ' A' ' 353' ' ' TYR . 14.8 ttt-85 -120.78 100.47 7.12 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 5.2 m -112.52 131.45 64.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.204 0.526 . . . . 0.0 112.09 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 6.3 ttm-85 -139.33 112.63 8.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.337 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 1.5 m120 72.97 49.78 0.15 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 61.67 24.46 14.56 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.487 178.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -143.45 145.75 32.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.053 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 22.2 t -83.41 135.75 24.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' MET . . . . . 0.454 ' SD ' ' HD3' ' A' ' 343' ' ' ARG . 87.9 mtp -83.2 156.07 23.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.995 0.426 . . . . 0.0 111.418 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -69.92 150.12 47.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.407 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . 0.665 ' HA3' HD11 ' B' ' 13' ' ' ILE . . . 95.04 -8.51 70.13 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.268 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' TYR . . . . . 0.569 ' HB3' ' HA ' ' A' ' 354' ' ' PRO . 32.8 m-85 -119.21 164.01 23.65 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.569 ' HA ' ' HB3' ' A' ' 353' ' ' TYR . 59.1 Cg_endo -70.58 159.82 91.55 Favored 'Cis proline' 0 C--N 1.348 0.501 0 C-N-CA 123.856 -1.31 . . . . 0.0 112.813 0.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 42.5 ttm -134.68 141.78 40.02 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.232 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -60.93 140.09 88.41 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.416 2.077 . . . . 0.0 111.165 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 78.7 mt -56.95 -44.15 81.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.605 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -69.86 3.04 10.38 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 114.283 0.473 . . . . 0.0 114.283 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.09 -46.5 7.41 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -93.79 -53.55 3.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.132 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -84.77 73.19 10.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.831 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 30.4 ttp-105 -64.46 93.88 0.11 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.187 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 129.72 -7.28 6.17 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.035 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.681 HD12 ' HD2' ' A' ' 365' ' ' PRO . 33.8 tp -99.41 126.37 37.85 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-O 120.57 0.224 . . . . 0.0 110.533 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' PRO . . . . . 0.681 ' HD2' HD12 ' A' ' 364' ' ' LEU . 73.9 Cg_endo -74.62 175.09 11.56 Favored 'Trans proline' 0 CA--C 1.528 0.216 0 C-N-CA 122.624 2.216 . . . . 0.0 111.961 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -85.8 154.91 21.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.494 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 35.0 m 55.5 82.41 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 22.7 pt -95.17 -171.22 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.29 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . 0.432 HD22 ' HA ' ' A' ' 369' ' ' ASN . 8.1 m120 -108.99 -47.7 3.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.724 0.297 . . . . 0.0 111.193 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . 0.876 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.3 OUTLIER -156.44 166.34 33.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.848 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -153.4 145.51 23.77 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . 0.442 ' HD2' ' HB2' ' A' ' 420' ' ' PHE . 2.0 p90 -161.42 159.94 28.8 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.129 0.49 . . . . 0.0 112.221 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -89.63 121.18 31.57 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 378' ' ' LYS . 6.2 ptm180 -78.1 177.97 7.91 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.434 ' HE3' ' HA3' ' A' ' 425' ' ' GLY . 70.2 tttt -68.3 -38.2 81.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.863 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -31.63 71.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.632 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 129.66 -32.82 3.11 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.51 -0.852 . . . . 0.0 113.043 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' LYS . . . . . 0.49 ' O ' ' HG2' ' A' ' 374' ' ' ARG . 35.6 mttm -65.66 157.56 29.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.073 0.463 . . . . 0.0 111.696 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . 0.449 ' HE1' ' HG3' ' A' ' 330' ' ' ARG . 16.4 m-85 -98.67 135.04 40.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.993 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 4.7 t -113.24 121.65 65.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.842 0.353 . . . . 0.0 110.668 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -108.51 138.26 45.11 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.436 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -120.29 143.5 48.3 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.826 0.346 . . . . 0.0 111.584 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.515 ' HB3' ' CZ3' ' A' ' 388' ' ' TRP . 83.6 tttt -158.34 105.75 1.91 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.517 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 76.33 -114.84 4.26 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.556 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -114.19 4.0 15.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.932 0.396 . . . . 0.0 110.7 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -112.6 155.92 23.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.847 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -136.3 146.78 47.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.944 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' TRP . . . . . 0.515 ' CZ3' ' HB3' ' A' ' 383' ' ' LYS . 20.5 m-90 -121.88 132.51 54.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.061 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 95.0 t -111.88 119.49 60.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -111.21 130.96 55.48 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.342 0.591 . . . . 0.0 112.211 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -95.31 87.82 4.94 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . 0.53 ' OE1' ' HB ' ' D' ' 213' ' ' ILE . 38.1 mm-40 67.35 -79.54 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.604 0.565 . . . . 0.0 110.539 -178.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -137.7 19.32 2.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.234 0.54 . . . . 0.0 109.991 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 8.1 m -121.12 157.79 29.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.782 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 64.9 tp -104.43 135.95 44.92 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.629 0.252 . . . . 0.0 110.829 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 24.9 mm-40 -70.57 125.89 92.11 Favored Pre-proline 0 C--O 1.232 0.184 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.047 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 31.9 Cg_exo -59.92 136.35 69.2 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.873 2.382 . . . . 0.0 111.842 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 101.04 -8.37 57.52 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.716 -0.755 . . . . 0.0 111.798 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' TYR . . . . . 0.402 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 22.6 m-85 -93.89 161.02 31.26 Favored Pre-proline 0 C--N 1.321 -0.659 0 O-C-N 122.85 -0.206 . . . . 0.0 110.815 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.458 ' HB3' ' NE1' ' A' ' 388' ' ' TRP . 74.0 Cg_endo -75.04 166.55 82.96 Favored 'Cis proline' 0 C--N 1.346 0.434 0 C-N-CA 123.819 -1.325 . . . . 0.0 112.943 0.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -137.66 163.04 32.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.388 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 0.517 ' HB2' ' HG2' ' A' ' 404' ' ' LYS . 8.6 m-70 -71.01 150.6 45.47 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 79.2 mt -54.61 -33.5 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 120.887 0.375 . . . . 0.0 111.33 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.517 ' HG2' ' HB2' ' A' ' 402' ' ' HIS . 19.4 pttp -64.22 -15.13 59.38 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.193 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -81.93 -20.22 39.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.911 0.386 . . . . 0.0 111.102 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 38.3 tp -74.94 -48.85 22.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.084 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.739 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -162.82 155.74 27.19 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.687 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -81.58 130.92 35.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.791 0.329 . . . . 0.0 110.939 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 102.29 1.76 50.91 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.308 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 51.3 mt -79.46 156.34 75.9 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 120.49 0.186 . . . . 0.0 111.026 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' PRO . . . . . 0.469 ' HG3' ' CE1' ' A' ' 436' ' ' TYR . 30.6 Cg_exo -61.51 118.14 5.0 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.614 2.209 . . . . 0.0 111.525 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.04 -3.5 59.09 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.99 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -92.3 -56.67 2.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.448 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 9.5 ptmt -176.38 171.8 2.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.863 0.363 . . . . 0.0 110.723 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 39.6 mm -117.16 133.09 65.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.694 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . 0.503 ' HB3' ' HD2' ' A' ' 463' ' ' PRO . 14.7 m-20 -90.79 -48.85 6.78 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.876 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -156.43 154.28 30.2 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.138 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -135.19 113.55 11.46 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 42.3 tp -107.94 132.69 53.22 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.269 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . 0.442 ' HB2' ' HD2' ' A' ' 372' ' ' TYR . 29.2 t80 -98.12 116.67 30.82 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.966 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' TRP . . . . . 0.409 ' HB2' ' CE1' ' A' ' 428' ' ' TYR . 9.4 t-105 -89.5 97.05 10.97 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.417 ' HB2' ' HD3' ' A' ' 423' ' ' PRO . 62.7 mtt -55.31 -50.81 84.56 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.417 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 81.7 Cg_exo -45.78 -53.33 5.78 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 123.151 2.567 . . . . 0.0 114.662 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 42.4 p30 -95.62 -10.67 28.84 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . 0.434 ' HA3' ' HE3' ' A' ' 375' ' ' LYS . . . 66.89 51.99 36.36 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.921 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -138.42 160.94 38.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.671 0.272 . . . . 0.0 111.03 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . 0.492 ' HB ' ' HB3' ' A' ' 438' ' ' PHE . 26.5 m -105.7 133.26 50.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.067 0.461 . . . . 0.0 111.525 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' TYR . . . . . 0.409 ' CE1' ' HB2' ' A' ' 421' ' ' TRP . 17.0 m-85 -110.31 110.77 21.69 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -93.97 138.97 31.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.509 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' PHE . . . . . 0.455 ' O ' ' HB2' ' A' ' 416' ' ' ASP . 95.0 m-85 -114.1 136.73 52.61 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.331 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.466 ' HA ' ' HE ' ' A' ' 431' ' ' ARG . 2.6 tpm_? -148.27 105.18 3.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.809 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 68.1 -109.89 3.14 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -115.12 11.4 16.35 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.23 0.538 . . . . 0.0 110.009 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . 0.622 ' HD2' ' HG2' ' A' ' 450' ' ' PRO . 19.6 mmtt -117.01 150.48 38.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.156 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' TYR . . . . . 0.447 ' CE2' ' HE1' ' A' ' 449' ' ' TYR . 5.1 p90 -131.41 140.26 49.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.589 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' TYR . . . . . 0.469 ' CE1' ' HG3' ' A' ' 411' ' ' PRO . 2.3 m-85 -110.5 144.38 39.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.497 -178.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -106.14 96.65 6.63 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . 0.739 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 79.5 t80 -80.85 128.49 33.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.125 -177.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -96.74 97.87 9.69 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' GLU . . . . . 0.445 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 1.3 mm-40 -44.95 -60.61 1.98 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -56.23 -36.35 68.4 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 67.1 mt -88.73 -20.56 24.65 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 67.0 mtp180 61.96 48.55 5.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.557 0.694 . . . . 0.0 110.847 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -162.03 164.53 28.17 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.749 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.0 t -88.62 138.74 18.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -61.97 166.4 4.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.201 0.524 . . . . 0.0 112.147 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.46 152.0 46.04 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 68.81 22.74 7.15 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.668 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . 0.447 ' HE1' ' CE2' ' A' ' 435' ' ' TYR . 31.2 m-85 -118.21 158.26 46.89 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.114 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . 0.622 ' HG2' ' HD2' ' A' ' 434' ' ' LYS . 91.9 Cg_endo -77.75 151.71 91.89 Favored 'Cis proline' 0 C--N 1.344 0.332 0 C-N-CA 123.643 -1.399 . . . . 0.0 113.521 0.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -102.38 177.09 4.97 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.847 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -75.24 140.93 43.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.573 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.2 tt -69.79 -11.5 14.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.909 0.385 . . . . 0.0 110.974 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -63.84 -6.31 5.68 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 70.7 t -67.54 -33.6 63.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 10.0 m95 -95.46 84.84 4.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.253 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -57.4 115.71 2.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.187 0.518 . . . . 0.0 112.358 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 115.17 -26.47 9.2 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.097 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.452 HD11 ' HB2' ' A' ' 486' ' ' PHE . 31.7 mm -73.47 130.48 83.96 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.714 0.292 . . . . 0.0 111.067 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.0 156.15 23.32 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.825 2.35 . . . . 0.0 111.869 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -77.57 141.09 39.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.412 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 5.2 m 58.0 74.59 0.62 Allowed Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . 0.503 ' HD2' ' HB3' ' A' ' 416' ' ' ASP . 2.4 Cg_endo -81.84 -173.87 1.94 Allowed 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.866 2.378 . . . . 0.0 112.017 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.87 20.37 3.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.239 0.542 . . . . 0.0 110.528 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 161.36 142.48 3.4 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.592 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 7.8 p -156.75 106.77 2.3 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -127.48 138.34 52.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.923 0.392 . . . . 0.0 111.613 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 46.2 ttm -90.31 142.06 28.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.291 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -71.18 162.26 54.16 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.917 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.7 -12.46 46.86 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 16.9 p30 -85.27 -13.2 50.52 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.623 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 66.98 10.84 7.99 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.14 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 40.1 t -104.43 -42.9 7.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.601 0.239 . . . . 0.0 111.44 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 474' ' ' PHE . . . . . 0.411 ' CD1' ' HE2' ' A' ' 485' ' ' LYS . 80.9 m-85 -112.05 144.84 40.74 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 97.8 m -126.99 134.31 50.38 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.316 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -101.82 124.89 48.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.954 0.407 . . . . 0.0 111.716 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 477' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 483' ' ' TYR . 14.6 m-85 -110.22 131.41 55.08 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -115.26 137.76 51.68 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.665 0.269 . . . . 0.0 111.669 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 479' ' ' LYS . . . . . 0.467 ' HB3' ' CZ3' ' A' ' 484' ' ' TRP . 79.5 tttt -163.01 104.1 1.0 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.961 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 65.94 66.03 2.6 Favored Glycine 0 CA--C 1.518 0.268 0 N-CA-C 114.828 0.691 . . . . 0.0 114.828 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 61.84 -1.2 0.37 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 482' ' ' LYS . . . . . 0.441 ' HB2' ' HE2' ' A' ' 482' ' ' LYS . 30.3 mtmm -119.56 148.02 43.8 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 122.291 -0.256 . . . . 0.0 110.526 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 483' ' ' TYR . . . . . 0.543 ' CE2' ' HE2' ' A' ' 497' ' ' TYR . 11.0 p90 -127.95 147.55 50.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.174 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 484' ' ' TRP . . . . . 0.467 ' CZ3' ' HB3' ' A' ' 479' ' ' LYS . 17.4 m-90 -113.04 143.84 43.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.879 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . 0.411 ' HE2' ' CD1' ' A' ' 474' ' ' PHE . 74.0 tttt -104.35 97.08 7.07 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 486' ' ' PHE . . . . . 0.452 ' HB2' HD11 ' A' ' 459' ' ' ILE . 89.4 t80 -90.68 134.54 34.33 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.477 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -98.63 119.27 37.06 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -68.52 -32.93 73.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.199 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -74.84 -43.14 56.16 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.701 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -85.24 -22.56 28.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.131 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 3.7 tp 65.56 42.67 3.6 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.525 0.679 . . . . 0.0 109.889 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 492' ' ' LYS . . . . . 0.412 ' HG2' ' N ' ' A' ' 493' ' ' VAL . 16.1 tttp -156.96 153.89 28.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.61 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 486' ' ' PHE . 69.9 t -85.15 140.18 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -61.48 131.46 92.54 Favored Pre-proline 0 C--O 1.234 0.278 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.264 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -62.11 141.84 90.04 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.669 2.246 . . . . 0.0 111.682 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 109.56 -10.24 32.83 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . 0.613 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 14.0 m-85 -94.73 170.46 8.02 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.61 -0.295 . . . . 0.0 110.333 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . 0.613 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 91.9 Cg_endo -78.88 169.5 72.11 Favored 'Cis proline' 0 C--N 1.349 0.604 0 C-N-CA 123.978 -1.259 . . . . 0.0 113.253 0.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -120.85 157.65 29.34 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.774 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 47.6 t -69.84 112.91 6.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.973 0.416 . . . . 0.0 110.263 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -66.55 -23.73 66.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.074 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 502' ' ' LEU . . . . . 0.485 ' HA ' ' HG2' ' A' ' 506' ' ' MET . 79.1 mt -65.94 -39.25 90.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.114 0.483 . . . . 0.0 110.711 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -89.06 -39.69 13.47 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.587 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.0 -36.67 61.97 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 42.9 m0 -106.37 -57.44 2.05 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 506' ' ' MET . . . . . 0.485 ' HG2' ' HA ' ' A' ' 502' ' ' LEU . 7.1 mmt -65.84 -35.42 80.63 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 91.67 38.03 5.95 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.218 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 23.0 m -115.74 86.95 16.75 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.3 160.69 48.06 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.475 2.117 . . . . 0.0 111.737 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 5.7 m 66.4 69.71 0.42 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.166 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.23 0 CA-C-O 118.306 -1.274 . . . . 0.0 111.258 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.766 0 N-CA-C 112.429 -0.268 . . . . 0.0 112.429 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' PRO . . . . . 0.443 ' HA ' HD23 ' B' ' 2' ' ' HYP . 60.0 Cg_endo -72.7 143.63 37.98 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.745 2.297 . . . . 0.0 112.471 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' HYP . . . . . 0.443 HD23 ' HA ' ' B' ' 1' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -85.76 161.15 34.74 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.181 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -80.77 161.57 21.45 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.488 2.126 . . . . 0.0 110.404 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.27 -136.02 1.23 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.887 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.422 ' HA ' HD23 ' B' ' 8' ' ' HYP . 34.4 Cg_exo -61.55 154.16 61.6 Favored 'Trans proline' 0 CA--C 1.527 0.154 0 C-N-CA 122.943 2.428 . . . . 0.0 111.766 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' HYP . . . . . 0.629 ' HA ' ' HD2' ' C' ' 107' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.03 160.23 17.84 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.062 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.35 149.77 69.89 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 123.006 2.471 . . . . 0.0 112.061 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -65.17 145.56 56.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.494 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.41 155.96 46.21 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.249 -0.5 . . . . 0.0 112.318 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.665 HD11 ' HA3' ' A' ' 352' ' ' GLY . 6.9 mt -67.44 147.28 12.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.572 0.225 . . . . 0.0 110.778 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.41 147.29 53.09 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.797 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' D' ' 213' ' ' ILE . . . -75.77 162.08 52.79 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.0 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -72.94 150.47 42.51 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -75.16 152.41 38.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.191 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' D' ' 216' ' ' GLN . . . -67.84 154.23 53.01 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.648 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 3.2 t -71.99 152.32 8.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 2.9 t -51.33 145.24 2.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 O-C-N 123.499 0.499 . . . . 0.0 110.948 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.39 160.12 53.99 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.739 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' B' ' 23' ' ' HYP . 94.0 mt -71.82 148.13 46.52 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.479 0.181 . . . . 0.0 110.604 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' HYP . . . . . 0.402 HD23 ' HA ' ' B' ' 22' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.73 154.66 48.76 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.451 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.439 ' HA ' HD23 ' B' ' 26' ' ' HYP . 38.3 Cg_endo -67.22 153.23 77.93 Favored 'Trans proline' 0 CA--C 1.529 0.258 0 C-N-CA 122.752 2.301 . . . . 0.0 111.764 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' HYP . . . . . 0.439 HD23 ' HA ' ' B' ' 25' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.93 155.38 53.2 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.723 -0.672 . . . . 0.0 113.399 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.3 166.95 26.72 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 123.244 2.629 . . . . 0.0 112.035 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.34 173.11 51.48 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.878 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.448 ' HA ' HD23 ' B' ' 32' ' ' HYP . 30.1 Cg_exo -64.07 157.52 52.86 Favored 'Trans proline' 0 CA--C 1.528 0.224 0 C-N-CA 123.176 2.584 . . . . 0.0 111.853 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' HYP . . . . . 0.448 HD23 ' HA ' ' B' ' 31' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.4 155.1 53.39 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.333 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . 0.403 ' HG2' ' HB2' ' D' ' 232' ' ' HYP . 69.2 Cg_endo -75.21 156.49 42.09 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.685 2.256 . . . . 0.0 111.479 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.402 0 CA-C-O 120.224 -0.209 . . . . 0.0 112.64 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 101' ' ' PRO . . . . . 0.408 ' HA ' HD23 ' C' ' 102' ' ' HYP . 11.5 Cg_exo -72.25 133.18 20.63 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 123.057 2.505 . . . . 0.0 111.142 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 102' ' ' HYP . . . . . 0.524 ' HA ' ' HD2' ' D' ' 201' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 103' ' ' GLY . . . . . 0.417 ' HA2' ' HD3' ' C' ' 104' ' ' PRO . . . -61.63 160.85 28.28 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.832 -0.622 . . . . 0.0 113.689 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 104' ' ' PRO . . . . . 0.417 ' HD3' ' HA2' ' C' ' 103' ' ' GLY . 2.8 Cg_exo -77.47 164.79 28.21 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 123.528 2.819 . . . . 0.0 112.413 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 105' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -84.22 -176.05 50.99 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.421 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 107' ' ' PRO . . . . . 0.629 ' HD2' ' HA ' ' B' ' 8' ' ' HYP . 83.1 Cg_endo -82.14 158.09 17.71 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 122.981 2.454 . . . . 0.0 111.756 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 108' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -58.22 167.47 6.04 Favored Glycine 0 N--CA 1.452 -0.243 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.553 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.19 156.82 64.36 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.66 2.24 . . . . 0.0 112.085 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -59.33 135.86 57.78 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.06 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -62.01 162.16 27.63 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.563 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 16.3 mt -69.3 134.73 29.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.621 0.248 . . . . 0.0 110.68 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.26 146.52 47.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.679 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -64.94 157.04 46.62 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 121.205 -0.521 . . . . 0.0 113.002 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -84.3 152.4 24.16 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 117' ' ' ARG . . . . . 0.412 ' HE ' ' HB2' ' C' ' 117' ' ' ARG . 4.6 ttm180 -66.5 148.52 51.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.328 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.07 171.91 41.65 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.027 -0.606 . . . . 0.0 113.053 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 15.9 t -72.85 142.49 15.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 97.3 t -62.9 138.39 22.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.954 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.46 158.52 39.32 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 116.081 -0.508 . . . . 0.0 112.538 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 59.1 mt -73.62 142.02 46.53 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.852 -0.174 . . . . 0.0 110.642 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 123' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -64.74 158.41 44.13 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.673 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 125' ' ' PRO . . . . . 0.423 ' HA ' HD23 ' C' ' 126' ' ' HYP . 36.4 Cg_endo -65.59 146.39 84.39 Favored 'Trans proline' 0 N--CA 1.464 -0.209 0 C-N-CA 122.475 2.117 . . . . 0.0 111.116 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 126' ' ' HYP . . . . . 0.423 HD23 ' HA ' ' C' ' 125' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -66.06 156.05 50.25 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.774 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.08 166.27 26.86 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.82 2.347 . . . . 0.0 111.552 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -70.58 -177.87 24.15 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.451 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 131' ' ' PRO . . . . . 0.429 ' HA ' HD23 ' C' ' 132' ' ' HYP . 13.1 Cg_exo -70.95 151.65 62.47 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.985 2.457 . . . . 0.0 111.731 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 132' ' ' HYP . . . . . 0.525 ' HA ' ' O ' ' D' ' 231' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . 0.407 ' HA2' ' HD3' ' C' ' 134' ' ' PRO . . . -78.92 119.87 5.17 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.805 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 134' ' ' PRO . . . . . 0.499 ' HA ' HD23 ' C' ' 135' ' ' HYP . 17.2 Cg_exo -67.45 110.84 2.15 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.107 2.538 . . . . 0.0 111.968 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 135' ' ' HYP . . . . . 0.499 HD23 ' HA ' ' C' ' 134' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.387 0 CA-C-O 120.197 -0.224 . . . . 0.0 112.712 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 201' ' ' PRO . . . . . 0.524 ' HD2' ' HA ' ' C' ' 102' ' ' HYP . 24.8 Cg_exo -65.85 155.45 69.26 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.153 2.569 . . . . 0.0 111.115 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 202' ' ' HYP . . . . . 0.428 HD23 ' HA ' ' D' ' 201' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 117.51 -156.6 15.55 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.071 -1.061 . . . . 0.0 113.606 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 204' ' ' PRO . . . . . 0.402 ' HA ' HD23 ' D' ' 205' ' ' HYP . 15.3 Cg_exo -69.57 159.95 51.62 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.735 2.956 . . . . 0.0 113.04 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 205' ' ' HYP . . . . . 0.402 HD23 ' HA ' ' D' ' 204' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 206' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' B' ' 8' ' ' HYP . . . 95.26 162.93 34.45 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.033 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 207' ' ' PRO . . . . . 0.401 ' HA ' HD23 ' D' ' 208' ' ' HYP . 3.1 Cg_endo -86.85 148.6 8.32 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.466 2.777 . . . . 0.0 111.995 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 208' ' ' HYP . . . . . 0.401 HD23 ' HA ' ' D' ' 207' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.95 169.9 55.05 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.428 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.06 158.48 57.25 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.502 2.134 . . . . 0.0 111.773 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -78.29 144.08 36.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.653 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -67.43 159.53 50.14 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.87 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 213' ' ' ILE . . . . . 0.53 ' HB ' ' OE1' ' A' ' 392' ' ' GLU . 15.2 pt -70.76 168.85 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.655 0.264 . . . . 0.0 111.026 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 214' ' ' ALA . . . . . 0.494 ' HB3' ' NH1' ' A' ' 330' ' ' ARG . . . -87.37 143.15 27.38 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.863 0.363 . . . . 0.0 110.595 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -65.99 162.25 42.93 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 116.02 -0.536 . . . . 0.0 113.216 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 216' ' ' GLN . . . . . 0.447 ' O ' ' HA3' ' B' ' 18' ' ' GLY . 68.0 mm-40 -71.08 158.94 35.62 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.783 0.325 . . . . 0.0 110.899 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -68.5 152.57 45.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.0 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -59.96 151.09 38.6 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.301 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 12.4 t -61.33 144.44 13.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 46.7 t -63.18 139.42 21.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -56.66 158.23 10.03 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.962 -0.563 . . . . 0.0 113.621 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 222' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' D' ' 223' ' ' HYP . 7.1 mp -71.09 150.8 45.14 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.656 -0.272 . . . . 0.0 110.668 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 223' ' ' HYP . . . . . 0.42 HD23 ' HA ' ' D' ' 222' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 224' ' ' GLY . . . . . 0.423 ' HA2' ' HD3' ' D' ' 225' ' ' PRO . . . -57.57 145.6 39.02 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.96 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 225' ' ' PRO . . . . . 0.433 ' HA ' HD23 ' D' ' 226' ' ' HYP . 24.2 Cg_exo -66.05 152.79 80.4 Favored 'Trans proline' 0 CA--C 1.528 0.177 0 C-N-CA 123.092 2.528 . . . . 0.0 111.223 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 226' ' ' HYP . . . . . 0.433 HD23 ' HA ' ' D' ' 225' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -74.56 171.08 53.46 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.638 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -87.36 163.59 8.27 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.93 2.42 . . . . 0.0 111.643 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 229' ' ' HYP . . . . . 0.434 ' HA ' ' O ' ' B' ' 31' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -67.68 174.68 27.94 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.219 -0.515 . . . . 0.0 113.816 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 231' ' ' PRO . . . . . 0.525 ' O ' ' HA ' ' C' ' 132' ' ' HYP . 35.1 Cg_exo -60.41 140.29 90.9 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 123.206 2.604 . . . . 0.0 111.995 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 232' ' ' HYP . . . . . 0.467 HD23 ' HA ' ' D' ' 231' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo . . . . . 0 N--CA 1.479 0.63 0 N-CA-C 110.238 -0.716 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 320' ' ' ASP . 20.7 t-20 -114.1 164.62 13.6 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 19.5 tt -71.37 -23.44 22.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.948 0.404 . . . . 0.0 111.036 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 31.2 m -87.68 6.07 36.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.727 0.299 . . . . 0.0 111.574 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 317' ' ' ASN . 0.2 OUTLIER -63.15 -50.5 70.16 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.132 0.491 . . . . 0.0 110.438 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 97.13 175.59 34.7 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . 0.43 HD22 ' HA ' ' A' ' 322' ' ' ASN . 8.0 m120 51.03 73.43 0.29 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.172 0.511 . . . . 0.0 112.172 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' PHE . . . . . 0.609 ' HD1' ' HD3' ' A' ' 337' ' ' LYS . 60.7 m-85 -88.62 173.3 8.7 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.03 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.37 -51.75 27.55 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 14.5 t -170.51 147.67 2.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.435 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 76.8 t -112.71 126.62 70.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -131.67 166.7 20.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.01 0.433 . . . . 0.0 111.151 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 42.2 ttp -136.36 108.18 7.08 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 45.3 mt -106.25 127.2 53.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.574 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.06 14.85 5.71 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.55 0.531 . . . . 0.0 112.13 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 102.99 -9.29 54.92 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.23 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -93.94 129.67 40.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.631 0.253 . . . . 0.0 110.738 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 45.6 ttm -82.59 123.07 28.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.228 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -114.86 123.22 48.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.355 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 9.2 t -103.49 109.75 27.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.954 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -92.16 125.41 36.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.457 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 0.609 ' HD3' ' HD1' ' A' ' 323' ' ' PHE . 22.0 tptp -136.5 95.5 3.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.656 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 62.7 -100.5 0.09 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.411 ' H ' ' HG2' ' A' ' 339' ' ' ARG . 7.7 ptm85 -104.22 -5.25 22.09 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -177.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 7.6 m0 -124.69 159.89 29.8 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.974 0.416 . . . . 0.0 111.425 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -135.93 138.2 42.13 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.372 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -108.39 152.78 24.21 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.954 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.513 ' HD3' ' SD ' ' A' ' 350' ' ' MET . 16.4 ttt180 -127.07 113.4 16.38 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -101.78 113.09 37.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.175 0.512 . . . . 0.0 111.206 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.23 120.18 40.87 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 5.5 m120 61.83 32.94 17.94 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.437 0.46 . . . . 0.0 110.577 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 70.89 16.22 6.62 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.192 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -121.51 137.64 54.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.251 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 22.9 t -73.47 120.74 22.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.044 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' MET . . . . . 0.513 ' SD ' ' HD3' ' A' ' 343' ' ' ARG . 79.0 mtp -70.45 167.93 17.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.987 0.422 . . . . 0.0 111.542 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -85.81 163.71 17.98 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.371 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 91.54 -1.55 76.01 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.772 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' TYR . . . . . 0.56 ' HB3' ' HA ' ' A' ' 354' ' ' PRO . 63.4 m-85 -113.78 160.99 29.93 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.56 ' HA ' ' HB3' ' A' ' 353' ' ' TYR . 56.3 Cg_endo -72.55 128.49 15.18 Favored 'Cis proline' 0 C--N 1.347 0.493 0 C-N-CA 123.505 -1.456 . . . . 0.0 112.519 0.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 54.2 ttm -102.87 133.52 20.35 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.711 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.76 136.09 68.1 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.398 2.065 . . . . 0.0 111.158 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 77.4 mt -53.0 -45.47 52.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.835 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -68.18 -13.55 64.85 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 121.145 -0.55 . . . . 0.0 114.04 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.51 -29.45 61.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.954 0.377 . . . . 0.0 110.202 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -112.38 -53.91 2.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.556 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -86.91 73.72 9.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.962 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -64.69 103.64 0.72 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.008 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 127.55 -13.3 6.55 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.416 HD12 ' HD2' ' A' ' 365' ' ' PRO . 20.0 tp -97.9 129.23 31.63 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' PRO . . . . . 0.416 ' HD2' HD12 ' A' ' 364' ' ' LEU . 94.3 Cg_endo -81.62 -178.72 4.39 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.782 2.321 . . . . 0.0 112.067 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -82.93 149.19 27.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.502 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 39.3 m 58.5 90.11 0.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.752 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 30.3 pt -95.62 168.59 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.965 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . 0.535 ' HB2' ' HA ' ' A' ' 383' ' ' LYS . 0.1 OUTLIER -92.81 -45.54 7.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.902 -179.289 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . 0.792 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.2 OUTLIER -157.38 168.08 28.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.741 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -157.37 141.14 15.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . 0.448 ' CE1' ' HB ' ' A' ' 380' ' ' VAL . 27.6 p90 -160.02 161.01 33.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.065 0.46 . . . . 0.0 111.859 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -94.99 125.68 39.81 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . 0.512 ' HB2' ' OE2' ' A' ' 440' ' ' GLU . 2.4 ptm180 -82.87 179.71 7.69 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -178.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.509 ' HD2' ' O ' ' A' ' 425' ' ' GLY . 71.4 tttt -64.46 -29.24 70.29 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . 0.443 ' OD2' ' HE2' ' A' ' 378' ' ' LYS . 0.0 OUTLIER -85.79 -17.21 36.41 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.07 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 116.53 -18.57 13.28 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.799 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' LYS . . . . . 0.443 ' HE2' ' OD2' ' A' ' 376' ' ' ASP . 44.4 mttm -72.48 156.05 39.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.195 0.497 . . . . 0.0 111.077 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -100.03 125.65 46.12 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.187 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . 0.448 ' HB ' ' CE1' ' A' ' 372' ' ' TYR . 15.4 t -108.25 116.3 51.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.041 0.448 . . . . 0.0 110.726 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -104.5 138.21 41.21 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.45 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -118.25 145.81 44.74 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.804 0.335 . . . . 0.0 111.233 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.668 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 64.4 tttp -155.0 99.55 2.12 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.957 178.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 71.56 -106.28 1.87 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.8 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -114.17 5.9 16.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.732 0.301 . . . . 0.0 111.432 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -116.95 154.52 30.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.91 0.386 . . . . 0.0 111.438 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . 0.401 ' NE2' ' HE2' ' A' ' 399' ' ' TYR . 23.9 p-80 -136.99 144.9 43.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.849 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' TRP . . . . . 0.668 ' HZ3' ' HB3' ' A' ' 383' ' ' LYS . 22.3 m-90 -118.8 135.13 54.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.964 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 53.3 t -113.37 114.55 47.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -107.06 121.6 44.81 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.411 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -91.5 100.13 12.94 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 69.0 -68.99 0.17 Allowed 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.722 0.639 . . . . 0.0 110.707 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -156.11 16.51 0.35 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.658 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.11 127.25 49.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.92 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 60.5 tp -75.14 131.51 40.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.218 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 20.1 mm-40 -66.87 133.21 93.94 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.956 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 39.3 Cg_exo -62.24 123.62 12.82 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.997 2.465 . . . . 0.0 112.361 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 113.82 -1.84 24.47 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.413 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' TYR . . . . . 0.406 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 31.0 m-85 -100.17 161.64 23.52 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.464 ' HB3' ' CE2' ' A' ' 388' ' ' TRP . 75.7 Cg_endo -76.35 160.53 95.27 Favored 'Cis proline' 0 C--N 1.345 0.365 0 C-N-CA 123.797 -1.335 . . . . 0.0 113.269 0.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 28.6 mttm -125.41 165.44 18.4 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.262 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -71.53 158.33 36.43 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 47.5 mt -57.78 -36.54 55.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.045 0.45 . . . . 0.0 111.374 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -66.52 -15.56 63.48 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.265 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -78.66 -25.02 44.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.887 0.375 . . . . 0.0 110.896 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 39.6 tp -74.83 -45.38 43.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.122 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.612 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -164.21 154.81 25.86 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.764 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 52.1 ttt85 -79.66 135.89 36.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.7 0.286 . . . . 0.0 110.51 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.08 -4.59 62.83 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.84 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 46.8 mt -72.66 151.32 91.33 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.858 0.329 . . . . 0.0 111.121 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.02 129.07 33.33 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.869 2.38 . . . . 0.0 112.123 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.59 -8.6 52.28 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -91.51 -54.37 3.93 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -176.95 -179.66 0.95 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.337 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 37.6 mm -124.24 137.18 58.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 430' ' ' PHE . 1.4 m-20 -88.52 -57.94 2.73 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.792 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -152.8 161.54 42.42 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.794 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -137.61 128.36 27.01 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 40.6 tp -118.92 122.17 41.65 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.824 0.345 . . . . 0.0 111.237 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -88.14 111.58 21.75 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.188 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 13.1 t-105 -80.24 96.25 6.54 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 67.9 mtt -51.35 -51.84 65.02 Favored Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -40.47 -54.52 2.25 Favored 'Trans proline' 0 C--N 1.358 1.067 0 C-N-CA 123.388 2.725 . . . . 0.0 115.139 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -104.24 -16.84 15.07 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . 0.509 ' O ' ' HD2' ' A' ' 375' ' ' LYS . . . 79.58 53.77 4.22 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.666 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -133.4 136.95 45.59 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.718 0.294 . . . . 0.0 110.436 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 17.6 m -91.65 127.42 37.1 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -99.56 114.69 27.85 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.631 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -96.17 123.31 39.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.658 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' PHE . . . . . 0.42 ' O ' ' HB2' ' A' ' 416' ' ' ASP . 86.9 m-85 -99.12 135.92 39.83 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.186 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.413 ' HA ' ' HE ' ' A' ' 431' ' ' ARG . 3.0 tpm_? -148.84 101.74 3.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.651 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 73.54 -116.71 5.53 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.737 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -110.08 14.38 22.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.99 0.424 . . . . 0.0 110.651 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . 0.521 ' HB3' ' HB2' ' A' ' 450' ' ' PRO . 33.7 mmtp -127.44 151.94 48.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.983 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' TYR . . . . . 0.506 ' CE2' ' HE2' ' A' ' 449' ' ' TYR . 30.8 p90 -130.09 143.43 50.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.657 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -111.05 151.21 28.29 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.211 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -111.6 99.57 8.28 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . 0.612 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 72.9 t80 -79.76 116.82 20.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.84 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -83.47 102.13 11.87 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.211 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' GLU . . . . . 0.512 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 4.1 mm-40 -56.93 -26.39 59.37 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -87.05 -14.37 41.7 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 93.0 mt -120.14 -11.65 9.2 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' ARG . . . . . 0.442 HH11 ' HD3' ' A' ' 443' ' ' ARG . 25.6 mtp180 58.69 45.01 16.47 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.323 0.583 . . . . 0.0 111.177 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -162.24 157.0 22.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.989 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 96.3 t -76.71 133.53 30.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -60.57 164.38 4.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.032 0.444 . . . . 0.0 111.731 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 74.4 m -70.64 159.16 34.92 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.768 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 72.62 20.25 3.86 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.126 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . 0.506 ' HE2' ' CE2' ' A' ' 435' ' ' TYR . 32.1 m-85 -120.41 159.08 49.37 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.5 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . 0.521 ' HB2' ' HB3' ' A' ' 434' ' ' LYS . 72.3 Cg_endo -75.04 165.52 85.71 Favored 'Cis proline' 0 C--N 1.344 0.34 0 C-N-CA 123.608 -1.413 . . . . 0.0 112.95 0.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 57.6 mttm -117.64 160.65 20.94 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.664 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . 0.437 ' HA ' ' HD3' ' A' ' 434' ' ' LYS . 30.9 t-20 -67.37 135.43 53.21 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.272 0.357 . . . . 0.0 110.453 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 14.4 tt -64.0 -12.91 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.075 0.464 . . . . 0.0 111.323 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -62.5 -15.21 48.98 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 75.7 t -58.75 -36.94 63.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' TRP . . . . . 0.445 ' HB2' ' HB ' ' A' ' 459' ' ' ILE . 17.4 m95 -86.06 88.53 7.6 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.11 109.04 0.38 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 107.89 -13.11 38.16 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.027 -0.606 . . . . 0.0 113.312 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.445 ' HB ' ' HB2' ' A' ' 456' ' ' TRP . 40.0 mm -83.33 126.24 72.27 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.81 0.305 . . . . 0.0 111.298 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.85 156.16 30.87 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.036 2.49 . . . . 0.0 111.983 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -73.04 149.55 43.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.177 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 3.5 m 51.64 69.46 2.49 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 114.484 1.291 . . . . 0.0 114.484 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -91.47 172.62 2.78 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.55 2.167 . . . . 0.0 109.956 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -142.91 74.56 1.45 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.542 0.686 . . . . 0.0 111.219 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 135.79 97.63 0.53 Allowed Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.345 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 476' ' ' TYR . 2.9 p -130.13 108.34 9.99 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -130.06 144.03 51.12 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.945 0.402 . . . . 0.0 111.475 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 43.1 ttm -97.11 133.87 41.2 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.521 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -65.31 164.69 36.79 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.379 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 2.4 m -65.5 -8.03 17.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.941 0.4 . . . . 0.0 111.825 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -87.89 -13.04 43.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.517 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 64.02 11.11 5.87 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.624 -0.717 . . . . 0.0 112.509 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 98.1 t -110.79 -41.5 4.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.845 0.355 . . . . 0.0 111.403 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -105.68 123.17 47.5 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 85.6 m -111.81 141.09 45.88 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 476' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 466' ' ' SER . 89.7 m-85 -113.52 135.0 54.37 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -118.66 127.27 53.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.415 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -109.27 133.85 52.52 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 56.6 tttt -165.66 127.69 2.01 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.223 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 61.98 38.19 95.65 Favored Glycine 0 N--CA 1.454 -0.118 0 CA-C-N 116.035 -0.53 . . . . 0.0 113.449 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . 0.511 HD21 HD12 ' A' ' 502' ' ' LEU . 53.7 t30 74.15 -4.79 2.21 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -106.85 155.29 19.9 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -127.26 139.35 52.97 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.137 0.494 . . . . 0.0 111.563 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 17.9 m-90 -108.84 133.28 53.09 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.742 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -99.03 100.81 12.02 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.958 0.408 . . . . 0.0 110.034 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 486' ' ' PHE . . . . . 0.497 ' HZ ' HD12 ' A' ' 491' ' ' LEU . 88.9 t80 -89.65 132.63 35.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.155 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . 0.414 ' HB3' ' HB3' ' A' ' 490' ' ' LYS . 32.6 t-20 -96.66 112.42 24.18 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -59.38 -47.8 84.08 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 41.3 tp60 -85.13 37.51 0.67 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.326 0.584 . . . . 0.0 111.41 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 490' ' ' LYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 487' ' ' ASN . 19.8 ttpt -153.33 -27.85 0.14 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.912 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.497 HD12 ' HZ ' ' A' ' 486' ' ' PHE . 14.7 tp 61.76 40.17 13.26 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.867 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -159.66 148.0 17.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.628 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 69.5 t -75.78 142.93 13.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -63.97 142.67 98.18 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.379 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -65.5 146.0 83.87 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.725 2.283 . . . . 0.0 111.753 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 96.12 1.75 61.05 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.21 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . 0.722 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 72.3 m-85 -108.87 167.39 9.23 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . 0.722 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 91.9 Cg_endo -76.46 176.75 42.48 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 124.037 -1.235 . . . . 0.0 113.42 0.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -133.12 166.0 23.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.939 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 500' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 504' ' ' ASP . 4.8 t -75.49 122.14 23.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.852 0.358 . . . . 0.0 110.849 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -73.92 -21.17 60.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.86 0.362 . . . . 0.0 110.866 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 502' ' ' LEU . . . . . 0.511 HD12 HD21 ' A' ' 481' ' ' ASN . 10.3 mt -70.96 -48.72 51.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.881 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -78.18 -40.18 38.53 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.999 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 504' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 500' ' ' SER . 0.6 OUTLIER -76.79 -56.33 4.69 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -177.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -85.17 -58.51 2.65 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -177.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 506' ' ' MET . . . . . 0.467 ' HG3' HD23 ' A' ' 502' ' ' LEU . 11.6 mmt -63.86 -32.51 74.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 87.82 38.01 7.67 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.938 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 59.9 m -121.29 90.8 47.84 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.01 166.2 30.31 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.804 2.336 . . . . 0.0 111.721 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 11.9 m 65.91 101.36 0.04 OUTLIER 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.459 0.647 . . . . 0.0 111.793 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.865 0 CA-C-O 118.361 -1.244 . . . . 0.0 111.473 179.914 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.889 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' PRO . . . . . 0.48 ' HA ' HD23 ' B' ' 2' ' ' HYP . 72.8 Cg_endo -78.77 142.68 18.04 Favored 'Trans proline' 0 CA--C 1.528 0.186 0 C-N-CA 122.421 2.081 . . . . 0.0 111.369 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' HYP . . . . . 0.48 HD23 ' HA ' ' B' ' 1' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' D' ' 201' ' ' PRO . . . -65.72 155.48 50.09 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.489 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.21 160.49 29.58 Favored 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.683 2.255 . . . . 0.0 111.253 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.06 -147.87 14.39 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.969 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.996 ' HG2' ' HA ' ' D' ' 205' ' ' HYP . 19.7 Cg_endo -62.01 163.01 20.65 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.995 2.463 . . . . 0.0 111.978 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' HYP . . . . . 0.509 ' O ' ' HA3' ' D' ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' D' ' 205' ' ' HYP . . . 161.61 170.15 25.91 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.538 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.91 144.55 96.68 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.119 2.546 . . . . 0.0 112.106 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -64.12 140.39 58.86 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.669 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.74 144.02 47.62 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.517 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 32.5 mt -63.67 144.69 14.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.592 0.234 . . . . 0.0 110.548 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.03 157.93 20.76 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.043 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' D' ' 213' ' ' ILE . . . -71.13 165.76 52.99 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.471 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -72.29 149.02 44.86 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.66 142.08 57.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.436 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' D' ' 216' ' ' GLN . . . -61.63 148.37 47.34 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.293 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.432 ' HB ' ' HG2' ' D' ' 217' ' ' ARG . 3.1 t -68.3 154.27 8.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.753 0.311 . . . . 0.0 110.502 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 14.7 t -58.33 141.4 15.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.689 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.46 168.37 53.92 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.567 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.429 ' HA ' HD23 ' B' ' 23' ' ' HYP . 79.8 mt -81.38 145.95 30.56 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' HYP . . . . . 0.429 HD23 ' HA ' ' B' ' 22' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.29 159.01 53.79 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.903 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.9 162.35 42.19 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.831 2.354 . . . . 0.0 111.798 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.95 154.17 46.32 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.991 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.22 152.67 79.14 Favored 'Trans proline' 0 C--O 1.237 0.459 0 C-N-CA 122.584 2.189 . . . . 0.0 111.924 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.19 169.19 54.72 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.789 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.461 ' HA ' HD23 ' B' ' 32' ' ' HYP . 23.9 Cg_exo -66.85 153.62 77.3 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.915 2.41 . . . . 0.0 111.1 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' HYP . . . . . 0.461 HD23 ' HA ' ' B' ' 31' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . 0.415 ' HA2' ' HD3' ' B' ' 34' ' ' PRO . . . -61.39 156.45 34.61 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.99 -0.55 . . . . 0.0 113.138 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . 0.462 ' HA ' HD22 ' B' ' 35' ' ' HYP . 14.8 Cg_endo -91.61 105.99 0.25 Allowed 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.419 2.746 . . . . 0.0 111.749 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' HYP . . . . . 0.462 HD22 ' HA ' ' B' ' 34' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.428 0 CA-C-O 120.077 -0.291 . . . . 0.0 112.665 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 101' ' ' PRO . . . . . 0.491 ' HA ' HD23 ' C' ' 102' ' ' HYP . 17.1 Cg_exo -69.17 139.22 41.72 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.929 2.42 . . . . 0.0 111.679 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 102' ' ' HYP . . . . . 0.491 HD23 ' HA ' ' C' ' 101' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.52 161.29 54.34 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.191 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -79.43 162.89 24.87 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 123.48 2.787 . . . . 0.0 111.739 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 105' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -77.89 178.72 52.02 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.095 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -77.21 145.01 23.91 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.926 2.417 . . . . 0.0 110.83 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 108' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -62.7 172.75 9.84 Favored Glycine 0 CA--C 1.519 0.292 0 CA-C-N 115.636 -0.711 . . . . 0.0 113.537 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.97 169.98 13.84 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 122.85 2.366 . . . . 0.0 112.553 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 111' ' ' GLN . . . . . 0.444 ' OE1' ' HB2' ' D' ' 210' ' ' PRO . 5.6 tp60 -64.75 137.78 58.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.548 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -62.23 161.35 29.95 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 116.02 -0.536 . . . . 0.0 113.095 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . 0.497 ' H ' HG13 ' C' ' 113' ' ' ILE . 2.3 mt -62.73 144.0 14.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.695 -0.252 . . . . 0.0 110.393 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.97 152.8 44.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.539 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -70.43 145.81 41.29 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.477 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -72.82 147.02 45.87 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 35.1 ttm-85 -62.45 145.81 53.14 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.758 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.18 177.39 32.34 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.806 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 61.9 t -72.84 137.48 23.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.466 -0.367 . . . . 0.0 110.365 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 93.7 t -63.94 139.25 21.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.983 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.22 157.41 28.01 Favored Glycine 0 N--CA 1.45 -0.424 0 O-C-N 123.51 0.506 . . . . 0.0 112.886 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 31.8 mt -73.2 151.19 41.56 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 123' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -67.13 162.43 46.47 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.237 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 125' ' ' PRO . . . . . 0.421 ' HA ' HD23 ' C' ' 126' ' ' HYP . 54.9 Cg_endo -70.39 150.5 64.44 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.684 2.256 . . . . 0.0 111.47 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 126' ' ' HYP . . . . . 0.421 HD23 ' HA ' ' C' ' 125' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -69.67 160.44 52.99 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.961 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.08 158.92 37.82 Favored 'Trans proline' 0 C--O 1.237 0.454 0 C-N-CA 122.595 2.196 . . . . 0.0 111.514 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -65.19 175.25 14.64 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.489 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 131' ' ' PRO . . . . . 0.433 ' HA ' HD23 ' C' ' 132' ' ' HYP . 24.0 Cg_exo -65.96 147.4 84.71 Favored 'Trans proline' 0 C--N 1.34 0.114 0 C-N-CA 123.038 2.492 . . . . 0.0 111.287 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 132' ' ' HYP . . . . . 0.433 HD23 ' HA ' ' C' ' 131' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . 0.503 ' HA2' ' HD3' ' C' ' 134' ' ' PRO . . . -70.65 132.86 22.78 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.112 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 134' ' ' PRO . . . . . 0.503 ' HD3' ' HA2' ' C' ' 133' ' ' GLY . 7.6 Cg_exo -73.42 111.61 3.33 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 123.084 2.523 . . . . 0.0 112.143 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 135' ' ' HYP . . . . . 0.438 HD23 ' HA ' ' C' ' 134' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 CA-C-O 120.043 -0.309 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 201' ' ' PRO . . . . . 0.502 ' HA ' HD23 ' D' ' 202' ' ' HYP . 35.4 Cg_exo -62.51 146.87 95.5 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.985 2.457 . . . . 0.0 111.724 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 202' ' ' HYP . . . . . 0.502 HD23 ' HA ' ' D' ' 201' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 83.42 -161.19 38.78 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.032 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 204' ' ' PRO . . . . . 0.419 ' HA ' HD23 ' D' ' 205' ' ' HYP . 4.4 Cg_endo -88.48 161.54 6.66 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 123.903 3.068 . . . . 0.0 112.148 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 205' ' ' HYP . . . . . 0.996 ' HA ' ' HG2' ' B' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 206' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' B' ' 8' ' ' HYP . . . 77.14 -177.07 52.84 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.993 -0.623 . . . . 0.0 113.567 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 207' ' ' PRO . . . . . 0.404 ' HA ' HD23 ' D' ' 208' ' ' HYP . 95.5 Cg_endo -98.27 160.86 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.656 2.904 . . . . 0.0 112.46 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 208' ' ' HYP . . . . . 0.404 HD23 ' HA ' ' D' ' 207' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.44 171.55 54.79 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.011 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 210' ' ' PRO . . . . . 0.444 ' HB2' ' OE1' ' C' ' 111' ' ' GLN . 12.4 Cg_exo -70.21 157.76 58.5 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.766 2.31 . . . . 0.0 111.901 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -82.56 142.33 31.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.988 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -64.74 162.66 37.92 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 116.08 -0.509 . . . . 0.0 113.295 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 213' ' ' ILE . . . . . 0.446 ' O ' ' HA3' ' B' ' 15' ' ' GLY . 42.2 pt -71.68 159.35 5.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.926 0.393 . . . . 0.0 111.403 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -71.27 139.1 49.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.081 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -64.37 165.6 31.45 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 116.01 -0.541 . . . . 0.0 113.864 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 216' ' ' GLN . . . . . 0.407 ' O ' ' HA3' ' B' ' 18' ' ' GLY . 91.0 mm-40 -78.58 153.42 31.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.794 0.33 . . . . 0.0 110.486 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 217' ' ' ARG . . . . . 0.432 ' HG2' ' HB ' ' B' ' 19' ' ' VAL . 33.8 mtp180 -69.79 156.23 39.34 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.543 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -64.36 154.52 47.79 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.735 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 24.5 t -65.31 144.53 14.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.98 135.98 25.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.887 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -54.15 161.22 4.16 Favored Glycine 0 N--CA 1.453 -0.216 0 O-C-N 123.799 0.687 . . . . 0.0 114.364 -178.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 10.8 mp -76.65 146.76 37.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.659 -0.271 . . . . 0.0 110.587 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 223' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 224' ' ' GLY . . . . . 0.445 ' HA2' ' HD3' ' D' ' 225' ' ' PRO . . . -60.83 154.13 36.42 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.102 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 225' ' ' PRO . . . . . 0.445 ' HD3' ' HA2' ' D' ' 224' ' ' GLY . 21.7 Cg_exo -66.43 146.16 79.4 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.925 2.417 . . . . 0.0 111.692 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 226' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.93 162.25 31.48 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.974 -0.631 . . . . 0.0 113.25 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -79.61 163.2 24.22 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 122.835 2.356 . . . . 0.0 111.645 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -69.11 174.2 34.18 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.954 -0.566 . . . . 0.0 113.096 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 231' ' ' PRO . . . . . 0.415 ' HA ' HD23 ' D' ' 232' ' ' HYP . 3.0 Cg_exo -76.69 154.8 34.97 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.077 2.518 . . . . 0.0 111.926 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 232' ' ' HYP . . . . . 0.415 HD23 ' HA ' ' D' ' 231' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo . . . . . 0 N--CA 1.477 0.558 0 N-CA-C 109.922 -0.838 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -113.25 149.15 34.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.308 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 16.1 tt -72.89 -18.63 18.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 20.6 m -91.76 0.25 57.5 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 121.152 -0.219 . . . . 0.0 111.263 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -67.86 -48.04 67.23 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.102 0.477 . . . . 0.0 110.288 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . 0.571 ' HA2' HD21 ' A' ' 502' ' ' LEU . . . 102.74 172.08 26.66 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.439 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 64.3 t30 55.56 85.73 0.06 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.468 0.651 . . . . 0.0 112.465 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' PHE . . . . . 0.567 ' HD1' ' HB2' ' A' ' 337' ' ' LYS . 92.9 m-85 -105.26 168.0 9.36 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.702 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.57 -46.87 83.92 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 6.6 t -175.43 160.75 2.62 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.472 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 49.0 t -127.56 127.51 68.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -135.23 167.93 20.1 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.007 0.432 . . . . 0.0 111.845 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . 0.426 ' HA ' ' O ' ' A' ' 332' ' ' GLU . 53.1 ttm -129.75 115.11 16.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.786 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 56.8 mt -111.28 117.05 32.1 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.182 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.408 ' HD3' ' OE2' ' A' ' 373' ' ' GLU . 0.0 OUTLIER 59.13 20.26 8.21 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.957 -179.48 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 105.69 -18.24 41.13 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.609 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . 0.457 ' OE1' ' HD3' ' A' ' 343' ' ' ARG . 35.3 mm-40 -82.75 131.24 35.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.633 0.254 . . . . 0.0 110.676 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 50.2 ttm -88.23 117.74 27.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.794 0.33 . . . . 0.0 110.975 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -109.12 122.8 48.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.264 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 37.5 t -108.46 114.74 47.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -100.46 130.37 46.54 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 0.567 ' HB2' ' HD1' ' A' ' 323' ' ' PHE . 13.0 tptt -138.19 101.81 4.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.298 178.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 61.49 -95.3 0.05 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.0 ptm85 -121.06 7.08 10.29 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . 0.405 ' HB3' ' HB2' ' A' ' 354' ' ' PRO . 5.6 m-90 -129.03 152.43 48.64 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -137.69 153.95 49.73 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.121 0.486 . . . . 0.0 111.76 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 24.5 m-90 -121.8 160.91 23.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.363 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.457 ' HD3' ' OE1' ' A' ' 332' ' ' GLU . 18.1 ttm-85 -124.38 112.18 16.64 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 91.6 t -90.71 122.66 42.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.889 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . 0.431 ' HD3' ' HA ' ' A' ' 345' ' ' ARG . 2.2 mmt180 -132.71 100.92 5.09 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.553 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 66.5 54.79 0.86 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.817 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 29.2 t30 62.09 12.92 5.34 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -133.41 146.7 51.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.665 0.269 . . . . 0.0 110.61 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 39.0 t -96.71 127.88 48.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 86.2 mtp -68.28 159.84 30.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.531 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -76.65 167.74 21.3 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.679 0.276 . . . . 0.0 110.9 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 94.98 -21.77 42.02 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -178.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' TYR . . . . . 0.464 ' HB3' ' HA ' ' A' ' 354' ' ' PRO . 87.9 m-85 -101.5 158.94 30.83 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.464 ' HA ' ' HB3' ' A' ' 353' ' ' TYR . 58.1 Cg_endo -71.16 139.21 57.13 Favored 'Cis proline' 0 C--N 1.346 0.424 0 C-N-CA 123.484 -1.465 . . . . 0.0 112.561 0.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 55.3 ttm -114.33 138.8 23.2 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . 0.442 ' HB2' ' HB2' ' A' ' 359' ' ' GLN . 52.3 Cg_exo -55.43 130.33 39.97 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.382 2.054 . . . . 0.0 111.175 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 76.8 mt -55.02 -45.51 76.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.987 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -71.35 -12.78 73.21 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.95 -0.643 . . . . 0.0 113.707 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' GLN . . . . . 0.442 ' HB2' ' HB2' ' A' ' 356' ' ' PRO . 3.7 tt0 -82.32 -34.32 28.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.034 0.445 . . . . 0.0 110.454 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -94.1 -55.21 3.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.357 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -90.28 74.39 7.02 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -58.29 95.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.925 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 135.37 -17.3 4.04 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.503 ' HA ' ' HD3' ' A' ' 365' ' ' PRO . 29.6 tp -94.37 125.16 53.14 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 364' ' ' LEU . 4.2 Cg_exo -77.21 -174.02 2.02 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.017 2.478 . . . . 0.0 111.84 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -87.8 153.96 20.93 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.08 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 72.1 m 59.23 94.92 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 27.1 pt -106.87 -166.24 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.403 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.09 -47.06 1.22 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . 0.643 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.2 OUTLIER -146.04 162.82 37.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.648 0.261 . . . . 0.0 111.178 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -158.35 138.48 12.37 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . 0.593 ' HE1' ' HE2' ' A' ' 382' ' ' PHE . 14.7 p90 -160.25 162.71 33.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.903 0.382 . . . . 0.0 111.532 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.408 ' OE2' ' HD3' ' A' ' 330' ' ' ARG . 64.9 tt0 -98.65 122.03 41.35 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . 0.568 ' HB2' ' OE2' ' A' ' 440' ' ' GLU . 5.2 ptm180 -78.76 -179.66 6.66 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -178.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -67.61 -34.52 77.15 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.908 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -37.29 85.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.68 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 129.27 -16.19 5.74 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.421 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' LYS . . . . . 0.625 ' HG2' ' HA ' ' A' ' 391' ' ' ASP . 72.8 mttt -80.46 166.16 21.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.881 0.372 . . . . 0.0 111.575 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -106.71 127.64 53.54 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.752 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 13.4 t -109.19 122.16 63.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.007 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -106.56 138.11 43.34 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.212 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.593 ' HE2' ' HE1' ' A' ' 372' ' ' TYR . 55.9 m-85 -117.83 141.69 48.14 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.61 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 83.0 tttt -154.14 107.6 2.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.6 177.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 414' ' ' LYS . . . 70.27 -112.2 4.21 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.566 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . 0.432 ' O ' HG13 ' A' ' 403' ' ' ILE . 3.7 p-10 -115.29 4.38 14.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.914 0.388 . . . . 0.0 110.606 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . 0.42 ' HB3' ' HB2' ' A' ' 400' ' ' PRO . 48.4 mmtm -112.07 150.79 30.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 48.5 p-80 -131.97 147.94 52.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.176 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' TRP . . . . . 0.61 ' HZ3' ' HB3' ' A' ' 383' ' ' LYS . 22.5 m-90 -121.7 125.62 47.05 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.82 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 85.5 t -109.42 119.96 59.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.897 0.38 . . . . 0.0 110.32 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -104.87 123.66 48.1 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.932 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.625 ' HA ' ' HG2' ' A' ' 378' ' ' LYS . 21.8 t0 -92.71 95.05 9.33 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 67.52 -73.2 0.08 Allowed 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.727 0.642 . . . . 0.0 111.021 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -146.18 11.83 1.2 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.986 0.422 . . . . 0.0 110.41 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 1.7 m -125.51 127.09 45.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.253 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 55.9 tp -71.77 132.04 43.92 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.035 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -62.96 147.01 94.94 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.651 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -74.08 144.59 34.08 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.544 2.163 . . . . 0.0 113.038 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 90.37 18.15 50.3 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.459 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' TYR . . . . . 0.496 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 39.1 m-85 -109.13 162.16 21.12 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-O 120.292 0.091 . . . . 0.0 110.774 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.496 ' HA ' ' HB3' ' A' ' 399' ' ' TYR . 71.8 Cg_endo -77.07 157.81 96.84 Favored 'Cis proline' 0 C--N 1.346 0.442 0 C-N-CA 123.529 -1.446 . . . . 0.0 112.562 0.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -116.48 157.82 24.58 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -73.21 151.19 41.56 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 385' ' ' ASP . 61.2 mt -56.64 -32.75 38.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.325 0.583 . . . . 0.0 110.603 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -65.97 -20.71 66.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.485 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -84.18 -10.52 57.68 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 50.7 tp -85.32 -55.16 4.16 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.9 0.381 . . . . 0.0 110.12 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.639 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -149.08 150.9 23.1 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.798 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -77.68 126.46 30.9 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.57 0.224 . . . . 0.0 110.495 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 99.27 14.01 37.11 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.599 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 38.7 mt -92.83 147.31 33.78 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 122.794 -0.239 . . . . 0.0 111.093 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.09 124.66 16.8 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.848 2.365 . . . . 0.0 111.26 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.44 -3.93 57.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.055 0.455 . . . . 0.0 111.273 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -87.53 -55.73 3.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.315 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . 0.493 ' HB2' ' HE3' ' A' ' 414' ' ' LYS . 6.4 ptmt -177.57 176.37 1.28 Allowed 'General case' 0 C--N 1.332 -0.196 0 O-C-N 123.306 0.378 . . . . 0.0 110.791 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 38.3 mm -127.47 133.23 68.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -87.76 -47.68 8.44 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.643 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -154.6 165.25 37.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.945 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -147.21 113.8 6.01 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.207 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 55.4 tp -106.98 124.95 50.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.932 0.396 . . . . 0.0 111.795 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -90.32 116.12 28.04 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.802 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 11.9 t-105 -86.26 94.4 9.31 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.443 ' HB2' ' HD3' ' A' ' 423' ' ' PRO . 61.5 mtt -51.19 -48.82 84.5 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.443 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 83.8 Cg_exo -50.02 -24.12 10.31 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.817 2.345 . . . . 0.0 115.269 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 26.0 p30 -125.51 -37.73 2.32 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 108.63 2.48 32.64 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.709 -0.757 . . . . 0.0 113.457 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -91.62 154.18 19.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 117.036 0.418 . . . . 0.0 111.271 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 7.0 m -108.4 128.17 54.53 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.517 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -98.84 108.96 21.77 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . 0.448 ' HB2' ' HB2' ' A' ' 436' ' ' TYR . 60.3 m-85 -90.48 136.74 32.87 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.21 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -112.57 132.74 54.98 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.85 0.357 . . . . 0.0 111.059 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -145.32 110.64 5.28 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.831 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 64.65 -102.66 0.65 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.694 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -127.61 20.78 6.6 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.158 0.504 . . . . 0.0 110.046 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 450' ' ' PRO . 63.3 mmtt -124.0 142.16 51.41 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.552 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' TYR . . . . . 0.523 ' CE1' ' HB2' ' A' ' 451' ' ' LYS . 4.1 p90 -119.02 137.9 53.21 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.748 0.309 . . . . 0.0 110.383 178.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' TYR . . . . . 0.448 ' HB2' ' HB2' ' A' ' 429' ' ' PHE . 23.4 m-85 -110.27 144.4 39.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.908 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.411 ' HB3' ' HB2' ' A' ' 446' ' ' ASP . 36.1 ttp180 -107.29 95.74 5.92 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . 0.639 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 83.7 t80 -84.95 129.42 34.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.117 0.484 . . . . 0.0 112.169 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -99.57 111.99 24.26 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.011 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' GLU . . . . . 0.568 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 2.4 mm-40 -61.08 -39.74 91.06 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -67.71 -38.5 83.7 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 94.8 mt -94.1 -10.42 33.38 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 6.8 mtt-85 56.48 41.12 29.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.195 0.521 . . . . 0.0 111.027 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -157.46 166.72 32.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.219 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 88.9 t -89.3 140.05 16.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . 0.411 ' HB2' ' HB3' ' A' ' 437' ' ' ARG . 0.5 OUTLIER -55.9 153.5 8.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.437 179.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 10.9 m -69.11 158.27 35.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.04 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 70.19 24.49 4.88 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.326 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -122.75 163.19 34.46 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.018 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . 0.433 ' HB2' ' HB3' ' A' ' 434' ' ' LYS . 96.8 Cg_endo -77.38 172.1 64.35 Favored 'Cis proline' 0 C--N 1.346 0.437 0 C-N-CA 123.653 -1.395 . . . . 0.0 112.673 0.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . 0.523 ' HB2' ' CE1' ' A' ' 435' ' ' TYR . 60.2 mttm -124.75 172.45 9.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.028 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -63.76 136.07 57.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.175 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.0 tt -71.8 -11.97 15.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.261 0.553 . . . . 0.0 110.565 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -71.18 -0.01 8.81 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 64.1 t -67.2 -32.75 59.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' TRP . . . . . 0.469 ' HE3' ' CZ ' ' A' ' 486' ' ' PHE . 8.2 m95 -86.75 85.49 7.28 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.08 108.78 0.35 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 118.34 -25.23 8.3 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.054 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.423 ' HB ' ' HB2' ' A' ' 456' ' ' TRP . 32.1 mm -77.08 130.18 76.15 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 120.86 0.362 . . . . 0.0 111.175 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . 0.414 ' HG3' ' CZ2' ' A' ' 484' ' ' TRP . 85.3 Cg_endo -81.96 166.3 16.93 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.887 2.391 . . . . 0.0 111.711 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 35.3 mp0 -80.52 136.89 36.37 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.04 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.4 m 61.13 65.4 1.94 Allowed Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . 0.491 ' O ' ' HB2' ' A' ' 417' ' ' ALA . 35.7 Cg_endo -96.43 118.34 0.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.184 2.589 . . . . 0.0 110.269 178.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 464' ' ' ARG . 3.1 ttm105 -89.59 68.55 7.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.087 0.47 . . . . 0.0 112.17 -178.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 158.55 124.92 0.79 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 25.3 p -158.81 120.7 3.49 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.493 -0.188 . . . . 0.0 110.493 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -150.13 147.35 27.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.715 0.293 . . . . 0.0 111.315 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 43.6 ttm -98.57 140.76 32.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.069 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -70.0 169.52 45.69 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.179 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 1.5 m -73.36 -0.17 13.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.001 0.429 . . . . 0.0 111.339 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.65 -17.64 24.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.156 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 67.88 8.05 6.18 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.878 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 43.6 t -109.73 -37.66 3.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.887 0.375 . . . . 0.0 111.458 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -107.0 129.06 54.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.19 0.519 . . . . 0.0 111.911 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 475' ' ' THR . . . . . 0.421 ' HB ' ' HB3' ' A' ' 486' ' ' PHE . 95.1 m -113.92 135.32 54.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.488 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -107.24 137.58 45.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.175 0.512 . . . . 0.0 112.195 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 477' ' ' PHE . . . . . 0.618 ' HB2' ' HB2' ' A' ' 484' ' ' TRP . 38.2 m-85 -121.16 145.34 47.92 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.682 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -127.34 131.95 50.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.861 0.363 . . . . 0.0 111.607 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 479' ' ' LYS . . . . . 0.466 ' HB3' ' CZ3' ' A' ' 484' ' ' TRP . 69.7 tttt -158.54 107.68 1.98 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.472 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 60.77 60.92 7.63 Favored Glycine 0 CA--C 1.518 0.238 0 N-CA-C 114.373 0.509 . . . . 0.0 114.373 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 69.44 -15.06 0.3 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 482' ' ' LYS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 498' ' ' PRO . 52.2 mtmt -99.39 144.58 28.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.828 0.346 . . . . 0.0 111.435 -178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 483' ' ' TYR . . . . . 0.49 ' CZ ' ' HE2' ' A' ' 497' ' ' TYR . 6.5 p90 -120.35 142.64 48.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.161 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 484' ' ' TRP . . . . . 0.618 ' HB2' ' HB2' ' A' ' 477' ' ' PHE . 11.8 m-90 -110.85 146.95 35.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.506 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -114.04 99.97 8.05 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 486' ' ' PHE . . . . . 0.469 ' CZ ' ' HE3' ' A' ' 456' ' ' TRP . 51.2 t80 -91.26 132.26 36.25 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.307 -178.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -95.5 112.12 23.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -64.86 -19.12 65.72 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -93.85 -14.43 26.12 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -112.5 -16.64 12.83 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.6 tp 61.91 34.85 16.67 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.653 0.74 . . . . 0.0 109.899 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 492' ' ' LYS . . . . . 0.442 ' HG2' ' N ' ' A' ' 493' ' ' VAL . 36.4 tttp -151.98 156.12 39.38 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.515 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . 0.442 ' N ' ' HG2' ' A' ' 492' ' ' LYS . 71.6 t -81.81 139.6 17.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.697 0.284 . . . . 0.0 110.623 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -62.49 147.39 92.28 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.566 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.64 152.1 81.38 Favored 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 122.6 2.2 . . . . 0.0 111.957 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 85.65 27.86 31.12 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . 0.493 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 42.6 m-85 -134.06 163.58 50.12 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.609 -0.295 . . . . 0.0 110.428 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . 0.493 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 89.8 Cg_endo -76.25 174.87 50.71 Favored 'Cis proline' 0 C--N 1.346 0.408 0 C-N-CA 123.979 -1.259 . . . . 0.0 112.849 0.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -133.99 164.21 27.81 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.596 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.81 110.54 6.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.519 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . 0.447 ' HB2' ' HB3' ' A' ' 483' ' ' TYR . . . -66.03 -24.08 66.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.152 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 502' ' ' LEU . . . . . 0.571 HD21 ' HA2' ' A' ' 321' ' ' GLY . 76.0 mt -62.47 -39.41 93.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.857 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -85.46 -42.67 14.26 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.744 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.64 -43.04 57.35 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 47.9 m0 -98.27 -60.41 1.56 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 10.9 mmt -62.85 -25.81 68.46 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 81.42 30.17 37.79 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.14 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 30.4 m -116.35 95.29 44.98 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 120.758 0.313 . . . . 0.0 110.567 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.32 -167.53 0.52 Allowed 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.967 2.444 . . . . 0.0 111.363 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 57.01 59.82 3.28 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.089 0.471 . . . . 0.0 110.941 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.503 -1.165 . . . . 0.0 112.185 -179.326 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.598 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' PRO . . . . . 0.485 ' HA ' HD23 ' B' ' 2' ' ' HYP . 88.2 Cg_endo -84.1 146.38 11.37 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.778 2.319 . . . . 0.0 111.964 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' HYP . . . . . 0.691 ' HA ' ' HB2' ' C' ' 101' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.71 170.65 45.96 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.983 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.7 163.42 38.29 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 123.042 2.495 . . . . 0.0 112.253 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' D' ' 202' ' ' HYP . . . -71.5 170.59 48.18 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.805 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.47 161.08 21.59 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.732 2.288 . . . . 0.0 111.456 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' HYP . . . . . 0.44 ' O ' ' HD2' ' D' ' 207' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 135.29 -168.64 23.7 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.785 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.11 150.48 15.76 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.65 2.233 . . . . 0.0 112.223 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -71.73 151.83 43.26 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.87 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.573 ' HA3' ' O ' ' D' ' 210' ' ' PRO . . . -60.1 151.5 38.35 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.25 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.512 ' O ' ' HG3' ' D' ' 211' ' ' GLN . 8.4 mt -66.73 150.01 11.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.23 151.36 31.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.369 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.41 163.73 53.05 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.937 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -70.63 141.21 51.73 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -67.47 144.5 55.67 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.314 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' D' ' 216' ' ' GLN . . . -57.16 151.6 26.65 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.925 -0.58 . . . . 0.0 113.154 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 12.1 t -69.85 147.15 11.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 19.9 t -53.31 145.01 3.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 O-C-N 123.326 0.391 . . . . 0.0 111.033 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.79 177.7 30.35 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.991 -0.549 . . . . 0.0 113.511 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 96.6 mt -90.77 160.65 15.68 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 122.234 0.213 . . . . 0.0 110.629 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -73.01 150.79 44.74 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.011 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.481 ' HA ' HD23 ' B' ' 26' ' ' HYP . 12.7 Cg_endo -57.43 137.72 82.84 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.501 2.134 . . . . 0.0 111.106 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' HYP . . . . . 0.481 HD23 ' HA ' ' B' ' 25' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.55 160.22 47.33 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.687 -0.688 . . . . 0.0 113.704 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' D' ' 226' ' ' HYP . 83.9 Cg_endo -82.84 163.88 15.91 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 123.035 2.49 . . . . 0.0 111.419 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.73 -179.1 44.73 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.205 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -70.9 165.16 33.17 Favored 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 123.423 2.748 . . . . 0.0 112.255 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.93 134.67 37.41 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.632 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -65.33 114.51 2.89 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.957 2.438 . . . . 0.0 111.735 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.345 0 CA-C-O 120.029 -0.317 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 101' ' ' PRO . . . . . 0.691 ' HB2' ' HA ' ' B' ' 2' ' ' HYP . 51.1 Cg_exo -55.14 114.62 1.95 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.051 2.5 . . . . 0.0 111.83 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 102' ' ' HYP . . . . . 0.477 HD23 ' HA ' ' C' ' 101' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.41 164.92 54.51 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.703 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -85.71 164.28 10.58 Favored 'Trans proline' 0 CA--C 1.533 0.459 0 C-N-CA 123.126 2.551 . . . . 0.0 112.542 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 105' ' ' HYP . . . . . 0.484 ' OD1' ' HG2' ' D' ' 204' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -82.68 -163.2 33.08 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.215 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -78.44 153.2 27.1 Favored 'Trans proline' 0 C--O 1.223 -0.233 0 C-N-CA 122.638 2.226 . . . . 0.0 110.533 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 108' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -58.63 165.17 8.2 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.89 -0.595 . . . . 0.0 113.064 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.21 160.38 38.77 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.692 2.262 . . . . 0.0 112.753 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -57.91 135.14 56.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.997 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -68.42 154.15 53.12 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.876 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 50.2 mt -68.41 133.75 31.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.686 0.279 . . . . 0.0 110.421 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.79 153.43 24.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.331 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -65.87 151.29 51.93 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.402 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 116' ' ' GLN . . . . . 0.413 ' HG2' ' N ' ' C' ' 117' ' ' ARG . 4.6 tt0 -71.18 159.12 35.23 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 117' ' ' ARG . . . . . 0.413 ' N ' ' HG2' ' C' ' 116' ' ' GLN . 11.3 ttm-85 -67.55 144.71 55.48 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.87 165.6 41.44 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.962 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 5.2 t -70.05 142.43 15.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 39.2 t -61.31 142.7 15.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.275 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.51 164.98 40.99 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.518 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 86.2 mt -79.84 141.73 35.92 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.586 0.231 . . . . 0.0 111.13 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 123' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -66.56 160.24 47.35 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.884 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.32 156.36 62.04 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.722 2.281 . . . . 0.0 111.501 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 126' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.74 162.71 37.85 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.878 -0.601 . . . . 0.0 113.305 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.37 162.12 36.66 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.677 2.252 . . . . 0.0 111.423 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -70.92 -176.08 21.7 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.929 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 131' ' ' PRO . . . . . 0.478 ' HA ' HD23 ' C' ' 132' ' ' HYP . 15.5 Cg_exo -69.95 150.66 67.33 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.921 2.414 . . . . 0.0 111.411 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 132' ' ' HYP . . . . . 0.478 HD23 ' HA ' ' C' ' 131' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . 0.42 ' HA2' ' HD3' ' C' ' 134' ' ' PRO . . . -71.88 120.47 8.04 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.976 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 134' ' ' PRO . . . . . 0.487 ' HA ' HD23 ' C' ' 135' ' ' HYP . 17.0 Cg_exo -68.19 111.96 2.63 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.002 2.468 . . . . 0.0 111.541 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 135' ' ' HYP . . . . . 0.487 HD23 ' HA ' ' C' ' 134' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.29 0 CA-C-O 120.031 -0.316 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 201' ' ' PRO . . . . . 0.453 ' HA ' HD23 ' D' ' 202' ' ' HYP . 74.3 Cg_exo -52.79 138.21 60.04 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.364 2.709 . . . . 0.0 112.304 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 202' ' ' HYP . . . . . 0.453 HD23 ' HA ' ' D' ' 201' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 203' ' ' GLY . . . . . 0.407 ' HA2' ' HD3' ' D' ' 204' ' ' PRO . . . 69.16 165.5 4.23 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 114.938 0.735 . . . . 0.0 114.938 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 204' ' ' PRO . . . . . 0.484 ' HG2' ' OD1' ' C' ' 105' ' ' HYP . 10.8 Cg_exo -75.58 172.28 16.62 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.934 3.09 . . . . 0.0 111.752 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 205' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . 105.0 169.5 24.18 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.72 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 207' ' ' PRO . . . . . 0.49 ' HA ' HD23 ' D' ' 208' ' ' HYP . 96.2 Cg_endo -88.42 150.29 6.49 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 123.177 2.584 . . . . 0.0 112.706 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 208' ' ' HYP . . . . . 0.49 HD23 ' HA ' ' D' ' 207' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -82.37 167.4 46.95 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.45 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 210' ' ' PRO . . . . . 0.573 ' O ' ' HA3' ' B' ' 12' ' ' GLY . 34.5 Cg_endo -65.96 146.66 83.3 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.764 2.309 . . . . 0.0 111.969 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 211' ' ' GLN . . . . . 0.512 ' HG3' ' O ' ' B' ' 13' ' ' ILE . 24.8 tt0 -77.13 147.04 36.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.199 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -65.43 158.28 46.4 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.923 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 41.3 pt -73.98 162.83 4.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.897 0.38 . . . . 0.0 111.324 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -70.83 137.39 49.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.347 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -63.43 164.54 29.56 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.904 -0.589 . . . . 0.0 113.146 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 216' ' ' GLN . . . . . 0.479 ' O ' ' HA3' ' B' ' 18' ' ' GLY . 35.7 mm-40 -75.44 151.34 38.1 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 26.4 mtp180 -67.72 153.75 43.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.829 0.347 . . . . 0.0 110.933 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -62.98 151.96 47.05 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.49 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 8.9 t -65.47 146.92 12.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 91.4 t -61.65 138.32 22.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -56.32 160.78 7.38 Favored Glycine 0 N--CA 1.451 -0.332 0 O-C-N 123.55 0.531 . . . . 0.0 113.502 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 7.3 mp -66.94 150.48 49.16 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.636 -0.282 . . . . 0.0 110.409 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 223' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 224' ' ' GLY . . . . . 0.459 ' HA2' ' HD3' ' D' ' 225' ' ' PRO . . . -64.03 146.91 50.65 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.993 -0.623 . . . . 0.0 112.166 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 225' ' ' PRO . . . . . 0.459 ' HD3' ' HA2' ' D' ' 224' ' ' GLY . 17.0 Cg_exo -69.14 150.49 72.05 Favored 'Trans proline' 0 C--O 1.238 0.476 0 C-N-CA 122.594 2.196 . . . . 0.0 111.568 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 226' ' ' HYP . . . . . 0.43 ' HA ' ' HD2' ' B' ' 28' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -73.48 170.71 52.26 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.033 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -78.95 163.46 25.79 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.874 2.383 . . . . 0.0 111.617 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -70.1 169.08 46.77 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.487 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 231' ' ' PRO . . . . . 0.455 ' HA ' HD23 ' D' ' 232' ' ' HYP . 27.6 Cg_exo -63.85 139.54 68.94 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.832 2.355 . . . . 0.0 111.586 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 232' ' ' HYP . . . . . 0.455 HD23 ' HA ' ' D' ' 231' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.478 0.57 0 N-CA-C 110.533 -0.603 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -118.4 166.83 12.18 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 19.1 tt -79.68 -30.81 13.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.899 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 57.4 m -71.18 -7.48 46.99 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -76.75 -14.06 59.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.365 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 76.44 -148.73 36.02 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 5.9 m120 51.51 68.45 0.8 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.042 0.449 . . . . 0.0 111.737 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -97.16 143.48 27.92 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.381 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -72.53 -43.08 64.02 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 1.3 t -170.18 150.43 3.68 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.553 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 48.3 t -128.25 124.11 61.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -147.57 166.73 26.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.277 0.561 . . . . 0.0 111.955 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . 0.439 ' HA ' ' HA ' ' A' ' 333' ' ' MET . 33.2 ttp -121.16 119.07 31.31 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 61.7 mt -112.56 119.76 39.28 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.464 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.733 ' HG3' ' HE1' ' A' ' 379' ' ' PHE . 57.0 mtp180 54.98 28.18 10.31 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 104.4 -24.97 27.37 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.593 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . 0.579 ' HG3' HH22 ' A' ' 343' ' ' ARG . 38.4 mm-40 -94.22 130.49 40.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.954 0.377 . . . . 0.0 111.163 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' MET . . . . . 0.439 ' HA ' ' HA ' ' A' ' 328' ' ' MET . 39.5 ttm -90.93 131.07 36.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.114 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -123.87 128.93 50.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.652 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 43.7 t -103.84 108.56 24.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -89.35 129.85 35.82 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.77 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -149.62 111.76 4.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.99 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 63.62 -110.54 0.3 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.784 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -113.18 9.96 18.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.03 0.443 . . . . 0.0 111.207 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -129.63 160.19 34.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.664 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.487 ' CE2' ' HE2' ' A' ' 353' ' ' TYR . 38.6 p90 -140.64 139.81 34.92 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.106 177.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 -102.41 151.14 22.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.656 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.61 ' HD3' ' SD ' ' A' ' 350' ' ' MET . 16.2 ttt-85 -111.24 95.24 5.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.678 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 2.3 m -93.37 110.7 23.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.355 0.598 . . . . 0.0 111.143 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.63 92.01 3.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.161 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 9.3 m120 60.42 58.45 2.53 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.623 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 7.0 t30 63.85 17.33 10.45 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.288 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -124.44 130.1 51.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.561 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 39.4 t -87.72 121.13 37.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' MET . . . . . 0.61 ' SD ' ' HD3' ' A' ' 343' ' ' ARG . 90.7 mtp -77.55 148.72 35.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.978 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.46 164.02 22.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.789 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 85.12 4.04 87.0 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' TYR . . . . . 0.538 ' CE1' ' HD2' ' A' ' 343' ' ' ARG . 76.5 m-85 -123.73 157.7 61.92 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.584 -0.308 . . . . 0.0 110.748 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 353' ' ' TYR . 42.9 Cg_endo -66.17 140.69 48.92 Favored 'Cis proline' 0 C--N 1.347 0.492 0 C-N-CA 123.646 -1.398 . . . . 0.0 113.012 0.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . 0.422 ' HA ' ' HD3' ' A' ' 356' ' ' PRO . 52.7 ttm -105.01 137.42 19.21 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.094 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 355' ' ' MET . 33.5 Cg_exo -60.83 133.31 47.11 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.446 2.098 . . . . 0.0 111.587 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 78.4 mt -59.15 -41.16 82.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -67.91 -16.63 68.58 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 121.104 -0.569 . . . . 0.0 113.88 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' GLN . . . . . 0.415 ' HG2' ' HG3' ' D' ' 210' ' ' PRO . 28.8 tt0 -81.25 -54.4 5.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.095 0.447 . . . . 0.0 110.796 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.747 ' HE2' ' HB3' ' D' ' 211' ' ' GLN . 24.1 t80 -77.38 -58.89 3.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.178 0.513 . . . . 0.0 110.261 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -88.48 63.17 6.92 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -57.04 103.43 0.11 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.91 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 126.85 -19.65 6.12 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.62 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.624 HD12 ' HD2' ' A' ' 365' ' ' PRO . 27.1 tp -88.72 129.76 47.58 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.69 0.281 . . . . 0.0 110.458 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' PRO . . . . . 0.624 ' HD2' HD12 ' A' ' 364' ' ' LEU . 73.5 Cg_endo -75.29 169.71 21.91 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.726 2.284 . . . . 0.0 112.029 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -77.96 150.13 34.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.186 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 60.2 m 59.9 94.94 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 21.1 pt -107.96 173.83 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.53 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -97.85 -47.93 5.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.254 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . 0.857 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.2 OUTLIER -155.65 165.51 36.33 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.856 0.36 . . . . 0.0 111.489 -179.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -153.23 141.69 20.73 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . 0.577 ' HE1' ' HE2' ' A' ' 382' ' ' PHE . 13.2 p90 -156.12 162.69 40.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.169 0.509 . . . . 0.0 112.276 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -90.89 124.3 35.08 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . 0.559 ' HG2' ' O ' ' A' ' 378' ' ' LYS . 11.6 ptm180 -85.92 174.53 9.2 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -65.64 -36.26 83.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.142 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -31.92 73.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.393 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 124.93 -28.03 5.26 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.678 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' LYS . . . . . 0.685 ' HG2' ' HA ' ' A' ' 391' ' ' ASP . 31.0 mttt -77.12 174.97 10.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.162 0.506 . . . . 0.0 112.217 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . 0.733 ' HE1' ' HG3' ' A' ' 330' ' ' ARG . 9.5 m-85 -106.47 134.71 49.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.4 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . 0.48 ' HB ' ' CE1' ' A' ' 372' ' ' TYR . 13.2 t -112.34 120.31 62.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.901 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -105.29 137.91 42.32 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.956 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.577 ' HE2' ' HE1' ' A' ' 372' ' ' TYR . 78.0 m-85 -119.07 138.1 53.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.92 0.391 . . . . 0.0 111.576 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.517 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 26.5 tttp -150.47 101.6 2.97 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.553 ' O ' ' HA ' ' A' ' 414' ' ' LYS . . . 74.15 -113.99 4.34 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.274 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -111.51 4.04 18.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.667 0.27 . . . . 0.0 111.17 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -113.68 148.94 35.45 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.248 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . 0.422 ' NE2' ' HE2' ' A' ' 399' ' ' TYR . 33.0 p-80 -130.32 147.43 52.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.222 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' TRP . . . . . 0.517 ' HZ3' ' HB3' ' A' ' 383' ' ' LYS . 23.3 m-90 -122.66 133.02 54.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.123 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 96.5 t -109.71 116.76 53.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -110.9 122.77 48.69 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.812 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.685 ' HA ' ' HG2' ' A' ' 378' ' ' LYS . 14.3 t70 -91.12 91.45 8.26 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 67.02 -77.51 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 O-C-N 123.874 0.734 . . . . 0.0 110.716 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -141.25 14.66 2.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.248 0.547 . . . . 0.0 109.912 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.57 118.9 28.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.91 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 47.5 tp -69.91 133.42 47.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.409 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -71.75 123.42 89.39 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -59.17 137.72 80.78 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.944 2.429 . . . . 0.0 112.257 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 108.94 6.5 30.08 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.352 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' TYR . . . . . 0.699 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 65.6 m-85 -113.43 167.12 9.84 Favored Pre-proline 0 C--N 1.323 -0.578 0 O-C-N 122.982 -0.128 . . . . 0.0 111.077 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.699 ' HA ' ' HB3' ' A' ' 399' ' ' TYR . 71.9 Cg_endo -77.68 161.73 91.27 Favored 'Cis proline' 0 C--N 1.348 0.541 0 C-N-CA 123.708 -1.372 . . . . 0.0 113.165 0.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -128.39 162.62 26.69 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.072 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -70.29 157.83 37.0 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 47.8 mt -57.16 -33.49 43.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.894 0.378 . . . . 0.0 110.971 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 404' ' ' LYS . 18.1 ptmt -67.88 -16.66 64.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.844 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -78.77 -15.52 58.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.898 0.38 . . . . 0.0 110.821 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 51.7 tp -83.44 -48.78 9.97 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -159.7 166.16 34.82 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.761 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -95.46 131.1 41.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.998 0.428 . . . . 0.0 110.999 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 106.83 5.87 35.39 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.586 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 411' ' ' PRO . 95.8 mt -92.39 148.97 37.52 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 410' ' ' LEU . 52.1 Cg_exo -56.1 135.41 69.75 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.185 2.59 . . . . 0.0 111.919 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.47 1.36 51.49 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.669 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -95.27 -56.41 2.73 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.733 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 384' ' ' GLY . 11.9 ptmt -174.85 173.59 2.72 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.752 0.311 . . . . 0.0 110.584 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 46.6 mm -121.84 132.93 69.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -87.68 -54.08 4.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.248 0.547 . . . . 0.0 109.8 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.857 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -149.83 150.95 32.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.368 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -132.54 120.92 22.5 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 61.8 tp -115.73 127.13 54.9 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.024 0.44 . . . . 0.0 111.686 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -94.85 114.31 26.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.719 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' TRP . . . . . 0.436 ' HB3' ' OD1' ' A' ' 424' ' ' ASN . 4.5 t-105 -84.98 94.82 8.89 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.432 ' HB2' ' HD3' ' A' ' 423' ' ' PRO . 66.5 mtt -53.84 -50.15 85.41 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.432 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 97.5 Cg_exo -46.1 -43.37 20.59 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 122.77 2.313 . . . . 0.0 114.867 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' ASN . . . . . 0.436 ' OD1' ' HB3' ' A' ' 421' ' ' TRP . 30.4 p30 -107.04 -23.06 12.45 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 87.05 26.8 30.26 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.036 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 38.6 mmtt -108.22 155.22 20.71 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 9.2 m -112.1 125.88 54.58 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.853 0.359 . . . . 0.0 110.828 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -103.47 119.54 39.1 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.001 0.429 . . . . 0.0 110.634 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -102.15 131.95 48.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.239 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -110.96 132.42 54.22 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.949 0.404 . . . . 0.0 111.444 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -145.29 108.39 4.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 70.54 -105.23 1.54 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.525 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -124.91 11.67 8.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.073 0.463 . . . . 0.0 110.498 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -121.38 143.02 49.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.523 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' TYR . . . . . 0.618 ' CE2' ' HE2' ' A' ' 449' ' ' TYR . 20.4 p90 -123.36 141.13 52.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.03 0.443 . . . . 0.0 111.43 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -110.75 152.38 26.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.573 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 26.7 ttp180 -113.43 96.89 6.13 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -89.52 134.01 34.32 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.387 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . 0.549 HD22 ' HG ' ' A' ' 442' ' ' LEU . 64.4 t30 -108.57 119.58 39.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.371 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.44 -45.49 73.09 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -66.55 -49.79 65.29 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' LEU . . . . . 0.549 ' HG ' HD22 ' A' ' 439' ' ' ASN . 49.9 mt -71.76 -22.02 61.66 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 60.47 33.49 20.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.369 0.604 . . . . 0.0 111.31 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -156.67 173.2 17.3 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.251 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 98.1 t -89.12 137.87 20.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.114 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.25 156.48 21.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.415 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . 0.558 ' O ' ' HB2' ' A' ' 448' ' ' GLU . 16.4 m -69.94 159.61 33.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.397 179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' GLU . . . . . 0.558 ' HB2' ' O ' ' A' ' 447' ' ' SER . 5.4 mm-40 80.15 6.06 1.73 Allowed 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.817 0.698 . . . . 0.0 111.067 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . 0.618 ' HE2' ' CE2' ' A' ' 435' ' ' TYR . 63.7 m-85 -117.13 162.73 26.36 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.089 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . 0.524 ' HA ' ' HB3' ' A' ' 449' ' ' TYR . 73.7 Cg_endo -74.2 156.19 99.78 Favored 'Cis proline' 0 C--N 1.347 0.493 0 C-N-CA 123.698 -1.376 . . . . 0.0 112.431 0.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -114.68 161.63 17.87 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.172 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -65.71 135.95 55.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.456 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.7 tt -64.63 -13.14 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.107 0.48 . . . . 0.0 111.153 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . 0.477 ' HD3' ' HA ' ' A' ' 454' ' ' LYS . 66.4 mmtt -62.88 -13.08 29.7 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.877 -0.602 . . . . 0.0 112.533 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 76.0 t -60.85 -37.82 77.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' TRP . . . . . 0.494 ' HZ3' HD11 ' A' ' 491' ' ' LEU . 26.4 m95 -86.72 91.42 8.61 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.171 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -61.46 112.25 2.12 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 115.29 -21.25 13.24 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.811 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 39.3 mm -81.08 125.77 78.82 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-O 120.815 0.34 . . . . 0.0 110.495 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . 0.405 ' HG3' ' CH2' ' A' ' 484' ' ' TRP . 97.7 Cg_endo -77.47 157.38 32.65 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.799 2.333 . . . . 0.0 111.686 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -78.46 145.06 35.23 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.36 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.9 m 57.68 70.44 1.3 Allowed Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -90.36 179.88 1.82 Allowed 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.68 2.253 . . . . 0.0 110.614 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 464' ' ' ARG . 0.3 OUTLIER -149.42 68.46 1.03 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.396 0.617 . . . . 0.0 110.801 179.363 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 137.34 111.7 1.07 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 3.2 p -137.96 115.3 11.09 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.791 0.329 . . . . 0.0 110.177 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -136.58 145.46 44.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 468' ' ' MET . . . . . 0.413 ' HA ' ' HA ' ' A' ' 475' ' ' THR . 46.4 ttm -101.33 142.53 32.61 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -68.99 163.21 50.86 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.514 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.99 9.29 0.57 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.08 -10.02 16.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.941 0.401 . . . . 0.0 110.8 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 69.42 5.07 4.95 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 43.9 t -111.85 -36.58 2.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 O-C-N 122.18 -0.325 . . . . 0.0 111.68 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -100.79 117.52 35.04 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 475' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 468' ' ' MET . 52.0 m -109.53 144.26 38.06 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.398 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 476' ' ' TYR . . . . . 0.55 ' CE1' ' HG3' ' A' ' 485' ' ' LYS . 92.9 m-85 -121.07 134.48 55.27 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -120.4 134.37 55.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.739 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -113.3 137.6 51.25 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.772 0.32 . . . . 0.0 111.807 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 479' ' ' LYS . . . . . 0.41 ' HB3' ' CZ3' ' A' ' 484' ' ' TRP . 77.1 tttt -161.98 109.77 1.4 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.424 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 65.12 58.94 8.58 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 114.614 0.606 . . . . 0.0 114.614 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 41.3 t30 62.89 4.19 1.41 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -121.99 151.07 41.19 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -130.0 152.8 49.07 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.936 0.398 . . . . 0.0 111.428 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 484' ' ' TRP . . . . . 0.5 ' CE2' ' HB3' ' A' ' 498' ' ' PRO . 15.1 m-90 -116.78 148.61 41.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.082 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . 0.55 ' HG3' ' CE1' ' A' ' 476' ' ' TYR . 24.1 tttp -106.86 100.59 10.09 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 486' ' ' PHE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 493' ' ' VAL . 62.4 t80 -93.12 125.36 37.68 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.297 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -94.9 115.14 27.1 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -66.92 -29.93 69.94 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -64.85 -53.7 42.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.991 0.424 . . . . 0.0 111.405 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -83.1 -14.22 54.14 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.983 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.494 HD11 ' HZ3' ' A' ' 456' ' ' TRP . 11.2 tp 63.6 42.26 6.59 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.448 0.642 . . . . 0.0 109.814 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 47.0 tttt -156.66 156.52 33.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.289 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 486' ' ' PHE . 53.5 t -79.96 139.81 17.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.149 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -69.82 146.12 95.19 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.025 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.45 153.6 73.56 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.651 2.234 . . . . 0.0 111.552 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 97.51 15.73 36.69 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . 0.623 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 24.6 m-85 -123.88 169.01 11.21 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.511 -0.344 . . . . 0.0 110.254 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . 0.623 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 72.4 Cg_endo -75.7 178.68 33.86 Favored 'Cis proline' 0 C--N 1.346 0.41 0 C-N-CA 123.851 -1.312 . . . . 0.0 112.965 0.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -136.01 150.58 49.27 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.401 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 37.3 t -69.47 128.17 35.57 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.67 -18.39 62.84 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.398 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 28.1 mt -61.68 -62.13 2.02 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.66 -11.53 59.88 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.17 -40.66 10.35 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 21.3 m0 -125.06 -39.3 2.25 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 10.8 mmt -71.82 -20.0 61.9 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 78.95 25.68 59.57 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.45 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 9.9 m -113.97 93.22 28.79 Favored Pre-proline 0 C--N 1.326 -0.434 0 O-C-N 122.845 -0.209 . . . . 0.0 110.658 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -83.58 171.29 11.05 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.866 2.377 . . . . 0.0 112.124 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 8.4 m 53.64 72.15 0.46 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.088 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.476 -1.18 . . . . 0.0 111.551 -179.949 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.735 0 N-CA-C 111.776 -0.529 . . . . 0.0 111.776 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' PRO . . . . . 0.48 ' HA ' HD23 ' B' ' 2' ' ' HYP . 83.5 Cg_endo -87.26 146.48 7.48 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.614 2.21 . . . . 0.0 112.002 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' HYP . . . . . 0.48 HD23 ' HA ' ' B' ' 1' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' D' ' 201' ' ' PRO . . . -67.36 160.48 49.15 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.906 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.88 162.43 41.95 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.555 2.17 . . . . 0.0 111.445 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.09 -176.82 44.69 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.947 -0.644 . . . . 0.0 113.207 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.576 ' HG2' ' HA ' ' D' ' 205' ' ' HYP . 26.2 Cg_endo -63.61 166.29 15.97 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.999 2.466 . . . . 0.0 111.865 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' HYP . . . . . 0.415 ' O ' ' HA3' ' D' ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 130.66 -166.75 22.37 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.087 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.87 141.66 30.58 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 123.216 2.611 . . . . 0.0 112.304 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . 0.5 ' HB2' ' HG2' ' C' ' 110' ' ' PRO . 45.9 tt0 -68.59 147.65 51.62 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' D' ' 210' ' ' PRO . . . -57.09 147.58 34.2 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.361 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.452 ' H ' HG13 ' B' ' 13' ' ' ILE . 6.6 mt -61.87 150.11 8.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.4 151.37 46.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.278 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.51 169.17 53.55 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.936 -0.65 . . . . 0.0 113.112 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -78.57 147.15 33.84 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -70.82 146.51 49.66 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' D' ' 216' ' ' GLN . . . -62.87 155.47 41.92 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.706 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 t -71.88 154.44 7.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.4 t -55.65 142.76 9.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 O-C-N 123.319 0.387 . . . . 0.0 110.874 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.64 163.54 51.67 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.788 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 97.1 mt -73.18 148.57 43.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.445 0.164 . . . . 0.0 110.693 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.79 156.26 53.43 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.788 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -70.56 158.77 54.95 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 122.868 2.378 . . . . 0.0 111.662 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.14 155.96 53.26 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.509 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.445 ' HA ' HD23 ' B' ' 29' ' ' HYP . 43.6 Cg_endo -69.59 155.25 67.03 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.539 2.159 . . . . 0.0 111.73 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' HYP . . . . . 0.445 HD23 ' HA ' ' B' ' 28' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.68 178.16 48.59 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.203 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -73.33 165.33 32.84 Favored 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 123.336 2.691 . . . . 0.0 111.676 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.28 156.4 53.34 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.092 -0.575 . . . . 0.0 113.116 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . 0.486 ' HA ' HD23 ' B' ' 35' ' ' HYP . 38.2 Cg_endo -67.93 118.48 5.64 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.764 2.309 . . . . 0.0 111.748 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' HYP . . . . . 0.486 HD23 ' HA ' ' B' ' 34' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.399 0 CA-C-O 120.082 -0.288 . . . . 0.0 112.67 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 101' ' ' PRO . . . . . 0.503 ' HA ' HD23 ' C' ' 102' ' ' HYP . 23.4 Cg_exo -66.1 139.74 56.94 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 123.139 2.559 . . . . 0.0 112.444 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 102' ' ' HYP . . . . . 0.503 HD23 ' HA ' ' C' ' 101' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.76 161.26 49.5 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.132 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.22 153.52 36.18 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.78 2.32 . . . . 0.0 112.657 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 105' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -74.49 -178.61 40.16 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.81 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.54 154.62 21.02 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.865 2.377 . . . . 0.0 111.336 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 108' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -57.68 171.16 3.49 Favored Glycine 0 CA--C 1.519 0.338 0 CA-C-N 115.71 -0.677 . . . . 0.0 114.043 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 110' ' ' PRO . . . . . 0.5 ' HG2' ' HB2' ' B' ' 11' ' ' GLN . 10.4 Cg_endo -53.95 148.9 36.54 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 123.516 2.81 . . . . 0.0 113.286 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -59.34 140.52 56.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.842 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.47 161.88 38.11 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 116.01 -0.541 . . . . 0.0 113.354 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 42.0 mt -83.24 135.28 25.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.7 146.7 51.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.79 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -69.44 159.56 53.05 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.108 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 116' ' ' GLN . . . . . 0.441 ' HG2' ' H ' ' C' ' 117' ' ' ARG . 4.6 tt0 -81.8 160.5 23.53 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.701 0.286 . . . . 0.0 110.742 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 117' ' ' ARG . . . . . 0.441 ' H ' ' HG2' ' C' ' 116' ' ' GLN . 42.8 ttm-85 -67.14 149.6 50.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.839 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.4 171.2 37.23 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.671 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 15.9 t -72.68 140.92 17.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 120' ' ' VAL . . . . . 0.594 HG13 ' HB ' ' D' ' 219' ' ' VAL . 24.1 t -57.56 135.96 21.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.209 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.86 162.33 42.37 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.566 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 122' ' ' LEU . . . . . 0.448 ' HA ' HD23 ' C' ' 123' ' ' HYP . 82.3 mt -78.39 139.92 38.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.607 0.242 . . . . 0.0 110.524 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 123' ' ' HYP . . . . . 0.448 HD23 ' HA ' ' C' ' 122' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -70.24 165.76 51.17 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.681 -0.691 . . . . 0.0 113.054 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -74.03 156.98 47.27 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.68 2.254 . . . . 0.0 111.19 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 126' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.63 162.85 37.21 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.778 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.56 161.0 34.63 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.555 2.17 . . . . 0.0 111.724 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -68.56 -173.33 8.06 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 121.192 -0.528 . . . . 0.0 113.461 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -72.45 157.53 52.85 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 123.141 2.561 . . . . 0.0 111.849 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 132' ' ' HYP . . . . . 0.499 ' HA ' ' O ' ' D' ' 231' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -65.68 126.11 29.37 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.825 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 134' ' ' PRO . . . . . 0.417 ' HD2' ' OD1' ' B' ' 35' ' ' HYP . 53.1 Cg_endo -70.57 114.12 3.73 Favored 'Trans proline' 0 CA--C 1.531 0.375 0 C-N-CA 122.49 2.127 . . . . 0.0 111.614 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 135' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.451 0 N-CA-C 112.339 -0.304 . . . . 0.0 112.339 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 201' ' ' PRO . . . . . 0.556 ' O ' ' HA3' ' B' ' 3' ' ' GLY . 52.0 Cg_exo -56.82 131.41 45.42 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.608 2.205 . . . . 0.0 111.384 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 202' ' ' HYP . . . . . 0.491 HD23 ' HA ' ' D' ' 201' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 82.21 -177.46 53.69 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.883 -0.675 . . . . 0.0 114.387 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 204' ' ' PRO . . . . . 0.411 ' HA ' HD23 ' D' ' 205' ' ' HYP . 13.6 Cg_exo -71.47 161.78 44.39 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 123.745 2.964 . . . . 0.0 112.168 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 205' ' ' HYP . . . . . 0.576 ' HA ' ' HG2' ' B' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 206' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' B' ' 8' ' ' HYP . . . 97.3 157.14 30.65 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.602 -0.808 . . . . 0.0 113.516 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -86.47 154.39 9.17 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 123.149 2.566 . . . . 0.0 112.727 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 208' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -81.35 171.64 53.31 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.503 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 210' ' ' PRO . . . . . 0.415 ' HG3' ' HG2' ' A' ' 359' ' ' GLN . 16.4 Cg_exo -69.11 148.45 69.32 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.957 2.438 . . . . 0.0 112.061 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 211' ' ' GLN . . . . . 0.747 ' HB3' ' HE2' ' A' ' 360' ' ' PHE . 60.0 tt0 -67.72 148.97 50.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.716 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -71.29 163.53 54.07 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.251 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 24.9 pt -69.55 165.38 2.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-O 120.65 0.262 . . . . 0.0 111.026 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 214' ' ' ALA . . . . . 0.496 ' HB3' ' NH1' ' A' ' 330' ' ' ARG . . . -87.49 139.23 30.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.924 0.393 . . . . 0.0 110.842 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -61.49 161.76 26.05 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.67 -0.695 . . . . 0.0 113.525 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 216' ' ' GLN . . . . . 0.443 ' O ' ' HA3' ' B' ' 18' ' ' GLY . 35.4 mm-40 -73.27 160.36 32.0 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -66.63 155.64 37.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.17 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -61.98 158.21 34.08 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.878 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 219' ' ' VAL . . . . . 0.594 ' HB ' HG13 ' C' ' 120' ' ' VAL . 25.8 t -61.74 141.88 17.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 24.6 t -62.48 138.51 22.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.206 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -58.12 154.11 24.98 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.613 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 222' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' D' ' 223' ' ' HYP . 7.2 mp -73.63 152.81 40.41 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.742 0.306 . . . . 0.0 111.044 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 223' ' ' HYP . . . . . 0.403 HD23 ' HA ' ' D' ' 222' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 224' ' ' GLY . . . . . 0.423 ' HA2' ' HD3' ' D' ' 225' ' ' PRO . . . -61.7 153.46 40.69 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.685 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 225' ' ' PRO . . . . . 0.423 ' HD3' ' HA2' ' D' ' 224' ' ' GLY . 24.0 Cg_exo -65.84 143.24 72.69 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.697 2.265 . . . . 0.0 111.222 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 226' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -63.87 163.23 33.6 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.813 -0.631 . . . . 0.0 113.734 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -82.54 168.43 14.49 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 122.968 2.445 . . . . 0.0 111.474 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -74.38 179.73 42.58 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.02 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 231' ' ' PRO . . . . . 0.499 ' O ' ' HA ' ' C' ' 132' ' ' HYP . 15.7 Cg_exo -69.21 146.42 63.55 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.952 2.435 . . . . 0.0 111.774 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 232' ' ' HYP . . . . . 0.457 HD23 ' HA ' ' D' ' 231' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo . . . . . 0 N--CA 1.479 0.674 0 N-CA-C 110.066 -0.782 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -109.34 145.39 36.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.425 0.155 . . . . 0.0 110.613 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.448 ' O ' ' HZ ' ' A' ' 323' ' ' PHE . 19.3 tt -81.05 -19.1 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-O 121.114 0.483 . . . . 0.0 111.349 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 7.9 m -95.68 12.59 29.28 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.094 0.473 . . . . 0.0 110.244 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -68.82 -33.77 74.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.445 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 82.48 179.85 52.91 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.624 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 5.5 t30 52.17 77.75 0.14 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.172 0.511 . . . . 0.0 111.448 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' PHE . . . . . 0.448 ' HZ ' ' O ' ' A' ' 318' ' ' ILE . 72.1 m-85 -98.75 157.53 16.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.235 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -68.48 -39.38 81.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.261 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 13.4 t -176.43 153.53 1.19 Allowed 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.79 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.506 HG22 HG13 ' A' ' 335' ' ' VAL . 60.6 t -135.84 123.53 35.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -144.3 178.1 8.15 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.963 0.411 . . . . 0.0 111.62 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 51.9 ttp -130.92 121.57 25.41 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 63.9 mt -114.9 122.09 45.23 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.012 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.695 ' HG3' ' HE1' ' A' ' 379' ' ' PHE . 64.1 mtp180 55.26 25.76 7.75 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 101.57 -8.67 56.77 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.509 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -105.79 127.92 53.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.993 0.396 . . . . 0.0 110.829 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 45.3 ttm -84.9 134.06 34.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.818 0.342 . . . . 0.0 111.633 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -126.49 128.39 46.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.64 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . 0.506 HG13 HG22 ' A' ' 326' ' ' VAL . 35.6 t -108.31 119.37 57.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.43 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -99.85 131.76 45.62 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 0.426 ' HB2' ' HD1' ' A' ' 323' ' ' PHE . 41.4 tptt -141.51 106.01 4.86 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.723 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 63.03 -105.18 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.55 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -115.07 10.68 16.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.868 0.366 . . . . 0.0 111.32 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 10.1 m-90 -123.93 163.02 22.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.12 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -143.83 144.44 31.78 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.978 0.418 . . . . 0.0 110.923 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -108.41 146.52 32.94 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.818 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.628 ' HD3' ' SD ' ' A' ' 350' ' ' MET . 23.9 ttt-85 -115.83 96.08 5.43 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 3.3 m -88.21 129.6 39.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.995 0.426 . . . . 0.0 111.184 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -142.87 122.44 13.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.853 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 14.3 m120 57.65 41.0 26.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.115 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 67.77 23.71 8.48 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.187 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -134.25 154.05 51.51 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 46.0 t -90.79 121.92 41.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' MET . . . . . 0.628 ' SD ' ' HD3' ' A' ' 343' ' ' ARG . 1.7 ttt -65.32 144.39 57.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.748 0.308 . . . . 0.0 111.133 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -66.87 147.1 53.68 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.546 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 100.94 -0.71 55.09 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.134 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' TYR . . . . . 0.514 ' HB3' ' HA ' ' A' ' 354' ' ' PRO . 80.3 m-85 -122.07 160.11 48.81 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.514 ' HA ' ' HB3' ' A' ' 353' ' ' TYR . 55.2 Cg_endo -69.86 136.61 39.87 Favored 'Cis proline' 0 C--N 1.347 0.497 0 C-N-CA 123.736 -1.36 . . . . 0.0 113.025 0.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 47.2 ttm -116.59 141.95 28.84 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.448 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.62 135.27 68.5 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.262 1.975 . . . . 0.0 111.352 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 95.3 mt -54.21 -43.74 61.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.354 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -69.87 -6.44 56.01 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 121.028 -0.606 . . . . 0.0 114.606 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -86.24 -37.11 18.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.501 0.65 . . . . 0.0 110.208 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -95.11 -53.65 3.72 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -92.26 71.73 5.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 -59.99 101.71 0.13 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.135 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 131.06 -19.42 4.91 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.452 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.518 HD12 ' HD2' ' A' ' 365' ' ' PRO . 22.2 tp -91.14 131.95 35.5 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.681 0.276 . . . . 0.0 110.626 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' PRO . . . . . 0.518 ' HD2' HD12 ' A' ' 364' ' ' LEU . 92.2 Cg_endo -82.67 -173.76 1.83 Allowed 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.789 2.326 . . . . 0.0 112.269 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -90.01 154.75 19.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.212 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.7 m 56.37 93.47 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 21.5 pt -110.53 179.82 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.447 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . 0.423 HD22 ' HA ' ' A' ' 369' ' ' ASN . 4.3 m120 -96.45 -55.81 2.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.949 0.404 . . . . 0.0 110.949 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . 0.919 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.2 OUTLIER -155.9 167.91 28.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.161 -179.668 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -142.86 139.21 30.76 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -152.86 166.26 32.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.06 0.457 . . . . 0.0 111.913 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -100.77 141.13 34.08 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.19 -0.914 . . . . 0.0 108.64 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 378' ' ' LYS . 7.1 ptm180 -100.77 -171.65 2.05 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 39.3 tttt -72.46 -25.74 61.55 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -177.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.21 -17.38 32.76 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 113.49 -17.27 21.26 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.805 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' LYS . . . . . 0.519 ' O ' ' HG2' ' A' ' 374' ' ' ARG . 46.1 mttp -74.66 158.21 34.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.097 0.475 . . . . 0.0 111.521 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . 0.695 ' HE1' ' HG3' ' A' ' 330' ' ' ARG . 9.7 m-85 -98.46 134.76 40.99 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.444 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 21.9 t -116.58 121.08 66.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.023 0.439 . . . . 0.0 110.496 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -105.57 139.03 40.79 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.451 ' HE1' HG12 ' A' ' 403' ' ' ILE . 3.8 m-85 -119.39 144.44 46.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.773 0.321 . . . . 0.0 111.702 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.461 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 83.5 tttt -155.51 98.89 1.99 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.954 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.471 ' O ' HD11 ' A' ' 403' ' ' ILE . . . 71.52 -114.75 5.29 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.815 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 402' ' ' HIS . 13.1 p-10 -105.07 6.43 33.27 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -118.28 151.4 37.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.795 0.331 . . . . 0.0 111.793 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 37.0 p-80 -136.0 145.35 46.0 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.238 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' TRP . . . . . 0.461 ' HZ3' ' HB3' ' A' ' 383' ' ' LYS . 17.8 m-90 -118.27 133.09 56.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.654 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 60.0 t -111.78 113.4 44.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -107.66 127.52 53.74 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -92.7 88.92 6.45 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . 0.459 ' OE1' ' HB ' ' D' ' 213' ' ' ILE . 59.5 mm-40 69.02 -71.3 0.12 Allowed 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.721 0.638 . . . . 0.0 111.002 -178.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -142.41 3.18 1.5 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.174 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.84 126.48 54.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.729 0.3 . . . . 0.0 111.582 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 47.8 tp -74.09 135.21 42.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.654 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 13.6 mt-10 -75.63 134.78 72.23 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.859 0.362 . . . . 0.0 111.068 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 45.2 Cg_exo -58.74 142.53 98.79 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.199 2.599 . . . . 0.0 112.28 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 104.23 -25.1 27.17 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.309 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' TYR . . . . . 0.602 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 95.2 m-85 -89.64 161.24 39.71 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 110.561 -0.163 . . . . 0.0 110.561 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.602 ' HA ' ' HB3' ' A' ' 399' ' ' TYR . 72.0 Cg_endo -75.03 152.84 98.68 Favored 'Cis proline' 0 C--N 1.345 0.355 0 C-N-CA 123.77 -1.346 . . . . 0.0 113.394 0.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -126.39 169.78 12.62 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.491 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 0.496 ' HA ' ' O ' ' A' ' 385' ' ' ASP . 76.3 m80 -71.75 158.09 36.74 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.656 0.265 . . . . 0.0 111.236 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . 0.471 HD11 ' O ' ' A' ' 384' ' ' GLY . 22.4 mt -59.22 -35.54 58.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.18 0.514 . . . . 0.0 110.03 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 44.1 pttt -67.05 -15.04 63.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.803 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.451 ' HG2' ' HB2' ' A' ' 402' ' ' HIS . 38.1 mm-40 -82.27 -28.66 31.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.851 0.357 . . . . 0.0 110.549 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 41.1 tp -72.14 -53.34 13.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.29 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.625 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -153.9 159.68 28.89 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.618 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -89.69 127.37 35.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.719 0.295 . . . . 0.0 110.533 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 106.31 -0.92 37.52 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.226 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 95.1 mt -79.0 156.51 76.91 Favored Pre-proline 0 C--N 1.32 -0.691 0 O-C-N 122.878 -0.189 . . . . 0.0 110.663 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -53.34 138.62 64.83 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.677 2.252 . . . . 0.0 112.013 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.01 -15.97 28.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.723 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -86.41 -61.01 1.84 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . 0.467 ' O ' ' HD2' ' A' ' 431' ' ' ARG . 10.0 pttp -175.33 179.15 1.55 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 33.4 mm -117.98 147.93 21.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -100.15 -49.54 4.25 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.919 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -157.65 156.15 31.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.258 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -136.78 120.03 16.76 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 21.9 tp -108.94 124.53 50.83 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.058 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -97.57 114.13 25.98 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' TRP . . . . . 0.886 ' HB2' ' HE2' ' A' ' 428' ' ' TYR . 10.9 t-105 -83.6 94.81 8.16 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 10.1 mmt -49.8 -52.84 48.07 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -47.55 -42.41 29.1 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 123.036 2.491 . . . . 0.0 115.177 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' ASN . . . . . 0.446 ' OD1' ' HB3' ' A' ' 421' ' ' TRP . 36.0 p30 -104.64 -19.36 13.99 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 78.56 34.89 34.14 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.209 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 37.4 mmtt -117.0 147.48 42.27 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.6 m -107.53 126.64 52.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.771 0.32 . . . . 0.0 110.491 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' TYR . . . . . 0.886 ' HE2' ' HB2' ' A' ' 421' ' ' TRP . 71.3 m-85 -104.04 110.61 22.84 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.862 0.363 . . . . 0.0 110.74 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -92.46 120.78 33.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.781 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -97.01 132.26 43.0 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.751 0.31 . . . . 0.0 111.183 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.467 ' HD2' ' O ' ' A' ' 414' ' ' LYS . 2.5 tpm_? -144.41 104.9 4.13 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.066 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . 0.41 ' HA2' ' OG ' ' A' ' 462' ' ' SER . . . 67.15 -111.66 4.27 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.591 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -109.3 10.64 25.59 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . 0.656 ' HD3' ' HG2' ' A' ' 450' ' ' PRO . 89.8 mttt -130.94 152.44 50.26 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.805 0.336 . . . . 0.0 111.681 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' TYR . . . . . 0.421 ' CE2' ' HE2' ' A' ' 449' ' ' TYR . 11.7 p90 -125.87 142.65 51.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.504 178.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -109.43 136.11 49.37 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.671 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -97.31 99.48 10.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.161 0.505 . . . . 0.0 109.651 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . 0.625 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 91.4 t80 -89.94 134.81 34.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.748 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -110.56 106.6 15.93 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.354 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' GLU . . . . . 0.41 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 0.6 OUTLIER -50.7 -47.23 59.08 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -178.404 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -59.3 -35.85 74.54 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 67.1 mt -98.63 -15.81 19.3 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 60.96 40.09 15.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.635 0.731 . . . . 0.0 110.992 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -150.97 168.24 25.15 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.458 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 87.6 t -92.01 141.58 14.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.553 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -62.13 163.39 8.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.161 0.505 . . . . 0.0 111.514 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 20.0 m -76.71 157.6 31.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.59 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 72.69 23.43 2.97 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.532 0.682 . . . . 0.0 111.01 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . 0.421 ' HE2' ' CE2' ' A' ' 435' ' ' TYR . 17.1 m-85 -122.37 164.13 28.03 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.119 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . 0.656 ' HG2' ' HD3' ' A' ' 434' ' ' LYS . 83.4 Cg_endo -77.61 161.29 92.21 Favored 'Cis proline' 0 C--N 1.345 0.378 0 C-N-CA 123.678 -1.384 . . . . 0.0 112.697 0.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -111.77 161.32 16.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.726 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 -66.08 140.06 58.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.821 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.4 tt -64.27 -13.07 13.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.427 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 36.9 mttm -61.46 -11.99 12.91 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 79.8 t -61.53 -34.79 63.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' TRP . . . . . 0.482 ' HB2' ' HB ' ' A' ' 459' ' ' ILE . 8.1 m95 -89.05 95.53 10.36 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -56.6 107.72 0.42 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 105.05 -1.73 40.97 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.698 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.482 ' HB ' ' HB2' ' A' ' 456' ' ' TRP . 20.1 mm -88.92 129.01 49.97 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.978 0.389 . . . . 0.0 111.335 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.26 149.07 19.27 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 123.063 2.509 . . . . 0.0 112.904 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -71.4 146.27 48.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.379 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 462' ' ' SER . . . . . 0.41 ' OG ' ' HA2' ' A' ' 432' ' ' GLY . 4.2 m 55.08 71.39 1.3 Allowed Pre-proline 0 N--CA 1.467 0.412 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -85.84 178.49 4.24 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.711 2.274 . . . . 0.0 111.745 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.6 8.44 6.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.042 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -177.23 147.57 8.35 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.824 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 19.4 p -164.19 98.17 0.82 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -128.61 140.35 51.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.925 0.393 . . . . 0.0 111.31 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 468' ' ' MET . . . . . 0.404 ' HA ' ' HA ' ' A' ' 475' ' ' THR . 39.2 ttm -84.78 138.82 32.37 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.965 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -72.33 160.04 53.91 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.467 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -15.45 57.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.969 0.414 . . . . 0.0 111.385 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -79.14 -18.53 53.01 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.222 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 69.21 1.77 3.38 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.22 -38.21 7.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.836 0.35 . . . . 0.0 111.458 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -120.84 143.69 48.76 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 475' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 468' ' ' MET . 55.3 m -115.88 139.97 49.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.32 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -106.18 123.6 48.28 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -107.18 144.99 33.13 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 94.1 t80 -129.02 134.7 48.24 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 59.7 tttt -170.81 134.35 1.01 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.991 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 60.11 43.37 98.38 Favored Glycine 0 N--CA 1.454 -0.125 0 CA-C-N 115.979 -0.555 . . . . 0.0 114.039 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 39.9 t30 67.07 3.58 3.21 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -118.22 157.13 27.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.733 0.301 . . . . 0.0 110.741 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -127.07 149.62 49.84 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.499 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 484' ' ' TRP . . . . . 0.423 ' CE2' ' HB3' ' A' ' 498' ' ' PRO . 19.2 m-90 -117.82 138.67 51.93 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.529 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -101.42 93.95 5.66 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 486' ' ' PHE . . . . . 0.465 ' CZ ' ' HE3' ' A' ' 456' ' ' TRP . 82.6 t80 -85.21 130.12 34.67 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.394 -178.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . 0.504 ' HB3' ' HB3' ' A' ' 490' ' ' LYS . 36.6 t-20 -86.65 121.53 29.29 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -65.94 -52.25 51.42 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.25 -40.39 86.26 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -178.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 490' ' ' LYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 487' ' ' ASN . 37.5 ttmt -78.26 -26.16 47.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.548 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 6.1 tp 63.24 38.78 10.18 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.572 0.701 . . . . 0.0 110.222 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -153.53 148.72 26.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.438 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 486' ' ' PHE . 77.8 t -75.83 131.27 35.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -59.45 137.35 89.15 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.836 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.28 143.1 99.86 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.912 2.408 . . . . 0.0 112.261 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 103.76 5.39 44.86 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.278 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . 0.51 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 18.6 m-85 -114.03 166.27 11.81 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.554 -0.323 . . . . 0.0 110.349 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . 0.51 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 88.3 Cg_endo -79.75 178.67 32.41 Favored 'Cis proline' 0 C--N 1.349 0.557 0 C-N-CA 123.752 -1.353 . . . . 0.0 113.075 0.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -135.23 160.12 39.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.277 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 42.4 t -69.66 125.92 28.16 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.812 0.339 . . . . 0.0 110.977 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -71.64 -22.9 61.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.284 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 502' ' ' LEU . . . . . 0.404 ' HA ' ' HG2' ' A' ' 506' ' ' MET . 26.4 mt -69.55 -47.34 64.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.53 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -75.9 -35.08 59.95 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -88.69 -46.86 8.68 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 36.1 m0 -92.72 -56.73 2.9 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -177.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 506' ' ' MET . . . . . 0.404 ' HG2' ' HA ' ' A' ' 502' ' ' LEU . 11.4 mmt -64.08 -45.43 88.74 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 105.85 29.63 4.87 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.398 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 15.1 m -106.45 105.38 54.23 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -81.11 160.92 20.6 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 123.289 2.66 . . . . 0.0 112.087 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 18.6 m 61.15 68.14 0.75 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.574 0.702 . . . . 0.0 111.653 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.388 -1.229 . . . . 0.0 111.474 -179.7 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.608 0 N-CA-C 111.893 -0.483 . . . . 0.0 111.893 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' PRO . . . . . 0.422 ' HA ' HD23 ' B' ' 2' ' ' HYP . 93.2 Cg_endo -79.56 151.66 22.54 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.621 2.214 . . . . 0.0 111.985 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' HYP . . . . . 0.422 HD23 ' HA ' ' B' ' 1' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' D' ' 201' ' ' PRO . . . -62.33 160.54 31.73 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.664 -0.698 . . . . 0.0 113.46 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.511 ' HG2' ' HA ' ' D' ' 202' ' ' HYP . 53.8 Cg_endo -68.03 163.49 35.63 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 123.002 2.468 . . . . 0.0 111.797 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' HYP . . . . . 0.532 ' HA ' ' HD2' ' C' ' 104' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.46 178.64 53.77 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.458 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.772 ' HG2' ' HA ' ' D' ' 205' ' ' HYP . 18.8 Cg_endo -59.82 161.59 18.06 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.553 2.168 . . . . 0.0 111.26 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 138.66 -179.92 17.95 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.198 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.51 147.59 71.07 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.837 2.358 . . . . 0.0 111.575 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -68.71 150.41 47.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.971 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.48 154.7 29.95 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.129 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.435 HG13 ' H ' ' B' ' 13' ' ' ILE . 5.2 mt -65.24 152.57 8.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.42 145.91 47.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.371 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.48 159.57 53.64 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 121.144 -0.551 . . . . 0.0 112.633 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -72.34 146.23 47.24 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -69.89 146.67 51.08 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.517 ' HA3' ' O ' ' D' ' 216' ' ' GLN . . . -61.2 150.97 43.18 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.76 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 4.6 t -67.11 146.34 13.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 16.0 t -53.76 144.94 4.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.33 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.86 167.16 54.12 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.87 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 96.0 mt -92.55 153.12 19.25 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 121.987 0.115 . . . . 0.0 110.746 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.45 170.45 54.91 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.252 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.46 ' HA ' HD23 ' B' ' 26' ' ' HYP . 36.8 Cg_endo -66.54 149.24 84.34 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.597 2.198 . . . . 0.0 111.275 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' HYP . . . . . 0.46 HD23 ' HA ' ' B' ' 25' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.18 161.52 47.66 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.994 -0.622 . . . . 0.0 113.551 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.13 155.9 47.12 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.835 2.357 . . . . 0.0 111.486 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.08 166.43 40.91 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.127 -0.558 . . . . 0.0 113.458 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -67.2 161.8 41.34 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.158 2.572 . . . . 0.0 111.731 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.75 156.2 53.4 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.765 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . 0.464 ' O ' ' C ' ' B' ' 35' ' ' HYP . 73.3 Cg_endo -75.25 154.97 41.71 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.695 2.263 . . . . 0.0 111.924 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' HYP . . . . . 0.464 ' C ' ' O ' ' B' ' 34' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.348 0 CA-C-O 120.086 -0.286 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 101' ' ' PRO . . . . . 0.463 ' HA ' HD23 ' C' ' 102' ' ' HYP . 17.4 Cg_exo -68.33 144.89 63.79 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 122.963 2.442 . . . . 0.0 111.875 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 102' ' ' HYP . . . . . 0.463 HD23 ' HA ' ' C' ' 101' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -82.05 175.84 53.89 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.851 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 104' ' ' PRO . . . . . 0.532 ' HD2' ' HA ' ' B' ' 5' ' ' HYP . 3.7 Cg_endo -87.07 158.01 8.52 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.592 2.862 . . . . 0.0 112.11 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 105' ' ' HYP . . . . . 0.441 HD23 ' HA ' ' C' ' 104' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -71.6 169.3 50.29 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.299 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.64 145.46 57.88 Favored 'Trans proline' 0 CA--C 1.528 0.209 0 C-N-CA 122.664 2.242 . . . . 0.0 111.353 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 108' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -54.83 166.18 2.78 Favored Glycine 0 CA--C 1.521 0.423 0 O-C-N 123.696 0.623 . . . . 0.0 113.915 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -65.14 163.97 26.97 Favored 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 122.841 2.361 . . . . 0.0 112.417 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -62.16 144.45 55.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.318 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -75.51 163.65 53.83 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.98 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 21.7 mt -65.14 136.61 26.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.17 148.14 50.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.254 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -61.36 154.43 37.87 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.117 -0.564 . . . . 0.0 112.873 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -83.51 163.25 20.58 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 43.5 ttm-85 -68.13 148.99 50.16 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.687 0.279 . . . . 0.0 110.357 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.93 175.35 38.6 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.06 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 25.3 t -73.49 140.24 18.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 90.4 t -63.27 136.07 26.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.105 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.18 157.62 46.54 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.269 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 122' ' ' LEU . . . . . 0.445 ' HA ' HD23 ' C' ' 123' ' ' HYP . 74.4 mt -73.04 146.5 45.83 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.658 0.266 . . . . 0.0 111.103 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 123' ' ' HYP . . . . . 0.445 HD23 ' HA ' ' C' ' 122' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -69.02 165.34 48.99 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.504 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 125' ' ' PRO . . . . . 0.413 ' HA ' HD23 ' C' ' 126' ' ' HYP . 73.6 Cg_endo -74.2 157.83 45.77 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.55 2.166 . . . . 0.0 111.737 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 126' ' ' HYP . . . . . 0.413 HD23 ' HA ' ' C' ' 125' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -68.19 160.64 50.72 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.818 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.55 160.0 50.94 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 122.494 2.129 . . . . 0.0 111.321 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -69.66 171.69 40.68 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.494 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 131' ' ' PRO . . . . . 0.477 ' HA ' HD23 ' C' ' 132' ' ' HYP . 17.1 Cg_exo -68.7 142.61 53.42 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.822 2.348 . . . . 0.0 111.353 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 132' ' ' HYP . . . . . 0.57 ' HA ' ' O ' ' D' ' 231' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.23 113.53 5.21 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.699 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 134' ' ' PRO . . . . . 0.474 ' HA ' HD23 ' C' ' 135' ' ' HYP . 68.0 Cg_endo -77.05 111.33 3.2 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.667 2.245 . . . . 0.0 111.891 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 135' ' ' HYP . . . . . 0.474 HD23 ' HA ' ' C' ' 134' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 201' ' ' PRO . . . . . 0.511 ' HA ' HD23 ' D' ' 202' ' ' HYP . 78.1 Cg_exo -54.23 139.69 72.45 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.014 2.476 . . . . 0.0 111.651 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 202' ' ' HYP . . . . . 0.511 ' HA ' ' HG2' ' B' ' 4' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 77.08 165.59 23.84 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 121.311 -0.471 . . . . 0.0 114.236 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 204' ' ' PRO . . . . . 0.439 ' HG2' ' OD1' ' C' ' 105' ' ' HYP . 13.3 Cg_exo -72.94 162.93 39.77 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.473 2.782 . . . . 0.0 111.965 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 205' ' ' HYP . . . . . 0.772 ' HA ' ' HG2' ' B' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . 97.19 174.11 34.37 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.824 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 207' ' ' PRO . . . . . 0.402 ' HA ' HD23 ' D' ' 208' ' ' HYP . 73.2 Cg_endo -94.25 156.44 2.1 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.475 2.783 . . . . 0.0 112.636 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 208' ' ' HYP . . . . . 0.402 HD23 ' HA ' ' D' ' 207' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -81.34 171.13 53.02 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.842 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -71.85 141.85 37.96 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 123.02 2.48 . . . . 0.0 111.949 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -65.84 146.42 54.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.943 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -70.05 162.97 52.66 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.897 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 213' ' ' ILE . . . . . 0.459 ' HB ' ' OE1' ' A' ' 392' ' ' GLU . 39.4 pt -69.84 166.85 2.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.606 0.241 . . . . 0.0 110.971 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 214' ' ' ALA . . . . . 0.558 ' HB3' ' NH1' ' A' ' 330' ' ' ARG . . . -83.15 144.44 29.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.884 0.373 . . . . 0.0 110.882 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -65.95 168.14 33.4 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.8 -0.636 . . . . 0.0 114.054 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 216' ' ' GLN . . . . . 0.517 ' O ' ' HA3' ' B' ' 18' ' ' GLY . 89.7 mm-40 -75.95 155.77 34.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.698 0.285 . . . . 0.0 110.955 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -66.14 153.06 43.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.5 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -59.83 150.25 39.54 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.086 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 13.8 t -61.2 143.12 15.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.61 142.16 16.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.888 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -59.88 154.79 31.41 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.358 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 5.2 mp -71.19 151.35 44.43 Favored 'General case' 0 C--N 1.32 -0.68 0 O-C-N 122.843 -0.21 . . . . 0.0 110.795 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 223' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 224' ' ' GLY . . . . . 0.442 ' HA2' ' HD3' ' D' ' 225' ' ' PRO . . . -58.19 150.22 33.56 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.806 -0.634 . . . . 0.0 113.575 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 225' ' ' PRO . . . . . 0.442 ' HD3' ' HA2' ' D' ' 224' ' ' GLY . 31.4 Cg_exo -62.79 156.78 51.46 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 123.213 2.608 . . . . 0.0 112.09 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 226' ' ' HYP . . . . . 0.432 HD23 ' HA ' ' D' ' 225' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -68.18 160.06 51.08 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.516 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.92 156.11 34.45 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 122.702 2.268 . . . . 0.0 111.809 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -68.71 168.98 42.52 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.699 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 231' ' ' PRO . . . . . 0.57 ' O ' ' HA ' ' C' ' 132' ' ' HYP . 14.7 Cg_exo -71.62 163.32 39.36 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 123.214 2.61 . . . . 0.0 111.263 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 232' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.418 ' HD2' ' CZ3' ' A' ' 340' ' ' TRP . 4.8 Cg_endo . . . . . 0 N--CA 1.479 0.62 0 N-CA-C 110.477 -0.624 . . . . 0.0 110.477 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -105.76 158.25 16.87 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.404 ' O ' ' HZ ' ' A' ' 323' ' ' PHE . 15.0 tt -75.39 -19.13 15.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.41 0.624 . . . . 0.0 110.046 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 69.5 m -85.7 -1.31 57.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.717 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -74.15 -23.59 59.28 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.366 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 74.46 -172.32 52.41 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.607 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 2.1 t30 54.6 81.7 0.1 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.113 0.565 . . . . 0.0 111.942 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' PHE . . . . . 0.469 ' HD1' ' HB2' ' A' ' 337' ' ' LYS . 50.8 m-85 -104.65 164.43 11.77 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.709 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -73.32 -41.26 63.73 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 9.4 t -172.78 152.5 2.49 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.535 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 97.6 t -133.0 118.28 32.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -141.58 172.94 12.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.063 0.459 . . . . 0.0 111.473 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 31.9 ttp -121.77 123.39 41.71 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.624 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 59.3 mt -116.6 118.43 32.59 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.933 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.404 ' HG3' ' CE1' ' A' ' 379' ' ' PHE . 43.7 mtp180 56.49 28.04 13.15 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 98.76 -11.86 62.69 Favored Glycine 0 CA--C 1.517 0.193 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.225 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -98.52 128.23 44.77 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.823 0.344 . . . . 0.0 110.875 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 48.7 ttm -87.39 119.9 28.13 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.504 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -112.04 128.4 56.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.055 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . 0.442 ' HB ' ' HB2' ' A' ' 342' ' ' TRP . 26.1 t -106.8 119.91 57.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.434 -0.803 . . . . 0.0 108.913 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -107.87 130.11 55.03 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 0.691 ' HB3' ' HZ3' ' A' ' 342' ' ' TRP . 87.7 tttt -153.44 108.24 3.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.75 177.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 69.89 -129.67 0.08 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.034 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 339' ' ' ARG . 12.8 ptm85 -94.94 2.63 55.4 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . 0.418 ' CZ3' ' HD2' ' A' ' 316' ' ' PRO . 6.9 m-90 -123.61 154.85 38.72 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.784 0.326 . . . . 0.0 111.053 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -134.16 149.76 51.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.568 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' TRP . . . . . 0.691 ' HZ3' ' HB3' ' A' ' 337' ' ' LYS . 26.2 m-90 -119.65 167.56 11.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.634 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.13 114.27 6.21 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.417 HG11 ' HA ' ' A' ' 506' ' ' MET . 10.5 m -102.78 143.99 14.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.165 0.507 . . . . 0.0 112.238 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 29.1 ttm-85 -150.79 126.91 10.52 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.924 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 22.7 m120 68.55 30.89 5.0 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.203 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 39.6 t30 66.06 24.23 11.0 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.224 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -136.45 146.27 46.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.339 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 32.8 t -79.0 124.69 37.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 60.4 mtp -71.15 160.55 32.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.774 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -72.32 153.61 41.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.118 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 98.64 -4.41 59.68 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.517 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -118.6 152.6 51.42 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -73.94 149.12 93.54 Favored 'Cis proline' 0 C--O 1.234 0.315 0 C-N-CA 123.356 -1.518 . . . . 0.0 112.884 0.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 55.1 ttm -129.57 139.68 36.39 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.42 -0.809 . . . . 0.0 108.949 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.88 131.26 44.96 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.211 1.941 . . . . 0.0 111.213 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' ILE . . . . . 0.475 HG23 ' HD1' ' A' ' 361' ' ' TRP . 65.6 mt -52.02 -46.21 41.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.047 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -65.05 -16.07 61.48 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 121.267 -0.492 . . . . 0.0 114.128 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -34.2 61.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.141 0.471 . . . . 0.0 110.574 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -101.25 -51.5 3.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.165 0.507 . . . . 0.0 110.062 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' TRP . . . . . 0.475 ' HD1' HG23 ' A' ' 357' ' ' ILE . 71.4 m95 -87.8 85.68 7.07 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.371 0.605 . . . . 0.0 109.571 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 362' ' ' ARG . 38.4 ttp180 -65.63 83.41 0.06 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.859 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.582 ' HA3' HD22 ' A' ' 395' ' ' LEU . . . 133.54 -3.6 4.7 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.164 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.583 HD12 ' HD2' ' A' ' 365' ' ' PRO . 22.9 tp -98.83 131.72 25.11 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 120.616 0.246 . . . . 0.0 110.858 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' PRO . . . . . 0.583 ' HD2' HD12 ' A' ' 364' ' ' LEU . 98.3 Cg_endo -79.55 -174.83 2.43 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.715 2.277 . . . . 0.0 111.598 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -91.35 151.34 20.9 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.938 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 18.1 m 57.45 93.52 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.483 0.919 . . . . 0.0 113.483 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 24.1 pt -107.19 172.39 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.409 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -96.64 -40.57 8.94 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . 0.86 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.1 OUTLIER -162.7 171.88 16.16 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.773 0.32 . . . . 0.0 111.347 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 380' ' ' VAL . . . -162.06 144.44 11.39 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -157.35 164.16 37.87 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -95.5 122.05 37.82 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . 0.549 ' HG2' ' O ' ' A' ' 378' ' ' LYS . 9.3 ptm180 -75.57 -175.7 2.96 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.478 ' HD2' ' HA3' ' A' ' 425' ' ' GLY . 77.6 tttt -67.46 -33.18 74.59 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.988 0.423 . . . . 0.0 111.375 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.75 -50.62 19.79 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.825 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 147.63 -29.76 1.43 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.214 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' LYS . . . . . 0.731 ' HG2' ' HA ' ' A' ' 391' ' ' ASP . 91.5 mttt -59.13 150.49 25.07 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.91 0.386 . . . . 0.0 111.088 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . 0.404 ' CE1' ' HG3' ' A' ' 330' ' ' ARG . 18.2 m-85 -95.73 136.09 36.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.612 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 371' ' ' ALA . 3.8 t -113.86 113.96 45.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.094 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -100.52 144.78 29.11 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -126.63 141.51 51.83 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.848 0.356 . . . . 0.0 111.632 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.56 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 84.2 tttt -152.99 105.48 2.93 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 177.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 72.49 -117.07 6.04 Favored Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -109.85 10.51 24.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.848 0.356 . . . . 0.0 110.946 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -118.75 151.08 38.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.878 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 27.8 p-80 -131.38 153.28 49.82 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.028 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' TRP . . . . . 0.575 ' CE2' ' HB3' ' A' ' 400' ' ' PRO . 26.7 m-90 -127.97 131.87 49.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.238 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . 0.409 HG12 ' HG3' ' A' ' 396' ' ' GLU . 78.8 t -111.02 122.78 66.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -113.57 122.41 47.15 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.731 ' HA ' ' HG2' ' A' ' 378' ' ' LYS . 32.8 t70 -85.03 82.42 8.45 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 177.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . 0.451 ' OE1' ' HB ' ' D' ' 213' ' ' ILE . 35.7 mm-40 71.92 -68.93 0.2 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.489 -177.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -143.8 7.52 1.45 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.93 0.395 . . . . 0.0 110.915 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 2.0 m -113.76 125.01 53.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.02 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.582 HD22 ' HA3' ' A' ' 363' ' ' GLY . 52.3 tp -76.52 128.22 34.34 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.533 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 1.4 mt-10 -64.42 136.54 96.8 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.985 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 31.5 Cg_exo -60.95 143.22 99.3 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.168 2.579 . . . . 0.0 112.447 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 96.51 -15.01 63.52 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.543 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -83.72 156.56 64.76 Favored Pre-proline 0 C--N 1.323 -0.577 0 O-C-N 122.672 -0.311 . . . . 0.0 110.782 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.575 ' HB3' ' CE2' ' A' ' 388' ' ' TRP . 59.9 Cg_endo -71.51 156.38 97.04 Favored 'Cis proline' 0 C--N 1.349 0.593 0 C-N-CA 123.963 -1.266 . . . . 0.0 113.522 0.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -128.19 159.6 34.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.0 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 0.545 ' ND1' ' HG2' ' A' ' 404' ' ' LYS . 5.4 t-80 -69.75 153.09 43.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.245 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 64.9 mt -56.52 -33.51 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.545 ' HG2' ' ND1' ' A' ' 402' ' ' HIS . 20.7 pttm -65.14 -12.53 51.97 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -80.91 -26.58 36.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.876 0.37 . . . . 0.0 110.772 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 32.2 tp -75.0 -47.14 30.67 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.477 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -169.37 147.82 11.44 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.759 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 33.0 ttt180 -84.68 132.96 34.41 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.745 0.307 . . . . 0.0 110.315 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 114.14 -14.77 21.1 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.551 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.443 HD21 ' HB2' ' A' ' 438' ' ' PHE . 96.0 mt -76.17 152.9 84.29 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.571 -0.314 . . . . 0.0 110.563 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.46 130.19 38.75 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.922 2.414 . . . . 0.0 111.545 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.11 3.82 55.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.985 0.421 . . . . 0.0 111.482 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -95.52 -57.53 2.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.579 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 5.1 ptmt -172.38 171.64 4.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.919 0.39 . . . . 0.0 110.858 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 49.2 mm -120.92 127.52 75.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -86.49 -48.01 8.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.935 0.398 . . . . 0.0 110.55 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.86 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -153.87 154.38 33.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.295 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -135.1 107.27 7.18 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 40.5 tp -99.14 117.21 33.11 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.281 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . 0.417 ' CZ ' ' HA ' ' A' ' 375' ' ' LYS . 44.7 t80 -89.0 115.44 26.57 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.035 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' TRP . . . . . 0.494 ' HB2' ' HE2' ' A' ' 428' ' ' TYR . 22.0 t-105 -84.26 90.44 7.53 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.463 ' HB2' ' HG2' ' A' ' 472' ' ' GLU . 62.9 mtt -47.97 -48.73 61.95 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.422 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 79.8 Cg_exo -48.87 -35.47 31.35 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 122.862 2.375 . . . . 0.0 114.787 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 38.3 p30 -113.29 -35.47 5.31 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . 0.478 ' HA3' ' HD2' ' A' ' 375' ' ' LYS . . . 104.62 10.44 33.17 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.617 -0.802 . . . . 0.0 113.367 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -97.88 155.41 17.08 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.418 -0.46 . . . . 0.0 110.605 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 7.4 m -113.16 130.36 56.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.994 0.426 . . . . 0.0 111.568 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' TYR . . . . . 0.494 ' HE2' ' HB2' ' A' ' 421' ' ' TRP . 99.4 m-85 -100.85 108.17 19.89 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.742 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -91.47 124.57 35.74 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.226 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -99.57 132.24 45.03 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.094 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.41 ' HA ' ' HE ' ' A' ' 431' ' ' ARG . 2.9 tpm_? -144.4 108.08 4.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.171 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 70.14 -110.22 3.21 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.774 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 28.1 p30 -117.71 17.69 14.3 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.837 0.351 . . . . 0.0 111.158 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 52.5 mttt -133.86 158.22 43.97 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.725 0.298 . . . . 0.0 110.959 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' TYR . . . . . 0.46 ' CE2' ' HE2' ' A' ' 449' ' ' TYR . 7.1 p90 -128.99 144.5 51.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.211 0.529 . . . . 0.0 110.984 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -110.53 133.74 53.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.596 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 19.2 ttp180 -94.86 92.14 6.78 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . 0.477 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 67.8 t80 -84.34 129.04 34.91 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.131 0.491 . . . . 0.0 111.642 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -99.39 108.89 21.49 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' GLU . . . . . 0.524 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 1.7 tt0 -58.57 -43.04 89.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.947 0.403 . . . . 0.0 110.621 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -84.24 48.65 1.52 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.797 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -169.6 -35.03 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.706 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 443' ' ' ARG . 37.6 mtp-105 69.58 36.94 2.04 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.429 0.633 . . . . 0.0 111.199 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -155.72 167.37 30.61 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.925 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 59.7 t -87.74 141.06 14.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.966 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -62.09 155.44 24.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.998 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 448' ' ' GLU . 0.9 OUTLIER -64.85 157.73 27.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.849 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' GLU . . . . . 0.577 ' HB3' ' HE2' ' A' ' 451' ' ' LYS . 8.3 mm-40 76.04 5.93 3.75 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.259 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . 0.524 ' HB3' ' HA ' ' A' ' 450' ' ' PRO . 42.6 m-85 -112.63 163.36 18.05 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.762 -0.199 . . . . 0.0 111.329 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . 0.524 ' HA ' ' HB3' ' A' ' 449' ' ' TYR . 73.1 Cg_endo -75.87 155.65 98.87 Favored 'Cis proline' 0 C--N 1.349 0.57 0 C-N-CA 123.624 -1.407 . . . . 0.0 112.967 0.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . 0.577 ' HE2' ' HB3' ' A' ' 448' ' ' GLU . 63.0 mttm -116.84 162.3 17.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.305 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -65.53 139.94 58.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.718 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.1 tt -67.48 -9.6 10.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.094 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -63.47 -7.35 6.6 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 95.7 t -65.94 -37.17 79.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' TRP . . . . . 0.563 ' HE3' ' CZ ' ' A' ' 486' ' ' PHE . 5.7 m95 -88.43 93.68 9.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.94 179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.28 116.32 4.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.149 0.5 . . . . 0.0 112.072 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 107.3 -15.57 39.02 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.716 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.424 ' HB ' ' HB2' ' A' ' 456' ' ' TRP . 33.6 mm -83.59 125.9 72.52 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 120.857 0.36 . . . . 0.0 111.304 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.44 152.93 30.55 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.758 2.306 . . . . 0.0 111.719 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -73.42 147.36 44.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.473 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 2.0 m 54.89 75.85 0.57 Allowed Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -83.5 -176.59 2.81 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.156 2.571 . . . . 0.0 112.173 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -134.81 18.96 3.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.207 0.527 . . . . 0.0 110.405 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 166.15 142.9 3.56 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 11.4 p -157.54 108.23 2.25 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -134.23 146.14 49.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.881 0.372 . . . . 0.0 111.507 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 48.0 ttm -99.03 141.06 32.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.167 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -67.69 166.74 42.5 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.179 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 2.7 m -68.74 -8.26 41.3 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.34 -14.27 27.1 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.969 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . 0.463 ' HG2' ' HB2' ' A' ' 422' ' ' MET . 36.4 mt-10 65.39 12.17 7.9 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.241 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.7 -45.05 12.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.941 0.4 . . . . 0.0 110.682 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -114.07 141.56 47.31 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.208 0.528 . . . . 0.0 112.0 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 475' ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' A' ' 486' ' ' PHE . 91.9 m -119.42 138.8 52.86 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.685 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -112.51 131.06 55.78 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.292 0.568 . . . . 0.0 112.506 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -114.65 142.78 46.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.215 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -123.75 136.84 54.67 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 111.526 0.195 . . . . 0.0 111.526 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -167.43 126.11 1.31 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.001 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 57.92 46.83 92.0 Favored Glycine 0 CA--C 1.519 0.341 0 CA-C-N 116.003 -0.544 . . . . 0.0 114.356 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 68.65 -2.25 1.72 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.775 0.658 . . . . 0.0 112.775 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 482' ' ' LYS . . . . . 0.436 ' HB3' ' HB2' ' A' ' 498' ' ' PRO . 34.7 mtmt -106.39 151.42 24.91 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 483' ' ' TYR . . . . . 0.5 ' CZ ' ' HE2' ' A' ' 497' ' ' TYR . 3.3 p90 -126.89 138.84 53.37 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.031 0.443 . . . . 0.0 111.332 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 484' ' ' TRP . . . . . . . . . . . . . 15.1 m-90 -108.33 145.65 34.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.23 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 53.5 tttt -111.86 100.45 8.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.075 0.464 . . . . 0.0 109.927 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 486' ' ' PHE . . . . . 0.563 ' CZ ' ' HE3' ' A' ' 456' ' ' TRP . 67.1 t80 -89.1 130.61 35.52 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.945 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -96.82 112.38 24.16 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -64.72 -23.43 67.25 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 31.3 tp60 -78.57 -24.5 45.52 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -114.1 -6.26 13.08 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 15.3 tp 58.02 34.22 24.01 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.525 0.679 . . . . 0.0 110.375 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 492' ' ' LYS . . . . . 0.432 ' HG2' ' N ' ' A' ' 493' ' ' VAL . 39.3 tttp -152.46 152.71 32.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.703 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 486' ' ' PHE . 66.7 t -76.1 133.36 31.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.696 178.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -61.38 148.22 86.1 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.386 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.23 149.56 85.27 Favored 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 122.743 2.295 . . . . 0.0 112.457 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 96.25 13.25 49.44 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.751 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . 0.567 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 51.1 m-85 -121.08 164.5 23.36 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.874 -0.163 . . . . 0.0 110.783 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . 0.567 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 95.8 Cg_endo -80.65 164.23 79.32 Favored 'Cis proline' 0 C--N 1.344 0.337 0 C-N-CA 123.806 -1.331 . . . . 0.0 113.647 0.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -118.68 160.77 21.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.651 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 30.1 t -71.97 115.47 11.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.946 0.403 . . . . 0.0 110.978 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -69.99 -23.67 63.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.61 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 502' ' ' LEU . . . . . 0.472 ' HA ' ' HG2' ' A' ' 506' ' ' MET . 83.5 mt -67.02 -32.0 72.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.074 0.464 . . . . 0.0 110.862 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -96.68 -35.08 11.14 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -89.65 -17.64 28.01 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 13.0 m0 -121.37 -52.63 2.04 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 506' ' ' MET . . . . . 0.472 ' HG2' ' HA ' ' A' ' 502' ' ' LEU . 11.2 mmt -67.95 -29.33 68.36 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 88.84 30.72 14.06 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.032 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 31.7 m -101.93 114.23 65.61 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.0 124.34 11.7 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.968 2.445 . . . . 0.0 112.652 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 3.9 m 68.28 153.68 0.1 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.482 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.188 -1.34 . . . . 0.0 111.19 179.957 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.771 0 N-CA-C 112.048 -0.421 . . . . 0.0 112.048 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' PRO . . . . . 0.461 ' HA ' HD23 ' B' ' 2' ' ' HYP . 50.1 Cg_endo -68.8 137.51 38.55 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 122.722 2.281 . . . . 0.0 112.01 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' HYP . . . . . 0.522 ' HA ' ' HB2' ' C' ' 101' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' D' ' 201' ' ' PRO . . . -64.37 158.54 42.61 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.175 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.77 166.78 28.43 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.764 2.309 . . . . 0.0 111.415 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.99 -171.98 43.44 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.318 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.834 ' HG2' ' HA ' ' D' ' 205' ' ' HYP . 29.1 Cg_endo -64.41 162.64 29.78 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.617 2.211 . . . . 0.0 111.361 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' HYP . . . . . 0.427 ' O ' ' HA3' ' D' ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.32 175.61 20.31 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.887 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.64 143.6 68.88 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.88 2.387 . . . . 0.0 111.514 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -64.89 150.82 47.08 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.607 ' HA3' ' O ' ' D' ' 210' ' ' PRO . . . -59.99 154.72 31.96 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.345 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.486 ' O ' ' HG3' ' D' ' 211' ' ' GLN . 6.5 mt -59.58 150.38 5.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.891 0.377 . . . . 0.0 110.924 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.59 145.27 56.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.127 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.32 153.85 45.54 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.903 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -69.27 148.59 49.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.756 0.312 . . . . 0.0 110.612 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -66.34 138.64 57.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.715 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.51 145.13 49.77 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.637 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 t -63.8 149.22 10.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.496 0.148 . . . . 0.0 110.766 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 11.0 t -52.13 146.05 2.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.262 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.54 165.08 52.45 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 121.187 -0.53 . . . . 0.0 113.4 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 81.2 mt -77.54 151.67 34.4 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.639 -0.28 . . . . 0.0 110.342 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.79 152.23 43.94 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.226 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.43 ' HA ' HD23 ' B' ' 26' ' ' HYP . 55.0 Cg_endo -71.01 153.07 63.33 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.756 2.304 . . . . 0.0 111.698 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' HYP . . . . . 0.43 HD23 ' HA ' ' B' ' 25' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.01 169.07 53.9 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.748 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -80.71 160.56 21.75 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 123.043 2.495 . . . . 0.0 112.031 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.01 177.23 39.05 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.52 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.434 ' HA ' HD23 ' B' ' 32' ' ' HYP . 24.4 Cg_exo -64.77 157.34 56.71 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.308 2.672 . . . . 0.0 112.455 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' HYP . . . . . 0.434 HD23 ' HA ' ' B' ' 31' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -55.57 128.76 45.44 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.665 -0.698 . . . . 0.0 113.8 -178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . 0.459 ' HA ' HD23 ' B' ' 35' ' ' HYP . 11.4 Cg_endo -57.21 114.01 1.74 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.952 2.435 . . . . 0.0 111.397 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' HYP . . . . . 0.459 HD23 ' HA ' ' B' ' 34' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.35 0 CA-C-O 120.019 -0.323 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 101' ' ' PRO . . . . . 0.522 ' HB2' ' HA ' ' B' ' 2' ' ' HYP . 36.9 Cg_exo -62.98 132.59 37.54 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.823 2.349 . . . . 0.0 111.63 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 102' ' ' HYP . . . . . 0.496 HD23 ' HA ' ' C' ' 101' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.6 159.55 52.12 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.519 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 104' ' ' PRO . . . . . 0.417 ' HA ' HD23 ' C' ' 105' ' ' HYP . 86.4 Cg_endo -81.84 160.62 18.73 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 123.074 2.516 . . . . 0.0 111.97 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 105' ' ' HYP . . . . . 0.572 ' OD1' ' HG2' ' D' ' 204' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -79.79 -167.7 35.47 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.504 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.32 154.12 45.8 Favored 'Trans proline' 0 N--CA 1.466 -0.142 0 C-N-CA 122.676 2.251 . . . . 0.0 110.743 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 108' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -55.23 160.6 5.79 Favored Glycine 0 CA--C 1.522 0.479 0 CA-C-N 115.953 -0.567 . . . . 0.0 113.282 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -62.26 160.07 32.48 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 123.216 2.611 . . . . 0.0 112.525 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -62.03 134.23 56.35 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.794 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -65.39 162.02 41.26 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.441 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 53.5 mt -72.94 138.72 20.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.8 153.09 37.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.306 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -66.56 159.39 48.29 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.351 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -88.94 150.53 22.8 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.617 0.246 . . . . 0.0 110.594 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 19.5 ttm-85 -60.97 142.11 56.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.323 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.24 167.12 49.79 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.41 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 86.0 t -66.73 142.28 16.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.675 0.274 . . . . 0.0 111.014 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 94.4 t -61.6 143.39 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.122 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.89 163.61 36.94 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.726 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 122' ' ' LEU . . . . . 0.423 ' HA ' HD23 ' C' ' 123' ' ' HYP . 87.3 mt -76.72 147.1 37.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.49 0.186 . . . . 0.0 110.755 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 123' ' ' HYP . . . . . 0.423 HD23 ' HA ' ' C' ' 122' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -64.72 164.33 35.1 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.462 -179.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 125' ' ' PRO . . . . . 0.432 ' HA ' HD23 ' C' ' 126' ' ' HYP . 45.7 Cg_endo -68.71 151.95 74.44 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.709 2.273 . . . . 0.0 111.629 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 126' ' ' HYP . . . . . 0.432 HD23 ' HA ' ' C' ' 125' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -65.81 162.67 41.71 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.318 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -80.86 159.86 21.3 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.666 2.244 . . . . 0.0 111.223 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -68.45 -178.32 15.7 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.997 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 131' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' B' ' 32' ' ' HYP . 3.6 Cg_exo -76.33 153.02 35.32 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.921 2.414 . . . . 0.0 111.691 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 132' ' ' HYP . . . . . 0.54 ' HA ' ' O ' ' D' ' 231' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -71.11 121.41 9.14 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.958 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 134' ' ' PRO . . . . . 0.409 ' HA ' HD23 ' C' ' 135' ' ' HYP . 43.1 Cg_endo -68.82 113.4 3.2 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.823 2.349 . . . . 0.0 111.463 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 135' ' ' HYP . . . . . 0.409 HD23 ' HA ' ' C' ' 134' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.287 0 CA-C-O 120.056 -0.302 . . . . 0.0 112.437 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 201' ' ' PRO . . . . . 0.446 ' O ' ' HA3' ' B' ' 3' ' ' GLY . 31.9 Cg_exo -61.59 120.1 7.57 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.789 2.326 . . . . 0.0 111.034 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 202' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 66.92 166.0 2.43 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 114.72 0.648 . . . . 0.0 114.72 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 204' ' ' PRO . . . . . 0.572 ' HG2' ' OD1' ' C' ' 105' ' ' HYP . 7.9 Cg_exo -77.84 166.76 24.79 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 123.528 2.819 . . . . 0.0 110.411 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 205' ' ' HYP . . . . . 0.834 ' HA ' ' HG2' ' B' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 206' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' B' ' 8' ' ' HYP . . . 95.01 167.64 36.05 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.454 178.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -90.57 155.79 4.33 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 123.33 2.686 . . . . 0.0 112.803 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 208' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -84.72 -178.85 51.24 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.319 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 210' ' ' PRO . . . . . 0.607 ' O ' ' HA3' ' B' ' 12' ' ' GLY . 2.6 Cg_exo -76.89 152.89 32.58 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 123.044 2.496 . . . . 0.0 111.786 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 211' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' B' ' 13' ' ' ILE . 57.0 tt0 -73.91 149.32 41.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.774 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -68.02 159.45 51.2 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.486 -0.645 . . . . 0.0 111.486 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 213' ' ' ILE . . . . . 0.451 ' HB ' ' OE1' ' A' ' 392' ' ' GLU . 42.1 pt -64.4 163.48 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-O 120.891 0.376 . . . . 0.0 111.484 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -74.56 145.16 43.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.333 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -67.42 158.02 51.34 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.518 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 -76.19 151.33 36.93 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -64.58 153.04 40.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.337 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -61.86 157.03 35.5 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.269 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 12.3 t -70.91 147.52 11.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.59 136.85 25.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.99 162.82 26.36 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.292 -0.48 . . . . 0.0 113.127 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 64.5 mt -69.36 154.04 42.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.846 -0.177 . . . . 0.0 110.795 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 223' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 224' ' ' GLY . . . . . 0.447 ' HA2' ' HD3' ' D' ' 225' ' ' PRO . . . -66.19 147.54 50.15 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.276 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 225' ' ' PRO . . . . . 0.447 ' HD3' ' HA2' ' D' ' 224' ' ' GLY . 17.3 Cg_exo -67.53 152.75 78.01 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.602 2.202 . . . . 0.0 111.903 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 226' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -64.56 169.18 25.43 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.135 -0.555 . . . . 0.0 114.087 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -75.88 163.35 33.54 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 123.418 2.745 . . . . 0.0 111.485 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -67.96 170.01 37.82 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.268 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 231' ' ' PRO . . . . . 0.54 ' O ' ' HA ' ' C' ' 132' ' ' HYP . 10.8 Cg_exo -72.16 145.52 44.26 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 123.002 2.468 . . . . 0.0 111.394 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 232' ' ' HYP . . . . . 0.433 HD23 ' HA ' ' D' ' 231' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo . . . . . 0 N--CA 1.477 0.54 0 N-CA-C 109.8 -0.885 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -110.42 -173.98 2.38 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 15.4 tt -117.46 -6.24 11.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.247 0.546 . . . . 0.0 110.54 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 99.6 m -100.11 -0.61 38.64 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -94.02 -9.17 37.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.81 0.338 . . . . 0.0 110.598 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 84.22 -149.05 24.7 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.808 -0.711 . . . . 0.0 111.843 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 2.8 t30 55.13 68.57 0.84 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.116 0.484 . . . . 0.0 111.756 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -100.99 152.17 20.89 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.547 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -80.31 -47.09 15.05 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 4.4 t -167.33 149.67 6.0 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.021 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 47.8 t -128.49 122.29 57.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -140.44 -177.98 5.29 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.065 0.459 . . . . 0.0 111.778 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 12.8 ttp -132.02 131.17 42.26 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 51.2 mt -127.58 116.86 20.99 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 123.295 0.372 . . . . 0.0 110.397 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.451 ' H ' ' CD ' ' A' ' 373' ' ' GLU . 0.9 OUTLIER 64.83 20.84 12.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.822 179.203 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 102.85 -18.59 49.54 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.347 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -89.47 135.03 33.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.669 0.271 . . . . 0.0 110.475 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 48.4 ttm -87.03 126.61 34.86 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.907 0.384 . . . . 0.0 110.632 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -116.87 122.32 44.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.32 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.72 112.46 37.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -95.3 130.4 42.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.792 0.33 . . . . 0.0 111.578 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -147.98 108.82 4.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.244 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 63.34 -113.2 0.4 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.632 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.456 HH11 ' HD2' ' A' ' 339' ' ' ARG . 13.3 ptm180 -110.23 10.35 23.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.053 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -126.19 157.47 38.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.908 0.385 . . . . 0.0 110.591 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -141.31 141.57 33.89 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.563 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -107.21 150.46 26.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.92 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.454 ' HD3' ' SD ' ' A' ' 350' ' ' MET . 14.5 ttt85 -125.5 106.32 9.7 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 3.7 m -92.79 129.01 43.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.409 0.623 . . . . 0.0 111.485 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.43 111.89 13.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.082 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 27.9 t30 55.69 52.06 11.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.031 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 68.14 7.07 5.62 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -122.38 158.06 30.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.724 0.297 . . . . 0.0 110.881 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 38.5 t -94.26 130.32 43.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 120.681 0.276 . . . . 0.0 110.475 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' MET . . . . . 0.454 ' SD ' ' HD3' ' A' ' 343' ' ' ARG . 4.0 mtp -72.04 156.72 38.9 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.204 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -79.08 150.55 31.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.81 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 99.69 -6.03 58.67 Favored Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' TYR . . . . . 0.459 ' HA ' ' C ' ' A' ' 354' ' ' PRO . 86.7 m-85 -112.64 157.69 39.61 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.459 ' C ' ' HA ' ' A' ' 353' ' ' TYR . 38.1 Cg_endo -66.55 131.7 15.38 Favored 'Cis proline' 0 C--N 1.347 0.466 0 C-N-CA 123.713 -1.369 . . . . 0.0 112.693 0.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . 0.441 ' HA ' ' HD3' ' A' ' 356' ' ' PRO . 52.6 ttm -104.38 136.08 19.23 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.24 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 355' ' ' MET . 31.4 Cg_exo -61.18 131.84 38.6 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.256 1.971 . . . . 0.0 111.058 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 66.5 mt -54.96 -44.1 71.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.179 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -67.99 -14.22 65.43 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 121.19 -0.529 . . . . 0.0 113.718 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -79.55 -45.79 18.57 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 117.182 0.491 . . . . 0.0 110.622 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -88.38 -53.11 4.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.591 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -88.12 74.67 8.79 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.242 0.544 . . . . 0.0 109.536 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -60.66 94.83 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.865 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 130.91 -17.31 5.2 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.264 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.55 HD12 ' HD2' ' A' ' 365' ' ' PRO . 19.4 tp -85.31 132.59 44.64 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.647 0.261 . . . . 0.0 111.138 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' PRO . . . . . 0.55 ' HD2' HD12 ' A' ' 364' ' ' LEU . 94.2 Cg_endo -79.59 178.81 6.92 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.817 2.345 . . . . 0.0 111.651 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -86.56 151.57 23.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.421 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 44.6 m 55.98 83.99 0.09 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 19.9 pt -95.56 172.86 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.924 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.42 -42.05 6.42 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.708 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . 0.729 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.2 OUTLIER -151.23 159.2 44.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.85 0.357 . . . . 0.0 111.513 -179.6 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -149.93 140.1 22.14 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -163.88 166.79 21.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.768 0.318 . . . . 0.0 111.42 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.52 ' HG2' ' HD1' ' A' ' 379' ' ' PHE . 33.5 mt-10 -97.56 138.38 35.07 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . 0.628 ' HG3' ' H ' ' A' ' 376' ' ' ASP . 10.0 ptm180 -89.41 -173.03 3.84 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.959 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.482 ' HB2' ' HG3' ' A' ' 440' ' ' GLU . 67.8 tttt -70.42 -19.51 62.99 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -177.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . 0.628 ' H ' ' HG3' ' A' ' 374' ' ' ARG . 0.4 OUTLIER -94.67 -23.05 17.76 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.377 -0.529 . . . . 0.0 112.422 -179.341 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 124.9 -18.99 7.01 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.603 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -70.45 152.0 44.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.842 0.353 . . . . 0.0 110.605 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . 0.52 ' HD1' ' HG2' ' A' ' 373' ' ' GLU . 21.5 m-85 -96.23 133.54 40.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.269 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 14.5 t -114.56 121.31 66.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 120.796 0.332 . . . . 0.0 110.276 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -107.65 138.62 43.55 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -121.3 137.7 54.57 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.461 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 79.0 tttt -155.25 103.54 2.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.408 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 76.61 -122.38 6.33 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.606 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . 0.52 ' O ' ' HA ' ' A' ' 402' ' ' HIS . 2.3 p-10 -106.52 4.87 28.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.884 0.373 . . . . 0.0 111.098 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . 0.4 ' HB3' ' HB2' ' A' ' 400' ' ' PRO . 46.3 mmtm -114.62 150.01 35.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.217 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 32.5 p-80 -131.78 148.79 52.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.019 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' TRP . . . . . 0.461 ' HZ3' ' HB3' ' A' ' 383' ' ' LYS . 27.1 m-90 -123.6 132.81 53.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.066 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 21.8 t -112.86 124.6 69.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -117.48 128.68 55.23 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -94.73 89.21 5.63 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . 0.46 ' HA ' ' HE2' ' A' ' 379' ' ' PHE . 76.9 mm-40 68.98 -80.41 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.409 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -136.05 11.47 3.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.089 0.471 . . . . 0.0 110.902 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 19.3 m -120.82 129.29 53.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.876 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 33.8 tp -76.07 142.04 41.87 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.961 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -69.14 148.49 97.65 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.392 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.41 133.64 19.47 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.9 2.4 . . . . 0.0 112.584 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 87.29 52.81 2.95 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.4 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' TYR . . . . . 0.432 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 25.4 m-85 -143.62 162.66 40.59 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.432 ' HA ' ' HB3' ' A' ' 399' ' ' TYR . 83.3 Cg_endo -80.4 165.32 77.96 Favored 'Cis proline' 0 C--N 1.347 0.489 0 C-N-CA 123.633 -1.403 . . . . 0.0 112.934 0.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -132.48 168.11 18.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.987 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 0.52 ' HA ' ' O ' ' A' ' 385' ' ' ASP . 5.4 m80 -68.82 156.36 38.53 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 123.236 0.335 . . . . 0.0 110.499 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 52.8 mt -55.84 -36.53 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.111 0.482 . . . . 0.0 110.879 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.416 ' HG2' ' HB2' ' A' ' 402' ' ' HIS . 22.8 pttp -65.43 -14.48 61.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.127 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -80.62 -22.06 40.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.318 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 40.6 tp -82.69 -48.21 11.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.99 0.424 . . . . 0.0 110.234 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.531 ' HA3' ' CE1' ' A' ' 438' ' ' PHE . . . -151.18 140.54 7.93 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.919 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 408' ' ' ARG . 0.1 OUTLIER -79.67 126.32 30.77 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.0 0.429 . . . . 0.0 110.714 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 110.77 -1.83 28.89 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.052 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 88.6 mt -83.72 150.18 58.75 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.496 0.189 . . . . 0.0 110.562 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.0 140.86 92.35 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.697 2.265 . . . . 0.0 111.871 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.14 -5.94 39.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.812 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.499 ' OD2' ' HD3' ' A' ' 431' ' ' ARG . 8.5 p-10 -79.27 -57.69 3.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.494 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -179.39 176.68 0.81 Allowed 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.823 0.344 . . . . 0.0 110.421 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 44.7 mm -124.55 134.64 66.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -89.4 -54.31 4.15 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.283 0.563 . . . . 0.0 110.206 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.729 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -150.84 155.93 40.2 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.978 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -139.14 121.51 16.03 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 35.2 tp -113.97 123.8 50.6 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.421 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -90.97 113.38 25.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.67 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' TRP . . . . . 0.487 ' HB2' ' HE2' ' A' ' 428' ' ' TYR . 19.2 t-105 -80.42 99.04 7.78 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 67.0 mtt -54.62 -49.41 91.4 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -47.54 -61.41 0.6 Allowed 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 122.557 2.171 . . . . 0.0 114.501 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' ASN . . . . . 0.428 ' H ' ' HD1' ' A' ' 421' ' ' TRP . 52.0 p30 -85.8 -24.9 26.61 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 83.56 47.43 5.67 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.514 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -131.49 152.58 50.6 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.8 m -106.24 126.55 52.36 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.141 0.496 . . . . 0.0 111.754 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' TYR . . . . . 0.487 ' HE2' ' HB2' ' A' ' 421' ' ' TRP . 95.6 m-85 -100.65 113.15 25.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.019 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . 0.448 ' HB2' ' HB2' ' A' ' 436' ' ' TYR . 46.4 m-85 -94.93 121.79 36.9 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.394 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -99.88 130.38 46.06 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.783 0.325 . . . . 0.0 110.929 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.499 ' HD3' ' OD2' ' A' ' 413' ' ' ASP . 3.1 tpm_? -141.75 98.7 3.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.829 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 67.79 -116.81 8.1 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.561 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -101.64 8.45 41.7 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 450' ' ' PRO . 65.9 mmtt -128.72 149.38 50.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.815 0.341 . . . . 0.0 111.195 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' TYR . . . . . 0.437 ' CE2' ' HE2' ' A' ' 449' ' ' TYR . 9.1 p90 -126.43 144.41 50.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.468 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' TYR . . . . . 0.448 ' HB2' ' HB2' ' A' ' 429' ' ' PHE . 26.6 m-85 -109.5 143.41 39.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.879 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -103.84 93.77 5.06 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . 0.531 ' CE1' ' HA3' ' A' ' 407' ' ' GLY . 76.5 t80 -82.79 129.57 35.0 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.533 -178.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -103.65 108.3 19.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.102 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' GLU . . . . . 0.507 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 4.1 mm-40 -54.98 -47.59 74.38 Favored 'General case' 0 C--O 1.231 0.115 0 O-C-N 123.486 0.491 . . . . 0.0 112.159 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -62.55 -32.71 73.71 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 68.2 mt -94.99 -10.94 29.46 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 443' ' ' ARG . 3.5 mmm180 58.07 29.32 17.64 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 123.32 0.387 . . . . 0.0 111.523 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -154.38 174.12 15.28 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.331 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.8 t -90.31 144.11 9.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.863 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -67.8 164.16 20.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.894 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.38 163.96 26.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.047 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 71.83 8.93 6.15 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.167 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . 0.449 ' HB3' ' HA ' ' A' ' 450' ' ' PRO . 31.6 m-85 -113.71 163.63 18.1 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.693 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . 0.473 ' HB2' ' HB3' ' A' ' 434' ' ' LYS . 66.1 Cg_endo -72.32 157.06 98.15 Favored 'Cis proline' 0 C--N 1.348 0.514 0 C-N-CA 123.631 -1.404 . . . . 0.0 112.301 -0.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -115.32 170.19 8.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.907 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -60.75 128.22 35.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.316 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 11.6 tt -66.74 -14.58 18.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.113 0.482 . . . . 0.0 111.347 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -69.89 3.7 2.47 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 39.1 t -66.6 -32.55 58.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' TRP . . . . . 0.412 ' HE3' ' CZ ' ' A' ' 486' ' ' PHE . 16.7 m95 -88.27 84.06 6.89 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.32 110.21 0.38 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.718 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 119.42 -23.67 8.4 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.173 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 43.7 mm -86.07 127.87 60.12 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.845 0.355 . . . . 0.0 111.383 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -85.49 162.49 11.01 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.809 2.339 . . . . 0.0 111.421 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -71.11 153.94 42.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.533 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 10.5 m 58.1 72.68 0.84 Allowed Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 115.591 -0.732 . . . . 0.0 112.942 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -82.52 176.51 7.83 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.093 2.529 . . . . 0.0 111.859 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 8.7 tpp85 -142.51 23.24 1.97 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.318 0.58 . . . . 0.0 110.472 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 172.97 142.03 3.68 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 12.3 p -165.43 101.42 0.72 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.728 0.299 . . . . 0.0 110.686 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -132.96 138.42 46.89 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.079 0.466 . . . . 0.0 111.656 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 40.0 ttm -93.65 135.9 34.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.526 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -68.2 163.62 48.2 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.391 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.93 -9.13 26.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.169 0.509 . . . . 0.0 111.605 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -84.99 -15.24 44.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.144 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 64.47 11.57 6.67 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 57.8 t -110.48 -40.69 4.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.921 0.391 . . . . 0.0 110.908 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -105.26 126.51 52.17 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 93.7 m -114.2 130.71 56.62 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -105.55 124.35 49.4 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.228 0.537 . . . . 0.0 112.389 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -105.55 152.35 23.17 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.971 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -131.82 137.59 48.17 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.514 0.197 . . . . 0.0 111.306 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 479' ' ' LYS . . . . . 0.403 ' HB3' ' CZ3' ' A' ' 484' ' ' TRP . 58.7 tttt -168.61 120.04 0.78 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.65 178.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 64.17 48.0 79.36 Favored Glycine 0 N--CA 1.453 -0.226 0 N-CA-C 114.561 0.584 . . . . 0.0 114.561 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . 0.568 ' OD1' ' HG ' ' A' ' 502' ' ' LEU . 66.5 t30 67.94 0.93 2.53 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 482' ' ' LYS . . . . . 0.543 ' HB3' ' HB2' ' A' ' 498' ' ' PRO . 41.5 mtmt -115.9 152.37 33.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.173 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 483' ' ' TYR . . . . . 0.475 ' CE2' ' HE2' ' A' ' 497' ' ' TYR . 32.6 p90 -126.12 152.23 46.19 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.892 0.377 . . . . 0.0 111.523 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 484' ' ' TRP . . . . . 0.494 ' HD1' HG11 ' A' ' 493' ' ' VAL . 18.5 m-90 -117.98 140.43 49.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.757 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -100.38 94.59 6.25 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 486' ' ' PHE . . . . . 0.412 ' CZ ' ' HE3' ' A' ' 456' ' ' TRP . 68.1 t80 -88.59 123.57 33.2 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.054 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . 0.407 ' ND2' ' HD3' ' A' ' 490' ' ' LYS . 40.1 t-20 -91.99 114.16 26.63 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -62.21 -33.02 73.76 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -76.06 -26.66 56.75 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 490' ' ' LYS . . . . . 0.407 ' HD3' ' ND2' ' A' ' 487' ' ' ASN . 55.4 mtpt -101.3 -16.91 16.78 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 10.7 tp 58.56 38.53 25.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.726 0.774 . . . . 0.0 110.25 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -156.41 152.6 27.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.595 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . 0.494 HG11 ' HD1' ' A' ' 484' ' ' TRP . 75.4 t -77.95 136.65 23.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.802 0.334 . . . . 0.0 110.585 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -62.93 146.35 95.47 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.284 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.98 155.68 66.77 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.571 2.18 . . . . 0.0 112.129 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 89.57 14.43 59.87 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.273 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . 0.686 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 66.3 m-85 -121.18 167.07 14.06 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . 0.686 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 76.8 Cg_endo -75.64 168.32 77.69 Favored 'Cis proline' 0 C--N 1.349 0.589 0 C-N-CA 123.905 -1.29 . . . . 0.0 113.016 0.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -123.39 169.67 11.11 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.945 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 39.9 t -79.24 117.57 20.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.777 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.02 -27.04 64.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.917 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 502' ' ' LEU . . . . . 0.568 ' HG ' ' OD1' ' A' ' 481' ' ' ASN . 14.2 mt -65.0 -48.33 74.34 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.195 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -79.68 -42.98 23.58 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -76.45 -54.31 6.91 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -177.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -79.36 -61.03 2.13 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 7.2 mmt -66.57 -37.68 85.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.976 0.417 . . . . 0.0 111.479 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 94.63 22.68 23.29 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.705 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 18.8 m -83.48 124.18 75.9 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-O 120.614 0.245 . . . . 0.0 110.465 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.86 156.04 61.19 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.812 2.342 . . . . 0.0 112.842 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 4.0 m 70.77 -70.23 0.16 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.466 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.327 0 CA-C-O 118.365 -1.241 . . . . 0.0 111.23 -179.487 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.731 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' PRO . . . . . 0.415 ' HA ' HD23 ' B' ' 2' ' ' HYP . 66.8 Cg_endo -74.48 153.32 44.46 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.673 2.249 . . . . 0.0 112.256 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' HYP . . . . . 0.415 HD23 ' HA ' ' B' ' 1' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.18 174.12 53.52 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.947 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.33 164.86 30.31 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.782 2.321 . . . . 0.0 111.237 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' D' ' 204' ' ' PRO . . . -75.79 -176.31 39.96 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.467 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.706 ' HG2' ' HA ' ' D' ' 205' ' ' HYP . 12.0 Cg_endo -56.51 163.27 7.01 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 122.979 2.452 . . . . 0.0 111.675 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' HYP . . . . . 0.443 ' O ' ' HA3' ' D' ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 149.58 175.87 22.26 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.094 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.78 141.47 65.74 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.848 2.366 . . . . 0.0 111.545 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -68.47 144.7 54.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.213 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' D' ' 210' ' ' PRO . . . -61.24 154.16 37.9 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.806 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.463 ' O ' ' HG3' ' D' ' 211' ' ' GLN . 1.4 mp -67.59 148.94 11.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.34 151.23 46.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.362 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' D' ' 213' ' ' ILE . . . -69.84 157.03 53.54 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.332 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -72.51 148.44 45.04 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -66.08 148.34 51.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 0.0 110.825 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' D' ' 216' ' ' GLN . . . -67.44 159.88 49.84 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.996 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.6 t -70.78 153.72 8.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.626 0.251 . . . . 0.0 110.481 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 11.9 t -58.95 145.47 10.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.454 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.87 161.51 52.89 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.127 -0.559 . . . . 0.0 113.062 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 95.9 mt -73.49 152.16 40.8 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.573 -0.158 . . . . 0.0 110.573 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.9 158.99 51.72 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.233 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.414 ' HA ' HD23 ' B' ' 26' ' ' HYP . 60.8 Cg_endo -73.63 153.54 49.1 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 122.653 2.236 . . . . 0.0 111.709 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' HYP . . . . . 0.414 HD23 ' HA ' ' B' ' 25' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.07 161.24 50.0 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.444 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.453 ' HA ' HD23 ' B' ' 29' ' ' HYP . 49.8 Cg_endo -69.68 155.42 66.25 Favored 'Trans proline' 0 C--O 1.237 0.441 0 C-N-CA 122.515 2.143 . . . . 0.0 111.482 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' HYP . . . . . 0.453 HD23 ' HA ' ' B' ' 28' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.03 168.61 36.9 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.982 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -73.58 166.55 29.53 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 123.053 2.502 . . . . 0.0 111.507 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.73 178.24 50.83 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.94 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -79.23 154.18 24.88 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 123.162 2.575 . . . . 0.0 111.804 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.659 -0.176 . . . . 0.0 112.659 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 101' ' ' PRO . . . . . 0.469 ' HA ' HD23 ' C' ' 102' ' ' HYP . 12.8 Cg_exo -71.74 124.94 10.63 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.932 2.421 . . . . 0.0 111.931 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 102' ' ' HYP . . . . . 0.469 HD23 ' HA ' ' C' ' 101' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.43 173.28 46.75 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.206 -0.521 . . . . 0.0 113.281 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -88.5 163.87 6.59 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 123.156 2.57 . . . . 0.0 112.367 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 105' ' ' HYP . . . . . 0.476 ' OD1' ' HG2' ' D' ' 204' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -77.9 -175.92 45.0 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.22 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.93 152.76 28.62 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.647 2.232 . . . . 0.0 111.052 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 108' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -60.48 172.18 6.29 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.388 -0.824 . . . . 0.0 113.567 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -61.5 154.1 61.76 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 123.042 2.495 . . . . 0.0 113.109 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -62.79 137.52 58.29 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.617 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.24 154.74 44.23 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.34 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 41.4 mt -70.4 137.56 23.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 122.762 -0.258 . . . . 0.0 110.363 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.1 147.48 47.3 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.526 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -65.19 155.95 48.53 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.843 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -82.72 158.67 22.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.651 0.262 . . . . 0.0 110.573 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -64.69 145.18 56.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.399 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.59 172.78 34.87 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.669 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 30.3 t -67.78 141.78 17.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.642 0.258 . . . . 0.0 110.81 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 120' ' ' VAL . . . . . 0.41 HG13 ' HB ' ' D' ' 219' ' ' VAL . 60.5 t -62.69 139.08 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.967 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.18 158.06 39.05 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 121.203 -0.523 . . . . 0.0 112.68 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 122' ' ' LEU . . . . . 0.47 ' HA ' HD23 ' C' ' 123' ' ' HYP . 97.1 mt -77.28 142.1 39.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.553 0.216 . . . . 0.0 110.546 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 123' ' ' HYP . . . . . 0.47 HD23 ' HA ' ' C' ' 122' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -65.1 165.41 34.75 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.455 -0.793 . . . . 0.0 113.252 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -74.98 158.17 42.42 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.8 2.333 . . . . 0.0 111.832 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 126' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -68.02 162.82 48.47 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.525 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.61 159.4 51.19 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.523 2.149 . . . . 0.0 110.742 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -67.48 -178.16 11.55 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.983 -0.627 . . . . 0.0 114.34 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 131' ' ' PRO . . . . . 0.452 ' HA ' HD23 ' C' ' 132' ' ' HYP . 14.4 Cg_exo -71.7 153.71 59.44 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 123.611 2.874 . . . . 0.0 111.926 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 132' ' ' HYP . . . . . 0.452 HD23 ' HA ' ' C' ' 131' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . 0.429 ' HA2' ' HD3' ' C' ' 134' ' ' PRO . . . -66.04 115.68 7.74 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 121.14 -0.553 . . . . 0.0 112.113 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 134' ' ' PRO . . . . . 0.469 ' HA ' HD23 ' C' ' 135' ' ' HYP . 20.6 Cg_exo -67.11 112.08 2.42 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 123.104 2.536 . . . . 0.0 112.061 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 135' ' ' HYP . . . . . 0.469 HD23 ' HA ' ' C' ' 134' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.49 0 CA-C-O 120.01 -0.328 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 201' ' ' PRO . . . . . 0.487 ' HA ' HD23 ' D' ' 202' ' ' HYP . 64.9 Cg_exo -55.45 151.19 38.61 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.302 2.668 . . . . 0.0 112.069 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 202' ' ' HYP . . . . . 0.487 HD23 ' HA ' ' D' ' 201' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 79.84 -177.6 54.21 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.013 -0.613 . . . . 0.0 114.102 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 204' ' ' PRO . . . . . 0.476 ' HG2' ' OD1' ' C' ' 105' ' ' HYP . 11.3 Cg_exo -74.94 169.28 22.96 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.907 3.072 . . . . 0.0 112.172 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 205' ' ' HYP . . . . . 0.706 ' HA ' ' HG2' ' B' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 206' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' B' ' 8' ' ' HYP . . . 92.89 170.73 40.19 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.404 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -90.61 156.74 4.3 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.905 3.07 . . . . 0.0 112.281 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 208' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -82.88 167.6 46.2 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.715 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 210' ' ' PRO . . . . . 0.502 ' O ' ' HA3' ' B' ' 12' ' ' GLY . 11.6 Cg_exo -70.04 156.42 62.66 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 122.762 2.308 . . . . 0.0 112.341 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 211' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' B' ' 13' ' ' ILE . 24.8 tt0 -76.61 147.15 37.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.441 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -69.2 165.31 49.4 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.35 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 213' ' ' ILE . . . . . 0.505 ' O ' ' HA3' ' B' ' 15' ' ' GLY . 10.8 pt -69.34 168.19 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 120.775 0.322 . . . . 0.0 111.141 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -83.18 146.46 28.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.951 0.405 . . . . 0.0 111.043 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -66.12 160.66 45.48 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.908 -0.587 . . . . 0.0 113.453 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 216' ' ' GLN . . . . . 0.481 ' O ' ' HA3' ' B' ' 18' ' ' GLY . 39.9 mm-40 -75.75 160.48 29.98 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -71.52 152.68 42.79 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -62.42 154.67 41.44 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.01 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 219' ' ' VAL . . . . . 0.41 ' HB ' HG13 ' C' ' 120' ' ' VAL . 10.7 t -62.28 142.43 16.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 30.8 t -61.45 137.91 22.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.258 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -59.37 154.56 29.81 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.673 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 5.6 mp -75.2 158.19 33.37 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.479 0.181 . . . . 0.0 110.813 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 223' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -71.81 156.3 52.51 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.652 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 225' ' ' PRO . . . . . 0.407 ' HA ' HD23 ' D' ' 226' ' ' HYP . 15.4 Cg_exo -69.8 154.58 67.42 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.796 2.33 . . . . 0.0 111.811 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 226' ' ' HYP . . . . . 0.407 HD23 ' HA ' ' D' ' 225' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.96 163.31 29.85 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.705 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.97 160.21 33.78 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.64 2.226 . . . . 0.0 111.34 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -67.54 -176.72 9.57 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.881 -0.6 . . . . 0.0 113.973 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 231' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.26 168.98 22.16 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.937 2.424 . . . . 0.0 112.145 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 232' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo . . . . . 0 N--CA 1.48 0.727 0 N-CA-C 109.68 -0.931 . . . . 0.0 109.68 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -133.44 159.46 40.29 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 13.8 tt -78.71 -17.62 13.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.263 0.554 . . . . 0.0 110.923 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' CYS . . . . . 0.508 ' HA ' HD22 ' A' ' 502' ' ' LEU . 6.8 m -95.8 14.98 21.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.669 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -60.42 -40.55 91.42 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.039 0.447 . . . . 0.0 111.072 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 98.85 146.92 21.28 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.084 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 23.9 t30 54.81 91.87 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' PHE . . . . . 0.418 ' HD1' ' HD3' ' A' ' 337' ' ' LYS . 47.4 m-85 -91.74 165.59 13.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.289 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -71.45 -41.56 69.28 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.579 HG22 ' HB2' ' A' ' 336' ' ' PHE . 1.2 t -167.6 149.77 5.76 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.354 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 90.6 t -134.33 123.98 44.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -147.88 176.53 10.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.812 0.339 . . . . 0.0 110.903 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 38.3 ttp -128.96 119.98 25.28 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 41.6 mt -119.98 125.89 49.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.301 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 330' ' ' ARG . 5.9 mmp_? 64.1 20.56 12.24 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.521 0.513 . . . . 0.0 111.183 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 91.31 1.44 72.05 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.875 -0.678 . . . . 0.0 111.857 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . 0.431 ' CD ' ' HE ' ' A' ' 343' ' ' ARG . 12.0 mm-40 -105.97 124.78 50.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.75 0.31 . . . . 0.0 110.597 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 36.4 ttm -78.67 114.87 17.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.855 0.359 . . . . 0.0 111.109 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -106.37 126.57 52.41 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.14 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 39.2 t -109.48 118.88 57.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.441 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' PHE . . . . . 0.579 ' HB2' HG22 ' A' ' 325' ' ' THR . 81.3 m-85 -104.29 130.54 52.1 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.809 0.338 . . . . 0.0 111.548 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 0.703 ' HB3' ' HZ3' ' A' ' 342' ' ' TRP . 17.7 ttpp -150.94 116.19 5.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.055 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 65.28 -119.96 0.39 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.14 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.3 ptm85 -109.56 13.61 23.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.962 0.411 . . . . 0.0 111.847 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 17.2 m-90 -129.62 152.7 48.85 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.588 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -129.77 147.49 51.55 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.973 0.416 . . . . 0.0 110.866 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' TRP . . . . . 0.703 ' HZ3' ' HB3' ' A' ' 337' ' ' LYS . 26.5 m-90 -119.2 169.26 10.11 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.263 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.431 ' HE ' ' CD ' ' A' ' 332' ' ' GLU . 0.0 OUTLIER -147.45 109.48 4.48 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.111 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.54 HG11 ' HA ' ' A' ' 506' ' ' MET . 1.1 m -99.94 122.88 52.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.105 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 21.1 ttm-85 -117.94 102.12 8.81 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 66.6 t30 66.72 51.87 1.02 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.5 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.537 ' HA ' ' O ' ' A' ' 505' ' ' TRP . 9.1 m120 69.2 1.7 3.34 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.242 -0.89 . . . . 0.0 113.317 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -118.71 127.73 53.84 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.963 0.411 . . . . 0.0 112.019 -179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 20.0 t -74.24 123.68 30.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.218 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 72.3 mtp -68.29 167.4 14.5 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -74.73 153.64 38.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.712 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 95.23 7.47 59.43 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.887 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' TYR . . . . . 0.43 ' HA ' ' C ' ' A' ' 354' ' ' PRO . 85.8 m-85 -122.71 153.93 63.36 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.43 ' C ' ' HA ' ' A' ' 353' ' ' TYR . 55.2 Cg_endo -70.3 143.32 74.52 Favored 'Cis proline' 0 C--N 1.345 0.349 0 C-N-CA 123.545 -1.44 . . . . 0.0 112.598 0.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 58.0 ttm -116.68 131.83 23.7 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.554 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.7 138.39 82.87 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.588 2.192 . . . . 0.0 111.41 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 78.4 mt -56.57 -46.6 82.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.34 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -73.07 3.04 31.61 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 121.175 -0.536 . . . . 0.0 113.85 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' GLN . . . . . 0.674 HE21 ' HA ' ' A' ' 359' ' ' GLN . 0.0 OUTLIER -87.38 -37.2 17.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.326 0.563 . . . . 0.0 110.42 179.386 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -106.67 -44.86 4.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.446 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 62.2 m95 -89.8 74.22 7.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.315 0.578 . . . . 0.0 110.122 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -62.23 103.63 0.41 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.173 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 120.98 -14.24 9.64 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.103 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.559 HD12 ' HD2' ' A' ' 365' ' ' PRO . 24.0 tp -93.38 133.85 27.75 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.744 0.306 . . . . 0.0 110.562 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' PRO . . . . . 0.559 ' HD2' HD12 ' A' ' 364' ' ' LEU . 93.9 Cg_endo -82.85 177.62 6.66 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.642 2.228 . . . . 0.0 111.585 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -86.86 160.61 18.68 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.781 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 54.8 m 53.57 79.87 0.12 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 23.0 pt -94.86 -178.63 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.496 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -105.63 -47.0 4.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.724 0.297 . . . . 0.0 111.658 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . 0.728 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.2 OUTLIER -152.85 163.45 39.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.746 0.308 . . . . 0.0 111.591 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -152.11 142.32 22.36 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . 0.636 ' HE1' ' HE1' ' A' ' 382' ' ' PHE . 17.5 p90 -165.07 168.69 17.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.638 0.256 . . . . 0.0 111.546 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -95.09 126.51 40.47 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 378' ' ' LYS . 13.5 ptm180 -84.7 171.96 11.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.66 0.267 . . . . 0.0 111.005 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.616 ' HB3' ' HG2' ' A' ' 440' ' ' GLU . 84.1 tttt -66.8 -32.33 73.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.999 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -33.16 71.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.407 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 124.57 -20.92 6.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.476 -0.869 . . . . 0.0 113.928 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' LYS . . . . . 0.57 ' HD3' ' HB2' ' A' ' 391' ' ' ASP . 19.8 mttp -90.32 175.27 7.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 117.196 0.498 . . . . 0.0 112.27 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . 0.508 ' HE2' ' HA ' ' A' ' 392' ' ' GLU . 22.1 m-85 -99.2 140.29 33.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.318 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . 0.477 ' HB ' ' CE1' ' A' ' 372' ' ' TYR . 5.9 t -120.23 122.03 67.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.199 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -108.45 144.55 35.91 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.636 ' HE1' ' HE1' ' A' ' 372' ' ' TYR . 53.6 m-85 -127.5 141.16 51.73 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -151.76 103.56 2.95 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 414' ' ' LYS . . . 76.12 -115.27 4.42 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.268 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -113.95 10.59 17.63 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.791 0.329 . . . . 0.0 111.125 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -116.27 151.46 35.78 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.691 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . 0.431 ' CE1' ' HB2' ' A' ' 406' ' ' LEU . 29.8 p-80 -132.88 150.46 52.16 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.604 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' TRP . . . . . 0.438 ' CE2' ' HB3' ' A' ' 400' ' ' PRO . 18.6 m-90 -123.36 137.3 54.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.938 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 69.7 t -117.45 117.37 54.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.049 0.452 . . . . 0.0 109.883 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -113.48 124.68 52.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.731 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.57 ' HB2' ' HD3' ' A' ' 378' ' ' LYS . 24.8 t0 -91.48 84.62 5.57 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . 0.508 ' HA ' ' HE2' ' A' ' 379' ' ' PHE . 57.7 mm-40 70.19 -70.25 0.15 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.995 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -143.39 16.06 1.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.921 0.391 . . . . 0.0 110.787 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 1.1 m -126.25 121.07 31.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.787 0.327 . . . . 0.0 111.359 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 52.7 tp -75.34 127.84 34.06 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 2.4 mt-10 -61.65 127.35 88.6 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.655 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 50.1 Cg_exo -56.44 141.04 90.07 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.059 2.506 . . . . 0.0 112.368 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 92.53 16.26 49.99 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.252 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' TYR . . . . . 0.444 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 19.4 m-85 -112.66 163.21 18.46 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 110.712 -0.107 . . . . 0.0 110.712 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.444 ' HA ' ' HB3' ' A' ' 399' ' ' TYR . 74.5 Cg_endo -76.47 169.43 74.48 Favored 'Cis proline' 0 C--N 1.347 0.491 0 C-N-CA 123.682 -1.382 . . . . 0.0 112.678 0.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -131.6 166.6 21.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.492 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 0.739 ' HB2' ' HG2' ' A' ' 405' ' ' GLU . 16.9 m-70 -71.47 154.79 41.25 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 68.9 mt -60.98 -38.2 78.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.205 0.526 . . . . 0.0 109.799 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.549 ' HB3' HG23 ' A' ' 412' ' ' THR . 50.2 pttt -66.7 -17.2 64.73 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.676 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.739 ' HG2' ' HB2' ' A' ' 402' ' ' HIS . 22.1 mm-40 -81.14 -23.79 38.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.921 0.391 . . . . 0.0 110.659 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . 0.431 ' HB2' ' CE1' ' A' ' 387' ' ' HIS . 49.0 tp -77.0 -43.87 33.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.08 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.444 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -155.91 146.23 13.73 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.852 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -77.24 126.31 30.73 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.625 0.25 . . . . 0.0 110.537 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.31 -0.93 46.76 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.383 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 40.6 mt -77.27 149.65 79.36 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 120.399 0.142 . . . . 0.0 111.025 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' PRO . . . . . 0.451 ' HG3' ' CE1' ' A' ' 436' ' ' TYR . 32.0 Cg_exo -58.96 112.53 1.24 Allowed 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.987 2.458 . . . . 0.0 112.201 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' THR . . . . . 0.549 HG23 ' HB3' ' A' ' 404' ' ' LYS . 0.0 OUTLIER -86.4 37.59 0.74 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.058 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -134.58 -56.7 0.84 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.271 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 384' ' ' GLY . 10.8 ptmt -173.32 166.41 4.8 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 122.335 0.254 . . . . 0.0 110.506 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 38.9 mm -121.85 130.37 74.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -86.47 -45.39 11.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.367 0.604 . . . . 0.0 109.678 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.728 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -158.15 157.57 32.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.745 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -141.64 123.61 15.38 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.444 ' HB2' ' HB2' ' A' ' 466' ' ' SER . 28.2 tp -120.62 134.67 55.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.297 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -106.46 117.11 33.17 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.359 -0.382 . . . . 0.0 109.982 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' TRP . . . . . 0.714 ' HB2' ' HE1' ' A' ' 428' ' ' TYR . 4.5 t-105 -86.09 98.91 11.13 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.545 ' HB2' ' HD3' ' A' ' 423' ' ' PRO . 66.8 mtt -57.31 -52.49 73.87 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -178.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.545 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 68.2 Cg_exo -53.23 -27.88 39.9 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.839 2.359 . . . . 0.0 115.301 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' ASN . . . . . 0.626 ' OD1' ' HB3' ' A' ' 421' ' ' TRP . 23.1 p-10 -112.93 -24.49 9.5 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 83.49 38.15 11.2 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.213 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -122.95 146.68 47.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.756 0.313 . . . . 0.0 110.737 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' A' ' 438' ' ' PHE . 7.1 m -107.05 129.35 54.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.513 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' TYR . . . . . 0.714 ' HE1' ' HB2' ' A' ' 421' ' ' TRP . 86.0 m-85 -108.36 117.47 34.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.911 0.386 . . . . 0.0 111.02 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . 0.448 ' HB2' ' HB2' ' A' ' 436' ' ' TYR . 53.4 m-85 -101.79 122.47 44.03 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.745 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -98.94 129.03 45.24 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.973 0.416 . . . . 0.0 111.535 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -139.2 103.71 4.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.409 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 67.21 -110.76 3.65 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.124 -0.791 . . . . 0.0 111.124 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -115.89 16.25 16.22 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.098 0.475 . . . . 0.0 110.236 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -119.17 145.96 45.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.115 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' TYR . . . . . 0.481 ' CE1' ' HB2' ' A' ' 451' ' ' LYS . 5.4 p90 -125.48 131.44 52.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.966 0.412 . . . . 0.0 110.679 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' TYR . . . . . 0.451 ' CE1' ' HG3' ' A' ' 411' ' ' PRO . 14.3 m-85 -102.71 148.1 26.01 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.947 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -114.19 98.0 6.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.313 0.578 . . . . 0.0 109.457 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . 0.556 ' HB3' ' HB ' ' A' ' 427' ' ' THR . 78.8 t80 -81.73 134.32 35.44 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.649 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -104.72 103.49 13.13 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.882 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' GLU . . . . . 0.616 ' HG2' ' HB3' ' A' ' 375' ' ' LYS . 5.4 tp10 -48.94 -45.33 41.62 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -179.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -53.85 -66.26 0.42 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 74.2 mt -75.72 -14.83 60.34 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' ARG . . . . . 0.425 ' O ' ' HA2' ' A' ' 407' ' ' GLY . 22.6 mtp180 60.37 48.41 7.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.695 0.76 . . . . 0.0 110.782 -178.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -156.43 161.7 40.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.105 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 74.4 t -81.81 141.85 14.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -60.12 160.85 7.58 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.373 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.3 m -68.32 151.81 46.36 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.671 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 69.06 30.81 4.31 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.064 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -125.43 159.12 61.76 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.645 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -80.43 166.8 75.22 Favored 'Cis proline' 0 C--N 1.342 0.23 0 C-N-CA 123.504 -1.457 . . . . 0.0 112.592 0.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . 0.481 ' HB2' ' CE1' ' A' ' 435' ' ' TYR . 64.5 mttm -116.42 171.32 7.91 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.338 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -71.68 146.68 48.08 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.643 0.259 . . . . 0.0 110.651 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 13.1 tt -70.44 -8.41 10.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.83 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 454' ' ' LYS . 66.1 mmtt -60.68 -12.08 9.31 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.76 -31.96 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' TRP . . . . . 0.431 ' HB2' ' HB ' ' A' ' 459' ' ' ILE . 24.4 m95 -89.36 95.34 10.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.026 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.49 105.75 1.26 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 110.9 -4.31 28.91 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.044 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 456' ' ' TRP . 30.6 mm -91.93 128.03 47.36 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-O 121.096 0.474 . . . . 0.0 111.391 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . 0.451 ' HG3' ' CH2' ' A' ' 484' ' ' TRP . 88.5 Cg_endo -79.08 158.19 26.84 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.853 2.369 . . . . 0.0 111.699 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 30.0 mp0 -80.1 148.62 30.93 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.425 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.9 m 55.45 69.4 1.97 Allowed Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.1 -175.9 2.6 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.339 2.026 . . . . 0.0 111.773 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 7.2 tpp85 -144.65 32.63 1.16 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.338 0.589 . . . . 0.0 110.328 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 167.51 140.7 2.97 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . 0.444 ' HB2' ' HB2' ' A' ' 419' ' ' LEU . 5.7 p -161.94 101.22 1.13 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.948 0.404 . . . . 0.0 109.959 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -130.19 135.56 48.3 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.047 0.451 . . . . 0.0 111.344 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 468' ' ' MET . . . . . 0.47 ' HA ' ' HA ' ' A' ' 475' ' ' THR . 47.3 ttm -86.96 142.3 28.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.954 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -71.8 164.59 54.13 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.911 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.54 -12.66 54.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.09 0.471 . . . . 0.0 111.587 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -83.17 -17.07 44.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.637 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 68.05 5.74 4.78 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 122.9 0.48 . . . . 0.0 111.911 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 35.1 t -104.5 -32.71 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.877 0.37 . . . . 0.0 111.13 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -117.8 138.05 52.33 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 475' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 468' ' ' MET . 90.6 m -120.82 133.08 55.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.409 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -104.8 129.58 53.06 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.197 0.522 . . . . 0.0 112.117 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -110.99 146.72 36.17 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.316 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -126.74 137.83 53.29 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -162.16 107.03 1.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.964 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 60.0 57.66 18.17 Favored Glycine 0 C--N 1.331 0.258 0 CA-C-N 115.998 -0.547 . . . . 0.0 113.401 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . 0.417 ' OD1' ' HG ' ' A' ' 502' ' ' LEU . 18.3 t30 73.24 -33.72 0.27 Allowed 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 482' ' ' LYS . . . . . 0.629 ' HB3' ' HB2' ' A' ' 498' ' ' PRO . 24.1 mtmt -78.66 136.54 37.49 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.048 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 483' ' ' TYR . . . . . 0.48 ' CE1' ' HB2' ' A' ' 499' ' ' LYS . 5.4 p90 -121.5 149.03 43.68 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.079 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 484' ' ' TRP . . . . . 0.471 ' CE2' ' HB3' ' A' ' 498' ' ' PRO . 23.0 m-90 -117.82 149.39 40.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.46 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -115.25 99.92 7.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.202 0.525 . . . . 0.0 109.787 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 486' ' ' PHE . . . . . 0.432 ' HA ' ' HA ' ' A' ' 493' ' ' VAL . 58.2 t80 -88.54 127.57 35.54 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.26 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -88.1 111.93 22.11 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -66.17 -23.94 66.56 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 36.4 tp60 -86.04 -25.95 25.63 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.902 0.382 . . . . 0.0 111.614 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -104.72 -14.47 15.55 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.0 tp 61.77 39.85 13.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.478 0.656 . . . . 0.0 110.189 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 51.3 tttt -154.23 148.97 26.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.589 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 486' ' ' PHE . 69.9 t -79.26 138.43 20.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.666 0.27 . . . . 0.0 110.401 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -62.21 153.03 76.83 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.161 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -75.56 150.94 36.5 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.749 2.3 . . . . 0.0 113.024 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 98.14 5.06 57.39 Favored Glycine 0 C--N 1.331 0.282 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.327 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . 0.737 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 67.6 m-85 -106.55 167.24 9.84 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 110.666 -0.124 . . . . 0.0 110.666 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . 0.737 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 87.6 Cg_endo -79.26 167.71 75.72 Favored 'Cis proline' 0 C--N 1.345 0.38 0 C-N-CA 123.72 -1.367 . . . . 0.0 112.756 0.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 499' ' ' LYS . . . . . 0.48 ' HB2' ' CE1' ' A' ' 483' ' ' TYR . 33.0 mtpt -125.73 154.82 41.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.988 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 2.7 m -72.36 111.95 8.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.494 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -62.23 -27.06 68.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.521 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 502' ' ' LEU . . . . . 0.508 HD22 ' HA ' ' A' ' 319' ' ' CYS . 36.3 mt -56.07 -44.23 78.72 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.58 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -89.28 -37.79 14.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.354 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.01 -39.51 83.18 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 505' ' ' TRP . . . . . 0.537 ' O ' ' HA ' ' A' ' 347' ' ' ASN . 15.4 m0 -122.02 -45.69 2.24 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 506' ' ' MET . . . . . 0.54 ' HA ' HG11 ' A' ' 344' ' ' VAL . 10.5 mmt -64.87 -29.01 69.94 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 86.98 28.21 26.5 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.898 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 508' ' ' CYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 509' ' ' PRO . 32.4 m -103.01 106.63 51.72 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 508' ' ' CYS . 6.2 Cg_exo -79.72 171.93 14.94 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 123.074 2.516 . . . . 0.0 111.59 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 5.3 m 60.55 52.1 4.76 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.375 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.369 -1.239 . . . . 0.0 111.562 179.783 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.611 0 N-CA-C 111.864 -0.494 . . . . 0.0 111.864 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' PRO . . . . . 0.454 ' HA ' HD23 ' B' ' 2' ' ' HYP . 56.9 Cg_endo -71.09 154.0 62.55 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.769 2.313 . . . . 0.0 111.793 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' HYP . . . . . 0.576 ' HA ' ' HB2' ' C' ' 101' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' D' ' 201' ' ' PRO . . . -89.84 172.49 38.83 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.333 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.584 ' HG2' ' HA ' ' D' ' 202' ' ' HYP . 73.5 Cg_endo -74.21 162.24 39.03 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.799 2.333 . . . . 0.0 111.782 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' D' ' 204' ' ' PRO . . . -72.15 173.02 46.3 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.367 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.577 ' HG2' ' HA ' ' D' ' 205' ' ' HYP . 19.0 Cg_endo -59.78 162.7 15.07 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.784 2.322 . . . . 0.0 111.484 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 130.63 -175.02 19.55 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.395 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' D' ' 208' ' ' HYP . 8.0 Cg_exo -74.54 144.32 31.91 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.183 2.589 . . . . 0.0 111.785 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -73.6 148.79 42.57 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' D' ' 210' ' ' PRO . . . -61.72 153.52 40.66 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.459 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.521 ' O ' ' HG3' ' D' ' 211' ' ' GLN . 13.1 mt -70.88 150.06 9.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' C' ' 113' ' ' ILE . . . -63.29 149.2 46.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.378 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' D' ' 213' ' ' ILE . . . -66.67 170.26 32.36 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.219 -0.515 . . . . 0.0 113.293 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -72.62 141.78 48.35 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' B' ' 17' ' ' ARG . 0.0 OUTLIER -65.58 141.18 58.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.645 -179.69 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.02 150.3 40.12 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.763 -0.653 . . . . 0.0 113.139 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 5.3 t -71.65 146.29 11.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 45.6 t -55.43 144.95 6.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.09 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.1 162.86 51.31 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.159 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 86.1 mt -77.28 154.38 32.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.619 -0.291 . . . . 0.0 110.429 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.22 157.55 52.57 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.508 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.412 ' HA ' HD23 ' B' ' 26' ' ' HYP . 46.6 Cg_endo -69.68 154.13 68.43 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.722 2.281 . . . . 0.0 111.835 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' HYP . . . . . 0.412 HD23 ' HA ' ' B' ' 25' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.42 156.11 51.86 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.532 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.418 ' HA ' HD23 ' B' ' 29' ' ' HYP . 55.2 Cg_endo -70.32 157.11 60.33 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.695 2.263 . . . . 0.0 112.06 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' HYP . . . . . 0.418 HD23 ' HA ' ' B' ' 28' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.27 178.09 51.89 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.959 -0.638 . . . . 0.0 113.164 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.51 ' HD2' ' HA ' ' D' ' 229' ' ' HYP . 11.8 Cg_exo -72.53 155.95 54.44 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.217 2.611 . . . . 0.0 111.493 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' HYP . . . . . 0.443 HD23 ' HA ' ' B' ' 31' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . 0.472 ' HA2' ' HD3' ' B' ' 34' ' ' PRO . . . -65.37 154.15 50.46 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.769 -0.65 . . . . 0.0 114.217 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . 0.472 ' HD3' ' HA2' ' B' ' 33' ' ' GLY . 7.0 Cg_exo -73.84 116.1 4.55 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 123.413 2.742 . . . . 0.0 111.303 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 CA-C-O 119.999 -0.334 . . . . 0.0 112.666 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 101' ' ' PRO . . . . . 0.576 ' HB2' ' HA ' ' B' ' 2' ' ' HYP . 52.2 Cg_exo -56.82 132.24 50.47 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.047 2.498 . . . . 0.0 112.357 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 102' ' ' HYP . . . . . 0.466 ' HA ' ' HD2' ' D' ' 201' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.71 163.67 44.31 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.127 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -81.18 157.07 19.98 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 123.488 2.792 . . . . 0.0 112.313 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 105' ' ' HYP . . . . . 0.423 ' OD1' ' HG2' ' D' ' 204' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -82.79 175.98 53.31 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.476 -0.868 . . . . 0.0 111.53 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 107' ' ' PRO . . . . . 0.429 ' HA ' HD22 ' C' ' 108' ' ' HYP . 55.5 Cg_endo -73.09 130.12 14.99 Favored 'Trans proline' 0 CA--C 1.528 0.203 0 C-N-CA 122.553 2.168 . . . . 0.0 110.65 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 108' ' ' HYP . . . . . 0.429 HD22 ' HA ' ' C' ' 107' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -53.13 167.31 1.23 Allowed Glycine 0 CA--C 1.522 0.53 0 CA-C-N 115.426 -0.806 . . . . 0.0 114.779 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.93 167.6 25.51 Favored 'Trans proline' 0 C--O 1.238 0.475 0 C-N-CA 122.958 2.438 . . . . 0.0 112.345 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -60.76 142.25 56.12 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.124 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -73.74 160.88 53.8 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.892 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' B' ' 14' ' ' ALA . 33.0 mt -68.45 141.15 17.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.733 0.301 . . . . 0.0 110.713 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.19 153.73 41.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.681 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -63.29 161.18 34.63 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.574 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -84.11 153.83 23.51 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 117' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' C' ' 117' ' ' ARG . 11.8 ttm180 -65.55 141.44 58.45 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.81 168.33 32.47 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.179 -0.534 . . . . 0.0 113.035 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 24.1 t -71.0 140.12 18.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 120' ' ' VAL . . . . . 0.435 HG13 ' HB ' ' D' ' 219' ' ' VAL . 24.2 t -65.77 131.79 31.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.095 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.84 158.73 36.7 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.883 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 13.4 mt -73.55 148.99 42.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.473 0.178 . . . . 0.0 110.885 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 123' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -72.05 164.39 54.33 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.548 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 125' ' ' PRO . . . . . 0.448 ' HA ' HD23 ' C' ' 126' ' ' HYP . 71.5 Cg_endo -75.08 149.98 37.16 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.532 2.155 . . . . 0.0 111.459 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 126' ' ' HYP . . . . . 0.448 HD23 ' HA ' ' C' ' 125' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.93 163.98 36.48 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.627 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -74.86 156.17 43.61 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.551 2.168 . . . . 0.0 111.452 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 130' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' B' ' 31' ' ' PRO . . . -66.97 168.88 36.19 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.862 -0.685 . . . . 0.0 113.139 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 131' ' ' PRO . . . . . 0.422 ' HA ' HD23 ' C' ' 132' ' ' HYP . 24.7 Cg_exo -64.47 153.69 75.69 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.77 2.313 . . . . 0.0 111.306 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 132' ' ' HYP . . . . . 0.491 ' HA ' ' O ' ' D' ' 231' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -83.13 118.76 4.7 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.354 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 134' ' ' PRO . . . . . 0.454 ' HA ' HD23 ' C' ' 135' ' ' HYP . 45.1 Cg_endo -70.72 113.93 3.69 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 122.563 2.175 . . . . 0.0 111.361 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 135' ' ' HYP . . . . . 0.454 HD23 ' HA ' ' C' ' 134' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 201' ' ' PRO . . . . . 0.476 ' O ' ' HA3' ' B' ' 3' ' ' GLY . 42.2 Cg_exo -58.49 146.97 88.63 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.092 2.528 . . . . 0.0 111.774 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 202' ' ' HYP . . . . . 0.584 ' HA ' ' HG2' ' B' ' 4' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 68.82 -178.7 24.51 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 114.713 0.645 . . . . 0.0 114.713 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 204' ' ' PRO . . . . . 0.439 ' O ' ' HA3' ' B' ' 6' ' ' GLY . 11.6 Cg_exo -74.6 166.73 28.72 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 123.593 2.862 . . . . 0.0 111.599 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 205' ' ' HYP . . . . . 0.577 ' HA ' ' HG2' ' B' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 206' ' ' GLY . . . . . 0.4 ' HA2' ' HD3' ' D' ' 207' ' ' PRO . . . 98.69 161.99 30.04 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.476 -0.868 . . . . 0.0 113.219 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 207' ' ' PRO . . . . . 0.454 ' HA ' HD23 ' D' ' 208' ' ' HYP . 1.2 Cg_endo -84.8 154.47 11.59 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 123.51 2.806 . . . . 0.0 112.453 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 208' ' ' HYP . . . . . 0.454 HD23 ' HA ' ' D' ' 207' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -77.82 173.97 54.94 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.345 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 210' ' ' PRO . . . . . 0.536 ' O ' ' HA3' ' B' ' 12' ' ' GLY . 7.1 Cg_exo -72.71 155.22 54.27 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.875 2.383 . . . . 0.0 112.005 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 211' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' B' ' 13' ' ' ILE . 27.3 tt0 -75.46 146.52 40.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.504 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -66.79 163.56 43.96 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.757 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 213' ' ' ILE . . . . . 0.444 ' O ' ' HA3' ' B' ' 15' ' ' GLY . 44.2 pt -69.94 168.47 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 120.858 0.361 . . . . 0.0 111.236 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -74.82 153.6 38.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.478 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -79.68 155.43 39.27 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.907 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -72.3 146.62 47.04 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.573 0.225 . . . . 0.0 110.41 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -65.1 155.47 34.72 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.739 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -65.75 153.99 51.11 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.793 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 219' ' ' VAL . . . . . 0.435 ' HB ' HG13 ' C' ' 120' ' ' VAL . 14.6 t -69.07 149.39 11.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 48.4 t -68.66 141.31 17.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -62.06 161.35 29.22 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.854 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 5.8 mp -67.4 158.0 32.76 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 223' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -61.02 148.7 45.72 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.89 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 225' ' ' PRO . . . . . 0.438 ' HA ' HD23 ' D' ' 226' ' ' HYP . 37.9 Cg_exo -62.98 143.3 90.81 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.626 2.217 . . . . 0.0 111.061 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 226' ' ' HYP . . . . . 0.438 HD23 ' HA ' ' D' ' 225' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 227' ' ' GLY . . . . . 0.412 ' HA2' ' HD3' ' D' ' 228' ' ' PRO . . . -60.84 158.64 28.73 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.985 -0.552 . . . . 0.0 113.747 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 228' ' ' PRO . . . . . 0.412 ' HD3' ' HA2' ' D' ' 227' ' ' GLY . 13.6 Cg_exo -72.37 159.67 48.81 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.14 2.56 . . . . 0.0 111.271 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 229' ' ' HYP . . . . . 0.51 ' HA ' ' HD2' ' B' ' 31' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -67.04 168.9 36.41 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.988 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 231' ' ' PRO . . . . . 0.491 ' O ' ' HA ' ' C' ' 132' ' ' HYP . 92.5 Cg_endo -86.59 160.14 9.33 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.869 2.379 . . . . 0.0 111.689 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 232' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo . . . . . 0 N--CA 1.479 0.655 0 N-CA-C 110.045 -0.79 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -105.82 151.98 23.81 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 21.1 tt -66.58 -31.74 54.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.822 0.344 . . . . 0.0 110.808 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' CYS . . . . . 0.427 ' HA ' HD22 ' A' ' 502' ' ' LEU . 57.7 m -75.72 -0.53 21.17 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.056 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -69.51 -27.24 65.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.87 0.367 . . . . 0.0 110.686 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 84.62 -176.6 51.16 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.951 -0.643 . . . . 0.0 113.121 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 6.4 t30 57.22 77.37 0.27 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.44 0.696 . . . . 0.0 112.671 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -96.9 148.32 23.07 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.661 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . 0.411 ' OD1' ' HA ' ' A' ' 337' ' ' LYS . 2.5 m-20 -70.55 -42.4 71.21 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 1.9 t -167.95 155.16 8.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.687 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 72.9 t -133.62 127.89 53.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -144.18 164.75 29.81 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.683 0.278 . . . . 0.0 110.9 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 36.4 ttp -122.14 105.55 10.36 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 28.8 mt -103.5 128.01 50.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.183 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.54 17.59 7.51 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.706 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 95.59 -4.54 66.51 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.184 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -97.49 126.9 43.04 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.613 0.244 . . . . 0.0 110.415 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 39.1 tpp -77.56 117.3 18.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.062 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -113.33 119.95 39.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.047 0.451 . . . . 0.0 110.974 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . 0.435 ' HB ' ' HB2' ' A' ' 342' ' ' TRP . 21.1 t -103.24 117.44 48.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -103.99 129.82 51.61 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 0.635 ' HB3' ' HZ3' ' A' ' 342' ' ' TRP . 83.3 tttt -147.13 122.12 10.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.268 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 60.12 -105.82 0.24 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.274 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 339' ' ' ARG . 10.0 ptm85 -125.58 18.63 8.08 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.019 0.437 . . . . 0.0 111.401 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 20.3 m-90 -130.3 152.92 49.19 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.888 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -132.77 141.95 48.77 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.208 0.527 . . . . 0.0 111.62 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' TRP . . . . . 0.635 ' HZ3' ' HB3' ' A' ' 337' ' ' LYS . 24.9 m-90 -111.17 159.54 17.77 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.902 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.37 106.25 6.6 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.428 HG11 ' HA ' ' A' ' 506' ' ' MET . 6.7 m -101.08 142.58 15.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.343 0.592 . . . . 0.0 111.667 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -133.11 100.57 4.91 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.478 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 59.04 67.06 0.96 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.698 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.493 ' HA ' ' O ' ' A' ' 505' ' ' TRP . 4.8 t-20 54.54 43.77 29.77 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -162.54 140.5 8.46 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 26.3 t -91.28 135.04 27.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 24.9 ttt -75.79 151.45 37.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.222 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.94 159.88 32.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.025 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 90.7 2.82 71.94 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' TYR . . . . . 0.566 ' HB3' ' HA ' ' A' ' 354' ' ' PRO . 96.9 m-85 -123.5 162.94 37.46 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.723 -0.239 . . . . 0.0 110.369 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.566 ' HA ' ' HB3' ' A' ' 353' ' ' TYR . 56.6 Cg_endo -70.5 150.94 92.89 Favored 'Cis proline' 0 C--N 1.346 0.412 0 C-N-CA 123.764 -1.348 . . . . 0.0 112.675 -0.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 56.2 ttm -123.29 135.99 26.59 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.66 139.9 88.17 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.45 2.1 . . . . 0.0 110.982 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 77.8 mt -57.14 -45.18 84.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.549 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -70.39 -8.0 61.67 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 121.188 -0.53 . . . . 0.0 114.15 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.61 -24.07 25.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.363 0.581 . . . . 0.0 110.646 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -113.28 -54.4 2.62 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.228 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 68.0 m95 -85.34 79.08 9.62 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.979 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' A' ' 362' ' ' ARG . 37.3 ttp180 -60.37 101.47 0.13 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.241 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 122.42 -13.07 8.89 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.431 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 14.8 tp -90.0 131.41 39.24 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.783 0.325 . . . . 0.0 111.067 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -84.13 -167.18 0.42 Allowed 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.937 2.424 . . . . 0.0 112.478 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -93.27 149.15 21.44 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.825 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 8.3 m 58.34 93.92 0.03 OUTLIER 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 22.0 pt -105.54 172.09 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.57 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -98.95 -52.4 3.57 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.673 0.273 . . . . 0.0 111.583 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . 0.737 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.2 OUTLIER -150.3 165.85 31.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.614 0.245 . . . . 0.0 111.238 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 380' ' ' VAL . . . -152.59 141.44 21.08 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -156.85 153.26 27.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.885 0.374 . . . . 0.0 111.818 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -96.2 115.38 27.34 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -82.01 172.26 13.46 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -58.29 -30.49 66.68 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.902 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -69.03 -5.94 24.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.567 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 76.94 33.73 44.87 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.06 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' LYS . . . . . 0.614 ' HG2' ' HA ' ' A' ' 391' ' ' ASP . 82.3 mttt -126.82 150.43 49.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.675 0.274 . . . . 0.0 110.865 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -94.62 117.37 30.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.082 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 371' ' ' ALA . 10.9 t -102.88 120.73 53.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.427 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -109.71 133.59 52.96 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -112.83 141.51 46.56 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.095 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.644 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 59.6 tttp -149.23 98.78 2.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.758 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 414' ' ' LYS . . . 71.64 -111.09 3.48 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.417 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -111.39 4.99 19.4 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.972 0.415 . . . . 0.0 111.193 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -114.76 152.2 32.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.68 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 36.9 p-80 -135.54 149.57 49.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.582 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' TRP . . . . . 0.644 ' HZ3' ' HB3' ' A' ' 383' ' ' LYS . 21.8 m-90 -124.87 137.1 54.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.708 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 87.7 t -119.75 117.3 53.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.008 0.432 . . . . 0.0 110.624 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -103.33 119.82 39.61 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.593 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.614 ' HA ' ' HG2' ' A' ' 378' ' ' LYS . 14.0 t70 -94.78 102.92 14.81 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 68.25 -72.04 0.1 Allowed 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.684 0.615 . . . . 0.0 111.615 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -153.78 21.8 0.52 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.922 0.391 . . . . 0.0 110.551 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 57.9 m -137.83 132.93 33.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.981 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 30.3 tp -75.41 130.3 38.75 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . 0.494 ' HB2' ' CE1' ' A' ' 399' ' ' TYR . 50.3 mt-10 -56.07 144.11 60.48 Favored Pre-proline 0 C--O 1.234 0.289 0 CA-C-O 120.746 0.307 . . . . 0.0 111.003 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 8.2 Cg_exo -73.19 125.79 10.58 Favored 'Trans proline' 0 CA--C 1.528 0.216 0 C-N-CA 122.81 2.34 . . . . 0.0 111.868 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 114.16 14.32 9.24 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.994 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' TYR . . . . . 0.614 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 38.7 m-85 -109.6 163.28 17.44 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.529 0.165 . . . . 0.0 110.611 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.614 ' HA ' ' HB3' ' A' ' 399' ' ' TYR . 71.7 Cg_endo -76.92 157.88 97.09 Favored 'Cis proline' 0 C--N 1.346 0.398 0 C-N-CA 123.522 -1.449 . . . . 0.0 112.861 0.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -121.13 164.35 17.0 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.071 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 0.567 ' HB3' ' HG2' ' A' ' 404' ' ' LYS . 1.9 m-70 -76.01 149.64 37.53 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 59.7 mt -55.14 -34.1 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 121.285 0.564 . . . . 0.0 110.775 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.567 ' HG2' ' HB3' ' A' ' 402' ' ' HIS . 19.8 pttp -68.34 -12.43 61.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.616 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.43 ' OE2' ' HG3' ' A' ' 404' ' ' LYS . 18.0 mm-40 -86.53 -19.2 29.83 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.065 0.459 . . . . 0.0 110.359 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 40.2 tp -80.39 -39.48 28.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.961 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -160.51 153.79 24.73 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.146 -1.026 . . . . 0.0 113.204 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.52 124.88 31.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.336 -0.432 . . . . 0.0 110.1 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.8 14.63 39.48 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 121.067 -0.587 . . . . 0.0 111.928 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 23.3 mt -89.67 147.29 37.38 Favored Pre-proline 0 C--N 1.322 -0.604 0 O-C-N 122.716 -0.285 . . . . 0.0 111.6 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -52.92 114.24 1.63 Allowed 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.146 2.564 . . . . 0.0 111.637 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.38 33.69 0.89 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.419 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -130.74 -52.67 1.07 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.868 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 384' ' ' GLY . 18.5 ptmt -176.31 172.94 2.2 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.374 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 38.0 mm -124.87 130.82 73.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 464' ' ' ARG . 14.6 m-20 -89.87 -52.52 4.94 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.234 0.54 . . . . 0.0 109.577 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.737 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -140.74 154.08 46.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.052 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -139.84 102.83 4.51 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 45.1 tp -108.04 128.57 54.79 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.829 0.347 . . . . 0.0 111.629 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -99.41 117.09 33.05 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' TRP . . . . . 0.429 ' HB3' ' OD1' ' A' ' 424' ' ' ASN . 8.5 t-105 -87.27 97.75 10.96 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.491 ' HB2' ' HD3' ' A' ' 423' ' ' PRO . 60.8 mtt -56.59 -50.76 85.98 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.491 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 84.7 Cg_exo -49.44 -33.29 29.36 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.717 2.278 . . . . 0.0 114.97 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' ASN . . . . . 0.429 ' OD1' ' HB3' ' A' ' 421' ' ' TRP . 41.5 p30 -111.62 -24.64 9.98 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 85.57 34.51 13.62 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.757 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 55.3 mttt -125.98 154.49 42.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.957 0.378 . . . . 0.0 110.777 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 15.4 m -105.97 135.03 48.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.018 0.437 . . . . 0.0 111.343 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -108.8 112.94 25.48 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.833 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -99.37 126.52 45.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.161 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' PHE . . . . . 0.595 ' HB2' ' HB3' ' A' ' 417' ' ' ALA . 64.4 m-85 -103.58 135.98 44.16 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.941 0.4 . . . . 0.0 111.212 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.406 ' HA ' ' HE ' ' A' ' 431' ' ' ARG . 2.8 tpm_? -146.0 107.01 4.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.863 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 70.11 -104.16 1.29 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.734 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -120.91 7.74 10.43 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.895 0.379 . . . . 0.0 110.683 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 48.9 mttm -120.72 153.2 37.28 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.676 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' TYR . . . . . 0.48 ' CE1' ' HB2' ' A' ' 451' ' ' LYS . 11.7 p90 -130.98 141.18 50.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.933 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -109.95 147.55 33.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.807 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -109.5 99.36 8.58 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -93.63 134.99 35.36 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.207 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -101.35 122.97 44.68 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.53 -31.19 72.3 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -80.81 -37.08 30.75 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 16.0 mt -89.1 -16.86 30.48 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 4.7 mtp-105 57.52 37.94 27.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.392 0.615 . . . . 0.0 111.299 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -153.31 167.53 29.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.329 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 88.5 t -90.1 144.22 9.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.913 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -64.55 153.17 39.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.261 0.553 . . . . 0.0 111.915 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . 0.519 ' O ' ' HB2' ' A' ' 448' ' ' GLU . 1.3 m -64.07 156.05 29.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.7 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 447' ' ' SER . 2.2 mm-40 77.69 -5.59 2.1 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.636 0.585 . . . . 0.0 111.891 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . 0.472 ' HE2' ' CE2' ' A' ' 435' ' ' TYR . 29.5 m-85 -98.41 161.05 26.57 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.361 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.42 160.43 95.32 Favored 'Cis proline' 0 C--O 1.234 0.304 0 C-N-CA 123.617 -1.409 . . . . 0.0 113.474 0.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . 0.497 ' HE2' ' O ' ' A' ' 448' ' ' GLU . 63.5 mmtt -112.46 169.75 8.66 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.563 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -73.03 140.69 47.44 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . 0.492 HG21 ' HG3' ' A' ' 461' ' ' GLU . 15.9 tt -66.69 -13.39 16.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.091 0.472 . . . . 0.0 110.912 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -63.53 -11.08 21.34 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 82.1 t -65.32 -31.26 53.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 29.0 m95 -87.69 87.34 7.35 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -58.42 109.36 0.76 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.888 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 110.04 -14.86 31.21 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.737 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 46.6 mm -88.76 125.93 61.26 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 120.722 0.296 . . . . 0.0 110.537 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.28 160.66 20.17 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.536 2.157 . . . . 0.0 111.704 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 461' ' ' GLU . . . . . 0.492 ' HG3' HG21 ' A' ' 453' ' ' ILE . 3.5 mp0 -71.67 149.52 45.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.096 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 462' ' ' SER . . . . . 0.442 ' N ' ' HD3' ' A' ' 463' ' ' PRO . 2.2 m 54.96 62.14 8.22 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . 0.591 ' O ' ' HB2' ' A' ' 417' ' ' ALA . 35.8 Cg_endo -96.04 100.93 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.966 2.444 . . . . 0.0 110.495 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 416' ' ' ASP . 7.4 ttm180 -77.17 78.24 3.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.225 0.536 . . . . 0.0 111.501 -179.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 149.55 120.22 1.02 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . 0.414 ' OG ' ' HB1' ' A' ' 417' ' ' ALA . 26.2 p -154.88 127.48 7.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.726 0.298 . . . . 0.0 110.791 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 467' ' ' PHE . . . . . 0.486 ' CE2' ' HB2' ' A' ' 476' ' ' TYR . 14.7 p90 -155.22 146.21 22.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.772 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 47.6 ttm -98.07 142.64 29.52 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.933 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -69.5 162.36 52.11 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.065 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.86 0.37 5.89 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.41 -15.34 21.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.922 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 69.11 6.63 5.76 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 123.753 0.658 . . . . 0.0 111.869 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 58.3 t -104.51 -39.4 5.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.931 0.396 . . . . 0.0 111.166 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -110.91 135.49 51.36 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 66.4 m -118.02 137.49 52.85 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.749 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 476' ' ' TYR . . . . . 0.486 ' HB2' ' CE2' ' A' ' 467' ' ' PHE . 82.4 m-85 -113.51 139.88 48.6 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.11 0.481 . . . . 0.0 112.133 -178.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -121.14 148.04 44.75 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.927 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . 0.421 ' CE1' ' HA ' ' A' ' 481' ' ' ASN . 73.0 t80 -127.87 131.5 49.44 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.773 0.32 . . . . 0.0 111.371 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 479' ' ' LYS . . . . . 0.42 ' HB3' ' CZ3' ' A' ' 484' ' ' TRP . 77.7 tttt -157.62 117.06 3.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.513 178.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 61.6 47.7 88.95 Favored Glycine 0 CA--C 1.518 0.241 0 CA-C-N 115.878 -0.601 . . . . 0.0 113.667 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . 0.421 ' HA ' ' CE1' ' A' ' 478' ' ' TYR . 52.0 t30 70.81 -2.94 2.11 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -105.56 142.74 34.78 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -118.65 146.27 44.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.93 0.395 . . . . 0.0 111.587 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 484' ' ' TRP . . . . . 0.438 ' CE2' ' HB3' ' A' ' 498' ' ' PRO . 19.2 m-90 -117.7 148.27 42.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.465 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 54.0 tttt -115.67 105.0 12.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.211 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 486' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -97.1 129.58 44.49 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.679 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -91.45 114.31 26.81 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -63.71 -29.22 70.47 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -178.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -84.68 -11.63 55.5 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -118.76 -14.2 9.53 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 92.2 mt 59.4 36.04 23.17 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.314 0.578 . . . . 0.0 110.45 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 9.9 tttp -149.74 154.75 39.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.893 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 38.8 t -85.1 142.49 13.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -64.13 132.89 95.44 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.621 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.32 151.59 72.97 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.968 2.445 . . . . 0.0 112.363 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 92.6 16.03 50.66 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.208 -0.52 . . . . 0.0 111.977 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . 0.496 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 22.6 m-85 -115.42 166.03 12.96 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.832 -0.184 . . . . 0.0 110.814 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . 0.496 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 66.5 Cg_endo -84.66 176.9 29.77 Favored 'Cis proline' 0 C--N 1.347 0.499 0 C-N-CA 123.827 -1.322 . . . . 0.0 112.94 0.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -133.2 156.54 47.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.057 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 23.0 t -72.07 123.63 23.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.864 0.364 . . . . 0.0 110.843 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -65.21 -27.12 68.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.53 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 502' ' ' LEU . . . . . 0.467 HD23 ' HG3' ' A' ' 506' ' ' MET . 14.0 mt -62.28 -46.54 88.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.662 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -79.39 -40.22 30.63 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.493 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.98 -40.95 37.6 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -177.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 505' ' ' TRP . . . . . 0.493 ' O ' ' HA ' ' A' ' 347' ' ' ASN . 11.8 m0 -110.93 -49.13 3.05 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 506' ' ' MET . . . . . 0.467 ' HG3' HD23 ' A' ' 502' ' ' LEU . 9.4 mmt -64.97 -28.19 69.35 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -177.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 84.74 32.91 20.4 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.162 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 42.8 m -106.67 104.94 53.3 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.77 146.66 48.79 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.767 2.311 . . . . 0.0 111.713 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 8.0 m 54.34 76.82 0.22 Allowed 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.654 0.596 . . . . 0.0 111.031 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.135 0 CA-C-O 118.794 -1.004 . . . . 0.0 112.314 -179.143 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.871 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' PRO . . . . . 0.515 ' HA ' HD23 ' B' ' 2' ' ' HYP . 64.1 Cg_endo -73.31 141.76 32.56 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.673 2.249 . . . . 0.0 112.316 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' HYP . . . . . 0.515 HD23 ' HA ' ' B' ' 1' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' D' ' 201' ' ' PRO . . . -68.86 162.43 51.03 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.986 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.73 166.28 29.67 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.849 2.366 . . . . 0.0 111.126 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.13 -168.38 41.5 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.335 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.56 168.86 23.26 Favored 'Trans proline' 0 CA--C 1.528 0.181 0 C-N-CA 122.905 2.403 . . . . 0.0 111.322 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 134.27 -159.5 23.83 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 119.677 -1.249 . . . . 0.0 113.415 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -74.37 138.12 24.22 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.027 2.485 . . . . 0.0 112.001 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . 0.453 ' HG3' ' HG2' ' C' ' 110' ' ' PRO . 50.2 tt0 -67.18 152.14 46.29 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' D' ' 210' ' ' PRO . . . -57.16 148.58 32.71 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.519 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 18.2 mt -64.02 148.03 11.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.58 141.75 57.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.851 0.358 . . . . 0.0 110.14 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.38 158.99 48.24 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.196 -0.526 . . . . 0.0 113.223 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -67.75 148.5 51.18 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -72.94 146.78 45.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.799 0.333 . . . . 0.0 110.4 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' D' ' 216' ' ' GLN . . . -62.74 157.01 39.02 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.819 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 3.8 t -73.91 152.87 7.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 12.8 t -55.41 142.92 9.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.915 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.98 162.23 48.88 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.859 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.427 ' HA ' HD23 ' B' ' 23' ' ' HYP . 96.0 mt -71.46 148.1 47.18 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.537 0.208 . . . . 0.0 111.165 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' HYP . . . . . 0.427 HD23 ' HA ' ' B' ' 22' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.96 155.81 33.97 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.797 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.51 155.03 50.47 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.711 2.274 . . . . 0.0 111.917 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.09 162.14 53.58 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.24 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.435 ' HA ' HD23 ' B' ' 29' ' ' HYP . 67.5 Cg_endo -74.22 157.59 45.9 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.747 2.298 . . . . 0.0 112.003 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' HYP . . . . . 0.435 HD23 ' HA ' ' B' ' 28' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' D' ' 228' ' ' PRO . . . -76.21 172.08 54.5 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.716 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.402 ' HA ' HD23 ' B' ' 32' ' ' HYP . 22.8 Cg_exo -67.29 161.52 42.7 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 123.289 2.659 . . . . 0.0 111.59 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' HYP . . . . . 0.402 HD23 ' HA ' ' B' ' 31' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.22 160.47 54.06 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.872 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . 0.617 ' HG2' ' HB2' ' D' ' 232' ' ' HYP . 72.0 Cg_endo -76.65 151.08 31.95 Favored 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 122.779 2.319 . . . . 0.0 112.109 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.47 0 CA-C-O 120.323 -0.154 . . . . 0.0 113.189 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 101' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -72.18 156.26 55.59 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.302 2.668 . . . . 0.0 111.735 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 102' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.03 171.32 48.44 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.458 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.81 161.25 21.42 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.984 2.456 . . . . 0.0 112.04 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 105' ' ' HYP . . . . . 0.434 ' OD1' ' HG2' ' D' ' 204' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -73.59 178.63 41.94 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.419 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.2 157.69 33.63 Favored 'Trans proline' 0 C--O 1.223 -0.254 0 C-N-CA 122.745 2.296 . . . . 0.0 110.762 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 108' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -57.61 165.68 6.27 Favored Glycine 0 CA--C 1.52 0.384 0 CA-C-N 115.663 -0.699 . . . . 0.0 113.484 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 110' ' ' PRO . . . . . 0.453 ' HG2' ' HG3' ' B' ' 11' ' ' GLN . 34.4 Cg_endo -64.57 159.93 42.34 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 123.118 2.545 . . . . 0.0 112.324 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 111' ' ' GLN . . . . . 0.405 ' OE1' ' HG2' ' D' ' 210' ' ' PRO . 5.8 tp60 -58.23 136.68 57.35 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.035 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -66.86 160.05 48.43 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.726 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 62.3 mt -72.8 131.21 35.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.55 151.67 28.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.137 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -69.58 155.53 53.36 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.492 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -76.75 157.43 31.67 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -65.22 150.25 48.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.285 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.47 167.34 44.3 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.935 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 21.5 t -67.02 139.38 21.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.572 0.225 . . . . 0.0 110.474 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 28.6 t -64.46 138.18 23.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.372 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.27 159.44 40.97 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.99 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 81.2 mt -79.36 153.67 29.61 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.519 -0.178 . . . . 0.0 110.519 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 123' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -65.83 171.16 27.15 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.889 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 125' ' ' PRO . . . . . 0.442 ' HA ' HD23 ' C' ' 126' ' ' HYP . 60.2 Cg_endo -74.3 147.81 37.75 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.466 2.11 . . . . 0.0 111.906 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 126' ' ' HYP . . . . . 0.442 HD23 ' HA ' ' C' ' 125' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -67.47 159.09 50.62 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.783 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.93 164.58 34.19 Favored 'Trans proline' 0 C--O 1.237 0.465 0 C-N-CA 122.671 2.247 . . . . 0.0 111.58 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -72.7 -172.51 21.34 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.718 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -78.74 148.65 22.8 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.628 2.219 . . . . 0.0 112.099 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 132' ' ' HYP . . . . . 0.693 ' HA ' ' O ' ' D' ' 231' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -62.3 126.28 37.72 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.418 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 134' ' ' PRO . . . . . 0.465 ' HA ' HD23 ' C' ' 135' ' ' HYP . 44.9 Cg_endo -68.52 110.75 2.37 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.195 2.597 . . . . 0.0 112.368 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 135' ' ' HYP . . . . . 0.465 HD23 ' HA ' ' C' ' 134' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.286 0 N-CA-C 112.405 -0.278 . . . . 0.0 112.405 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 201' ' ' PRO . . . . . 0.486 ' HA ' HD23 ' D' ' 202' ' ' HYP . 38.1 Cg_exo -62.8 143.12 91.26 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.869 2.379 . . . . 0.0 111.502 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 202' ' ' HYP . . . . . 0.486 HD23 ' HA ' ' D' ' 201' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 84.89 -176.77 50.89 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.83 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 204' ' ' PRO . . . . . 0.434 ' HG2' ' OD1' ' C' ' 105' ' ' HYP . 19.0 Cg_exo -69.12 161.02 47.54 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 123.823 3.015 . . . . 0.0 112.67 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 205' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . 90.09 178.59 44.53 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.73 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 207' ' ' PRO . . . . . 0.442 ' HA ' HD23 ' D' ' 208' ' ' HYP . 72.7 Cg_endo -97.9 160.49 0.86 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.889 3.059 . . . . 0.0 112.682 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 208' ' ' HYP . . . . . 0.442 HD23 ' HA ' ' D' ' 207' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -79.13 171.81 55.09 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.723 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 210' ' ' PRO . . . . . 0.561 ' O ' ' HA3' ' B' ' 12' ' ' GLY . 50.5 Cg_endo -71.96 155.99 56.81 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.731 2.288 . . . . 0.0 112.014 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -73.22 147.92 44.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.301 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -68.17 158.75 51.89 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.186 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 213' ' ' ILE . . . . . 0.446 ' H ' HG13 ' D' ' 213' ' ' ILE . 20.5 mt -60.05 142.67 15.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.786 0.327 . . . . 0.0 110.948 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -65.26 139.94 58.67 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.582 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -60.37 156.04 31.12 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.11 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 216' ' ' GLN . . . . . 0.488 ' O ' ' HA3' ' B' ' 18' ' ' GLY . 9.5 mm-40 -78.56 159.25 28.24 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -67.75 154.33 41.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.783 0.325 . . . . 0.0 110.784 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -64.47 160.12 40.72 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.913 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 15.9 t -70.02 144.15 14.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 39.3 t -61.55 142.7 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.95 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.84 160.7 37.5 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.757 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 82.1 mt -73.79 153.55 39.93 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.823 -0.189 . . . . 0.0 110.741 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 223' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -59.59 149.4 40.14 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.505 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 225' ' ' PRO . . . . . 0.473 ' HA ' HD23 ' D' ' 226' ' ' HYP . 51.7 Cg_exo -56.03 137.47 79.33 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.841 2.361 . . . . 0.0 111.595 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 226' ' ' HYP . . . . . 0.473 HD23 ' HA ' ' D' ' 225' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -64.92 164.13 36.23 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.939 -0.573 . . . . 0.0 113.971 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 228' ' ' PRO . . . . . 0.409 ' O ' ' HA3' ' B' ' 30' ' ' GLY . 97.3 Cg_endo -89.03 166.03 5.71 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 123.339 2.692 . . . . 0.0 111.339 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -62.94 159.27 36.25 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.896 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 231' ' ' PRO . . . . . 0.693 ' O ' ' HA ' ' C' ' 132' ' ' HYP . 21.3 Cg_exo -66.93 140.38 54.72 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.614 2.209 . . . . 0.0 110.679 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 232' ' ' HYP . . . . . 0.617 ' HB2' ' HG2' ' B' ' 34' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.615 ' HB2' ' HH2' ' A' ' 342' ' ' TRP . 4.3 Cg_exo . . . . . 0 N--CA 1.474 0.361 0 N-CA-C 110.733 -0.526 . . . . 0.0 110.733 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -128.81 154.85 46.03 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.419 HG12 ' HB3' ' A' ' 506' ' ' MET . 11.2 tt -73.65 -19.54 17.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.999 0.428 . . . . 0.0 112.08 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 62.1 m -90.94 1.72 56.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.724 0.297 . . . . 0.0 111.51 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.3 -44.68 74.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.191 0.519 . . . . 0.0 110.451 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . 0.533 ' HA2' HD21 ' A' ' 502' ' ' LEU . . . 93.28 -177.65 38.06 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.096 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 52.59 69.82 0.64 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.299 0.571 . . . . 0.0 111.634 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' PHE . . . . . 0.485 ' HD1' ' HB2' ' A' ' 337' ' ' LYS . 85.0 m-85 -87.24 156.36 19.69 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.682 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -65.35 -41.19 94.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.019 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 5.7 t -173.4 149.88 1.77 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.156 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.452 HG22 HG13 ' A' ' 335' ' ' VAL . 60.7 t -134.24 118.12 26.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -140.17 -172.18 3.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.843 0.354 . . . . 0.0 111.412 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 44.6 ttp -136.96 126.71 25.53 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.824 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 42.5 mt -120.92 119.93 34.01 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.313 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.17 17.82 9.54 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.14 0.576 . . . . 0.0 111.918 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 102.73 -9.2 55.28 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.154 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . 0.5 ' HB3' ' NH1' ' A' ' 343' ' ' ARG . 70.1 mm-40 -99.5 127.69 45.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.637 0.256 . . . . 0.0 110.66 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 44.5 ttm -77.28 137.23 38.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.95 0.405 . . . . 0.0 111.424 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -125.42 117.05 22.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.618 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . 0.452 HG13 HG22 ' A' ' 326' ' ' VAL . 33.3 t -107.7 114.61 46.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -99.15 129.33 45.39 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 0.485 ' HB2' ' HD1' ' A' ' 323' ' ' PHE . 50.9 tptt -139.27 102.47 4.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.774 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 63.33 -99.14 0.07 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.493 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -116.27 -0.56 12.58 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . 0.646 ' HD1' ' HA ' ' A' ' 356' ' ' PRO . 18.3 m0 -119.27 154.86 32.8 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.323 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -129.05 133.98 47.93 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.104 0.478 . . . . 0.0 110.83 178.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' TRP . . . . . 0.615 ' HH2' ' HB2' ' A' ' 316' ' ' PRO . 5.6 m-90 -102.28 153.48 19.95 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.686 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.597 ' HG3' ' CZ ' ' A' ' 353' ' ' TYR . 6.3 mmm180 -129.49 105.77 8.31 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.17 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -102.36 123.99 56.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.738 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -118.57 107.16 13.4 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.01 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 63.45 45.25 4.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.26 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 45.1 t30 66.34 32.54 7.64 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.075 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -139.64 142.8 37.0 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 24.7 t -81.79 130.65 35.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 74.7 mtp -74.97 166.32 23.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.034 0.445 . . . . 0.0 112.073 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -83.75 154.93 23.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.762 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 80.76 26.16 54.45 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.329 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' TYR . . . . . 0.597 ' CZ ' ' HG3' ' A' ' 343' ' ' ARG . 73.4 m-85 -135.22 162.57 56.7 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 122.97 -0.135 . . . . 0.0 110.644 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.583 ' HA ' ' HB3' ' A' ' 353' ' ' TYR . 70.7 Cg_endo -75.23 146.23 85.76 Favored 'Cis proline' 0 C--N 1.346 0.408 0 C-N-CA 123.754 -1.353 . . . . 0.0 112.948 0.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 56.3 ttm -114.57 140.96 25.92 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.188 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . 0.646 ' HA ' ' HD1' ' A' ' 340' ' ' TRP . 32.2 Cg_exo -61.32 140.94 90.99 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.275 1.983 . . . . 0.0 111.02 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 91.8 mt -55.7 -43.95 75.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.225 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -72.02 -6.71 64.85 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 121.052 -0.594 . . . . 0.0 113.434 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.39 -21.53 30.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.239 0.52 . . . . 0.0 110.087 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.496 ' HE2' ' HB3' ' D' ' 211' ' ' GLN . 8.9 t80 -111.6 -55.42 2.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.789 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 65.1 m95 -91.27 83.62 5.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.366 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -63.32 105.35 0.73 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.264 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 116.55 -6.65 18.39 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.552 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.534 HD12 ' HD2' ' A' ' 365' ' ' PRO . 18.3 tp -91.68 131.4 35.92 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.703 0.287 . . . . 0.0 110.596 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' PRO . . . . . 0.534 ' HD2' HD12 ' A' ' 364' ' ' LEU . 86.4 Cg_endo -81.3 170.9 14.34 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.778 2.319 . . . . 0.0 111.371 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -80.59 153.49 28.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.704 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 15.7 m 56.68 84.07 0.09 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 16.8 pt -98.97 -174.07 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -134.29 -24.14 1.63 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . 0.931 ' HB ' ' HB2' ' A' ' 382' ' ' PHE . 4.8 m -141.83 145.92 35.25 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.555 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -153.58 131.46 11.67 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -163.53 165.28 23.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.888 0.375 . . . . 0.0 111.496 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -94.23 141.63 28.34 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . 0.534 ' HB2' ' OE2' ' A' ' 440' ' ' GLU . 12.2 ptm180 -97.2 -169.4 1.85 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.385 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 34.9 tttt -69.39 -34.43 74.51 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.645 0.979 . . . . 0.0 113.645 -177.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 44.7 p30 -83.02 -10.37 58.79 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 107.83 -6.2 35.12 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.669 -0.776 . . . . 0.0 113.241 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 17.4 mttp -76.54 164.24 26.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.906 0.353 . . . . 0.0 110.879 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -107.82 123.32 48.4 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -178.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 12.2 t -105.98 119.82 55.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.036 0.446 . . . . 0.0 110.446 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -106.18 143.38 34.38 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.508 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.931 ' HB2' ' HB ' ' A' ' 370' ' ' THR . 23.2 m-85 -124.1 138.26 54.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.069 0.461 . . . . 0.0 111.897 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -150.69 98.24 2.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.78 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 77.58 -111.94 3.38 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.618 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 402' ' ' HIS . 4.3 p-10 -113.09 6.9 17.81 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.685 0.278 . . . . 0.0 111.345 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -114.61 148.97 37.33 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.514 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -128.86 146.0 51.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.218 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' TRP . . . . . 0.407 ' CE2' ' HB3' ' A' ' 400' ' ' PRO . 16.4 m-90 -120.21 131.75 55.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.09 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 99.2 t -115.52 110.44 31.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.059 0.456 . . . . 0.0 109.972 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -102.68 128.18 49.49 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.613 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -99.35 103.15 14.94 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 71.89 -53.36 0.69 Allowed 'General case' 0 N--CA 1.469 0.519 0 O-C-N 123.663 0.602 . . . . 0.0 111.298 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -166.27 -29.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.844 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.37 138.8 32.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.814 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 27.9 tp -78.29 139.84 38.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.803 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 3.3 mt-10 -67.21 140.75 95.72 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.443 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 21.6 Cg_exo -67.77 147.4 75.22 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.715 2.276 . . . . 0.0 111.238 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 89.18 15.04 59.55 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.718 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' TYR . . . . . 0.502 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 50.1 m-85 -117.99 162.58 28.77 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.502 ' HA ' ' HB3' ' A' ' 399' ' ' TYR . 84.0 Cg_endo -76.74 164.44 87.43 Favored 'Cis proline' 0 C--N 1.345 0.375 0 C-N-CA 123.634 -1.402 . . . . 0.0 113.306 0.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . 0.402 ' HD3' ' HB3' ' A' ' 405' ' ' GLU . 39.3 mttp -130.68 163.41 27.29 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.167 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 0.585 ' HB2' ' HG2' ' A' ' 404' ' ' LYS . 4.6 m80 -73.22 159.87 32.8 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 33.0 mt -59.61 -31.78 47.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.344 0.592 . . . . 0.0 110.222 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.585 ' HG2' ' HB2' ' A' ' 402' ' ' HIS . 20.4 pttp -69.38 -12.03 61.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.183 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.402 ' HB3' ' HD3' ' A' ' 401' ' ' LYS . 10.2 mm-40 -85.58 -21.95 28.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.971 0.415 . . . . 0.0 111.253 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 47.8 tp -76.51 -53.95 7.38 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.126 0.488 . . . . 0.0 110.25 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.466 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -151.54 157.64 27.32 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.127 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 38.2 ttt180 -86.68 130.18 34.58 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.798 0.333 . . . . 0.0 110.676 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 106.34 -5.93 38.78 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.797 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 66.7 mt -76.98 151.44 81.94 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 120.633 0.254 . . . . 0.0 111.235 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.27 131.44 44.96 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.907 2.404 . . . . 0.0 111.633 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.74 -7.45 33.83 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.848 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -87.12 -56.59 3.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.197 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . 0.477 ' O ' ' HD2' ' A' ' 431' ' ' ARG . 8.4 ptmt -175.42 173.74 2.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.955 0.407 . . . . 0.0 111.224 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 34.6 mm -125.4 130.67 72.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.341 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -89.11 -41.95 11.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.165 0.507 . . . . 0.0 110.532 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -163.64 164.4 24.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.903 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -148.73 127.25 12.36 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.434 HD11 ' HB2' ' A' ' 468' ' ' MET . 24.9 tp -118.47 119.83 35.74 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.06 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -87.81 113.91 23.93 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' TRP . . . . . 0.507 ' HB3' ' OD1' ' A' ' 424' ' ' ASN . 4.2 t-105 -81.81 96.36 7.58 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.414 ' HB2' ' HD3' ' A' ' 423' ' ' PRO . 58.2 mtt -52.09 -51.21 73.62 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 86.5 Cg_exo -49.29 -57.25 2.47 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.681 2.254 . . . . 0.0 114.383 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' ASN . . . . . 0.507 ' OD1' ' HB3' ' A' ' 421' ' ' TRP . 37.1 p30 -84.29 -24.72 29.75 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 82.92 37.44 13.03 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 121.009 -0.615 . . . . 0.0 113.438 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -128.08 150.39 49.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 117.031 0.416 . . . . 0.0 110.913 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 2.0 m -101.04 127.01 47.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.035 0.445 . . . . 0.0 111.753 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -101.85 111.62 23.94 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.556 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . 0.408 ' HB2' ' HB2' ' A' ' 436' ' ' TYR . 69.3 m-85 -94.45 137.42 33.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.124 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -113.08 129.89 56.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.003 0.43 . . . . 0.0 111.321 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.477 ' HD2' ' O ' ' A' ' 414' ' ' LYS . 2.8 tpm_? -141.26 105.01 4.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.23 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 67.47 -108.88 2.62 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.073 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -114.39 13.09 17.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.835 0.35 . . . . 0.0 110.763 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . 0.524 ' HD3' ' HG2' ' A' ' 450' ' ' PRO . 97.2 mttt -123.62 151.46 42.98 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.276 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' TYR . . . . . 0.476 ' CE1' ' HB2' ' A' ' 451' ' ' LYS . 9.0 p90 -126.95 138.92 53.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.435 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' TYR . . . . . 0.408 ' HB2' ' HB2' ' A' ' 429' ' ' PHE . 9.5 m-85 -110.58 143.78 40.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.716 -178.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -109.35 99.5 8.74 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . 0.466 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 75.4 t80 -92.25 132.55 36.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.521 -178.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -106.8 113.38 26.83 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.621 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' GLU . . . . . 0.534 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 3.3 mm-40 -50.89 -52.43 41.93 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 -64.89 -14.35 59.43 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -178.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 47.9 mt -113.86 -7.77 13.18 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 47.3 40.67 10.92 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.599 0.714 . . . . 0.0 112.472 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -154.73 171.32 19.75 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.505 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.5 t -96.81 142.8 13.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.278 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.55 153.0 10.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.64 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 11.1 m -70.48 155.26 40.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.365 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 71.41 26.97 3.18 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.483 0.658 . . . . 0.0 110.918 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -123.72 164.47 28.64 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.094 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . 0.524 ' HG2' ' HD3' ' A' ' 434' ' ' LYS . 86.5 Cg_endo -79.85 155.68 88.2 Favored 'Cis proline' 0 C--N 1.344 0.34 0 C-N-CA 123.637 -1.401 . . . . 0.0 112.631 0.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . 0.476 ' HB2' ' CE1' ' A' ' 435' ' ' TYR . 64.6 mttm -106.78 171.84 7.14 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.853 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . 0.464 ' O ' HG23 ' A' ' 455' ' ' VAL . 18.3 t-20 -68.85 136.93 53.44 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.556 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 12.9 tt -67.72 -15.73 20.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.079 0.466 . . . . 0.0 111.381 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -67.07 -2.3 5.33 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 455' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 452' ' ' ASN . 71.6 t -62.62 -34.96 68.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 456' ' ' TRP . . . . . 0.474 ' HZ3' HD11 ' A' ' 491' ' ' LEU . 14.0 m95 -88.34 90.05 8.24 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -53.02 114.62 1.51 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.606 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . 0.403 ' HA3' ' HB ' ' A' ' 493' ' ' VAL . . . 113.25 -15.96 22.57 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.347 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 460' ' ' PRO . 45.8 mm -89.68 117.61 68.29 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.694 0.283 . . . . 0.0 111.083 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 459' ' ' ILE . 4.9 Cg_exo -79.2 153.24 24.49 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 123.088 2.525 . . . . 0.0 111.374 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -67.54 149.6 49.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.601 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.3 m 60.58 78.08 0.34 Allowed Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -88.05 -174.98 1.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.966 2.444 . . . . 0.0 111.481 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.79 9.6 3.34 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.108 0.48 . . . . 0.0 110.856 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 169.94 141.83 3.38 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 6.3 p -152.73 106.15 3.04 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -128.26 142.15 51.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.057 0.456 . . . . 0.0 111.605 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 468' ' ' MET . . . . . 0.434 ' HB2' HD11 ' A' ' 419' ' ' LEU . 47.9 ttm -95.44 134.63 38.05 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.556 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -67.08 163.22 45.39 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.018 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 1.4 m -66.46 -7.33 18.82 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.911 0.386 . . . . 0.0 111.346 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -84.94 -15.09 45.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.069 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 65.77 6.76 4.11 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 46.6 t -109.62 -40.09 4.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.738 0.304 . . . . 0.0 111.362 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -105.02 123.0 47.04 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 90.9 m -111.16 138.06 48.08 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -113.4 128.3 56.41 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -110.22 125.92 53.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.298 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -106.25 136.33 46.16 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 479' ' ' LYS . . . . . 0.519 ' HB3' ' CZ3' ' A' ' 484' ' ' TRP . 78.6 tttt -158.19 102.89 1.8 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.814 0.34 . . . . 0.0 111.89 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 57.63 72.33 0.61 Allowed Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 114.823 0.689 . . . . 0.0 114.823 178.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 69.62 -24.87 0.15 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -104.32 156.05 18.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.885 0.374 . . . . 0.0 111.63 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 483' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -133.29 147.04 51.89 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.107 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 484' ' ' TRP . . . . . 0.519 ' CZ3' ' HB3' ' A' ' 479' ' ' LYS . 10.5 m-90 -109.93 148.27 31.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.782 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -107.23 97.13 6.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.823 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 486' ' ' PHE . . . . . 0.409 ' CE1' ' HB3' ' A' ' 456' ' ' TRP . 88.1 t80 -91.61 124.81 36.04 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.973 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -92.52 117.36 29.86 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -68.15 -32.15 72.22 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -76.4 -26.44 55.56 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -102.92 -15.98 16.0 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.423 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.474 HD11 ' HZ3' ' A' ' 456' ' ' TRP . 4.1 tp 60.09 39.28 19.85 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.565 0.698 . . . . 0.0 110.641 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 31.2 tttp -159.31 149.19 18.85 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.255 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . 0.403 ' HB ' ' HA3' ' A' ' 458' ' ' GLY . 54.9 t -73.03 134.76 29.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.114 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -70.55 146.97 94.51 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.286 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.4 160.25 40.13 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.938 2.425 . . . . 0.0 112.781 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 87.21 17.25 59.4 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . 0.536 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 20.5 m-85 -128.4 166.82 21.72 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.431 -0.385 . . . . 0.0 110.39 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . 0.536 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 72.0 Cg_endo -74.5 167.94 78.51 Favored 'Cis proline' 0 C--N 1.346 0.425 0 C-N-CA 123.857 -1.309 . . . . 0.0 113.102 0.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -121.99 164.94 16.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.155 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 22.5 t -77.56 109.35 11.44 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.94 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -68.46 -25.37 64.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.988 0.423 . . . . 0.0 110.429 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 502' ' ' LEU . . . . . 0.533 HD21 ' HA2' ' A' ' 321' ' ' GLY . 74.1 mt -65.57 -26.74 67.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.747 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 503' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 503' ' ' ARG . 30.2 ttm105 -99.74 -40.82 7.56 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.091 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.96 -23.57 36.03 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -177.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -114.1 -48.09 2.91 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 506' ' ' MET . . . . . 0.419 ' HB3' HG12 ' A' ' 318' ' ' ILE . 11.5 mmt -77.53 -26.52 51.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.026 -178.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 83.15 26.42 44.37 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.208 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 60.4 m -98.21 110.42 56.12 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-O 120.719 0.295 . . . . 0.0 110.698 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.07 175.71 10.61 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.895 2.396 . . . . 0.0 112.07 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 6.9 m 66.55 15.63 10.17 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 CA-C-O 118.163 -1.354 . . . . 0.0 110.929 179.833 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.8 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' PRO . . . . . 0.464 ' HA ' HD23 ' B' ' 2' ' ' HYP . 59.6 Cg_endo -71.89 140.37 34.99 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.503 2.135 . . . . 0.0 111.903 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' HYP . . . . . 0.464 HD23 ' HA ' ' B' ' 1' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.35 171.65 51.13 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.439 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -81.33 176.63 8.52 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.967 2.444 . . . . 0.0 110.331 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.65 -160.5 20.31 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.35 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.612 ' HD2' ' HA ' ' D' ' 205' ' ' HYP . 51.1 Cg_exo -57.27 164.72 6.41 Favored 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 122.961 2.441 . . . . 0.0 111.183 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' HYP . . . . . 0.505 ' O ' ' HA3' ' D' ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.35 152.47 7.66 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.712 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -58.07 135.4 68.3 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.804 2.336 . . . . 0.0 111.735 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . 0.419 ' HG3' ' HG2' ' C' ' 110' ' ' PRO . 62.0 tt0 -61.28 147.0 46.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.611 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' D' ' 210' ' ' PRO . . . -62.23 153.48 42.51 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.261 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.491 ' H ' HG13 ' B' ' 13' ' ' ILE . 2.4 mt -67.0 150.63 11.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 122.669 0.388 . . . . 0.0 110.577 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.21 145.39 49.68 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.29 156.04 50.91 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.766 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -66.25 141.72 57.93 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.456 ' HG3' ' HB3' ' C' ' 116' ' ' GLN . 15.1 ttt180 -65.61 148.5 51.64 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.656 0.265 . . . . 0.0 110.967 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' D' ' 216' ' ' GLN . . . -61.78 150.56 45.34 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 116.001 -0.545 . . . . 0.0 113.447 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.41 ' HB ' ' HG2' ' D' ' 217' ' ' ARG . 8.2 t -65.9 147.53 12.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.684 -0.258 . . . . 0.0 110.513 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 6.6 t -53.42 145.1 3.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.401 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.25 165.41 46.38 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.243 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.43 ' HA ' HD23 ' B' ' 23' ' ' HYP . 69.2 mt -84.92 149.89 25.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.793 -0.204 . . . . 0.0 110.969 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' HYP . . . . . 0.43 HD23 ' HA ' ' B' ' 22' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -72.58 164.77 54.65 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.411 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.406 ' HA ' HD23 ' B' ' 26' ' ' HYP . 57.0 Cg_endo -70.74 152.9 64.62 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.54 2.16 . . . . 0.0 111.668 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' HYP . . . . . 0.406 HD23 ' HA ' ' B' ' 25' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.19 153.1 44.51 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.824 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.33 162.17 42.32 Favored 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 122.944 2.429 . . . . 0.0 111.823 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.16 171.46 53.98 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.302 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -65.24 158.21 53.47 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 123.134 2.556 . . . . 0.0 112.076 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . 0.465 ' HA2' ' HD3' ' B' ' 34' ' ' PRO . . . -69.07 139.63 32.88 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.787 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . 0.465 ' HD3' ' HA2' ' B' ' 33' ' ' GLY . 16.4 Cg_exo -70.3 144.63 51.72 Favored 'Trans proline' 0 CA--C 1.529 0.251 0 C-N-CA 122.766 2.311 . . . . 0.0 110.909 179.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 100' ' ' GLY . . . . . 0.451 ' HA3' ' HD3' ' C' ' 101' ' ' PRO . . . . . . . . 0 N--CA 1.448 -0.507 0 N-CA-C 112.278 -0.329 . . . . 0.0 112.278 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 101' ' ' PRO . . . . . 0.451 ' HD3' ' HA3' ' C' ' 100' ' ' GLY . 6.9 Cg_exo -75.05 150.46 37.97 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 123.211 2.608 . . . . 0.0 111.738 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 102' ' ' HYP . . . . . 0.402 HD23 ' HA ' ' C' ' 101' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.79 175.9 54.11 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.559 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -85.88 161.95 10.44 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.114 2.543 . . . . 0.0 112.361 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 105' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -71.13 173.48 42.5 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.565 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 107' ' ' PRO . . . . . 0.403 ' HA ' HD23 ' C' ' 108' ' ' HYP . 73.0 Cg_endo -75.12 150.5 37.75 Favored 'Trans proline' 0 CA--C 1.528 0.185 0 C-N-CA 122.674 2.249 . . . . 0.0 111.549 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 108' ' ' HYP . . . . . 0.403 HD23 ' HA ' ' C' ' 107' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -57.9 163.33 8.44 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-N 115.662 -0.699 . . . . 0.0 113.687 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 110' ' ' PRO . . . . . 0.419 ' HG2' ' HG3' ' B' ' 11' ' ' GLN . 28.5 Cg_endo -62.44 150.04 88.78 Favored 'Trans proline' 0 C--O 1.237 0.425 0 C-N-CA 122.883 2.388 . . . . 0.0 112.524 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -55.84 134.72 52.02 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.951 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -61.23 160.77 26.74 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.799 -0.637 . . . . 0.0 113.277 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 53.4 mt -74.03 138.43 21.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 120.755 0.312 . . . . 0.0 110.231 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.19 146.39 55.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.899 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -63.79 156.08 44.04 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.448 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 116' ' ' GLN . . . . . 0.456 ' HB3' ' HG3' ' B' ' 17' ' ' ARG . 7.8 tt0 -75.04 159.06 32.19 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.64 0.257 . . . . 0.0 110.577 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 14.6 ttm-85 -68.72 146.65 52.76 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.67 168.21 36.2 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.024 -0.608 . . . . 0.0 113.158 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 4.3 t -75.51 144.98 11.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 92.6 t -61.57 139.11 21.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.516 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.28 167.3 40.15 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.701 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 122' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' C' ' 123' ' ' HYP . 82.5 mt -76.9 142.24 40.22 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.478 0.18 . . . . 0.0 111.033 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 123' ' ' HYP . . . . . 0.457 HD23 ' HA ' ' C' ' 122' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -68.63 169.2 41.84 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.75 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -75.51 158.37 40.25 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.685 2.257 . . . . 0.0 111.592 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 126' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.75 163.76 32.17 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.913 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -80.29 162.14 22.7 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.673 2.249 . . . . 0.0 111.427 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -66.89 177.09 19.85 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.972 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.47 147.97 90.58 Favored 'Trans proline' 0 C--O 1.237 0.454 0 C-N-CA 122.739 2.293 . . . . 0.0 111.868 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 132' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -62.18 129.04 42.88 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.072 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 134' ' ' PRO . . . . . 0.461 ' HA ' HD23 ' C' ' 135' ' ' HYP . 59.0 Cg_endo -75.4 110.98 3.21 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.65 2.234 . . . . 0.0 111.78 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 135' ' ' HYP . . . . . 0.461 HD23 ' HA ' ' C' ' 134' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 112.173 -0.371 . . . . 0.0 112.173 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' D' D ' 201' ' ' PRO . . . . . 0.46 ' HA ' HD23 ' D' ' 202' ' ' HYP . 43.7 Cg_exo -58.19 142.9 97.51 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.935 2.423 . . . . 0.0 111.743 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 202' ' ' HYP . . . . . 0.46 HD23 ' HA ' ' D' ' 201' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 99.75 -160.62 19.54 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.344 178.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 204' ' ' PRO . . . . . 0.4 ' HA ' HD23 ' D' ' 205' ' ' HYP . 13.8 Cg_exo -70.82 157.35 58.56 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 123.551 2.834 . . . . 0.0 112.824 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 205' ' ' HYP . . . . . 0.612 ' HA ' ' HD2' ' B' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 206' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' B' ' 8' ' ' HYP . . . 88.05 164.32 40.1 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.394 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -90.98 148.17 3.8 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.743 2.962 . . . . 0.0 112.137 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 208' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -72.2 167.84 52.74 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.887 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 210' ' ' PRO . . . . . 0.408 ' O ' ' HA3' ' B' ' 12' ' ' GLY . 37.2 Cg_endo -66.6 160.0 48.19 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.785 2.323 . . . . 0.0 112.456 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 211' ' ' GLN . . . . . 0.496 ' HB3' ' HE2' ' A' ' 360' ' ' PHE . 62.5 tt0 -77.22 143.87 38.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.416 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -65.57 158.76 46.2 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.683 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 38.3 pt -67.01 151.42 10.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.893 0.377 . . . . 0.0 111.033 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -66.81 149.37 50.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.917 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -67.49 172.04 32.25 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 116.05 -0.523 . . . . 0.0 113.285 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 216' ' ' GLN . . . . . 0.481 ' O ' ' HA3' ' B' ' 18' ' ' GLY . 51.3 mm-40 -87.95 154.32 20.6 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 217' ' ' ARG . . . . . 0.41 ' HG2' ' HB ' ' B' ' 19' ' ' VAL . 27.5 mtp180 -62.88 151.98 37.64 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.763 0.316 . . . . 0.0 111.191 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -64.23 156.81 44.53 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.324 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 6.4 t -67.43 147.2 12.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 50.5 t -63.71 143.01 16.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.98 162.05 23.27 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.225 -0.512 . . . . 0.0 112.687 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 5.9 mp -75.3 154.02 37.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.872 -0.164 . . . . 0.0 110.914 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 223' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -59.26 150.67 36.81 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.674 -0.694 . . . . 0.0 113.055 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 225' ' ' PRO . . . . . 0.435 ' HA ' HD23 ' D' ' 226' ' ' HYP . 52.0 Cg_exo -55.43 139.72 82.12 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 123.208 2.605 . . . . 0.0 111.843 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 226' ' ' HYP . . . . . 0.435 HD23 ' HA ' ' D' ' 225' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -64.6 158.39 43.65 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.369 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -83.42 162.37 14.9 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.897 2.398 . . . . 0.0 111.362 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -66.53 164.52 41.71 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.799 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 231' ' ' PRO . . . . . 0.46 ' HA ' HD23 ' D' ' 232' ' ' HYP . 91.3 Cg_endo -83.36 145.24 11.9 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.577 2.185 . . . . 0.0 111.195 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 232' ' ' HYP . . . . . 0.46 HD23 ' HA ' ' D' ' 231' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo . . . . . 0 N--CA 1.477 0.508 0 N-CA-C 109.776 -0.894 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -119.84 155.51 32.47 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 10.5 tt -69.84 -17.93 21.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.007 0.432 . . . . 0.0 111.517 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 61.3 m -88.94 3.7 50.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.243 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -72.66 -38.71 67.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.016 0.436 . . . . 0.0 110.747 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . 0.465 ' O ' ' HE2' ' A' ' 337' ' ' LYS . . . 80.5 -164.85 47.61 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.309 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 51.51 56.18 8.29 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.211 0.529 . . . . 0.0 110.877 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -79.31 160.46 26.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.412 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -73.17 -36.25 66.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.897 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 8.9 t -177.62 149.22 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.207 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.507 HG22 HG13 ' A' ' 335' ' ' VAL . 91.4 t -129.4 124.19 59.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -148.6 -176.32 5.27 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.942 0.401 . . . . 0.0 111.299 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 24.3 ttp -128.89 133.88 48.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.801 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 79.7 mt -125.91 111.24 14.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.376 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.773 ' HG3' ' HE1' ' A' ' 379' ' ' PHE . 60.7 mtp180 58.24 33.06 22.79 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 102.82 -32.86 7.09 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.334 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -81.92 135.81 35.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.807 0.304 . . . . 0.0 111.24 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 44.9 ttm -90.54 124.53 35.09 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -114.49 129.85 56.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.091 0.472 . . . . 0.0 111.809 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . 0.507 HG13 HG22 ' A' ' 326' ' ' VAL . 13.7 t -114.56 128.45 71.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -109.63 139.46 44.63 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 0.465 ' HE2' ' O ' ' A' ' 321' ' ' GLY . 12.8 tptp -144.23 100.07 3.49 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.63 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 60.27 -104.46 0.19 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.13 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -110.47 8.77 23.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.588 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 15.3 m-90 -122.43 157.8 31.11 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -139.01 148.24 43.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.013 0.435 . . . . 0.0 111.351 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' TRP . . . . . . . . . . . . . 4.2 m-90 -120.29 160.52 22.84 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.008 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.32 108.81 6.53 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 2.3 m -97.02 139.31 19.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.407 0.622 . . . . 0.0 111.96 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . 0.407 ' HD3' ' HA ' ' A' ' 345' ' ' ARG . 7.6 mmt180 -138.87 111.96 7.96 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.943 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 62.87 46.5 4.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.585 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 48.5 t30 63.81 27.56 14.61 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.758 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . 0.483 HE21 ' HB2' ' A' ' 348' ' ' GLN . 10.1 mt-30 -136.28 142.81 43.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.359 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 21.9 t -90.13 124.11 42.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 49.6 mtp -70.41 157.22 38.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.704 0.288 . . . . 0.0 111.035 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.32 158.76 34.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.024 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 95.16 -2.78 66.1 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.456 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' TYR . . . . . 0.416 ' HB3' ' HA ' ' A' ' 354' ' ' PRO . 70.1 m-85 -118.17 156.25 50.72 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.416 ' HA ' ' HB3' ' A' ' 353' ' ' TYR . 57.0 Cg_endo -71.07 137.6 47.74 Favored 'Cis proline' 0 C--N 1.345 0.389 0 C-N-CA 123.504 -1.457 . . . . 0.0 112.536 0.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . 0.413 ' HA ' ' HD3' ' A' ' 356' ' ' PRO . 59.6 ttm -114.69 135.56 22.36 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.422 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 355' ' ' MET . 47.2 Cg_exo -58.86 138.0 83.16 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.369 2.046 . . . . 0.0 111.08 178.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' ILE . . . . . 0.403 HG23 ' HD1' ' A' ' 361' ' ' TRP . 74.3 mt -52.27 -40.36 30.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.257 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -66.55 -12.66 59.4 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 121.087 -0.577 . . . . 0.0 114.255 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -79.94 -17.37 53.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.037 0.419 . . . . 0.0 111.541 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -126.82 -55.36 1.39 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.006 0.432 . . . . 0.0 110.453 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' TRP . . . . . 0.403 ' HD1' HG23 ' A' ' 357' ' ' ILE . 48.4 m95 -86.99 76.82 9.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.319 0.581 . . . . 0.0 110.136 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -65.72 94.74 0.21 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.491 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 129.47 -12.68 5.97 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.162 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 365' ' ' PRO . 21.3 tp -88.81 127.5 55.83 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.805 0.336 . . . . 0.0 111.117 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 364' ' ' LEU . 3.3 Cg_exo -78.81 167.89 21.68 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.096 2.531 . . . . 0.0 111.793 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -73.18 152.86 40.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.223 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 5.7 m 57.65 86.88 0.07 Allowed 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 22.9 pt -95.44 179.97 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.329 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.36 -45.3 4.12 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 121.146 -0.222 . . . . 0.0 111.525 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . 0.771 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.0 OUTLIER -158.73 172.32 18.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.969 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -162.67 138.04 6.97 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . 0.454 ' CE1' ' HB ' ' A' ' 380' ' ' VAL . 11.2 p90 -150.47 162.29 40.87 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -96.78 117.69 31.6 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . 0.593 HH21 ' HB3' ' A' ' 440' ' ' GLU . 7.6 ptm180 -87.62 175.95 7.67 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -66.69 -16.97 64.6 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.616 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.22 -26.78 30.47 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.7 0.286 . . . . 0.0 111.675 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 114.87 -9.03 21.43 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.689 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' LYS . . . . . 0.525 ' HG2' ' HA ' ' A' ' 391' ' ' ASP . 76.6 mttt -94.98 164.88 12.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.908 0.385 . . . . 0.0 111.427 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . 0.773 ' HE1' ' HG3' ' A' ' 330' ' ' ARG . 10.9 m-85 -99.0 127.38 44.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.591 -179.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . 0.454 ' HB ' ' CE1' ' A' ' 372' ' ' TYR . 15.7 t -107.57 113.6 44.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.126 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . 0.402 ' HB2' ' HB2' ' A' ' 388' ' ' TRP . 61.9 m-85 -99.27 145.1 27.64 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.803 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -124.79 143.55 50.74 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.419 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.648 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 44.3 tttp -155.21 99.28 2.07 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 414' ' ' LYS . . . 75.08 -105.6 1.93 Allowed Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.539 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -119.42 7.74 11.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.937 0.399 . . . . 0.0 110.87 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -114.44 152.74 31.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.959 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -132.47 150.49 52.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.645 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' TRP . . . . . 0.648 ' HZ3' ' HB3' ' A' ' 383' ' ' LYS . 24.6 m-90 -127.53 138.96 53.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.105 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 75.3 t -117.38 115.67 49.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -106.49 126.04 51.76 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.525 ' HA ' ' HG2' ' A' ' 378' ' ' LYS . 21.2 t70 -91.88 84.68 5.4 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 177.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 69.85 -64.15 0.36 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.316 -178.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -145.51 -3.93 0.7 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 11.6 m -111.43 135.39 52.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.711 0.291 . . . . 0.0 111.284 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 62.3 tp -81.07 138.96 35.95 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.129 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 2.2 mm-40 -65.39 146.71 98.93 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.63 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 24.7 Cg_exo -65.48 148.11 87.47 Favored 'Trans proline' 0 C--O 1.238 0.496 0 C-N-CA 123.036 2.491 . . . . 0.0 112.663 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 73.19 45.08 32.65 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.626 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -128.25 159.04 69.27 Favored Pre-proline 0 C--N 1.321 -0.649 0 O-C-N 122.859 -0.201 . . . . 0.0 110.811 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.6 ' HB3' ' CE2' ' A' ' 388' ' ' TRP . 92.2 Cg_endo -77.6 156.61 95.78 Favored 'Cis proline' 0 C--O 1.236 0.397 0 C-N-CA 123.568 -1.43 . . . . 0.0 113.577 0.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -112.58 156.48 22.59 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 0.425 ' HB2' ' HG2' ' A' ' 405' ' ' GLU . 19.1 m-70 -72.11 156.96 38.62 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 78.2 mt -57.33 -39.28 67.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.943 0.401 . . . . 0.0 111.087 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -69.58 -7.53 39.44 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.425 ' HG2' ' HB2' ' A' ' 402' ' ' HIS . 10.8 mm-40 -87.32 -15.04 39.15 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 48.8 tp -86.36 -36.83 18.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.888 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.689 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -169.65 156.09 26.7 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.731 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -90.65 136.14 33.25 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.722 0.296 . . . . 0.0 110.75 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 102.18 4.83 50.39 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.426 -0.669 . . . . 0.0 111.426 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 88.9 mt -89.79 148.51 40.04 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 120.47 0.176 . . . . 0.0 111.014 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -58.0 119.24 6.37 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.696 2.264 . . . . 0.0 111.075 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.96 7.37 31.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.58 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -99.2 -54.99 2.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.82 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 384' ' ' GLY . 15.6 ptmt -175.53 169.69 3.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.561 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.448 HD12 ' HD2' ' A' ' 429' ' ' PHE . 46.2 mm -121.82 126.23 74.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . 0.424 ' HB3' ' HD2' ' A' ' 463' ' ' PRO . 15.4 m-20 -82.38 -43.7 17.04 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.895 0.378 . . . . 0.0 110.698 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.771 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -157.65 154.8 28.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.301 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -134.83 119.32 17.99 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 42.0 tp -115.17 117.97 32.03 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.872 0.368 . . . . 0.0 111.778 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -91.24 118.25 30.31 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.208 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' TRP . . . . . 0.731 ' HB2' ' HE2' ' A' ' 428' ' ' TYR . 15.6 t-105 -87.67 99.02 11.76 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.486 ' HB2' ' HD3' ' A' ' 423' ' ' PRO . 63.3 mtt -52.44 -52.57 62.12 Favored Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.486 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 86.6 Cg_exo -48.23 -40.34 35.01 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.898 2.399 . . . . 0.0 114.913 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' ASN . . . . . 0.514 ' OD1' ' HB3' ' A' ' 421' ' ' TRP . 39.6 p30 -103.09 -28.79 11.75 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 88.24 29.49 19.65 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.612 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -122.29 141.61 51.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.833 0.349 . . . . 0.0 110.589 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 60.1 m -103.17 130.03 50.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.419 0.628 . . . . 0.0 111.646 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' TYR . . . . . 0.731 ' HE2' ' HB2' ' A' ' 421' ' ' TRP . 65.7 m-85 -98.64 122.79 42.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.839 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . 0.448 ' HD2' HD12 ' A' ' 415' ' ' ILE . 43.1 m-85 -98.54 121.73 40.84 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.653 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -98.6 132.31 44.11 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.473 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.404 ' HD2' ' O ' ' A' ' 414' ' ' LYS . 3.4 tpm_? -145.07 107.14 4.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.205 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 69.71 -117.41 7.58 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' ASN . . . . . 0.51 ' HA ' ' HB3' ' A' ' 461' ' ' GLU . 24.6 p-10 -113.22 16.28 19.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.258 0.551 . . . . 0.0 110.712 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -125.89 150.51 47.86 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.366 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' TYR . . . . . 0.492 ' CE1' ' HB2' ' A' ' 451' ' ' LYS . 6.7 p90 -129.85 142.7 50.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.063 0.459 . . . . 0.0 111.457 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' TYR . . . . . 0.747 ' HD1' HG11 ' A' ' 445' ' ' VAL . 53.5 m-85 -109.09 147.57 32.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.428 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -107.14 94.74 5.26 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . 0.689 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 71.8 t80 -81.49 119.59 23.93 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.414 0.626 . . . . 0.0 112.068 -178.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -86.33 94.93 9.48 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' GLU . . . . . 0.593 ' HB3' HH21 ' A' ' 374' ' ' ARG . 8.8 mt-10 -54.8 -30.74 57.83 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -82.89 -10.74 58.68 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 50.3 mt -119.28 -12.41 9.42 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 52.9 mtm180 61.24 44.39 9.88 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.443 0.639 . . . . 0.0 111.858 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -163.24 154.95 17.52 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.769 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . 0.747 HG11 ' HD1' ' A' ' 436' ' ' TYR . 93.9 t -80.99 137.56 21.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.048 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -62.79 163.47 9.34 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.306 0.574 . . . . 0.0 111.883 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.99 161.93 30.19 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.283 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 72.03 20.85 4.22 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.188 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . 0.425 ' HE2' ' CE2' ' A' ' 435' ' ' TYR . 29.0 m-85 -125.0 158.97 61.15 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.999 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.0 161.16 91.5 Favored 'Cis proline' 0 C--N 1.345 0.386 0 C-N-CA 123.766 -1.347 . . . . 0.0 112.574 1.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . 0.492 ' HB2' ' CE1' ' A' ' 435' ' ' TYR . 68.0 mttm -114.24 172.51 6.96 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.78 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -72.42 140.99 48.67 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . 0.667 HD13 ' HA ' ' A' ' 461' ' ' GLU . 13.2 tt -67.51 -12.04 14.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.078 0.466 . . . . 0.0 110.772 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . 0.481 ' HD3' ' HA ' ' A' ' 454' ' ' LYS . 27.6 mmtp -65.84 -10.16 35.46 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 81.2 t -61.34 -34.51 61.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 177.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 456' ' ' TRP . . . . . 0.505 ' HB2' ' HB ' ' A' ' 459' ' ' ILE . 9.8 m95 -88.1 84.39 6.93 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.48 115.67 2.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.763 -178.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 103.24 -11.59 55.05 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.833 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 456' ' ' TRP . 27.5 mm -89.36 126.09 59.62 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 120.808 0.337 . . . . 0.0 111.188 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . 0.426 ' HG3' ' CZ2' ' A' ' 484' ' ' TRP . 94.2 Cg_endo -79.91 152.26 21.86 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.827 2.351 . . . . 0.0 111.41 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 461' ' ' GLU . . . . . 0.667 ' HA ' HD13 ' A' ' 453' ' ' ILE . 0.1 OUTLIER -75.64 157.6 33.52 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.84 -179.773 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.5 m 56.86 69.43 1.72 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.577 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 416' ' ' ASP . 4.6 Cg_endo -87.91 -179.29 2.47 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.04 2.493 . . . . 0.0 111.637 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 7.7 tpp85 -144.46 36.11 1.2 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.519 0.676 . . . . 0.0 110.08 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 161.81 132.8 1.38 Allowed Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.342 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 6.0 p -155.56 106.32 2.51 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -133.35 142.67 48.53 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.028 0.442 . . . . 0.0 111.782 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 42.2 ttm -92.61 140.31 29.67 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.542 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -69.32 166.95 47.59 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.274 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 1.5 m -68.03 -7.41 28.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.15 0.5 . . . . 0.0 111.681 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -86.27 -20.87 27.79 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.756 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 70.34 13.65 7.54 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.748 0.655 . . . . 0.0 112.27 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 19.4 t -114.82 -34.3 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 120.781 0.324 . . . . 0.0 111.343 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -113.76 133.79 55.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.209 0.528 . . . . 0.0 111.986 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 84.9 m -119.03 140.07 50.65 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.936 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -110.32 134.38 52.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.882 0.372 . . . . 0.0 111.782 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -116.08 141.66 47.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.47 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -120.69 134.92 55.25 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.994 0.184 . . . . 0.0 111.27 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -168.52 126.68 1.1 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.443 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 63.63 42.6 98.71 Favored Glycine 0 N--CA 1.454 -0.154 0 CA-C-N 116.086 -0.506 . . . . 0.0 113.751 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 54.6 t30 68.29 3.19 3.59 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 25.6 mtmt -116.24 157.89 24.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.048 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 483' ' ' TYR . . . . . 0.53 ' CE2' ' HE2' ' A' ' 497' ' ' TYR . 24.5 p90 -130.57 146.7 52.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.023 0.44 . . . . 0.0 111.695 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 484' ' ' TRP . . . . . 0.426 ' CZ2' ' HG3' ' A' ' 460' ' ' PRO . 16.8 m-90 -114.62 151.25 33.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.615 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -110.76 98.65 7.75 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 486' ' ' PHE . . . . . 0.548 ' HZ ' HD12 ' A' ' 491' ' ' LEU . 82.4 t80 -90.96 131.65 36.44 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.768 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -96.02 120.42 36.27 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -66.91 -29.49 69.38 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 52.0 tp60 -83.16 -39.35 21.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.827 0.346 . . . . 0.0 111.726 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -83.53 -19.87 34.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.484 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.548 HD12 ' HZ ' ' A' ' 486' ' ' PHE . 18.3 tp 61.22 34.02 18.93 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.481 0.658 . . . . 0.0 110.036 -179.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 25.8 tttp -156.03 150.2 25.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.567 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 486' ' ' PHE . 56.8 t -70.19 137.79 23.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.42 138.71 86.5 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.821 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -60.08 145.01 99.42 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 123.156 2.571 . . . . 0.0 112.644 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 109.61 -6.69 31.63 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . 0.744 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 57.0 m-85 -109.75 169.1 6.77 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . 0.744 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 96.6 Cg_endo -76.85 171.53 67.64 Favored 'Cis proline' 0 C--N 1.35 0.647 0 C-N-CA 124.022 -1.241 . . . . 0.0 113.083 0.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -131.83 164.28 26.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.97 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 48.1 t -72.72 122.27 21.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.512 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -67.98 -29.76 68.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.068 0.461 . . . . 0.0 110.605 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 502' ' ' LEU . . . . . 0.44 ' HA ' ' HG2' ' A' ' 506' ' ' MET . 63.6 mt -68.01 -41.58 82.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.354 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -77.75 -37.33 49.35 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -93.58 -27.49 16.59 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -176.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 36.6 m0 -109.56 -50.7 2.96 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 506' ' ' MET . . . . . 0.44 ' HG2' ' HA ' ' A' ' 502' ' ' LEU . 11.3 mmt -73.02 -26.57 61.36 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -178.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 88.77 25.91 28.49 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.813 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 21.7 m -106.03 105.74 54.58 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 120.627 0.251 . . . . 0.0 110.743 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -84.61 176.15 6.5 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.867 2.378 . . . . 0.0 111.82 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 40.2 m 62.14 46.83 6.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.468 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.421 -1.211 . . . . 0.0 110.589 179.561 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.897 0 N-CA-C 112.295 -0.322 . . . . 0.0 112.295 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' PRO . . . . . 0.444 ' HA ' HD23 ' B' ' 2' ' ' HYP . 72.4 Cg_endo -74.05 156.56 47.3 Favored 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 122.821 2.347 . . . . 0.0 111.777 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' HYP . . . . . 0.444 HD23 ' HA ' ' B' ' 1' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.04 169.05 51.48 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.52 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -82.32 174.27 10.04 Favored 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 122.88 2.387 . . . . 0.0 111.021 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.04 -157.59 17.46 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.326 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.684 ' HD2' ' HA ' ' D' ' 205' ' ' HYP . 48.1 Cg_exo -58.55 159.48 19.96 Favored 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 122.973 2.449 . . . . 0.0 111.866 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 160.57 155.49 7.8 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.687 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -63.19 137.28 60.39 Favored 'Trans proline' 0 C--O 1.238 0.498 0 C-N-CA 122.87 2.38 . . . . 0.0 111.839 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -65.47 143.35 57.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.133 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' D' ' 210' ' ' PRO . . . -57.63 153.2 24.99 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.987 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 mt -72.62 150.85 8.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.73 142.45 58.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.226 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.03 168.49 33.1 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.886 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -74.36 145.09 44.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.678 0.275 . . . . 0.0 110.782 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.55 136.18 54.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.973 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -55.8 144.34 34.79 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.985 -0.552 . . . . 0.0 113.687 -179.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 4.1 t -64.39 147.11 12.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 9.7 t -54.57 147.13 3.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.05 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.55 177.82 46.16 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.639 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 86.7 mt -87.96 153.45 21.28 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.418 0.151 . . . . 0.0 110.648 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.4 154.16 48.22 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.993 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.452 ' HA ' HD23 ' B' ' 26' ' ' HYP . 42.1 Cg_endo -69.2 151.99 72.24 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.772 2.314 . . . . 0.0 112.154 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' HYP . . . . . 0.452 HD23 ' HA ' ' B' ' 25' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.88 165.07 34.52 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.212 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.05 171.42 17.19 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.187 2.591 . . . . 0.0 111.627 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.49 174.75 53.59 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.76 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.401 ' HA ' HD23 ' B' ' 32' ' ' HYP . 14.2 Cg_exo -72.48 148.97 49.16 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 123.153 2.569 . . . . 0.0 111.643 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' HYP . . . . . 0.401 HD23 ' HA ' ' B' ' 31' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.28 139.13 47.43 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.783 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -69.72 130.74 19.91 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.487 2.124 . . . . 0.0 111.098 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 100' ' ' GLY . . . . . 0.479 ' HA3' ' HD3' ' C' ' 101' ' ' PRO . . . . . . . . 0 N--CA 1.449 -0.433 0 N-CA-C 112.29 -0.324 . . . . 0.0 112.29 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 101' ' ' PRO . . . . . 0.479 ' HD3' ' HA3' ' C' ' 100' ' ' GLY . 14.5 Cg_exo -69.96 130.7 19.53 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.898 2.399 . . . . 0.0 111.9 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 102' ' ' HYP . . . . . 0.455 HD23 ' HA ' ' C' ' 101' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -78.08 164.49 51.46 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.834 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 104' ' ' PRO . . . . . 0.421 ' HA ' HD23 ' C' ' 105' ' ' HYP . 94.1 Cg_endo -80.95 158.21 20.84 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.895 2.396 . . . . 0.0 112.528 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 105' ' ' HYP . . . . . 0.455 ' OD1' ' HG2' ' D' ' 204' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.61 -178.69 43.7 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.297 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -80.1 165.28 21.7 Favored 'Trans proline' 0 CA--C 1.528 0.18 0 C-N-CA 123.213 2.608 . . . . 0.0 110.886 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 108' ' ' HYP . . . . . 0.491 ' HA ' ' HG2' ' D' ' 207' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -65.99 165.98 37.32 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.811 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 110' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.85 157.45 61.31 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.749 2.299 . . . . 0.0 112.552 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -60.78 139.0 58.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.815 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -67.61 168.33 39.54 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.029 -0.605 . . . . 0.0 113.256 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 28.4 mt -68.6 138.18 22.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.86 147.58 51.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.966 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.54 149.27 48.72 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 116.058 -0.519 . . . . 0.0 113.196 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -78.27 143.61 36.89 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 122.283 0.233 . . . . 0.0 110.617 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 52.9 ttm-85 -62.19 145.25 54.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.632 0.253 . . . . 0.0 110.742 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.45 168.9 37.92 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.691 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -77.26 149.15 6.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.521 0.2 . . . . 0.0 110.475 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 120' ' ' VAL . . . . . 0.611 HG22 ' HB ' ' D' ' 219' ' ' VAL . 63.4 t -64.61 137.55 24.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.982 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.36 161.78 50.24 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 121.11 -0.566 . . . . 0.0 112.42 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 122' ' ' LEU . . . . . 0.429 ' HA ' HD23 ' C' ' 123' ' ' HYP . 88.9 mt -71.64 136.97 47.56 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 123' ' ' HYP . . . . . 0.429 HD23 ' HA ' ' C' ' 122' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -63.81 162.86 33.95 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.737 -0.665 . . . . 0.0 113.595 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.18 152.52 50.65 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.916 2.411 . . . . 0.0 111.647 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 126' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -63.79 163.55 32.7 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.365 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.38 160.64 44.35 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.632 2.222 . . . . 0.0 111.484 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -69.41 171.12 40.95 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.653 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -62.58 151.38 83.67 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.795 2.33 . . . . 0.0 111.59 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 132' ' ' HYP . . . . . 0.494 ' HA ' ' O ' ' D' ' 231' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.11 123.38 12.46 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.551 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -77.28 107.96 2.51 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 123.005 2.47 . . . . 0.0 111.88 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 135' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.387 0 N-CA-C 112.17 -0.372 . . . . 0.0 112.17 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' D' D ' 201' ' ' PRO . . . . . 0.461 ' HA ' HD23 ' D' ' 202' ' ' HYP . 36.0 Cg_exo -62.2 144.98 96.33 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.783 2.322 . . . . 0.0 111.488 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 202' ' ' HYP . . . . . 0.461 HD23 ' HA ' ' D' ' 201' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 94.18 -175.86 35.27 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.253 -0.975 . . . . 0.0 114.346 178.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 204' ' ' PRO . . . . . 0.455 ' HG2' ' OD1' ' C' ' 105' ' ' HYP . 28.4 Cg_exo -64.13 156.43 59.17 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.896 3.064 . . . . 0.0 113.265 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 205' ' ' HYP . . . . . 0.684 ' HA ' ' HD2' ' B' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . 91.28 170.16 42.37 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.988 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 207' ' ' PRO . . . . . 0.491 ' HG2' ' HA ' ' C' ' 108' ' ' HYP . 86.5 Cg_endo -89.15 151.32 5.65 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.187 2.591 . . . . 0.0 112.326 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 208' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -78.59 166.61 52.39 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.086 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 210' ' ' PRO . . . . . 0.452 ' O ' ' HA3' ' B' ' 12' ' ' GLY . 38.9 Cg_endo -68.12 158.35 57.85 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.643 2.229 . . . . 0.0 112.237 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -79.49 147.31 32.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.886 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.97 161.49 36.78 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.167 -0.54 . . . . 0.0 112.286 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 40.5 pt -66.79 166.92 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.63 0.252 . . . . 0.0 111.168 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 214' ' ' ALA . . . . . 0.432 ' HB3' ' NH1' ' A' ' 330' ' ' ARG . . . -80.64 138.99 36.45 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.912 0.387 . . . . 0.0 110.685 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -63.15 156.08 41.98 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.017 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -71.0 150.18 45.9 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -62.29 152.25 34.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.45 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -58.97 154.2 28.87 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.667 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 219' ' ' VAL . . . . . 0.611 ' HB ' HG22 ' C' ' 120' ' ' VAL . 15.8 t -66.74 143.15 15.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 21.9 t -63.01 143.26 15.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.047 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.22 162.66 31.98 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.777 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 7.3 mp -76.15 157.33 32.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.489 0.185 . . . . 0.0 110.778 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 223' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -65.52 148.22 51.08 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.339 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 225' ' ' PRO . . . . . 0.48 ' HA ' HD23 ' D' ' 226' ' ' HYP . 38.9 Cg_exo -62.27 148.28 93.52 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.837 2.358 . . . . 0.0 111.506 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 226' ' ' HYP . . . . . 0.48 HD23 ' HA ' ' D' ' 225' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 227' ' ' GLY . . . . . 0.419 ' HA2' ' HD3' ' D' ' 228' ' ' PRO . . . -64.11 159.61 40.12 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.999 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 228' ' ' PRO . . . . . 0.419 ' HD3' ' HA2' ' D' ' 227' ' ' GLY . 2.7 Cg_exo -77.87 162.26 29.61 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.03 2.487 . . . . 0.0 111.443 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -73.2 167.3 54.29 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.561 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 231' ' ' PRO . . . . . 0.494 ' O ' ' HA ' ' C' ' 132' ' ' HYP . 90.5 Cg_endo -83.39 157.79 14.67 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.654 2.236 . . . . 0.0 110.816 179.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 232' ' ' HYP . . . . . 0.411 HD23 ' HA ' ' D' ' 231' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 N--CA 1.479 0.65 0 N-CA-C 110.06 -0.785 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 320' ' ' ASP . 18.2 t-20 -115.27 161.2 18.8 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 17.6 tt -70.42 -23.42 24.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.08 0.467 . . . . 0.0 110.875 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 59.0 m -80.9 -1.1 42.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.227 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 317' ' ' ASN . 3.5 m-20 -71.33 -20.98 62.11 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.13 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 76.22 -177.31 50.83 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.822 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 24.4 m120 48.79 83.52 0.04 OUTLIER 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' PHE . . . . . 0.417 ' HD2' ' HH ' ' A' ' 478' ' ' TYR . 23.4 m-85 -100.62 168.67 9.55 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.222 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -77.35 -40.73 43.02 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 7.0 t -171.46 154.72 3.92 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.928 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 67.7 t -130.5 125.71 59.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -136.89 170.47 16.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.006 0.431 . . . . 0.0 110.898 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . 0.433 ' HA ' ' O ' ' A' ' 332' ' ' GLU . 41.4 ttp -130.08 87.06 2.47 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.568 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.426 ' HB3' ' CE1' ' A' ' 379' ' ' PHE . 45.5 mt -85.7 123.8 31.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.48 -178.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 330' ' ' ARG . 31.5 mmt-85 63.71 19.37 11.69 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.203 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 93.2 -3.61 73.04 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.631 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . 0.451 ' HA ' ' NH2' ' A' ' 345' ' ' ARG . 15.4 mm-40 -95.45 128.44 42.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.853 0.359 . . . . 0.0 110.356 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 38.5 ttm -77.03 110.92 12.07 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.251 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -110.29 122.83 48.61 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.988 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 27.2 t -109.73 122.34 64.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.47 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -106.21 132.04 52.75 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.731 0.3 . . . . 0.0 111.46 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 0.783 ' HB3' ' HZ3' ' A' ' 342' ' ' TRP . 61.2 tttp -148.37 112.38 5.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.42 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 64.76 -113.01 0.31 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.922 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 15.4 ptt-85 -114.63 11.78 17.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.857 0.361 . . . . 0.0 111.107 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 15.0 m-90 -122.99 155.07 37.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.933 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -135.85 148.69 48.76 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.686 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' TRP . . . . . 0.783 ' HZ3' ' HB3' ' A' ' 337' ' ' LYS . 29.2 m-90 -124.47 162.5 23.82 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.462 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.13 114.99 9.07 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 2.5 m -103.3 136.86 34.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.262 0.553 . . . . 0.0 112.083 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . 0.451 ' NH2' ' HA ' ' A' ' 332' ' ' GLU . 18.0 tpp180 -135.84 123.26 22.0 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 5.6 m120 66.14 35.21 6.27 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 123.564 0.54 . . . . 0.0 110.614 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 17.5 t30 63.14 33.12 14.71 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.048 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -143.03 143.52 31.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.563 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 14.0 t -83.65 131.39 33.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 91.1 mtp -84.44 172.57 11.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.904 0.383 . . . . 0.0 111.513 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -77.47 158.38 30.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.23 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 98.02 -5.47 61.48 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.045 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -117.64 152.72 50.08 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.406 ' HB3' ' CE2' ' A' ' 342' ' ' TRP . 74.0 Cg_endo -76.58 140.01 63.1 Favored 'Cis proline' 0 C--N 1.343 0.286 0 C-N-CA 123.215 -1.577 . . . . 0.0 112.834 0.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . . . . . . . . . 57.1 ttm -119.85 135.94 24.56 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.94 134.77 64.59 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.327 2.018 . . . . 0.0 110.931 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 94.0 mt -51.91 -42.32 33.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.814 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -67.83 -8.11 51.61 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 116.029 -0.532 . . . . 0.0 114.271 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.72 -32.87 27.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.259 0.529 . . . . 0.0 110.447 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -104.47 -56.32 2.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.966 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -86.13 74.95 9.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.712 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 362' ' ' ARG . 25.6 ttp180 -63.45 100.92 0.28 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.896 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 129.31 -16.7 5.68 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.299 -0.721 . . . . 0.0 111.299 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.555 HD12 ' HD2' ' A' ' 365' ' ' PRO . 22.6 tp -92.38 134.05 28.82 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' PRO . . . . . 0.555 ' HD2' HD12 ' A' ' 364' ' ' LEU . 96.3 Cg_endo -82.87 -167.08 0.43 Allowed 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 123.033 2.488 . . . . 0.0 112.258 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -96.94 157.81 15.72 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.051 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 27.7 m 54.73 80.31 0.13 Allowed 'General case' 0 C--O 1.233 0.207 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 17.9 pt -93.57 170.26 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.013 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.93 -39.25 7.02 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -178.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . 0.532 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.2 OUTLIER -153.13 160.45 42.89 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.657 0.265 . . . . 0.0 111.288 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -153.08 138.2 17.35 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . 0.474 ' HE1' ' HE2' ' A' ' 382' ' ' PHE . 11.8 p90 -166.09 174.66 9.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.683 0.278 . . . . 0.0 111.076 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.418 ' OE1' ' HD3' ' A' ' 330' ' ' ARG . 33.4 mt-10 -104.92 131.51 52.33 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . 0.492 ' HB2' ' OE2' ' A' ' 440' ' ' GLU . 6.3 ptm180 -88.61 -177.99 5.7 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.404 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.449 ' HZ3' ' CD ' ' A' ' 441' ' ' GLU . 7.6 tttp -65.64 -34.23 77.75 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -21.82 64.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.98 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 109.77 -10.99 32.45 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.962 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 19.8 mttp -86.06 160.28 19.34 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 117.266 0.533 . . . . 0.0 111.409 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . 0.426 ' CE1' ' HB3' ' A' ' 329' ' ' LEU . 45.6 m-85 -88.35 130.57 35.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.181 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . 0.448 ' HB ' ' CE1' ' A' ' 372' ' ' TYR . 8.9 t -113.86 119.7 61.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.004 0.431 . . . . 0.0 110.194 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . 0.444 ' HB2' ' HB2' ' A' ' 388' ' ' TRP . 94.5 m-85 -107.37 140.16 40.73 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.67 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.474 ' HE2' ' HE1' ' A' ' 372' ' ' TYR . 32.9 m-85 -121.49 139.91 52.87 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.983 0.421 . . . . 0.0 111.603 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.456 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 86.1 tttt -154.2 114.05 3.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.744 178.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 66.76 -107.24 1.92 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.692 -0.765 . . . . 0.0 111.481 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -122.62 8.82 9.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.21 0.529 . . . . 0.0 110.165 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -114.84 152.37 32.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.795 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . 0.407 ' NE2' ' HE2' ' A' ' 399' ' ' TYR . 25.8 p-80 -134.27 150.93 51.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.394 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' TRP . . . . . 0.535 ' CE2' ' HB3' ' A' ' 400' ' ' PRO . 16.7 m-90 -122.64 142.58 50.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.186 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 85.6 t -124.38 119.13 55.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -118.62 126.79 52.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.977 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -93.79 95.08 8.9 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 177.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . 0.416 ' HA ' ' HE2' ' A' ' 379' ' ' PHE . 72.2 mm-40 69.96 -78.32 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.812 0.695 . . . . 0.0 110.273 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -140.87 16.87 2.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.965 0.412 . . . . 0.0 111.05 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 9.1 m -123.24 126.9 47.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.956 0.407 . . . . 0.0 111.723 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 46.6 tp -76.54 140.19 41.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.428 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 5.5 mm-40 -71.6 136.63 83.31 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.307 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 24.6 Cg_exo -64.0 131.99 32.83 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.81 2.34 . . . . 0.0 112.096 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 108.07 -11.44 37.42 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.841 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' TYR . . . . . 0.505 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 58.2 m-85 -93.5 161.01 31.85 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 110.543 -0.169 . . . . 0.0 110.543 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.535 ' HB3' ' CE2' ' A' ' 388' ' ' TRP . 55.3 Cg_endo -68.96 160.33 85.77 Favored 'Cis proline' 0 C--N 1.348 0.537 0 C-N-CA 123.909 -1.288 . . . . 0.0 113.205 0.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -135.45 161.93 34.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.819 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 0.501 ' HB2' ' HG2' ' A' ' 405' ' ' GLU . 30.5 m-70 -70.37 153.91 42.48 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 77.6 mt -57.61 -37.81 60.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.099 0.476 . . . . 0.0 111.095 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -68.1 -10.08 51.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.99 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.501 ' HG2' ' HB2' ' A' ' 402' ' ' HIS . 65.3 mm-40 -79.65 -20.6 46.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.809 0.337 . . . . 0.0 110.767 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 36.9 tp -80.15 -61.81 1.87 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.264 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.845 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -143.21 154.91 25.74 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.524 -0.846 . . . . 0.0 113.063 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -79.61 132.06 36.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.667 -0.266 . . . . 0.0 110.336 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 102.29 -4.3 51.5 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.317 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 411' ' ' PRO . 50.2 mt -77.33 146.0 73.46 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 120.63 0.252 . . . . 0.0 110.976 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 410' ' ' LEU . 47.8 Cg_exo -57.07 131.91 48.22 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.734 2.289 . . . . 0.0 112.075 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.69 -0.5 37.24 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.293 0.568 . . . . 0.0 110.42 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -90.13 -53.13 4.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.941 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -179.15 170.9 1.39 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.826 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 42.6 mm -124.61 133.01 70.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -90.63 -47.15 7.85 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.117 0.485 . . . . 0.0 110.234 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.532 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -155.26 159.68 40.23 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.339 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -142.45 113.68 7.7 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 35.1 tp -109.61 123.2 49.04 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.407 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -88.36 114.64 25.18 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.062 0.458 . . . . 0.0 110.086 178.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 15.3 t-105 -83.63 94.23 8.06 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.509 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 62.6 mtt -50.74 -50.72 71.69 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -43.01 -48.97 7.32 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 123.011 2.474 . . . . 0.0 114.867 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -105.07 -13.8 15.62 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 75.23 33.7 53.23 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.162 -0.542 . . . . 0.0 113.204 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -116.38 149.22 39.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.796 0.298 . . . . 0.0 110.456 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 6.4 m -98.23 128.0 44.47 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.203 0.525 . . . . 0.0 112.218 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -102.78 109.08 20.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.948 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -91.89 129.68 37.81 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.461 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -106.18 129.62 54.2 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.004 0.431 . . . . 0.0 110.988 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.562 ' HB3' ' HE1' ' A' ' 436' ' ' TYR . 3.1 tpm_? -139.21 102.98 4.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.336 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 63.44 -109.5 2.78 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.318 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -110.82 11.96 22.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.031 0.443 . . . . 0.0 110.62 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -122.91 152.38 40.86 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.966 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' TYR . . . . . 0.551 ' CE2' ' HE2' ' A' ' 449' ' ' TYR . 8.2 p90 -133.82 139.2 46.11 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.383 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' TYR . . . . . 0.562 ' HE1' ' HB3' ' A' ' 431' ' ' ARG . 4.2 m-85 -111.62 145.2 39.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.829 -178.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 20.9 ttp180 -106.01 100.62 10.16 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . 0.845 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 83.2 t80 -85.06 120.41 26.54 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.235 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -95.61 106.79 18.93 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.537 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' GLU . . . . . 0.492 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 4.5 mm-40 -58.16 -39.06 77.85 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.597 0.56 . . . . 0.0 111.48 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' GLU . . . . . 0.449 ' CD ' ' HZ3' ' A' ' 375' ' ' LYS . 1.9 mp0 -61.16 -20.56 62.85 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 13.8 mt -127.72 3.5 6.09 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 43.03 47.37 5.03 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.493 0.663 . . . . 0.0 112.315 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -154.51 172.65 17.45 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.132 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.6 t -88.24 138.94 18.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.149 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.32 160.81 15.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.525 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . 0.543 ' O ' ' HB2' ' A' ' 448' ' ' GLU . 1.7 m -67.13 151.96 46.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.446 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' GLU . . . . . 0.543 ' HB2' ' O ' ' A' ' 447' ' ' SER . 26.7 mt-10 78.45 -6.68 1.9 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.51 0.724 . . . . 0.0 111.786 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . 0.551 ' HE2' ' CE2' ' A' ' 435' ' ' TYR . 54.2 m-85 -98.23 154.68 37.55 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.702 -0.227 . . . . 0.0 111.418 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.4 162.71 91.94 Favored 'Cis proline' 0 C--N 1.345 0.364 0 C-N-CA 123.439 -1.484 . . . . 0.0 112.998 0.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -121.94 178.17 5.0 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -78.07 137.01 38.01 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.721 0.296 . . . . 0.0 110.298 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 15.5 tt -63.97 -17.48 20.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -63.48 -9.16 11.53 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 53.7 t -63.07 -33.9 63.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 456' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -91.5 94.76 9.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.362 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . 0.722 ' HB3' ' HG3' ' A' ' 492' ' ' LYS . 13.3 mm-40 -56.08 105.2 0.17 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 114.25 -7.8 22.95 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.515 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 24.7 mm -84.58 127.44 65.56 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 121.006 0.431 . . . . 0.0 111.065 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -77.99 138.93 16.87 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.893 2.395 . . . . 0.0 113.042 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 461' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -66.66 140.81 57.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.293 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 2.7 m 57.74 71.44 1.07 Allowed Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -87.28 -171.28 0.7 Allowed 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.423 2.082 . . . . 0.0 111.632 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -143.63 20.55 1.84 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.212 0.529 . . . . 0.0 110.891 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 177.92 142.0 4.44 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 13.0 p -162.65 110.65 1.31 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.6 0.238 . . . . 0.0 110.731 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -138.98 144.44 38.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.866 0.365 . . . . 0.0 111.251 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 468' ' ' MET . . . . . . . . . . . . . 48.7 ttm -95.47 143.05 27.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.022 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . 0.442 ' C ' ' H ' ' A' ' 471' ' ' ASP . . . -72.67 163.91 54.76 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.962 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.94 30.25 0.09 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.167 0.508 . . . . 0.0 111.901 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . 0.442 ' H ' ' C ' ' A' ' 469' ' ' GLY . 1.0 OUTLIER -126.73 -14.28 5.71 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.294 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 67.24 9.44 6.96 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.3 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 40.2 t -106.71 -45.25 7.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.859 0.361 . . . . 0.0 111.133 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -108.09 132.13 53.89 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 475' ' ' THR . . . . . . . . . . . . . 97.0 m -116.79 138.95 51.13 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.689 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 476' ' ' TYR . . . . . 0.491 ' HE1' ' HE2' ' A' ' 485' ' ' LYS . 28.3 m-85 -114.15 126.52 55.17 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -110.08 141.78 42.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.145 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . 0.417 ' HH ' ' HD2' ' A' ' 323' ' ' PHE . 76.8 t80 -123.04 135.0 54.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.705 0.288 . . . . 0.0 111.566 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 479' ' ' LYS . . . . . 0.4 ' HB3' ' CZ3' ' A' ' 484' ' ' TRP . 61.8 tttt -166.87 128.25 1.66 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.078 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 59.56 43.18 97.82 Favored Glycine 0 CA--C 1.516 0.148 0 N-CA-C 114.667 0.627 . . . . 0.0 114.667 178.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 58.4 t30 68.92 3.94 4.25 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 178.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -116.84 152.19 34.95 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 483' ' ' TYR . . . . . 0.481 ' CE2' ' HE2' ' A' ' 497' ' ' TYR . 7.3 p90 -128.12 145.17 51.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.114 0.483 . . . . 0.0 111.813 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 484' ' ' TRP . . . . . 0.4 ' CZ3' ' HB3' ' A' ' 479' ' ' LYS . 16.8 m-90 -112.77 138.09 50.11 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.499 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . 0.491 ' HE2' ' HE1' ' A' ' 476' ' ' TYR . 32.6 ttmt -101.88 96.12 6.84 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 486' ' ' PHE . . . . . 0.552 ' HA ' ' HA ' ' A' ' 493' ' ' VAL . 90.0 t80 -87.77 133.26 33.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.566 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -100.32 117.13 33.89 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -66.55 -34.44 77.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.768 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -68.76 -32.93 73.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.68 -178.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -98.5 -20.54 17.02 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 1.3 tp 66.11 39.26 4.4 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.795 0.807 . . . . 0.0 109.814 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 492' ' ' LYS . . . . . 0.722 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 31.5 tttp -160.17 153.36 21.88 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.386 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 486' ' ' PHE . 52.8 t -78.04 133.5 30.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 178.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -59.42 137.46 89.04 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.41 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -61.85 152.01 77.39 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.979 2.453 . . . . 0.0 112.284 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 94.37 9.48 59.07 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.684 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . 0.633 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 21.7 m-85 -117.43 170.17 6.49 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . 0.633 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 87.4 Cg_endo -78.29 -178.72 24.76 Favored 'Cis proline' 0 C--N 1.348 0.53 0 C-N-CA 124.104 -1.207 . . . . 0.0 112.865 0.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -135.29 155.25 50.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.176 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.29 116.33 10.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.565 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -63.47 -23.6 67.47 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 502' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 502' ' ' LEU . 13.4 mt -61.15 -49.65 76.35 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -83.05 -29.08 29.12 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.05 -35.73 21.69 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 44.3 m0 -116.29 -45.07 2.85 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -177.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 9.7 mmt -75.5 -17.77 60.01 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -177.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 76.41 21.95 74.15 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.742 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 16.9 m -104.38 111.07 65.11 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 120.754 0.311 . . . . 0.0 110.898 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -86.27 -167.47 0.38 Allowed 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.873 2.382 . . . . 0.0 111.525 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 16.2 m 60.34 37.63 20.08 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.046 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.386 -1.23 . . . . 0.0 111.832 -179.506 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.669 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -80.06 150.3 20.44 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 122.543 2.162 . . . . 0.0 111.433 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' HYP . . . . . 0.516 ' HA ' ' HB2' ' C' ' 101' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -60.71 164.37 16.73 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.9 -0.591 . . . . 0.0 113.661 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.34 171.1 17.48 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.874 2.383 . . . . 0.0 110.966 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.6 -164.67 35.47 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.768 -0.73 . . . . 0.0 111.913 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.703 ' HG2' ' HA ' ' D' ' 205' ' ' HYP . 22.3 Cg_endo -63.07 165.81 15.89 Favored 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 122.678 2.252 . . . . 0.0 111.463 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' HYP . . . . . 0.539 ' O ' ' HA3' ' D' ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 149.24 176.2 22.29 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.65 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.11 138.33 51.56 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.769 2.312 . . . . 0.0 111.561 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . 0.664 ' HG3' ' HG2' ' C' ' 110' ' ' PRO . 27.2 tt0 -66.67 150.27 49.3 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.084 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.18 143.07 46.24 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.355 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.475 ' H ' HD12 ' B' ' 13' ' ' ILE . 4.0 mp -64.86 137.93 24.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.01 143.41 22.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.129 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.64 164.77 41.8 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.106 -0.568 . . . . 0.0 113.17 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -75.11 150.34 38.83 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -70.22 146.49 50.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.525 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' D' ' 216' ' ' GLN . . . -64.95 155.24 48.84 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.492 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.42 ' H ' HG23 ' B' ' 19' ' ' VAL . 2.2 t -66.3 149.76 11.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.554 0.216 . . . . 0.0 110.667 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 6.0 t -53.92 145.71 3.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.24 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.99 161.25 52.08 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 116.035 -0.529 . . . . 0.0 113.153 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 87.4 mt -76.78 147.22 37.38 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.703 -0.248 . . . . 0.0 110.756 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.12 157.11 52.69 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.847 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.42 158.54 51.12 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.609 2.206 . . . . 0.0 111.412 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.96 164.61 49.6 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.864 -0.607 . . . . 0.0 113.153 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.418 ' HA ' HD23 ' B' ' 29' ' ' HYP . 68.0 Cg_endo -74.62 157.39 44.38 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.798 2.332 . . . . 0.0 111.864 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' HYP . . . . . 0.418 HD23 ' HA ' ' B' ' 28' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.2 174.14 52.2 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.168 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.403 ' HA ' HD23 ' B' ' 32' ' ' HYP . 9.1 Cg_exo -74.71 152.95 42.96 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.29 2.66 . . . . 0.0 111.766 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' HYP . . . . . 0.403 HD23 ' HA ' ' B' ' 31' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.62 137.46 42.11 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.596 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . 0.499 ' HA ' HD23 ' B' ' 35' ' ' HYP . 25.1 Cg_endo -63.64 117.21 4.19 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.759 2.306 . . . . 0.0 111.033 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' HYP . . . . . 0.499 HD23 ' HA ' ' B' ' 34' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.506 0 CA-C-O 119.952 -0.36 . . . . 0.0 112.586 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 101' ' ' PRO . . . . . 0.516 ' HB2' ' HA ' ' B' ' 2' ' ' HYP . 31.5 Cg_exo -60.72 124.49 15.12 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.952 2.435 . . . . 0.0 112.084 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 102' ' ' HYP . . . . . 0.511 HD23 ' HA ' ' C' ' 101' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -67.97 160.08 50.67 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.446 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -84.05 162.91 13.62 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.957 2.438 . . . . 0.0 111.95 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 105' ' ' HYP . . . . . 0.465 ' OD1' ' HG2' ' D' ' 204' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -74.68 176.79 48.1 Favored Glycine 0 C--O 1.24 0.511 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.52 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.8 148.32 36.11 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.961 2.44 . . . . 0.0 110.742 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 108' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -67.91 172.88 32.21 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.615 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 110' ' ' PRO . . . . . 0.664 ' HG2' ' HG3' ' B' ' 11' ' ' GLN . 59.1 Cg_endo -72.27 163.98 37.01 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.886 2.391 . . . . 0.0 112.116 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -65.6 137.63 57.49 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.15 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.48 166.63 30.02 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.841 -0.618 . . . . 0.0 113.562 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 79.9 mt -63.8 137.72 24.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.752 0.31 . . . . 0.0 110.847 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.11 145.15 54.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.538 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -59.16 148.37 40.4 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.627 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -75.2 156.8 35.44 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.673 0.273 . . . . 0.0 110.464 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 38.0 ttm-85 -69.67 147.34 50.74 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.302 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.9 170.0 52.13 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.485 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 21.6 t -69.23 138.95 21.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.606 0.241 . . . . 0.0 110.651 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 58.0 t -62.42 137.33 24.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.661 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.31 158.62 30.77 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.26 -0.495 . . . . 0.0 112.851 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 122' ' ' LEU . . . . . . . . . . . . . 95.7 mt -75.91 152.55 37.1 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.391 0.138 . . . . 0.0 110.922 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 123' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -70.46 165.41 51.99 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.496 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 125' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.53 155.15 55.17 Favored 'Trans proline' 0 CA--C 1.529 0.233 0 C-N-CA 122.691 2.261 . . . . 0.0 111.581 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 126' ' ' HYP . . . . . 0.405 ' HA ' ' HD2' ' D' ' 225' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -66.0 166.75 36.09 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.902 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 128' ' ' PRO . . . . . 0.455 ' HA ' HD23 ' C' ' 129' ' ' HYP . 46.9 Cg_endo -69.37 148.91 68.64 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.579 2.186 . . . . 0.0 111.562 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 129' ' ' HYP . . . . . 0.455 HD23 ' HA ' ' C' ' 128' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 130' ' ' GLY . . . . . 0.408 ' HA2' ' HD3' ' C' ' 131' ' ' PRO . . . -60.3 156.72 29.6 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.885 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 131' ' ' PRO . . . . . 0.418 ' HA ' HD23 ' C' ' 132' ' ' HYP . 14.0 Cg_exo -70.73 158.49 55.56 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.913 2.409 . . . . 0.0 111.696 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 132' ' ' HYP . . . . . 0.418 HD23 ' HA ' ' C' ' 131' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -74.89 127.23 9.32 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.925 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 134' ' ' PRO . . . . . 0.485 ' HA ' HD23 ' C' ' 135' ' ' HYP . 40.8 Cg_endo -68.83 114.95 3.72 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 122.881 2.387 . . . . 0.0 111.889 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 135' ' ' HYP . . . . . 0.485 HD23 ' HA ' ' C' ' 134' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.335 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' 201' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' C' ' 102' ' ' HYP . 24.0 Cg_exo -65.98 156.64 63.45 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 122.946 2.431 . . . . 0.0 111.807 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 202' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 89.94 -172.29 38.42 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.993 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 204' ' ' PRO . . . . . 0.465 ' HG2' ' OD1' ' C' ' 105' ' ' HYP . 25.5 Cg_exo -65.64 155.64 68.01 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 123.454 2.769 . . . . 0.0 112.722 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 205' ' ' HYP . . . . . 0.703 ' HA ' ' HG2' ' B' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 206' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' B' ' 8' ' ' HYP . . . 91.05 171.82 43.36 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.965 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 207' ' ' PRO . . . . . 0.415 ' HA ' HD23 ' D' ' 208' ' ' HYP . 81.7 Cg_endo -96.05 160.43 1.36 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.424 2.75 . . . . 0.0 112.519 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 208' ' ' HYP . . . . . 0.415 HD23 ' HA ' ' D' ' 207' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -77.16 169.09 54.88 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.05 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.26 141.1 73.97 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.471 2.114 . . . . 0.0 112.23 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 211' ' ' GLN . . . . . 0.451 ' HG3' ' N ' ' D' ' 212' ' ' GLY . 1.4 tt0 -65.87 150.93 47.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.929 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 212' ' ' GLY . . . . . 0.451 ' N ' ' HG3' ' D' ' 211' ' ' GLN . . . -67.46 160.33 49.47 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.357 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 213' ' ' ILE . . . . . . . . . . . . . 45.6 pt -69.21 174.11 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 120.819 0.343 . . . . 0.0 111.439 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -77.67 147.86 35.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.499 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -74.48 158.02 51.28 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.773 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 216' ' ' GLN . . . . . 0.453 ' O ' ' HA3' ' B' ' 18' ' ' GLY . 33.4 mm-40 -77.52 151.6 34.48 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.623 0.249 . . . . 0.0 110.488 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 217' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' D' ' 217' ' ' ARG . 8.8 mtp180 -66.58 156.23 35.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.989 0.424 . . . . 0.0 110.571 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -66.23 151.37 52.09 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.185 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 219' ' ' VAL . . . . . . . . . . . . . 11.5 t -65.82 148.77 11.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 61.6 t -63.03 139.1 21.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-O 120.725 0.297 . . . . 0.0 110.425 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.33 157.22 28.86 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.516 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 222' ' ' LEU . . . . . 0.409 ' HA ' HD23 ' D' ' 223' ' ' HYP . 9.2 mp -65.03 149.2 50.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.751 -0.224 . . . . 0.0 110.889 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 223' ' ' HYP . . . . . 0.409 HD23 ' HA ' ' D' ' 222' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 224' ' ' GLY . . . . . 0.418 ' HA2' ' HD3' ' D' ' 225' ' ' PRO . . . -60.04 153.26 34.91 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.855 -0.612 . . . . 0.0 113.175 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 225' ' ' PRO . . . . . 0.433 ' HA ' HD23 ' D' ' 226' ' ' HYP . 15.5 Cg_exo -69.98 148.85 64.58 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 123.031 2.487 . . . . 0.0 111.466 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 226' ' ' HYP . . . . . 0.433 HD23 ' HA ' ' D' ' 225' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -64.45 158.7 42.65 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.773 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.93 161.45 33.05 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 122.701 2.267 . . . . 0.0 111.954 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -78.32 -175.74 45.68 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.444 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 231' ' ' PRO . . . . . 0.418 ' HA ' HD23 ' D' ' 232' ' ' HYP . 95.2 Cg_endo -92.82 155.04 2.79 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.298 2.665 . . . . 0.0 112.511 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 232' ' ' HYP . . . . . 0.418 HD23 ' HA ' ' D' ' 231' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo . . . . . 0 N--CA 1.479 0.665 0 N-CA-C 110.26 -0.708 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' ASN . . . . . 0.534 ' O ' ' HB2' ' A' ' 320' ' ' ASP . 14.3 t-20 -110.79 166.3 11.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.423 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.466 HG13 ' HB3' ' A' ' 506' ' ' MET . 8.5 tp -72.78 -31.04 34.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.051 0.453 . . . . 0.0 110.64 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 59.0 m -82.77 10.24 8.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.94 0.4 . . . . 0.0 111.457 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.534 ' HB2' ' O ' ' A' ' 317' ' ' ASN . 0.1 OUTLIER -69.72 -32.02 70.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.437 179.626 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 79.96 -176.81 54.57 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.481 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 3.5 t30 53.9 78.79 0.15 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.046 0.45 . . . . 0.0 111.218 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -96.04 154.79 17.05 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.902 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . 0.418 ' OD1' ' HA ' ' A' ' 337' ' ' LYS . 3.0 m-20 -74.25 -40.53 62.31 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.221 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 1.8 t -170.86 146.54 2.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.448 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.431 HG22 HG13 ' A' ' 335' ' ' VAL . 60.6 t -131.97 126.25 56.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -149.33 176.81 10.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.053 0.454 . . . . 0.0 111.231 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 41.3 ttp -127.16 122.37 33.93 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.419 ' HB3' ' CE1' ' A' ' 379' ' ' PHE . 54.3 mt -114.64 119.75 37.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.902 -179.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.609 ' HG3' ' HE1' ' A' ' 379' ' ' PHE . 63.6 mtp180 55.82 26.04 9.14 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 101.96 -10.63 57.17 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.684 -0.77 . . . . 0.0 113.356 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -100.25 130.01 46.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.929 0.395 . . . . 0.0 111.306 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 45.2 ttm -84.05 124.43 31.08 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -119.56 120.5 36.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.132 0.492 . . . . 0.0 111.572 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . 0.431 HG13 HG22 ' A' ' 326' ' ' VAL . 23.1 t -105.31 115.22 46.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -99.74 131.67 45.58 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 0.695 ' HB3' ' HZ3' ' A' ' 342' ' ' TRP . 38.7 tttp -144.18 109.25 5.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.174 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 61.31 -102.39 0.12 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.894 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 339' ' ' ARG . 11.7 ptm85 -119.48 12.97 12.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.878 0.37 . . . . 0.0 111.361 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 13.3 m-90 -125.71 153.73 43.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.71 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -136.35 141.76 43.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.863 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' TRP . . . . . 0.695 ' HZ3' ' HB3' ' A' ' 337' ' ' LYS . 21.0 m-90 -115.59 147.09 41.15 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.882 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -116.48 92.81 3.99 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.476 HG12 HG22 ' A' ' 349' ' ' VAL . 10.2 m -91.42 128.39 43.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.619 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 42.5 ttm-85 -131.82 118.85 20.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.428 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 63.03 41.42 8.29 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.869 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 34.9 t30 68.29 15.37 9.3 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.353 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -126.58 129.26 48.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.72 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.476 HG22 HG12 ' A' ' 344' ' ' VAL . 21.7 t -76.57 121.98 29.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.661 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' MET . . . . . . . . . . . . . 26.0 ttp -66.94 151.57 47.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.788 0.327 . . . . 0.0 110.501 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -69.51 161.08 30.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.195 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 90.21 7.07 68.13 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.06 -0.591 . . . . 0.0 111.908 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' TYR . . . . . 0.561 ' HB3' ' HA ' ' A' ' 354' ' ' PRO . 80.5 m-85 -128.78 162.22 52.88 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.561 ' HA ' ' HB3' ' A' ' 353' ' ' TYR . 56.8 Cg_endo -70.37 144.04 76.77 Favored 'Cis proline' 0 C--N 1.346 0.396 0 C-N-CA 123.815 -1.327 . . . . 0.0 112.943 0.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . 0.502 ' HB2' ' CD1' ' A' ' 353' ' ' TYR . 0.0 OUTLIER -113.23 144.36 31.04 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.36 179.528 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 355' ' ' MET . 17.5 Cg_exo -68.2 129.65 19.74 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.541 2.16 . . . . 0.0 111.358 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 85.3 mt -56.53 -41.6 73.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.479 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -65.7 -17.57 64.99 Favored Glycine 0 CA--C 1.518 0.25 0 N-CA-C 114.603 0.601 . . . . 0.0 114.603 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -84.65 -45.11 12.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.237 0.519 . . . . 0.0 111.063 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -82.72 -53.92 5.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.189 0.519 . . . . 0.0 110.555 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -92.61 70.24 4.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.553 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -59.41 101.88 0.12 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.208 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 128.95 -20.79 5.35 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.464 HD12 ' HD2' ' A' ' 365' ' ' PRO . 18.8 tp -85.7 134.61 39.39 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' PRO . . . . . 0.464 ' HD2' HD12 ' A' ' 364' ' ' LEU . 97.5 Cg_endo -82.43 -175.17 2.36 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.813 2.342 . . . . 0.0 112.145 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -91.06 153.0 20.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.502 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 4.0 m 57.12 83.06 0.11 Allowed 'General case' 0 C--O 1.233 0.232 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 13.7 pt -94.9 176.19 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.898 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -111.55 -38.2 4.99 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . . . . . . . . . 1.6 m -149.97 156.23 41.36 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.798 0.332 . . . . 0.0 111.54 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -149.15 135.82 19.54 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . 0.459 ' CE1' ' HB ' ' A' ' 380' ' ' VAL . 33.6 p90 -158.48 165.08 35.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.117 0.484 . . . . 0.0 112.191 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 62.5 tt0 -99.14 133.92 42.73 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . 0.469 ' HB2' ' OE2' ' A' ' 440' ' ' GLU . 15.2 ptm180 -95.44 -170.69 2.21 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -77.17 -23.56 51.55 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -177.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.63 -11.05 57.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 104.23 -14.37 51.51 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.854 -0.689 . . . . 0.0 113.949 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' LYS . . . . . 0.513 ' HD3' ' HB2' ' A' ' 391' ' ' ASP . 25.2 mttp -82.05 163.66 21.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.305 0.553 . . . . 0.0 111.867 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . 0.609 ' HE1' ' HG3' ' A' ' 330' ' ' ARG . 10.5 m-85 -99.96 135.56 41.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.351 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . 0.459 ' HB ' ' CE1' ' A' ' 372' ' ' TYR . 12.2 t -116.43 122.02 68.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.254 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -108.2 139.8 42.35 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.56 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.437 ' HE2' HG23 ' A' ' 403' ' ' ILE . 17.6 m-85 -122.01 140.15 52.83 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.71 0.291 . . . . 0.0 111.163 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -154.69 114.13 3.72 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.741 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 67.24 -110.25 3.37 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.833 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -119.32 12.96 12.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.941 0.401 . . . . 0.0 111.185 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -122.14 152.96 39.35 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.894 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 -133.9 148.31 51.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.22 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' TRP . . . . . 0.453 ' CE2' ' HB3' ' A' ' 400' ' ' PRO . 21.5 m-90 -122.4 140.41 52.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.149 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 69.5 t -120.34 120.2 62.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -115.8 127.77 55.33 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.513 ' HB2' ' HD3' ' A' ' 378' ' ' LYS . 19.7 t70 -90.79 86.26 6.28 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 176.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . 0.418 ' OE1' ' HB ' ' D' ' 213' ' ' ILE . 57.0 mm-40 69.52 -71.47 0.12 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.402 -177.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -142.56 4.56 1.55 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.546 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 13.3 m -106.45 129.05 54.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.713 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 65.1 tp -84.16 133.75 34.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 397' ' ' PRO . 4.0 mt-10 -66.1 135.34 95.08 Favored Pre-proline 0 C--O 1.238 0.489 0 CA-C-O 120.823 0.344 . . . . 0.0 111.039 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 396' ' ' GLU . 23.7 Cg_exo -64.81 128.82 21.78 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 123.152 2.568 . . . . 0.0 112.192 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 108.02 -5.27 34.17 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.836 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' TYR . . . . . 0.411 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 33.9 m-85 -94.0 159.56 34.12 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 111.526 0.195 . . . . 0.0 111.526 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.453 ' HB3' ' CE2' ' A' ' 388' ' ' TRP . 71.9 Cg_endo -74.44 162.5 92.4 Favored 'Cis proline' 0 C--N 1.344 0.314 0 C-N-CA 123.477 -1.468 . . . . 0.0 112.939 0.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -125.59 161.39 27.32 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 0.452 ' ND1' ' HG3' ' A' ' 404' ' ' LYS . 23.7 t-80 -69.9 155.89 39.89 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . 0.437 HG23 ' HE2' ' A' ' 382' ' ' PHE . 67.5 mt -56.33 -40.98 69.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.872 0.368 . . . . 0.0 111.481 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.452 ' HG3' ' ND1' ' A' ' 402' ' ' HIS . 0.0 OUTLIER -67.55 -12.18 59.77 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -179.441 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -78.93 -18.39 53.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.87 0.367 . . . . 0.0 110.946 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 38.5 tp -79.5 -31.97 42.36 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.268 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.519 ' HA2' ' HG2' ' A' ' 443' ' ' ARG . . . -176.82 165.77 36.12 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.261 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -90.33 132.87 35.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.572 0.225 . . . . 0.0 110.804 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.16 12.85 47.73 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.193 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 61.3 mt -92.25 146.31 32.38 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.638 0.256 . . . . 0.0 111.372 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.65 115.65 2.55 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.036 2.49 . . . . 0.0 111.232 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 1.1 m -84.49 1.88 43.56 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.505 -179.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -97.24 -59.78 1.72 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.305 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -174.48 173.03 3.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.872 0.368 . . . . 0.0 110.933 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 43.9 mm -122.41 136.23 59.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.599 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -94.54 -43.31 8.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.202 0.525 . . . . 0.0 110.154 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -156.8 163.24 39.45 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.844 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -149.32 127.0 11.69 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 36.4 tp -121.88 128.86 52.07 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.028 0.442 . . . . 0.0 111.16 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -92.39 119.39 31.89 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 18.3 t-105 -85.21 91.65 8.2 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.341 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 13.9 mmt -47.28 -49.9 50.54 Favored Pre-proline 0 N--CA 1.47 0.533 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -45.93 -41.98 20.41 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.02 2.48 . . . . 0.0 115.476 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -115.34 -28.53 6.85 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 98.85 16.59 30.47 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.498 -0.858 . . . . 0.0 113.151 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -92.5 147.3 23.01 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 3.0 m -104.9 122.73 46.41 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.92 0.391 . . . . 0.0 110.867 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -99.35 111.79 24.09 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.946 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -95.69 137.37 34.84 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.876 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -112.69 127.58 56.16 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.976 0.417 . . . . 0.0 111.504 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.486 ' HB3' ' HE1' ' A' ' 436' ' ' TYR . 2.9 tpm_? -134.51 98.29 4.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.776 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 67.0 -107.37 1.98 Allowed Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.872 -0.603 . . . . 0.0 112.285 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' ASN . . . . . 0.597 ' HB3' ' HG2' ' A' ' 461' ' ' GLU . 4.9 p30 -112.59 15.65 19.99 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.96 0.409 . . . . 0.0 111.278 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . 0.516 ' HB3' ' HB2' ' A' ' 450' ' ' PRO . 68.0 mmtt -128.77 141.39 51.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.823 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' TYR . . . . . 0.538 ' CE2' ' HE2' ' A' ' 449' ' ' TYR . 14.3 p90 -120.86 142.69 49.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.031 0.443 . . . . 0.0 110.659 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' TYR . . . . . 0.486 ' HE1' ' HB3' ' A' ' 431' ' ' ARG . 4.3 m-85 -112.84 148.48 34.81 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.506 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 19.7 ttp180 -112.5 91.43 3.65 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . 0.412 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 81.3 t80 -85.14 134.99 34.16 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.143 0.497 . . . . 0.0 111.144 -178.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . 0.552 ' HB3' ' HB3' ' A' ' 442' ' ' LEU . 3.8 t30 -107.35 118.61 37.17 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.791 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' GLU . . . . . 0.469 ' OE2' ' HB2' ' A' ' 374' ' ' ARG . 0.4 OUTLIER -55.52 -57.05 13.52 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.37 -179.502 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -80.12 54.52 1.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.908 0.385 . . . . 0.0 110.951 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' LEU . . . . . 0.552 ' HB3' ' HB3' ' A' ' 439' ' ' ASN . 29.4 tp -168.35 -33.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.098 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' ARG . . . . . 0.519 ' HG2' ' HA2' ' A' ' 407' ' ' GLY . 20.8 ttt180 64.45 31.96 12.18 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.551 0.691 . . . . 0.0 111.055 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -152.36 163.83 38.69 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.454 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 86.8 t -89.37 143.0 12.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.025 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.63 156.83 18.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.462 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . 0.592 ' O ' ' HB2' ' A' ' 448' ' ' GLU . 1.5 m -69.01 151.13 46.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.343 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' GLU . . . . . 0.736 ' HB3' ' HE2' ' A' ' 451' ' ' LYS . 6.8 mt-10 85.03 -6.53 0.92 Allowed 'General case' 0 N--CA 1.471 0.575 0 O-C-N 124.269 0.981 . . . . 0.0 112.01 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . 0.538 ' HE2' ' CE2' ' A' ' 435' ' ' TYR . 92.3 m-85 -100.12 157.94 32.93 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.796 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . 0.516 ' HB2' ' HB3' ' A' ' 434' ' ' LYS . 61.2 Cg_endo -72.07 155.22 98.34 Favored 'Cis proline' 0 C--N 1.345 0.39 0 C-N-CA 123.585 -1.423 . . . . 0.0 112.797 0.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . 0.736 ' HE2' ' HB3' ' A' ' 448' ' ' GLU . 51.4 mttm -118.88 165.71 13.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.682 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . 0.557 ' ND2' ' HB2' ' A' ' 454' ' ' LYS . 38.9 t30 -61.06 128.07 34.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.446 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . 0.501 HG21 ' HG3' ' A' ' 461' ' ' GLU . 10.7 tt -65.03 -17.23 21.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.799 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . 0.557 ' HB2' ' ND2' ' A' ' 452' ' ' ASN . 67.1 mttm -67.73 -2.79 7.62 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 50.4 t -65.24 -33.38 63.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 456' ' ' TRP . . . . . 0.419 ' HE3' ' CZ ' ' A' ' 486' ' ' PHE . 26.4 m95 -83.23 90.85 7.16 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . 0.636 ' HB3' ' HG3' ' A' ' 492' ' ' LYS . 0.3 OUTLIER -51.68 108.82 0.3 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -178.61 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 108.32 -17.34 34.33 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.935 -0.65 . . . . 0.0 113.818 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.414 ' HB ' ' HB2' ' A' ' 456' ' ' TRP . 29.8 mm -79.32 122.93 84.64 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.98 0.419 . . . . 0.0 111.694 -179.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.33 155.22 36.83 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.865 2.377 . . . . 0.0 111.778 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 461' ' ' GLU . . . . . 0.597 ' HG2' ' HB3' ' A' ' 433' ' ' ASN . 0.9 OUTLIER -74.77 144.97 43.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.679 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 2.9 m 57.03 75.28 0.58 Allowed Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.913 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.27 -176.8 3.39 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 123.011 2.474 . . . . 0.0 111.868 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . 0.489 ' HA ' ' HE ' ' A' ' 464' ' ' ARG . 0.2 OUTLIER -135.87 27.44 3.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.248 0.547 . . . . 0.0 110.327 179.602 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 153.22 144.62 3.95 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.432 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 4.1 p -156.25 123.41 5.34 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -144.43 149.61 36.32 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.721 0.296 . . . . 0.0 111.128 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 468' ' ' MET . . . . . 0.412 ' HA ' ' HA ' ' A' ' 475' ' ' THR . 49.5 ttm -103.68 141.66 35.68 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -69.0 168.76 43.96 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.677 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 4.9 m -72.23 -10.89 60.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.084 0.469 . . . . 0.0 110.919 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . 0.465 ' OD2' ' HB ' ' A' ' 473' ' ' VAL . 11.9 p-10 -83.36 -17.15 43.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.007 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 68.22 7.92 6.22 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 473' ' ' VAL . . . . . 0.465 ' HB ' ' OD2' ' A' ' 471' ' ' ASP . 48.8 t -105.8 -35.39 3.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.766 0.317 . . . . 0.0 111.443 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -110.55 131.02 55.41 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 475' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 468' ' ' MET . 94.1 m -114.7 141.87 47.25 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.593 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 476' ' ' TYR . . . . . 0.418 ' HE1' ' HD2' ' A' ' 485' ' ' LYS . 73.0 m-85 -118.97 134.49 55.15 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 477' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 483' ' ' TYR . 20.0 m-85 -117.84 134.8 54.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.232 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -109.45 133.7 52.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.562 0.22 . . . . 0.0 111.154 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 479' ' ' LYS . . . . . 0.437 ' HB3' ' CZ3' ' A' ' 484' ' ' TRP . 54.4 tttp -170.07 133.88 1.2 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.594 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 64.27 35.21 91.69 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 121.311 -0.471 . . . . 0.0 113.603 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . 0.4 HD21 ' CD1' ' A' ' 502' ' ' LEU . 58.1 t30 67.21 10.92 8.08 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.589 0.709 . . . . 0.0 111.442 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -125.97 161.54 27.28 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.525 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 483' ' ' TYR . . . . . 0.413 ' CE2' ' HE2' ' A' ' 497' ' ' TYR . 15.4 p90 -129.83 151.65 50.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.845 0.355 . . . . 0.0 111.571 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 484' ' ' TRP . . . . . 0.437 ' CZ3' ' HB3' ' A' ' 479' ' ' LYS . 12.4 m-90 -112.51 145.84 39.54 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.149 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . 0.418 ' HD2' ' HE1' ' A' ' 476' ' ' TYR . 18.2 tttt -107.25 98.2 7.87 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 486' ' ' PHE . . . . . 0.458 ' HA ' ' HA ' ' A' ' 493' ' ' VAL . 51.8 t80 -90.35 125.16 35.44 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.264 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -90.21 115.08 27.16 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -63.7 -33.21 75.13 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -71.17 -40.88 71.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.928 0.394 . . . . 0.0 111.725 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -91.02 -14.28 31.68 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.4 tp 59.68 37.32 22.35 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.434 0.635 . . . . 0.0 110.618 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 492' ' ' LYS . . . . . 0.636 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 59.1 tttp -154.37 151.78 29.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.888 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 486' ' ' PHE . 58.5 t -74.52 132.77 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -67.53 143.56 97.13 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.549 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -61.18 149.92 86.98 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.257 2.638 . . . . 0.0 112.919 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 97.76 17.34 30.86 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . 0.546 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 19.2 m-85 -126.59 167.56 16.96 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . 0.546 ' HA ' ' HB3' ' A' ' 497' ' ' TYR . 94.3 Cg_endo -76.91 169.75 73.57 Favored 'Cis proline' 0 C--N 1.344 0.331 0 C-N-CA 124.001 -1.25 . . . . 0.0 112.962 0.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -124.97 150.35 46.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.537 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 37.4 t -64.4 119.76 10.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.257 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -64.83 -32.75 74.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.892 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 502' ' ' LEU . . . . . 0.571 HD23 ' HG3' ' A' ' 506' ' ' MET . 20.5 mt -62.81 -47.45 83.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.146 0.498 . . . . 0.0 111.16 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -75.48 -31.9 60.38 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.51 -33.47 17.76 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -177.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 505' ' ' TRP . . . . . . . . . . . . . 15.9 m0 -127.64 -27.75 2.82 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -177.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 506' ' ' MET . . . . . 0.571 ' HG3' HD23 ' A' ' 502' ' ' LEU . 14.6 mmt -85.64 -6.46 59.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -177.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 71.2 42.87 57.11 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.937 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 508' ' ' CYS . . . . . 0.562 ' HB2' ' HB3' ' A' ' 502' ' ' LEU . 59.9 m -120.55 93.57 48.46 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-O 120.707 0.289 . . . . 0.0 110.939 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -73.23 134.26 20.76 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.009 2.472 . . . . 0.0 111.814 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 5.1 m 55.53 68.9 0.79 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.341 0.591 . . . . 0.0 111.725 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.536 -1.146 . . . . 0.0 112.401 -179.626 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.598 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' PRO . . . . . 0.476 ' HA ' HD23 ' B' ' 2' ' ' HYP . 66.3 Cg_endo -74.97 149.88 37.48 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.468 2.112 . . . . 0.0 111.304 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' HYP . . . . . 0.538 ' HA ' ' HG2' ' C' ' 101' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.94 167.52 34.49 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.275 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -78.36 172.42 15.36 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.939 2.426 . . . . 0.0 111.635 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -74.2 -169.4 20.59 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.722 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.669 ' HG2' ' HA ' ' D' ' 205' ' ' HYP . 28.9 Cg_endo -63.23 172.41 5.23 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.133 2.556 . . . . 0.0 112.755 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.69 158.95 21.7 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.598 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -64.76 140.91 69.7 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.987 2.458 . . . . 0.0 112.022 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . 0.596 ' HG3' ' HG2' ' C' ' 110' ' ' PRO . 61.1 tt0 -69.64 149.48 48.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.414 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.9 153.42 47.6 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.231 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 8.9 mt -67.64 149.3 11.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.66 152.89 37.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.882 0.372 . . . . 0.0 111.282 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' D' ' 213' ' ' ILE . . . -74.76 166.03 54.81 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.343 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -80.54 148.74 30.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.733 0.301 . . . . 0.0 110.353 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -76.4 141.56 41.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.356 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.28 150.85 46.43 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.787 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.9 t -69.68 155.46 7.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.402 HG23 ' H ' ' B' ' 20' ' ' VAL . 3.1 t -52.89 146.6 2.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.454 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.81 168.64 54.81 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.747 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 96.5 mt -77.8 148.85 34.57 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.39 161.91 44.74 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.238 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -71.02 154.47 62.71 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.652 2.235 . . . . 0.0 111.576 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.24 154.09 53.07 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.517 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -74.17 157.56 46.11 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.828 2.352 . . . . 0.0 111.802 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.15 176.4 53.82 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.377 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.436 ' HA ' HD23 ' B' ' 32' ' ' HYP . 8.1 Cg_exo -74.44 155.37 45.7 Favored 'Trans proline' 0 CA--C 1.53 0.308 0 C-N-CA 123.356 2.704 . . . . 0.0 111.734 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' HYP . . . . . 0.436 HD23 ' HA ' ' B' ' 31' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . 0.429 ' HA2' ' HD3' ' B' ' 34' ' ' PRO . . . -69.93 154.28 52.67 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.665 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . 0.429 ' HD3' ' HA2' ' B' ' 33' ' ' GLY . 3.2 Cg_exo -77.67 125.81 7.76 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.909 2.406 . . . . 0.0 111.794 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 112.733 -0.147 . . . . 0.0 112.733 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 101' ' ' PRO . . . . . 0.538 ' HG2' ' HA ' ' B' ' 2' ' ' HYP . 72.6 Cg_endo -78.72 147.19 21.69 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 122.909 2.406 . . . . 0.0 112.769 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 102' ' ' HYP . . . . . 0.565 ' HA ' ' HD2' ' D' ' 201' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.65 173.18 49.99 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.824 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 104' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -80.14 158.25 23.44 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 122.803 2.335 . . . . 0.0 112.296 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 105' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.16 169.37 43.37 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.787 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -79.72 177.97 7.83 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.115 2.543 . . . . 0.0 110.437 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 108' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -64.41 179.03 7.76 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.171 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 110' ' ' PRO . . . . . 0.596 ' HG2' ' HG3' ' B' ' 11' ' ' GLN . 32.3 Cg_endo -64.03 150.06 89.16 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.872 2.381 . . . . 0.0 112.021 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -61.61 140.91 58.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.261 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 112' ' ' GLY . . . . . . . . . . . . . . . -66.81 152.27 52.57 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.016 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 23.3 mt -65.57 137.11 25.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.7 149.98 38.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.889 0.376 . . . . 0.0 111.123 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -65.44 162.34 40.94 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.972 -0.632 . . . . 0.0 111.909 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -85.21 153.58 22.54 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.906 -0.317 . . . . 0.0 110.604 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 35.7 ttm-85 -61.74 144.77 54.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.329 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.08 169.56 27.2 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.545 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.33 142.12 14.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.821 0.343 . . . . 0.0 110.324 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 120' ' ' VAL . . . . . 0.496 HG13 ' HB ' ' D' ' 219' ' ' VAL . 24.8 t -62.48 143.48 15.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.427 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.02 161.05 54.23 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.406 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 122' ' ' LEU . . . . . 0.429 ' HA ' HD23 ' C' ' 123' ' ' HYP . 67.8 mt -75.97 150.13 37.51 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 123' ' ' HYP . . . . . 0.429 HD23 ' HA ' ' C' ' 122' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -67.1 166.6 40.69 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.956 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 125' ' ' PRO . . . . . 0.412 ' HA ' HD23 ' C' ' 126' ' ' HYP . 36.4 Cg_endo -66.1 149.71 85.6 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.565 2.177 . . . . 0.0 111.409 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 126' ' ' HYP . . . . . 0.412 HD23 ' HA ' ' C' ' 125' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -64.76 158.41 44.2 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.903 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.3 158.62 29.69 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.672 2.248 . . . . 0.0 111.332 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -67.39 179.13 16.22 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.123 -0.561 . . . . 0.0 113.557 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 131' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -71.36 160.09 49.75 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 123.141 2.561 . . . . 0.0 111.687 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 132' ' ' HYP . . . . . 0.427 ' HA ' ' O ' ' D' ' 231' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . 0.44 ' HA2' ' HD3' ' C' ' 134' ' ' PRO . . . -74.73 134.11 16.84 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.294 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 134' ' ' PRO . . . . . 0.458 ' HA ' HD23 ' C' ' 135' ' ' HYP . 14.7 Cg_exo -69.99 111.69 2.92 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 123.287 2.658 . . . . 0.0 112.14 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 135' ' ' HYP . . . . . 0.458 HD23 ' HA ' ' C' ' 134' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 N-CA-C 112.553 -0.219 . . . . 0.0 112.553 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 201' ' ' PRO . . . . . 0.565 ' HD2' ' HA ' ' C' ' 102' ' ' HYP . 52.4 Cg_exo -57.95 146.72 85.66 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.15 2.567 . . . . 0.0 112.074 179.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 202' ' ' HYP . . . . . 0.514 HD23 ' HA ' ' D' ' 201' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 86.07 169.46 45.96 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.725 -0.75 . . . . 0.0 113.978 178.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 204' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -75.12 159.64 40.7 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 123.53 2.82 . . . . 0.0 111.952 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 205' ' ' HYP . . . . . 0.669 ' HA ' ' HG2' ' B' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . 98.34 -175.81 29.72 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.61 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -85.35 156.45 10.89 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.078 2.519 . . . . 0.0 112.137 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 208' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -73.4 164.82 54.88 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.988 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.42 141.14 73.06 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.589 2.193 . . . . 0.0 111.797 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -63.88 145.05 56.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.004 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -66.76 159.84 48.39 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.758 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 213' ' ' ILE . . . . . 0.418 ' HB ' ' OE1' ' A' ' 392' ' ' GLU . 47.4 pt -74.35 164.75 3.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.774 0.321 . . . . 0.0 111.02 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 214' ' ' ALA . . . . . 0.477 ' HB3' ' NH1' ' A' ' 330' ' ' ARG . . . -82.25 137.46 34.86 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.918 0.39 . . . . 0.0 110.725 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -65.3 164.87 36.47 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.853 -0.612 . . . . 0.0 113.039 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -68.81 156.46 38.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.675 0.274 . . . . 0.0 110.323 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -70.75 162.03 29.82 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -60.41 154.02 34.94 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.526 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 219' ' ' VAL . . . . . 0.496 ' HB ' HG13 ' C' ' 120' ' ' VAL . 21.0 t -70.78 149.4 10.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 42.9 t -64.41 140.45 19.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.56 167.69 13.85 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.299 -0.477 . . . . 0.0 113.318 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 4.2 mp -78.84 155.43 29.16 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 223' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 224' ' ' GLY . . . . . . . . . . . . . . . -62.32 150.97 46.41 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.139 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 225' ' ' PRO . . . . . 0.423 ' HA ' HD23 ' D' ' 226' ' ' HYP . 31.8 Cg_exo -60.38 139.89 88.93 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.877 2.385 . . . . 0.0 111.577 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 226' ' ' HYP . . . . . 0.423 HD23 ' HA ' ' D' ' 225' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -64.49 155.53 47.05 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.946 -0.57 . . . . 0.0 113.323 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -80.51 170.21 16.14 Favored 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 123.054 2.502 . . . . 0.0 111.475 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -76.88 -179.4 48.18 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.94 -0.647 . . . . 0.0 113.286 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 231' ' ' PRO . . . . . 0.453 ' HA ' HD23 ' D' ' 232' ' ' HYP . 60.2 Cg_endo -73.87 156.26 48.21 Favored 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 123.182 2.588 . . . . 0.0 111.928 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 232' ' ' HYP . . . . . 0.453 HD23 ' HA ' ' D' ' 231' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.425 ' HB2' ' HH2' ' A' ' 342' ' ' TRP . 6.0 Cg_exo . . . . . 0 N--CA 1.478 0.588 0 N-CA-C 109.714 -0.918 . . . . 0.0 109.714 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -102.69 148.61 25.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.663 0.268 . . . . 0.0 110.775 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 8.1 tp -73.57 -26.71 22.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.383 0.611 . . . . 0.0 110.681 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' CYS . . . . . . . . . . . . . 37.3 m -88.74 26.33 1.54 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.81 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -76.77 -41.83 43.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.306 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 83.37 170.68 46.6 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.205 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . . . . . . . . . 50.3 t30 50.65 68.97 0.69 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.198 0.523 . . . . 0.0 111.125 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -87.17 175.49 8.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.47 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 464' ' ' ARG . 4.7 m-20 -74.62 -46.96 34.95 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 14.5 t -171.34 153.95 3.75 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.518 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 57.0 t -131.39 124.42 54.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . 0.446 ' HA ' ' CD1' ' A' ' 467' ' ' PHE . . . -141.59 169.04 18.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.009 0.433 . . . . 0.0 111.832 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 39.3 ttp -120.84 121.0 37.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.358 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 58.9 mt -112.18 115.7 29.26 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.666 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' ARG . . . . . 0.464 ' HG3' ' HE1' ' A' ' 379' ' ' PHE . 44.9 mtp180 57.16 22.31 7.4 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . 109.85 -14.77 31.73 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.85 -0.69 . . . . 0.0 113.656 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -99.84 129.46 45.94 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.938 0.369 . . . . 0.0 111.324 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' MET . . . . . . . . . . . . . 47.1 ttm -89.1 126.18 35.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.923 0.392 . . . . 0.0 111.082 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -119.68 132.86 55.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.114 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 23.9 t -107.02 117.33 52.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.502 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -100.68 126.62 47.21 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 0.794 ' HB3' ' HZ3' ' A' ' 342' ' ' TRP . 27.5 tptt -139.71 102.78 4.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.157 178.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 63.92 -102.25 0.1 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.66 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.5 ptm85 -117.49 8.09 12.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.917 0.389 . . . . 0.0 111.962 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 3.0 m-90 -127.01 146.03 50.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.048 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -128.66 146.1 50.97 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.966 0.412 . . . . 0.0 110.985 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' TRP . . . . . 0.794 ' HZ3' ' HB3' ' A' ' 337' ' ' LYS . 20.4 m-90 -108.66 150.87 26.93 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.425 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.637 ' HD3' ' SD ' ' A' ' 350' ' ' MET . 24.1 ttt-85 -113.8 100.89 8.79 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 3.1 m -93.49 129.43 43.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.137 0.494 . . . . 0.0 111.386 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.15 109.87 6.68 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.536 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 63.66 47.01 3.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.774 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 7.2 m120 64.68 27.96 13.13 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.185 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -142.06 150.17 40.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.952 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 47.4 t -91.76 129.19 42.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' MET . . . . . 0.637 ' SD ' ' HD3' ' A' ' 343' ' ' ARG . 89.5 mtp -77.23 165.44 24.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.026 0.441 . . . . 0.0 111.78 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -77.72 154.51 32.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.696 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . 94.76 -5.8 69.75 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 111.701 -0.56 . . . . 0.0 111.701 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' TYR . . . . . 0.494 ' CE1' ' HD2' ' A' ' 343' ' ' ARG . 83.1 m-85 -118.85 159.0 46.25 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 110.448 -0.205 . . . . 0.0 110.448 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.478 ' C ' ' HA ' ' A' ' 353' ' ' TYR . 37.9 Cg_endo -65.67 137.88 34.4 Favored 'Cis proline' 0 C--N 1.348 0.542 0 C-N-CA 123.966 -1.264 . . . . 0.0 112.564 0.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' MET . . . . . 0.42 ' HA ' ' HD3' ' A' ' 356' ' ' PRO . 10.6 ttt -112.72 141.34 25.21 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.429 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 355' ' ' MET . 50.7 Cg_exo -58.19 127.3 24.39 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.574 2.183 . . . . 0.0 111.204 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 66.8 mt -56.11 -42.42 72.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.942 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . -70.3 -16.38 73.31 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.794 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -82.51 -28.28 31.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.046 0.451 . . . . 0.0 110.791 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -98.66 -53.0 3.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.239 0.543 . . . . 0.0 109.725 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -93.32 71.15 4.43 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -56.93 99.44 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.672 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . 128.27 -17.09 5.95 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.969 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.475 ' HA ' ' HD3' ' A' ' 365' ' ' PRO . 30.9 tp -91.84 125.52 56.91 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-O 120.561 0.22 . . . . 0.0 110.764 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 364' ' ' LEU . 3.0 Cg_exo -77.38 170.19 19.85 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 123.06 2.507 . . . . 0.0 111.774 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -77.26 159.41 29.64 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.654 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 16.6 m 57.92 82.95 0.12 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.41 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 27.9 pt -100.38 173.23 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.911 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . 0.418 HD22 ' HA ' ' A' ' 369' ' ' ASN . 1.5 m120 -95.79 -55.84 2.87 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' THR . . . . . 0.7 HG21 ' HA ' ' A' ' 417' ' ' ALA . 0.2 OUTLIER -155.49 164.13 39.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.575 -179.838 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -147.75 149.02 31.61 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . 0.61 ' HE1' ' HE2' ' A' ' 382' ' ' PHE . 19.3 p90 -164.64 166.35 20.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.867 0.365 . . . . 0.0 111.768 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -97.3 125.53 41.94 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . 0.498 ' HB2' ' OE2' ' A' ' 440' ' ' GLU . 10.6 ptm180 -84.44 -172.05 3.96 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.576 ' HB2' ' HG3' ' A' ' 440' ' ' GLU . 4.7 tttp -63.5 -40.72 97.81 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.01 -30.09 58.37 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 127.17 -14.7 6.54 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.731 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' LYS . . . . . . . . . . . . . 38.2 mttp -70.45 149.13 47.55 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.746 0.307 . . . . 0.0 110.798 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . 0.464 ' HE1' ' HG3' ' A' ' 330' ' ' ARG . 16.0 m-85 -95.65 126.71 41.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.058 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . 0.513 ' HB ' ' CE1' ' A' ' 372' ' ' TYR . 17.1 t -106.31 115.49 48.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.981 0.419 . . . . 0.0 110.558 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -102.72 128.95 49.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.531 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.61 ' HE2' ' HE1' ' A' ' 372' ' ' TYR . 59.1 m-85 -107.77 143.32 36.49 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.398 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.699 ' HB3' ' HZ3' ' A' ' 388' ' ' TRP . 60.5 tttp -152.01 92.93 1.77 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 414' ' ' LYS . . . 75.71 -113.09 3.8 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -108.11 -0.73 20.94 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.032 0.444 . . . . 0.0 110.772 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -109.3 147.3 32.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.977 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' HIS . . . . . . . . . . . . . 37.3 p-80 -132.64 147.87 52.35 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.357 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' TRP . . . . . 0.699 ' HZ3' ' HB3' ' A' ' 383' ' ' LYS . 20.9 m-90 -121.28 131.17 54.05 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.169 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 55.9 t -107.0 114.64 46.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -106.41 125.48 51.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.645 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -97.43 89.25 4.64 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 67.82 -85.98 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.308 -178.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -130.65 21.13 5.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.21 0.529 . . . . 0.0 110.886 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 10.2 m -133.83 135.29 43.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.02 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 57.3 tp -80.97 136.92 36.09 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.442 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . 0.648 ' HB3' ' CE1' ' A' ' 399' ' ' TYR . 0.0 OUTLIER -67.25 143.16 97.35 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.388 179.221 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.01 140.83 28.94 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 122.602 2.201 . . . . 0.0 112.581 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 91.24 26.26 21.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.542 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' TYR . . . . . 0.657 ' HB3' ' HA ' ' A' ' 400' ' ' PRO . 42.8 m-85 -118.88 163.54 25.59 Favored Pre-proline 0 C--N 1.324 -0.534 0 O-C-N 122.679 -0.307 . . . . 0.0 111.081 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.657 ' HA ' ' HB3' ' A' ' 399' ' ' TYR . 84.1 Cg_endo -77.44 162.87 89.8 Favored 'Cis proline' 0 C--N 1.345 0.38 0 C-N-CA 123.529 -1.446 . . . . 0.0 113.067 0.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -121.0 161.46 21.59 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 0.668 ' HB2' ' HG2' ' A' ' 405' ' ' GLU . 7.6 m-70 -74.84 153.54 38.66 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' ILE . . . . . . . . . . . . . 71.2 mt -57.75 -38.62 66.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.27 0.557 . . . . 0.0 109.845 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.417 ' HG3' ' HB3' ' A' ' 402' ' ' HIS . 0.0 OUTLIER -68.9 -10.74 58.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.469 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.668 ' HG2' ' HB2' ' A' ' 402' ' ' HIS . 78.4 mm-40 -84.45 -30.8 24.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.861 0.363 . . . . 0.0 110.435 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 47.6 tp -63.81 -51.88 62.74 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.859 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.816 ' HA3' ' HE1' ' A' ' 438' ' ' PHE . . . -152.69 162.45 29.99 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.296 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -86.85 129.05 35.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.592 0.234 . . . . 0.0 110.404 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 103.57 6.79 43.55 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.32 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' LEU . . . . . . . . . . . . . 65.6 mt -86.95 156.05 55.24 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 122.961 -0.141 . . . . 0.0 110.624 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -65.13 144.47 81.78 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.626 2.217 . . . . 0.0 112.371 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.24 25.17 9.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.031 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.479 ' OD2' ' HD3' ' A' ' 431' ' ' ARG . 1.7 p-10 -119.42 -76.03 0.58 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.606 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 384' ' ' GLY . 7.8 ptmt -160.61 -176.75 5.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.82 0.343 . . . . 0.0 110.445 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 34.4 mm -125.59 135.61 63.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -94.48 -52.19 4.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.325 0.583 . . . . 0.0 110.062 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.7 ' HA ' HG21 ' A' ' 370' ' ' THR . . . -147.13 145.63 29.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.946 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' ALA . . . . . . . . . . . . . . . -129.01 117.18 20.5 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 57.8 tp -114.09 147.96 37.89 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.051 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -120.65 119.42 32.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.617 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' TRP . . . . . 0.466 ' HB2' ' HE2' ' A' ' 428' ' ' TYR . 7.0 t-105 -86.85 94.8 9.66 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.446 ' HB2' ' HD3' ' A' ' 423' ' ' PRO . 64.1 mtt -51.42 -51.71 66.56 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' A' ' 422' ' ' MET . 92.5 Cg_exo -47.18 -33.82 16.54 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 123.029 2.486 . . . . 0.0 115.278 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' ASN . . . . . 0.408 ' OD1' ' HB3' ' A' ' 421' ' ' TRP . 33.0 p30 -115.06 -24.54 8.52 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 87.47 23.02 41.39 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.403 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -108.21 149.9 27.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 117.131 0.465 . . . . 0.0 111.169 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.45 146.16 25.49 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.436 -178.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' TYR . . . . . 0.466 ' HE2' ' HB2' ' A' ' 421' ' ' TRP . 81.8 m-85 -124.9 110.16 13.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.498 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -98.98 123.14 43.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.797 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' PHE . . . . . 0.442 ' HB2' ' HB3' ' A' ' 417' ' ' ALA . 89.8 m-85 -98.79 130.28 45.23 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.608 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' ARG . . . . . 0.479 ' HD3' ' OD2' ' A' ' 413' ' ' ASP . 2.0 tpm_? -140.05 106.81 5.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.163 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' GLY . . . . . . . . . . . . . . . 66.72 -102.62 0.78 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.742 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -123.67 14.44 9.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.068 0.461 . . . . 0.0 110.154 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 52.0 mmtt -122.46 156.29 34.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.067 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' TYR . . . . . 0.537 ' CE2' ' HE1' ' A' ' 449' ' ' TYR . 7.8 p90 -135.3 139.36 44.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.928 0.394 . . . . 0.0 110.573 178.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -108.07 143.72 36.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.699 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -106.79 103.4 12.83 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . 0.816 ' HE1' ' HA3' ' A' ' 407' ' ' GLY . 66.6 t80 -92.42 135.23 34.22 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.482 -178.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -107.86 107.74 18.61 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' GLU . . . . . 0.576 ' HG3' ' HB2' ' A' ' 375' ' ' LYS . 4.9 mm-40 -49.39 -51.3 35.93 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -54.76 -48.71 72.28 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' LEU . . . . . . . . . . . . . 52.5 mt -86.45 -18.05 32.69 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 61.36 39.45 15.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.631 0.729 . . . . 0.0 110.57 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . . . . . . . . . . . -148.79 155.07 40.45 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.497 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 97.8 t -80.31 140.13 17.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.845 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -62.49 156.95 21.48 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 1.4 m -66.71 152.43 45.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.82 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 72.34 29.4 2.19 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.272 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . 0.537 ' HE1' ' CE2' ' A' ' 435' ' ' TYR . 27.5 m-85 -126.39 160.9 55.5 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.192 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.81 160.77 95.51 Favored 'Cis proline' 0 C--N 1.347 0.479 0 C-N-CA 123.728 -1.363 . . . . 0.0 112.337 -0.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . 0.506 ' HB2' ' CE1' ' A' ' 435' ' ' TYR . 60.4 mttm -109.71 176.76 4.95 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.106 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -76.8 139.82 40.49 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.518 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . 0.438 HD13 ' HA ' ' A' ' 461' ' ' GLU . 15.4 tt -66.83 -11.99 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.109 0.48 . . . . 0.0 110.709 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . 0.446 ' HD3' ' HA ' ' A' ' 454' ' ' LYS . 48.5 mmtt -68.69 -7.0 29.48 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.151 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 455' ' ' VAL . . . . . . . . . . . . . 76.7 t -66.21 -30.95 51.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 456' ' ' TRP . . . . . 0.477 ' HE3' ' CZ ' ' A' ' 486' ' ' PHE . 6.7 m95 -97.72 85.59 3.6 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.545 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . 0.467 ' HB3' ' HG3' ' A' ' 492' ' ' LYS . 1.6 tm-20 -54.43 114.78 1.79 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.62 -178.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 108.0 -21.16 29.98 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.065 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 19.1 mm -71.04 127.15 91.94 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 120.868 0.366 . . . . 0.0 111.077 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.25 139.51 32.32 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.925 2.417 . . . . 0.0 112.603 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 461' ' ' GLU . . . . . 0.438 ' HA ' HD13 ' A' ' 453' ' ' ILE . 27.6 mp0 -68.34 138.78 55.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.002 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 1.3 m 59.33 70.31 1.14 Allowed Pre-proline 0 C--O 1.234 0.288 0 O-C-N 123.58 0.55 . . . . 0.0 112.177 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -85.95 -179.53 3.31 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.013 2.476 . . . . 0.0 111.164 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 324' ' ' ASP . 0.0 OUTLIER -142.39 29.21 1.61 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.439 0.638 . . . . 0.0 110.738 179.768 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 174.05 135.15 1.97 Allowed Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 5.3 p -158.49 114.38 2.69 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.706 0.289 . . . . 0.0 110.236 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 467' ' ' PHE . . . . . 0.446 ' CD1' ' HA ' ' A' ' 327' ' ' ALA . 30.3 p90 -145.14 140.7 28.17 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.696 0.284 . . . . 0.0 111.215 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 468' ' ' MET . . . . . 0.434 ' HA ' ' HA ' ' A' ' 475' ' ' THR . 46.5 ttm -89.93 141.14 28.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.244 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -70.38 166.16 51.1 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.769 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 470' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.36 -14.62 57.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.895 0.378 . . . . 0.0 111.906 -179.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -81.43 -18.39 45.53 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.391 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 472' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 68.09 11.96 8.58 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.015 0.526 . . . . 0.0 112.254 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 49.1 t -110.46 -36.12 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.891 0.377 . . . . 0.0 111.057 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 474' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -111.53 133.68 53.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.275 0.559 . . . . 0.0 111.996 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 475' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 468' ' ' MET . 88.3 m -116.54 133.03 56.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.381 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 476' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -101.42 135.93 42.11 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.967 0.413 . . . . 0.0 111.807 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 477' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -122.2 138.49 54.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.422 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -121.74 134.36 54.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.803 0.335 . . . . 0.0 111.524 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 48.0 tttt -166.06 131.94 2.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.222 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 480' ' ' GLY . . . . . . . . . . . . . . . 56.12 44.74 88.54 Favored Glycine 0 C--N 1.33 0.227 0 CA-C-N 115.944 -0.571 . . . . 0.0 114.307 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 23.0 t30 65.47 8.49 5.07 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 482' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -118.28 158.35 25.35 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 483' ' ' TYR . . . . . 0.458 ' CE2' ' HE2' ' A' ' 497' ' ' TYR . 3.5 p90 -131.7 147.6 52.52 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.989 0.424 . . . . 0.0 111.934 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 484' ' ' TRP . . . . . 0.548 ' CE2' ' HB3' ' A' ' 498' ' ' PRO . 11.3 m-90 -116.36 157.21 25.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.133 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -120.45 99.38 6.53 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 486' ' ' PHE . . . . . 0.477 ' CZ ' ' HE3' ' A' ' 456' ' ' TRP . 77.4 t80 -86.28 127.41 34.77 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.941 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -93.18 112.81 24.86 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 488' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -63.68 -26.99 68.91 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 489' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -76.6 -30.85 57.13 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 490' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -99.2 -21.02 16.31 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.8 tp 66.17 33.4 7.4 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -177.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 492' ' ' LYS . . . . . 0.467 ' HG3' ' HB3' ' A' ' 457' ' ' GLU . 6.0 tttp -152.45 159.92 43.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.044 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . 0.429 ' N ' ' HG2' ' A' ' 492' ' ' LYS . 77.8 t -79.29 139.55 18.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.643 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -65.98 138.44 96.3 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.322 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.19 138.36 80.96 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 123.225 2.617 . . . . 0.0 112.59 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 111.21 -1.61 28.25 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . 0.526 ' HB3' ' HA ' ' A' ' 498' ' ' PRO . 37.5 m-85 -108.87 164.49 14.6 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.825 -0.187 . . . . 0.0 111.226 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . 0.548 ' HB3' ' CE2' ' A' ' 484' ' ' TRP . 83.2 Cg_endo -75.98 174.75 51.27 Favored 'Cis proline' 0 C--N 1.351 0.666 0 C-N-CA 124.058 -1.226 . . . . 0.0 113.045 0.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 499' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -134.41 166.61 22.44 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.991 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 500' ' ' SER . . . . . . . . . . . . . 44.3 t -71.54 118.07 13.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.597 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . 0.624 ' O ' ' HB2' ' A' ' 505' ' ' TRP . . . -70.7 -24.26 62.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.83 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 16.8 mt -70.96 -38.81 72.82 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.974 0.416 . . . . 0.0 110.652 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 503' ' ' ARG . . . . . . . . . . . . . 8.7 ttm180 -84.37 -55.31 4.23 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 504' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -73.14 -18.02 61.32 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 505' ' ' TRP . . . . . 0.624 ' HB2' ' O ' ' A' ' 501' ' ' ALA . 9.5 m0 -111.95 -69.79 0.85 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 9.6 mmt -59.33 -44.54 92.61 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.976 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . 109.85 14.03 14.77 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.51 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 508' ' ' CYS . . . . . . . . . . . . . 35.1 m -81.87 113.6 44.16 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -83.29 153.57 14.12 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.576 2.184 . . . . 0.0 111.903 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 510' ' ' SER . . . . . . . . . . . . . 16.4 m 64.34 92.33 0.07 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.722 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.155 0 CA-C-O 118.166 -1.352 . . . . 0.0 110.796 -179.917 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.758 0 N-CA-C 111.531 -0.627 . . . . 0.0 111.531 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' PRO . . . . . 0.464 ' HA ' HD23 ' B' ' 2' ' ' HYP . 72.2 Cg_endo -77.34 144.0 22.65 Favored 'Trans proline' 0 CA--C 1.529 0.246 0 C-N-CA 122.613 2.209 . . . . 0.0 111.477 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' HYP . . . . . 0.464 HD23 ' HA ' ' B' ' 1' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.07 168.71 44.24 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.466 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -73.44 163.5 37.51 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 123.0 2.467 . . . . 0.0 112.025 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.04 175.42 54.55 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.698 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.788 ' HG2' ' HA ' ' D' ' 205' ' ' HYP . 15.3 Cg_endo -59.27 167.28 6.24 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 122.803 2.335 . . . . 0.0 111.429 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . 133.57 174.51 13.58 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.642 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -62.59 139.18 74.39 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.859 2.373 . . . . 0.0 111.869 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . 0.882 ' HG3' ' HG2' ' C' ' 110' ' ' PRO . 34.0 tt0 -64.97 150.04 48.7 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.27 157.3 24.07 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.198 -0.525 . . . . 0.0 113.198 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.499 ' H ' HG13 ' B' ' 13' ' ' ILE . 2.7 mt -71.21 153.93 8.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.47 150.47 47.17 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.384 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' D' ' 213' ' ' ILE . . . -72.72 160.03 53.88 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.15 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -71.49 145.29 49.29 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -68.76 140.65 55.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.794 0.331 . . . . 0.0 110.608 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.22 154.98 36.4 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.834 -0.621 . . . . 0.0 113.16 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 8.0 t -65.72 147.94 12.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.665 0.269 . . . . 0.0 110.6 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 3.9 t -54.32 148.69 2.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.335 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.36 154.46 53.19 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.31 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 71.7 mt -76.56 152.21 36.06 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.482 0.182 . . . . 0.0 110.78 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.05 170.41 44.27 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.663 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.417 ' HA ' HD23 ' B' ' 26' ' ' HYP . 73.2 Cg_endo -77.02 151.4 30.69 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.638 2.225 . . . . 0.0 111.645 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' HYP . . . . . 0.417 HD23 ' HA ' ' B' ' 25' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.72 160.72 53.85 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.868 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.419 ' HG2' ' HB2' ' D' ' 226' ' ' HYP . 55.9 Cg_endo -72.72 149.88 49.35 Favored 'Trans proline' 0 C--O 1.237 0.453 0 C-N-CA 122.492 2.128 . . . . 0.0 111.432 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' HYP . . . . . 0.412 HD23 ' HA ' ' B' ' 28' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.5 170.19 48.77 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.935 -0.65 . . . . 0.0 113.174 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -73.79 163.4 37.25 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.969 2.446 . . . . 0.0 111.567 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' HYP . . . . . 0.474 ' HA ' ' HD2' ' C' ' 131' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.5 119.71 18.76 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.253 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . 0.491 ' O ' ' HB2' ' D' ' 232' ' ' HYP . 28.0 Cg_endo -64.19 114.6 2.72 Favored 'Trans proline' 0 CA--C 1.528 0.207 0 C-N-CA 122.917 2.412 . . . . 0.0 111.786 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' HYP . . . . . 0.44 HD23 ' HA ' ' B' ' 34' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.565 0 CA-C-O 119.985 -0.342 . . . . 0.0 112.865 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 101' ' ' PRO . . . . . 0.471 ' HA ' HD23 ' C' ' 102' ' ' HYP . 16.3 Cg_exo -70.15 151.66 66.92 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.498 2.798 . . . . 0.0 112.604 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 102' ' ' HYP . . . . . 0.504 ' HA ' ' HD2' ' D' ' 201' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.41 166.66 53.66 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.552 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 104' ' ' PRO . . . . . 0.402 ' HA ' HD23 ' C' ' 105' ' ' HYP . 90.7 Cg_endo -81.06 158.45 20.55 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 123.216 2.611 . . . . 0.0 113.066 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 105' ' ' HYP . . . . . 0.517 ' HA ' ' HD2' ' D' ' 204' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.65 178.69 47.72 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.083 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 107' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -85.49 138.05 6.17 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.648 2.232 . . . . 0.0 111.324 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 108' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -61.94 176.2 6.02 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.698 -0.683 . . . . 0.0 113.125 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 110' ' ' PRO . . . . . 0.882 ' HG2' ' HG3' ' B' ' 11' ' ' GLN . 37.4 Cg_endo -66.58 162.91 34.82 Favored 'Trans proline' 0 C--O 1.238 0.519 0 C-N-CA 122.577 2.185 . . . . 0.0 112.514 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 111' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -64.5 151.38 44.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.737 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 112' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' B' ' 13' ' ' ILE . . . -69.76 166.3 49.47 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.438 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . 0.468 ' H ' HG13 ' C' ' 113' ' ' ILE . 2.7 mt -67.11 144.34 14.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.01 140.73 58.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.408 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . -59.38 147.68 42.07 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.277 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 116' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -69.73 153.59 43.16 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 122.47 0.308 . . . . 0.0 110.336 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 53.9 ttm-85 -71.77 150.51 44.34 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.83 164.05 46.63 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.26 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 119' ' ' VAL . . . . . . . . . . . . . 8.8 t -68.97 144.32 14.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 120' ' ' VAL . . . . . 0.442 HG13 ' HB ' ' D' ' 219' ' ' VAL . 32.3 t -62.23 134.56 27.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.988 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.26 160.78 45.79 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.995 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 122' ' ' LEU . . . . . 0.43 ' HA ' HD23 ' C' ' 123' ' ' HYP . 75.2 mt -78.11 145.05 35.96 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 123' ' ' HYP . . . . . 0.43 HD23 ' HA ' ' C' ' 122' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . -63.29 161.12 34.74 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.695 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 125' ' ' PRO . . . . . 0.401 ' HA ' HD23 ' C' ' 126' ' ' HYP . 29.2 Cg_endo -62.72 151.13 85.47 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.68 2.253 . . . . 0.0 111.854 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 126' ' ' HYP . . . . . 0.401 HD23 ' HA ' ' C' ' 125' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . -74.08 158.69 52.2 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.954 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 128' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -75.54 160.8 38.02 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.506 2.137 . . . . 0.0 111.105 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 129' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 130' ' ' GLY . . . . . . . . . . . . . . . -73.55 -178.31 36.38 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.289 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 131' ' ' PRO . . . . . 0.474 ' HD2' ' HA ' ' B' ' 32' ' ' HYP . 3.1 Cg_exo -74.82 145.28 31.98 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.912 2.408 . . . . 0.0 111.275 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 132' ' ' HYP . . . . . 0.535 ' HA ' ' O ' ' D' ' 231' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -57.52 125.12 38.21 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.917 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 134' ' ' PRO . . . . . 0.506 ' HA ' HD23 ' C' ' 135' ' ' HYP . 74.1 Cg_endo -77.41 112.48 3.37 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.922 2.415 . . . . 0.0 112.06 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 135' ' ' HYP . . . . . 0.506 HD23 ' HA ' ' C' ' 134' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 200' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.504 0 CA-C-O 119.939 -0.367 . . . . 0.0 112.239 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' D' D ' 201' ' ' PRO . . . . . 0.504 ' HD2' ' HA ' ' C' ' 102' ' ' HYP . 74.5 Cg_exo -53.72 140.95 66.08 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.148 2.566 . . . . 0.0 111.354 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 202' ' ' HYP . . . . . 0.439 HD23 ' HA ' ' D' ' 201' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 203' ' ' GLY . . . . . . . . . . . . . . . 66.6 172.66 5.04 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 114.667 0.627 . . . . 0.0 114.667 178.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 204' ' ' PRO . . . . . 0.517 ' HD2' ' HA ' ' C' ' 105' ' ' HYP . 6.7 Cg_exo -76.82 166.17 27.4 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.673 2.915 . . . . 0.0 111.084 178.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 205' ' ' HYP . . . . . 0.788 ' HA ' ' HG2' ' B' ' 7' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 206' ' ' GLY . . . . . . . . . . . . . . . 99.55 168.92 30.07 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.879 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 207' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -87.95 158.2 7.31 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 123.891 3.061 . . . . 0.0 112.182 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 208' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' D' D ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.4 166.82 54.4 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.061 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 210' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.73 147.15 68.79 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.627 2.218 . . . . 0.0 112.088 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -65.24 151.41 46.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.629 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 212' ' ' GLY . . . . . . . . . . . . . . . -71.79 169.44 50.47 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.358 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 213' ' ' ILE . . . . . 0.414 ' O ' ' HA3' ' B' ' 15' ' ' GLY . 32.3 pt -71.54 162.41 4.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 120.91 0.386 . . . . 0.0 111.052 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 214' ' ' ALA . . . . . . . . . . . . . . . -79.76 142.21 35.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.084 0.469 . . . . 0.0 110.709 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . -62.65 160.94 32.41 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.369 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 216' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -81.08 155.94 26.05 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -66.1 151.44 46.9 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.806 0.336 . . . . 0.0 110.815 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -62.4 157.4 37.07 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.862 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 219' ' ' VAL . . . . . 0.442 ' HB ' HG13 ' C' ' 120' ' ' VAL . 16.3 t -65.25 138.83 22.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 33.1 t -60.74 142.3 16.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.941 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.12 157.95 26.65 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.238 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 222' ' ' LEU . . . . . . . . . . . . . 9.2 mp -72.43 157.83 36.9 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.782 -0.209 . . . . 0.0 110.585 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 223' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' D' D ' 224' ' ' GLY . . . . . 0.437 ' HA2' ' HD3' ' D' ' 225' ' ' PRO . . . -61.92 153.66 41.15 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.066 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 225' ' ' PRO . . . . . 0.437 ' HD3' ' HA2' ' D' ' 224' ' ' GLY . 17.7 Cg_exo -67.99 142.78 57.8 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.856 2.371 . . . . 0.0 111.352 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 226' ' ' HYP . . . . . 0.419 ' HB2' ' HG2' ' B' ' 28' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 227' ' ' GLY . . . . . . . . . . . . . . . -67.74 167.66 41.18 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.892 -0.595 . . . . 0.0 113.142 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -84.44 164.32 12.66 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.906 2.404 . . . . 0.0 111.606 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 229' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' D' D ' 230' ' ' GLY . . . . . . . . . . . . . . . -70.81 -179.21 28.22 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.08 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 231' ' ' PRO . . . . . 0.535 ' O ' ' HA ' ' C' ' 132' ' ' HYP . 35.1 Cg_exo -61.76 133.28 44.17 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.945 2.43 . . . . 0.0 111.777 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 232' ' ' HYP . . . . . 0.491 ' HB2' ' O ' ' B' ' 34' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_